PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Labalette, C; Nouet, Y; Levillayer, F; Colnot, S; Chen, J; Claude, V; Huerre, M; Perret, C; Buendia, MA; Wei, Y				Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Colnot, Sabine; Chen, Ju; Claude, Valere; Huerre, Michel; Perret, Christine; Buendia, Marie-Annick; Wei, Yu			Deficiency of the LIM-Only Protein FHL2 Reduces Intestinal Tumorigenesis in Apc Mutant Mice	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR FHL2; FAMILIAL ADENOMATOUS POLYPOSIS; BETA-CATENIN; CYCLIN D1; ANDROGEN RECEPTOR; CELL-DIFFERENTIATION; PROSTATE-CANCER; BREAST-CANCER; EXPRESSION; INTERACTS	Background: The four and a half LIM-only protein 2 (FHL2) is capable of shuttling between focal adhesion and nucleus where it signals through direct interaction with a number of proteins including beta-catenin. Although FHL2 activation has been found in various human cancers, evidence of its functional contribution to carcinogenesis has been lacking. Methodology/Principal Findings: Here we have investigated the role of FHL2 in intestinal tumorigenesis in which activation of the Wnt pathway by mutations in the adenomatous polyposis coli gene (Apc) or in beta-catenin constitutes the primary transforming event. In this murine model, introduction of a biallelic deletion of FHL2 into mutant Apc(Delta 14/+) mice substantially reduces the number of intestinal adenomas but not tumor growth, suggesting a role of FHL2 in the initial steps of tumorigenesis. In the lesions, Wnt signalling is not affected by FHL2 deficiency, remaining constitutively active. Nevertheless, loss of FHL2 activity is associated with increased epithelial cell migration in intestinal epithelium, which might allow to eliminate more efficiently deleterious cells and reduce the risk of tumorigenesis. This finding may provide a mechanistic basis for tumor suppression by FHL2 deficiency. In human colorectal carcinoma but not in low-grade dysplasia, we detected up-regulation and enhanced nuclear localization of FHL2, indicating the activation of FHL2 during the development of malignancy. Conclusions/Significance: Our data demonstrate that FHL2 represents a critical factor in intestinal tumorigenesis.	[Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Buendia, Marie-Annick; Wei, Yu] Inst Pasteur, Dept Virol, Paris, France; [Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Buendia, Marie-Annick; Wei, Yu] INSERM, U579, Paris, France; [Colnot, Sabine; Perret, Christine] Inst Cochin, Dept Endocrinol Metab & Canc, Paris, France; [Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Colnot, Sabine; Perret, Christine] INSERM, U567, Paris, France; [Claude, Valere] Hop Begin, Dept Anapathol, St Mande, France; [Huerre, Michel] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Labalette, C (corresponding author), Inst Pasteur, Dept Virol, Paris, France.	yu.wei@pasteur.fr	Chen, Ju/E-5579-2011; Perret-Mayeux, Christine/L-3297-2017; Colnot, Sabine/A-9169-2008; Wei, Yu/A-7289-2016	Colnot, Sabine/0000-0002-3949-9107; perret, christine/0000-0003-4710-7051	Association pour la Recherche sur le Cancer; Ligue contre le Cancer (Comite de Paris); French Institut National du Cancer; Ecole Normale Superieure de Lyon; Canceropele Ile-de-France	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer); French Institut National du Cancer(Institut National du Cancer (INCA) France); Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Canceropele Ile-de-France	This work was supported in part by grants from the Association pour la Recherche sur le Cancer, the Ligue contre le Cancer (Comite de Paris) and the French Institut National du Cancer. C. L. was supported by the Ecole Normale Superieure de Lyon and Y.N. by the Canceropele Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Campo-Fernandez B, 2007, J VIROL, V81, P1027, DOI 10.1128/JVI.01699-06; Chen DH, 2003, CANCER RES, V63, P6626; Chu PH, 2008, INVEST OPHTH VIS SCI, V49, P5314, DOI 10.1167/iovs.08-2209; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Du XJ, 2002, BBA-GENE STRUCT EXPR, V1577, P93, DOI 10.1016/S0167-4781(02)00414-1; Fenton JI, 2002, CARCINOGENESIS, V23, P1065, DOI 10.1093/carcin/23.6.1065; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Gabriel B, 2006, J SOC GYNECOL INVEST, V13, P69, DOI 10.1016/j.jsgi.2005.10.001; Gabriel B, 2004, ANTICANCER RES, V24, P921; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Heemers HV, 2007, CANCER RES, V67, P10592, DOI 10.1158/0008-5472.CAN-07-1917; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kirfel J, 2008, EXP CELL RES, V314, P3684, DOI 10.1016/j.yexcr.2008.09.023; Kong YF, 2001, CIRCULATION, V103, P2731; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Labalette C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003761; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Mahmoud NN, 1999, CANCER RES, V59, P353; Mahmoud NN, 1997, CANCER RES, V57, P5045; Mahmoud NN, 1998, SURGERY, V124, P225, DOI 10.1016/S0039-6060(98)70124-2; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Park J, 2008, FASEB J, V22, P2508, DOI 10.1096/fj.07-095521; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2007, GUT, V56, P1410, DOI 10.1136/gut.2006.116921; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wilding J, 2002, CANCER RES, V62, P4562; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Yan JH, 2003, FEBS LETT, V553, P183, DOI 10.1016/S0014-5793(03)00978-5; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10371	10.1371/journal.pone.0010371	http://dx.doi.org/10.1371/journal.pone.0010371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442768	gold, Green Submitted, Green Published			2022-12-27	WOS:000277154200013
J	Gopal, S; Berg, D; Hagen, N; Schriefer, EM; Stoll, R; Goebel, W; Kreft, J				Gopal, Shubha; Berg, Daniela; Hagen, Nicole; Schriefer, Eva-Maria; Stoll, Regina; Goebel, Werner; Kreft, Juergen			Maltose and Maltodextrin Utilization by Listeria monocytogenes Depend on an Inducible ABC Transporter which Is Repressed by Glucose	PLOS ONE			English	Article							BACILLUS-SUBTILIS; PHOSPHOTRANSFERASE SYSTEM; LACTOBACILLUS-PLANTARUM; GASTROINTESTINAL-TRACT; CATABOLITE REPRESSION; COMPARATIVE GENOMICS; LACTOCOCCUS-LACTIS; VIRULENCE GENES; MINIMAL MEDIUM; FOOD SAFETY	Background: In the environment as well as in the vertebrate intestine, Listeriae have access to complex carbohydrates like maltodextrins. Bacterial exploitation of such compounds requires specific uptake and utilization systems. Methodology/Principal Findings: We could show that Listeria monocytogenes and other Listeria species contain genes/gene products with high homology to the maltodextrin ABC transporter and utilization system of B. subtilis. Mutant construction and growth tests revealed that the L. monocytogenes gene cluster was required for the efficient utilization of maltodextrins as well as maltose. The gene for the ATP binding protein of the transporter was located distant from the cluster. Transcription analyses demonstrated that the system was induced by maltose/maltodextrins and repressed by glucose. Its induction was dependent on a LacI type transcriptional regulator. Repression by glucose was independent of the catabolite control protein CcpA, but was relieved in a mutant defective for Hpr kinase/phosphorylase. Conclusions/Significance: The data obtained show that in L. monocytogenes the uptake of maltodextrin and, in contrast to B. subtilis, also maltose is exclusively mediated by an ABC transporter. Furthermore, the results suggest that glucose repression of the uptake system possibly is by inducer exclusion, a mechanism not described so far in this organism.	[Gopal, Shubha] Univ Mysore, Dept Studies Microbiol, Mysore, Karnataka, India; [Berg, Daniela; Hagen, Nicole; Schriefer, Eva-Maria; Stoll, Regina; Goebel, Werner; Kreft, Juergen] Univ Wurzburg, Lehrstuhl Mikrobiol, Biozentrum, Wurzburg, Germany; [Berg, Daniela] Tech Univ Munich, Inst Pathol, Munich, Germany; [Schriefer, Eva-Maria; Goebel, Werner] Univ Munich, Max Von Pettenkofer Inst, Lehrstuhl Bakteriol, Munich, Germany	University of Mysore; University of Wurzburg; Technical University of Munich; University of Munich	Gopal, S (corresponding author), Univ Mysore, Dept Studies Microbiol, Mysore, Karnataka, India.	sguom@yahoo.com			Deutsche Forschungsgemeinschaft DFG [SFB479/B1]; Deutscher Akademischer Austauschdienst DAAD	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (www.dfg.de) (SFB479/B1) and a research fellowship (to SG) from the Deutscher Akademischer Austauschdienst DAAD (www.daad.de). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson U, 2005, SYST APPL MICROBIOL, V28, P187, DOI 10.1016/j.syapm.2004.11.004; Andersson U, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-28; Behari J, 1998, J BACTERIOL, V180, P6316; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Creti R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-60; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; EGETER O, 1995, J BACTERIOL, V177, P2408, DOI 10.1128/jb.177.9.2408-2415.1995; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fichant G, 2006, FEMS MICROBIOL LETT, V256, P333, DOI 10.1111/j.1574-6968.2006.00139.x; Francke C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-145; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Glaser P, 2001, SCIENCE, V294, P849; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Ivanek R, 2006, FOODBORNE PATHOG DIS, V3, P319, DOI 10.1089/fpd.2006.3.319; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kuenne CT, 2007, BIOINFORMATICS, V23, P125, DOI 10.1093/bioinformatics/btl556; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Le Breton Y, 2005, J APPL MICROBIOL, V98, P806, DOI 10.1111/j.1365-2672.2004.02468.x; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Milillo SR, 2008, FOOD MICROBIOL, V25, P698, DOI 10.1016/j.fm.2008.03.003; Monedero V, 2001, J BACTERIOL, V183, P3391, DOI 10.1128/JB.183.11.3391-3398.2001; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Nieto C, 1997, J BIOL CHEM, V272, P30860, DOI 10.1074/jbc.272.49.30860; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Palumbo JD, 2005, APPL ENVIRON MICROB, V71, P5236, DOI 10.1128/AEM.71.9.5236-5243.2005; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; PINE L, 1989, CAN J MICROBIOL, V35, P245, DOI 10.1139/m89-037; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; Sambrook J., 2001, MOL CLONING LAB MANU; SAUNDERS B, 2007, LISTERIA LISTERIOSIS, P21; Schlosser A, 2001, FEMS MICROBIOL LETT, V196, P77, DOI 10.1016/S0378-1097(00)00566-8; Schmid MW, 2005, SYST APPL MICROBIOL, V28, P1, DOI 10.1016/j.syapm.2004.09.005; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shim JH, 2009, J BACTERIOL, V191, P4835, DOI 10.1128/JB.00176-09; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sue D, 2004, MICROBIOL-SGM, V150, P3843, DOI 10.1099/mic.0.27257-0; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Titgemeyer F, 2002, ANTON LEEUW INT J G, V82, P59, DOI 10.1023/A:1020628909429; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; Tsai HN, 2003, APPL ENVIRON MICROB, V69, P6943, DOI 10.1128/AEM.69.11.6943-6945.2003; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; WEIS J, 1975, APPL MICROBIOL, V30, P29, DOI 10.1128/AEM.30.1.29-32.1975; WELSHIMER HJ, 1960, J BACTERIOL, V80, P316, DOI 10.1128/JB.80.3.316-320.1960; WELSHIMER HJ, 1971, APPL MICROBIOL, V21, P516, DOI 10.1128/AEM.21.3.516-519.1971; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465; Yip VLY, 2007, BIOCHEMISTRY-US, V46, P9840, DOI 10.1021/bi700536p	63	42	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10349	10.1371/journal.pone.0010349	http://dx.doi.org/10.1371/journal.pone.0010349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436965	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000277079700008
J	Reigadas, S; Anies, G; Masquelier, B; Calmels, C; Stuyver, LJ; Parissi, V; Fleury, H; Andreola, ML				Reigadas, Sandrine; Anies, Guerric; Masquelier, Bernard; Calmels, Christina; Stuyver, Lieven J.; Parissi, Vincent; Fleury, Herve; Andreola, Marie-Line			The HIV-1 Integrase Mutations Y143C/R Are an Alternative Pathway for Resistance to Raltegravir and Impact the Enzyme Functions	PLOS ONE			English	Article							OPTIMIZED BACKGROUND THERAPY; INHIBITORS; REPLICATION; VIRUS; ELVITEGRAVIR; PATTERNS; MK-0518; GENE	Resistance to HIV-1 integrase (IN) inhibitor raltegravir (RAL), is encoded by mutations in the IN region of the pol gene. The emergence of the N155H mutation was replaced by a pattern including the Y143R/C/H mutations in three patients with anti-HIV treatment failure. Cloning analysis of the IN gene showed an independent selection of the mutations at loci 155 and 143. Characterization of the phenotypic evolution showed that the switch from N155H to Y143C/R was linked to an increase in resistance to RAL. Wild-type (WT) IN and IN with mutations Y143C or Y143R were assayed in vitro in 3' end-processing, strand transfer and concerted integration assays. Activities of mutants were moderately impaired for 3' end-processing and severely affected for strand transfer. Concerted integration assay demonstrated a decrease in mutant activities using an uncleaved substrate. With 3' end-processing assay, IC50 were 0.4 mu M, 0.9 mu M (FC = 2.25) and 1.2 mu M (FC = 3) for WT, IN Y143C and IN Y143R, respectively. An FC of 2 was observed only for IN Y143R in the strand transfer assay. In concerted integration, integrases were less sensitive to RAL than in ST or 3'P but mutants were more resistant to RAL than WT.	[Reigadas, Sandrine; Anies, Guerric; Masquelier, Bernard; Fleury, Herve] Univ Victor Segalen, EA 2968, CHU Bordeaux, Virol Lab, Bordeaux, France; [Stuyver, Lieven J.] Virco BVBA, Mechelen, Belgium; [Calmels, Christina; Parissi, Vincent; Andreola, Marie-Line] Univ Victor Segalen, UMR 5234, CNRS, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Reigadas, S (corresponding author), Univ Victor Segalen, EA 2968, CHU Bordeaux, Virol Lab, Bordeaux, France.	marie-line.andreola@reger.u-bordeaux2.fr		Andreola, Marie-Line/0000-0001-9808-7391	French Ministry of Education and Research [EA2968, AI18-3-01354]; European Community's [FP7/2007-2013, 223131]; Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS, France); Centre National de la Recherche Scientifique (CNRS, France)	French Ministry of Education and Research; European Community's(European Commission); Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS, France)(ANRS); Centre National de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the French Ministry of Education and Research through the quadrennial contract of the EA2968 and by grant number AI18-3-01354 from Sidaction. The research leading to these results received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" - grant agreement no 223131. The authors also thank the Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS, France) and the Centre National de la Recherche Scientifique (CNRS, France) for support and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Bonnenfant S, 2004, J VIROL, V78, P5728, DOI 10.1128/JVI.78.11.5728-5736.2004; Canducci F, 2010, J ANTIMICROB CHEMOTH, V65, P425, DOI 10.1093/jac/dkp477; Canducci F, 2009, AIDS, V23, P455, DOI 10.1097/QAD.0b013e328323da60; Caumont AB, 1996, CURR GENET, V29, P503; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; De Luca L, 2005, BIOCHEM BIOPH RES CO, V336, P1010, DOI 10.1016/j.bbrc.2005.08.211; de Soultrait VR, 2002, J MOL BIOL, V324, P195, DOI 10.1016/S0022-2836(02)01064-1; Delelis O, 2010, ANTIMICROB AGENTS CH, V54, P491, DOI 10.1128/AAC.01075-09; Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fransen S, 2009, ANTIVIR THER, V14, pA109; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Lataillade M, 2007, ANTIVIR THER, V12, P563; Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796; Marinello J, 2008, BIOCHEMISTRY-US, V47, P9345, DOI 10.1021/bi800791q; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Mouscadet JF, 2009, J MOL RECOGNIT, V22, P480, DOI 10.1002/jmr.970; Pannecouque C, 2002, CURR BIOL, V12, P1169, DOI 10.1016/S0960-9822(02)00952-1; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Van Baelen K, 2008, AIDS, V22, P1877, DOI 10.1097/QAD.0b013e32830f9703; Van Baelen K, 2009, J VIROL METHODS, V161, P231, DOI 10.1016/j.jviromet.2009.06.015; Wittkop L, 2009, J ANTIMICROB CHEMOTH, V63, P1251, DOI 10.1093/jac/dkp114; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	31	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10311	10.1371/journal.pone.0010311	http://dx.doi.org/10.1371/journal.pone.0010311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436677	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079500005
J	Madar-Balakirski, N; Tempel-Brami, C; Kalchenko, V; Brenner, O; Varon, D; Scherz, A; Salomon, Y				Madar-Balakirski, Noa; Tempel-Brami, Catherine; Kalchenko, Vyacheslav; Brenner, Ori; Varon, David; Scherz, Avigdor; Salomon, Yoram			Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad	PLOS ONE			English	Article							NITRIC-OXIDE; SYSTEMIC HYPOXIA; MELANOMA TUMORS; PROSTATE-CANCER; BLOOD-VESSELS; PD-BACTERIOPHEOPHORBIDE; OXYGEN-CONSUMPTION; ANGIOGENESIS; RAT; PHOTOSENSITIZER	Background: Antiangiogenic and anti-vascular therapies present intriguing alternatives to cancer therapy. However, despite promising preclinical results and significant delays in tumor progression, none have demonstrated long-term curative features to date. Here, we show that a single treatment session of Tookad-based vascular targeted photodynamic therapy (VTP) promotes permanent arrest of tumor blood supply by rapid occlusion of the tumor feeding arteries (FA) and draining veins (DV), leading to tumor necrosis and eradication within 24-48 h. Methodology/Principal Findings: A mouse earlobe MADB106 tumor model was subjected to Tookad-VTP and monitored by three complementary, non-invasive online imaging techniques: Fluorescent intravital microscopy, Dynamic Light Scattering Imaging and photosensitized MRI. Tookad-VTP led to prompt tumor FA vasodilatation (a mean volume increase of 70%) with a transient increase (60%) in blood-flow rate. Rapid vasoconstriction, simultaneous blood clotting, vessel permeabilization and a sharp decline in the flow rates then followed, culminating in FA occlusion at 63.2 sec+/-1.5SEM. This blockage was deemed irreversible after 10 minutes of VTP treatment. A decrease in DV blood flow was demonstrated, with a slight lag from FA response, accompanied by frequent changes in flow direction before reaching a complete standstill. In contrast, neighboring, healthy tissue vessels of similar sizes remained intact and functional after Tookad-VTP. Conclusion/Significance: Tookad-VTP selectively targets the tumor feeding and draining vessels. To the best of our knowledge, this is the first mono-therapeutic modality that primarily aims at the larger tumor vessels and leads to high cure rates, both in the preclinical and clinical arenas.	[Madar-Balakirski, Noa; Tempel-Brami, Catherine; Salomon, Yoram] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Kalchenko, Vyacheslav; Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Varon, David] Hadassah Hebrew Univ, Med Ctr, Dept Hematol, Jerusalem, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center	Madar-Balakirski, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yoram.salomon@weizmann.ac.il	Kalchenko, Vyacheslav/F-2924-2012	Kalchenko, Vyacheslav/0000-0002-3166-7049	STEBA Biotech, France	STEBA Biotech, France	This study was funded solely by STEBA Biotech, France. YS and AS are the incumbents of the Tillie and Charles Lubin Professorial Chair in Biochemical Endocrinology, and the Robert and Yaddele Sklare Professorial Chair in Biochemistry, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashur I, 2009, J PHYS CHEM A, V113, P8027, DOI 10.1021/jp900580e; BAATZ H, 1995, INT J MICROCIRC, V15, P85, DOI 10.1159/000178955; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Berdugo M, 2008, INVEST OPHTH VIS SCI, V49, P1633, DOI 10.1167/iovs.07-0767; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Bryan PT, 1999, J PHYSIOL-LONDON, V514, P163, DOI 10.1111/j.1469-7793.1999.163af.x; CHAPLIN DJ, 1987, CANCER RES, V47, P597; Chen B, 2006, CLIN CANCER RES, V12, P917, DOI 10.1158/1078-0432.CCR-05-1673; Chen B, 2008, INT J CANCER, V123, P695, DOI 10.1002/ijc.23538; Chen B, 2006, CRIT REV EUKAR GENE, V16, P279, DOI 10.1615/CritRevEukarGeneExpr.v16.i4.10; Cooney MM, 2006, NAT CLIN PRACT ONCOL, V3, P682, DOI 10.1038/ncponc0663; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dolmans DEJGJ, 2002, CANCER RES, V62, P2151; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; DVORAK HF, 1988, AM J PATHOL, V133, P95; Eberhard A, 2000, CANCER RES, V60, P1388; Edmunds NJ, 2001, J PHYSIOL-LONDON, V532, P251, DOI 10.1111/j.1469-7793.2001.0251g.x; Eggener SE, 2008, THESCIENTIFICWORLDJO, V8, P963, DOI 10.1100/tsw.2008.127; Fleshker S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1231, DOI 10.1111/j.1751-1097.2008.00340.x; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GERTNER MRW, 2003, CAPCURE SCI RETREAT; Gross S, 2003, NAT MED, V9, P1327, DOI 10.1038/nm940; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; He C, 2008, PHARM RES-DORDR, V25, P1873, DOI 10.1007/s11095-008-9604-5; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jung O, 2007, ARTERIOSCL THROM VAS, V27, P470, DOI 10.1161/01.ATV.0000254823.15843.1f; Kalchenko V, 2007, J MICROSC-OXFORD, V228, P118, DOI 10.1111/j.1365-2818.2007.01832.x; Kawamura Y, 2009, J ATHEROSCLER THROMB, V16, P807; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Koudinova NV, 2003, INT J CANCER, V104, P782, DOI 10.1002/ijc.11002; Lepor Herbert, 2008, Rev Urol, V10, P254; MARSHALL JM, 1988, J PHYSIOL-LONDON, V407, P385, DOI 10.1113/jphysiol.1988.sp017422; Mazor O, 2005, PHOTOCHEM PHOTOBIOL, V81, P342, DOI 10.1562/2004-06-14-RA-199.1; Moncada S., 2006, V176, P213; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore CM, 2009, NAT CLIN PRACT UROL, V6, P18, DOI 10.1038/ncpuro1274; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Scherz A., 2003, U.S. Patent, Patent No. [6569846, 6,569,846]; SCHERZ A, 2004, Patent No. 04045492; Takaya T, 2007, ARTERIOSCL THROM VAS, V27, P1632, DOI 10.1161/ATVBAHA.107.142182; Tempel-Brami C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001191; Tozer GM, 2004, SEMIN RADIAT ONCOL, V14, P222, DOI 10.1016/j.semradonc.2004.04.009; Tozer GM, 2005, ADV DRUG DELIVER REV, V57, P135, DOI 10.1016/j.addr.2004.07.015; Trachtenberg J, 2007, J UROLOGY, V178, P1974, DOI 10.1016/j.juro.2007.07.036; TRACHTENBERG J, 2008, BJU INT; Vakrat-Haglili Y, 2005, J AM CHEM SOC, V127, P6487, DOI 10.1021/ja046210j; Zangari M, 2003, SEMIN THROMB HEMOST, V29, P275; Zilberstein J, 1997, PHOTOCHEM PHOTOBIOL, V65, P1012, DOI 10.1111/j.1751-1097.1997.tb07962.x; Zilberstein J, 2001, PHOTOCHEM PHOTOBIOL, V73, P257, DOI 10.1562/0031-8655(2001)073<0257:ATOSMT>2.0.CO;2	50	53	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10282	10.1371/journal.pone.0010282	http://dx.doi.org/10.1371/journal.pone.0010282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421983	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600006
J	Willberg, CB; Garrison, KE; Jones, RB; Meiklejohn, DJ; Spotts, G; Liegler, TJ; Ostrowski, MA; Karlsson, AC; Hecht, FM; Nixon, DF				Willberg, Christian B.; Garrison, Keith E.; Jones, R. Brad; Meiklejohn, Duncan J.; Spotts, Gerald; Liegler, Teri J.; Ostrowski, Mario A.; Karlsson, Annika C.; Hecht, Frederick M.; Nixon, Douglas F.			Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+T Cells Recognize Vestigial CTL Epitopes	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; HIV-1 GENOTYPING KIT; MHC CLASS-I; HIV-1-INFECTED INDIVIDUALS; HLA-B; AIDS; INFECTION; ANTIGEN; IDENTIFICATION; IMMUNIZATION	Background: The HLA-B*35-Px allele has been associated with rapid disease progression in HIV-1 infection, in contrast to the HLA-B*35-Py allele. Methodology/Principal Findings: Immune responses to two HLA-B*35 restricted HIV-1 specific CTL epitopes and their variants were followed longitudinally during early HIV-1 infection in 16 HLA-B*35+ individuals. Subjects expressing HLA-B*35-Px alleles showed no difference in response to the consensus epitopes compared to individuals with HLA-B*35-Py alleles. Surprisingly, all the HLA-B*35-Px+ individuals responded to epitope-variants even in the absence of a consensus response. Sequencing of the viral population revealed no evidence of variant virus in any of the individuals. Conclusions/Significance: This demonstrates a novel phenomenon that distinguishes individuals with the HLA-B*35-Px rapid progressing allele and those with the HLA-B*35-Py slower progressing allele.	[Willberg, Christian B.; Garrison, Keith E.; Meiklejohn, Duncan J.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Jones, R. Brad; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Spotts, Gerald; Liegler, Teri J.; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, Div HIV AIDS, San Francisco, CA USA; [Karlsson, Annika C.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Solna, Sweden; [Karlsson, Annika C.] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden	University of California System; University of California San Francisco; University of Toronto; University of California System; University of California San Francisco; Karolinska Institutet; Swedish Institute for Infectious Disease Control	Willberg, CB (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	douglas.nixon@ucsf.edu	Karlsson, Annika/R-2255-2016; Nixon, Douglas/AAU-5734-2020	Karlsson, Annika/0000-0002-2028-8393; Nixon, Douglas/0000-0002-2801-1786; Willberg, Christian/0000-0001-5299-9344; Hecht, Frederick/0000-0002-5782-1171	AIDS Research Institute (ARI); National Institutes of Health (NIH) [AI056988, AI71713, AI65241, AI62333, AI41531]; Swedish Agency for International Development Cooperation-SIDA [2005001756]; Swedish Research Council [K2007-56X-20345-01-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071713, R01AI062333, U01AI041531, R01AI056988, R21AI065241] Funding Source: NIH RePORTER	AIDS Research Institute (ARI); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Agency for International Development Cooperation-SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of California San Francisco (UCSF) AIDS Biology Program of the AIDS Research Institute (ARI), National Institutes of Health (NIH) grants AI056988, AI71713, AI65241, AI62333, AI41531, and the Swedish Agency for International Development Cooperation-SIDA (2005001756), and the Swedish Research Council (K2007-56X-20345-01-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; BARBER LD, 1995, CURR BIOL, V5, P179, DOI 10.1016/S0960-9822(95)00039-X; Brown ME, 2007, J IMMUNOTHER, V30, P350, DOI 10.1097/CJI.0b013e31802b5005; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 2002, AIDS, V16, pS105, DOI 10.1097/00002030-200216004-00015; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dyall R, 1998, J EXP MED, V188, P1553, DOI 10.1084/jem.188.9.1553; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gold JS, 2003, J IMMUNOL, V170, P5188, DOI 10.4049/jimmunol.170.10.5188; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Jin X, 2002, J VIROL, V76, P12603, DOI 10.1128/JVI.76.24.12603-12610.2002; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kuritzkes DR, 2003, J CLIN MICROBIOL, V41, P1594, DOI 10.1128/JCM.41.4.1594-1599.2003; Larsson M, 1999, AIDS, V13, P767, DOI 10.1097/00002030-199905070-00005; Menendez-Arias L, 1998, VIRAL IMMUNOL, V11, P167, DOI 10.1089/vim.1998.11.167; Nicholson LB, 2000, INT IMMUNOL, V12, P205, DOI 10.1093/intimm/12.2.205; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Sipsas NV, 1997, J CLIN INVEST, V99, P752, DOI 10.1172/JCI119221; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10249	10.1371/journal.pone.0010249	http://dx.doi.org/10.1371/journal.pone.0010249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422053	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952500014
J	Ferreira, APRB; Ferreira, RF; Rajgor, D; Shah, J; Menezes, A; Pietrobon, R				Ribeiro Bonilauri Ferreira, Ana Paula; Ferreira, Rodrigo Fernando; Rajgor, Dimple; Shah, Jatin; Menezes, Andrea; Pietrobon, Ricardo			Clinical Reasoning in the Real World Is Mediated by Bounded Rationality: Implications for Diagnostic Clinical Practice Guidelines	PLOS ONE			English	Article							DECISION-MAKING; PHYSICIANS USE; INFORMATION; MODELS; UNCERTAINTY; MEDICINE	Background: Little is known about the reasoning mechanisms used by physicians in decision-making and how this compares to diagnostic clinical practice guidelines. We explored the clinical reasoning process in a real life environment. Method: This is a qualitative study evaluating transcriptions of sixteen physicians' reasoning during appointments with patients, clinical discussions between specialists, and personal interviews with physicians affiliated to a hospital in Brazil. Results: Four main themes were identified: simple and robust heuristics, extensive use of social environment rationality, attempts to prove diagnostic and therapeutic hypothesis while refuting potential contradictions using positive test strategy, and reaching the saturation point. Physicians constantly attempted to prove their initial hypothesis while trying to refute any contradictions. While social environment rationality was the main factor in the determination of all steps of the clinical reasoning process, factors such as referral letters and number of contradictions associated with the initial hypothesis had influence on physicians' confidence and determination of the threshold to reach a final decision. Discussion: Physicians rely on simple heuristics associated with environmental factors. This model allows for robustness, simplicity, and cognitive energy saving. Since this model does not fit into current diagnostic clinical practice guidelines, we make some propositions to help its integration.	[Ribeiro Bonilauri Ferreira, Ana Paula; Ferreira, Rodrigo Fernando] Univville, Joinville, Brazil; [Rajgor, Dimple; Shah, Jatin; Pietrobon, Ricardo] Duke NUS Grad Med Sch, Singapore, Singapore; [Menezes, Andrea] Hosp Angelina Caron, Curitiba, Parana, Brazil; [Pietrobon, Ricardo] Duke Univ Hlth Syst, Durham, NC USA; [Ribeiro Bonilauri Ferreira, Ana Paula; Rajgor, Dimple; Shah, Jatin; Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA	Universidade da Regiao de Joinville; National University of Singapore; Duke University; Duke University	Ferreira, APRB (corresponding author), Univville, Joinville, Brazil.	rpietro@duke.edu	Shah, Jatin/B-6039-2011; Rajgor, Dimple/C-7317-2015	Shah, Jatin/0000-0002-2457-491X; Rajgor, Dimple/0000-0002-6940-7656; Pietrobon, Ricardo/0000-0003-2996-2193	Department of Surgery, Duke University Medical Center, Durham, NC, USA	Department of Surgery, Duke University Medical Center, Durham, NC, USA	Financial support for this study was provided entirely by the Department of Surgery, Duke University Medical Center, Durham, NC, USA. The funding agreement ensured independence in designing the study, interpreting the data, writing, and publishing the report. The following authors are employed by the sponsor: RP, DOJ.	BAUMANN AO, 1991, SOC SCI MED, V32, P167, DOI 10.1016/0277-9536(91)90057-J; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; BOCKENHOLT U, 1993, INVEST RADIOL, V28, P76; Broder A, 2003, J EXP PSYCHOL LEARN, V29, P611, DOI 10.1037/0278-7393.29.4.611; Bruyninckx R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-55; Burgers JS, 2003, BRIT J GEN PRACT, V53, P15; CHRISTENSENSZALANSKI JJJ, 1981, J EXP PSYCHOL HUMAN, V7, P928, DOI 10.1037/0096-1523.7.4.928; Cote L, 2005, MED TEACH, V27, P71, DOI 10.1080/01421590400016308; Croskerry P, 2002, ACAD EMERG MED, V9, P1184, DOI 10.1111/j.1553-2712.2002.tb01574.x; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Federspil G, 2001, Ann Ital Med Int, V16, P17; Freeborn DK, 1997, J GEN INTERN MED, V12, P619, DOI 10.1046/j.1525-1497.1997.07122.x; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gigerenzer G., 1991, EUROPEAN REV SOCIAL, V2, P83, DOI [https://doi.org/10.1080/14792779143000033, DOI 10.1080/14792779143000033, 10.1080/14792779143000033]; Gigerenzer G., 2002, BOUNDED RATIONALITY; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; GRIFFIN D, 1992, COGNITIVE PSYCHOL, V24, P411, DOI 10.1016/0010-0285(92)90013-R; GROSS R, 1984, LANGENBECK ARCH CHIR, V364, P371, DOI 10.1007/BF01823238; GRUPPEN LD, 1991, MED DECIS MAKING, V11, P233, DOI 10.1177/0272989X9101100401; Isaac CA, 2008, J EVAL CLIN PRACT, V14, P656, DOI 10.1111/j.1365-2753.2008.01043.x; Jackson L, 1997, CAN FAM PHYSICIAN, V43, P649; Kapoor WN, 1998, SYNCOPE: MECHANISMS AND MANAGEMENT, P1; KAPOOR WN, 1995, MED CLIN N AM, V79, P1153, DOI 10.1016/S0025-7125(16)35877-1; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Lee A, 2009, J GEN INTERN MED, V24, P642, DOI 10.1007/s11606-009-0918-8; MANE K, 2009, AMIA C UNPUB; McDonald CJ, 1996, ANN INTERN MED, V124, P56, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00009; Norman G, 2007, MED EDUC, V41, P1140, DOI 10.1111/j.1365-2923.2007.02914.x; Olshansky B, 1998, SYNCOPE: MECHANISMS AND MANAGEMENT, P15; Patel VL, 2002, J BIOMED INFORM, V35, P52, DOI 10.1016/S1532-0464(02)00009-6; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; *QSR INT, 2010, N6 SOFTW VERS 6 0; Rieskamp J, 2008, ACTA PSYCHOL, V127, P258, DOI 10.1016/j.actpsy.2007.05.004; ROBERT D, 2004, J PHILOS, V101, P389; Saver BG, 1997, AM J PREV MED, V13, P358, DOI 10.1016/S0749-3797(18)30155-7; Selten R, 1998, J MATH PSYCHOL, V42, P191, DOI 10.1006/jmps.1997.1205; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Sinuff T, 2007, CRIT CARE MED, V35, P2083, DOI 10.1097/01.ccm.0000281446.15342.74; Swoboda DA, 2008, HEALTH-LONDON, V12, P453, DOI 10.1177/1363459308094420; TERRENCE R, 2009, JAMA-J AM MED ASSOC, V301, P868; THOMPSON M, 2009, BRIT MED J, V338, pB948; Woolf S. H., 1995, AHCPR PUB, V95-0009, P105	44	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10265	10.1371/journal.pone.0010265	http://dx.doi.org/10.1371/journal.pone.0010265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	585UH	20421920	Green Published, gold, Green Submitted			2022-12-27	WOS:000276854300018
J	Viel, S; Vaugoyeau, M; Assaiante, C				Viel, Sebastien; Vaugoyeau, Marianne; Assaiante, Christine			Postural Adaptation of the Spatial Reference Frames to Microgravity: Back to the Egocentric Reference Frame	PLOS ONE			English	Article							VOLUNTARY HEAD STABILIZATION; OSCILLATORY TRUNK MOVEMENTS; ORIENTATION; INTEGRATION; SPACE; WEIGHTLESSNESS; READAPTATION; PERCEPTION; CHILDREN; DEFICITS	Background: In order to test how gravitational information would affect the choice of stable reference frame used to control posture and voluntary movement, we have analysed the forearm stabilisation during sit to stand movement under microgravity condition obtained during parabolic flights. In this study, we hypothesised that in response to the transient loss of graviceptive information, the postural adaptation might involve the use of several strategies of segmental stabilisation, depending on the subject's perceptual typology (dependence - independence with respect to the visual field). More precisely, we expected a continuum of postural strategies across subjects with 1) at one extreme the maintaining of an egocentric reference frame and 2) at the other the re-activation of childhood strategies consisting in adopting an egocentric reference frame. Methodology/Principal Findings: To check this point, a forearm stabilisation task combined with a sit to stand movement was performed with eyes closed by 11 subjects during parabolic flight campaigns. Kinematic data were collected during 1-g and 0-g periods. The postural adaptation to microgravity's constraint may be described as a continuum of strategies ranging from the use of an exo-to an egocentric reference frame for segmental stabilisation. At one extremity, the subjects used systematically an exocentric frame to control each of their body segments independently, as under normogravity conditions. At the other, the segmental stabilisation strategies consist in systematically adopting an egocentric reference frame to control their forearm's stabilisation. A strong correlation between the mode of segmental stabilisation used and the perceptual typology ( dependence - independence with respect to the visual field) of the subjects was reported. Conclusion: The results of this study show different subjects' typologies from those that use the forearm orientation in a mainly exocentric reference frame to those that use the forearm orientation in a mainly egocentric reference frame.	[Viel, Sebastien] Univ Aix Marseille 1, Grp DPA, UMR 6149, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Viel, S (corresponding author), Univ Aix Marseille 1, Grp DPA, UMR 6149, Marseille, France.	christine.assaiante@univ-provence.fr			Centre National d'Etudes Spatiales (CNES); CNRS (Centre National de la recherche Scientifique)	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); CNRS (Centre National de la recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National d'Etudes Spatiales (CNES) and the CNRS (Centre National de la recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard B, 1997, EXP BRAIN RES, V114, P214, DOI 10.1007/PL00005630; Amblard B, 2001, EXP BRAIN RES, V137, P170, DOI 10.1007/s002210000621; Amblard B, 1995, ACTA ASTRONAUT, V36, P415, DOI 10.1016/0094-5765(95)00126-3; Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; Assaiante C, 1997, J VESTIBUL RES-EQUIL, V7, P145, DOI 10.1016/S0957-4271(96)00168-1; ASSAIANTE C, 1993, EXP BRAIN RES, V93, P499; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Baroni G, 2001, J APPL PHYSIOL, V90, P205, DOI 10.1152/jappl.2001.90.1.205; BETH H, 1971, PERCEPT PSYCHOPHYS, V9, P353; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; CHEUNG BSK, 1990, EXP BRAIN RES, V81, P391; CLEMENT G, 1984, EXP BRAIN RES, V57, P61; Clement G, 2007, NEUROSCI LETT, V413, P150, DOI 10.1016/j.neulet.2006.11.047; FRIEDERICI AD, 1990, PERCEPT PSYCHOPHYS, V47, P253, DOI 10.3758/BF03205000; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Gurfinkel V, 1988, STANCE MOTION FACTS, P185; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 2003, EXP BRAIN RES, V150, P208, DOI 10.1007/s00221-003-1446-0; Isableu B, 2006, EXP BRAIN RES, V174, P763, DOI 10.1007/s00221-006-0630-4; Kluzik J, 2005, EXP BRAIN RES, V162, P474, DOI 10.1007/s00221-004-2124-6; Lackner J R, 1993, J Vestib Res, V3, P361; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; MONEY KE, 1991, J CLIN PHARMACOL, V31, P1007, DOI 10.1002/j.1552-4604.1991.tb03664.x; Mouchnino L, 1996, J NEUROPHYSIOL, V76, P1212, DOI 10.1152/jn.1996.76.2.1212; NYBORG H, 1979, PERCEPT MOTOR SKILL, V48, P67, DOI 10.2466/pms.1979.48.1.67; OLTMAN PK, 1968, PERCEPT MOTOR SKILL, V26, P503, DOI 10.2466/pms.1968.26.2.503; Paillard J., 1991, BRAIN SPACE, P81; Paillard J., 1974, S ASS PSYCH SCI LANG, P7; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; Roncesvalles MN, 2005, J MOTOR BEHAV, V37, P404, DOI 10.3200/JMBR.37.5.404-416; Schmitz C, 1999, EXP BRAIN RES, V126, P200, DOI 10.1007/s002210050729; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; VAUGOYEAU M, 2007, SIT SATND BACK STAND; VAUGOYEAU M, 2005, GAIT POSTURE, V21, pS31; Vaugoyeau M, 2009, ACTA ASTRONAUT, V65, P347, DOI 10.1016/j.actaastro.2009.03.016; Vernazza-Martin S, 2000, J NEUROPHYSIOL, V83, P453, DOI 10.1152/jn.2000.83.1.453; Viel S, 2009, MOTOR CONTROL, V13, P25, DOI 10.1123/mcj.13.1.25; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; YOUNG LR, 1986, EXP BRAIN RES, V64, P291; Zoccolotti P, 1997, PERCEPTION, V26, P1485, DOI 10.1068/p261485	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10259	10.1371/journal.pone.0010259	http://dx.doi.org/10.1371/journal.pone.0010259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422038	gold, Green Submitted, Green Published			2022-12-27	WOS:000276854300015
J	Xu, J; Zhou, JY; Wei, WZ; Wu, GS				Xu, Jing; Zhou, Jun-Ying; Wei, Wei-Zen; Wu, Gen Sheng			Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; DOWN-REGULATION; CISPLATIN RESISTANCE; CARCINOMA CELLS; LEUKEMIA-CELLS; INDUCED DEATH; PROLIFERATION; RECEPTOR; BREAST	The mechanism of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL) resistance in cancer cells is not fully understood. Here, we show that the Akt survival pathway plays an important role in TRAIL resistance in human cancer cells. Specifically, we found that TRAIL treatment activates the Akt survival pathway and that inhibition of this pathway by the PI3K inhibitor LY294002 or knockdown of Akt sensitizes resistant cancer cells to TRAIL. Since Akt is negatively regulated by the tumor suppressor PTEN, we examined the TRAIL sensitivity in PTEN knockdown mouse prostate epithelial cells and found that PTEN(-/-) cells are more resistant than PTEN(+/+) cells while the sensitivity of PTEN(+/-) cells fell in between. Further, we showed that overexpression of a mutant PTEN confers TRAIL resistance in PTEN(+/+) cells, supporting a role of PTEN in TRAIL sensitivity. In TRAIL resistant breast T47D cells, overexpression of the mutant PTEN further increased their resistance to TRAIL. Taken together, our data indicate that inactivation of functional PTEN and the consequent activation of the Akt pathway prevents TRAIL-induced apoptosis, leading to TRAIL resistance. Therefore, our results suggest that TRAIL resistance can be overcome by targeting PTEN or the Akt survival pathway in cancer cells.	[Xu, Jing; Zhou, Jun-Ying; Wu, Gen Sheng] Wayne State Univ, Sch Med, Dept Pathol, Program Mol Biol & Genet,Karmanos Canc Inst, Detroit, MI 48201 USA; [Wei, Wei-Zen] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Program Breast Canc,Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Xu, J (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Program Mol Biol & Genet,Karmanos Canc Inst, Detroit, MI 48201 USA.	wug@karmanos.org			NIH/NCI [R01 CA100073]; Department of Defense Breast Cancer Program [W81XWH-07-1-05-21]; NATIONAL CANCER INSTITUTE [R01CA100073] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Breast Cancer Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH/NCI grant R01 CA100073 and Department of Defense Breast Cancer Program W81XWH-07-1-05-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Burns TF, 2001, J BIOL CHEM, V276, P37879; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Cuello M, 2001, CANCER RES, V61, P4892; Dida F, 2008, EXP HEMATOL, V36, P1343, DOI 10.1016/j.exphem.2008.04.011; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kandasamy K, 2002, CANCER RES, V62, P4929; Keane MM, 1999, CANCER RES, V59, P734; Kim MJ, 2009, BIOCHEM PHARMACOL, V78, P573, DOI 10.1016/j.bcp.2009.05.016; Lane D, 2007, INT J CANCER, V121, P1227, DOI 10.1002/ijc.22840; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Plastaras JP, 2008, CANCER BIOL THER, V7, P2047, DOI 10.4161/cbt.7.12.7570; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Sun SY, 2001, BIOCHEM BIOPH RES CO, V280, P788, DOI 10.1006/bbrc.2000.4218; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310	31	65	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10226	10.1371/journal.pone.0010226	http://dx.doi.org/10.1371/journal.pone.0010226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419107	Green Published, gold, Green Submitted			2022-12-27	WOS:000276853800016
J	Lahat, G; Zhu, QS; Huang, KL; Wang, SZ; Bolshakov, S; Liu, J; Torres, K; Langley, RR; Lazar, AJ; Hung, MC; Lev, D				Lahat, Guy; Zhu, Quan-Sheng; Huang, Kai-Lieh; Wang, Suizhao; Bolshakov, Svetlana; Liu, Jeffery; Torres, Keila; Langley, Robert R.; Lazar, Alexander J.; Hung, Mien Chie; Lev, Dina			Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN PERIPHERAL-BLOOD; COMPOUND WITHAFERIN-A; SOFT-TISSUE SARCOMAS; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; INTERMEDIATE-FILAMENTS; P21-ACTIVATED KINASE; WITHANIA-SOMNIFERA; TUMOR-CELLS	Background: Vimentin is a ubiquitous mesenchymal intermediate filament supporting mechano-structural integrity of quiescent cells while participating in adhesion, migration, survival, and cell signaling processes via dynamic assembly/disassembly in activated cells. Soft tissue sarcomas and some epithelial cancers exhibiting "epithelial to mesenchymal transition'' phenotypes express vimentin. Withaferin-A, a naturally derived bioactive compound, may molecularly target vimentin, so we sought to evaluate its effects on tumor growth in vitro and in vivo thereby elucidating the role of vimentin in drug-induced responses. Methods and Findings: Withaferin-A elicited marked apoptosis and vimentin cleavage in vimentin-expressing tumor cells but significantly less in normal mesenchymal cells. This proapoptotic response was abrogated after vimentin knockdown or by blockade of caspase-induced vimentin degradation via caspase inhibitors or overexpression of mutated caspase-resistant vimentin. Pronounced anti-angiogenic effects of Withaferin-A were demonstrated, with only minimal effects seen in non-proliferating endothelial cells. Moreover, Withaferin-A significantly blocked soft tissue sarcoma growth, local recurrence, and metastasis in a panel of soft tissue sarcoma xenograft experiments. Apoptosis, decreased angiogenesis, and vimentin degradation were all seen in Withaferin-A treated specimens. Conclusions: In light of these findings, evaluation of Withaferin-A, its analogs, or other anti-vimentin therapeutic approaches in soft tissue sarcoma and "epithelial to mesenchymal transition'' clinical contexts is warranted.	[Lahat, Guy; Zhu, Quan-Sheng; Wang, Suizhao; Bolshakov, Svetlana; Liu, Jeffery; Torres, Keila] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Lahat, Guy; Zhu, Quan-Sheng; Huang, Kai-Lieh; Wang, Suizhao; Bolshakov, Svetlana; Liu, Jeffery; Torres, Keila; Lazar, Alexander J.; Lev, Dina] Univ Texas MD Anderson Canc Ctr, Sarcoma Res Ctr, Houston, TX 77030 USA; [Huang, Kai-Lieh; Langley, Robert R.; Lev, Dina] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hung, Mien Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lahat, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	dlev@mdanderson.org	Lazar, Alexander J/A-3416-2008; Hung, Mien-Chie/ABD-5911-2021	Lazar, Alexander J/0000-0002-6395-4499; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Kai-Lieh/0000-0001-5407-648X; Torres, Keila E/0000-0002-1855-0989	NCI/NIH [CA138345]; Amschwand Sarcoma Cancer Foundation; NCI Cancer Center; NATIONAL CANCER INSTITUTE [R01CA138345] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amschwand Sarcoma Cancer Foundation; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by NCI/NIH R01 grant CA138345 ( to DL) and an Amschwand Sarcoma Cancer Foundation seed grant (to SW). The MD Anderson Cancer Center cell line characterization and cytogenetic Core Facilities are both supported by an NCI Cancer Center Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHINDAWI MK, 1992, J ETHNOPHARMACOL, V37, P113, DOI 10.1016/0378-8741(92)90069-4; Balachandran P, 2005, PHARMACOL RES, V51, P19, DOI 10.1016/j.phrs.2004.04.010; Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; BENZEEV A, 1986, P NATL ACAD SCI USA, V83, P2894, DOI 10.1073/pnas.83.9.2894; Bhattacharya S K, 1997, Indian J Exp Biol, V35, P236; Bhattacharya SK, 2002, PHYTOMEDICINE, V9, P167, DOI 10.1078/0944-7113-00089; Bibi R, 2006, BRIT J CANCER, V95, P1258, DOI 10.1038/sj.bjc.6603398; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; CARPEN O, 1983, J IMMUNOL, V131, P2695; CHAN D, 1989, P NATL ACAD SCI USA, V86, P2747, DOI 10.1073/pnas.86.8.2747; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; CHOWDHURY K, 1975, BIOCHEM PHARMACOL, V24, P919, DOI 10.1016/0006-2952(75)90165-3; CiesielskiTreska J, 1995, EUR J CELL BIOL, V68, P369; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; CORDONCARDO C, 1994, CANCER RES, V54, P794; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; de Alava E, 1998, J CLIN ONCOL, V16, P1248, DOI 10.1200/JCO.1998.16.4.1248; Devi P. Uma, 1996, Indian Journal of Experimental Biology, V34, P927; DUGINA VB, 1995, J CELL SCI, V108, P1659; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Fletcher CDM, 2002, WHO CLASSIFICATION T; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Hashimoto M, 1998, BIOCHEM BIOPH RES CO, V247, P401, DOI 10.1006/bbrc.1998.8799; HAY ED, 1989, AM J MED GENET, V34, P14, DOI 10.1002/ajmg.1320340107; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HERMAN B, 1982, CELL MOTIL CYTOSKEL, V2, P583, DOI 10.1002/cm.970020607; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; INAGAKI M, 1989, CELL STRUCT FUNCT, V14, P279, DOI 10.1247/csf.14.279; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Janosch P, 2000, FASEB J, V14, P2008, DOI 10.1096/fj.99-0883com; Jin Z, 2008, CLIN CANCER RES, V14, P5033, DOI 10.1158/1078-0432.CCR-08-0092; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Kim SJ, 2006, JNCI-J NATL CANCER I, V98, P783, DOI 10.1093/jnci/djj211; Lahat G, 2009, CLIN CANCER RES, V15, P2637, DOI 10.1158/1078-0432.CCR-08-2442; LANE EB, 1983, NATURE, V303, P701, DOI 10.1038/303701a0; Langley RR, 2003, CANCER RES, V63, P2971; Lee SY, 2001, CELL DEATH DIFFER, V8, P1093, DOI 10.1038/sj.cdd.4400923; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; MAISON C, 1995, EMBO J, V14, P3311, DOI 10.1002/j.1460-2075.1995.tb07338.x; Malara N, 2008, CELL CYCLE, V7, P3235, DOI 10.4161/cc.7.20.6832; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; McCarty MF, 2002, INT J ONCOL, V21, P5; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Meriane M, 2000, J BIOL CHEM, V275, P33046, DOI 10.1074/jbc.M001566200; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Morishima N, 1999, GENES CELLS, V4, P401, DOI 10.1046/j.1365-2443.1999.00270.x; NDLOVU MN, 2009, MOL CELL BIOL; OCONNOR CM, 1981, CELL, V23, P135, DOI 10.1016/0092-8674(81)90278-6; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Oh JH, 2008, EUR J PHARMACOL, V599, P11, DOI 10.1016/j.ejphar.2008.09.017; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; PALMBERG L, 1985, DIFFERENTIATION, V29, P275, DOI 10.1111/j.1432-0436.1985.tb00327.x; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Prasad SC, 1998, BIOCHEM BIOPH RES CO, V249, P332, DOI 10.1006/bbrc.1998.9137; Sabo E, 1997, BRIT J UROL, V80, P864, DOI 10.1046/j.1464-410X.1997.00489.x; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; SHOHAT B., 1967, CANCER CHEMOTHER REP, V51, P271; SHOHAT B, 1976, CANCER LETT, V2, P71, DOI 10.1016/S0304-3835(76)80014-6; SHOHAT B, 1976, CANCER LETT, V2, P63, DOI 10.1016/S0304-3835(76)80013-4; Singh D, 2007, PHYTOTHER RES, V21, P905, DOI 10.1002/ptr.2180; SKALLI O, 1992, P NATL ACAD SCI USA, V89, P11959, DOI 10.1073/pnas.89.24.11959; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang JL, 2009, CANCER LETT, V275, P1, DOI 10.1016/j.canlet.2008.06.013; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039; Zhang LL, 2006, CANCER RES, V66, P8770, DOI 10.1158/0008-5472.CAN-06-1217	99	153	163	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10105	10.1371/journal.pone.0010105	http://dx.doi.org/10.1371/journal.pone.0010105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419128	Green Published, gold			2022-12-27	WOS:000276743500007
J	Ting, C; Rajji, TK; Ismail, Z; Tang-Wai, DF; Apanasiewicz, N; Miranda, D; Mamo, D; Mulsant, BH				Ting, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H.			Differentiating the Cognitive Profile of Schizophrenia from That of Alzheimer Disease and Depression in Late Life	PLOS ONE			English	Article							LATE-ONSET SCHIZOPHRENIA; NEUROPSYCHOLOGICAL DEFICITS; DEMENTIA	Background: To compare the cognitive profile of older patients with schizophrenia to those with other neuropsychiatric disorders assessed in a hospital-based memory clinic. Methods: Demographic, clinical, and cognitive data of all patients referred to the memory clinic at the Centre for Addiction and Mental Health between April 1, 2006 and August 15, 2008 were reviewed. We then identified four groups of older patients with: (1) late-life schizophrenia (LLS) and no dementia or depression (DEP); (2) Alzheimer's disease (AD); (3) DEP and no dementia or LLS; (4) normal cognition (NC) and no DEP or LLS. Results: The four groups did not differ in demographic data except that patients with AD were about 12 years older than those with LLS. However, they differed on cognitive tests even after controlling for age. Patients with LLS were impaired on most cognitive tests in comparison with patients with NC but not on recalling newly learned verbal information at a short delay. They experienced equivalent performance on learning new verbal information in comparison with patients with AD, but better performance on all other tests of memory, including the ability to recall newly learned verbal information. Finally, they were more impaired than patients with DEP in overall memory. Conclusions: Patients with LLS have a different cognitive profile than patients with AD or DEP. Particularly, memory impairment in LLS seems to be more pronounced in learning than recall. These findings suggest that cognitive and psychosocial interventions designed to compensate for learning deficits may be beneficial in LLS.	[Ting, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H.] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada; [Rajji, Tarek K.; Ismail, Zahinoor; Mamo, David; Mulsant, Benoit H.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Ismail, Zahinoor] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Tang-Wai, David F.] Univ Toronto, Div Neurol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Calgary; University of Toronto	Ting, C (corresponding author), Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada.	Tarek_Rajji@camh.net	Rajji, Tarek K/K-1543-2015		Canadian Institutes of Health [CIHR180087]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research Fellowship Award to Dr. Rajji (CIHR180087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P5; Butters MA, 2000, AM J PSYCHIAT, V157, P1949, DOI 10.1176/appi.ajp.157.12.1949; Davidson M, 1996, AM J PSYCHIAT, V153, P1274; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Freedman M., 1994, CLOCK DRAWING NEUROP, pVI; Friedman JI, 2001, AM J PSYCHIAT, V158, P1441, DOI 10.1176/appi.ajp.158.9.1441; Golden C. J., 1979, LURIA NEBRASKA NEURO; Goodglass H., 1983, BOSTON NAMING TEST; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; HEATON R, 1994, ARCH GEN PSYCHIAT, V51, P469; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; JESTE DV, 1995, AM J PSYCHIAT, V152, P722; Kongs SK, 2000, WISCONSIN CARD SORTI; Mattis S, 1988, DEMENTIA RATING SCAL; McBride T, 2002, SCHIZOPHR RES, V55, P217, DOI 10.1016/S0920-9964(01)00232-8; McGurk SR, 2000, SCHIZOPHR RES, V42, P47, DOI 10.1016/S0920-9964(99)00097-3; NADLER JD, 1993, ARCH CLIN NEUROPSYCH, V8, P449, DOI 10.1016/0887-6177(93)90008-O; Palmer BW, 2003, J NEUROPSYCH CLIN N, V15, P45, DOI 10.1176/appi.neuropsych.15.1.45; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; Rajji TK, 2008, SCHIZOPHR RES, V102, P122, DOI 10.1016/j.schres.2008.03.015; Reitan R.M., 1993, HALSTEAD REITAN NEUR	23	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10151	10.1371/journal.pone.0010151	http://dx.doi.org/10.1371/journal.pone.0010151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405043	Green Published, gold, Green Submitted			2022-12-27	WOS:000276705900024
J	Golden, E; Emiliano, A; Maudsley, S; Windham, BG; Carlson, OD; Egan, JM; Driscoll, I; Ferrucci, L; Martin, B; Mattson, MP				Golden, Erin; Emiliano, Ana; Maudsley, Stuart; Windham, B. Gwen; Carlson, Olga D.; Egan, Josephine M.; Driscoll, Ira; Ferrucci, Luigi; Martin, Bronwen; Mattson, Mark P.			Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; PLASMA-CONCENTRATIONS; FUNCTIONAL MODULES; SURVIVAL FACTOR; HUMAN PLATELETS; SEVERE OBESITY; FACTOR BDNF; IN-VITRO; PROTEIN	Background: Besides its well-established role in nerve cell survival and adaptive plasticity, brain-derived neurotrophic factor (BDNF) is also involved in energy homeostasis and cardiovascular regulation. Although BDNF is present in the systemic circulation, it is unknown whether plasma BDNF correlates with circulating markers of dysregulated metabolism and an adverse cardiovascular profile. Methodology/Principal Findings: To determine whether circulating BDNF correlates with indices of metabolic and cardiovascular health, we measured plasma BDNF levels in 496 middle-age and elderly subjects (mean age similar to 70), in the Baltimore Longitudinal Study of Aging. Linear regression analysis revealed that plasma BDNF is associated with risk factors for cardiovascular disease and metabolic syndrome, regardless of age. In females, BDNF was positively correlated with BMI, fat mass, diastolic blood pressure, total cholesterol, and LDL-cholesterol, and inversely correlated with folate. In males, BDNF was positively correlated with diastolic blood pressure, triglycerides, free thiiodo-thyronine (FT3), and bioavailable testosterone, and inversely correlated with sex-hormone binding globulin, and adiponectin. Conclusion/Significance: Plasma BDNF significantly correlates with multiple risk factors for metabolic syndrome and cardiovascular dysfunction. Whether BDNF contributes to the pathogenesis of these disorders or functions in adaptive responses to cellular stress (as occurs in the brain) remains to be determined.	[Golden, Erin; Mattson, Mark P.] NIA, Cellular & Mol Neurosci Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Emiliano, Ana; Martin, Bronwen] NIA, Metab Unit, Intramural Res Program, Baltimore, MD 21224 USA; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Intramural Res Program, Baltimore, MD 21224 USA; [Windham, B. Gwen; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Carlson, Olga D.; Egan, Josephine M.] NIA, Diabet Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Driscoll, Ira] NIA, Lab Personal & Cognit, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Golden, E (corresponding author), NIA, Cellular & Mol Neurosci Sect, Intramural Res Program, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Mattson, Mark P/F-6038-2012	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institutes of Health (NIH) [5 T32 DK007751-09]; National Institute on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000325, ZIAAG000214, ZIAAG000917, ZIAAG000015, ZIAAG000319, ZIAAG000915, ZIAAG000916, ZIAAG000318] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging. Ana Emiliano was supported by grant number NIH 5 T32 DK007751-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barde Y A, 1994, Prog Clin Biol Res, V390, P45; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Brady R, 1999, J NEUROSCI, V19, P2131; Byerly MS, 2009, AM J PHYSIOL-REG I, V296, pR1180, DOI 10.1152/ajpregu.90813.2008; Cai DQ, 2006, PHYSIOL GENOMICS, V24, P191, DOI 10.1152/physiolgenomics.00165.2005; Caldwell JD, 2009, HORM METAB RES, V41, P173, DOI 10.1055/s-0028-1093351; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Ejiri J, 2005, CIRCULATION, V112, P2114, DOI 10.1161/CIRCULATIONAHA.104.476903; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flint AJ, 2006, INT J EPIDEMIOL, V35, P187, DOI 10.1093/ije/dyi298; Franzosi MG, 2006, LANCET, V368, P624, DOI 10.1016/S0140-6736(06)69222-2; Fujinami A, 2008, CLIN BIOCHEM, V41, P812, DOI 10.1016/j.clinbiochem.2008.03.003; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ishii S, 2003, NEUROENDOCRINOLOGY, V78, P321, DOI 10.1159/000074885; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Klebanov L, 2006, STAT APPL GENET MOL, V5; Klee GG, 1996, CLIN CHEM, V42, P155; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Krabbe KS, 2009, J AM GERIATR SOC, V57, P1447, DOI 10.1111/j.1532-5415.2009.02345.x; Kragelund C, 2005, LANCET, V366, P1589, DOI 10.1016/S0140-6736(05)67642-8; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lapice E, 2009, DIABETES CARE, V32, P1734, DOI 10.2337/dc09-0176; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Merhi ZO, 2009, FERTIL STERIL, V91, P1544, DOI 10.1016/j.fertnstert.2008.09.032; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Nedvidkova J, 2005, PHYSIOL RES, V54, P133, DOI 10.33549/physiolres.930600; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Seifer DB, 2002, J CLIN ENDOCR METAB, V87, P655, DOI 10.1210/jc.87.2.655; SHOCK NW, 1984, NORMAL HUMAN AGING B, V84, P2450; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; TREMBLAY RR, 1974, CONTRACEPTION, V10, P599, DOI 10.1016/0010-7824(74)90099-7; VERMEULEN A, 1971, J CLIN ENDOCR METAB, V33, P759, DOI 10.1210/jcem-33-5-759; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Wang H, 2002, NEUROSCIENCE, V112, P967, DOI 10.1016/S0306-4522(02)00085-4; Wellens RI, 1996, OBES RES, V4, P35, DOI 10.1002/j.1550-8528.1996.tb00510.x; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yeap BB, 2009, NAT CLIN PRACT ENDOC, V5, P113, DOI 10.1038/ncpendmet1050; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336	60	153	154	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10099	10.1371/journal.pone.0010099	http://dx.doi.org/10.1371/journal.pone.0010099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404913	Green Submitted, gold, Green Published			2022-12-27	WOS:000276482100015
J	Weth, O; Weth, C; Bartkuhn, M; Leers, J; Uhle, F; Renkawitz, R				Weth, Oliver; Weth, Christine; Bartkuhn, Marek; Leers, Joerg; Uhle, Florian; Renkawitz, Rainer			Modular Insulators: Genome Wide Search for Composite CTCF/Thyroid Hormone Receptor Binding Sites	PLOS ONE			English	Article							IMPRINTING CONTROL REGION; ENHANCER-BLOCKING ACTIVITY; C-MYC GENE; CTCF-BINDING; THYROID-HORMONE; PROTEIN CTCF; RESPONSE ELEMENTS; CHROMATIN INSULATOR; BREAST-CANCER; METHYLATION	The conserved 11 zinc-finger protein CTCF is involved in several transcriptional mechanisms, including insulation and enhancer blocking. We had previously identified two composite elements consisting of a CTCF and a TR binding site at the chicken lysozyme and the human c-myc genes. Using these it has been demonstrated that thyroid hormone mediates the relief of enhancer blocking even though CTCF remains bound to its binding site. Here we wished to determine whether CTCF and TR combined sites are representative of a general feature of the genome, and whether such sites are functional in regulating enhancer blocking. Genome wide analysis revealed that about 18% of the CTCF regions harbored at least one of the four different palindromic or repeated sequence arrangements typical for the binding of TR homodimers or TR/RXR heterodimers. Functional analysis of 10 different composite elements of thyroid hormone responsive genes was performed using episomal constructs. The episomal system allowed recapitulating CTCF mediated enhancer blocking function to be dependent on poly (ADP)-ribose modification and to mediate histone deacetylation. Furthermore, thyroid hormone sensitive enhancer blocking could be shown for one of these new composite elements. Remarkably, not only did the regulation of enhancer blocking require functional TR binding, but also the basal enhancer blocking activity of CTCF was dependent on the binding of the unliganded TR. Thus, a number of composite CTCF/TR binding sites may represent a subset of other modular CTCF composite sites, such as groups of multiple CTCF sites or of CTCF/Oct4, CTCF/Kaiso or CTCF/Yy1 combinations.	[Weth, Oliver; Weth, Christine; Bartkuhn, Marek; Leers, Joerg; Uhle, Florian; Renkawitz, Rainer] Univ Giessen, Inst Genet, Giessen, Germany	Justus Liebig University Giessen	Weth, O (corresponding author), Univ Giessen, Inst Genet, Giessen, Germany.	rainer.renkawitz@gen.bio.uni-giessen.de	Uhle, Florian/G-8649-2012; Uhle, Florian/Q-6191-2019	Bartkuhn, Marek/0000-0001-6872-9082	DFG	DFG(German Research Foundation (DFG))	This work was supported by grants from the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Chan CS, 2008, CANCER RES, V68, P9041, DOI 10.1158/0008-5472.CAN-08-2632; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; De K, 2004, J ENDOCRINOL, V182, P303, DOI 10.1677/joe.0.1820303; Defossez PA, 2005, J BIOL CHEM, V280, P43017, DOI 10.1074/jbc.M510802200; DESVERGNE B, 1994, MOL CELL ENDOCRINOL, V100, P125, DOI 10.1016/0303-7207(94)90291-7; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Eckey M, 2007, MOL CELL BIOL, V27, P3557, DOI 10.1128/MCB.01106-06; Feng X, 2001, J BIOL CHEM, V276, P15066, DOI 10.1074/jbc.M011027200; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Jackson DA, 2003, NUCLEIC ACIDS RES, V31, P1180, DOI 10.1093/nar/gkg217; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kanduri M, 2002, MOL CELL BIOL, V22, P3339, DOI 10.1128/MCB.22.10.3339-3344.2002; Kim J, 2008, EPIGENETICS-US, V3, P115, DOI 10.4161/epi.3.3.6176; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; LEBEL JM, 1994, P NATL ACAD SCI USA, V91, P2644, DOI 10.1073/pnas.91.7.2644; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Li LP, 2007, BIOINFORMATICS, V23, P1188, DOI 10.1093/bioinformatics/btm080; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lutz M, 2003, EMBO J, V22, P1579, DOI 10.1093/emboj/cdg147; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; NEGRE N, PLOS GENET, V6; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Parnell TJ, 2000, EMBO J, V19, P5864, DOI 10.1093/emboj/19.21.5864; Perez-Juste G, 2000, J BIOL CHEM, V275, P1307, DOI 10.1074/jbc.275.2.1307; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; SHULEMOVICH K, 1995, NUCLEIC ACIDS RES, V23, P811, DOI 10.1093/nar/23.5.811; Szabo PE, 2006, CYTOGENET GENOME RES, V113, P238, DOI 10.1159/000090838; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4858, DOI 10.1128/MCB.24.11.4858-4868.2004; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832; ZLATANOVA J, 2009, CELL MOL LIFE SCI; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	64	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10119	10.1371/journal.pone.0010119	http://dx.doi.org/10.1371/journal.pone.0010119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404925	gold, Green Published, Green Submitted			2022-12-27	WOS:000276482100025
J	Yu, ZW; Xu, XH; Xiang, ZH; Zhou, JF; Zhang, ZH; Hu, C; He, C				Yu, Zhongwang; Xu, Xiaohui; Xiang, Zhenghua; Zhou, Jianfeng; Zhang, Zhaohuan; Hu, Chun; He, Cheng			Nitrated alpha-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; PROTEIN TRANSDUCTION; TYROSINE NITRATION; LEWY BODIES; D2 RECEPTOR; MOUSE MODEL; CELL-DEATH; IN-VITRO	Background: The pathology of Parkinson's disease (PD) is characterized by the degeneration of the nigrostriatal dopaminergic pathway, as well as the formation of intraneuronal inclusions known as Lewy bodies and Lewy neurites in the substantia nigra. Accumulations of nitrated alpha-synuclein are demonstrated in the signature inclusions of Parkinson's disease. However, whether the nitration of alpha-synuclein is relevant to the pathogenesis of PD is unknown. Methodology/Principal Findings: In this study, effect of nitrated alpha-synuclein to dopaminergic (DA) neurons was determined by delivering nitrated recombinant TAT-alpha-synuclein intracellular. We provide evidence to show that the nitrated alpha-synuclein was toxic to cultured dopaminergic SHSY-5Y neurons and primary mesencephalic DA neurons to a much greater degree than unnitrated alpha-synuclein. Moreover, we show that administration of nitrated alpha-synuclein to the substantia nigra pars compacta of rats caused severe reductions in the number of DA neurons therein, and led to the down-regulation of D2R in the striatum in vivo. Furthermore, when administered to the substantia nigra of rats, nitrated alpha-synuclein caused PD-like motor dysfunctions, such as reduced locomotion and motor asymmetry, however unmodified alpha-synuclein had significantly less severe behavioral effects. Conclusions/Significance: Our results provide evidence that alpha-synuclein, principally in its nitrated form, induce DA neuron death and may be a major factor in the etiology of PD.	[Yu, Zhongwang] Second Mil Med Univ, Inst Neurosci, Changzheng Hosp, Neurosci Res Ctr, Shanghai, Peoples R China; Second Mil Med Univ, Key Lab Mol Neurobiol Minister Educ, Changzheng Hosp, Neurosci Res Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Yu, ZW (corresponding author), Second Mil Med Univ, Inst Neurosci, Changzheng Hosp, Neurosci Res Ctr, Shanghai, Peoples R China.	chenghe@smmu.edu.cn		Yu, Zhong-wang/0000-0002-8212-0158; Xu, Xiao-Hui/0000-0001-7608-4114	National Key Basic Research Program [2006CB500702]; Ministry of Science and Technology of China [2007CB947100]; National 863 Program [2006AA02A114]; National Natural Science Foundation of China [30530240, 30770657]; Shanghai Metropolitan Fund for Research and Development [07DJ14005]	National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Metropolitan Fund for Research and Development	This study was supported by the National Key Basic Research Program (2006CB500702), the Ministry of Science and Technology of China (2007CB947100), the National 863 Program (2006AA02A114), the National Natural Science Foundation of China (30530240, 30770657), and the Shanghai Metropolitan Fund for Research and Development (07DJ14005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Aoyama K, 2000, ANN NEUROL, V47, P524, DOI 10.1002/1531-8249(200004)47:4<524::AID-ANA19>3.0.CO;2-5; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Beyer K, 2004, NEUROPATH APPL NEURO, V30, P601, DOI 10.1111/j.1365-2990.2004.00572.x; Beyer K, 2008, NEUROGENETICS, V9, P15, DOI 10.1007/s10048-007-0106-0; Bixby M, 2005, LIFE SCI, V77, P345, DOI 10.1016/j.lfs.2004.11.030; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cai GP, 2000, J NEUROSCI, V20, P1849; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung CY, 2007, J NEUROSCI, V27, P8314, DOI 10.1523/JNEUROSCI.1972-07.2007; Cole NB, 2008, CURR ALZHEIMER RES, V5, P599, DOI 10.2174/156720508786898523; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; CUNHA CD, 2008, BEHAV BRAIN RES, V189, P364; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Daveu C, 1997, NITRIC OXIDE-BIOL CH, V1, P234, DOI 10.1006/niox.1997.0123; de Oliveira MR, 2009, PROG NEURO-PSYCHOPH, V33, P353, DOI 10.1016/j.pnpbp.2008.12.020; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee SJ, 2006, J BIOL CHEM, V281, P2215, DOI 10.1074/jbc.M509509200; Liberatore GT, 1999, NAT MED, V5, P1403; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Mihm MJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-11-j0003.2001; NITSCH C, 1995, SYNAPSE, V19, P247, DOI 10.1002/syn.890190404; Norris EH, 2003, J BIOL CHEM, V278, P27230, DOI 10.1074/jbc.M212436200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tao L, 2006, CIRCULATION, V114, P1395, DOI 10.1161/CIRCULATIONAHA.106.625061; Tieu K, 2003, IUBMB LIFE, V55, P329, DOI 10.1080/1521654032000114320; Turnbull S, 2001, FREE RADICAL BIO MED, V30, P1163, DOI 10.1016/S0891-5849(01)00513-5; Uversky VN, 2005, MOL BRAIN RES, V134, P84, DOI 10.1016/j.molbrainres.2004.11.014; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P553, DOI 10.1089/ars.2006.1524; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Yu S, 2007, NEUROSCIENCE, V145, P539, DOI 10.1016/j.neuroscience.2006.12.028; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhen XC, 2002, MOL PHARMACOL, V62, P1356, DOI 10.1124/mol.62.6.1356	63	77	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9956	10.1371/journal.pone.0009956	http://dx.doi.org/10.1371/journal.pone.0009956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386702	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482000003
J	Amrit, FRG; Boehnisch, CML; May, RC				Amrit, Francis R. G.; Boehnisch, Claudia M. L.; May, Robin C.			Phenotypic Covariance of Longevity, Immunity and Stress Resistance in the Caenorhabditis Nematodes	PLOS ONE			English	Article							LIFE-SPAN; SALMONELLA-TYPHIMURIUM; MODEL HOST; ELEGANS; DAF-16; MUTANTS; LONG; GENE; EVOLUTION; TARGETS	Background: Ageing, immunity and stresstolerance are inherent characteristics of all organisms. In animals, these traits are regulated, at least in part, by forkhead transcription factors in response to upstream signals from the Insulin/Insulin-like growth factor signalling (IIS) pathway. In the nematode Caenorhabditis elegans, these phenotypes are molecularly linked such that activation of the forkhead transcription factor DAF-16 both extends lifespan and simultaneously increases immunity and stress resistance. It is known that lifespan varies significantly among the Caenorhabditis species but, although DAF-16 signalling is highly conserved, it is unclear whether this phenotypic linkage occurs in other species. Here we investigate this phenotypic covariance by comparing longevity, stress resistance and immunity in four Caenorhabditis species. Methodology/Principal Findings: We show using phenotypic analysis of DAF-16 influenced phenotypes that among four closely related Caenorhabditis nematodes, the gonochoristic species (Caenorhabditis remanei and Caenorhabditis brenneri) have diverged significantly with a longer lifespan, improved stress resistance and higher immunity than the hermaphroditic species (C. elegans and Caenorhabditis briggsae). Interestingly, we also observe significant differences in expression levels between the daf-16 homologues in these species using Real-Time PCR, which positively correlate with the observed phenotypes. Finally, we provide additional evidence in support of a role for DAF-16 in regulating phenotypic coupling by using a combination of wildtype isolates, constitutively active daf-16 mutants and bioinformatic analysis. Conclusions: The gonochoristic species display a significantly longer lifespan (p<0.0001) and more robust immune and stress response (p<0.0001, thermal stress; p<0.01, heavy metal stress; p<0.0001, pathogenic stress) than the hermaphroditic species. Our data suggests that divergence in DAF-16 mediated phenotypes may underlie many of the differences observed between these four species of Caenorhabditis nematodes. These findings are further supported by the correlative higher daf-16 expression levels among the gonochoristic species and significantly higher lifespan, immunity and stress tolerance in the constitutively active daf-16 hermaphroditic mutants.	[Amrit, Francis R. G.; Boehnisch, Claudia M. L.; May, Robin C.] Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham, W Midlands, England	University of Birmingham	Amrit, FRG (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham, W Midlands, England.	r.c.may@bham.ac.uk	Amrit, Francis/AAU-1222-2021; May, Robin Charles/ABA-9266-2021	Amrit, Francis/0000-0003-1928-3234; May, Robin Charles/0000-0001-5364-1838	BBSRC [BB/F000138/1]; Darwin Trust of Edinburgh; MRC; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/F000138/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Darwin Trust of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was made possible with financial support from the BBSRC (BB/F000138/1) and the Darwin Trust of Edinburgh. Work in the May Laboratory is supported by the BBSRC, MRC and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; BERG MCW, 2006, GENETICS, V173, P677; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; FODOR A, 1983, NEMATOLOGICA, V29, P203, DOI 10.1163/187529283X00456; FRIEDMAN DB, 1988, GENETICS, V118, P75; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Galbadage T, 2008, MECH AGEING DEV, V129, P507, DOI 10.1016/j.mad.2008.04.012; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hope IA., 1999, C ELEGANS PRACTICAL; HUANG DW, 2008, RESOURCES, V4, P44; Inoue T, 2007, GENETICS, V177, P809, DOI 10.1534/genetics.107.078857; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiontke K, 2006, ECOLOGY CAENORHABDIT; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X; McCulloch D, 2003, AGING CELL, V2, P165, DOI 10.1046/j.1474-9728.2003.00047.x; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Partridge L, 2002, CURR BIOL, V12, pR544, DOI 10.1016/S0960-9822(02)01048-5; Patel MN, 2002, P NATL ACAD SCI USA, V99, P769, DOI 10.1073/pnas.012511099; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Riddle DL, 1997, C ELEGANS; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; van Helden J, 2000, NUCLEIC ACIDS RES, V28, P1000; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]	56	27	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9978	10.1371/journal.pone.0009978	http://dx.doi.org/10.1371/journal.pone.0009978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20369008	Green Submitted, gold, Green Published			2022-12-27	WOS:000276418200049
J	Garritty, C; Tsertsvadze, A; Tricco, AC; Sampson, M; Moher, D				Garritty, Chantelle; Tsertsvadze, Alexander; Tricco, Andrea C.; Sampson, Margaret; Moher, David			Updating Systematic Reviews: An International Survey	PLOS ONE			English	Article							QUESTIONNAIRES; STRATEGIES	Background: Systematic reviews (SRs) should be up to date to maintain their importance in informing healthcare policy and practice. However, little guidance is available about when and how to update SRs. Moreover, the updating policies and practices of organizations that commission or produce SRs are unclear. Methodology/Principal Findings: The objective was to describe the updating practices and policies of agencies that sponsor or conduct SRs. An Internet-based survey was administered to a purposive non-random sample of 195 healthcare organizations within the international SR community. Survey results were analyzed using descriptive statistics. The completed response rate was 58% (n = 114) from across 26 countries with 70% (75/107) of participants identified as producers of SRs. Among responders, 79% (84/107) characterized the importance of updating as high or very-high and 57% (60/106) of organizations reported to have a formal policy for updating. However, only 29% (35/106) of organizations made reference to a written policy document. Several groups (62/105; 59%) reported updating practices as irregular, and over half (53/103) of organizational respondents estimated that more than 50% of their respective SRs were likely out of date. Authors of the original SR (42/106; 40%) were most often deemed responsible for ensuring SRs were current. Barriers to updating included resource constraints, reviewer motivation, lack of academic credit, and limited publishing formats. Most respondents (70/100; 70%) indicated that they supported centralization of updating efforts across institutions or agencies. Furthermore, 84% (83/99) of respondents indicated they favoured the development of a central registry of SRs, analogous to efforts within the clinical trials community. Conclusions/Significance: Most organizations that sponsor and/or carry out SRs consider updating important. Despite this recognition, updating practices are not regular, and many organizations lack a formal written policy for updating SRs. This research marks the first baseline data available on updating from an organizational perspective.	[Garritty, Chantelle; Tsertsvadze, Alexander; Tricco, Andrea C.; Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada; [Garritty, Chantelle] Univ Toronto, Fac Med, Dept Publ Hlth Sci, Toronto, ON, Canada; [Sampson, Margaret] Univ Wales, Dept Informat Studies, Aberystwyth, Dyfed, Wales; [Sampson, Margaret] Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Aberystwyth University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa	Garritty, C (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada.	cgarritty@ohri.ca	Garritty, Chantelle/ABG-7790-2020; Sampson, Margaret/A-9128-2011; Tricco, Andrea/B-9920-2011; Garritty, Chantelle Marie/AAC-4136-2022	Sampson, Margaret/0000-0003-2550-9893; Tricco, Andrea/0000-0002-4114-8971; Moher, David/0000-0003-2434-4206	Agency for Healthcare Research and Quality (AHRQ); Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI)	This work was funded in part by the Agency for Healthcare Research and Quality (AHRQ) and in-kind support from the Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support provided to Dr. David Moher as a University of Ottawa Research Chair, and to Dr. Andrea Tricco who received a University of Ottawa National Excellence Scholarship and a Canadian Institutes of Health Research Canada Graduate Award at the time of study conduct.	Brown M, 2007, PLOS MED, V4, P1421, DOI 10.1371/journal.pmed.0040288; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; DILLON A, 2005, UPDATING GUIDELINES; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Ervin AM, 2008, PAEDIATR PERINAT EP, V22, P33, DOI 10.1111/j.1365-3016.2007.00910.x; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; GARRITTY C, 2009, UPDATING SYSTEMATIC, P53; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Leece P, 2004, J MED INTERNET RES, V6, P26, DOI 10.2196/jmir.6.3.e30; Meltzer DO., 2009, IMPLEMENTING COMP EF, P15; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; Moher D, 2007, J CLIN EPIDEMIOL, V60, P1095, DOI 10.1016/j.jclinepi.2007.03.008; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; *NAT LIB MED, FACT SHEET ERR RETR; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Shojania KG, 2007, AHRQ PUBLICATION; Wyatt JC, 2000, J AM MED INFORM ASSN, V7, P426, DOI 10.1136/jamia.2000.0070426	17	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9914	10.1371/journal.pone.0009914	http://dx.doi.org/10.1371/journal.pone.0009914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376338	Green Submitted, gold, Green Published			2022-12-27	WOS:000276418200008
J	Gordon, A; Videa, E; Saborio, S; Lopez, R; Kuan, G; Balmaseda, A; Harris, E				Gordon, Aubree; Videa, Elsa; Saborio, Saira; Lopez, Roger; Kuan, Guillermina; Balmaseda, Angel; Harris, Eva			Diagnostic Accuracy of a Rapid Influenza Test for Pandemic Influenza A H1N1	PLOS ONE			English	Article							CHILDREN; IMPACT; PERFORMANCE; MANAGEMENT	Background: With the current influenza A H1N1 pandemic (H1N1pdm), it is extremely important that clinicians can quickly and accurately identify influenza cases. Methodology/Principal Findings: To investigate the performance of the QuickVue Influenza A+B rapid test, we conducted a prospective study of the diagnostic accuracy of the QuickVue Influenza A+B test compared to real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for influenza A H1N1pdm in Nicaraguan children aged 2 to 14 years. Rapid test sensitivity and specificity compared to real-time RT-PCR were 64.1% (95% CI 53.5, 73.9) and 98.3% (95.0, 99.6), respectively. Agreement between the two tests was 86.4% (95% CI 81.7, 90.3), and kappa was calculated to be 0.67 (95% CI 0.56, 0.76). Performance of the rapid test varied by day of presentation, with a sensitivity of 41.7% (95% CI 22.1, 63.4) for samples from children presenting on the day of symptom onset and a sensitivity of 72.1% (95% CI 59.9, 82.3) for samples from children presenting one or more days post-symptom onset. Conclusions/Significance: We found that the rapid test performed with moderate sensitivity and high specificity. Test performance varied by day of onset, with lower sensitivity on the day of symptom onset.	[Gordon, Aubree] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA; [Gordon, Aubree] NIH, John E Fogarty Int Ctr, Bethesda, MD 20892 USA; [Videa, Elsa] Sustainable Sci Inst, Managua, Nicaragua; [Saborio, Saira; Lopez, Roger; Balmaseda, Angel] Minist Hlth, Dept Virol, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua; [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua; [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; University of California System; University of California Berkeley	Gordon, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA.	aubree@berkeley.edu	Gordon, Aubree/X-1113-2019	Gordon, Aubree/0000-0002-9352-7877	John E. Fogarty International Center; National Institutes of Allergy and Infectious Disease; Pediatric Dengue Vaccine Initiative [VE-1]	John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pediatric Dengue Vaccine Initiative	This study was funded by the John E. Fogarty International Center, the National Institutes of Allergy and Infectious Disease, and the Pediatric Dengue Vaccine Initiative (VE-1). Rapid tests were provided free of charge by Quidel Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanses JC, 2006, PEDIATR EMERG CARE, V22, P145, DOI 10.1097/01.pec.0000202454.19237.b0; Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gordon A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007907; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; KOK J, 2009, J CLIN MICROBIO 1104; Poehling KA, 2006, ARCH PEDIAT ADOL MED, V160, P713, DOI 10.1001/archpedi.160.7.713; SUNTARATTIWONG P, 2009, PEDIAT INFECT D 1125; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; WATCHARANANAN S, 2009, J INFECT        1027	16	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10364	10.1371/journal.pone.0010364	http://dx.doi.org/10.1371/journal.pone.0010364			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442773	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200006
J	Isingrini, E; Camus, V; Le Guisquet, AM; Pingaud, M; Devers, S; Belzung, C				Isingrini, Elsa; Camus, Vincent; Le Guisquet, Anne-Marie; Pingaud, Maryse; Devers, Severine; Belzung, Catherine			Association between Repeated Unpredictable Chronic Mild Stress (UCMS) Procedures with a High Fat Diet: A Model of Fluoxetine Resistance in Mice	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; DEFINED VASCULAR DEPRESSION; STAR-ASTERISK-D; HIPPOCAMPAL NEUROGENESIS; RISK-FACTORS; SUBCORTICAL HYPERINTENSITIES; ANTIDEPRESSANT REVERSAL; GERIATRIC DEPRESSION; SUCROSE PREFERENCE; STRAIN DIFFERENCES	Major depressive disorder is a debilitating disease. Unfortunately, treatment with antidepressants (ADs) has limited therapeutic efficacy since resistance to AD is common. Research in this field is hampered by the lack of a reliable natural animal model of AD resistance. Depression resistance is related to various factors, including the attendance of cardiovascular risk factors and past depressive episodes. We aimed to design a rodent model of depression resistance to ADs, associating cardiovascular risk factors with repeated unpredicted chronic mild stress (UCMS). Male BALB/c mice were given either a regular (4% fat) or a high fat diet (45% fat) and subjected to two 7-week periods of UCMS separated by 6 weeks. From the second week of each UCMS procedure, vehicle or fluoxetine (10 mg/kg, i.p.) was administrated daily. The effects of the UCMS and fluoxetine in both diet conditions were assessed using physical (coat state and body weight) and behavioural tests (the reward maze test and the splash test). The results demonstrate that during the second procedure, UCMS induced behavioural changes, including coat state degradation, disturbances in self-care behaviour (splash test) and anhedonia (reward maze test) and these were reversed by fluoxetine in the regular diet condition. In contrast, the high-fat diet regimen prevented the AD fluoxetine from abolishing the UCMS-induced changes. In conclusion, by associating UCMS-an already validated animal model of depression-with high-fat diet regimen, we designed a naturalistic animal model of AD resistance related to a sub-nosographic clinical entity of depression.	[Isingrini, Elsa; Camus, Vincent; Le Guisquet, Anne-Marie; Pingaud, Maryse; Devers, Severine; Belzung, Catherine] Univ Tours, ERL 3106, CNRS, INSERM,U930,UMRS UMR, Tours, France; [Camus, Vincent] CHRU Tours, Clin Psychiat Univ, Tours, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Isingrini, E (corresponding author), Univ Tours, ERL 3106, CNRS, INSERM,U930,UMRS UMR, Tours, France.	Isingrini.elsa@voila.fr	Camus, Vincent/ABC-4021-2020; Belzung, Catherine/P-6512-2016; Elsa, Isingrini/T-2406-2018	Belzung, Catherine/0000-0001-6095-5974; Elsa, Isingrini/0000-0002-0698-4237; Camus, Vincent/0000-0002-6845-221X				Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Alexopoulos GS, 2004, NEUROPSYCHOPHARMACOL, V29, P2278, DOI 10.1038/sj.npp.1300557; Alexopoulos GS, 1997, AM J PSYCHIAT, V154, P562; Camus V, 2004, J AFFECT DISORDERS, V81, P1, DOI 10.1016/j.jad.2003.08.003; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; Cryan JF, 2001, J PHARMACOL EXP THER, V298, P651; Ducottet C, 2004, BEHAV BRAIN RES, V155, P291, DOI 10.1016/j.bbr.2004.04.020; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Hickie I, 1997, BIOL PSYCHIAT, V42, P367, DOI 10.1016/S0006-3223(96)00363-0; HICKIE I, 1995, BIOL PSYCHIAT, V37, P151, DOI 10.1016/0006-3223(94)00174-2; Ibarguen-Vargas Y, 2009, BEHAV BRAIN RES, V202, P245, DOI 10.1016/j.bbr.2009.03.040; Ibarguen-Vargas Y, 2008, PSYCHONEUROENDOCRINO, V33, P1357, DOI 10.1016/j.psyneuen.2008.07.010; Iosifescu DV, 2005, PSYCHOSOM MED, V67, P703, DOI 10.1097/01.psy.0000170338.75346.d0; Jama A, 2008, PSYCHOPHARMACOLOGY, V198, P333, DOI 10.1007/s00213-008-1126-7; Jans V, 2006, Tijdschr Psychiatr, V48, P223; Kaymaz N, 2008, J CLIN PSYCHIAT, V69, P1423, DOI 10.4088/JCP.v69n0910; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kong H, 2009, NEUROPSYCHOPHARMACOL, V34, P1263, DOI 10.1038/npp.2008.185; Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Lyness JM, 2000, AM J PSYCHIAT, V157, P1499, DOI 10.1176/appi.ajp.157.9.1499; Mast BT, 2004, AM J GERIAT PSYCHIAT, V12, P93, DOI 10.1176/appi.ajgp.12.1.93; Mineur YS, 2006, BEHAV BRAIN RES, V175, P43, DOI 10.1016/j.bbr.2006.07.029; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Papakostas GI, 2003, NEUROPSYCHOBIOLOGY, V47, P146, DOI 10.1159/000070584; Partonen T, 1999, BRIT J PSYCHIAT, V175, P259, DOI 10.1192/bjp.175.3.259; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sonawalla SB, 2002, PSYCHOSOMATICS, V43, P310, DOI 10.1176/appi.psy.43.4.310; Souery D, 2007, J CLIN PSYCHIAT, V68, P1062, DOI 10.4088/JCP.v68n0713; Steegmans PHA, 2000, PSYCHOSOM MED, V62, P205, DOI 10.1097/00006842-200003000-00009; Steiner MA, 2008, PHARMACOGENOMICS J, V8, P196, DOI 10.1038/sj.tpj.6500466; Stewart LQ, 2008, PSYCHONEUROENDOCRINO, V33, P405, DOI 10.1016/j.psyneuen.2007.12.009; Surget A, 2008, EXPT MODELS NEUROBEH, P79; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Yalcin I, 2008, BEHAV BRAIN RES, V193, P140, DOI 10.1016/j.bbr.2008.04.021; Yalcin I, 2007, BEHAV PHARMACOL, V18, P623, DOI 10.1097/FBP.0b013e3282eff109	45	149	151	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10404	10.1371/journal.pone.0010404	http://dx.doi.org/10.1371/journal.pone.0010404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436931	Green Published, Green Submitted, gold			2022-12-27	WOS:000277154200030
J	Montaner, D; Dopazo, J				Montaner, David; Dopazo, Joaquin			Multidimensional Gene Set Analysis of Genomic Data	PLOS ONE			English	Article							WIDE ASSOCIATION; EXPRESSION DATA; BREAST-CANCER; BIOLOGICAL PROCESSES; MICROARRAY DATA; ONTOLOGY; ENRICHMENT; DISCOVERY; TERMS; TOOL	Understanding the functional implications of changes in gene expression, mutations, etc., is the aim of most genomic experiments. To achieve this, several functional profiling methods have been proposed. Such methods study the behaviour of different gene modules (e.g. gene ontology terms) in response to one particular variable (e.g. differential gene expression). In spite to the wealth of information provided by functional profiling methods, a common limitation to all of them is their inherent unidimensional nature. In order to overcome this restriction we present a multidimensional logistic model that allows studying the relationship of gene modules with different genome-scale measurements (e.g. differential expression, genotyping association, methylation, copy number alterations, heterozygosity, etc.) simultaneously. Moreover, the relationship of such functional modules with the interactions among the variables can also be studied, which produces novel results impossible to be derived from the conventional unidimensional functional profiling methods. We report sound results of gene sets associations that remained undetected by the conventional one-dimensional gene set analysis in several examples. Our findings demonstrate the potential of the proposed approach for the discovery of new cell functionalities with complex dependences on more than one variable.	[Montaner, David; Dopazo, Joaquin] CIPF, Dept Bioinformat & Genom, Valencia, Spain; [Montaner, David; Dopazo, Joaquin] CIPF, Funct Genom Node INB, Valencia, Spain; [Dopazo, Joaquin] CIBERER, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Montaner, D (corresponding author), CIPF, Dept Bioinformat & Genom, Valencia, Spain.	jdopazo@cipf.es	Dopazo, Joaquin/A-9270-2014; Montaner, David/A-9362-2014	Dopazo, Joaquin/0000-0003-3318-120X; Montaner, David/0000-0002-2484-3278	Spanish Ministry of Science and Innovation [BIO2008-04212]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/1019]; Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Science and Innovation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is supported by grants from project BIO BIO2008-04212 from the Spanish Ministry of Science and Innovation. The National Institute of Bioinformatics (www.inab.org), is a platform of Genoma Espana. The CIBER de Enfermedades Raras is an initiative of the ISCIII. The RTICC is an initiative of the ISCIII. This work is also partly supported by a grant (RD06/0020/1019) from Red Tematica de Investigacion Cooperativa en Cancer ( RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Al-Shahrour F, 2005, BIOINFORMATICS, V21, P2988, DOI 10.1093/bioinformatics/bti457; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bardelli A, 2005, CURR OPIN GENET DEV, V15, P5, DOI 10.1016/j.gde.2004.12.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentink S, 2008, LEUKEMIA, V22, P1746, DOI 10.1038/leu.2008.166; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bitton DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-118; Bonifaci N, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-62; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Dopazo J, 2006, OMICS, V10, P398, DOI 10.1089/omi.2006.10.398; Dopazo J, 2009, ARTIF INTELL MED, V45, P97, DOI 10.1016/j.artmed.2008.08.003; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garcia-Martinez J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r222; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang BH, 2008, INDIAN J MAR SCI, V37, P13; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; McLendon R, 2008, NATURE; Medina I, 2009, NUCLEIC ACIDS RES, V37, pW340, DOI 10.1093/nar/gkp481; Montaner D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-197; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Okoniewski MJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040006; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perez-Ortin Jose E., 2007, Briefings in Functional Genomics & Proteomics, V6, P282, DOI 10.1093/bfgp/elm029; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Singh RK, 1996, CANCER INVEST, V14, P6, DOI 10.3109/07357909609018433; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Srinivasan K, 2005, METHODS, V37, P345, DOI 10.1016/j.ymeth.2005.09.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070	50	53	53	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10348	10.1371/journal.pone.0010348	http://dx.doi.org/10.1371/journal.pone.0010348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436964	gold, Green Submitted, Green Published			2022-12-27	WOS:000277079700007
J	King, LE; Soltis, J; Douglas-Hamilton, I; Savage, A; Vollrath, F				King, Lucy E.; Soltis, Joseph; Douglas-Hamilton, Iain; Savage, Anne; Vollrath, Fritz			Bee Threat Elicits Alarm Call in African Elephants	PLOS ONE			English	Article							ACOUSTIC STRUCTURE; VOCALIZATIONS; DISTANCE; COMMUNICATION; EXPRESSION; RESPONSES; CONFLICT; IDENTITY; MONKEYS	Unlike the smaller and more vulnerable mammals, African elephants have relatively few predators that threaten their survival. The sound of disturbed African honeybees Apis meliffera scutellata causes African elephants Loxodonta africana to retreat and produce warning vocalizations that lead other elephants to join the flight. In our first experiment, audio playbacks of bee sounds induced elephants to retreat and elicited more head-shaking and dusting, reactive behaviors that may prevent bee stings, compared to white noise control playbacks. Most importantly, elephants produced distinctive "rumble" vocalizations in response to bee sounds. These rumbles exhibited an upward shift in the second formant location, which implies active vocal tract modulation, compared to rumbles made in response to white noise playbacks. In a second experiment, audio playbacks of these rumbles produced in response to bees elicited increased headshaking, and further and faster retreat behavior in other elephants, compared to control rumble playbacks with lower second formant frequencies. These responses to the bee rumble stimuli occurred in the absence of any bees or bee sounds. This suggests that these elephant rumbles may function as referential signals, in which a formant frequency shift alerts nearby elephants about an external threat, in this case, the threat of bees.	[King, Lucy E.; Douglas-Hamilton, Iain; Vollrath, Fritz] Univ Oxford, Dept Zool, Anim Behav Res Grp, Oxford OX1 3PS, England; [Soltis, Joseph; Savage, Anne] Disneys Anim Kingdom, Educ & Sci, Bay Lake, FL USA; [King, Lucy E.; Douglas-Hamilton, Iain; Vollrath, Fritz] Save Elephants, Nairobi, Kenya	University of Oxford; Walt Disney Company	King, LE (corresponding author), Univ Oxford, Dept Zool, Anim Behav Res Grp, S Parks Rd, Oxford OX1 3PS, England.	lucy.king@zoo.ox.ac.uk		King, Dr Lucy/0000-0002-2877-5225; Vollrath, Fritz/0000-0003-3484-9005	ESRC/NERC; Disney Worldwide Conservation; Save the Elephants	ESRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Disney Worldwide Conservation; Save the Elephants	ESRC/NERC Joint Studentship Grant; Disney Worldwide Conservation Fund; Save the Elephants. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bates LA, 2007, CURR BIOL, V17, P1938, DOI 10.1016/j.cub.2007.09.060; BAYART F, 1990, BEHAV NEUROSCI, V104, P98, DOI 10.1037/0735-7044.104.1.98; Blumstein DT, 1997, ANIM BEHAV, V53, P143, DOI 10.1006/anbe.1996.0285; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Fichtel C, 2002, ETHOLOGY, V108, P763, DOI 10.1046/j.1439-0310.2002.00816.x; Hoare R, 2000, ORYX, V34, P34, DOI 10.1017/S0030605300030878; King LE, 2007, CURR BIOL, V17, pR832, DOI 10.1016/j.cub.2007.07.038; King LE, 2009, AFR J ECOL, V47, P131, DOI 10.1111/j.1365-2028.2009.01114.x; Langbauer WR, 2000, ZOO BIOL, V19, P425, DOI 10.1002/1098-2361(2000)19:5&lt;425::AID-ZOO11&gt;3.0.CO;2-A; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Leong K. M., 2003, Bioacoustics, V13, P213; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; MCCOMB K, AMBOSELI EL IN PRESS; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Monticelli PE, 2004, AN ACAD BRAS CIENC, V76, P368, DOI 10.1590/S0001-37652004000200027; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; SHAW RG, 1993, ECOLOGY, V74, P1638, DOI 10.2307/1939922; SOLTIS J, ZOO BIOL IN PRESS; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Titze IR, 1994, PRINCIPLES VOICE PRO; Vollrath F, 2002, NATURWISSENSCHAFTEN, V89, P508, DOI 10.1007/s00114-002-0375-2; Wesolek CM, 2009, BIOACOUSTICS, V18, P227, DOI 10.1080/09524622.2009.9753603; Wittemyer G, 2007, ANIM BEHAV, V73, P671, DOI 10.1016/j.anbehav.2006.10.008; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wood JD, 2005, BIOACOUSTICS, V15, P143, DOI 10.1080/09524622.2005.9753544; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334; Zuberbuhler K, 2000, ANIM BEHAV, V59, P917, DOI 10.1006/anbe.1999.1317	35	36	36	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10346	10.1371/journal.pone.0010346	http://dx.doi.org/10.1371/journal.pone.0010346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436682	Green Published, gold			2022-12-27	WOS:000277079500016
J	Wong, A				Wong, Albert			Quantitative Modeling of the High-Throughput Production and In Vivo Kinetics of (Drug-Encapsulating) Liposomes	PLOS ONE			English	Article							EGF	In developing liposomes for in vivo use, it is important to design the liposomes to have optimal in vivo kinetics, and it is also necessary to identify optimal high-throughput production conditions for these liposomes. Previous work has not definitively established the general relationship between liposomes' configuration and composition, and their in vivo kinetics. Also, no straightforward method exists to calculate optimal liposome high-throughput production conditions for specific liposome compositions. This work presents first-principles quantitative correlations describing liposomes' in vivo drug leakage and vascular mass transfer kinetics. This work further presents a simple quantitative model relating specific liposome compositions to ideal high-throughput production parameters. The results have implications for the identification of promising liposome compositions via high-throughput screening methodologies, as well as the design and optimization of high-throughput reactors for liposome production.	Yale Univ, Program Biol & Biomed Sci, New Haven, CT 06520 USA	Yale University	Wong, A (corresponding author), Yale Univ, Program Biol & Biomed Sci, New Haven, CT 06520 USA.	albert.wong@yale.edu			MIT Office of the Provost; MIT Portugal	MIT Office of the Provost; MIT Portugal	This work was supported by funding from the MIT Office of the Provost and the MIT Portugal Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro AL, 2004, PROG COLL POL SCI S, V128, P273, DOI 10.1007/b97107; COLTON CK, 1971, AICHE J, V17, P773, DOI 10.1002/aic.690170404; Deen, 1998, ANAL TRANSPORT PHENO; Ishida O, 2001, PHARMACEUT RES, V18, P1042, DOI 10.1023/A:1010960900254; Johnston MJW, 2006, BBA-BIOMEMBRANES, V1758, P55, DOI 10.1016/j.bbamem.2006.01.009; Kullberg EB, 2002, BIOCONJUGATE CHEM, V13, P737, DOI 10.1021/bc0100713; ROSS SM, 1974, J FLUID MECH, V63, P157, DOI 10.1017/S0022112074001066; Scott Fogler H., 2006, ELEMENTS CHEM REACTI; Semple SC, 2005, J PHARMACOL EXP THER, V312, P1020, DOI 10.1124/jpet.104.078113; Suita T, 1997, ANAL SCI, V13, P577, DOI 10.2116/analsci.13.577; Wong A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007391	11	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10280	10.1371/journal.pone.0010280	http://dx.doi.org/10.1371/journal.pone.0010280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428243	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300005
J	Deng, S; Yang, XJ; Lassus, H; Liang, S; Kaur, S; Ye, QR; Li, CS; Wang, LP; Roby, KF; Orsulic, S; Connolly, DC; Zhang, YC; Montone, K; Butzow, R; Coukos, G; Zhang, L				Deng, Shan; Yang, Xiaojun; Lassus, Heini; Liang, Shun; Kaur, Sippy; Ye, Qunrui; Li, Chunsheng; Wang, Li-Ping; Roby, Katherine F.; Orsulic, Sandra; Connolly, Denise C.; Zhang, Youcheng; Montone, Kathleen; Butzow, Ralf; Coukos, George; Zhang, Lin			Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; PROGENITOR CELLS; OVARIAN-CANCER; PHENOTYPIC CHARACTERIZATION; IN-VIVO; IDENTIFICATION; CHEMOTHERAPY; TUMORIGENESIS; ASSOCIATION	Aldehyde dehydrogenase isoform 1 (ALDH1) has been proved useful for the identification of cancer stem cells. However, our knowledge of the expression and activity of ALDH1 in common epithelial cancers and their corresponding normal tissues is still largely absent. Therefore, we characterized ALDH1 expression in 24 types of normal tissues and a large collection of epithelial tumor specimens (six cancer types, n = 792) by immunohistochemical staining. Using the ALDEFUOR assay, ALDH1 activity was also examined in 16 primary tumor specimens and 43 established epithelial cancer cell lines. In addition, an ovarian cancer transgenic mouse model and 7 murine ovarian cancer cell lines were analyzed. We found that the expression levels and patterns of ALDH1 in epithelial cancers are remarkably distinct, and they correlate with their corresponding normal tissues. ALDH1 protein expression levels are positively correlated with ALDH1 enzymatic activity measured by ALDEFLUOR assay. Long-term in vitro culture doesn't significantly affect ALDH1 activity in epithelial tumor cells. Consistent with research on other cancers, we found that high ALDH1 expression is significantly associated with poor clinical outcomes in serous ovarian cancer patients (n = 439, p = 0.0036). Finally, ALDH(br) tumor cells exhibit cancer stem cell properties and are resistant to chemotherapy. As a novel cancer stem cell marker, ALDH1 can be used for tumors whose corresponding normal tissues express ALDH1 in relatively restricted or limited levels such as breast, lung, ovarian or colon cancer.	[Deng, Shan; Yang, Xiaojun; Liang, Shun; Ye, Qunrui; Li, Chunsheng; Coukos, George; Zhang, Lin] Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Wang, Li-Ping; Montone, Kathleen] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Deng, Shan] Chinese Acad Med Sci, Peking Union Med Coll, Dept Obstet & Gynecol, Beijing 100037, Peoples R China; [Yang, Xiaojun; Zhang, Youcheng] Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730000, Peoples R China; [Lassus, Heini; Kaur, Sippy; Butzow, Ralf] Univ Helsinki, Dept Obstet & Gynecol & Pathol, Helsinki, Finland; [Lassus, Heini; Kaur, Sippy; Butzow, Ralf] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Roby, Katherine F.] Univ Kansas, Ctr Reprod Sci, Kansas City, KS USA; [Orsulic, Sandra] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Connolly, Denise C.] Fox Chase Canc Ctr, Womens Canc Program, Philadelphia, PA 19111 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Lanzhou University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Kansas; Cedars Sinai Medical Center; Fox Chase Cancer Center	Deng, S (corresponding author), Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Zhang, Lin/K-8478-2012; Coukos, George/ABG-7389-2020; Li, chunsheng/G-4418-2011	Coukos, George/0000-0001-8813-7367; Lassus, Heini/0000-0003-0598-5147	Breast Cancer Alliance; Ovarian Cancer Research Found; Mary Kay Ash Charitable Foundation; National Cancer Institute [R01CA142776, P50-CA83638-7951]; US Department of Defense [W81XWH-10-1-0082]; NATIONAL CANCER INSTITUTE [P50CA083638, R01CA142776] Funding Source: NIH RePORTER	Breast Cancer Alliance; Ovarian Cancer Research Found; Mary Kay Ash Charitable Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Breast Cancer Alliance (LZ), the Ovarian Cancer Research Found (Liz Tilberis Scholar, LZ), the Mary Kay Ash Charitable Foundation (LZ), National Cancer Institute (R01CA142776 and Ovarian Cancer SPORE P50-CA83638-7951 project 3, LZ), and US Department of Defense (W81XWH-10-1-0082, LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BURGER PE, 2009, STEM CELLS; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Connolly DC, 2003, CANCER RES, V63, P1389; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dontu G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2130; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gentry T, 2007, CYTOTHERAPY, V9, P259, DOI 10.1080/14653240701218516; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee JT, 2007, J CELL PHYSIOL, V213, P603, DOI 10.1002/jcp.21252; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Wang L, 2010, INT J CANC; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1	53	313	330	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10277	10.1371/journal.pone.0010277	http://dx.doi.org/10.1371/journal.pone.0010277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422001	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952500022
J	Rozhdestvenskaya, AS; Totolian, AA; Dmitriev, AV				Rozhdestvenskaya, Anastasia S.; Totolian, Artem A.; Dmitriev, Alexander V.			Inactivation of DNA-Binding Response Regulator Sak189 Abrogates beta-Antigen Expression and Affects Virulence of Streptococcus agalactiae	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; GROUP-B STREPTOCOCCI; COMPLETE GENOME SEQUENCE; CLONALLY RELATED GROUPS; WALL-SPANNING DOMAIN; STRAIN R6; BAC GENE; SYSTEM; PROTEIN; PNEUMONIAE	Background: Streptococcus agalactiae is able to colonize numerous tissues employing different mechanisms of gene regulation, particularly via two-component regulatory systems. These systems sense the environmental stimuli and regulate expression of the genes including virulence genes. Recently, the novel two-component regulatory system Sak188/Sak189 was identified. In S. agalactiae genome, it was adjacent to the bac gene encoding for beta-antigen, an important virulence factor. Methodology/Principal Findings: In this study, the sak188 and sak189 genes were inactivated, and the functional role of Sak188/Sak189 two-component system in regulation of the beta-antigen expression was investigated. It was demonstrated that both transcription of bac gene and expression of encoded beta-antigen were controlled by Sak189 response regulator, but not Sak188 histidine kinase. It was also found that the regulation occurred at transcriptional level. Finally, insertional inactivation of sak189 gene, but not sak188 gene, significantly affected virulent properties of S. agalactiae. Conclusions/Significance: Sak189 response regulator is necessary for activation of bac gene transcription. It also controls the virulent properties of S. agalactiae. Given that the primary functional role of Sak188/Sak189 two-component systems is a control of bac gene transcription, this system can be annotated as BgrR/S ( bac gene regulatory system).	[Rozhdestvenskaya, Anastasia S.; Totolian, Artem A.; Dmitriev, Alexander V.] Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences	Rozhdestvenskaya, AS (corresponding author), Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia.	admitriev10@yandex.ru	Dmitriev, Alexander/C-9407-2012; Totolian, Artem/J-4218-2014	Totolian, Artem/0000-0002-3310-9294				Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Berner R, 2002, PEDIATR RES, V51, P106, DOI 10.1203/00006450-200201000-00019; BRADY LJ, 1989, INFECT IMMUN, V57, P1573, DOI 10.1128/IAI.57.5.1573-1581.1989; Dmitriev A, 2006, FOLIA MICROBIOL, V51, P229, DOI 10.1007/BF02932127; Dmitriev A, 2002, FEMS MICROBIOL LETT, V208, P93, DOI 10.1111/j.1574-6968.2002.tb11066.x; Dmitriev A, 1999, FOLIA MICROBIOL, V44, P449, DOI 10.1007/BF02903721; Dogan B, 2005, J CLIN MICROBIOL, V43, P5899, DOI 10.1128/JCM.43.12.5899-5906.2005; Dopazo J, 2001, MICROB DRUG RESIST, V7, P99, DOI 10.1089/10766290152044995; Facklam RR, 1991, MANUAL CLIN MICROBIO, P238; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; GRUBB A, 1982, INT ARCH ALLER A IMM, V67, P369, DOI 10.1159/000233049; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hynes W, 2009, MICROB PATHOGENESIS, V47, P308, DOI 10.1016/j.micpath.2009.09.008; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; JERLSTROM PG, 1991, MOL MICROBIOL, V5, P843, DOI 10.1111/j.1365-2958.1991.tb00757.x; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Johnson DR., 1996, LAB DIAGNOSIS GROUP; Keefe GP, 1997, CAN VET J, V38, P429; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kong FR, 2006, J MED MICROBIOL, V55, P829, DOI 10.1099/jmm.0.46307-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LEONTEVA GF, 2005, ZH MIKROBIOL EPIDEMI, V2, P35; Ma Z, 2007, J BACTERIOL, V189, P2497, DOI 10.1128/JB.01429-06; Maniatis T., 1982, MOL CLONING; Murdoch C, 2002, J INFECT DIS, V186, P1253, DOI 10.1086/344527; Nagano N, 2006, MICROBIOL-SGM, V152, P771, DOI 10.1099/mic.0.28535-0; Nagano N, 2002, INFECT IMMUN, V70, P4643, DOI 10.1128/IAI.70.8.4643-4649.2002; Panda B, 2009, J MATERN-FETAL NEO M, V22, P111, DOI 10.1080/14767050802488212; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; Standish AJ, 2007, J BACTERIOL, V189, P5591, DOI 10.1128/JB.00335-07; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Towbin H, 1992, Biotechnology, V24, P145	44	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10212	10.1371/journal.pone.0010212	http://dx.doi.org/10.1371/journal.pone.0010212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419089	Green Submitted, Green Published, gold			2022-12-27	WOS:000276853800009
J	Divoli, A; Wooldridge, MA; Hearst, MA				Divoli, Anna; Wooldridge, Michael A.; Hearst, Marti A.			Full Text and Figure Display Improves Bioscience Literature Search	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPE IMAGES; INFORMATION EXTRACTION; ARTICLES; CLASSIFICATION; NETWORK; ENGINE	When reading bioscience journal articles, many researchers focus attention on the figures and their captions. This observation led to the development of the BioText literature search engine [1], a freely available Web-based application that allows biologists to search over the contents of Open Access Journals, and see figures from the articles displayed directly in the search results. This article presents a qualitative assessment of this system in the form of a usability study with 20 biologist participants using and commenting on the system. 19 out of 20 participants expressed a desire to use a bioscience literature search engine that displays articles' figures alongside the full text search results. 15 out of 20 participants said they would use a caption search and figure display interface either frequently or sometimes, while 4 said rarely and 1 said undecided. 10 out of 20 participants said they would use a tool for searching the text of tables and their captions either frequently or sometimes, while 7 said they would use it rarely if at all, 2 said they would never use it, and 1 was undecided. This study found evidence, supporting results of an earlier study, that bioscience literature search systems such as PubMed should show figures from articles alongside search results. It also found evidence that full text and captions should be searched along with the article title, metadata, and abstract. Finally, for a subset of users and information needs, allowing for explicit search within captions for figures and tables is a useful function, but it is not entirely clear how to cleanly integrate this within a more general literature search interface. Such a facility supports Open Access publishing efforts, as it requires access to full text of documents and the lifting of restrictions in order to show figures in the search interface.	[Divoli, Anna; Wooldridge, Michael A.; Hearst, Marti A.] Univ Calif Berkeley, Sch Informat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Divoli, A (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hearst@ischool.berkeley.edu			National Science Foundation (NSF) [DBI-0317510]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported by National Science Foundation (NSF) grant DBI-0317510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agichtein E., 2006, P 29 ANN INT ACM SIG; Boren MT, 2000, IEEE T PROF COMMUN, V43, P261, DOI 10.1109/47.867942; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; CHRISTIANSEN A, 2007, P SPIE; Cohen W.W., 2003, P 9 ACM SIGKDD INT C; CZERWINSKI M, 1999, P HUM COMP INT INTER; DESERNO T, 2007, P SPIE; Divoli Anna, 2008, Pac Symp Biocomput, P568; DZIADOSZ S, 2002, P 25 ANN INT ACM SIG; Guan Z., 2007, P SIGCHI C HUM FACT; Hearst M, 2002, COMMUN ACM, V45, P42, DOI 10.1145/567498.567525; Hearst M. A., 2009, SEARCH USER INTERFAC; Hearst M. A., 2007, P BIONLP 2007 WORKSH; Hearst MA, 2007, BIOINFORMATICS, V23, P2196, DOI 10.1093/bioinformatics/btm301; HERSH W, 2006, 15 TEXT RETR C 2006; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; iProspect, 2006, IPROSPECT SEARCH ENG; Kaasten S, 2002, BCS CONF SERIES, P247; Kaisser M., 2008, P 46 ANN M ASS COMP; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; LIN J, 2008, INFORM PROCESSING MA; Lin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-423; Liu F, 2004, BIOINFORMATICS, V20, P2880, DOI 10.1093/bioinformatics/bth316; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Qian YT, 2008, BIOINFORMATICS, V24, P569, DOI 10.1093/bioinformatics/btm561; Rafkind B., 2006, P BIONLP WORKSH LINK; Shah PK, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-20; Shatkay H, 2006, BIOINFORMATICS, V22, pE446, DOI 10.1093/bioinformatics/btl235; SRIHARI R, 1991, P AAAI 91; SRIHARI RK, 1995, COMPUTER, V28, P49, DOI 10.1109/2.410153; Sun HS, 2006, INT J HUM-COMPUT ST, V64, P53, DOI 10.1016/j.ijhcs.2005.04.013; Venkatesh V., 2003, MANAGEMENT INFORM SY, V27, P18; Xu SH, 2008, BIOINFORMATICS, V24, P1968, DOI 10.1093/bioinformatics/btn340; Yee IC -P., 2003, P SIGCHI C HUM FACT; Yeh AS, 2003, BIOINFORMATICS, V19, pi331, DOI 10.1093/bioinformatics/btg1046; Yu H, 2006, BIOINFORMATICS, V22, pE547, DOI 10.1093/bioinformatics/btl261; Yu Hong, 2009, J Biomed Discov Collab, V4, P1, DOI 10.1186/1747-5333-4-1	38	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e9619	10.1371/journal.pone.0009619	http://dx.doi.org/10.1371/journal.pone.0009619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418942	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706800001
J	Lanni, C; Nardinocchi, L; Puca, R; Stanga, S; Uberti, D; Memo, M; Govoni, S; D'Orazi, G; Racchi, M				Lanni, Cristina; Nardinocchi, Lavinia; Puca, Rosa; Stanga, Serena; Uberti, Daniela; Memo, Maurizio; Govoni, Stefano; D'Orazi, Gabriella; Racchi, Marco			Homeodomain Interacting Protein Kinase 2: A Target for Alzheimer's Beta Amyloid Leading to Misfolded p53 and Inappropriate Cell Survival	PLOS ONE			English	Article							PRECURSOR PROTEIN; DISEASE PATIENTS; HYPOXIC RESPONSE; HIPK2; APOPTOSIS; FIBROBLASTS; PHOSPHORYLATION; CONFORMATION; DOXORUBICIN; SECRETION	Background: Homeodomain interacting protein kinase 2 (HIPK2) is an evolutionary conserved serine/threonine whose activity is fundamental in maintaining wild-type p53 function, thereby controlling the destiny of cells when to DNA damaging agents. We recently reported an altered conformational state of p53 in tissues from patients Alzheimer's Disease (AD) that led to an impaired and dysfunctional response to stressors. Methodology/Principal Findings: Here we examined the molecular mechanisms underlying the impairment of p53 in two cellular models, HEK-293 cells overexpressing the amyloid precursor protein and fibroblasts from AD starting from recent findings showing that p53 conformation may be regulated by HIPK2. We demonstrated that amyloid 1-40 induces HIPK2 degradation and alters HIPK2 binding activity to DNA, in turn regulating the conformational state and vulnerability to a noxious stimulus. Expression of HIPK2 was analysed by western experiments, whereas HIPK2 DNA binding was examined by chromatin immunoprecipitation analysis. In particular, evaluated the recruitment of HIPK2 onto some target promoters, including hypoxia inducible factor-1 alpha and 2A. Conclusions/Significance: These results support the existence of a novel amyloid-based pathogenetic mechanism in potentially leading to the survival of injured dysfunctional cells.	[Lanni, Cristina; Stanga, Serena; Govoni, Stefano; Racchi, Marco] Univ Pavia, Ctr Excellence Appl Biol, Dept Expt & Appl Pharmacol, I-27100 Pavia, Italy; [Nardinocchi, Lavinia; Puca, Rosa; D'Orazi, Gabriella] Natl Canc Inst Regina Elena, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Nardinocchi, Lavinia; Puca, Rosa; D'Orazi, Gabriella] Univ G DAnnunzio, Dept Oncol & Neurosci, Chieti, Italy; [Uberti, Daniela; Memo, Maurizio] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy	University of Pavia; G d'Annunzio University of Chieti-Pescara; University of Brescia	Lanni, C (corresponding author), Univ Pavia, Ctr Excellence Appl Biol, Dept Expt & Appl Pharmacol, Via Palestro 3, I-27100 Pavia, Italy.	cristina.lanni@unipv.it	Stanga, Serena/AAP-1558-2020; Govoni, Stefano/K-2965-2015; Racchi, Marco/G-6104-2018; Memo, Maurizio/C-2555-2011; Memo, Maurizio/AAK-7197-2020; Uberti, Daniela/K-1551-2019; Lanni, Cristina/AAI-2182-2020; D'Orazi, Gabriella/T-2792-2019	Govoni, Stefano/0000-0002-7243-6837; Racchi, Marco/0000-0002-7185-7808; D'Orazi, Gabriella/0000-0001-6876-9105; LANNI, CRISTINA/0000-0002-3061-4738; Stanga, Serena/0000-0003-1454-0713; UBERTI, Daniela Letizia/0000-0002-5926-9122; MEMO, Maurizio/0000-0002-7543-0289	Ministry of University and Research (MIUR) [2007HJCCSF]; CARIPLO; Fondo Ateneo Ricerca (University of Pavia); Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Italina per la Ricerca sul cancro (FIRC)	Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); CARIPLO(Fondazione Cariplo); Fondo Ateneo Ricerca (University of Pavia); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italina per la Ricerca sul cancro (FIRC)	This work was supported by the contribution of grants from the Ministry of University and Research (MIUR, Grant #2007HJCCSF to S. G.), CARIPLO to M. R., Fondo Ateneo Ricerca (University of Pavia to C. L., M. R. and S. G.) and from Associazione Italiana per la Ricerca sul Cancro (AIRC) (to G.D.O.). R. P. has been supported by a Fellowship from Fondazione Italina per la Ricerca sul cancro (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi S, 1995, NEUROSCI LETT, V201, P1, DOI 10.1016/0304-3940(95)12168-4; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Calzado MA, 2009, CELL CYCLE, V8, P1659, DOI 10.4161/cc.8.11.8597; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; Gasparini L, 1998, FASEB J, V12, P17, DOI 10.1096/fasebj.12.1.17; GOVONI S, 1993, NEUROLOGY, V43, P2581, DOI 10.1212/WNL.43.12.2581; HAINAUT P, 1993, CANCER RES, V53, P4469; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Lanni C, 2008, MOL PSYCHIATR, V13, P641, DOI 10.1038/sj.mp.4002060; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; Lanni C, 2007, J ALZHEIMERS DIS, V12, P93; Li H, 2009, NEUROBIOL AGING, V30, P2010, DOI 10.1016/j.neurobiolaging.2008.02.015; Meplan C, 2000, BIOCHEM PHARMACOL, V59, P25, DOI 10.1016/S0006-2952(99)00297-X; Nardinocchi L, 2010, CELL CYCLE, V9, P1270, DOI 10.4161/cc.9.7.11125; Nardinocchi L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006819; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Puca R, 2008, CANCER RES, V68, P3707, DOI 10.1158/0008-5472.CAN-07-6776; Puca R, 2009, EXP CELL RES, V315, P67, DOI 10.1016/j.yexcr.2008.10.018; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Ryu J, 2008, BIOCHEMISTRY-US, V47, P5328, DOI 10.1021/bi800012e; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Uberti D, 2002, J CELL SCI, V115, P3131; Uberti D, 2007, J NEUROCHEM, V103, P322, DOI 10.1111/j.1471-4159.2007.04757.x; Uberti D, 2006, NEUROBIOL AGING, V27, P1193, DOI 10.1016/j.neurobiolaging.2005.06.013; Verdile G, 2004, PHARMACOL RES, V50, P397, DOI 10.1016/j.phrs.2003.12.028; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; Zhang JS, 2007, NAT NEUROSCI, V10, P77, DOI 10.1038/nn1816	35	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10171	10.1371/journal.pone.0010171	http://dx.doi.org/10.1371/journal.pone.0010171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418953	gold, Green Published, Green Submitted			2022-12-27	WOS:000276706800013
J	Gjesing, AP; Larsen, LH; Torekov, SS; Hainerova, IA; Kapur, R; Johansen, A; Albrechtsen, A; Boj, S; Holst, B; Harper, A; Urhammer, SA; Borch-Johnsen, K; Pisinger, C; Echwald, SM; Eiberg, H; Astrup, A; Lebl, J; Ferrer, J; Schwartz, TW; Hansen, T; Pedersen, O				Gjesing, Anette P.; Larsen, Lesli H.; Torekov, Signe S.; Hainerova, Irena Aldhoon; Kapur, Rahul; Johansen, Anders; Albrechtsen, Anders; Boj, Sylvia; Holst, Birgitte; Harper, Angela; Urhammer, Soren A.; Borch-Johnsen, Knut; Pisinger, Charlotta; Echwald, Soren M.; Eiberg, Hans; Astrup, Arne; Lebl, Jan; Ferrer, Jorge; Schwartz, Thue W.; Hansen, Torben; Pedersen, Oluf			Family and Population-Based Studies of Variation within the Ghrelin Receptor Locus in Relation to Measures of Obesity	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; FOOD-INTAKE; GENE; ASSOCIATION; LINKAGE	Background: The growth hormone secretagogue receptor (GHSR) is mediating hunger sensation when stimulated by its natural ligand ghrelin. In the present study, we tested the hypothesis that common and rare variation in the GHSR locus are related to increased prevalence of obesity and overweight among Whites. Methodology/Principal Findings: In a population-based study sample of 15,854 unrelated, middle-aged Danes, seven variants were genotyped to capture common variation in an 11 kbp region including GHSR. These were investigated for their individual and haplotypic association with obesity. None of these analyses revealed consistent association with measures of obesity. A -151C/T promoter mutation in the GHSR was found in two unrelated obese patients. One family presented with complete co-segregation, but the other with incomplete co-segregation. The mutation resulted in an increased transcriptional activity (p < 0.02) and introduction of a specific binding for Sp-1-like nuclear extracts relative to the wild type. The -151C/T mutation was genotyped in the 15,854 Danes with a minor allele frequency of 0.01%. No association with obesity in carriers (mean BMI: 27 +/- 4 kg/m(2)) versus non-carriers (mean BMI: 28 +/- 5 kg/m(2)) (p > 0.05) could be shown. Conclusions/Significance: In a population-based study sample of 15,854 Danes no association between GHSR genotypes and measures of obesity and overweight was found. Also, analyses of GHSR haplotypes lack consistent associations with obesity related traits. A rare functional GHSR promoter mutation variant was identified, yet there was no consistent relationship with obesity in neither family- nor population-based studies.	[Gjesing, Anette P.; Torekov, Signe S.; Kapur, Rahul; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Larsen, Lesli H.; Johansen, Anders; Albrechtsen, Anders; Borch-Johnsen, Knut; Echwald, Soren M.; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Larsen, Lesli H.; Astrup, Arne] Univ Copenhagen, Inst Human Nutr, Copenhagen, Denmark; [Hainerova, Irena Aldhoon] Charles Univ Prague, Dept Paediat, Prague, Czech Republic; [Hainerova, Irena Aldhoon] Charles Univ Prague, Ctr Res Diabet Metab & Nutr, Fac Med 3, Prague, Czech Republic; [Boj, Sylvia; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Hosp Clin Barcelona, Endocrinol Unit, Barcelona, Spain; [Holst, Birgitte; Schwartz, Thue W.] Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Harper, Angela] Royal Vet & Agr Univ, Inst Human Nutr, Copenhagen, Denmark; [Urhammer, Soren A.] Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark; [Pisinger, Charlotta] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Echwald, Soren M.] Exiqon, Vedbaek, Denmark; [Eiberg, Hans] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Pisinger, Charlotta; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Lebl, Jan] Charles Univ Prague, Dept Pediat, Fac Med 2, Prague, Czech Republic	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; University of Copenhagen; Charles University Prague; Charles University Prague; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark; Charles University Prague	Gjesing, AP (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	apri@hagedorn.dk	Pedersen, Oluf/AAG-8015-2020; Lebl, Jan/D-9563-2017; Gjesing, Anette/ACC-7521-2022; Pedersen, Oluf/Z-1731-2019; Albrechtsen, Anders/K-4281-2013; Palmer, David/E-6824-2010; Larsen, Lesli H/D-2252-2011; Ferrer, Jorge/A-3176-2012; Astrup, Arne/B-1407-2015	Lebl, Jan/0000-0002-3365-5375; Gjesing, Anette/0000-0003-4580-1576; Pedersen, Oluf/0000-0002-3321-3972; Albrechtsen, Anders/0000-0001-7306-031X; Larsen, Lesli H/0000-0001-8827-7992; Ferrer, Jorge/0000-0002-5959-5729; Holst, Birgitte/0000-0001-7432-097X; Schwartz, Thue W./0000-0002-0261-6904; Torekov, Signe/0000-0001-6779-0252; Pisinger, Charlotta/0000-0002-7970-3168; Astrup, Arne/0000-0001-8968-8996	University of Copenhagen; Danish Diabetes Association; European Union [LSHM-CT-2005-018734]; Danish Medical Research Council; Danish Agency for Science Technology and Innovation [271-06-0539]; Czech Research Project of MSM [0021620814]; Novo Nordisk	University of Copenhagen; Danish Diabetes Association; European Union(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science Technology and Innovation; Czech Research Project of MSM; Novo Nordisk(Novo Nordisk)	The study is part of the DanORC project (http://www.danorc.dk) and was additionally supported by the University of Copenhagen, the Danish Diabetes Association, the European Union (HEPADIP, grant no. LSHM-CT-2005-018734), the Danish Medical Research Council, the Danish Agency for Science Technology and Innovation (grant no. 271-06-0539), the Czech Research Project of MSM No. 0021620814 and a European Society of Paediatric Endocrinology (ESPE) research fellowship sponsored by Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa A, 2003, GUT, V52, P947, DOI 10.1136/gut.52.7.947; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Gil-Campos M, 2006, BRIT J NUTR, V96, P201, DOI 10.1079/BJN20061787; Gueorguiev M, 2009, OBESITY, V17, P745, DOI 10.1038/oby.2008.589; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Klausen B, 1997, AM J CLIN NUTR, V65, P895; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Kojima M, 2002, CURR OPIN PHARMACOL, V2, P665, DOI 10.1016/S1471-4892(02)00220-5; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; MOLLER A, 1974, METHODS ENZYMATIC AN; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Perusse L, 2005, OBES RES, V13, P381, DOI 10.1038/oby.2005.50; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shuto Y, 2002, J CLIN INVEST, V109, P1429, DOI 10.1172/JCI0213300; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8	19	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10084	10.1371/journal.pone.0010084	http://dx.doi.org/10.1371/journal.pone.0010084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404923	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482100010
J	Lalou, C; Scamuffa, N; Mourah, S; Plassa, F; Podgorniak, MP; Soufir, N; Dumaz, N; Calvo, F; Basset-Seguin, N; Khatib, AM				Lalou, Claude; Scamuffa, Nathalie; Mourah, Samia; Plassa, Francois; Podgorniak, Marie-Pierre; Soufir, Nadem; Dumaz, Nicolas; Calvo, Fabien; Basset-Seguin, Nicole; Khatib, Abdel-Majid			Inhibition of the Proprotein Convertases Represses the Invasiveness of Human Primary Melanoma Cells with Altered p53, CDKN2A and N-Ras Genes	PLOS ONE			English	Article							SUPPRESSOR PROTEIN P53; TUMOR-SUPPRESSOR; IN-VITRO; PLASMINOGEN-ACTIVATOR; UROKINASE EXPRESSION; REGRESSIVE MELANOMA; GLIOMA INVASION; CANCER-CELLS; GROWTH; RECEPTOR	Background: Altered tumor suppressor p53 and/or CDKN2A as well as Ras genes are frequently found in primary and metastatic melanomas. These alterations were found to be responsible for acquisition of invasive and metastatic potential through their defective regulatory control of metalloproteinases and urokinase genes. Methodology/Principal Findings: Using primary human melanoma M10 cells with altered p53, CDKN2A and N-Ras genes, we found that inhibition of the proprotein convertases (PCs), enzymes involved in the proteolytic activation of various cancer-related protein precursors resulted in significantly reduced invasiveness. Analysis of M10 cells and their gastric and lymph node derived metastatic cells revealed the presence of all the PCs found in the secretory pathway. Expression of the general PCs inhibitor alpha 1-PDX in these cells in a stable manner (M10/PDX) had no effect on the mRNA expression levels of these PCs. Whereas, in vitro digestion assays and cell transfection experiments, revealed that M10/PDX cells display reduced PCs activity and are unable to process the PCs substrates proIGF-1R and proPDGF-A. These cells showed reduced migration and invasion that paralleled decreased gelatinase MMP-2 activity and increased expression and secretion of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2. Furthermore, these cells showed decreased levels of urokinase-type plasminogen activator receptor (uPAR) and increased levels of plasminogen activator inhibitor-1 (PAI-1). Conclusions: Taken together, these data suggest that inhibition of PCs activity results in decreased invasiveness of primary human melanoma cells despite their altered p53, CDKN2A and N-Ras genes, suggesting that PCs may serve as novel therapeutic targets in melanoma.	[Lalou, Claude; Scamuffa, Nathalie; Mourah, Samia; Podgorniak, Marie-Pierre; Calvo, Fabien; Basset-Seguin, Nicole; Khatib, Abdel-Majid] Univ Paris 07, Hop St Louis, INSERM, Inst Genet Mol,UMRS940,Equipe Avenir, Paris, France; [Plassa, Francois] Hop St Louis, Biochim Lab, Paris, France; [Soufir, Nadem] Hop Bichat Claude Bernard, Lab Biochim Hormonale & Genet, F-75877 Paris, France; [Dumaz, Nicolas] Hop St Louis, INSERM, U976, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lalou, C (corresponding author), Univ Paris 07, Hop St Louis, INSERM, Inst Genet Mol,UMRS940,Equipe Avenir, Paris, France.	Majid.Khatib@inserm.fr	KHATIB, Abdel-Majid/A-9948-2015; Dumaz, Nicolas/B-5907-2008	KHATIB, Abdel-Majid/0000-0001-6957-0384; Dumaz, Nicolas/0000-0003-3511-2160; LALOU, Claude/0000-0002-5271-7439; calvo, fabien/0000-0002-0298-7633	Institut National du Cancer (INCA); Socite Francaise de Dermatologie (SFD)	Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Socite Francaise de Dermatologie (SFD)	This work was supported by Institut National du Cancer (INCA) to A. M. K. and by Socite Francaise de Dermatologie (SFD) to N. B. S. and A. M. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2002, ONCOGENE, V21, P87, DOI 10.1038/sj.onc.1204999; Barnhill RL, 2008, AM J SURG PATHOL, V32, P36, DOI 10.1097/PAS.0b013e3181573aaf; Bartkova J, 1996, CANCER RES, V56, P5475; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bontemps Y, 2007, MED RES REV, V27, P631, DOI 10.1002/med.20072; Carcelain G, 1997, INT J CANCER, V72, P241, DOI 10.1002/(SICI)1097-0215(19970717)72:2<241::AID-IJC7>3.0.CO;2-R; Chintala SK, 1997, ONCOGENE, V15, P2049, DOI 10.1038/sj.onc.1201382; Cohen M, 2008, HUM REPROD, V23, P2273, DOI 10.1093/humrep/den264; DELBALDO C, 1994, CANCER RES, V54, P4547; Eskandarpour M, 2009, INT J CANCER, V124, P16, DOI 10.1002/ijc.23876; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; FERRADINI L, 1993, J CLIN INVEST, V91, P1183, DOI 10.1172/JCI116278; Fujita M, 1999, MELANOMA RES, V9, P279, DOI 10.1097/00008390-199906000-00010; Gondi Christopher S., 2009, V487, P267, DOI 10.1007/978-1-60327-547-7_13; Gu ML, 1996, INFECT IMMUN, V64, P524, DOI 10.1128/IAI.64.2.524-527.1996; Khatib AM, 2005, J MOL MED, V83, P856, DOI 10.1007/s00109-005-0692-y; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; La Porta CAM, 2007, CURR MED CHEM, V14, P387; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Page RE, 2007, CELL ONCOL, V29, P289; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Shetty P, 2008, AM J RESP CELL MOL, V39, P364, DOI 10.1165/rcmb.2007-0406OC; Shetty S, 2008, J BIOL CHEM, V283, P19570, DOI 10.1074/jbc.M710268200; Siegfried G, 2003, CANCER RES, V63, P1458; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Tsao H, 2000, CANCER RES, V60, P1800; Tzimas GN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-149; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CH, 2006, J CELL PHYSIOL, V208, P246, DOI 10.1002/jcp.20660; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Zhao Y, 2008, GLIA, V56, P917, DOI 10.1002/glia.20667	39	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e9992	10.1371/journal.pone.0009992	http://dx.doi.org/10.1371/journal.pone.0009992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404912	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100001
J	O'Donovan, KJ; Diedler, J; Couture, GC; Fak, JJ; Darnell, RB				O'Donovan, Kevin J.; Diedler, Jennifer; Couture, Graeme C.; Fak, John J.; Darnell, Robert B.			The Onconeural Antigen cdr2 Is a Novel APC/C Target that Acts in Mitosis to Regulate C-Myc Target Genes in Mammalian Tumor Cells	PLOS ONE			English	Article							PARANEOPLASTIC CEREBELLAR DEGENERATION; ANAPHASE-PROMOTING COMPLEX; GENOMIC TARGETS; PROTEIN-KINASE; GRANULE CELLS; KEN BOX; EXPRESSION; IDENTIFICATION; CYCLE; DIFFERENTIATION	Cdr2 is a tumor antigen expressed in a high percentage of breast and ovarian tumors and is the target of a naturally occurring tumor immune response in patients with paraneoplastic cerebellar degeneration, but little is known of its regulation or function in cancer cells. Here we find that cdr2 is cell cycle regulated in tumor cells with protein levels peaking in mitosis. As cells exit mitosis, cdr2 is ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) and rapidly degraded by the proteasome. Previously we showed that cdr2 binds to the oncogene c-myc, and here we extend this observation to show that cdr2 and c-myc interact to synergistically regulate c-myc-dependent transcription during passage through mitosis. Loss of cdr2 leads to functional consequences for dividing cells, as they show aberrant mitotic spindle formation and impaired proliferation. Conversely, cdr2 overexpression is able to drive cell proliferation in tumors. Together, these data indicate that the onconeural antigen cdr2 acts during mitosis in cycling cells, at least in part through interactions with c-myc, to regulate a cascade of actions that may present new targeting opportunities in gynecologic cancer.	[O'Donovan, Kevin J.] Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY USA; Rockefeller Univ, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donovan, KJ (corresponding author), Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088	NIH [R01 CA85784]; NATIONAL CANCER INSTITUTE [R01CA085784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH grant R01 CA85784. RBD is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Balamurugan K, 2009, ONCOGENE, V28, P3274, DOI 10.1038/onc.2009.186; BANKER G, 1998, CULTURING NERVE CELL, V12; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Corradi JP, 1997, J NEUROSCI, V17, P1406; Dang CV, 1999, MOL CELL BIOL, V19, P1; Darnell JC, 2000, CANCER RES, V60, P2136; DARNELL RB, 1985, MOL CELL BIOL, V5, P3157, DOI 10.1128/MCB.5.11.3157; Darnell RB, 2006, SEMIN ONCOL, V33, P270, DOI 10.1053/j.seminoncol.2006.03.008; Delcuve GP, 2008, J CELL BIOCHEM, V105, P1, DOI 10.1002/jcb.21806; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FATHALLAHSHAYKH H, 1991, P NATL ACAD SCI USA, V88, P3451, DOI 10.1073/pnas.88.8.3451; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fletcher CF, 1997, GENOMICS, V45, P313, DOI 10.1006/geno.1997.4925; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Gatti G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005442; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; JORDAN MA, 1992, J CELL SCI, V102, P401; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kimmelman AC, 2002, MOL CELL BIOL, V22, P5946, DOI 10.1128/MCB.22.16.5946-5961.2002; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Liu D, 2000, ONCOGENE, V19, P5964, DOI 10.1038/sj.onc.1203992; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; O'Donovan KJ, 1999, MOL CELL BIOL, V19, P4711; O'Donovan KJ, 1998, J NEUROCHEM, V70, P1241; Okano HJ, 1999, GENE DEV, V13, P2087, DOI 10.1101/gad.13.16.2087; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfleger CM, 2000, GENE DEV, V14, P655; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Roberts WK, 2004, CURR OPIN IMMUNOL, V16, P616, DOI 10.1016/j.coi.2004.07.009; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; SAKAI K, 1990, ANN NEUROL, V28, P692, DOI 10.1002/ana.410280515; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Santomasso BD, 2007, P NATL ACAD SCI USA, V104, P19073, DOI 10.1073/pnas.0704336104; SETH A, 1993, MOL CELL BIOL, V13, P4125, DOI 10.1128/MCB.13.7.4125; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; WAKAMATSU Y, 1993, NEURON, V10, P1, DOI 10.1016/0896-6273(93)90236-K; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	61	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10045	10.1371/journal.pone.0010045	http://dx.doi.org/10.1371/journal.pone.0010045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383333	Green Published, gold, Green Submitted			2022-12-27	WOS:000276454000010
J	de Sousa, JD; Muller, V; Lemey, P; Vandamme, AM				de Sousa, Joao Dinis; Mueller, Viktor; Lemey, Philippe; Vandamme, Anne-Mieke			High GUD Incidence in the Early 20(th) Century Created a Particularly Permissive Time Window for the Origin and Initial Spread of Epidemic HIV Strains	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; MALE CIRCUMCISION; GEOGRAPHICAL-DISTRIBUTION; URBAN COMMUNITIES; CONGO SUGGESTS; GENITAL HERPES; CENTRAL-AFRICA; INFECTION; TRANSMISSION	The processes that permitted a few SIV strains to emerge epidemically as HIV groups remain elusive. Paradigmatic theories propose factors that may have facilitated adaptation to the human host (e.g., unsafe injections), none of which provide a coherent explanation for the timing, geographical origin, and scarcity of epidemic HIV strains. Our updated molecular clock analyses established relatively narrow time intervals (roughly 1880-1940) for major SIV transfers to humans. Factors that could favor HIV emergence in this time frame may have been genital ulcer disease (GUD), resulting in high HIV-1 transmissibility (4-43%), largely exceeding parenteral transmissibility; lack of male circumcision increasing male HIV infection risk; and gender-skewed city growth increasing sexual promiscuity. We surveyed colonial medical literature reporting incidences of GUD for the relevant regions, concentrating on cities, suffering less reporting biases than rural areas. Coinciding in time with the origin of the major HIV groups, colonial cities showed intense GUD outbreaks with incidences 1.5-2.5 orders of magnitude higher than in mid 20 th century. We surveyed ethnographic literature, and concluded that male circumcision frequencies were lower in early 20(th) century than nowadays, with low rates correlating spatially with the emergence of HIV groups. We developed computer simulations to model the early spread of HIV-1 group M in Kinshasa before, during and after the estimated origin of the virus, using parameters derived from the colonial literature. These confirmed that the early 20(th) century was particularly permissive for the emergence of HIV by heterosexual transmission. The strongest potential facilitating factor was high GUD levels. Remarkably, the direct effects of city population size and circumcision frequency seemed relatively small. Our results suggest that intense GUD in promiscuous urban communities was the main factor driving HIV emergence. Low circumcision rates may have played a role, probably by their indirect effects on GUD.	[de Sousa, Joao Dinis; Lemey, Philippe; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst Med Res, Lab Clin & Evolutionary Virol, Louvain, Belgium; [Mueller, Viktor] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal	KU Leuven; Eotvos Lorand University; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	de Sousa, JD (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Lab Clin & Evolutionary Virol, Louvain, Belgium.	joao.sousa@rega.kuleuven.be	Lemey, Philippe/C-3755-2018; Vandamme, Anne-Mieke/I-4127-2012; Müller, Viktor/B-3493-2009	Lemey, Philippe/0000-0003-2826-5353; Vandamme, Anne-Mieke/0000-0002-6594-2766; Müller, Viktor/0000-0001-8212-4880; Sousa, Joao/0000-0002-7604-3109	Fonds voor Wetenschappelijk Onderzoek [G.0513.06.V.M]; Hungarian Scientific Research Fund [NF72791]; European Commission [027446]	Fonds voor Wetenschappelijk Onderzoek(FWO); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre)	P. L. was supported by a postdoctoral fellowship from the Fonds voor Wetenschappelijk Onderzoek (FWO; http://www.fwo.be) Flanders, and FWO grant G.0513.06.V.M. was supported by the Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alap (OTKA); http://www.otka.hu) grant NF72791. Both P. L. and V. M. were also supported by the European Commission Virolab Project (http://www.virolab.org) grant 027446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetrei C, 2006, AIDS, V20, P317, DOI 10.1097/01.aids.0000206498.71041.0e; Ayouba A, 2001, EMERG INFECT DIS, V7, P466, DOI 10.3201/eid0703.017321; Baeten JM, 2005, J INFECT DIS, V191, P546, DOI 10.1086/427656; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BANGNA CN, 2007, CARACTERISTICAS SOCI; BONGAARTS J, 1989, AIDS, V3, P373, DOI 10.1097/00002030-198906000-00006; BRODEN A, 1908, RAPPORT TRAVAUX FAIS; BRUAUX P, 1957, Ann Soc Belg Med Trop (1920), V37, P801; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; BUVE A, 2001, AIDS S, V15; CAMERON DW, 1989, LANCET, V2, P403; Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; Clifford SL, 2004, MOL ECOL, V13, P1551, DOI 10.1111/j.1365-294X.2004.02140.x; *COM DISTR URB LEO, 1928, RAPP REC POP IND AFR; Croix Rouge du Congo, 1928, RAPP ANN; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; DECOCK KM, 1991, AIDS, V5, pS21; Demma LJ, 2005, PLOS PATHOG, V1, P29, DOI 10.1371/journal.ppat.0010003; DIZIAIN R, 1956, ETUDE POPULATION QUA; DOMERGUECLOAREC D, 1986, SANTE COTE IVORIE 19; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fraenkel Merran, 1964, TRIBE CLASS MONROVIA; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; FRAZER JG, 1938, NATIVE RACES AFRICA; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; FRIEDRICHS A, 1924, WISSENSCHAFTLICHE ER; FROBENIUS L, 1929, ATLAS AFRICANUS BELE; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Georgelin D, 1920, ANN MED PHARM COLON, V19, P58; Gisselquist D, 2003, AIDS RES HUM RETROV, V19, P1071, DOI 10.1089/088922203771881158; Gisselquist D, 2006, INFECT CONT HOSP EP, V27, P944, DOI 10.1086/506408; GOEMAN J, 1997, HLTH CENTRAL AFRICA; GONDOLA D, 1997, VILLES MIROIRS MIGRA; Gordon Jr Raymond G., 2009, ETHNOLOGUE LANGUAGES; GOUROU P, 1953, DENSITE POPULATION R; Gray J.P., 1999, ETHNOGRAPHIC ATLAS R; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; GROVES C P, 1978, Primates, V19, P1, DOI 10.1007/BF02373224; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Harms RW, 1981, RIVER WEALTH RIVER S; HAYES RJ, 1995, J TROP MED HYG, V98, P1; Headrick R., 1994, COLONIALISM HLTH ILL; Heim G, 1913, ARCH DERMATOL SYPH-G, V118, P165, DOI 10.1007/BF02076097; Hempstone H, 2004, HIV AIDS HAITI LIT R; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hooper E., 2000, RIVER JOURNEY SOURCE; Kalish ML, 2005, EMERG INFECT DIS, V11, P1928; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kermorgant A., 1903, ANN HYG MED COLON, V6, P428; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Lahmeyer J., 2006, POPULATION STAT HIST; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; LEGALL R, 1941, MED TROP, V1, P575; Lemey P, 2005, MOL BIOL EVOL, V22, P942, DOI 10.1093/molbev/msi078; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; LETONTURIER M, 1924, ANN MED PHARM COLON, V22, P396; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; *MACR INT, 2009, DEM HLTH SURV; Marx PA, 2001, PHILOS T R SOC B, V356, P911, DOI 10.1098/rstb.2001.0867; MEHEUS A, 1997, HLTH CENTRAL AFRICA; MORISON L, 2001, AIDS S, V15; Morris BJ, 2007, BIOESSAYS, V29, P1147, DOI 10.1002/bies.20654; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; MOUCHET R., 1926, Kenya Medical Journal, V3, P242; Mouchet R., 1913, B SOC PATHOL EXOTIQU, V6, P14; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; NAHMIAS AJ, 1986, LANCET, V1, P1279; Novembre FJ, 1997, J VIROL, V71, P4086, DOI 10.1128/JVI.71.5.4086-4091.1997; Novembre FJ, 2001, J VIROL, V75, P1533, DOI 10.1128/JVI.75.3.1533-1539.2001; O'Farrell N, 1999, SEX TRANSM INFECT, V75, P377, DOI 10.1136/sti.75.6.377; Oates J.F., 1996, AFRICAN PRIMATES STA; Orroth KK, 2006, SEX TRANSM DIS, V33, P536, DOI 10.1097/01.olq.0000204667.11192.71; Oxman GL, 1996, SEX TRANSM DIS, V23, P30, DOI 10.1097/00007435-199601000-00008; PATTERSON KD, 1975, J AFR HIST, V16, P217, DOI 10.1017/S0021853700001134; Peeters M, 1997, AIDS, V11, P493, DOI 10.1097/00002030-199704000-00013; PEPIN J, 2008, TROP MED INT HEALTH, V13, P1; Pepin J, 2006, AIDS, V20, P1303, DOI 10.1097/01.aids.0000232239.05545.33; Phillips R, 2005, J HIST SEXUALITY, V14, P291, DOI 10.1353/sex.2006.0029; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; QUINONESMATEU ME, 2000, AIDS REV, V2, P190; R Core Team, 2020, R LANG ENV STAT COMP; REMY G, 1993, ANN SOC BELG MED TR, V73, P127; Retel-Laurentin A., 1979, PAYS DERIVE SOC REGR; ROUCH J, 1957, ETUDES EBURNEENNES, V6, P231; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; Salemi M, 2000, MOL BIOL EVOL, V17, P374, DOI 10.1093/oxfordjournals.molbev.a026317; Salemi M, 1999, AIDS REV, V1, P131; Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Schler L, 2003, J AFR HIST, V44, P51, DOI 10.1017/S0021853702008332; Schwab C., 1947, TRIBES LIBERIAN HINT; *SERV HYG PUBL, 1933, RAPP HYG PUBL CONG B; *SERV SANT, 1937, RAPP ANN MED COL COT; Sloot PMA, 2008, INT J COMPUT MATH, V85, P1175, DOI 10.1080/00207160701750583; STAUB A, 1926, RAPPORT RESUMANT OBS; Steen R, 2001, B WORLD HEALTH ORGAN, V79, P818; TELEKI G, 1989, UNDERSTANDING CHIMPA; THOMAS JM, 1963, NGBAKA LOBAYE DEPEUP; Trezenem E., 1936, J SOC AFRICANISTES, V6, P65; Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Van Wing J, 1938, ETUDES BAKONGO SOCIO; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WENDELL B, 2004, MALE CIRCUMCISION IM; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377; White RG, 2008, JAIDS-J ACQ IMM DEF, V47, P346, DOI 10.1097/QAI.0b013e318160d56a; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yamaguchi J, 2000, AIDS RES HUM RETROV, V16, P925; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P83, DOI 10.1089/aid.2006.22.83; Yusim K, 2001, PHILOS T R SOC B, V356, P855, DOI 10.1098/rstb.2001.0859	125	36	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9936	10.1371/journal.pone.0009936	http://dx.doi.org/10.1371/journal.pone.0009936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376191	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200013
J	Gaiteri, C; Guilloux, JP; Lewis, DA; Sibille, E				Gaiteri, Chris; Guilloux, Jean-Philippe; Lewis, David A.; Sibille, Etienne			Altered Gene Synchrony Suggests a Combined Hormone-Mediated Dysregulated State in Major Depression	PLOS ONE			English	Article								Coordinated gene transcript levels across tissues (denoted "gene synchrony") reflect converging influences of genetic, biochemical and environmental factors; hence they are informative of the biological state of an individual. So could brain gene synchrony also integrate the multiple factors engaged in neuropsychiatric disorders and reveal underlying pathologies? Using bootstrapped Pearson correlation for transcript levels for the same genes across distinct brain areas, we report robust gene transcript synchrony between the amygdala and cingulate cortex in the human postmortem brain of normal control subjects (n = 14; Control/Permutated data, p<0.000001). Coordinated expression was confirmed across distinct prefrontal cortex areas in a separate cohort (n = 19 subjects) and affected different gene sets, potentially reflecting regional network- and function-dependent transcriptional programs. Genewise regional transcript coordination was independent of age-related changes and array technical parameters. Robust shifts in amygdala-cingulate gene synchrony were observed in subjects with major depressive disorder (MDD, denoted here "depression") (n = 14; MDD/Permutated data, p<0.000001), significantly affecting between 100 and 250 individual genes (10-30% false discovery rate). Biological networks and signal transduction pathways corresponding to the identified gene set suggested putative dysregulated functions for several hormone-type factors previously implicated in depression (insulin, interleukin-1, thyroid hormone, estradiol and glucocorticoids; p<0.01 for association with depression-related networks). In summary, we showed that coordinated gene expression across brain areas may represent a novel molecular probe for brain structure/function that is sensitive to disease condition, suggesting the presence of a distinct and integrated hormone-mediated corticolimbic homeostatic, although maladaptive and pathological, state in major depression.	[Gaiteri, Chris; Guilloux, Jean-Philippe; Lewis, David A.; Sibille, Etienne] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Gaiteri, Chris; Lewis, David A.; Sibille, Etienne] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Guilloux, Jean-Philippe] Univ Paris 11, Fac Pharm, EA 3544, F-92290 Chatenay Malabry, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UDICE-French Research Universities; Universite Paris Saclay	Gaiteri, C (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	sibilleel@upmc.edu	JP, Guilloux/Z-5069-2019; Guilloux, Jean-Philippe/B-3726-2015; Lewis, David A/G-4053-2014	JP, Guilloux/0000-0003-0982-3751; Guilloux, Jean-Philippe/0000-0003-0982-3751; Lewis, David A/0000-0002-3225-6778; Gaiteri, Chris/0000-0001-7838-8664	National Institute of Mental Health [MH077159, MH084060, MH084053]; University of Pittsburgh Institute for Clinical Research Education; Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, TL1TR000145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077159, K02MH084060, P50MH084053] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Pittsburgh Institute for Clinical Research Education; Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the following grants from the National Institute of Mental Health (NIMH): MH077159 (E.S.), MH084060 (E.S.) and MH084053 (D.A.L.), and by a fellowship from the University of Pittsburgh Institute for Clinical Research Education and the Clinical and Translational Science (C.G.). The funding agency had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health.	Altar CA, 2008, BIOL PSYCHIAT, V64, P1077, DOI 10.1016/j.biopsych.2008.08.031; BAUER M, 2003, CURR PSYCHIAT REP, V53, P163; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Galfalvy HC, 2003, BMC BIOINFORMATICS, V4, P1, DOI 10.1186/1471-2105-4-37; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hsiung S, 2003, J NEUROCHEM, V87, P182, DOI 10.1046/j.1471-4159.2003.01987.x; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; LEWIS DA, 1983, ARCH GEN PSYCHIAT, V40, P167; Matthews SC, 2008, J AFFECT DISORDERS, V111, P13, DOI 10.1016/j.jad.2008.05.022; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Sibille E, 2009, AM J PSYCHIAT, V166, P1011, DOI 10.1176/appi.ajp.2009.08121760; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Sliwerska E, 2007, BIOL PSYCHIAT, V61, P13, DOI 10.1016/j.biopsych.2006.01.023; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; WARDEN D, 2007, CURR PSYCHIAT REP, V96, P449	38	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9970	10.1371/journal.pone.0009970	http://dx.doi.org/10.1371/journal.pone.0009970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376317	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000276418200043
J	Guiot, J; Corona, C				Guiot, Joel; Corona, Christophe		ESCARSEL	Growing Season Temperatures in Europe and Climate Forcings Over the Past 1400 Years	PLOS ONE			English	Article							NORTHERN-HEMISPHERE TEMPERATURES; CENTRAL JOTUNHEIMEN; GLACIER; RECONSTRUCTION; MILLENNIUM; INFERENCES; RESOLUTION; NORWAY	Background: The lack of instrumental data before the mid-19th-century limits our understanding of present warming trends. In the absence of direct measurements, we used proxies that are natural or historical archives recording past climatic changes. A gridded reconstruction of spring-summer temperature was produced for Europe based on tree-rings, documentaries, pollen assemblages and ice cores. The majority of proxy series have an annual resolution. For a better inference of long-term climate variation, they were completed by low-resolution data (decadal or more), mostly on pollen and ice-core data. Methodology/ Principal Findings: An original spectral analog method was devised to deal with this heterogeneous dataset, and to preserve long-term variations and the variability of temperature series. So we can replace the recent climate changes in a broader context of the past 1400 years. This preservation is possible because the method is not based on a calibration (regression) but on similarities between assemblages of proxies. The reconstruction of the April-September temperatures was validated with a Jack-knife technique. It was also compared to other spatially gridded temperature reconstructions, literature data, and glacier advance and retreat curves. We also attempted to relate the spatial distribution of European temperature anomalies to known solar and volcanic forcings. Conclusions: We found that our results were accurate back to 750. Cold periods prior to the 20(th) century can be explained partly by low solar activity and/or high volcanic activity. The Medieval Warm Period (MWP) could be correlated to higher solar activity. During the 20(th) century, however only anthropogenic forcing can explain the exceptionally high temperature rise. Warm periods of the Middle Age were spatially more heterogeneous than last decades, and then locally it could have been warmer. However, at the continental scale, the last decades were clearly warmer than any period of the last 1400 years. The heterogeneity of MWP versus the homogeneity of the last decades is likely an argument that different forcings could have operated. These results support the fact that we are living a climate change in Europe never seen in the past 1400 years.	[Guiot, Joel; Corona, Christophe] Aix Marseille Univ, European Ctr Res & Teaching Geosci Environm, UMR 6635, CNRS, Aix En Provence, France; [Guiot, Joel] Aix Marseille Univ, FR 3098, CNRS, Aix En Provence, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Guiot, J (corresponding author), Aix Marseille Univ, European Ctr Res & Teaching Geosci Environm, UMR 6635, CNRS, Aix En Provence, France.	guiot@cerege.fr	Swingedouw, Didier/D-1408-2010; CORONA, Christophe/I-2095-2012; Guiot, Joel/G-7818-2011; Swingedouw, Didier/M-5471-2019	Swingedouw, Didier/0000-0002-0583-0850; Guiot, Joel/0000-0001-7345-4466; Swingedouw, Didier/0000-0002-0583-0850; CORONA, Christophe/0000-0002-7645-6157	French National Agency of Research [ANR-06-VULN-010]	French National Agency of Research(French National Research Agency (ANR))	This paper is a contribution to the ESCARSEL project funded by the French National Agency of Research (program VMC, project ANR-06-VULN-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briffa KR, 2004, GLOBAL PLANET CHANGE, V40, P11, DOI 10.1016/S0921-8181(03)00095-X; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Burger G, 2007, CLIM PAST, V3, P397; Buntgen U, 2006, J CLIMATE, V19, P5606, DOI 10.1175/JCLI3917.1; Burger G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024155; Casty C, 2007, CLIM DYNAM, V29, P791, DOI 10.1007/s00382-007-0257-6; Dahl SO, 1996, HOLOCENE, V6, P381, DOI 10.1177/095968369600600401; Davis BAS, 2003, QUATERNARY SCI REV, V22, P1701, DOI 10.1016/S0277-3791(03)00173-2; Esper J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021236; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Esper J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030844; Frank D, 2007, QUATERNARY SCI REV, V26, P3298, DOI 10.1016/j.quascirev.2007.08.002; Goosse H, 2006, CLIM PAST, V2, P99, DOI 10.5194/cp-2-99-2006; GUIOT J, 1985, J CLIMATOL, V5, P325, DOI 10.1002/joc.3370050308; HAEBERLI W, 2003, PAGES NEWS, V11, P13; IPCC, 2007, CLIM CHANG 2007 PHYS; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Juckes MN, 2007, CLIM PAST, V3, P591, DOI 10.5194/cp-3-591-2007; Ladurie E. L. R., 2007, ABREGE HIST CLIMAT M; Le Roy Ladurie Emmanuel, 1967, HIST CLIMAT DEPUIS M; Lie O, 2004, QUATERNARY SCI REV, V23, P1925, DOI 10.1016/j.quascirev.2004.03.012; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; MANN ME, 2000, IGBP PAGES WORLD DAT; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Matthews JA, 2005, QUATERNARY SCI REV, V24, P67, DOI 10.1016/j.quascirev.2004.07.003; Matthews JA, 2000, QUATERNARY SCI REV, V19, P1625, DOI 10.1016/S0277-3791(00)00008-1; McIntyre S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021750; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Nicault A, 2010, DENDROCHRONOLOGIA, V28, P1, DOI 10.1016/j.dendro.2008.02.003; Pauling A, 2006, CLIM DYNAM, V26, P387, DOI 10.1007/s00382-005-0090-8; PFISTER C, 1993, HIST WEATHER INDICES; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; Solanki SK, 2004, NATURE, V431, P1084, DOI 10.1038/nature02995; Solomina O, 2008, GLOBAL PLANET CHANGE, V60, P1, DOI 10.1016/j.gloplacha.2007.02.001; von Storch H, 2004, SCIENCE, V306, P679, DOI 10.1126/science.1096109	39	75	78	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9972	10.1371/journal.pone.0009972	http://dx.doi.org/10.1371/journal.pone.0009972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376366	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200045
J	Macia, L; Viltart, O; Delacre, M; Sachot, C; Heliot, L; Di Santo, JP; Wolowczuk, I				Macia, Laurence; Viltart, Odile; Delacre, Myriam; Sachot, Christelle; Heliot, Laurent; Di Santo, James P.; Wolowczuk, Isabelle			Interleukin-7, a New Cytokine Targeting the Mouse Hypothalamic Arcuate Nucleus: Role in Body Weight and Food Intake Regulation	PLOS ONE			English	Article							NERVOUS-SYSTEM CONTROL; IL-7; MICE; OBESITY; NEURONS; CELLS; BCL-2; LEADS; MTOR; STAT	Body weight is controlled through peripheral (white adipose tissue) and central (mainly hypothalamus) mechanisms. We have recently obtained evidence that overexpression of interleukin (IL)-7, a critical cytokine involved in lymphopoiesis, can protect against the development of diet-induced obesity in mice. Here we assessed whether IL-7 mediated its effects by modulating hypothalamic function. Acute subcutaneous injection of IL-7 prevented monosodium glutamate-induced obesity, this being correlated with partial protection against cell death in the hypothalamic arcuate nucleus (ARC). Moreover, we showed that IL-7 activated hypothalamic areas involved in regulation of feeding behavior,as indicated by induction of the activation marker c-Fos in neural cells located in the ventromedial part of the ARC and by inhibition of food intake after fasting. Both chains of the IL-7 receptor (IL-7R alpha and gamma c) were expressed in the ARC and IL-7 injection induced STAT-3 phosphorylation in this area. Finally, we established that IL-7 modulated the expression of neuropeptides that tune food intake, with a stimulatory effect on the expression of pro-opiomelanocortin and an inhibitory effect on agouti-related peptide expression in accordance with IL-7 promoting anorectic effects. These results suggest that the immunomodulatory cytokine IL-7 plays an important and unappreciated role in hypothalamic body weight regulation.	[Macia, Laurence; Viltart, Odile; Delacre, Myriam; Sachot, Christelle; Heliot, Laurent; Wolowczuk, Isabelle] Univ Lille Nord France, Lille, France; [Macia, Laurence; Viltart, Odile; Delacre, Myriam; Wolowczuk, Isabelle] Inst Pasteur, Lab Neuroimmunoendocrinol, F-59019 Lille, France; [Macia, Laurence; Viltart, Odile; Delacre, Myriam; Wolowczuk, Isabelle] Inst Pasteur, IFR 142, F-59019 Lille, France; [Viltart, Odile; Sachot, Christelle] USTL, INSERM, U837, JPARC, Lille, France; [Heliot, Laurent] USTL, Interdisciplinary Res Inst, CNRS, USR 3078, Villeneuve Dascq, France; [Di Santo, James P.] Inst Pasteur, Cytokines & Lymphoid Dev Unit, Paris, France; [Di Santo, James P.] INSERM, U668, Paris, France	Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Macia, L (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurobiol Res Program, Darlinghurst, NSW 2010, Australia.	Isabelle.Wolowczuk@ibl.fr	Macia, laurence/D-5983-2016; Di Santo, James P/M-4298-2014	Macia, laurence/0000-0003-0835-851X; Di Santo, James P/0000-0002-7146-1862; wolowczuk, isabelle/0000-0001-6692-6904	Centre National de la Recherche Scientifique (CNRS); Pasteur Institute in Lille; French Ministry for Research and Education	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute in Lille; French Ministry for Research and Education	This work was in part supported by the Centre National de la Recherche Scientifique (CNRS), the Pasteur Institute in Lille, and the French Ministry for Research and Education (to L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; Chou WC, 2006, BLOOD, V108, P3005, DOI 10.1182/blood-2006-05-024430; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cui H, 2006, FASEB J, V20, P2654, DOI 10.1096/fj.06-5989fje; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; INGRAM DK, 1982, J GEN PSYCHOL, V106, P233; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lee JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001639; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Liu X, 1999, MOL BRAIN RES, V71, P210, DOI 10.1016/S0169-328X(99)00186-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; MEISTER B, 1989, EXP BRAIN RES, V76, P343; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; PAXINOS G, 2005, NEW CORONAL SET, P209; Rosenthal LA, 1997, CELL IMMUNOL, V181, P172, DOI 10.1006/cimm.1997.1208; Roye O, 1998, J IMMUNOL, V161, P4161; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WILES MV, 1992, EUR J IMMUNOL, V22, P1037, DOI 10.1002/eji.1830220424; Williams IR, 1997, J IMMUNOL, V159, P3044; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	45	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9953	10.1371/journal.pone.0009953	http://dx.doi.org/10.1371/journal.pone.0009953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376352	gold, Green Published, Green Submitted			2022-12-27	WOS:000276418200029
J	Cross, PC; Heisey, DM; Scurlock, BM; Edwards, WH; Ebinger, MR; Brennan, A				Cross, Paul C.; Heisey, Dennis M.; Scurlock, Brandon M.; Edwards, William H.; Ebinger, Michael R.; Brennan, Angela			Mapping Brucellosis Increases Relative to Elk Density Using Hierarchical Bayesian Models	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; ROCKY-MOUNTAIN ELK; TIME-SERIES; TRANSMISSION; WILDLIFE; MANAGEMENT; REGRESSION; EPIDEMIC; SURVIVAL; CLIMATE	The relationship between host density and parasite transmission is central to the effectiveness of many disease management strategies. Few studies, however, have empirically estimated this relationship particularly in large mammals. We applied hierarchical Bayesian methods to a 19-year dataset of over 6400 brucellosis tests of adult female elk (Cervus elaphus) in northwestern Wyoming. Management captures that occurred from January to March were over two times more likely to be seropositive than hunted elk that were killed in September to December, while accounting for site and year effects. Areas with supplemental feeding grounds for elk had higher seroprevalence in 1991 than other regions, but by 2009 many areas distant from the feeding grounds were of comparable seroprevalence. The increases in brucellosis seroprevalence were correlated with elk densities at the elk management unit, or hunt area, scale (mean 2070 km(2); range = [95-10237]). The data, however, could not differentiate among linear and non-linear effects of host density. Therefore, control efforts that focus on reducing elk densities at a broad spatial scale were only weakly supported. Additional research on how a few, large groups within a region may be driving disease dynamics is needed for more targeted and effective management interventions. Brucellosis appears to be expanding its range into new regions and elk populations, which is likely to further complicate the United States brucellosis eradication program. This study is an example of how the dynamics of host populations can affect their ability to serve as disease reservoirs.	[Cross, Paul C.] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Heisey, Dennis M.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Scurlock, Brandon M.] Wyoming Game & Fish Dept, Pinedale, WY USA; [Edwards, William H.] Wyoming Game & Fish Dept, Laramie, WY USA; [Ebinger, Michael R.] Montana State Univ, Big Sky Inst, Bozeman, MT 59717 USA; [Brennan, Angela] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Cross, PC (corresponding author), US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA.	pcross@usgs.gov	Cross, Paul/K-6987-2012	Cross, Paul/0000-0001-8045-5213; Brennan, Angela/0000-0003-4360-0738	Wyoming Game and Fish Department; United States Geological Survey	Wyoming Game and Fish Department; United States Geological Survey(United States Geological Survey)	Wyoming Game and Fish Department (http://gf.state.wy.us) and the United States Geological Survey (http://www.usgs.gov) provided funding for this study. The funding agencies did not influence the authors' study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Barber-Meyer SM, 2007, AM MIDL NAT, V158, P369, DOI 10.1674/0003-0031(2007)158[369:SOSPAB]2.0.CO;2; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bienen L, 2006, FRONT ECOL ENVIRON, V4, P319, DOI 10.1890/1540-9295(2006)4[319:AAEATB]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caley P, 1998, WILDLIFE RES, V25, P383, DOI 10.1071/WR97029; CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cheville NF, 1998, BRUCELLOSIS GREATER; Conner MM, 2007, ECOL APPL, V17, P140, DOI 10.1890/1051-0761(2007)017[0140:AMAFEM]2.0.CO;2; Creel S, 2009, J ANIM ECOL, V78, P1291, DOI 10.1111/j.1365-2656.2009.01581.x; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Cross PC, 2007, ECOL APPL, V17, P957, DOI 10.1890/06-1603; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; Eberly LE, 2000, STAT MED, V19, P2279, DOI 10.1002/1097-0258(20000915/30)19:17/18<2279::AID-SIM569>3.0.CO;2-R; Farnsworth ML, 2006, ECOL APPL, V16, P1026, DOI 10.1890/1051-0761(2006)016[1026:LCWDTM]2.0.CO;2; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P2365, DOI 10.2193/2006-201; GALEY F, 2005, WYOMING BRUCELLOSIS; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2004, BAYESIAN DATA ANAL; GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Gourdon F, 1999, EMERG INFECT DIS, V5, P719, DOI 10.3201/eid0505.990516; HEISEY DM, ECOLOGICAL IN PRESS; Hudson PJ, 2001, ECOLOGY WILDLIFE DIS; Joly DO, 2005, J ANIM ECOL, V74, P543, DOI 10.1111/j.1365-2656.2005.00953.x; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; KING R. O. C., 1940, Australian Veterinary Journal, V16, P117, DOI 10.1111/j.1751-0813.1940.tb01297.x; Klepac P, 2009, P ROY SOC B-BIOL SCI, V276, P2469, DOI 10.1098/rspb.2009.0175; Knorr-Held L, 2003, J R STAT SOC C-APPL, V52, P169, DOI 10.1111/1467-9876.00396; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; LUBBENHUSIN RE, 1926, J AM VET MED ASSOC, V69, P467; Maichak EJ, 2009, J WILDLIFE DIS, V45, P398, DOI 10.7589/0090-3558-45.2.398; *MT DEP LIV, 2008, PREL EP REP; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; R Core Team, 2020, R LANG ENV STAT COMP; Reeve A. F., 2003, ELK POPULATIONS WYOM; Rhyan JC, 2009, J WILDLIFE DIS, V45, P729, DOI 10.7589/0090-3558-45.3.729; Robison C. D., 1994, CONSERVATION GERM PL; *ROCK MOUNT ELK FD, 2009, ELK POP REFL SUCC RM; SCURLOCK BM, 2010, J WILDLIFE IN PRESS; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thomsen Axel, 1943, JOUR COMP PATH AND THERAP, V53, P199, DOI 10.1016/S0368-1742(43)80019-9; Thorne E. Tom, 2001, P372, DOI 10.1002/9780470344880.ch22; THORNE ET, 1978, J WILDLIFE DIS, V14, P280, DOI 10.7589/0090-3558-14.3.280; Van Houten CK, 2003, J WILDLIFE DIS, V39, P316, DOI 10.7589/0090-3558-39.2.316; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Woodroffe R, 2009, J ANIM ECOL, V78, P818, DOI 10.1111/j.1365-2656.2009.01545.x; Wyoming Game and Fish Department, 2007, ANN BIG GAM HERD UN	54	36	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10322	10.1371/journal.pone.0010322	http://dx.doi.org/10.1371/journal.pone.0010322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428240	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079300012
J	Skoglund, P; Hoglund, J				Skoglund, Pontus; Hoglund, Jacob			Sequence Polymorphism in Candidate Genes for Differences in Winter Plumage between Scottish and Scandinavian Willow Grouse (Lagopus lagopus)	PLOS ONE			English	Article							EVOLUTION; COLOR; MUTATION; MC1R; PIGMENTATION; MELANISM; GENETICS	Background: Population variation in the degree of seasonal polymorphism is rare in birds, and the genetic basis of this phenomenon remains largely undescribed. Both sexes of Scandinavian and Scottish Willow grouse (Lagopus lagopus) display marked differences in their winter phenotypes, with Scottish grouse retaining a pigmented plumage year-round and Scandinavian Willow grouse molting to a white morph during winter. A widely studied pathway implicated in vertebrate pigmentation is the melanin system, for which functional variation has been characterised in many taxa. Methodology/Principal Findings: We sequenced coding regions from four genes involved in melanin pigmentation (DCT, MC1R, TYR and TYRP1), and an additional control involved in the melanocortin pathway (AGRP), to investigate the genetic basis of winter plumage in Lagopus. Despite the well documented role of the melanin system in animal coloration, we found no plumage-associated polymorphism or evidence for selection in a total of similar to 2.6 kb analysed sequence. Conclusions/Significance: Our results indicate that the genetic basis of alternating between pigmented and unpigmented seasonal phenotypes is more likely explained by regulatory changes controlling the expression of these or other loci in the physiological pathway leading to pigmentation.	[Skoglund, Pontus; Hoglund, Jacob] Uppsala Univ, Dept Populat Biol & Conservat Biol, Uppsala, Sweden	Uppsala University	Skoglund, P (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden.	pontus.skoglund@ebc.uu.se		Skoglund, Pontus/0000-0002-3021-5913; Hoglund, Jacob/0000-0002-5840-779X	Swedish Research Council [2008:5418]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Swedish Research Council (No. 2008:5418; http://vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Berlin S, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-89; CHEVIRON ZA, 2006, P R SOC B, V287, P1613; CRAMP S, HDB BIRDS EUROPE MID, V2, P695; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; Doucet SM, 2004, P ROY SOC B-BIOL SCI, V271, P1663, DOI 10.1098/rspb.2004.2779; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fay JC, 2000, GENETICS, V155, P1405; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Kelly JK, 1997, GENETICS, V146, P1197; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; KETTLEWELL HBD, 1956, PROC R SOC SER B-BIO, V145, P297, DOI 10.1098/rspb.1956.0037; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nadeau NJ, 2007, P ROY SOC B-BIOL SCI, V274, P1807, DOI 10.1098/rspb.2007.0174; NADEAU NJ, 2007, ANIM GENET, V37, P1; Piertney SB, 2010, GENETICA, V138, P419, DOI 10.1007/s10709-008-9322-2; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; TAJIMA F, 1989, GENETICS, V123, P585; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Vage DI, 2005, PEPTIDES, V26, P1814, DOI 10.1016/j.peptides.2004.11.040; WRIGHT S, 1951, ANN EUGENIC, V15, P323	32	15	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10334	10.1371/journal.pone.0010334	http://dx.doi.org/10.1371/journal.pone.0010334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428241	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079300018
J	Stokes, EJ; Strindberg, S; Bakabana, PC; Elkan, PW; Iyenguet, FC; Madzoke, B; Malanda, GAF; Mowawa, BS; Moukoumbou, C; Ouakabadio, FK; Rainey, HJ				Stokes, Emma J.; Strindberg, Samantha; Bakabana, Parfait C.; Elkan, Paul W.; Iyenguet, Fortune C.; Madzoke, Bola; Malanda, Guy Aime F.; Mowawa, Brice S.; Moukoumbou, Calixte; Ouakabadio, Franck K.; Rainey, Hugo J.			Monitoring Great Ape and Elephant Abundance at Large Spatial Scales: Measuring Effectiveness of a Conservation Landscape	PLOS ONE			English	Article							LOXODONTA-AFRICANA-CYCLOTIS; WESTERN LOWLAND GORILLAS; LOGGING CONCESSION; FOREST ELEPHANTS; SPECIES APPROACH; PROTECTED AREAS; SWAMP FOREST; CONGO; CHIMPANZEES; MANAGEMENT	Protected areas are fundamental to biodiversity conservation, but there is growing recognition of the need to extend beyond protected areas to meet the ecological requirements of species at larger scales. Landscape-scale conservation requires an evaluation of management impact on biodiversity under different land-use strategies; this is challenging and there exist few empirical studies. In a conservation landscape in northern Republic of Congo we demonstrate the application of a large-scale monitoring program designed to evaluate the impact of conservation interventions on three globally threatened species: western gorillas, chimpanzees and forest elephants, under three land-use types: integral protection, commercial logging, and community-based natural resource management. We applied distance-sampling methods to examine species abundance across different land-use types under varying degrees of management and human disturbance. We found no clear trends in abundance between land-use types. However, units with interventions designed to reduce poaching and protect habitats irrespective of land-use type - harboured all three species at consistently higher abundance than a neighbouring logging concession undergoing no wildlife management. We applied Generalized-Additive Models to evaluate a priori predictions of species response to different landscape processes. Our results indicate that, given adequate protection from poaching, elephants and gorillas can profit from herbaceous vegetation in recently logged forests and maintain access to ecologically important resources located outside of protected areas. However, proximity to the single integrally protected area in the landscape maintained an overriding positive influence on elephant abundance, and logging roads - even subject to anti-poaching controls - were exploited by elephant poachers and had a major negative influence on elephant distribution. Chimpanzees show a clear preference for unlogged or more mature forests and human disturbance had a negative influence on chimpanzee abundance, in spite of anti-poaching interventions. We caution against the pitfalls of missing and confounded co-variables in model-based estimation approaches and highlight the importance of spatial scale in the response of different species to landscape processes. We stress the importance of a stratified design-based approach to monitoring species status in response to conservation interventions and advocate a holistic framework for landscape-scale monitoring that includes smaller-scale targeted research and punctual assessment of threats.	[Stokes, Emma J.; Strindberg, Samantha; Elkan, Paul W.; Rainey, Hugo J.] Wildlife Conservat Soc, Global Conservat Program, New York, NY USA; [Bakabana, Parfait C.; Iyenguet, Fortune C.; Madzoke, Bola; Malanda, Guy Aime F.; Ouakabadio, Franck K.] Wildlife Conservat Soc, Congo Program, Brazzaville, Rep Congo; [Mowawa, Brice S.] Minist Econ Forestiere, Brazzaville, Rep Congo	Wildlife Conservation Society	Stokes, EJ (corresponding author), Wildlife Conservat Soc, Global Conservat Program, New York, NY USA.	estokes@wcs.org	Rainey, Hugo/I-6047-2012		United States Fish and Wildlife Service; United States Agency for International Development; Wildlife Conservation Society	United States Fish and Wildlife Service(US Fish & Wildlife Service); United States Agency for International Development(United States Agency for International Development (USAID)); Wildlife Conservation Society	This work was funded by the United States Fish and Wildlife Service Great Ape and African Elephant Conservation Funds (http://www.fws.gov/international/DIC/species/species.html) with additional support from the United States Agency for International Development, Central African Regional Program for the Environment (http://carpe.umd.edu), and the Wildlife Conservation Society's Global Conservation Program (http://www.wcs.org). The views expressed here do not necessarily represent those of the US government or its agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ESTIMATION ANIMAL AB; Arnhem E, 2008, FOLIA PRIMATOL, V79, P1, DOI 10.1159/000107664; Balcomb SR, 2000, AM J PRIMATOL, V51, P197, DOI 10.1002/1098-2345(200007)51:3&lt;197::AID-AJP4&gt;3.0.CO;2-C; BARNES R, 1987, TECHNICAL B AFRICAN, P1; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; BARNES RFW, 1995, J TROP ECOL, V11, P27, DOI 10.1017/S0266467400008361; Barnes RFW, 2001, AFR J ECOL, V39, P1, DOI 10.1046/j.1365-2028.2001.00266.x; Barrows CW, 2007, NAT AREA J, V27, P194, DOI 10.3375/0885-8608(2007)27[194:BMABTG]2.0.CO;2; Blake S, 2004, BIOTROPICA, V36, P392, DOI 10.1646/03215; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blom A, 2004, BIODIVERS CONSERV, V13, P2661, DOI 10.1007/s10531-004-2138-1; Bradley BJ, 2008, J ZOOL, V275, P333, DOI 10.1111/j.1469-7998.2008.00431.x; Brandon K, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P443; Breuer T, 2007, PACHYDERM, P43; Buckland S.T., 2001, pi; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; Congo Basin Forest Partnership, 2006, FOR CONG BAS STAT FO; Coppolillo P, 2004, BIOL CONSERV, V115, P419, DOI 10.1016/S0006-3207(03)00159-9; Danielsen F, 2003, ORYX, V37, P407, DOI 10.1017/S0030605303000735; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; Di Stefano J, 2003, FUNCT ECOL, V17, P707, DOI 10.1046/j.1365-2435.2003.00782.x; Didier KA, 2009, ORYX, V43, P476, DOI 10.1017/S0030605309000945; Dixon PM, 1998, ECOL APPL, V8, P225, DOI 10.1890/1051-0761(1998)008[0225:MTIER]2.0.CO;2; Dupain J, 2004, ORYX, V38, P209, DOI 10.1017/S0030605304000365; Elkan Paul W., 2006, P393; FAY JM, 1991, AFR J ECOL, V29, P177, DOI 10.1111/j.1365-2028.1991.tb01000.x; FAY JM, 1989, INT J PRIMATOL, V10, P477, DOI 10.1007/BF02736372; FAY JM, 1992, AM J PRIMATOL, V27, P275, DOI 10.1002/ajp.1350270405; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Gardner TA, 2007, CONSERV BIOL, V21, P1516, DOI 10.1111/j.1523-1739.2007.00794.x; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Grossmann F, 2008, DEV PRIMATOL-PROG PR, P189, DOI 10.1007/978-0-387-74787-3_11; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Kamdem-Toham A, 2003, SCIENCE, V299, P346, DOI 10.1126/science.299.5605.346; Kano Takayoshi, 1994, African Study Monographs, V15, P143; Kapos V, 2009, ORYX, V43, P336, DOI 10.1017/S0030605309990275; Klaus G, 1998, J TROP ECOL, V14, P829, DOI 10.1017/S0266467498000595; Kuehl HS, 2007, ECOL APPL, V17, P2403, DOI 10.1890/06-0934.1; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; Manley PN, 2004, ECOL APPL, V14, P296, DOI 10.1890/02-5249; Matthews A, 2004, PRIMATES, V45, P15, DOI 10.1007/s10329-003-0058-4; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; Morgan D., 2007, BEST PRACTICE GUIDEL, P32; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Plumptre AJ, 2000, J APPL ECOL, V37, P356, DOI 10.1046/j.1365-2664.2000.00499.x; Plumptre Andrew J., 2001, P71; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Poulsen JR, 2009, CONSERV BIOL, V23, P1597, DOI 10.1111/j.1523-1739.2009.01251.x; Poulsen JR, 2007, CONSERV SCI PRACT, V2, P140; Poulsen JR, 2004, INT J PRIMATOL, V25, P285, DOI 10.1023/B:IJOP.0000019153.50161.58; Pullin AS, 2009, BIOL CONSERV, V142, P931, DOI 10.1016/j.biocon.2009.01.010; R Core Team, 2018, R LANG ENV STAT COMP; Rainey HJ, 2010, ORYX, V44, P124, DOI 10.1017/S003060530999010X; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Sanz C, 2007, J APPL ECOL, V44, P263, DOI 10.1111/j.1365-2664.2007.01278.x; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; TCHAMBA MN, 1992, MAMMALIA, V56, P155; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; *TROP FOR TRUST, 2008, CIBS TOT FSC CERT AR; TURNER MG, 1995, ECOL APPL, V5, P12, DOI 10.2307/1942046; Tutin C., 2005, REGIONAL ACTION PLAN; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; TUTIN CEG, 1995, INT J PRIMATOL, V16, P53, DOI 10.1007/BF02700153; Vogel G, 2008, SCIENCE, V321, P756, DOI 10.1126/science.321.5890.756b; Walsh PD, 2005, ECOL APPL, V15, P1342, DOI 10.1890/03-5283; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walters C, 1986, ADAPTIVE MANAGEMENT; WHITE F, 1981, VEGETATION AFRICA; White Lee J.T., 2001, P449; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	86	112	114	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10294	10.1371/journal.pone.0010294	http://dx.doi.org/10.1371/journal.pone.0010294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428233	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079300006
J	Posey, KL; Liu, PM; Wang, HR; Veerisetty, AC; Alcorn, JL; Hecht, JT				Posey, Karen L.; Liu, Peiman; Wang, Huiqiu R.; Veerisetty, Alka C.; Alcorn, Joseph L.; Hecht, Jacqueline T.			RNAi Reduces Expression and Intracellular Retention of Mutant Cartilage Oligomeric Matrix Protein	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; SMALL INTERFERING RNA; SHORT HAIRPIN RNAS; ENDOPLASMIC-RETICULUM; IN-VIVO; ARTICULAR-CARTILAGE; COMP MUTATIONS; IX COLLAGEN; CELL-DEATH; PSEUDOACHONDROPLASIA	Mutations in cartilage oligomeric matrix protein (COMP), a large extracellular glycoprotein expressed in musculoskeletal tissues, cause two skeletal dysplasias, pseudoachondroplasia and multiple epiphyseal dysplasia. These mutations lead to massive intracellular retention of COMP, chondrocyte death and loss of growth plate chondrocytes that are necessary for linear growth. In contrast, COMP null mice have only minor growth plate abnormalities, normal growth and longevity. This suggests that reducing mutant and wild-type COMP expression in chondrocytes may prevent the toxic cellular phenotype causing the skeletal dysplasias. We tested this hypothesis using RNA interference to reduce steady state levels of COMP mRNA. A panel of shRNAs directed against COMP was tested. One shRNA (3B) reduced endogenous and recombinant COMP mRNA dramatically, regardless of expression levels. The activity of the shRNA against COMP mRNA was maintained for up to 10 weeks. We also demonstrate that this treatment reduced ER stress. Moreover, we show that reducing steady state levels of COMP mRNA alleviates intracellular retention of other extracellular matrix proteins associated with the pseudoachondroplasia cellular pathology. These findings are a proof of principle and the foundation for the development of a therapeutic intervention based on reduction of COMP expression.	[Posey, Karen L.; Liu, Peiman; Wang, Huiqiu R.; Veerisetty, Alka C.; Alcorn, Joseph L.; Hecht, Jacqueline T.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Hecht, Jacqueline T.] Shriners Hosp Children, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Posey, KL (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA.	Karen.Posey@uth.tmc.edu		, karen/0000-0003-1234-6087	Department of Pediatrics at the University of Texas Medical School at Houston; Shriners Hospital	Department of Pediatrics at the University of Texas Medical School at Houston; Shriners Hospital	This research was funded by a grant from the Department of Pediatrics at the University of Texas Medical School at Houston to Karen Posey and a grant from Shriners Hospital to Jacqueline Hecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. C., 1995, THROMBOSPONDIN GENE; Andersson MLE, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-98; Bahi A, 2005, J NEUROCHEM, V92, P1243, DOI 10.1111/j.1471-4159.2004.02961.x; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Campbell Tessa N, 2004, Genet Mol Res, V3, P282; Cashman SM, 2006, INVEST OPHTH VIS SCI, V47, P3496, DOI 10.1167/iovs.05-1610; Chen TLL, 2008, J CELL BIOCHEM, V103, P778, DOI 10.1002/jcb.21445; Christoph T, 2007, NEUROCHEM INT, V50, P281, DOI 10.1016/j.neuint.2006.08.017; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; COOPER RR, 1973, J BONE JOINT SURG AM, VA 55, P475, DOI 10.2106/00004623-197355030-00003; Davidson BL, 2005, METHOD ENZYMOL, V392, P145, DOI 10.1016/S0076-6879(04)92009-5; Deere M, 1999, AM J MED GENET, V85, P486, DOI 10.1002/(SICI)1096-8628(19990827)85:5<486::AID-AJMG10>3.0.CO;2-O; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Diab M, 1996, BIOCHEM J, V314, P327, DOI 10.1042/bj3140327; Diaz-Font A, 2006, BLOOD CELL MOL DIS, V37, P197, DOI 10.1016/j.bcmd.2006.07.002; DICESARE PE, 1995, J ORTHOPAED RES, V13, P422, DOI 10.1002/jor.1100130316; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; Eter N, 2006, BIODRUGS, V20, P167, DOI 10.2165/00063030-200620030-00004; Fang C, 2000, J ORTHOPAED RES, V18, P593, DOI 10.1002/jor.1100180412; Fang C, 2001, J ORTHOPAED RES, V19, P634, DOI 10.1016/S0736-0266(00)00039-5; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Kappel S, 2006, NUCLEIC ACIDS RES, V34, P4527, DOI 10.1093/nar/gkl628; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Kim SS, 2010, MOL THER, V18, P370, DOI 10.1038/mt.2009.271; King KB, 2003, J CELL BIOCHEM, V89, P992, DOI 10.1002/jcb.10571; Kleerekoper Q, 2002, J BIOL CHEM, V277, P10581, DOI 10.1074/jbc.M109944200; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Koelling S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1922; Lopez-Fraga M., 2008, Infectious Disorders - Drug Targets, V8, P262; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Merritt TM, 2006, J ORTHOP RES, V24, P700, DOI 10.1002/jor.20100; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Perkins GL, 2005, DIFFERENTIATION, V73, P199, DOI 10.1111/j.1432-0436.2005.00024.x; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; Posey KL, 2005, MATRIX BIOL, V24, P539, DOI 10.1016/j.matbio.2005.07.007; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Takahashi Y, 2008, GENE THER, V15, P572, DOI 10.1038/sj.gt.3303103; Takanashi M, 2009, GENE THER, V16, P982, DOI 10.1038/gt.2009.66; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Takeshita Fumitaka, 2009, V487, P83, DOI 10.1007/978-1-60327-547-7_4; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Unger S, 2001, AM J MED GENET, V106, P244, DOI 10.1002/ajmg.10234; Vorhies JS, 2007, BIOL-TARGETS THER, V1, P367; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Xia CF, 2009, MOL PHARMACEUT, V6, P747, DOI 10.1021/mp800194y; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023; ZAMORAAVILA DE, 2009, CANC GENE THER	59	10	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10302	10.1371/journal.pone.0010302	http://dx.doi.org/10.1371/journal.pone.0010302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421976	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952600019
J	Baber, I; Keita, M; Sogoba, N; Konate, M; Diallo, M; Doumbia, S; Traore, SF; Ribeiro, JMC; Manoukis, NC				Baber, Ibrahima; Keita, Moussa; Sogoba, Nafomon; Konate, Mamadou; Diallo, M'Bouye; Doumbia, Seydou; Traore, Sekou F.; Ribeiro, Jose M. C.; Manoukis, Nicholas C.			Population Size and Migration of Anopheles gambiae in the Bancoumana Region of Mali and Their Significance for Efficient Vector Control	PLOS ONE			English	Article							MALARIA TRANSMISSION; DRY SEASON; COMPLEX MOSQUITOS; CHROMOSOMAL FORMS; SUDAN SAVANNA; DISPERSAL; IDENTIFICATION; SURVIVAL; VILLAGE; ECOLOGY	We present results of two intensive mark-release-recapture surveys conducted during the wet and dry seasons of 2008 in the villages of Fourda and Kenieroba, Mali. The former is a small fishing village by the Niger River with a moderate to high densities of Anopheles gambiae Giles s.s. (Diptera: Culicidae) throughout the year, while the latter is a large agricultural community 2 km inland that experiences strong seasonal fluctuation in An. gambiae densities. We estimate the population size of female An. gambiae in Fourda to be in less than 3,000 during the dry season. We found evidence of large population size and migration from Fourda in Kenieroba during the wet season, but very low numbers and no sign of migrants during the dry season. We suggest that malaria vector control measures aimed at adult mosquitoes might be made more efficient in this region and other seasonal riparian habitats by targeting disruption of mosquito populations by the river during the dry season. This would decrease the size of an already small population, and would be likely to delay the explosive growth in vector numbers in the larger inland villages as rainfall increases.	[Baber, Ibrahima; Keita, Moussa; Sogoba, Nafomon; Konate, Mamadou; Diallo, M'Bouye; Doumbia, Seydou; Traore, Sekou F.] Univ Mali, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Ribeiro, Jose M. C.; Manoukis, Nicholas C.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Baber, I (corresponding author), Univ Mali, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali.	manoukisn@niaid.nih.gov	Manoukis, Nicholas C./V-9063-2019	Manoukis, Nicholas C./0000-0001-5062-7256; Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Allergies and Infectious Diseases (NIAID); National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001062] Funding Source: NIH RePORTER	National Institutes of Allergies and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the intramural program of the National Institutes of Allergies and Infectious Diseases (NIAID), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; BARTMANN RM, 1987, J WILDLIFE MANAGE, V51, P41, DOI 10.2307/3801626; Bates M., 1949, NATURAL HIST MOSQUIT; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Dingle H., 1996, MIGRATION; Diuk-Wasser MA, 2005, AM J TROP MED HYG, V72, P725, DOI 10.4269/ajtmh.2005.72.725; Dolo A, 2003, Bull Soc Pathol Exot, V96, P308; Dolo A, 2003, Bull Soc Pathol Exot, V96, P287; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Kulkarni MA, 2006, J MED ENTOMOL, V43, P580, DOI 10.1603/0022-2585(2006)43[580:EEOMVA]2.0.CO;2; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; OMER SM, 1970, B WORLD HEALTH ORGAN, V42, P319; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; TAYLOR CE, 2007, ECOLOGICAL ASPECTS A, P133; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Toure YT, 1998, AM J TROP MED HYG, V59, P481, DOI 10.4269/ajtmh.1998.59.481; WARBURG A, 2002, ESTIVATION ANOPHELES; White GC, 1996, WILDLIFE SOC B, V24, P50	36	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10270	10.1371/journal.pone.0010270	http://dx.doi.org/10.1371/journal.pone.0010270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422013	gold, Green Published, Green Submitted			2022-12-27	WOS:000276952500025
J	Fang, XF; Du, PS; Liu, Y; Tang, J				Fang, Xianfeng; Du, Peishuang; Liu, Yang; Tang, Jie			Efficient Isolation of Mouse Liver NKT Cells by Perfusion	PLOS ONE			English	Article							T-CELLS	Background: NKT cell is a population of unconventional T cells that mediate both innate and adaptive T cell responses. Since NKT cells are most abundant in the liver, much of NKT biology has been learnt from studies of NKT cells isolated from liver. This is a cumbersome procedure with variations in cell yield. Results: Based on recent evidence that NKT cells reside in liver vascular compartment, we developed a simple method to isolate NKT cells by perfusion with PBS-containing 10 mM of EDTA. The number and cell surface phenotype of liver NKT cells recovered by perfusion and by the traditional method were comparable. The yield of other lymphocytes was also comparable. Conclusion/Significance: Our data demonstrated that liver lymphocytes can be efficiently isolated by simple perfusion. These data provide a convenient method to isolate liver lymphocyte while preserving liver tissue for other analysis.	[Fang, Xianfeng; Du, Peishuang; Tang, Jie] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China; [Fang, Xianfeng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Yang] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fang, XF (corresponding author), Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China.	yangl@umich.edu; jtang@sun5.ibp.ac.cn	fang, xianfeng/E-6301-2012	fang, xianfeng/0000-0003-0161-0209	Chinese Natural Science Foundation; United States National Institutes of Health	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is supported by the Chinese Natural Science Foundation and United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Eberl G, 1999, J IMMUNOL, V162, P6410; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741	5	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10288	10.1371/journal.pone.0010288	http://dx.doi.org/10.1371/journal.pone.0010288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422018	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500033
J	Malmendal, A; Underhaug, J; Otzen, DE; Nielsen, NC				Malmendal, Anders; Underhaug, Jarl; Otzen, Daniel E.; Nielsen, Niels C.			Fast Mapping of Global Protein Folding States by Multivariate NMR: A GPS for Proteins	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; MOLTEN GLOBULE STATE; ALPHA-LACTALBUMIN; FIBRIL FORMATION; SPECTROSCOPY; LYSOZYME; PH	To obtain insight into the functions of proteins and their specific roles, it is important to establish efficient procedures for exploring the states that encapsulate their conformational space. Global Protein folding State mapping by multivariate NMR (GPS NMR) is a powerful high-throughput method that provides such an overview. GPS NMR exploits the unique ability of NMR to simultaneously record signals from individual hydrogen atoms in complex macromolecular systems and of multivariate analysis to describe spectral variations from these by a few variables for establishment of, and positioning in, protein-folding state maps. The method is fast, sensitive, and robust, and it works without isotope-labelling. The unique capabilities of GPS NMR to identify different folding states and to compare different unfolding processes are demonstrated by mapping of the equilibrium folding space of bovine alpha-lactalbumin in the presence of the anionic surfactant sodium dodecyl sulfate, SDS, and compare these with other surfactants, acid, denaturants and heat.	[Malmendal, Anders; Underhaug, Jarl; Otzen, Daniel E.; Nielsen, Niels C.] Aarhus Univ, Interdisciplinary Nanosci Ctr, Ctr Insoluble Prot Struct, Aarhus, Denmark; [Malmendal, Anders; Underhaug, Jarl; Nielsen, Niels C.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Malmendal, A (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr, Ctr Insoluble Prot Struct, Aarhus, Denmark.	anders@chem.au.dk; ncn@inano.dk	Malmendal, Anders/S-2014-2019; Malmendal, Anders/F-1198-2017	Malmendal, Anders/0000-0002-8413-9717; Malmendal, Anders/0000-0002-8413-9717; Underhaug, Jarl/0000-0003-0346-3986; Nielsen, Niels Chr./0000-0003-2978-4366; Otzen, Daniel/0000-0002-2918-8989	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	The research was funded by the Danish National Research Foundation (http://www.dg.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDRESCU AT, 1993, BIOCHEMISTRY-US, V32, P1707, DOI 10.1021/bi00058a003; ALEXANDRESCU AT, 1994, J MOL BIOL, V235, P587, DOI 10.1006/jmbi.1994.1015; Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; BALARAM P, 1973, BIOCHEMISTRY-US, V12, P4695, DOI 10.1021/bi00747a024; Balbach J, 1996, SCIENCE, V274, P1161, DOI 10.1126/science.274.5290.1161; BALBACH J, 1995, NAT STRUCT BIOL, V2, P865, DOI 10.1038/nsb1095-865; Berglund A, 2005, J MAGN RESON, V172, P24, DOI 10.1016/j.jmr.2004.09.010; Chaudhuri TK, 1999, J MOL BIOL, V285, P1179, DOI 10.1006/jmbi.1998.2362; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; DOMBI GW, 1985, BIOCHEM J, V228, P551, DOI 10.1042/bj2280551; Forge V, 1999, J MOL BIOL, V288, P673, DOI 10.1006/jmbi.1999.2687; Halskau O, 2005, J MOL BIOL, V349, P1072, DOI 10.1016/j.jmb.2005.04.020; HAMADA S, 1993, J PROTEIN CHEM, V12, P477, DOI 10.1007/BF01025048; IKEGUCHI M, 1986, J BIOCHEM-TOKYO, V99, P1191, DOI 10.1093/oxfordjournals.jbchem.a135582; KLEFHABER T, 1995, NATURE, V375, P513; KUWAJIMA K, 1976, J MOL BIOL, V106, P359, DOI 10.1016/0022-2836(76)90091-7; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Moosavi-Movahedi AA, 2007, COLLOID SURFACE B, V60, P55, DOI 10.1016/j.colsurfb.2007.05.018; Otzen DE, 2009, J COLLOID INTERF SCI, V329, P273, DOI 10.1016/j.jcis.2008.10.021; Perlo J, 2007, SCIENCE, V315, P1110, DOI 10.1126/science.1135499; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sakurai K, 2007, P NATL ACAD SCI USA, V104, P15346, DOI 10.1073/pnas.0702112104; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; Schlepckow K, 2008, J MOL BIOL, V378, P686, DOI 10.1016/j.jmb.2008.02.033; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10262	10.1371/journal.pone.0010262	http://dx.doi.org/10.1371/journal.pone.0010262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421996	Green Published, gold			2022-12-27	WOS:000276952500017
J	Tong, ZQ; Luo, WH; Wang, YQ; Yang, F; Han, Y; Li, H; Luo, HJ; Duan, B; Xu, TL; Maoying, QL; Tan, HY; Wang, J; Zhao, HM; Liu, FY; Wan, Y				Tong, Zhiqian; Luo, Wenhong; Wang, Yanqing; Yang, Fei; Han, Ying; Li, Hui; Luo, Hongjun; Duan, Bo; Xu, Tianle; Maoying, Qiliang; Tan, Huangying; Wang, Jun; Zhao, Hongmei; Liu, Fengyu; Wan, You			Tumor Tissue-Derived Formaldehyde and Acidic Microenvironment Synergistically Induce Bone Cancer Pain	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; COMPLETE FREUNDS-ADJUVANT; ISOLATED RAT HEPATOCYTES; HUMAN OSTEOBLASTIC CELLS; BREAST-CANCER; CAPSAICIN RECEPTOR; ION-CHANNEL; GLUTATHIONE; EXPRESSION; MELATONIN	Background: There is current interest in understanding the molecular mechanisms of tumor-induced bone pain. Accumulated evidence shows that endogenous formaldehyde concentrations are elevated in the blood or urine of patients with breast, prostate or bladder cancer. These cancers are frequently associated with cancer pain especially after bone metastasis. It is well known that transient receptor potential vanilloid receptor 1 (TRPV1) participates in cancer pain. The present study aims to demonstrate that the tumor tissue-derived endogenous formaldehyde induces bone cancer pain via TRPV1 activation under tumor acidic environment. Methodology/Principal Findings: Endogenous formaldehyde concentration increased significantly in the cultured breast cancer cell lines in vitro, in the bone marrow of breast MRMT-1 bone cancer pain model in rats and in tissues from breast cancer and lung cancer patients in vivo. Low concentrations (1 similar to 5 mM) of formaldehyde induced pain responses in rat via TRPV1 and this pain response could be significantly enhanced by pH 6.0 (mimicking the acidic tumor microenvironment). Formaldehyde at low concentrations (1 mM to 100 mM) induced a concentration-dependent increase of [Ca2+]i in the freshly isolated rat dorsal root ganglion neurons and TRPV1-transfected CHO cells. Furthermore, electrophysiological experiments showed that low concentration formaldehyde-elicited TRPV1 currents could be significantly potentiated by low pH (6.0). TRPV1 antagonists and formaldehyde scavengers attenuated bone cancer pain responses. Conclusions/Significance: Our data suggest that cancer tissues directly secrete endogenous formaldehyde, and this formaldehyde at low concentration induces metastatic bone cancer pain through TRPV1 activation especially under tumor acidic environment.	[Tong, Zhiqian; Yang, Fei; Han, Ying; Liu, Fengyu; Wan, You] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Luo, Wenhong; Li, Hui; Luo, Hongjun] Shantou Univ, Coll Med, Cent Lab, Shantou, Peoples R China; [Wang, Yanqing; Maoying, Qiliang] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Dept Integrat Med & Neurobiol, Shanghai 200433, Peoples R China; [Duan, Bo; Xu, Tianle] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Duan, Bo; Xu, Tianle] Chinese Acad Sci, Natl Key Lab Neurosci, Shanghai, Peoples R China; [Tan, Huangying] China Japan Friendship Hosp, Dept TCM Oncol, Beijing, Peoples R China; [Wang, Jun] Peking Univ, Peoples Hosp, Dept Thorat Surg, Beijing, Peoples R China; [Wan, You] Minist Publ Hlth, Minist Educ, Key Lab Neurosci, Beijing, Peoples R China	Peking University; Shantou University; Fudan University; Chinese Academy of Sciences; Chinese Academy of Sciences; China-Japan Friendship Hospital; Peking University	Tong, ZQ (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	tzq88666883@sina.com; ywan@hsc.pku.edu.cn	Wan, You/M-5279-2019	Wan, You/0000-0001-6110-7192	National Natural Science Foundation of China [30700206, 30800332]; Ministry of Education of China [B07001]; National Basic Research Program of the Ministry of Science and Technology of China [2007CB512501]; Key Project of Chinese Ministry of Education [109003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National Basic Research Program of the Ministry of Science and Technology of China; Key Project of Chinese Ministry of Education(Ministry of Education, China)	This research was supported by grants from the National Natural Science Foundation of China (30700206, 30800332), the 111 Project of the Ministry of Education of China (B07001), the National Basic Research Program of the Ministry of Science and Technology of China (2007CB512501) and Beijing Outstanding Ph.D. Program Mentor Grant, Key Project of Chinese Ministry of Education (109003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Audinot V, 2008, BIOCHEM PHARMACOL, V75, P2007, DOI 10.1016/j.bcp.2008.02.022; Ayar A, 2001, NEUROSCI LETT, V313, P73, DOI 10.1016/S0304-3940(01)02188-7; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Barber RD, 1998, J MOL BIOL, V280, P775, DOI 10.1006/jmbi.1998.1900; Bode AM, 2009, CANCER RES, V69, P905, DOI 10.1158/0008-5472.CAN-08-3263; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi JY, 2003, PHARMACOGENETICS, V13, P67, DOI 10.1097/00008571-200302000-00002; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Delaisse Jean-Marie, 1992, P289; Ebeler SE, 1997, J CHROMATOGR B, V702, P211, DOI 10.1016/S0378-4347(97)00369-1; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Gronvall JLE, 1998, LIFE SCI, V63, P759, DOI 10.1016/S0024-3205(98)00331-2; Hartel M, 2006, GUT, V55, P519, DOI 10.1136/gut.2005.073205; Heck HD, 2004, REGUL TOXICOL PHARM, V40, P92, DOI 10.1016/j.yrtph.2004.05.001; Hedberg JJ, 2000, AM J PATHOL, V157, P1745, DOI 10.1016/S0002-9440(10)64811-0; Ho YC, 2007, J BIOMED MATER RES B, V83B, P340, DOI 10.1002/jbm.b.30801; Huang FM, 2005, J BIOMED MATER RES B, V74B, P768, DOI 10.1002/jbm.b.30283; Kanai Y, 2006, J PHARM PHARMACOL, V58, P489, DOI 10.1211/jpp.58.4.0008; KU RH, 1984, CHEM-BIOL INTERACT, V51, P25, DOI 10.1016/0009-2797(84)90017-6; Lazzeri M, 2005, EUR UROL, V48, P691, DOI 10.1016/j.eururo.2005.05.018; LIZCANO JM, 1991, BIOCHEM PHARMACOL, V42, P263, DOI 10.1016/0006-2952(91)90712-E; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Luo WH, 2001, J CHROMATOGR B, V753, P253, DOI 10.1016/S0378-4347(00)00552-1; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nagae M, 2007, J BONE MINER METAB, V25, P99, DOI 10.1007/s00774-006-0734-8; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Perissin L, 2004, PAIN, V110, P250, DOI 10.1016/j.pain.2004.03.039; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Ray M, 2004, Indian J Med Sci, V58, P122; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Retfalvi T, 1998, ACTA BIOL HUNG, V49, P375; Rozylo TK, 2000, BIOMED CHROMATOGR, V14, P173, DOI 10.1002/1099-0801(200005)14:3<173::AID-BMC957>3.0.CO;2-O; Sabino Mary Ann C, 2005, J Support Oncol, V3, P15; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; Santos ARS, 1997, NEUROSCI LETT, V235, P73, DOI 10.1016/S0304-3940(97)00722-2; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shin CY, 2003, MOL CELL NEUROSCI, V24, P57, DOI 10.1016/S1044-7431(03)00121-0; Shinoda M, 2008, J PAIN, V9, P687, DOI 10.1016/j.jpain.2008.02.007; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; STAAB CA, 2008, BIOCHEM J, P493; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szende B, 1998, ACTA BIOL HUNG, V49, P323; Szende B, 2000, EXP MOL MED, V32, P88, DOI 10.1038/emm.2000.16; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Terry MB, 2006, CARCINOGENESIS, V27, P840, DOI 10.1093/carcin/bgi285; THORNDIKE J, 1977, CANCER RES, V37, P1125; Tian Li-Juan, 2009, Shengli Xuebao, V61, P404; Torres-Lopez JE, 2002, LIFE SCI, V70, P1669, DOI 10.1016/S0024-3205(02)01491-1; Tortorici S, 2007, BRIT DENT J, V203, P511, DOI 10.1038/bdj.2007.995; Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; TREZL L, 1983, BIOCHEM J, V214, P289, DOI 10.1042/bj2140289; Tu HY, 2004, J NEUROSCI RES, V76, P713, DOI 10.1002/jnr.20109; Tu YJ, 2004, PAIN, V109, P340, DOI 10.1016/j.pain.2004.01.027; Tyihak E, 2001, CELL PROLIFERAT, V34, P135, DOI 10.1046/j.1365-2184.2001.00206.x; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Walker K, 2002, PAIN, V100, P219, DOI 10.1016/S0304-3959(02)00040-4; Wang MY, 2009, CANCER RES, V69, P7170, DOI 10.1158/0008-5472.CAN-09-1571; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yeh CC, 2006, CELL BIOCHEM FUNCT, V24, P555, DOI 10.1002/cbf.1275; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Yu PH, 1997, NEUROCHEM RES, V22, P615, DOI 10.1023/A:1022478221421; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	71	85	93	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10234	10.1371/journal.pone.0010234	http://dx.doi.org/10.1371/journal.pone.0010234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422007	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952500011
J	Chan, CEZ; Lim, APC; Chan, AHY; MacAry, PA; Hanson, BJ				Chan, Conrad En Zuo; Lim, Angeline Pei Chiew; Chan, Annie Hoi Yi; MacAry, Paul A.; Hanson, Brendon John			Optimized Expression of Full-Length IgG1 Antibody in a Common E. coli Strain	PLOS ONE			English	Article							ESCHERICHIA-COLI; CARBOHYDRATE STRUCTURE; EFFECTOR FUNCTIONS; GLYCOSYLATION; CYTOPLASM; FRAGMENT; MUTANTS; LEVEL; CELLS	Multi-polypeptide proteins such as antibodies are difficult to express in prokaryotic systems such as E. coli due to the complexity of protein folding plus secretion. Thus far, proprietary strains or fermenter cultures have been required for appreciable yields. Previous studies have shown that expression of heterologous proteins in E. coli can be enhanced by the reduction of protein translation rates. In this paper, we demonstrate that useful quantities of full-length IgG can be expressed and purified from the common E. coli laboratory strain HB2151 in standard shaking culture using a simple strategy of reduced inducer concentration combined with delayed induction times to modulate translation rates. Purified IgG had only marginally reduced avidity compared to mammalian derived IgG. This indicates that this technique can be used to derive antibodies of potentially equal utility as those expressed in mammalian cell culture, particularly for applications where effector functions mediated by the glycosylated residues in the Fragment Crystallizable (Fc) portion of the immunoglobulin are not required.	[Chan, Conrad En Zuo; Lim, Angeline Pei Chiew; Chan, Annie Hoi Yi; Hanson, Brendon John] DSO Natl Labs, Def Med & Environm Res Inst, Med Countermeasures Biol Lab, Singapore, Singapore; [Chan, Conrad En Zuo; MacAry, Paul A.] Natl Univ Singapore, Program Immunol, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore	Chan, CEZ (corresponding author), DSO Natl Labs, Def Med & Environm Res Inst, Med Countermeasures Biol Lab, Singapore, Singapore.	hbrendon@dso.org.sg		MacAry, Paul/0000-0002-1139-8996				Chadd HE, 2001, CURR OPIN BIOTECH, V12, P188, DOI 10.1016/S0958-1669(00)00198-1; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Levy R, 2001, PROTEIN EXPRES PURIF, V23, P338, DOI 10.1006/prep.2001.1520; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Presta LG, 2006, ADV DRUG DELIVER REV, V58, P640, DOI 10.1016/j.addr.2006.01.026; Simmons LC, 1996, NAT BIOTECHNOL, V14, P629, DOI 10.1038/nbt0596-629; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; TAO MH, 1989, J IMMUNOL, V143, P2595; Venturi M, 2002, J MOL BIOL, V315, P1, DOI 10.1006/jmbi.2001.5221; WALKER MR, 1989, BIOCHEM J, V259, P347, DOI 10.1042/bj2590347; Wright A, 1998, J IMMUNOL, V160, P3393; WRIGHT A, 1994, J EXP MED, V180, P1087, DOI 10.1084/jem.180.3.1087	16	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10261	10.1371/journal.pone.0010261	http://dx.doi.org/10.1371/journal.pone.0010261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422027	Green Published, Green Submitted, gold			2022-12-27	WOS:000276854300017
J	Li, N; McMurry, T; Berg, A; Wang, Z; Berceli, SA; Wu, RL				Li, Ning; McMurry, Timothy; Berg, Arthur; Wang, Zhong; Berceli, Scott A.; Wu, Rongling			Functional Clustering of Periodic Transcriptional Profiles through ARMA(p,q)	PLOS ONE			English	Article							COVARIANCE-MATRIX; LONGITUDINAL DATA; EXPRESSED GENES; MODEL; SERIES; PATTERNS	Background: Gene clustering of periodic transcriptional profiles provides an opportunity to shed light on a variety of biological processes, but this technique relies critically upon the robust modeling of longitudinal covariance structure over time. Methodology: We propose a statistical method for functional clustering of periodic gene expression by modeling the covariance matrix of serial measurements through a general autoregressive moving-average process of order (p,q), the so-called ARMA(p,q). We derive a sophisticated EM algorithm to estimate the proportions of each gene cluster, the Fourier series parameters that define gene-specific differences in periodic expression trajectories, and the ARMA parameters that model the covariance structure within a mixture model framework. The orders p and q of the ARMA process that provide the best fit are identified by model selection criteria. Conclusions: Through simulated data we show that whenever it is necessary, employment of sophisticated covariance structures such as ARMA is crucial in order to obtain unbiased estimates of the mean structure parameters and increased precision of estimation. The methods were implemented on recently published time-course gene expression data in yeast and the procedure was shown to effectively identify interesting periodic clusters in the dataset. The new approach will provide a powerful tool for understanding biological functions on a genomic scale.	[Li, Ning] Univ Florida, Dept Epidemiol & Biostat, Gainesville, FL 32610 USA; [McMurry, Timothy] Depaul Univ, Dept Math Sci, Chicago, IL 60604 USA; [Berg, Arthur; Wang, Zhong; Wu, Rongling] Penn State Univ, Coll Med, Div Biostat, Hershey, PA USA; [Berg, Arthur; Wu, Rongling] Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China; [Berceli, Scott A.] Univ Florida, Dept Surg, Gainesville, FL USA	State University System of Florida; University of Florida; DePaul University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing Forestry University; State University System of Florida; University of Florida	Li, N (corresponding author), Univ Florida, Dept Epidemiol & Biostat, Gainesville, FL 32610 USA.	rwu@hes.hmc.psu.edu	Wang, Zhong/C-3737-2014	Berceli, Scott/0000-0003-2257-0111; Berg, Arthur/0000-0002-4097-7348	National Science Foundation (NSF) [00060643]; Changjiang Scholarship Award at Beijing Forestry University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095508] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Changjiang Scholarship Award at Beijing Forestry University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Science Foundation (NSF) grant (00060643) and the Changjiang Scholarship Award at Beijing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ATTINGER EO, 1966, BIOPHYS J, V6, P291, DOI 10.1016/S0006-3495(66)86657-2; Begum Esmot ara, 2006, J Circadian Rhythms, V4, P11, DOI 10.1186/1740-3391-4-11; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Brockwell P.J., 1991, TIME SERIES THEORY M; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; FAN J, 2008, J ROYAL STAT SOC B; Fan JQ, 2007, J AM STAT ASSOC, V102, P632, DOI 10.1198/016214507000000095; Fan JQ, 2008, J ECONOMETRICS, V147, P186, DOI 10.1016/j.jeconom.2008.09.017; Fraley C., 2009, MCLUST MODEL BASED C; Frank O, 1926, Z BIOL-MUNICH, V85, P91; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Haddad JN, 2004, J TIME SER ANAL, V25, P443, DOI 10.1111/j.1467-9892.2004.01454.x; Inoue L. Y., 2007, BIOSTATISTICS; KIM B, 2008, GENETICS; Kim BR, 2006, CURR GENOMICS, V7, P197, DOI 10.2174/138920206777780229; LAKINTHOMAS P, 2004, CIRCADIAN RHYTHMS MI; Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Mager DE, 2007, J PHARMACOL EXP THER, V321, P423, DOI 10.1124/jpet.106.113183; McLachlan G., 2000, WILEY SER PROB STAT; MCMURRY T, 2009, GENEARMA SIMULATE MO; MITCHISON J, 2003, INT REV CYTOL, P166; Ng SK, 2006, BIOINFORMATICS, V22, P1745, DOI 10.1093/bioinformatics/btl165; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pandit SM, 1983, TIME SERIES SYSTEM A; Park T, 2003, BIOINFORMATICS, V19, P694, DOI 10.1093/bioinformatics/btg068; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Rovery C, 2005, ANN NY ACAD SCI, V1063, P79, DOI 10.1196/annals.1355.011; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Zeng DL, 2005, LIFETIME DATA ANAL, V11, P151, DOI 10.1007/s10985-004-0381-0	35	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e9894	10.1371/journal.pone.0009894	http://dx.doi.org/10.1371/journal.pone.0009894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419127	gold, Green Submitted, Green Published			2022-12-27	WOS:000276743500005
J	Maher, MT; Mo, RG; Flozak, AS; Peled, ON; Gottardi, CJ				Maher, Meghan T.; Mo, Rigen; Flozak, Annette S.; Peled, Ofra N.; Gottardi, Cara J.			beta-Catenin Phosphorylated at Serine 45 Is Spatially Uncoupled from beta-Catenin Phosphorylated in the GSK3 Domain: Implications for Signaling	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NUCLEAR-LOCALIZATION; ALPHA-CATENIN; TRANSCRIPTIONAL ACTIVITY; PLASMA-MEMBRANE; XENOPUS EMBRYOS; COMPLEX; ADHESION; CELL; APC	C. elegans and Drosophila generate distinct signaling and adhesive forms of beta-catenin at the level of gene expression. Whether vertebrates, which rely on a single beta-catenin gene, generate unique adhesive and signaling forms at the level of protein modification remains unresolved. We show that beta-catenin unphosphorylated at serine 37 (S37) and threonine 41 (T41), commonly referred to as transcriptionally Active beta-Catenin (ABC), is a minor nuclear-enriched monomeric form of beta-catenin in SW480 cells, which express low levels of E-cadherin. Despite earlier indications, the superior signaling activity of ABC is not due to reduced cadherin binding, as ABC is readily incorporated into cadherin contacts in E-cadherin-restored cells. beta-catenin phosphorylated at serine 45 (S45) or threonine 41 (T41) (T41/S45) or along the GSK3 regulatory cassette S33, S37 or T41 (S33/37/T41), however, is largely unable to associate with cadherins. b-catenin phosphorylated at T41/S45 and unphosphorylated at S37 and T41 is predominantly nuclear, while beta-catenin phosphorylated at S33/37/T41 is mostly cytoplasmic, suggesting that beta-catenin hypophosphorylated at S37 and T41 may be more active in transcription due to its enhanced nuclear accumulation. Evidence that phosphorylation at T41/S45 can be spatially separated from phosphorylations at S33/37/T41 suggests that these phosphorylations may not always be coupled, raising the possibility that phosphorylation at S45 serves a distinct nuclear function.	[Maher, Meghan T.; Mo, Rigen; Flozak, Annette S.; Gottardi, Cara J.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Maher, Meghan T.] Northwestern Univ, Integrated Grad Program Life Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Peled, Ofra N.] Natl Louis Univ, Dept Biol Sci, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Louis University	Maher, MT (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	c-gottardi@northwestern.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health (NIH) [T32 GM08061]; American Heart Association [09PRE2261197]; Malkin Family Scholars Award; American Recovery and Reinvestment Act [NIH GM076561]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561, T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Malkin Family Scholars Award; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MTM was supported by National Institutes of Health (NIH) T32 GM08061, an American Heart Association Pre-doctoral Award (#09PRE2261197), a Malkin Family Scholars Award and an American Recovery and Reinvestment Act supplement awarded to CJG (NIH GM076561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cox RT, 1999, GENETICS, V153, P319; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FLOZAK AS, J BIOL CHEM, V285, P3157; Giannini AL, 2000, J BIOL CHEM, V275, P21883, DOI 10.1074/jbc.M001929200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; GOTTARDI CJ, 1995, AM J PHYSIOL, V268, P285; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hatsell S, 2003, J BIOL CHEM, V278, P37745, DOI 10.1074/jbc.M301346200; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-5; Malik HS, 1997, P NATL ACAD SCI USA, V94, P13738, DOI 10.1073/pnas.94.25.13738; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Polakis P, 1999, ADV EXP MED BIOL, V470, P23; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang Z, 2006, P NATL ACAD SCI USA, V103, P1422, DOI 10.1073/pnas.0510516103	48	68	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10184	10.1371/journal.pone.0010184	http://dx.doi.org/10.1371/journal.pone.0010184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419129	Green Published, gold, Green Submitted			2022-12-27	WOS:000276743500001
J	Schwarzinger, M; Flicoteaux, R; Cortarenoda, S; Obadia, Y; Moatti, JP				Schwarzinger, Michael; Flicoteaux, Remi; Cortarenoda, Sebastien; Obadia, Yolande; Moatti, Jean-Paul			Low Acceptability of A/H1N1 Pandemic Vaccination in French Adult Population: Did Public Health Policy Fuel Public Dissonance?	PLOS ONE			English	Article							HUMAN AVIAN INFLUENZA; PERCEPTIONS; IMMUNIZATION; WILLINGNESS; INFORMATION; KNOWLEDGE; ATTITUDES; BEHAVIOR; RATES	Background: In July 2009, French public health authorities embarked in a mass vaccination campaign against A/H1N1 2009 pandemic-influenza. We explored the attitudes and behaviors of the general population toward pandemic vaccination. Methodology/Principal Findings: We conducted a cross-sectional online survey among 2,253 French representative adults aged 18 to 64 from November 17 to 25, 2009 (completion rate: 93.8%). The main outcome was the acceptability of A/H1N1 vaccination as defined by previous receipt or intention to get vaccinated ("Yes, certainly", "Yes, probably"). Overall 17.0% (CI 95%, 15.5% to 18.7%) of respondents accepted A/H1N1 vaccination. Independent factors associated with acceptability included: male sex (p = .0001); older age (p = .002); highest or lowest level of education (p = .016); non-clerical occupation (p = .011); having only one child (p = .008); and having received seasonal flu vaccination in prior 3 years (p,.0001). Acceptability was also significantly higher among pregnant women (37.9%) and other at risk groups with chronic diseases (34.8%) (p = .002). Only 35.5% of respondents perceived A/H1N1 influenza illness as a severe disease and 12.7% had experienced A/H1N1 cases in their close relationships with higher acceptability (p,.0001 and p = .006, respectively). In comparison to 26.0% respondents who did not consult their primary care physician, acceptability was significantly higher among 8.0% respondents who were formally advised to get vaccinated, and lower among 63.7% respondents who were not advised to get vaccinated (respectively: 15.8%, 59.5% and 11.7%- p,.0001). Among respondents who refused vaccination, 71.2% expressed concerns about vaccine safety. Conclusions/Significance: Our survey occurred one week before the peak of the pandemic in France. We found that alarming public health messages aiming at increasing the perception of risk severity were counteracted by daily personal experience which did not confirm the threat, while vaccine safety was a major issue. This dissonance may have been amplified by having not involved primary care physicians in the mass vaccination campaign.	[Schwarzinger, Michael; Cortarenoda, Sebastien; Obadia, Yolande; Moatti, Jean-Paul] INSERM, Econ & Social Sci U912, Marseille, France; [Schwarzinger, Michael; Cortarenoda, Sebastien; Obadia, Yolande; Moatti, Jean-Paul] Univ Aix Marseille, IRD, UMR S912, Marseille, France; [Schwarzinger, Michael; Flicoteaux, Remi; Cortarenoda, Sebastien; Obadia, Yolande] So Hlth Reg Observ, ORS PACA, Marseille, France; [Flicoteaux, Remi] Univ Paris 07, Lab Pathol Infect, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite	Schwarzinger, M (corresponding author), INSERM, Econ & Social Sci U912, Marseille, France.	michael.schwarzinger@inserm.fr	Schwarzinger, Michael/F-7367-2011	Schwarzinger, Michael/0000-0002-0573-6856; Cortaredona, Sebastien/0000-0003-3523-7158	French National Research Institute for Microbiology and Infectious Diseases; French Institute for Prevention and Education for Health	French National Research Institute for Microbiology and Infectious Diseases; French Institute for Prevention and Education for Health	The study was funded by the French National Research Institute for Microbiology and Infectious Diseases (Institut de Microbiologie et Maladies Infectieuses/IMMI; http://extranet.inserm.fr/instituts-thematiques/microbiologie-et-maladies-infectieuses/organisation-de-l-institut) as well as the French Institute for Prevention and Education for Health (Institut National de Prevention et d Education pour la Sante/INPES; http://www.inpes.sante.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG FRANC SEC SAN, 2010, AFSSAPS B, V16; [Anonymous], WHO REC PAND H1N1 20; Baker L, 2003, JAMA-J AM MED ASSOC, V289, P2400, DOI 10.1001/jama.289.18.2400; Barr M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-117; BIGOT R, 2008, DIFFUSION TECHNOL IN; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Blank PR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-272; Breakwell G.M., 2007, PSYCHOL RISK; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; CUMMINGS KM, 1979, MED CARE, V17, P639, DOI 10.1097/00005650-197906000-00008; *DE NOS CORR, 2010, AVEC 60 SA POP VACC; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; FIELDING N, 2008, SAGE HDB ONLINE; Frank E, 2000, ARCH FAM MED, V9, P359, DOI 10.1001/archfami.9.4.359; *HAUT CONS SANT PU, 2009, AV REC PRIOR SAN UT; Henrich N, 2009, Emerg Health Threats J, V2, pe8, DOI 10.3134/ehtj.09.008; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; *INST NATL STAT, 2006, RES REC POP 2006; *INST VEILL SAN, 2009, B EP GRIPP A H1N1; *INST VEILL SAN, 2010, B EP GRIPP A H1N1; *INT RES INFL, 2009, MMWR-MORBID MORTAL W, V59, P44; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kmietowicz Z, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3815; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; LANOE J, 2005, TAT SANTE FRANCE 200; Lau JTF, 2008, INFECTION, V36, P434, DOI [10.1007/s15010-008-7277-y, 10.1007/s15010-008-7277-Y]; Lau JTF, 2007, AM J INFECT CONTROL, V35, P38, DOI 10.1016/j.ajic.2006.07.010; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; LEPPIN A, 2006, EMERG INFECT DIS, V12, P29; Maurer J, 2009, J HEALTH ECON, V28, P704, DOI 10.1016/j.jhealeco.2009.01.005; *MIN INT, 2009, POINT TAP CAMP VACC; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Quinn SC, 2009, BIOSECUR BIOTERROR, V7, P275, DOI 10.1089/bsp.2009.0041; Rubin G., 2009, BMJ-BRIT MED J, V339, P2651, DOI DOI 10.1136/BMJ.B2651; Schwarzinger M, 2010, VACCINE, V28, P2743, DOI 10.1016/j.vaccine.2010.01.027; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Sypsa V., 2009, EURO SURVEILL; Tuppin P, 2009, MED MALADIES INFECT, V39, P780, DOI 10.1016/j.medmal.2009.08.013; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	43	161	161	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10199	10.1371/journal.pone.0010199	http://dx.doi.org/10.1371/journal.pone.0010199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20421908	Green Published, gold			2022-12-27	WOS:000276743500019
J	Rajan, A; Freddolino, PL; Schulten, K				Rajan, Aruna; Freddolino, Peter L.; Schulten, Klaus			Going beyond Clustering in MD Trajectory Analysis: An Application to Villin Headpiece Folding	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; PRINCIPAL COMPONENT ANALYSIS; PROTEIN; HETEROGENEITY; PROXIMITIES; ENSEMBLE; INSIGHTS	Recent advances in computing technology have enabled microsecond long all-atom molecular dynamics ( MD) simulations of biological systems. Methods that can distill the salient features of such large trajectories are now urgently needed. Conventional clustering methods used to analyze MD trajectories suffer from various setbacks, namely (i) they are not data driven, (ii) they are unstable to noise and changes in cut-off parameters such as cluster radius and cluster number, and (iii) they do not reduce the dimensionality of the trajectories, and hence are unsuitable for finding collective coordinates. We advocate the application of principal component analysis (PCA) and a non-metric multidimensional scaling (nMDS) method to reduce MD trajectories and overcome the drawbacks of clustering. To illustrate the superiority of nMDS over other methods in reducing data and reproducing salient features, we analyze three complete villin headpiece folding trajectories. Our analysis suggests that the folding process of the villin headpiece is structurally heterogeneous.	[Rajan, Aruna; Schulten, Klaus] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Freddolino, Peter L.; Schulten, Klaus] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rajan, A (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	kschulte@ks.uiuc.edu	Schulten, Klaus/D-5561-2009		National Institutes of Health (NIH) [P41-RR05969]; National Science Foundation (NSF) [PHY0822613]; National Center for Supercomputing Applications [MCA93S028]; University of Illinois at Urbana-Champaign (UIUC); Keio University through Yoshi Oono; Department of Physics, UIUC; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); National Center for Supercomputing Applications; University of Illinois at Urbana-Champaign (UIUC); Keio University through Yoshi Oono; Department of Physics, UIUC; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (NIH) grant P41-RR05969 and National Science Foundation (NSF) grant PHY0822613. Computer time was provided by the National Center for Supercomputing Applications through grant MCA93S028. A. R. was supported in part by the NSF funded Center for the Physics of Living Cells, University of Illinois at Urbana-Champaign (UIUC), Keio University through Yoshi Oono, and the Department of Physics, UIUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; Borg I., 1997, MODERN MULTIDIMENSIO; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Ensign DL, 2007, J MOL BIOL, V374, P806, DOI 10.1016/j.jmb.2007.09.069; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Green P.E., 1970, MULTIDIMENSIONAL SCA; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hubner IA, 2006, P NATL ACAD SCI USA, V103, P17747, DOI 10.1073/pnas.0605580103; KARPEN ME, 1993, BIOCHEMISTRY-US, V32, P412, DOI 10.1021/bi00053a005; Krivov SV, 2008, J PHYS CHEM B, V112, P8701, DOI 10.1021/jp711864r; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; Li AJ, 1996, J MOL BIOL, V257, P412, DOI 10.1006/jmbi.1996.0172; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; Ota M, 2004, P NATL ACAD SCI USA, V101, P17658, DOI 10.1073/pnas.0407015102; Rajaram S, 2005, PHYSICA D, V205, P207, DOI 10.1016/j.physd.2005.02.001; RAJARAM S, 2009, THESIS U ILLINOIS UR; Rajaram S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-45; Rajaram S, 2009, BIOINFORMATICS, V25, P636, DOI 10.1093/bioinformatics/btp007; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; Taguchi Y, 2005, BIOINFORMATICS, V21, P730, DOI 10.1093/bioinformatics/bti067; TAGUCHI YH, 2004, SPECIAL VOLUME ADV C, V130, P315; Udgaonkar JB, 2008, ANNU REV BIOPHYS, V37, P489, DOI 10.1146/annurev.biophys.37.032807.125920; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang J, 2006, J CHEM THEORY COMPUT, V2, P18, DOI 10.1021/ct050118b; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023	34	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e9890	10.1371/journal.pone.0009890	http://dx.doi.org/10.1371/journal.pone.0009890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419160	Green Published, gold, Green Submitted			2022-12-27	WOS:000276707100002
J	Geething, NC; To, W; Spink, BJ; Scholle, MD; Wang, CW; Yin, Y; Yao, Y; Schellenberger, V; Cleland, JL; Stemmer, WPC; Silverman, J				Geething, Nathan C.; To, Wayne; Spink, Benjamin J.; Scholle, Michael D.; Wang, Chia-wei; Yin, Yong; Yao, Yi; Schellenberger, Volker; Cleland, Jeffrey L.; Stemmer, Willem P. C.; Silverman, Joshua			Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose	PLOS ONE			English	Article							DIABETES-MELLITUS; TYPE-1; ADOLESCENTS; CHILDREN; THERAPY; IMPACT	Objective: While the majority of current diabetes treatments focus on reducing blood glucose levels, hypoglycemia represents a significant risk associated with insulin treatment. Glucagon plays a major regulatory role in controlling hypoglycemia in vivo, but its short half-life and hyperglycemic effects prevent its therapeutic use for non-acute applications. The goal of this study was to identify a modified form of glucagon suitable for prophylactic treatment of hypoglycemia without increasing baseline blood glucose levels. Methodology/Principal Findings: Through application of the XTEN technology, we report the construction of a glucagon fusion protein with an extended exposure profile (Gcg-XTEN). The in vivo half-life of the construct was tuned to support nightly dosing through design and testing in cynomolgus monkeys. Efficacy of the construct was assessed in beagle dogs using an insulin challenge to induce hypoglycemia. Dose ranging of Gcg-XTEN in fasted beagle dogs demonstrated that the compound was biologically active with a pharmacodynamic profile consistent with the designed half-life. Prophylactic administration of 0.6 nmol/kg Gcg-XTEN to dogs conferred resistance to a hypoglycemic challenge at 6 hours post-dose without affecting baseline blood glucose levels. Consistent with the designed pharmacokinetic profile, hypoglycemia resistance was not observed at 12 hours post-dose. Importantly, the solubility and stability of the glucagon peptide were also significantly improved by fusion to XTEN. Conclusions/Significance: The data show that Gcg-XTEN is effective in preventing hypoglycemia without the associated hyperglycemia expected for unmodified glucagon. While the plasma clearance of this Gcg-XTEN has been optimized for overnight dosing, specifically for the treatment of nocturnal hypoglycemia, constructs with significantly longer exposure profiles are feasible. Such constructs may have multiple applications such as allowing for more aggressive insulin treatment regimens, treating hypoglycemia due to insulin-secreting tumors, providing synergistic efficacy in combination therapies with long-acting GLP1 analogs, and as an appetite suppressant for treatment of obesity. The improved physical properties of the Gcg-XTEN molecule may also allow for novel delivery systems not currently possible with native glucagon.	[Geething, Nathan C.; To, Wayne; Spink, Benjamin J.; Scholle, Michael D.; Wang, Chia-wei; Yin, Yong; Yao, Yi; Schellenberger, Volker; Stemmer, Willem P. C.; Silverman, Joshua] Amunix Inc, Mountain View, CA USA; [Cleland, Jeffrey L.] Versartis Inc, Mountain View, CA USA		Geething, NC (corresponding author), Amunix Inc, Mountain View, CA USA.	jsilverman@amunix.com	Wang, Chia Wei/GXF-9984-2022		National Institute of General Medical Sciences [R44GM079873]; Amunix, Inc.; Versartis, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM079873] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Amunix, Inc.; Versartis, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by Award Number R44GM079873 from the National Institute of General Medical Sciences. In addition, the project was supported by funding from Amunix, Inc. and Versartis, Inc., and was conducted by employees of both companies. Employees of the funding companies had a primary role in the design, data collection and analysis, decision to publish, and preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Bode BW, 2005, DIABETES CARE, V28, P2361, DOI 10.2337/diacare.28.10.2361; Bray GA, 2000, P NUTR SOC, V59, P373, DOI 10.1017/S0029665100000422; Bulsara MK, 2004, DIABETES CARE, V27, P2293, DOI 10.2337/diacare.27.10.2293; CRYER PE, 1983, DIABETES CARE, V6, P95, DOI 10.2337/diacare.6.1.95; Davis EA, 1998, ARCH DIS CHILD, V78, P111, DOI 10.1136/adc.78.2.111; Davis EA, 1997, DIABETES CARE, V20, P22, DOI 10.2337/diacare.20.1.22; DAVIS MR, 1991, J CLIN ENDOCR METAB, V73, P995, DOI 10.1210/jcem-73-5-995; DAY JW, 2009, NAT CHEM BIOL; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; EDELMAN SV, AM DIAB ASS ANN M CH; *EL LILL INC, 2009, GLUC PACK INS; Fanelli CG, 2006, NUTR METAB CARDIOVAS, V16, pS28, DOI 10.1016/j.numecd.2005.10.018; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Lawson ML, 1999, DIABETES CARE, V22, pB35; Radan I, 2004, ACTA DIABETOL, V41, P33, DOI 10.1007/s00592-004-0141-3; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Schultes B, 2007, PLOS MED, V4, P361, DOI 10.1371/jourmal.pmed.0040069; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tu E, 2008, MED J AUSTRALIA, V188, P699, DOI 10.5694/j.1326-5377.2008.tb01849.x; Wiltshire EJ, 2006, J PAEDIATR CHILD H, V42, P758, DOI 10.1111/j.1440-1754.2006.00973.x; Zick R, 2007, DIABETES TECHNOL THE, V9, P483, DOI 10.1089/dia.2007.0230	22	39	53	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10175	10.1371/journal.pone.0010175	http://dx.doi.org/10.1371/journal.pone.0010175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418955	gold, Green Submitted, Green Published			2022-12-27	WOS:000276706800015
J	Xu, XL; Jiang, M; Wang, YH; Smith, T; Baumgarten, CM; Wood, MA; Tseng, GN				Xu, Xulin; Jiang, Min; Wang, Yuhong; Smith, Timothy; Baumgarten, Clive M.; Wood, Mark A.; Tseng, Gea-Ny			Long-Term Fish Oil Supplementation Induces Cardiac Electrical Remodeling by Changing Channel Protein Expression in the Rabbit Model	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; RAT VENTRICULAR MYOCYTES; SODIUM-CHANNEL; NA+ CHANNELS; CURRENTS; ARRHYTHMIAS; MODULATION; ADULT; HEART; BLOCK	Clinical trials and epidemiological studies have suggested that dietary fish oil (FO) supplementation can provide an antiarrhythmic benefit in some patient populations. The underlying mechanisms are not entirely clear. We wanted to understand how FO supplementation (for 4 weeks) affected the action potential configuration/duration of ventricular myocytes, and the ionic mechanism(s)/molecular basis for these effects. The experiments were conducted on adult rabbits, a widely used animal model for cardiac electrophysiology and pathophysiology. We used gas chromatography - mass spectroscopy to confirm that FO feeding produced a marked increase in the content of n-3 polyunsaturated fatty acids in the phospholipids of rabbit hearts. Left ventricular myocytes were used in current and voltage clamp experiments to monitor action potentials and ionic currents, respectively. Action potentials of myocytes from FO-fed rabbits exhibited much more positive plateau voltages and prolonged durations. These changes could be explained by an increase in the L-type Ca current (I(CaL)) and a decrease in the transient outward current (I(to)) in these myocytes. FO feeding did not change the delayed rectifier or inward rectifier current. Immunoblot experiments showed that the FO-feeding induced changes in I(CaL) and I(to) were associated with corresponding changes in the protein levels of major pore-forming subunits of these channels: increase in Cav1.2 and decrease in Kv4.2 and Kv1.4. There was no change in other channel subunits (Cav1.1, Kv4.3, KChIP2, and ERG1). We conclude that long-term fish oil supplementation can impact on cardiac electrical activity at least partially by changing channel subunit expression in cardiac myocytes.	[Xu, Xulin; Jiang, Min; Wang, Yuhong; Baumgarten, Clive M.; Tseng, Gea-Ny] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Smith, Timothy] Univ Richmond, Dept Chem, Richmond, VA 23173 USA; [Baumgarten, Clive M.; Wood, Mark A.] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Cardiol, Richmond, VA 23298 USA	Virginia Commonwealth University; University of Richmond; Virginia Commonwealth University	Xu, XL (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	gtseng@vcu.edu			National Center for Complementary and Alternative Medicine [R21 AT0044601]; National Heart, Lung, and Blood Institute of the National Institutes of Health [RO1 HL67840]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067840] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by R21 AT0044601 from the National Center for Complementary and Alternative Medicine, and RO1 HL67840 from the National Heart, Lung, and Blood Institute of the National Institutes of Health ( to G.N.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanov KY, 1998, AM J PHYSIOL-HEART C, V274, pH571, DOI 10.1152/ajpheart.1998.274.2.H571; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; CHRISTIE WW, 1989, GAS CHROMATOGRAPHY L, P5; Dujardin KS, 2008, AM J PHYSIOL-HEART C, V295, pH1414, DOI 10.1152/ajpheart.01219.2007; Edwards IJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/358052; FOLCH J, 1957, J BIOL CHEM, V226, P497; Jia Y, 2006, CIRC RES, V98, P386, DOI 10.1161/01.RES.0000201956.86258.e1; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Pepe S, 2005, EXP GERONTOL, V40, P369, DOI 10.1016/j.exger.2005.03.005; Rose J, 2005, AM J PHYSIOL-HEART C, V288, pH2077, DOI 10.1152/ajpheart.00526.2003; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Verkerk AO, 2006, CARDIOVASC RES, V70, P509, DOI 10.1016/j.cardiores.2006.02.022; Wassall SR, 2004, CHEM PHYS LIPIDS, V132, P79, DOI 10.1016/j.chemphyslip.2004.09.007; Wickenden AD, 1999, CELL PHYSIOL BIOCHEM, V9, P11, DOI 10.1159/000016299; Xiao YF, 2005, J MEMBRANE BIOL, V206, P141, DOI 10.1007/S00232-005-0786-Z; Xiao YF, 2001, P NATL ACAD SCI USA, V98, P3606, DOI 10.1073/pnas.061003798; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182; XIAO YF, 1995, P NATL ACAD SCI USA, V92, P11000, DOI 10.1073/pnas.92.24.11000	20	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10140	10.1371/journal.pone.0010140	http://dx.doi.org/10.1371/journal.pone.0010140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405051	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706300004
J	Ingold, B; Simon, E; Ungethum, U; Kuban, RJ; Muller, BM; Lupp, A; Neumann, U; Ebert, MPA; Denkert, C; Weichert, W; Schulz, S; Rocken, C				Ingold, Barbara; Simon, Eva; Ungethuem, Ute; Kuban, Ralf-Juergen; Mueller, Berit M.; Lupp, Amelie; Neumann, Ulf; Ebert, Matthias P. A.; Denkert, Carsten; Weichert, Wilko; Schulz, Stefan; Roecken, Christoph			Vascular CXCR4 Expression - a Novel Antiangiogenic Target in Gastric Cancer?	PLOS ONE			English	Article							HORMONE-RELEASING HORMONE; CHEMOKINE RECEPTORS; PROSTATE-CANCER; TUMOR-GROWTH; DUFFY ANTIGEN/RECEPTOR; COLORECTAL-CANCER; BREAST-CANCER; ANGIOGENESIS; METASTASIS; LYMPHOPOIESIS	Background: G-protein-coupled receptors (GPCRs) are prime candidates for novel cancer prevention and treatment strategies. We searched for differentially expressed GPCRs in node positive gastric carcinomas. Methodology/Principal Findings: Differential expression of GPCRs in three node positive vs. three node negative intestinal type gastric carcinomas was analyzed by gene array technology. The candidate genes CXCL12 and its receptor CXCR4 were validated by real-time reverse-transcription polymerase chain reaction in an independent set of 37 gastric carcinomas. Translation was studied by immunohistochemistry in 347 gastric carcinomas using tissue microarrays as well as in 61 matching lymph node metastases. Protein expression was correlated with clinicopathological patient characteristics and survival. 52 GPCRs and GPCR-related genes were up-or down-regulated in node positive gastric cancer, including CXCL12. Differential expression of CXCL12 was confirmed by RT-PCR and correlated with local tumour growth. CXCL12 immunopositivity was negatively associated with distant metastases and tumour grade. Only 17% of gastric carcinomas showed CXCR4 immunopositive tumour cells, which was associated with higher local tumour extent. 29% of gastric carcinomas showed CXCR4 positive tumour microvessels. Vascular CXCR4 expression was significantly associated with higher local tumour extent as well as higher UICC-stages. When expressing both, CXCL12 in tumour cells and CXCR4 in tumour microvessels, these tumours also were highly significantly associated with higher T-and UICC-stages. Three lymph node metastases revealed vascular CXCR4 expression while tumour cells completely lacked CXCR4 in all cases. The expression of CXCL12 and CXCR4 had no impact on patient survival. Conclusions/Significance: Our results substantiate the significance of GPCRs on the biology of gastric carcinomas and provide evidence that the CXCL12-CXCR4 pathway might be a novel promising antiangiogenic target for the treatment of gastric carcinomas.	[Ingold, Barbara; Simon, Eva; Mueller, Berit M.; Denkert, Carsten; Weichert, Wilko; Roecken, Christoph] Charite, Inst Pathol Campus Mitte, Berlin, Germany; [Ungethuem, Ute; Kuban, Ralf-Juergen] Charite, Lab Funct Genom, Berlin, Germany; [Lupp, Amelie; Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, D-6900 Jena, Germany; [Neumann, Ulf] Charite, Dept Gen Visceral & Transplantat Surg, Berlin, Germany; [Ebert, Matthias P. A.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Ingold, B (corresponding author), Charite, Inst Pathol Campus Mitte, Berlin, Germany.	christoph.roecken@uk-sh.de	Schulz, Stefan/A-6928-2017; Röcken, Christoph/A-9239-2010; Denkert, Carsten/AHE-2675-2022	Schulz, Stefan/0000-0002-5997-8885; Röcken, Christoph/0000-0002-6989-8002; Denkert, Carsten/0000-0002-2249-0982	Berliner Krebshilfe	Berliner Krebshilfe	This study was supported by grants of the Berliner Krebshilfe (Berlin Canceraid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Dicken BJ, 2004, ANN SURG ONCOL, V11, P629, DOI 10.1245/ASO.2004.09.002; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Horak CE, 2007, CANCER RES, V67, P11751, DOI 10.1158/0008-5472.CAN-07-3175; INGOLD B, ROLE VASCUL IN PRESS; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee HJ, 2009, INT J ONCOL, V34, P473, DOI 10.3892/ijo_00000172; Lentsch AB, 2002, FASEB J, V16, P1093, DOI 10.1096/fj.02-0066hyp; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagy A, 2005, CURR PHARM DESIGN, V11, P1167, DOI 10.2174/1381612053507594; Nagy A, 2000, P NATL ACAD SCI USA, V97, P829, DOI 10.1073/pnas.97.2.829; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Richard DE, 2001, ONCOGENE, V20, P1556, DOI 10.1038/sj.onc.1204193; Rocken C, 2007, CANCER EPIDEM BIOMAR, V16, P1206, DOI 10.1158/1055-9965.EPI-05-0934; SAIGUSA S, ANN SURG ONCOL; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Schimanski CC, 2005, CLIN CANCER RES, V11, P1743, DOI 10.1158/1078-0432.CCR-04-1195; Scotton CJ, 2002, CANCER RES, V62, P5930; Shen H, 2006, FASEB J, V20, P59, DOI 10.1096/fj.05-4764com; Smith CJ, 2005, NUCL MED BIOL, V32, P733, DOI 10.1016/j.nucmedbio.2005.05.005; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Taichman RS, 2002, CANCER RES, V62, P1832; Thomas L, 2005, LANCET ONCOL, V6, P266, DOI 10.1016/S1470-2045(05)70156-X; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	39	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10087	10.1371/journal.pone.0010087	http://dx.doi.org/10.1371/journal.pone.0010087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386750	Green Published, gold			2022-12-27	WOS:000276482000016
J	Bates, LA; Handford, R; Lee, PC; Njiraini, N; Poole, JH; Sayialel, K; Sayialel, S; Moss, CJ; Byrne, RW				Bates, Lucy A.; Handford, Rosie; Lee, Phyllis C.; Njiraini, Norah; Poole, Joyce H.; Sayialel, Katito; Sayialel, Soila; Moss, Cynthia J.; Byrne, Richard W.			Why Do African Elephants (Loxodonta africana) Simulate Oestrus? An Analysis of Longitudinal Data	PLOS ONE			English	Article							FEMALE CHOICE; BEHAVIOR; SIGNALS; MUSTH	Female African elephants signal oestrus via chemicals in their urine, but they also exhibit characteristic changes to their posture, gait and behaviour when sexually receptive. Free-ranging females visually signal receptivity by holding their heads and tails high, walking with an exaggerated gait, and displaying increased tactile behaviour towards males. Parous females occasionally exhibit these visual signals at times when they are thought not to be cycling and without attracting interest from musth males. Using demographic and behavioural records spanning a continuous 28-year period, we investigated the occurrence of this "simulated" oestrus behaviour. We show that parous females in the Amboseli elephant population do simulate receptive oestrus behaviours, and this false oestrus occurs disproportionately in the presence of naive female kin who are observed coming into oestrus for the first time. We compare several alternative hypotheses for the occurrence of this simulation: 1) false oestrus has no functional purpose (e. g., it merely results from abnormal hormonal changes); 2) false oestrus increases the reproductive success of the simulating female, by inducing sexual receptivity; and 3) false oestrus increases the inclusive fitness of the simulating female, either by increasing the access of related females to suitable males, or by encouraging appropriate oestrus behaviours from female relatives who are not responding correctly to males. Although the observed data do not fully conform to the predictions of any of these hypotheses, we rule out the first two, and tentatively suggest that parous females most likely exhibit false oestrus behaviours in order to demonstrate to naive relatives at whom to direct their behaviour.	[Bates, Lucy A.; Handford, Rosie; Byrne, Richard W.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Lee, Phyllis C.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Lee, Phyllis C.; Njiraini, Norah; Poole, Joyce H.; Sayialel, Katito; Sayialel, Soila; Moss, Cynthia J.] Amboseli Trust Elephants, Nairobi, Kenya	University of St Andrews; University of Stirling	Bates, LA (corresponding author), Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland.	rwb@st-andrews.ac.uk	Bates, Lucy A/N-6371-2017	Bates, Lucy A/0000-0003-4746-3312; Lee, Phyllis/0000-0002-4296-3513; Byrne, Richard/0000-0001-9862-9373	Leverhulme Trust [F/00268/W]	Leverhulme Trust(Leverhulme Trust)	This analysis was supported by a project grant from The Leverhulme Trust (F/00268/W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley KR, 2006, ANIM BEHAV, V71, P1439, DOI 10.1016/j.anbehav.2006.01.003; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Elder JH, 1936, ANAT RECORD, V67, P119, DOI 10.1002/ar.1090670112; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Ganswindt A, 2005, HORM BEHAV, V47, P83, DOI 10.1016/j.yhbeh.2004.09.002; Heistermann M, 2001, P ROY SOC B-BIOL SCI, V268, P2445, DOI 10.1098/rspb.2001.1833; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Leadbeater E, 2006, CURR BIOL, V16, pR323, DOI 10.1016/j.cub.2006.03.078; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; MCCOMB K, 1987, NATURE, V330, P648, DOI 10.1038/330648a0; MOSS CJ, 1983, BEHAVIOUR, V86, P167, DOI 10.1163/156853983X00354; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Ortolani A, 2005, ZOO BIOL, V24, P311, DOI 10.1002/zoo.20053; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; POOLE JH, AMBOSELI EL IN PRESS; POOLE JH, 2008, ELEPHANTS ETHICS MOR; Raihani NJ, 2008, ANIM BEHAV, V75, P3, DOI 10.1016/j.anbehav.2007.07.024; Rapaport LG, 2008, EVOL ANTHROPOL, V17, P189, DOI 10.1002/evan.20180; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; Rasmussen LEL, 2002, NATURE, V415, P975, DOI 10.1038/415975a; Schulte BA, 2007, APPL ANIM BEHAV SCI, V102, P344, DOI 10.1016/j.applanim.2006.05.035; SCHULTZ ADOLPH H., 1938, JOUR MAMMAL, V19, P363, DOI 10.2307/1374577; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Thornton A, 2008, ANIM BEHAV, V75, P1823, DOI [10.1016/j.anbehav.2007.12.014, 10.1111/j.1558-5646.2011.01370.x]; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a	31	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10052	10.1371/journal.pone.0010052	http://dx.doi.org/10.1371/journal.pone.0010052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383331	Green Published, gold, Green Accepted			2022-12-27	WOS:000276454000012
J	Bratlie, KM; Dang, TT; Lyle, S; Nahrendorf, M; Weissleder, R; Langer, R; Anderson, DG				Bratlie, Kaitlin M.; Dang, Tram T.; Lyle, Stephen; Nahrendorf, Matthias; Weissleder, Ralph; Langer, Robert; Anderson, Daniel G.			Rapid Biocompatibility Analysis of Materials via In Vivo Fluorescence Imaging of Mouse Models	PLOS ONE			English	Article							FOREIGN-BODY REACTION; NEUTROPHIL GRANULES; ALGINATE; ISLETS; MICROSPHERES; INFLAMMATION; FIBROBLASTS; MACROPHAGES; ARTHRITIS; HISTOLOGY	Background: Many materials are unsuitable for medical use because of poor biocompatibility. Recently, advances in the high throughput synthesis of biomaterials has significantly increased the number of potential biomaterials, however current biocompatibility analysis methods are slow and require histological analysis. Methodology/Principal Findings: Here we develop rapid, non-invasive methods for in vivo quantification of the inflammatory response to implanted biomaterials. Materials were placed subcutaneously in an array format and monitored for host responses as per ISO 10993-6: 2001. Host cell activity in response to these materials was imaged kinetically, in vivo using fluorescent whole animal imaging. Data captured using whole animal imaging displayed similar temporal trends in cellular recruitment of phagocytes to the biomaterials compared to histological analysis. Conclusions/Significance: Histological analysis similarity validates this technique as a novel, rapid approach for screening biocompatibility of implanted materials. Through this technique there exists the possibility to rapidly screen large libraries of polymers in vivo.	[Bratlie, Kaitlin M.; Dang, Tram T.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Bratlie, Kaitlin M.; Dang, Tram T.; Langer, Robert; Anderson, Daniel G.] Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Lyle, Stephen] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Nahrendorf, Matthias; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Bratlie, KM (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	dgander@mit.edu	Dang, Tram/AAF-1289-2021; Dang, Tram T/E-7966-2011	Dang, Tram/0000-0001-6464-0101; Dang, Tram T/0000-0001-6464-0101; /0000-0003-0828-4143	Juvenile Diabetes Research Foundation [17-2007-1063]; Agency for Science, Technology and Research of Singapore	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grant 17-2007-1063 from the Juvenile Diabetes Research Foundation. T. D. is grateful to the support from the Agency for Science, Technology and Research of Singapore for the A*STAR National Science graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; BARNETT SE, 1987, ANN ROY COLL SURG, V69, P153; Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X; Christen T, 2009, CIRCULATION, V119, P1925, DOI 10.1161/CIRCULATIONAHA.108.796888; De Vos P, 1998, TRANSPLANT P, V30, P496, DOI 10.1016/S0041-1345(97)01373-0; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; Delves PJ, 2017, ROITTS ESSENTIAL IMM; Duvivier-Kali VF, 2004, AM J TRANSPLANT, V4, P1991, DOI 10.1111/j.1600-6143.2004.00628.x; Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Gerstner AOH, 2004, CYTOM PART A, V59A, P210, DOI 10.1002/cyto.a.20054; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Hansch A, 2004, ARTHRITIS RHEUM-US, V50, P961, DOI 10.1002/art.20112; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HOM DB, 1995, OTOLARYNG CLIN N AM, V28, P933; HOUGLUM PA, 2005, THERAPUTIC EXERCISE; KAUFMANN SHE, INNATE IMMUNE RESPON; Kendall WF, 2004, J MICROENCAPSUL, V21, P821, DOI 10.1080/02652040400015452; Kumar V, 2009, ROBBINS COTRAN PATHO; Kvist PH, 2006, DIABETES TECHNOL THE, V8, P463, DOI 10.1089/dia.2006.8.463; Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Makino K, 2003, COLLOID SURFACE B, V27, P33, DOI 10.1016/S0927-7765(02)00042-5; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; REN W, 2007, J BIOMEDICAL MAT R A, V85, P1043; Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sartor R. Balfour, 1996, Methods (Orlando), V9, P233, DOI 10.1006/meth.1996.0030; Schuster DP, 2004, AM J RESP CELL MOL, V30, P129, DOI 10.1165/rcmb.2003-0213TR; SHISHATSKAYA EI, 2001, DOKL AKAD NAUK, V383, P123; Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018; Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096; WALLACE AM, 2008, J CHRONIC OBSTRUCTIV, V5, P13; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; WILFLINGSEDER P, 1974, CHIR PLAST, V2, P215, DOI 10.1007/BF00265651; Wunder A, 2004, ARTHRITIS RHEUM-US, V50, P2459, DOI 10.1002/art.20379	42	48	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10032	10.1371/journal.pone.0010032	http://dx.doi.org/10.1371/journal.pone.0010032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386609	Green Published, gold			2022-12-27	WOS:000276420400009
J	Harding, MJ; Lepus, CM; Gibson, TF; Shepherd, BR; Gerber, SA; Graham, M; Paturzo, FX; Rahner, C; Madri, JA; Bothwell, ALM; Lindenbach, BD; Pober, JS				Harding, Martha J.; Lepus, Christin M.; Gibson, Thomas F.; Shepherd, Benjamin R.; Gerber, Scott A.; Graham, Morven; Paturzo, Frank X.; Rahner, Christoph; Madri, Joseph A.; Bothwell, Alfred L. M.; Lindenbach, Brett D.; Pober, Jordan S.			An Implantable Vascularized Protein Gel Construct That Supports Human Fetal Hepatoblast Survival and Infection by Hepatitis C Virus in Mice	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; HUMAN ENDOTHELIAL-CELLS; LIVER EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; MOUSE-LIVER; STEM-CELLS; RAT-LIVER; ANGIOGENESIS; REPLICATION	Background: Widely accessible small animal models suitable for the study of hepatitis C virus (HCV) in vivo are lacking, primarily because rodent hepatocytes cannot be productively infected and because human hepatocytes are not easily engrafted in immunodeficient mice. Methodology/Principal Findings: We report here on a novel approach for human hepatocyte engraftment that involves subcutaneous implantation of primary human fetal hepatoblasts (HFH) within a vascularized rat collagen type I/human fibronectin (rCI/hFN) gel containing Bcl-2-transduced human umbilical vein endothelial cells (Bcl-2-HUVEC) in severe combined immunodeficient X beige (SCID/bg) mice. Maturing hepatic epithelial cells in HFH/Bcl-2-HUVEC co-implants displayed endocytotic activity at the basolateral surface, canalicular microvilli and apical tight junctions between adjacent cells assessed by transmission electron microscopy. Some primary HFH, but not Huh-7.5 hepatoma cells, appeared to differentiate towards a cholangiocyte lineage within the gels, based on histological appearance and cytokeratin 7 (CK7) mRNA and protein expression. Levels of human albumin and hepatic nuclear factor 4 alpha (HNF4 alpha) mRNA expression in gel implants and plasma human albumin levels in mice engrafted with HFH and Bcl-2-HUVEC were somewhat enhanced by including murine liver-like basement membrane (mLBM) components and/or hepatocyte growth factor (HGF)-HUVEC within the gel matrix. Following ex vivo viral adsorption, both HFH/Bcl-2-HUVEC and Huh-7.5/Bcl-2-HUVEC co-implants sustained HCV Jc1 infection for at least 2 weeks in vivo, based on qRT-PCR and immunoelectron microscopic (IEM) analyses of gel tissue. Conclusion/Significance: The system described here thus provides the basis for a simple and robust small animal model of HFH engraftment that is applicable to the study of HCV infections in vivo.	[Harding, Martha J.; Lepus, Christin M.; Paturzo, Frank X.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Gibson, Thomas F.; Shepherd, Benjamin R.; Gerber, Scott A.; Bothwell, Alfred L. M.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Graham, Morven; Rahner, Christoph] Yale Univ, Sch Med, Ctr Cellular & Mol Imaging, New Haven, CT 06510 USA; [Madri, Joseph A.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Lindenbach, Brett D.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA; [Pober, Jordan S.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Harding, MJ (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA.	martha.harding@yale.edu			American Gastroenterology Association; Section of Comparative Medicine; NIH [NIH-R01HL085416, NIH-T32AR07107, NIH-RO1HL-088258, NIH-KO1CA107092, NIH-RO1HL62188]; NATIONAL CANCER INSTITUTE [K01CA107092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085416, R01HL062188, R01HL088258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007107] Funding Source: NIH RePORTER	American Gastroenterology Association; Section of Comparative Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the American Gastroenterology Association (Research Scholar Award to M.J.H.), Section of Comparative Medicine (M.J.H., C.M.L.), NIH-R01HL085416 (B.R.S.), NIH-T32AR07107 (S.A.G.), NIH-RO1HL-088258 (A.L. M.B.), NIH-KO1CA107092 (B.D.L.) and NIH-RO1HL62188 (J.S.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bouhadir KH, 2001, J DRUG TARGET, V9, P397, DOI 10.3109/10611860108998775; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHEN FMC, 1976, CHING SHIH WEN TI, V3, P1; Chen Y, 2005, TRANSPLANTATION, V79, P1378, DOI 10.1097/01.TP.0000160813.37515.97; Dabeva MD, 2000, AM J PATHOL, V156, P2017, DOI 10.1016/S0002-9440(10)65074-2; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X; DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; FUJIWARA K, 1993, HEPATOLOGY, V18, P1443, DOI 10.1016/0270-9139(93)90237-H; Gerber SA, 2003, BRIT J CANCER, V88, P1453, DOI 10.1038/sj.bjc.6600907; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; GM A, 1976, PROG HEMOST THROMB, V3, P1; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Iacovacci S, 1997, HEPATOLOGY, V26, P1328; IACOVACCI S, 1993, RES VIROLOGY, V144, P275, DOI 10.1016/S0923-2516(06)80040-3; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Kedem A, 2005, TISSUE ENG, V11, P715, DOI 10.1089/ten.2005.11.715; Kelm JM, 2005, J BIOTECHNOL, V118, P213, DOI 10.1016/j.jbiotec.2005.03.016; Kirkiles-Smith NC, 2009, TRANSPLANTATION, V87, P189, DOI 10.1097/TP.0b013e318192e05d; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Lazaro CA, 2007, AM J PATHOL, V170, P478, DOI 10.2353/ajpath.2007.060789; LEPUS CM, 2009, HUM IMMUNOL; LINDENBACH BD, 2005, SCIENCE; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Liu YH, 1998, BIOCHEM BIOPH RES CO, V246, P821, DOI 10.1006/bbrc.1998.8676; MAHER JJ, 1988, GASTROENTEROLOGY, V94, P1053, DOI 10.1016/0016-5085(88)90566-5; Mahieu-Caputo D, 2004, HUM GENE THER, V15, P1219, DOI 10.1089/hum.2004.15.1219; Malhi H, 2002, J CELL SCI, V115, P2679; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Matsumoto S, 1999, LIVER, V19, P32, DOI 10.1111/j.1478-3231.1999.tb00006.x; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C; NAGAKI M, 1995, BIOCHEM BIOPH RES CO, V210, P38, DOI 10.1006/bbrc.1995.1624; Neubauer K, 2001, CAN J GASTROENTEROL, V15, P187, DOI 10.1155/2001/870205; Nguyen TH, 2005, J HEPATOL, V43, P1031, DOI 10.1016/j.jhep.2005.05.036; Nierhoff D, 2005, HEPATOLOGY, V42, P130, DOI 10.1002/hep.20735; Nowak G, 2005, GUT, V54, P972, DOI 10.1136/gut.2005.064477; Ogawa K, 2004, TRANSPLANTATION, V77, P1783, DOI 10.1097/01.tp.0000131153.78169.24; Ohashi K, 2005, HEPATOLOGY, V41, P132, DOI 10.1002/hep.20484; Ohashi K, 2000, NAT MED, V6, P327; Petersen J, 1998, P NATL ACAD SCI USA, V95, P310, DOI 10.1073/pnas.95.1.310; Phan T, 2009, J VIROL; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; ROOS F, 1995, AM J PHYSIOL-GASTR L, V268, pG380, DOI 10.1152/ajpgi.1995.268.2.G380; Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SHIMA N, 1994, BIOCHEM BIOPH RES CO, V200, P808, DOI 10.1006/bbrc.1994.1523; Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709; STOKER M, 1985, J CELL SCI, V77, P209; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Tsukada Y, 2009, BIOCHEM BIOPH RES CO, V381, P733, DOI 10.1016/j.bbrc.2009.02.158; Turrini P, 2006, TRANSPL P, V38, P1181, DOI 10.1016/j.transproceed.2006.02.149; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Xiong AM, 2008, TISSUE ENG PT A, V14, P995, DOI 10.1089/tea.2007.0087; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Yao C, 2004, CELLS TISSUES ORGANS, V178, P189, DOI 10.1159/000083730; Yokoyama T, 2006, AM J TRANSPLANT, V6, P50, DOI 10.1111/j.1600-6143.2005.01155.x; Zeisberg M, 2006, MOL CELL BIOCHEM, V283, P181, DOI 10.1007/s11010-006-2677-8; Zheng L, 2000, J IMMUNOL, V164, P4665, DOI 10.4049/jimmunol.164.9.4665; ZHONG J, 2005, P NATL ACAD SCI US; Zhou YJ, 2006, BIOCHEM BIOPH RES CO, V344, P658, DOI 10.1016/j.bbrc.2006.03.167; Zhu Q, 2006, ANTIMICROB AGENTS CH, V50, P3260, DOI 10.1128/AAC.00413-06	77	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9987	10.1371/journal.pone.0009987	http://dx.doi.org/10.1371/journal.pone.0009987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376322	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200057
J	Kong, EC; Woo, K; Li, HY; Lebestky, T; Mayer, N; Sniffen, MR; Heberlein, U; Bainton, RJ; Hirsh, J; Wolf, FW				Kong, Eric C.; Woo, Katherine; Li, Haiyan; Lebestky, Tim; Mayer, Nasima; Sniffen, Melissa R.; Heberlein, Ulrike; Bainton, Roland J.; Hirsh, Jay; Wolf, Fred W.			A Pair of Dopamine Neurons Target the D1-Like Dopamine Receptor DopR in the Central Complex to Promote Ethanol-Stimulated Locomotion in Drosophila	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; MUSHROOM BODIES; SYNAPTIC-TRANSMISSION; DIFFERENT FORMS; ELLIPSOID BODY; MOTOR-ACTIVITY; TERM-MEMORY; COCAINE; LOCALIZATION	Dopamine is a mediator of the stimulant properties of drugs of abuse, including ethanol, in mammals and in the fruit fly Drosophila. The neural substrates for the stimulant actions of ethanol in flies are not known. We show that a subset of dopamine neurons and their targets, through the action of the D1-like dopamine receptor DopR, promote locomotor activation in response to acute ethanol exposure. A bilateral pair of dopaminergic neurons in the fly brain mediates the enhanced locomotor activity induced by ethanol exposure, and promotes locomotion when directly activated. These neurons project to the central complex ellipsoid body, a structure implicated in regulating motor behaviors. Ellipsoid body neurons are required for ethanol-induced locomotor activity and they express DopR. Elimination of DopR blunts the locomotor activating effects of ethanol, and this behavior can be restored by selective expression of DopR in the ellipsoid body. These data tie the activity of defined dopamine neurons to D1-like DopR-expressing neurons to form a neural circuit that governs acute responding to ethanol.	[Kong, Eric C.; Heberlein, Ulrike; Wolf, Fred W.] Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Woo, Katherine; Sniffen, Melissa R.; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Li, Haiyan; Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Lebestky, Tim] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mayer, Nasima; Bainton, Roland J.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Virginia; California Institute of Technology; University of California System; University of California San Francisco	Kong, EC (corresponding author), Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	frederick.wolf@ucsf.edu			United States National Institutes of Health [AA014594-04, GM27318, DA19573, GM081863-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081863, R01GM027318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019573] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this research was provided by United States National Institutes of Health grant AA014594-04 (FWW), GM27318 (JH), DA19573 (UH), and GM081863-03 (RJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Berger KH, 2004, ALCOHOL CLIN EXP RES, V28, P1469, DOI 10.1097/01.ALC.0000141817.15993.98; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; BOOKER R, 1981, P NATL ACAD SCI-BIOL, V78, P3940, DOI 10.1073/pnas.78.6.3940; Borue X, 2010, J NEUROCHEM, V113, P188, DOI 10.1111/j.1471-4159.2010.06588.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; DICHIARA G, 1986, ANN NY ACAD SCI, V473, P367; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Feng GP, 1996, J NEUROSCI, V16, P3925; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Gotzes F, 1996, BIOCHEM BIOPH RES CO, V222, P121, DOI 10.1006/bbrc.1996.0708; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ilius M, 2007, J NEUROGENET, V21, P321, DOI 10.1080/01677060701693503; Ito K, 1998, LEARN MEMORY, V5, P52; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; KONG EC, 2009, ALCOHOL CLIN EXP RES; Konopka RJ, 1996, J NEUROGENET, V11, P117, DOI 10.3109/01677069609107066; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Martin JR, 1998, LEARN MEMORY, V5, P179; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Meyer PJ, 2009, GENES BRAIN BEHAV, V8, P346, DOI 10.1111/j.1601-183X.2009.00481.x; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; MORGAN BA, 1986, EMBO J, V5, P3335, DOI 10.1002/j.1460-2075.1986.tb04648.x; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Neckameyer W, 2001, J NEUROBIOL, V47, P280, DOI 10.1002/neu.1035; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; RISINGER FO, 1994, PSYCHOPHARMACOLOGY, V116, P207, DOI 10.1007/BF02245064; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rodan AR, 2002, J NEUROSCI, V22, P9490; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Szumlinski KK, 2008, BIOCHEM PHARMACOL, V75, P112, DOI 10.1016/j.bcp.2007.07.031; Thimgan MS, 2006, J EXP BIOL, V209, P3383, DOI 10.1242/jeb.02328; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Urizar NL, 2007, J NEUROSCI, V27, P4541, DOI 10.1523/JNEUROSCI.0305-07.2007; WALLER MB, 1986, PHARMACOL BIOCHEM BE, V24, P617, DOI 10.1016/0091-3057(86)90567-8; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wolf FW, 2002, J NEUROSCI, V22, P11035; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	78	130	131	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9954	10.1371/journal.pone.0009954	http://dx.doi.org/10.1371/journal.pone.0009954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376353	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000276418200030
J	Singh, IR; Gorzynski, JE; Drobysheva, D; Bassit, L; Schinazi, RF				Singh, Ila R.; Gorzynski, John E.; Drobysheva, Daria; Bassit, Leda; Schinazi, Raymond F.			Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; CONTROLLED TRIAL; PREVALENCE; RETROVIRUS; RESISTANT; THERAPY; BLIND	Background: Xenotropic murine leukemia-related retrovirus (XMRV) is a recently discovered retrovirus that has been linked to human prostate cancer and chronic fatigue syndrome (CFS). Both diseases affect a large fraction of the world population, with prostate cancer affecting one in six men, and CFS affecting an estimated 0.4 to 1% of the population. Principal Findings: Forty-five compounds, including twenty-eight drugs approved for use in humans, were evaluated against XMRV replication in vitro. We found that the retroviral integrase inhibitor, raltegravir, was potent and selective against XMRV at submicromolar concentrations, in MCF-7 and LNCaP cells, a breast cancer and prostate cancer cell line, respectively. Another integrase inhibitor, L-000870812, and two nucleoside reverse transcriptase inhibitors, zidovudine (ZDV), and tenofovir disoproxil fumarate (TDF) also inhibited XMRV replication. When combined, these drugs displayed mostly synergistic effects against this virus, suggesting that combination therapy may delay or prevent the selection of resistant viruses. Conclusions: If XMRV proves to be a causal factor in prostate cancer or CFS, these discoveries may allow for rational design of clinical trials.	[Singh, Ila R.; Gorzynski, John E.; Drobysheva, Daria] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Bassit, Leda; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Decatur, GA 30033 USA; [Bassit, Leda; Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Utah System of Higher Education; University of Utah; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Singh, IR (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	ila.singh@path.utah.edu	Schinazi, Raymond F/B-6777-2017	Gorzynski, John/0000-0002-9034-9016	NIH [2P30-AI-50409]; Department of Veterans Affairs (RFS); NATIONAL CANCER INSTITUTE [R01CA149719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (RFS)(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by NIH grant 2P30-AI-50409 (CFAR to RFS), and by the Department of Veterans Affairs (RFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; Bassit Leda, 2008, Antiviral Chemistry & Chemotherapy, V19, P25; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; Coffin JM, 2009, SCIENCE, V326, P530, DOI 10.1126/science.1181349; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Ernst E, 2004, J PSYCHOSOM RES, V57, P503, DOI 10.1016/j.jpsychores.2004.08.005; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FLOYD RA, 1998, USPTO PATENT FULL TE; Gregg VH, 1997, J ROY SOC MED, V90, P682, DOI 10.1177/014107689709001213; GROOM HCT, 2010, RETROVIROLOGY, V7, DOI DOI 10.1186/1742-4690-1187-1110; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; HO W, 1995, J MED CHEM, V38, P794, DOI 10.1021/jm00005a006; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; LAND S, 1992, J INFECT DIS, V166, P1139, DOI 10.1093/infdis/166.5.1139; LLOYD A, 1990, AM J MED, V89, P561, DOI 10.1016/0002-9343(90)90173-B; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Mears Tim, 2005, Acupunct Med, V23, P141; Naarding MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-6; PETERSON PK, 1990, AM J MED, V89, P554, DOI 10.1016/0002-9343(90)90172-A; Reid S, 2000, BMJ-BRIT MED J, V320, P292, DOI 10.1136/bmj.320.7230.292; RUPRECHT RM, 1986, NATURE, V323, P467, DOI 10.1038/323467a0; Sackner MA, 2004, MED HYPOTHESES, V63, P118, DOI 10.1016/j.mehy.2004.01.025; SAKUMA R, 2009, VIROLOGY; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; SCHINAZI RF, 1990, BIOL ROLE DEHYDROEPI, P157; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Telesnitsky A, 1995, METHOD ENZYMOL, V262, P347; Tharakan B, 2006, PHYTOTHER RES, V20, P91, DOI 10.1002/ptr.1794; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; VOLBERDING PA, 1994, JAMA-J AM MED ASSOC, V272, P437, DOI 10.1001/jama.272.6.437; VollmerConna U, 1997, AM J MED, V103, P38, DOI 10.1016/S0002-9343(97)90045-0; Weatherley-Jones E, 2004, J PSYCHOSOM RES, V56, P189, DOI 10.1016/S0022-3999(03)00377-5; Yamada Akihiro, 2009, Nihon Shokakibyo Gakkai Zasshi, V106, P1758; Zachrisson O, 2002, EUR J PAIN-LONDON, V6, P455, DOI 10.1016/S1090-3801(02)00044-7	42	43	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9948	10.1371/journal.pone.0009948	http://dx.doi.org/10.1371/journal.pone.0009948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376347	gold, Green Published, Green Submitted			2022-12-27	WOS:000276418200024
J	Kauh, J; Fan, SQ; Xia, MJ; Yue, P; Yang, L; Khuri, FR; Sun, SY				Kauh, John; Fan, Songqing; Xia, Mingjing; Yue, Ping; Yang, Lily; Khuri, Fadlo R.; Sun, Shi-Yong			c-FLIP Degradation Mediates Sensitization of Pancreatic Cancer Cells to TRAIL-Induced Apoptosis by the Histone Deacetylase Inhibitor LBH589	PLOS ONE			English	Article							CELECOXIB-INDUCED APOPTOSIS; DOWN-REGULATION; HDAC INHIBITORS; LIGAND TRAIL; HEPATOMA-CELLS; DEATH; XIAP; ACTIVATION; RESISTANCE; SURVIVIN	Great efforts have been made to develop novel and efficacious therapeutics against pancreatic cancer to improve the treatment outcomes. Tumor-necrosis factor-related apoptosis-inducing ligand ( TRAIL) is such a therapeutic cytokine with selective killing effect toward malignant cells. However, some human pancreatic cancers are intrinsically resistant to TRAIL-mediated apoptosis or therapy. In this study, we have shown that the histone deacetylase inhibitor LBH589 can synergize with TRAIL to augment apoptosis even in TRAIL-resistant cells. LBH589 decreased c-FLIP levels in every tested cell line and survivin levels in some of the tested cell lines. Enforced expression of ectopic c-FLIP, but not survivin, abolished the cooperative induction of apoptosis by the combination of LBH589 and TRAIL, indicating that c-FLIP downregulation plays a critical role in LBH589 sensitization of pancreatic cancer cells to TRAIL. Moreover, LBH589 decreased c-FLIP stability and the presence of the proteasome inhibitor MG132 prevented c-FLIP from reduction by LBH589. Correspondingly, we detected increased levels of ubiqutinated c-FLIP in LBH589-treated cells. These data thus indicate that LBH589 promotes ubiqutin/proteasome-mediated degradation of c-FLIP, leading to downregulation of c-FLIP. Collectively, LBH589 induces c-FLIP degradation and accordingly sensitizes pancreatic cancer cells to TRAIL-induced apoptosis, highlighting a novel therapeutic regimen against pancreatic cancer.	[Kauh, John; Fan, Songqing; Xia, Mingjing; Yue, Ping; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Kauh, John; Fan, Songqing; Xia, Mingjing; Yue, Ping; Yang, Lily; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA; [Yang, Lily] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Kauh, J (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618	Georgia Cancer Coalition Distinguished Cancer Scholar	Georgia Cancer Coalition Distinguished Cancer Scholar	This work was supported by the Georgia Cancer Coalition Distinguished Cancer Scholar award (to S-Y.S.) and departmental research fund (to J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; DARVAS K, 2010, INT J CANC; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Haefner M, 2008, WORLD J GASTROENTERO, V14, P3681, DOI 10.3748/wjg.14.3681; Hamacher R, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-64; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Hylander BL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-22; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim EH, 2005, ONCOGENE, V24, P6877, DOI 10.1038/sj.onc.1208851; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lucas DM, 2004, LEUKEMIA, V18, P1207, DOI 10.1038/sj.leu.2403388; Matsuzaki H, 2001, CLIN CANCER RES, V7, P407; Murtaza I, 2009, CANCER RES, V69, P1156, DOI 10.1158/0008-5472.CAN-08-2917; Neuzil H, 2004, BIOCHEM BIOPH RES CO, V314, P186, DOI 10.1016/j.bbrc.2003.12.074; Pathil A, 2006, HEPATOLOGY, V43, P425, DOI 10.1002/hep.21054; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Sanda T, 2007, LEUKEMIA, V21, P2344, DOI 10.1038/sj.leu.2404902; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Schuchmann M, 2006, ONCOL REP, V15, P227; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Sun SY, 1997, CANCER RES, V57, P4931; Symanowski J, 2009, J THORAC ONCOL, V4, P149, DOI 10.1097/JTO.0b013e318194f991; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wajant Harald, 2003, Mol Interv, V3, P124, DOI 10.1124/mi.3.3.124; Wang P, 2007, CELL SIGNAL, V19, P2237, DOI 10.1016/j.cellsig.2007.06.001; Watanabe K, 2005, CELL DEATH DIFFER, V12, P10, DOI 10.1038/sj.cdd.4401507; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu ZW, 2003, ANTICANCER RES, V23, P251; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang XD, 2003, BIOCHEM PHARMACOL, V66, P1537, DOI 10.1016/S0006-2952(03)00509-4; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	53	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10376	10.1371/journal.pone.0010376	http://dx.doi.org/10.1371/journal.pone.0010376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442774	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200016
J	Hou, J; Aerts, J; den Hamer, B; van IJcken, W; den Bakker, M; Riegman, P; van der Leest, C; van der Spek, P; Foekens, JA; Hoogsteden, HC; Grosveld, F; Philipsen, S				Hou, Jun; Aerts, Joachim; den Hamer, Bianca; van IJcken, Wilfred; den Bakker, Michael; Riegman, Peter; van der Leest, Cor; van der Spek, Peter; Foekens, John A.; Hoogsteden, Henk C.; Grosveld, Frank; Philipsen, Sjaak			Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER; ADENOCARCINOMA; MICROARRAYS; IDENTIFICATION; SIGNATURE; PROFILES; EGFR	Background: Current clinical therapy of non-small cell lung cancer depends on histo-pathological classification. This approach poorly predicts clinical outcome for individual patients. Gene expression profiling holds promise to improve clinical stratification, thus paving the way for individualized therapy. Methodology and Principal Findings: A genome-wide gene expression analysis was performed on a cohort of 91 patients. We used 91 tumor-and 65 adjacent normal lung tissue samples. We defined sets of predictor genes (probe sets) with the expression profiles. The power of predictor genes was evaluated using an independent cohort of 96 non-small cell lung cancer-and 6 normal lung samples. We identified a tumor signature of 5 genes that aggregates the 156 tumor and normal samples into the expected groups. We also identified a histology signature of 75 genes, which classifies the samples in the major histological subtypes of non-small cell lung cancer. Correlation analysis identified 17 genes which showed the best association with post-surgery survival time. This signature was used for stratification of all patients in two risk groups. Kaplan-Meier survival curves show that the two groups display a significant difference in post-surgery survival time (p = 5.6E-6). The performance of the signatures was validated using a patient cohort of similar size (Duke University, n = 96). Compared to previously published prognostic signatures for NSCLC, the 17 gene signature performed well on these two cohorts. Conclusions: The gene signatures identified are promising tools for histo-pathological classification of non-small cell lung cancer, and may improve the prediction of clinical outcome.	[Hou, Jun; den Hamer, Bianca; Foekens, John A.; Grosveld, Frank; Philipsen, Sjaak] Erasmus Univ, Med Ctr, Canc Genom Ctr, Rotterdam, Netherlands; [van IJcken, Wilfred] Erasmus Univ, Med Ctr, Ctr Biom, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hou, J (corresponding author), Erasmus Univ, Med Ctr, Canc Genom Ctr, Rotterdam, Netherlands.	j.philipsen@erasmusmc.nl	van ijcken, willem/N-9805-2018; Riegman, Peter/GLS-0041-2022; Aerts, Joachim GJV/I-7885-2018; Hou, Jun/AGJ-0692-2022	van ijcken, willem/0000-0002-0421-8301; 	Netherlands Genomics Initiative	Netherlands Genomics Initiative	Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, AM J RESP CRIT CARE, V156, P320; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; COX DR, 1972, J R STAT SOC B, V34, P187; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fujii T, 2002, CANCER RES, V62, P3340; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Jones MH, 2004, LANCET, V363, P775, DOI 10.1016/S0140-6736(04)15693-6; Kikuchi T, 2003, ONCOGENE, V22, P2192, DOI 10.1038/sj.onc.1206288; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Meche A, 2009, ROM J MORPHOL EMBRYO, V50, P217; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Press OA, 2008, CANCER RES, V68, P3037, DOI 10.1158/0008-5472.CAN-07-2718; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Skrzypski M, 2008, CLIN CANCER RES, V14, P4794, DOI 10.1158/1078-0432.CCR-08-0576; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yao RS, 2002, ONCOGENE, V21, P5814, DOI 10.1038/sj.onc.1205422	32	563	581	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10312	10.1371/journal.pone.0010312	http://dx.doi.org/10.1371/journal.pone.0010312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421987	Green Published, gold			2022-12-27	WOS:000276952600025
J	Kang, KS; Wang, P; Yamabe, N; Fukui, M; Jay, T; Zhu, BT				Kang, Ki Sung; Wang, Pan; Yamabe, Noriko; Fukui, Masayuki; Jay, Taylor; Zhu, Bao Ting			Docosahexaenoic Acid Induces Apoptosis in MCF-7 Cells In Vitro and In Vivo via Reactive Oxygen Species Formation and Caspase 8 Activation	PLOS ONE			English	Article							BREAST-CANCER CELLS; POLYUNSATURATED FATTY-ACIDS; FISH-OIL; LIPID-PEROXIDATION; PROLIFERATION; GROWTH; N-3; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; ANTHRACYCLINES	Background: The present study sought to further investigate the in vitro and in vivo anticancer effects of a representative omega-3 fatty acid, docosahexaenoic acid (DHA), with a focus on assessing the induction of oxidative stress and apoptosis as an important mechanism for its anticancer actions. Methodology/Principal Findings: In vitro studies showed that DHA strongly reduces the viability and DNA synthesis of MCF-7 human breast cancer cells in culture, and also promotes cell death via apoptosis. Mechanistically, accumulation of reactive oxygen species and activation of caspase 8 contribute critically to the induction of apoptotic cell death. Co-presence of antioxidants or selective inhibition or knockdown of caspase 8 each effectively abrogates the cytotoxic effect of DHA. Using athymic nude mice as an in vivo model, we found that feeding animals the 5% fish oil-supplemented diet for 6 weeks significantly reduces the growth of MCF-7 human breast cancer cells in vivo through inhibition of cancer cell proliferation as well as promotion of cell death. Using 3-nitrotyrosine as a parameter, we confirmed that the fish oil-supplemented diet significantly increases oxidative stress in tumor cells in vivo. Analysis of fatty acid content in plasma and tissues showed that feeding animals a 5% fish oil diet increases the levels of DHA and eicosapentaenoic acid in both normal and tumorous mammary tissues by 329% and 300%, respectively. Conclusions/Significance: DHA can strongly induce apoptosis in human MCF-7 breast cancer cells both in vitro and in vivo. The induction of apoptosis in these cells is selectively mediated via caspase 8 activation. These observations call for further studies to assess the effectiveness of fish oil as a dietary supplement in the prevention and treatment of human breast cancer.	[Kang, Ki Sung; Wang, Pan; Yamabe, Noriko; Fukui, Masayuki; Jay, Taylor; Zhu, Bao Ting] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Kang, KS (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu		Jay, Taylor/0000-0003-3878-7059	National Institutes of Health [ES015242]; National Center for Research Resources, NIH [P20RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in part, by a grant from the National Institutes of Health (ES015242). Some of the analytical and imaging instruments employed in this study are part of the Centers of Biomedical Research Excellence core facility that is supported by the NIH Grant P20RR021940 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTI M, 1992, GASTROENTEROLOGY, V103, P883, DOI 10.1016/0016-5085(92)90021-P; Arita K, 2001, BIOCHEM PHARMACOL, V62, P821, DOI 10.1016/S0006-2952(01)00723-7; Bagga D, 2002, NUTR CANCER, V42, P180, DOI 10.1207/S15327914NC422_5; BARTRAM HP, 1993, GASTROENTEROLOGY, V105, P1317, DOI 10.1016/0016-5085(93)90135-Y; BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053; Bougnoux P, 2009, BRIT J CANCER, V101, P1978, DOI 10.1038/sj.bjc.6605441; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; Cognault S, 2000, NUTR CANCER, V36, P33, DOI 10.1207/S15327914NC3601_6; Colas S, 2005, NUTR CANCER, V51, P178, DOI 10.1207/s15327914nc5102_8; Connolly JM, 1999, NUTR CANCER, V35, P44, DOI 10.1207/S1532791444-49; Day TW, 2008, BIOCHEM PHARMACOL, V76, P1694, DOI 10.1016/j.bcp.2008.09.007; Ding WQ, 2004, MOL CANCER THER, V3, P1109; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gago-Dominguez M, 2005, CANCER EPIDEM BIOMAR, V14, P2829, DOI 10.1158/1055-9965.EPI-05-0015; Gajate C, 2009, BIOCHEM BIOPH RES CO, V380, P780, DOI 10.1016/j.bbrc.2009.01.147; Hammamieh R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-138; Hardman WE, 2002, J NUTR, V132, p3508S, DOI 10.1093/jn/132.11.3508S; Hardman WE, 1999, BRIT J CANCER, V81, P440, DOI 10.1038/sj.bjc.6690713; Hardman WE, 1997, BRIT J CANCER, V76, P347, DOI 10.1038/bjc.1997.389; KAIZER L, 1989, NUTR CANCER, V12, P61, DOI 10.1080/01635588909514002; Koh YH, 1997, J BIOCHEM MOL BIOL, V30, P188; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; MORRISON WR, 1964, J LIPID RES, V5, P600; Noguchi M, 1997, BRIT J CANCER, V75, P348, DOI 10.1038/bjc.1997.57; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Rose DP, 1996, CLIN CANCER RES, V2, P1751; Sauer LA, 2005, J NUTR, V135, P2124, DOI 10.1093/jn/135.9.2124; Siddiqui RA, 2001, BBA-MOL CELL RES, V1499, P265, DOI 10.1016/S0167-4889(00)00128-2; SPECTOR AA, 1987, CANCER RES, V47, P4529; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vibet S, 2008, FREE RADICAL BIO MED, V44, P1483, DOI 10.1016/j.freeradbiomed.2008.01.009; WELSCH CW, 1995, FREE RADICAL BIO MED, V18, P757, DOI 10.1016/0891-5849(94)00187-O; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Ye YN, 2005, CARCINOGENESIS, V26, P827, DOI 10.1093/carcin/bgi012; Zamboni WC, 1998, J NATL CANCER I, V90, P505, DOI 10.1093/jnci/90.7.505	41	149	151	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10296	10.1371/journal.pone.0010296	http://dx.doi.org/10.1371/journal.pone.0010296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421971	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952600013
J	Ligresti, A; De Petrocellis, L; de la Ossa, DHP; Aberturas, R; Cristino, L; Moriello, AS; Finizio, A; Gil, ME; Torres, AI; Molpeceres, J; Di Marzo, V				Ligresti, Alessia; De Petrocellis, Luciano; Hernan Perez de la Ossa, Dolores; Aberturas, Rosario; Cristino, Luigia; Moriello, Aniello Schiano; Finizio, Andrea; Esther Gil, Ma; Torres, Ana-Isabel; Molpeceres, Jesus; Di Marzo, Vincenzo			Exploiting Nanotechnologies and TRPV1 Channels to Investigate the Putative Anandamide Membrane Transporter	PLOS ONE			English	Article							TYPE-1 CANNABINOID RECEPTORS; PHASE-CONTRAST MICROSCOPY; CELLULAR UPTAKE; INHIBITORS; NANOPARTICLES; TEMPERATURE; HYDROLYSIS; CELLS; PALMITOYLETHANOLAMIDE; INACTIVATION	Background: Considerable efforts have been made to characterize the pathways regulating the extracellular levels of the endocannabinoid anandamide. However, none of such pathways has been so argued as the existence of a carrier-mediated transport of anandamide across the membrane. Apart from the lack of molecular evidence for such a carrier, the main reasons of this controversy lie in the methodologies currently used to study anandamide cellular uptake. Furthermore, the main evidence in favor of the existence of an "anandamide transporter" relies on synthetic inhibitors of this process, the selectivity of which has been questioned. Methodology/Principal Findings: We used the cytosolic binding site for anandamide on TRPV1 channels as a biosensor to detect anandamide entry into cells, and exploited nanotechnologies to study anandamide membrane transport into intact TRPV1-overexpressing HEK-293 cells. Both fluorescence and digital holographic (DH) quantitative phase microscopy were used to study TRPV1 activation. Poly-epsilon-caprolactone nanoparticles (PCL-NPs) were used to incorporate anandamide, which could thus enter the cell and activate TRPV1 channels bypassing any possible specific protein(s) involved in the uptake process. We reasoned that in the absence of such protein(s), pharmacological tools previously shown to inhibit the "anandamide transporter" would affect in the same way the uptake of anandamide and PCL-NP-anandamide, and hence the activation of TRPV1. However, when masked into PCL-NPs, anandamide cellular uptake became much less sensitive to these agents, although it maintained the same pharmacokinetics and pharmacodynamics as that of "free" anandamide. Conclusions: We found here that several agents previously reported to inhibit anandamide cellular uptake lose their efficacy when anandamide is prevented from interacting directly with plasma membrane proteins, thus arguing in favor of the specificity of such agents for the putative "anandamide transporter", and of the existence of such mechanism.	[Ligresti, Alessia; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Pozzuoli, Italy; [Ligresti, Alessia; De Petrocellis, Luciano; Cristino, Luigia; Moriello, Aniello Schiano; Di Marzo, Vincenzo] Endocannabinoid Res Grp, Pozzuoli, Italy; [Ligresti, Alessia; De Petrocellis, Luciano; Cristino, Luigia; Moriello, Aniello Schiano; Di Marzo, Vincenzo] Endocannabinoid Res Grp, Naples, Italy; [De Petrocellis, Luciano; Cristino, Luigia; Moriello, Aniello Schiano; Finizio, Andrea] CNR, Inst Cybernet, Pozzuoli, Italy; [Hernan Perez de la Ossa, Dolores; Esther Gil, Ma; Torres, Ana-Isabel] Univ Complutense, Dept Pharm & Pharmaceut Technol, Sch Pharm, E-28040 Madrid, Spain; [Aberturas, Rosario; Molpeceres, Jesus] Alcala Univ, Dept Pharm & Pharmaceut Technol, Sch Pharm, Madrid, Spain	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); Complutense University of Madrid; Universidad de Alcala	Ligresti, A (corresponding author), CNR, Inst Biomol Chem, Pozzuoli, Italy.	vdimarzo@icmib.na.cnr.it	Ligresti, Alessia/B-7564-2015; Di Marzo, Vincenzo/AAD-7742-2019; Torres-SuÃrez, Ana Isabel/AAR-9320-2020; /Y-9512-2019; Torres-Suárez, Ana I/N-4666-2013; Cristino, Luigia/AAE-3934-2020; del Rosario Aberturas, María/AAA-9014-2019	Ligresti, Alessia/0000-0003-1787-3900; Di Marzo, Vincenzo/0000-0002-1490-3070; Torres-SuÃrez, Ana Isabel/0000-0003-2468-6177; /0000-0003-4201-0795; Torres-Suárez, Ana I/0000-0003-2468-6177; Cristino, Luigia/0000-0002-0182-4699; del Rosario Aberturas, María/0000-0001-7875-6009; GIL-ALEGRE, MARIA ESTHER/0000-0002-8313-8261	Consiglio Nazionale delle Ricerche	Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR))	This study was partly funded by the Consiglio Nazionale delle Ricerche. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bari M, 2008, NEUROPHARMACOLOGY, V54, P45, DOI 10.1016/j.neuropharm.2007.06.030; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Bojesen IN, 2005, J LIPID RES, V46, P1652, DOI 10.1194/jlr.M400498-JLR200; Bojesen IN, 2006, J LIPID RES, V47, P561, DOI 10.1194/jlr.M500411-JLR200; Chawla JS, 2002, INT J PHARM, V249, P127, DOI 10.1016/S0378-5173(02)00483-0; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Dausend J, 2008, MACROMOL BIOSCI, V8, P1135, DOI 10.1002/mabi.200800123; Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1; de Lago E, 2004, EUR J PHARMACOL, V484, P249, DOI 10.1016/j.ejphar.2003.11.027; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; De Petrocellis L, 2001, J BIOL CHEM, V276, P12856, DOI 10.1074/jbc.M008555200; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, FEBS LETT, V436, P449, DOI 10.1016/S0014-5793(98)01175-2; Di Pasquale E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004989; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Ferraro P, 2006, OPT LETT, V31, P1405, DOI 10.1364/OL.31.001405; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; GARRETT ER, 1974, J PHARM SCI-US, V63, P1056, DOI 10.1002/jps.2600630705; Hajos N, 2004, EUR J NEUROSCI, V19, P2991, DOI 10.1111/j.0953-816X.2004.03433.x; Hillard CJ, 2007, J MOL NEUROSCI, V33, P18, DOI 10.1007/s12031-007-0045-0; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Jeong K, 2007, OPT EXPRESS, V15, P14057, DOI 10.1364/OE.15.014057; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Karlsson M, 2004, EUR J PHARM SCI, V22, P181, DOI 10.1016/j.ejps.2004.03.009; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Lopez-Rodriguez ML, 2003, EUR J MED CHEM, V38, P403, DOI 10.1016/S0223-5234(03)00045-X; Maccarrone M, 2000, J BIOL CHEM, V275, P13484, DOI 10.1074/jbc.275.18.13484; Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r; Maione S, 2008, BRIT J PHARMACOL, V155, P775, DOI 10.1038/bjp.2008.308; Mann CJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-21; Mann CJ, 2005, OPT EXPRESS, V13, P8693, DOI 10.1364/OPEX.13.008693; MICCIO L, 2007, SPIE P, V6631; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Rappaz B, 2009, BLOOD CELL MOL DIS, V42, P228, DOI 10.1016/j.bcmd.2009.01.018; Thors L, 2006, BRIT J PHARMACOL, V149, P73, DOI 10.1038/sj.bjp.0706831; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003	45	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10239	10.1371/journal.pone.0010239	http://dx.doi.org/10.1371/journal.pone.0010239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20422025	gold, Green Published, Green Submitted			2022-12-27	WOS:000276952600002
J	Chanut-Delalande, H; Jung, AC; Baer, MM; Lin, L; Payre, F; Affolter, M				Chanut-Delalande, Helene; Jung, Alain C.; Baer, Magdalena M.; Lin, Li; Payre, Francois; Affolter, Markus			The Hrs/Stam Complex Acts as a Positive and Negative Regulator of RTK Signaling during Drosophila Development	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; TRACHEAL CELL-MIGRATION; DOWN-REGULATION; BRANCHING MORPHOGENESIS; ENDOSOMAL TRAFFICKING; ESCRT MACHINERY; MOSAIC ANALYSIS; EGF-RECEPTOR; HRS	Background: Endocytosis is a key regulatory step of diverse signalling pathways, including receptor tyrosine kinase (RTK) signalling. Hrs and Stam constitute the ESCRT-0 complex that controls the initial selection of ubiquitinated proteins, which will subsequently be degraded in lysosomes. It has been well established ex vivo and during Drosophila embryogenesis that Hrs promotes EGFR down regulation. We have recently isolated the first mutations of stam in flies and shown that Stam is required for air sac morphogenesis, a larval respiratory structure whose formation critically depends on finely tuned levels of FGFR activity. This suggest that Stam, putatively within the ESCRT-0 complex, modulates FGF signalling, a possibility that has not been examined in Drosophila yet. Principal Findings: Here, we assessed the role of the Hrs/Stam complex in the regulation of signalling activity during Drosophila development. We show that stam and hrs are required for efficient FGFR signalling in the tracheal system, both during cell migration in the air sac primordium and during the formation of fine cytoplasmic extensions in terminal cells. We find that stam and hrs mutant cells display altered FGFR/Btl localisation, likely contributing to impaired signalling levels. Electron microscopy analyses indicate that endosome maturation is impaired at distinct steps by hrs and stam mutations. These somewhat unexpected results prompted us to further explore the function of stam and hrs in EGFR signalling. We show that while stam and hrs together downregulate EGFR signalling in the embryo, they are required for full activation of EGFR signalling during wing development. Conclusions/Significance: Our study shows that the ESCRT-0 complex differentially regulates RTK signalling, either positively or negatively depending on tissues and developmental stages, further highlighting the importance of endocytosis in modulating signalling pathways during development.	[Chanut-Delalande, Helene; Jung, Alain C.; Baer, Magdalena M.; Lin, Li; Affolter, Markus] Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland; [Chanut-Delalande, Helene; Payre, Francois] Univ Toulouse 3, Ctr Biol Dev, UPS, Univ Toulouse, F-31062 Toulouse, France; [Chanut-Delalande, Helene; Payre, Francois] Ctr Dev Biol, CNRS, UMR5547, Toulouse, France	University of Basel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chanut-Delalande, H (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland.	chanut@cict.fr; markus.affolter@unibas.ch	Jung, Alain/X-5384-2019; Jung, Alain/AAC-6598-2019	Jung, Alain/0000-0002-4049-4151; PAYRE, Francois/0000-0002-8144-6711; Affolter, Markus/0000-0002-5171-0016; Baer, Magdalena/0000-0003-3315-0921; CHANUT-DELALANDE, Helene/0000-0002-1720-2069	Swiss National Science Foundation; Kantons Basel-Stadt and Basel-Land; European Commission; Association pour la Recherche contre le Cancer n [1111]; ANR Programme Blanc Netoshape	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kantons Basel-Stadt and Basel-Land; European Commission(European CommissionEuropean Commission Joint Research Centre); Association pour la Recherche contre le Cancer n; ANR Programme Blanc Netoshape(French National Research Agency (ANR))	Studies done in the laboratory of Markus Affolter are supported by research grants from the Swiss National Science Foundation, the Kantons Basel-Stadt and Basel-Land, and the European Commission via the FP6 Network of Excellence "Cells into organs''. Experiments performed in Francois Payre laboratory are supported by Association pour la Recherche contre le Cancer n degrees 1111 and ANR Programme Blanc Netoshape. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Chanut-Delalande H, 2007, GENETICS, V176, P2177, DOI 10.1534/genetics.107.073890; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Devergne O, 2007, J CELL SCI, V120, P3457, DOI 10.1242/jcs.005926; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; Gabay L, 1997, DEVELOPMENT, V124, P3535; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Golembo M, 1996, DEVELOPMENT, V122, P223; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Reich A, 2002, EMBO J, V21, P4287, DOI 10.1093/emboj/cdf439; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615; WEAVER M, 2008, SCIENCE; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	49	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10245	10.1371/journal.pone.0010245	http://dx.doi.org/10.1371/journal.pone.0010245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422006	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500013
J	Alvarez, MM; Lopez-Pacheco, F; Aguilar-Yanez, JM; Portillo-Lara, R; Mendoza-Ochoa, GI; Garcia-Echauri, S; Freiden, P; Schultz-Cherry, S; Zertuche-Guerra, MI; Bulnes-Abundis, D; Salgado-Gallegos, J; Elizondo-Montemayor, L; Hernandez-Torre, M				Alvarez, Mario M.; Lopez-Pacheco, Felipe; Aguilar-Yanez, Jose M.; Portillo-Lara, Roberto; Mendoza-Ochoa, Gonzalo I.; Garcia-Echauri, Sergio; Freiden, Pamela; Schultz-Cherry, Stacey; Zertuche-Guerra, Manuel I.; Bulnes-Abundis, David; Salgado-Gallegos, Johari; Elizondo-Montemayor, Leticia; Hernandez-Torre, Martin			Specific Recognition of Influenza A/H1N1/2009 Antibodies in Human Serum: A Simple Virus-Free ELISA Method	PLOS ONE			English	Article							A H5N1 VIRUS; HEMAGGLUTINATION INHIBITION; ANTIGENIC STRUCTURE; RECEPTOR-BINDING; CELL-CULTURE; VACCINE; BURDEN; STRAIN; SITES; ASSAY	Background: Although it has been estimated that pandemic Influenza A H1N1/2009 has infected millions of people from April to October 2009, a more precise figure requires a worldwide large-scale diagnosis of the presence of Influenza A/H1N1/2009 antibodies within the population. Assays typically used to estimate antibody titers (hemagglutination inhibition and microneutralization) would require the use of the virus, which would seriously limit broad implementation. Methodology/Principal Findings: An ELISA method to evaluate the presence and relative concentration of specific Influenza A/H1N1/2009 antibodies in human serum samples is presented. The method is based on the use of a histidine-tagged recombinant fragment of the globular region of the hemagglutinin (HA) of the Influenza A H1N1/2009 virus expressed in E. coli. Conclusions/Significance: The ELISA method consistently discerns between Inf A H1N1 infected and non-infected subjects, particularly after the third week of infection/exposure. Since it does not require the use of viral particles, it can be easily and quickly implemented in any basic laboratory. In addition, in a scenario of insufficient vaccine availability, the use of this ELISA could be useful to determine if a person has some level of specific antibodies against the virus and presumably at least partial protection.	[Alvarez, Mario M.; Lopez-Pacheco, Felipe; Aguilar-Yanez, Jose M.; Portillo-Lara, Roberto; Mendoza-Ochoa, Gonzalo I.; Garcia-Echauri, Sergio; Zertuche-Guerra, Manuel I.; Bulnes-Abundis, David; Salgado-Gallegos, Johari; Elizondo-Montemayor, Leticia; Hernandez-Torre, Martin] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, New Leon, Mexico; [Freiden, Pamela; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Tecnologico de Monterrey; St Jude Children's Research Hospital	Alvarez, MM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, New Leon, Mexico.	mario.alvarez@itesm.mx	Schultz-Cherry, Stacey/N-2506-2018; Portillo-Lara, Roberto/AAX-5002-2020	Portillo-Lara, Roberto/0000-0002-1781-3126; Mendoza-Ochoa, Gonzalo I/0000-0002-7361-8915; Aguilar-Yanez, Jose M/0000-0002-8590-9111; Alvarez, Mario Moises/0000-0002-9131-5344; Garcia, Sergio/0000-0001-8738-7356	National Institute of Allergy and Infectious Diseases, the National Institutes of Health [HHSN266200700005C]	National Institute of Allergy and Infectious Diseases, the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful for the financial support received from the Zambrano-Hellion family and Tecnologico de Monterrey (seed funding CAT-122). This work was funded in part by the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, under contract number HHSN266200700005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILARYANEZ JM, 2009, Patent No. 2009009565; ALLWINN R, 2010, MED MICROBIOL I 0217; ALVAREZ MM, 2009, E COLI BL21 DE3 PLYS; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hassantoufighi A, 2010, VACCINE, V28, P790, DOI 10.1016/j.vaccine.2009.10.066; He QG, 2007, CLIN VACCINE IMMUNOL, V14, P617, DOI 10.1128/CVI.00444-06; HIDAYATULLAH TA, 2009, INT J INTEGRATIVE BI, V6, P137; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Li OTW, 2009, EXPERT REV ANTI-INFE, V7, P687, DOI [10.1586/eri.09.48, 10.1586/ERI.09.48]; MILLER E, 2010, LANCET          0120; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; Paal M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-7; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Reisinger KS, 2009, J INFECT DIS, V200, P849, DOI 10.1086/605506; ROSS T, 2010, PLOS CURR INFLUENZA; Sabarth N, 2010, VACCINE, V28, P650, DOI 10.1016/j.vaccine.2009.10.105; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Salk JE, 1944, J IMMUNOL, V49, P87; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; Schwahn AB, 2009, J IMMUNOASS IMMUNOCH, V30, P245, DOI 10.1080/15321810903084350; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Sirskyj D, 2010, J VIROL METHODS, V163, P459, DOI 10.1016/j.jviromet.2009.11.014; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Stelzer-Braid S, 2008, J CLIN VIROL, V43, P241, DOI 10.1016/j.jcv.2008.06.012; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Szucs T, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.suppl_2.11; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WHO, 2009, CDC PROT REALT RT PC; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	46	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10176	10.1371/journal.pone.0010176	http://dx.doi.org/10.1371/journal.pone.0010176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418957	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706800016
J	Boles, BR; Thoendel, M; Roth, AJ; Horswill, AR				Boles, Blaise R.; Thoendel, Matthew; Roth, Aleeza J.; Horswill, Alexander R.			Identification of Genes Involved in Polysaccharide-Independent Staphylococcus aureus Biofilm Formation	PLOS ONE			English	Article							EXTRACELLULAR DNA; STREPTOCOCCUS-PNEUMONIAE; METHICILLIN RESISTANCE; PROTEOLYTIC ACTIVITY; BINDING PROTEINS; EXPRESSION; RELEASE; SYSTEM; AUTOLYSIS; SUSCEPTIBILITY	Staphylococcus aureus is a potent biofilm former on host tissue and medical implants, and biofilm growth is a critical virulence determinant for chronic infections. Recent studies suggest that many clinical isolates form polysaccharide-independent biofilms. However, a systematic screen for defective mutants has not been performed to identify factors important for biofilm formation in these strains. We created a library of 14,880 mariner transposon mutants in a S. aureus strain that generates a proteinaceous and extracellular DNA based biofilm matrix. The library was screened for biofilm defects and 31 transposon mutants conferred a reproducible phenotype. In the pool, 16 mutants overproduced extracellular proteases and the protease inhibitor alpha(2)-macroglobulin restored biofilm capacity to 13 of these mutants. The other 15 mutants in the pool displayed normal protease levels and had defects in genes involved in autolysis, osmoregulation, or uncharacterized membrane proteins. Two transposon mutants of interest in the GraRS two-component system and a putative inositol monophosphatase were confirmed in a flow cell biofilm model, genetically complemented, and further verified in a community-associated methicillin-resistant S. aureus (CA-MRSA) isolate. Collectively, our screen for biofilm defective mutants identified novel loci involved in S. aureus biofilm formation and underscored the importance of extracellular protease activity and autolysis in biofilm development.	[Boles, Blaise R.; Thoendel, Matthew; Roth, Aleeza J.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Horswill, AR (corresponding author), Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu			National Institute of Allergy and Infectious Diseases [AI083211]; American Heart Association [0825877G]; National Science Foundation [DBI-0647982]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI081748, P01AI083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PO1 award AI083211 (Project 3 to A. R. H.) from the National Institute of Allergy and Infectious Diseases. B. R. B. was supported by an American Heart Association Postdoctoral Training Grant (0825877G). A.J.R. was supported by grant DBI-0647982 (REU in Microbiology at The University of Iowa) from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; BISWAS R, 2006, FEMS MICROBIOL LETT, V268, P259; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HEINS JN, 1967, J BIOL CHEM, V242, P1016; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Kapfhammer D, 2005, APPL ENVIRON MICROB, V71, P3840, DOI 10.1128/AEM.71.7.3840-3847.2005; Komatsuzawa H, 1999, ANTIMICROB AGENTS CH, V43, P2121, DOI 10.1128/AAC.43.9.2121; Komatsuzawa H, 1997, ANTIMICROB AGENTS CH, V41, P2355, DOI 10.1128/AAC.41.11.2355; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Malone CL, 2007, APPL ENVIRON MICROB, V73, P6036, DOI 10.1128/AEM.00912-07; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; O'Neill AJ, 2004, J ANTIMICROB CHEMOTH, V54, P1127, DOI 10.1093/jac/dkh476; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Roberts Mary F., 2006, V39, P103; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	56	250	255	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10146	10.1371/journal.pone.0010146	http://dx.doi.org/10.1371/journal.pone.0010146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418950	gold, Green Published, Green Submitted			2022-12-27	WOS:000276706800009
J	Tay, HG; Ng, YW; Manser, E				Tay, Hwee Goon; Ng, Yuen Wai; Manser, Ed			A Vertebrate-Specific Chp-PAK-PIX Pathway Maintains E-Cadherin at Adherens Junctions during Zebrafish Epiboly	PLOS ONE			English	Article							CELL-CELL ADHESION; CONVERGENT EXTENSION MOVEMENTS; NUCLEOTIDE EXCHANGE FACTOR; RHO-FAMILY GTPASES; EPITHELIAL-MESENCHYMAL TRANSITIONS; ACTIN CYTOSKELETON; SIGNALING PATHWAY; EMBRYONIC-DEVELOPMENT; P21-ACTIVATED KINASE; DISTINCT ROLES	Background: In early vertebrate development, embryonic tissues modulate cell adhesiveness and acto-myosin contractility to correctly orchestrate the complex processes of gastrulation. E-cadherin (E-cadh) is the earliest expressed cadherin and is needed in the mesendodermal progenitors for efficient migration [1,2]. Regulatory mechanisms involving directed E-cadh trafficking have been invoked downstream of Wnt11/5 signaling [3]. This non-canonical Wnt pathway regulates RhoA-ROK/DAAM1 to control the acto-myosin network. However, in this context nothing is known of the intracellular signals that participate in the correct localization of E-cadh, other than a need for Rab5c signaling [3]. Methodology/Principal Findings: By studying loss of Chp induced by morpholino-oligonucleotide injection in zebrafish, we find that the vertebrate atypical Rho-GTPase Chp is essential for the proper disposition of cells in the early embryo. The underlying defect is not leading edge F-actin assembly ( prominent in the cells of the envelope layer), but rather the failure to localize E-cadh and beta-catenin at the adherens junctions. Loss of Chp results in delayed epiboly that can be rescued by mRNA co-injection, and phenocopies zebrafish E-cadh mutants [4,5]. This new signaling pathway involves activation of an effector kinase PAK, and involvement of the adaptor PAK-interacting exchange factor PIX. Loss of signaling by any of the three components results in similar underlying defects, which is most prominent in the epithelial-like envelope layer. Conclusions/Significance: Our current study uncovers a developmental pathway involving Chp/PAK/PIX signaling, which helps co-ordinate E-cadh disposition to promote proper cell adhesiveness, and coordinate movements of the three major cell layers in epiboly. Our data shows that without Chp signaling, E-cadh shifts to intracellular vesicles rather than the adhesive contacts needed for directed cell movement. These events may mirror the requirement for PAK2 signaling essential for the proper formation of the blood-brain barrier [6,7].	[Tay, Hwee Goon; Manser, Ed] IMB, RGS Rho GTPases Stem Cells Grp, Singapore, Singapore; [Ng, Yuen Wai; Manser, Ed] IMCB, SGSK, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Tay, HG (corresponding author), IMB, RGS Rho GTPases Stem Cells Grp, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		Agency for Science, Technology and Research (A-STAR)	Agency for Science, Technology and Research (A-STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A-STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Bahri SM, 2009, DEV BIOL, V325, P15, DOI 10.1016/j.ydbio.2008.09.001; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361; Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Djiane A, 2000, DEVELOPMENT, V127, P3091; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Guemar L, 2007, DEV BIOL, V310, P113, DOI 10.1016/j.ydbio.2007.07.031; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harden N, 1999, J CELL SCI, V112, P273; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kardash E., NAT CELL BIOL, V12, P47; KARDASH E, NAT CELL BIOL, V12, P41; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Koh CG, 2001, J CELL SCI, V114, P4239; Kuroda S, 1997, BIOCHEM BIOPH RES CO, V240, P430, DOI 10.1006/bbrc.1997.7675; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Liu J, 2007, P NATL ACAD SCI USA, V104, P13990, DOI 10.1073/pnas.0700825104; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Missy K, 2008, MOL CELL BIOL, V28, P3776, DOI 10.1128/MCB.00507-07; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Montero JA, 2004, TRENDS CELL BIOL, V14, P620, DOI 10.1016/j.tcb.2004.09.008; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Munoz-Descalzo S, 2007, INT J DEV BIOL, V51, P379, DOI 10.1387/ijdb.062250sm; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Notarnicola C, 2008, DEV DYNAM, V237, P1165, DOI 10.1002/dvdy.21507; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pirraglia C, 2006, DEV BIOL, V290, P435, DOI 10.1016/j.ydbio.2005.12.005; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Salas-Vidal E, 2005, GENOMICS, V86, P25, DOI 10.1016/j.ygeno.2005.03.010; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; SOLNICAKREZEL L, 1994, DEVELOPMENT, V120, P2443; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; STRAHLE U, 1993, DEVELOPMENT, V119, P909; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Ulrich Florian, 2008, V440, P371, DOI 10.1007/978-1-59745-178-9_27; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wherlock M, 2002, J CELL SCI, V115, P239; Williams MJ, 2005, BRAIN RES, V1058, P62, DOI 10.1016/j.brainres.2005.07.078; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	90	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10125	10.1371/journal.pone.0010125	http://dx.doi.org/10.1371/journal.pone.0010125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405038	gold, Green Published, Green Submitted			2022-12-27	WOS:000276705900009
J	Polidoro, BA; Carpenter, KE; Collins, L; Duke, NC; Ellison, AM; Ellison, JC; Farnsworth, EJ; Fernando, ES; Kathiresan, K; Koedam, NE; Livingstone, SR; Miyagi, T; Moore, GE; Vien, NN; Ong, JE; Primavera, JH; Salmo, SG; Sanciangco, JC; Sukardjo, S; Wang, YM; Yong, JWH				Polidoro, Beth A.; Carpenter, Kent E.; Collins, Lorna; Duke, Norman C.; Ellison, Aaron M.; Ellison, Joanna C.; Farnsworth, Elizabeth J.; Fernando, Edwino S.; Kathiresan, Kandasamy; Koedam, Nico E.; Livingstone, Suzanne R.; Miyagi, Toyohiko; Moore, Gregg E.; Vien Ngoc Nam; Ong, Jin Eong; Primavera, Jurgenne H.; Salmo, Severino G., III; Sanciangco, Jonnell C.; Sukardjo, Sukristijono; Wang, Yamin; Yong, Jean Wan Hong			The Loss of Species: Mangrove Extinction Risk and Geographic Areas of Global Concern	PLOS ONE			English	Article							RED LIST INDEXES; CONSERVATION; BIODIVERSITY; ECOSYSTEM; FORESTS; MANAGEMENT; DYNAMICS; TRENDS; FISH; SUSTAINABILITY	Mangrove species are uniquely adapted to tropical and subtropical coasts, and although relatively low in number of species, mangrove forests provide at least US $1.6 billion each year in ecosystem services and support coastal livelihoods worldwide. Globally, mangrove areas are declining rapidly as they are cleared for coastal development and aquaculture and logged for timber and fuel production. Little is known about the effects of mangrove area loss on individual mangrove species and local or regional populations. To address this gap, species-specific information on global distribution, population status, life history traits, and major threats were compiled for each of the 70 known species of mangroves. Each species' probability of extinction was assessed under the Categories and Criteria of the IUCN Red List of Threatened Species. Eleven of the 70 mangrove species (16%) are at elevated threat of extinction. Particular areas of geographical concern include the Atlantic and Pacific coasts of Central America, where as many as 40% of mangroves species present are threatened with extinction. Across the globe, mangrove species found primarily in the high intertidal and upstream estuarine zones, which often have specific freshwater requirements and patchy distributions, are the most threatened because they are often the first cleared for development of aquaculture and agriculture. The loss of mangrove species will have devastating economic and environmental consequences for coastal communities, especially in those areas with low mangrove diversity and high mangrove area or species loss. Several species at high risk of extinction may disappear well before the next decade if existing protective measures are not enforced.	[Polidoro, Beth A.; Carpenter, Kent E.; Livingstone, Suzanne R.; Sanciangco, Jonnell C.] Old Dominion Univ, IUCN Species Programme, SSC, Norfolk, VA 23529 USA; [Collins, Lorna] Nature Conservancy, Ctr Global Trends, Arlington, VA USA; [Collins, Lorna] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Duke, Norman C.; Salmo, Severino G., III] Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia; [Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Ellison, Joanna C.] Univ Tasmania, Sch Geog & Environm Studies, Launceston, Tas 7250, Australia; [Farnsworth, Elizabeth J.] New England Wild Flower Soc, Framingham, MA USA; [Fernando, Edwino S.] Univ Philippines, Los Banos Coll, Dept Forest Biol Sci, Laguna, Philippines; [Kathiresan, Kandasamy] Annamalai Univ, Ctr Adv Study Marine Biol, Parangipettai, India; [Koedam, Nico E.] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Brussels, Belgium; [Miyagi, Toyohiko] Tohoku Gakuin Univ, Fac Liberal Art, Dept Reg Management, Sendai, Miyagi 980, Japan; [Moore, Gregg E.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Moore, Gregg E.] Univ New Hampshire, Jackson Estuarine Lab, Durham, NH 03824 USA; [Vien Ngoc Nam] Nong Lam Univ, Fac Forestry, Ho Chi Minh City, Vietnam; [Ong, Jin Eong] Univ Sains Malaysia, Ctr Marine & Coastal Studies, George Town, Malaysia; [Primavera, Jurgenne H.] SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo, Philippines; [Salmo, Severino G., III] Cent Luzon State Univ, Coll Agr, Sci City Of Munoz, Nueva Ecija, Philippines; [Sukardjo, Sukristijono] Indonesian Inst Sci, Ctr Oceanol Res & Dev, Jakarta, Indonesia; [Wang, Yamin] Shandong Univ, Coll Ocean, Weihai, Peoples R China; [Yong, Jean Wan Hong] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ Acad Grp, Singapore, Singapore	Old Dominion University; Nature Conservancy; University of Plymouth; University of Queensland; Harvard University; University of Tasmania; University of the Philippines System; University of the Philippines Los Banos; Annamalai University; Vrije Universiteit Brussel; Tohoku Gakuin University; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Nong Lam University; Universiti Sains Malaysia; Southeast Asian Fisheries Development Center; Central Luzon State University; Indonesian Institute of Sciences; Shandong University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Polidoro, BA (corresponding author), Old Dominion Univ, IUCN Species Programme, SSC, Norfolk, VA 23529 USA.	bpolidor@odu.edu	Salmo, Severino G./T-4794-2018; Duke, Norman C/K-5729-2013; Yong, Jean/B-9976-2019; Ellison, Joanna C/C-2372-2014; Kandasamy, Kathiresan/X-7933-2019; Yong, Jean W. H./H-4671-2012; Yong, Jean WH/G-4839-2012	Salmo, Severino G./0000-0001-6807-4397; Duke, Norman C/0000-0003-2081-9120; Yong, Jean/0000-0003-3325-8254; Ellison, Joanna C/0000-0003-0692-8347; Kandasamy, Kathiresan/0000-0003-1203-0023; Yong, Jean W. H./0000-0003-3325-8254; Fernando, Edwino/0000-0001-9422-5451; Ellison, Aaron/0000-0003-4151-6081; Sanciangco, Jonnell Cueto/0000-0001-8268-3180	Tom Haas; New Hampshire Charitable Foundation	Tom Haas; New Hampshire Charitable Foundation	This research was generously supported by core funding from Tom Haas and the New Hampshire Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 1986, CONSERVATION BIOL SC; [Anonymous], WORLD ATLAS MANGROVE; Armitage D, 2002, GLOBAL ENVIRON CHANG, V12, P203, DOI 10.1016/S0959-3780(02)00023-7; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CLARKE PJ, 1995, HYDROBIOLOGIA, V295, P83, DOI 10.1007/BF00029114; Cohen JE, 1997, SCIENCE, V278, P1211; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahdouh-Guebas F, 2008, AQUAT BOT, V89, P80, DOI 10.1016/j.aquabot.2008.03.012; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; Dahdouh-Guebas F., 2004, Systematics and Biodiversity, V2, P113; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; Dittmar T, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002570; Dodd Richard S., 2008, P172, DOI 10.1017/CBO9780511751790.017; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Duarte Carlos M., 1999, Mangroves and Salt Marshes, V3, P251, DOI 10.1023/A:1009967401337; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Duke N.C., 1992, TROPICAL MANGROVE EC, V41, P63, DOI [10.1029/ce041p0063, DOI 10.1029/CE041P0063]; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; DUKE NC, 1992, BIOTROPICA, V24, P173, DOI 10.2307/2388671; Duke NC, 1997, BIOTROPICA, V29, P2, DOI 10.1111/j.1744-7429.1997.tb00001.x; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Ellison AM, 2000, J ECOL, V88, P813, DOI 10.1046/j.1365-2745.2000.00500.x; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; Ellison J, 2005, PALAEOGEOGR PALAEOCL, V220, P291, DOI 10.1016/j.palaeo.2005.01.008; Ellison JC, 2009, WETL ECOL MANAG, V17, P169, DOI 10.1007/s11273-008-9097-3; EMERTON L, 2002, 4 IUCN SRI LANK COUN; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; FAO, 2007, 153 FAO FOR RES DIV; Farnsworth EJ, 1997, AMBIO, V26, P328; Field CB, 1998, GLOBAL ECOL BIOGEOGR, V7, P3, DOI 10.2307/2997693; Fosberg FR, 1971, BIOL CONSERV, V4, P38; Glaser M, 2003, WETL ECOL MANAG, V11, P265, DOI 10.1023/A:1025015600125; Green EP, 1998, INT J REMOTE SENS, V19, P935, DOI 10.1080/014311698215801; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jayatissa LP, 2002, BOT J LINN SOC, V138, P29, DOI 10.1046/j.1095-8339.2002.00002.x; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; KOEDAM N, 2008, SCIENCE, V319, P321; Kovacs JM, 2005, ESTUAR COAST SHELF S, V62, P377, DOI 10.1016/j.ecss.2004.09.027; Kress W. John, 2003, Contributions from the United States National Herbarium, V45, P1; LAMPARELLI CC, 1997, MANGROVE ECOSYSTEM S, P191; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Lopez-Hoffman L, 2006, ECOL SOC, V11; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Lugo A.E., 2002, MADERA BOSQUES, V8, P5, DOI DOI 10.21829/MYB.2002.801289; Luther DA, 2009, BIOSCIENCE, V59, P602, DOI 10.1525/bio.2009.59.7.11; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Miththapala S., 2008, COASTAL ECOSYSTEMS S, V2; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Neukermans G, 2008, J SPAT SCI, V53, P75, DOI 10.1080/14498596.2008.9635137; Ong J. E., 2003, FOLIA MALAYSIANA, V4, P1; ONG JE, 1995, HYDROBIOLOGIA, V295, P343; ONG JE, 1993, CHEMOSPHERE, V27, P1097; PAGLIOSA PA, 2004, IMPACT URBANIZATION; Primavera J., 2004, HDB MANGROVES PHILIP; Primavera JH, 2000, ECOL ECON, V35, P91, DOI 10.1016/S0921-8009(00)00170-1; Primavera JH, 1998, ESTUAR COAST SHELF S, V46, P457, DOI 10.1006/ecss.1997.0275; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; Rodrigues ASL, 2002, CONSERV BIOL, V16, P674, DOI 10.1046/j.1523-1739.2002.00455.x; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Ronnback P, 1999, ECOL ECON, V29, P235, DOI 10.1016/S0921-8009(99)00016-6; Saenger P, 2013, MANGROVE ECOLOGY SIL; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SHEUE CR, 2009, BLUMEA IN PRESS, V54; SIMBERLOFF D, 1988, ANNU REV ECOL SYST, V19, P473, DOI 10.1146/annurev.ecolsys.19.1.473; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sullivan C, 2005, IMPORTANCE MANGROVES; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tovilla-Hernandez C, 2001, REV BIOL TROP, V49, P571; Upadhyay VP, 2002, CURR SCI INDIA, V83, P1328; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Verheyden A, 2004, ANN BOT-LONDON, V94, P59, DOI 10.1093/aob/mch115; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Wang L, 2004, REMOTE SENS ENVIRON, V91, P432, DOI 10.1016/j.rse.2004.04.005; WILKIE ML, 2003, 63 FAO FOR RES DIV; Xue XZ, 2004, J ENVIRON MANAGE, V71, P271, DOI 10.1016/j.jenvman.2004.03.006	86	647	680	11	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10095	10.1371/journal.pone.0010095	http://dx.doi.org/10.1371/journal.pone.0010095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386710	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000276482000021
J	Gujral, TS; MacBeath, G				Gujral, Taranjit S.; MacBeath, Gavin			A System-Wide Investigation of the Dynamics of Wnt Signaling Reveals Novel Phases of Transcriptional Regulation	PLOS ONE			English	Article							BETA-CATENIN; CANCER; ACTIVATION; CELLS; COLON; ASSOCIATION; MECHANISMS; APOPTOSIS; PATHWAYS; PROTEINS	Aberrant Wnt signaling has been implicated in a wide variety of cancers and many components of the Wnt signaling network have now been identified. Much less is known, however, about how these proteins are coordinately regulated. Here, a broad, quantitative, and dynamic study of Wnt3a-mediated stimulation of HEK 293 cells revealed two phases of transcriptional regulation: an early phase in which signaling antagonists were downregulated, providing positive feedback, and a later phase in which many of these same antagonists were upregulated, attenuating signaling. The dynamic expression profiles of several response genes, including MYC and CTBP1, correlated significantly with proliferation and migration (P<0.05). Additionally, their levels tracked with the tumorigenicity of colon cancer cell lines and they were significantly overexpressed in colorectal adenocarcinomas (P<0.05). Our data highlight CtBP1 as a transcription factor that contributes to positive feedback during the early phases of Wnt signaling and serves as a novel marker for colorectal cancer progression.	[Gujral, Taranjit S.; MacBeath, Gavin] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Gujral, TS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	gavin_macbeath@harvard.edu		Gujral, Taran/0000-0002-4453-3031; MacBeath, Gavin/0000-0003-2585-6772	WM Keck Foundation; Camille and Henry Dreyfus Foundation; National Institutes of Health [R33 CA128726, R21 CA126720, P50 GM068762]; NATIONAL CANCER INSTITUTE [R33CA128726, R21CA126720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); Camille and Henry Dreyfus Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by awards from the WM Keck Foundation and the Camille and Henry Dreyfus Foundation, and by grants from the National Institutes of Health (R33 CA128726, R21 CA126720, and P50 GM068762). TSG is a Human Frontier Science Program Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Oyama T, 2008, CARCINOGENESIS, V29, P666, DOI 10.1093/carcin/bgn001; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Shi SR, 1999, APPL IMMUNOHISTO M M, V7, P201, DOI 10.1097/00022744-199909000-00005; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	37	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10024	10.1371/journal.pone.0010024	http://dx.doi.org/10.1371/journal.pone.0010024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383323	Green Submitted, Green Published, gold			2022-12-27	WOS:000276454000005
J	Paccalet, T; Coulombe, Z; Tremblay, JP				Paccalet, Thomas; Coulombe, Zoe; Tremblay, Jacques P.			Ganglioside GM3 Levels Are Altered in a Mouse Model of HIBM: GM3 as a Cellular Marker of the Disease	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE GNE; SIALIC-ACID BIOSYNTHESIS; DISTAL MYOPATHY; SKELETAL-MUSCLE; NEUTRAL GLYCOSPHINGOLIPIDS; ALPHA-DYSTROGLYCAN; RIMMED VACUOLES; KEY ENZYME; HEREDITARY	Objective: HIBM (Hereditary Inclusion Body Myopathy) is a recessive hereditary disease characterized by adult-onset, slowly progressive muscle weakness sparing the quadriceps. It is caused by a single missense mutation of each allele of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene, a bifunctional enzyme catalyzing the first two steps of sialic acid synthesis in mammals. However, the mechanisms and cellular pathways affected by the GNE mutation and causing the muscle weakness could not be identified so far. Based on recent evidence in literature, we investigated a new hypothesis, i.e. the involvement in the disease of the GM3 ganglioside, a specific glycolipid implicated in muscle cell proliferation and differentiation. Methods: qRT-PCR analysis of St3gal5 (GM3 synthase) gene expression and HPLC quantification of GM3 ganglioside were conducted on muscle tissue from a mouse model of HIBM harboring the M712T mutation of GNE (Gne(M712T/M712T) mouse) vs control mice (Gne(+/+) mouse). Results: St3gal5 mRNA levels were significantly lower in Gne(M712T/M712T) mouse muscles vs Gne(+/+) mouse muscles (64.41% +/- 610% of Gne(+/+) levels). GM3 ganglioside levels showed also a significant decrease in Gne(M712T/M712T) mouse muscle compared to Gne(+/+) mouse muscle (18.09% +/- 65.33% of Gne(+/+) levels). Although these Gne(M712T/M712T) mice were described to suffer severe glomerular proteinuria, no GM3 alterations were noted in kidneys, highlighting a tissue specific alteration of gangliosides. Conclusion: The M712T mutation of GNE hampers the muscle ability to synthesize normal levels of GM3. This is the first time that a mutation of GNE can be related to the molecular pathological mechanism of HIBM.	[Paccalet, Thomas; Coulombe, Zoe; Tremblay, Jacques P.] Univ Laval, CHU Quebec, Unite Genet Humaine, Ctr Rech, Quebec City, PQ, Canada	Laval University	Paccalet, T (corresponding author), Univ Laval, CHU Quebec, Unite Genet Humaine, Ctr Rech, Quebec City, PQ, Canada.	Jacques-P.Tremblay@crchul.ulaval.ca	; Paccalet, Thomas/F-9137-2014	Tremblay, Jacques P./0000-0001-9404-9195; Paccalet, Thomas/0000-0003-4955-2140	Ministere du Developpement economique, de l'Innovation et de l'Exportation; Neuromuscular Disease Foundation	Ministere du Developpement economique, de l'Innovation et de l'Exportation; Neuromuscular Disease Foundation	This study is supported partly by the "Ministere du Developpement economique, de l'Innovation et de l'Exportation" and the Neuromuscular Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RS, 2008, SKELETAL RADIOL, V37, P43, DOI 10.1007/s00256-007-0367-6; Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; AMSILI S, 2007, CELL DEATH DIFFER; Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Broccolini A, 2005, NEUROMUSCULAR DISORD, V15, P177, DOI 10.1016/j.nmd.2004.10.001; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; CACIC M, 1995, GLYCOCONJUGATE J, V12, P721, DOI 10.1007/BF00731270; CACIC M, 1994, GLYCOCONJUGATE J, V11, P477, DOI 10.1007/BF00731284; CAMBRON LD, 1994, MOL CELL BIOCHEM, V130, P173, DOI 10.1007/BF01457398; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Hollister J, 2003, GLYCOBIOLOGY, V13, P487, DOI 10.1093/glycob/cwg053; Holthofer H, 1996, AM J PATHOL, V149, P1009; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010; Krause S, 2007, NEUROLOGY, V69, P655, DOI 10.1212/01.wnl.0000267426.97138.fd; Kumamoto T, 1998, ACTA NEUROPATHOL, V95, P571, DOI 10.1007/s004010050842; Kumamoto T, 2000, MUSCLE NERVE, V23, P1686, DOI 10.1002/1097-4598(200011)23:11<1686::AID-MUS3>3.0.CO;2-F; Kwak DH, 2003, LIFE SCI, V72, P1997, DOI 10.1016/S0024-3205(03)00090-0; LADISCH S, 1985, ANAL BIOCHEM, V146, P220, DOI 10.1016/0003-2697(85)90419-1; Langeveld M, 2008, J CLIN ENDOCR METAB, V93, P845, DOI 10.1210/jc.2007-1702; LESKAWA KC, 1988, MOL CELL BIOCHEM, V83, P47; LESKAWA KC, 1990, MOL CELL BIOCHEM, V96, P163, DOI 10.1007/BF00420908; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; Malik KA, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/03/004; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; MitraniRosenbaum S, 1996, HUM MOL GENET, V5, P159, DOI 10.1093/hmg/5.1.159; MOHOS SC, 1969, SCIENCE, V164, P1519, DOI 10.1126/science.164.3887.1519; Muthing J, 1997, GLYCOCONJUGATE J, V14, P19, DOI 10.1023/A:1018552729572; MUTHING J, 1994, J BIOCHEM, V115, P248; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Nonaka I, 1998, NEUROMUSCULAR DISORD, V8, P333, DOI 10.1016/S0960-8966(98)00027-3; Nonaka I, 1999, CURR OPIN NEUROL, V12, P493, DOI 10.1097/00019052-199910000-00002; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Penner J, 2006, BIOCHEMISTRY-US, V45, P2968, DOI 10.1021/bi0522504; Pilkington GJ, 2005, CELL PROLIFERAT, V38, P423, DOI 10.1111/j.1365-2184.2005.00358.x; Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f; SADEH M, 1993, BRAIN, V116, P217, DOI 10.1093/brain/116.1.217; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; SHAYMAN JA, 1991, AM J PHYSIOL, V260, pF291, DOI 10.1152/ajprenal.1991.260.3.F291; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Sparks SE, 2005, GLYCOBIOLOGY, V15, P1102, DOI 10.1093/glycob/cwi100; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; Tsuruta Y, 2001, ACTA NEUROPATHOL, V101, P579; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100	63	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10055	10.1371/journal.pone.0010055	http://dx.doi.org/10.1371/journal.pone.0010055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383336	Green Published, gold, Green Submitted			2022-12-27	WOS:000276454000015
J	Liu, JY; Morgan, M; Hutchison, K; Calhoun, VD				Liu, Jingyu; Morgan, Marilee; Hutchison, Kent; Calhoun, Vince D.			A Study of the Influence of Sex on Genome Wide Methylation	PLOS ONE			English	Article							DNA METHYLATION; ALCOHOL DEPENDENCE; SYNOVIAL SARCOMA; GENDER; EXPRESSION; TLE1; GENE; PROMOTER; COMPLEX; CDKN2B	Sex differences in methylation status have been observed in specific gene-disease studies and healthy methylation variation studies, but little work has been done to study the impact of sex on methylation at the genome wide locus-to-locus level or to determine methods for accounting for sex in genomic association studies. In this study we investigate the genomic sex effect on saliva DNA methylation of 197 subjects (54 females) using 20,493 CpG sites. Three methods, two-sample T-test, principle component analysis and independent component analysis, all successfully identify sex influences. The results show that sex not only influences the methylation of genes in the X chromosome but also in autosomes. 580 autosomal sites show strong differences between males and females. They are found to be highly involved in eight functional groups, including DNA transcription, RNA splicing, membrane, etc. Equally important is that we identify some methylation sites associated with not only sex, but also other phenotypes (age, smoking and drinking level, and cancer). Verification was done through an independent blood cell DNA methylation data (1298 CpG sites from a cancer panel array). The same genomic site-specific influence pattern and potential confounding effects with cancer were observed. The overlapping rate of identified sex affected genes between saliva and blood cell is 81% for X chromosome, and 8% for autosomes. Therefore, correction for sex is necessary. We propose a simple correction method based on independent component analysis, which is a data driven method and accommodates sample differences. Comparison before and after the correction suggests that the method is able to effectively remove the potentially confounding effects of sex, and leave other phenotypes untouched. As such, our method is able to disentangle the sex influence on a genome wide level, and paves the way to achieve more accurate association analyses in genome wide methylation studies.	[Liu, Jingyu; Morgan, Marilee; Hutchison, Kent; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Liu, Jingyu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Hutchison, Kent] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico	Liu, JY (corresponding author), Mind Res Network, Albuquerque, NM USA.	jliu@mrn.org	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747; Liu, Jingyu/0000-0002-1724-7523	National Institutes of Health [NIH R01EB005846, NIH R01AA012238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the National Institutes of Health (NIH R01EB005846 to V. Calhoun and NIH R01AA012238 to K. Hutchison). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Au WY, 2005, BRIT J HAEMATOL, V131, P632, DOI 10.1111/j.1365-2141.2005.05818.x; Babor TF, 2006, AUDIT ALCOHOL USE DI; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Cardoso JF, 1997, IEEE SIGNAL PROC LET, V4, P112, DOI 10.1109/97.566704; Chim CS, 2006, LEUKEMIA, V20, P149, DOI 10.1038/sj.leu.2404052; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jackson JE, 1991, USERS GUIDE PRINCIPA; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Kosemehmetoglu K, 2009, MODERN PATHOL, V22, P872, DOI 10.1038/modpathol.2009.47; Liu JY, 2009, HUM BRAIN MAPP, V30, P241, DOI 10.1002/hbm.20508; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Okabe H, 2003, CANCER RES, V63, P3043; Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778; Raj K, 2007, LEUKEMIA, V21, P1937, DOI 10.1038/sj.leu.2404796; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Terry J, 2007, AM J SURG PATHOL, V31, P240, DOI 10.1097/01.pas.0000213330.71745.39; Tost J, 2008, DNA METHYLATION METH, P3; Wiencke JK, 1999, CANCER EPIDEM BIOMAR, V8, P501; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Xiao YM, 2008, CELL BIOL TOXICOL, V24, P265, DOI 10.1007/s10565-007-9035-9	32	169	170	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10028	10.1371/journal.pone.0010028	http://dx.doi.org/10.1371/journal.pone.0010028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386599	gold, Green Published, Green Submitted			2022-12-27	WOS:000276420400006
J	Auburn, S; Fry, AE; Clark, TG; Campino, S; Diakite, M; Green, A; Richardson, A; Jallow, M; Sisay-Joof, F; Pinder, M; Molyneux, ME; Taylor, TE; Haldar, K; Rockett, KA; Kwiatkowski, DP				Auburn, Sarah; Fry, Andrew E.; Clark, Taane G.; Campino, Susana; Diakite, Mahamadou; Green, Angela; Richardson, Anna; Jallow, Muminatou; Sisay-Joof, Fatou; Pinder, Margaret; Molyneux, Malcolm E.; Taylor, Terrie E.; Haldar, Kasturi; Rockett, Kirk A.; Kwiatkowski, Dominic P.			Further Evidence Supporting a Role for Gs Signal Transduction in Severe Malaria Pathogenesis	PLOS ONE			English	Article							ADENYLYL-CYCLASE; ADENOSINE RECEPTORS; ETHNIC DISTRIBUTION; BLOOD-PRESSURE; PROTEIN; ASSOCIATION; GENE; POLYMORPHISM; HAPLOTYPES; LINKAGE	With the functional demonstration of a role in erythrocyte invasion by Plasmodium falciparum parasites, implications in the aetiology of common conditions that prevail in individuals of African origin, and a wealth of pharmacological knowledge, the stimulatory G protein (Gs) signal transduction pathway presents an exciting target for anti-malarial drug intervention. Having previously demonstrated a role for the G-alpha-s gene, GNAS, in severe malaria disease, we sought to identify other important components of the Gs pathway. Using meta-analysis across case-control and family trio (affected child and parental controls) studies of severe malaria from The Gambia and Malawi, we sought evidence of association in six Gs pathway candidate genes: adenosine receptor 2A (ADORA2A) and 2B (ADORA2B), beta-adrenergic receptor kinase 1 (ADRBK1), adenylyl cyclase 9 (ADCY9), G protein beta subunit 3 (GNB3), and regulator of G protein signalling 2 (RGS2). Our study amassed a total of 2278 cases and 2364 controls. Allele-based models of association were investigated in all genes, and genotype and haplotype-based models were investigated where significant allelic associations were identified. Although no significant associations were observed in the other genes, several were identified in ADORA2A. The most significant association was observed at the rs9624472 locus, where the G allele (similar to 20% frequency) appeared to confer enhanced risk to severe malaria [OR = 1.22 (1.09-1.37); P = 0.001]. Further investigation of the ADORA2A gene region is required to validate the associations identified here, and to identify and functionally characterize the responsible causal variant(s). Our results provide further evidence supporting a role of the Gs signal transduction pathway in the regulation of severe malaria, and request further exploration of this pathway in future studies.	[Auburn, Sarah; Fry, Andrew E.; Campino, Susana; Diakite, Mahamadou; Green, Angela; Richardson, Anna; Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Jallow, Muminatou; Sisay-Joof, Fatou; Pinder, Margaret] MRC, Banjul, Gambia; [Auburn, Sarah; Clark, Taane G.; Campino, Susana; Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Molyneux, Malcolm E.] Coll Med, Malawi Liverpool Wellcome Trust Programme Clin Tr, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Taylor, Terrie E.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Taylor, Terrie E.] Michigan State Univ, Dept Internal Med, Coll Osteopath Med, E Lansing, MI 48824 USA; [Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, South Bend, IN USA	University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Notre Dame	Auburn, S (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	sa3@sanger.ac.uk	Haldar, Kasturi/C-6685-2014; Clark, Taane G./AAM-2570-2020; Fry, Andrew/AFK-7448-2022; Fry, Andrew/AAN-2730-2020; Campino, Susana/AAM-2577-2020; Auburn, Sarah/N-2266-2013	Clark, Taane G./0000-0001-8985-9265; Fry, Andrew/0000-0001-9778-6924; Fry, Andrew/0000-0001-9778-6924; Campino, Susana/0000-0003-1403-6138; Auburn, Sarah/0000-0002-4638-536X; Kwiatkowski, Dominic/0000-0002-5023-0176	Medical Research Council (UK); National Institutes of Health (USA) [5R01AI034969-09]; Wellcome Trust Training Fellowship; Bill and Melinda Gates Foundation; Marie-Curie intra-European fellowship; International Atomic Energy Agency; MRC [G0600230, G19/9] Funding Source: UKRI; Medical Research Council [G19/9, G0600230] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034969] Funding Source: NIH RePORTER	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Training Fellowship(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Marie-Curie intra-European fellowship(European Commission); International Atomic Energy Agency(International Atomic Energy Agency); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The genetic component of this research was funded by a Medical Research Council (UK) (http://www.mrc.ac.uk/index.htm) grant to Prof. Dominic Kwiatkowski and a National Institutes of Health (USA)(http://www.nih.gov/) grant to Prof. Kasturi Haldar. SA was supported by a PhD studentship from the Medical Research council (UK) (http://www.mrc.ac.uk/index.htm). AEF was funded by a Wellcome Trust Training Fellowship (http://www.wellcome.ac.uk/). TC was funded by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/Pages/home.aspx). SC was funded by a Marie-Curie intra-European fellowship (FP6) (http://cordis.europa.eu/mariecurie-actions/eif/home.html). MD was supported by a training fellowship from the International Atomic Energy Agency (http://www.iaea.org/). Sample collection in Malawi was supported by NIH grant 5R01AI034969-09 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Auburn S, 2008, HUM GENET, V124, P499, DOI 10.1007/s00439-008-0575-8; BRUNS RF, 1986, MOL PHARMACOL, V29, P331; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dong YB, 2004, PHARMACOGENETICS, V14, P419, DOI 10.1097/01.fpc.0000114748.08559.ad; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanchard NA, 2006, AM J HUM GENET, V78, P153, DOI 10.1086/499252; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Jackson EK, 2008, HYPERTENSION, V51, P719, DOI 10.1161/HYPERTENSIONAHA.107.096297; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Liclican EL, 2005, AM J PHYSIOL-RENAL, V289, pF386, DOI 10.1152/ajprenal.00421.2004; Liclican EL, 2008, AM J PHYSIOL-RENAL, V295, pF1696, DOI 10.1152/ajprenal.90502.2008; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; MILLER LH, 1994, P NATL ACAD SCI USA, V91, P2415, DOI 10.1073/pnas.91.7.2415; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rosskopf D, 2002, PHARMACOGENETICS, V12, P209, DOI 10.1097/00008571-200204000-00005; Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Small KM, 2003, PHARMACOGENETICS, V13, P535, DOI 10.1097/00008571-200309000-00002; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tang CM, 2005, PHARMACOGENET GENOM, V15, P321, DOI 10.1097/01213011-200505000-00007; Tantisira KG, 2005, HUM MOL GENET, V14, P1671, DOI 10.1093/hmg/ddi175; Teo YY, 2009, HUM HERED, V67, P26, DOI 10.1159/000164396; Thompson Miles D., 2008, V448, P77, DOI 10.1007/978-1-59745-205-2_6; Wright S., 1986, EVOLUTION SELECTED P	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e10017	10.1371/journal.pone.0010017	http://dx.doi.org/10.1371/journal.pone.0010017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20386734	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000276418200065
J	Bandyopadhyay, A; Wang, L; Agyin, J; Tang, YP; Lin, S; Yeh, IT; De, K; Sun, LZ				Bandyopadhyay, Abhik; Wang, Long; Agyin, Joseph; Tang, Yuping; Lin, Shu; Yeh, I-Tien; De, Keya; Sun, Lu-Zhe			Doxorubicin in Combination with a Small TGF beta Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR KINASE INHIBITOR; IN-VIVO; STEM-CELLS; MAMMARY-CARCINOMA; TRANSFORMING GROWTH-FACTOR-BETA-1; DISEASE PROGRESSION; MDA-MB-231 CELLS; DRUG-RESISTANCE	Background: Recent studies suggested that induction of epithelial-mesenchymal transition (EMT) might confer both metastatic and self-renewal properties to breast tumor cells resulting in drug resistance and tumor recurrence. TGF beta is a potent inducer of EMT and has been shown to promote tumor progression in various breast cancer cell and animal models. Principal Findings: We report that chemotherapeutic drug doxorubicin activates TGF beta signaling in human and murine breast cancer cells. Doxorubicin induced EMT, promoted invasion and enhanced generation of cells with stem cell phenotype in murine 4T1 breast cancer cells in vitro, which were significantly inhibited by a TGF beta type I receptor kinase inhibitor (T beta RI-KI). We investigated the potential synergistic anti-tumor activity of T beta R1-KI in combination with doxorubicin in animal models of metastatic breast cancer. Combination of Doxorubicin and T beta RI-KI enhanced the efficacy of doxorubicin in reducing tumor growth and lung metastasis in the 4T1 orthotopic xenograft model in comparison to single treatments. Doxorubicin treatment alone enhanced metastasis to lung in the human breast cancer MDA-MB-231 orthotopic xenograft model and metastasis to bone in the 4T1 orthotopic xenograft model, which was significantly blocked when T beta R1-KI was administered in combination with doxorubicin. Conclusions: These observations suggest that the adverse activation of TGF beta pathway by chemotherapeutics in the cancer cells together with elevated TGF beta levels in tumor microenvironment may lead to EMT and generation of cancer stem cells resulting in the resistance to the chemotherapy. Our results indicate that the combination treatment of doxorubicin with a TGF beta inhibitor has the potential to reduce the dose and consequently the toxic side-effects of doxorubicin, and improve its efficacy in the inhibition of breast cancer growth and metastasis.	[Bandyopadhyay, Abhik; Wang, Long; Tang, Yuping; Lin, Shu; De, Keya; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Agyin, Joseph] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Yeh, I-Tien] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Bandyopadhyay, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	sunl@uthscsa.edu	Lin, Shu/C-3790-2013; , LuZhe/AAW-4095-2021		NIH [R01CA079683, R01CA075253, P01CA040035, P30CA054174]; Shelby Rae Tang Foundation; NATIONAL CANCER INSTITUTE [R01CA079683, R01CA075253, P01CA040035, P30CA054174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shelby Rae Tang Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH Grants R01CA079683, R01CA075253, P01CA040035, and P30CA054174, and by Shelby Rae Tang Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Bandyopadhyay A, 2002, CANCER RES, V62, P4690; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bandyopadhyay Abhik, 2008, V2, P723, DOI 10.1007/978-1-59745-293-9_44; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen JH, 2005, ENDOCR-RELAT CANCER, V12, P93, DOI 10.1677/erc.1.00871; DALAL BI, 1993, AM J PATHOL, V143, P381; Davies JA, 1996, ACTA ANAT, V156, P187; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; ELLIS MJ, 2004, TREATMENT METASTATIC, P749; Gamucci T, 2007, BRIT J CANCER, V97, P1040, DOI 10.1038/sj.bjc.6603982; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; GORSCH SM, 1992, CANCER RES, V52, P6949; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Kolodziejski L, 1999, Pneumonol Alergol Pol, V67, P228; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Liu PC, 2000, INT J ONCOL, V16, P599; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TJ, 2000, ENDOCR-RELAT CANCER, V7, P271, DOI 10.1677/erc.0.0070271; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; Nikolic-Vukosavljevic D, 2004, CLIN EXP METASTAS, V21, P581; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Planchard D, 2004, CANCER-AM CANCER SOC, V100, P28, DOI 10.1002/cncr.11881; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013; SOSROSENO W, 1995, BRIT J BIOMED SCI, V52, P142; Sun LZ, 2004, FRONT BIOSCI, V9, P1925, DOI 10.2741/1382; Sun LZ, 1997, J BIOL CHEM, V272, P25367, DOI 10.1074/jbc.272.40.25367; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Teicher BA, 1997, IN VIVO, V11, P453; Teicher BA, 1997, IN VIVO, V11, P463; Tsushima H, 2001, CLIN CANCER RES, V7, P1258; Verona EV, 2007, CANCER RES, V67, P5737, DOI 10.1158/0008-5472.CAN-07-0444; WALKER RA, 1995, J PATHOL, V177, P123, DOI 10.1002/path.1711770204; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yoneda Toshiyuki, 2000, Cancer, V88, P2979, DOI 10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U	56	140	150	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10365	10.1371/journal.pone.0010365	http://dx.doi.org/10.1371/journal.pone.0010365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442777	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200007
J	Lira-Medeiros, CF; Parisod, C; Fernandes, RA; Mata, CS; Cardoso, MA; Ferreira, PCG				Lira-Medeiros, Catarina Fonseca; Parisod, Christian; Fernandes, Ricardo Avancini; Mata, Camila Souza; Cardoso, Monica Aires; Gomes Ferreira, Paulo Cavalcanti			Epigenetic Variation in Mangrove Plants Occurring in Contrasting Natural Environment	PLOS ONE			English	Article							DNA METHYLATION; POLYMORPHISM; INHERITANCE; POPULATION; HYBRIDIZATION; CONSEQUENCES; VARIABILITY; POLYPLOIDY; PATTERNS; DISPLAYS	Background: Epigenetic modifications, such as cytosine methylation, are inherited in plant species and may occur in response to biotic or abiotic stress, affecting gene expression without changing genome sequence. Laguncularia racemosa, a mangrove species, occurs in naturally contrasting habitats where it is subjected daily to salinity and nutrient variations leading to morphological differences. This work aims at unraveling how CpG-methylation variation is distributed among individuals from two nearby habitats, at a riverside (RS) or near a salt marsh (SM), with different environmental pressures and how this variation is correlated with the observed morphological variation. Principal Findings: Significant differences were observed in morphological traits such as tree height, tree diameter, leaf width and leaf area between plants from RS and SM locations, resulting in smaller plants and smaller leaf size in SM plants. Methyl-Sensitive Amplified Polymorphism (MSAP) was used to assess genetic and epigenetic (CpG-methylation) variation in L. racemosa genomes from these populations. SM plants were hypomethylated (14.6% of loci had methylated samples) in comparison to RS (32.1% of loci had methylated samples). Within-population diversity was significantly greater for epigenetic than genetic data in both locations, but SM also had less epigenetic diversity than RS. Frequency-based (G(ST)) and multivariate (beta(ST)) methods that estimate population structure showed significantly greater differentiation among locations for epigenetic than genetic data. Co-Inertia analysis, exploring jointly the genetic and epigenetic data, showed that individuals with similar genetic profiles presented divergent epigenetic profiles that were characteristic of the population in a particular environment, suggesting that CpG-methylation changes may be associated with environmental heterogeneity. Conclusions: In spite of significant morphological dissimilarities, individuals of L. racemosa from salt marsh and riverside presented little genetic but abundant DNA methylation differentiation, suggesting that epigenetic variation in natural plant populations has an important role in helping individuals to cope with different environments.	[Lira-Medeiros, Catarina Fonseca; Fernandes, Ricardo Avancini; Mata, Camila Souza; Cardoso, Monica Aires; Gomes Ferreira, Paulo Cavalcanti] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Parisod, Christian] INRA Ctr Versailles, Inst JP Bourgin, Biol Cellulaire Lab, Versailles, France; [Gomes Ferreira, Paulo Cavalcanti] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil	Jardim Botanico do Rio de Janeiro; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal do Rio de Janeiro	Lira-Medeiros, CF (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil.	paulof@bioqmed.ufrj.br	Parisod, Christian/A-1140-2010; Lira-Medeiros, Catarina F/G-1248-2012; Lira, Catarina F/S-3193-2019; Ferreira, Paulo C G/I-2836-2015	Parisod, Christian/0000-0001-8798-0897; Lira-Medeiros, Catarina F/0000-0001-8971-4226; Lira, Catarina F/0000-0001-8971-4226; Ferreira, Paulo C G/0000-0002-5510-999X	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientafico e Tecnolagico)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientafico e Tecnolagico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientafico e Tecnolagico) for financial support for the molecular genetic studies and also scholarships for CFL-M and PCGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainouche ML, 2009, BIOL INVASIONS, V11, P1159, DOI 10.1007/s10530-008-9383-2; Araujo RJ, 1997, B MAR SCI, V60, P643; Barth OM, 2006, AN ACAD BRAS CIENC, V78, P227, DOI 10.1590/S0001-37652006000200004; Bender J, 2002, CURR BIOL, V12, pR412, DOI 10.1016/S0960-9822(02)00910-7; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Brooks RA, 2005, ESTUAR COAST SHELF S, V65, P440, DOI 10.1016/j.ecss.2005.06.019; Bussell JD, 1999, MOL ECOL, V8, P775, DOI 10.1046/j.1365-294X.1999.00627.x; Cardoso MA, 1998, MOL ECOL, V7, P601, DOI 10.1046/j.1365-294x.1998.00363.x; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Hao YJ, 2004, J PLANT PHYSIOL, V161, P479, DOI 10.1078/0176-1617-01102; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Jablonka E, 1998, J EVOLUTION BIOL, V11, P159, DOI 10.1007/s000360050073; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Landry CL, 2007, NEW PHYTOL, V176, P891, DOI 10.1111/j.1469-8137.2007.02228.x; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Marfil CF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-21; PARISOD C, 2010, NEW PHYTOL IN PRESS; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Pavet V, 2006, MOL PLANT MICROBE IN, V19, P577, DOI 10.1094/MPMI-19-0577; Peraza-Echeverria S, 2001, PLANT SCI, V161, P359, DOI 10.1016/S0168-9452(01)00421-6; *R FDN STAT COMP, AUSTR R VERS 2 6 0; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards EJ, 1997, TRENDS GENET, V13, P319, DOI 10.1016/S0168-9525(97)01199-2; Saenger P., 2003, MANGROVE ECOLOGY SIL; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; SCHAEFFERNOVELLI Y, 1990, ESTUARIES, V13, P204, DOI 10.2307/1351590; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; SCOTT R, 2006, CURR BIOL, V14, pR200; Takata M, 2005, BREEDING SCI, V55, P57, DOI 10.1270/jsbbs.55.57; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	56	249	267	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10326	10.1371/journal.pone.0010326	http://dx.doi.org/10.1371/journal.pone.0010326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436669	Green Published, gold			2022-12-27	WOS:000277079500010
J	Medic, S; Ziman, M				Medic, Sandra; Ziman, Mel			PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas)	PLOS ONE			English	Article							TUMOR ALVEOLAR RHABDOMYOSARCOMA; DOWNSTREAM TARGET GENES; CELL ADHESION MOLECULE; STEM-CELLS; TRANSCRIPTION FACTORS; BCL-XL; MICROARRAY ANALYSIS; MALIGNANT-MELANOMA; FATE DETERMINATION; DIFFERENTIATION	Background: Cutaneous Malignant Melanoma is an aggressive form of skin cancer, arising in cutaneous melanocytes. The transcription factor PAX3 regulates melanocyte specification from neural crest cells during development but expression in differentiated melanocytes is uncertain. By contrast it is frequently found in melanomas and naevi and is a marker for melanoma staging and detection. In this study we analysed the expression of PAX3 across the spectrum of melanocytic cells, from normal melanocytes to cells of benign and malignant lesions to better assess its function in these various tissues. Pax3 and PAX3 (italicized) refer to the mouse and human gene, respectively; whereas Pax3 and PAX3 (non-italicized) refer to the corresponding mouse and human protein. Methodology and Principal Findings: PAX3 expression was analysed by immunohistochemistry and qRT-PCR. Immunofluorescence was used for co-expression with differentiation, migration and survival markers. As expected PAX3 expression was observed in naevi and melanoma cells. It was also found in melanocytes of normal skin where it coexpressed with melanocyte markers, MITF and MLANA. Co-expression with its downstream target, antiapoptotic factor BCL2L1 confirms PAX3 as a cell survival regulator. PAX3 was also co-expressed with melanoma cell migration marker MCAM in dermal naevi and melanoma cell nests, but this downstream target of PAX3 was not present in normal epidermal melanocytes, suggesting differential roles for PAX3 in normal epidermal melanocytes and melanoma cells. Most interestingly, a proportion of PAX3-positive epidermal melanocytes in normal skin show HES1 and Ki67 co-expression, indicating their less differentiated proliferative phenotype. Conclusions and Significance: Our results suggest that a previously identified role for PAX3, that of regulator of an undifferentiated plastic state, may operate in melanocytes of normal skin. This role, possibly required for cellular response to environmental stimuli, may contribute to formation and development of melanocytic lesions in which PAX3 expression is prominent.	[Medic, Sandra; Ziman, Mel] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia; [Ziman, Mel] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia	Edith Cowan University; University of Western Australia	Medic, S (corresponding author), Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia.	m.ziman@ecu.edu.au		Ziman, Mel/0000-0001-7527-3538	Cancer Council of Western Australia	Cancer Council of Western Australia(Cancer Council Western Australia)	This project was partially funded by the Cancer Council of Western Australia (http://www.cancerwa.asn.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler CA, 2007, DEV DYNAM, V236, P1595, DOI 10.1002/dvdy.21151; Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120; Bang AG, 1997, DEVELOPMENT, V124, P2075; Barber TD, 1999, GENE, V237, P311, DOI 10.1016/S0378-1119(99)00339-X; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Barr FG, 1999, CANCER RES, V59, P5443; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Blake JA, 2005, DEV GROWTH DIFFER, V47, P627; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Cook AL, 2005, EXP CELL RES, V308, P222, DOI 10.1016/j.yexcr.2005.04.019; DENTON KJ, 1992, J PATHOL, V167, P187, DOI 10.1002/path.1711670205; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Galibert MD, 1999, J BIOL CHEM, V274, P26894, DOI 10.1074/jbc.274.38.26894; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; He S., 2010, J INVEST DERMATOL; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Heere-Ress E, 2002, INT J CANCER, V99, P29, DOI 10.1002/ijc.10248; Himoudi N, 2007, CANCER IMMUNOL IMMUN, V56, P1381, DOI 10.1007/s00262-007-0294-3; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Johnson JP, 1997, INT J CANCER, V73, P769; Koyanagi K, 2005, CLIN CHEM, V51, P981, DOI 10.1373/clinchem.2004.045096; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; Kraus A, 1997, MELANOMA RES, V7, pS75; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; LEHMANN JM, 1987, CANCER RES, V47, P841; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; LUCA M, 1993, MELANOMA RES, V3, P35, DOI 10.1097/00008390-199304000-00006; Lyle S, 1998, J CELL SCI, V111, P3179; Margue CM, 2000, ONCOGENE, V19, P2921, DOI 10.1038/sj.onc.1203607; Matsuzaki Y, 2005, J IMMUNOTHER, V28, P10, DOI 10.1097/00002371-200501000-00002; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Olie RA, 2002, J INVEST DERMATOL, V118, P505, DOI 10.1046/j.0022-202x.2001.01677.x; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Pacifico MD, 2005, PLAST RECONSTR SURG, V115, P367, DOI 10.1097/01.PRS.0000148417.86768.C9; Pearl RA, 2008, J PLAST RECONSTR AES, V61, P265, DOI 10.1016/j.bjps.2007.04.010; Plummer RS, 2008, MODERN PATHOL, V21, P525, DOI 10.1038/modpathol.3801019; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Rodeberg DA, 2006, INT J CANCER, V119, P126, DOI 10.1002/ijc.21817; Scholl FA, 2001, CANCER RES, V61, P823; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Shih IM, 1997, CANCER RES, V57, P3835; SHIH IM, 1994, CANCER RES, V54, P2514; Takeuchi H, 2004, J CLIN ONCOL, V22, P2671, DOI 10.1200/JCO.2004.12.009; Venters SJ, 2004, DEV DYNAM, V229, P591, DOI 10.1002/dvdy.20016; Wang QY, 2007, INT J CANCER, V120, P1223, DOI 10.1002/ijc.22316; Wang QY, 2008, J CELL MOL MED, V12, P2281, DOI 10.1111/j.1582-4934.2008.00427.x; Xie SH, 1997, CANCER RES, V57, P2295; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750; Ziman M, 2006, MOLECULAR AND CELLULAR PATHOLOGY OF CANCER PROGRESSION AND PROGNOSIS, P235	70	47	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e9977	10.1371/journal.pone.0009977	http://dx.doi.org/10.1371/journal.pone.0009977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421967	Green Published, gold			2022-12-27	WOS:000276952600001
J	Ohshima, Y; Yajima, I; Takeda, K; Iida, M; Kumasaka, M; Matsumoto, Y; Kato, M				Ohshima, Yuichiro; Yajima, Ichiro; Takeda, Kozue; Iida, Machiko; Kumasaka, Mayuko; Matsumoto, Yoshinari; Kato, Masashi			c-RET Molecule in Malignant Melanoma from Oncogenic RET-Carrying Transgenic Mice and Human Cell Lines	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; TYROSINE KINASES; MOUSE MODEL; CANCER; PROGRESSION; EXPRESSION; MUTATION; DISEASE; SUPERACTIVATION; PROLIFERATION	Malignant melanoma is one of the most aggressive cancers and its incidence worldwide has been increasing at a greater rate than that of any other cancer. We previously reported that constitutively activated RFP-RET-carrying transgenic mice (RET-mice) spontaneously develop malignant melanoma. In this study, we showed that expression levels of intrinsic c-Ret, glial cell line-derived neurotrophic factor (Gdnf) and Gdnf receptor alpha 1 (Gfra1) transcripts in malignant melanomas from RET-transgenic mice were significantly upregulated compared with those in benign melanocytic tumors. These results suggest that not only introduced oncogenic RET but also intrinsic c-Ret/Gdnf are involved in murine melanomagenesis in RET-mice. We then showed that c-RET and GDNF transcript expression levels in human malignant melanoma cell lines (HM3KO and MNT-1) were higher than those in primary cultured normal human epithelial melanocytes (NHEM), while GFRa1 transcript expression levels were comparable among NHEM, HM3KO and MNT-1. We next showed c-RET and GFRa1 protein expression in HM3KO cells and GDNF-mediated increased levels of their phosphorylated c-RET tyrosine kinase and signal transduction molecules (ERK and AKT) sited potentially downstream of c-RET. Taken together with the finding of augmented proliferation of HM3KO cells after GDNF stimulation, our results suggest that GDNF-mediated c-RET kinase activation is associated with the pathogenesis of malignant melanoma.	[Ohshima, Yuichiro; Yajima, Ichiro; Takeda, Kozue; Iida, Machiko; Kumasaka, Mayuko; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Ohshima, Yuichiro; Matsumoto, Yoshinari] Aichi Med Univ, Sch Med, Dept Dermatol, Nagakute, Aichi 48011, Japan	Chubu University; Aichi Medical University	Ohshima, Y (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@isc.chubu.ac.jp	KATO, Masashi/I-7250-2014; YAJIMA, Ichiro/I-7467-2014		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19390168, 20406003]; MEXT [S0801055]; Japan Society for the Promotion of Science (JSPS) [20790775, 20790821, 20700370]; ROHTO Award; Uehara Memorial Foundation; Chubu University	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ROHTO Award; Uehara Memorial Foundation(Uehara Memorial Foundation); Chubu University	This study was supported in part by Grants-in-Aid for Scientific Research (B) (No. 19390168 and 20406003) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), COE Project for Private Universities (No. S0801055) from MEXT, Grant-in-Aid for Young Scientists (B) (No. 20790775, 20790821, 20700370) from the Japan Society for the Promotion of Science (JSPS), the ROHTO Award, the Uehara Memorial Foundation and Chubu University grants A and C. MEXT: http://www.mext.go.jp. JSPS:http://www.jsps.go.jp. ROHTO Award: no web sites. Uehara Memorial Foundation: http://www.ueharazaidan. com/. Chubu University grants:http://www.chubu.ac.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drosten M, 2006, NAT CLIN PRACT ONCOL, V3, P564, DOI 10.1038/ncponc0610; EASTY DJ, 1995, INT J CANCER, V60, P129, DOI 10.1002/ijc.2910600119; Emionite L, 2003, ANTICANCER RES, V23, P13; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Hasselblatt M, 2009, CANCER RES, V69, P2219, DOI 10.1158/0008-5472.CAN-08-3176; Hussein MR, 2005, J CLIN PATHOL, V58, P453, DOI 10.1136/jcp.2004.019422; Iwahashi N, 2002, CANCER, V94, P167, DOI 10.1002/cncr.10169; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; KATO M, 1994, CELL IMMUNOL, V159, P15, DOI 10.1006/cimm.1994.1291; Kato M, 2004, CANCER RES, V64, P801, DOI 10.1158/0008-5472.CAN-03-2532; Kato M, 2003, P NATL ACAD SCI USA, V100, P6398, DOI 10.1073/pnas.1132162100; Kato M, 2002, CANCER RES, V62, P2414; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Kato M, 2000, MOL BIOL CELL, V11, P93, DOI 10.1091/mbc.11.1.93; Kato M, 2007, J INVEST DERMATOL, V127, P1244, DOI 10.1038/sj.jid.5700659; Kato M, 2000, ANTIOXID REDOX SIGN, V2, P841, DOI 10.1089/ars.2000.2.4-841; KUMASAKA YM, 2010, CANC RES IN PRESS; Mologni L, 2006, J MOL ENDOCRINOL, V37, P199, DOI 10.1677/jme.1.01999; Narita N, 2009, ONCOGENE, V28, P3058, DOI 10.1038/onc.2009.164; Oka M, 1996, J CELL PHYSIOL, V167, P406, DOI 10.1002/(SICI)1097-4652(199606)167:3<406::AID-JCP4>3.3.CO;2-A; Peterson S, 2004, ONCOGENE, V23, P213, DOI 10.1038/sj.onc.1206980; Takahashi M, 1999, HUM MUTAT, V13, P331, DOI 10.1002/(SICI)1098-1004(1999)13:4<331::AID-HUMU11>3.3.CO;2-R; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Yajima I, 2009, J DERMATOL SCI, V55, P68, DOI 10.1016/j.jdermsci.2009.02.010; Zeng Q, 2008, J INT MED RES, V36, P656, DOI 10.1177/147323000803600406	27	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10279	10.1371/journal.pone.0010279	http://dx.doi.org/10.1371/journal.pone.0010279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422010	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952500023
J	Yamaji, S; Saegusa, J; Ieguchi, K; Fujita, M; Takada, YK; Takada, Y				Yamaji, Satoshi; Saegusa, Jun; Ieguchi, Katsuaki; Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu			A Novel Fibroblast Growth Factor-1 (FGF1) Mutant that Acts as an FGF Antagonist	PLOS ONE			English	Article							TYROSINE PHOSPHATASE; INDUCED ANGIOGENESIS; KINASE-ACTIVITY; CYCLIN D1; RECEPTOR; ACTIVATION; INTEGRINS; SHP-2; PHOSPHORYLATION; ALPHA-V-BETA-3	Background: Crosstalk between integrins and FGF receptors has been implicated in FGF signaling, but the specifics of the crosstalk are unclear. We recently discovered that 1) FGF1 directly binds to integrin alpha v beta 3, 2) the integrin-binding site and FGF receptor (FGFR) binding site are distinct, and 3) the integrin-binding-defective FGF1 mutant (R50E) is defective in inducing FGF signaling although R50E still binds to FGFR and heparin and induces transient ERK1/2 activation. Principal Findings: We tested if excess R50E affect DNA synthesis and cell survival induced by WT FGF1 in BaF3 mouse proB cells expressing human FGFR1. R50E suppressed DNA synthesis and cell proliferation induced by WT FGF1. We tested if WT FGF1 and R50E generate integrin-FGF1-FGFR ternary complex. WT FGF1 induced ternary complex formation (integrin-FGF-FGFR1) and recruitment of SHP-2 to the complex in NIH 3T3 cells and human umbilical endothelial cells, but R50E was defective in these functions. It has been reported that sustained ERK1/2 activation is integrin-dependent and crucial to cell cycle entry upon FGF stimulation. We thus determined the time-course of ERK1/2 activation induced by WT FGF1 and R50E. We found that WT FGF1 induced sustained activation of ERK1/2, but R50E was defective in this function. Conclusions/Significance: Our results suggest that 1) R50E is a dominant-negative mutant, 2) Ternary complex formation is involved in FGF signaling, 3) The defect of R50E to bind to integrin may be directly related to the antagonistic action of R50E. Taken together, these results suggest that R50E has potential as a therapeutic in cancer.	[Yamaji, Satoshi; Saegusa, Jun; Ieguchi, Katsuaki; Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Yamaji, S (corresponding author), Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	NIH [CA113298, CA13105, CA093373]; NATIONAL CANCER INSTITUTE [U19CA113298, P30CA093373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA113298, CA13105, and CA093373 to YT (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Forsten-Williams K, 2008, ANN BIOMED ENG, V36, P2134, DOI 10.1007/s10439-008-9575-z; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KLINT P, 1999, FRONT BIOSCI, V4, P165; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Li X, 2004, J CELL SCI, V117, P6007, DOI 10.1242/jcs.01519; Ling Y, 2003, MOL ENDOCRINOL, V17, P1824, DOI 10.1210/me.2003-0143; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Paleolog EM, 2002, ARTHRITIS RES THER, V4, pS81, DOI 10.1186/ar575; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Schwartz MA, 2001, J CELL SCI, V114, P2553; Sharrocks AD, 2006, CURR BIOL, V16, pR540, DOI 10.1016/j.cub.2006.06.038; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Zhang BL, 2006, J BIOL CHEM, V281, P905, DOI 10.1074/jbc.M503945200	24	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10273	10.1371/journal.pone.0010273	http://dx.doi.org/10.1371/journal.pone.0010273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422052	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500028
J	Alfonso-Parra, C; Maggert, KA				Alfonso-Parra, Catalina; Maggert, Keith A.			Drosophila SAF-B Links the Nuclear Matrix, Chromosomes, and Transcriptional Activity	PLOS ONE			English	Article							HUMAN BREAST-CANCER; PROTEIN-PHOSPHORYLATION SITES; ATTACHMENT FACTOR-B; HEAT-SHOCK; GENE-EXPRESSION; LIVING CELLS; HET/SAF-B; IN-VIVO; MELANOGASTER; INTERACTS	Induction of gene expression is correlated with alterations in nuclear organization, including proximity to other active genes, to the nuclear cortex, and to cytologically distinct domains of the nucleus. Chromosomes are tethered to the insoluble nuclear scaffold/matrix through interaction with Scaffold/Matrix Attachment Region (SAR/MAR) binding proteins. Identification and characterization of proteins involved in establishing or maintaining chromosome-scaffold interactions is necessary to understand how the nucleus is organized and how dynamic changes in attachment are correlated with alterations in gene expression. We identified and characterized one such scaffold attachment factor, a Drosophila homolog of mammalian SAF-B. The large nuclei and chromosomes of Drosophila have allowed us to show that SAF-B inhabits distinct subnuclear compartments, forms weblike continua in nuclei of salivary glands, and interacts with discrete chromosomal loci in interphase nuclei. These interactions appear mediated either by DNA-protein interactions, or through RNA-protein interactions that can be altered during changes in gene expression programs. Extraction of soluble nuclear proteins and DNA leaves SAF-B intact, showing that this scaffold/matrix-attachment protein is a durable component of the nuclear matrix. Together, we have shown that SAF-B links the nuclear scaffold, chromosomes, and transcriptional activity.	[Alfonso-Parra, Catalina] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Maggert, Keith A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Alfonso-Parra, C (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	kmaggert@tamu.edu		Alfonso-Parra, Catalina/0000-0002-5689-9356; Maggert, Keith/0000-0002-9291-9481	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076092] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076092] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005; ANGSHUMAN S, 2007, COLD SPRING HARB PRO; Arao Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P228, DOI 10.1006/abbi.2000.1938; ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Chan CW, 2007, BIOCHEM J, V407, P355, DOI 10.1042/BJ20070170; Chiodi I, 2000, J CELL SCI, V113, P4043; Clegg NJ, 1998, GENOME, V41, P495, DOI 10.1139/gen-41-4-495; COOK PR, 1991, CELL, V66, P627, DOI 10.1016/0092-8674(91)90109-C; Debril MB, 2005, J MOL ENDOCRINOL, V35, P503, DOI 10.1677/jme.1.01856; Dillon N, 2008, DEV CELL, V15, P182, DOI 10.1016/j.devcel.2008.07.013; Dobrzycka KM, 2006, CANCER RES, V66, P7859, DOI 10.1158/0008-5472.CAN-06-1381; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; GELBART WM, 1982, GENETICS, V102, P179; Gonzalez AN, 2008, P NATL ACAD SCI USA, V105, P18436, DOI 10.1073/pnas.0805993105; Hallson G, 2008, P NATL ACAD SCI USA, V105, P12405, DOI 10.1073/pnas.0801698105; HAMMERICHHILLE S, 2009, BREAST CANC RES TREA; HAMMERICHHILLE S, 2009, J BIOL CHEM; HESSLER AY, 1958, GENETICS, V43, P395; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; Lee YB, 2007, EXP CELL RES, V313, P3914, DOI 10.1016/j.yexcr.2007.06.023; Lehman JA, 2008, BIOCHEMISTRY-US, V47, P4359, DOI 10.1021/bi702284c; Lin JJ, 2008, J BIOL CHEM, V283, P29681, DOI 10.1074/jbc.M802076200; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Morris JR, 1998, P NATL ACAD SCI USA, V95, P10740, DOI 10.1073/pnas.95.18.10740; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Nikolakaki E, 2001, J BIOL CHEM, V276, P40175, DOI 10.1074/jbc.M104755200; Oegema K, 1997, J CELL SCI, V110, P1573; Oesterreich S, 2000, MOL ENDOCRINOL, V14, P369, DOI 10.1210/me.14.3.369; Oesterreich S, 2003, J CELL BIOCHEM, V90, P653, DOI 10.1002/jcb.10685; Oesterreich S, 1997, J CELL BIOCHEM, V67, P275, DOI 10.1002/(SICI)1097-4644(19971101)67:2<275::AID-JCB13>3.0.CO;2-E; Oesterreich S, 2001, BRIT J CANCER, V84, P493, DOI 10.1054/bjoc.2000.1606; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Pathak RU, 2007, MOL CELL BIOL, V27, P4796, DOI 10.1128/MCB.00305-07; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Sandhu KS, 2009, J MOL RECOGNIT, V22, P1, DOI 10.1002/jmr.915; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tai HH, 2003, BIOCHEM BIOPH RES CO, V308, P170, DOI 10.1016/S0006-291X(03)01354-8; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Townson SM, 2004, J BIOL CHEM, V279, P26074, DOI 10.1074/jbc.M313726200; Townson SM, 2003, J BIOL CHEM, V278, P20059, DOI 10.1074/jbc.M212988200; Townson SM, 2000, CLIN CANCER RES, V6, P3788; Weighardt F, 1999, J CELL SCI, V112, P1465; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	57	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10248	10.1371/journal.pone.0010248	http://dx.doi.org/10.1371/journal.pone.0010248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422039	Green Published, gold, Green Submitted			2022-12-27	WOS:000276854300012
J	Matveeva, OV; Kang, YB; Spiridonov, AN; Saetrom, P; Nemtsov, VA; Ogurtsov, AY; Nechipurenko, YD; Shabalina, SA				Matveeva, Olga V.; Kang, Yibin; Spiridonov, Alexey N.; Saetrom, Pal; Nemtsov, Vladimir A.; Ogurtsov, Aleksey Y.; Nechipurenko, Yury D.; Shabalina, Svetlana A.			Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; SIRNA DESIGN; MAMMALIAN-CELLS; FUNCTIONAL SIRNAS; EFFICIENCY; INTERFERENCE; SPECIFICITY; EXPRESSION; PARAMETERS; KNOCKDOWN	Prediction of efficient oligonucleotides for RNA interference presents a serious challenge, especially for the development of genome-wide RNAi libraries which encounter difficulties and limitations due to ambiguities in the results and the requirement for significant computational resources. Here we present a fast and practical algorithm for shRNA design based on the thermodynamic parameters. In order to identify shRNA and siRNA features universally associated with high silencing efficiency, we analyzed structure-activity relationships in thousands of individual RNAi experiments from publicly available databases (ftp://ftp.ncbi.nlm.nih.gov/pub/shabalin/siRNA/si_shRNA_selector/). Using this statistical analysis, we found free energy ranges for the terminal duplex asymmetry and for fully paired duplex stability, such that shRNAs or siRNAs falling in both ranges have a high probability of being efficient. When combined, these two parameters yield a similar to 72% success rate on shRNAs from the siRecords database, with the target RNA levels reduced to below 20% of the control. Two other parameters correlate well with silencing efficiency: the stability of target RNA and the antisense strand secondary structure. Both parameters also correlate with the short RNA duplex stability; as a consequence, adding these parameters to our prediction scheme did not substantially improve classification accuracy. To test the validity of our predictions, we designed 83 shRNAs with optimal terminal asymmetry, and experimentally verified that small shifts in duplex stability strongly affected silencing efficiency. We showed that shRNAs with short fully paired stems could be successfully selected by optimizing only two parameters: terminal duplex asymmetry and duplex stability of the hypothetical cleavage product, which also relates to the specificity of mRNA target recognition. Our approach performs at the level of the best currently utilized algorithms that take into account prediction of the secondary structure of the target and antisense RNAs, but at significantly lower computational costs. Based on this study, we created the si-shRNA Selector program that predicts both highly efficient shRNAs and functional siRNAs ( ftp://ftp.ncbi.nlm.nih.gov/pub/shabalin/siRNA/si_shRNA_selector/).	[Matveeva, Olga V.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Spiridonov, Alexey N.] MIT, Dept Appl Math, Cambridge, MA 02139 USA; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, N-7034 Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Nemtsov, Vladimir A.] Russian Acad Sci, MGGT, Moscow, Russia; [Nechipurenko, Yury D.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia; [Ogurtsov, Aleksey Y.; Shabalina, Svetlana A.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Utah System of Higher Education; University of Utah; Princeton University; Massachusetts Institute of Technology (MIT); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Matveeva, OV (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	olga.matveeva@gmail.com; shabalin@ncbi.nlm.nih.gov	Matveeva, Olga/AAH-3851-2020; Нечипуренко, Юрий/GXF-6465-2022; Nechipurenko, Yury/AAN-9515-2020; Shabalina, Svetlana/N-8939-2013; Sætrom, Pål/AAH-1216-2019	Shabalina, Svetlana/0000-0003-2272-7473; Sætrom, Pål/0000-0001-8142-7441; Matveeva, Olga/0000-0001-8555-9847; Kang, Yibin/0000-0002-1626-6730	Department of Health and Human Services (National Institutes of Health, National Library of Medicine); Russian Foundation for Basic Research and the RAS Presidium "Molecular and cell biology''	Department of Health and Human Services (National Institutes of Health, National Library of Medicine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Russian Foundation for Basic Research and the RAS Presidium "Molecular and cell biology''	The research was supported by the Department of Health and Human Services (National Institutes of Health, National Library of Medicine) intramural funds. YDN was supported by the Russian Foundation for Basic Research and the RAS Presidium "Molecular and cell biology''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cullen BR, 2006, GENE THER, V13, P503, DOI 10.1038/sj.gt.3302656; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gong WM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-516; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jia PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-271; Jiang P, 2007, COMPUT METH PROG BIO, V87, P230, DOI 10.1016/j.cmpb.2007.06.001; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kondrashov AS, 2002, HUM MOL GENET, V11, P669, DOI 10.1093/hmg/11.6.669; Ladunga I, 2007, NUCLEIC ACIDS RES, V35, P433, DOI 10.1093/nar/gkl1065; Li LM, 2007, RNA, V13, P1765, DOI 10.1261/rna.599107; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takasaki S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S22; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yiu SM, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bth498	38	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10180	10.1371/journal.pone.0010180	http://dx.doi.org/10.1371/journal.pone.0010180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422034	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000276854300001
J	Ravetti, MG; Rosso, OA; Berretta, R; Moscato, P				Gomez Ravetti, Martin; Rosso, Osvaldo A.; Berretta, Regina; Moscato, Pablo			Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SYNAPTIC VESICLE PROTEIN; CYCLIN-DEPENDENT KINASE-5; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; PERIPHERAL BENZODIAZEPINE-RECEPTOR; IMMEDIATE-EARLY GENES; GROWTH-FACTOR-I; GLYCOGEN-SYNTHASE KINASE-3; MARIE-TOOTH-DISEASE	Background: Alzheimer's disease (AD) is characterized by a neurodegenerative progression that alters cognition. On a phenotypical level, cognition is evaluated by means of the MiniMental State Examination (MMSE) and the post-morten examination of Neurofibrillary Tangle count (NFT) helps to confirm an AD diagnostic. The MMSE evaluates different aspects of cognition including orientation, short-term memory (retention and recall), attention and language. As there is a normal cognitive decline with aging, and death is the final state on which NFT can be counted, the identification of brain gene expression biomarkers from these phenotypical measures has been elusive. Methodology/Principal Findings: We have reanalysed a microarray dataset contributed in 2004 by Blalock et al. of 31 samples corresponding to hippocampus gene expression from 22 AD subjects of varying degree of severity and 9 controls. Instead of only relying on correlations of gene expression with the associated MMSE and NFT measures, and by using modern bioinformatics methods based on information theory and combinatorial optimization, we uncovered a 1,372-probe gene expression signature that presents a high-consensus with established markers of progression in AD. The signature reveals alterations in calcium, insulin, phosphatidylinositol and wnt-signalling. Among the most correlated gene probes with AD severity we found those linked to synaptic function, neurofilament bundle assembly and neuronal plasticity. Conclusions/Significance: A transcription factors analysis of 1,372-probe signature reveals significant associations with the EGR/KROX family of proteins, MAZ, and E2F1. The gene homologous of EGR1, zif268, Egr-1 or Zenk, together with other members of the EGR family, are consolidating a key role in the neuronal plasticity in the brain. These results indicate a degree of commonality between putative genes involved in AD and prion-induced neurodegenerative processes that warrants further investigation.	[Gomez Ravetti, Martin; Rosso, Osvaldo A.; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Gomez Ravetti, Martin; Rosso, Osvaldo A.; Berretta, Regina; Moscato, Pablo] John Hunter Hosp, Informat Based Med Program, Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Gomez Ravetti, Martin; Moscato, Pablo] Ctr Excellence Bioinformat, Australian Res Council, Callaghan, NSW, Australia; [Rosso, Osvaldo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Calculo, Buenos Aires, DF, Argentina	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Buenos Aires	Ravetti, MG (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	pablo.moscato@newcastle.edu.au	Ravetti, Martin/K-1108-2012; Rosso, Osvaldo/O-4929-2019; MOSCATO, PABLO ALBERTO/G-7668-2013; Rosso, Osvaldo A/B-7275-2013	Ravetti, Martin/0000-0001-7781-0034; Rosso, Osvaldo/0000-0002-1288-2528; Rosso, Osvaldo A/0000-0002-1288-2528; Berretta, Regina/0000-0002-4420-3446; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Centre for Bioinformatics, Australia; Consejo Nacional de Investigaciones Cienti-ficias y Tecnicas (CONICET), Argentina	Australian Research Council (ARC) Centre for Bioinformatics, Australia(Australian Research Council); Consejo Nacional de Investigaciones Cienti-ficias y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors acknowledge partial support from the Australian Research Council (ARC) Centre for Bioinformatics, Australia. OAR acknowledges partial support from the Consejo Nacional de Investigaciones Cienti-ficias y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS T, 2009, BEHAV BRAIN RES; Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Aguado-Llera D, 2005, J NEUROCHEM, V92, P607, DOI 10.1111/j.1471-4159.2004.02889.x; Ahtiainen L, 2003, J COMP NEUROL, V455, P368, DOI 10.1002/cne.10492; Ahtiainen L, 2007, NEUROBIOL DIS, V28, P52, DOI 10.1016/j.nbd.2007.06.012; Aisa B, 2009, PSYCHONEUROENDOCRINO; Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Alder J, 2003, J NEUROSCI, V23, P10800; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; An L, 2009, NEUROSCI LETT, V452, P277, DOI 10.1016/j.neulet.2009.01.071; Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; *AR GEN I, 2007, PATHW STUD 5 0; Aschner M, 2005, J ALZHEIMERS DIS, V8, P139; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Azim E, 2009, CEREB CORTEX, V19, pI62, DOI 10.1093/cercor/bhp030; Bachar-Dahan L, 2006, MOL BIOL CELL, V17, P2572, DOI 10.1091/mbc.E06-01-0052; Baer K, 2007, EXP NEUROL, V204, P828, DOI 10.1016/j.expneurol.2006.12.008; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Bajo M, 2001, AMINO ACIDS, V21, P293, DOI 10.1007/s007260170015; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Banks GB, 2009, MOL CELL NEUROSCI, V40, P433, DOI 10.1016/j.mcn.2008.12.011; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Bardoni B, 2000, CYTOGENET CELL GENET, V89, P11, DOI 10.1159/000015580; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Bataller L, 2003, ANN NEUROL, V53, P123, DOI 10.1002/ana.10434; Bauer J, 1997, Ann N Y Acad Sci, V826, P379, DOI 10.1111/j.1749-6632.1997.tb48487.x; Becker M, 2007, P NATL ACAD SCI USA, V104, P1691, DOI 10.1073/pnas.0610180104; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Bennett MR, 2008, AUST NZ J PSYCHIAT, V42, P662, DOI 10.1080/00048670802203467; Bergamaschini L, 1999, CLIN EXP IMMUNOL, V115, P526; Bernstein HG, 2009, CLIN CHEM, V55, P1041, DOI 10.1373/clinchem.2008.116970; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Biessels GJ, 2004, EUR J PHARMACOL, V490, P1, DOI 10.1016/j.ejphar.2004.02.057; BINDRA PS, 1993, GENE, V137, P299, DOI 10.1016/0378-1119(93)90024-W; Bischof HJ, 2006, REV NEUROSCIENCE, V17, P43; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blanchard J, 2008, NEUROBIOL AGING, V29, P1011, DOI 10.1016/j.neurobiolaging.2007.02.010; Blanchard J, 2009, BEHAV BRAIN RES, V201, P147, DOI 10.1016/j.bbr.2009.02.005; BLASS JP, 1994, J NEUROL SCI, V121, P132, DOI 10.1016/0022-510X(94)90341-7; BlumDegen D, 1995, J NEURAL TRANSM-SUPP, P139; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Boczan J, 2004, J BIOL CHEM, V279, P18911, DOI 10.1074/jbc.M400496200; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bogdanik L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002084; Bohm D, 2002, MOL CELL NEUROSCI, V21, P584, DOI 10.1006/mcne.2002.1199; BOISSONNEAULT V, 2009, BRAIN; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bonin RP, 2007, J NEUROPHYSIOL, V98, P2244, DOI 10.1152/jn.00482.2007; Bonomo SM, 2009, NEUROBIOL AGING, V30, P71, DOI 10.1016/j.neurobiolaging.2007.05.017; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Bourgeron T, 2007, COLD SPRING HARB SYM, V72, P645, DOI 10.1101/sqb.2007.72.020; BOURGERON T, 2009, CURR OPIN NEUROBIOL; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brandstatter JH, 2004, J COMP NEUROL, V475, P551, DOI 10.1002/cne.20194; Braunewell KH, 2001, DEMENT GERIATR COGN, V12, P110, DOI 10.1159/000051244; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Briand C, 2001, FEBS LETT, V505, P18, DOI 10.1016/S0014-5793(01)02764-8; Brito I, 2006, BEHAV NEUROSCI, V120, P353, DOI 10.1037/0735-7044.120.2.353; Brune S, 2003, J NEURAL TRANSM, V110, P1041, DOI 10.1007/s00702-003-0018-6; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Bulbarelli A, 2009, MOL CELL NEUROSCI, V42, P75, DOI 10.1016/j.mcn.2009.06.001; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Busby V, 2004, NEUROMOL MED, V5, P133, DOI 10.1385/NMM:5:2:133; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Cai C, 2008, NEUROSCIENCE, V157, P833, DOI 10.1016/j.neuroscience.2008.09.048; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Cairney CJ, 2009, BBA-MOL BASIS DIS, V1792, P353, DOI 10.1016/j.bbadis.2009.01.015; Cairns NJ, 2004, ACTA NEUROPATHOL, V108, P213, DOI 10.1007/s00401-004-0882-7; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Camins A, 2006, DRUG NEWS PERSPECT, V19, P453, DOI 10.1358/dnp.2006.19.8.1043961; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Caraiscos VB, 2004, J NEUROSCI, V24, P8454, DOI 10.1523/JNEUROSCI.2063-04.2004; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Caricasole A, 2003, TRENDS PHARMACOL SCI, V24, P233, DOI 10.1016/S0165-6147(03)00100-7; Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Castri P, 2007, EUR J NEUROSCI, V26, P2469, DOI 10.1111/j.1460-9568.2007.05869.x; Cerpa W, 2008, CURR ALZHEIMER RES, V5, P233, DOI 10.2174/156720508784533321; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Chen Honghui, 2002, J Huazhong Univ Sci Technolog Med Sci, V22, P250; Chen Ming-Ling, 2008, J Biomed Sci, V15, P169, DOI 10.1007/s11373-007-9217-8; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Cheng LY, 2000, NEUROCHEM RES, V25, P107, DOI 10.1023/A:1007547701518; Cheong JK, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-8; Chiang CW, 2008, METHOD ENZYMOL, V446, P237, DOI 10.1016/S0076-6879(08)01614-5; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Choi KH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-87; Chong ZZ, 2004, HISTOL HISTOPATHOL, V19, P495, DOI 10.14670/HH-19.495; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; CONNOR JR, 1995, J NEUROCHEM, V65, P717; Cooper-Kuhn CM, 2002, MOL CELL NEUROSCI, V21, P312, DOI 10.1006/mcne.2002.1176; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; COTTA C, 2007, HDB APPROXIMATION AL; Cowburn RF, 2007, PHYSIOL BEHAV, V92, P93, DOI 10.1016/j.physbeh.2007.05.053; CREWS FT, 1992, J NEUROCHEM, V58, P1205, DOI 10.1111/j.1471-4159.1992.tb11330.x; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Crowther DC, 2002, HUM MUTAT, V20, P1, DOI 10.1002/humu.10100; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dai JP, 2004, BRIT J PHARMACOL, V143, P606, DOI 10.1038/sj.bjp.0705995; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Das S, 2003, J BIOL CHEM, V278, P41221, DOI 10.1074/jbc.M304851200; Das S, 2003, MOL BRAIN RES, V116, P38, DOI 10.1016/S0169-328X(03)00212-2; Davidsson P, 1996, MOL CHEM NEUROPATHOL, V27, P195, DOI 10.1007/BF02815094; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Dawson GR, 2006, J PHARMACOL EXP THER, V316, P1335, DOI 10.1124/jpet.105.092320; de Bartolomeis A, 2004, INT REV NEUROBIOL, V59, P221; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; de Quervain DJF, 2004, HUM MOL GENET, V13, P47, DOI 10.1093/hmg/ddg361; De Strooper B, 2001, J CELL BIOL, V152, pF17, DOI 10.1083/jcb.152.4.F17; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; DEGIORGIO LA, 1994, J NEUROL SCI, V124, P141, DOI 10.1016/0022-510X(94)90319-0; Deng YQ, 2008, FASEB J, V22, P138, DOI 10.1096/fj.07-8309com; Desjardins P, 1998, NEUROSCI LETT, V244, P69, DOI 10.1016/S0304-3940(98)00138-4; Desjardins S, 1997, NEUROBIOL AGING, V18, P37, DOI 10.1016/S0197-4580(96)00206-0; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; Deutsch SI, 2006, PROG NEURO-PSYCHOPH, V30, P1369, DOI 10.1016/j.pnpbp.2006.04.007; Dhar SS, 2009, J NEUROCHEM, V108, P1595, DOI 10.1111/j.1471-4159.2009.05929.x; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dubois M, 2005, J NEUROSCI RES, V80, P741, DOI 10.1002/jnr.20449; Dufour A, 2000, ANN NEUROL, V47, P680; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Eckert A, 1996, LIFE SCI, V59, P499, DOI 10.1016/0024-3205(96)00329-3; Eckert A, 1997, NEUROBIOL AGING, V18, P281, DOI 10.1016/S0197-4580(97)80308-9; Eda-Fujiwara H, 2003, EUR J NEUROSCI, V17, P149, DOI 10.1046/j.1460-9568.2003.02414.x; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Eran A, 2009, J CLIN INVEST, V119, P679, DOI 10.1172/JCI38620; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; FAIGON M, 1991, J NEUROSCI RES, V29, P490, DOI 10.1002/jnr.490290409; Falangola MF, 2007, NMR BIOMED, V20, P343, DOI 10.1002/nbm.1163; Falasca Marco, 2006, Archives of Physiology and Biochemistry, V112, P274, DOI 10.1080/13813450601094664; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Faraut B, 2003, J CELL PHYSIOL, V196, P105, DOI 10.1002/jcp.10280; Fatemi SH, 2009, CEREBELLUM, V8, P64, DOI 10.1007/s12311-008-0075-3; FAYYAD UM, 1993, P 13 INT JOINT C ART, P1022; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Fernandez F, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-109; Fernandez M, 2007, J NEUROCHEM, V103, P190, DOI 10.1111/j.1471-4159.2007.04767.x; Ferrer I, 1998, J NEUROPATH EXP NEUR, V57, P218, DOI 10.1097/00005072-199803000-00002; Ferrero Alejandro, 2006, Vertex, V17, P165; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Flanagan A M, 1998, Curr Opin Hematol, V5, P181, DOI 10.1097/00062752-199805000-00006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Fradkin LG, 2008, J NEUROSCI, V28, P5105, DOI 10.1523/JNEUROSCI.4950-07.2008; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Francis SC, 2002, J BIOL CHEM, V277, P7816, DOI 10.1074/jbc.M109743200; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; Fritschy JM, 2003, BIOCHEM SOC T, V31, P889, DOI 10.1042/bst0310889; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Funfschilling U, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-1; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Fukuda M, 2008, J NEUROSCI, V28, P13640, DOI 10.1523/JNEUROSCI.4023-08.2008; Funakoshi E, 2006, GENE EXPRESSION, V13, P27, DOI 10.3727/000000006783991917; Funakoshi E, 2005, GENE, V344, P259, DOI 10.1016/j.gene.2004.10.024; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gallagher JP, 2008, EUR J PHARMACOL, V583, P215, DOI 10.1016/j.ejphar.2007.11.075; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; Garver TD, 1996, J NEUROSCI RES, V44, P12, DOI 10.1002/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L; Geddes JW, 1997, NEUROBIOL AGING, V18, pS99, DOI 10.1016/S0197-4580(97)00063-8; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gerdjikov TV, 2008, NEUROBIOL LEARN MEM, V89, P87, DOI 10.1016/j.nlm.2007.06.003; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Gierke P, 2008, NEUROBIOL DIS, V32, P162, DOI 10.1016/j.nbd.2008.07.008; GILMORE GC, 1994, J GERONTOL, V49, pP52, DOI 10.1093/geronj/49.2.P52; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Go RCP, 2005, AM J MED GENET B, V139B, P28, DOI 10.1002/ajmg.b.30219; Goncalves I, 2008, BIOCHEMISTRY-US, V47, P2244, DOI 10.1021/bi7016377; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; Grabs D, 1996, EUR J NEUROSCI, V8, P162, DOI 10.1111/j.1460-9568.1996.tb01177.x; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grilli M, 2003, FUNCT NEUROL, V18, P145; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Grunblatt E, 2004, J NEURAL TRANSM, V111, P367, DOI 10.1007/s00702-003-0030-x; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Gulyas B, 2009, NEUROCHEM INT, V54, P28, DOI 10.1016/j.neuint.2008.10.001; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hagen T, 2006, J BIOL CHEM, V281, P35021, DOI 10.1074/jbc.M607003200; Hahn Y, 2006, HUM GENET, V119, P169, DOI 10.1007/s00439-005-0125-6; Hamilton JA, 2002, BRAIN RES, V940, P49, DOI 10.1016/S0006-8993(02)02589-1; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Harrill JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-546; Hasegawa Y, 2000, GERONTOLOGY, V46, P185, DOI 10.1159/000022157; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hayashi T, 1998, J NEUROCHEM, V71, P356; HAYES TL, 1992, CEREB CORTEX, V2, P56, DOI 10.1093/cercor/2.1.56; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Hazell AS, 2002, NEUROCHEM INT, V41, P271, DOI 10.1016/S0197-0186(02)00013-X; Heese K, 2002, MOL BRAIN RES, V104, P127, DOI 10.1016/S0169-328X(02)00326-1; Heese K, 2001, BIOCHEM BIOPH RES CO, V289, P924, DOI 10.1006/bbrc.2001.5932; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; Heneka MT, 2001, J NEUROPATH EXP NEUR, V60, P906, DOI 10.1093/jnen/60.9.906; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Hernandez-Ortega K, 2007, J NEUROSCI RES, V85, P1744, DOI 10.1002/jnr.21301; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; HOLLOSI M, 1995, BIOPOLYMERS, V36, P381, DOI 10.1002/bip.360360311; HOLLOSI M, 1994, P NATL ACAD SCI USA, V91, P4902, DOI 10.1073/pnas.91.11.4902; HOLLOSI M, 1992, J MOL BIOL, V223, P673, DOI 10.1016/0022-2836(92)90983-Q; Holloway AF, 1997, FEBS LETT, V404, P41, DOI 10.1016/S0014-5793(97)00082-3; HOLLY S, 1993, BIOCHEM BIOPH RES CO, V197, P755, DOI 10.1006/bbrc.1993.2543; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; HOYER S, 1991, J NEURAL TRANSM-PARK, V3, P1, DOI 10.1007/BF02251132; HOYER S, 1994, ANN NY ACAD SCI, V719, P248, DOI 10.1111/j.1749-6632.1994.tb56833.x; HOYER S, 1987, J NEUROL, V234, P266, DOI 10.1007/BF00618265; Hoyer S, 2002, J NEURAL TRANSM, V109, P341, DOI 10.1007/s007020200028; Hoyer S, 2002, J NEURAL TRANSM, V109, P991, DOI 10.1007/s007020200082; Hoyer S, 1996, ACTA NEUROL SCAND, V93, P18; Hoyer S, 2000, ANN NY ACAD SCI, V920, P256; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; HOYER S, 1989, J NEURAL TRANSM, V75, P227, DOI 10.1007/BF01258634; Hoyer S, 1999, ANN NY ACAD SCI, V893, P301, DOI 10.1111/j.1749-6632.1999.tb07842.x; Hoyer S, 1994, J Neural Transm Suppl, V44, P259; Hoyer S, 1997, J NEURAL TRANSM-SUPP, P11; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Hughes V, 2007, MICROBIOL-SGM, V153, P196, DOI 10.1099/mic.0.29129-0; Hunter RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004328; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Ihara H, 2006, BIOCHEM BIOPH RES CO, V345, P1149, DOI 10.1016/j.bbrc.2006.05.029; Illing RB, 2001, AUDIOL NEURO-OTOL, V6, P319, DOI 10.1159/000046844; Illing RB, 2002, EXP NEUROL, V175, P226, DOI 10.1006/exnr.2002.7895; Inestrosa NC, 2000, ACTA NEUROL SCAND, V102, P53, DOI 10.1034/j.1600-0404.2000.00308.x; Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490; Inestrose Nibaldo C., 2004, Current Alzheimer Research, V1, P249, DOI 10.2174/1567205043332063; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Irie Y, 2001, BIOCHEM BIOPH RES CO, V282, P416, DOI 10.1006/bbrc.2001.4594; Ito S, 2005, FEBS LETT, V579, P1995, DOI 10.1016/j.febslet.2005.02.048; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Jafferali S, 2000, SYNAPSE, V38, P450, DOI 10.1002/1098-2396(20001215)38:4<450::AID-SYN10>3.0.CO;2-J; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jaworski A, 2006, J NEUROSCI, V26, P655, DOI 10.1523/JNEUROSCI.4506-05.2006; Jenkins TA, 2006, NEUROSCIENCE, V137, P747, DOI 10.1016/j.neuroscience.2005.09.034; Ji BH, 2009, J PROTEOME RES, V8, P3633, DOI 10.1021/pr800876z; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Jing H, 2008, LIFE SCI, V82, P1137, DOI 10.1016/j.lfs.2008.03.022; Johansson S, 2007, BRAIN RES, V1132, P20, DOI 10.1016/j.brainres.2006.11.026; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Jordan-Sciutto K, 2001, MECH AGEING DEV, V123, P11, DOI 10.1016/S0047-6374(01)00334-7; Jordan-Sciutto KL, 2002, J NEUROSCI, V22, P2185, DOI 10.1523/JNEUROSCI.22-06-02185.2002; Jordan-Sciutto KL, 2002, J NEUROPATH EXP NEUR, V61, P358, DOI 10.1093/jnen/61.4.358; Jordan-Sciutto KL, 2001, EXP NEUROL, V167, P205, DOI 10.1006/exnr.2000.7594; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Jordan-Sciutto KL, 2000, AM J PATHOL, V157, P497, DOI 10.1016/S0002-9440(10)64561-0; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kaku M, 2003, BRAIN RES PROTOC, V12, P104, DOI 10.1016/j.brainresprot.2003.09.001; Kallur T, 2008, MOL CELL NEUROSCI, V38, P616, DOI 10.1016/j.mcn.2008.05.010; Kalviainen R, 2007, EUR J NEUROL, V14, P369, DOI 10.1111/j.1468-1331.2007.01668.x; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KARNIGUIAN A, 1993, P NATL ACAD SCI USA, V90, P7647, DOI 10.1073/pnas.90.16.7647; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; KAWAMATA T, 1993, AM J PATHOL, V142, P1574; Kawata T, 2005, J INT MED RES, V33, P654, DOI 10.1177/147323000503300607; Kelberman D, 2008, J CLIN ENDOCR METAB, V93, P1865, DOI 10.1210/jc.2007-2337; KERI S, 2009, SCHIZOPHR B; KERI S, 2009, NEUROCHEM INT; Kerr F, 2006, FEBS LETT, V580, P3121, DOI 10.1016/j.febslet.2006.04.064; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Killick R, 2001, J BIOL CHEM, V276, P48554, DOI 10.1074/jbc.M108332200; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kim AH, 2008, CELL CYCLE, V7, P3819, DOI 10.4161/cc.7.24.7215; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; KIRCHER T, 2009, HUM BRAIN MAPP; Kircher T, 2009, EUR ARCH PSY CLIN N, V259, P72, DOI 10.1007/s00406-008-0837-4; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kittur S, 1994, J Geriatr Psychiatry Neurol, V7, P153; Klemmer P, 2009, J PROTEOMICS, V72, P82, DOI 10.1016/j.jprot.2008.10.005; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kobayashi K, 1998, DEMENT GERIATR COGN, V9, P13, DOI 10.1159/000017015; Kobayashi K, 2004, J ALZHEIMERS DIS, V6, P623; Kobayashi K, 2002, NEUROPATH APPL NEURO, V28, P238, DOI 10.1046/j.1365-2990.2002.00390.x; Kondo Y, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-31; Kong Qing-li, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P298; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konno D, 2002, J CELL SCI, V115, P4695, DOI 10.1242/jcs.00127; Korostynski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r128; Korzus E, 2003, ACTA BIOCHIM POL, V50, P775; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Kreienkamp HJ, 2002, BIOCHEM SOC T, V30, P464, DOI 10.1042/bst0300464; Kreienkamp HJ, 2000, J PHYSIOLOGY-PARIS, V94, P193, DOI 10.1016/S0928-4257(00)00204-7; KSIEZAKREDING H, 1987, J NEUROCHEM, V48, P455, DOI 10.1111/j.1471-4159.1987.tb04114.x; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lahiri DK, 2003, ANN NY ACAD SCI, V1010, P639, DOI 10.1196/annals.1299.117; Lam BYH, 2009, J BIOL CHEM, V284, P12562, DOI 10.1074/jbc.M901121200; Lambeng N, 2006, NEUROSCI LETT, V398, P107, DOI 10.1016/j.neulet.2005.12.059; Landfield PW, 2007, CURR ALZHEIMER RES, V4, P205, DOI 10.2174/156720507780362083; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Laquintana V, 2007, BIOCONJUGATE CHEM, V18, P1397, DOI 10.1021/bc060393c; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35; Lauriat TL, 2008, J NEUROSCI RES, V86, P785, DOI 10.1002/jnr.21534; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Le Strat Y, 2009, CURR MOL MED, V9, P506; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lee JM, 2008, CLIN CHEM, V54, P1617, DOI 10.1373/clinchem.2008.104497; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee MS, 2003, J ALZHEIMERS DIS, V5, P127, DOI 10.3233/JAD-2003-5207; LEE MY, 2009, STEM CELLS; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; Levers TE, 2001, J NEUROBIOL, V48, P265, DOI 10.1002/neu.1056; LEVEUGLE B, 1994, BRAIN RES, V650, P20, DOI 10.1016/0006-8993(94)90202-X; Levine S, 2009, EXP MOL PATHOL, V86, P18, DOI 10.1016/j.yexmp.2008.10.006; Lezzi M, 2005, J CELL SCI, V118, P5647, DOI 10.1242/jcs.02658; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Li DB, 2008, HIPPOCAMPUS, V18, P692, DOI 10.1002/hipo.20428; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Li M, 2004, J NEUROCHEM, V91, P623, DOI 10.1111/j.1471-4159.2004.02765.x; Li SP, 2004, J PINEAL RES, V36, P186, DOI 10.1111/j.1600-079X.2004.00116.x; Lian QY, 2001, EXP NEUROL, V167, P158, DOI 10.1006/exnr.2000.7534; Liang ZH, 2008, J ALZHEIMERS DIS, V13, P295; Lillo C, 2006, ADV EXP MED BIOL, V572, P341; Lim ACB, 2003, J ALZHEIMERS DIS, V5, P329, DOI 10.3233/JAD-2003-5409; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Litosch I, 2002, IUBMB LIFE, V54, P253, DOI 10.1080/15216540215673; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Liu Y, 2007, BIOCHEM BIOPH RES CO, V354, P505, DOI 10.1016/j.bbrc.2007.01.009; LLEDO PM, 1993, NATURE, V364, P540, DOI 10.1038/364540a0; LLEDO PM, 1993, CR SOC BIOL, V187, P726; Lockhart ST, 2000, J NEUROBIOL, V42, P460, DOI 10.1002/(SICI)1097-4695(200003)42:4<460::AID-NEU7>3.3.CO;2-R; Lopes JP, 2007, CELL MOL NEUROBIOL, V27, P943, DOI 10.1007/s10571-007-9224-3; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; Lowe XR, 2007, BRAIN RES, V1174, P7, DOI 10.1016/j.brainres.2007.07.039; Lu Y, 2007, NUCLEIC ACIDS RES, V35, pW105, DOI 10.1093/nar/gkm408; Lue LF, 2001, NEUROBIOL AGING, V22, P945, DOI 10.1016/S0197-4580(01)00311-6; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Lukas J, 2009, NUCLEIC ACIDS RES, V37, P3007, DOI 10.1093/nar/gkp179; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lus G, 2003, NEUROLOGY, V61, P988, DOI 10.1212/WNL.61.7.988; Lyly A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-22; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Macauley SL, 2009, EXP NEUROL, V217, P124, DOI 10.1016/j.expneurol.2009.01.022; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; MacDonald AW, 2006, DEV PSYCHOPATHOL, V18, P853, DOI 10.1017/S0954579406060421; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Madison DL, 1996, J NEUROSCI RES, V45, P258; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Maiese K, 2007, CURR MED CHEM, V14, P1729; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Malaterre J, 2008, STEM CELLS, V26, P173, DOI 10.1634/stemcells.2007-0293; Malm TM, 2008, GLIA, V56, P1767, DOI 10.1002/glia.20726; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Marchand S, 2001, EUR J NEUROSCI, V13, P221, DOI 10.1046/j.1460-9568.2001.01373.x; Marsagishvili LG, 2005, BIOFIZIKA+, V50, P803; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Masumoto N, 1998, J EXP ZOOL, V280, P91, DOI 10.1002/(SICI)1097-010X(19980101)280:1&lt;91::AID-JEZ11&gt;3.0.CO;2-Z; Mata I, 2009, BIOL PSYCHIAT, V65, P535, DOI 10.1016/j.biopsych.2008.10.020; MATEO I, 2008, ACTA NEUROL SCAND; Matsuno A, 2003, MICROSC RES TECHNIQ, V62, P232, DOI 10.1002/jemt.10364; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Mead AN, 2006, BEHAV NEUROSCI, V120, P241, DOI 10.1037/0735-7044.120.2.241; Mead AN, 2003, J NEUROSCI, V23, P9500; Medvedev NI, 2008, EUR J NEUROSCI, V27, P315, DOI 10.1111/j.1460-9568.2007.06005.x; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mendes Alexandre, 2008, V141, P131; Mercado-Gomez O, 2008, NEUROCHEM RES, V33, P1599, DOI 10.1007/s11064-008-9714-9; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Migues PV, 2007, DEV NEUROSCI-BASEL, V29, P232, DOI 10.1159/000096408; MILLER CCJ, 1986, EMBO J, V5, P269, DOI 10.1002/j.1460-2075.1986.tb04209.x; Minatel E, 2003, MUSCLE NERVE, V28, P561, DOI 10.1002/mus.10416; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; Mitrasinovic OM, 2004, J NEUROSCI RES, V77, P420, DOI 10.1002/jnr.20168; Mitrasinovic OM, 2003, NEUROBIOL AGING, V24, P807, DOI 10.1016/S0197-4580(02)00237-3; Mitrasinovic OM, 2003, NEUROSCI LETT, V344, P185, DOI 10.1016/S0304-3940(03)00474-9; Mitrasinovic OM, 2001, J BIOL CHEM, V276, P30142, DOI 10.1074/jbc.M104265200; Miyajima N, 2009, BIOCHEM BIOPH RES CO, V381, P383, DOI 10.1016/j.bbrc.2009.02.059; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; MONROIG O, 2009, BIOCH BIOPHYS ACTA; Moreira PI, 2007, J NEUROL SCI, V257, P206, DOI 10.1016/j.jns.2007.01.017; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Mori M, 2007, EXP ANIM TOKYO, V56, P93, DOI 10.1538/expanim.56.93; Morozova N, 2007, GENES CELLS, V12, P561, DOI 10.1111/j.1365-2443.2007.01074.x; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Motonaga K, 2001, BRAIN RES, V905, P250, DOI 10.1016/S0006-8993(01)02535-5; Munch G, 2003, BIOCHEM SOC T, V31, P1397; Murphy GM, 2000, AM J PATHOL, V157, P895, DOI 10.1016/S0002-9440(10)64603-2; Murray KD, 2008, J NEUROSCI, V28, P12010, DOI 10.1523/JNEUROSCI.3800-08.2008; Murray KD, 2007, P NATL ACAD SCI USA, V104, P1989, DOI 10.1073/pnas.0610742104; Nacher J, 2005, J NEUROSCI RES, V81, P753, DOI 10.1002/jnr.20596; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Nakagawa Masanori, 2004, Rinsho Shinkeigaku, V44, P991; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Nash JE, 2005, FASEB J, V19, P583, DOI 10.1096/fj.04-1854fje; Nazwar TA, 2009, J NEUROSCI RES, V87, P1532, DOI 10.1002/jnr.21989; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Neiva TJC, 1997, BRAZ J MED BIOL RES, V30, P599, DOI 10.1590/S0100-879X1997000500005; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Gomez Ravetti M., 2009, FDN COMPUTATIONAL IN, V5, P149; Nelson TJ, 2005, BIOCHEM SOC T, V33, P1033, DOI 10.1042/BST0331033; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Nikitin V P, 2007, Neurosci Behav Physiol, V37, P607, DOI 10.1007/s11055-007-0059-7; Nikitin V P, 2007, Neurosci Behav Physiol, V37, P559, DOI 10.1007/s11055-007-0053-0; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Nishimura H, 2003, J NEUROCHEM, V85, P1216, DOI 10.1046/j.1471-4159.2003.01760.x; Nishioka H, 2005, ACTA NEUROPATHOL, V109, P598, DOI 10.1007/s00401-005-1008-6; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Nowotny P, 2007, NEUROSCI LETT, V419, P15, DOI 10.1016/j.neulet.2007.03.071; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; Ogasawara H, 2008, NEUROSIGNALS, V16, P300, DOI 10.1159/000123040; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; Orellana DI, 2007, BBA-MOL CELL RES, V1773, P254, DOI 10.1016/j.bbamcr.2006.10.010; Owen MJ, 2009, CURR OPIN GENET DEV, V19, P266, DOI 10.1016/j.gde.2009.02.008; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Pankonin MS, 2009, BRAIN RES, V1258, P1, DOI 10.1016/j.brainres.2008.12.047; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Parent A, 1999, NEUROBIOL DIS, V6, P56, DOI 10.1006/nbdi.1998.0207; Parisiadou L, 2008, NEUROBIOL DIS, V30, P353, DOI 10.1016/j.nbd.2008.02.004; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pedersen WA, 2001, NEUROBIOL DIS, V8, P492, DOI 10.1006/nbdi.2001.0395; Pedrosa E, 2009, NEUROPSYCHOBIOLOGY, V59, P205, DOI 10.1159/000223732; Peers C, 2004, BIOL CHEM, V385, P285, DOI 10.1515/BC.2004.023; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Perlis RH, 2009, AM J PSYCHIAT, V166, P718, DOI 10.1176/appi.ajp.2009.08111633; Pfenning AR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-20; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Poduslo SE, 2010, AM J MED GENET B, V153B, P114, DOI 10.1002/ajmg.b.30963; Poirier GL, 2008, J NEUROSCI, V28, P1034, DOI 10.1523/JNEUROSCI.4607-07.2008; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Poirier R, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/006.2007, 10.3389/neuro.08.006.2007]; Pollak D, 2003, J NEURAL TRANSM-SUPP, P149; Polleri A, 2002, J ENDOCRINOL INVEST, V25, P73, DOI 10.1007/BF03343964; Polter A, 2009, BIOL PSYCHIAT, V65, P150, DOI 10.1016/j.biopsych.2008.08.005; Poona HF, 2005, NEUROCHEM INT, V46, P159, DOI 10.1016/j.neuint.2004.07.008; Prata DP, 2009, PSYCHIAT GENET, V19, P113, DOI 10.1097/YPG.0b013e32832a4f69; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; PRICE JL, 1993, NEUROBIOL AGING, V14, P661, DOI 10.1016/0197-4580(93)90062-G; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Putzer Brigitte M, 2006, Discov Med, V6, P123; Qiao X, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-95; Qin WP, 2008, ANN NY ACAD SCI, V1147, P335, DOI 10.1196/annals.1427.024; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Rademakers R, 2005, NEUROBIOL AGING, V26, P1145, DOI 10.1016/j.neurobiolaging.2004.10.003; Rahman A, 2006, J NEURAL TRANSM, V113, P219, DOI 10.1007/s00702-005-0313-5; Rahman A, 2005, NEUROCHEM RES, V30, P277, DOI 10.1007/s11064-005-2483-9; Ramadan H, 2007, NEUROLOGY, V68, P387, DOI 10.1212/01.wnl.0000252825.85947.2f; Ramanathan Subhadra, 2004, BMC Med Genet, V5, P10, DOI 10.1186/1471-2350-5-10; Rametti A, 2004, J BIOL CHEM, V279, P54518, DOI 10.1074/jbc.M408186200; Ranganathan S, 2003, AM J PATHOL, V162, P823, DOI 10.1016/S0002-9440(10)63879-5; Rasmuson S, 2001, BIOL PSYCHIAT, V49, P547, DOI 10.1016/S0006-3223(00)01015-5; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; RAY A, 2009, FEBS J; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; REDECKER P, 1995, NEUROENDOCRINOLOGY, V62, P101, DOI 10.1159/000126994; Reimers K, 2006, INT J MOL MED, V18, P729; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Reinhard S, 2009, NEUROCHEM RES, V34, P17, DOI 10.1007/s11064-008-9732-7; Renaudineau S, 2009, P NATL ACAD SCI USA, V106, P11771, DOI 10.1073/pnas.0900484106; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Rhein Virginie, 2007, Archives of Physiology and Biochemistry, V113, P131, DOI 10.1080/13813450701572288; Ribeiro S, 1998, NEURON, V21, P359, DOI 10.1016/S0896-6273(00)80545-0; Richarz AN, 2002, ANAL BIOANAL CHEM, V372, P412, DOI 10.1007/s00216-001-1187-5; ROBBINS K, 2006, ONLINE J BIOINFORMAT, V7, P9; Roberts JC, 2009, EXP NEUROL, V216, P459, DOI 10.1016/j.expneurol.2009.01.002; RODER HM, 1991, J NEUROSCI, V11, P3325; Romcy-Pereira RN, 2009, PHYSIOL BEHAV, V98, P44, DOI 10.1016/j.physbeh.2009.04.010; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rosso OA, 2009, J NEUROSCI METH, V181, P257, DOI 10.1016/j.jneumeth.2009.04.028; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; SADAKATA T, 2009, CEREBELLUM; Sadakata T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-25; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sadakata T, 2007, J HISTOCHEM CYTOCHEM, V55, P301, DOI 10.1369/jhc.6A7033.2006; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Sahara N, 2004, J NEUROCHEM, V90, P829, DOI 10.1111/j.1471-4159.2004.02558.x; Saitoh T, 2001, BIOCHEM BIOPH RES CO, V281, P815, DOI 10.1006/bbrc.2001.4421; Sajan Farrah D, 2007, Am J Alzheimers Dis Other Demen, V22, P319, DOI 10.1177/1533317507302447; Sakae N, 2008, HUM MOL GENET, V17, P3191, DOI 10.1093/hmg/ddn215; Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Samarin J, 2009, J CELL COMMUN SIGNAL, V3, P79, DOI 10.1007/s12079-009-0055-5; Sambamurti K, 1999, J BIOL CHEM, V274, P26810, DOI 10.1074/jbc.274.38.26810; SANDEEP J, 2008, SILICO BIOL, V8, P9; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Sasaki T, 2006, BRAIN RES, V1108, P98, DOI 10.1016/j.brainres.2006.06.009; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Sato S, 2008, J NEUROSCI, V28, P14511, DOI 10.1523/JNEUROSCI.3417-08.2008; Save MP, 2004, NEUROPATH APPL NEURO, V30, P635, DOI 10.1111/j.1365-2990.2004.00578.x; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; SCHIJNDEL JE, 2009, J PSYCHIAT RES; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; SCHMIDT ML, 1989, LAB INVEST, V60, P513; SCHMIDT ML, 1991, LAB INVEST, V64, P352; Schmitt FA, 2001, GERONTOLOGIST, V41, P716, DOI 10.1093/geront/41.6.716; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Schnurra I, 2001, NEUROBIOL DIS, V8, P900, DOI 10.1006/nbdi.2001.0432; Schubert P, 1998, J NEURAL TRANSM-SUPP, P167; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; SCRANTON TW, 1993, J NEUROCHEM, V61, P29, DOI 10.1111/j.1471-4159.1993.tb03535.x; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; SHEN Y, 1995, BRAIN RES, V671, P282, DOI 10.1016/0006-8993(94)01264-I; SHEN ZM, 1994, BIOCHEMISTRY-US, V33, P9627, DOI 10.1021/bi00198a031; Sheng M, 2000, J CELL SCI, V113, P1851; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; Shimizu T, 2004, BEHAV NEUROSCI, V118, P845, DOI 10.1037/0735-7044.118.4.845; SHIMOHAMA S, 1995, ALZ DIS ASSOC DIS, V9, P15, DOI 10.1097/00002093-199501002-00004; Shimohama S, 1997, BIOCHEM BIOPH RES CO, V236, P239, DOI 10.1006/bbrc.1997.6940; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; Sidhu RS, 2001, BIOCHEM BIOPH RES CO, V289, P1039, DOI 10.1006/bbrc.2001.6113; Sim KG, 2006, CELL CYCLE, V5, P1111, DOI 10.4161/cc.5.10.2797; Small D H, 2000, IDrugs, V3, P740; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; SO HC, 2009, AM J MED GENET B; SOMERVILLE MJ, 1991, MOL BRAIN RES, V9, P1, DOI 10.1016/0169-328X(91)90123-F; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Sons MS, 2006, BRAIN RES, V1089, P126, DOI 10.1016/j.brainres.2006.03.055; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Sotiropoulos I, 2008, NEUROSCI BIOBEHAV R, V32, P1161, DOI 10.1016/j.neubiorev.2008.05.007; Soule Jonathan, 2008, Neural Plasticity, V2008, P269097, DOI 10.1155/2008/269097; Spires TL, 2005, CEREB CORTEX, V15, P385, DOI 10.1093/cercor/bhh141; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; STETTLER O, 1995, EUR J NEUROSCI, V7, P702, DOI 10.1111/j.1460-9568.1995.tb00674.x; Steventon B, 2009, DEVELOPMENT, V136, P771, DOI 10.1242/dev.029017; Strachan GD, 2005, J CELL BIOCHEM, V96, P728, DOI 10.1002/jcb.20574; Strachan GD, 2005, EXP NEUROL, V193, P455, DOI 10.1016/j.expneurol.2004.08.038; Straessle A, 2003, EUR J NEUROSCI, V18, P2213, DOI 10.1046/j.1460-9568.2003.02964.x; Strosznajder JB, 1999, J MOL NEUROSCI, V12, P101, DOI 10.1007/BF02736924; Surena AL, 2009, BBA-MOL CELL RES, V1793, P264, DOI 10.1016/j.bbamcr.2008.09.005; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Tabira Takeshi, 2003, Rinsho Shinkeigaku, V43, P775; Tajes M, 2009, MECH AGEING DEV, V130, P253, DOI 10.1016/j.mad.2008.12.006; TAKAHATA T, 2009, P NATL ACAD SCI US; Takashima Hiroshi, 2006, Rinsho Shinkeigaku, V46, P1; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tanahashi H, 1999, NEUROSCI LETT, V261, P143, DOI 10.1016/S0304-3940(98)00995-1; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V258, P385, DOI 10.1006/bbrc.1999.0639; Tanahashi H, 2002, ANN NEUROL, V52, P691, DOI 10.1002/ana.10368; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Tardy C, 2009, BBA-MOL CELL RES, V1793, P1250, DOI 10.1016/j.bbamcr.2009.03.007; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Terai K, 1997, BRAIN RES, V769, P385, DOI 10.1016/S0006-8993(97)00849-4; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Terpstra NJ, 2005, J COMP NEUROL, V488, P342, DOI 10.1002/cne.20592; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Thomas M, 2004, CURR OPIN NEUROL, V17, P437, DOI 10.1097/01.wco.0000137534.61244.d1; Thomas U, 2002, J NEUROCHEM, V81, P407, DOI 10.1046/j.1471-4159.2002.00869.x; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Tippens AL, 2007, J BIOL CHEM, V282, P8464, DOI 10.1074/jbc.M611384200; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Tiveci S, 2005, COMPUT BIOL CHEM, V29, P151, DOI 10.1016/j.compbiolchem.2005.03.002; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; Todd KJ, 2007, EUR J NEUROSCI, V25, P1287, DOI 10.1111/j.1460-9568.2007.05385.x; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Toscano CD, 2006, EXP NEUROL, V200, P209, DOI 10.1016/j.expneurol.2006.02.006; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; TROJANOWSKI JQ, 1989, ANN MED, V21, P113, DOI 10.3109/07853898909149196; TROY CM, 1992, J CELL BIOL, V117, P1085, DOI 10.1083/jcb.117.5.1085; Tsim KWK, 2003, J NEUROCYTOL, V32, P603, DOI 10.1023/B:NEUR.0000020613.25367.78; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Vafai SB, 2002, FEBS LETT, V518, P1, DOI 10.1016/S0014-5793(02)02702-3; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Veerhuis R, 1999, EXP NEUROL, V160, P289, DOI 10.1006/exnr.1999.7199; Veinbergs I, 1999, PROG NEURO-PSYCHOPH, V23, P519, DOI 10.1016/S0278-5846(99)00013-5; Velho TAF, 2008, J NEUROSCI, V28, P11871, DOI 10.1523/JNEUROSCI.2307-08.2008; Velho TAF, 2007, J COMP NEUROL, V500, P477, DOI 10.1002/cne.21180; Verdaguer E, 2007, BIOMED PHARMACOTHER, V61, P390, DOI 10.1016/j.biopha.2006.11.001; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Vignal C, 2008, CR BIOL, V331, P347, DOI 10.1016/j.crvi.2008.02.004; Vincent VAM, 2002, J NEUROCHEM, V82, P1388, DOI 10.1046/j.1471-4159.2002.01087.x; Vincent VAM, 2002, NEUROBIOL AGING, V23, P349, DOI 10.1016/S0197-4580(01)00338-4; Voineskos D, 2009, J NEURAL TRANSM, V116, P479, DOI 10.1007/s00702-008-0182-9; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wakabayashi K, 1999, NEUROBIOL AGING, V20, P287, DOI 10.1016/S0197-4580(99)00035-4; Walker DG, 2008, MICROVASC RES, V75, P411, DOI 10.1016/j.mvr.2007.10.004; WALLACE MA, 1994, BBA-MOL BASIS DIS, V1227, P183, DOI 10.1016/0925-4439(94)90093-0; Walton JR, 2007, J INORG BIOCHEM, V101, P1275, DOI 10.1016/j.jinorgbio.2007.06.001; Wang CY, 2007, MOL VIS, V13, P719; Wang CY, 2007, J GLAUCOMA, V16, P230, DOI 10.1097/IJG.0b013e3180300818; Wang F, 2009, J PSYCHIATR NEUROSCI, V34, P181; Wang HJ, 2009, BRAIN RES, V1249, P237, DOI 10.1016/j.brainres.2008.10.046; Wang Huiling, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P63; Wang JZ, 2001, FEBS LETT, V507, P81, DOI 10.1016/S0014-5793(01)02944-1; Wang M, 2009, EUR J MED CHEM, V44, P2748, DOI 10.1016/j.ejmech.2008.08.001; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang Y P, 2001, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V23, P445; Wang YH, 2008, INT J CANCER, V123, P561, DOI 10.1002/ijc.23600; Wang Yipeng, 2002, Zhonghua Yi Xue Za Zhi, V82, P519; Washizuka S, 2009, NEUROSCI RES, V63, P199, DOI 10.1016/j.neures.2008.12.004; Wei Q, 2002, CELL MOL NEUROBIOL, V22, P13, DOI 10.1023/A:1015385527187; Weidenhofer J, 2008, J PSYCHIATR RES, V43, P282, DOI 10.1016/j.jpsychires.2008.04.001; Weihl CC, 1999, J NEUROSCI, V19, P5360; Weiss J, 2008, MOL CELL NEUROSCI, V37, P40, DOI 10.1016/j.mcn.2007.08.012; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; WILLIAMS D, 2009, INVEST OPHTHALMOL VI; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wollmer MA, 2006, NEURODEGENER DIS, V3, P334, DOI 10.1159/000097302; Wong J, 2009, J BIOL CHEM, V284, P18824, DOI 10.1074/jbc.M109.013243; Wong-Riley M, 2000, GENE, V247, P63, DOI 10.1016/S0378-1119(00)00121-9; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; Xu C, 2008, BIPOLAR DISORD, V10, P105, DOI 10.1111/j.1399-5618.2008.00535.x; Xu WH, 2007, J NEURAL TRANSM, V114, P373, DOI 10.1007/s00702-006-0588-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yan SD, 1998, RESTOR NEUROL NEUROS, V12, P167; Yang GF, 2008, NEUROL RES, V30, P613, DOI 10.1179/174313208X284124; Yang HC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S30; YANG X, 2009, CELL MOL NEUROBIOL; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200; Yao PJ, 1998, NEUROSCI LETT, V252, P33, DOI 10.1016/S0304-3940(98)00547-3; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0; Yasojima K, 1999, BRAIN RES, V833, P297, DOI 10.1016/S0006-8993(99)01514-0; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Youn HS, 2007, J ALZHEIMERS DIS, V11, P385; Yu WH, 2008, NEUROCHEM RES, V33, P902, DOI 10.1007/s11064-007-9533-4; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zambrzycka A, 2003, POL J PHARMACOL, V55, P915; Zang ZJ, 2007, CANCER BIOL THER, V6, P712, DOI 10.4161/cbt.6.5.3964; Zarnowska ED, 2009, J NEUROPHYSIOL, V101, P1179, DOI 10.1152/jn.91203.2008; Zhang GC, 2007, MOL PHARMACOL, V71, P1148, DOI 10.1124/mol.106.028399; Zhang Jian-min, 2004, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V26, P62; Zhang J, 2009, J NEURAL TRANSM, V116, P357, DOI 10.1007/s00702-009-0185-1; Zhang ZJ, 2007, HUM MOL GENET, V16, P837, DOI 10.1093/hmg/ddm029; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451; Zhao C, 2008, NEUROSCIENCE, V153, P1202, DOI 10.1016/j.neuroscience.2007.10.067; ZHAO C, 2008, MOL CELL NEUROSCI; ZHAO C, 2008, CELL MOL NEUROBIOL; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zhuo JM, 2008, CURR ALZHEIMER RES, V5, P385, DOI 10.2174/156720508785132280	781	99	100	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10153	10.1371/journal.pone.0010153	http://dx.doi.org/10.1371/journal.pone.0010153			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405009	Green Published, gold			2022-12-27	WOS:000276706300009
J	Handel, AE; Handunnetthi, L; Berlanga, AJ; Watson, CT; Morahan, JM; Ramagopalan, SV				Handel, Adam E.; Handunnetthi, Lahiru; Berlanga, Antonio J.; Watson, Corey T.; Morahan, Julia M.; Ramagopalan, Sreeram V.			The Effect of Single Nucleotide Polymorphisms from Genome Wide Association Studies in Multiple Sclerosis on Gene Expression	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; REPLICATION; VARIANTS; DISEASES; ISOLATE	Background: Multiple sclerosis (MS) is a complex neurological disorder. Its aetiology involves both environmental and genetic factors. Recent genome-wide association studies have identified a number of single nucleotide polymorphisms (SNPs) associated with susceptibility to (MS). We investigated whether these genetic variations were associated with alteration in gene expression. Methods/Principal Findings: We used a database of mRNA expression and genetic variation derived from immortalised peripheral lymphocytes to investigate polymorphisms associated with MS for correlation with gene expression. Several SNPs were found to be associated with changes in expression: in particular two with HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRB1, HLA-DRB4 and HLA-DRB5, one with ZFP57, one with CD58, two with IL7 and FAM164A, and one with FAM119B, TSFM and KUB3. We found minimal cross-over with a recent whole genome expression study in MS patients. Discussion: We have shown that many susceptibility loci in MS are associated with changes in gene expression using an unbiased expression database. Several of these findings suggest novel gene candidates underlying the effects of MS-associated genetic variation.	[Handel, Adam E.; Handunnetthi, Lahiru; Berlanga, Antonio J.; Morahan, Julia M.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Handel, Adam E.; Handunnetthi, Lahiru; Berlanga, Antonio J.; Morahan, Julia M.; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Watson, Corey T.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Simon Fraser University; University of London; Queen Mary University London	Handel, AE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	sreeramr@well.ox.ac.uk	Handel, Adam/F-2489-2011	Watson, Corey/0000-0001-7248-8787; Morahan, Julia/0000-0001-9278-0603; Handel, Adam/0000-0001-8385-6346; Handunnetthi, Lahiru/0000-0002-8242-3722	Wellcome Trust [075491/Z/04]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (Grant Number 075491/Z/04). SVR is a Goodger Scholar at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), 2009, NAT GENET, V41, P824; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI US, V106, P5264; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; GANDHI KS, 2010, HUM MOL GEN IN PRESS; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Handel AE, 2009, TRENDS MOL MED; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Kallio SP, 2009, HUM MOL GENET, V18, P1670, DOI 10.1093/hmg/ddp073; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; LINCOLN MR, 2009, P NATL ACAD SCI US; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Peltonen L, 2007, NEW ENGL J MED, V357, P927, DOI 10.1056/NEJMe078147; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	25	52	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10142	10.1371/journal.pone.0010142	http://dx.doi.org/10.1371/journal.pone.0010142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405052	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706300005
J	Bjarnsholt, T; Jensen, PO; Jakobsen, TH; Phipps, R; Nielsen, AK; Rybtke, MT; Tolker-Nielsen, T; Givskov, M; Hoiby, N; Ciofu, O				Bjarnsholt, Thomas; Jensen, Peter Ostrup; Jakobsen, Tim Holm; Phipps, Richard; Nielsen, Anne Kirstine; Rybtke, Morten Theil; Tolker-Nielsen, Tim; Givskov, Michael; Hoiby, Niels; Ciofu, Oana		Scandinavian Cystic Fibrosis Study	Quorum Sensing and Virulence of Pseudomonas aeruginosa during Lung Infection of Cystic Fibrosis Patients	PLOS ONE			English	Article								Pseudomonas aeruginosa is the predominant microorganism in chronic lung infection of cystic fibrosis patients. The chronic lung infection is preceded by intermittent colonization. When the chronic infection becomes established, it is well accepted that the isolated strains differ phenotypically from the intermittent strains. Dominating changes are the switch to mucoidity ( alginate overproduction) and loss of epigenetic regulation of virulence such as the Quorum Sensing (QS). To elucidate the dynamics of P. aeruginosa QS systems during long term infection of the CF lung, we have investigated 238 isolates obtained from 152 CF patients at different stages of infection ranging from intermittent to late chronic. Isolates were characterized with regard to QS signal molecules, alginate, rhamnolipid and elastase production and mutant frequency. The genetic basis for change in QS regulation were investigated and identified by sequence analysis of lasR, rhlR, lasI and rhlI. The first QS system to be lost was the one encoded by las system 12 years ( median value) after the onset of the lung infection with subsequent loss of the rhl encoded system after 17 years ( median value) shown as deficiencies in production of the 3-oxo-C12-HSL and C4-HSL QS signal molecules respectively. The concomitant development of QS malfunction significantly correlated with the reduced production of rhamnolipids and elastase and with the occurrence of mutations in the regulatory genes lasR and rhlR. Accumulation of mutations in both lasR and rhlR correlated with development of hypermutability. Interestingly, a higher number of mucoid isolates were found to produce C4-HSL signal molecules and rhamnolipids compared to the non-mucoid isolates. As seen from the present data, we can conclude that P. aeruginosa and particularly the mucoid strains do not lose the QS regulation or the ability to produce rhamnolipids until the late stage of the chronic infection.	[Bjarnsholt, Thomas; Jakobsen, Tim Holm; Nielsen, Anne Kirstine; Rybtke, Morten Theil; Tolker-Nielsen, Tim; Givskov, Michael; Hoiby, Niels; Ciofu, Oana] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Jensen, Peter Ostrup; Hoiby, Niels] Univ Hosp, Dept Clin Microbiol, Rigshosp, Copenhagen, Denmark; [Phipps, Richard] Tech Univ Denmark, DK-2800 Lyngby, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Technical University of Denmark	Bjarnsholt, T (corresponding author), Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	ociofu@sund.ku.dk	Rybtke, Morten/G-7182-2017; Jensen, Peter Ostrup/HGD-7725-2022; Ciofu, Oana/AAE-2413-2020; Bjarnsholt, Thomas/ABD-6178-2021	Rybtke, Morten/0000-0002-6218-6774; Bjarnsholt, Thomas/0000-0002-8003-7414; Tolker-Nielsen, Tim/0000-0002-9751-474X; Givskov, Michael/0000-0001-5004-8609; Hoiby, Niels/0000-0002-1347-725X; Jakobsen, Tim Holm/0000-0002-1671-2155; Ciofu, Oana/0000-0001-5648-4858; Jensen, Peter Ostrup/0000-0003-1648-7186	Carlsberg Foundation; Lundbeck Foundation; German Mukoviszidose e.V.; Danish Strategic Research Council	Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); German Mukoviszidose e.V.; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This study was supported by The Carlsberg Foundation and Lundbeck Foundation to TB and grants from the German Mukoviszidose e.V. and the Danish Strategic Research Council to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEDE M, 2009, MICROBIOLOGY, P3500; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; BOE L, 1994, J BACTERIOL, V176, P2781, DOI 10.1128/JB.176.10.2781-2787.1994; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; CHOI SH, 1991, P NATL ACAD SCI USA, V88, P11115, DOI 10.1073/pnas.88.24.11115; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; DEKIMPE V, 2009, MICROBIOLOGY 3, P712; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Garde C, 2010, J MOL BIOL, V396, P849, DOI 10.1016/j.jmb.2010.01.002; Geisenberger O, 2000, FEMS MICROBIOL LETT, V184, P273, DOI 10.1111/j.1574-6968.2000.tb09026.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; HENTZER M, 2002, MICROBIOLOGY 1, P87; Heurlier K, 2006, INT J MED MICROBIOL, V296, P93, DOI 10.1016/j.ijmm.2006.01.043; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018; HOIBY N, 1977, SCAND J RESPIR DIS, V58, P65; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; JENSEN PO, 2007, MICROBIOLOGY 5, P1329, DOI 10.1099/mic.0.2006/003863-0; KHARAZMI A, 1984, INFECT IMMUN, V43, P161, DOI 10.1128/IAI.43.1.161-165.1984; Kiratisin P, 2002, J BACTERIOL, V184, P4912, DOI 10.1128/JB.184.17.4912-4919.2002; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KRONBORG G, 1992, J CLIN MICROBIOL, V30, P1848, DOI 10.1128/JCM.30.7.1848-1855.1992; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lequette Y, 2006, J BACTERIOL, V188, P3365, DOI 10.1128/JB.188.9.3365-3370.2006; LUJAN AM, 2007, MICROBIOLOGY 1, P225; Mandsberg LF, 2009, ANTIMICROB AGENTS CH, V53, P2483, DOI 10.1128/AAC.00428-08; MATHEE K, 1999, MICROBIOLOGY, P1349; Moser C, 2009, APMIS, V117, P95, DOI 10.1111/j.1600-0463.2008.00018.x; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; OJENIYI B, 1991, APMIS, V99, P492, DOI 10.1111/j.1699-0463.1991.tb05181.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PEDERSEN SS, 1992, THORAX, V47, P6, DOI 10.1136/thx.47.1.6; PEDERSEN SS, 1990, INFECT IMMUN, V58, P3363, DOI 10.1128/IAI.58.10.3363-3368.1990; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Romling U, 2000, J CLIN MICROBIOL, V38, P464; Rumbaugh KP, 2000, MICROBES INFECT, V2, P1721, DOI 10.1016/S1286-4579(00)01327-7; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schelstraete P, 2008, EUR RESPIR J, V31, P822, DOI 10.1183/09031936.00088907; Skindersoe ME, 2008, ANTIMICROB AGENTS CH, V52, P3648, DOI 10.1128/AAC.01230-07; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Song ZJ, 2003, J MED MICROBIOL, V52, P731, DOI 10.1099/jmm.0.05122-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607	51	168	180	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10115	10.1371/journal.pone.0010115	http://dx.doi.org/10.1371/journal.pone.0010115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404933	Green Published, Green Submitted, gold			2022-12-27	WOS:000276705900002
J	Chen, J; Tang, B; Chen, HX; Yao, Q; Huang, XF; Chen, J; Zhang, DW; Zhang, WQ				Chen, Jie; Tang, Bin; Chen, Hongxin; Yao, Qiong; Huang, Xiaofeng; Chen, Jing; Zhang, Daowei; Zhang, Wenqing			Different Functions of the Insect Soluble and Membrane-Bound Trehalase Genes in Chitin Biosynthesis Revealed by RNA Interference	PLOS ONE			English	Article							MOLECULAR-CLONING; TENEBRIO-MOLITOR; MIDGUT TREHALASE; ACCESSORY-GLAND; SYNTHASE GENE; LARVAL MIDGUT; EXPRESSION; LOCALIZATION; SILKWORM; PURIFICATION	Background: Trehalase, an enzyme that hydrolyzes trehalose to yield two glucose molecules, plays a pivotal role in various physiological processes. In recent years, trehalase proteins have been purified from several insect species and are divided into soluble (Tre-1) and membrane-bound (Tre-2) trehalases. However, no functions of the two trehalases in chitin biosynthesis in insects have yet been reported. Principal Findings: The membrane-bound trehalase of Spodoptera exigua (SeTre-2) was characterized in our laboratory previously. In this study, we cloned the soluble trehalase gene (SeTre-1) and investigated the tissue distribution and developmental expression pattern of the two trehalase genes. SeTre-1 was expressed highly in cuticle and Malpighian tubules, while SeTre-2 was expressed in tracheae and fat body. In the midgut, the two trehalase genes were expressed in different locations. Additionally, the expression profiles of both trehalase mRNAs and their enzyme activities suggest that they may play different roles in chitin biosynthesis. The RNA interference (RNAi) of either SeTre-1 or SeTre-2 was gene-specific and effective, with efficiency rates up to 83% at 72 h post injection. After RNAi of SeTre-1 and SeTre-2, significant higher mortality rates were observed during the larva-pupa stage and pupa-adult stage, and the lethal phenotypes were classified and analyzed. Additionally, the change trends of concentration of trehalose and glucose appeared reciprocally in RNAi-mutants. Moreover, knockdown of SeTre-1 gene largely inhibited the expression of chitin synthase gene A (CHSA) and reduced the chitin content in the cuticle to two-thirds relative to the control insects. The chitin synthase gene B (CHSB) expression, however, was inhibited more by the injection of dsRNA for SeTre-2, and the chitin content in the midgut decreased by about 25%. Conclusions: SeTre-1 plays a major role in CHSA expression and chitin synthesis in the cuticle, and SeTre-2 has an important role in CHSB expression and chitin synthesis in the midgut.	[Chen, Jie; Tang, Bin; Chen, Hongxin; Yao, Qiong; Huang, Xiaofeng; Chen, Jing; Zhang, Daowei; Zhang, Wenqing] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Bin] Hangzhou Normal Univ, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Sun Yat Sen University; Hangzhou Normal University	Chen, J (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	Lsszwq@mail.sysu.edu.cn	zhang, wenqing/GYA-0786-2022	Chen, Hongxin/0000-0002-2955-4619	National Natural Science Foundation of China [30871634]; Research Fund for the Doctoral Program of Higher Education of China [20070558027]; Science Foundation of the State Key Laboratory of Biocontrol [SKLBC09A01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of the State Key Laboratory of Biocontrol	This work was supported by National Natural Science Foundation of China (30871634), Research Fund for the Doctoral Program of Higher Education of China (20070558027) and Science Foundation of the State Key Laboratory of Biocontrol (SKLBC09A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; AZUMA M, 1985, TISSUE CELL, V17, P539, DOI 10.1016/0040-8166(85)90030-8; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Borgia PT, 1996, MOL MICROBIOL, V20, P1287, DOI 10.1111/j.1365-2958.1996.tb02647.x; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; de Almeida FM, 2009, PROTEIN EXPRES PURIF, V65, P185, DOI 10.1016/j.pep.2008.11.010; FRIEDMAN S, 1978, ANNU REV ENTOMOL, V23, P389, DOI 10.1146/annurev.en.23.010178.002133; Friedman S., 1985, P43; Gu JH, 2009, J INSECT PHYSIOL, V55, P997, DOI 10.1016/j.jinsphys.2009.07.003; Hallsworth JE, 1997, J MICROBIOL METH, V29, P7, DOI 10.1016/S0167-7012(97)00976-7; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; KLEIN U, 1991, J EXP BIOL, V161, P61; Kramer K.J., 1985, P75; Kumar NS, 2008, COMP BIOCHEM PHYS B, V149, P447, DOI 10.1016/j.cbpb.2007.11.005; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mitsumasu K, 2005, INSECT MOL BIOL, V14, P501, DOI 10.1111/j.1365-2583.2005.00581.x; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; Sanchez-Fresneda R, 2009, BIOCHEM BIOPH RES CO, V383, P98, DOI 10.1016/j.bbrc.2009.03.134; Silva MCP, 2009, INSECT MOL BIOL, V18, P769, DOI 10.1111/j.1365-2583.2009.00920.x; SU ZH, 1993, BIOCHIM BIOPHYS ACTA, V1173, P217, DOI 10.1016/0167-4781(93)90184-F; SUMIDA M, 1983, INSECT BIOCHEM, V13, P257, DOI 10.1016/0020-1790(83)90047-1; TAKIGUCHI M, 1992, BIOCHEM J, V288, P19, DOI 10.1042/bj2880019; Tang B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-51; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Yaginuma T, 1996, J COMP PHYSIOL B, V166, P1, DOI 10.1007/BF00264633; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	34	92	128	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10133	10.1371/journal.pone.0010133	http://dx.doi.org/10.1371/journal.pone.0010133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405036	Green Published, gold, Green Submitted			2022-12-27	WOS:000276705900015
J	Gaston, MA; Fuji, A; Weckerly, FW; Forstner, MRJ				Gaston, Michele A.; Fuji, Akiko; Weckerly, Floyd W.; Forstner, Michael R. J.			Potential Component Allee Effects and Their Impact on Wetland Management in the Conservation of Endangered Anurans	PLOS ONE			English	Article							HOUSTON TOADS; CALL SURVEYS; BEHAVIOR; ECOLOGY; DENSITY; SEX; DYNAMICS; MODELS	Effective management of wetland quantity and quality is crucial for effective conservation of declining amphibian populations. In particular, frogs and toads that employ aggregative breeding strategies may suffer negative population impacts in response to changes in availability of aquatic breeding habitat, including overabundance of suitable habitat, if density of conspecifics attending aggregations is positively correlated with reproductive success. Here we document such a positive relationship, potentially the first example of a component Allee effect in an anuran, in the critically endangered Houston toad (Bufo houstonensis). We assessed the relationship between mean yearly chorus size and reproductive success of males at the pond level using an information theoretic model selection approach and a two-sample t-test. The chosen model contained the single variable of mean yearly chorus size to predict probability of reproduction, as selected using the Akaike Information Criterion corrected for small sample size and Akaike weight. Mean chorus sizes were significantly higher among ponds exhibiting evidence of reproduction than in those that showed no evidence of reproduction. Our results suggest that chorusing alone is a poor proxy for inference of population stability and highlight a need for reassessment of widely-used amphibian monitoring protocols. Further, amphibian conservation efforts should account for potential Allee effects in order to optimize benefits and avoid underestimating critical population thresholds, particularly in species exhibiting rapid population declines.	[Gaston, Michele A.; Fuji, Akiko; Weckerly, Floyd W.; Forstner, Michael R. J.] Texas State Univ San Marcos, Dept Biol, San Marcos, TX USA	Texas State University System; Texas State University San Marcos	Gaston, MA (corresponding author), Texas State Univ San Marcos, Dept Biol, San Marcos, TX USA.	mg45447@txstate.edu			US Fish and Wildlife Service [04ERAG0002]; Texas Parks and Wildlife Department; Boy Scouts of America; United States Geological Survey; Texas Department of Transportation; US Department of Interior [14-6XXIA006]	US Fish and Wildlife Service(US Fish & Wildlife Service); Texas Parks and Wildlife Department; Boy Scouts of America; United States Geological Survey(United States Geological Survey); Texas Department of Transportation; US Department of Interior	This research was funded by a joint grant from the US Fish and Wildlife Service, Texas Parks and Wildlife Department, and the Boy Scouts of America (traditional Section 6); a grant from the United States Geological Survey and US Fish and Wildlife Service (04ERAG0002); and a grant from the Texas Department of Transportation and US Department of Interior (14-6XXIA006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2001, NATURE, V412, P499, DOI 10.1038/35087658; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Crouch WB, 2002, J HERPETOL, V36, P185, DOI 10.1670/0022-1511(2002)036[0185:ATUOCS]2.0.CO;2; De Solla SR, 2006, BIODIVERS CONSERV, V15, P3481, DOI 10.1007/s10531-004-6905-9; Duellman W. E., 1986, BIOL AMPHIBIANS; Forstner MRJ, 2003, TEX J SCI, V55, P315; HILLIS DM, 1984, J HERPETOL, V18, P56, DOI 10.2307/1563672; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Jackson JT, 2006, J WILDLIFE MANAGE, V70, P1461, DOI 10.2193/0022-541X(2006)70[1461:IAOHTG]2.0.CO;2; JACOBSON NL, 1989, SOUTHWEST NAT, V34, P374, DOI 10.2307/3672166; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Pfennig KS, 2000, BEHAV ECOL SOCIOBIOL, V48, P69, DOI 10.1007/s002650000205; POTTER FE, 1984, HOUSTON RECOVERY PLA; PRICE A, 2003, HOUSTON TOAD BASTROP, P1; RYAN MJ, 1990, EVOLUTION, V44; Semlitsch RD, 2002, CONSERV BIOL, V16, P619, DOI 10.1046/j.1523-1739.2002.00512.x; Semlitsch RD, 2003, AMPHIBIAN CONSERVATI; Smith MA, 2005, ECOGRAPHY, V28, P110; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stevens CE, 2004, J HERPETOL, V38, P404, DOI 10.1670/195-03A; Swannack TM, 2007, SOUTHWEST NAT, V52, P386, DOI 10.1894/0038-4909(2007)52[386:PCFTSD]2.0.CO;2; TEJEDO M, 1993, COPEIA, P75, DOI 10.2307/1446297; US Fish and Wildlife Service, END THREAT WILDL PLA; WAGNER WE, 1992, COPEIA, P647, DOI 10.2307/1446140; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; YANTIS JH, 1990, 76 TEX PARKS WILDL D; YANTIS JH, 1989, 76 TEX PARKS WILDL D; YANTIS JH, 1991, 76 TEX PARKS WILDL D; YANTIS JH, 1992, 76 TEX PARKS WILDL D	36	13	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10102	10.1371/journal.pone.0010102	http://dx.doi.org/10.1371/journal.pone.0010102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404930	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482100018
J	Carvalho, FM; Tinoco, EMB; Deeley, K; Duarte, PM; Faveri, M; Marques, MR; Mendonca, AC; Wang, XJ; Cuenco, K; Menezes, R; Garlet, GP; Vieira, AR				Carvalho, Flavia M.; Tinoco, Eduardo M. B.; Deeley, Kathleen; Duarte, Poliana M.; Faveri, Marcelo; Marques, Marcelo R.; Mendonca, Adriana C.; Wang, Xiaojing; Cuenco, Karen; Menezes, Renato; Garlet, Gustavo P.; Vieira, Alexandre R.			FAM5C Contributes to Aggressive Periodontitis	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; JUVENILE PERIODONTITIS; ASSOCIATION; LINKAGE; SUSCEPTIBILITY; CELLS; DISEASE; LESIONS	Aggressive periodontitis is characterized by a rapid and severe periodontal destruction in young systemically healthy subjects. A greater prevalence is reported in Africans and African descendent groups than in Caucasians and Hispanics. We first fine mapped the interval 1q24.2 to 1q31.3 suggested as containing an aggressive periodontitis locus. Three hundred and eighty-nine subjects from 55 pedigrees were studied. Saliva samples were collected from all subjects, and DNA was extracted. Twenty-one single nucleotide polymorphisms were selected and analyzed by standard polymerase chain reaction using TaqMan chemistry. Non-parametric linkage and transmission distortion analyses were performed. Although linkage results were negative, statistically significant association between two markers, rs1935881 and rs1342913, in the FAM5C gene and aggressive periodontitis (p = 0.03) was found. Haplotype analysis showed an association between aggressive periodontitis and the haplotype A-G (rs1935881-rs1342913; p = 0.009). Sequence analysis of FAM5C coding regions did not disclose any mutations, but two variants in conserved intronic regions of FAM5C, rs57694932 and rs10494634, were found. However, these two variants are not associated with aggressive periodontitis. Secondly, we investigated the pattern of FAM5C expression in aggressive periodontitis lesions and its possible correlations with inflammatory/immunological factors and pathogens commonly associated with periodontal diseases. FAM5C mRNA expression was significantly higher in diseased versus healthy sites, and was found to be correlated to the IL-1 beta, IL-17A, IL-4 and RANKL mRNA levels. No correlations were found between FAM5C levels and the presence and load of red complex periodontopathogens or Aggregatibacter actinomycetemcomitans. This study provides evidence that FAM5C contributes to aggressive periodontitis.	[Carvalho, Flavia M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil; [Tinoco, Eduardo M. B.] Univ Estado Rio De Janeiro, Sch Dent, Dept Periodontol, Rio De Janeiro, Brazil; [Tinoco, Eduardo M. B.] UNIGRANRIO, Sch Hlth Sci, Postgrad Program Dent, Rio De Janeiro, Brazil; [Deeley, Kathleen; Wang, Xiaojing; Cuenco, Karen; Menezes, Renato; Vieira, Alexandre R.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA USA; [Vieira, Alexandre R.] Univ Pittsburgh, Dept Pediat Dent, Pittsburgh, PA USA; [Deeley, Kathleen; Wang, Xiaojing; Cuenco, Karen; Menezes, Renato; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Cuenco, Karen; Vieira, Alexandre R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Vieira, Alexandre R.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15261 USA; [Duarte, Poliana M.; Faveri, Marcelo; Mendonca, Adriana C.] Univ Guarulhos, Dent Res Div, Dept Periodont, Sao Paulo, Brazil; [Marques, Marcelo R.] Univ Estadual Campinas, Dept Morphol, Div Histol, Sch Dent Piracicaba, Sao Paulo, Brazil; [Garlet, Gustavo P.] Univ Sao Paulo, Dept Biol Sci, FOB USP, Sch Dent Bauru, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Grande Rio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade Guarulhos; Universidade Estadual de Campinas; Universidade de Sao Paulo	Carvalho, FM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.	arv11@pitt.edu	de Carvalho, Flavia/AAF-3922-2019; Tinoco, Eduardo/B-5571-2014; Faveri, Marcelo MF/A-8915-2010; Tinoco, Eduardo/H-8000-2012; Marques, Marcelo Rocha/F-5318-2014; DE CARVALHO, FLAVIA MARTINEZ/H-6932-2012; Faveri, Marcelo/C-4738-2012; Garlet, Gustavo Pompermaier/E-6762-2012	Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Tinoco, Eduardo/0000-0003-4798-7175; Marques, Marcelo/0000-0001-9771-9844; Faveri, Marcelo/0000-0002-9830-1391	Coordenacao de Aperfeiacoamento de Pessoal de Nivel Superior [CAPES/BEX 094308-8]; National Institutes of Health [K99-DE018413]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE018413] Funding Source: NIH RePORTER	Coordenacao de Aperfeiacoamento de Pessoal de Nivel Superior; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Coordenacao de Aperfeiacoamento de Pessoal de Nivel Superior [CAPES/BEX 094308-8 to F. M. C.; http://www.capes.gov.br/]; and the National Institutes of Health [K99-DE018413 to R. M.; http://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Albandar JM, 1997, J PERIODONTOL, V68, P545, DOI 10.1902/jop.1997.68.6.545; Albandar JM, 2002, PERIODONTOL 2000, V29, P153, DOI 10.1034/j.1600-0757.2002.290108.x; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOUGHMAN JA, 1986, J CRAN GENET DEV BIO, V6, P341; Brett PM, 2005, J DENT RES, V84, P1149, DOI 10.1177/154405910508401211; Cardoso CR, 2009, ORAL MICROBIOL IMMUN, V24, P1, DOI 10.1111/j.1399-302X.2008.00463.x; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Conner Anthony J., 2008, New Zealand Natural Sciences, V33, P47; Covani U, 2008, J PERIODONTOL, V79, P1974, DOI [10.1902/jop.2008.080062, 10.1902/jop.2008.080062 ]; de Carvalho FM, 2009, J CLIN PERIODONTOL, V36, P468, DOI 10.1111/j.1600-051X.2009.01410.x; EASTCOTT JW, 1994, ORAL MICROBIOL IMMUN, V9, P284, DOI 10.1111/j.1399-302X.1994.tb00072.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garlet GP, 2004, J CLIN PERIODONTOL, V31, P671, DOI 10.1111/j.1600-051X.2004.00545.x; Gemmell E, 2002, CRIT REV ORAL BIOL M, V13, P17, DOI 10.1177/154411130201300104; Gonzales JR, 2010, MOL IMMUNOL, V47, P701, DOI 10.1016/j.molimm.2009.10.025; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Greenberg DA, 1996, GENET EPIDEMIOL, V13, P243; HART TC, 1993, HUM GENET, V91, P416; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2008, SINT IND SOC 2008; Jin QM, 2007, J PERIODONTOL, V78, P1300, DOI 10.1902/jop.2007.070073; Kawano H, 2004, MOL BRAIN RES, V125, P60, DOI 10.1016/j.molbrainres.2004.04.001; Kinane DF, 2005, PERIODONTOL 2000, V39, P91, DOI 10.1111/j.1600-0757.2005.00118.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li YF, 2004, HUM GENET, V114, P291, DOI 10.1007/s00439-003-1065-7; LOE H, 1991, J PERIODONTOL, V62, P608, DOI 10.1902/jop.1991.62.10.608; MARAZITA ML, 1994, J PERIODONTOL, V65, P623, DOI 10.1902/jop.1994.65.6.623; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meng HX, 2007, PERIODONTOL 2000, V43, P133, DOI 10.1111/j.1600-0757.2006.00204.x; Novak M J, 1996, Curr Opin Periodontol, V3, P45; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranade K, 2001, GENOME RES, V11, P1262; Repeke CE, 2009, J CLIN PERIODONTOL, V36, P726, DOI 10.1111/j.1600-051X.2009.01447.x; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Schaefer AS, 2010, HUM MOL GENET, V19, P553, DOI 10.1093/hmg/ddp508; Shorts-Cary L, 2007, ENDOCRINOLOGY, V148, P967, DOI 10.1210/en.2006-0905; Tinoco EMB, 1998, J CLIN PERIODONTOL, V25, P99, DOI 10.1111/j.1600-051X.1998.tb02415.x; Tinoco EMB, 1997, EUR J ORAL SCI, V105, P9, DOI 10.1111/j.1600-0722.1997.tb00174.x; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; VANDERVELDEN U, 1993, J CLIN PERIODONTOL, V20, P683; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Yu MJ, 2009, J BIOL CHEM, V284, P32968, DOI 10.1074/jbc.M109.001016	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10053	10.1371/journal.pone.0010053	http://dx.doi.org/10.1371/journal.pone.0010053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383335	Green Accepted, Green Published, gold			2022-12-27	WOS:000276454000013
J	Dietrich, MF; van der Weyden, L; Prosser, HM; Bradley, A; Herz, J; Adams, DJ				Dietrich, Martin F.; van der Weyden, Louise; Prosser, Haydn M.; Bradley, Allan; Herz, Joachim; Adams, David J.			Ectodomains of the LDL Receptor-Related Proteins LRP1b and LRP4 Have Anchorage Independent Functions In Vivo	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TYROSINE PHOSPHORYLATION; GROWTH; CANCER; GENE; MICE; EXPRESSION; REGIONS; DOMAIN; PDGF	Background: The low-density lipoprotein (LDL) receptor gene family is a highly conserved group of membrane receptors with diverse functions in developmental processes, lipoprotein trafficking, and cell signaling. The low-density lipoprotein (LDL) receptor-related protein 1b (LRP1B) was reported to be deleted in several types of human malignancies, including non-small cell lung cancer. Our group has previously reported that a distal extracellular truncation of murine Lrp1b that is predicted to secrete the entire intact extracellular domain (ECD) is fully viable with no apparent phenotype. Methods and Principal Findings: Here, we have used a gene targeting approach to create two mouse lines carrying internally rearranged exons of Lrp1b that are predicted to truncate the protein closer to the N-terminus and to prevent normal trafficking through the secretary pathway. Both mutations result in early embryonic lethality, but, as expected from the restricted expression pattern of LRP1b in vivo, loss of Lrp1b does not cause cellular lethality as homozygous Lrp1b-deficient blastocysts can be propagated normally in culture. This is similar to findings for another LDL receptor family member, Lrp4. We provide in vitro evidence that Lrp4 undergoes regulated intramembraneous processing through metalloproteases and gamma-secretase cleavage. We further demonstrate negative regulation of the Wnt signaling pathway by the soluble extracellular domain. Conclusions and Significance: Our results underline a crucial role for Lrp1b in development. The expression in mice of truncated alleles of Lrp1b and Lrp4 with deletions of the transmembrane and intracellular domains leads to release of the extracellular domain into the extracellular space, which is sufficient to confer viability. In contrast, null mutations are embryonically (Lrp1b) or perinatally (Lrp4) lethal. These findings suggest that the extracellular domains of both proteins may function as a scavenger for signaling ligands or signal modulators in the extracellular space, thereby preserving signaling thresholds that are critical for embryonic development, as well as for the clear, but poorly understood role of LRP1b in cancer.	[Dietrich, Martin F.; Herz, Joachim] UT Southwestern, Dept Mol Genet, Dallas, TX USA; [van der Weyden, Louise; Prosser, Haydn M.; Bradley, Allan; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; Wellcome Trust Sanger Institute	Dietrich, MF (corresponding author), UT Southwestern, Dept Mol Genet, Dallas, TX USA.	joachim.herz@utsouthwestern.edu; da1@sanger.ac.uk	van der Weyden, Louise/AAV-5711-2021	van der Weyden, Louise/0000-0002-0645-1879; Adams, David/0000-0001-9490-0306; Bradley, Allan/0000-0002-2349-8839	Kay Kendall Leukaemia Foundation; Cancer Research UK; Wellcome Trust; Boehringer Ingelheim; National Institutes of Health; Perot Family Foundation; American Health Assistance Foundation; Humboldt Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	Kay Kendall Leukaemia Foundation; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Boehringer Ingelheim(Boehringer Ingelheim); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; American Health Assistance Foundation; Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LvdW is supported by a fellowship from the Kay Kendall Leukaemia Foundation, and DJA is supported by Cancer Research UK and the Wellcome Trust. MFD is supported by a Boehringer Ingelheim Fellowship, and JH is supported by the National Institutes of Health, the Perot Family Foundation, the American Health Assistance Foundation and the Humboldt Foundation. HP and AB are supported by the Wellcome Trust. The funders have or had no influence on data collection and sharing, experimental planning, data interpretation, decision to publish or time of publication.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Cengiz B, 2007, ORAL ONCOL, V43, P241, DOI 10.1016/j.oraloncology.2006.03.004; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Croy JE, 2003, BIOCHEMISTRY-US, V42, P13049, DOI 10.1021/bi034752s; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Langbein S, 2002, LAB INVEST, V82, P639, DOI 10.1038/labinvest.3780458; Liu CX, 2007, J BIOL CHEM, V282, P7504, DOI 10.1074/jbc.M608088200; Liu CX, 2000, CANCER RES, V60, P1961; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Nakagawa T, 2006, CANCER SCI, V97, P1070, DOI 10.1111/j.1349-7006.2006.00283.x; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Pastrana DV, 2005, BBA-MOL BASIS DIS, V1741, P234, DOI 10.1016/j.bbadis.2005.06.007; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Tanaga K, 2004, ARTERIOSCL THROM VAS, V24, P1422, DOI 10.1161/01.ATV.0000133607.80554.09; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	27	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e9960	10.1371/journal.pone.0009960	http://dx.doi.org/10.1371/journal.pone.0009960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383322	Green Submitted, Green Published, gold			2022-12-27	WOS:000276454000002
J	Gal, R; Libersat, F				Gal, Ram; Libersat, Frederic			A Wasp Manipulates Neuronal Activity in the Sub-Esophageal Ganglion to Decrease the Drive for Walking in Its Cockroach Prey	PLOS ONE			English	Article							OCTOPAMINE-LIKE IMMUNOREACTIVITY; DROSOPHILA-MELANOGASTER; AMPULEX-COMPRESSA; LOCOMOTOR-ACTIVITY; CENTRAL COMPLEX; FRUIT-FLY; SUBESOPHAGEAL GANGLION; PERIPLANETA-AMERICANA; TRANSIENT PARALYSIS; MOTIVATED BEHAVIORS	Background: The parasitoid Jewel Wasp hunts cockroaches to serve as a live food supply for its offspring. The wasp stings the cockroach in the head and delivers a cocktail of neurotoxins directly inside the prey's cerebral ganglia. Although not paralyzed, the stung cockroach becomes a living yet docile 'zombie', incapable of self-initiating spontaneous or evoked walking. We show here that such neuro-chemical manipulation can be attributed to decreased neuronal activity in a small region of the cockroach cerebral nervous system, the sub-esophageal ganglion (SEG). A decrease in descending permissive inputs from this ganglion to thoracic central pattern generators decreases the propensity for walking-related behaviors. Methodology and Principal Findings: We have used behavioral, neuro-pharmacological and electrophysiological methods to show that: (1) Surgically removing the cockroach SEG prior to wasp stinging prolongs the duration of the sting 5-fold, suggesting that the wasp actively targets the SEG during the stinging sequence; (2) injecting a sodium channel blocker, procaine, into the SEG of non-stung cockroaches reversibly decreases spontaneous and evoked walking, suggesting that the SEG plays an important role in the up-regulation of locomotion; (3) artificial focal injection of crude milked venom into the SEG of non-stung cockroaches decreases spontaneous and evoked walking, as seen with naturally-stung cockroaches; and (4) spontaneous and evoked neuronal spiking activity in the SEG, recorded with an extracellular bipolar microelectrode, is markedly decreased in stung cockroaches versus non-stung controls. Conclusions and Significance: We have identified the neuronal substrate responsible for the venom-induced manipulation of the cockroach's drive for walking. Our data strongly support previous findings suggesting a critical and permissive role for the SEG in the regulation of locomotion in insects. By injecting a venom cocktail directly into the SEG, the parasitoid Jewel Wasp selectively manipulates the cockroach's motivation to initiate walking without interfering with other non-related behaviors.	[Gal, Ram; Libersat, Frederic] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Libersat, Frederic] Univ Aix Marseille 2, Inst Neurobiol Mediterranee, INSERM, U901, Marseille, France	Ben Gurion University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Gal, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	galra@bgu.ac.il; libersat@bgu.ac.il	LIBERSAT, FREDERIC/AAL-1437-2020	libersat, frederic/0000-0002-2379-6078	Israeli Science Foundation [848/07]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israeli Science Foundation (848/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER U, 1986, J COMP PHYSIOL A, V158, P345, DOI 10.1007/BF00603618; BLAGBURN JM, 1987, J COMP PHYSIOL A, V161, P215, DOI 10.1007/BF00615242; Braunig P, 2004, J COMP NEUROL, V478, P164, DOI 10.1002/cne.20287; BRAUNIG P, 1991, PHILOS T ROY SOC B, V332, P221, DOI 10.1098/rstb.1991.0051; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Cholewa J, 2009, ZOOLOGY, V112, P251, DOI 10.1016/j.zool.2008.10.004; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Crisp KM, 2006, J EXP BIOL, V209, P1746, DOI 10.1242/jeb.02204; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Delcomyn F, 1999, AUTON ROBOT, V7, P259, DOI 10.1023/A:1008928605612; Devaud JM, 2007, EUR J NEUROSCI, V26, P3193, DOI 10.1111/j.1460-9568.2007.05904.x; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Duch C, 1999, J COMP NEUROL, V403, P119, DOI 10.1002/(SICI)1096-9861(19990105)403:1<119::AID-CNE9>3.0.CO;2-F; ECKERT M, 1992, J COMP NEUROL, V322, P1, DOI 10.1002/cne.903220102; FOUAD K, 1994, ZOOL-ANAL COMPLEX SY, V98, P23; Fouad K, 1996, J COMP PHYSIOL A, V178, P91, DOI 10.1007/BF00189593; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gal R, 2005, ARCH INSECT BIOCHEM, V60, P198, DOI 10.1002/arch.20092; Gal R, 2008, CURR BIOL, V18, P877, DOI 10.1016/j.cub.2008.04.076; Gal R, 2006, J COMP PHYSIOL A, V192, P1003, DOI 10.1007/s00359-006-0135-4; GRAHAM D, 1979, BIOL CYBERN, V32, P147, DOI 10.1007/BF00337391; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Haspel G, 2005, J COMP PHYSIOL A, V191, P529, DOI 10.1007/s00359-005-0620-1; Haspel G, 2003, J NEUROBIOL, V56, P287, DOI 10.1002/neu.10238; Haspel G, 2003, J NEUROBIOL, V54, P628, DOI 10.1002/neu.10195; HUBER F, 1960, Z VERGL PHYSIOL, V44, P60, DOI 10.1007/BF00297863; Huber R, 2005, J COMP PHYSIOL A, V191, P231, DOI 10.1007/s00359-004-0585-5; Keasar T, 2006, ETHOLOGY, V112, P699, DOI 10.1111/j.1439-0310.2006.01214.x; KIEN J, 1992, COMP BIOCHEM PHYS A, V103, P15, DOI 10.1016/0300-9629(92)90236-J; Kien J., 1992, PERGAMON STUDIES NEU, V4, P147; Libersat F, 2003, J COMP PHYSIOL A, V189, P497, DOI 10.1007/s00359-003-0432-0; LIBERSAT F, 1994, J EXP BIOL, V197, P405; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Martin JR, 1998, LEARN MEMORY, V5, P179; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Moore EL, 2006, J NEUROBIOL, V66, P811, DOI 10.1002/neu.20254; Muller D, 2003, BRAIN RES, V977, P124, DOI 10.1016/S0006-8993(03)02760-4; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; PEARSON KG, 1973, J EXP BIOL, V58, P725; Pielage J, 2002, DEV BIOL, V249, P283, DOI 10.1006/dbio.2002.0770; Ridgel AL, 2005, J COMP PHYSIOL A, V191, P559, DOI 10.1007/s00359-005-0621-0; Ridgel AL, 2007, J COMP PHYSIOL A, V193, P385, DOI 10.1007/s00359-006-0193-7; Ritzmann RE, 2005, J COMP PHYSIOL A, V191, P253, DOI 10.1007/s00359-004-0537-0; Roeder KD, 1937, J EXP ZOOL, V76, P353, DOI 10.1002/jez.1400760302; Rosenberg LA, 2007, J EXP BIOL, V210, P4411, DOI 10.1242/jeb.010488; Schaefer PL, 2001, J NEUROBIOL, V49, P9, DOI 10.1002/neu.1062; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; WATSON JT, 1994, ANIM BEHAV, V48, P476, DOI 10.1006/anbe.1994.1263; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001	60	30	30	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10019	10.1371/journal.pone.0010019	http://dx.doi.org/10.1371/journal.pone.0010019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383324	Green Published, gold			2022-12-27	WOS:000276454000004
J	Chiliveru, S; Birkelund, S; Paludan, SR				Chiliveru, Srikanth; Birkelund, Svend; Paludan, Soren R.			Induction of Interferon-Stimulated Genes by Chlamydia pneumoniae in Fibroblasts Is Mediated by Intracellular Nucleotide-Sensing Receptors	PLOS ONE			English	Article							DENDRITIC CELLS; I IFNS; TRACHOMATIS SEROVAR-L2; RIG-I; INFECTION; RECOGNITION; ACTIVATION; PATHOGEN; PATHWAY; SUSCEPTIBILITY	Background: Recognition of microorganisms by the innate immune system is mediated by pattern recognition receptors, including Toll-like receptors and cytoplasmic RIG-I-like receptors. Chlamydia, which include several human pathogenic species, are obligate intracellular gram-negative bacteria that replicate in cytoplasmic vacuoles. The infection triggers a host response contributing to both bacterial clearance and tissue damage. For instance, type I interferons (IFN)s have been demonstrated to exacerbate the course of Chlamydial lung infections in mice. Methods/Principal Findings: Here we show that Chlamydia pneumoniae induces expression of IFN-stimulated genes (ISG)s dependent on recognition by nucleotide-sensing Toll-like receptors and RIG-I-like receptors, localized in endosomes and the cytoplasm, respectively. The ISG response was induced with a delayed kinetics, compared to virus infections, and was dependent on bacterial replication and the bacterial type III secretion system (T3SS). Conclusions/Significance: Activation of the IFN response during C. pneumoniae infection is mediated by intracellular nucleotide-sensing PRRs, which operate through a mechanism dependent on the bacterial T3SS. Strategies to inhibit the chlamydial T3SS may be used to limit the detrimental effects of the type I IFN system in the host response to Chlamydia infection.	[Chiliveru, Srikanth; Birkelund, Svend; Paludan, Soren R.] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark	Aarhus University	Chiliveru, S (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	srp@microbiology.au.dk		Birkelund, Svend/0000-0001-6171-5606	Danish Medical Research Council [271-05-0488, 09-072636]; Lundbeck Foundation [R17-A1526, R19-A2023]; Kathrine og Vigo Skovgards Fond; Aase and Ejnar Danielsens Fond; Aarhus University Research Foundation; Lundbeck Foundation [R17-2007-1526] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Kathrine og Vigo Skovgards Fond; Aase and Ejnar Danielsens Fond; Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Danish Medical Research Council Grant nos. 271-05-0488 and 09-072636, the Lundbeck Foundation (Grants no. R17-A1526 and R19-A2023), the Kathrine og Vigo Skovgards Fond, the Aase and Ejnar Danielsens Fond, and The Aarhus University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; BIRKELUND S, 1992, J BACTERIOL, V174, P2742, DOI 10.1128/JB.174.9.2742-2747.1992; BIRKELUND S, 1989, INFECT IMMUN, V57, P2683, DOI 10.1128/IAI.57.9.2683-2690.1989; BIRKELUND S, 1989, INFECT IMMUN, V57, P3250, DOI 10.1128/IAI.57.10.3250-3253.1989; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Derbigny WA, 2007, INFECT IMMUN, V75, P1280, DOI 10.1128/IAI.01525-06; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hvid M, 2007, CELL MICROBIOL, V9, P2795, DOI 10.1111/j.1462-5822.2007.00996.x; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Prantner D, 2009, INFECT IMMUN, V77, P76, DOI 10.1128/IAI.00963-08; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Slepenkin A, 2003, INFECT IMMUN, V71, P2555, DOI 10.1128/IAI.71.5.2555-2562.2003; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	37	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10005	10.1371/journal.pone.0010005	http://dx.doi.org/10.1371/journal.pone.0010005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386592	Green Published, gold, Green Submitted			2022-12-27	WOS:000276420400004
J	Schmidberger, JW; Bate, MA; Reboul, CF; Androulakis, SG; Phan, JMN; Whisstock, JC; Goscinski, WJ; Abramson, D; Buckle, AM				Schmidberger, Jason W.; Bate, Mark A.; Reboul, Cyril F.; Androulakis, Steve G.; Phan, Jennifer M. N.; Whisstock, James C.; Goscinski, Wojtek J.; Abramson, David; Buckle, Ashley M.			MrGrid: A Portable Grid Based Molecular Replacement Pipeline	PLOS ONE			English	Article							PROTEIN; DATABASE	Background: The crystallographic determination of protein structures can be computationally demanding and for difficult cases can benefit from user-friendly interfaces to high-performance computing resources. Molecular replacement (MR) is a popular protein crystallographic technique that exploits the structural similarity between proteins that share some sequence similarity. But the need to trial permutations of search models, space group symmetries and other parameters makes MR time-and labour-intensive. However, MR calculations are embarrassingly parallel and thus ideally suited to distributed computing. In order to address this problem we have developed MrGrid, web-based software that allows multiple MR calculations to be executed across a grid of networked computers, allowing high-throughput MR. Methodology/Principal Findings: MrGrid is a portable web based application written in Java/JSP and Ruby, and taking advantage of Apple Xgrid technology. Designed to interface with a user defined Xgrid resource the package manages the distribution of multiple MR runs to the available nodes on the Xgrid. We evaluated MrGrid using 10 different protein test cases on a network of 13 computers, and achieved an average speed up factor of 5.69. Conclusions: MrGrid enables the user to retrieve and manage the results of tens to hundreds of MR calculations quickly and via a single web interface, as well as broadening the range of strategies that can be attempted. This high-throughput approach allows parameter sweeps to be performed in parallel, improving the chances of MR success.	[Schmidberger, Jason W.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Bate, Mark A.; Reboul, Cyril F.; Androulakis, Steve G.; Phan, Jennifer M. N.; Whisstock, James C.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Reboul, Cyril F.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Androulakis, Steve G.; Goscinski, Wojtek J.; Abramson, David] Monash Univ, Monash eRes Ctr, Clayton, Vic 3800, Australia; [Abramson, David] Monash Univ, Clayton Sch Informat Technol, Clayton, Vic 3800, Australia	Karolinska Institutet; Monash University; Monash University; Monash University; Monash University	Schmidberger, JW (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	ashley.buckle@med.monash.edu.au	Schmidberger, Jason/D-5978-2015; Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Whisstock, James/0000-0003-4200-5611; Reboul, Cyril/0000-0002-6258-2697; Goscinski, Wojtek James/0000-0001-6587-1016; Abramson, David/0000-0003-0441-4596	National Health & Medical Research Council; Australian Research Council; Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; state government of Victoria (Australia)	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; state government of Victoria (Australia)	The authors thank the National Health & Medical Research Council, Australian Research Council, Victorian Partnership for Advanced Computing, the Victorian Bioinformatics Consortium, Monash eResearch Centre, and the state government of Victoria (Australia) for funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Ito K, 2006, PROTEIN SCI, V15, P1187, DOI 10.1110/ps.062148506; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159	9	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10049	10.1371/journal.pone.0010049	http://dx.doi.org/10.1371/journal.pone.0010049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386612	gold, Green Submitted, Green Published			2022-12-27	WOS:000276420400018
J	Aguilar, HN; Zielnik, B; Tracey, CN; Mitchell, BF				Aguilar, Hector N.; Zielnik, Barbara; Tracey, Curtis N.; Mitchell, Bryan F.			Quantification of Rapid Myosin Regulatory Light Chain Phosphorylation Using High-Throughput In-Cell Western Assays: Comparison to Western Immunoblots	PLOS ONE			English	Article							POLYACRYLAMIDE-GELS; LOADING CONTROLS; PROTEINS; NITROCELLULOSE; BINDING; KINASE; MEMBRANES; SIGNAL	Background: Quantification of phospho-proteins (PPs) is crucial when studying cellular signaling pathways. Western immunoblotting (WB) is commonly used for the measurement of relative levels of signaling intermediates in experimental samples. However, WB is in general a labour-intensive and low-throughput technique. Because of variability in protein yield and phospho-signal preservation during protein harvesting, and potential loss of antigen during protein transfer, WB provides only semi-quantitative data. By comparison, the "in-cell western" (ICW) technique has high-throughput capacity and requires less extensive sample preparation. Thus, we compared the ICW technique to WB for measuring phosphorylated myosin regulatory light chain (PMLC20) in primary cultures of uterine myocytes to assess their relative specificity, sensitivity, precision, and quantification of biologically relevant responses. Methodology/Principal Findings: ICWs are cell-based microplate assays for quantification of protein targets in their cellular context. ICWs utilize a two-channel infrared (IR) scanner (Odyssey (R)) to quantify signals arising from near-infrared (NIR) fluorophores conjugated to secondary antibodies. One channel is dedicated to measuring the protein of interest and the second is used for data normalization of the signal in each well of the microplate. Using uterine myocytes, we assessed oxytocin (OT)-stimulated MLC20 phosphorylation measured by ICW and WB, both using NIR fluorescence. ICW and WB data were comparable regarding signal linearity, signal specificity, and time course of phosphorylation response to OT. Conclusion/Significance: ICW and WB yield comparable biological data. The advantages of ICW over WB are its high-throughput capacity, improved precision, and reduced sample preparation requirements. ICW might provide better sensitivity and precision with low-quantity samples or for protocols requiring large numbers of samples. These features make the ICW technique an excellent tool for the study of phosphorylation endpoints. However, the drawbacks of ICW include the need for a cell culture format and the lack of utility where protein purification, concentration or stoichiometric analyses are required.	[Aguilar, Hector N.; Tracey, Curtis N.; Mitchell, Bryan F.] Univ Alberta, Dept Physiol, Fac Med & Dent, Edmonton, AB, Canada; [Zielnik, Barbara; Mitchell, Bryan F.] Univ Alberta, Dept Obstet & Gynecol, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta; University of Alberta	Aguilar, HN (corresponding author), Univ Alberta, Dept Physiol, Fac Med & Dent, Edmonton, AB, Canada.	brymitch@ualberta.ca			Canadian Institutes of Health Research [MOP 81384]; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	The authors are grateful to the Canadian Institutes of Health Research (#MOP 81384, http://www.cihr-irsc.gc.ca/e/) and the Alberta Heritage Foundation for Medical Research (http://www.ahfmr.ab.ca/) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2007, CAN J MICROBIOL, V53, P526, DOI 10.1139/W07-007; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; ARNON R, 1992, FASEB J, V6, P3265, DOI 10.1096/fasebj.6.14.1385242; Bhadriraju K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-43; Bolt MW, 1997, ANAL BIOCHEM, V247, P185, DOI 10.1006/abio.1997.2061; Bond D, 2008, BIOL PROCED ONLINE, V10, P20, DOI 10.1251/bpo139; Coevoets R, 2009, EUR J HUM GENET, V17, P301, DOI 10.1038/ejhg.2008.184; DENHOLLANDER N, 1989, J IMMUNOL METHODS, V122, P129, DOI 10.1016/0022-1759(89)90343-8; Egger Denise, 1994, Molecular Biotechnology, V1, P289, DOI 10.1007/BF02921696; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JUNGBLUT P, 1990, ELECTROPHORESIS, V11, P581, DOI 10.1002/elps.1150110709; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; Mandell JW, 2003, AM J PATHOL, V163, P1687, DOI 10.1016/S0002-9440(10)63525-0; Schroter T, 2008, BIOCHEM BIOPH RES CO, V374, P356, DOI 10.1016/j.bbrc.2008.07.028; Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608; Sharma SK, 2002, ANAL BIOCHEM, V307, P187, DOI 10.1016/S0003-2697(02)00008-8; Smith PJ, 1999, J IMMUNOL METHODS, V229, P131, DOI 10.1016/S0022-1759(99)00116-7; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; TOVEY ER, 1989, J BIOCHEM BIOPH METH, V19, P169, DOI 10.1016/0165-022X(89)90024-9; TOVEY ER, 1987, ELECTROPHORESIS, V8, P384, DOI 10.1002/elps.1150080904; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Weldon S, 2008, ANAL BIOCHEM, V375, P156, DOI 10.1016/j.ab.2007.11.035; WORD RA, 1993, J CLIN INVEST, V92, P29, DOI 10.1172/JCI116564; Zhou XB, 2007, MOL ENDOCRINOL, V21, P740, DOI 10.1210/me.2006-0220	31	40	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9965	10.1371/journal.pone.0009965	http://dx.doi.org/10.1371/journal.pone.0009965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376358	Green Submitted, gold, Green Published			2022-12-27	WOS:000276418200039
J	Lesimple, C; Fureix, C; Menguy, H; Hausberger, M				Lesimple, Clemence; Fureix, Carole; Menguy, Herve; Hausberger, Martine			Human Direct Actions May Alter Animal Welfare, a Study on Horses (Equus caballus)	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; LOW-BACK-PAIN; MANIPULATION; KINEMATICS; DISORDERS; SPINE; WORK	Background: Back pain is the cause of bad welfare in humans and animals. Although vertebral problems are regularly reported on riding horses, these problems are not always identified nor noticed enough to prevent these horses to be used for work. Methodology/Principal Findings: Nineteen horses from two riding centres were submitted to chiropractic examinations performed by an experienced chiropractor and both horses' and riders' postures were observed during a riding lesson. The results show that 74% of horses were severely affected by vertebral problems, while only 26% were mildly or not affected. The degree of vertebral problems identified at rest was statistically correlated with horses' attitudes at work (neck height and curve), and horses' attitudes at work were clearly correlated with riders' positions. Clear differences appeared between schools concerning both riders' and horses' postures, and the analysis of the teachers' speech content and duration highlighted differences in the attention devoted to the riders' position. Conclusion/Significance: These findings are to our knowledge the first to underline the impact of riding on horses' back problems and the importance of teaching proper balance to beginner riders in order to increase animals' welfare.	[Lesimple, Clemence; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Stn Biol,UMR 6552, Paimpont, France; [Fureix, Carole; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, UMR 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Lesimple, C (corresponding author), Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Stn Biol,UMR 6552, Paimpont, France.	clemence.lesimple@univ-rennes1.fr		/0000-0003-0664-1151	Caisse Centrale de la Mutualite Sociale Agricole(MSA); CNRS; French Ministry of Research	Caisse Centrale de la Mutualite Sociale Agricole(MSA); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by the Caisse Centrale de la Mutualite Sociale Agricole(MSA), the CNRS and the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGOS SJ, 1991, SPINE, V16, P1, DOI 10.1097/00007632-199101000-00001; Cauvin E, 1997, IN PRACTICE, V19, P522; Cook WR, 2002, J EQUINE VET SCI, V22, P7, DOI 10.1016/S0737-0806(02)70207-4; Denoix J.M., 1987, EQUINE EXERCISE PHYS, V2, P607; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fureix C, 2009, ANIM COGN, V12, P643, DOI 10.1007/s10071-009-0223-2; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; Haussler KK, 1999, AM J VET RES, V60, P143; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; JEFFCOTT LB, 1980, EQUINE VET J, V12, P197, DOI 10.1111/j.2042-3306.1980.tb03427.x; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Marras WS, 2000, ERGONOMICS, V43, P880, DOI 10.1080/001401300409080; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; Odberg F O, 1999, Equine Vet J Suppl, P26; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; Rhodin M, 2005, EQUINE VET J, V37, P7, DOI 10.2746/0425164054406928; Ridgway K, 1999, VET CLIN N AM-EQUINE, V15, P263; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; Vieira ER, 2004, J OCCUP REHABIL, V14, P143, DOI 10.1023/B:JOOR.0000018330.46029.05; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	41	41	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10257	10.1371/journal.pone.0010257	http://dx.doi.org/10.1371/journal.pone.0010257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589MV	20442766	Green Published, Green Submitted, gold			2022-12-27	WOS:000277154200001
J	Favaro, E; Ramachandran, A; McCormick, R; Gee, H; Blancher, C; Crosby, M; Devlin, C; Blick, C; Buffa, F; Li, JL; Vojnovic, B; das Neves, RP; Glazer, P; Iborra, F; Ivan, M; Ragoussis, J; Harris, AL				Favaro, Elena; Ramachandran, Anassuya; McCormick, Robert; Gee, Harriet; Blancher, Christine; Crosby, Meredith; Devlin, Cecilia; Blick, Christopher; Buffa, Francesca; Li, Ji-Liang; Vojnovic, Borivoj; das Neves, Ricardo Pires; Glazer, Peter; Iborra, Francisco; Ivan, Mircea; Ragoussis, Jiannis; Harris, Adrian L.			MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; INDUCIBLE FACTOR; MUTATION; HEAD; DEHYDROGENASE; RESPIRATION; BIOGENESIS; SIGNATURE; HELICASES	Background: Hypoxia in cancers results in the upregulation of hypoxia inducible factor 1 (HIF-1) and a microRNA, hsa-miR-210 (miR-210) which is associated with a poor prognosis. Methods and Findings: In human cancer cell lines and tumours, we found that miR-210 targets the mitochondrial iron sulfur scaffold protein ISCU, required for assembly of iron-sulfur clusters, cofactors for key enzymes involved in the Krebs cycle, electron transport, and iron metabolism. Down regulation of ISCU was the major cause of induction of reactive oxygen species (ROS) in hypoxia. ISCU suppression reduced mitochondrial complex 1 activity and aconitase activity, caused a shift to glycolysis in normoxia and enhanced cell survival. Cancers with low ISCU had a worse prognosis. Conclusions: Induction of these major hallmarks of cancer show that a single microRNA, miR-210, mediates a new mechanism of adaptation to hypoxia, by regulating mitochondrial function via iron-sulfur cluster metabolism and free radical generation.	[Favaro, Elena; Blancher, Christine; Ragoussis, Jiannis] Univ Oxford, Genom Grp, Wellcome Trust Ctr Human Genet, Oxford, England; [Favaro, Elena; Ramachandran, Anassuya; McCormick, Robert; Gee, Harriet; Blick, Christopher; Buffa, Francesca; Li, Ji-Liang; das Neves, Ricardo Pires; Iborra, Francisco; Harris, Adrian L.] Univ Oxford, John Radcliffe Hosp, Mol Oncol Labs, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Crosby, Meredith; Glazer, Peter] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Devlin, Cecilia; Ivan, Mircea] Indiana Univ, Indianapolis, IN 46204 USA; [Vojnovic, Borivoj] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Yale University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Oxford	Favaro, E (corresponding author), Univ Oxford, Genom Grp, Wellcome Trust Ctr Human Genet, Oxford, England.	mivan@iupui.edu; aharris.lab@imm.ox.ac.uk	Glazer, Peter/S-7651-2019; Neves, Ricardo N Pires das/A-3322-2009; Vojnovic, Borivoj/AAV-4756-2021; Harris, Adrian L/ABA-3343-2020; Ragoussis, Ioannis/AAD-9790-2022; iborra, francisco j/K-9313-2015; Ivan, Mircea/A-8109-2012; Buffa, Francesca/D-2574-2013; Favaro, Elena/Q-4566-2016; Gee, Harriet/I-5598-2017	Neves, Ricardo N Pires das/0000-0003-2291-6610; Vojnovic, Borivoj/0000-0001-9013-3816; Harris, Adrian L/0000-0003-1376-8409; iborra, francisco j/0000-0002-0692-3696; Buffa, Francesca/0000-0003-0409-406X; Favaro, Elena/0000-0001-5376-5515; Crosby, Meredith/0000-0002-3626-9445; Glazer, Peter/0000-0003-4525-5560; Ivan, Mircea/0000-0003-3424-6642; Ragoussis, Ioannis/0000-0002-8515-0934; Gee, Harriet/0000-0001-7397-8585; Ramachandran, Anassuya/0000-0002-0123-6539	Cancer Research UK; Friends of Kennington Cancer Research; Wellcome Trust; Royal College of Surgeons & British Urology Foundation; European Union; ACGT; Rhodes Scholarship; Nuffield Medical Fellowship; FIRC Studentship; NIHR Biomedical Research Centre Oxford; Elsa Pardee Foundation; American Cancer Society; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Medical Research Council [G1000801f] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Friends of Kennington Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Royal College of Surgeons & British Urology Foundation; European Union(European Commission); ACGT; Rhodes Scholarship; Nuffield Medical Fellowship; FIRC Studentship(Fondazione AIRC per la ricerca sul cancro); NIHR Biomedical Research Centre Oxford(National Institute for Health Research (NIHR)); Elsa Pardee Foundation; American Cancer Society(American Cancer Society); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Cancer Research UK and Friends of Kennington Cancer Research Fund (EF, ALH, JL), The Wellcome Trust (CB1, CC, IR), Royal College of Surgeons & British Urology Foundation (CB2, RMcC), European Union, ACGT (FB), Rhodes Scholarship (HG), Nuffield Medical Fellowship (AR), FIRC Studentship (EF). Biobanking supported by NIHR Biomedical Research Centre Oxford; Elsa Pardee Foundation (MI), American Cancer Society (MC, MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell EL, 2007, ESSAYS BIOCHEM, V43, P17, DOI 10.1042/bse0430017; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Iborra FJ, 2008, HISTOCHEM CELL BIOL, V129, P45, DOI 10.1007/s00418-007-0352-0; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; KIM HW, 2009, J BIOL CHEM; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	44	238	252	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10345	10.1371/journal.pone.0010345	http://dx.doi.org/10.1371/journal.pone.0010345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436681	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079500015
J	Kuroda, M; Katano, H; Nakajima, N; Tobiume, M; Ainai, A; Sekizuka, T; Hasegawa, H; Tashiro, M; Sasaki, Y; Arakawa, Y; Hata, S; Watanabe, M; Sata, T				Kuroda, Makoto; Katano, Harutaka; Nakajima, Noriko; Tobiume, Minoru; Ainai, Akira; Sekizuka, Tsuyoshi; Hasegawa, Hideki; Tashiro, Masato; Sasaki, Yuko; Arakawa, Yoshichika; Hata, Satoru; Watanabe, Masahide; Sata, Tetsutaro			Characterization of Quasispecies of Pandemic 2009 Influenza A Virus (A/H1N1/2009) by De Novo Sequencing Using a Next-Generation DNA Sequencer	PLOS ONE			English	Article							ANTIGENIC STRUCTURE; HEMAGGLUTININ; H1N1; INFECTIONS; SPECIMENS	Pandemic 2009 influenza A virus (A/H1N1/2009) has emerged globally. In this study, we performed a comprehensive detection of potential pathogens by de novo sequencing using a next-generation DNA sequencer on total RNAs extracted from an autopsy lung of a patient who died of viral pneumonia with A/H1N1/2009. Among a total of 9.4x10(6) 40-mer short reads, more than 98% appeared to be human, while 0.85% were identified as A/H1N1/2009 (A/Nagano/RC1-L/2009(H1N1)). Suspected bacterial reads such as Streptococcus pneumoniae and other oral bacteria flora were very low at 0.005%, and a significant bacterial infection was not histologically observed. De novo assembly and read mapping analysis of A/Nagano/RC1-L/2009(H1N1) showed more than x 200 coverage on average, and revealed nucleotide heterogeneity on hemagglutinin as quasispecies, specifically at two amino acids (Gly(172)Glu and Gly(239)Asn of HA) located on the Sa and Ca2 antigenic sites, respectively. Gly239 and Asn239 on antigenic site Ca2 appeared to be minor amino acids compared with the highly distributed Asp239 in H1N1 HAs. This study demonstrated that de novo sequencing can comprehensively detect pathogens, and such in-depth investigation facilitates the identification of influenza A viral heterogeneity. To better characterize the A/H1N1/2009 virus, unbiased comprehensive techniques will be indispensable for the primary investigations of emerging infectious diseases.	[Kuroda, Makoto; Sekizuka, Tsuyoshi] Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan; [Katano, Harutaka; Nakajima, Noriko; Tobiume, Minoru; Ainai, Akira; Sata, Tetsutaro] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Hasegawa, Hideki; Tashiro, Masato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan; [Sasaki, Yuko; Arakawa, Yoshichika] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo, Japan; [Hata, Satoru] Nagano Red Cross Hosp, Dept Clin Lab, Nagano, Japan; [Watanabe, Masahide] Nagano Red Cross Hosp, Dept Pathol, Nagano, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nagano Red Cross Hospital; Nagano Red Cross Hospital	Kuroda, M (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan.	makokuro@nih.go.jp	Hasegawa, Hideki/C-7978-2014; Arakawa, Yoshichika/P-5997-2015	Katano, Harutaka/0000-0002-5332-4434; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Ministry of Health, Labour, and Welfare, Japan	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants for Research on Emerging and Re-emerging Infectious Diseases (H20 and 21 Shinko-Ippan-6), from the Ministry of Health, Labour, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air G M, 1987, Contrib Microbiol Immunol, V8, P20; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341; Nakajima N, 2010, JPN J INFECT DIS, V63, P67; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Ramakrishnan MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007105; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Squires B, 2008, NUCLEIC ACIDS RES, V36, pD497, DOI 10.1093/nar/gkm905; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	91	96	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10256	10.1371/journal.pone.0010256	http://dx.doi.org/10.1371/journal.pone.0010256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428231	Green Submitted, Green Published, gold			2022-12-27	WOS:000277079300002
J	Oshikawa, J; Urao, N; Kim, HW; Kaplan, N; Razvi, M; McKinney, R; Poole, LB; Fukai, T; Ushio-Fukai, M				Oshikawa, Jin; Urao, Norifumi; Kim, Ha Won; Kaplan, Nihal; Razvi, Masooma; McKinney, Ronald; Poole, Leslie B.; Fukai, Tohru; Ushio-Fukai, Masuko			Extracellular SOD-Derived H2O2 Promotes VEGF Signaling in Caveolae/Lipid Rafts and Post-Ischemic Angiogenesis in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; SULFENIC ACID FORMATION; SUPEROXIDE-DISMUTASE; HEPARAN-SULFATE; ANGIOTENSIN-II; NAD(P)H OXIDASE; CELL MIGRATION; NADPH OXIDASE; ACTIVATION	Reactive oxygen species (ROS), in particular, H2O2, is essential for full activation of VEGF receptor2 (VEGFR2) signaling involved in endothelial cell (EC) proliferation and migration. Extracellular superoxide dismutase (ecSOD) is a major secreted extracellular enzyme that catalyzes the dismutation of superoxide to H2O2, and anchors to EC surface through heparin-binding domain (HBD). Mice lacking ecSOD show impaired postnatal angiogenesis. However, it is unknown whether ecSOD-derived H2O2 regulates VEGF signaling. Here we show that gene transfer of ecSOD, but not ecSOD lacking HBD (ecSOD-Delta HBD), increases H2O2 levels in adductor muscle of mice, and promotes angiogenesis after hindlimb ischemia. Mice lacking ecSOD show reduction of H2O2 in non-ischemic and ischemic limbs. In vitro, overexpression of ecSOD, but not ecSOD-Delta HBD, in cultured medium in ECs enhances VEGF-induced tyrosine phosphorylation of VEGFR2 (VEGFR2-pY), which is prevented by short-term pretreatment with catalase that scavenges extracellular H2O2. Either exogenous H2O2 (<500 mu M), which is diffusible, or nitric oxide donor has no effect on VEGF-induced VEGFR2-pY. These suggest that ecSOD binding to ECs via HBD is required for localized generation of extracellular H2O2 to regulate VEGFR2-pY. Mechanistically, VEGF-induced VEGFR2-pY in caveolae/lipid rafts, but non-lipid rafts, is enhanced by ecSOD, which localizes at lipid rafts via HBD. One of the targets of ROS is protein tyrosine phosphatases (PTPs). ecSOD induces oxidation and inactivation of both PTP1B and DEP1, which negatively regulates VEGFR2-pY, in caveolae/lipid rafts, but not non-lipid rafts. Disruption of caveolae/lipid rafts, or PTPs inhibitor orthovanadate, or siRNAs for PTP1B and DEP1 enhances VEGF-induced VEGFR2-pY, which prevents ecSOD-induced effect. Functionally, ecSOD promotes VEGF-stimulated EC migration and proliferation. In summary, extracellular H2O2 generated by ecSOD localized at caveolae/lipid rafts via HBD promotes VEGFR2 signaling via oxidative inactivation of PTPs in these microdomains. Thus, ecSOD is a potential therapeutic target for angiogenesis-dependent cardiovascular diseases.	[Oshikawa, Jin; Urao, Norifumi; Kaplan, Nihal; Razvi, Masooma; McKinney, Ronald; Ushio-Fukai, Masuko] Univ Chicago, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60637 USA; [Kim, Ha Won; McKinney, Ronald; Fukai, Tohru] Univ Chicago, Dept Med & Pharmacol, Chicago, IL 60637 USA; [Oshikawa, Jin; Urao, Norifumi; Kim, Ha Won; Kaplan, Nihal; Razvi, Masooma; McKinney, Ronald; Fukai, Tohru; Ushio-Fukai, Masuko] Univ Chicago, Cardiovasc Res Ctr, Chicago, IL 60637 USA; [Poole, Leslie B.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA	University of Chicago; University of Chicago; University of Chicago; Wake Forest University; Wake Forest Baptist Medical Center	Oshikawa, J (corresponding author), Univ Chicago, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60637 USA.	mfukai@uic.edu	Urao, Norifumi/O-7313-2015	Urao, Norifumi/0000-0001-9750-8406; Poole, Leslie/0000-0003-0334-7328; Kim, Ha Won/0000-0001-6272-4248	National Institutes of Health (NIH) [R01, 077524, HL077524-S1, HL070187, 126659]; American Heart Association (AHA) [0755805Z]; AHA National Center Research Program (NCRP) Innovative Research [0970336N]; AHA Post-doctoral Fellowship [09POST2250151]; Ruth L. Kirschstein-National Service Research [T32]; Uehara Memorial Foundation; Naito Foundation; NATIONAL CANCER INSTITUTE [R33CA126659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077524, R01HL070187] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA National Center Research Program (NCRP) Innovative Research; AHA Post-doctoral Fellowship(American Heart Association); Ruth L. Kirschstein-National Service Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) R01 Heart and Lung (HL) 077524 and HL077524-S1 (to M.U.-F.), HL070187 (to T.F.) and Cancer (CA) 126659 (to L.B.P.), American Heart Association (AHA) Grant-In-Aid 0755805Z (to M.U.-F.) and AHA National Center Research Program (NCRP) Innovative Research Grant 0970336N (to M.U.-F), AHA Post-doctoral Fellowship 09POST2250151 (to N.U.), Ruth L. Kirschstein-National Service Research Award (Kirschstein-NRSA) T32 Training Grant (to N.K. and M.R.), Uehara Memorial Foundation and Naito Foundation (to J.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baljinnyam E, 2009, AM J PHYSIOL-CELL PH, V297, pC802, DOI 10.1152/ajpcell.00129.2009; Buczek-Thomas JA, 2002, J CELL PHYSIOL, V192, P294, DOI 10.1002/jcp.10135; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Chaiswing L, 2008, CANCER RES, V68, P5820, DOI 10.1158/0008-5472.CAN-08-0162; Chaiswing L, 2018, ANTIOXID REDOX SIGN, V29, P1237, DOI 10.1089/ars.2017.7485; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chu Y, 2003, CIRC RES, V92, P461, DOI 10.1161/01.RES.0000057755.02845.F9; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Fukai T, 1998, J CLIN INVEST, V101, P2101, DOI 10.1172/JCI2105; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GO YM, 2009, FREE RADIC BIOL MED; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Hink HU, 2002, ARTERIOSCL THROM VAS, V22, P1402, DOI 10.1161/01.ATV.0000027524.86752.02; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Insel PA, 2009, CURR OPIN NEPHROL HY, V18, P50, DOI 10.1097/MNH.0b013e3283186f82; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jung O, 2007, ARTERIOSCL THROM VAS, V27, P470, DOI 10.1161/01.ATV.0000254823.15843.1f; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; MARKLUND SL, 1990, BIOCHEM J, V266, P213, DOI 10.1042/bj2660213; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mavromatis K, 2000, ARTERIOSCL THROM VAS, V20, P1889, DOI 10.1161/01.ATV.20.8.1889; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Qin ZY, 2008, HYPERTENSION, V52, P945, DOI 10.1161/HYPERTENSIONAHA.108.116467; Rhee S G, 2000, Sci STKE, V2000, ppe1; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Souchard JP, 1998, FREE RADICAL RES, V29, P441, DOI 10.1080/10715769800300491; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2001, J BIOL CHEM, V276, P48269, DOI 10.1074/jbc.M105901200; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Wheeler MD, 2003, MOL CANCER RES, V1, P871; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60	51	119	121	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10189	10.1371/journal.pone.0010189	http://dx.doi.org/10.1371/journal.pone.0010189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422004	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952500006
J	Tsutsumi, K; Takano, T; Endo, R; Fukuda, M; Ohshima, T; Tomomura, M; Hisanaga, S				Tsutsumi, Koji; Takano, Tetsuya; Endo, Ryo; Fukuda, Mitsunori; Ohshima, Toshio; Tomomura, Mineko; Hisanaga, Shin-ichi			Phosphorylation of AATYK1 by Cdk5 Suppresses Its Tyrosine Phosphorylation	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURONAL DIFFERENTIATION; SUBSTRATE-SPECIFICITY; MEMBRANE TRAFFICKING; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; BINDING-PROTEIN; MYOSIN-VI; P35; CELLS	Apoptosis-associated tyrosine kinase 1 (AATYK1), a novel serine/threonine kinase that is highly expressed in the brain, is involved in neurite extension and apoptosis of cerebellar granule neurons; however, its precise function remains unknown. In this study, we investigated the interaction of AATYK1A with Cyclin-dependent kinase 5 (Cdk5)/p35, a proline-directed protein kinase that is predominantly expressed in neurons. AATYK1A bound to the p35 activation subunit of Cdk5 in cultured cells and in mouse brains and colocalized with p35 on endosomes in COS-7 cells. AATYK1A was phosphorylated at Ser34 by Cdk5/p35 in vitro, in cultured neurons and in mouse brain. In PC12D cells, Ser34 phosphorylation increased after treatment with nerve growth factor and phosphorylated AATYK1A accumulated in growth cones of PC12D cells. Ser34 phosphorylation suppressed the tyrosine phosphorylation of AATYK1A by Src family kinases. These results suggest a possibility that AATYK1A plays a role in early to recycling endosomes and its function is regulated by phosphorylation with Cdk5 or Src-family kinases.	[Tsutsumi, Koji; Takano, Tetsuya; Endo, Ryo; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan; [Fukuda, Mitsunori] Tohoku Univ, Dept Dev Biol & Neurosci, Sendai, Miyagi, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biol Sci, Tokyo, Japan; [Tomomura, Mineko] Meikai Univ, Sch Dent, MPL, Saitama, Japan	Tokyo Metropolitan University; Tohoku University; Waseda University; Meikai University	Tsutsumi, K (corresponding author), Hamamatsu Univ, Sch Med, Dept Mol Anat,Mol Imaging Frontier Res Ctr, Higashi Ku, Shizuoka, Japan.	hisanaga-shinichi@tmu.ac.jp	Fukuda, MItsunori/I-1511-2015; Takano, Tetsuya/GMX-3535-2022	Fukuda, MItsunori/0000-0002-8620-5853; Takano, Tetsuya/0000-0002-2599-3155	Ministry of Education, Culture, Sports, and Science and Technology of Japan	Ministry of Education, Culture, Sports, and Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid from Ministry of Education, Culture, Sports, and Science and Technology of Japan (S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Gaozza E, 1997, ONCOGENE, V15, P3127, DOI 10.1038/sj.onc.1201575; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Honma N, 2003, BIOCHEM BIOPH RES CO, V310, P398, DOI 10.1016/j.bbrc.2003.08.143; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Jin E, 2007, NEUROCHEM INT, V51, P216, DOI 10.1016/j.neuint.2007.04.032; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Kesavapany S, 2003, J NEUROSCI, V23, P4975; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, BRAIN RES, V1140, P84, DOI 10.1016/j.brainres.2006.01.121; Paglini G, 2001, EMBO REP, V2, P1139, DOI 10.1093/embo-reports/kve250; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Raghunath M, 2000, MOL BRAIN RES, V77, P151, DOI 10.1016/S0169-328X(00)00048-6; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; SANO M, 1988, BRAIN RES, V459, P404, DOI 10.1016/0006-8993(88)90660-9; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Tomomura M, 2005, J BIOL CHEM, V280, P35157, DOI 10.1074/jbc.M500353200; Tomomura M, 2003, MOL BRAIN RES, V112, P103, DOI 10.1016/S0169-328X(03)00054-8; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Tsutsumi K, 2008, GENES CELLS, V13, P949, DOI 10.1111/j.1365-2443.2008.01219.x; Wang H, 2002, J BIOL CHEM, V277, P49605, DOI 10.1074/jbc.M209335200; Wang H, 2006, MOL CELL PROTEOMICS, V5, P2124, DOI 10.1074/mcp.M600188-MCP200; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x	38	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10260	10.1371/journal.pone.0010260	http://dx.doi.org/10.1371/journal.pone.0010260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422042	gold, Green Published, Green Submitted			2022-12-27	WOS:000276854300016
J	Rice, WL; Kaplan, DL; Georgakoudi, I				Rice, William L.; Kaplan, David L.; Georgakoudi, Irene			Two-Photon Microscopy for Non-Invasive, Quantitative Monitoring of Stem Cell Differentiation	PLOS ONE			English	Article							MATRIX-MEDIATED RETENTION; OSTEOGENIC DIFFERENTIATION; FLUORESCENCE SPECTROSCOPY; OXYGEN-TENSION; IN-VITRO; EXPRESSION; LIPOFUSCIN; NADH; HYPOXIA; ACCUMULATION	Background: The engineering of functional tissues is a complex multi-stage process, the success of which depends on the careful control of culture conditions and ultimately tissue maturation. To enable the efficient optimization of tissue development protocols, techniques suitable for monitoring the effects of added stimuli and induced tissue changes are needed. Methodology/Principal Findings: Here, we present the quantitative use of two-photon excited fluorescence (TPEF) and second harmonic generation (SHG) as a noninvasive means to monitor the differentiation of human mesenchymal stem cells (hMSCs) using entirely endogenous sources of contrast. We demonstrate that the individual fluorescence contribution from the intrinsic cellular fluorophores NAD(P) H, flavoproteins and lipofuscin can be extracted from TPEF images and monitored dynamically from the same cell population over time. Using the redox ratio, calculated from the contributions of NAD(P) H and flavoproteins, we identify distinct patterns in the evolution of the metabolic activity of hMSCs maintained in either propagation, osteogenic or adipogenic differentiation media. The differentiation of these cells is mirrored by changes in cell morphology apparent in high resolution TPEF images and by the detection of collagen production via SHG imaging. Finally, we find dramatic increases in lipofuscin levels in hMSCs maintained at 20% oxygen vs. those in 5% oxygen, establishing the use of this chromophore as a potential biomarker for oxidative stress. Conclusions/Significance: In this study we demonstrate that it is possible to monitor the metabolic activity, morphology, ECM production and oxidative stress of hMSCs in a non-invasive manner. This is accomplished using generally available multiphoton microscopy equipment and simple data analysis techniques, such that the method can widely adopted by laboratories with a diversity of comparable equipment. This method therefore represents a powerful tool, which enables researchers to monitor engineered tissues and optimize culture conditions in a near real time manner.	[Rice, William L.; Kaplan, David L.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Rice, WL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	irene.georgakoudi@tufts.edu			National Science Foundation (NSF) [0547292]; National Institutes of Health (NIH) [R01EB007542]; National Institute of Biomedical Imaging and Bioengineering [NIH EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520, R01EB007542] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by the National Science Foundation (NSF 0547292), the National Institutes of Health (NIH R01EB007542), and the Tissue Engineering Resource Center (TERC) - NIH EB002520 from the National Institute of Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Bindewald-Wittich A, 2006, INVEST OPHTH VIS SCI, V47, P4553, DOI 10.1167/iovs.05-1562; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; CHANCE B, 1959, NATURE, V184, P931, DOI 10.1038/184931a0; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Croce AC, 2007, PHOTOCH PHOTOBIO SCI, V6, P1202, DOI 10.1039/b707309g; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; Engelbrecht CJ, 2008, OPT EXPRESS, V16, P5556, DOI 10.1364/OE.16.005556; Furr HC, 2004, J NUTR, V134, p281S, DOI 10.1093/jn/134.1.281S; Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043; Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Haralampus-Grynaviski NM, 2003, P NATL ACAD SCI USA, V100, P3179, DOI 10.1073/pnas.0630280100; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HENSHAW JM, 1994, ANAL CHEM, V66, P3328, DOI 10.1021/ac00092a008; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Huber R, 2000, J NEUROCHEM, V75, P329, DOI 10.1046/j.1471-4159.2000.0750329.x; Karner E, 2009, BBA-GEN SUBJECTS, V1790, P110, DOI 10.1016/j.bbagen.2008.10.004; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kim P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839043; Kirkpatrick ND, 2007, CANCER EPIDEM BIOMAR, V16, P2048, DOI 10.1158/1055-9965.EPI-07-0009; Kirkpatrick ND, 2005, PHOTOCHEM PHOTOBIOL, V81, P125, DOI 10.1562/2004-08-09-RA-267.1; Konig K, 2005, BIOMATERIALS, V26, P495, DOI 10.1016/j.biomaterials.2004.02.059; LEE HS, 2006, TISSUE ENG; Lee PF, 2009, EXP CELL RES, V315, P396, DOI 10.1016/j.yexcr.2008.10.040; LEHNINGER AL, 1994, PRINCIPLES BIOCH EXT; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Levitt JM, 2007, OPT LETT, V32, P3305, DOI 10.1364/OL.32.003305; Li LZ, 2009, P NATL ACAD SCI USA, V106, P6608, DOI 10.1073/pnas.0901807106; Liu F, 2008, J BONE MINER METAB, V26, P312, DOI 10.1007/s00774-007-0842-0; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Mauney JR, 2006, J BIOMED MATER RES A, V79A, P464, DOI 10.1002/jbm.a.30876; Mauney JR, 2005, BIOMATERIALS, V26, P6167, DOI 10.1016/j.biomaterials.2005.03.024; Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Milne M, 1998, J CELL BIOCHEM, V71, P382, DOI 10.1002/(SICI)1097-4644(19981201)71:3<382::AID-JCB7>3.3.CO;2-I; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; NUUTINEN EM, 1984, BASIC RES CARDIOL, V79, P49, DOI 10.1007/BF01935806; Overstreet M, 2004, IN VITRO CELL DEV-AN, V40, P4; PERRY RP, 1959, NATURE, V184, P929, DOI 10.1038/184929a0; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200; Schenke-Layland K, 2006, ANN THORAC SURG, V81, P918, DOI 10.1016/j.athoracsur.2005.09.016; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Shiino A, 1999, NEUROSCIENCE, V91, P1581, DOI 10.1016/S0306-4522(98)00670-8; Sitte N, 2001, EXP GERONTOL, V36, P475, DOI 10.1016/S0531-5565(00)00253-9; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Spalazzi JP, 2008, CLIN ORTHOP RELAT R, V466, P1938, DOI 10.1007/s11999-008-0310-8; Stolzing A, 2006, FREE RADICAL BIO MED, V41, P326, DOI 10.1016/j.freeradbiomed.2006.04.018; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; TAKAHASHI N, 2009, BIOCH BIOPHYS RES CO; Terman A, 1998, MECH AGEING DEV, V104, P277, DOI 10.1016/S0047-6374(98)00073-6; Terman Alexei, 2006, Molecular Aspects of Medicine, V27, P471, DOI 10.1016/j.mam.2006.08.006; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Vacanti JP, 1999, LANCET, V354, pSI32; VOLKMER E, 2009, TISSUE ENG A; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; Wang B, 2008, J ENDOCRINOL, V198, P127, DOI 10.1677/JOE-08-0156; Wang FN, 2006, CLONING STEM CELLS, V8, P108, DOI 10.1089/clo.2006.8.108; YIN DZ, 1991, MECH AGEING DEV, V59, P95, DOI 10.1016/0047-6374(91)90076-C; Zhuo SM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982534	70	111	113	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10075	10.1371/journal.pone.0010075	http://dx.doi.org/10.1371/journal.pone.0010075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419124	gold, Green Submitted, Green Published			2022-12-27	WOS:000276743500006
J	Chen, HD; Fan, WL; Kong, SG; Lee, HC				Chen, Hong-Da; Fan, Wen-Lang; Kong, Sing-Guan; Lee, Hoong-Chien			Universal Global Imprints of Genome Growth and Evolution - Equivalent Length and Cumulative Mutation Density	PLOS ONE			English	Article							NONCODING DNA-SEQUENCES; LONG-RANGE CORRELATIONS; SEGMENTAL DUPLICATIONS; LINGUISTIC FEATURES; GENE DUPLICATION; TRANSPOSABLE ELEMENTS; PSEUDOGENES; ORGANIZATION; RECONSTRUCTION; REARRANGEMENT	Background: Segmental duplication is widely held to be an important mode of genome growth and evolution. Yet how this would affect the global structure of genomes has been little discussed. Methods/Principal Findings: Here, we show that equivalent length, or L-e, a quantity determined by the variance of fluctuating part of the distribution of the k-mer frequencies in a genome, characterizes the latter's global structure. We computed the L(e)s of 865 complete chromosomes and found that they have nearly universal but (k-dependent) values. The differences among the L-e of a chromosome and those of its coding and non-coding parts were found to be slight. Conclusions: We verified that these non-trivial results are natural consequences of a genome growth model characterized by random segmental duplication and random point mutation, but not of any model whose dominant growth mechanism is not segmental duplication. Our study also indicates that genomes have a nearly universal cumulative "point'' mutation density of about 0.73 mutations per site that is compatible with the relatively low mutation rates of ( 1 similar to 5) x 10(-3)/site/Mya previously determined by sequence comparison for the human and E. coli genomes.	[Chen, Hong-Da; Kong, Sing-Guan; Lee, Hoong-Chien] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Chungli 32054, Taiwan; [Chen, Hong-Da; Fan, Wen-Lang; Kong, Sing-Guan; Lee, Hoong-Chien] Natl Cent Univ, Dept Phys, Chungli 32054, Taiwan; [Fan, Wen-Lang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Hoong-Chien] Cathay Gen Hosp, Cathay Med Res Inst, Taipei, Taiwan; [Lee, Hoong-Chien] Natl Ctr Theoret Sci, Shinchu, Taiwan	National Central University; National Central University; Academia Sinica - Taiwan; Cathay General Hospital	Chen, HD (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Chungli 32054, Taiwan.	hclee@phy.ncu.edu.tw		Sing Guan, Kong/0000-0001-8817-781X; Chen, HongDa/0000-0002-9330-5473	National Science Council (ROC); Cathay General Hospital; National Central University	National Science Council (ROC)(Ministry of Science and Technology, Taiwan); Cathay General Hospital; National Central University	This work was funded by the National Science Council (ROC) (http://web1.nsc.gov.tw/mp.aspx?mp=7), Cathay General Hospital (http://www.cgh.org.tw/en/index.html), National Central University (http://www.ncu.edu.tw/e_web/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bapteste E, 2004, TRENDS MICROBIOL, V12, P406, DOI 10.1016/j.tim.2004.07.002; BARTEL DP, 2004, BIOGENESIS, V116, P281; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernaola-Galvan P, 2002, GENE, V300, P105, DOI 10.1016/S0378-1119(02)01037-5; Bonhoeffer S, 1996, PHYS REV LETT, V76, P1977, DOI 10.1103/PhysRevLett.76.1977; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Chen HD, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178103; Chen TY, 2005, COMPUT PHYS COMMUN, V169, P218, DOI 10.1016/j.cpc.2005.03.050; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Doolittle WF, 1997, P NATL ACAD SCI USA, V94, P12751, DOI 10.1073/pnas.94.24.12751; Drake JW, 1998, GENETICS, V148, P1667; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; FICKETT JW, 1992, GENOMICS, V13, P1056, DOI 10.1016/0888-7543(92)90019-O; FORSDYKE DR, 1995, J MOL EVOL, V41, P573; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; *GENBANK, 2009, GENB GEN DAT; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Grant D, 2000, P NATL ACAD SCI USA, V97, P4168, DOI 10.1073/pnas.070430597; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; HANSCHE PE, 1978, GENETICS, V88, P673; Hao BL, 2000, CHAOS SOLITON FRACT, V11, P825, DOI 10.1016/S0960-0779(98)00182-9; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HSIEH LC, 2003, AAPPS B, V13, P22; Israeloff NE, 1996, PHYS REV LETT, V76, P1976, DOI 10.1103/PhysRevLett.76.1976; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KLECKNER N, 1981, ANNU REV GENET, V15, P341, DOI 10.1146/annurev.ge.15.120181.002013; Kong SG, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061911; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; LEWIN B, 2000, GENES, V7, P89; Li W. H, 1997, MOL EVOLUTION; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; MANTEGNA RN, 1994, PHYS REV LETT, V73, P3169, DOI 10.1103/PhysRevLett.73.3169; Mantegna RN, 1996, PHYS REV LETT, V76, P1979, DOI 10.1103/PhysRevLett.76.1979; MCGRATH JM, 1993, THEOR APPL GENET, V86, P880, DOI 10.1007/BF00212616; Messer PW, 2007, J COMPUT BIOL, V14, P655, DOI 10.1089/cmb.2007.R008; Messer PW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138103; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nachman MW, 2000, GENETICS, V156, P297; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ohno S., 1970, EVOLUTION GENE DUPLI; PENG CK, 1993, PHYS REV E, V47, P3730, DOI 10.1103/PhysRevE.47.3730; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; RUDNER R, 1968, P NATL ACAD SCI USA, V60, P921, DOI 10.1073/pnas.60.3.921; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Spring J, 2002, NAT GENET, V31, P128, DOI 10.1038/ng0602-128; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voss RF, 1996, PHYS REV LETT, V76, P1978, DOI 10.1103/PhysRevLett.76.1978; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Xie HM, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P31, DOI 10.1109/CSB.2002.1039327; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546	70	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e9844	10.1371/journal.pone.0009844	http://dx.doi.org/10.1371/journal.pone.0009844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418954	Green Published, Green Submitted, gold			2022-12-27	WOS:000276706800003
J	Langille, MGI; Eisen, JA				Langille, Morgan G. I.; Eisen, Jonathan A.			BioTorrents: A File Sharing Service for Scientific Data	PLOS ONE			English	Article							MINIMUM INFORMATION; MANAGEMENT; STANDARDS	The transfer of scientific data has emerged as a significant challenge, as datasets continue to grow in size and demand for open access sharing increases. Current methods for file transfer do not scale well for large files and can cause long transfer times. In this study we present BioTorrents, a website that allows open access sharing of scientific data and uses the popular BitTorrent peer-to-peer file sharing technology. BioTorrents allows files to be transferred rapidly due to the sharing of bandwidth across multiple institutions and provides more reliable file transfers due to the built-in error checking of the file sharing technology. BioTorrents contains multiple features, including keyword searching, category browsing, RSS feeds, torrent comments, and a discussion forum. BioTorrents is available at http://www.biotorrents.net.	[Langille, Morgan G. I.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Langille, MGI (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	mlangille@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Langille, Morgan/0000-0002-6604-3009	Gordon and Betty Moore Foundation [1660]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was funded by a grant from the Gordon and Betty Moore Foundation (http://www.moore.org/) #1660. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Birney E., 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cohen B, 2003, WORKSHOP EC PEERTOPE, V6; Field D, 2009, SCIENCE, V326, P234, DOI 10.1126/science.1180598; FIELDING R, 1999, RFC2616 INT ENG TASK; Frazier Zach, 2009, V541, P535, DOI 10.1007/978-1-59745-243-4_23; Gattiker A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-151; Holt RA, 2003, SCIENCE, V300, P2033; Jones AR, 2007, NAT BIOTECHNOL, V25, P1127, DOI 10.1038/nbt1347; Keator DB, 2009, METHODS MOL BIOL, V569, P1, DOI 10.1007/978-1-59745-524-4_1; Krestyaninova M, 2009, BIOINFORMATICS, V25, P2768, DOI 10.1093/bioinformatics/btp420; Leebens-Mack J, 2006, OMICS, V10, P231, DOI 10.1089/omi.2006.10.231; Lynch C, 2008, NATURE, V455, P28, DOI 10.1038/455028a; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; POSTEL J, 1985, RF959 INT ENG TASK F; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; SHALUNOV S, 2009, LOW EXTRA DELAY BACK; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329	20	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10071	10.1371/journal.pone.0010071	http://dx.doi.org/10.1371/journal.pone.0010071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418944	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706800006
J	Anand, PK; Anand, E; Bleck, CKE; Anes, E; Griffiths, G				Anand, Paras K.; Anand, Ellis; Bleck, Christopher K. E.; Anes, Elsa; Griffiths, Gareth			Exosomal Hsp70 Induces a Pro-Inflammatory Response to Foreign Particles Including Mycobacteria	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; NF-KAPPA-B; INFECTED MACROPHAGES; PHAGOLYSOSOME FUSION; IMMUNE-RESPONSE; STRESS-PROTEINS; TUBERCULOSIS; PATHWAY; CELL; PHAGOSOME	Background: Exosomes are endosome-derived vesicles that are released when multi-vesicular bodies (MVBs) fuse with the plasma membrane. Exosomes released from mycobacteria-infected cells have recently been shown to be pro-inflammatory. A prominent host molecule that is found within these exosomes is Hsp70, a member of the heat-shock family of proteins. Methodology/Principal Findings: We first characterized the exosomes purified from control and mycobacteria-infected cells. We found that relative to uninfected cells, macrophages infected with M. smegmatis and M. avium release more exosomes and the exosomes they released had more Hsp70 on their surface. Both exosomes and exogenous Hsp70 treatment of macrophages led to NF-kappa B activation and TNF alpha release in uninfected macrophages; Hsp70 levels were elevated in mycobacteria-infected cells. Macrophage treatment with Hsp70 also led to increase in the phagocytosis and maturation of latex-bead phagosomes. Finally, Hsp70 pre-incubation of M. smegmatis- and M. avium-infected cells led to increased phago-lysosome fusion, as well as more killing of mycobacteria within macrophages. Conclusions/Significance: Our results fit into an emerging concept whereby exosomes-containing Hsp70 are effective inducers of inflammation, also in response to mycobacterial infection.	[Anand, Paras K.; Anand, Ellis; Bleck, Christopher K. E.; Griffiths, Gareth] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Anes, Elsa] Univ Lisbon, URIA, Ctr Patogenese Mol, Fac Farm, P-1699 Lisbon, Portugal; [Anes, Elsa] Inst Mol Med, Lisbon, Portugal	European Molecular Biology Laboratory (EMBL); Universidade de Lisboa; Universidade de Lisboa	Anand, PK (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Paras.Anand@stjude.org	Anes, Elsa/K-3124-2013; iMed.ULisboa, HPI/B-4239-2014; Anand, Paras/D-3219-2012	Anes, Elsa/0000-0001-5934-0198; iMed.ULisboa, HPI/0000-0001-5934-0198; Anand, Paras/0000-0003-2503-3653; Bleck, Christopher/0000-0003-1029-3444	Fundacao para a Ciencia e a tecnologia (FCT) [PIC/IC/82859/2007, PTDC/SAU-MII/098024/2008]; Alexander von Humboldt foundation, Germany; European Union [MIF1-CT-2006-039351]	Fundacao para a Ciencia e a tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Alexander von Humboldt foundation, Germany(Alexander von Humboldt Foundation); European Union(European Commission)	E. A. was supported by Fundacao para a Ciencia e a tecnologia (FCT) Grant PIC/IC/82859/2007 and PTDC/SAU-MII/098024/2008. P. K. A was supported by a post-doctoral research grant from Alexander von Humboldt foundation, Germany and Marie-Curie fellowship from European Union, FP6 programme MIF1-CT-2006-039351. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2005, EXERC IMMUNOL REV, V11, P34; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea Alexzander, 2008, V183, P111; Asea A, 2007, METHODS, V43, P194, DOI 10.1016/j.ymeth.2007.06.002; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Multhoff G, 1998, ANN NY ACAD SCI, V851, P86, DOI 10.1111/j.1749-6632.1998.tb08980.x; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Schartz NEC, 2002, CURR OPIN MOL THER, V4, P372; Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vega VL, 2005, J IMMUNOL, V175, P5280, DOI 10.4049/jimmunol.175.8.5280; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Zhou CG, 2005, J HIGH ENERGY PHYS; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	49	83	89	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10136	10.1371/journal.pone.0010136	http://dx.doi.org/10.1371/journal.pone.0010136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405033	Green Published, Green Submitted, gold			2022-12-27	WOS:000276705900017
J	Huang, N; Jacobson, MP				Huang, Niu; Jacobson, Matthew P.			Binding-Site Assessment by Virtual Fragment Screening	PLOS ONE			English	Article							PROTEIN-LIGAND BINDING; MOLECULAR DOCKING; MAXIMAL AFFINITY; LEAD DISCOVERY; DRUG DESIGN; DRUGGABILITY; PREDICTION; IDENTIFICATION; DATABASE; POCKETS	The accurate prediction of protein druggability (propensity to bind high-affinity drug-like small molecules) would greatly benefit the fields of chemical genomics and drug discovery. We have developed a novel approach to quantitatively assess protein druggability by computationally screening a fragment-like compound library. In analogy to NMR-based fragment screening, we dock similar to 11000 fragments against a given binding site and compute a computational hit rate based on the fraction of molecules that exceed an empirically chosen score cutoff. We perform a large-scale evaluation of the approach on four datasets, totaling 152 binding sites. We demonstrate that computed hit rates correlate with hit rates measured experimentally in a previously published NMR-based screening method. Secondly, we show that the in silico fragment screening method can be used to distinguish known druggable and non-druggable targets, including both enzymes and protein-protein interaction sites. Finally, we explore the sensitivity of the results to different receptor conformations, including flexible protein-protein interaction sites. Besides its original aim to assess druggability of different protein targets, this method could be used to identifying druggable conformations of flexible binding site for lead discovery, and suggesting strategies for growing or joining initial fragment hits to obtain more potent inhibitors.	[Huang, Niu] Natl Inst Biol Sci, Beijing, Peoples R China; [Huang, Niu; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	National Institute of Biological Sciences, Beijing; University of California System; University of California San Francisco	Huang, N (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	huangniu@nibs.ac.cn	Jacobson, Matthew/Y-5161-2018; Huang, Niu/J-9656-2012	Jacobson, Matthew/0000-0001-6262-655X; Huang, Niu/0000-0002-6912-033X	NIH [GM082250, AI035707]; Chinese Ministry of Science and Technology [2008AA022313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants GM082250 and AI035707 (to M. P. J.), and the Chinese Ministry of Science and Technology 863 Grant 2008AA022313 (to N. H.). M. P. J. is a member of the Scientific Advisory Board of Schrodinger LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Jianghong, 2004, Genome Inform, V15, P31; Blundell TL, 2006, PHILOS T R SOC B, V361, P413, DOI 10.1098/rstb.2005.1800; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brown SP, 2006, CHEMMEDCHEM, V1, P70, DOI 10.1002/cmdc.200500013; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Clark M, 2006, J CHEM INF MODEL, V46, P231, DOI 10.1021/ci050268f; Domling A, 2008, CURR OPIN CHEM BIOL, V12, P281, DOI 10.1016/j.cbpa.2008.04.603; Fauman Eric B, 2003, Methods Biochem Anal, V44, P477; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glaser F, 2006, PROTEINS, V62, P479, DOI 10.1002/prot.20769; Hajduk PJ, 2005, DRUG DISCOV TODAY, V10, P1675, DOI 10.1016/S1359-6446(05)03624-X; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hartshorn MJ, 2005, J MED CHEM, V48, P403, DOI 10.1021/jm0495778; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang N, 2006, J CHEM INF MODEL, V46, P243, DOI 10.1021/ci0502855; Huang N, 2007, CURR OPIN DRUG DISC, V10, P325; Huang N, 2006, PHYS CHEM CHEM PHYS, V8, P5166, DOI 10.1039/b608269f; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; IHLENFELDT WD, 1994, J CHEM INF COMP SCI, V34, P109, DOI 10.1021/ci00017a013; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Landon MR, 2007, J MED CHEM, V50, P1231, DOI 10.1021/jm061134b; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laurie ATR, 2006, CURR PROTEIN PEPT SC, V7, P395; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liu G, 2003, J MED CHEM, V46, P4232, DOI 10.1021/jm034122o; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossi A, 2006, PROTEIN SCI, V15, P2366, DOI 10.1110/ps.062247506; Shakespeare W, 2000, P NATL ACAD SCI USA, V97, P9373, DOI 10.1073/pnas.97.17.9373; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Soga S, 2007, J CHEM INF MODEL, V47, P400, DOI 10.1021/ci6002202; Stuart AC, 2002, BIOINFORMATICS, V18, P200, DOI 10.1093/bioinformatics/18.1.200; Vajda S, 2006, CURR OPIN DRUG DISC, V9, P354; van Dongen MJP, 2002, J AM CHEM SOC, V124, P11874, DOI 10.1021/ja017830c; Voigt JH, 2001, J CHEM INF COMP SCI, V41, P702, DOI 10.1021/ci000150t; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhu K, 2007, J CHEM THEORY COMPUT, V3, P640, DOI 10.1021/ct600129f	52	50	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10109	10.1371/journal.pone.0010109	http://dx.doi.org/10.1371/journal.pone.0010109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404926	Green Submitted, gold, Green Published			2022-12-27	WOS:000276482100021
J	Thompson, BJ				Thompson, Barry J.			Mal/SRF Is Dispensable for Cell Proliferation in Drosophila	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; SRF; GRADIENT	The Mal/SRF transcription factor is regulated by the level of G-actin in cells and has important roles in cell migration and other actin-dependent processes in Drosophila. A recent report suggests that Mal/SRF and an upstream regulator, Pico, are required for cell proliferation and tissue growth in Drosophila. I find otherwise. Mutation of Mal or SRF does not affect cell proliferation in the fly wing. Furthermore, I cannot reproduce the reported effects of Pico RNAi or Pico overexpression on body size. Nevertheless, I can confirm that overexpression of Pico or Mal causes tissue overgrowth specifically in the fly wing - where SRF is most highly expressed. My results indicate that Mal/SRF can promote tissue growth when abnormally active, but is not normally required for tissue growth during development.	London Res Inst, Canc Res UK, London, England	Cancer Research UK	Thompson, BJ (corresponding author), London Res Inst, Canc Res UK, London, England.	barry.thompson@cancer.org.uk		Thompson, Barry/0000-0002-0103-040X	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Hafen E, 2003, CURR TOP MICROBIOL, V279, P153; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Montagne J, 1996, DEVELOPMENT, V122, P2589; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084	9	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10077	10.1371/journal.pone.0010077	http://dx.doi.org/10.1371/journal.pone.0010077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404916	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100006
J	Gil, O; Diaz, I; Vilaplana, C; Tapia, G; Diaz, J; Fort, M; Caceres, N; Pinto, S; Cayla, J; Corner, L; Domingo, M; Cardona, PJ				Gil, Olga; Diaz, Ivan; Vilaplana, Cristina; Tapia, Gustavo; Diaz, Jorge; Fort, Maria; Caceres, Neus; Pinto, Sergio; Cayla, Joan; Corner, Leigh; Domingo, Mariano; Cardona, Pere-Joan			Granuloma Encapsulation Is a Key Factor for Containing Tuberculosis Infection in Minipigs	PLOS ONE			English	Article							MOUSE PERITONEAL-MACROPHAGES; MYCOBACTERIUM-TUBERCULOSIS; TUBERCLE-BACILLI; GUINEA-PIGS; MICE; AEROSOL; MODEL; LUNG; CELL; MYOFIBROBLAST	A transthoracic infection involving a low dose of Mycobacterium tuberculosis has been used to establish a new model of infection in minipigs. The 20-week monitoring period showed a marked Th1 response and poor humoral response for the whole infection. A detailed histopathological analysis was performed after slicing the formalin-fixed whole lungs of each animal. All lesions were recorded and classified according to their microscopic aspect, their relationship with the intralobular connective network and their degree of maturity in order to obtain a dissemination ratio (DR) between recent and old lesions. CFU counts and evolution of the DR with time showed that the proposed model correlated with a contained infection, decreasing from week 9 onwards. These findings suggest that the infection induces an initial Th1 response, which is followed by local fibrosis and encapsulation of the granulomas, thereby decreasing the onset of new lesions. Two therapeutic strategies were applied in order to understand how they could influence the model. Thus, chemotherapy with isoniazid alone helped to decrease the total number of lesions, despite the increase in DR after week 9, with similar kinetics to those of the control group, whereas addition of a therapeutic M. tuberculosis fragment-based vaccine after chemotherapy increased the Th1 and humoral responses, as well as the number of lesions, but decreased the DR. By providing a local pulmonary structure similar to that in humans, the mini-pig model highlights new aspects that could be key to a better understanding tuberculosis infection control in humans.	[Gil, Olga; Vilaplana, Cristina; Diaz, Jorge; Caceres, Neus; Pinto, Sergio; Cardona, Pere-Joan] Univ Autonoma Barcelona, UTE, Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Catalonia, Spain; [Gil, Olga; Vilaplana, Cristina; Diaz, Jorge; Caceres, Neus; Pinto, Sergio; Cardona, Pere-Joan] Inst Carlos III, CIBER Enfermedades Resp, Palma de Mallorca, Spain; [Diaz, Ivan; Fort, Maria; Domingo, Mariano] UAB IRTA, CReSA, Bellaterra, Catalonia, Spain; [Tapia, Gustavo] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Badalona, Catalonia, Spain; [Cayla, Joan] Agencia Salut Publ, Serv Epidemiol, TB Invest Unit Barcelona, Barcelona, Catalonia, Spain; [Corner, Leigh] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; IRTA; Hospital Germans Trias i Pujol; Public Health Agency of Barcelona; University College Dublin	Gil, O (corresponding author), Univ Autonoma Barcelona, UTE, Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Catalonia, Spain.	pjcardona.igtp.germanstrias@gencat.cat	Domingo, Mariano/A-1015-2009; Tapia, Gustavo/M-9938-2017; Vilaplana, Cristina/K-7216-2012; Cardona, Pere-Joan/A-5258-2011; luque, ivan diaz/I-2654-2015; diaz, ivan/C-7043-2008	Domingo, Mariano/0000-0002-9623-4826; Vilaplana, Cristina/0000-0002-2808-7270; Cardona, Pere-Joan/0000-0001-5623-7873; luque, ivan diaz/0000-0002-8090-1073; diaz, ivan/0000-0002-8090-1073; Cayla, Joan A./0000-0003-3891-111X; Tapia Melendo, Gustavo/0000-0003-1882-0368	Spanish Ministry of Health [FIS PI080785, CM06/00123]; Spanish Ministry of Science and Innovation [BIO2005-07949-C02-02]; Bill and Melinda Gates Foundation [GC12]; European Community [FP7/2007-2013, 200999]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Community(European Commission)	Archivel Farma S.L. supported the study by providing the vaccine RUTI (R). The Spanish Ministry of Health (FIS PI080785; National Plan I+D+I FIS CM06/00123); the Spanish Ministry of Science and Innovation (BIO2005-07949-C02-02; CIBER Enfermedades Respiratorias, programa CRP-TB); the Bill and Melinda Gates Foundation (Grand Challenges GC12) and the European Community's 7th Framework Programme (FP7/2007-2013: STOPLATENT-TB project under grant agreement 200999) collaborated in funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2006, INFECT IMMUN, V74, P5397, DOI 10.1128/IAI.00332-06; Bezuidenhout J., 2009, TUBERCULOSIS COMPREH, P117; Bolin CA, 1997, J INFECT DIS, V176, P1559, DOI 10.1086/514155; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Buddle BM, 2005, TUBERCULOSIS, V85, P19, DOI 10.1016/j.tube.2004.09.003; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Canetti G., 1955, TUBERCLE BACILLUS PU; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2000, SCAND J IMMUNOL, V52, P156, DOI 10.1046/j.1365-3083.2000.00763.x; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Cardona PJ, 2002, SCAND J IMMUNOL, V55, P639, DOI 10.1046/j.1365-3083.2002.01088.x; Corner LAL, 2007, RES VET SCI, V83, P53, DOI 10.1016/j.rvsc.2006.10.016; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Diaz I, 2005, VET IMMUNOL IMMUNOP, V106, P107, DOI 10.1016/j.vetimm.2005.01.005; Domingo M, 2009, SCAND J IMMUNOL, V69, P500, DOI 10.1111/j.1365-3083.2009.02251.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fraser R. S., 2005, PHYSL BASIS RESP DIS; Fujita J, 2002, MICROBIOL IMMUNOL, V46, P67, DOI 10.1111/j.1348-0421.2002.tb02660.x; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guirado E, 2008, CLIN VACCINE IMMUNOL, V15, P1229, DOI 10.1128/CVI.00094-08; Guirado E, 2006, MICROBES INFECT, V8, P1252, DOI 10.1016/j.micinf.2005.12.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsu HHT, 2004, BBA-MOL BASIS DIS, V1690, P118, DOI 10.1016/j.bbadis.2004.06.001; Huitema LFA, 2007, FRONT BIOSCI-LANDMRK, V12, P2631, DOI 10.2741/2260; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; KIERNAN JA, 2008, HISTOLOGICAL HISTOCH, V16; Krasnow I, 1966, Tech Bull Regist Med Technol, V36, P34; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lenzi HL, 1999, BRAZ J MED BIOL RES, V32, P639, DOI 10.1590/S0100-879X1999000500018; LURIE MB, 1952, J EXP MED, V95, P119, DOI 10.1084/jem.95.2.119; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Mullarky IK, 2006, INFECT IMMUN, V74, P1181, DOI 10.1128/IAI.74.2.1181-1188.2006; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; NISHIKAWA K, 1993, BIOCHIM BIOPHYS ACTA, V1169, P257; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Orme IM, 2005, TUBERCULOSIS, V85, P13, DOI 10.1016/j.tube.2004.08.001; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; PLOPPER CG, 2005, LAB PRIMATE, V30, P503; POTTENGER FM, 1934, TUBERCULOSIS CHILD A; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; Thoen C., 1995, MYCOBACTERIUM BOVIS; Thoen Charles O., 1994, P157; Torday JS, 2007, AM J PHYSIOL-LUNG C, V292, pL608, DOI 10.1152/ajplung.00379.2006; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; WALLACE JG, 1961, AM REV RESPIR DIS, V83, P866; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; World Health Organization, 2009, GLOB TUB CONTR EP ST; WRIGHT AE, 1906, P ROY SOC LOND B BIO, P194	62	70	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10030	10.1371/journal.pone.0010030	http://dx.doi.org/10.1371/journal.pone.0010030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386605	Green Published, Green Submitted, gold			2022-12-27	WOS:000276420400008
J	Greenbaum, JA; Assarsson, E; Chung, JL; Head, S; Sette, A; Peters, B				Greenbaum, Jason A.; Assarsson, Erika; Chung, Jo L.; Head, Steven; Sette, Alessandro; Peters, Bjoern			TiArA: A Virtual Appliance for the Analysis of Tiling Array Data	PLOS ONE			English	Article								Background: Genomic tiling arrays have been described in the scientific literature since 2003, yet there is a shortage of user-friendly applications available for their analysis. Methodology/Principal Findings: Tiling Array Analyzer (TiArA) is a software program that provides a user-friendly graphical interface for the background subtraction, normalization, and summarization of data acquired through the Affymetrix tiling array platform. The background signal is empirically measured using a group of nonspecific probes with varying levels of GC content and normalization is performed to enforce a common dynamic range. Conclusions/Significance: TiArA is implemented as a standalone program for Linux systems and is available as a cross-platform virtual machine that will run under most modern operating systems using virtualization software such as Sun VirtualBox or VMware. The software is available as a Debian package or a virtual appliance at http://purl.org/NET/tiara.	[Greenbaum, Jason A.; Assarsson, Erika; Chung, Jo L.; Sette, Alessandro; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Head, Steven] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Scripps Research Institute	Greenbaum, JA (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.	jgbaum@liai.org	Sette, Alessandro/AFO-8916-2022		National Institutes of Health [HHSN266200400124C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health contract HHSN266200400124C. KKC publication number 1114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2006, AFF TIL AN SOFTW VER; Affymetrix, 2005, EX ARR BACKGR CORR; Affymetrix, 2002, STAT ALG DESCR DOC; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halasz G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r59; R Core Team, 2020, R LANG ENV STAT COMP; *SUN MICR, 2009, SUN VIRT US MAN; Zhang ZD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r81	11	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9993	10.1371/journal.pone.0009993	http://dx.doi.org/10.1371/journal.pone.0009993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376318	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200061
J	Pachulec, E; van der Does, C				Pachulec, Emilia; van der Does, Chris			Conjugative Plasmids of Neisseria gonorrhoeae	PLOS ONE			English	Article							TETRACYCLINE-RESISTANCE PLASMID; BETA-LACTAMASE PLASMID; TOXIN-ANTITOXIN SYSTEM; MOLECULAR EPIDEMIOLOGY; DEOXYRIBONUCLEIC-ACID; GENETIC ORGANIZATION; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; RHODOCOCCUS-EQUI; TETM GENES	Many clinical isolates of the human pathogen Neisseria gonorrhoeae contain conjugative plasmids. The host range of these plasmids is limited to Neisseria species, but presence of a tetracycline (tetM) determinant inserted in several of these plasmids is an important cause of the rapid spread of tetracycline resistance. Previously plasmids with different backbones (Dutch and American type backbones) and with and without different tetM determinants (Dutch and American type tetM determinants) have been identified. Within the isolates tested, all plasmids with American or Dutch type tetM determinants contained a Dutch type plasmid backbone. This demonstrated that tetM determinants should not be used to differentiate between conjugal plasmid backbones. The nucleotide sequences of conjugative plasmids with Dutch type plasmid backbones either not containing the tetM determinant (pEP5233) or containing Dutch (pEP5289) or American (pEP5050) type tetM determinants were determined. Analysis of the backbone sequences showed that they belong to a novel IncP1 subfamily divergent from the IncP1 alpha, beta, gamma, delta and epsilon subfamilies. The tetM determinants were inserted in a genetic load region found in all these plasmids. Insertion was accompanied by the insertion of a gene with an unknown function, and rearrangement of a toxin/antitoxin gene cluster. The genetic load region contains two toxin/antitoxins of the Zeta/Epsilon toxin/antitoxin family previously only found in Gram positive organisms and the virulence associated protein D of the VapD/VapX toxin/antitoxin family. Remarkably, presence of VapX of pJD1, a small cryptic neisserial plasmid, in the acceptor strain strongly increased the conjugation efficiency, suggesting that it functions as an antitoxin for the conjugative plasmid. The presence of the toxin and antitoxin on different plasmids might explain why the host range of this IncP1 plasmid is limited to Neisseria species. The isolated plasmids conjugated efficiently between N. gonorrhoeae strains, but did not enhance transfer of a genetic marker.	[Pachulec, Emilia; van der Does, Chris] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands; [Pachulec, Emilia; van der Does, Chris] Univ Groningen, Zernike Inst Adv Mat, Haren, Netherlands; [van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	University of Groningen; University of Groningen; Max Planck Society	Pachulec, E (corresponding author), Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Kerklaan 30, NL-9751 NN Haren, Netherlands.	does@mpi-marburg.mpg.de	Institute, Zernike/W-7033-2019					ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Benoit S, 2001, RES MICROBIOL, V152, P439, DOI 10.1016/S0923-2508(01)01217-7; BURDETT V, 1982, J BACTERIOL, V149, P995, DOI 10.1128/JB.149.3.995-1004.1982; Catani CF, 2004, PROTEIN EXPRES PURIF, V37, P320, DOI 10.1016/j.pep.2004.07.002; Chalkley LJ, 1997, J ANTIMICROB CHEMOTH, V40, P817, DOI 10.1093/jac/40.6.817; Daines DA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-30; EISENSTEIN BI, 1977, SCIENCE, V195, P998, DOI 10.1126/science.402693; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FLETCHER HM, 1989, J GEN MICROBIOL, V135, P3067; FLETT F, 1981, J GEN MICROBIOL, V125, P123; GALLI DM, 1994, PLASMID, V31, P148, DOI 10.1006/plas.1994.1016; GASCOYNE DM, 1990, J ANTIMICROB CHEMOTH, V25, P39, DOI 10.1093/jac/25.1.39; GASCOYNE DM, 1991, J ANTIMICROB CHEMOTH, V28, P173, DOI 10.1093/jac/28.2.173; GASCOYNEBINZI DM, 1993, J ANTIMICROB CHEMOTH, V32, P667, DOI 10.1093/jac/32.5.667; GASCOYNEBINZI DM, 1994, J ANTIMICROB CHEMOTH, V33, P1011, DOI 10.1093/jac/33.5.1011; GENCO CA, 1984, J INFECT DIS, V150, P397, DOI 10.1093/infdis/150.3.397; Gharizadeh B, 2005, INT J ANTIMICROB AG, V26, P486, DOI 10.1016/j.ijantimicag.2005.08.017; Giebelhaus LA, 1996, J BACTERIOL, V178, P6378, DOI 10.1128/jb.178.21.6378-6381.1996; GUINEY DG, 1983, P NATL ACAD SCI-BIOL, V80, P3595, DOI 10.1073/pnas.80.12.3595; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; ISON CA, 1993, SEX TRANSM DIS, V20, P329, DOI 10.1097/00007435-199320060-00005; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P369, DOI 10.1128/CVI.00448-06; JOHNSON SR, 1991, J ANTIMICROB CHEMOTH, V27, P864, DOI 10.1093/jac/27.6.864; KATZ ME, 1994, J BACTERIOL, V176, P2663, DOI 10.1128/JB.176.9.2663-2669.1994; KATZ ME, 1992, INFECT IMMUN, V60, P4586, DOI 10.1128/IAI.60.11.4586-4592.1992; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; KNAPP JS, 1987, J INFECT DIS, V155, P819, DOI 10.1093/infdis/155.4.819; KNAPP JS, 1988, ANTIMICROB AGENTS CH, V32, P765, DOI 10.1128/AAC.32.5.765; Kolader ME, 2006, J CLIN MICROBIOL, V44, P2689, DOI 10.1128/JCM.02311-05; KORCH C, 1985, J BACTERIOL, V163, P430, DOI 10.1128/JB.163.2.430-438.1985; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Marques MV, 2001, PLASMID, V45, P184, DOI 10.1006/plas.2000.1514; Marquez C, 1999, SEX TRANSM DIS, V26, P157, DOI 10.1097/00007435-199903000-00006; MAYER LW, 1974, INFECT IMMUN, V10, P712, DOI 10.1128/IAI.10.4.712-717.1974; MCGEE ZA, 1981, J INFECT DIS, V143, P413, DOI 10.1093/infdis/143.3.413; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; MORSE SA, 1986, ANTIMICROB AGENTS CH, V30, P664, DOI 10.1128/AAC.30.5.664; ROBERTS M, 1979, J GEN MICROBIOL, V114, P491, DOI 10.1099/00221287-114-2-491; ROBERTS MC, 1986, ANTIMICROB AGENTS CH, V30, P810, DOI 10.1128/AAC.30.5.810; ROBERTS MC, 1986, PEDIATR INFECT DIS J, V5, pS338, DOI 10.1097/00006454-198611010-00032; ROBERTS MC, 1985, ANTIMICROB AGENTS CH, V28, P141, DOI 10.1128/AAC.28.1.141; ROBERTS MC, 1988, ANTIMICROB AGENTS CH, V32, P488, DOI 10.1128/AAC.32.4.488; Rodriguez-Bonano NM, 2004, PLASMID, V52, P89, DOI 10.1016/j.plasmid.2004.05.002; Scharbaai-Vazquez R, 2007, PLASMID, V57, P156, DOI 10.1016/j.plasmid.2006.07.006; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STIFFLER PW, 1975, J BACTERIOL, V122, P1293, DOI 10.1128/JB.122.3.1293-1300.1975; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; SWARTLEY JS, 1993, MOL MICROBIOL, V10, P299, DOI 10.1111/j.1365-2958.1993.tb01956.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner A, 1999, SEX TRANSM INFECT, V75, P60, DOI 10.1136/sti.75.1.60; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Weng SC, 1999, FEMS MICROBIOL LETT, V179, P11, DOI 10.1111/j.1574-6968.1999.tb08701.x; XIA MS, 1995, MOL CELL PROBE, V9, P327, DOI 10.1016/S0890-8508(95)91620-2; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	63	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9962	10.1371/journal.pone.0009962	http://dx.doi.org/10.1371/journal.pone.0009962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376355	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200036
J	Mihardja, SS; Gao, DW; Sievers, RE; Fang, QZ; Feng, JJ; Wang, JM; Vanbrocklin, HF; Larrick, JW; Huang, M; Dae, M; Lee, RJ				Mihardja, Shirley S.; Gao, Dongwei; Sievers, Richard E.; Fang, Qizhi; Feng, Jinjin; Wang, Jianming; Vanbrocklin, Henry F.; Larrick, James W.; Huang, Manley; Dae, Michael; Lee, Randall J.			Targeted In Vivo Extracellular Matrix Formation Promotes Neovascularization in a Rodent Model of Myocardial Infarction	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; LEFT-VENTRICULAR GEOMETRY; IV-COLLAGEN; SYNTHETIC PEPTIDE; ALPHA(V)BETA(3) INTEGRIN; GROWTH-FACTOR; ANGIOGENESIS; ADHESION; MIGRATION; FIBRONECTIN	Background: The extracellular matrix plays an important role in tissue regeneration. We investigated whether extracellular matrix protein fragments could be targeted with antibodies to ischemically injured myocardium to promote angiogenesis and myocardial repair. Methodology/Principal Findings: Four peptides, 2 derived from fibronectin and 2 derived from Type IV Collagen, were assessed for in vitro and in vivo tendencies for angiogenesis. Three of the four peptides-Hep I, Hep III, RGD-were identified and shown to increase endothelial cell attachment, proliferation, migration and cell activation in vitro. By chemically conjugating these peptides to an anti-myosin heavy chain antibody, the peptides could be administered intravenously and specifically targeted to the site of the myocardial infarction. When administered into Sprague-Dawley rats that underwent ischemia-reperfusion myocardial infarction, these peptides produced statistically significantly higher levels of angiogenesis and arteriogenesis 6 weeks post treatment. Conclusions/Significance: We demonstrated that antibody-targeted ECM-derived peptides alone can be used to sufficiently alter the extracellular matrix microenvironment to induce a dramatic angiogenic response in the myocardial infarct area. Our results indicate a potentially new non-invasive strategy for repairing damaged tissue, as well as a novel tool for investigating in vivo cell biology.	[Mihardja, Shirley S.; Gao, Dongwei; Fang, Qizhi; Dae, Michael; Lee, Randall J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Sievers, Richard E.; Lee, Randall J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lee, Randall J.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Gao, Dongwei; Feng, Jinjin; Vanbrocklin, Henry F.; Dae, Michael] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Lee, Randall J.] Univ Calif Berkeley, UCSF, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA; [Wang, Jianming; Larrick, James W.; Huang, Manley] Panorama Res Inst, Sunnyvale, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco	Mihardja, SS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	lee@medicine.ucsf.edu			NIH [R21 HL084121]; California Institute of Regenerative Medicine [RC1-00124-1]; American Heart Association; Margoes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); American Heart Association(American Heart Association); Margoes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH R21 HL084121 and by the California Institute of Regenerative Medicine (RC1-00124-1). SSM was supported by the American Heart Association Postdoctoral Fellowship and by the Margoes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Azarnoush K, 2005, J THORAC CARDIOV SUR, V130, P173, DOI 10.1016/j.jtcvs.2004.11.044; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bonanno E, 2000, IN VITRO CELL DEV-AN, V36, P336; Bouchentouf M, 2008, GENE THER, V15, P404, DOI 10.1038/sj.gt.3303059; CAMERON JD, 1991, INVEST OPHTH VIS SCI, V32, P2766; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Corda S, 2000, Heart Fail Rev, V5, P119, DOI 10.1023/A:1009806403194; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; FORM DM, 1986, LAB INVEST, V55, P521; Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063; Heiss C, 2008, J CELL PHYSIOL, V215, P366, DOI 10.1002/jcp.21313; Huang NF, 2006, NAT PROTOC, V1, P1596, DOI 10.1038/nprot.2006.188; Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; MALDONADO BA, 1995, INVEST OPHTH VIS SCI, V36, P364; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; MOORADIAN DL, 1993, INVEST OPHTH VIS SCI, V34, P153; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; NICOSIA RF, 1987, AM J PATHOL, V128, P78; Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Patel S, 2007, J BIOMED MATER RES A, V83A, P423, DOI 10.1002/jbm.a.31320; PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Senger DR, 1996, AM J PATHOL, V149, P293; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Setty S, 1998, J BIOL CHEM, V273, P12244, DOI 10.1074/jbc.273.20.12244; Simons M, 2004, MOL CELL BIOCHEM, V264, P99, DOI 10.1023/B:MCBI.0000044379.25823.03; Springer ML, 2000, MOL THER, V1, P82, DOI 10.1006/mthe.1999.0006; Springer ML, 2003, MOL THER, V7, P441, DOI 10.1016/S1525-0016(03)00010-8; Strauer BE, 2003, CIRCULATION, V107, P929, DOI 10.1161/01.CIR.0000057525.13182.24; SUDA T, 1981, CURRENT EYE RES, V1; Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b; TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036	44	19	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10384	10.1371/journal.pone.0010384	http://dx.doi.org/10.1371/journal.pone.0010384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442783	Green Submitted, Green Published, gold			2022-12-27	WOS:000277154200020
J	Romanuk, TN; Vogt, RJ; Young, A; Tuck, C; Carscallen, MW				Romanuk, Tamara N.; Vogt, Richard J.; Young, Angela; Tuck, Constance; Carscallen, Mather W.			Maintenance of Positive Diversity-Stability Relations along a Gradient of Environmental Stress	PLOS ONE			English	Article							SPECIES-DIVERSITY; COMMUNITY STRUCTURE; ECOSYSTEM FUNCTION; PLANT DIVERSITY; BIODIVERSITY; VARIABILITY; RICHNESS; DESICCATION	Background: Environmental stress is widely considered to be an important factor in regulating whether changes in diversity will affect the functioning and stability of ecological communities. Methodology/Principal Findings: We investigated the effects of a major environmental stressor (a decrease in water volume) on diversity-abundance and diversity-stability relations in laboratory microcosms composed of temperate multitrophic rock pool communities to identify differences in community and functional group responses to increasing functional group richness along a gradient of environmental stress (low, medium, and high water volume). When a greater number of functional groups were present, communities were less temporally variable and achieved higher abundances. The stabilizing effect of increased functional group richness was observed regardless of the level of environmental stress the community was subjected too. Despite the strong consistent stabilizing effect of increased functional group richness on abundance, the way that individual functional groups were affected by functional group richness differed along the stress gradient. Under low stress, communities with more functional groups present were more productive and showed evidence of strong facilitative interactions. As stress increased, the positive effect of functional group richness on community abundance was no longer observed and compensatory responses became more common. Responses of individual functional groups to functional group richness became increasing heterogeneous are stress increased, prompting shifts from linear diversity-variability/abundance relations under low stress to a mix of linear and non-linear responses under medium and high stress. The strength of relations between functional group richness and both the abundances and temporal variability of functional groups also increased as stress increased. Conclusions/Significance: While stress did not affect the relation between functional group richness and stability per se, the way in which functional groups responded to changes in functional group richness differed as stress increased. These differences, which include increases in the heterogeneity of responses of individual functional groups, increases in compensatory dynamics, and increases in the strength of richness-abundance and richness-variability relations, may be critical to maintaining stability under increasingly stressful environmental conditions.	[Romanuk, Tamara N.; Young, Angela; Tuck, Constance; Carscallen, Mather W.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Vogt, Richard J.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Dalhousie University; University of Quebec; University of Quebec Montreal	Romanuk, TN (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tromanuk@gmail.com	Romanuk, t N/C-6493-2008		National Sciences and Engineering Research of Council Canada (NSERC)	National Sciences and Engineering Research of Council Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a National Sciences and Engineering Research of Council Canada (NSERC) Discovery Grant to TNR (http://www.nserccrsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004703; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; Fukami T, 2004, POPUL ECOL, V46, P137, DOI 10.1007/s10144-004-0182-z; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Paradise CJ, 1997, OECOLOGIA, V109, P303, DOI 10.1007/s004420050088; Petchey OL, 2002, OIKOS, V99, P231, DOI 10.1034/j.1600-0706.2002.990203.x; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Romanuk TN, 2006, BIOL LETT-UK, V2, P374, DOI 10.1098/rsbl.2006.0464; Romanuk TN, 2006, OIKOS, V114, P291, DOI 10.1111/j.2006.0030-1299.14739.x; Romanuk TN, 2009, OIKOS, V118, P819, DOI 10.1111/j.1600-0706.2008.17273.x; Romanuk TN, 2005, BIOL INVASIONS, V7, P711, DOI 10.1007/s10530-004-0997-8; Romanuk TN, 2004, ECOSCIENCE, V11, P455, DOI 10.1080/11956860.2004.11682855; Romanuk TN, 2002, ECOSCIENCE, V9, P55, DOI 10.1080/11956860.2002.11682690; ROMANUK TN, 2002, THESIS MCMASTER U HA; SCHLUTER D, 1984, ECOLOGY, V65, P998, DOI 10.2307/1938071; Solow AR, 2007, ECOSYSTEMS, V10, P1034, DOI 10.1007/s10021-007-9076-1; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Steiner CF, 2005, ECOL LETT, V8, P819, DOI 10.1111/j.1461-0248.2005.00785.x; Symstad AJ, 2000, ECOLOGY, V81, P99, DOI 10.1890/0012-9658(2000)081[0099:ATOTEO]2.0.CO;2; Symstad AJ, 2000, OIKOS, V89, P243, DOI 10.1034/j.1600-0706.2000.890204.x; Therriault TW, 2001, ISR J ZOOL, V47, P477, DOI 10.1560/BWWA-DTXB-LBJK-5GV5; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Valone TJ, 2003, OIKOS, V103, P519, DOI 10.1034/j.1600-0706.2003.12279.x; Vogt RJ, 2006, OIKOS, V113, P55, DOI 10.1111/j.0030-1299.2006.14494.x; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Williams D. D., 2006, ECOLOGY TEMPORARY WA; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Zhang QG, 2006, OIKOS, V112, P218, DOI 10.1111/j.0030-1299.2006.14220.x	44	12	12	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10378	10.1371/journal.pone.0010378	http://dx.doi.org/10.1371/journal.pone.0010378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436913	Green Published, gold			2022-12-27	WOS:000277079700012
J	Borderia, AV; Lorenzo-Redondo, R; Pernas, M; Casado, C; Alvaro, T; Domingo, E; Lopez-Galindez, C				Borderia, Antonio V.; Lorenzo-Redondo, Ramon; Pernas, Maria; Casado, Concepcion; Alvaro, Tamara; Domingo, Esteban; Lopez-Galindez, Cecilio			Initial Fitness Recovery of HIV-1 Is Associated with Quasispecies Heterogeneity and Can Occur without Modifications in the Consensus Sequence	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MISMATCH CLEAVAGE METHOD; MOUTH-DISEASE VIRUS; TYPE-1 INFECTION; CELL-CULTURE; RNA VIRUSES; MUTATIONS; POPULATION; EVOLUTION; PROGRESSION	Background: Fitness recovery of HIV-1 "in vitro" was studied using viral clones that had their fitness decreased as a result of plaque-to-plaque passages. Principal Findings: After ten large population passages, the viral populations showed an average increase of fitness, although with wide variations among clones. While 5 clones showed significant fitness increases, 3 clones showed increases that were only marginally significant (p<0.1), and 4 clones did not show any change. Fitness recovery was not accompanied by an increase in p24 production, but was associated with an increase in viral titer. Few mutations (an average of 2 mutations per genome) were detected in the consensus nucleotide sequence of the entire genome in all viral populations. Five of the populations did not fix any mutation, and three of them displayed marginally significant fitness increases, illustrating that fitness recovery can occur without detectable alterations of the consensus genomic sequence. The investigation of other possible viral factors associated with the initial steps of fitness recovery, showed that viral quasispecies heterogeneity increased between the initial clones and the passaged populations. A direct statistical correlation between viral heterogeneity and viral fitness was obtained. Conclusions: Thus, the initial fitness recovery of debilitated HIV-1 clones was mediated by an increase in quasispecies heterogeneity. This observation, together with the invariance of the consensus sequence despite fitness increases demonstrates the relevance of quasispecies heterogeneity in the evolution of HIV-1 in cell culture.	[Borderia, Antonio V.; Lorenzo-Redondo, Ramon; Pernas, Maria; Casado, Concepcion; Alvaro, Tamara; Lopez-Galindez, Cecilio] Inst Salud Carlos III, CNM, Madrid, Spain; [Domingo, Esteban] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Domingo, Esteban] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); Instituto de Salud Carlos III; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Borderia, AV (corresponding author), Inst Salud Carlos III, CNM, Madrid, Spain.	clopez@isciii.es	Pernas, Maria/E-3998-2018; Lopez-Galindez, Cecilio/A-3603-2008; Casado, Concepcion/F-3060-2016; Domingo, Esteban/K-3937-2014	Pernas, Maria/0000-0003-2966-0160; Lopez-Galindez, Cecilio/0000-0002-2324-9584; Casado, Concepcion/0000-0003-3412-2877; Domingo, Esteban/0000-0002-0573-1676; Lorenzo-Redondo, Ramon/0000-0002-5462-9483; Borderia, Antonio V./0000-0003-0623-1988	Plan Nacional del SIDA [SAF 2005/03833, SAF 2007/61036]; Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss); Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE) [36558/06, 36641/07, 36779/08, 360766/09]; Ministerio de Ciencia e Innovacion [BFU 2008-02816/BMC]; Fundacion Ramon Areces; Instituto de Salud Carlos III	Plan Nacional del SIDA; Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss)(Instituto de Salud Carlos III); Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Work in the Centro Nacional de Microbiologia was supported by grants, SAF 2005/03833, SAF 2007/61036 by the Plan Nacional del SIDA and in part by the Red Tematica Cooperativa de investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss) and Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE) grant 36558/06, 36641/07, 36779/08, 36641/07 and 360766/09. Work in the Centro de Biologia Molecular "Severo Ochoa" was supported by grant BFU 2008-02816/BMC from Ministerio de Ciencia e Innovacion, FIPSE 36558/06 and 360766/09 and Fundacion Ramon Areces. Centro de Investigaciones Biomedica en Red (CIBER): enfermedades hepaticas y digestivas (ehd) is funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Baranowski E, 1998, J VIROL, V72, P6362, DOI 10.1128/JVI.72.8.6362-6372.1998; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brander C, 1999, CURR OPIN IMMUNOL, V11, P451, DOI 10.1016/S0952-7915(99)80076-4; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; DIEZ J, 1990, J VIROL, V64, P5519; Domingo E, 2005, ARCH VIROL, P59; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; DOMINGO E, ORIGIN EVOLUTION VIR; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1988, SEQUENCE SPACE QUASI, P211; EIGEN M, 1988, RNA GENETICS, P211; Escarmis C, 1999, J MOL BIOL, V285, P495, DOI 10.1006/jmbi.1998.2366; Gonzalez-Lopez Claudia, 2005, Infection Genetics and Evolution, V5, P366, DOI 10.1016/j.meegid.2005.05.001; GOONETILLEKE N, 2009, 1 T CELL RESPONSE TR; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; HOLLAND JJ, 1991, J VIROL, V65, P2960, DOI 10.1128/JVI.65.6.2960-2967.1991; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; KUIKEN C, 2009, 0903280 LAUR; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; LOPEZGALINDEZ C, 1988, P NATL ACAD SCI USA, V85, P3522, DOI 10.1073/pnas.85.10.3522; LOPEZGALINDEZ C, 1991, P NATL ACAD SCI USA, V88, P4280, DOI 10.1073/pnas.88.10.4280; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Novella IS, 2004, J MOL BIOL, V342, P1423, DOI 10.1016/j.jmb.2004.08.004; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Olivares I, 1997, AIDS RES HUM RETROV, V13, P979, DOI 10.1089/aid.1997.13.979; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SANCHEZPALOMINO S, 1993, J VIROL, V67, P2938; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Sauder CJ, 2006, VIROLOGY, V350, P48, DOI 10.1016/j.virol.2006.01.035; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Thome KC, 1997, J VIROL, V71, P8149, DOI 10.1128/JVI.71.11.8149-8156.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Yuste E, 2005, J VIROL, V79, P5421, DOI 10.1128/JVi.79.9.5421-5427.2005; Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000; Yuste E, 1999, J VIROL, V73, P2745, DOI 10.1128/JVI.73.4.2745-2751.1999	46	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10319	10.1371/journal.pone.0010319	http://dx.doi.org/10.1371/journal.pone.0010319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436678	Green Published, gold			2022-12-27	WOS:000277079500008
J	Cattaert, T; Urrea, V; Naj, AC; De Lobel, L; De Wit, V; Fu, M; John, JMM; Shen, HQ; Calle, ML; Ritchie, MD; Edwards, TL; Van Steen, K				Cattaert, Tom; Urrea, Victor; Naj, Adam C.; De Lobel, Lizzy; De Wit, Vanessa; Fu, Mao; John, Jestinah M. Mahachie; Shen, Haiqing; Luz Calle, M.; Ritchie, Marylyn D.; Edwards, Todd L.; Van Steen, Kristel			FAM-MDR: A Flexible Family-Based Multifactor Dimensionality Reduction Technique to Detect Epistasis Using Related Individuals	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OLD ORDER AMISH; GENE-ENVIRONMENT INTERACTIONS; BETA(3)-ADRENERGIC RECEPTOR GENE; QUANTITATIVE TRAIT LOCI; DROSOPHILA-MERCATORUM; ECOLOGICAL GENETICS; INSULIN-RESISTANCE; ABNORMAL-ABDOMEN; HUMAN-DISEASES	We propose a novel multifactor dimensionality reduction method for epistasis detection in small or extended pedigrees, FAM-MDR. It combines features of the Genome-wide Rapid Association using Mixed Model And Regression approach (GRAMMAR) with Model-Based MDR (MB-MDR). We focus on continuous traits, although the method is general and can be used for outcomes of any type, including binary and censored traits. When comparing FAM-MDR with Pedigree-based Generalized MDR (PGMDR), which is a generalization of Multifactor Dimensionality Reduction (MDR) to continuous traits and related individuals, FAM-MDR was found to outperform PGMDR in terms of power, in most of the considered simulated scenarios. Additional simulations revealed that PGMDR does not appropriately deal with multiple testing and consequently gives rise to overly optimistic results. FAM-MDR adequately deals with multiple testing in epistasis screens and is in contrast rather conservative, by construction. Furthermore, simulations show that correcting for lower order (main) effects is of utmost importance when claiming epistasis. As Type 2 Diabetes Mellitus (T2DM) is a complex phenotype likely influenced by gene-gene interactions, we applied FAM-MDR to examine data on glucose area-under-the-curve (GAUC), an endophenotype of T2DM for which multiple independent genetic associations have been observed, in the Amish Family Diabetes Study (AFDS). This application reveals that FAM-MDR makes more efficient use of the available data than PGMDR and can deal with multi-generational pedigrees more easily. In conclusion, we have validated FAM-MDR and compared it to PGMDR, the current state-of-the-art MDR method for family data, using both simulations and a practical dataset. FAM-MDR is found to outperform PGMDR in that it handles the multiple testing issue more correctly, has increased power, and efficiently uses all available information.	[Cattaert, Tom; De Wit, Vanessa; John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, Inst Montefiore, B-4000 Liege, Belgium; [Cattaert, Tom; De Wit, Vanessa; John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, Grp Interdisciplinaire Genoprote Appl Res, Liege, Belgium; [Urrea, Victor; Luz Calle, M.] Univ Vic, Dept Syst Biol, Vic, Spain; [Naj, Adam C.; Edwards, Todd L.] Univ Miami, Miami Inst Human Genom, Miami, FL USA; [De Lobel, Lizzy] Univ Ghent, Dept Appl Math & Comp Sci, B-9000 Ghent, Belgium; [Fu, Mao; Shen, Haiqing] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Ritchie, Marylyn D.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	University of Liege; University of Liege; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Miami; Ghent University; University System of Maryland; University of Maryland Baltimore; Vanderbilt University	Cattaert, T (corresponding author), Univ Liege, Inst Montefiore, B-4000 Liege, Belgium.	tom.cattaert@ulg.ac.be	Edwards, Todd/B-9750-2012; Calle, M.Luz/D-2704-2015; Urrea, Victor/ABF-9634-2021; Ritchie, Marylyn/C-1114-2012; Pillay, Nischalan/F-9536-2012	Calle, M.Luz/0000-0001-9334-415X; Van Steen, Kristel/0000-0001-9868-5033; Urrea, Victor/0000-0002-2577-856X	Fonds de la Recherche Scientifique-FNRS; Ministerio de Ciencia y Tecnologia, Spain [MTM2008-06747-C02-00]; Belgian Network [IAP P6/25]; Belgian State, Science Policy Office; European Community [IST-2007-216886]	Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Belgian Network; Belgian State, Science Policy Office(Belgian Federal Science Policy Office); European Community(European Commission)	The first author is a Postdoctoral Researcher of the Fonds de la Recherche Scientifique-FNRS. This work is also partially supported by grant MTM2008-06747-C02-00 from the Ministerio de Ciencia y Tecnologia, Spain, by the Belgian Network BIOMAGNET (IAP P6/25), funded by the Interuniversity Attraction Poles Programme, initiated by the Belgian State, Science Policy Office, and by the IST Programme of the European Community, under the PASCAL2 Network of Excellence, IST-2007-216886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Bogardus C, 2009, OBESITY, V17, P209, DOI 10.1038/oby.2008.613; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; CHANDA P, 2009, EUR J HUM GENET; Chanda P, 2007, AM J HUM GENET, V81, P939, DOI 10.1086/521878; CHEVERUD JM, 1995, GENETICS, V139, P1455; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Damcott CM, 2005, DIABETES, V54, P2245, DOI 10.2337/diabetes.54.7.2245; Damcott CM, 2004, DIABETES, V53, P3337, DOI 10.2337/diabetes.53.12.3337; DESALLE R, 1986, GENETICS, V112, P877; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu M, 2004, DIABETES, V53, P3292, DOI 10.2337/diabetes.53.12.3292; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hartmann B, 2001, MECH DEVELOP, V109, P161, DOI 10.1016/S0925-4773(01)00519-6; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; HOLLOCHER H, 1992, GENETICS, V130, P355; HOLLOCHER H, 1994, GENETICS, V136, P1373; Hsueh WC, 2003, DIABETES, V52, P550, DOI 10.2337/diabetes.52.2.550; Hsueh WC, 2001, DIABETES CARE, V24, P672, DOI 10.2337/diacare.24.4.672; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ishii T, 2001, METABOLISM, V50, P1301, DOI 10.1053/meta.2001.27228; Kelly LE, 2005, BIOCHEM J, V388, P195, DOI 10.1042/BJ20041797; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Maxwell CA, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-4; McArdle PF, 2007, HUM HERED, V64, P234, DOI 10.1159/000103861; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P767, DOI 10.1002/gepi.20345; Nettleton D, 2000, BIOMETRICS, V56, P52, DOI 10.1111/j.0006-341X.2000.00052.x; Onkamo Paivi, 2006, Hum Genomics, V2, P336; Pollin TI, 2005, DIABETES, V54, P268, DOI 10.2337/diabetes.54.1.268; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sivenius K, 2000, INT J OBESITY, V24, P514, DOI 10.1038/sj.ijo.0801194; THOMPSON EA, 1990, BIOMETRICS, V46, P399, DOI 10.2307/2531445; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Urhammer SA, 2000, J CLIN ENDOCR METAB, V85, P3151, DOI 10.1210/jc.85.9.3151; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398	72	41	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10304	10.1371/journal.pone.0010304	http://dx.doi.org/10.1371/journal.pone.0010304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421984	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600021
J	Abu-Ali, GS; Ouellette, LM; Henderson, ST; Lacher, DW; Riordan, JT; Whittam, TS; Manning, SD				Abu-Ali, Galeb S.; Ouellette, Lindsey M.; Henderson, Scott T.; Lacher, David W.; Riordan, James T.; Whittam, Thomas S.; Manning, Shannon D.			Increased Adherence and Expression of Virulence Genes in a Lineage of Escherichia coli O157:H7 Commonly Associated with Human Infections	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT GENES; SHIGA-TOXIN; GENOME SEQUENCE; O157-H7; STRAINS; LOCUS; DISEASE; SECRETION; VARIANTS; LER	Background: Enterohemorrhagic Escherichia coli (EHEC) O157:H7, a food and waterborne pathogen, can be classified into nine phylogenetically distinct lineages, as determined by single nucleotide polymorphism genotyping. One lineage (clade 8) was found to be associated with hemolytic uremic syndrome (HUS), which can lead to kidney failure and death in some cases, particularly young children. Another lineage (clade 2) differs considerably in gene content and is phylogenetically distinct from clade 8, but caused significantly fewer cases of HUS in a prior study. Little is known, however, about how these two lineages vary with regard to phenotypic traits important for disease pathogenesis and in the expression of shared virulence genes. Methodology/Principal Findings: Here, we quantified the level of adherence to and invasion of MAC-T bovine epithelial cells, and examined the transcriptomes of 24 EHEC O157:H7 strains with varying Shiga toxin profiles from two common lineages. Adherence to epithelial cells was >2-fold higher for EHEC O157:H7 strains belonging to clade 8 versus clade 2, while no difference in invasiveness was observed between the two lineages. Whole-genome 70-mer oligo microarrays, which probe for 6088 genes from O157:H7 Sakai, O157:H7 EDL 933, pO157, and K12 MG1655, detected significant differential expression between clades in 604 genes following co-incubation with epithelial cells for 30 min; 186 of the 604 genes had a >1.5 fold change difference. Relative to clade 2, clade 8 strains showed upregulation of major virulence genes, including 29 of the 41 locus of enterocyte effacement (LEE) pathogenicity island genes, which are critical for adherence, as well as Shiga toxin genes and pO157 plasmid-encoded virulence genes. Differences in expression of 16 genes that encode colonization factors, toxins, and regulators were confirmed by qRT-PCR, which revealed a greater magnitude of change than microarrays. Conclusions/Significance: These findings demonstrate that the EHEC O157:H7 lineage associated with HUS expresses higher levels of virulence genes and has an enhanced ability to attach to epithelial cells relative to another common lineage.	[Abu-Ali, Galeb S.; Ouellette, Lindsey M.; Henderson, Scott T.; Riordan, James T.; Whittam, Thomas S.; Manning, Shannon D.] Michigan State Univ, Natl Food Safety & Toxicol Ctr, Microbial Evolut Lab, E Lansing, MI 48824 USA; [Lacher, David W.] US FDA, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Manning, Shannon D.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Michigan State University; US Food & Drug Administration (FDA); Michigan State University	Abu-Ali, GS (corresponding author), Michigan State Univ, Natl Food Safety & Toxicol Ctr, Microbial Evolut Lab, E Lansing, MI 48824 USA.	Shannon.Manning@ht.msu.edu	Abu-Ali, Galeb/AAE-9742-2020; Manning, Shannon/GXA-0622-2022	Abu-Ali, Galeb/0000-0002-2599-2937; Manning, Shannon/0000-0001-9581-0660	NIAID; NIH [N01-AI-30058]; DHHS	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS	This project was funded by the NIAID, NIH, DHHS, under NIH research contract N01-AI-30058 (TSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Aldick T, 2007, MICROBES INFECT, V9, P282, DOI 10.1016/j.micinf.2006.12.001; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; Dahan S, 2004, INFECT IMMUN, V72, P5452, DOI 10.1128/IAI.72.9.5452-5459.2004; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dibb-Fuller MP, 2001, J MED MICROBIOL, V50, P759, DOI 10.1099/0022-1317-50-9-759; Dowd SE, 2008, J FOOD PROTECT, V71, P1673, DOI 10.4315/0362-028X-71.8.1673; Eaton KA, 2008, INFECT IMMUN, V76, P3054, DOI 10.1128/IAI.01626-07; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Friedberg D, 1999, MOL MICROBIOL, V34, P941, DOI 10.1046/j.1365-2958.1999.01655.x; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Haack KR, 2003, INFECT IMMUN, V71, P384, DOI 10.1128/IAI.71.1.384-392.2003; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Iyoda S, 2005, J BACTERIOL, V187, P4086, DOI 10.1128/JB.187.12.4086-4094.2005; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kerr MK, 2003, J COMPUT BIOL, V10, P891, DOI 10.1089/106652703322756131; Kim Y, 2009, INT J FOOD MICROBIOL, V131, P224, DOI 10.1016/j.ijfoodmicro.2009.03.002; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; Klapproth JMA, 2005, INFECT IMMUN, V73, P1441, DOI 10.1128/IAI.73.3.1441-1451.2005; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Koitabashi T, 2006, MICROBIOL IMMUNOL, V50, P135, DOI 10.1111/j.1348-0421.2006.tb03779.x; KULASEKARA BR, 2009, INFECT IMMUN; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; Los JM, 2009, MICROB PATHOGENESIS, V47, P289, DOI 10.1016/j.micpath.2009.09.006; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; OSTROFF SM, 1989, JAMA-J AM MED ASSOC, V262, P355, DOI 10.1001/jama.262.3.355; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Robinson CM, 2006, P NATL ACAD SCI USA, V103, P9667, DOI 10.1073/pnas.0602359103; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Saitoh T, 2008, J BACTERIOL, V190, P4822, DOI 10.1128/JB.00231-08; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serra-Moreno R, 2008, J BACTERIOL, V190, P4722, DOI 10.1128/JB.00069-08; Shin S, 2001, MOL MICROBIOL, V41, P1133, DOI 10.1046/j.1365-2958.2001.02570.x; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; STEVENS MP, 2005, ECOSAL ESCHERICHIA C; Strauch E, 2008, INFECT IMMUN, V76, P5466, DOI 10.1128/IAI.00875-08; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tatsuno I, 2001, INFECT IMMUN, V69, P6660, DOI 10.1128/IAI.69.11.6660-6669.2001; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tomoyasu T, 2005, FEMS MICROBIOL LETT, V253, P59, DOI 10.1016/j.femsle.2005.09.020; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; R MAANOVA	62	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10167	10.1371/journal.pone.0010167	http://dx.doi.org/10.1371/journal.pone.0010167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422047	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952500002
J	Ciribilli, Y; Andreotti, V; Menendez, D; Langen, JS; Schoenfelder, G; Resnick, MA; Inga, A				Ciribilli, Yari; Andreotti, Virginia; Menendez, Daniel; Langen, Jan-Stephan; Schoenfelder, Gilbert; Resnick, Michael A.; Inga, Alberto			The Coordinated P53 and Estrogen Receptor Cis-Regulation at an FLT1 Promoter SNP Is Specific to Genotoxic Stress and Estrogenic Compound	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-SUPPRESSOR P53; FACTOR-BINDING-SITES; RESPONSE ELEMENTS; TRANSCRIPTION-FACTOR; BREAST-CANCER; DNA-DAMAGE; GENE-EXPRESSION; VEGF; CELLS	Background: Recently, we established that a C>T single nucleotide polymorphism (SNP) in the promoter of the VEGF receptor FLT1 gene generates a 1/2 site p53 response element (RE-T) that results in p53 responsiveness of the promoter. The transcriptional control required an estrogen receptor (ER) 1/2 site response element (ERE1) 225 nt upstream to the RE-T. Methodology/Principal Findings: Here we report the identification of a second ER K site (ERE2) located 145 bp downstream of the RE-T and establish that both EREs can impact p53-mediated transactivation of FLT1-T in a manner that is cell type and ER level dependent. Gene reporter assays and ChIP experiments conducted in the breast cancer-derived MCF7 cells revealed that the ERE2 site was sufficient for p53-mediated ER alpha recruitment and transactivation of the FLT1-T promoter/reporter construct. Surprisingly, unlike the case for other p53 target promoters, p53-mediated transactivation of FLT1-T constructs or expression of the endogenous FLT1 gene, as well as binding of p53 and ER at the promoter constructs, was inducible by doxorubicin but not by 5-fluorouracil. Furthermore, ER activity at FLT1-T was differentially affected by ER ligands, compared to a control TFF1/pS2 ER target promoter. The p53-related transcription factors (TFs) p73 and p63 had no effect on FLT1 transactivation. Conclusions/Significance: We establish a new dimension to the p53 master regulatory network where p53-mediated transcription from a 1/2 site RE can be determined by ER binding at one or more cis-acting EREs in manner that is dependent on level of ER protein, the type of ER ligand and the specific p53-inducing agent.	[Ciribilli, Yari; Andreotti, Virginia; Inga, Alberto] Natl Inst Canc Res, IST, Unit Mol Mutagenesis & DNA Repair, Genoa, Italy; [Menendez, Daniel; Resnick, Michael A.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Langen, Jan-Stephan; Schoenfelder, Gilbert] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Schoenfelder, Gilbert] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Inga, Alberto] Univ Trent, CIBIO, Ctr Integrat Biol, Trento, Italy	University of Genoa; IRCCS AOU San Martino IST; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University of Trento	Ciribilli, Y (corresponding author), Natl Inst Canc Res, IST, Unit Mol Mutagenesis & DNA Repair, Genoa, Italy.	inga@science.unitn.it	Andreotti, Virginia/AAB-5169-2022; Ciribilli, Yari/K-2751-2018; Andreotti, Virginia/K-4506-2016; resnick, Michael/F-1668-2019; Inga, Alberto/AAC-3815-2022	Andreotti, Virginia/0000-0002-2569-0832; Ciribilli, Yari/0000-0001-9231-379X; Andreotti, Virginia/0000-0002-2569-0832; resnick, Michael/0000-0002-8473-7506; Inga, Alberto/0000-0002-8767-1637; Schonfelder, Gilbert/0000-0001-6134-1990	Italian Association for Cancer Research, AIRC; NIEHS [1 Z01 ES065079]; Charite-Universitaetsmedizin Berlin; PhD School of Genetics Oncology and Developmental Biology, University of Genoa, Italy; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065079, ZIAES065079] Funding Source: NIH RePORTER	Italian Association for Cancer Research, AIRC(Fondazione AIRC per la ricerca sul cancro); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Charite-Universitaetsmedizin Berlin; PhD School of Genetics Oncology and Developmental Biology, University of Genoa, Italy; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by the Italian Association for Cancer Research, AIRC (to AI), intramural research funds from NIEHS project 1 Z01 ES065079 (to DM and MAR) and by the Charite-Universitaetsmedizin Berlin (to GS). YC was supported by a fellowship from the PhD School of Genetics Oncology and Developmental Biology, University of Genoa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2004, INT J CANCER, V111, P165, DOI 10.1002/ijc.20214; Andre T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO;2-5; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Das B, 2005, CANCER RES, V65, P7267, DOI 10.1158/0008-5472.CAN-04-4575; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; GEWIRTH DT, 1995, NAT STRUCT BIOL, V2, P386, DOI 10.1038/nsb0595-386; Ghanem MA, 2003, J CLIN PATHOL, V56, P107, DOI 10.1136/jcp.56.2.107; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heidenreich R, 2004, INT J CANCER, V111, P348, DOI 10.1002/ijc.20260; Hyder SM, 2000, CANCER RES, V60, P3183; Ilhan N, 2004, CLIN BIOCHEM, V37, P840, DOI 10.1016/j.clinbiochem.2004.03.012; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Ishizaki H, 2006, CLIN CANCER RES, V12, P5841, DOI 10.1158/1078-0432.CCR-06-0750; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Ju J, 2007, CLIN CANCER RES, V13, P4245, DOI 10.1158/1078-0432.CCR-06-2890; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kaeser MD, 2004, ONCOGENE, V23, P4007, DOI 10.1038/sj.onc.1207536; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; LaVallee TM, 2002, CANCER RES, V62, P3691; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Levrero M, 2000, J CELL SCI, V113, P1661; Luttun A, 2002, ANN NY ACAD SCI, V979, P80, DOI 10.1111/j.1749-6632.2002.tb04870.x; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Newman SP, 2004, INT J CANCER, V109, P533, DOI 10.1002/ijc.20045; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pal S, 2001, CANCER RES, V61, P6952; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sutherland TE, 2005, CLIN CANCER RES, V11, P1722, DOI 10.1158/1078-0432.CCR-04-1789; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Wang SZE, 2007, J BIOL CHEM, V282, P5661, DOI 10.1074/jbc.M608499200; WANG Y, 1995, MOL CELL BIOL, V15, P2157; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015	68	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10236	10.1371/journal.pone.0010236	http://dx.doi.org/10.1371/journal.pone.0010236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422012	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500012
J	Kansra, S; Chen, SL; Bangaru, MLY; Sneade, L; Dunckley, JA; Ben-Jonathan, N				Kansra, Sanjay; Chen, Shenglin; Bangaru, Madhavi Latha Yadav; Sneade, Leighton; Dunckley, Joseph A.; Ben-Jonathan, Nira			Selective Estrogen Receptor Down-Regulator and Selective Estrogen Receptor Modulators Differentially Regulate Lactotroph Proliferation	PLOS ONE			English	Article							PITUITARY-TUMOR CELLS; PURE ANTIESTROGEN; HORMONE-RECEPTOR; ER BETA; ALPHA; ACTIVATION; BINDING; PROTEIN; DEATH; TRANSCRIPTION	Background: We recently reported that estrogen receptor alpha (ER alpha), even in absence of estrogen (E2), plays a critical role in lactotroph homeostasis. The anti-estrogen ICI 182780 ( ICI), but not tamoxifen or raloxifene, rapidly promoted the degradation of ER alpha, and inhibited cell proliferation. However, all three ER antagonists suppressed PRL release, suggesting that receptor occupation is sufficient to inhibit prl gene expression whereas receptor degradation is required to suppress lactotroph proliferation. In this study our objective was to determine whether ER alpha degradation versus occupation, differentially modulates the biological outcome of anti-estrogens. Principal Findings: Using the rat lactotroph cell line, GH3 cells, we report that ICI induced proteosome mediated degradation of ER alpha. In contrast, an ER alpha specific antagonist, MPP, that does not promote degradation of ER alpha, did not inhibit cell proliferation. Further, ICI, but not MPP, abolished anchorage independent growth of GH3 cells. Yet, both ICI and MPP were equally effective in suppressing prl expression and release, as well as ERE-mediated transcriptional activity. Conclusion: Taken together, our results demonstrate that in lactotrophs, ER alpha degradation results in decreased cell proliferation, whereas ER alpha occupation by an antagonist that does not promote degradation of ER alpha is sufficient to inhibit prl expression.	[Kansra, Sanjay; Sneade, Leighton; Dunckley, Joseph A.; Ben-Jonathan, Nira] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA; [Kansra, Sanjay; Chen, Shenglin; Bangaru, Madhavi Latha Yadav] Med Coll Wisconsin, Dept Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA; [Kansra, Sanjay] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	University of Cincinnati; Medical College of Wisconsin; Medical College of Wisconsin	Kansra, S (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	skansra@mcw.edu	Chen, Shenglin/B-4049-2010		NCI NIH HHS [R01 CA096613, CA096613] Funding Source: Medline; NIEHS NIH HHS [ES012212, P30-ES06096, R01 ES012212, P30 ES006096] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012212, P30ES006096] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Caporali S, 2003, MOL BIOL CELL, V14, P5051, DOI 10.1091/mbc.E03-05-0303; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Imhof MO, 1996, MOL CELL BIOL, V16, P2594; JENSEN EV, 1969, STEROIDS, V13, P417, DOI 10.1016/0039-128X(69)90053-1; Ji Y, 2007, MOL CANCER RES, V5, P1041, DOI 10.1158/1541-7786.MCR-06-0379; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Laios I, 2003, J STEROID BIOCHEM, V87, P207, DOI 10.1016/j.jsbmb.2003.09.011; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Newton CJ, 1995, J STEROID BIOCHEM, V55, P327, DOI 10.1016/0960-0760(95)00191-3; NIRMALA PB, 1995, BIOCHEM BIOPH RES CO, V213, P24, DOI 10.1006/bbrc.1995.2093; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; STEINMETZ R, 1994, ENDOCRINOLOGY, V135, P2737, DOI 10.1210/en.135.6.2737; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; WAKELING AE, 1991, CANCER RES, V51, P3867; Wong JK, 2003, J NEUROSCI, V23, P4984; Yu R, 2002, J ENDOCRINOL, V174, P379, DOI 10.1677/joe.0.1740379	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10060	10.1371/journal.pone.0010060	http://dx.doi.org/10.1371/journal.pone.0010060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419096	Green Published, Green Submitted, gold			2022-12-27	WOS:000276853800002
J	Mazumdar, K; Alvarez, X; Borda, JT; Dufour, J; Martin, E; Bethune, MT; Khosla, C; Sestak, K				Mazumdar, Kaushiki; Alvarez, Xavier; Borda, Juan T.; Dufour, Jason; Martin, Edith; Bethune, Michael T.; Khosla, Chaitan; Sestak, Karol			Visualization of Transepithelial Passage of the Immunogenic 33-Residue Peptide from alpha-2 Gliadin in Gluten-Sensitive Macaques	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; T-CELLS; INTERFERON-GAMMA; DERMATITIS-HERPETIFORMIS; STRUCTURAL BASIS; TIGHT JUNCTIONS; MUCOSA; SPRUE	Background: Based on clinical, histopathological and serological similarities to human celiac disease ( CD), we recently established the rhesus macaque model of gluten sensitivity. In this study, we further characterized this condition based on presence of anti-tissue transglutaminase 2 (TG2) antibodies, increased intestinal permeability and transepithelial transport of a proteolytically resistant, immunotoxic, 33-residue peptide from alpha(2)-gliadin in the distal duodenum of gluten-sensitive macaques. Methodology/Principal Findings: Six rhesus macaques were selected for study from a pool of 500, including two healthy controls and four gluten-sensitive animals with elevated anti-gliadin or anti-TG2 antibodies as well as history of noninfectious chronic diarrhea. Pediatric endoscope-guided pinch biopsies were collected from each animal's distal duodenum following administration of a gluten-containing diet (GD) and again after remission by gluten-free diet (GFD). Control biopsies always showed normal villous architecture, whereas gluten-sensitive animals on GD exhibited histopathology ranging from mild lymphocytic infiltration to villous atrophy, typical of human CD. Immunofluorescent microscopic analysis of biopsies revealed IgG+ and IgA+ plasma-like cells producing antibodies that colocalized with TG2 in gluten-sensitive macaques only. Following instillation in vivo, the Cy-3-labeled 33-residue gluten peptide colocalized with the brush border protein villin in all animals. In a substantially enteropathic macaque with "leaky'' duodenum, the peptide penetrated beneath the epithelium into the lamina propria. Conclusions/Significance: The rhesus macaque model of gluten sensitivity not only resembles the histopathology of CD but it also may provide a model for studying intestinal permeability in states of epithelial integrity and disrepair.	[Mazumdar, Kaushiki; Sestak, Karol] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Alvarez, Xavier; Borda, Juan T.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Dufour, Jason] Tulane Natl Primate Res Ctr, Div Vet Med, Covington, LA USA; [Martin, Edith; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bethune, Michael T.; Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Sestak, Karol] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Stanford University; Stanford University; Stanford University; Tulane University	Mazumdar, K (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA.	ksestak@tulane.edu	Mazumdar, Kaushiki/AAW-6879-2020	Mazumdar, Kaushiki/0000-0002-1036-1980; Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [RO1DK076653, P51RR000164, RO1DK063158]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158, R01DK076653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health grants RO1DK076653 and P51RR000164 to KS, and RO1DK063158 grant to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Bethune MT, 2009, CHEM BIOL, V16, P868, DOI 10.1016/j.chembiol.2009.07.009; Bethune MT, 2009, J PHARMACOL EXP THER, V329, P657, DOI 10.1124/jpet.108.148007; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001614; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001857; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; DICKE W K, 1953, Acta Paediatr, V42, P34, DOI 10.1111/j.1651-2227.1953.tb05563.x; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; FRIIS S, 1992, GUT, V33, P1487, DOI 10.1136/gut.33.11.1487; Gass J, 2006, J PHARMACOL EXP THER, V318, P1178, DOI 10.1124/jpet.106.104315; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Jabri B, 2005, IMMUNOL REV, V206, P219, DOI 10.1111/j.0105-2896.2005.00294.x; JAVID J, 1971, AM J HUM GENET, V23, P496; Kaukinen K, 2005, SCAND J GASTROENTERO, V40, P564, DOI 10.1080/00365520510023422; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Korponay-Szabo IR, 2000, J PEDIATR GASTR NUTR, V31, P520, DOI 10.1097/00005176-200011000-00013; Lock RJ, 1999, J CLIN PATHOL, V52, P274, DOI 10.1136/jcp.52.4.274; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; MAWHINNEY H, 1975, CLIN EXP IMMUNOL, V21, P394; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Montalto M, 2002, DIGESTION, V65, P227, DOI 10.1159/000063817; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Papp M, 2008, CLIN CHEM, V54, P697, DOI 10.1373/clinchem.2007.098780; Pizzuti D, 2004, DIGEST LIVER DIS, V36, P337, DOI 10.1016/j.dld.2004.01.013; Qiao SW, 2004, J IMMUNOL, V173, P1757, DOI 10.4049/jimmunol.173.3.1757; Quarsten H, 1999, EUR J IMMUNOL, V29, P2506, DOI 10.1002/(SICI)1521-4141(199908)29:08<2506::AID-IMMU2506>3.0.CO;2-9; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; Ryan BM, 2000, GASTROENTEROLOGY, V119, P243, DOI 10.1053/gast.2000.8530; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; SHINER M, 1972, LANCET, V1, P1202; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Spurkland A, 1997, TISSUE ANTIGENS, V49, P29, DOI 10.1111/j.1399-0039.1997.tb02706.x; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Troncone R, 1998, DIGEST DIS SCI, V43, P156, DOI 10.1023/A:1018896625699; Tursi A, 2001, HEPATO-GASTROENTEROL, V48, P462; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	45	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10228	10.1371/journal.pone.0010228	http://dx.doi.org/10.1371/journal.pone.0010228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419103	Green Published, gold, Green Submitted			2022-12-27	WOS:000276853800018
J	Rajala, K; Lindroos, B; Hussein, SM; Lappalainen, RS; Pekkanen-Mattila, M; Inzunza, J; Rozell, B; Miettinen, S; Narkilahti, S; Kerkela, E; Aalto-Setala, K; Otonkoski, T; Suuronen, R; Hovatta, O; Skottman, H				Rajala, Kristiina; Lindroos, Bettina; Hussein, Samer M.; Lappalainen, Riikka S.; Pekkanen-Mattila, Mari; Inzunza, Jose; Rozell, Bjorn; Miettinen, Susanna; Narkilahti, Susanna; Kerkela, Erja; Aalto-Setala, Katriina; Otonkoski, Timo; Suuronen, Riitta; Hovatta, Outi; Skottman, Heli			A Defined and Xeno-Free Culture Method Enabling the Establishment of Clinical-Grade Human Embryonic, Induced Pluripotent and Adipose Stem Cells	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; SERUM REPLACEMENT MEDIUM; HUMAN FIBROBLASTS; HUMAN FEEDERS; DERIVATION; LINES; DIFFERENTIATION; EXPANSION; MEDIA; TISSUE	Background: The growth of stem cells in in vitro conditions requires optimal balance between signals mediating cell survival, proliferation, and self-renewal. For clinical application of stem cells, the use of completely defined conditions and elimination of all animal-derived materials from the establishment, culture, and differentiation processes is desirable. Methodology/Principal Findings: Here, we report the development of a fully defined xeno-free medium (RegES), capable of supporting the expansion of human embryonic stem cells (hESC), induced pluripotent stem cells (iPSC) and adipose stem cells (ASC). We describe the use of the xeno-free medium in the derivation and long-term (>80 passages) culture of three pluripotent karyotypically normal hESC lines: Regea 06/015, Regea 07/046, and Regea 08/013. Cardiomyocytes and neural cells differentiated from these cells exhibit features characteristic to these cell types. The same formulation of the xeno-free medium is capable of supporting the undifferentiated growth of iPSCs on human feeder cells. The characteristics of the pluripotent hESC and iPSC lines are comparable to lines derived and cultured in standard undefined culture conditions. In the culture of ASCs, the xeno-free medium provided significantly higher proliferation rates than ASCs cultured in medium containing allogeneic human serum (HS), while maintaining the differentiation potential and characteristic surface marker expression profile of ASCs, although significant differences in the surface marker expression of ASCs cultured in HS and RegES media were revealed. Conclusion/Significance: Our results demonstrate that human ESCs, iPSCs and ASCs can be maintained in the same defined xeno-free medium formulation for a prolonged period of time while maintaining their characteristics, demonstrating the applicability of the simplified xeno-free medium formulation for the production of clinical-grade stem cells. The basic xeno-free formulation described herein has the potential to be further optimized for specific applications relating to establishment, expansion and differentiation of various stem cell types.	[Rajala, Kristiina; Lindroos, Bettina; Lappalainen, Riikka S.; Pekkanen-Mattila, Mari; Miettinen, Susanna; Narkilahti, Susanna; Kerkela, Erja; Aalto-Setala, Katriina; Suuronen, Riitta; Skottman, Heli] Univ Tampere, Tampere Univ Hosp, Regea Inst Regenerat Med, FIN-33101 Tampere, Finland; [Hussein, Samer M.; Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Hussein, Samer M.; Otonkoski, Timo] Univ Helsinki, Biomedicum, Stem Cell Ctr, Helsinki, Finland; [Inzunza, Jose] Karolinska Inst, Dept Biosci & Nutr, Div Med Nutr, Stockholm, Sweden; [Rozell, Bjorn] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Suuronen, Riitta] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland; [Suuronen, Riitta] Tampere Univ Hosp, Dept Eye Ear & Oral Dis, Tampere, Finland; [Hovatta, Outi] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Tampere University; Tampere University; Tampere University Hospital; Karolinska Institutet; Karolinska University Hospital	Rajala, K (corresponding author), Univ Tampere, Tampere Univ Hosp, Regea Inst Regenerat Med, FIN-33101 Tampere, Finland.	kristiina.m.rajala@regea.fi	Otonkoski, Timo/F-1189-2011; Kerkelä, Erja/P-9459-2016; Seppänen-Kaijasinkko, Riitta/AAE-1476-2021; Mannerström, Bettina IC/F-4002-2016; Mannerström, Bettina/AAL-4214-2020	Kerkelä, Erja/0000-0002-2923-5300; Mannerström, Bettina IC/0000-0001-9316-5581; Skottman, Heli/0000-0002-4127-8792; Pekkanen-Mattila, Mari/0000-0002-8621-4303; Inzunza, Jose/0000-0003-0876-6767; Miettinen, Susanna/0000-0002-0647-9556	Academy of Finland [212776]; Finnish Funding Agency for Technology and Innovation [1128/31/05, 3524/31/07]; Pirkanmaa Hospital District [9H197]; ESTOOLS; European Union;  [K2007-54X-15080-04-3]	Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Pirkanmaa Hospital District; ESTOOLS(European Commission); European Union(European Commission); 	This research was supported by the Academy of Finland (grant number 212776) http://www.aka.fi; TEKES the Finnish Funding Agency for Technology and Innovation (grant number 1128/31/05 and 3524/31/07) http://www.tekes.fi; the Competitive Research Funding of the Pirkanmaa Hospital District (grant number 9H197) http://www.pshp.fi; and the (grant number K2007-54X-15080-04-3) http://www.vr.se. The generation of iPS cell lines was supported by funding for the ESTOOLS consortium under the Sixth Research Framework Program of the European Union. The funders had no role in study design, data collection and analysis, decision to pu Swedish Research Councilblish, or preparation of the manuscript.	AKOPIAN V, 2010, IN VITRO CELL DEV BI; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Cobo F, 2005, APPL MICROBIOL BIOT, V68, P456, DOI 10.1007/s00253-005-0062-2; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Haimi S, 2009, J BIOMED MATER RES A, V91A, P540, DOI 10.1002/jbm.a.32233; Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241; HAKALA H, 2009, TISSUE ENG, V15, P1; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Koivisto H, 2004, REPROD BIOMED ONLINE, V9, P330, DOI 10.1016/S1472-6483(10)62150-5; Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolreprod.104.033480; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Mirabet V, 2008, CELL TISSUE BANK, V9, P1, DOI 10.1007/s10561-007-9048-x; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Skottman H, 2006, REPRODUCTION, V132, P691, DOI 10.1530/rep.1.01079; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	43	119	124	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10246	10.1371/journal.pone.0010246	http://dx.doi.org/10.1371/journal.pone.0010246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419109	Green Submitted, gold, Green Published			2022-12-27	WOS:000276853800021
J	Bangaru, MLY; Woodliff, J; Raff, H; Kansra, S				Bangaru, Madhavi Latha Yadav; Woodliff, Jeffrey; Raff, Hershel; Kansra, Sanjay			Growth Suppression of Mouse Pituitary Corticotroph Tumor AtT20 Cells by Curcumin: A Model for Treating Cushing's Disease	PLOS ONE			English	Article							FACTOR-KAPPA-B; PROSTATE-CANCER CELLS; BCL-XL; TRANSCRIPTION FACTOR; APOPTOSIS; ACTIVATION; EXPRESSION; PROLIFERATION; INHIBITION; ADENOMAS	Background: Pituitary corticotroph tumors secrete excess adrenocorticotrophic hormone (ACTH) resulting in Cushing's disease (CD). Standard treatment includes surgery and, if not successful, radiotherapy, both of which have undesirable side effects and frequent recurrence of the tumor. Pharmacotherapy using PPAR gamma agonists, dopamine receptor agonists, retinoic acid or somatostatin analogs is still experimental. Curcumin, a commonly used food additive in South Asian cooking, has potent growth inhibitory effects on cell proliferation. Our laboratory recently demonstrated that curcumin inhibited growth and induced apoptosis in prolactin-and growth hormone-producing tumor cells [1]. Subsequently, Schaaf et. al. confirmed our findings and also showed the in vivo effectiveness of curcumin to suppress pituitary tumorigenesis. However the molecular mechanism that mediate this effect of curcumin are still unknown. Principal Findings: Using the mouse corticotroph tumor cells, AtT20 cells, we report that curcumin had a robust, irreversible inhibitory effect on cell proliferation and clonogenic property. The curcumin-induced growth inhibition was accompanied by decreased NFkB activity. Further, curcumin down-regulated the pro-survival protein Bcl-xL, depolarized the mitochondrial membrane, increased PARP cleavage, which led to apoptotic cell death. Finally, curcumin had a concentration-dependent suppressive effect on ACTH secretion from AtT20 cells. Conclusion: The ability of curcumin to inhibit NFkB and induce apoptosis in pituitary corticotroph tumor cells leads us to propose developing it as a novel therapeutic agent for the treatment of CD.	[Bangaru, Madhavi Latha Yadav; Raff, Hershel; Kansra, Sanjay] Aurora St Lukes Med Ctr, Dept Endocrinol Metab & Clin Nutr, Milwaukee, WI USA; [Woodliff, Jeffrey] Aurora St Lukes Med Ctr, Dept Pediat, Milwaukee, WI USA; [Raff, Hershel] Aurora St Lukes Med Ctr, Endocrine Res Lab, Milwaukee, WI USA; [Kansra, Sanjay] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Bangaru, MLY (corresponding author), Aurora St Lukes Med Ctr, Dept Endocrinol Metab & Clin Nutr, Milwaukee, WI USA.	skansra@mcw.edu			Medical College of Wisconsin	Medical College of Wisconsin(General Electric)	Start up funds from the Medical College of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Boscaro M, 2009, J CLIN ENDOCR METAB, V94, P115, DOI 10.1210/jc.2008-1008; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Deeb D, 2007, J PHARMACOL EXP THER, V321, P616, DOI 10.1124/jpet.106.117721; Ezzat S, 2006, MOL ENDOCRINOL, V20, P2976, DOI 10.1210/me.2006-0265; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Heaney AP, 2002, NAT MED, V8, P1281, DOI 10.1038/nm784; Jee SH, 1998, J INVEST DERMATOL, V111, P656, DOI 10.1046/j.1523-1747.1998.00352.x; Jiang MC, 1996, ONCOGENE, V13, P609; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Katznelson L, 2001, CLIN ENDOCRINOL, V54, P183, DOI 10.1046/j.1365-2265.2001.01214.x; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; KLEIN SB, 1992, J CELL PHYSIOL, V151, P326, DOI 10.1002/jcp.1041510214; LUD CJ, 2000, SYNAPSE, V35, P228; Miller M, 2008, ENDOCRINOLOGY, V149, P4158, DOI 10.1210/en.2007-1760; Miyoshi T, 2004, J ENDOCRINOL INVEST, V27, P1055, DOI 10.1007/BF03345309; Ohori H, 2006, MOL CANCER THER, V5, P2563, DOI 10.1158/1535-7163.MCT-06-0174; Ozer E, 2003, TUMORI, V89, P54, DOI 10.1177/030089160308900112; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; ROSS EJ, 1982, LANCET, V2, P646; Schaaf C, 2009, ENDOCR-RELAT CANCER, V16, P1339, DOI 10.1677/ERC-09-0129; Shah BH, 1999, BIOCHEM PHARMACOL, V58, P1167, DOI 10.1016/S0006-2952(99)00206-3; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Wang WX, 1999, CLIN CANCER RES, V5, P119; ZALDIVAR V, NEUROENDOCRINOLOGY, V90, P292	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e9893	10.1371/journal.pone.0009893	http://dx.doi.org/10.1371/journal.pone.0009893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405005	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706300001
J	Pang, YP; Davis, J; Wang, SH; Park, JG; Nambiar, MP; Schmidt, JJ; Millard, CB				Pang, Yuan-Ping; Davis, Jon; Wang, Shaohua; Park, Jewn Giew; Nambiar, Madhusoodana P.; Schmidt, James J.; Millard, Charles B.			Small Molecules Showing Significant Protection of Mice against Botulinum Neurotoxin Serotype A	PLOS ONE			English	Article							AB-INITIO CALCULATIONS; DYNAMICS SIMULATION; ZINC ENDOPEPTIDASE; TOXIN; INHIBITORS; IDENTIFICATION; AMBER; RECOGNITION; PERFORMANCE; MANAGEMENT	Botulinum neurotoxin serotype A (BoNTA) causes a life-threatening neuroparalytic disease known as botulism that could afflict large, unprotected populations if the toxin were employed in an act of bioterrorism. Current post-exposure therapy is limited to symptomatic treatment or passive immunization that is effective for treating infant botulism at a cost of US $45,300 per treatment regimen. Antibodies can neutralize the extracellular but not the intracellular BoNTA. Moreover, antibody production, storage, and administration in a mass casualty scenario pose logistical challenges. Alternatively, small-molecule inhibitors of BoNTA endopeptidase (BoNTAe) are sought to antagonize the extracellular or intracellular toxin. While several such molecules reportedly demonstrated efficacy in protecting cells against BoNTA, there is scant information to show that small molecules can significantly protect mammals against BoNTA. Herein we report the development of effective small-molecules BoNTAe inhibitors with promising in vivo pharmacokinetics. One such molecule has an in vivo half-life of 6.5 hours and is devoid of obvious sign of toxicity. Pre-treatment with this molecule at 2 mg/kg protected 100% and 70% of treated mice against BoNTA at 5 times of its median-lethal dose during the periods of 2 and 4 half-lives of the inhibitor, respectively. In contrast, 40% and 0% of untreated mice survived during the respective periods. Similar levels of protection were also observed with two other small molecules. These results demonstrate that small molecules can significantly protect mice against BoNTA and support the pursuit of small-molecule antagonists as a cost-effective alternative or as an adjunct to passive immunity for treating botulism.	[Pang, Yuan-Ping; Wang, Shaohua; Park, Jewn Giew] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA; [Davis, Jon; Nambiar, Madhusoodana P.; Millard, Charles B.] Walter Reed Army Inst Res, Div Biochem, Silver Spring, MD USA; [Schmidt, James J.] USA, Med Res Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD 21702 USA	Mayo Clinic; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu; charles.b.millard@us.army.mil		Pang, Yuan-Ping/0000-0003-0838-2560	United States Army Medical Research and Materiel Command [W81XWH-04-2-0001, W81XWH-08-1-0154]; United States Army Research Office [W911NF-09-1-0095]; United States Defense Threat Reduction Agency [3.10023_07_RD_B, 3.10014_08_WR_B]; University of Minnesota Supercomputing Institute	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); United States Army Research Office; United States Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); University of Minnesota Supercomputing Institute	This work was supported by the United States Army Medical Research and Materiel Command (W81XWH-04-2-0001 and W81XWH-08-1-0154), the United States Army Research Office (W911NF-09-1-0095), the United States Defense Threat Reduction Agency (3.10023_07_RD_B and 3.10014_08_WR_B), and the University of Minnesota Supercomputing Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the United States Army, Navy or the Department of Defense.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Arnon SS, 2007, PEDIATRICS, V119, P785, DOI 10.1542/peds.2006-0646; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boldt GE, 2006, CHEM COMMUN, P3063, DOI 10.1039/b603099h; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Cai SW, 2010, TOXICON, V55, P818, DOI 10.1016/j.toxicon.2009.11.017; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Crowner BE, 2007, CLIN NEUROPHARMACOL, V30, P310, DOI 10.1097/WNF.0B013E31804B1A0D; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; El Yazal J, 2000, J PHYS CHEM B, V104, P6662, DOI 10.1021/jp994283x; El Yazal J, 1999, J PHYS CHEM B, V103, P8773, DOI 10.1021/jp991787m; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Frisch M J, 1999, GAUSSIAN 98 REVISION; HATHEWAY CH, 1984, J INFECT DIS, V150, P407, DOI 10.1093/infdis/150.3.407; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Johnson SL, 2008, CHEM BIOL DRUG DES, V71, P131, DOI 10.1111/j.1747-0285.2007.00617.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kessler KR, 1997, NEUROTOXICOLOGY, V18, P761; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P2316, DOI 10.1001/jama.2009.780; Larsen JC, 2009, DRUG DEVELOP RES, V70, P266, DOI 10.1002/ddr.20304; Liang BA, 2006, AM J LAW MED, V32, P279, DOI 10.1177/009885880603200207; Moe ST, 2009, BIOORGAN MED CHEM, V17, P3072, DOI 10.1016/j.bmc.2009.03.013; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007730; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; SARVAS H, 1993, J CLIN IMMUNOL, V13, P145, DOI 10.1007/BF00919271; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; SPRINGEN K, 2002, NEWSWEEK, P50; Tang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000761; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063	45	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10129	10.1371/journal.pone.0010129	http://dx.doi.org/10.1371/journal.pone.0010129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405003	Green Published, Green Submitted, gold			2022-12-27	WOS:000276706300002
J	Azakir, BA; Di Fulvio, S; Therrien, C; Sinnreich, M				Azakir, Bilal A.; Di Fulvio, Sabrina; Therrien, Christian; Sinnreich, Michael			Dysferlin Interacts with Tubulin and Microtubules in Mouse Skeletal Muscle	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; SYNAPTIC VESICLES; PLASMA-MEMBRANE; SYNAPTOTAGMIN-I; DISTINCT POOLS; PHAGE DISPLAY; PROTEIN; REPAIR; TRAFFICKING; CELLS	Dysferlin is a type II transmembrane protein implicated in surface membrane repair in muscle. Mutations in dysferlin lead to limb girdle muscular dystrophy 2B, Miyoshi Myopathy and distal anterior compartment myopathy. Dysferlin's mode of action is not well understood and only a few protein binding partners have thus far been identified. Using affinity purification followed by liquid chromatography/mass spectrometry, we identified alpha-tubulin as a novel binding partner for dysferlin. The association between dysferlin and alpha-tubulin, as well as between dysferlin and microtubules, was confirmed in vitro by glutathione S-transferase pulldown and microtubule binding assays. These interactions were confirmed in vivo by co-immunoprecipitation. Confocal microscopy revealed that dysferlin and alpha-tubulin co-localized in the perinuclear region and in vesicular structures in myoblasts, and along thin longitudinal structures reminiscent of microtubules in myotubes. We mapped dysferlin's alpha-tubulin-binding region to its C2A and C2B domains. Modulation of calcium levels did not affect dysferlin binding to alpha-tubulin, suggesting that this interaction is calcium-independent. Our studies identified a new binding partner for dysferlin and suggest a role for microtubules in dysferlin trafficking to the sarcolemma.	[Azakir, Bilal A.; Di Fulvio, Sabrina; Therrien, Christian; Sinnreich, Michael] McGill Univ, Neuromuscular Res Grp, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Ctr, Dept Neurol, CH-4031 Basel, Switzerland; [Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Ctr, Dept Biomed, CH-4031 Basel, Switzerland	McGill University; University of Basel; University of Basel	Azakir, BA (corresponding author), McGill Univ, Neuromuscular Res Grp, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.	michael.sinnreich@unibas.ch	Azakir, Bilal/AAP-9345-2020	Azakir, Bilal/0000-0003-3084-0265; Sinnreich, Michael/0000-0002-9835-1276	Canadian Institute for Health Research - ALS Society Canada - Muscular Dystrophy Association Canada (CIHR-ALS-MDAC); Fond pour la recherche en sante Quebec (FRSQ); Association Francaise contre les Myopathies, Myosuisse	Canadian Institute for Health Research - ALS Society Canada - Muscular Dystrophy Association Canada (CIHR-ALS-MDAC)(Canadian Institutes of Health Research (CIHR)); Fond pour la recherche en sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Association Francaise contre les Myopathies, Myosuisse(Association Francaise contre les Myopathies)	This work was supported by the Canadian Institute for Health Research - ALS Society Canada - Muscular Dystrophy Association Canada (CIHR-ALS-MDAC) Partnership Program, Fond pour la recherche en sante Quebec (FRSQ), Association Francaise contre les Myopathies, Myosuisse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampong Beryl N, 2005, Acta Myol, V24, P134; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Farnaes L, 2003, J BIOL CHEM, V278, P33120, DOI 10.1074/jbc.M210852200; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Haberman Y, 2003, J CELL SCI, V116, P4307, DOI 10.1242/jcs.00719; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Hino M, 2009, CELL STRUCT FUNCT, V34, P11, DOI 10.1247/csf.08033; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Honda A, 2002, J BIOL CHEM, V277, P20234, DOI 10.1074/jbc.M112080200; HUANG Y, 2008, HUM MOL GENET; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Huber K, 2008, MOL CANCER THER, V7, P143, DOI 10.1158/1535-7163.MCT-07-0486; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; PRYDZ K, 1995, BIOCHEM SOC T, V23, P535, DOI 10.1042/bst0230535; Ramsay TG, 2003, J ANIM SCI, V81, P3046; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; Subramanian VS, 2007, AM J PHYSIOL-CELL PH, V293, pC1717, DOI 10.1152/ajpcell.00309.2007; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Togo T, 2006, J CELL SCI, V119, P2780, DOI 10.1242/jcs.03006; Vandre DD, 2007, BIOL REPROD, V77, P533, DOI 10.1095/biolreprod.107.062190	47	40	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10122	10.1371/journal.pone.0010122	http://dx.doi.org/10.1371/journal.pone.0010122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405035	Green Submitted, gold, Green Published			2022-12-27	WOS:000276705900007
J	Lau, NC; Mulder, KW; Brenkman, AB; Mohammed, S; van den Broek, NJF; Heck, AJR; Timmers, HTM				Lau, Nga-Chi; Mulder, Klaas W.; Brenkman, Arjan B.; Mohammed, Shabaz; van den Broek, Niels J. F.; Heck, Albert J. R.; Timmers, H. Th. Marc			Phosphorylation of Not4p Functions Parallel to BUR2 to Regulate Resistance to Cellular Stresses in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA METABOLISM; CYCLIN-DEPENDENT KINASE; TRANSCRIPTION IN-VIVO; CCR4-NOT COMPLEX; HISTONE METHYLATION; GENE-EXPRESSION; PROTEIN-KINASE; POLYMERASE-II; SET1 COMPLEX; YEAST	Background: The evolutionarily conserved Ccr4-Not and Bur1/2 kinase complexes are functionally related in Saccharomyces cerevisiae. In this study, we further explore the relationship between the subunits Not4p and Bur2p. Methodology/Principal Findings: First, we investigated the presence of post-translational modifications on the Ccr4-Not complex. Using mass spectrometry analyses we identified several SP/TP phosphorylation sites on its Not4p, Not1p and Caf1p subunits. Secondly, the influence of Not4p phosphorylation on global H3K4 tri-methylation status was examined by immunoblotting. This histone mark is severely diminished in the absence of Not4p or of Bur2p, but did not require the five identified Not4p phosphorylation sites. Thirdly, we found that Not4p phosphorylation is not affected by the kinase-defective bur1-23 mutant. Finally, phenotypic analyses of the Not4p phosphomutant (not4S/T5A) and bur2D strains showed overlapping sensitivities to drugs that abolish cellular stress responses. The double-mutant not4S/T5A and bur2D strain even revealed enhanced phenotypes, indicating that phosphorylation of Not4p and BUR2 are active in parallel pathways for drug tolerance. Conclusions: Not4p is a phospho-protein with five identified phosphorylation sites that are likely targets of a cyclin-dependent kinase(s) other than the Bur1/2p complex. Not4p phosphorylation on the five Not4 S/T sites is not required for global H3K4 tri-methylation. In contrast, Not4p phosphorylation is involved in tolerance to cellular stresses and acts in pathways parallel to BUR2 to affect stress responses in Saccharomyces cerevisiae.	[Lau, Nga-Chi; Mulder, Klaas W.; Brenkman, Arjan B.; van den Broek, Niels J. F.; Timmers, H. Th. Marc] Univ Med Ctr Utrecht, Dept Physiol Chem, Utrecht, Netherlands; [Lau, Nga-Chi; Mohammed, Shabaz; Heck, Albert J. R.; Timmers, H. Th. Marc] Netherlands Prote Ctr, Utrecht, Netherlands; [Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Lau, NC (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Utrecht, Netherlands.	h.t.m.timmers@umcutrecht.nl	Mulder, Klaas/A-1882-2013; Mohammed, Shabaz/AAY-6313-2020; Heck, Albert/D-7098-2011; Mohammed, Shabaz/D-1042-2010	Mulder, Klaas/0000-0001-8516-4458; Mohammed, Shabaz/0000-0003-2640-9560; Heck, Albert/0000-0002-2405-4404; Mohammed, Shabaz/0000-0003-2640-9560	Netherlands Organization for Scientific Research [NWO-CW 700-50-034]; European Union [RTN2-2001-00026, LSHG-CT-2004-502950]; EMBO [ASTF 184.00-02]; Netherlands Proteomics Centre [NPC4.5, NPC4.7]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Netherlands Proteomics Centre	This work was supported by the Netherlands Organization for Scientific Research (NWO-CW #700-50-034), European Union (Improving Human Potential RTN2-2001-00026 and STREP LSHG-CT-2004-502950), EMBO (ASTF 184.00-02) and the Netherlands Proteomics Centre (NPC4.5 and NPC4.7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Chuang SM, 2005, GENETICS, V171, P1477, DOI 10.1534/genetics.105.046888; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Mulder KW, 2005, NUCLEIC ACIDS RES, V33, P6384, DOI 10.1093/nar/gki938; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; PRELICH G, 1993, GENETICS, V135, P665; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	28	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9864	10.1371/journal.pone.0009864	http://dx.doi.org/10.1371/journal.pone.0009864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386698	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482000001
J	Konagurthu, AS; Reboul, CF; Schmidberger, JW; Irving, JA; Lesk, AM; Stuckey, PJ; Whisstock, JC; Buckle, AM				Konagurthu, Arun S.; Reboul, Cyril F.; Schmidberger, Jason W.; Irving, James A.; Lesk, Arthur M.; Stuckey, Peter J.; Whisstock, James C.; Buckle, Ashley M.			MUSTANG-MR Structural Sieving Server: Applications in Protein Structural Analysis and Crystallography	PLOS ONE			English	Article							ALIGNMENT; DATABASE	Background: A central tenet of structural biology is that related proteins of common function share structural similarity. This has key practical consequences for the derivation and analysis of protein structures, and is exploited by the process of "molecular sieving" whereby a common core is progressively distilled from a comparison of two or more protein structures. This paper reports a novel web server for "sieving" of protein structures, based on the multiple structural alignment program MUSTANG. Methodology/Principal Findings: "Sieved" models are generated from MUSTANG-generated multiple alignment and superpositions by iteratively filtering out noisy residue-residue correspondences, until the resultant correspondences in the models are optimally "superposable" under a threshold of RMSD. This residue-level sieving is also accompanied by iterative elimination of the poorly fitting structures from the input ensemble. Therefore, by varying the thresholds of RMSD and the cardinality of the ensemble, multiple sieved models are generated for a given multiple alignment and superposition from MUSTANG. To aid the identification of structurally conserved regions of functional importance in an ensemble of protein structures, Lesk-Hubbard graphs are generated, plotting the number of residue correspondences in a superposition as a function of its corresponding RMSD. The conserved "core" (or typically active site) shows a linear trend, which becomes exponential as divergent parts of the structure are included into the superposition. Conclusions: The application addresses two fundamental problems in structural biology: First, the identification of common substructures among structurally related proteins-an important problem in characterization and prediction of function; second, generation of sieved models with demonstrated uses in protein crystallographic structure determination using the technique of Molecular Replacement.	[Konagurthu, Arun S.; Stuckey, Peter J.] Univ Melbourne, NICTA Victoria Res Lab, Melbourne, Vic, Australia; [Konagurthu, Arun S.; Stuckey, Peter J.] Univ Melbourne, Dept Comp Sci & Software Engn, Melbourne, Vic, Australia; [Reboul, Cyril F.; Schmidberger, Jason W.; Irving, James A.; Whisstock, James C.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Reboul, Cyril F.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Lesk, Arthur M.] Penn State Univ, Dept Biochem & Mol Biol, Huck Inst Genom Prote & Bioinformat, University Pk, PA 16802 USA	University of Melbourne; University of Melbourne; Monash University; Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Konagurthu, AS (corresponding author), Univ Melbourne, NICTA Victoria Res Lab, Melbourne, Vic, Australia.	ashley.buckle@med.monash.edu.au	Irving, James A/I-8467-2015; Buckle, Ashley/P-8366-2016; Irving, James/P-3860-2019; Schmidberger, Jason/D-5978-2015	Buckle, Ashley/0000-0003-2943-9044; Irving, James/0000-0003-3204-6356; Konagurthu, Arun/0000-0002-1610-8329; Whisstock, James/0000-0003-4200-5611; Stuckey, Peter/0000-0003-2186-0459; Lesk, Arthur/0000-0002-2596-0601; Reboul, Cyril/0000-0002-6258-2697	Australian Research Council; National Health and Medical Research Council; Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; State Government of Victoria (Australia); Australian Government's Department of Communications, Information Technology and the Arts; ICT Centre of Excellence program	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Partnership for Advanced Computing; Victorian Bioinformatics Consortium; Monash eResearch Centre; State Government of Victoria (Australia); Australian Government's Department of Communications, Information Technology and the Arts(Australian Government); ICT Centre of Excellence program	Australian Research Council, National Health and Medical Research Council, Victorian Partnership for Advanced Computing, the Victorian Bioinformatics Consortium, Monash eResearch Centre, the State Government of Victoria (Australia), National ICT Australia (NICTA) is funded by: the Australian Government's Department of Communications, Information Technology and the Arts; the Australian Research Council through Backing Australia's Ability and ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Irving JA, 2001, PROTEINS, V42, P378, DOI 10.1002/1097-0134(20010215)42:3<378::AID-PROT70>3.0.CO;2-3; Ito K, 2006, PROTEIN SCI, V15, P1187, DOI 10.1110/ps.062148506; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622	16	40	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10048	10.1371/journal.pone.0010048	http://dx.doi.org/10.1371/journal.pone.0010048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386610	Green Published, gold, Green Submitted			2022-12-27	WOS:000276420400017
J	Robert, D; Nguyen, TH; Gallet, F; Wilhelm, C				Robert, Damien; Nguyen, Thi-Hanh; Gallet, Francois; Wilhelm, Claire			In Vivo Determination of Fluctuating Forces during Endosome Trafficking Using a Combination of Active and Passive Microrheology	PLOS ONE			English	Article							MOTOR PROTEINS; LIVING CELLS; MECHANICS; KINESIN; MOVE; VISCOELASTICITY; CYTOPLASM; DIFFUSION; DYNAMICS; TRACKING	Background: Regulation of intracellular trafficking is a central issue in cell biology. The forces acting on intracellular vesicles (endosomes) can be assessed in living cells by using a combination of active and passive microrheology. Methodology/Principal Findings: This dual approach is based on endosome labeling with magnetic nanoparticles. The resulting magnetic endosomes act both as probes that can be manipulated with external magnetic fields to infer the viscoelastic modulus of their surrounding microenvironment, and as biological vehicles that are trafficked along the microtubule network by means of forces generated by molecular motors. The intracellular viscoelastic modulus exhibits power law dependence with frequency, which is microtubule and actin-dependent. The mean square displacements of endosomes do not follow the predictions of the fluctuation-dissipation theorem, which offers evidence for active force generation. Microtubule disruption brings the intracellular medium closer to thermal equilibrium: active forces acting on the endosomes depend on microtubule-associated motors. The power spectra of these active forces, deduced through the use of a generalized Langevin equation, show a power law decrease with frequency and reveal an actin-dependent persistence of the force with time. Experimental spectra have been reproduced by a simple model consisting in a series of force steps power-law distributed in time. This model enlightens the role of the cytoskeleton dependent force exerted on endosomes to perform intracellular trafficking. Conclusions/Significance: In this work, the influence of cytoskeleton components and molecular motors on intracellular viscoelasticity and transport is addressed. The use of an original probe, the magnetic endosome, allows retrieving the power spectrum of active forces on these organelles thanks to interrelated active and passive measures. Finally a computational model gives estimates of the force itself and hence of the number of the motors pulling on endosomes.	[Robert, Damien] CNRS, UMR 7057, Lab Matiere & Syst Complexes, Paris, France; Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Robert, D (corresponding author), CNRS, UMR 7057, Lab Matiere & Syst Complexes, Paris, France.	claire.wilhelm@univ-paris-diderot.fr	Gallet, Francois/B-9862-2008	Wilhelm, Claire/0000-0001-7024-9627	ANR Physique et Chimie du Vivant	ANR Physique et Chimie du Vivant(French National Research Agency (ANR))	This work was supported by ANR Physique et Chimie du Vivant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcizet D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248103; Balland M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021911; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; Caspi A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011916; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Feneberg W, 2001, EUR BIOPHYS J BIOPHY, V30, P284, DOI 10.1007/s002490100135; Gallet F, 2009, SOFT MATTER, V5, P2947, DOI 10.1039/b901311c; Girard KD, 2006, P NATL ACAD SCI USA, V103, P2103, DOI 10.1073/pnas.0508819103; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Heidemann SR, 2004, TRENDS CELL BIOL, V14, P160, DOI 10.1016/j.tcb.2004.02.003; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Levine AJ, 2009, J PHYS CHEM B, V113, P3820, DOI 10.1021/jp808192w; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Marion S, 2004, J CELL SCI, V117, P3271, DOI 10.1242/jcs.01178; Masson JB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.048103; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Nan XL, 2008, CHEMPHYSCHEM, V9, P707, DOI 10.1002/cphc.200700839; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Pottier N, 2005, PHYSICA A, V345, P472, DOI 10.1016/j.physa.2004.07.019; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Taunton J, 2001, CURR OPIN CELL BIOL, V13, P85, DOI 10.1016/S0955-0674(00)00178-2; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Trepat X, 2008, SOFT MATTER, V4, P1750, DOI 10.1039/b804866e; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Wilhelm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.011504; Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Yanai M, 2004, AM J PHYSIOL-CELL PH, V287, pC603, DOI 10.1152/ajpcell.00347.2003; Zeldovich KB, 2005, EUR PHYS J E, V17, P155, DOI 10.1140/epje/i2004-10137-6	41	100	100	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10046	10.1371/journal.pone.0010046	http://dx.doi.org/10.1371/journal.pone.0010046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386607	Green Published, gold, Green Submitted			2022-12-27	WOS:000276420400016
J	Caccia, S; Hernandez-Rodriguez, CS; Mahon, RJ; Downes, S; James, W; Bautsoens, N; Van Rie, J; Ferre, J				Caccia, Silvia; Sara Hernandez-Rodriguez, Carmen; Mahon, Rod J.; Downes, Sharon; James, William; Bautsoens, Nadine; Van Rie, Jeroen; Ferre, Juan			Binding Site Alteration Is Responsible for Field-Isolated Resistance to Bacillus thuringiensis Cry2A Insecticidal Proteins in Two Helicoverpa Species	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; ARMIGERA LEPIDOPTERA; PLUTELLA-XYLOSTELLA; DIAMONDBACK MOTH; DELTA-ENDOTOXIN; BT CROPS; AUSTRALIAN POPULATIONS; EVOLVED RESISTANCE; CROSS-RESISTANCE; TOXINS CRY1AC	Background: Evolution of resistance by target pests is the main threat to the long-term efficacy of crops expressing Bacillus thuringiensis (Bt) insecticidal proteins. Cry2 proteins play a pivotal role in current Bt spray formulations and transgenic crops and they complement Cry1A proteins because of their different mode of action. Their presence is critical in the control of those lepidopteran species, such as Helicoverpa spp., which are not highly susceptible to Cry1A proteins. In Australia, a transgenic variety of cotton expressing Cry1Ac and Cry2Ab (Bollgard II) comprises at least 80% of the total cotton area. Prior to the widespread adoption of Bollgard II, the frequency of alleles conferring resistance to Cry2Ab in field populations of Helicoverpa armigera and Helicoverpa punctigera was significantly higher than anticipated. Colonies established from survivors of F-2 screens against Cry2Ab are highly resistant to this toxin, but susceptible to Cry1Ac. Methodology/Principal Findings: Bioassays performed with surface-treated artificial diet on neonates of H. armigera and H. punctigera showed that Cry2Ab resistant insects were cross-resistant to Cry2Ae while susceptible to Cry1Ab. Binding analyses with I-125-labeled Cry2Ab were performed with brush border membrane vesicles from midguts of Cry2Ab susceptible and resistant insects. The results of the binding analyses correlated with bioassay data and demonstrated that resistant insects exhibited greatly reduced binding of Cry2Ab toxin to midgut receptors, whereas no change in I-125-labeled-Cry1Ac binding was detected. As previously demonstrated for H. armigera, Cry2Ab binding sites in H. punctigera were shown to be shared by Cry2Ae, which explains why an alteration of the shared binding site would lead to cross-resistance between the two Cry2A toxins. Conclusion/Significance: This is the first time that a mechanism of resistance to the Cry2 class of insecticidal proteins has been reported. Because we found the same mechanism of resistance in multiple strains representing several field populations, we conclude that target site alteration is the most likely means that field populations evolve resistance to Cry2 proteins in Helicoverpa spp. Our work also confirms the presence in the insect midgut of specific binding sites for this class of proteins. Characterizing the Cry2 receptors and their mutations that enable resistance could lead to the development of molecular tools to monitor resistance in the field.	[Caccia, Silvia; Sara Hernandez-Rodriguez, Carmen; Ferre, Juan] Univ Valencia, Dept Genet, E-46100 Burjassot, Spain; [Mahon, Rod J.; James, William] CSIRO Entomol, Canberra, ACT, Australia; [Downes, Sharon] CSIRO Entomol, Narrabri, Australia; [Bautsoens, Nadine; Van Rie, Jeroen] Bayer BioSci, Ghent, Belgium	University of Valencia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Bayer AG	Caccia, S (corresponding author), Univ Valencia, Dept Genet, E-46100 Burjassot, Spain.	juan.ferre@uv.es	James, Bill J/C-8908-2012; Hernandez Rodriguez, C Sara Hernández-Rodríguez/J-6739-2012; Ferré, Juan/L-9426-2014; Downes, Sharon Joy/C-1770-2008; Hernandez-Rodriguez, Carmen Sara/D-5648-2012	Hernandez Rodriguez, C Sara Hernández-Rodríguez/0000-0002-1234-1190; Ferré, Juan/0000-0001-5535-0612; Downes, Sharon Joy/0000-0002-3729-1732; CACCIA, Silvia/0000-0003-1954-7180	The Cotton Research and Development Corporation in Australia CSIRO; Spanish Ministry of Science and Innovation [AGL2006-11914]; European FEDER; Bayer BioScience; EU [PIEF-GA-2008-219993]	The Cotton Research and Development Corporation in Australia CSIRO(Cotton R&D Corp); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European FEDER(European Commission); Bayer BioScience; EU(European Commission)	The Cotton Research and Development Corporation in Australia CSIRO, the Spanish Ministry of Science and Innovation (project AGL2006-11914), European FEDER funds, and Bayer BioScience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript except for JVR and NB, employed by Bayer BioScience. SC was supported by a Marie Curie fellowship No. PIEF-GA-2008-219993 from the EU.	Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Baxter SW, 2008, INSECT BIOCHEM MOLEC, V38, P125, DOI 10.1016/j.ibmb.2007.09.014; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bird LJ, 2007, BIOL CONTROL, V40, P196, DOI 10.1016/j.biocontrol.2006.11.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CONVENTS D, 1990, J BIOL CHEM, V265, P1369; CRICKMORE N, 1992, MOL MICROBIOL, V6, P1533, DOI 10.1111/j.1365-2958.1992.tb00874.x; DOWNES S, 2009, J ECON ENTOMOL, V100, P1844; DOWNES S, 2009, J EC ENTOMO IN PRESS; ENGLISH L, 1994, INSECT BIOCHEM MOLEC, V24, P1025, DOI 10.1016/0965-1748(94)90140-6; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; Ferre Juan, 2008, V5, P41; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gao YL, 2009, J ECON ENTOMOL, V102, P1217, DOI 10.1603/029.102.0347; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; GOULD F, 1992, P NATL ACAD SCI USA, V89, P7986, DOI 10.1073/pnas.89.17.7986; Granero F, 1996, BIOCHEM BIOPH RES CO, V224, P779, DOI 10.1006/bbrc.1996.1099; Hernandez CS, 2004, J INVERTEBR PATHOL, V85, P182, DOI 10.1016/j.jip.2004.03.002; Herrero S, 2001, APPL ENVIRON MICROB, V67, P1085, DOI 10.1128/AEM.67.3.1085-1089.2001; Jurat-Fuentes JL, 2003, APPL ENVIRON MICROB, V69, P5898, DOI 10.1128/AEM.69.10.5898-5906.2003; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; LEE MK, 1995, APPL ENVIRON MICROB, V61, P3836, DOI 10.1128/AEM.61.11.3836-3842.1995; *LEORA SOFTW, 2008, POLO PC; Luo SD, 2007, J ECON ENTOMOL, V100, P909, DOI 10.1603/0022-0493(2007)100[909:CSOCSO]2.0.CO;2; Mahon RJ, 2008, J ECON ENTOMOL, V101, P909, DOI 10.1603/0022-0493(2008)101[909:IOCRIA]2.0.CO;2; Mahon RJ, 2007, J ECON ENTOMOL, V100, P1844, DOI 10.1603/0022-0493(2007)100[1844:FOACRT]2.0.CO;2; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2; Matten Sharlene R., 2008, V5, P27, DOI 10.1007/978-1-4020-8373-0_2; Moar W, 2008, NAT BIOTECHNOL, V26, P1072, DOI 10.1038/nbt1008-1072; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nester E., 2002, 100 YEARS BACILLUS T; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Sayyed AH, 2000, APPL ENVIRON MICROB, V66, P1509, DOI 10.1128/AEM.66.4.1509-1516.2000; Sayyed AH, 2005, APPL ENVIRON MICROB, V71, P6863, DOI 10.1128/AEM.71.11.6863-6869.2005; SAYYED AH, 2004, APPL ENVIRON MICROB, V70, P1710; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P1074, DOI 10.1038/nbt1008-1074; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; VANRIE J, 1990, APPL ENVIRON MICROB, V56, P1378, DOI 10.1128/AEM.56.5.1378-1385.1990; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wright DJ, 1997, APPL ENVIRON MICROB, V63, P1814, DOI 10.1128/AEM.63.5.1814-1819.1997; Yang YJ, 2006, INSECT BIOCHEM MOLEC, V36, P735, DOI 10.1016/j.ibmb.2006.06.003	55	68	75	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9975	10.1371/journal.pone.0009975	http://dx.doi.org/10.1371/journal.pone.0009975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376312	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200048
J	Garcia-Jimenez, B; Juan, D; Ezkurdia, I; Andres-Leon, E; Valencia, A				Garcia-Jimenez, Beatriz; Juan, David; Ezkurdia, Iakes; Andres-Leon, Eduardo; Valencia, Alfonso			Inference of Functional Relations in Predicted Protein Networks with a Machine Learning Approach	PLOS ONE			English	Article							IDENTIFICATION; ALIGNMENT	Background: Molecular biology is currently facing the challenging task of functionally characterizing the proteome. The large number of possible protein-protein interactions and complexes, the variety of environmental conditions and cellular states in which these interactions can be reorganized, and the multiple ways in which a protein can influence the function of others, requires the development of experimental and computational approaches to analyze and predict functional associations between proteins as part of their activity in the interactome. Methodology/Principal Findings: We have studied the possibility of constructing a classifier in order to combine the output of the several protein interaction prediction methods. The AODE (Averaged One-Dependence Estimators) machine learning algorithm is a suitable choice in this case and it provides better results than the individual prediction methods, and it has better performances than other tested alternative methods in this experimental set up. To illustrate the potential use of this new AODE-based Predictor of Protein InterActions (APPIA), when analyzing high-throughput experimental data, we show how it helps to filter the results of published High-Throughput proteomic studies, ranking in a significant way functionally related pairs. Availability: All the predictions of the individual methods and of the combined APPIA predictor, together with the used datasets of functional associations are available at http://ecid.bioinfo.cnio.es/. Conclusions: We propose a strategy that integrates the main current computational techniques used to predict functional associations into a unified classifier system, specifically focusing on the evaluation of poorly characterized protein pairs. We selected the AODE classifier as the appropriate tool to perform this task. AODE is particularly useful to extract valuable information from large unbalanced and heterogeneous data sets. The combination of the information provided by five prediction interaction prediction methods with some simple sequence features in APPIA is useful in establishing reliability values and helpful to prioritize functional interactions that can be further experimentally characterized.	[Garcia-Jimenez, Beatriz] Univ Carlos III Madrid, Dept Comp Sci, Madrid, Spain; [Juan, David; Ezkurdia, Iakes; Andres-Leon, Eduardo; Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain	Universidad Carlos III de Madrid; Centro Nacional de Investigaciones Oncologicas (CNIO)	Garcia-Jimenez, B (corresponding author), Univ Carlos III Madrid, Dept Comp Sci, Madrid, Spain.	valencia@cnio.es	García-Jiménez, Beatriz/ABH-2355-2020; Andrés-León., Eduardo/K-8944-2014; Juan, David/AAA-2614-2020; Valencia, Alfonso/I-3127-2015	García-Jiménez, Beatriz/0000-0002-8129-6506; Andrés-León., Eduardo/0000-0002-0621-9914; Juan, David/0000-0003-1912-9667; Valencia, Alfonso/0000-0002-8937-6789	BioSapiens [LSHG-CT-2003-503265]; Experimental Network for Functional Integration (ENFIN) Networks of Excellence [LSHG-CT-2005-518254]; Consolider BSC [CSD2007-00050]; Spanish Ministry of Education and Science [BIO2007-66855]	BioSapiens; Experimental Network for Functional Integration (ENFIN) Networks of Excellence; Consolider BSC; Spanish Ministry of Education and Science(Spanish Government)	This work was funded by the BioSapiens (grant number LSHG-CT-2003-503265) and the Experimental Network for Functional Integration (ENFIN) Networks of Excellence (contract number LSHG-CT-2005-518254), by Consolider BSC (grant number CSD2007-00050) and by the project "Functions for gene sets" from the Spanish Ministry of Education and Science (BIO2007-66855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Leon E, 2009, NUCLEIC ACIDS RES, V37, pD629, DOI 10.1093/nar/gkn853; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Bishop C.M., 1995, NEURAL NETWORKS PATT; Bouckaert R., BAYESIAN NETWORK CLA; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cleary JG, 1995, ED INN EC BUS ADM, P108; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Drummond C, 2006, MACH LEARN, V65, P95, DOI 10.1007/s10994-006-8199-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FRANK E, 1998, P 15 INT C MACH LEAR, P144; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Sahami M., 1996, P 2 INT C KNOWL DISC, P335; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Webb GI, 2005, MACH LEARN, V58, P5, DOI 10.1007/s10994-005-4258-6; Witten I.H., 2005, DATA MINING PRACTICA; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9969	10.1371/journal.pone.0009969	http://dx.doi.org/10.1371/journal.pone.0009969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376314	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200042
J	Markusic, DM; de Waart, DR; Seppen, J				Markusic, David M.; de Waart, Dirk R.; Seppen, Jurgen			Separating Lentiviral Vector Injection and Induction of Gene Expression in Time, Does Not Prevent an Immune Response to rtTA in Rats	PLOS ONE			English	Article							IN-VIVO; TRANSGENE EXPRESSION; ADENOASSOCIATED VIRUS; MAMMALIAN-CELLS; TETRACYCLINE; THERAPY; SYSTEM; TRANSACTIVATOR; DANGER; MUSCLE	Background: Lentiviral gene transfer can provide long-term expression of therapeutic genes such as erythropoietin. Because overexpression of erythropoietin can be toxic, regulated expression is needed. Doxycycline inducible vectors can regulate expression of therapeutic transgenes efficiently. However, because they express an immunogenic transactivator (rtTA), their utility for gene therapy is limited. In addition to immunogenic proteins that are expressed from inducible vectors, injection of the vector itself is likely to elicit an immune response because viral capsid proteins will induce "danger signals" that trigger an innate response and recruit inflammatory cells. Methodology and Principal Findings: We have developed an autoregulatory lentiviral vector in which basal expression of rtTA is very low. This enabled us to temporally separate the injection of virus and the expression of the therapeutic gene and rtTA. Wistar rats were injected with an autoregulatory rat erythropoietin expression vector. Two or six weeks after injection, erythropoietin expression was induced by doxycycline. This resulted in an increase of the hematocrit, irrespective of the timing of the induction. However, most rats only responded once to doxycycline administration. Antibodies against rtTA were detected in the early and late induction groups. Conclusions: Our results suggest that, even when viral vector capsid proteins have disappeared, expression of foreign proteins in muscle will lead to an immune response.	[Markusic, David M.; de Waart, Dirk R.; Seppen, Jurgen] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Markusic, DM (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.seppen@amc.uva.nl		Seppen, Jurgen/0000-0001-9689-9919; Markusic, David/0000-0002-3774-0825	NWO [016.026.012]	NWO(Netherlands Organization for Scientific Research (NWO))	This research was partially funded by NWO (http://www.zonmw.nl/), 016.026.012, to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha-Mohammadi S, 2000, J CLIN INVEST, V105, P1177, DOI 10.1172/JCI10027; Ailles LE, 2002, CURR TOP MICROBIOL, V261, P31; Brown BD, 2002, BLOOD, V100, P1133, DOI 10.1182/blood-2001-11-0067; Centlivre M, 2010, GENE THER, V17, P14, DOI 10.1038/gt.2009.109; Clackson T, 2000, GENE THER, V7, P120, DOI 10.1038/sj.gt.3301120; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; DERELANKO MJ, 1987, FUND APPL TOXICOL, V9, P271, DOI 10.1016/0272-0590(87)90049-2; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Favre D, 2002, J VIROL, V76, P11605, DOI 10.1128/JVI.76.22.11605-11611.2002; Galimi F, 2002, CURR TOP MICROBIOL, V261, P245; Ginhoux F, 2004, MOL THER, V10, P279, DOI 10.1016/j.ymthe.2004.05.012; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Hartigan-O'Connor D, 2001, MOL THER, V4, P525, DOI 10.1006/mthe.2001.0496; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Lena AM, 2005, J GENE MED, V7, P1086, DOI 10.1002/jgm.758; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; May T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002372; Scherr M, 2002, GENE THER, V9, P1708, DOI 10.1038/sj.gt.3301848; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Seppen J, 2001, BLOOD, V98, P594, DOI 10.1182/blood.V98.3.594; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9974	10.1371/journal.pone.0009974	http://dx.doi.org/10.1371/journal.pone.0009974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376311	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200047
J	Machida, RJ; Tsuda, A				Machida, Ryuji J.; Tsuda, Atsushi			Dissimilarity of Species and Forms of Planktonic Neocalanus Copepods Using Mitochondrial COI, 12S, Nuclear ITS, and 28S Gene Sequences	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; OYASHIO REGION; LIFE-CYCLE; CRISTATUS CRUSTACEA; CALANIDAE COPEPODA; EUCALANUS-BUNGII; GRAZING COPEPODS; DNA; PLUMCHRUS; FLEMINGERI	Background: A total of six Neocalanus species inhabit the oceans of the world. Of these, three species plus form variants (N. cristatus, N. plumchrus, N. flemingeri large form, and N. flemingeri small form), which constitute a monophyletic group among Neocalanus copepods, occur in the Northwestern Pacific off Japan. In the present study, we have tried to discriminate the three species plus form variants of Neocalanus copepods based on sequences of four DNA marker regions. Methodology/Principal Findings: Discrimination was performed based on the DNA sequence information from four genetic markers, including the mitochondrial COI, 12S, nuclear ITS, and 28S gene regions. Sequence dissimilarity was compared using both distance- and character-based approaches. As a result, all three species were confirmed to be distinct based on the four genetic marker regions. On the contrary, distinction of the form variants was only confirmed based on DNA sequence of the mitochondrial COI gene region. Conclusions/Significance: Although discrimination was not successful for the form variants based on the mitochondrial 12S, nuclear ITS, and 28S genes, diagnostic nucleotide sequence characters were observed in their mitochondrial COI gene sequences. Therefore, these form variants are considered to be an important unit of evolution below the species level, and constitute a part of the Neocalanus biodiversity.	[Machida, Ryuji J.; Tsuda, Atsushi] Univ Tokyo, Ocean Res Inst, Tokyo 164, Japan	University of Tokyo	Machida, RJ (corresponding author), Smithsonian Natl Museum Nat Hist, Washington, DC USA.	MachidaR@si.edu			Ministry of Education, Culture, Sports, Science and Technology of Japan [20241003]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors gratefully acknowledge the support of the Alfred P. Sloan Foundation. Additional support for this project was provided to R.J.M. and A. T. by a Grant-in-Aid for Scientific Research No. 20241003 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Data Integration & Analysis System from the Ministry of Education, Culture, Sports, Science and Technology of Japan provided funding to R.J.M. This study is a contribution from the Census of Marine Zooplankton (CMarZ), an ocean realm field project of the Census of Marine Life.	Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; BIRKY CW, 1989, GENETICS, V121, P613; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; BRADFORD JM, 1988, HYDROBIOLOGIA, V167, P73, DOI 10.1007/BF00026295; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kobari T, 2001, J PLANKTON RES, V23, P287, DOI 10.1093/plankt/23.3.287; Kobari T, 2001, MAR ECOL PROG SER, V209, P243, DOI 10.3354/meps209243; Kobari T, 1999, MAR BIOL, V134, P683, DOI 10.1007/s002270050584; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Machida RJ, 2002, MAR BIOTECHNOL, V4, P406, DOI 10.1007/s10126-002-0033-x; Maddison DR, 2000, MACCLADE, V4; Mayr E., 1963, ANIMAL SPECIES EVOLU; MILLER CB, 1984, PROG OCEANOGR, V13, P201, DOI 10.1016/0079-6611(84)90009-0; MILLER CB, 1988, PROG OCEANOGR, V20, P293, DOI 10.1016/0079-6611(88)90044-4; MILLER CB, 1988, PROG OCEANOGR, V20, P223, DOI 10.1016/0079-6611(88)90042-0; MIYAMOTO H, 1904, CAECOSAGITTA M UNPUB; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Tsuda A, 1999, MAR BIOL, V135, P533, DOI 10.1007/s002270050654; Tsuda Atsushi, 2001, Journal of Oceanography, V57, P341, DOI 10.1023/A:1012490730792	31	31	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10278	10.1371/journal.pone.0010278	http://dx.doi.org/10.1371/journal.pone.0010278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442767	gold, Green Published, Green Submitted			2022-12-27	WOS:000277154200002
J	Zhang, G; Karns, R; Narancic, NS; Sun, GY; Cheng, H; Missoni, S; Durakovic, Z; Rudan, P; Chakraborty, R; Deka, R				Zhang, Ge; Karns, Rebekah; Narancic, Nina Smolej; Sun, Guangyun; Cheng, Hong; Missoni, Sasa; Durakovic, Zijad; Rudan, Pavao; Chakraborty, Ranajit; Deka, Ranjan			Common SNPs in FTO Gene Are Associated with Obesity Related Anthropometric Traits in an Island Population from the Eastern Adriatic Coast of Croatia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTILOCUS GENOTYPE DATA; BODY-MASS INDEX; ADULT OBESITY; FRAME SIZE; QUANTITATIVE TRAITS; WAIST CIRCUMFERENCE; CHILDHOOD OBESITY; EARLY-ONSET; RISK LOCI	Background: Multiple studies have provided compelling evidence that the FTO gene variants are associated with obesity measures. The objective of the study was to investigate whether FTO variants are associated with a broad range of obesity related anthropometric traits in an island population. Methodology/Principal Findings: We examined genetic association between 29 FTO SNPs and a comprehensive set of anthropometric traits in 843 unrelated individuals from an island population in the eastern Adriatic coast of Croatia. The traits include 11 anthropometrics (height, weight, waist circumference, hip circumference, bicondilar upper arm width, upper arm circumference, and biceps, triceps, subscapular, suprailiac and abdominal skin-fold thicknesses) and two derived measures (BMI and WHR). Using single locus score tests, 15 common SNPs were found to be significantly associated with "body fatness'' measures such as weight, BMI, hip and waist circumferences with P-values ranging from 0.0004 to 0.01. Similar but less significant associations were also observed between these markers and bicondilar upper arm width and upper arm circumference. Most of these significant findings could be explained by a mediating effect of "body fatness''. However, one unique association signal between upper arm width and rs16952517 (P-value = 0.00156) could not be explained by this mediating effect. In addition, using a principle component analysis and conditional association tests adjusted for "body fatness'', two novel association signals were identified between upper arm circumference and rs11075986 (P-value = 0.00211) and rs16945088 (P-value = 0.00203). Conclusions/Significance: The current study confirmed the association of common variants of FTO gene with "body fatness'' measures in an isolated island population. We also observed evidence of pleiotropic effects of FTO gene on fat-free mass, such as frame size and muscle mass assessed by bicondilar upper arm width and upper arm circumference respectively and these pleiotropic effects might be influenced by variants that are different from the ones associated with "body fatness''.	[Zhang, Ge; Karns, Rebekah; Sun, Guangyun; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA; [Zhang, Ge] Univ Cincinnati, Dept Family & Community Med, Cincinnati, OH USA; [Narancic, Nina Smolej; Missoni, Sasa; Durakovic, Zijad; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Chakraborty, Ranajit] Univ N Texas, Hlth Sci Ctr, Ctr Computat Genom, Ft Worth, TX USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Institute for Anthropological Research Zagreb; University of North Texas System; University of North Texas Health Science Center	Zhang, G (corresponding author), Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA.	ranjan.deka@uc.edu	Missoni, Sasa/G-8821-2013; Zhang, Ge/F-1809-2011	Missoni, Sasa/0000-0002-6542-9970	National Institutes of Health, USA [R01 DK069845]; Croatian Ministry of Science, Education and Sports [196-1962766-2751, 196-1962766-2747, 196-0342282-0291]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069845] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a grant from the National Institutes of Health, USA (R01 DK069845) and grants from the Croatian Ministry of Science, Education and Sports (196-1962766-2751 to PR, 196-1962766-2747 to NSN, 196-0342282-0291 to ZD). GZ was supported partially by a gift fund from Ellen and the late Dr. George Rieveschl Jr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chumlea WC, 2002, AM J CLIN NUTR, V75, P1012, DOI 10.1093/ajcn/75.6.1012; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Clement K, 2008, OBESITY GENOMICS POS; COTSAPAS C, 2009, HUM MOL GENET; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Falush D, 2003, GENETICS, V164, P1567; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FRISANCHO AR, 1983, AM J CLIN NUTR, V37, P311, DOI 10.1093/ajcn/37.2.311; FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hubacek JA, 2008, OBESITY, V16, P2764, DOI 10.1038/oby.2008.421; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Kring SII, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002958; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; Pal P, 2007, HUM GENET, V122, P251, DOI 10.1007/s00439-007-0394-3; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Pritchard JK, 2000, GENETICS, V155, P945; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Rudan P, 2004, COLLEGIUM ANTROPOL, V28, P321; RUDAN P, 1992, SOC ST HUM, V33, P204; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Weiner J.S., 1981, PRACTICAL HUMAN BIOL; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	52	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10375	10.1371/journal.pone.0010375	http://dx.doi.org/10.1371/journal.pone.0010375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442772	gold, Green Published, Green Submitted			2022-12-27	WOS:000277154200015
J	Muller, YD; Mai, G; Morel, P; Serre-Beinier, V; Gonelle-Gispert, C; Yung, GP; Ehirchiou, D; Wyss, JC; Bigenzahn, S; Irla, M; Heusser, C; Golshayan, D; Seebach, JD; Wekerle, T; Buhler, LH				Muller, Yannick D.; Mai, Gang; Morel, Philippe; Serre-Beinier, Veronique; Gonelle-Gispert, Carmen; Yung, Gisella Puga; Ehirchiou, Driss; Wyss, Jean-Christophe; Bigenzahn, Sinda; Irla, Magali; Heusser, Christoph; Golshayan, Dela; Seebach, Joerg D.; Wekerle, Thomas; Buehler, Leo H.			Anti-CD154 mAb and Rapamycin Induce T Regulatory Cell Mediated Tolerance in Rat-to-Mouse Islet Transplantation	PLOS ONE			English	Article							LONG-TERM SURVIVAL; COSTIMULATION BLOCKADE; ALLOGRAFT-REJECTION; KIDNEY ALLOGRAFTS; MIXED CHIMERISM; TYPE-1 CELLS; MODEL; MECHANISMS; EXPANSION; APOPTOSIS	Background: Anti-CD154 (MR1) monoclonal antibody (mAb) and rapamycin (RAPA) treatment both improve survival of ratto- mouse islet xenograft. The present study investigated the effect of combined RAPA/MR1 treatment on rat-to-mouse islet xenograft survival and analyzed the role of CD4(+)CD25(+)Foxp3(+) T regulatory cells (Treg) in the induction and maintenance of the ensuing tolerance. Methodology/Principal Findings: C57BL/6 mice were treated with MR1/RAPA and received additional monoclonal anti-IL2 mAb or anti CD25 mAb either early (0-28 d) or late (100-128 d) post-transplantation. Treg were characterised in the blood, spleen, draining lymph nodes and within the graft of tolerant and rejecting mice by flow cytometry and immunohistochemistry. Fourteen days of RAPA/MR1 combination therapy allowed indefinite islet graft survival in >80% of the mice. Additional administration of anti-IL-2 mAb or depleting anti-CD25 mAb at the time of transplantation resulted in rejection (100% and 89% respectively), whereas administration at 100 days post transplantation lead to lower rejection rates (25% and 40% respectively). Tolerant mice showed an increase of Treg within the graft and in draining lymph nodes early post transplantation, whereas 100 days post transplantation no significant increase of Treg was observed. Rejecting mice showed a transient increase of Treg in the xenograft and secondary lymphoid organs, which disappeared within 7 days after rejection. Conclusions/Significances: These results suggest a critical role for Treg in the induction phase of tolerance early after islet xenotransplantation. These encouraging data support the need of developing further Treg therapy for overcoming the species barrier in xenotransplantation.	[Muller, Yannick D.; Mai, Gang; Morel, Philippe; Serre-Beinier, Veronique; Gonelle-Gispert, Carmen; Buehler, Leo H.] Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland; [Muller, Yannick D.; Yung, Gisella Puga; Ehirchiou, Driss; Seebach, Joerg D.] Univ Hosp & Med Fac, Dept Internal Med, Serv Clin Immunol & Allergol, Geneva, Switzerland; [Mai, Gang] Si Chuan Univ, W China Hosp, Hepatobiliopancreat Dept, Chengdu, Si Chuan, Peoples R China; [Wyss, Jean-Christophe; Golshayan, Dela] Univ Lausanne, Transplantat Immunopathol Lab, Dept Med, Lausanne, Switzerland; [Bigenzahn, Sinda; Wekerle, Thomas] Med Univ Vienna, Vienna Gen Hosp, Dept Surg, Div Transplantat, Vienna, Austria; [Heusser, Christoph] Novartis Inst Biomed Res, Basel, Switzerland; [Irla, Magali] Univ Geneva, Sch Med, CMU, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; Sichuan University; University of Lausanne; Medical University of Vienna; Novartis; University of Geneva	Muller, YD (corresponding author), Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland.	leo.buhler@hcuge.ch	Seebach, Jörg/AAA-3746-2020; IRLA, Magali/AAH-7941-2019; Serre-Beinier, Véronique/T-8064-2019	IRLA, Magali/0000-0001-8803-9708; Serre-Beinier, Véronique/0000-0002-6016-1645; Golshayan, Dela/0000-0001-5631-6096; Buhler, Leo/0000-0002-9461-8498; mai, gang/0000-0002-5843-2821; Seebach, Jorg/0000-0001-5748-4577; Muller, Yannick/0000-0003-0513-7156; , Gisella/0000-0002-2283-7798; Wekerle, Thomas/0000-0001-5159-2796	Swiss National Research [3200BO-102134, 3200B0-109921]; Sir Jules Thorn Charitable Overseas Trust; Fondation Pierre Mercier Pour La Science	Swiss National Research; Sir Jules Thorn Charitable Overseas Trust; Fondation Pierre Mercier Pour La Science	This work was supported by Swiss National Research Fund grants #3200BO-102134 ( to P. M., D. B., T. B. and L. H. B.) and #3200B0-109921 ( to J. D. S.), and the Sir Jules Thorn Charitable Overseas Trust and Fondation Pierre Mercier Pour La Science. Novartis Pharma AG employed one of the authors of this study (Christoph Heusser, PhD) and provided several monoclonal antibodies (anti-CD25 mAb, anti-IL2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREFANIAN H, 2010, DIABETES; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Bigenzahn S, 2005, AM J TRANSPLANT, V5, P1237, DOI 10.1111/j.1600-6143.2005.00862.x; Bucher P, 2005, TRANSPLANTATION, V79, P1545, DOI 10.1097/01.TP.0000163505.63159.69; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Codarri L, 2007, J EXP MED, V204, P1533, DOI 10.1084/jem.20062120; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dijke IE, 2008, HUM IMMUNOL, V69, P389, DOI 10.1016/j.humimm.2008.05.006; Dijke IE, 2007, TRANSPLANTATION, V83, P1477, DOI 10.1097/01.tp.0000264997.53153.8b; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Golshayan D, 2007, TRANSPL INT, V20, P12, DOI 10.1111/j.1432-2277.2006.00401.x; Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Haanstra KG, 2007, AM J TRANSPLANT, V7, P2236, DOI 10.1111/j.1600-6143.2007.01917.x; Jaeckel E, 2005, DIABETES, V54, P306, DOI 10.2337/diabetes.54.2.306; Jarvinen LZ, 2003, TRANSPLANTATION, V76, P1375, DOI 10.1097/01.TP.0000093462.16309.73; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jovanovic V, 2008, TRANSPL INT, V21, P199, DOI 10.1111/j.1432-2277.2007.00599.x; Kurtz J, 2004, TRENDS IMMUNOL, V25, P518, DOI 10.1016/j.it.2004.08.007; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Mai G, 2005, AM J TRANSPLANT, V5, P1021, DOI 10.1111/j.1600-6143.2005.00795.x; MONTI P, 2008, DIABETES; Muller YD, 2009, XENOTRANSPLANTATION, V16, P121, DOI 10.1111/j.1399-3089.2009.00531.x; Onizuka S, 1999, CANCER RES, V59, P3128; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2008, IMMUNOLOGY, V123, P3, DOI 10.1111/j.1365-2567.2007.02777.x; Snanoudj R, 2006, TRANSPLANT INT, V19, P693, DOI 10.1111/j.1432-2277.2006.00332.x; Waldmann H, 2008, J CLIN IMMUNOL, V28, P716, DOI 10.1007/s10875-008-9249-5; Wang S, 2008, TRANSPL IMMUNOL, V19, P93, DOI 10.1016/j.trim.2008.03.004; Wekerle T, 2002, CURR OPIN IMMUNOL, V14, P592, DOI 10.1016/S0952-7915(02)00378-3; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Xia G, 2008, AM J TRANSPLANT, V8, P298, DOI 10.1111/j.1600-6143.2007.02088.x; Zeiser R, 2008, CELL CYCLE, V7, P458, DOI 10.4161/cc.7.4.5454	39	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10352	10.1371/journal.pone.0010352	http://dx.doi.org/10.1371/journal.pone.0010352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436684	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079500020
J	Jo, H; Loison, F; Hattori, H; Silberstein, LE; Yu, HT; Luo, HR				Jo, Hakryul; Loison, Fabien; Hattori, Hidenori; Silberstein, Leslie E.; Yu, Hongtao; Luo, Hongbo R.			Natural Product Celastrol Destabilizes Tubulin Heterodimer and Facilitates Mitotic Cell Death Triggered by Microtubule-Targeting Anti-Cancer Drugs	PLOS ONE			English	Article							INDUCED APOPTOSIS; PROTEIN; BINDING; ARREST; PARTHENOLIDE; TRITERPENE; INHIBITOR; DISCOVERY; CLEAVAGE; PATHWAY	Background: Microtubule drugs are effective anti-cancer agents, primarily due to their ability to induce mitotic arrest and subsequent cell death. However, some cancer cells are intrinsically resistant or acquire a resistance. Lack of apoptosis following mitotic arrest is thought to contribute to drug resistance that limits the efficacy of the microtubule-targeting anticancer drugs. Genetic or pharmacological agents that selectively facilitate the apoptosis of mitotic arrested cells present opportunities to strengthen the therapeutic efficacy. Methodology and Principal Findings: We report a natural product Celastrol targets tubulin and facilitates mitotic cell death caused by microtubule drugs. First, in a small molecule screening effort, we identify Celastrol as an inhibitor of neutrophil chemotaxis. Subsequent time-lapse imaging analyses reveal that inhibition of microtubule-mediated cellular processes, including cell migration and mitotic chromosome alignment, is the earliest events affected by Celastrol. Disorganization, not depolymerization, of mitotic spindles appears responsible for mitotic defects. Celastrol directly affects the biochemical properties of tubulin heterodimer in vitro and reduces its protein level in vivo. At the cellular level, Celastrol induces a synergistic apoptosis when combined with conventional microtubule-targeting drugs and manifests an efficacy toward Taxol-resistant cancer cells. Finally, by time-lapse imaging and tracking of microtubule drug-treated cells, we show that Celastrol preferentially induces apoptosis of mitotic arrested cells in a caspase-dependent manner. This selective effect is not due to inhibition of general cell survival pathways or mitotic kinases that have been shown to enhance microtubule drug-induced cell death. Conclusions and Significance: We provide evidence for new cellular pathways that, when perturbed, selectively induce the apoptosis of mitotic arrested cancer cells, identifying a potential new strategy to enhance the therapeutic efficacy of conventional microtubule-targeting anti-cancer drugs.	[Jo, Hakryul; Loison, Fabien; Hattori, Hidenori; Silberstein, Leslie E.; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol, Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA; [Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jo, H (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA.	Hongbo.Luo@childrens.harvard.edu	loison, fabien/G-3385-2014	loison, fabien/0000-0002-6678-1730; Yu, Hongtao/0000-0002-8861-049X	National Institutes of Health (NIH) [HL066987, HL085100, AI076471, HL092020, GM076084]; American Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085100, T32HL066987, R01HL092020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H. Jo is supported by National Institutes of Health (NIH) Training Grant HL066987. H. Luo is supported by NIH grants HL085100, AI076471, HL092020, and GM076084 and a Research Scholar Grant from American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee M, 2005, J MED CHEM, V48, P547, DOI 10.1021/jm0494974; BARTON JS, 1982, BIOCHIM BIOPHYS ACTA, V705, P8, DOI 10.1016/0167-4838(82)90328-4; Burris HA, 2008, SEMIN ONCOL, V35, pS15, DOI 10.1053/j.seminoncol.2008.02.002; CARLIER MF, 1984, BIOCHEMISTRY-US, V23, P1582, DOI 10.1021/bi00302a037; CORREIA JJ, 1994, ARCH BIOCHEM BIOPHYS, V309, P94, DOI 10.1006/abbi.1994.1090; CORREIA JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P105, DOI 10.1006/abbi.1993.1015; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hunt JT, 2009, MOL CANCER THER, V8, P275, DOI 10.1158/1535-7163.MCT-08-0999; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Jo H, 2008, MOL CELL BIOL, V28, P4285, DOI 10.1128/MCB.01240-07; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Lin YF, 2009, CANCER RES, V69, P6879, DOI 10.1158/0008-5472.CAN-08-4700; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; MARTIN SR, 1982, BIOCHEM J, V203, P643, DOI 10.1042/bj2030643; MI L, 2009, J BIOL CHEM; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Miyata N, 2008, INT IMMUNOPHARMACOL, V8, P874, DOI 10.1016/j.intimp.2008.02.002; Mooberry Susan L, 2007, Methods Mol Med, V137, P289, DOI 10.1007/978-1-59745-442-1_20; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nagle A, 2006, CURR DRUG TARGETS, V7, P305, DOI 10.2174/138945006776054933; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; Symmans WF, 2000, CLIN CANCER RES, V6, P4610; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhu D, 2006, P NATL ACAD SCI USA, V103, P14836, DOI 10.1073/pnas.0605722103	44	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10318	10.1371/journal.pone.0010318	http://dx.doi.org/10.1371/journal.pone.0010318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428237	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079300010
J	Khachane, AN; Harrison, PM				Khachane, Amit N.; Harrison, Paul M.			Mining Mammalian Transcript Data for Functional Long Non-Coding RNAs	PLOS ONE			English	Article							FATE DETERMINATION FACTOR; ACTIVATED-RECEPTOR-DELTA; E-2 SIGNALING PATHWAYS; BREAST-CANCER; TUMOR-SUPPRESSOR; MESSENGER-RNA; IN-VIVO; GENE; GROWTH; EXPRESSION	Background: The role of long non-coding RNAs (lncRNAs) in controlling gene expression has garnered increased interest in recent years. Sequencing projects, such as Fantom3 for mouse and H-InvDB for human, have generated abundant data on transcribed components of mammalian cells, the majority of which appear not to be protein-coding. However, much of the non-protein-coding transcriptome could merely be a consequence of 'transcription noise'. It is therefore essential to use bioinformatic approaches to identify the likely functional candidates in a high throughput manner. Principal Findings: We derived a scheme for classifying and annotating likely functional lncRNAs in mammals. Using the available experimental full-length cDNA data sets for human and mouse, we identified 78 lncRNAs that are either syntenically conserved between human and mouse, or that originate from the same protein-coding genes. Of these, 11 have significant sequence homology. We found that these lncRNAs exhibit: (i) patterns of codon substitution typical of non-coding transcripts; (ii) preservation of sequences in distant mammals such as dog and cow, (iii) significant sequence conservation relative to their corresponding flanking regions (in 50% cases, flanking regions do not have homology at all; and in the remaining, the degree of conservation is significantly less); (iv) existence mostly as single-exon forms (8/11); and, (v) presence of conserved and stable secondary structure motifs within them. We further identified orthologous protein-coding genes that are contributing to the pool of lncRNAs; of which, genes implicated in carcinogenesis are significantly over-represented. Conclusion: Our comparative mammalian genomics approach coupled with evolutionary analysis identified a small population of conserved long non-protein-coding RNAs (lncRNAs) that are potentially functional across Mammalia. Additionally, our analysis indicates that amongst the orthologous protein-coding genes that produce lncRNAs, those implicated in cancer pathogenesis are significantly over-represented, suggesting that these lncRNAs could play an important role in cancer pathomechanisms.	[Khachane, Amit N.; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Khachane, AN (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	amit.khachane@mail.mcgill.ca			National Science and Engineering Research Council of Canada (NSERC); Les Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	A.N.K. and P.M.H. would like to thank the funding support from the National Science and Engineering Research Council of Canada (NSERC), and from Les Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, NATURE, V457, P1028; Bajdik CD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-78; Batey RT, 2006, CURR OPIN STRUC BIOL, V16, P299, DOI 10.1016/j.sbi.2006.05.001; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blank C, 2001, CYTOGENET CELL GENET, V95, P17, DOI 10.1159/000057011; Brosius J, 2005, TRENDS GENET, V21, P287, DOI 10.1016/j.tig.2005.02.014; Buim ME, 2005, ONCOLOGY-BASEL, V69, P445, DOI 10.1159/000090984; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Faridi J, 2003, CLIN CANCER RES, V9, P2933; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hooi CSF, 2006, ONCOGENE, V25, P3924, DOI 10.1038/sj.onc.1209418; Ishiguro H, 2002, ONCOGENE, V21, P6387, DOI 10.1038/sj.onc.1205751; Jaskula-Sztul Renata, 2001, Journal of Applied Genetics, V42, P223; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Morton LM, 2006, PHARMACOGENET GENOM, V16, P537, DOI 10.1097/01.fpc.0000215071.59836.29; Moslehi R, 2006, PHARMACOGENOMICS, V7, P819, DOI 10.2217/14622416.7.6.819; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nordstrom KJV, 2009, GENOMICS, V94, P169, DOI 10.1016/j.ygeno.2009.05.012; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rusiniak ME, 2000, CANCER RES, V60, P1824; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; Sharma A, 2009, CLIN CANCER RES, V15, P1674, DOI 10.1158/1078-0432.CCR-08-2214; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tran MA, 2008, CANCER RES, V68, P7638, DOI 10.1158/0008-5472.CAN-07-6614; Vazquez-Martinez R, 2008, J CLIN ENDOCR METAB, V93, P2269, DOI 10.1210/jc.2007-1893; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu KM, 2009, CANCER RES, V69, P3347, DOI 10.1158/0008-5472.CAN-08-3821; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu LH, 2006, J BIOL CHEM, V281, P33982, DOI 10.1074/jbc.M600135200; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	54	120	128	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10316	10.1371/journal.pone.0010316	http://dx.doi.org/10.1371/journal.pone.0010316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428234	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079300009
J	Sijwali, PS; Rosenthal, PJ				Sijwali, Puran Singh; Rosenthal, Philip J.			Functional Evaluation of Plasmodium Export Signals in Plasmodium berghei Suggests Multiple Modes of Protein Export	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; HIGH-EFFICIENCY TRANSFECTION; MALARIA PARASITE PROTEINS; VARIANT ANTIGENS; HOST ERYTHROCYTE; MAURERS CLEFTS; GENE FAMILY; VIRULENCE; SURFACE; SELECTION	The erythrocytic stage development of malaria parasites occurs within the parasitophorous vacuole inside the infected-erythrocytes, and requires transport of several parasite-encoded proteins across the parasitophorous vacuole to several locations, including the cytosol and membrane of the infected cell. These proteins are called exported proteins; and a large number of such proteins have been predicted for Plasmodium falciparum based on the presence of an N-terminal motif known as the Plasmodium export element (PEXEL) or vacuolar transport signal (VTS), which has been shown to mediate export. The majority of exported proteins contain one or more transmembrane domains at the C-terminus and one of three types of N-terminuswdomain architectures. ( 1) The majority, including the knob-associated histidine rich protein ( KAHRP), contain a signal/hydrophobic sequence preceding the PEXEL/VTS motif. ( 2) Other exported proteins, including the P. berghei variant antigen family bir and the P. falciparum skeleton binding protein-1, do not appear to contain a PEXEL/VTS motif. ( 3) The P. falciparum erythrocyte membrane protein-1 (PfEMP1) family lacks a signal/hydrophobic sequence before the motif. These different domain architectures suggest the presence of multiple export pathways in malaria parasites. To determine if export pathways are conserved in plasmodia and to develop an experimental system for studying these processes, we investigated export of GFP fused with N- and C-terminus putative export domains in the rodent malaria parasite P. berghei. Export was dependent on specific N- and C-terminal domains. Constructs with a KAHRP-like or bir N- terminus, but not the PfEMP1 N- terminus, exported GFP into the erythrocyte. The C-terminus of a P. falciparum variant antigen rifin prevented GFP export by the KAHRP-like N- terminus. In contrast, GFP chimeras containing KAHRP-like N- termini and the PfEMP1 C-terminus were exported to the surface of erythrocytes. Taken together, these results suggest that proteins with KAHRP-like architecture follow a common export pathway, but that PfEMP1s utilize an alternative pathway. Functional validation of common putative export domains of malaria parasites in P. berghei provides an alternative and simpler system to investigate export mechanisms.	[Sijwali, Puran Singh] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Sijwali, PS (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	psijwali@ccmb.res.in; prosenthal@medsfgh.ucsf.edu			Medicines for Malaria Venture; National Institutes of Health [AI35800, RR01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035800, R56AI035800, R29AI035800] Funding Source: NIH RePORTER	Medicines for Malaria Venture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Medicines for Malaria Venture and the National Institutes of Health (AI35800 and RR01081). PJR is a Distinguished Clinical Scientist of the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; MacKenzie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002405; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Niang M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000307; Pasternak ND, 2009, INT J BIOCHEM CELL B, V41, P1463, DOI 10.1016/j.biocel.2008.12.012; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Templeton TJ, 2005, TRENDS PARASITOL, V21, P399, DOI 10.1016/j.pt.2005.07.006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	36	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10227	10.1371/journal.pone.0010227	http://dx.doi.org/10.1371/journal.pone.0010227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419102	gold, Green Submitted, Green Published			2022-12-27	WOS:000276853800017
J	Wu, G; Zhu, LS; Dent, JE; Nardini, C				Wu, Gang; Zhu, Lisha; Dent, Jennifer E.; Nardini, Christine			A Comprehensive Molecular Interaction Map for Rheumatoid Arthritis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; DNA STRAND BREAKS; FACTOR-KAPPA-B; HISTONE DEACETYLASE INHIBITOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARTILAGE-PANNUS JUNCTION; ANTI-TNF TREATMENT; GENE-EXPRESSION	Background: Computational biology contributes to a variety of areas related to life sciences and, due to the growing impact of translational medicine - the scientific approach to medicine in tight relation with basic science -, it is becoming an important player in clinical-related areas. In this study, we use computation methods in order to improve our understanding of the complex interactions that occur between molecules related to Rheumatoid Arthritis (RA). Methodology: Due to the complexity of the disease and the numerous molecular players involved, we devised a method to construct a systemic network of interactions of the processes ongoing in patients affected by RA. The network is based on high-throughput data, refined semi-automatically with carefully curated literature-based information. This global network has then been topologically analysed, as a whole and tissue-specifically, in order to translate the experimental molecular connections into topological motifs meaningful in the identification of tissue-specific markers and targets in the diagnosis, and possibly in the therapy, of RA. Significance: We find that some nodes in the network that prove to be topologically important, in particular AKT2, IL6, MAPK1 and TP53, are also known to be associated with drugs used for the treatment of RA. Importantly, based on topological consideration, we are also able to suggest CRKL as a novel potentially relevant molecule for the diagnosis or treatment of RA. This type of finding proves the potential of in silico analyses able to produce highly refined hypotheses, based on vast experimental data, to be tested further and more efficiently. As research on RA is ongoing, the present map is in fieri, despite being -at the moment-a reflection of the state of the art. For this reason we make the network freely available in the standardised and easily exportable. xml CellDesigner format at 'www.picb.ac.cn/ClinicalGenomicNTW/temp. html' and 'www.celldesigner.org'.	[Wu, Gang; Zhu, Lisha; Dent, Jennifer E.; Nardini, Christine] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Grp Clin Genom Networks, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Wu, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Grp Clin Genom Networks, Shanghai, Peoples R China.	christine@picb.ac.cn	Nardini, Christine/AGD-4177-2022; Dent, Jennifer/C-7573-2011; Nardini, Christine/G-6802-2017	Nardini, Christine/0000-0001-7601-321X	European Union, China; European commission	European Union, China; European commission(European CommissionEuropean Commission Joint Research Centre)	JED is fully funded by The European Union Science and Technology Fellowship Programme, China. The contracting authority for the Programme is the European commission, reference: EuropeAidl128952/L/ACT/CN, budget line: BGUE-B2009-19.100104-CI-AIDCO, http://www.euchinastf.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; ALBERGHINA L, 2009, J BIOTECHNOLOGY; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; AMANO Y, 1993, MOL PHARMACOL, V43, P176; Andreas K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2358; Arranz A, 2008, MOL IMMUNOL, V45, P3065, DOI 10.1016/j.molimm.2008.03.011; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Auer J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2294; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Benito MJ, 2004, ARTHRITIS RHEUM-US, V50, P1781, DOI 10.1002/art.20260; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Carl HD, 2008, Z RHEUMATOL, V67, P485, DOI 10.1007/s00393-008-0314-5; Coenen MJH, 2007, PHARMACOGENOMICS, V8, P761, DOI 10.2217/14622416.8.7.761; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Devauchelle V, 2004, GENES IMMUN, V5, P597, DOI 10.1038/sj.gene.6364132; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Edwards CJ, 2007, MOL MED, V13, P40, DOI 10.2119/2006-000056.Edwards; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; EYRE S, 2009, ANN RHEUM DIS; Fassbender HG, 1998, ARCH ORTHOP TRAUM SU, V117, P2, DOI 10.1007/BF00703430; FASSBENDER HG, 1984, ARTHRITIS RHEUM, V27, P956, DOI 10.1002/art.1780270819; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Galligan CL, 2007, GENES IMMUN, V8, P480, DOI 10.1038/sj.gene.6364400; Giladi H, 2008, JCR-J CLIN RHEUMATOL, V14, P97, DOI 10.1097/RHU.0b013e31816d5ea5; Glaysher S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-300; Hammaker D, 2003, ANN RHEUM DIS, V62, P86; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hodgkinson CP, 2008, PHARMACOGENET GENOM, V18, P803, DOI 10.1097/FPC.0b013e3283050aff; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JY, 2004, J BIOL CHEM, V279, P21637, DOI 10.1074/jbc.M400956200; Huang QC, 2008, RHEUMATOL INT, V28, P697, DOI 10.1007/s00296-008-0534-7; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Julia A, 2009, PHARMACOGENOMICS, V10, P1697, DOI 10.2217/PGS.09.99; Junta CM, 2009, IMMUNOLOGY, V127, P365, DOI 10.1111/j.1365-2567.2008.03005.x; Kalatzis FG, 2009, IEEE ENG MED BIO, P827, DOI 10.1109/IEMBS.2009.5333743; Kawasaki H, 2003, ONCOGENE, V22, P6839, DOI 10.1038/sj.onc.1206903; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; KLIPP E, 2007, NAT BIOTECHNOL, P390; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Kooloos WM, 2007, DRUG DISCOV TODAY, V12, P125, DOI 10.1016/j.drudis.2006.11.013; Kraan TCV, 2008, ANN RHEUM DIS, V67, P563, DOI 10.1136/ard.2007.081950; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Kuo CC, 2007, MOL MED, V13, P561, DOI 10.2119/2007-00021.Kuo; Lacroix BD, 2009, CLIN PHARMACOL THER, V86, P387, DOI 10.1038/clpt.2009.136; LEA P, 2009, CLIN REV ALLERGY IMM; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Lequerre T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2744; Levin J, 2006, BEST PRACT RES CL RH, V20, P809, DOI 10.1016/j.berh.2006.05.001; LI JC, 1984, P NATL ACAD SCI-BIOL, V81, P5694, DOI 10.1073/pnas.81.18.5694; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; LINDBERG J, 2006, ARTHRITIS RES THER, V8; LORICO A, 1988, CANCER RES, V48, P2036; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Ludikhuize J, 2007, ARTHRITIS RHEUM-US, V56, P2180, DOI 10.1002/art.22653; MEHINDATE K, 1994, INFECT IMMUN, V62, P4716, DOI 10.1128/IAI.62.11.4716-4721.1994; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Morel J, 2004, JOINT BONE SPINE, V71, P503, DOI 10.1016/j.jbspin.2004.03.004; Murakami M, 2004, BIOCHEM BIOPH RES CO, V319, P114, DOI 10.1016/j.bbrc.2004.04.153; Nakamura C, 2008, RHEUMATOLOGY, V47, P418, DOI 10.1093/rheumatology/ken003; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oki K, 2009, INFLAMM RES, V58, P571, DOI 10.1007/s00011-009-0021-y; Olsen NJ, 2004, ANN RHEUM DIS, V63, P1387, DOI 10.1136/ard.2003.017194; Pander J, 2007, DRUG DISCOV TODAY, V12, P1054, DOI 10.1016/j.drudis.2007.10.016; Parker A, 2007, J RHEUMATOL, V34, P1817; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Schneider M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-54; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Sha N, 2003, COMP FUNCT GENOM, V4, P171, DOI 10.1002/cfg.264; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHIOZAWA S, 1983, ARTHRITIS RHEUM-US, V26, P472, DOI 10.1002/art.1780260404; Shiozawa S, 2009, CELL CYCLE, V8, P1539, DOI 10.4161/cc.8.10.8411; Silva GL, 2007, ANN NY ACAD SCI, V1110, P33, DOI 10.1196/annals.1423.005; Singh K, 2008, J IMMUNOL, V180, P1971, DOI 10.4049/jimmunol.180.3.1971; SMITHGALL TE, 1995, J PHARMACOL TOX MET, V34, P125, DOI 10.1016/1056-8719(95)00082-7; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Sweeney SE, 2004, CURR OPIN RHEUMATOL, V16, P231, DOI 10.1097/00002281-200405000-00011; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; TOBLER A, 1992, BLOOD, V79, P45; Tolusso B, 2006, PHARMACOGENOMICS, V7, P683, DOI 10.2217/14622416.7.5.683; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1663, DOI 10.1136/ard.2007.076588; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; van Baarsen LGM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2557; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; VISMARA P, 1997, UNION MINIMUM CYCLE; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu CC, 2009, HUM GENET, V126, P303, DOI 10.1007/s00439-009-0672-3; Wuchty S, 2005, PROTEOMICS, V5, P444, DOI 10.1002/pmic.200400962; Zer C, 2007, PHYSIOL GENOMICS, V31, P343, DOI 10.1152/physiolgenomics.00080.2007; Zhu MZ, 2009, SCI CHINA SER C, V52, P398, DOI 10.1007/s11427-009-0055-y; Zinovyev A, 2008, BIOINFORMATICS, V24, P876, DOI 10.1093/bioinformatics/btm553; Ziober AF, 2006, CLIN CANCER RES, V12, P5960, DOI 10.1158/1078-0432.CCR-06-0535	123	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10137	10.1371/journal.pone.0010137	http://dx.doi.org/10.1371/journal.pone.0010137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419126	gold, Green Published, Green Submitted			2022-12-27	WOS:000276743500008
J	Srinivasan, S; Liu, CZ; Mitchell, CM; Fiedler, TL; Thomas, KK; Agnew, KJ; Marrazzo, JM; Fredricks, DN				Srinivasan, Sujatha; Liu, Congzhou; Mitchell, Caroline M.; Fiedler, Tina L.; Thomas, Katherine K.; Agnew, Kathy J.; Marrazzo, Jeanne M.; Fredricks, David N.			Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis	PLOS ONE			English	Article							GARDNERELLA-VAGINALIS; METRONIDAZOLE THERAPY; QUANTITATIVE PCR; ACQUISITION; IRON; ASSOCIATIONS; VAGINOLYSIN; PREVALENCE; CYTOLYSIN; FLORA	Background: Little is known about short-term bacterial fluctuations in the human vagina. This study used PCR to assess variability in concentrations of key vaginal bacteria in healthy women and the immediate response to antibiotic in women with bacterial vaginosis (BV). Methodology/Principal Findings: Twenty-two women assessed for BV using Amsel's criteria were evaluated daily for 7 14 days, then at 2, 3 and 4 weeks, using a panel of 11 bacterium-specific quantitative PCR assays. Participants with BV treated with 5 days of intravaginal metronidazole. Participants without BV had vaginal biotas dominated by whose levels fluctuated with menses. With onset of menstruation, quantities of Lactobacillus jensenii and crispatus decreased and were found to be inversely related to Gardnerella vaginalis concentrations (p<0.001). Women BV had a variety of fastidious bacteria whose concentrations dropped below detection thresholds 1-5 days after metronidazole. Recurrent BV was characterized by initial profound decreases of BV-associated bacteria after followed by subsequent increases at relapse. Conclusions/Significance: The microbiota of the human vagina can be highly dynamic. Healthy women are colonized Lactobacillus species, but levels can change dramatically over a month. Marked increases in G. vaginalis were during menses. Participants with BV have diverse communities of fastidious bacteria that are depleted by metronidazole therapy. Women with recurrent BV initially respond to antibiotic treatment with steep declines in concentrations, but these bacteria later reemerge, suggesting that antibiotic resistance in these bacteria is not an factor mediating BV recurrence.	[Srinivasan, Sujatha; Liu, Congzhou; Fiedler, Tina L.; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Mitchell, Caroline M.; Agnew, Kathy J.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Thomas, Katherine K.] Univ Washington, Ctr AIDS & STDs, Seattle, WA 98195 USA; [Marrazzo, Jeanne M.; Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA; [Fredricks, David N.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, 1124 Columbia St, Seattle, WA 98104 USA.	ssriniva@fhcrc.org; dfredric@fhcrc.org		Thomas, Katherine K/0000-0002-7024-468X; Marrazzo, Jeanne/0000-0002-9277-7364; Mitchell, Caroline M/0000-0001-9924-2349	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI061628]; National Institutes of Health (NIH); National Institute of Child Health and Human Development (NICHD) [HD-01-264]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded with a grant (R01 AI061628) to Dr. Fredricks from the National Institute of Allergy and Infectious Diseases (NIAID) (www3.niaid.nih.gov), division of National Institutes of Health (NIH). Dr. Mitchell received salary support from a Women's Reproductive Health grant (HD-01-264) from the National Institute of Child Health and Human Development (NICHD) (www.nichd.nih.gov), division of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Haggerty CL, 2004, CLIN INFECT DIS, V39, P990, DOI 10.1086/423963; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; Jarosik GP, 1998, INFECT IMMUN, V66, P5041, DOI 10.1128/IAI.66.10.5041-5047.1998; Kalra Apoorv, 2007, Curr Infect Dis Rep, V9, P485, DOI 10.1007/s11908-007-0074-4; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mitchell CM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-89; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; SAUTTER RL, 1980, J CLIN MICROBIOL, V11, P479, DOI 10.1128/JCM.11.5.479-484.1980; Schwebke JR, 1997, SEX TRANSM DIS, V24, P236, DOI 10.1097/00007435-199704000-00009; Srinivasan S., 2008, INTERDISCIP PERSPECT, V2008; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07	25	276	295	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10197	10.1371/journal.pone.0010197	http://dx.doi.org/10.1371/journal.pone.0010197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419168	Green Published, Green Submitted, gold			2022-12-27	WOS:000276707100013
J	Aziz, RK; Kansal, R; Aronow, BJ; Taylor, WL; Rowe, SL; Kubal, M; Chhatwal, GS; Walker, MJ; Kotb, M				Aziz, Ramy K.; Kansal, Rita; Aronow, Bruce J.; Taylor, William L.; Rowe, Sarah L.; Kubal, Michael; Chhatwal, Gursharan S.; Walker, Mark J.; Kotb, Malak			Microevolution of Group A Streptococci In Vivo: Capturing Regulatory Networks Engaged in Sociomicrobiology, Niche Adaptation, and Hypervirulence	PLOS ONE			English	Article							HYALURONIC-ACID CAPSULE; CYSTEINE PROTEASE; RESPONSE REGULATOR; 2-COMPONENT SYSTEM; VIRULENCE FACTOR; GENOME SEQUENCE; SPEB EXPRESSION; MOLECULAR-BASIS; STREPTOLYSIN-S; M1T1 CLONE	The onset of infection and the switch from primary to secondary niches are dramatic environmental changes that not only alter bacterial transcriptional programs, but also perturb their sociomicrobiology, often driving minor subpopulations with mutant phenotypes to prevail in specific niches. Having previously reported that M1T1 Streptococcus pyogenes become hypervirulent in mice due to selection of mutants in the covRS regulatory genes, we set out to dissect the impact of these mutations in vitro and in vivo from the impact of other adaptive events. Using a murine subcutaneous chamber model to sample the bacteria prior to selection or expansion of mutants, we compared gene expression dynamics of wild type (WT) and previously isolated animal-passaged (AP) covS mutant bacteria both in vitro and in vivo, and we found extensive transcriptional alterations of pathoadaptive and metabolic gene sets associated with invasion, immune evasion, tissue-dissemination, and metabolic reprogramming. In contrast to the virulence-associated differences between WT and AP bacteria, Phenotype Microarray analysis showed minor in vitro phenotypic differences between the two isogenic variants. Additionally, our results reflect that WT bacteria's rapid host-adaptive transcriptional reprogramming was not sufficient for their survival, and they were outnumbered by hypervirulent covS mutants with SpeB(-)/Sda(high) phenotype, which survived up to 14 days in mice chambers. Our findings demonstrate the engagement of unique regulatory modules in niche adaptation, implicate a critical role for bacterial genetic heterogeneity that surpasses transcriptional in vivo adaptation, and portray the dynamics underlying the selection of hypervirulent covS mutants over their parental WT cells.	[Aziz, Ramy K.; Kansal, Rita; Rowe, Sarah L.; Kotb, Malak] Vet Affairs Med Ctr, Res Serv, Memphis, TN USA; [Aziz, Ramy K.; Kansal, Rita; Rowe, Sarah L.; Kotb, Malak] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Aziz, Ramy K.; Kubal, Michael] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Aronow, Bruce J.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Taylor, William L.; Rowe, Sarah L.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Chhatwal, Gursharan S.] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Kotb, Malak] Univ Cincinnati, Coll Med, Cincinnati, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; Egyptian Knowledge Bank (EKB); Cairo University; University of Chicago; Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Helmholtz Association; Helmholtz-Center for Infection Research; University of Wollongong; University System of Ohio; University of Cincinnati	Aziz, RK (corresponding author), Vet Affairs Med Ctr, Res Serv, Memphis, TN USA.	ramy.aziz@salmonella.org; kotbmk@uc.edu	Aronow, Bruce J/F-8438-2012; Walker, Mark J./F-6940-2011; Aziz, Ramy/B-2918-2009	Aziz, Ramy/0000-0002-4448-7100; Walker, Mark/0000-0001-7423-2769	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [AI40198-06]; NIH [P30DK078392]; United States Army Medical Research Acquisition Activity [W81XWH-05-1-0227]; Research and Development Office, Medical Research Service, Department of Veterans Affairs; National Health and Medical Research Council of Australia [459103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research Acquisition Activity; Research and Development Office, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants AI40198-06 from National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) to M. K. and NIH P30DK078392 to B. A.; by the United States Army Medical Research Acquisition Activity (W81XWH-05-1-0227 to M. K); by the Research and Development Office, Medical Research Service, Department of Veterans Affairs (Merit Award to M. K.); and by the National Health and Medical Research Council of Australia project grant 459103 (M. W. and M. K.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; AZIZ RK, 2009, MOL DISSECTION CLONA; AZIZ RK, 2006, INT C SERIES, V1289, P175; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Bessen DE, 2010, J INFECT DIS, V201, P800, DOI 10.1086/651020; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Cleary PP, 1998, MOL MICROBIOL, V28, P157, DOI 10.1046/j.1365-2958.1998.00786.x; Cleary PP, 1998, INFECT IMMUN, V66, P5592, DOI 10.1128/IAI.66.11.5592-5597.1998; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; Egesten A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004769; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; HOLLANDS A, 2010, J INFECT DI IN PRESS; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; Kacharmina JE, 1999, METHOD ENZYMOL, V303, P3; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Leday TV, 2008, INFECT IMMUN, V76, P4659, DOI 10.1128/IAI.00597-08; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; McIver KS, 2009, CONTRIB MICROBIOL, V16, P103, DOI 10.1159/000219375; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Nooh MM, 2006, J BIOL CHEM, V281, P35281, DOI 10.1074/jbc.M605544200; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 1999, In Silico Biol, V1, P93; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Podbielski A, 1999, MED MICROBIOL IMMUN, V188, P99, DOI 10.1007/s004300050111; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Rasmussen M, 1999, J BIOL CHEM, V274, P15336, DOI 10.1074/jbc.274.22.15336; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ribardo DA, 2004, INFECT IMMUN, V72, P3668, DOI 10.1128/IAI.72.6.3668-3673.2004; Rosch JW, 2007, MOL MICROBIOL, V64, P257, DOI 10.1111/j.1365-2958.2007.05667.x; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2007, INFECT IMMUN, V75, P2981, DOI 10.1128/IAI.00081-07; Shelburne SA, 2007, J BACTERIOL, V189, P2610, DOI 10.1128/JB.01539-06; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Sugareva V, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-34; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Taylor TB, 2004, CYTOM PART A, V59A, P254, DOI 10.1002/cyto.a.20051; TREVINO J, 2009, INFECT IMMUN; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	79	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e9798	10.1371/journal.pone.0009798	http://dx.doi.org/10.1371/journal.pone.0009798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418946	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706800002
J	Kozlov, G; Gehring, K				Kozlov, Guennadi; Gehring, Kalle			Molecular Basis of eRF3 Recognition by the MLLE Domain of Poly(A)-Binding Protein	PLOS ONE			English	Article							C-TERMINAL DOMAIN; POLYADENYLATE-BINDING PROTEIN; EUKARYOTIC RELEASE FACTOR-3; MESSENGER-RNA DEADENYLATION; TRANSLATION TERMINATION; PABC DOMAIN; POLY(A) NUCLEASE; STRUCTURAL BASIS; GTP-BINDING; COMPLEX	PABPC1 (cytosolic poly(A)-binding protein 1) is an RNA-binding protein that binds to the poly(A) tail of mRNAs to promote translation and mRNA turnover. In addition to RNA-binding domains, PABPC1 contains a unique protein-protein interaction domain, MLLE (also known as PABC) that binds regulatory proteins and translation factors that contain a conserved 12 amino acid peptide motif termed PAM2. Eukaryotic Release Factor 3 (eRF3/GSPT1) contains two overlapping PAM2 sequences, which are required for its activity. Here, we determined the crystal structures of the MLLE domain from PABPC1 in complex with the two PAM2 regions of eRF3. The structures reveal a mechanism of cooperativity between the two PAM2 sites that increases the binding affinity but prevents the binding of more than one molecule of eRF3 to PABPC1. Relative to previous structures, the high-resolution crystal structures force a re-evaluation of the PAM2 motif and improve our understanding of the molecular basis of MLLE peptide recognition.	[Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Kozlov, Guennadi; Gehring, Kalle] Grp Rech Axe Struct Prote, Montreal, PQ, Canada	McGill University	Kozlov, G (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-14219]; National Science Foundation; National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Canadian Institutes of Health Research grant MOP-14219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the National Institutes of Health. The coordinates and structure factors have been deposited in the RCSB Protein Data Bank under codes 3KUI and 3KUJ.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hauryliuk V, 2006, BIOCHIMIE, V88, P747, DOI 10.1016/j.biochi.2006.06.001; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Katzenellenbogen RA, 2007, J VIROL, V81, P3786, DOI 10.1128/JVI.02007-06; Kononenko AV, 2008, PROTEINS, V70, P388, DOI 10.1002/prot.21544; Kononenko AV, 2010, NUCLEIC ACIDS RES, V38, P548, DOI 10.1093/nar/gkp908; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; KOZLOV G, 2010, J BIOL CHEM, V285; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; Kozlov Guennadi, 2002, Journal of Biological Chemistry, V277, P22822, DOI 10.1074/jbc.M201230200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mitkevich VA, 2006, NUCLEIC ACIDS RES, V34, P3947, DOI 10.1093/nar/gkl549; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel GP, 2006, FEBS J, V273, P5678, DOI 10.1111/j.1742-4658.2006.05556.x; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Siddiqui N, 2003, PROTEIN SCI, V12, P1925, DOI 10.1110/ps.0390103; Siddiqui N, 2007, BIOCHEMISTRY-US, V46, P4221, DOI 10.1021/bi061986d; Siddiqui N, 2007, J BIOL CHEM, V282, P25067, DOI 10.1074/jbc.M701256200; Simon E, 2007, NUCLEIC ACIDS RES, V35, P6017, DOI 10.1093/nar/gkm452; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	39	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10169	10.1371/journal.pone.0010169	http://dx.doi.org/10.1371/journal.pone.0010169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418951	Green Submitted, gold, Green Published			2022-12-27	WOS:000276706800012
J	Bellan, SE				Bellan, Steve E.			The Importance of Age Dependent Mortality and the Extrinsic Incubation Period in Models of Mosquito-Borne Disease Transmission and Control	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; MALARIA-CONTROL; VECTOR CONTROL; ADULT SIZE; CULICIDAE; TEMPERATURE; DYNAMICS; VIRUS; SIMULATION; SURVIVAL	Nearly all mathematical models of vector-borne diseases have assumed that vectors die at constant rates. However, recent empirical research suggests that mosquito mortality rates are frequently age dependent. This work develops a simple mathematical model to assess how relaxing the classical assumption of constant mortality affects the predicted effectiveness of anti-vectorial interventions. The effectiveness of mosquito control when mosquitoes die at age dependent rates was also compared across different extrinsic incubation periods. Compared to a more realistic age dependent model, constant mortality models overestimated the sensitivity of disease transmission to interventions that reduce mosquito survival. Interventions that reduce mosquito survival were also found to be slightly less effective when implemented in systems with shorter EIPs. Future transmission models that examine anti-vectorial interventions should incorporate realistic age dependent mortality rates.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bellan, SE (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	sbellan@berkeley.edu	Bellan, Steve/D-6368-2013	Bellan, Steve/0000-0002-4110-272X	James S. McDonnell 21st Century Science Initiative Award; National Institute of Health [GM083863]; Center for Discrete Mathematics & Theoretical Computer Science; United States National Science Foundation; South African Centre for Epidemiological Modelling and Analysis; African Institute for Mathematical Sciences; Tanada Entomology Fellowship; Rocca Center for African Studies Dissertation Fellowship; Chang-Lin Tien Environmental Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	James S. McDonnell 21st Century Science Initiative Award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Discrete Mathematics & Theoretical Computer Science; United States National Science Foundation(National Science Foundation (NSF)); South African Centre for Epidemiological Modelling and Analysis; African Institute for Mathematical Sciences; Tanada Entomology Fellowship; Rocca Center for African Studies Dissertation Fellowship; Chang-Lin Tien Environmental Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a James S. McDonnell 21st Century Science Initiative Award to Wayne M. Getz and National Institute of Health Ecology of Infectious Disease Grant GM083863, and arose from work begun at the 2007 Advanced Study Institute on Mathematical Modeling of Infectious Diseases of Africa that was jointly funded by the Center for Discrete Mathematics & Theoretical Computer Science, the United States National Science Foundation, the South African Centre for Epidemiological Modelling and Analysis, and the African Institute for Mathematical Sciences. During this research S. Bellan was also funded by a Tanada Entomology Fellowship, a Rocca Center for African Studies Dissertation Fellowship and a Chang-Lin Tien Environmental Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd MF, 1932, AM J HYG, V16, P851, DOI 10.1093/oxfordjournals.aje.a117892; Chan AST, 1998, ANN TROP MED PARASIT, V92, P317, DOI 10.1080/00034989859898; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GRATZ NG, 1994, AM J TROP MED HYG, V50, P11, DOI 10.4269/ajtmh.1994.50.6_Suppl.TM05006S0011; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Gunasekaran K, 2005, TROP MED INT HEALTH, V10, P160, DOI 10.1111/j.1365-3156.2004.01369.x; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Killeen Gerry F, 2002, Malar J, V1, P8, DOI 10.1186/1475-2875-1-8; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x; Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mani TR, 2005, TROP MED INT HEALTH, V10, P1298, DOI 10.1111/j.1365-3156.2005.01522.x; MILLER BR, 1989, T ROY SOC TROP MED H, V83, P252, DOI 10.1016/0035-9203(89)90667-6; MOON TE, 1976, BIOMETRICS, V32, P355, DOI 10.2307/2529503; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Rozilawati H, 2005, Trop Biomed, V22, P143; Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SCOTT TW, 2003, AEDES AEGYPTI DENSIT, P187; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; TESH RB, 1975, AM J TROP MED HYG, V24, P876, DOI 10.4269/ajtmh.1975.24.876; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Watson RT, 2005, J ENVIRON MONITOR, V7, P834, DOI 10.1039/b504683a; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x	45	61	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10165	10.1371/journal.pone.0010165	http://dx.doi.org/10.1371/journal.pone.0010165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405010	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706300019
J	Luo, XL; Ding, QR; Wang, M; Li, ZG; Mao, KR; Sun, B; Pan, Y; Wang, ZZ; Zang, YQ; Chen, Y				Luo, Xiaolin; Ding, Qiurong; Wang, Min; Li, Zhigang; Mao, Kairui; Sun, Bing; Pan, Yi; Wang, Zhenzhen; Zang, Ying Qin; Chen, Yan			In Vivo Disruption of TGF-(beta) Signaling by Smad7 in Airway Epithelium Alleviates Allergic Asthma but Aggravates Lung Carcinogenesis in Mouse	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TGF-BETA; T-CELLS; INFLAMMATION; CANCER; MACROPHAGE; EXPRESSION; RECEPTOR; HYPERRESPONSIVENESS; INTERLEUKIN-10	Background: TGF-beta has been postulated to play an important role in the maintenance of epithelial homeostasis and the development of epithelium-derived cancers. However, most of previous studies are mainly focused on the function of TGF-beta in immune cells to the development of allergic asthma and how TGF-beta signaling in airway epithelium itself in allergic inflammation is largely unknown. Furthermore, the in vivo TGF-beta function specifically in the airway epithelium during lung cancer development has been largely elusive. Methodology/Principal Findings: To evaluate the in vivo contribution of TGF-beta signaling in lung epithelium to the development of allergic disease and lung cancer, we generated a transgenic mouse model with Smad7, an intracellular inhibitor of TGF-beta signaling, constitutively expressed in mouse airway Clara cells using a mouse CC10 promoter. The mice were subjected to the development of OVA-induced allergic asthma and urethane-induced lung cancer. The Smad7 transgenic animals significantly protected from OVA-induced asthma, with reduced airway inflammation, airway mucus production, extracellular matrix deposition, and production of OVA-specific IgE. Further analysis of cytokine profiles in lung homogenates revealed that the Th2 cytokines including IL-4, IL-5 and IL-13, as well as other cytokines including IL-17, IL-1, IL-6, IP10, G-CSF, and GM-CSF were significantly reduced in the transgenic mice upon OVA induction. In contrast, the Smad7 transgenic animals had an increased incidence of lung carcinogenesis when subjected to urethane treatment. Conclusion/Significance: These studies, therefore, demonstrate for the first time the in vivo function of TGF-beta signaling specifically in airway epithelium during the development of allergic asthma and lung cancer.	[Luo, Xiaolin; Ding, Qiurong; Wang, Min; Li, Zhigang; Pan, Yi; Wang, Zhenzhen; Zang, Ying Qin; Chen, Yan] Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Mao, Kairui; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, XL (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	yqin@sibs.ac.cn; ychen3@sibs.ac.cn	Luo, Xiaolin/D-7159-2014	Luo, Xiaolin/0000-0003-3215-8112	National Natural Science Foundation of China [30830037, 30971660]; Science & Technology Commission of Shanghai Municipality [75407001]; Ministry of Science and Technology of China [2007CB947100, 2006CB503900, 2010CB529500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by research grants from National Natural Science Foundation of China (30830037), Science & Technology Commission of Shanghai Municipality (75407001), and the Ministry of Science and Technology of China (2007CB947100 and 2006CB503900) to YC. The work was also supported by Ministry of Science and Technology of China (2010CB529500) to YP and ZW, and National Natural Science Foundation of China (30971660) to YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; BALIS JU, 1985, LAB INVEST, V52, P657; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boulet LP, 1997, CHEST, V112, P45, DOI 10.1378/chest.112.1.45; BURGESS AW, 1980, BLOOD, V56, P947; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Ding QR, 2007, J LEUKOCYTE BIOL, V81, P1568, DOI 10.1189/jlb.1106672; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Haneda K, 1997, J IMMUNOL, V159, P4484; Haneda K, 1999, AM J RESP CELL MOL, V21, P268, DOI 10.1165/ajrcmb.21.2.3576; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He J, 2009, BBA-MOL BASIS DIS, V1792, P56, DOI 10.1016/j.bbadis.2008.10.010; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Koulis A, 2000, CLIN EXP ALLERGY, V30, P747; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Lai ST, 2008, PEDIATR INT, V50, P99, DOI 10.1111/j.1442-200X.2007.02533.x; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakao A, 2001, TRENDS IMMUNOL, V22, P115, DOI 10.1016/S1471-4906(00)01827-5; Nakao A, 2002, J ALLERGY CLIN IMMUN, V110, P873, DOI 10.1067/mai.2002.129236; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; OZEKI Y, 1994, JPN J CANCER RES, V85, P840, DOI 10.1111/j.1349-7006.1994.tb02956.x; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pilette C, 2004, EUR RESPIR J, V23, P876, DOI 10.1183/09031936.04.00102504; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; REYNOLDS SD, 2009, INT J BIOCH CELL BIO; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Selzman CH, 1998, J MOL CELL CARDIOL, V30, P889, DOI 10.1006/jmcc.1998.0642; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; TOMONAGA M, 1986, BLOOD, V67, P31; Undevia NS, 2004, AM J PHYSIOL-LUNG C, V287, pL515, DOI 10.1152/ajplung.00044.2004; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yamashita N, 2002, CELL IMMUNOL, V219, P92, DOI 10.1016/S0008-8749(02)00565-8; Yamauchi K, 2006, TOHOKU J EXP MED, V209, P75, DOI 10.1620/tjem.209.75	52	22	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10149	10.1371/journal.pone.0010149	http://dx.doi.org/10.1371/journal.pone.0010149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405019	Green Submitted, gold, Green Published			2022-12-27	WOS:000276706300006
J	Baptista, MS; Melo, CV; Armelao, M; Herrmann, D; Pimentel, DO; Leal, G; Caldeira, MV; Bahr, BA; Bengtson, M; Almeida, RD; Duarte, CB				Baptista, Marcio S.; Melo, Carlos V.; Armelao, Mario; Herrmann, Dennis; Pimentel, Diogo O.; Leal, Graciano; Caldeira, Margarida V.; Bahr, Ben A.; Bengtson, Mario; Almeida, Ramiro D.; Duarte, Carlos B.			Role of the Proteasome in Excitotoxicity-Induced Cleavage of Glutamic Acid Decarboxylase in Cultured Hippocampal Neurons	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; REDUCES INFARCTION; GABAERGIC NEURONS; GABA TRANSPORTER; MESSENGER-RNAS; BRAIN-INJURY; RAT MODEL; H-3 GABA; 2 FORMS; UBIQUITIN	Glutamic acid decarboxylase is responsible for synthesizing GABA, the major inhibitory neurotransmitter, and exists in two isoforms-GAD65 and GAD67. The enzyme is cleaved under excitotoxic conditions, but the mechanisms involved and the functional consequences are not fully elucidated. We found that excitotoxic stimulation of cultured hippocampal neurons with glutamate leads to a time-dependent cleavage of GAD65 and GAD67 in the N-terminal region of the proteins, and decrease the corresponding mRNAs. The cleavage of GAD67 was sensitive to the proteasome inhibitors MG132, YU102 and lactacystin, and was also abrogated by the E1 ubiquitin ligase inhibitor UBEI-41. In contrast, MG132 and UBEI-41 were the only inhibitors tested that showed an effect on GAD65 cleavage. Excitotoxic stimulation with glutamate also increased the amount of GAD captured in experiments where ubiquitinated proteins and their binding partners were isolated. However, no evidences were found for direct GADs ubiquitination in cultured hippocampal neurons, and recombinant GAD65 was not cleaved by purified 20S or 26S proteasome preparations. Since calpains, a group of calcium activated proteases, play a key role in GAD65/67 cleavage under excitotoxic conditions the results suggest that GADs are cleaved after ubiquitination and degradation of an unknown binding partner by the proteasome. The characteristic punctate distribution of GAD65 along neurites of differentiated cultured hippocampal neurons was significantly reduced after excitotoxic injury, and the total GAD activity measured in extracts from the cerebellum or cerebral cortex at 24h postmortem ( when there is a partial cleavage of GADs) was also decreased. The results show a role of the UPS in the cleavage of GAD65/67 and point out the deregulation of GADs under excitotoxic conditions, which is likely to affect GABAergic neurotransmission. This is the first time that the UPS has been implicated in the events triggered during excitotoxicity and the first molecular target of the UPS affected in this cell death process.	[Baptista, Marcio S.; Melo, Carlos V.; Armelao, Mario; Herrmann, Dennis; Pimentel, Diogo O.; Leal, Graciano; Caldeira, Margarida V.; Almeida, Ramiro D.; Duarte, Carlos B.] Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, Coimbra, Portugal; [Bahr, Ben A.] Univ N Carolina, Biotechnol Res & Training Ctr, Pembroke, NC USA; [Bengtson, Mario] Genom Inst Novartis Res Fdn GNF, Dept Canc & Cell Biol, San Diego, CA USA	Universidade de Coimbra; University of North Carolina; Novartis	Baptista, MS (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, Coimbra, Portugal.	cvmelo@stanford.edu	Almeida, Ramiro D./J-2656-2013; Duarte, Carlos B/K-6358-2013	Almeida, Ramiro D./0000-0001-5830-2595; Duarte, Carlos B/0000-0002-1474-0208; Vieira Melo, Carlos/0000-0001-5392-1258; Caldeira, Margarida/0000-0001-5107-1499; Leal, Graciano/0000-0001-6333-6095	Fundacao para a Ciencia e a Tecnologia (FCT); FEDER (Fundo Europeu de Desenvolvimento Regional) [PTDC/SAU-FCF/72283/2006]; Calouste Gulbenkian Foundation [71949]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER (Fundo Europeu de Desenvolvimento Regional)(European Commission); Calouste Gulbenkian Foundation	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) and FEDER (Fundo Europeu de Desenvolvimento Regional) (PTDC/SAU-FCF/72283/2006; to CBD) and by the Calouste Gulbenkian Foundation (Proc. 71949; to CVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asai A, 2002, J CEREBR BLOOD F MET, V22, P705, DOI 10.1097/00004647-200206000-00009; Bahr BA, 2000, J NEUROSCI RES, V59, P827, DOI 10.1002/(SICI)1097-4547(20000315)59:6<827::AID-JNR15>3.0.CO;2-Q; Baliova M, 2009, NEUROCHEM INT, V55, P288, DOI 10.1016/j.neuint.2009.03.012; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Battaglioli G, 2005, NEUROCHEM RES, V30, P989, DOI 10.1007/s11064-005-6772-0; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Caba E, 2002, J NEUROSCI RES, V67, P787, DOI 10.1002/jnr.10163; CARVALHO AP, 1995, ANN NY ACAD SCI, V757, P439, DOI 10.1111/j.1749-6632.1995.tb17504.x; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; de Almeida OMMS, 2002, BRAIN RES, V925, P89, DOI 10.1016/S0006-8993(01)03265-6; DEMELLO FG, 1991, CELL MOL NEUROBIOL, V11, P485, DOI 10.1007/BF00734811; Di Napoli Mario, 2005, Curr Opin Investig Drugs, V6, P686; DUARTE CB, 1993, BRAIN RES, V611, P130, DOI 10.1016/0006-8993(93)91784-P; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Frick KM, 2002, NEUROBIOL AGING, V23, P145, DOI 10.1016/S0197-4580(01)00237-8; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Ge PF, 2007, STROKE, V38, P3230, DOI 10.1161/STROKEAHA.107.487108; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsu CC, 1999, J BIOL CHEM, V274, P24366, DOI 10.1074/jbc.274.34.24366; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kanaani J, 2008, J CELL SCI, V121, P437, DOI 10.1242/jcs.011916; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; KUBISTA K, 2007, GIT LAB J, V9, P2; Lernmark A, 1996, J INTERN MED, V240, P259, DOI 10.1046/j.1365-2796.1996.27859000.x; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu CL, 2004, J CEREBR BLOOD F MET, V24, P1219, DOI 10.1097/01.WCB.0000136706.77918.21; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martin SB, 2003, NEUROCHEM INT, V42, P549, DOI 10.1016/S0197-0186(02)00189-4; Monnerie H, 2008, EXP NEUROL, V213, P145, DOI 10.1016/j.expneurol.2008.05.013; Monnerie H, 2007, EXP NEUROL, V205, P367, DOI 10.1016/j.expneurol.2007.02.007; Munirathinam S, 2002, TOXICOL APPL PHARM, V185, P111, DOI 10.1006/taap.2002.9534; Myung J, 2001, MOL CELL, V7, P411, DOI 10.1016/S1097-2765(01)00188-5; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; NATHAN B, 1995, J NEUROSCI RES, V40, P134, DOI 10.1002/jnr.490400115; Noga M, 1996, MOL BRAIN RES, V36, P261, DOI 10.1016/0169-328X(95)00260-Y; Phillips JB, 2000, STROKE, V31, P1686, DOI 10.1161/01.STR.31.7.1686; QIN ZH, 1994, MOL BRAIN RES, V21, P293, DOI 10.1016/0169-328X(94)90260-7; Ray SK, 2006, CURR MED CHEM, V13, P3425, DOI 10.2174/092986706779010342; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SALIN P, 1993, EXP NEUROL, V119, P291, DOI 10.1006/exnr.1993.1033; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Saransaari P, 2008, NEUROCHEM RES, V33, P962, DOI 10.1007/s11064-007-9499-2; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Sha D, 2008, BRAIN RES, V1207, P9, DOI 10.1016/j.brainres.2008.02.033; Shah IM, 2002, BRIT J CLIN PHARMACO, V54, P269, DOI 10.1046/j.1365-2125.2002.01638.x; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; SOLIMENA M, 1994, J CELL BIOL, V126, P331, DOI 10.1083/jcb.126.2.331; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Swanwick CC, 2004, J COMP NEUROL, V478, P405, DOI 10.1002/cne.20295; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; Vannucci SJ, 1998, J CEREBR BLOOD F MET, V18, P376, DOI 10.1097/00004647-199804000-00005; Vemuganti R, 2005, NEUROCHEM INT, V47, P136, DOI 10.1016/j.neuint.2005.04.015; Wei JN, 2008, NEUROCHEM RES, V33, P1459, DOI 10.1007/s11064-008-9600-5; Wei JN, 2006, J NEUROCHEM, V98, P1688, DOI 10.1111/j.1471-4159.2006.04074.x; Wei JN, 2003, J BIOMED SCI, V10, P617, DOI 10.1159/000073527; Williams AJ, 2003, J CEREBR BLOOD F MET, V23, P75, DOI 10.1097/01.WCB.0000039285.37737.C2; Wu H, 2007, BRAIN RES, V1154, P80, DOI 10.1016/j.brainres.2007.04.008; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zhang L, 2001, STROKE, V32, P2926, DOI 10.1161/hs1201.100207	77	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10139	10.1371/journal.pone.0010139	http://dx.doi.org/10.1371/journal.pone.0010139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405034	Green Submitted, Green Published, gold			2022-12-27	WOS:000276705900018
J	Bazaa, A; Pasquier, E; Defilles, C; Limam, I; Kessentini-Zouari, R; Kallech-Ziri, O; El Battari, A; Braguer, D; El Ayeb, M; Marrakchi, N; Luis, J				Bazaa, Amine; Pasquier, Eddy; Defilles, Celine; Limam, Ines; Kessentini-Zouari, Raoudha; Kallech-Ziri, Olfa; El Battari, Assou; Braguer, Diane; El Ayeb, Mohamed; Marrakchi, Naziha; Luis, Jose			MVL-PLA2, a Snake Venom Phospholipase A2, Inhibits Angiogenesis through an Increase in Microtubule Dynamics and Disorganization of Focal Adhesions	PLOS ONE			English	Article							MACROVIPERA-LEBETINA VENOM; C-TYPE LECTIN; TUMOR ANGIOGENESIS; CELL-MIGRATION; ENDOTHELIAL-CELLS; IN-VITRO; INTEGRIN; ACTIN; LEBECTIN; DISINTEGRINS	Integrins are essential protagonists of the complex multi-step process of angiogenesis that has now become a major target for the development of anticancer therapies. We recently reported and characterized that MVL-PLA2, a novel phospholipase A2 from Macrovipera lebetina venom, exhibited anti-integrin activity. In this study, we show that MVL-PLA2 also displays potent anti-angiogenic properties. This phospholipase A2 inhibited adhesion and migration of human microvascular-endothelial cells (HMEC-1) in a dose-dependent manner without being cytotoxic. Using Matrigel (TM) and chick chorioallantoic membrane assays, we demonstrated that MVL-PLA2, as well as its catalytically inactivated form, significantly inhibited angiogenesis both in vitro and in vivo. We have also found that the actin cytoskeleton and the distribution of alpha v beta 3 integrin, a critical regulator of angiogenesis and a major component of focal adhesions, were disturbed after MVL-PLA2 treatment. In order to further investigate the mechanism of action of this protein on endothelial cells, we analyzed the dynamic instability behavior of microtubules in living endothelial cells. Interestingly, we showed that MVL-PLA2 significantly increased microtubule dynamicity in HMEC-1 cells by 40%. We propose that the enhancement of microtubule dynamics may explain the alterations in the formation of focal adhesions, leading to inhibition of cell adhesion and migration.	[Bazaa, Amine; Limam, Ines; Kessentini-Zouari, Raoudha; Kallech-Ziri, Olfa; El Ayeb, Mohamed; Marrakchi, Naziha] Inst Pasteur Tunis, Lab Venins & Toxines, Tunis, Tunisia; [Pasquier, Eddy; Defilles, Celine; El Battari, Assou; Braguer, Diane; Luis, Jose] Aix Marseille Univ, INSERM, UMR 911, CRO2, Marseille, France; [Marrakchi, Naziha] Fac Med Tunis, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Bazaa, A (corresponding author), Inst Pasteur Tunis, Lab Venins & Toxines, Tunis, Tunisia.	jose.luis@univmed.fr	Limam, Ines/AHE-2257-2022; LUIS, José/M-3071-2013; Pasquier, Eddy/A-8112-2018	Limam, Ines/0000-0002-7334-7692; Pasquier, Eddy/0000-0003-2824-5002	Institut National de la Sante et de la Recherche Medicale (INSERM); Comite Mixte de Cooperation Universitaire France-Tunisie (CMCU); Conseil Regional; Canceropole of Provence-Alpes-Cote d'Azur;  [MRST/IPT/LVT-LR005 SP 05]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Comite Mixte de Cooperation Universitaire France-Tunisie (CMCU); Conseil Regional; Canceropole of Provence-Alpes-Cote d'Azur; 	This work was supported by grant MRST/IPT/LVT-LR005 SP 05, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Comite Mixte de Cooperation Universitaire France-Tunisie (CMCU), the Conseil Regional and the Canceropole of Provence-Alpes-Cote d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalu A, 2005, EXPERT OPIN INV DRUG, V14, P1475, DOI 10.1517/13543784.14.12.1475; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Andrews RK, 2000, TOXICON, V38, P775, DOI 10.1016/S0041-0101(99)00187-7; Bazaa A, 2009, MATRIX BIOL, V28, P188, DOI 10.1016/j.matbio.2009.03.007; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Calvete JJ, 2007, CURR PHARM DESIGN, V13, P2853, DOI 10.2174/138161207782023766; Castel S, 2000, EUR J CELL BIOL, V79, P502, DOI 10.1078/0171-9335-00067; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; DRAKE CJ, 1995, J CELL SCI, V108, P2655; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Garmy-Susini Barbara, 2008, Lymphatic Research and Biology, V6, P155, DOI 10.1089/lrb.2008.1011; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Honore S, 2008, MOL CANCER THER, V7, P2080, DOI 10.1158/1535-7163.MCT-08-0156; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim SY, 2007, ARCH BIOCHEM BIOPHYS, V459, P40, DOI 10.1016/j.abb.2006.11.001; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; McLane MA, 2008, FRONT BIOSCI-LANDMRK, V13, P6617, DOI 10.2741/3177; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Olfa KZ, 2005, LAB INVEST, V85, P1507, DOI 10.1038/labinvest.3700350; Pasquier E, 2005, CANCER RES, V65, P2433, DOI 10.1158/0008-5472.CAN-04-2624; Pasquier E, 2004, MOL CANCER THER, V3, P1301; Pasquier E, 2007, CURR CANCER DRUG TAR, V7, P566, DOI 10.2174/156800907781662266; Pasquier E, 2006, DRUG RESIST UPDATE, V9, P74, DOI 10.1016/j.drup.2006.04.003; Pilorget A, 2007, J CELL PHYSIOL, V211, P307, DOI 10.1002/jcp.20935; PLETJUSHKINA OJ, 1994, EXP CELL RES, V212, P201, DOI 10.1006/excr.1994.1135; Pourroy B, 2006, CANCER RES, V66, P3256, DOI 10.1158/0008-5472.CAN-05-3885; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sarray S, 2004, LAB INVEST, V84, P573, DOI 10.1038/labinvest.3700088; Sarray S, 2007, MATRIX BIOL, V26, P306, DOI 10.1016/j.matbio.2007.01.001; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Sheu JR, 1997, BBA-GEN SUBJECTS, V1336, P445, DOI 10.1016/S0304-4165(97)00057-3; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zouari-Kessentini R, 2009, TOXICON, V53, P444, DOI 10.1016/j.toxicon.2009.01.003	45	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10124	10.1371/journal.pone.0010124	http://dx.doi.org/10.1371/journal.pone.0010124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405031	Green Published, gold, Green Submitted			2022-12-27	WOS:000276705900008
J	Noguchi, K; Riggins, DP; Eldahan, KC; Kitko, RD; Slonczewski, JL				Noguchi, Ken; Riggins, Daniel P.; Eldahan, Khalid C.; Kitko, Ryan D.; Slonczewski, Joan L.			Hydrogenase-3 Contributes to Anaerobic Acid Resistance of Escherichia coli	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; GASTROINTESTINAL-TRACT; MOLECULAR-HYDROGEN; SHIGELLA-FLEXNERI; ENERGY-SOURCE; PH; FORMATE; ENZYME; EXPRESSION; GROWTH	Background: Hydrogen production by fermenting bacteria such as Escherichia coli offers a potential source of hydrogen biofuel. Because H-2 production involves consumption of 2H(+), hydrogenase expression is likely to involve pH response and regulation. Hydrogenase consumption of protons in E. coli has been implicated in acid resistance, the ability to survive exposure to acid levels (pH 2-2.5) that are three pH units lower than the pH limit of growth ( pH 5-6). Enhanced survival in acid enables a larger infective inoculum to pass through the stomach and colonize the intestine. Most acid resistance mechanisms have been defined using aerobic cultures, but the use of anaerobic cultures will reveal novel acid resistance mechanisms. Methods and Principal Findings: We analyzed the pH regulation of bacterial hydrogenases in live cultures of E. coli K-12 W3110. During anaerobic growth in the range of pH 5 to 6.5, E. coli expresses three hydrogenase isoenzymes that reversibly oxidize H-2 to 2H(+). Anoxic conditions were used to determine which of the hydrogenase complexes contribute to acid resistance, measured as the survival of cultures grown at pH 5.5 without aeration and exposed for 2 hours at pH 2 or at pH 2.5. Survival of all strains in extreme acid was significantly lower in low oxygen than for aerated cultures. Deletion of hyc (Hyd-3) decreased anoxic acid survival 3-fold at pH 2.5, and 20-fold at pH 2, but had no effect on acid survival with aeration. Deletion of hyb (Hyd-2) did not significantly affect acid survival. The pH-dependence of H-2 production and consumption was tested using a H-2-specific Clark-type electrode. Hyd-3-dependent H-2 production was increased 70-fold from pH 6.5 to 5.5, whereas Hyd-2-dependent H-2 consumption was maximal at alkaline pH. H-2 production, was unaffected by a shift in external or internal pH. H-2 production was associated with hycE expression levels as a function of external pH. Conclusions: Anaerobic growing cultures of E. coli generate H-2 via Hyd-3 at low external pH, and consume H-2 via Hyd-2 at high external pH. Hyd-3 proton conversion to H-2 is required for acid resistance in anaerobic cultures of E. coli.	[Noguchi, Ken; Riggins, Daniel P.; Eldahan, Khalid C.; Kitko, Ryan D.; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA	Kenyon College	Noguchi, K (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu	Riggins, Daniel P/C-6560-2011	Riggins, Daniel P/0000-0002-6240-6212	National Science Foundation [MCB-0644167]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant MCB-0644167 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; AUGER EA, 1989, MOL MICROBIOL, V3, P609, DOI 10.1111/j.1365-2958.1989.tb00208.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bagramyan K, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1159, DOI 10.1023/B:BIRY.0000009129.18714.a4; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; BENJAMIN MM, 1995, APPL ENVIRON MICROB, V61, P1669, DOI 10.1128/AEM.61.4.1669-1672.1995; Bergholz TM, 2007, J APPL MICROBIOL, V102, P352, DOI 10.1111/j.1365-2672.2006.03099.x; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GOODSON M, 1989, LETT APPL MICROBIOL, V8, P77, DOI 10.1111/j.1472-765X.1989.tb00227.x; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Hansel A, 1998, APPL MICROBIOL BIOT, V50, P153, DOI 10.1007/s002530051270; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; KNAPPE J, 1969, EUR J BIOCHEM, V11, P316, DOI 10.1111/j.1432-1033.1969.tb00775.x; Laurinavichene TV, 2001, FEMS MICROBIOL LETT, V202, P121, DOI 10.1111/j.1574-6968.2001.tb10790.x; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Maeda T, 2007, APPL MICROBIOL BIOT, V76, P1035, DOI 10.1007/s00253-007-1086-6; Maier RJ, 2004, INFECT IMMUN, V72, P6294, DOI 10.1128/IAI.72.11.6294-6299.2004; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Mnatsakanyan N, 2004, CELL BIOCHEM BIOPHYS, V41, P357, DOI 10.1385/CBB:41:3:357; MOORE WEC, 1969, J INFECT DIS, V119, P641, DOI 10.1093/infdis/119.6.641; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; PECK HD, 1957, J BACTERIOL, V73, P706, DOI 10.1128/JB.73.6.706-721.1957; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; ROSSMANN R, 1991, MOL MICROBIOL, V5, P2807, DOI 10.1111/j.1365-2958.1991.tb01989.x; SANKAR P, 1988, J BACTERIOL, V170, P5440, DOI 10.1128/jb.170.12.5440-5445.1988; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; SAWERS RG, 1986, EUR J BIOCHEM, V156, P265, DOI 10.1111/j.1432-1033.1986.tb09577.x; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Self WT, 2004, J BACTERIOL, V186, P580, DOI 10.1128/JB.186.2.580-587.2004; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; Valdez-Vazquez I, 2009, RENEW SUST ENERG REV, V13, P1000, DOI 10.1016/j.rser.2008.03.003; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yohannes E, 2004, J BACTERIOL, V186, P192, DOI 10.1128/JB.186.1.192-199.2004; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P6762, DOI 10.1128/AEM.71.11.6762-6768.2005; Zilberstein B, 2007, CLINICS, V62, P47, DOI 10.1590/S1807-59322007000100008	46	79	80	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10132	10.1371/journal.pone.0010132	http://dx.doi.org/10.1371/journal.pone.0010132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405029	Green Published, gold			2022-12-27	WOS:000276705900014
J	Zhu, J; He, FH; Wang, DP; Liu, K; Huang, DW; Xiao, JF; Wu, JY; Hu, SN; Yu, J				Zhu, Jiang; He, Fuhong; Wang, Dapeng; Liu, Kan; Huang, Dawei; Xiao, Jingfa; Wu, Jiayan; Hu, Songnian; Yu, Jun			A Novel Role for Minimal Introns: Routing mRNAs to the Cytosol	PLOS ONE			English	Article							GENE-EXPRESSION; CHROMOSOME TERRITORIES; SPLICEOSOMAL INTRONS; NUCLEAR ARCHITECTURE; MAMMALIAN-CELLS; HUMAN GENOME; ORGANIZATION; EXPORT; EVOLUTION; COMPLEX	Background: Introns and their splicing are tightly coupled with the subsequent mRNA maturation steps, especially nucleocytoplasmic export. A remarkable fraction of vertebrate introns have a minimal size of about 100 bp, while majority of introns expand to several kilobases even megabases in length. Principal Findings: We carried out analyses on the evolution and function of minimal introns (50-150 bp) in human and mouse genomes. We found that minimal introns are conserved in terms of both length and sequence. They are preferentially located toward 39 end of mRNA and non-randomly distributed among chromosomes. Both the evolutionary conservation and non-random distribution are indicative of biological relevance. We showed that genes with minimal introns have higher abundance, larger size, and tend to be universally expressed as compared to genes with only large introns and intron-less genes. Genes with minimal introns replicate earlier and preferentially reside in the vicinities of open chromatin, suggesting their unique nuclear position and potential relevance to the regulation of gene expression and transcript export. Conclusions: Based on these observations, we proposed a nuclear-export routing model, where minimal introns play a regulatory role in selectively exporting the highly abundant and large housekeeping genes that reside at the surface of chromatin territories, and thus preventing entanglement with other genes located at the interior locations.	[Zhu, Jiang; He, Fuhong; Wang, Dapeng; Liu, Kan; Huang, Dawei; Xiao, Jingfa; Wu, Jiayan; Hu, Songnian; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhu, Jiang; He, Fuhong; Wang, Dapeng; Liu, Kan; Huang, Dawei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, J (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	junyu@big.ac.cn	郑, 征/C-8514-2011; He, Fuhong/T-4887-2019; Wang, Dapeng/HGD-4818-2022; Zhu, Jiang/E-3049-2013; He, Fuhong/HHZ-2474-2022; Hu, Songnian/C-6509-2013	He, Fuhong/0000-0002-3176-8309; wu, jia yan/0000-0001-6048-405X; Hu, Songnian/0000-0003-3966-3111; Liu, Kan/0000-0001-5625-8180	Ministry of Science and Technology of the People's Republic of China [2006CB910404]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National Basic Research Program ( 973 Program) from the Ministry of Science and Technology of the People's Republic of China (2006CB910404 to J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Niu DK, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-46; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sironi M, 2005, TRENDS GENET, V21, P484, DOI 10.1016/j.tig.2005.06.009; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	39	18	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10144	10.1371/journal.pone.0010144	http://dx.doi.org/10.1371/journal.pone.0010144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20419085	Green Submitted, Green Published, gold			2022-12-27	WOS:000276705900021
J	Shang, LS; Ananthakrishnan, R; Li, Q; Quadri, N; Abdillahi, M; Zhu, ZB; Qu, W; Rosario, R; Toure, F; Yan, SF; Schmidt, AM; Ramasamy, R				Shang, Linshan; Ananthakrishnan, Radha; Li, Qing; Quadri, Nosirudeen; Abdillahi, Mariane; Zhu, Zhengbin; Qu, Wu; Rosario, Rosa; Toure, Fatouma; Yan, Shi Fang; Schmidt, Ann Marie; Ramasamy, Ravichandran			RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3 beta Signaling Pathways	PLOS ONE			English	Article							N-TERMINAL KINASE; GLYCOGEN-SYNTHASE KINASE-3-BETA; PROMOTES SURVIVAL; CARDIAC MYOCYTES; CELL-DEATH; IN-VITRO; ACTIVATION; APOPTOSIS; ISCHEMIA; STRESS	Background: Advanced glycation end-products (AGEs) have been implicated in diverse pathological settings including diabetes, inflammation and acute ischemia/reperfusion injury in the heart. AGEs interact with the receptor for AGEs (RAGE) and transduce signals through activation of MAPKs and proapoptotic pathways. In the current study, adult cardiomyocytes were studied in an in vitro ischemia/reperfusion (I/R) injury model to delineate the molecular mechanisms underlying RAGE-mediated injury due to hypoxia/reoxygenation (H/R). Methodology/Principal Findings: Cardiomyocytes isolated from adult wild-type (WT), homozygous RAGE-null (RKO), and WT mice treated with soluble RAGE (sRAGE) were subjected to hypoxia for 30 minutes alone or followed by reoxygenation for 1 hour. In specific experiments, RAGE ligand carboxymethyllysine (CML)-AGE (termed "CML" in this manuscript) was evaluated in vitro. LDH, a marker of cellular injury, was assayed in the supernatant in the presence or absence of signaling inhibitor-treated cardiomyocytes. Cardiomyocyte levels of heterogeneous AGEs were measured using ELISA. A pronounced increase in RAGE expression along with AGEs was observed in H/R vs. normoxia in WT cardiomyocytes. WT cardiomyocytes after H/R displayed increased LDH release compared to RKO or sRAGE-treated cardiomyocytes. Our results revealed significant increases in phospho-JNK in WT cardiomyocytes after H/R. In contrast, neither RKO nor sRAGE-treated cardiomyocytes exhibited increased phosphorylation of JNK after H/R stress. The impact of RAGE deletion on GSK-3 beta phosphorylation in the cardiomyocytes subjected to H/R revealed significantly higher levels of phospho-GSK-3 beta/total GSK-3 beta in RKO, as well as in sRAGE-treated cardiomyocytes versus WT cardiomyocytes after H/R. Further investigation established a key role for Akt, which functions upstream of GSK-3 beta, in modulating H/R injury in adult cardiomyocytes. Conclusions/Significance: These data illustrate key roles for RAGE-ligand interaction in the pathogenesis of cardiomyocyte injury induced by hypoxia/reoxygenation and indicate that the effects of RAGE are mediated by JNK activation and dephosphorylation of GSK-3 beta. The outcome in this study lends further support to the potential use of RAGE blockade as an adjunctive therapy for protection of the ischemic heart.	[Shang, Linshan; Ananthakrishnan, Radha; Li, Qing; Quadri, Nosirudeen; Abdillahi, Mariane; Zhu, Zhengbin; Qu, Wu; Rosario, Rosa; Toure, Fatouma; Yan, Shi Fang; Schmidt, Ann Marie; Ramasamy, Ravichandran] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Surg Sci, New York, NY 10027 USA	Columbia University	Shang, LS (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Surg, Div Surg Sci, New York, NY 10027 USA.	rr260@columbia.edu		Ramasamy, Ravichandran/0000-0002-3666-3346	National Heart, Lung, and Blood Institute [HL-61783, HL-60901, AG026467]; Juvenile Diabetes Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901, R01HL061783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026467] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Heart, Lung, and Blood Institute Grants HL-61783, HL-60901, AG026467 and the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Bucciarelli LG, 2008, DIABETES, V57, P1941, DOI 10.2337/db07-0326; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kajstura J, 1996, LAB INVEST, V74, P86; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kumar Y, 2003, PROTEOMICS, V3, P513, DOI 10.1002/pmic.200390065; MacLellan WR, 1997, CIRC RES, V81, P137, DOI 10.1161/01.RES.81.2.137; Markou T, 2008, CELL SIGNAL, V20, P206, DOI 10.1016/j.cellsig.2007.10.004; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; WOODGETT JR, 2001, SCI STKE, pRE12; Yun H, 2009, CARCINOGENESIS, V30, P529, DOI 10.1093/carcin/bgn259	35	68	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10092	10.1371/journal.pone.0010092	http://dx.doi.org/10.1371/journal.pone.0010092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404919	gold, Green Published, Green Submitted			2022-12-27	WOS:000276482100012
J	John, K; Fitzpatrick, J; French, N; Kazwala, R; Kambarage, D; Mfinanga, GS; MacMillan, A; Cleaveland, S				John, Kunda; Fitzpatrick, Julie; French, Nigel; Kazwala, Rudovick; Kambarage, Dominic; Mfinanga, Godfrey S.; MacMillan, Alastair; Cleaveland, Sarah			Quantifying Risk Factors for Human Brucellosis in Rural Northern Tanzania	PLOS ONE			English	Article							UNITED-STATES	Background: Brucellosis is a zoonosis of veterinary, public health and economic significance in most developing countries. Human brucellosis is a severely debilitating disease that requires prolonged treatment with a combination of antibiotics. The disease can result in permanent and disabling sequel, and results in considerable medical expenses in addition to loss of income due to loss of working hours. A study was conducted in Northern Tanzania to determine the risk factors for transmission of brucellosis to humans in Tanzania. Methods: This was a matched case-control study. Any patient with a positive result by a competitive ELISA (c-ELISA) test for brucellosis, and presenting to selected hospitals with at least two clinical features suggestive of brucellosis such as headache, recurrent or continuous fever, sweating, joint pain, joint swelling, general body malaise or backache, was defined as a case. For every case in a district, a corresponding control was traced and matched by sex using multistage cluster sampling. Other criteria for inclusion as a control included a negative c-ELISA test result and that the matched individual would present to hospital if falls sick. Results: Multivariable analysis showed that brucellosis was associated with assisted parturition during abortion in cattle, sheep or goat. It was shown that individuals living in close proximity to other households had a higher risk of brucellosis. People who were of Christian religion were found to have a higher risk of brucellosis compared to other religions. The study concludes that assisting an aborting animal, proximity to neighborhoods, and Christianity were associated with brucellosis infection. There was no association between human brucellosis and Human Immunodeficiency Virus (HIV) serostatus. Protecting humans against contact with fluids and tissues during assisted parturition of livestock may be an important means of reducing the risk of transferring brucellosis from livestock to humans. These can be achieved through health education to the communities where brucellosis is common.	[John, Kunda; Mfinanga, Godfrey S.] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [John, Kunda; Cleaveland, Sarah] Univ Glasgow, Div Ecol & Evolutionary Biol, Glasgow, Lanark, Scotland; [Fitzpatrick, Julie] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [French, Nigel] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Kambarage, Dominic] Sokoine Univ Agr, Morogoro, Tanzania; [MacMillan, Alastair] Dept Environm Food & Rural Affairs, Vet Res Directorate, London, England	National Institute of Medical Research; University of Glasgow; Moredun Research Institute; Massey University; Sokoine University of Agriculture	John, K (corresponding author), Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania.	jkundas@yahoo.com	French, Nigel/F-5725-2011; Stephen, Kunda/ABE-9681-2020	French, Nigel/0000-0002-6334-0657; Cleaveland, Sarah/0000-0002-0456-0959	Department for International Development of the UK	Department for International Development of the UK	The study was funded by the Department for International Development of the UK through the Animal Health Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M M, 2001, Cent Eur J Public Health, V9, P158; Bikas C, 2003, EUR J EPIDEMIOL, V18, P267, DOI 10.1023/A:1023368420840; Bouza E, 2005, J HOSP INFECT, V61, P80, DOI 10.1016/j.jhin.2005.02.018; BUCHANAN TM, 1974, MEDICINE, V53, P415, DOI 10.1097/00005792-197411000-00002; BUSCH LA, 1972, J INFECT DIS, V125, P289, DOI 10.1093/infdis/125.3.289; COOPER CW, 1992, T ROY SOC TROP MED H, V86, P206, DOI 10.1016/0035-9203(92)90575-W; COX PSV, 1966, E AFR MED J, P43; DAVIES G, 1971, VET REC, V88, P447, DOI 10.1136/vr.88.17.447; KOZUKEEV TB, 2006, MORBIDITY MORTALI S1, P31; KUNDA J, 2007, THESIS U EDINBURGH; LAROCHE R, 1987, MED TROPICALE REV CO, V1, P35; LIM HS, 2005, J PREVENTIVE MED PUB, V4, P482; MANTHEI CA, 1950, AM J VET RES, V173, P180; MARTIN SW, 1986, CAN J VET RES, V50, P15; Mfinanga S G M, 2004, East Afr Med J, V81, P171; Mfinanga SG, 2003, INT J TUBERC LUNG D, V7, P933; *MIN AGR COOP, 1995, EMERG INFECT DIS, V2, P213; MOHD MG, 1989, J TROP MED HYG, V2, P86; Moreno S, 1998, EUR J CLIN MICROBIOL, V17, P319, DOI 10.1007/BF01709454; PAUL J, 1995, T ROY SOC TROP MED H, V89, P228, DOI 10.1016/0035-9203(95)90508-1; Perret L., 2001, GUIDE EIA TECHNIQUES; PERRY BD, 2001, PREVENTIVE VET MED H, P228; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Shirima GM, 2005, THESIS U GLASGOW; Smits HL, 2004, AFRICAN J BIOTECHNOL, V12, P631; Solera J, 1997, DRUGS, V53, P245, DOI 10.2165/00003495-199753020-00005; STARK C, 1973, B EPIZOOTIC DIS AFRI, V67; WHO, 2006, CONTR NEGL ZOON DIS; *WHO, 1997, N173 WHO; YOUNG EJ, 1983, REV INFECT DIS, V5, P821	30	71	76	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9968	10.1371/journal.pone.0009968	http://dx.doi.org/10.1371/journal.pone.0009968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376363	Green Published, gold			2022-12-27	WOS:000276418200041
J	Null, SE; Viers, JH; Mount, JF				Null, Sarah E.; Viers, Joshua H.; Mount, Jeffrey F.			Hydrologic Response and Watershed Sensitivity to Climate Warming in California's Sierra Nevada	PLOS ONE			English	Article							JOAQUIN RIVER-BASIN; POTENTIAL IMPACTS; UNCERTAINTY; MEADOWS; MODEL	This study focuses on the differential hydrologic response of individual watersheds to climate warming within the Sierra Nevada mountain region of California. We describe climate warming models for 15 west-slope Sierra Nevada watersheds in California under unimpaired conditions using WEAP21, a weekly one-dimensional rainfall-runoff model. Incremental climate warming alternatives increase air temperature uniformly by 2 degrees, 4 degrees, and 6 degrees C, but leave other climatic variables unchanged from observed values. Results are analyzed for changes in mean annual flow, peak runoff timing, and duration of low flow conditions to highlight which watersheds are most resilient to climate warming within a region, and how individual watersheds may be affected by changes to runoff quantity and timing. Results are compared with current water resources development and ecosystem services in each watershed to gain insight into how regional climate warming may affect water supply, hydropower generation, and montane ecosystems. Overall, watersheds in the northern Sierra Nevada are most vulnerable to decreased mean annual flow, southern-central watersheds are most susceptible to runoff timing changes, and the central portion of the range is most affected by longer periods with low flow conditions. Modeling results suggest the American and Mokelumne Rivers are most vulnerable to all three metrics, and the Kern River is the most resilient, in part from the high elevations of the watershed. Our research seeks to bridge information gaps between climate change modeling and regional management planning, helping to incorporate climate change into the development of regional adaptation strategies for Sierra Nevada watersheds.	[Null, Sarah E.; Viers, Joshua H.; Mount, Jeffrey F.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Null, SE (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.	senull@ucdavis.edu	Kostin, Yurii/H-6755-2018; Orlov, Mykhailo/D-2417-2019; Reheilo, Iryna/B-6365-2016; Vorobev, Alexander/C-1918-2016; Bazeliuk, Oleksandr/B-2657-2016; Mykheliev, Ihor/A-5709-2019; Steksova, Tatiana I/J-5397-2016; Savychuk, Natali O/X-9305-2018; Kavura, Victor/M-9646-2018; Null, Sarah/E-4422-2011; Orlova, Nelya/N-1393-2018; Doroshenko, Alexander/N-7175-2015; Viers, Joshua/ABC-1851-2020	Kostin, Yurii/0000-0002-1823-5110; Orlov, Mykhailo/0000-0002-3705-8631; Reheilo, Iryna/0000-0003-0512-2456; Vorobev, Alexander/0000-0002-7324-428X; Bazeliuk, Oleksandr/0000-0002-3206-2287; Mykheliev, Ihor/0000-0001-9579-6547; Steksova, Tatiana I/0000-0003-4275-7450; Savychuk, Natali O/0000-0001-9532-665X; Kavura, Victor/0000-0003-0876-8332; Null, Sarah/0000-0001-7451-7908; Orlova, Nelya/0000-0002-0518-3593; Doroshenko, Alexander/0000-0003-3693-3876; Viers, Joshua/0000-0001-7957-7942	Resources Legacy Fund Foundation (RLFF) [2008-0201]	Resources Legacy Fund Foundation (RLFF)	This study was funded by Resources Legacy Fund Foundation (RLFF) under the Delta Solutions Grant (#2008-0201). Funder's website: http://www.resourceslegacyfund.org/rlff.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ASP ENV M CUB, 2005, POT CHANG HYDR PROD; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Berlow EL, 2002, ECOL APPL, V12, P1103, DOI 10.1890/1051-0761(2002)012[1103:SEIMMT]2.0.CO;2; Brekke LD, 2004, J AM WATER RESOUR AS, V40, P149, DOI 10.1111/j.1752-1688.2004.tb01016.x; *CWR, 2009, B CDWR; *CWR, 1988, B CDWR, V1788; Daly C., 2008, INT J CLIMATOLOGY; DETTINGER MD, 2009, CEC5002009050D CALEP; DETTINGER MD, 2005, SAN FRANCISCO ESTUAR, V3; Fu G, 2007, J HYDROL ENG, V12, P452, DOI 10.1061/(ASCE)1084-0699(2007)12:5(452); GLEICK PH, 1987, WATER RESOUR RES, V23, P1049, DOI 10.1029/WR023i006p01049; Hammersmark CT, 2008, RIVER RES APPL, V24, P735, DOI 10.1002/rra.1077; Hanak E., 2008, ADAPTING CALIFORNIAS; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Jefferson A, 2008, HYDROL PROCESS, V22, P4371, DOI 10.1002/hyp.7041; Jeton A. E., 1996, 954260 US GEOL SURV; KAPNICK S, 2009, CEC5002009016D CALEP; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; LETTENMAIER DP, 1990, WATER RESOUR RES, V26, P69, DOI 10.1029/WR026i001p00069; MADANI K, 2007, HYDROLOGICAL SCI TEC, V23, P137; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; Medellin-Azuara J, 2008, CLIMATIC CHANGE, V87, pS75, DOI 10.1007/s10584-007-9355-z; MEDELLINAZUARA J, 2009, CEC5002009049D CALEP; Micheli ER, 2002, EARTH SURF PROC LAND, V27, P687, DOI 10.1002/esp.340; Miller NL, 2003, J AM WATER RESOUR AS, V39, P771, DOI 10.1111/j.1752-1688.2003.tb04404.x; PATTON DR, 1970, J RANGE MANAGE, V23, P272, DOI 10.2307/3896220; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Stonefelt MD, 2000, J AM WATER RESOUR AS, V36, P321, DOI 10.1111/j.1752-1688.2000.tb04271.x; Vicuna S, 2008, CLIMATIC CHANGE, V87, pS123, DOI 10.1007/s10584-007-9365-x; Vrba J, INT CONTRIBUTIONS HY, V16; Xu CY, 1999, AGR FOREST METEOROL, V98-9, P295, DOI 10.1016/S0168-1923(99)00106-9; Yates D, 2005, WATER INT, V30, P487, DOI 10.1080/02508060508691893; YOUNG CA, 2009, J AM WATER RESOURCES	33	96	96	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9932	10.1371/journal.pone.0009932	http://dx.doi.org/10.1371/journal.pone.0009932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20368984	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200010
J	Poppe, J; Sutcliffe, P; Hooper, JNA; Worheide, G; Erpenbeck, D				Poeppe, Judith; Sutcliffe, Patricia; Hooper, John N. A.; Woerheide, Gert; Erpenbeck, Dirk			CO I Barcoding Reveals New Clades and Radiation Patterns of Indo-Pacific Sponges of the Family Irciniidae (Demospongiae: Dictyoceratida)	PLOS ONE			English	Article							MARINE SPONGE; SEQUENCE EVOLUTION; PHYLUM PORIFERA; MITOCHONDRIAL; GENUS; ALIGNMENT; SPECIATION; PHYLOGENY; GENES	Background: DNA barcoding is a promising tool to facilitate a rapid and unambiguous identification of sponge species. Demosponges of the order Dictyoceratida are particularly challenging to identify, but are of ecological as well as biochemical importance. Methodology/Principal Findings: Here we apply DNA barcoding with the standard CO1-barcoding marker on selected Indo-Pacific specimens of two genera, Ircinia and Psammocinia of the family Irciniidae. We show that the CO1 marker identifies several species new to science, reveals separate radiation patterns of deep-sea Ircinia sponges and indicates dispersal patterns of Psammocinia species. However, some species cannot be unambiguously barcoded by solely this marker due to low evolutionary rates. Conclusions/Significance: We support previous suggestions for a combination of the standard CO1 fragment with an additional fragment for sponge DNA barcoding.	[Poeppe, Judith] Humboldt Univ, Museum Nat Kunde, Dept Malacozool, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany; [Sutcliffe, Patricia; Hooper, John N. A.] Queensland Museum, Biodivers Program, Brisbane, Australia; [Woerheide, Gert; Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Woerheide, Gert; Erpenbeck, Dirk] Univ Munich, GeoBioCtr, Munich, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Queensland Museum; University of Munich; University of Munich	Poppe, J (corresponding author), Humboldt Univ, Museum Nat Kunde, Dept Malacozool, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany.	erpenbeck@lmu.de	Wörheide, Gert/C-1080-2008	Wörheide, Gert/0000-0002-6380-7421; Hooper, John/0000-0003-1722-5954	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This study benefited from funding by the German Research Foundation (DFG, www.dfg.de) to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bergquist P. R., 2002, SYSTEMA PORIFERA GUI; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; BIFULCO G, 1995, J NAT PRODUCTS, V58, P1444, DOI 10.1021/np50123a017; Blanquer A, 2007, MOL PHYLOGENET EVOL, V45, P392, DOI 10.1016/j.ympev.2007.03.004; Blunt J., 2003, MARINLIT DATABASE LI; Chombard C, 1997, BIOL BULL, V193, P359, DOI 10.2307/1542938; Cook SDC, 1998, NEW ZEAL J MAR FRESH, V32, P399; COOK SDC, 2002, SYSTEMA PORIFERA GUI; COOK SDC, 2002, SYSTEMA PORIFERA GUI, P1022, DOI DOI 10.1007/978-1-4615-0747-5_99; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Fromont J.P., 1990, P273; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEIM I, 2007, J MAR BIOL ASSOC UK, V87, P14; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; LOPEZLEGENTIL S, 2008, CORAL REEFS, P9; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mikkelsen PM, 2001, B MAR SCI, V69, P525; Nichols SA, 2005, J EXP MAR BIOL ECOL, V323, P1, DOI 10.1016/j.jembe.2005.02.012; Palumbi SR, 1997, EVOLUTION, V51, P1506, DOI 10.1111/j.1558-5646.1997.tb01474.x; Park MH, 2007, MOL CELLS, V23, P220; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raleigh J, 2007, J MAR BIOL ASSOC UK, V87, P1577, DOI 10.1017/S0025315407058341; Schlacher-Hoenlinger MA, 2005, ZOOSYSTEMA, V27, P649; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Sole-Cava Antonio M., 1999, Memoirs of the Queensland Museum, V44, P591; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; VANSOEST RWM, 2008, WORLD PORIFERA DATAB; VETHAAK AD, 1982, BIJDR DIERKD, V52, P82, DOI 10.1163/26660644-05202002; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1629, DOI 10.1017/S0025315407058274; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Worheide G, 2008, PORIFERA RES BIODIVE, P123; Worheide Gert, 1999, Memoirs of the Queensland Museum, V43, P859	45	35	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9950	10.1371/journal.pone.0009950	http://dx.doi.org/10.1371/journal.pone.0009950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376349	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200026
J	Wang, B; Liu, P; Tang, YY; Pan, HH; Xu, XR; Tang, RK				Wang, Ben; Liu, Peng; Tang, Yanyan; Pan, Haihua; Xu, Xurong; Tang, Ruikang			Guarding Embryo Development of Zebrafish by Shell Engineering: A Strategy to Shield Life from Ozone Depletion	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; UV-B; MORTALITY; REPAIR; LARVAE; EGGS	Background: The reduced concentration of stratospheric ozone results in an increased flux of biologically damaging midultraviolet radiation (UVB, 280 to 320 nm) reaching earth surfaces. Environmentally relevant levels of UVB negatively impact various natural populations of marine organisms, which is ascribed to suppressed embryonic development by increased radiation. Methodology/Principal Findings: Inspired by strategies in the living systems generated by evolution, we induce an extra UVB-adsorbed coat on the chorion (eggshell surrounding embryo) of zebrafish, during the blastula period. Short and long UV exposure experiments show that the artificial mineral-shell reduces the UV radiation effectively and the enclosed embryos become more robust. In contrast, the uncoated embryos cannot survive under the enhanced UVB condition. Conclusions: We suggest that an engineered shell of functional materials onto biological units can be developed as a strategy to shield lives to counteract negative changes of global environment, or to provide extra protection for the living units in biological research.	[Wang, Ben; Liu, Peng; Tang, Yanyan; Pan, Haihua; Xu, Xurong; Tang, Ruikang] Zhejiang Univ, Ctr Biomat & Biopathways, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Ben] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Tang, Ruikang] Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Harvard University; Zhejiang University	Wang, B (corresponding author), Zhejiang Univ, Ctr Biomat & Biopathways, Hangzhou 310003, Zhejiang, Peoples R China.	rtang@zju.edu.cn	xu, xurong/AAA-7823-2020; Pan, Haihua/O-7512-2018; Wang, Ben/B-6488-2011; Wang, Ben/P-4732-2017; Wang, Ben/AAE-7987-2021	xu, xurong/0000-0002-0626-0597; Pan, Haihua/0000-0003-0327-7622; Wang, Ben/0000-0002-4134-1835; Wang, Ben/0000-0002-4134-1835; 	National Natural Science Foundation of China [20871102]; National Basic Research Program of China [2007CB516806]; Cheung Kong Scholars Program; Chinese Universities Scientific Fund [2008632016]; Zhejiang Provincial Natural Science Foundation [R407087]; Daming Biomineralization Fundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Cheung Kong Scholars Program; Chinese Universities Scientific Fund; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Daming Biomineralization Fundation	This work was supported by the National Natural Science Foundation of China (20871102)(http://www.nsfc.gov.cn/Portal0/default106.htm), the National Basic Research Program of China (2007CB516806)(http://www.973.gov.cn/English/Index.aspx), Cheung Kong Scholars Program (RT)(http://www.lksf.org/eng/project/education/ckh_award/main01.shtml), Chinese Universities Scientific Fund (2008632016), Zhejiang Provincial Natural Science Foundation (R407087) and Daming Biomineralization Fundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; BLAUSTEIN AR, 1994, P NATL ACAD SCI USA, V91, P1791, DOI 10.1073/pnas.91.5.1791; Blaustein AR, 1997, P NATL ACAD SCI USA, V94, P13735, DOI 10.1073/pnas.94.25.13735; Bonsignorio D, 1996, ZYGOTE, V4, P101, DOI 10.1017/S0967199400002975; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; Dethlefsen V, 2001, HELGOLAND MAR RES, V55, P45, DOI 10.1007/s101520000062; DIFFEY BL, 1991, PHYS MED BIOL, V36, P299, DOI 10.1088/0031-9155/36/3/001; Feldmann C, 2003, ADV FUNCT MATER, V13, P511, DOI 10.1002/adfm.200301005; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; FREDERICK JE, 1988, SCIENCE, V241, P438, DOI 10.1126/science.241.4864.438; HALEY TJ, 1965, J PHARM SCI-US, V54, P663, DOI 10.1002/jps.2600540502; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; HUNTER JR, 1979, PHOTOCHEM PHOTOBIOL, V29, P325, DOI 10.1111/j.1751-1097.1979.tb07055.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; PRATHER MJ, 1984, NATURE, V312, P227, DOI 10.1038/312227a0; Quintero-Torres R, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.032901; SMITH RC, 1989, PHOTOCHEM PHOTOBIOL, V50, P459, DOI 10.1111/j.1751-1097.1989.tb05550.x; SOLOMON S, 1990, NATURE, V347, P347, DOI 10.1038/347347a0; Staehelin J, 2001, REV GEOPHYS, V39, P231, DOI 10.1029/1999RG000059; Tang RK, 2005, ANGEW CHEM INT EDIT, V44, P3698, DOI 10.1002/anie.200500153; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wang B, 2008, ANGEW CHEM INT EDIT, V47, P3560, DOI 10.1002/anie.200704718; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wubben DL, 2000, J PLANKTON RES, V22, P2095, DOI 10.1093/plankt/22.11.2095	28	28	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9963	10.1371/journal.pone.0009963	http://dx.doi.org/10.1371/journal.pone.0009963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376356	gold, Green Published, Green Submitted			2022-12-27	WOS:000276418200037
J	Bertrand, A; Ballon, M; Chaigneau, A				Bertrand, Arnaud; Ballon, Michael; Chaigneau, Alexis			Acoustic Observation of Living Organisms Reveals the Upper Limit of the Oxygen Minimum Zone	PLOS ONE			English	Article							HUMBOLDT CURRENT SYSTEM; HYPOXIA; WATER; ECOSYSTEM; SARDINE; ANCHOVY; ANOXIA; PERU	Background: Oxygen minimum zones (OMZs) are expanding in the World Ocean as a result of climate change and direct anthropogenic influence. OMZ expansion greatly affects biogeochemical processes and marine life, especially by constraining the vertical habitat of most marine organisms. Currently, monitoring the variability of the upper limit of the OMZs relies on time intensive sampling protocols, causing poor spatial resolution. Methodology/Principal Findings: Using routine underwater acoustic observations of the vertical distribution of marine organisms, we propose a new method that allows determination of the upper limit of the OMZ with a high precision. Applied in the eastern South-Pacific, this original sampling technique provides high-resolution information on the depth of the upper OMZ allowing documentation of mesoscale and submesoscale features (e. g., eddies and filaments) that structure the upper ocean and the marine ecosystems. We also use this information to estimate the habitable volume for the world's most exploited fish, the Peruvian anchovy (Engraulis ringens). Conclusions/Significance: This opportunistic method could be implemented on any vessel geared with multi-frequency echosounders to perform comprehensive high-resolution monitoring of the upper limit of the OMZ. Our approach is a novel way of studying the impact of physical processes on marine life and extracting valid information about the pelagic habitat and its spatial structure, a crucial aspect of Ecosystem-based Fisheries Management in the current context of climate change.	[Bertrand, Arnaud; Ballon, Michael] Inst Rech Dev, EME UMR212, CRH, Sete, France; [Bertrand, Arnaud; Ballon, Michael; Chaigneau, Alexis] Inst Mar Peru, Lima, Peru; [Chaigneau, Alexis] Inst Rech Dev, IPSL LOCEAN, UPMC CNRS IRD MNHN, Paris, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Bertrand, A (corresponding author), Inst Rech Dev, EME UMR212, CRH, Sete, France.	Arnaud.Bertrand@ird.fr	Bertrand, Arnaud/E-4251-2010; Chaigneau, Alexis/E-4324-2010	Bertrand, Arnaud/0000-0003-4723-179X; chaigneau, alexis/0000-0001-6770-0114	IRD	IRD	Funding: This work is a contribution to the cooperation agreement between the Instituto del Mar del Peru (IMARPE) and the Institut de Recherche pour le Developpement (IRD). Michael Ballon was supported by an individual predoctoral research grant (BSTD) proposed by the "Support and training of scientific communities of the South Department" (DSF) from IRD, managed by Egide. Myriax Software Pty. Ltd. kindly provided free access to Echoview. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayon P, 2008, PROG OCEANOGR, V79, P238, DOI 10.1016/j.pocean.2008.10.020; Bertrand A, 2004, FISH FISH, V5, P296, DOI 10.1111/j.1467-2679.2004.00165.x; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Capet X, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034736; CARRITT DE, 1966, J MAR RES, V24, P286; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Cressie N. A., 1980, MATH GEOL, V1, P115, DOI DOI 10.1007/BF01035243; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Farias L, 2007, DEEP-SEA RES PT I, V54, P164, DOI 10.1016/j.dsr.2006.11.003; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Foote K, 1987, 144 ICES; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; Garcia-Castellano JM, 2005, EJC SUPPL, V3, P63; GUTIERREZ M, 1999, B I MAR PERU, V18, P77; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Hazen EL, 2009, MAR ECOL PROG SER, V375, P195, DOI 10.3354/meps07791; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; ICES, 2007, 287 ICES; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keister JE, 2000, MAR ECOL PROG SER, V205, P43, DOI 10.3354/meps205043; Kloser RJ, 2002, CAN J FISH AQUAT SCI, V59, P1065, DOI 10.1139/F02-076; Lau KM, 1995, B AM METEOROL SOC, V76, P2391, DOI 10.1175/1520-0477(1995)076<2391:CSDUWT>2.0.CO;2; LEBOURGESDHAUSS.A, 2010, ICES J MAR IN PRESS; Levi M., 2003, PERSPECT POLIT, V1, P45, DOI [10.1017/S1537592703000045, DOI 10.1017/S1537592703000045]; Liu YG, 2007, J ATMOS OCEAN TECH, V24, P2093, DOI 10.1175/2007JTECHO511.1; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Manriquez K, 2009, J PLANKTON RES, V31, P1075, DOI 10.1093/plankt/fbp053; McWilliams JC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039402; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nevison CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002110; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oschlies A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003147; Paulmier A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026801; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; PRATHER M, 1995, SCI CLIMATE CHANGE I, P86; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Simmonds EJ, 2009, ICES J MAR SCI, V66, P1341, DOI 10.1093/icesjms/fsp118; Simmonds J., 2005, FISHERIES ACOUSTICS; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Taylor JC, 2003, AQUAT LIVING RESOUR, V16, P191, DOI 10.1016/S0990-7440(03)00012-3; THOMAS LN, 2008, EDDY RESOLVING OCEAN; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; WISHNER KF, 1995, DEEP-SEA RES PT I, V42, P93, DOI 10.1016/0967-0637(94)00021-J	50	105	110	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2010	5	4							e10330	10.1371/journal.pone.0010330	http://dx.doi.org/10.1371/journal.pone.0010330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PV	20442791	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240200002
J	Satish, L; Johnson, S; Wang, JHC; Post, JC; Ehrlich, GD; Kathju, S				Satish, Latha; Johnson, Sandra; Wang, James H-C; Post, J. Christopher; Ehrlich, Garth D.; Kathju, Sandeep			Chaperonin Containing T-Complex Polypeptide Subunit Eta (CCT-eta) Is a Specific Regulator of Fibroblast Motility and Contractility	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; CYTOSOLIC CHAPERONIN; NITRIC-OXIDE; FETAL SKIN; SENSORY NEUROPATHY; EPSILON-SUBUNIT; CELL-MIGRATION; ADULT; EXPRESSION; GENES	Integumentary wounds in mammalian fetuses heal without scar; this scarless wound healing is intrinsic to fetal tissues and is notable for absence of the contraction seen in postnatal (adult) wounds. The precise molecular signals determining the scarless phenotype remain unclear. We have previously reported that the eta subunit of the chaperonin containing T-complex polypeptide (CCT-eta) is specifically reduced in healing fetal wounds in a rabbit model. In this study, we examine the role of CCT-eta in fibroblast motility and contractility, properties essential to wound healing and scar formation. We demonstrate that CCT-eta (but not CCT-beta) is underexpressed in fetal fibroblasts compared to adult fibroblasts. An in vitro wound healing assay demonstrated that adult fibroblasts showed increased cell migration in response to epidermal growth factor (EGF) and platelet derived growth factor (PDGF) stimulation, whereas fetal fibroblasts were unresponsive. Downregulation of CCT-eta in adult fibroblasts with short inhibitory RNA (siRNA) reduced cellular motility, both basal and growth factor-induced; in contrast, siRNA against CCT-beta had no such effect. Adult fibroblasts were more inherently contractile than fetal fibroblasts by cellular traction force microscopy; this contractility was increased by treatment with EGF and PDGF. CCT-eta siRNA inhibited the PDGF-induction of adult fibroblast contractility, whereas CCT-beta siRNA had no such effect. In each of these instances, the effect of downregulating CCT-eta was to modulate the behavior of adult fibroblasts so as to more closely approximate the characteristics of fetal fibroblasts. We next examined the effect of CCT-eta modulation on alpha-smooth muscle actin (alpha-SMA) expression, a gene product well known to play a critical role in adult wound healing. Fetal fibroblasts were found to constitutively express less alpha-SMA than adult cells. Reduction of CCT-eta with siRNA had minimal effect on cellular beta-actin but markedly decreased alpha-SMA; in contrast, reduction of CCT-beta had minimal effect on either actin isoform. Direct inhibition of alpha-SMA with siRNA reduced both basal and growth factor-induced fibroblast motility. These results indicate that CCT-eta is a specific regulator of fibroblast motility and contractility and may be a key determinant of the scarless wound healing phenotype by means of its specific regulation of alpha-SMA expression.	[Satish, Latha; Johnson, Sandra; Post, J. Christopher; Ehrlich, Garth D.; Kathju, Sandeep] Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA; [Wang, James H-C] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15261 USA	Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Satish, L (corresponding author), Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA.	skathju@wpahs.org	Latha, Satish/AAH-4977-2019	Latha, Satish/0000-0003-0154-7094; Ehrlich, Garth/0000-0003-1140-6594	Allegheny Singer Research Institute; Allegheny General Hospital; Pittsburgh Tissue Engineering Institute (PTEI); United States Department of Defense [W81XWH-08-2-0032];  [K08 DE014780];  [DC 05659];  [DC04173];  [NIHR01 AR049921]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE014780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005659, R01DC004173] Funding Source: NIH RePORTER	Allegheny Singer Research Institute; Allegheny General Hospital(General Electric); Pittsburgh Tissue Engineering Institute (PTEI); United States Department of Defense(United States Department of Defense); ; ; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This study was supported by Allegheny Singer Research Institute, Allegheny General Hospital and Pittsburgh Tissue Engineering Institute (PTEI). This work was funded from the grants awarded to S. K. (K08 DE014780; United States Department of Defense, W81XWH-08-2-0032), J. C. P. (DC 05659), G. D. E. (DC04173) and to L. S. (3M Fellowship). Funding support for cellular traction force microscopy work was provided from the grant awarded to J. H- C. W. (NIHR01 AR049921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadeu TP, 2008, J SURG RES, V149, P84, DOI 10.1016/j.jss.2007.10.015; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; BRIAN JB, 1999, ARCH OTOLARYNGOL, V125, P676; Brink HE, 2006, WOUND REPAIR REGEN, V14, P179, DOI 10.1111/j.1743-6109.2006.00108.x; Brink HE, 2005, IN VITRO CELL DEV-AN, V41, P252; Broker BJ, 1999, ARCH OTOLARYNGOL, V125, P676, DOI 10.1001/archotol.125.6.676; Burton K, 1999, MOL BIOL CELL, V10, P3745, DOI 10.1091/mbc.10.11.3745; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cass DL, 1997, J PEDIATR SURG, V32, P1017, DOI 10.1016/S0022-3468(97)90390-0; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Colwell AS, 2008, WOUND REPAIR REGEN, V16, P450, DOI 10.1111/j.1524-475X.2008.00383.x; Colwell AS, 2005, ADV BIOCHEM ENG BIOT, V93, P83, DOI 10.1007/b99972; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Cyrne L, 1996, FEBS LETT, V383, P277, DOI 10.1016/0014-5793(96)00240-2; Darden DL, 2000, J PEDIATR SURG, V35, P406, DOI 10.1016/S0022-3468(00)90204-5; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; DEPALMA RL, 1989, MATRIX, V9, P224; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; ELLIS I, 1992, J CELL SCI, V102, P447; ESTES JM, 1994, DIFFERENTIATION, V56, P173, DOI 10.1046/j.1432-0436.1994.5630173.x; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hanafy KA, 2004, J BIOL CHEM, V279, P46946, DOI 10.1074/jbc.M404134200; Hantash BM, 2008, FRONT BIOSCI-LANDMRK, V13, P51, DOI 10.2741/2559; Himmelspach R, 1997, PLANT J, V12, P1299, DOI 10.1046/j.1365-313x.1997.12061299.x; HYNES G, 1995, FEBS LETT, V358, P129, DOI 10.1016/0014-5793(94)01408-S; Jain K, 2008, J SURG RES, V148, P45, DOI 10.1016/j.jss.2008.02.053; Kashuba E, 1999, J HUMAN VIROL, V2, P33; Kathju S, 2006, WOUND REPAIR REGEN, V14, P413, DOI 10.1111/j.1743-6109.2006.00140.x; KONDO H, 1995, EXP CELL RES, V220, P501, DOI 10.1006/excr.1995.1342; Kondo H, 2000, IN VITRO CELL DEV-AN, V36, P256; Koulikovska M, 2005, ACTA OPHTHALMOL SCAN, V83, P543, DOI 10.1111/j.1600-0420.2005.00482.x; Kubota H, 1999, EUR J BIOCHEM, V262, P492, DOI 10.1046/j.1432-1327.1999.00405.x; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; KUBOTA H, 1995, GENE, V154, P231, DOI 10.1016/0378-1119(94)00880-2; Landau L. D., 1986, COURSE THEORETICAL P, V7; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; LORENZ HP, 1995, PLAST RECONSTR SURG, V96, P1251, DOI 10.1097/00006534-199511000-00001; Matsuda N, 2004, DEVELOPMENT, V131, P1913, DOI 10.1242/dev.01085; Park JC, 2001, YONSEI MED J, V42, P587, DOI 10.3349/ymj.2001.42.6.587; Rizk M, 2004, WORLD J SURG, V28, P301, DOI 10.1007/s00268-003-7396-7; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; Roobol A, 1999, EUR J CELL BIOL, V78, P21, DOI 10.1016/S0171-9335(99)80004-1; Sandulache VC, 2005, CELL TRANSPLANT, V14, P331, DOI 10.3727/000000005783983025; Satish L, 2003, J INVEST DERMATOL, V120, P1110, DOI 10.1046/j.1523-1747.2003.12230.x; Satish L, 2008, CELL STRESS CHAPERON, V13, P527, DOI 10.1007/s12192-008-0040-6; SCHOR SL, 1985, J CELL SCI, V73, P221; Shiraha H, 1999, J CELL BIOL, V146, P243; Staykova MA, 2003, FASEB J, V17, P1337, DOI 10.1096/fj.02-0577fje; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Tsai WC, 2003, J ORTHOPAED RES, V21, P265, DOI 10.1016/S0736-0266(02)00151-1; Tsai WC, 2008, CONNECT TISSUE RES, V49, P367, DOI 10.1080/03008200802325359; Webb Donna J., 2004, V294, P3; Wilgus TA, 2007, OSTOMY WOUND MANAG, V53, P16	59	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2010	5	4							e10063	10.1371/journal.pone.0010063	http://dx.doi.org/10.1371/journal.pone.0010063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PV	20442790	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000277240200001
J	Lambertini, C; Pantano, S; Dotto, GP				Lambertini, Chiara; Pantano, Serafino; Dotto, G. Paolo			Differential Control of Notch1 Gene Transcription by Klf4 and Sp3 Transcription Factors in Normal versus Cancer-Derived Keratinocytes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SIGNALING PATHWAY; FACTOR FAMILY; CELL-GROWTH; EXPRESSION; P53; PROMOTER; INDUCTION; COMPLEX; TARGET	In specific cell types like keratinocytes, Notch signaling plays an important pro-differentiation and tumor suppressing function, with down-modulation of the Notch1 gene being associated with cancer development. Besides being controlled by p53, little else is known on regulation of Notch1 gene expression in this context. We report here that transcription of this gene is driven by a TATA-less "sharp peak'' promoter and that the minimal functional region of this promoter, which extends from the -342 bp position to the initiation codon, is differentially active in normal versus cancer cells. This GC rich region lacks p53 binding sites, but binds Klf4 and Sp3. This finding is likely to be of biological significance, as Klf4 and, to a lesser extent, Sp3 are up-regulated in a number of cancer cells where Notch1 expression is down-modulated, and Klf4 overexpression in normal cells is sufficient to down-modulate Notch1 gene transcription. The combined knock-down of Klf4 and Sp3 was necessary for the reverse effect of increasing Notch1 transcription, consistent with the two factors exerting an overlapping repressor function through their binding to the Notch1 promoter.	[Lambertini, Chiara; Pantano, Serafino; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA	University of Lausanne; Harvard University; Massachusetts General Hospital	Lambertini, C (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Gian-Paolo.Dotto@unil.ch			Swiss National Foundation; European Union [LSHB-CT-2005-019067]; NIH [AR39190, AR054856]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054856, R01AR039190] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the Swiss National Foundation, a grant from the European Union (Epistem, Sixth Framework Program, LSHB-CT-2005-019067), and NIH Grants AR39190 and AR054856 and to G. P. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2007, NEOPLASIA, V9, P427, DOI 10.1593/neo.07211; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto G. P., 2000, BIOCHIM BIOPHYS ACTA, V87483, P1; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Fasken MB, 2009, RNA BIOL, V6, P237, DOI 10.4161/rna.6.3.8330; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Liu ZL, 2009, CANCER BIOL THER, V8, P1840, DOI 10.4161/cbt.8.19.9440; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Secchiero P, 2009, BLOOD, V113, P4300, DOI 10.1182/blood-2008-11-187708; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Song J, 2003, INT J MOL MED, V11, P547; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Thelu Jacques, 2002, BMC Dermatol, V2, P7, DOI 10.1186/1471-5945-2-7; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	54	30	30	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10369	10.1371/journal.pone.0010369	http://dx.doi.org/10.1371/journal.pone.0010369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442780	Green Submitted, Green Published, gold			2022-12-27	WOS:000277154200011
J	Nguyen, M; Leuridan, E; Zhang, T; De Wit, D; Willems, F; Van Damme, P; Goldman, M; Goriely, S				Nguyen, Muriel; Leuridan, Elke; Zhang, Tong; De Wit, Dominique; Willems, Fabienne; Van Damme, Pierre; Goldman, Michel; Goriely, Stanislas			Acquisition of Adult-Like TLR4 and TLR9 Responses during the First Year of Life	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; CORD BLOOD; INNATE IMMUNITY; HUMAN NEWBORNS; MONONUCLEAR-CELLS; ALPHA PRODUCTION; DENDRITIC CELLS; LIPOPOLYSACCHARIDE; INTERLEUKIN-12; TRANSCRIPTION	Background: Characteristics of the human neonatal immune system are thought to be responsible for heightened susceptibility to infectious pathogens and poor responses to vaccine antigens. Using cord blood as a source of immune cells, many reports indicate that the response of neonatal monocytes and dendritic cells (DC) to Toll-like receptor (TLR) agonists differs significantly from that of adult cells. Herein, we analyzed the evolution of these responses within the first year of life. Methodology/Principal Findings: Blood samples from children (0, 3, 6, 9, 12 month old) and healthy adults were stimulated ex vivo with bacterial lipopolysaccharide (LPS, TLR4 agonist) or CpG oligonucleotides (TLR9 agonist). We determined phenotypic maturation of monocytes, myeloid (m) and plasmacytoid (p) DC and production of cytokines in the culture supernatants. We observed that surface expression of CD80 and HLA-DR reaches adult levels within the first 3 months of life for mDCs and 6-9 months of life for monocytes and pDCs. In response to LPS, production of TNF-alpha, IP-10 and IL-12p70 reached adult levels between 6-9 months of life. In response to CpG stimulation, production of type I IFN-dependent chemokines (IP-10 and CXCL9) gradually increased with age but was still limited in 1-year old infants as compared to adult controls. Finally, cord blood samples stimulated with CpG ODN produced large amounts of IL-6, IL-8, IL-1b and IL-10, a situation that was not observed for 3 month-old infants. Conclusions: The first year of life represents a critical period during which adult-like levels of TLR responses are reached for most but not all cytokine responses.	[Nguyen, Muriel; Zhang, Tong; De Wit, Dominique; Willems, Fabienne; Goldman, Michel; Goriely, Stanislas] Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium; [Leuridan, Elke; Van Damme, Pierre] Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Antwerp, Belgium	Universite Libre de Bruxelles; University of Antwerp	Nguyen, M (corresponding author), Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium.	stgoriel@ulb.ac.be	van damme, pierre/I-4846-2013	Goriely, Stanislas/0000-0002-7005-6195; van damme, pierre/0000-0002-8642-1249; Leuridan, Elke/0000-0001-7482-799X	Fonds National de la Recherche Scientifique (FNRS, Belgium); Interuniversity Attraction Pole of the Belgian Federal Science Policy; University of Antwerp	Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole of the Belgian Federal Science Policy(Belgian Federal Science Policy Office); University of Antwerp	The Institute for Medical Immunology is sponsored by the government of the Walloon Region and GlaxoSmithKline Biologicals. This study was supported by the Fonds National de la Recherche Scientifique (FNRS, Belgium) and an Interuniversity Attraction Pole of the Belgian Federal Science Policy. S. G. is a research associate of the FRS-FNRS. E. L. received a research grant from the University of Antwerp for the conduction of the longitudinal study on maternal antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862; Al-Hertani W, 2007, CLIN INVEST MED, V30, pE44; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Brown MA, 2003, PEDIATR ALLERGY IMMU, V14, P106, DOI 10.1034/j.1399-3038.2003.00015.x; COHEN L, 1995, J IMMUNOL, V155, P5337; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Malamitsi-Puchner A, 2005, EARLY HUM DEV, V81, P387, DOI 10.1016/j.earlhumdev.2004.10.017; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Rowe J, 2000, INFECT IMMUN, V68, P3873, DOI 10.1128/IAI.68.7.3873-3877.2000; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; WEATHERSTONE KB, 1989, PEDIATR RES, V25, P342, DOI 10.1203/00006450-198904000-00006; WILSON CB, 1990, REV INFECT DIS, V12, pS410; Yan SR, 2004, INFECT IMMUN, V72, P1223, DOI 10.1128/IAI.72.3.1223-1229.2004; YERKOVICH ST, 2007, PEDIAT RES	27	109	115	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10407	10.1371/journal.pone.0010407	http://dx.doi.org/10.1371/journal.pone.0010407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442853	Green Submitted, Green Published, gold			2022-12-27	WOS:000277154200031
J	Eriksson, D; Valentiniene, S; Papaioannou, S				Eriksson, David; Valentiniene, Sonata; Papaioannou, Stylianos			Relating Information, Encoding and Adaptation: Decoding the Population Firing Rate in Visual Areas 17/18 in Response to a Stimulus Transition	PLOS ONE			English	Article							REPRESENTATION; NEURONS; MODEL	Neurons in the primary visual cortex typically reach their highest firing rate after an abrupt image transition. Since the mutual information between the firing rate and the currently presented image is largest during this early firing period it is tempting to conclude this early firing encodes the current image. This view is, however, made more complicated by the fact that the response to the current image is dependent on the preceding image. Therefore we hypothesize that neurons encode a combination of current and previous images, and that the strength of the current image relative to the previous image changes over time. The temporal encoding is interesting, first, because neurons are, at different time points, sensitive to different features such as luminance, edges and textures; second, because the temporal evolution provides temporal constraints for deciphering the instantaneous population activity. To study the temporal evolution of the encoding we presented a sequence of 250 ms stimulus patterns during multiunit recordings in areas 17 and 18 of the anaesthetized ferret. Using a novel method we decoded the pattern given the instantaneous population-firing rate. Following a stimulus transition from stimulus A to B the decoded stimulus during the first 90ms was more correlated with the difference between A and B (B-A) than with B alone. After 90ms the decoded stimulus was more correlated with stimulus B than with B-A. Finally we related our results to information measures of previous (B) and current stimulus (A). Despite that the initial transient conveys the majority of the stimulus-related information; we show that it actually encodes a difference image which can be independent of the stimulus. Only later on, spikes gradually encode the stimulus more exclusively.	[Eriksson, David] Max Planck Inst Brain Res, D-60496 Frankfurt, Germany; [Valentiniene, Sonata; Papaioannou, Stylianos] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Max Planck Society; Karolinska Institutet	Eriksson, D (corresponding author), Max Planck Inst Brain Res, D-60496 Frankfurt, Germany.	eriksson@mpih-frankfurt.mpg.de		Papaioannou, Stylianos/0000-0002-9666-1094	Swedish Research Council to Per Roland [027198, K2007-63X-09456-17-3]	Swedish Research Council to Per Roland	This work was supported by EU contract IST 2006, 027198, and K2007-63X-09456-17-3 from the Swedish Research Council to Per Roland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; CLELAND BG, 1971, J PHYSL, P473; CLELAND BG, 1973, J PHYSL, P649; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; Duysens J, 1996, VISION RES, V36, P3243, DOI 10.1016/0042-6989(96)00040-5; DUYSENS J, 1985, VISION RES, P171; ENROTHCUGELL C, 1963, J NEUROPHYSIOL, V26, P894, DOI 10.1152/jn.1963.26.6.894; ENROTHCUGELL C, 1961, SCIENCE, V134, P1884, DOI 10.1126/science.134.3493.1884; Eriksson D, 2006, J PHYSIOL-PARIS, V100, P100, DOI 10.1016/j.jphysparis.2006.09.009; Eriksson D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002673; FUKUSHIMA K, 1975, BIOL CYBERN, V20, P121, DOI 10.1007/BF00342633; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gawne TJ, 2003, NEUROREPORT, V14, P105, DOI 10.1097/00001756-200301200-00020; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; Huang X, 2005, J NEUROPHYSIOL, V94, P4314, DOI 10.1152/jn.01309.2004; HUGHES GW, 1966, J NEUROPHYSIOL, V29, P333, DOI 10.1152/jn.1966.29.3.333; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; KJAER TW, 1994, J COMPUT NEUROSCI, P109; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Manger PR, 2002, CEREB CORTEX, V12, P423, DOI 10.1093/cercor/12.4.423; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; NIKOLIC D, 2006, TEMPORAL DYNAMICS IN; Paz R, 2004, PLOS BIOL, V2, P264, DOI 10.1371/journal.pbio.0020045; Peng XM, 2005, J NEUROPHYSIOL, V93, P1620, DOI 10.1152/jn.00793.2004; Richmond BJ, 1999, NEUROCOMPUTING, V26-7, P247, DOI 10.1016/S0925-2312(99)00018-1; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P370, DOI 10.1152/jn.1990.64.2.370; RICHTER J, 1982, BIOL CYBERN, V43, P127, DOI 10.1007/BF00336975; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; SINGER W, 1974, NEUROPHYSIOLOGY EXP, P507; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Young RA, 2001, SPATIAL VISION, V14, P261, DOI 10.1163/156856801753253582	50	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10327	10.1371/journal.pone.0010327	http://dx.doi.org/10.1371/journal.pone.0010327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436907	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079700006
J	Kim, DJ; Tremblay, ML; DiGiovanni, J				Kim, Dae Joon; Tremblay, Michel L.; DiGiovanni, John			Protein Tyrosine Phosphatases, TC-PTP, SHP1, and SHP2, Cooperate in Rapid Dephosphorylation of Stat3 in Keratinocytes Following UVB Irradiation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SIGNAL TRANSDUCER; SKIN CARCINOGENESIS; TRANSCRIPTION 3; EPITHELIAL CARCINOGENESIS; NEGATIVE REGULATOR; PROMOTION STAGES; ACTIVATION; SUBSTRATE; PROLIFERATION	Stat3 is initially dephosphorylated in murine keratinocytes in response to UVB irradiation. Treatment with Na(3)VO(4) desensitized keratinocytes to UVB-induced apoptosis with the recovery of phosphorylated Stat3 protein levels, implying that a protein tyrosine phosphatase (PTP) is involved in this mechanism. In the current work, we report that three PTPs including TC45 (the nuclear form of TC-PTP), SHP1, and SHP2 are involved in this rapid dephosphorylation of Stat3 in keratinocytes induced by UVB irradiation. Dephosphorylation of Stat3 was increased rapidly after UVB irradiation of cultured keratinocytes. Knockdown of TC-PTP, SHP1, or SHP2 using RNAi showed that these PTPs are likely responsible for most of the rapid Stat3 dephosphorylation observed following UVB irradiation. The level of phosphorylated Stat3 was significantly higher in keratinocytes transfected with TC-PTP, SHP1, or SHP2 siRNA in the presence or absence of UVB compared with keratinocytes transfected with control siRNA. TC45 was mainly localized in the cytoplasm of keratinocytes and translocated from cytoplasm to nucleus upon UVB irradiation. Stat3 dephosphorylation was associated with nuclear translocation of TC45. Further studies revealed that knockdown of all three phosphatases, using RNAi, prevented the rapid dephosphorylation of Stat3 following UVB irradiation. In mouse epidermis, the level of phosphorylated Stat3 was initially decreased, followed by a significant increase at later time points after UVB exposure. The levels of Stat3 target genes, such as cyclin D1 and c-Myc, followed the changes in activated Stat3 in response to UVB irradiation. Collectively, these results suggest that three phosphatases, TC45, SHP1, and SHP2, are primarily responsible for UVB-mediated Stat3 dephosphorylation and may serve as part of an initial protective mechanism against UV skin carcinogenesis.	[Kim, Dae Joon; DiGiovanni, John] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	University of Texas System; UTMD Anderson Cancer Center; McGill University	Kim, DJ (corresponding author), Univ Texas Austin, Dell Pediat Res Inst, Div Pharmacol & Toxicol, Austin, TX 78712 USA.	daejkim@mail.utexas.edu; jdigiovanni@mail.utexas.edu		KIM, DAE/0000-0002-7977-9955	NCI [CA105345, CA76520]; University of Texas M. D. Anderson Cancer Center [CA16672]; National Institute of Environmental Health Sciences [ES07784]; Odyssey Program; H-E-B Award for Scientific Achievement at The University of Texas; NATIONAL CANCER INSTITUTE [R01CA076520, U01CA105345, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas M. D. Anderson Cancer Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Odyssey Program; H-E-B Award for Scientific Achievement at The University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NCI grants, CA105345, CA76520, University of Texas M. D. Anderson Cancer Center support Grant CA16672, and National Institute of Environmental Health Sciences Center Grant ES07784. Funding as an Odyssey Fellow was supported by the Odyssey Program and The H-E-B Award for Scientific Achievement at The University of Texas M. D. Anderson Cancer Center (to D.J. Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kim DJ, 2009, CANCER RES, V69, P7587, DOI 10.1158/0008-5472.CAN-09-1180; KLANN RC, 1989, CANCER RES, V49, P699; Kunnumakkara AB, 2009, MOL CANCER RES, V7, P118, DOI 10.1158/1541-7786.MCR-08-0154; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Pandey MK, 2009, MOL PHARMACOL, V75, P525, DOI 10.1124/mol.108.052548; Peus D, 2000, PHOTOCHEM PHOTOBIOL, V72, P135, DOI 10.1562/0031-8655(2000)072<0135:UIEGFR>2.0.CO;2; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; SANO S, 2007, J DERMATOL SCI; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; TILLMANN U, 1994, MOL CELL BIOL, V14, P3030, DOI 10.1128/MCB.14.5.3030; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104	53	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10290	10.1371/journal.pone.0010290	http://dx.doi.org/10.1371/journal.pone.0010290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421975	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952600009
J	McGregor, TL; Misri, A; Bartlett, J; Orabona, G; Friedman, RD; Sexton, D; Maheshwari, S; Morgan, TM				McGregor, Tracy L.; Misri, Amit; Bartlett, Jackie; Orabona, Guilherme; Friedman, Richard D.; Sexton, David; Maheshwari, Sunita; Morgan, Thomas M.			Consanguinity Mapping of Congenital Heart Disease in a South Indian Population	PLOS ONE			English	Article							VAN-CREVELD-SYNDROME; PARENTAL CONSANGUINITY; GENE; AUTISM; LINKAGE; DISEQUILIBRIUM; CITRULLINE; CHILDREN; SURGERY; TRAITS	Background: Parental consanguinity is a risk factor for congenital heart disease (CHD) worldwide, suggesting that a recessive inheritance model may contribute substantially to CHD. In Bangalore, India, uncle-niece and first cousin marriages are common, presenting the opportunity for an international study involving consanguinity mapping of structural CHD. We sought to explore the recessive model of CHD by conducting a genome-wide linkage analysis utilizing high-density oligonucleotide microarrays and enrolling 83 CHD probands born to unaffected consanguineous parents. Methodology/Principal Findings: In this linkage scan involving single nucleotide polymorphism (SNP) markers, the threshold for genome-wide statistical significance was set at the standard log-of-odds (LOD) score threshold of 3.3, corresponding to 1995:1 odds in favor of linkage. We identified a maximal single-point LOD score of 3.76 (5754:1 odds) implicating linkage of CHD with the major allele (G) of rs1055061 on chromosome 14 in the HOMEZ gene, a ubiquitously expressed transcription factor containing leucine zipper as well as zinc finger motifs. Re-sequencing of HOMEZ exons did not reveal causative mutations in Indian probands. In addition, genotyping of the linked allele (G) in 325 U. S. CHD cases revealed neither genotypic nor allele frequency differences in varied CHD cases compared to 605 non-CHD controls. Conclusions/Significance: Despite the statistical power of the consanguinity mapping approach, no single gene of major effect could be convincingly identified in a clinically heterogeneous sample of Indian CHD cases born to consanguineous parents. However, we are unable to exclude the possibility that noncoding regions of HOMEZ may harbor recessive mutations leading to CHD in the Indian population. Further research involving large multinational cohorts of patients with specific subtypes of CHD is needed to attempt replication of the observed linkage peak on chromosome 14. In addition, we anticipate that a targeted re-sequencing approach may complement linkage analysis in future studies of recessive mutation detection in CHD.	[McGregor, Tracy L.; Orabona, Guilherme; Friedman, Richard D.; Morgan, Thomas M.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [McGregor, Tracy L.; Orabona, Guilherme; Friedman, Richard D.; Morgan, Thomas M.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Misri, Amit; Maheshwari, Sunita] Narayana Hrudayalaya Inst Cardiac Sci, Bangalore, Karnataka, India; [Bartlett, Jackie; Sexton, David; Morgan, Thomas M.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	McGregor, TL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.	thomas.morgan@vanderbilt.edu	Morgan, Tom/C-3478-2012		Children's Discovery Institute	Children's Discovery Institute	This work was funded by the Children's Discovery Institute (http://www.childrensdiscovery.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; [Anonymous], DAT SINGL NUCL POL D; Barr FE, 2007, J THORAC CARDIOV SUR, V134, P319, DOI 10.1016/j.jtcvs.2007.02.043; Barrett S, 1999, AM J MED GENET, V88, P609; Bayarsaihan D, 2003, P NATL ACAD SCI USA, V100, P10358, DOI 10.1073/pnas.1834010100; Becker S, 1999, Community Genet, V2, P69, DOI 10.1159/000016189; Becker SM, 2001, AM J MED GENET, V99, P8, DOI 10.1002/1096-8628(20010215)99:1<8::AID-AJMG1116>3.0.CO;2-U; Bittles A. H., 2002, Indian Journal of Human Genetics, V8, P45; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Galdzicka M, 2002, MOL GENET METAB, V77, P291, DOI 10.1016/S1096-7192(02)00178-6; Genin E, 2002, GENET EPIDEMIOL, V22, P116, DOI 10.1002/gepi.0174; Gnanalingham MG, 1999, ACTA PAEDIATR, V88, P473, DOI 10.1080/08035259950169936; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu-Lince D, 2005, AM J PHARMACOGENOMIC, V5, P233, DOI 10.2165/00129785-200505040-00004; Hutcheson HB, 2003, AM J MED GENET B, V117B, P90, DOI 10.1002/ajmg.b.10033; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIFTON RP, 2010, N ENGL J MED    0310; LUPSKI JR, 2010, N ENGL J MED    0310; Mani A, 2002, P NATL ACAD SCI USA, V99, P15054, DOI 10.1073/pnas.192582999; *MCKUS NATH I GEN, 2009, ONL MEND INH MAN OMI; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Nabulsi MM, 2003, AM J MED GENET A, V116A, P342, DOI 10.1002/ajmg.a.10020; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Petrini J, 2002, TERATOLOGY, V66, pS3, DOI 10.1002/tera.90002; Polymeropoulos MH, 1996, GENOMICS, V35, P1, DOI 10.1006/geno.1996.0315; Ramegowda S, 2006, ANN HUM BIOL, V33, P519, DOI 10.1080/03014460600909349; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; Saxena Anita, 2005, Indian Journal of Pediatrics, V72, P595, DOI 10.1007/BF02724185; SEXTON DP, 2007, WHOLE GENOME ASS STU; Smith HAB, 2006, J THORAC CARDIOV SUR, V132, P58, DOI 10.1016/j.jtcvs.2006.02.012	35	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10286	10.1371/journal.pone.0010286	http://dx.doi.org/10.1371/journal.pone.0010286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422016	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952500031
J	Luah, YH; Chaal, BK; Ong, EZ; Bozdech, Z				Luah, Yen-Hoon; Chaal, Balbir Kaur; Ong, Eugenia Ziying; Bozdech, Zbynek			A Moonlighting Function of Plasmodium falciparum Histone 3, Mono-Methylated at Lysine 9?	PLOS ONE			English	Article							HOST CELL INTERFACE; MALARIA PARASITES; ANTIGENIC VARIATION; VIRULENCE GENES; EXPRESSION; PROTEIN; BLOOD; LOCALIZATION; ACETYLATION; GENOME	Background: In the human malaria parasites Plasmodium falciparum, histone modifications have been implicated in the transcriptional regulation. The acetylation and methylation status of the histones have been linked with transcriptional regulation of the parasite surface virulence factors as well as other genes with stage specific expression. In P. falciparum as well as other eukaryotes, different histone modifications were found to be compartmentalized to distinct regions in the nuclei. This compartmentalization is believed to be one of the main prerequisites for their function in epigenetic regulation of gene expression. Methodology/Principal Findings: Here we investigate intracellular distributions of five previously uncharacterized histone modifications including histone 4 acetylation on lysine residue 5 (H4K5Ac), H4K8Ac, H3K9Ac, H4Ac4 and H3K9Me1 during the asexual developmental stages. With the exception of H3K9Me1, the modified histones were localized to the nuclear periphery. This provides a strong indication that the P. falciparum nuclear periphery is one of the most active regions in epigenetic regulation of gene expression. Interestingly, H3K9Me1 is not associated with the nuclei but instead resides in the parasitophorous vacuole (PV), the double membrane compartments surrounding the parasite cell within the host erythrocyte. In this compartment, H3K9Me1 partially co-localizes with Etramp proteins. The localization of H3K9Me1 in the PV is conserved in the other species including P. yoelii and P. vivax. Conclusions: Similar to other eukaryotes, the periphery of the P. falciparum nuclei is likely one of the most active areas in epigenetic regulation of gene expression involving multiple histone modifications. On the other hand, H3K9Me1 evolved a new function that is linked with the PV. This functional role appears to be evolutionarily conserved in Plasmodium species.	[Luah, Yen-Hoon; Chaal, Balbir Kaur; Ong, Eugenia Ziying; Bozdech, Zbynek] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Luah, YH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	zbozdech@ntu.edu.sg	Bozdech, Zbynek/A-2205-2011	Ong, Eugenia/0000-0003-2187-7058; Bozdech, Zbynek/0000-0002-9830-8446	Singapore Biomedical Research Council [ID BMRC 07/1/22/19/518]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was funded by the Singapore Biomedical Research Council Grant ID BMRC 07/1/22/19/518. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Bozdech Z, 1998, MOL BIOCHEM PARASIT, V97, P81, DOI 10.1016/S0166-6851(98)00135-2; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; CHAAL BK, PLOS PATHOG, V6; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Cui L, 2007, EUKARYOT CELL, V6, P1219, DOI 10.1128/EC.00062-07; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gabler C, 2004, ANN RHEUM DIS, V63, P1135, DOI 10.1136/ard.2003.011452; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Issar N, 2009, MICROBES INFECT, V11, P403, DOI 10.1016/j.micinf.2008.12.010; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Martini EMD, 2002, GENETICS, V160, P1375; Miao J, 2006, GENE, V369, P53, DOI 10.1016/j.gene.2005.10.022; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007; Rose FRAJ, 1998, INFECT IMMUN, V66, P3255, DOI 10.1128/IAI.66.7.3255-3263.1998; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; VOLZ J, INT J PARASITOL, V40, P109; WATSON K, 1995, BIOCHEM PHARMACOL, V50, P299, DOI 10.1016/0006-2952(95)00142-M	38	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10252	10.1371/journal.pone.0010252	http://dx.doi.org/10.1371/journal.pone.0010252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419108	Green Submitted, Green Published, gold			2022-12-27	WOS:000276853800022
J	Wang, PW; Henning, SM; Heber, D				Wang, Piwen; Henning, Susanne M.; Heber, David			Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols	PLOS ONE			English	Article							IN-VITRO; CELL-PROLIFERATION; BREAST-CANCER; MECHANISMS; ATP; BIOLUMINESCENCE; CARCINOGENESIS; GALLATE; NUMBER; GROWTH	Background: The chemopreventive effect of green tea polyphenols, such as (-)-epigallocatechin-3-gallate (EGCG), has been well demonstrated in cell culture studies. However, a wide range of IC50 concentrations has been observed in published studies of the anti-proliferative activity of EGCG from different laboratories. Although the susceptibility to EGCG treatment is largely dependent on cancer cell type, the particular cell viability and proliferation assays utilized may significantly influence quantitative results reported in the literature. Methodology/Principal Findings: We compared five widely used methods to measure cell proliferation and viability after EGCG treatment using LNCaP prostate cancer cells and MCF-7 breast cancer cells. Both methods using dyes to quantify adenosine triphosphate (ATP) and deoxynucleic acid (DNA) showed accuracy in the measurement of viable cells when compared to trypan blue assay and results showed good linear correlation (r = 0.95). However, the use of MTT (3-(4,5Dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide) and MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)2-( 4-sulfophenyl)-2H-tetrazolium) as indicators of metabolically active mitochondria overestimated the number of viable cells by comparison with the ATP, DNA, or trypan blue determinations. As a result, the observed IC50 concentration of EGCG was 2-fold higher using MTT and MTS compared to dyes quantifying ATP and DNA. In contrast, when cells were treated with apigenin MTT and MTS assays showed consistent results with ATP, DNA, or trypan blue assays. Conclusions/Significance: These results demonstrate that MTT and MTS -based assays will provide an underestimation of the anti-proliferative effect of EGCG, and suggest the importance of careful evaluation of the method for in vitro assessment of cell viability and proliferation depending on the chemical nature of botanical supplements.	[Wang, Piwen; Henning, Susanne M.; Heber, David] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, PW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA.	shenning@mednet.ucla.edu	Pieprzyk, Josef/C-2365-2017	Pieprzyk, Josef/0000-0002-1917-6466	NIH [RO1 CA116242]; NATIONAL CANCER INSTITUTE [R01CA116242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant RO1 CA116242. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Bruggisser R, 2002, PLANTA MED, V68, P445, DOI 10.1055/s-2002-32073; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Devika PT, 2008, PHARMACOL RES, V57, P351, DOI 10.1016/j.phrs.2008.03.008; Farabegoli F, 2007, CANCER DETECT PREV, V31, P499, DOI 10.1016/j.cdp.2007.10.018; Harper CE, 2007, PROSTATE, V67, P1576, DOI 10.1002/pros.20643; Hsu S, 2003, J PHARMACOL EXP THER, V306, P29, DOI 10.1124/jpet.103.049734; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; KANGAS L, 1984, MED BIOL, V62, P338; KATIYAR S, 1996, INT J ONCOL, P221; Li YY, 2009, MOL PHARMACEUT, V6, P1152, DOI 10.1021/mp900037p; O'Toole SA, 2003, CANCER DETECT PREV, V27, P47, DOI 10.1016/S0361-090X(02)00171-X; Ohishi T, 2002, CANCER LETT, V177, P49, DOI 10.1016/S0304-3835(01)00767-4; PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105; PLUMB JA, 1989, CANCER RES, V49, P4435; Thangapazham RL, 2007, CANCER LETT, V245, P232, DOI 10.1016/j.canlet.2006.01.027; Wang AW, 1996, HAND CLIN, V12, P43; Wisman KN, 2008, J AGR FOOD CHEM, V56, P7831, DOI 10.1021/jf8011954; Yang CS, 1997, ENVIRON HEALTH PERSP, V105, P971, DOI 10.2307/3433312; Yang GY, 2000, CARCINOGENESIS, V21, P2035, DOI 10.1093/carcin/21.11.2035; Yu HN, 2007, FOOD CHEM TOXICOL, V45, P244, DOI 10.1016/j.fct.2006.08.015; Zhang M, 2007, CARCINOGENESIS, V28, P1074, DOI 10.1093/carcin/bgl252; ZHOU D, 1990, CANCER RES, V50, P6949	24	275	284	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10202	10.1371/journal.pone.0010202	http://dx.doi.org/10.1371/journal.pone.0010202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419137	Green Submitted, Green Published, gold			2022-12-27	WOS:000276743500014
J	Rizkallah, J; Sin, DD				Rizkallah, Jacques; Sin, Don D.			Integrative Approach to Quality Assessment of Medical Journals Using Impact Factor, Eigenfactor, and Article Influence Scores	PLOS ONE			English	Article							CITATION; PAGERANK; COUNTS	Background: Impact factor ( IF) is a commonly used surrogate for assessing the scientific quality of journals and articles. There is growing discontent in the medical community with the use of this quality assessment tool because of its many inherent limitations. To help address such concerns, Eigenfactor (ES) and Article Influence scores (AIS) have been devised to assess scientific impact of journals. The principal aim was to compare the temporal trends in IF, ES, and AIS on the rank order of leading medical journals over time. Methods: The 2001 to 2008 IF, ES, AIS, and number of citable items (CI) of 35 leading medical journals were collected from the Institute of Scientific Information (ISI) and the http://www.eigenfactor.orgdatabases. The journals were ranked based on the published 2008 ES, AIS, and IF scores. Temporal score trends and variations were analyzed. Results: In general, the AIS and IF values provided similar rank orders. Using ES values resulted in large changes in the rank orders with higher ranking being assigned to journals that publish a large volume of articles. Since 2001, the IF and AIS of most journals increased significantly; however the ES increased in only 51% of the journals in the analysis. Conversely, 26% of journals experienced a downward trend in their ES, while the rest experienced no significant changes (23%). This discordance between temporal trends in IF and ES was largely driven by temporal changes in the number of CI published by the journals. Conclusion: The rank order of medical journals changes depending on whether IF, AIS or ES is used. All of these metrics are sensitive to the number of citable items published by journals. Consumers should thus consider all of these metrics rather than just IF alone in assessing the influence and importance of medical journals in their respective disciplines.	[Rizkallah, Jacques] St Pauls Hosp, Dept Med, Div Resp, Vancouver, BC V6Z 1Y6, Canada; St Pauls Hosp, Providence Heart & Lung Inst, Vancouver, BC V6Z 1Y6, Canada	St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan	Rizkallah, J (corresponding author), St Pauls Hosp, Dept Med, Div Resp, Vancouver, BC V6Z 1Y6, Canada.	don.sin@hli.ubc.ca	Sin, Don/AAC-2219-2021		Michael Smith Foundation for Health Research	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Funder: Michael Smith Foundation for Health Research (a government organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom CT, 2008, J NEUROSCI, V28, P11433, DOI 10.1523/JNEUROSCI.0003-08.2008; Bollen J, 2006, SCIENTOMETRICS, V69, P669, DOI 10.1007/s11192-006-0176-z; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Chew M, 2007, J ROY SOC MED, V100, P142, DOI 10.1258/jrsm.100.3.142; Davis PM, 2008, J AM SOC INF SCI TEC, V59, P2186, DOI 10.1002/asi.20943; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Dellavalle RP, 2007, J AM ACAD DERMATOL, V57, P116, DOI 10.1016/j.jaad.2007.03.005; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Falagas ME, 2008, FASEB J, V22, P2623, DOI 10.1096/fj.08-107938; Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P7, DOI 10.1055/s-2008-1066030; Fersht A, 2009, P NATL ACAD SCI USA, V106, P6883, DOI 10.1073/pnas.0903307106; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; Hakkalamani S, 2006, J BONE JOINT SURG BR, V88B, P159, DOI 10.1302/0301-620X.88B2.16983; Horgan Andrea, 2002, BMJ, V325, P8; Marashi SA, 2005, MED HYPOTHESES, V65, P822, DOI 10.1016/j.mehy.2005.05.003; Parrillo Joseph E, 2005, Crit Care Med, V33, P923, DOI 10.1097/01.CCM.0000162566.09112.1C; Perneger TV, 2004, BRIT MED J, V329, P546, DOI 10.1136/bmj.329.7465.546; PINSKI G, 1976, INFORM PROCESS MANAG, V12, P297, DOI 10.1016/0306-4573(76)90048-0; Saha S, 2003, J MED LIBR ASSOC, V91, P42; Seglen PO, 1997, BRIT MED J, V314, P498; Tobin MJ, 2004, AM J RESP CRIT CARE, V170, P351, DOI 10.1164/rccm.2406005; Weale Andy R, 2004, BMC Med Res Methodol, V4, P14, DOI 10.1186/1471-2288-4-14; Wedzicha JA, 2005, THORAX, V60, P712, DOI 10.1136/thx.2005.050922	26	58	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10204	10.1371/journal.pone.0010204	http://dx.doi.org/10.1371/journal.pone.0010204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419115	Green Published, gold, Green Submitted			2022-12-27	WOS:000276707100016
J	Koene, JM; Sloot, W; Montagne-Wajer, K; Cummins, SF; Degnan, BM; Smith, JS; Nagle, GT; ter Maat, A				Koene, Joris M.; Sloot, Wiebe; Montagne-Wajer, Kora; Cummins, Scott F.; Degnan, Bernard M.; Smith, John S.; Nagle, Gregg T.; ter Maat, Andries			Male Accessory Gland Protein Reduces Egg Laying in a Simultaneous Hermaphrodite	PLOS ONE			English	Article							FRESH-WATER SNAIL; SEMINAL FLUID; LYMNAEA-STAGNALIS; SEXUAL SELECTION; POND SNAIL; SPERM; ALLOCATION; CONFLICT; ALLOHORMONES; ADAPTATION	Seminal fluid is an important part of the ejaculate of internally fertilizing animals. This fluid contains substances that nourish and activate sperm for successful fertilization. Additionally, it contains components that influence female physiology to further enhance fertilization success of the sperm donor, possibly beyond the recipient's optimum. Although evidence for such substances abounds, few studies have unraveled their identities, and focus has been exclusively on separate-sex species. We present the first detailed study into the seminal fluid composition of a hermaphrodite ( Lymnaea stagnalis). Eight novel peptides and proteins were identified from the seminal-fluid-producing prostate gland and tested for effects on oviposition, hatching and consumption. The gene for the protein found to suppress egg mass production, Ovipostatin, was sequenced, thereby providing the first fully-characterized seminal fluid substance in a simultaneous hermaphrodite. Thus, seminal fluid peptides and proteins have evolved and can play a crucial role in sexual selection even when the sexes are combined.	[Koene, Joris M.; Sloot, Wiebe; Montagne-Wajer, Kora] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Cummins, Scott F.; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Smith, John S.] Univ Texas Med Branch, Biomol Resource Facil, Galveston, TX USA; [Nagle, Gregg T.] Univ Georgia, Dept Cellular Biol & Anat, Med Coll Georgia, Athens, GA 30602 USA; [ter Maat, Andries] Max Planck Inst Ornithol, Seewiesen, Germany	Vrije Universiteit Amsterdam; University of Queensland; University of Texas System; University of Texas Medical Branch Galveston; University System of Georgia; Augusta University; University of Georgia; Max Planck Society	Koene, JM (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands.	joris.koene@falw.vu.nl	Koene, Joris M./B-4502-2009; Smith, John/GYJ-1302-2022; Cummins, Scott/I-6420-2016	Koene, Joris M./0000-0001-8188-3439; Cummins, Scott/0000-0002-1454-2076; Degnan, Bernard/0000-0001-7573-8518	Netherlands Organization for Scientific Research (NWO) [814.01.011]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Research Council for Earth and Life Sciences (ALW) with financial aid from the Netherlands Organization for Scientific Research (NWO) to ATM and JMK (grant number 814.01.011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anthes N, 2007, BIOL LETTERS, V3, P121, DOI 10.1098/rsbl.2006.0596; Arnqvist Goran, 2005, pUnpaginated; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; Bedhomme S, 2009, BIOL LETTERS, V5, P717, DOI 10.1098/rsbl.2009.0401; Birkhead T.R., 2008, SPERM BIOL EVOLUTION; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Chase R, 2006, P ROY SOC B-BIOL SCI, V273, P1471, DOI 10.1098/rspb.2006.3474; Cinelli LP, 2009, COMP BIOCHEM PHYS B, V154, P108, DOI 10.1016/j.cbpb.2009.05.004; Darwin C., 1871, P423; DeBoer PACM, 1997, J EXP BIOL, V200, P941; DEVISSER JAGM, 1994, AM NAT, V144, P861; Engqvist L, 2006, J EVOLUTION BIOL, V19, P1448, DOI 10.1111/j.1420-9101.2006.01134.x; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Koene JM, 2005, INVERTEBR REPROD DEV, V48, P101, DOI 10.1080/07924259.2005.9652176; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; Koene JM, 2005, BEHAV ECOL SOCIOBIOL, V59, P243, DOI 10.1007/s00265-005-0030-y; Koene JM, 1998, J EXP BIOL, V201, P2313; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Koene JM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-212; Koene JM, 2006, INTEGR COMP BIOL, V46, P419, DOI 10.1093/icb/icj040; Koene JM, 2006, BEHAV ECOL SOCIOBIOL, V60, P332, DOI 10.1007/s00265-006-0169-1; Koene JM, 2009, ANIM BIOL, V59, P435, DOI 10.1163/157075509X12499949744306; Koene JM, 2009, EVOL ECOL, V23, P533, DOI 10.1007/s10682-008-9253-5; LEONARD JL, 1984, AM NAT, V124, P282, DOI 10.1086/284269; Loose MJ, 2008, INVERTEBR BIOL, V127, P162, DOI 10.1111/j.1744-7410.2007.00121.x; Lung O, 2002, GENETICS, V160, P211; Mann T, 1981, MALE REPROD FUNCTION; Michiels NK, 2006, INTEGR COMP BIOL, V46, P473, DOI 10.1093/icb/icj043; Michiels NK, 1998, NATURE, V391, P647, DOI 10.1038/35527; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PLESCH B, 1971, Netherlands Journal of Zoology, V21, P180; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; VANDUIVENBODEN YA, 1985, ANIM BEHAV, V33, P1184, DOI 10.1016/S0003-3472(85)80179-2; VANDUIVENBODEN YA, 1983, INT J INVER REP DEV, V6, P249, DOI 10.1080/01651269.1983.10510049; Watts RA, 2004, MOL BIOL EVOL, V21, P1032, DOI 10.1093/molbev/msh093; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051	43	53	54	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10117	10.1371/journal.pone.0010117	http://dx.doi.org/10.1371/journal.pone.0010117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404934	Green Published, Green Submitted, gold			2022-12-27	WOS:000276705900004
J	Ren, J; Dong, F; Cai, GJ; Zhao, P; Nunn, JM; Wold, LE; Pei, JM				Ren, Jun; Dong, Feng; Cai, Guo-Jun; Zhao, Peng; Nunn, Jennifer M.; Wold, Loren E.; Pei, Jianming			Interaction between Age and Obesity on Cardiomyocyte Contractile Function: Role of Leptin and Stress Signaling	PLOS ONE			English	Article							IMPAIRED CARDIAC-FUNCTION; VENTRICULAR MYOCYTES; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; HEART-DISEASE; UP-REGULATION; OB/OB MICE; IGF-I; DYSFUNCTION	Objectives: This study was designed to evaluate the interaction between aging and obesity on cardiac contractile and intracellular Ca2+ properties. Methods: Cardiomyocytes from young (4-mo) and aging (12- and 18-mo) male lean and the leptin deficient ob/ob obese mice were treated with leptin (0.5, 1.0 and 50 nM) for 4 hrs in vitro. High fat diet (45% calorie from fat) and the leptin receptor mutant db/db obesity models at young and older age were used for comparison. Cardiomyocyte contractile and intracellular Ca2+ properties were evaluated including peak shortening (PS), maximal velocity of shortening/relengthening (+/- dL/dt), time-to-PS (TPS), time-to-90% relengthening (TR90), intracellular Ca2+ levels and decay. O-2(-) levels were measured by dihydroethidium fluorescence. Results: Our results revealed reduced survival in ob/ob mice. Aging and obesity reduced PS, +/- dL/dt, intracellular Ca2+ rise, prolonged TR90 and intracellular Ca2+ decay, enhanced O-2(-) production and p(47phox) expression without an additive effect of the two, with the exception of intracellular Ca2+ rise. Western blot analysis exhibited reduced Ob-R expression and STAT-3 phosphorylation in both young and aging ob/ob mice, which was restored by leptin. Aging and obesity reduced phosphorylation of Akt, eNOS and p38 while promoting pJNK and pI kappa B. Low levels of leptin reconciled contractile, intracellular Ca2+ and cell signaling defects as well as O-2(-) production and p(47phox) upregulation in young but not aging ob/ob mice. High level of leptin (50 nM) compromised contractile and intracellular Ca2+ response as well as O-2(-) production and stress signaling in all groups. High fat diet-induced and db/db obesity displayed somewhat comparable aging-induced mechanical but not leptin response. Conclusions: Taken together, our data suggest that aging and obesity compromise cardiac contractile function possibly via phosphorylation of Akt, eNOS and stress signaling-associated O-2(-) release.	[Ren, Jun; Pei, Jianming] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Ren, Jun; Dong, Feng; Zhao, Peng; Nunn, Jennifer M.] Univ Wyoming, Coll Hlth Sci, Laramie, WY 82071 USA; [Ren, Jun; Cai, Guo-Jun] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Wold, Loren E.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Wold, Loren E.] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH USA	Air Force Military Medical University; University of Wyoming; Naval Medical University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Ren, J (corresponding author), Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China.	jren@uwyo.edu; jmpei8@fmmu.edu.cn	Ren, Jun/ACG-5366-2022; Wold, Loren E/E-4320-2011	Ren, Jun/0000-0002-0275-0783; 	American Heart Association Pacific Mountain Affiliate [0355521Z]; American Diabetes Association [7-08-RA-130]; National Institutes of Health/National Center for Research Resources (NIH/NCRR) North Rockies Regional INBRE [P20 RR 016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019923] Funding Source: NIH RePORTER	American Heart Association Pacific Mountain Affiliate(American Heart Association); American Diabetes Association(American Diabetes Association); National Institutes of Health/National Center for Research Resources (NIH/NCRR) North Rockies Regional INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the American Heart Association Pacific Mountain Affiliate (#0355521Z), American Diabetes Association (7-08-RA-130) and National Institutes of Health/National Center for Research Resources (NIH/NCRR) North Rockies Regional INBRE (P20 RR 016474) to J. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch LA, 2006, CIRC RES, V98, P119, DOI 10.1161/01.RES.0000199348.10580.1d; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Bellisari A, 2008, OBES REV, V9, P165, DOI 10.1111/j.1467-789X.2007.00392.x; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Ceddia RB, 1999, INT J OBESITY, V23, P75, DOI 10.1038/sj.ijo.0800762; Chernoff R, 2001, J GERONTOL A-BIOL, V56, P47, DOI 10.1093/gerona/56.suppl_2.47; Cope MB, 2006, OBESITY, V14, p156S, DOI 10.1038/oby.2006.297; Denys K, 2009, ACTA CLIN BELG, V64, P23, DOI 10.1179/acb.2009.006; Dobrian AD, 2000, HYPERTENSION, V35, P1009, DOI 10.1161/01.HYP.35.4.1009; Dong F, 2006, DIABETOLOGIA, V49, P1421, DOI 10.1007/s00125-006-0230-7; Dong F, 2006, J ENDOCRINOL, V188, P25, DOI 10.1677/joe.1.06241; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; Dong F, 2007, OBESITY, V15, P2699, DOI 10.1038/oby.2007.322; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Duan JH, 2003, AM J PHYSIOL-ENDOC M, V284, pE366, DOI 10.1152/ajpendo.00254.2002; Eckel RH, 2002, CIRCULATION, V105, P2923, DOI 10.1161/01.CIR.0000017823.53114.4C; Fang CX, 2005, DIABETOLOGIA, V48, P2412, DOI 10.1007/s00125-005-1940-y; Gao ZQ, 2008, GEN PHYSIOL BIOPHYS, V27, P152; Gat-Yablonski G, 2008, CURR OPIN CLIN NUTR, V11, P303, DOI 10.1097/MCO.0b013e3282f795cf; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hosoi T, 2005, BIOL PHARM BULL, V28, P1514, DOI 10.1248/bpb.28.1514; Hutchinson DS, 2008, PHARMACOL THERAPEUT, V119, P291, DOI 10.1016/j.pharmthera.2008.05.008; Jensen D, 2009, RESP PHYSIOL NEUROBI, V167, P87, DOI 10.1016/j.resp.2009.01.011; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Kuo JJ, 2003, AM J PHYSIOL-REG I, V284, pR1037, DOI 10.1152/ajpregu.00480.2002; Leung FW, 2008, DIGEST DIS SCI, V53, P1084, DOI 10.1007/s10620-007-9972-4; Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Miard S, 2008, INT J OBESITY, V32, P1873, DOI 10.1038/ijo.2008.214; Minhas KM, 2005, J PHYSIOL-LONDON, V565, P463, DOI 10.1113/jphysiol.2005.084566; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nickola MW, 2000, HYPERTENSION, V36, P501, DOI 10.1161/01.HYP.36.4.501; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Ren J, 2004, J ENDOCRINOL, V181, P1, DOI 10.1677/joe.0.1810001; Ren J, 2000, AM J PHYSIOL-HEART C, V279, pH1708, DOI 10.1152/ajpheart.2000.279.4.H1708; Ren J, 2008, CURR HYPERTENS REP, V10, P448, DOI 10.1007/s11906-008-0084-0; Ren J, 2009, OBESITY, V17, P1114, DOI 10.1038/oby.2009.8; Ross SA, 2004, CHEM REV, V104, P1255, DOI 10.1021/cr0204653; Sattar N, 2009, J AM COLL CARDIOL, V53, P167, DOI 10.1016/j.jacc.2008.09.035; Sowers JR, 1998, CLIN CHEM, V44, P1821; Sweeney G, 2010, NAT REV CARDIOL, V7, P22, DOI 10.1038/nrcardio.2009.224; Tiemann K, 2003, AM J PHYSIOL-HEART C, V284, pH464, DOI 10.1152/ajpheart.00540.2002; Wold LE, 2002, HYPERTENSION, V39, P69, DOI 10.1161/hy0102.100777; Xu FP, 2004, CIRCULATION, V110, P1269, DOI 10.1161/01.CIR.0000140766.52771.6D; Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje; Zeidan A, 2006, CARDIOVASC RES, V72, P101, DOI 10.1016/j.cardiores.2006.06.024	47	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10085	10.1371/journal.pone.0010085	http://dx.doi.org/10.1371/journal.pone.0010085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20396382	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100011
J	Asai, T; Sugimori, E; Tanno, Y				Asai, Tomohisa; Sugimori, Eriko; Tanno, Yoshihiko			Two Agents in the Brain: Motor Control of Unimanual and Bimanual Reaching Movements	PLOS ONE			English	Article							INTERHEMISPHERIC-TRANSFER; HEMISPHERIC-ASYMMETRY; MANUAL ASYMMETRIES; CONSTANT ERROR; LEFT-HANDERS; PERSPECTIVES; HANDEDNESS; MODELS; ATTENTION; DYNAMICS	Previous studies have suggested that the left and right hands have different specialties for motor control that can be represented as two agents in the brain. This study examined how coordinated movements are performed during bimanual reaching tasks to highlight differences in the characteristics of the hands. We examined motor movement accuracy, reaction time, and movement time in right-handed subjects performing a three-dimensional motor control task (visually guided reaching). In the no-visual-feedback condition, right-hand movement had lower accuracy and a shorter reaction time than did left-hand movement, whereas bimanual movement had the longest reaction time, but the best accuracy. This suggests that the two hands have different internal models and specialties: closed-loop control for the right hand and open-loop control for the left hand. Consequently, during bimanual movements, both models might be used, creating better control and planning (or prediction), but requiring more computation time compared to the use of one hand only.	[Asai, Tomohisa; Sugimori, Eriko; Tanno, Yoshihiko] Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo	Asai, T (corresponding author), Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Arts & Sci, Tokyo, Japan.	as@beck.c.u-tokyo.ac.jp			JSPS [198987]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for JSPS Fellowship (198987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2008, CONSCIOUS COGN, V17, P1131, DOI 10.1016/j.concog.2008.04.004; Baldauf D, 2008, VISION RES, V48, P549, DOI 10.1016/j.visres.2007.11.023; Barthelemy S, 2001, NEUROSCI LETT, V315, P41, DOI 10.1016/S0304-3940(01)02313-8; Boulinguez P, 2001, CORTEX, V37, P123, DOI 10.1016/S0010-9452(08)70562-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; ELLIOTT D, 1994, ACTA PSYCHOL, V85, P1, DOI 10.1016/0001-6918(94)90016-7; Elliott D, 1999, HUM MOVEMENT SCI, V18, P121, DOI 10.1016/S0167-9457(99)00004-4; Elliott D, 2000, BRAIN COGNITION, V42, P153, DOI 10.1006/brcg.1999.1188; Elliott Digby, 1996, P143; FLOWERS K, 1975, BRIT J PSYCHOL, V66, P39, DOI 10.1111/j.2044-8295.1975.tb01438.x; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; GUIARD Y, 1983, NEUROPSYCHOLOGIA, V21, P111, DOI 10.1016/0028-3932(83)90106-9; Haaland KY, 1996, CURR OPIN NEUROBIOL, V6, P796, DOI 10.1016/S0959-4388(96)80030-4; Hatta T., 1975, PAPERS CELEBRATING 6, P224; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Lenhard A, 2007, LATERALITY, V12, P227, DOI 10.1080/13576500701203891; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mieschke PE, 2001, BRAIN COGNITION, V45, P129, DOI 10.1006/brcg.2000.1262; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; ROY EA, 1989, Q J EXP PSYCHOL-A, V41, P501, DOI 10.1080/14640748908402379; ROY EA, 1978, CORTEX, V14, P250, DOI 10.1016/S0010-9452(78)80051-3; RUDEL RG, 1977, NEUROLOGY, V27, P160, DOI 10.1212/WNL.27.2.160; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; TODOR JI, 1985, J MOTOR BEHAV, V17, P355, DOI 10.1080/00222895.1985.10735354; Velay JL, 2001, CORTEX, V37, P75, DOI 10.1016/S0010-9452(08)70559-8; Velay JL, 1999, NEUROPSYCHOLOGIA, V37, P895, DOI 10.1016/S0028-3932(98)00149-3; WITELSON S F, 1974, Cortex, V10, P3; Witney AG, 2004, HUM MOVEMENT SCI, V23, P747, DOI 10.1016/j.humov.2004.10.009; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3; Yamauchi M, 2004, PERCEPT MOTOR SKILL, V98, P1199, DOI 10.2466/PMS.98.3.1199-1209	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10086	10.1371/journal.pone.0010086	http://dx.doi.org/10.1371/journal.pone.0010086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580WT	20386749	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482000015
J	Doshi, N; Mitragotri, S				Doshi, Nishit; Mitragotri, Samir			Macrophages Recognize Size and Shape of Their Targets	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; POLYMERIC NANOPARTICLES; DRUG-DELIVERY; PARTICLE-SIZE; PHAGOCYTOSIS; INNATE; BIODISTRIBUTION; INTERNALIZATION; CLEARANCE; SYSTEM	Recognition by macrophages is a key process in generating immune response against invading pathogens. Previous studies have focused on recognition of pathogens through surface receptors present on the macrophage's surface. Here, using polymeric particles of different geometries that represent the size and shape range of a variety of bacteria, the importance of target geometry in recognition was investigated. The studies reported here reveal that attachment of particles of different geometries to macrophages exhibits a strong dependence on size and shape. For all sizes and shapes studied, particles possessing the longest dimension in the range of 2-3 mu m exhibited highest attachment. This also happens to be the size range of most commonly found bacteria in nature. The surface features of macrophages, in particular the membrane ruffles, might play an important role in this geometry-based target recognition by macrophages. These findings have significant implications in understanding the pathogenicity of bacteria and in designing drug delivery carriers.	[Doshi, Nishit; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Doshi, N (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	samir@engineering.ucsb.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Institutes of Health [1UO1 HL080718]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (1UO1 HL080718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Beningo KA, 2002, J CELL SCI, V115, P849; *CDCP, 2006, 5776 CDCP; *CDCP PHIL, 2006, MYC TUB; *CDCS PUBL HLTH IM, 2006, AC BAUM; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Champion JA, 2009, PHARM RES-DORDR, V26, P244, DOI 10.1007/s11095-008-9626-z; COLI E, 2006, MOUNTAIN LAB; Doshi N, 2009, ADV FUNCT MATER, V19, P3843, DOI 10.1002/adfm.200901538; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; JOEL D, 2006, PHAGOCYTOSIS BACTERI; JULIANO RL, 1975, BIOCHEM BIOPH RES CO, V63, P651, DOI 10.1016/S0006-291X(75)80433-5; KAMMER GM, 1970, J BACTERIOL, V104, P499, DOI 10.1128/JB.104.1.499-502.1970; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thomas P, 2004, BACTERIA VIRUSES; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; *WHO, 2010, N331 WHO; 2005, PLOS BIOL, V3, pE166, DOI DOI 10.1371/JOURNAL.PBIO.0030166; 2006, VIBRIO CHOLERAE	35	221	225	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10051	10.1371/journal.pone.0010051	http://dx.doi.org/10.1371/journal.pone.0010051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386614	Green Published, Green Submitted, gold			2022-12-27	WOS:000276420400019
J	Rosa-Rosa, JM; Gracia-Aznarez, FJ; Hodges, E; Pita, G; Rooks, M; Xuan, ZY; Bhattacharjee, A; Brizuela, L; Silva, JM; Hannon, GJ; Benitez, J				Manuel Rosa-Rosa, Juan; Javier Gracia-Aznarez, Francisco; Hodges, Emily; Pita, Guillermo; Rooks, Michelle; Xuan, Zhenyu; Bhattacharjee, Arindam; Brizuela, Leonardo; Silva, Jose M.; Hannon, Gregory J.; Benitez, Javier			Deep Sequencing of Target Linkage Assay-Identified Regions in Familial Breast Cancer: Methods, Analysis Pipeline and Troubleshooting	PLOS ONE			English	Article							GENOME; MUTATIONS; CAPTURE; GENES	Background: The classical candidate-gene approach has failed to identify novel breast cancer susceptibility genes. Nowadays, massive parallel sequencing technology allows the development of studies unaffordable a few years ago. However, analysis protocols are not yet sufficiently developed to extract all information from the huge amount of data obtained. Methodology/Principal Findings: In this study, we performed high throughput sequencing in two regions located on chromosomes 3 and 6, recently identified by linkage studies by our group as candidate regions for harbouring breast cancer susceptibility genes. In order to enrich for the coding regions of all described genes located in both candidate regions, a hybrid-selection method on tiling microarrays was performed. Conclusions/Significance: We developed an analysis pipeline based on SOAP aligner to identify candidate variants with a high real positive confirmation rate (0.89), with which we identified eight variants considered candidates for functional studies. The results suggest that the present strategy might be a valid second step for identifying high penetrance genes.	[Manuel Rosa-Rosa, Juan; Javier Gracia-Aznarez, Francisco; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain; [Hodges, Emily; Rooks, Michelle; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Pita, Guillermo; Benitez, Javier] Spanish Natl Canc Res Ctr, Genotyping Unit CEGEN, Madrid, Spain; [Xuan, Zhenyu] Univ Texas Richardson, Dept Mol & Cell Biol, Richardson, TX USA; [Bhattacharjee, Arindam; Brizuela, Leonardo] Agilent Technol, Santa Clara, CA USA; [Silva, Jose M.] Irving Canc Res Ctr, New York, NY USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; University of Texas Dallas; Agilent Technologies	Rosa-Rosa, JM (corresponding author), Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain.	jbenitez@cnio.es	Hannon, Gregory/AAB-3568-2019; Gracia Aznarez, Francisco Javier/AFV-2344-2022	Xuan, Zhenyu/0000-0001-9344-8493; Hodges, Emily/0000-0001-6513-610X	Spanish Association Against Cancer (AECC); Agilent, Inc.; Ministerio de Eduacion y Cultura; Universidad Autonoma de Madrid; European Association for Cancer Research	Spanish Association Against Cancer (AECC); Agilent, Inc.; Ministerio de Eduacion y Cultura; Universidad Autonoma de Madrid; European Association for Cancer Research	This project was funded by the Spanish Association Against Cancer (AECC) with no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; and Agilent, Inc. supplying the arrays that can be used for the hybrid selection procedures described in this manuscript. JMRR's short stay at CSHL was supported by funding from the Ministerio de Eduacion y Cultura, the Universidad Autonoma de Madrid, and the European Association for Cancer Research, with no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bergman A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-108; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Rosa-Rosa JM, 2009, BREAST CANCER RES TR, V118, P151, DOI 10.1007/s10549-009-0317-1; Rosa-Rosa JM, 2009, AM J HUM GENET, V84, P115, DOI 10.1016/j.ajhg.2008.12.013; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Oldenburg RA, 2008, GENE CHROMOSOME CANC, V47, P947, DOI 10.1002/gcc.20597; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PUSHKAREV D, 2009, NAT BIOTECHNOL; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	21	6	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e9976	10.1371/journal.pone.0009976	http://dx.doi.org/10.1371/journal.pone.0009976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368986	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000276419900001
J	Weiser, SD; Tuller, DM; Frongillo, EA; Senkungu, J; Mukiibi, N; Bangsberg, DR				Weiser, Sheri D.; Tuller, David M.; Frongillo, Edward A.; Senkungu, Jude; Mukiibi, Nozmu; Bangsberg, David R.			Food Insecurity as a Barrier to Sustained Antiretroviral Therapy Adherence in Uganda	PLOS ONE			English	Article							HIV-POSITIVE INDIVIDUALS; INFECTED INDIVIDUALS; MEDICATION ADHERENCE; IMPROVE ADHERENCE; DRUG-RESISTANCE; ADULTS; FACILITATORS; SUPPRESSION; PROGRESSION; MORTALITY	Background: Food insecurity is emerging as an important barrier to antiretroviral (ARV) adherence in sub-Saharan Africa and elsewhere, but little is known about the mechanisms through which food insecurity leads to ARV non-adherence and treatment interruptions. Methodology: We conducted in-depth, open-ended interviews with 47 individuals (30 women, 17 men) living with HIV/AIDS recruited from AIDS treatment programs in Mbarara and Kampala, Uganda to understand how food insecurity interferes with ARV therapy regimens. Interviews were transcribed, coded for key themes, and analyzed using grounded theory. Findings: Food insecurity was common and an important barrier to accessing medical care and ARV adherence. Five mechanisms emerged for how food insecurity can contribute to ARV non-adherence and treatment interruptions or to postponing ARV initiation: 1) ARVs increased appetite and led to intolerable hunger in the absence of food; 2) Side effects of ARVs were exacerbated in the absence of food; 3) Participants believed they should skip doses or not start on ARVs at all if they could not afford the added nutritional burden; 4) Competing demands between costs of food and medical expenses led people either to default from treatment, or to give up food and wages to get medications; 5) While working for food for long days in the fields, participants sometimes forgot medication doses. Despite these obstacles, many participants still reported high ARV adherence and exceptional motivation to continue therapy. Conclusions: While reports from sub-Saharan Africa show excellent adherence to ARVs, concerns remain that these successes are not sustainable in the presence of widespread poverty and food insecurity. We provide further evidence on how food insecurity can compromise sustained ARV therapy in a resource-limited setting. Addressing food insecurity as part of emerging ARV treatment programs is critical for their long-term success.	[Weiser, Sheri D.] San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Tuller, David M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Frongillo, Edward A.] Univ S Carolina, Dept Hlth Promot Educ & Behav, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Senkungu, Jude; Mukiibi, Nozmu; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bangsberg, David R.] Massachusetts Inst Technol & Harvard, Ragon Inst, Massachusetts Gen Hosp, Boston, MA USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Global Hlth, Cambridge, MA 02138 USA; [Bangsberg, David R.] Harvard Initiat Global Hlth, Boston, MA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard University	Weiser, SD (corresponding author), San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA.	Sheri.Weiser@ucsf.edu			National Institute of Mental Health [K23 MH079713-01]; NIMH [RO-1 54907, K24 87227]; Meyers Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907, K24MH087227, K23MH079713] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Meyers Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by National Institute of Mental Health K23 MH079713-01, NIMH RO-1 54907, and the Meyers Family Foundation. Dr. Bangsberg received support from NIMH K24 87227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Crane JT, 2006, AIDS BEHAV, V10, P437, DOI 10.1007/s10461-006-9080-z; Danel C, 2009, J INFECT DIS, V199, P66, DOI 10.1086/595298; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kadiyala S, 2009, J DEV EFFECT, V1, P470, DOI 10.1080/19439340903370469; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kumarasamy N, 2005, AIDS PATIENT CARE ST, V19, P526, DOI 10.1089/apc.2005.19.526; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; NASH D, 2008, CHARACTERISTICS FACI; *NAT AGR ADV SERV, 2003, IMP HIV AIDS AGR SEC; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; SEUMEFOSSO E, 2004, FOOD NUTR TECHNICAL; Strauss A., 1990, BASICS QUALITATIVE R; TULLER DM, 2009, AIDS BEHAV; *UN ADM COMM COORD, 2001, NUTR HIV AIDS; van Sighem AI, 2003, AIDS, V17, P2227, DOI 10.1097/00002030-200310170-00011; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WEISER SD, 2009, J AIDS IN PRESS; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Food Programme, 2003, PROGR ER AIDS WPFS R; World Health Organisation, 2003, NUTR REQ PEOPL LIV H	42	161	162	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10340	10.1371/journal.pone.0010340	http://dx.doi.org/10.1371/journal.pone.0010340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589MV	20442769	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200004
J	Lohmann, G; Margulies, DS; Horstmann, A; Pleger, B; Lepsien, J; Goldhahn, D; Schloegl, H; Stumvoll, M; Villringer, A; Turner, R				Lohmann, Gabriele; Margulies, Daniel S.; Horstmann, Annette; Pleger, Burkhard; Lepsien, Joeran; Goldhahn, Dirk; Schloegl, Haiko; Stumvoll, Michael; Villringer, Arno; Turner, Robert			Eigenvector Centrality Mapping for Analyzing Connectivity Patterns in fMRI Data of the Human Brain	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; CORTICAL HUBS; DEFAULT MODE; NETWORKS; FREQUENCY; DYNAMICS; IDENTIFICATION; ANATOMY; DISEASE	Functional magnetic resonance data acquired in a task-absent condition ("resting state'') require new data analysis techniques that do not depend on an activation model. In this work, we introduce an alternative assumption- and parameter-free method based on a particular form of node centrality called eigenvector centrality. Eigenvector centrality attributes a value to each voxel in the brain such that a voxel receives a large value if it is strongly correlated with many other nodes that are themselves central within the network. Google's PageRank algorithm is a variant of eigenvector centrality. Thus far, other centrality measures - in particular "betweenness centrality'' - have been applied to fMRI data using a pre-selected set of nodes consisting of several hundred elements. Eigenvector centrality is computationally much more efficient than betweenness centrality and does not require thresholding of similarity values so that it can be applied to thousands of voxels in a region of interest covering the entire cerebrum which would have been infeasible using betweenness centrality. Eigenvector centrality can be used on a variety of different similarity metrics. Here, we present applications based on linear correlations and on spectral coherences between fMRI times series. This latter approach allows us to draw conclusions of connectivity patterns in different spectral bands. We apply this method to fMRI data in task-absent conditions where subjects were in states of hunger or satiety. We show that eigenvector centrality is modulated by the state that the subjects were in. Our analyses demonstrate that eigenvector centrality is a computationally efficient tool for capturing intrinsic neural architecture on a voxel-wise level.	[Lohmann, Gabriele; Margulies, Daniel S.; Horstmann, Annette; Pleger, Burkhard; Lepsien, Joeran; Goldhahn, Dirk; Villringer, Arno; Turner, Robert] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Schloegl, Haiko; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany	Max Planck Society; Leipzig University	Lohmann, G (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	lohmann@cbs.mpg.de	Stumvoll, Michael/ABE-1121-2021; Horstmann, Annette/C-9083-2011; Lohmann, Gabriele/C-3590-2008; Lohmann, Gabriele/AGE-9413-2022; Margulies, Daniel/L-4719-2016	Stumvoll, Michael/0000-0001-6225-8240; Horstmann, Annette/0000-0001-6184-8484; Lohmann, Gabriele/0000-0002-5922-9016; Villringer, Arno/0000-0003-2604-2404; Goldhahn, Dirk/0000-0003-1681-567X; Margulies, Daniel/0000-0002-8880-9204	Bundesministerium Bildung und Forschung (BMBF) [01GI0850, 934000-391]; European Union [223057]	Bundesministerium Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Bundesministerium Bildung und Forschung (BMBF), http://www.bmbf.de/, Foerderkennzeichen: 01GI0850, Projekt-Nr.: 934000-391; and the European Union's Seventh Framework Programme (Grant No. 223057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; BALLANGER B, ANN NEUROLO IN PRESS; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Bonacich P, 2004, SOC NETWORKS, V26, P331, DOI 10.1016/j.socnet.2004.08.007; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; CHATFIELD C, 1975, ANAL TIME SERIES THE; Comings DE, 2000, PROG BRAIN RES, V126, P325; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Golub GH., 2013, MATRIX COMPUTATIONS; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HE Y, 2009, PLOS ONE, V4, pE5526; Kiviniemi V, 2004, MAGN RESON IMAGING, V22, P197, DOI 10.1016/j.mri.2003.09.007; Langville A., 2006, GOOGLES PAGERANK SCI; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Mezer A, 2009, NEUROIMAGE, V45, P1117, DOI 10.1016/j.neuroimage.2008.12.015; Muller K, 2007, J MAGN RESON IMAGING, V26, P1642, DOI 10.1002/jmri.21169; Muller K, 2003, J MAGN RESON IMAGING, V17, P375, DOI 10.1002/jmri.10268; Newman MEJ, 2008, NEW PALGRAVE ENCY EC; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Portas CM, 1998, J NEUROSCI, V18, P8979; Priestley M. B., 1981, SPECTRAL ANAL TIME S; RAO TS, 1967, ANN MATH STAT, V38, P593, DOI 10.1214/aoms/1177698976; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; SAJONZ B, NEUROIMAGE; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; TATARANNI P, 2003, OBESITY REV; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; van Albada SJ, 2007, J NEUROSCI METH, V161, P205, DOI 10.1016/j.jneumeth.2006.11.004; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; ZUO X, NEUROIMAGE IN PRESS	48	321	327	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10232	10.1371/journal.pone.0010232	http://dx.doi.org/10.1371/journal.pone.0010232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436911	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079700003
J	Pothuri, B; Leitao, MM; Levine, DA; Viale, A; Olshen, AB; Arroyo, C; Bogomolniy, F; Olvera, N; Lin, O; Soslow, RA; Robson, ME; Offit, K; Barakat, RR; Boyd, J				Pothuri, Bhavana; Leitao, Mario M.; Levine, Douglas A.; Viale, Agnes; Olshen, Adam B.; Arroyo, Crispinita; Bogomolniy, Faina; Olvera, Narciso; Lin, Oscar; Soslow, Robert A.; Robson, Mark E.; Offit, Kenneth; Barakat, Richard R.; Boyd, Jeff			Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma	PLOS ONE			English	Article							PROPHYLACTIC OOPHORECTOMY; SURFACE EPITHELIUM; HUMAN-CELLS; INSTABILITY; PROTEIN; BRCA1; P53; PATHOGENESIS; EXPRESSION; MUTATION	Background: The high mortality rate associated with epithelial ovarian carcinoma (EOC) reflects diagnosis commonly at an advanced stage, but improved early detection is hindered by uncertainty as to the histologic origin and early natural history of this malignancy. Methodology/Principal Findings: Here we report combined molecular genetic and morphologic analyses of normal human ovarian tissues and early stage cancers, from both BRCA mutation carriers and the general population, indicating that EOCs frequently arise from dysplastic precursor lesions within epithelial inclusion cysts. In pathologically normal ovaries, molecular evidence of oncogenic stress was observed specifically within epithelial inclusion cysts. To further explore potential very early events in ovarian tumorigenesis, ovarian tissues from women not known to be at high risk for ovarian cancer were subjected to laser catapult microdissection and gene expression profiling. These studies revealed a quasineoplastic expression signature in benign ovarian cystic inclusion epithelium compared to surface epithelium, specifically with respect to genes affecting signal transduction, cell cycle control, and mitotic spindle formation. Consistent with this gene expression profile, a significantly higher cell proliferation index (increased cell proliferation and decreased apoptosis) was observed in histopathologically normal ovarian cystic compared to surface epithelium. Furthermore, aneuploidy was frequently identified in normal ovarian cystic epithelium but not in surface epithelium. Conclusions/Significance: Together, these data indicate that EOC frequently arises in ovarian cystic inclusions, is preceded by an identifiable dysplastic precursor lesion, and that increased cell proliferation, decreased apoptosis, and aneuploidy are likely to represent very early aberrations in ovarian tumorigenesis.	[Pothuri, Bhavana; Leitao, Mario M.; Levine, Douglas A.; Arroyo, Crispinita; Bogomolniy, Faina; Olvera, Narciso; Barakat, Richard R.; Boyd, Jeff] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Olshen, Adam B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Lin, Oscar; Soslow, Robert A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Robson, Mark E.; Offit, Kenneth; Boyd, Jeff] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Boyd, Jeff] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Fox Chase Cancer Center	Pothuri, B (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	jeff.boyd@fccc.edu		Robson, Mark/0000-0002-3109-1692; Soslow, Robert/0000-0002-7269-5898; Levine, Douglas/0000-0003-1038-8232; Boyd, Jeff/0000-0002-3517-7637; Pothuri, Bhavana/0000-0003-4578-2061	National Institutes of Health [R01 CA71840]; W.M. Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA071840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Institutes of Health, R01 CA71840, and by a grant from the W.M. Keck Foundation, http://www.wmkeck.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Bunz F, 2002, CANCER RES, V62, P1129; Deligdisch L, 1999, CANCER-AM CANCER SOC, V86, P1544, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I; DELIGDISCH L, 1989, CANCER, V63, P748, DOI 10.1002/1097-0142(19890215)63:4<748::AID-CNCR2820630424>3.0.CO;2-8; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; Faire K, 1999, J CELL SCI, V112, P4243; Fleming GF, 2009, PRINCIPLES PRACTICE, P763; Flory MR, 2000, P NATL ACAD SCI USA, V97, P5919, DOI 10.1073/pnas.97.11.5919; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; GAJEWSKI WH, 1994, GYNECOL ONCOL, V53, P5, DOI 10.1006/gyno.1994.1078; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; HUTSON R, 1995, HISTOPATHOLOGY, V27, P367, DOI 10.1111/j.1365-2559.1995.tb01528.x; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Kohn EC, 2007, DIS MARKERS, V23, P411, DOI 10.1155/2007/967023; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Leitao MM, 2004, GYNECOL ONCOL, V93, P301, DOI 10.1016/j.ygyno.2004.01.043; Lengauer C, 2005, SEMIN CANCER BIOL, V15, P1, DOI 10.1016/j.semcancer.2004.09.001; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Michor F, 2005, SEMIN CANCER BIOL, V15, P43, DOI 10.1016/j.semcancer.2004.09.007; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Narod SA, 2002, CURR OPIN OBSTET GYN, V14, P19, DOI 10.1097/00001703-200202000-00004; Piek JMJ, 2004, AM J OBSTET GYNECOL, V191, P718, DOI 10.1016/j.ajog.2004.02.067; RADISAVLJEVIC SV, 1977, OBSTET GYNECOL, V49, P424; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; RESTA L, 1993, OBSTET GYNECOL, V82, P181; Rhei E, 1998, CANCER RES, V58, P3193; Rosenthal AN, 2006, CLIN OBSTET GYNECOL, V49, P433, DOI 10.1097/00003081-200609000-00004; Schlosshauer PW, 2003, CANCER, V98, P2599, DOI 10.1002/cncr.11848; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully RE, 1995, J CELL BIOCHEM, P208; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Werness BA, 1999, HUM PATHOL, V30, P151, DOI 10.1016/S0046-8177(99)90269-1; Werness BA, 2000, J NATL CANCER I, V92, P1088, DOI 10.1093/jnci/92.13.1088; Zanetta G, 1996, AM J OBSTET GYNECOL, V175, P1217, DOI 10.1016/S0002-9378(96)70031-5	45	78	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10358	10.1371/journal.pone.0010358	http://dx.doi.org/10.1371/journal.pone.0010358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436685	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000277079500022
J	Maan, S; Maan, NS; van Rijn, PA; van Gennip, RGP; Sanders, A; Wright, IM; Batten, C; Hoffmann, B; Eschbaumer, M; Oura, CAL; Potgieter, AC; Nomikou, K; Mertens, PPC				Maan, Sushila; Maan, Narender S.; van Rijn, Piet A.; van Gennip, Rene G. P.; Sanders, Anna; Wright, Isabel M.; Batten, Carrie; Hoffmann, Bernd; Eschbaumer, Michael; Oura, Chris A. L.; Potgieter, Abraham C.; Nomikou, Kyriaki; Mertens, Peter P. C.			Full Genome Characterisation of Bluetongue Virus Serotype 6 from the Netherlands 2008 and Comparison to Other Field and Vaccine Strains	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; MEDITERRANEAN BASIN; INFECTION; SEQUENCE; SHEEP; EUROPE; PROTEIN; GENES; DIFFERENTIATION	In mid September 2008, clinical signs of bluetongue (particularly coronitis) were observed in cows on three different farms in eastern Netherlands (Luttenberg, Heeten, and Barchem), two of which had been vaccinated with an inactivated BTV-8 vaccine (during May-June 2008). Bluetongue virus (BTV) infection was also detected on a fourth farm (Oldenzaal) in the same area while testing for export. BTV RNA was subsequently identified by real time RT-PCR targeting genome-segment (Seg-) 10, in blood samples from each farm. The virus was isolated from the Heeten sample (IAH "dsRNA virus reference collection" [dsRNA-VRC] isolate number NET2008/05) and typed as BTV-6 by RT-PCR targeting Seg-2. Sequencing confirmed the virus type, showing an identical Seg-2 sequence to that of the South African BTV-6 live-vaccine-strain. Although most of the other genome segments also showed very high levels of identity to the BTV-6 vaccine (99.7 to 100%), Seg-10 showed greatest identity (98.4%) to the BTV-2 vaccine (RSAvvv2/02), indicating that NET2008/05 had acquired a different Seg-10 by reassortment. Although Seg-7 from NET2008/05 was also most closely related to the BTV-6 vaccine (99.7/100% nt/aa identity), the Seg-7 sequence derived from the blood sample of the same animal (NET2008/06) was identical to that of the Netherlands BTV-8 (NET2006/04 and NET2007/01). This indicates that the blood contained two different Seg-7 sequences, one of which (from the BTV-6 vaccine) was selected during virus isolation in cell-culture. The predominance of the BTV-8 Seg-7 in the blood sample suggests that the virus was in the process of reassorting with the northern field strain of BTV-8. Two genome segments of the virus showed significant differences from the BTV-6 vaccine, indicating that they had been acquired by reassortment event with BTV-8, and another unknown parental-strain. However, the route by which BTV-6 and BTV-8 entered northern Europe was not established.	[Maan, Sushila; Maan, Narender S.; Sanders, Anna; Batten, Carrie; Oura, Chris A. L.; Nomikou, Kyriaki; Mertens, Peter P. C.] AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England; [van Rijn, Piet A.; van Gennip, Rene G. P.] Cent Vet Inst Wageningen UR, Dept Virol, Lelystad, Netherlands; [Wright, Isabel M.; Potgieter, Abraham C.] Onderstepoort Vet Inst, Div Virol, Onderstepoort, South Africa; [Hoffmann, Bernd; Eschbaumer, Michael] Fed Res Inst Anim Hlth, Greifswald, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; Wageningen University & Research; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council	Maan, S (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England.	peter.mertens@bbsrc.ac.uk	van Rijn, Piet A/C-1163-2017; Nomikou, Kyriaki/P-1840-2018; van Rijn, Piet A./AAG-7398-2019; Nomikou, Kyriaki/Q-5555-2016	van Rijn, Piet A/0000-0002-2594-1232; Nomikou, Kyriaki/0000-0002-7013-1853; van Rijn, Piet A./0000-0002-2594-1232; Nomikou, Kyriaki/0000-0002-7013-1853; Eschbaumer, Michael/0000-0002-1104-0695; Batten, Carrie/0000-0003-4274-7375; van Gennip, Rene/0000-0002-5450-3493; Mertens, Peter/0000-0002-3438-3738	Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; European Commission; BBSRC; Ministry of Agriculture, Nature and Food Safety, The Netherlands; EU Commission; South African National Department of Agriculture, Forestry and Fisheries (DAFF); Federal Ministry of Food, Agriculture and Consumer Protection (Germany); EPIZONE; EU Network of Excellence for Epizootic Disease Diagnosis and Control [FOOD-CT-2006-016236]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001159, BBS/E/I/00001446] Funding Source: researchfish; BBSRC [BBS/E/I/00001446] Funding Source: UKRI	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Agriculture, Nature and Food Safety, The Netherlands(Netherlands Government); EU Commission(European CommissionEuropean Commission Joint Research Centre); South African National Department of Agriculture, Forestry and Fisheries (DAFF); Federal Ministry of Food, Agriculture and Consumer Protection (Germany); EPIZONE; EU Network of Excellence for Epizootic Disease Diagnosis and Control; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SM and KN are funded by the Department for Environment, Food and Rural Affairs (Defra)(SE2617); NSM by the Biotechnology and Biological Sciences Research Council (BBSRC) and the European Union (EU) (SANCO/940/2002); PCM by Defra, the European Commission and BBSRC; PVR and RVG by the Ministry of Agriculture, Nature and Food Safety, The Netherlands; AS, CB and CO by Defra and the EU Commission; ACP and IW by the South African National Department of Agriculture, Forestry and Fisheries (DAFF); BH by the Federal Ministry of Food, Agriculture and Consumer Protection (Germany); ME by EPIZONE, the EU Network of Excellence for Epizootic Disease Diagnosis and Control (FOOD-CT-2006-016236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, AM J TROP MED HYG, V51, P568, DOI 10.4269/ajtmh.1994.51.568; ALPAR OH, 2009, BLUETONGUE, P235; Anthony SJ, 2009, VIRUS RES, V145, P187, DOI 10.1016/j.virusres.2009.07.011; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Balasuriya UBR, 2008, VET MICROBIOL, V126, P91, DOI 10.1016/j.vetmic.2007.07.006; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Barzilai E., 1971, Refuah Veterinarith, V28, P11; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Bonneau KR, 2000, ARCH VIROL, V145, P1163, DOI 10.1007/s007050070116; Bonneau KR, 1999, VIRUS RES, V61, P153, DOI 10.1016/S0168-1702(99)00034-9; Brown CC, 1996, VET PATHOL, V33, P337, DOI 10.1177/030098589603300311; CALLIS J, 1985, P37; COWLEY JA, 1989, VET MICROBIOL, V19, P37, DOI 10.1016/0378-1135(89)90089-8; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; De Clercq K, 2008, VET REC, V162, P564, DOI 10.1136/vr.162.17.564; De Clercq K, 2009, TRANSBOUND EMERG DIS, V56, P355, DOI 10.1111/j.1865-1682.2009.01092.x; Desmecht D, 2008, VET REC, V163, P50, DOI 10.1136/vr.163.2.50; Dungu B, 2004, DEV BIOLOGICALS, V119, P463; ESCHBAUMER M, 2009, VET MICROBIOL; Fernandez-Pacheco P, 2008, VET REC, V162, P659, DOI 10.1136/vr.162.20.659; Ferrari G, 2005, PREV VET MED, V68, P103, DOI 10.1016/j.prevetmed.2004.11.011; GOULD AR, 1990, VIRUS RES, V17, P31, DOI 10.1016/0168-1702(90)90078-P; GRIST NR, 1974, DIAGNOSTIC METHODS C, P64; Henrich M, 2007, VET REC, V161, P764, DOI 10.1136/vr.161.22.764; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOOGENDAM K, 2007, THESIS U VANHALLLARE; Howell P G, 1971, Virol Monogr, V9, P35; HOWELL PG, 1963, BLUETONGUE EMERGING, P111; HOWERTH EW, 1988, AM J VET RES, V49, P1906; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; HYATT AD, 1989, VIROLOGY, V173, P21, DOI 10.1016/0042-6822(89)90218-3; HYATT AD, 1993, VIROLOGY, V193, P592, DOI 10.1006/viro.1993.1167; HYATT AD, 1991, J GEN VIROL, V72, P2263, DOI 10.1099/0022-1317-72-9-2263; Jauniaux TP, 2008, EMERG INFECT DIS, V14, P1496, DOI 10.3201/eid1409.080434; JEGGO MH, 1986, RES VET SCI, V40, P386, DOI 10.1016/S0034-5288(18)30556-3; JEGGO MH, 1983, RES VET SCI, V34, P205, DOI 10.1016/S0034-5288(18)32261-6; JEGGO MJ, 1987, RES VET SCI, V42, P24, DOI 10.1016/S0034-5288(18)30651-9; Koumbati M, 1999, VET MICROBIOL, V64, P277, DOI 10.1016/S0378-1135(98)00255-7; Listes E, 2009, VET MICROBIOL, V138, P92, DOI 10.1016/j.vetmic.2009.03.011; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2009, BIOL ANIM INFECT, P135, DOI 10.1016/B978-012369368-6.50011-3; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; MACLACHLAN NJ, 1994, COMP IMMUNOL MICROB, V17, P197, DOI 10.1016/0147-9571(94)90043-4; Mauroy A, 2008, EMERG INFECT DIS, V14, P675, DOI 10.3201/eid1404.071416; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2009, BIOL ANIM INFECT, P235, DOI 10.1016/B978-012369368-6.50015-0; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1989, VIROLOGY, V170, P561, DOI 10.1016/0042-6822(89)90447-9; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; MERTENS PPC, 1987, VIROLOGY, V161, P438, DOI 10.1016/0042-6822(87)90137-1; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Meyer G, 2009, EMERG INFECT DIS, V15, P608, DOI 10.3201/eid1504.081514; MO CL, 1994, AM J VET RES, V55, P211; Monaco F, 2006, VET MICROBIOL, V116, P45, DOI 10.1016/j.vetmic.2006.03.024; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; *OIE, 2006, MANUAL DIAGNOSTIC TE, pCH219; Ortega J, 2010, J VET DIAGN INVEST, V22, P134, DOI 10.1177/104063871002200129; OSBURN BI, 1994, VET CLIN N AM-FOOD A, V10, P547, DOI 10.1016/S0749-0720(15)30538-7; PARSONSON IM, 1990, CURR TOP MICROBIOL, V162, P119; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Pritchard LI, 2004, VIRUS RES, V101, P193, DOI 10.1016/j.virusres.2004.01.004; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; Shimshony A, 2004, VETER ITAL SER, V40, P116; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toussaint JF, 2007, EMERG INFECT DIS, V13, P614, DOI 10.3201/eid1304.061136; Vandenbussche F, 2009, TRANSBOUND EMERG DIS, V56, P346, DOI 10.1111/j.1865-1682.2009.01093.x; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; Vercauteren G, 2008, TRANSBOUND EMERG DIS, V55, P293, DOI 10.1111/j.1865-1682.2008.01034.x; VERWOERD D W, 1970, Onderstepoort Journal of Veterinary Research, V37, P225; VERWOERD DW, 1970, J VIROL, V5, P1; VOSDING RA, 1968, CAN J COMPARAT MED, V32, P382; WADEEVANS AM, 1992, J GEN VIROL, V73, P3023, DOI 10.1099/0022-1317-73-11-3023; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wilson WC, 2000, VIRUS RES, V67, P141, DOI 10.1016/S0168-1702(00)00138-6; Worwa G, 2009, VET REC, V164, P499, DOI 10.1136/vr.164.16.499; Wouda W, 2008, VET REC, V162, P424, DOI 10.1136/vr.162.13.422-b; Xu G, 1997, J GEN VIROL, V78, P1617, DOI 10.1099/0022-1317-78-7-1617	92	109	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10323	10.1371/journal.pone.0010323	http://dx.doi.org/10.1371/journal.pone.0010323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428242	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000277079300013
J	Poeggeler, B; Sambamurti, K; Siedlak, SL; Perry, G; Smith, MA; Pappolla, MA				Poeggeler, Burkhard; Sambamurti, Kumar; Siedlak, Sandra L.; Perry, George; Smith, Mark A.; Pappolla, Miguel A.			A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer Lifespan	PLOS ONE			English	Article							COMPLEX-I; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MELATONIN; BRAIN; GENERATION; PREVENTION; CHEMISTRY; NITRONE; SITES	Aging is a multi-factorial process, however, it is generally accepted that reactive oxygen species (ROS) are significant contributors. Mitochondria are important players in the aging process because they produce most of the cellular ROS. Despite the strength of the free-radical hypothesis, the use of free radical scavengers to delay aging has generated mixed results in vertebrate models, and clinical evidence of efficacy is lacking. This is in part due to the production of pro-oxidant metabolites by many antioxidants while scavenging ROS, which counteract their potentially beneficial effects. As such, a more effective approach is to enhance mitochondrial metabolism by reducing electron leakage with attendant reduction of ROS generation. Here, we report on the actions of a novel endogenous indole derivative, indolepropionamide (IPAM), which is similar in structure to melatonin. Our results suggest that IPAM binds to the rate-limiting component of oxidative phosphorylation in complex I of the respiratory chain and acts as a stabilizer of energy metabolism, thereby reducing ROS production. IPAM reversed the age-dependent decline of mitochondrial energetic capacity and increased rotifer lifespan, and it may, in fact, constitute a novel endogenous anti-aging substance of physiological importance.	[Poeggeler, Burkhard] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Sambamurti, Kumar; Pappolla, Miguel A.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Perry, George] Univ Texas San Antonio, Coll Sci, UTSA Neurosci Inst, San Antonio, TX USA; [Perry, George] Univ Texas San Antonio, Dept Biol, Coll Sci, San Antonio, TX USA; [Siedlak, Sandra L.; Smith, Mark A.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	University of Lubeck; Medical University of South Carolina; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Case Western Reserve University	Poeggeler, B (corresponding author), Univ Lubeck, Dept Dermatol, Lubeck, Germany.	sambak@musc.e; pappolla@aol.com	Pappolla, Miguel/ABE-4966-2021; Perry, George/A-8611-2009; Sambamurti, Kumar/A-1620-2012; Smith, Mark A/A-9053-2009	Perry, George/0000-0002-6547-0172; Sambamurti, Kumar/0000-0001-9507-9214; 	Alzheimer's Association [IIRG-09-132087]; National Institutes of Health [AG022103, AG10483, AG023055, AG028679]; German Research Foundation DFG [662/1-1]; NATIONAL INSTITUTE ON AGING [U01AG010483, R01AG022103, R01AG028679, R01AG023055] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work in the authors' laboratories is supported by the Alzheimer's Association (Zenith Award to MAP; IIRG-09-132087 to MAS), the National Institutes of Health (AG022103, AG10483, and AG023055 to MAP and KS; AG028679 to MAS), and the German Research Foundation DFG (Deutsche Forschungsgemeinschaft PO 662/1-1 to BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brenner-Lavie H, 2008, BBA-BIOENERGETICS, V1777, P173, DOI 10.1016/j.bbabio.2007.10.006; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Dabbeni-Sala F, 2001, FASEB J, V15, P164, DOI 10.1096/fj.00-0129com; Durand G, 2007, J MED CHEM, V50, P3976, DOI 10.1021/jm0706968; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hensley K, 1998, J NEUROCHEM, V71, P2549; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Lee SJ, 2005, BRIT J PHARMACOL, V145, P469, DOI 10.1038/sj.bjp.0706206; Lenaz G, 2006, ANTIOXID REDOX SIGN, V8, P417, DOI 10.1089/ars.2006.8.417; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Martin M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8; Martin M, 2000, FASEB J, V14, P1677; Poeggeler B, 2005, J NEUROCHEM, V95, P962, DOI 10.1111/j.1471-4159.2005.03425.x; Poeggeler B, 2005, ENDOCRINE, V27, P201, DOI 10.1385/ENDO:27:2:201; POEGGELER B, 1994, ANN NY ACAD SCI, V738, P419, DOI 10.1111/j.1749-6632.1994.tb21831.x; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Sohal RS, 2000, RES PRO CEL, V29, P45; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; YUAN H, 1991, J ENDOCRINOL, V128, P475, DOI 10.1677/joe.0.1280475	25	37	37	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10206	10.1371/journal.pone.0010206	http://dx.doi.org/10.1371/journal.pone.0010206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421998	Green Submitted, gold, Green Published			2022-12-27	WOS:000276952500007
J	Block, GJ; DiMattia, GD; Prockop, DJ				Block, Gregory J.; DiMattia, Gabriel D.; Prockop, Darwin J.			Stanniocalcin-1 Regulates Extracellular ATP-Induced Calcium Waves in Human Epithelial Cancer Cells by Stimulating ATP Release from Bystander Cells	PLOS ONE			English	Article							ADENINE-NUCLEOTIDES; RECEPTORS; GROWTH; COMMUNICATION; ACTIVATION; INHIBITOR; MIGRATION; GENE; ACTS; UTP	Background: The epithelial cell response to stress involves the transmission of signals between contiguous cells that can be visualized as a calcium wave. In some cell types, this wave is dependent on the release of extracellular trinucleotides from injured cells. In particular, extracellular ATP has been reported to be critical for the epithelial cell response to stress and has recently been shown to be upregulated in tumors in vivo. Methodology/Principal Findings: Here, we identify stanniocalcin-1 (STC1), a secreted pleiotrophic protein, as a critical mediator of calcium wave propagation in monolayers of pulmonary (A549) and prostate (PC3) epithelial cells. Addition of STC1 enhanced and blocking STC1 decreased the distance traveled by an extracellular ATP-dependent calcium wave. The same effects were observed when calcium was stimulated by the addition of exogenous ATP. We uncover a positive feedback loop in which STC1 promotes the release of ATP from cells in vitro and in vivo. Conclusions/Significance: The results indicated that STC1 plays an important role in the early response to mechanical injury by epithelial cells by modulating signaling of extracellular ATP. This is the first report to describe STC1 as a modulator or purinergic receptor signaling.	[Block, Gregory J.; Prockop, Darwin J.] Scott & White Hosp, Inst Regenerat Med, Texas A&M Hlth Sci Ctr, Temple, TX USA; [DiMattia, Gabriel D.] Univ Western Ontario, London Reg Canc Program, London, ON, Canada; [DiMattia, Gabriel D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Block, GJ (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	Prockop@medicine.tamhsc.edu			NIH [P40 RR 17447, P01 HL 075161]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075161] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grants P40 RR 17447 and P01 HL 075161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; BLOCK GJ, 2008, STEM CELLS; BOITANO S, 1994, J CELL SCI, V107, P3037; Chakraborty A, 2007, AM J PHYSIOL-RENAL, V292, pF895, DOI 10.1152/ajprenal.00219.2006; Chang ACM, 2005, MOL CELL BIOL, V25, P10604, DOI 10.1128/MCB.25.23.10604-10610.2005; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Dignass AU, 1998, EUR J CLIN INVEST, V28, P554; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Ehring GR, 2000, J PHYSIOL PHARMACOL, V51, P799; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Gagliardi AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE92, DOI 10.1152/ajpendo.00268.2004; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V250, P252, DOI 10.1006/bbrc.1998.9300; Janssens R, 2001, BRIT J PHARMACOL, V132, P536, DOI 10.1038/sj.bjp.0703833; KALCKAR HM, 1947, AM J PHYSIOL, V149, P240, DOI 10.1152/ajplegacy.1947.149.1.240; Kanellis J, 2004, AM J PHYSIOL-RENAL, V286, pF356, DOI 10.1152/ajprenal.00138.2003; Kawamura M, 2004, J NEUROSCI, V24, P10835, DOI 10.1523/JNEUROSCI.3028-04.2004; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; LAFEBER FPJG, 1989, J EXP BIOL, V143, P165; Madsen KL, 1998, AM J PHYSIOL-GASTR L, V274, pG96, DOI 10.1152/ajpgi.1998.274.1.G96; Nguyen A, 2009, ONCOGENE, V28, P1982, DOI 10.1038/onc.2009.65; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Satterwhite CM, 1999, AM J PHYSIOL-HEART C, V276, pH1091, DOI 10.1152/ajpheart.1999.276.3.H1091; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Shabir S, 2008, CELL CALCIUM, V44, P453, DOI 10.1016/j.ceca.2008.02.008; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; WAGNER GF, 1986, GEN COMP ENDOCR, V63, P481, DOI 10.1016/0016-6480(86)90149-8; Wagner GF, 1997, J BONE MINER RES, V12, P165, DOI 10.1359/jbmr.1997.12.2.165; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; WESTBERG JA, 2007, AM J PHYSL HEART CIR; Westberg JA, 2007, STROKE, V38, P1025, DOI 10.1161/01.STR.0000258113.67252.fa; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389	45	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10237	10.1371/journal.pone.0010237	http://dx.doi.org/10.1371/journal.pone.0010237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422040	Green Published, Green Submitted, gold			2022-12-27	WOS:000276854300006
J	Wenger, JB; Naumova, EN				Wenger, Julia B.; Naumova, Elena N.			Seasonal Synchronization of Influenza in the United States Older Adult Population	PLOS ONE			English	Article							MORTALITY; EPIDEMICS; SPREAD; VIRUS; HOSPITALIZATIONS; SURVEILLANCE; PNEUMONIA; EVOLUTION; DYNAMICS	Background: In temperate regions, influenza epidemics occur annually with the highest activity occurring during the winter months. While seasonal dynamics of the influenza virus, such as time of onset and circulating strains, are well documented by the Centers for Disease Control and Prevention Influenza Surveillance System, an accurate prediction of timing, magnitude, and composition of circulating strains of seasonal influenza remains elusive. To facilitate public health preparedness for seasonal influenza and to obtain better insights into the spatiotemporal behavior of emerging strains, it is important to develop measurable characteristics of seasonal oscillation and to quantify the relationships between those parameters on a spatial scale. The objectives of our research were to examine the seasonality of influenza on a national and state level as well as the relationship between peak timing and intensity of influenza in the United States older adult population. Methodology/Principal Findings: A total of 248,889 hospitalization records were extracted from the Centers for Medicare and Medicaid Services for the influenza seasons 1991-2004. Harmonic regression models were used to quantify the peak timing and absolute intensity for each of the 48 contiguous states and Washington, DC. We found that individual influenza seasons showed spatial synchrony with consistent late or early timing occurring across all 48 states during each influenza season in comparison to the overall average. On a national level, seasons that had an earlier peak also had higher rates of influenza (r(s) = -0.5). We demonstrated a spatial trend in peak timing of influenza; western states such as Nevada, Utah, and California peaked earlier and New England States such as Rhode Island, Maine, and New Hampshire peaked later. Conclusions/Significance: Our findings suggest that a systematic description of influenza seasonal patterns is a valuable tool for disease surveillance and can facilitate strategies for prevention of severe disease in the vulnerable, older adult population.	[Wenger, Julia B.; Naumova, Elena N.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	Massachusetts Department of Public Health; Tufts University	Wenger, JB (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	elena.naumova@tufts.edu	Naumova, Elena N/C-5954-2011; Naumova, Elena/AAP-3395-2020	Naumova, Elena/0000-0002-9562-4734	National Institute of Allergy and Infectious Diseases [HHSN266200500032C]; National Institute of Environmental Health Sciences [R01ES013171]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013171] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding Sources: National Institute of Allergy and Infectious Diseases (HHSN266200500032C) and the National Institute of Environmental Health Sciences (R01ES013171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P1197; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1095; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P375; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Lofgren E, 2007, LECT NOTES COMPUT SC, V4506, P114; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Naumova EN, 2005, ENVIRONMETRICS, V16, P749, DOI 10.1002/env.734; NAUMOVA EN, SPATIOTEMPORAL UNPUB; NAUMOVA EN, 2009, J AM GERIAT IN PRESS; Nuno M, 2007, LECT NOTES COMPUT SC, V4506, P37; Proff R, 2009, EMERG INFECT DIS, V15, P892, DOI 10.3201/eid1506.081645; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Simonsen L, 1997, EPIDEMIOLOGY, V8, P390, DOI 10.1097/00001648-199707000-00007; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Toubiana L, 1998, EUR J EPIDEMIOL, V14, P465, DOI 10.1023/A:1007481929237; Upshur REG, 1999, AM J EPIDEMIOL, V149, P85, DOI 10.1093/oxfordjournals.aje.a009731; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000	38	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10187	10.1371/journal.pone.0010187	http://dx.doi.org/10.1371/journal.pone.0010187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419169	Green Published, gold, Green Submitted			2022-12-27	WOS:000276707100008
J	Winkler, CJ; Ponce, A; Courey, AJ				Winkler, Clint J.; Ponce, Alberto; Courey, Albert J.			Groucho-Mediated Repression May Result from a Histone Deacetylase-Dependent Increase in Nucleosome Density	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSION; DROSOPHILA EMBRYO; GENE-EXPRESSION; FUNCTIONAL INTERACTION; VESTIGIAL GENE; CO-REPRESSORS; BHLH PROTEINS; IN-VIVO; ACETYLATION; DOMAIN	Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts with the histone deacetylase Rpd3. Although previous studies suggest that this interaction is required for repression of Gro-responsive reporters in cultured cells, the in vivo significance of this interaction and the mechanism by which it leads to repression remain largely unexplored. In this study, we show that Gro is partially dependent on Rpd3 for repression, supporting the idea that Rpd3-mediated repression is one mode of Gro-mediated repression. We demonstrate that Gro colocalizes with Rpd3 to the chromatin of a target gene and that this is accompanied by the deacetylation of specific lysines within the N-terminal tails of histones H3 and H4. Gro overexpression leads to wing patterning defects and ectopic repression in the wing disc of transcription directed by the vestigial quadrant enhancer. These effects are reversed by the histone deacetylase inhibitors TSA and HC-Toxin and by the reduction of Rpd3 gene dosage. Furthermore, repression of the vestigial quadrant enhancer is accompanied by a Gro-mediated increase in nucleosome density, an effect that is reversed by histone deacetylase inhibitors. We propose a model in which Gro-mediated histone deacetylation results in increased nucleosome density leading to transcriptional repression.	[Winkler, Clint J.; Ponce, Alberto; Courey, Albert J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Winkler, CJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	courey@chem.ucla.edu			National Institutes of Health (NIH) [RO1 GM44522]; United States Public Health Service (USPHS) [GM07104]; NIH/Minority Access to Research Careers [T34GM-08563-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R01GM044522, T32GM007104] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service (USPHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NIH/Minority Access to Research Careers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant RO1 GM44522. C. Winkler was supported by United States Public Health Service (USPHS) National Research Service Award GM07104 while a portion of this work was conducted. A. Ponce was supported by NIH/Minority Access to Research Careers - Undergraduate Student Training in Academic Research (MARC U*STAR) T34GM-08563-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Barolo S, 1997, EMBO J, V16, P2883, DOI 10.1093/emboj/16.10.2883; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Cinnamon E, 2008, DEVELOPMENT, V135, P829, DOI 10.1242/dev.015206; Courey AJ, 2001, GENE DEV, V15, P2786; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; deCelis JF, 1997, DEVELOPMENT, V124, P1919; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; KEENE MA, 1981, P NATL ACAD SCI-BIOL, V78, P143, DOI 10.1073/pnas.78.1.143; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Liu ZC, 2008, TRENDS PLANT SCI, V13, P137, DOI 10.1016/j.tplants.2007.12.005; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Martinez CA, 2008, MOL CELL BIOL, V28, P2792, DOI 10.1128/MCB.01203-07; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nuthall HN, 2002, J BIOL CHEM, V277, P51049, DOI 10.1074/jbc.M111660200; Orian A, 2007, P NATL ACAD SCI USA, V104, P15771, DOI 10.1073/pnas.0707418104; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Payankaulam S, 2009, P NATL ACAD SCI USA, V106, P17314, DOI 10.1073/pnas.0904507106; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; Ruebel KH, 2006, ENDOCRINE, V29, P435, DOI 10.1385/ENDO:29:3:435; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yao LC, 2008, DEVELOPMENT, V135, P2183, DOI 10.1242/dev.015826; Zhang HL, 1999, P NATL ACAD SCI USA, V96, P535, DOI 10.1073/pnas.96.2.535; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	52	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10166	10.1371/journal.pone.0010166	http://dx.doi.org/10.1371/journal.pone.0010166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405012	Green Published, Green Submitted, gold			2022-12-27	WOS:000276706300020
J	Mott, NN; Chung, WCJ; Tsai, PS; Pak, TR				Mott, Natasha N.; Chung, Wilson C. J.; Tsai, Pei-San; Pak, Toni R.			Differential Fibroblast Growth Factor 8 (FGF8)-Mediated Autoregulation of Its Cognate Receptors, Fgfr1 and Fgfr3, in Neuronal Cell Lines	PLOS ONE			English	Article							HORMONE PROMOTER ACTIVITY; DOWN-REGULATION; BREAST-CANCER; KINASE DOMAIN; PROTEIN; PROLIFERATION; EXPRESSION; PATHWAY; MODULATION; ACTIVATION	Fibroblast growth factors (FGFs) mediate a vast range of CNS developmental processes including neural induction, proliferation, migration, and cell survival. Despite the critical role of FGF signaling for normal CNS development, few reports describe the mechanisms that regulate FGF receptor gene expression in the brain. We tested whether FGF8 could autoregulate two of its cognate receptors, Fgfr1 and Fgfr3, in three murine cell lines with different lineages: fibroblast-derived cells (3T3 cells), neuronal cells derived from hippocampus (HT-22 cells), and neuroendocrine cells derived from hypothalamic gonadotropin-releasing hormone ( GnRH) neurons (GT1-7 cells). GnRH is produced by neurons in the hypothalamus and is absolutely required for reproductive competence in vertebrate animals. Several lines of evidence strongly suggest that Fgf8 is critical for normal development of the GnRH system, therefore, the GT1-7 cells provided us with an additional endpoint, Gnrh gene expression and promoter activity, to assess potential downstream consequences of FGF8-induced modulation of FGF receptor levels. Results from this study suggest that the autoregulation of its cognate receptor represents a common downstream effect of FGF8. Further, we show that Fgfr1 and Fgfr3 are differentially regulated within the same cell type, implicating these two receptors in different biological roles. Moreover, Fgfr1 and Fgfr3 are differentially regulated among different cell types, suggesting such autoregulation occurs in a cell type-specific fashion. Lastly, we demonstrate that FGF8b decreases Gnrh promoter activity and gene expression, possibly reflecting a downstream consequence of altered FGF receptor populations. Together, our data bring forth the possibility that, in addition to the FGF synexpression group, autoregulation of FGFR expression by FGF8 represents a mechanism by which FGF8 could fine-tune its regulatory actions.	[Mott, Natasha N.; Pak, Toni R.] Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Chung, Wilson C. J.; Tsai, Pei-San] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	Loyola University Chicago; University of Colorado System; University of Colorado Boulder	Mott, NN (corresponding author), Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpak@lumc.edu		Tsai, Pei-San/0000-0002-8650-647X; Chung, Wilson/0000-0003-0550-7567	NIH [RO1 AG033605, RO1 HD042634]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042634] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD058044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH RO1 AG033605 to TRP and NIH RO1 HD042634 to PST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Arnaud-Dabernat S, 2008, J CELL PHYSIOL, V216, P261, DOI 10.1002/jcp.21401; Arnaud-Dabernat S, 2007, DIABETES, V56, P96, DOI 10.2337/db05-1073; Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f; CHANDRAN UR, 1994, ENDOCRINOLOGY, V134, P1467, DOI 10.1210/en.134.3.1467; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Estival A, 1996, J BIOL CHEM, V271, P5663, DOI 10.1074/jbc.271.10.5663; Gill JC, 2004, ENDOCRINOLOGY, V145, P3830, DOI 10.1210/en.2004-0214; Grand EK, 2004, LEUKEMIA, V18, P962, DOI 10.1038/sj.leu.2403347; GUO Q, DEV BIOL, V338, P183; Guo QX, 2007, DEVELOPMENT, V134, P2251, DOI 10.1242/dev.004929; Inglis-Broadgate SL, 2005, DEV BIOL, V279, P73, DOI 10.1016/j.ydbio.2004.11.035; Jang JH, 2005, ONCOGENE, V24, P945, DOI 10.1038/sj.onc.1208254; Jen WC, 1999, GENE DEV, V13, P1486, DOI 10.1101/gad.13.11.1486; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Kwabi-Addo B, 2004, ENDOCR-RELAT CANCER, V11, P709, DOI 10.1677/erc.1.00535; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; MOSCATELLI D, 1989, J CELL BIOL, V109, P2519, DOI 10.1083/jcb.109.5.2519; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pak TR, 2006, ENDOCRINOLOGY, V147, P1924, DOI 10.1210/en.2005-1297; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Schoff CK, 2004, JCT COATINGSTECH, V1, P8; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Thomson RE, 2007, J NEUROCHEM, V100, P1565, DOI 10.1111/j.1471-4159.2006.04285.x; Tomlinson DC, 2009, CANCER RES, V69, P4613, DOI 10.1158/0008-5472.CAN-08-2816; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Walker DM, 2009, ENDOCRINOLOGY, V150, P2308, DOI 10.1210/en.2008-1396; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	34	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10143	10.1371/journal.pone.0010143	http://dx.doi.org/10.1371/journal.pone.0010143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405041	Green Submitted, gold, Green Published			2022-12-27	WOS:000276705900020
J	Tunney, RJ; Fernie, G; Astle, DE				Tunney, Richard J.; Fernie, Gordon; Astle, Duncan E.			An ERP Analysis of Recognition and Categorization Decisions in a Prototype-Distortion Task	PLOS ONE			English	Article							PERCEPTUAL CATEGORIZATION; CATEGORY KNOWLEDGE; MEMORY; CLASSIFICATION; RECOLLECTION; POTENTIALS; VARIANCE; PATTERNS; IMPLICIT; EXPLICIT	Background: Theories of categorization make different predictions about the underlying processes used to represent categories. Episodic theories suggest that categories are represented in memory by storing previously encountered exemplars in memory. Prototype theories suggest that categories are represented in the form of a prototype independently of memory. A number of studies that show dissociations between categorization and recognition are often cited as evidence for the prototype account. These dissociations have compared recognition judgements made to one set of items to categorization judgements to a different set of items making a clear interpretation difficult. Instead of using different stimuli for different tests this experiment compares the processes by which participants make decisions about category membership in a prototype-distortion task and with recognition decisions about the same set of stimuli by examining the Event Related Potentials (ERPs) associated with them. Method: Sixty-three participants were asked to make categorization or recognition decisions about stimuli that either formed an artificial category or that were category non-members. We examined the ERP components associated with both kinds of decision for pre-exposed and control participants. Conclusion: In contrast to studies using different items we observed no behavioural differences between the two kinds of decision; participants were equally able to distinguish category members from non-members, regardless of whether they were performing a recognition or categorisation judgement. Interestingly, this did not interact with prior-exposure. However, the ERP data demonstrated that the early visual evoked response that discriminated category members from nonmembers was modulated by which judgement participants performed and whether they had been pre-exposed to category members. We conclude from this that any differences between categorization and recognition reflect differences in the information that participants focus on in the stimuli to make the judgements at test, rather than any differences in encoding or process.	[Tunney, Richard J.] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Fernie, Gordon] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England; [Astle, Duncan E.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Nottingham; University of Liverpool; University of Oxford	Tunney, RJ (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	richard.tunney@nottingham.ac.uk		Astle, Duncan/0000-0002-7042-5392; Tunney, Richard/0000-0003-4673-757X	UK Economic and Social Research Council [RES-000-22-1830]; Economic and Social Research Council [ES/E002730/1] Funding Source: researchfish; ESRC [ES/E002730/1] Funding Source: UKRI	UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by a grant to Richard Tunney from the UK Economic and Social Research Council (RES-000-22-1830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T, 2002, COGN AFFECT BEHAV NE, V2, P1, DOI 10.3758/CABN.2.1.1; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; KOLODNY JA, 1994, PSYCHOL SCI, V5, P164, DOI 10.1111/j.1467-9280.1994.tb00654.x; Little DM, 2006, BRAIN COGNITION, V60, P233, DOI 10.1016/j.bandc.2005.06.004; Little DM, 2006, BRAIN COGNITION, V60, P244, DOI 10.1016/j.bandc.2005.09.016; Luck S.J., 2005, INTRO EVENT RELATED; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Nosofsky RM, 1998, PSYCHOL SCI, V9, P247, DOI 10.1111/1467-9280.00051; Nosofsky RM, 2000, PSYCHON B REV, V7, P375; NOSOFSKY RM, 1992, ANNU REV PSYCHOL, V43, P25, DOI 10.1146/annurev.ps.43.020192.000325; Palmeri TJ, 1999, PSYCHOL SCI, V10, P526, DOI 10.1111/1467-9280.00200; POSNER MI, 1967, J EXP PSYCHOL, V73, P28, DOI 10.1037/h0024135; Reber PJ, 1998, P NATL ACAD SCI USA, V95, P747, DOI 10.1073/pnas.95.2.747; Reber PJ, 1998, LEARN MEMORY, V5, P420; Reber PJ, 2003, J COGNITIVE NEUROSCI, V15, P574, DOI 10.1162/089892903321662958; Reber PJ, 2002, COGNITIVE BRAIN RES, V14, P245, DOI 10.1016/S0926-6410(02)00122-2; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; SHIN HJ, 1992, J EXP PSYCHOL GEN, V121, P278, DOI 10.1037/0096-3445.121.3.278; SMITH JD, 2002, J EXPT PSYCHOL LEARN, V28, P200; Squire LR, 1995, P NATL ACAD SCI USA, V92, P12470, DOI 10.1073/pnas.92.26.12470; Tucker DM., 1994, HUM BRAIN MAPP, V1, DOI DOI 10.1002/HBM.460010206; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190	29	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10116	10.1371/journal.pone.0010116	http://dx.doi.org/10.1371/journal.pone.0010116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583UR	20404932	Green Published, Green Accepted, gold			2022-12-27	WOS:000276705900003
J	Marmolino, D; Manto, M; Acquaviva, F; Vergara, P; Ravella, A; Monticelli, A; Pandolfo, M				Marmolino, Daniele; Manto, Mario; Acquaviva, Fabio; Vergara, Paola; Ravella, Ajay; Monticelli, Antonella; Pandolfo, Massimo			PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia	PLOS ONE			English	Article							PROMOTES MITOCHONDRIAL BIOGENESIS; OXIDATIVE STRESS; TRANSCRIPTIONAL COACTIVATOR; IRON ACCUMULATION; GENE-EXPRESSION; YEAST FRATAXIN; TRIPLET REPEAT; MOUSE MODELS; PGC-1-ALPHA; PROTEIN	Background: Cells from individuals with Friedreich's ataxia (FRDA) show reduced activities of antioxidant enzymes and cannot up-regulate their expression when exposed to oxidative stress. This blunted antioxidant response may play a central role in the pathogenesis. We previously reported that Peroxisome Proliferator Activated Receptor Gamma (PPAR gamma) Coactivator 1-alpha (PGC-1 alpha), a transcriptional master regulator of mitochondrial biogenesis and antioxidant responses, is down-regulated in most cell types from FRDA patients and animal models. Methodology/Principal Findings: We used primary fibroblasts from FRDA patients and the knock in-knock out animal model for the disease (KIKO mouse) to determine basal superoxide dismutase 2 (SOD2) levels and the response to oxidative stress induced by the addition of hydrogen peroxide. We measured the same parameters after pharmacological stimulation of PGC-1 alpha. Compared to control cells, PGC-1 alpha and SOD2 levels were decreased in FRDA cells and did not change after addition of hydrogen peroxide. PGC-1 alpha direct silencing with siRNA in control fibroblasts led to a similar loss of SOD2 response to oxidative stress as observed in FRDA fibroblasts. PGC-1 alpha activation with the PPAR gamma agonist (Pioglitazone) or with a cAMP-dependent protein kinase (AMPK) agonist (AICAR) restored normal SOD2 induction. Treatment of the KIKO mice with Pioglitazone significantly up-regulates SOD2 in cerebellum and spinal cord. Conclusions/Significance: PGC-1 alpha down-regulation is likely to contribute to the blunted antioxidant response observed in cells from FRDA patients. This response can be restored by AMPK and PPAR gamma agonists, suggesting a potential therapeutic approach for FRDA.	[Marmolino, Daniele; Manto, Mario; Ravella, Ajay; Pandolfo, Massimo] Univ Libre Bruxelles, Lab Neurol Expt, Brussels, Belgium; [Manto, Mario] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Acquaviva, Fabio; Vergara, Paola] Univ Naples Federico II, Dept Cellular & Mol Biol, Naples, Italy; [Monticelli, Antonella] CNR, IEOS, I-80125 Naples, Italy	Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Marmolino, D (corresponding author), Univ Libre Bruxelles, Lab Neurol Expt, Brussels, Belgium.	massimo.pandolfo@ulb.ac.be	Vergara, Paola/K-9145-2013; Acquaviva, Fabio/N-6402-2016; Manto, Mario/ABF-6008-2021	Acquaviva, Fabio/0000-0001-9192-1232; 	GOFAR Association; Fonds Erasme; Belgian Fonds National de la Recherche Scientifique [3.4572.08]	GOFAR Association; Fonds Erasme; Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the GOFAR Association (grant to M. P.), the Fonds Erasme (grant Jean Van Damme for Orphan Diseases to M. P.), the Belgian Fonds National de la Recherche Scientifique (grant n. 3.4572.08 to M. P.). M. M. is supported by FNRS-Belgium. Takeda pharmaceuticals provided the compound pioglitazone-AD4833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bird AJ, 2008, ADV MICROB PHYSIOL, V53, P231, DOI 10.1016/SO065-2911(07)53004-3; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Clark J, 2009, ANTIOXID REDOX SIGN, V11, P509, DOI 10.1089/ARS.2008.2241; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Delatycki MB, 2000, J MED GENET, V37, P1, DOI 10.1136/jmg.37.1.1; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Filla A, 2000, MOVEMENT DISORD, V15, P1255, DOI 10.1002/1531-8257(200011)15:6<1255::AID-MDS1031>3.0.CO;2-C; FILLA A, 1990, J NEUROL, V237, P345, DOI 10.1007/BF00315657; FINOCCHIARO G, 1988, NEUROLOGY, V38, P1292, DOI 10.1212/WNL.38.8.1292; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Fujisawa K, 2009, BIOCHEM BIOPH RES CO, V379, P43, DOI 10.1016/j.bbrc.2008.11.141; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Jiralerspong S, 2001, FEBS LETT, V509, P101, DOI 10.1016/S0014-5793(01)03140-4; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lodi R, 2006, ANTIOXID REDOX SIGN, V8, P438, DOI 10.1089/ars.2006.8.438; LOTTE L, 2010, EXP GERONTOL    0118; Marmolino D, 2009, CEREBELLUM, V8, P245, DOI 10.1007/s12311-008-0084-2; Marmolino D, 2009, CEREBELLUM, V8, P98, DOI 10.1007/s12311-008-0087-z; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; PANDOLFO M, 2006, GENETIC INSTABILITIE, V2, P277; PANDOLFO M, 2003, NEUROL          0910, P163; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; PI J, 2009, TOXICOL APPL PHARM; Pianese L, 2002, HUM MOL GENET, V11, P2989, DOI 10.1093/hmg/11.23.2989; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Santos MM, 2001, HUM MOL GENET, V10, P1935, DOI 10.1093/hmg/10.18.1935; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; SHAPCOTT D, 1976, Canadian Journal of Neurological Sciences, V3, P361; Spiegelman Bruce M, 2007, Novartis Found Symp, V286, P3; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tabrizi SJ, 1999, BIOCHEM SOC SYMP, V66, P99, DOI 10.1042/bss0660099; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vina J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006; WENZ T, 2009, CURR OPIN LIPIDOL, V20, P98; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wu ZD, 1999, CURR OPIN CELL BIOL, V11, P689, DOI 10.1016/S0955-0674(99)00037-X; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200	80	103	104	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10025	10.1371/journal.pone.0010025	http://dx.doi.org/10.1371/journal.pone.0010025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383327	Green Submitted, gold, Green Published			2022-12-27	WOS:000276454000006
J	Boeke, J; Regnard, C; Cai, WL; Johansen, J; Johansen, KM; Becker, PB; Imhof, A				Boeke, Joern; Regnard, Catherine; Cai, Weili; Johansen, Jorgen; Johansen, Kristen M.; Becker, Peter B.; Imhof, Axel			Phosphorylation of SU(VAR)3-9 by the Chromosomal Kinase JIL-1	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; CHROMATIN-STRUCTURE; HETEROCHROMATIN PROTEIN-1; METHYLTRANSFERASE SUV39H1; DROSOPHILA SU(VAR)3-9; HISTONE; BINDING; HP1; METHYLATION; HP1-ALPHA	The histone methyltransferase SU(VAR)3-9 plays an important role in the formation of heterochromatin within the eukaryotic nucleus. Several studies have shown that the formation of condensed chromatin is highly regulated during development, suggesting that SU(VAR)3-9's activity is regulated as well. However, no mechanism by which this may be achieved has been reported so far. As we and others had shown previously that the N-terminus of SU(VAR)3-9 plays an important role for its activity, we purified interaction partners from Drosophila embryo nuclear extract using as bait a GST fusion protein containing the SU(VAR)3-9 N-terminus. Among several other proteins known to bind Su(VAR)3-9 we isolated the chromosomal kinase JIL-1 as a strong interactor. We show that SU(VAR)3-9 is a substrate for JIL-1 in vitro as well as in vivo and map the site of phosphorylation. These findings may provide a molecular explanation for the observed genetic interaction between SU(VAR)3-9 and JIL-1.	[Boeke, Joern; Regnard, Catherine; Becker, Peter B.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Boeke, Joern; Regnard, Catherine; Becker, Peter B.; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci CIPS, Munich, Germany; [Cai, Weili; Johansen, Jorgen; Johansen, Kristen M.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of Munich; University of Munich; Iowa State University	Boeke, J (corresponding author), Univ Munich, Adolf Butenandt Inst, Munich, Germany.	Imhof@lmu.de	Imhof, Axel/AAU-5313-2021; Cai, Weili/B-7691-2013	Imhof, Axel/0000-0003-2993-8249; Regnard, Catherine/0000-0001-9915-7494; Cai, Weili/0000-0002-6781-5322; Becker, Peter/0000-0001-7186-0372	Deutsche Forschungsgemeinschaft [IM 23/4-3, SFB-TR5]; National Institutes of Health [GM62916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Imhof and Becker labs is supported by grants from the Deutsche Forschungsgemeinschaft [IM 23/4-3 and SFB-TR5 accordingly]. Work in the Johansen laboratory is supported by a grant from the National Institutes of Health [GM62916]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Aagaard L, 2000, J CELL SCI, V113, P817; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Cattaneo F, 2008, J CELL BIOCHEM, V105, P344, DOI 10.1002/jcb.21869; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Deng H, 2007, GENETICS, V177, P79, DOI 10.1534/genetics.107.075143; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; EISSENBERG JC, 1994, J BIOL CHEM, V269, P21315; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fan JY, 2007, METHODS, V41, P286, DOI 10.1016/j.ymeth.2006.11.001; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; JOHANSEN KM, 2009, NETHODS, V48, P387; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lerach S, 2006, GENETICS, V173, P2403, DOI 10.1534/genetics.106.059253; LeRoy G, 2009, MOL CELL PROTEOMICS, pS11; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Ogawa M, 2003, IMMUNOL LETT, V86, P57, DOI 10.1016/S0165-2478(02)00293-6; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rudenko A, 2003, EMBO REP, V4, P59, DOI 10.1038/sj.embor.embor712; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Spensberger D, 2008, FEBS LETT, V582, P2761, DOI 10.1016/j.febslet.2008.06.056; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhao T, 1999, J BIOL CHEM, V274, P15095, DOI 10.1074/jbc.274.21.15095; Zhou J, 2008, RNA, V14, P1773, DOI 10.1261/rna.1036308	52	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10042	10.1371/journal.pone.0010042	http://dx.doi.org/10.1371/journal.pone.0010042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386606	gold, Green Published, Green Submitted			2022-12-27	WOS:000276420400013
J	Lundin, S; Stranneheim, H; Pettersson, E; Klevebring, D; Lundeberg, J				Lundin, Sverker; Stranneheim, Henrik; Pettersson, Erik; Klevebring, Daniel; Lundeberg, Joakim			Increased Throughput by Parallelization of Library Preparation for Massive Sequencing	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; DNA; PRECIPITATION	Background: Massively parallel sequencing systems continue to improve on data output, while leaving labor-intensive library preparations a potential bottleneck. Efforts are currently under way to relieve the crucial and time-consuming work to prepare DNA for high-throughput sequencing. Methodology/Principal Findings: In this study, we demonstrate an automated parallel library preparation protocol using generic carboxylic acid-coated superparamagnetic beads and polyethylene glycol precipitation as a reproducible and flexible method for DNA fragment length separation. With this approach the library preparation for DNA sequencing can easily be adjusted to a desired fragment length. The automated protocol, here demonstrated using the GS FLX Titanium instrument, was compared to the standard manual library preparation, showing higher yield, throughput and great reproducibility. In addition, 12 libraries were prepared and uniquely tagged in parallel, and the distribution of sequence reads between these indexed samples could be improved using quantitative PCR-assisted pooling. Conclusions/Significance: We present a novel automated procedure that makes it possible to prepare 36 indexed libraries per person and day, which can be increased to up to 96 libraries processed simultaneously. The yield, speed and robust performance of the protocol constitute a substantial improvement to present manual methods, without the need of extensive equipment investments. The described procedure enables a considerable efficiency increase for small to midsize sequencing centers.	[Lundin, Sverker; Stranneheim, Henrik; Pettersson, Erik; Klevebring, Daniel; Lundeberg, Joakim] Royal Inst Technol KTH, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden	Royal Institute of Technology	Lundin, S (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden.	joalun@kth.se		Klevebring, Daniel/0000-0002-9810-3838	Swedish Scientific Council; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation	Swedish Scientific Council; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Scientific Council, the Swedish Foundation for Strategic Research and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Klevebring D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/396808; Lis J T, 1980, Methods Enzymol, V65, P347; LIS JT, 1975, NUCLEIC ACIDS RES, V2, P383, DOI 10.1093/nar/2.3.383; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maricic T, 2009, BIOTECHNIQUES, V46, P51, DOI 10.2144/000113042; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; NYREN P, 1993, ANAL BIOCHEM, V208, P171, DOI 10.1006/abio.1993.1024; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Sandberg J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp188; Sauer ML, 2008, ANAL BIOCHEM, V380, P310, DOI 10.1016/j.ab.2008.05.044; Schmitz A, 2006, ANAL BIOCHEM, V354, P311, DOI 10.1016/j.ab.2006.03.014; Wiley G., 2009, CURR PROTOC HUM GENE	18	86	95	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10029	10.1371/journal.pone.0010029	http://dx.doi.org/10.1371/journal.pone.0010029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386591	Green Published, Green Submitted, gold			2022-12-27	WOS:000276420400007
J	Anand, B; Surana, P; Prakash, B				Anand, Baskaran; Surana, Parag; Prakash, Balaji			Deciphering the Catalytic Machinery in 30S Ribosome Assembly GTPase YqeH	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSITION-STATE ANALOG; BACILLUS-SUBTILIS; HYDROLYSIS; PROTEIN; SUBUNIT; BINDING; COMPLEX; MUTAGENESIS; BIOGENESIS	Background: YqeH, a circularly permuted GTPase (cpGTPase), which is conserved across bacteria and eukaryotes including humans is important for the maturation of small (30S) ribosomal subunit in Bacillus subtilis. Recently, we have shown that it binds 30S in a GTP/GDP dependent fashion. However, the catalytic machinery employed to hydrolyze GTP is not recognized for any of the cpGTPases, including YqeH. This is because they possess a hydrophobic substitution in place of a catalytic glutamine (present in Ras-like GTPases). Such GTPases were categorized as HAS-GTPases and were proposed to follow a catalytic mechanism, different from the Ras-like proteins. Methodology/Principal Findings: MnmE, another HAS-GTPase, but not circularly permuted, utilizes a potassium ion and water mediated interactions to drive GTP hydrolysis. Though the G-domain of MnmE and YqeH share only similar to 25% sequence identity, the conservation of characteristic sequence motifs between them prompted us to probe GTP hydrolysis machinery in YqeH, by employing homology modeling in conjunction with biochemical experiments. Here, we show that YqeH too, uses a potassium ion to drive GTP hydrolysis and stabilize the transition state. However, unlike MnmE, it does not dimerize in the transition state, suggesting alternative ways to stabilize switches I and II. Furthermore, we identify a potential catalytic residue in Asp-57, whose recognition, in the absence of structural information, was non-trivial due to the circular permutation in YqeH. Interestingly, when compared with MnmE, helix alpha 2 that presents Asp-57 is relocated towards the N-terminus in YqeH. An analysis of the YqeH homology model, suggests that despite such relocation, Asp-57 may facilitate water mediated catalysis, similarly as the catalytic Glu-282 of MnmE. Indeed, an abolished catalysis by D571 mutant supports this inference. Conclusions/Significance: An uncommon means to achieve GTP hydrolysis utilizing a K(+) ion has so far been demonstrated only for MnmE. Here, we show that YqeH also utilizes a similar mechanism. While the catalytic machinery is similar in both, mechanistic differences may arise based on the way they are deployed. It appears that K(+) driven mechanism emerges as an alternative theme to stabilize the transition state and hydrolyze GTP in a subset of GTPases, such as the HAS-GTPases.	[Anand, Baskaran; Surana, Parag; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Anand, B (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	bprakash@iitk.ac.in		, Anand/0000-0002-7125-4011	Wellcome Trust, United Kingdom [073616]; Department of Biotechnology, India [BT/PR7897/Med/14/1178/2006]; All India Council for Technical Education (AICTE)	Wellcome Trust, United Kingdom(Wellcome Trust); Department of Biotechnology, India(Department of Biotechnology (DBT) India); All India Council for Technical Education (AICTE)	This work was supported by funding from Wellcome Trust (Grant No: 073616), United Kingdom (http://www. wellcome. ac. uk/) and Department of Biotechnology (Grant No: BT/PR7897/Med/14/1178/2006), India (http://dbtindia.nic.in/index.asp). B. P. is a Wellcome Trust International Senior Research Fellow. B. A. acknowledges the All India Council for Technical Education (AICTE) for the National Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Anand B, 2009, BIOCHEM BIOPH RES CO, V386, P602, DOI 10.1016/j.bbrc.2009.06.078; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Campbell TL, 2008, J BACTERIOL, V190, P2537, DOI 10.1128/JB.01744-07; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Martinez-Vicente M, 2005, J BIOL CHEM, V280, P30660, DOI 10.1074/jbc.M503223200; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008	38	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9944	10.1371/journal.pone.0009944	http://dx.doi.org/10.1371/journal.pone.0009944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376346	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200020
J	Kuenzli, A; Bucher, HC; Anand, I; Arutiunov, G; Kum, LC; McKelvie, R; Afzal, R; White, M; Nordmann, AJ				Kuenzli, Andrea; Bucher, Heiner C.; Anand, Inder; Arutiunov, Gregory; Kum, Leo C.; McKelvie, Robert; Afzal, Rizwan; White, Michel; Nordmann, Alain J.			Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CONVERTING-ENZYME-INHIBITOR; MYOCARDIAL-INFARCTION; BLOCKER VALSARTAN; DOUBLE-BLIND; HIGH-RISK; COMBINATION; CANDESARTAN; MORBIDITY; MORTALITY	Background: There is insufficient evidence whether the benefit of adding angiotensin II receptor blockers (ARBs) to angiotensin-converting enzyme ( ACE) inhibitors outweighs the increased risk of adverse effects in patients with heart failure. Methodology/Principal Findings: Two independent reviewers searched and abstracted randomized controlled trials of ARBs and ACE inhibitors compared to ACE inhibitor therapy alone in patients with heart failure reporting mortality and hospitalizations having a follow- up of at least 6 months identified by a systematic literature search. Eight trials including a total of 18,061 patients fulfilled our inclusion criteria. There was no difference between patients treated with combination therapy and ACE inhibitor therapy alone for overall mortality, hospitalization for any reason, fatal or nonfatal MI. Combination therapy was, however, associated with fewer hospital admissions for heart failure (RR 0.81, 95%CI 0.72-0.91), although there was significant heterogeneity across trials (p-value for heterogeneity = 0.04; I-2 = 57% [95% CI 0-83%]). Patients treated with combination therapy had a higher risk of worsening renal function and symptomatic hypotension, and their trial medications were more often permanently discontinued. Lack of individual patient data precluded the analysis of time-to-event data and identification of subgroups which potentially benefit more from combination therapy such as younger patients with preserved renal function and thus at lower risk to experience worsening renal function or hyperkalemia. Conclusions/Significance: Combination therapy with ARBs and ACE inhibitors reduces admissions for heart failure in patients with congestive heart failure when compared to ACE inhibitor therapy alone, but does not reduce overall mortality or all-cause hospitalization and is associated with more adverse events. Thus, based on current evidence, combination therapy with ARBs and ACE inhibitors may be reserved for patients who remain symptomatic on therapy with ACE inhibitors under strict monitoring for any signs of worsening renal function and/or symptomatic hypotension.	[Kuenzli, Andrea; Bucher, Heiner C.; Nordmann, Alain J.] Univ Basel Hosp, Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Anand, Inder] Univ Minnesota, Sch Med, Div Cardiovasc, Vet Affairs Med Ctr, Minneapolis, MN 55455 USA; [Arutiunov, Gregory] Russian State Med Univ, Moscow 117437, Russia; [Kum, Leo C.] Chinese Univ Hong Kong, Prince Wales Hosp, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [McKelvie, Robert; Afzal, Rizwan] McMaster Univ, Hamilton, ON, Canada; [McKelvie, Robert; Afzal, Rizwan] Populat Hlth Res Inst, Hamilton Hlth Sci Gen Site, Hamilton, ON, Canada; [White, Michel] Univ Montreal, Montreal, PQ, Canada; [White, Michel] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada	University of Basel; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Pirogov Russian National Research Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; McMaster University; Population Health Research Institute; Universite de Montreal; Universite de Montreal	Kuenzli, A (corresponding author), Univ Basel Hosp, Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.	nordmanna@uhbs.ch	Arutyunov, Gregory/M-7368-2019; Arutyunov, Gregory/K-9721-2018; VALLET, Yannick/F-9979-2011	Arutyunov, Gregory/0000-0002-6645-2515; Arutyunov, Gregory/0000-0002-6645-2515; Anand, Inder/0000-0003-1308-4963				Arutyunov G. P., 2000, Terapevticheskii Arkhiv, V72, P52; BALL SG, 1993, LANCET, V342, P821; Baruch L, 1999, CIRCULATION, V99, P2658, DOI 10.1161/01.CIR.99.20.2658; BIOLLAZ J, 1982, J CARDIOVASC PHARM, V4, P966, DOI 10.1097/00005344-198211000-00014; Bonet S, 2000, ARCH INTERN MED, V160, P621, DOI 10.1001/archinte.160.5.621; Carson PE, 2000, AM HEART J, V140, P361, DOI 10.1067/mhj.2000.109215; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Cohn JN, 2003, CIRCULATION, V108, P1306, DOI 10.1161/01.CIR.0000091234.45664.62; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimopoulos K, 2004, INT J CARDIOL, V93, P105, DOI 10.1016/j.ijcard.2003.10.001; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Hamroff G, 1999, CIRCULATION, V99, P990, DOI 10.1161/01.CIR.99.8.990; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Kum LCC, 2008, INT J CARDIOL, V125, P16, DOI 10.1016/j.ijcard.2007.02.016; Lakhdar R, 2008, J CARD FAIL, V14, P181, DOI 10.1016/j.cardfail.2007.11.008; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; Lee VC, 2004, ANN INTERN MED, V141, P693, DOI 10.7326/0003-4819-141-9-200411020-00011; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; McKelvie RS, 1999, CIRCULATION, V100, P1056, DOI 10.1161/01.CIR.100.10.1056; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2006, EUR HEART J, V27, P1447, DOI 10.1093/eurheartj/ehl016; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; O'Meara E, 2005, EUR J HEART FAIL, V7, P650, DOI 10.1016/j.ejheart.2005.01.021; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Phillips CO, 2007, ARCH INTERN MED, V167, P1930, DOI 10.1001/archinte.167.18.1930; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Reed SD, 2005, AM HEART J, V150, P323, DOI 10.1016/j.ahj.2004.08.037; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; URATA H, 1990, CIRC RES, V66, P883, DOI 10.1161/01.RES.66.4.883; White M, 2007, J CARD FAIL, V13, P86, DOI 10.1016/j.cardfail.2006.10.013; Wong M, 2002, J AM COLL CARDIOL, V40, P970, DOI 10.1016/S0735-1097(02)02063-6; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	40	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9946	10.1371/journal.pone.0009946	http://dx.doi.org/10.1371/journal.pone.0009946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376345	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200022
J	Cool, BH; Chan, GCK; Lee, L; Oshima, J; Martin, GM; Hu, QB				Cool, Bethany H.; Chan, Guy C-K.; Lee, Lin; Oshima, Junko; Martin, George M.; Hu, Qubai			A Flanking Gene Problem Leads to the Discovery of a Gprc5b Splice Variant Predominantly Expressed in C57Bl/6J Mouse Brain and in Maturing Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; METABOTROPIC GLUTAMATE RECEPTORS; QUANTITATIVE TRAIT LOCI; ALZHEIMERS-DISEASE; RAT-BRAIN; FE65; COMPLEX; DOMAIN; CELLS; ORGANIZATION	Background: Gprc5b, a retinoic acid-inducible orphan G protein-coupled receptor (GPCR), is a member of the group C metabotropic glutamate receptor family proteins possibly involved in non-canonical Wnt signaling. Many GPCR transcripts are alternatively spliced, which diversifies this class of proteins in their cell-and tissue-specific signaling, regulatory and/or pharmacological properties. We previously generated p97FE65 isoform-specific knockout mice that showed learning/memory deficits. In this study, we further characterized the 97FE65 null mice using cDNA microarray and RT-PCR analyses. Methodology/Principal Findings: We discovered a novel brain-specific C-terminal splice variant of Gprc5b, Gprc5b_v2, which was differentially expressed in p97FE65 wild type and null mouse brains. The null mice were generated in 129/Sv ES cells, and backcrossed to C57Bl/6J for ten generations. We found that expression of Gprc5b_v2 mRNA in the brains of p97FE65 null mice was dramatically down-regulated (more than 20 fold) compared to their wild type littermates. However, expression profiles of Gprc5b variants and SNP analysis surrounding the FE65 locus suggest that the down-regulation is unlikely due to the altered FE65 function, but rather is caused by gene retention from the 129/Sv ES cells. Consistently, in contrast to ubiquitously expressed Gprc5b_v1, Gprc5b_v2 was predominantly expressed in the brain tissues of C57Bl/6J mice. The alternative splicing of the 39 terminal exon also altered the protein coding sequences, giving rise to the characteristic C-termini. Levels of Gprc5b_v2 mRNA were increased during neuronal maturation, paralleling the expression of synaptic proteins. Overexpression of both Gprc5b variants stimulated neurite-like outgrowth in a neuroblastoma cell line. Conclusions/Significance: Our results suggest that Gprc5b-v2 may play a role during brain maturation and in matured brain, possibly through the regulation of neuronal morphology and protein-protein interaction. This study also highlights the fact that unexpected gene retention following repeated backcrosses can lead to important biological consequences.	[Cool, Bethany H.; Lee, Lin; Oshima, Junko; Martin, George M.; Hu, Qubai] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Chan, Guy C-K.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cool, BH (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	gmmartin@u.washington.edu; qhu@u.washington.edu			National Institute on Aging, and National Institutes of Health (NIH) [R01 AG19711, T32 AG00057, NS20498]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R01AG019711] Funding Source: NIH RePORTER	National Institute on Aging, and National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported, in part, by R01 AG19711 and T32 AG00057 from the National Institute on Aging, and National Institutes of Health (NIH) grant NS20498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Bolivar VJ, 2001, GENOME RES, V11, P1549, DOI 10.1101/gr.194001; Brauner-Osborne H, 2000, GENOMICS, V65, P121, DOI 10.1006/geno.2000.6164; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chan GCK, 2005, J NEUROSCI, V25, P9913, DOI 10.1523/JNEUROSCI.2376-05.2005; CICCARONE V, 1989, CANCER RES, V49, P219; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Festing Michael F. W., 1992, V8, P17; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Harada Y, 2007, BIOCHEM BIOPH RES CO, V358, P968, DOI 10.1016/j.bbrc.2007.04.208; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hu QB, 1999, J NEUROSCI RES, V58, P632, DOI 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P; Hu QB, 2000, J NEUROSCI RES, V60, P73, DOI 10.1002/(SICI)1097-4547(20000401)60:1<73::AID-JNR8>3.0.CO;2-S; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; MARKOVIC D, 2009, CELL MOL LIFE SCI; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; MINAKAMI R, 1995, J NEUROCHEM, V65, P1536; Mirnics K, 2001, NAT REV NEUROSCI, V2, P444, DOI 10.1038/35077587; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Robbins MJ, 2002, MOL BRAIN RES, V106, P136, DOI 10.1016/S0169-328X(02)00420-5; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Strosberg AD, 1996, CANCER SURV, V27, P65; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Wang Y, 2009, LEARN MEMORY, V16, P537, DOI 10.1101/lm.1499309; Wurmbach E, 2002, NEUROCHEM RES, V27, P1027, DOI 10.1023/A:1020900720328; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10351	10.1371/journal.pone.0010351	http://dx.doi.org/10.1371/journal.pone.0010351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436672	Green Submitted, gold, Green Published			2022-12-27	WOS:000277079500019
J	Tatro, ET; Scott, ER; Nguyen, TB; Salaria, S; Banerjee, S; Moore, DJ; Masliah, E; Achim, CL; Everall, IP				Tatro, Erick T.; Scott, Erick R.; Nguyen, Timothy B.; Salaria, Shahid; Banerjee, Sugato; Moore, David J.; Masliah, Eliezer; Achim, Cristian L.; Everall, Ian P.			Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-Infected Brain: Novel Analysis of Retrospective Cases	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; GLIAL-CELL DENSITY; NEURONAL SIZE; RNA; EXPRESSION; CORTEX; DYSREGULATION; MICROARRAY; PATHWAY; PROTEIN	HIV infection disturbs the central nervous system (CNS) through inflammation and glial activation. Evidence suggests roles for microRNA (miRNA) in host defense and neuronal homeostasis, though little is known about miRNAs' role in HIV CNS infection. MiRNAs are non-coding RNAs that regulate gene translation through post-transcriptional mechanisms. Messenger-RNA profiling alone is insufficient to elucidate the dynamic dance of molecular expression of the genome. We sought to clarify RNA alterations in the frontal cortex (FC) of HIV-infected individuals and those concurrently infected and diagnosed with major depressive disorder (MDD). This report is the first published study of large-scale miRNA profiling from human HIV-infected FC. The goals of this study were to: 1. Identify changes in miRNA expression that occurred in the frontal cortex (FC) of HIV individuals, 2. Determine whether miRNA expression profiles of the FC could differentiate HIV from HIV/MDD, and 3. Adapt a method to meaningfully integrate gene expression data and miRNA expression data in clinical samples. We isolated RNA from the FC (n = 3) of three separate groups (uninfected controls, HIV, and HIV/MDD) and then pooled the RNA within each group for use in large-scale miRNA profiling. RNA from HIV and HIV/MDD patients (n = 4 per group) were also used for non-pooled mRNA analysis on Affymetrix U133 Plus 2.0 arrays. We then utilized a method for integrating the two datasets in a Target Bias Analysis. We found miRNAs of three types: A) Those with many dysregulated mRNA targets of less stringent statistical significance, B) Fewer dysregulated target-genes of highly stringent statistical significance, and C) unclear bias. In HIV/MDD, more miRNAs were downregulated than in HIV alone. Specific miRNA families at targeted chromosomal loci were dysregulated. The dysregulated miRNAs clustered on Chromosomes 14, 17, 19, and X. A small subset of dysregulated genes had many 3' untranslated region (3'UTR) target-sites for dysregulated miRNAs. We provide evidence that certain miRNAs serve as key elements in gene regulatory networks in HIV-infected FC and may be implicated in neurobehavioral disorder. Finally, our data indicates that some genes may serve as hubs of miRNA activity.	[Tatro, Erick T.; Salaria, Shahid; Moore, David J.; Achim, Cristian L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Tatro, Erick T.; Banerjee, Sugato; Moore, David J.; Masliah, Eliezer; Achim, Cristian L.] Univ Calif San Diego, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Scott, Erick R.; Banerjee, Sugato; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Everall, Ian P.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Melbourne	Tatro, ET (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	etatro@ucsd.edu	BANERJEE, SUGATO/M-7317-2017; BANERJEE, SUGATO/L-9012-2019	BANERJEE, SUGATO/0000-0002-4402-3066; 	National Institutes of Health [R21MH076681, R01MH062962, R01MH079881]; HIV Neurobehavioral Research Center [U01 MH83506]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083506, R01MH062962, R01MH079881, R21MH076681, U01MH083545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Neurobehavioral Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The following grants from the National Institutes of Health (nih.gov) funded this project: R21MH076681, R01MH062962, R01MH079881. The HIV Neurobehavioral Research Center is funded under grant number U01 MH83506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*APPL BIOS INC, 2005, APPL BIOS RQ MANG 1; Ashraf SI, 2006, CURR OPIN NEUROBIOL, V16, P535, DOI 10.1016/j.conb.2006.08.007; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Everall IP, 2001, J NEUROPATH EXP NEUR, V60, P293, DOI 10.1093/jnen/60.3.293; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; *ING SYST, 2009, ING PATHW AN; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kolbus A, 2003, BLOOD, V102, P3136, DOI 10.1182/blood-2003-03-0923; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LANTOS PL, 1989, LANCET, V1, P309; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manakov SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-419; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; O'Connor MF, 2009, NEUROIMAGE, V47, P891, DOI 10.1016/j.neuroimage.2009.05.049; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Salaria S, 2006, NEUROBIOL DIS, V23, P630, DOI 10.1016/j.nbd.2006.05.003; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; SPSS Inc, 2004, SPSS WIND REL 13 0; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; WANG X, 2008, BLOOD; White MG, 1999, CELL TRANSPLANT, V8, P59, DOI 10.1177/096368979900800115; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	51	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10337	10.1371/journal.pone.0010337	http://dx.doi.org/10.1371/journal.pone.0010337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436668	Green Submitted, Green Published, gold			2022-12-27	WOS:000277079500013
J	Wong, KKL				Wong, Kelvin Kian Loong			A Geometrical Perspective for the Bargaining Problem	PLOS ONE			English	Article								A new treatment to determine the Pareto-optimal outcome for a non-zero-sum game is presented. An equilibrium point for any game is defined here as a set of strategy choices for the players, such that no change in the choice of any single player will increase the overall payoff of all the players. Determining equilibrium for multi-player games is a complex problem. An intuitive conceptual tool for reducing the complexity, via the idea of spatially representing strategy options in the bargaining problem is proposed. Based on this geometry, an equilibrium condition is established such that the product of their gains over what each receives is maximal. The geometrical analysis of a cooperative bargaining game provides an example for solving multi-player and non-zero-sum games efficiently.	RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Wong, KKL (corresponding author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia.	k.wong@rmit.edu.au	Wong, Kelvin Kian Loong/ABA-3915-2021; Wong, Kelvin/AAL-8636-2021	Wong, Kelvin Kian Loong/0000-0002-8600-1105; 				BARON R, 2002, 0219 U COP; Broom M, 1997, B MATH BIOL, V59, P931; Broom M., 2003, Comments on Theoretical Biology, V8, P103, DOI 10.1080/08948550302450; DASKALAKIS C, 2005, EL C COMP COMPL; Davis M., 1973, GAME THEORY NONTECHN; Hart S, 2002, HDB GAME THEORY; Hofbauer J., 1988, EVOLUTIONARY GAMES P; Iqbal A, 2008, PHYS LETT A, V372, P6564, DOI 10.1016/j.physleta.2008.09.026; Khan M., 2002, HDB GAME THEORY, V3; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1997, ESSAYS GAME THEORY; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Owen G, 1995, GAME THEORY; RAPOPORT A, 1962, BEHAV SCI, V7, P38; Rasmusen E., 2001, GAMES INFORM INTRO G; VIOSSAT Y, 2006, PAPER SERIES EC FINA, V641; Von Neumann J, 1980, THEORY GAMES EC BEHA	17	27	29	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10331	10.1371/journal.pone.0010331	http://dx.doi.org/10.1371/journal.pone.0010331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436675	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079500011
J	Thompson, CL; Hofer, MJ; Campbell, IL; Holmes, AJ				Thompson, Claire L.; Hofer, Markus J.; Campbell, Iain L.; Holmes, Andrew J.			Community Dynamics in the Mouse Gut Microbiota: A Possible Role for IRF9-Regulated Genes in Community Homeostasis	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; INFLAMMATORY-BOWEL-DISEASE; INBRED MICE; TARGETED DISRUPTION; IMMUNE-RESPONSES; INNATE IMMUNITY; REVEALS; CELLS; SUSCEPTIBILITY; ACTIVATION	Background: Gut microbial communities of mammals are thought to show stable differences between individuals. This means that the properties imparted by the gut microbiota become a unique and constant characteristic of the host. Manipulation of the microbiota has been proposed as a useful tool in health care, but a greater understanding of mechanisms which lead to community stability is required. Here we have examined the impact of host immunoregulatory phenotype on community dynamics. Methods and Findings: Denaturing gradient gel electrophoresis was used to analyse the faecal bacterial community of BALB/c and C57BL/6 mice and C57BL/6 mice deficient for either type I interferon (IFN) signalling (IRF9 KO mice) or type I and type II IFN signalling (STAT1 KO mice). Temporal variation was found in all mouse strains. A measure of the ability for a community structure characteristic of the host to be maintained over time, the individuality index, varied between mouse strains and available data from pigs and human models. IRF9 KO mice had significantly higher temporal variation, and lower individuality, than other mouse strains. Examination of the intestinal mucosa of the IRF9 KO mice revealed an increased presence of T-cells and neutrophils in the absence of inflammation. Significance: The high temporal variation observed in the gut microbiota of inbred laboratory mice has implications for their use as experimental models for the human gut microbiota. The distinct IRF9 and STAT1 phenotypes suggest a role for IRF9 in immune regulation within the gut mucosa and that further study of interferon responsive genes is necessary to understand host-gut microbe relationships.	[Thompson, Claire L.; Hofer, Markus J.; Campbell, Iain L.; Holmes, Andrew J.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Hofer, Markus J.] Univ Marburg, Dept Neuropathol, Marburg, Germany	University of Sydney; Philipps University Marburg	Thompson, CL (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	claire.thompson@mpi-marburg.mpg.de	Hofer, Markus J/C-3688-2013; Holmes, Andrew/AAI-2845-2020	Hofer, Markus J/0000-0001-5111-3978; 	National Health and Medical Research Council (NHMRC) [512407]; Selby Research Trust; Australian Postgraduate Award (APA); Deutsche Forschungsgemeinschaft (DFG) [HO3298/1-1]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Selby Research Trust; Australian Postgraduate Award (APA)(Australian Government); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the National Health and Medical Research Council (NHMRC) (512407) and the Selby Research Trust. CT was the recipient of an Australian Postgraduate Award (APA). MJH was a postdoctoral fellow from the Deutsche Forschungsgemeinschaft (DFG HO3298/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; ALPERS JH, 1972, CLIN EXP IMMUNOL, V12, P121; AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590, DOI 10.1128/IAI.62.6.2590-2599.1994; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; BRALEY HC, 1971, CELL IMMUNOL, V2, P73, DOI 10.1016/0008-8749(71)90026-8; Calleri DV, 2006, P ROY SOC B-BIOL SCI, V273, P2633, DOI 10.1098/rspb.2006.3622; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DELPRETE GF, 1993, EUR J IMMUNOL, V23, P1445, DOI 10.1002/eji.1830230707; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EBINO KY, 1988, LAB ANIM, V22, P1, DOI 10.1258/002367788780746548; Ferrari VC, 1999, HYDROBIOLOGIA, V401, P55, DOI 10.1023/A:1003773907789; Fushuku S, 2008, EXP ANIM TOKYO, V57, P95, DOI 10.1538/expanim.57.95; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; KETT K, 1995, GASTROENTEROLOGY, V109, P819, DOI 10.1016/0016-5085(95)90389-5; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li HK, 2007, J PROTEOME RES, V6, P1364, DOI 10.1021/pr060513q; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Moeseneder MM, 1999, APPL ENVIRON MICROB, V65, P3518; Munder A, 2005, MICROBES INFECT, V7, P600, DOI 10.1016/j.micinf.2004.12.021; Neaville WA, 2003, J ALLERGY CLIN IMMUN, V112, P740, DOI 10.1016/S0091-6749(03)01868-2; NIESSNER M, 1995, CLIN EXP IMMUNOL, V101, P428; Nubel U, 1996, J BACTERIOL, V178, P5636; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977; Sambrook J., 2001, MOL CLONING LAB MANU; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Schindler C, 1999, CELL MOL LIFE SCI, V55, P1509, DOI 10.1007/s000180050391; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Simpson JM, 2000, APPL ENVIRON MICROB, V66, P4705, DOI 10.1128/AEM.66.11.4705-4714.2000; Simpson JM, 1999, J MICROBIOL METH, V36, P167, DOI 10.1016/S0167-7012(99)00029-9; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun B, 1997, J IMMUNOL, V159, P1004; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; WEAVER GA, 1989, GUT, V30, P19, DOI 10.1136/gut.30.1.19; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yeates C, 1998, Biol Proced Online, V1, P40, DOI 10.1251/bpo6; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	60	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10335	10.1371/journal.pone.0010335	http://dx.doi.org/10.1371/journal.pone.0010335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428250	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300019
J	Kolwijck, E; Wevers, RA; Engelke, UF; Woudenberg, J; Bulten, J; Blom, HJ; Massuger, LFAG				Kolwijck, Eva; Wevers, Ron A.; Engelke, Udo F.; Woudenberg, Jannes; Bulten, Johan; Blom, Henk J.; Massuger, Leon F. A. G.			Ovarian Cyst Fluid of Serous Ovarian Tumors Contains Large Quantities of the Brain Amino Acid N-acetylaspartate	PLOS ONE			English	Article							MAST-CELLS; NERVOUS-SYSTEM; BLOOD	Background: In humans, N-acetyl L-aspartate (NAA) has not been detected in other tissues than the brain. The physiological function of NAA is yet undefined. Recently, it has been suggested that NAA may function as a molecular water pump, responsible for the removal of large amounts of water from the human brain. Ovarian tumors typically present as large cystic masses with considerable fluid accumulation. Methodology and Principal Findings: Using Gas Chromatography-Mass Spectrometry, we demonstrated that NAA was present in a high micromolar concentration in oCF of epithelial ovarian tumors (EOTs) of serous histology, sometimes in the same range as found in the extracellular space of the human brain. In contrast, oCF of EOTs with a mucinous, endometrioid and clear cell histological subtype contained a low micromolar concentration of NAA. Serous EOTs have a cellular differentiation pattern which resembles the lining of the fallopian tube and differs from the other histological subtypes. The NAA concentration in two samples of fluid accumulation in the fallopian tube (hydrosalpinx) was in the same ranges as NAA found in oCF of serous EOTs. The NAA concentration in oCF of patients with serous EOTs was mostly 10 to 50 fold higher than their normal serum NAA concentration, whereas in patients with other EOT subtypes, serum and cyst fluid NAA concentration was comparable. Conclusions and Significance: The high concentration of NAA in cyst fluid of serous EOTs and low serum concentrations of NAA in these patients, suggest a local production of NAA in serous EOTs. Our findings provide the first identification of NAA concentrations high enough to suggest local production outside the human brain. Our findings contribute to the ongoing research understanding the physiological function of NAA in the human body.	[Kolwijck, Eva; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands; [Wevers, Ron A.; Engelke, Udo F.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, NL-6525 ED Nijmegen, Netherlands; [Woudenberg, Jannes] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands; [Bulten, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Blom, Henk J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Kolwijck, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands.	r.wevers@labgk.umcn.nl	Engelke, U.F.H./L-4293-2015; Kolwijck, E./L-4444-2015; Wevers, Ron A./H-8116-2014; Bulten, J./L-4237-2015; Massuger, Leon F.A.G./H-8072-2014	Wevers, Ron A./0000-0003-2278-9746; Bulten, J./0000-0002-8168-6045; Blom, Henk/0000-0001-5202-9241				Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Baslow MH, 1999, NEUROCHEM INT, V34, P77, DOI 10.1016/S0197-0186(98)00073-4; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Baslow MH, 1997, EXP EYE RES, V64, P283, DOI 10.1006/exer.1996.0205; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Boss EA, 2000, NMR BIOMED, V13, P297, DOI 10.1002/1099-1492(200008)13:5<297::AID-NBM648>3.0.CO;2-I; Burlina AP, 2006, ADV EXP MED BIOL, V576, P283; Burlina AP, 1997, J NEUROCHEM, V69, P1314; Chan JK, 2005, GYNECOL ONCOL, V99, P20, DOI 10.1016/j.ygyno.2005.05.042; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Galinsky DST, 2008, CRIT REV ONCOL HEMAT, V68, P115, DOI 10.1016/j.critrevonc.2008.06.001; George RL, 2004, BBA-MOL BASIS DIS, V1690, P63, DOI 10.1016/j.bbadis.2004.05.009; JAKOBS C, 1991, J INHERIT METAB DIS, V14, P653, DOI 10.1007/BF01799929; KOLWIJCK E, 2009, NMR BIOMED, V10; KURMAN RJ, 2002, BLAUSTEINS PATHOLOGY, P3; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Naora Honami, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000324; Pecorelli S, 1999, INT J GYNECOL OBSTET, V65, P243, DOI 10.1016/S0020-7292(99)00070-3; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; SCHRAGER J, 1970, GUT, V11, P450, DOI 10.1136/gut.11.5.450; SERVOV SF, 1973, INT HISTOLOGIC CLASS, V9; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; VALENT P, 1989, BLOOD, V73, P1778	23	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10293	10.1371/journal.pone.0010293	http://dx.doi.org/10.1371/journal.pone.0010293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421982	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600011
J	Ge, BS; Yang, F; Yu, DY; Liu, S; Xu, H				Ge, Baosheng; Yang, Feng; Yu, Daoyong; Liu, Shuang; Xu, Hai			Designer Amphiphilic Short Peptides Enhance Thermal Stability of Isolated Photosystem-I	PLOS ONE			English	Article							CYANOBACTERIUM SPIRULINA-PLATENSIS; PROTEIN-COUPLED RECEPTOR; CIRCULAR-DICHROISM; HIGHER-PLANTS; MEMBRANE; COMPLEX; PURIFICATION; ANGSTROM; FORMS	Stability of membrane protein is crucial during protein purification and crystallization as well as in the fabrication of protein-based devices. Several recent studies have examined how various surfactants can stabilize membrane proteins out of their native membrane environment. However, there is still no single surfactant that can be universally employed for all membrane proteins. Because of the lack of knowledge on the interaction between surfactants and membrane proteins, the choice of a surfactant for a specific membrane protein remains purely empirical. Here we report that a group of short amphiphilic peptides improve the thermal stability of the multi-domain protein complex photosystem-I (PS-I) in aqueous solution and that the peptide surfactants have obvious advantages over other commonly used alkyl chain based surfactants. Of all the short peptides studied, Ac-I(5)K(2)-CONH(2) (I(5)K(2)) showed the best stabilizing effect by enhancing the melting temperature of PS-I from 48.0 degrees C to 53.0 degrees C at concentration of 0.65 mM and extending the half life of isolated PS-I significantly. AFM experiments showed that PS-I/I(5)K(2)/Triton X-100 formed large and stable vesicles and thus provide interfacial environment mimicking that of native membranes, which may partly explain why I(5)K(2) enhanced the thermal stability of PS-I. Hydrophobic and hydrophilic group length of I(x)K(y) had an important influence on the stabilization of PS-I. Our results showed that longer hydrophobic group was more effective in stabilizing PS-I. These simple short peptides therefore exhibit significant potential for applications in membrane protein studies.	[Ge, Baosheng; Yang, Feng; Yu, Daoyong; Liu, Shuang; Xu, Hai] China Univ Petr, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China	China University of Petroleum	Ge, BS (corresponding author), China Univ Petr, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China.	daoyong@upc.edu.cn; xuh@upc.edu.cn	Yu, Daoyong/E-5269-2013; Ge, Baosheng/AAT-4788-2020	Yu, Daoyong/0000-0002-3380-1897; Ge, Baosheng/0000-0001-9906-2081	Jiangsu Key Laboratory of Marine Biotechnology; Huaihai Institute of Technology [2007HS008]; Fundamental Research Funds for the Central Universitiesty [09CX05005A]; National Natural Science Foundation of China [20773164]	Jiangsu Key Laboratory of Marine Biotechnology; Huaihai Institute of Technology; Fundamental Research Funds for the Central Universitiesty; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the Open-End Funds of Jiangsu Key Laboratory of Marine Biotechnology, Huaihai Institute of Technology (2007HS008), the Fundamental Research Funds for the Central Universitiesty (09CX05005A), and the National Natural Science Foundation of China (20773164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Baumann MK, 2008, LANGMUIR, V24, P7645, DOI 10.1021/la801605b; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bieri C, 1999, NAT BIOTECHNOL, V17, P1105, DOI 10.1038/15090; Brettel K, 1998, BBA-BIOENERGETICS, V1363, P175, DOI 10.1016/S0005-2728(98)00010-3; BRUCE BD, 1988, J BIOL CHEM, V263, P7302; Cometta A, 2000, BIOPHYS J, V79, P3235, DOI 10.1016/S0006-3495(00)76556-8; Dahlin C, 2003, PHOTOSYNTHETICA, V41, P635, DOI 10.1023/B:PHOT.0000027532.55335.a7; Das R, 2004, NANO LETT, V4, P1079, DOI 10.1021/nl049579f; Engelmann E, 2001, FEBS LETT, V499, P112, DOI 10.1016/S0014-5793(01)02533-9; Fang Ye, 2004, Methods Mol Biol, V264, P233; Fersht A, 1999, STRUCTURE MECH PROTE, P510; HOFFMAN A, 1997, PLAYBACK        1201, P1; Hong Q, 2001, BIOCHEM SOC T, V29, P578, DOI 10.1042/BST0290578; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230; KOMIYAMA T, 1984, J BIOCHEM-TOKYO, V95, P1569, DOI 10.1093/oxfordjournals.jbchem.a134769; Li DH, 2004, ACTA BOT SIN, V46, P423; Matsumoto K, 2009, J PHYS CHEM B, V113, P75, DOI 10.1021/jp8021425; NAO T, 2008, THIN SOLID FILMS, V516, P2553; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; SCHAFMEISTER CE, 1993, SCIENCE, V262, P734, DOI 10.1126/science.8235592; Sener MK, 2005, BIOPHYS J, V89, P1630, DOI 10.1529/biophysj.105.066464; SHUBIN VV, 1993, FEBS LETT, V334, P79, DOI 10.1016/0014-5793(93)81685-S; Sun HX, 2008, J SEP SCI, V31, P1201, DOI 10.1002/jssc.200700508; YANG F, 2009, SEPARATION CHARACTER, P22; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Zhao BB, 2008, PLANT SCI, V175, P556, DOI 10.1016/j.plantsci.2008.06.003; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103; Zhao XJ, 2009, CURR OPIN COLLOID IN, V14, P340, DOI 10.1016/j.cocis.2009.07.002	30	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10233	10.1371/journal.pone.0010233	http://dx.doi.org/10.1371/journal.pone.0010233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422003	gold, Green Published, Green Submitted			2022-12-27	WOS:000276952500010
J	Kim, S; Rusmevichientong, A; Dong, BH; Remenyi, R; Silverman, RH; Chow, SA				Kim, Sanggu; Rusmevichientong, Alice; Dong, Beihua; Remenyi, Roland; Silverman, Robert H.; Chow, Samson A.			Fidelity of Target Site Duplication and Sequence Preference during Integration of Xenotropic Murine Leukemia Virus-Related Virus	PLOS ONE			English	Article							RETROVIRAL DNA INTEGRATION; GENOME-WIDE ANALYSIS; PROSTATE-CANCER; CONCERTED INTEGRATION; INFECTIOUS RETROVIRUS; HIV-1 INTEGRATION; CORE DOMAIN; RNASE-L; TYPE-1; SPECIFICITY	Xenotropic murine leukemia virus (MLV)-related virus (XMRV) is a new human retrovirus associated with prostate cancer and chronic fatigue syndrome. The causal relationship of XMRV infection to human disease and the mechanism of pathogenicity have not been established. During retrovirus replication, integration of the cDNA copy of the viral RNA genome into the host cell chromosome is an essential step and involves coordinated joining of the two ends of the linear viral DNA into staggered sites on target DNA. Correct integration produces proviruses that are flanked by a short direct repeat, which varies from 4 to 6 bp among the retroviruses but is invariant for each particular retrovirus. Uncoordinated joining of the two viral DNA ends into target DNA can cause insertions, deletions, or other genomic alterations at the integration site. To determine the fidelity of XMRV integration, cells infected with XMRV were clonally expanded and DNA sequences at the viral-host DNA junctions were determined and analyzed. We found that a majority of the provirus ends were correctly processed and flanked by a 4-bp direct repeat of host DNA. A weak consensus sequence was also detected at the XMRV integration sites. We conclude that integration of XMRV DNA involves a coordinated joining of two viral DNA ends that are spaced 4 bp apart on the target DNA and proceeds with high fidelity.	[Kim, Sanggu; Chow, Samson A.] Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90024 USA; [Rusmevichientong, Alice; Remenyi, Roland; Chow, Samson A.] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Rusmevichientong, Alice; Remenyi, Roland; Chow, Samson A.] Univ Calif Los Angeles, Sch Med, AIDS Inst, Los Angeles, CA 90024 USA; [Dong, Beihua; Silverman, Robert H.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation	Kim, S (corresponding author), Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90024 USA.	schow@mednet.ucla.edu	/D-4928-2018	/0000-0003-1644-6464	National Institutes of Health (NIH) [CA68859]; The Margaret E. Early Medical Research Trust; U.S. Department of Defense Prostate Cancer Research Program [W81XWH-07-1-338]; NIH [CA103943]; Charlotte Geyer Foundation; Mal and Lea Bank Chair; UCLA Graduate Division; NATIONAL CANCER INSTITUTE [R01CA068859, R01CA103943] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Margaret E. Early Medical Research Trust; U.S. Department of Defense Prostate Cancer Research Program(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Geyer Foundation; Mal and Lea Bank Chair; UCLA Graduate Division; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health (NIH) Grant CA68859 and The Margaret E. Early Medical Research Trust Grant to S. A. C., and by grant number W81XWH-07-1-338 from the U.S. Department of Defense Prostate Cancer Research Program, NIH Grant CA103943, the Charlotte Geyer Foundation, and the Mal and Lea Bank Chair to R. H. S. S. K. is partly supported by a Dissertation Year Fellowship Award from the UCLA Graduate Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1996, J VIROL, V70, P3571, DOI 10.1128/JVI.70.6.3571-3580.1996; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; BOR YC, 1995, P NATL ACAD SCI USA, V92, P10334, DOI 10.1073/pnas.92.22.10334; Brown P. O., 1997, P161; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; CRAIGIE R, 1992, TRENDS GENET, V8, P187, DOI 10.1016/0168-9525(92)90223-Q; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Goodarzi G, 1999, J VIROL, V73, P8104, DOI 10.1128/JVI.73.10.8104-8111.1999; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hacker CV, 2006, MOL THER, V14, P536, DOI 10.1016/j.ymthe.2006.06.006; Hindmarsh P, 1999, J VIROL, V73, P2994, DOI 10.1128/JVI.73.4.2994-3003.1999; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Holmes-Son M L, 2001, Adv Genet, V43, P33, DOI 10.1016/S0065-2660(01)43003-3; HOROWITZ JM, 1987, J VIROL, V61, P701, DOI 10.1128/JVI.61.3.701-707.1987; Kang YB, 2006, J VIROL, V80, P8820, DOI 10.1128/JVI.00719-06; KATZMAN M, 1995, J VIROL, V69, P5687, DOI 10.1128/JVI.69.9.5687-5696.1995; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Kim S, 2006, J VIROL, V80, P11313, DOI 10.1128/JVI.01737-06; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Moalic Y, 2006, J VIROL, V80, P10980, DOI 10.1128/JVI.00904-06; Moreau K, 2004, VIROLOGY, V318, P566, DOI 10.1016/j.virol.2003.09.037; Moreau K, 2000, VIROLOGY, V278, P133, DOI 10.1006/viro.2000.0641; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; MURPHY JE, 1992, J VIROL, V66, P5092, DOI 10.1128/JVI.66.8.5092-5095.1992; Nowrouzi A, 2006, J GEN VIROL, V87, P1339, DOI 10.1099/vir.0.81554-0; Oh J, 2006, J VIROL, V80, P451, DOI 10.1128/JVI.80.1.451-459.2006; Oh J, 2006, J VIROL, V80, P10281, DOI 10.1128/JVI.00361-06; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Rosenberg N., 1997, P475; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shibagaki Y, 1997, J BIOL CHEM, V272, P8361, DOI 10.1074/jbc.272.13.8361; SHIMOTOHNO K, 1980, P NATL ACAD SCI-BIOL, V77, P7357, DOI 10.1073/pnas.77.12.7357; SHIMOTOHNO K, 1980, NATURE, V285, P550, DOI 10.1038/285550a0; SHOEMAKER C, 1981, J VIROL, V40, P164, DOI 10.1128/JVI.40.1.164-172.1981; SHOEMAKER C, 1980, P NATL ACAD SCI-BIOL, V77, P3932, DOI 10.1073/pnas.77.7.3932; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Sinha S, 2002, J VIROL, V76, P3105, DOI 10.1128/JVI.76.7.3105-3113.2002; Taganov K, 2001, J VIROL, V75, P9549, DOI 10.1128/JVI.75.19.9549-9552.2001; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Vatakis DN, 2009, J VIROL, V83, P6222, DOI 10.1128/JVI.00356-09; VINCENT KA, 1990, NUCLEIC ACIDS RES, V18, P6045, DOI 10.1093/nar/18.20.6045; VINK C, 1990, J VIROL, V64, P5626, DOI 10.1128/JVI.64.11.5626-5627.1990; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; WITHERSWARD ES, 1994, GENE DEV, V8, P1473, DOI 10.1101/gad.8.12.1473; Xiang Y, 2003, CANCER RES, V63, P6795; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000	61	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10255	10.1371/journal.pone.0010255	http://dx.doi.org/10.1371/journal.pone.0010255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421928	Green Published, Green Submitted, gold			2022-12-27	WOS:000276854300014
J	Hu, JW; Ljubimova, JY; Inoue, S; Konda, B; Patil, R; Ding, H; Espinoza, A; Wawrowsky, KA; Patil, C; Ljubimov, AV; Black, KL				Hu, Jinwei; Ljubimova, Julia Y.; Inoue, Satoshi; Konda, Bindu; Patil, Rameshwar; Ding, Hui; Espinoza, Andres; Wawrowsky, Kolja A.; Patil, Chirag; Ljubimov, Alexander V.; Black, Keith L.			Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; BREAST-CANCER; BLOOD-BRAIN; BARRIER PERMEABILITY; INTRACAROTID INFUSION; BRADYKININ ANALOG; NITRIC-OXIDE; LUNG-CANCER; IN-VIVO; CHEMOTHERAPY	Background: Chemotherapeutic drugs and newly developed therapeutic monoclonal antibodies are adequately delivered to most solid and systemic tumors. However, drug delivery into primary brain tumors and metastases is impeded by the blood-brain tumor barrier (BTB), significantly limiting drug use in brain cancer treatment. Methodology/Principal Findings: We examined the effect of phosphodiesterase 5 (PDE5) inhibitors in nude mice on drug delivery to intracranially implanted human lung and breast tumors as the most common primary tumors forming brain metastases, and studied underlying mechanisms of drug transport. In vitro assays demonstrated that PDE5 inhibitors enhanced the uptake of [C-14] dextran and trastuzumab (Herceptin (R), a humanized monoclonal antibody against HER2/neu) by cultured mouse brain endothelial cells (MBEC). The mechanism of drug delivery was examined using inhibitors for caveolae-mediated endocytosis, macropinocytosis and coated pit/clathrin endocytosis. Inhibitor analysis strongly implicated caveolae and macropinocytosis endocytic pathways involvement in the PDE5 inhibitor-enhanced Herceptin uptake by MBEC. Oral administration of PDE5 inhibitor, vardenafil, to mice with HER2-positive intracranial lung tumors led to an increased tumor permeability to high molecular weight [C-14] dextran (2.6-fold increase) and to Herceptin (2-fold increase). Survival time of intracranial lung cancer-bearing mice treated with Herceptin in combination with vardenafil was significantly increased as compared to the untreated, vardenafil- or Herceptin-treated mice (p<0.01). Log-rank survival analysis of mice bearing HER2-positive intracranial breast tumor also showed a significant survival increase (p<0.02) in the group treated with Herceptin plus vardenafil as compared to other groups. However, vardenafil did not exert any beneficial effect on survival of mice bearing intracranial breast tumor with low HER2 expression and co-treated with Herceptin (p>0.05). Conclusions/Significance: These findings suggest that PDE5 inhibitors may effectively modulate BTB permeability, and enhance delivery and therapeutic efficacy of monoclonal antibodies in hard-to-treat brain metastases from different primary tumors that had metastasized to the brain.	[Hu, Jinwei; Ljubimova, Julia Y.; Inoue, Satoshi; Konda, Bindu; Patil, Rameshwar; Ding, Hui; Espinoza, Andres; Patil, Chirag; Black, Keith L.] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; [Wawrowsky, Kolja A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Ljubimov, Alexander V.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hu, JW (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA.	ljubimovaj@cshs.org	Ljubimov, Alexander/CAE-9130-2022; Ljubimov, Alexander V/E-5883-2013	Patil, Chirag/0000-0001-9068-1898; Ljubimov, Alexander/0000-0003-2398-5319; Black, Keith/0000-0002-0546-4934	NATIONAL CANCER INSTITUTE [R01CA123495] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013431] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA123495] Funding Source: Medline; NCRR NIH HHS [M01 RR000425, M01 RR00425] Funding Source: Medline; NEI NIH HHS [R01 EY13431, R01 EY013431] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; Asotra Kamlesh, 2003, Methods Mol Med, V89, P177; Black KL, 2008, BRAIN RES, V1230, P290, DOI 10.1016/j.brainres.2008.06.122; Black KL, 1997, J NEUROSURG, V86, P603, DOI 10.3171/jns.1997.86.4.0603; Boolell M, 1996, Int J Impot Res, V8, P47; Contessa JN, 2008, MOL PHARMACOL, V73, P271, DOI 10.1124/mol.107.042986; Cornford Eain M, 2005, NeuroRx, V2, P27, DOI 10.1007/BF03206640; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Doolittle ND, 2007, J NEURO-ONCOL, V81, P81, DOI 10.1007/s11060-006-9209-y; Fine RL, 2006, CLIN CANCER RES, V12, P5770, DOI 10.1158/1078-0432.CCR-05-2356; Fujita Manabu, 2006, Angiogenesis, V9, P183, DOI 10.1007/s10456-006-9046-9; Hashizume K, 2002, J NEUROPATH EXP NEUR, V61, P725, DOI 10.1093/jnen/61.8.725; Hau P, 2004, CANCER, V100, P1199, DOI 10.1002/cncr.20073; Hu JW, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-22; INAMURA T, 1994, J CEREBR BLOOD F MET, V14, P862, DOI 10.1038/jcbfm.1994.108; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Linder AE, 2005, J PHARMACOL EXP THER, V314, P9, DOI 10.1124/jpet.105.083634; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Matsukado K, 1996, NEUROSURGERY, V39, P125, DOI 10.1097/00006123-199607000-00025; Meijering BDM, 2009, CIRC RES, V104, P679, DOI 10.1161/CIRCRESAHA.108.183806; Menendez JA, 2005, ANN ONCOL, V16, P359, DOI 10.1093/annonc/mdi090; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Michel CC, 1998, J MOL CELL CARDIOL, V30, P2541, DOI 10.1006/jmcc.1998.0825; Nakano S, 1996, CANCER RES, V56, P4027; Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018; Ningaraj NS, 2009, EUR J PHARMACOL, V602, P188, DOI 10.1016/j.ejphar.2008.10.056; Ningaraj NS, 2003, CANCER RES, V63, P8899; Ningaraj NS, 2003, DRUG NEWS PERSPECT, V16, P291, DOI 10.1358/dnp.2003.16.5.878815; Ningaraj NS, 2002, J PHARMACOL EXP THER, V301, P838, DOI 10.1124/jpet.301.3.838; Ono M, 2009, INT J CLIN ONCOL, V14, P48, DOI 10.1007/s10147-008-0797-8; Pestalozzi BC, 2000, J CLIN ONCOL, V18, P2350, DOI 10.1200/JCO.2000.18.11.2349; RIZZI A, 1990, TUMORI, V76, P579, DOI 10.1177/030089169007600614; Sagita M, 1998, CANCER RES, V58, P914; SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stark S, 2001, EUR UROL, V40, P181, DOI 10.1159/000049770; STEWART PA, 1994, MICROSC RES TECHNIQ, V27, P516, DOI 10.1002/jemt.1070270606; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Yau T, 2006, ACTA ONCOL, V45, P196, DOI 10.1080/02841860500486630; Yumoto R, 2006, AM J PHYSIOL-LUNG C, V290, pL946, DOI 10.1152/ajplung.00173.2005	43	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10108	10.1371/journal.pone.0010108	http://dx.doi.org/10.1371/journal.pone.0010108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419092	gold, Green Submitted, Green Published			2022-12-27	WOS:000276853800005
J	Nergiz-Unal, R; Cosemans, JMEM; Feijge, MAH; van der Meijden, PEJ; Storey, RF; van Giezen, JJJ; Egbrink, MGAO; Heemskerk, JWM; Kuijpers, MJE				Nergiz-Unal, Reyhan; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; van der Meijden, Paola E. J.; Storey, Robert F.; van Giezen, J. J. J.; Egbrink, Mirjam G. A. Oude; Heemskerk, Johan W. M.; Kuijpers, Marijke J. E.			Stabilizing Role of Platelet P2Y(12) Receptors in Shear-Dependent Thrombus Formation on Ruptured Plaques	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; GLYCOPROTEIN-VI; PROCOAGULANT ACTIVITY; WHOLE-BLOOD; ATHEROSCLEROTIC PLAQUES; COMPLEMENTARY ROLES; FLOWING BLOOD; ACTIVATION; COLLAGEN; ADHESION	Background: In most models of experimental thrombosis, healthy blood vessels are damaged. This results in the formation of a platelet thrombus that is stabilized by ADP signaling via P2Y(12) receptors. However, such models do not predict involvement of P2Y(12) in the clinically relevant situation of thrombosis upon rupture of atherosclerotic plaques. We investigated the role of P2Y(12) in thrombus formation on (collagen-containing) atherosclerotic plaques in vitro and in vivo, by using a novel mouse model of atherothrombosis. Methodology: Plaques in the carotid arteries from Apoe(-/-) mice were acutely ruptured by ultrasound treatment, and the thrombotic process was monitored via intravital fluorescence microscopy. Thrombus formation in vitro was assessed in mouse and human blood perfused over collagen or plaque material under variable conditions of shear rate and coagulation. Effects of two reversible P2Y(12) blockers, ticagrelor (AZD6140) and cangrelor (AR-C69931MX), were investigated. Principal Findings: Acute plaque rupture by ultrasound treatment provoked rapid formation of non-occlusive thrombi, which were smaller in size and unstable in the presence of P2Y(12) blockers. In vitro, when mouse or human blood was perfused over collagen or atherosclerotic plaque material, blockage or deficiency of P2Y(12) reduced the thrombi and increased embolization events. These P2Y(12) effects were present at shear rates >500 s(-1), and they persisted in the presence of coagulation. P2Y(12)-dependent thrombus stabilization was accompanied by increased fibrin(ogen) binding. Conclusions/Significance: Platelet P2Y(12) receptors play a crucial role in the stabilization of thrombi formed on atherosclerotic plaques. This P2Y(12) function is restricted to high shear flow conditions, and is preserved in the presence of coagulation.	[Nergiz-Unal, Reyhan; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; van der Meijden, Paola E. J.; Heemskerk, Johan W. M.; Kuijpers, Marijke J. E.] Maastricht Univ, Dept Biochem, CARIM, Maastricht, Netherlands; [Storey, Robert F.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [van Giezen, J. J. J.] AstraZeneca R&D, Molndal, Sweden; [Egbrink, Mirjam G. A. Oude] Maastricht Univ, Dept Physiol, CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); University of Sheffield; AstraZeneca; Maastricht University; Maastricht University Medical Centre (MUMC)	Nergiz-Unal, R (corresponding author), Maastricht Univ, Dept Biochem, CARIM, Maastricht, Netherlands.	Marijke.Kuijpers@bioch.unimaas.nl	Heemskerk, Johan/AAM-8323-2021; Egbrink, Mirjam oude/AAZ-7305-2020; Cosemans, Judith MEM/C-8161-2016; Storey, Robert/AAA-6853-2019; Kuijpers, Marijke/AAN-9876-2021; Nergiz Unal, Reyhan/I-9967-2013	Heemskerk, Johan/0000-0002-2848-5121; Cosemans, Judith MEM/0000-0001-7429-0109; Storey, Robert/0000-0002-6677-6229; Nergiz Unal, Reyhan/0000-0002-3143-7710; van der Meijden, Paola/0000-0002-6532-2583	AstraZeneca; Hacettepe University (Ankara, Turkey); Netherlands Organization for Scientific Research [11.400.0076]; Netherlands Heart Foundation [2005B079]	AstraZeneca(AstraZeneca); Hacettepe University (Ankara, Turkey)(Hacettepe University); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation)	Partial financial support for the conductance of this study was provided by AstraZeneca. Support is acknowledged from the Hacettepe University (Ankara, Turkey), the Netherlands Organization for Scientific Research (11.400.0076) and the Netherlands Heart Foundation (2005B079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; Cosemans JMEM, 2005, ATHEROSCLEROSIS, V181, P19, DOI 10.1016/j.atherosclerosis.2004.12.037; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; De Meyer GRY, 1999, ARTERIOSCL THROM VAS, V19, P2524, DOI 10.1161/01.ATV.19.10.2524; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Evans DJW, 2009, CIRCULATION, V119, P116, DOI 10.1161/CIRCULATIONAHA.107.762690; Fintel DJ, 2007, CLIN CARDIOL, V30, P604, DOI 10.1002/clc.20154; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Goto S, 2006, J AM COLL CARDIOL, V47, P155, DOI 10.1016/j.jacc.2005.08.055; Griend JPV, 2008, PHARMACOTHERAPY, V28, P1233, DOI 10.1592/phco.28.10.1233; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Haseruck N, 2004, BLOOD, V103, P2585, DOI 10.1182/blood-2003-04-1127; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jakubowski JA, 2007, CARDIOVASC DRUG REV, V25, P357, DOI 10.1111/j.1527-3466.2007.00027.x; Katsuda Shogo, 2003, J Atheroscler Thromb, V10, P267; Kuijpers MJE, 2009, J THROMB HAEMOST, V7, P152, DOI 10.1111/j.1538-7836.2008.03186.x; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Leon C, 2003, ARTERIOSCL THROM VAS, V23, P1941, DOI 10.1161/01.ATV.0000092127.16125.E6; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Penz S, 2005, FASEB J, V19, P898, DOI 10.1096/fj.04-2748com; Penz SM, 2007, THROMB HAEMOSTASIS, V97, P435, DOI 10.1160/TH06-07-0415; Remijn JA, 2002, ARTERIOSCL THROM VAS, V22, P686, DOI 10.1161/01.ATV.0000012805.49079.23; Resendiz JC, 2003, MOL PHARMACOL, V63, P639, DOI 10.1124/mol.63.3.639; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Siljander P, 1999, ARTERIOSCL THROM VAS, V19, P3033, DOI 10.1161/01.ATV.19.12.3033; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Strassel C, 2009, J THROMB HAEMOST, V7, P1935, DOI 10.1111/j.1538-7836.2009.03608.x; Turner NA, 2001, BLOOD, V98, P3340, DOI 10.1182/blood.V98.12.3340; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; van der Meijden PEJ, 2005, THROMB HAEMOSTASIS, V93, P1128, DOI 10.1160/TH04-09-0597; VANGIEZEN JJ, 2009, J THROMB HAEMOST; Vanschoonbeek K, 2004, J THROMB HAEMOST, V2, P476, DOI 10.1111/j.1538-7933.2004.00618.x; VARON D, 2002, PLATELETS, P337; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	42	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10130	10.1371/journal.pone.0010130	http://dx.doi.org/10.1371/journal.pone.0010130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405028	gold, Green Published			2022-12-27	WOS:000276705900013
J	Collins, RM; Afzal, M; Ward, DA; Prescott, MC; Sait, SM; Rees, HH; Tomsett, AB				Collins, Richard M.; Afzal, Muhammed; Ward, Deborah A.; Prescott, Mark C.; Sait, Steven M.; Rees, Huw H.; Tomsett, A. Brian			Differential Proteomic Analysis of Arabidopsis thaliana Genotypes Exhibiting Resistance or Susceptibility to the Insect Herbivore, Plutella xylostella	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GERMIN-LIKE PROTEINS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; IN-VIVO; OXALATE OXIDASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; POLYACRYLAMIDE GELS; CARBONIC-ANHYDRASE; DIAMONDBACK MOTH	A proteomic study was conducted to investigate physiological factors affecting feeding behaviour by larvae of the insect, Plutella xylostella, on herbivore-susceptible and herbivore-resistant Arabidopsis thaliana. The leaves of 162 recombinant inbred lines (Rils) were screened to detect genotypes upon which Plutella larvae fed least (P. xylostella-resistant) or most (P. xylostella-susceptible). 2D-PAGE revealed significant differences in the proteomes between the identified resistant and susceptible Rils. The proteomic results, together with detection of increased production of hydrogen peroxide in resistant Rils, suggest a correlation between P. xylostella resistance and the production of increased levels of reactive oxygen species (ROS), in particular H2O2, and that this was expressed prior to herbivory. Many of the proteins that were more abundant in the Plutella-resistant Rils are known in other biological systems to be involved in limiting ROS damage. Such proteins included carbonic anhydrases, malate dehydrogenases, glutathione S-transferases, isocitrate dehydrogenase-like protein (R1), and lipoamide dehydrogenase. In addition, patterns of germin-like protein 3 isoforms could also be indicative of higher levels of reactive oxygen species in the resistant Rils. Consistent with the occurrence of greater oxidative stress in the resistant Rils is the observation of greater abundance in susceptible Rils of polypeptides of the photosynthetic oxygen-evolving complex, which are known to be damaged under oxidative stress. The combined results suggest that enhanced production of ROS may be a major pre-existing mechanism of Plutella resistance in Arabidopsis, but definitive corroboration of this requires much further work.	[Collins, Richard M.; Afzal, Muhammed; Ward, Deborah A.; Prescott, Mark C.; Rees, Huw H.; Tomsett, A. Brian] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Sait, Steven M.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Liverpool; University of Leeds	Collins, RM (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	R.M.Collins@leeds.ac.uk			NERC (Natural Environment Research Council); BBSRC (Biotechnology and Biological Sciences Research Council)	NERC (Natural Environment Research Council)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was enabled by a postgraduate studentship from NERC (Natural Environment Research Council). BBSRC (Biotechnology and Biological Sciences Research Council) provided proteomic facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2005, PLANT PHYSIOL BIOCH, V43, P213, DOI 10.1016/j.plaphy.2005.01.007; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; ANGELINI R, 1990, PLANTA, V182, P89, DOI 10.1007/BF00239989; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; Berna A, 1999, PLANT MOL BIOL, V39, P539, DOI 10.1023/A:1006123432157; BI JL, 1995, J CHEM ECOL, V21, P1511, DOI 10.1007/BF02035149; Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Cesaratto L, 2005, FREE RADICAL RES, V39, P255, DOI 10.1080/10715760400029603; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Chivasa S, 2002, ELECTROPHORESIS, V23, P1754, DOI 10.1002/1522-2683(200206)23:11&lt;1754::AID-ELPS1754&gt;3.0.CO;2-E; Clauss MJ, 2006, J CHEM ECOL, V32, P2351, DOI 10.1007/s10886-006-9150-8; DUMAS B, 1995, PLANT PHYSIOL, V107, P1091, DOI 10.1104/pp.107.4.1091; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; FELTON GW, 1994, J CHEM ECOL, V20, P639, DOI 10.1007/BF02059604; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Giavalisco P, 2003, ELECTROPHORESIS, V24, P207, DOI 10.1002/elps.200390016; Gong HB, 2005, PLANT MOL BIOL, V57, P53, DOI 10.1007/s11103-004-4516-1; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Hoh J, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-14; Huang HS, 1998, INSECT BIOCHEM MOLEC, V28, P651, DOI 10.1016/S0965-1748(98)00049-6; Hurkman WJ, 1996, PLANT PHYSIOL, V111, P735, DOI 10.1104/pp.111.3.735; Ivanov S, 2005, J PLANT PHYSIOL, V162, P275, DOI 10.1016/j.jplph.2004.07.010; Kil IS, 2004, REDOX REP, V9, P271, DOI 10.1179/135100004225006056; Kim JH, 2005, PLANT SCI, V168, P1115, DOI 10.1016/j.plantsci.2004.12.012; Kim JH, 2003, J NEUROCHEM, V85, P1228, DOI 10.1046/j.1471-4159.2003.01755.x; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kliebenstein D, 2002, GENETICS, V161, P325; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Le Deunff E, 2004, PLANT J, V38, P421, DOI 10.1111/j.1365-313X.2004.02056.x; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Liu K, 2004, PHOTOSYNTH RES, V81, P41, DOI 10.1023/B:PRES.0000028340.44043.6c; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Mohan M, 2001, CROP PROT, V20, P311, DOI 10.1016/S0261-2194(00)00157-5; Mooney BP, 2006, PHYSIOL PLANTARUM, V128, P237, DOI 10.1111/j.1399-3054.2006.00746.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Oh TJ, 2002, ENVIRON TOXICOL PHAR, V11, P9, DOI 10.1016/S1382-6689(01)00093-X; OLSON PD, 1993, PLANT J, V4, P887, DOI 10.1046/j.1365-313X.1993.04050887.x; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Pfalz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000578; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Preisser EL, 2007, ACTA OECOL, V31, P210, DOI 10.1016/j.actao.2006.09.004; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Ramputh AI, 2002, PLANT SCI, V162, P431, DOI 10.1016/S0168-9452(01)00584-2; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Rodriguez CE, 2005, CHEM-BIOL INTERACT, V155, P97, DOI 10.1016/j.cbi.2005.05.002; Schlesier B, 2004, PHYTOCHEMISTRY, V65, P1565, DOI 10.1016/j.phytochem.2004.04.027; Singh R, 2005, EXTREMOPHILES, V9, P367, DOI 10.1007/s00792-005-0450-7; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; Subramanian B, 2005, J AGR FOOD CHEM, V53, P313, DOI 10.1021/jf048922z; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Underwood N, 2002, OECOLOGIA, V131, P211, DOI 10.1007/s00442-002-0867-y; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zhang PJ, 2009, ENTOMOL EXP APPL, V131, P58, DOI 10.1111/j.1570-7458.2009.00829.x; ZHANG ZG, 1995, PLANT J, V8, P139, DOI 10.1046/j.1365-313X.1995.08010139.x	72	42	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10103	10.1371/journal.pone.0010103	http://dx.doi.org/10.1371/journal.pone.0010103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386709	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482000022
J	Utani, K; Kohno, Y; Okamoto, A; Shimizu, N				Utani, Koh-ichi; Kohno, Yuka; Okamoto, Atsushi; Shimizu, Noriaki			Emergence of Micronuclei and Their Effects on the Fate of Cells under Replication Stress	PLOS ONE			English	Article							EXTRACHROMOSOMALLY AMPLIFIED DNA; CANCER-CELLS; CHROMOSOME SEGREGATION; SELECTIVE ELIMINATION; DOUBLE MINUTES; S PHASE; INDUCTION; CHROMATIN; ASSAY; MYC	The presence of micronuclei in mammalian cells is related to several mutagenetic stresses. In order to understand how micronuclei emerge, behave in cells, and affect cell fate, we performed extensive time-lapse microscopy of HeLa H2B-GFP cells in the presence of hydroxyurea at low concentration. Micronuclei formed after mitosis from lagging chromatids or chromatin bridges between anaphase chromosomes and were stably maintained in the cells for up to one cell cycle. Nuclear buds also formed from chromatin bridges or during interphase. If the micronuclei-bearing cells entered mitosis, they either produced daughter cells without micronuclei or, more frequently, produced cells with additional micronuclei. Low concentrations of hydroxyurea efficiently induced multipolar mitosis, which generated lagging chromatids or chromatin bridges, and also generated multinuclear cells that were tightly linked to apoptosis. We found that the presence of micronuclei is related to apoptosis but not to multipolar mitosis. Furthermore, the structural heterogeneity among micronuclei, with respect to chromatin condensation or the presence of lamin B, derived from the mechanism of micronuclei formation. Our study reinforces the notion that micronucleation has important implications in the genomic plasticity of tumor cells.	[Utani, Koh-ichi; Kohno, Yuka; Okamoto, Atsushi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Hiroshima University	Utani, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp		Utani, Koichi/0000-0002-8065-3161	Japan Society for the Promotion of Science [17370002]; Ministry of Education, Science, Sports and Culture of Japan [19038016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) [grant number 17370002] from the Japan Society for the Promotion of Science to N.S. and a Grant-in-Aid for Scientific Research on Priority Areas Nuclear Dynamics [grant number 19038016] from the Ministry of Education, Science, Sports and Culture of Japan to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Cimini D, 2002, J CELL SCI, V115, P507; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; El-Zein RA, 2006, CANCER RES, V66, P6449, DOI 10.1158/0008-5472.CAN-06-0326; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2009, MUTAT RES-REV MUTAT, V681, P111, DOI 10.1016/j.mrrev.2008.11.003; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; Mateuca R, 2006, BIOCHIMIE, V88, P1515, DOI 10.1016/j.biochi.2006.07.004; Offer T, 2004, FASEB J, V18, P485, DOI 10.1096/fj.04-2729fje; PaulinLevasseur M, 1996, CHROMOSOMA, V104, P367, DOI 10.1007/s004120050128; Rao XT, 2008, MUTAT RES-FUND MOL M, V646, P41, DOI 10.1016/j.mrfmmm.2008.09.004; RUDDLE FH, 1962, J NATL CANCER I, V28, P1247; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; SCHULTZ N, 1994, MUTAGENESIS, V9, P117, DOI 10.1093/mutage/9.2.117; Serrano-Garcia L, 2001, ENVIRON MOL MUTAGEN, V38, P38, DOI 10.1002/em.1048; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2000, MUTAT RES-FUND MOL M, V448, P81, DOI 10.1016/S0027-5107(00)00003-8; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Tanaka T, 2000, J CELL SCI, V113, P697; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651; Zaharopoulos P, 1998, ACTA CYTOL, V42, P317, DOI 10.1159/000331610	27	104	110	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10089	10.1371/journal.pone.0010089	http://dx.doi.org/10.1371/journal.pone.0010089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386692	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482000017
J	Qin, QY; Liao, GH; Baudry, M; Bi, XN				Qin, Qingyu; Liao, Guanghong; Baudry, Michel; Bi, Xiaoning			Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation	PLOS ONE			English	Article							DISEASE TYPE-C; RHO-KINASE; LOCAL TRANSLATION; GROWTH CONES; MOUSE-BRAIN; PATHWAY; NEURONS; NPC1; NEURODEGENERATION; UBIQUITINATION	Perturbation of lipid metabolism, especially of cholesterol homeostasis, can be catastrophic to mammalian brain, as it has the highest level of cholesterol in the body. This notion is best illustrated by the severe progressive neurodegeneration in Niemann-Pick Type C (NPC) disease, one of the lysosomal storage diseases, caused by mutations in the NPC1 or NPC2 gene. In this study, we found that growth cone collapse induced by genetic or pharmacological disruption of cholesterol egress from late endosomes/lysosomes was directly related to a decrease in axonal and growth cone levels of the phosphorylated form of the tumor suppressor factor p53. Cholesterol perturbation-induced growth cone collapse and decrease in phosphorylated p53 were reduced by inhibition of p38 mitogen-activated protein kinase (MAPK) and murine double minute (Mdm2) E3 ligase. Growth cone collapse induced by genetic (npc1-/-) or pharmacological modification of cholesterol metabolism was Rho kinase (ROCK)-dependent and associated with increased RhoA protein synthesis; both processes were significantly reduced by P38 MAPK or Mdm2 inhibition. Finally, in vivo ROCK inhibition significantly increased phosphorylated p53 levels and neurofilaments in axons, and axonal bundle size in npc1-/- mice. These results indicate that NPC-related and cholesterol perturbation-induced axonal pathology is associated with an abnormal signaling pathway consisting in p38 MAPK activation leading to Mdm2-mediated p53 degradation, followed by ROCK activation. These results also suggest new targets for pharmacological treatment of NPC disease and other diseases associated with disruption of cholesterol metabolism.	[Qin, Qingyu; Liao, Guanghong; Bi, Xiaoning] Western Univ Hlth Sci, COMP, Dept Basic Med Sci, Pomona, CA USA; [Baudry, Michel] Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA	Western University of Health Sciences; University of Southern California	Qin, QY (corresponding author), Western Univ Hlth Sci, COMP, Dept Basic Med Sci, Pomona, CA USA.	xbi@westernu.edu	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022		National Institute of Neurological Disorders and Stroke [NS048423, NS45260]; Daljit and Elaine Sarkaria Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045260, R01NS048423] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Daljit and Elaine Sarkaria Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NS048423 (Xiaoning Bi) and NS45260 (Christine M. Gall) from the National Institute of Neurological Disorders and Stroke. Xiaoning Bi was also supported by funds from the Daljit and Elaine Sarkaria Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Bi XN, 2005, AM J PATHOL, V167, P1081, DOI 10.1016/S0002-9440(10)61197-2; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Distl R, 2003, J PATHOL, V200, P104, DOI 10.1002/path.1320; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fu XH, 1998, FEBS LETT, V440, P183, DOI 10.1016/S0014-5793(98)01455-0; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hackeng CM, 1999, THROMB HAEMOSTASIS, V82, P1749, DOI 10.1055/s-0037-1614909; Haupt S, 2003, J CELL BIOCHEM, V88, P76, DOI 10.1002/jcb.10311; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Ishibashi S, 2009, J CLIN NEUROSCI, V16, P954, DOI 10.1016/j.jocn.2008.09.020; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; March PA, 1997, ACTA NEUROPATHOL, V94, P164, DOI 10.1007/s004010050689; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ong WY, 2001, EXP BRAIN RES, V141, P218, DOI 10.1007/s002210100870; Qin QY, 2009, J NEUROSCI, V29, P5183, DOI 10.1523/JNEUROSCI.0420-09.2009; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; Satoh S, 2007, BRAIN RES, V1128, P175, DOI 10.1016/j.brainres.2006.10.027; Shirao S, 2002, CIRC RES, V91, P112, DOI 10.1161/01.RES.0000026057.13161.42; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; Tashiro Y, 2004, EUR J NEUROSCI, V20, P2015, DOI 10.1111/j.1460-9568.2004.03677.x; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Wood NT, 2009, FEBS LETT, V583, P615, DOI 10.1016/j.febslet.2009.01.003; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yang SR, 2006, STEM CELLS, V24, P292, DOI 10.1634/stemcells.2005-0221; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	46	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e9999	10.1371/journal.pone.0009999	http://dx.doi.org/10.1371/journal.pone.0009999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386595	Green Submitted, Green Published, gold			2022-12-27	WOS:000276420400003
J	Vijay, S; Kumar, P; Chauhan, LS; Vollepore, BH; Kizhakkethil, UP; Rao, SG				Vijay, Sophia; Kumar, Prahlad; Chauhan, Lakbir Singh; Vollepore, Balasangameshwara Hanumanthappa; Kizhakkethil, Unnikrishnan Pallikkara; Rao, Sumathi Govinda			Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; NONCOMPLIANCE; ADHERENCE; BARRIERS; DISTRICT	Background: Poor treatment adherence leading to risk of drug resistance, treatment failure, relapse, death and persistent infectiousness remains an impediment to the tuberculosis control programmes. The objective of the study was to identify predictors of default among new smear positive TB patients registered for treatment to suggest possible interventions to set right the problems to sustain and enhance the programme performance. Methodology & Principal Findings: Twenty districts selected from six states were assigned to six strata formed, considering the geographic, socio-cultural and demographic setup of the area. New smear positive patients registered for treatment in two consecutive quarters during III quarter 2004 to III quarter 2005 formed the retrospective study cohort. Case control analysis was done including defaulted patients as "cases" and equal number of age and sex matched patients completing treatment as "controls". The presence and degree of association between default and determinant factors was computed through univariate and multivariate logistic regression analysis. Data collection was through patient interviews using pretested semi structured questionnaire and review of treatment related records. Information on a wide range of socio demographic and patient related factors was obtained. Among the 687 defaulted and equal numbers of patients in completed group, 389 and 540 patients respectively were satisfactorily interviewed. In the logistic regression analysis, factors independently associated with default were alcoholism [AOR-1.72 (1.23-2.44)], illiteracy [AOR-1.40 (1.03-1.92)], having other commitments during treatment [AOR-3.22 (1.1-9.09)], inadequate knowledge of TB [AOR-1.88(1.35-2.63)], poor patient provider interaction [AOR-1.72(1.23-2.44)], lack of support from health staff [AOR-1.93(1.41-2.64)], having instances of missed doses [AOR-2.56(1.82-3.57)], side effects to anti TB drugs [AOR-2.55 (1.87-3.47)] and dissatisfaction with services provided [AOR-1.73 (1.14-2.6)]. Conclusion: Majority of risk factors for default were treatment and provider oriented and rectifiable with appropriate interventions, which would help in sustaining the good programme performance.	[Vijay, Sophia; Kumar, Prahlad; Rao, Sumathi Govinda] Natl TB Inst, Bangalore, Karnataka, India; [Chauhan, Lakbir Singh] Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Vollepore, Balasangameshwara Hanumanthappa] TB Lab Support, Bangalore, Karnataka, India; [Kizhakkethil, Unnikrishnan Pallikkara] Zonal Off, NSSO FOD, Bangalore, Karnataka, India		Vijay, S (corresponding author), Natl TB Inst, Bangalore, Karnataka, India.	nti@ntiindia.org.in			Ministry of Health and Family Welfare, government of India [47]	Ministry of Health and Family Welfare, government of India	This study was funded by Ministry of Health and Family Welfare, government of India under NTCP (plan) Demand No. 47 major head -2210 medical and public health-06101 - prevention and control of diseases (minor head - 30 NTCP - 3002 TB Cell at HQ (EAC) 300220 Other Administrative expenses (plan) for the year 2004-2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; Burman WJ, 1997, CHEST, V111, P1168, DOI 10.1378/chest.111.5.1168; *CENTR TB DIV, MAN REV TUB CONTR PR, P97; *CENTR TB DIV, 2003, RNTCP PERF REP IND 2; *CENTR TB DIV, 2006, RNTCP PERF REP IND 3; *CENTR TB DIV, 2004, TB IND 2004 RNTCP ST; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Comolet TM, 1998, INT J TUBERC LUNG D, V2, P891; CORCORAN R, 1986, IRISH MED J, V79, P87; Dandona R, 2004, NATL MED J INDIA, V17, P292; DEMISSIE M, 1994, ETHIOPIAN MED J, V32, P97; ESTIFANOS B, 2007, PLOS MED, V4, P280; FERRER X, 1991, Boletin de la Oficina Sanitaria Panamericana, V111, P423; Gopi P G, 2007, Indian J Tuberc, V54, P66; Hane F, 2007, INT J TUBERC LUNG D, V11, P539; *ISTC, 2006, TUB COAL TECHN ASS; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; JANANIPINIDIYAP, 2008, SE ASIAN J TROP MED, V39, P1076; Kangangi JK, 2003, INT J TUBERC LUNG D, V7, pS5; Kruyt ML, 1999, B WORLD HEALTH ORGAN, V77, P386; LAGARDA LP, 2008, KEKKAKU, V83, P765; Liam CK, 1998, INT J TUBERC LUNG D, V2, P818; NYUREBDA TE, 2003, INT J TUBERC LUNG S, pS21; Office of the Registrar General & Census Commissioner Ministry of Home Affairs Government of India, 2001, CENS IND; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Shargie EB, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-62; Snider, 1982, B INT UNION TUBERC, V57, P247; SOPHIAVIJAY, 2003, IND J TUB, V50, P185; SOPHIAVIJAY, 2005, IND J TUB, V3, P163; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; *WHO, WHOHTMTB2006362	35	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10043	10.1371/journal.pone.0010043	http://dx.doi.org/10.1371/journal.pone.0010043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386611	Green Published, Green Submitted, gold			2022-12-27	WOS:000276420400014
J	Wang, F; Zhang, RX; Wu, XM; Hankinson, O				Wang, Feng; Zhang, Ruixue; Wu, Xiaomeng; Hankinson, Oliver			Roles of Coactivators in Hypoxic Induction of the Erythropoietin Gene	PLOS ONE			English	Article							STEROID-RECEPTOR COACTIVATOR-1; ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTIONAL ACTIVATION; HISTONE ACETYLTRANSFERASE; ENHANCER ELEMENT; TRANSGENIC MICE; BINDING-PROTEIN; CBP; COMPLEX; SRC-1	Background Hypoxia-inducible expression of the erythropoietin (EPO) gene is mediated principally by hypoxia-inducible factor 2a (HIF-2a) in Hep3B cells under physiologic conditions. How/whether p300/CBP and the members of p160 coactivator family potentiate hypoxic induction of endogenous EPO and other HIF-2a and hypoxia-inducible factor 1a (HIF-1a) target genes remains unclear. Methodology/Principal Findings We demonstrate, using chromatin immunoprecipitation (ChIP) analysis, that the histone acetyl transferase (HAT) coactivators p300, SRC-1 and SRC-3 are recruited to the 3' enhancer of the EPO gene upon hypoxic stimulation, and that each associates with the enhancer in a periodic fashion. Hypoxia induced acetylation of the EPO gene 5' promoter at histone 4 and lysine 23 of histone 3. Knocking down SRC-3, but not SRC-1 or SRC-2, using short interfering RNAs (siRNAs), reduced EPO transcriptional activity. Knocking down p300 resulted in dramatic down-regulation of hypoxic stimulation of EPO gene transcription, negated recruitment of RNA polymerase II to the gene's promoter, and eliminated hypoxia-stimulated acetylation at the promoter and recruitments of SRC-1 and SRC-3 to the enhancer. The inhibitory effects of knocking down p300 and the chromatin remodeling coactivator, Brm/Brg-1, on EPO transcription were additive, suggesting that p300 and Brm/Brg-1 act independently. p300 was also required for hypoxia induced transcription of the HIF-1a target gene, VEGF, but was dispensable for induction of two other HIF-1a target genes, PGK and LDHA. Knocking down CBP, a homolog of p300, augmented hypoxic induction of VEGF, LDHA and PGK. Different HIF target genes also exhibited different requirements for members of the p160 coactivator family. Conclusions/Significance p300 plays a central coactivator role in hypoxic induction of EPO. The coactivators exhibit different specificities for different HIF target genes and each can behave differently in transcriptional regulation of different target genes mediated by the same transcription factor.	[Wang, Feng; Zhang, Ruixue; Wu, Xiaomeng; Hankinson, Oliver] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Wang, Feng; Zhang, Ruixue; Wu, Xiaomeng; Hankinson, Oliver] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hankinson, O (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA.	ohank@mednet.ucla.edu			NIH [R01 CA28868]; NATIONAL CANCER INSTITUTE [R01CA028868] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 CA28868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; BECK I, 1991, J BIOL CHEM, V266, P15563; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; PROBST MR, 1993, MOL PHARMACOL, V44, P511; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Ruas JL, 2005, J CELL SCI, V118, P301, DOI 10.1242/jcs.01617; Sanchez-Elsner T, 2004, J MOL BIOL, V336, P9, DOI 10.1016/j.jmb.2003.12.023; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P8725, DOI 10.1073/pnas.88.19.8725; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922	39	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10002	10.1371/journal.pone.0010002	http://dx.doi.org/10.1371/journal.pone.0010002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368990	gold, Green Published, Green Submitted			2022-12-27	WOS:000276419900006
J	Plaghki, L; Decruynaere, C; Van Dooren, P; Le Bars, D				Plaghki, Leon; Decruynaere, Celine; Van Dooren, Paul; Le Bars, Daniel			The Fine Tuning of Pain Thresholds: A Sophisticated Double Alarm System	PLOS ONE			English	Article							C-FIBER NOCICEPTORS; SPATIAL SUMMATION; THERMAL THRESHOLDS; ANESTHETIZED MONKEY; TEMPERATURE-CHANGE; WARM RECEPTORS; HEAT STIMULI; LOW RATES; SKIN; RESPONSES	Two distinctive features characterize the way in which sensations including pain, are evoked by heat: (1) a thermal stimulus is always progressive; (2) a painful stimulus activates two different types of nociceptors, connected to peripheral afferent fibers with medium and slow conduction velocities, namely A delta-and C-fibers. In the light of a recent study in the rat, our objective was to develop an experimental paradigm in humans, based on the joint analysis of the stimulus and the response of the subject, to measure the thermal thresholds and latencies of pain elicited by A delta-and C-fibers. For comparison, the same approach was applied to the sensation of warmth elicited by thermoreceptors. A CO2 laser beam raised the temperature of the skin filmed by an infrared camera. The subject stopped the beam when he/she perceived pain. The thermal images were analyzed to provide four variables: true thresholds and latencies of pain triggered by heat via A delta- and C-fibers. The psychophysical threshold of pain triggered by A delta-fibers was always higher (2.5-3 degrees C) than that triggered by C-fibers. The initial skin temperature did not influence these thresholds. The mean conduction velocities of the corresponding fibers were 13 and 0.8 m/s, respectively. The triggering of pain either by C-or by A delta-fibers was piloted by several factors including the low/high rate of stimulation, the low/high base temperature of the skin, the short/long peripheral nerve path and some pharmacological manipulations (e. g. Capsaicin). Warming a large skin area increased the pain thresholds. Considering the warmth detection gave a different picture: the threshold was strongly influenced by the initial skin temperature and the subjects detected an average variation of 2.7 degrees C, whatever the initial temperature. This is the first time that thresholds and latencies for pain elicited by both A delta-and C-fibers from a given body region have been measured in the same experimental run. Such an approach illustrates the role of nociception as a "double level" and "double release" alarm system based on level detectors. By contrast, warmth detection was found to be based on difference detectors. It is hypothesized that pain results from a CNS build-up process resulting from population coding and strongly influenced by the background temperatures surrounding at large the stimulation site. We propose an alternative solution to the conventional methods that only measure a single "threshold of pain", without knowing which of the two systems is involved.	[Plaghki, Leon; Decruynaere, Celine] Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium; [Van Dooren, Paul] Catholic Univ Louvain, CESAME, B-3000 Louvain, Belgium; [Le Bars, Daniel] CNRS, UMR 7225, INSERM UMRS 975, Team Pain, Paris, France; [Le Bars, Daniel] Univ Paris 06, Fac Med, Paris, France	Universite Catholique Louvain; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Plaghki, L (corresponding author), Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium.	daniel.le_bars@upmc.fr			Fondation de France, Caisse Nationale de prevoyance and Cooperation Franco-Belge en recherche medicale; INSERM - FNRS - CGRI (Institut national de la sante et de la recherche medicale - Fonds de la Recherche Scientifique - Commissariat general aux relations internationales)	Fondation de France, Caisse Nationale de prevoyance and Cooperation Franco-Belge en recherche medicale(Fondation de France); INSERM - FNRS - CGRI (Institut national de la sante et de la recherche medicale - Fonds de la Recherche Scientifique - Commissariat general aux relations internationales)	This work was supported by grants of Fondation de France, Caisse Nationale de prevoyance and Cooperation Franco-Belge en recherche medicale, Accord INSERM - FNRS - CGRI (Institut national de la sante et de la recherche medicale - Fonds de la Recherche Scientifique - Commissariat general aux relations internationales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Assoc Electrodiagnost Med, 2004, MUSCLE NERVE, V29, P734, DOI 10.1002/mus.20053; BANKS WP, 1973, PERCEPT PSYCHOPHYS, V13, P321, DOI 10.3758/BF03214147; Benoist JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003125; BROMM B, 1984, HUM NEUROBIOL, V3, P33; CAMPBELL JN, 1983, BRAIN RES, V266, P203, DOI 10.1016/0006-8993(83)90650-9; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1297, DOI 10.1152/jn.1979.42.5.1297; Defrin R, 2006, CLIN J PAIN, V22, P130, DOI 10.1097/01.ajp.0000154048.68273.d8; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Diller KR, 1999, ANN NY ACAD SCI, V888, P153, DOI 10.1111/j.1749-6632.1999.tb07954.x; DUCLAUX R, 1980, J NEUROPHYSIOL, V43, P1; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Gibbons C, 2004, NEUROL CLIN, V22, P683, DOI 10.1016/j.ncl.2004.03.002; Golub G.H., 1996, MATRIX COMPUTATIONS, V3rd; Granot M, 2003, EUR J PAIN, V7, P139, DOI 10.1016/S1090-3801(02)00087-3; Hagander L. G., 2000, Clinical Neurophysiology, V111, P17, DOI 10.1016/S1388-2457(99)00192-3; HALLIN RG, 1982, J NEUROL NEUROSUR PS, V45, P313, DOI 10.1136/jnnp.45.4.313; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; Hardy JD, 1937, J CLIN INVEST, V16, P533, DOI 10.1172/JCI100879; HENSEL H, 1974, ANNU REV PHYSIOL, V36, P233, DOI 10.1146/annurev.ph.36.030174.001313; Hensel H., 1973, Handbook of sensory physiology, volume II., P79; Iannetti GD, 2006, J PHYSIOL-LONDON, V577, P235, DOI 10.1113/jphysiol.2006.115675; JAMAL GA, 1985, J NEUROL NEUROSUR PS, V48, P354, DOI 10.1136/jnnp.48.4.354; KANUI TI, 1985, PAIN, V21, P231, DOI 10.1016/0304-3959(85)90087-9; KANUI TI, 1987, BRAIN RES, V402, P160, DOI 10.1016/0006-8993(87)91060-2; KAVALIERS M, 1988, BRAIN RES BULL, V21, P923, DOI 10.1016/0361-9230(88)90030-5; Kelly KG, 2005, MUSCLE NERVE, V32, P179, DOI 10.1002/mus.20355; Kenshalo D R, 1970, Contrib Sens Physiol, V4, P19; KENSHALO DR, 1975, J APPL PHYSIOL, V39, P1038, DOI 10.1152/jappl.1975.39.6.1038; KENSHALO DR, 1967, J COMP PHYSIOL PSYCH, V63, P510, DOI 10.1037/h0024610; Kirk J A, 1968, Ann Phys Med, V9, P270; Kumazawa T, 1998, NEUROSCI RES, V32, P9, DOI 10.1016/S0168-0102(98)00060-1; LAMOTTE RH, 1983, FED PROC, V42, P2548; LAMOTTE RH, 1982, J NEUROSCI, V2, P765; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Lewis T, 1937, CLIN SCI, V3, P67; Lin YH, 2005, J PERIPHER NERV SYST, V10, P269, DOI 10.1111/j.1085-9489.2005.10305.x; Luce R, 1986, RESPONSE TIMES THEIR, DOI [10.1093/acprof:oso/9780195070019.001.0001, DOI 10.1093/ACPROF:OSO/9780195070019.001.0001]; MACKENZIE RA, 1975, J NEUROL NEUROSUR PS, V38, P865, DOI 10.1136/jnnp.38.9.865; Magda P, 2002, J PERIPHER NERV SYST, V7, P225, DOI 10.1046/j.1529-8027.2002.02029.x; MARKS LE, 1973, AM J PSYCHOL, V86, P251, DOI 10.2307/1421436; Masuda A, 2005, PSYCHOTHER PSYCHOSOM, V74, P288, DOI 10.1159/000086319; McKemy DD, 2007, PFLUG ARCH EUR J PHY, V454, P777, DOI 10.1007/s00424-006-0199-6; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; MEYER RA, 1981, SCIENCE, V213, P1527, DOI 10.1126/science.7280675; MORITZ AR, 1947, AM J PATHOL, V23, P695; Nagasako EM, 2003, PAIN, V101, P213, DOI 10.1016/S0304-3959(02)00482-7; NATHAN PW, 1986, BRAIN, V109, P1003, DOI 10.1093/brain/109.5.1003; Nuhr M, 2004, SPINE, V29, P1499, DOI 10.1097/01.BRS.0000131439.87553.99; Palmer ST, 2000, SOMATOSENS MOT RES, V17, P325; Pastor J, 1996, J NEUROPHYSIOL, V75, P2268, DOI 10.1152/jn.1996.75.6.2268; PERTOVAARA A, 1985, EXP NEUROL, V87, P439, DOI 10.1016/0014-4886(85)90174-8; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reulen JPH, 2003, CLIN NEUROPHYSIOL, V114, P556, DOI 10.1016/S1388-2457(02)00405-4; RINGKAMP M, 2008, SENSES COMPREHENSIVE, V5, P97, DOI DOI 10.1016/B978-012370880-9.00146-8; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schepers RJ, 2009, NEUROSCI BIOBEHAV R, V33, P205, DOI 10.1016/j.neubiorev.2008.07.009; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; STEVENS JC, 1974, PHYSIOL BEHAV, V13, P825, DOI 10.1016/0031-9384(74)90269-8; STEVENS JC, 1971, PERCEPT PSYCHOPHYS, V9, P391, DOI 10.3758/BF03210236; STOLL AM, 1959, J APPL PHYSIOL, V14, P373, DOI 10.1152/jappl.1959.14.3.373; STOLWIJK JA, 1965, J APPL PHYSIOL, V20, P1006, DOI 10.1152/jappl.1965.20.5.1006; Svensson P, 1997, SOMATOSENS MOT RES, V14, P113, DOI 10.1080/08990229771114; SWERUP C, 1987, ACTA PHYSIOL SCAND, V131, P623, DOI 10.1111/j.1748-1716.1987.tb08284.x; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; Tobin DM, 2004, J NEUROBIOL, V61, P161, DOI 10.1002/neu.20082; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; VERDUGO RJ, 1993, MUSCLE NERVE, V16, P1056, DOI 10.1002/mus.880161009; Vriens J, 2004, PFLUG ARCH EUR J PHY, V449, P213, DOI 10.1007/s00424-004-1314-1; WALTERS ET, 1994, INT REV NEUROBIOL, V36, P325, DOI 10.1016/S0074-7742(08)60307-4; WALTERS ET, 2008, SENSES COMPREHENSIVE, V5, P175; YARNITSKY D, 1990, PAIN, V40, P85, DOI 10.1016/0304-3959(90)91055-N; YARNITSKY D, 1994, J NEUROL SCI, V125, P39, DOI 10.1016/0022-510X(94)90239-9; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819; Yarnitsky D, 2006, HAND CLINIC, V81, P397, DOI 10.1016/S0072-9752(06)80031-X; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4; YEOMANS DC, 1994, PAIN, V59, P85, DOI 10.1016/0304-3959(94)90051-5	80	35	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10269	10.1371/journal.pone.0010269	http://dx.doi.org/10.1371/journal.pone.0010269			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428245	Green Submitted, Green Published, gold			2022-12-27	WOS:000277079300004
J	Wang, L; Clark, ME; Crossman, DK; Kojima, K; Messinger, JD; Mobley, JA; Curcio, CA				Wang, Lan; Clark, Mark E.; Crossman, David K.; Kojima, Kyoko; Messinger, Jeffrey D.; Mobley, James A.; Curcio, Christine A.			Abundant Lipid and Protein Components of Drusen	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; HUMAN BRUCHS MEMBRANE; HIGH-DENSITY-LIPOPROTEIN; MACULAR DEGENERATION; SCAVENGER RECEPTORS; BASAL DEPOSITS; UNESTERIFIED CHOLESTEROL; PROGRESSIVE STAGES; APOLIPOPROTEIN-E	Background: Drusen are extracellular lesions characteristic of aging and age-related maculopathy, a major retinal disease of the elderly. We determined the relative proportions of lipids and proteins in drusen capped with retinal pigment epithelium (RPE) and in RPE isolated from non-macular regions of 36 human retinas with grossly normal maculas obtained <6 hr after death. Methodology/Principal Findings: Druse pellets were examined by light and electron microscopy. Component proteins were extracted using novel methods for preserved tissues, separated, subjected to tryptic digestion and LC-MS(MS)(2) analysis using an ion trap mass spectrometer, and identified with reference to databases. Lipid classes were separated using thin layer chromatography and quantified by densitometry. Major druse components were esterified cholesterol (EC), phosphatidylcholine (PC), and protein (37.5 +/- 13.7, 36.9 +/- 12.9, and 43.0 +/- 11.5 ng/druse, respectively). Lipid-containing particles (median diameter, 77 nm) occupied 37-44% of druse volume. Major proteins include vitronectin, complement component 9, apoE, and clusterin, previously seen in drusen, and ATP synthase subunit beta, scavenger receptor B2, and retinol dehydrogenase 5, previously seen in RPE. Drusen and RPE had similar protein profiles, with higher intensities and greater variability in drusen. C8, part of the complement membrane attack complex, was localized in drusen by immunofluorescence. Conclusions/Significance: At least 40% of druse content is comprised by lipids dominated by EC and PC, 2 components that are potentially accounted for by just one pathway, the secretion of lipoproteins by RPE. Manipulating genes encoding apolipoprotein pathways would be a fruitful approach to producing drusen with high EC content in laboratory animals. Therapies that directly mitigate drusen should prepare for the substantial volume of neutral lipids. The catalog of major druse proteins is nearing completion.	[Wang, Lan; Clark, Mark E.; Messinger, Jeffrey D.; Curcio, Christine A.] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA; [Crossman, David K.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Kojima, Kyoko] Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA; [Mobley, James A.] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, L (corresponding author), Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA.	curcio@uab.edu		Crossman, David/0000-0002-0981-169X; mobley, james/0000-0002-3229-7975	NIH [EY06109]; International Retinal Research Foundation; Research to Prevent Blindness, Inc.; EyeSight Foundation of Alabama; Roger Johnson Prize in Macular Degeneration Research (CAC); NIAID [T32AI007041-15]; NATIONAL EYE INSTITUTE [R01EY006109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Retinal Research Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); EyeSight Foundation of Alabama; Roger Johnson Prize in Macular Degeneration Research (CAC); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant EY06109, International Retinal Research Foundation, unrestricted funds to the Department of Ophthalmology from Research to Prevent Blindness, Inc., EyeSight Foundation of Alabama, and the 2002 Roger Johnson Prize in Macular Degeneration Research (CAC); NIAID, T32AI007041-15 (DKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar O, 2009, MOL CELL PROTEOMICS, V8, P2201, DOI 10.1074/mcp.M900203-MCP200; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; CasaroliMarano RP, 1996, J LIPID RES, V37, P1037; Chang AA, 2003, CLIN EXP OPHTHALMOL, V31, P300, DOI 10.1046/j.1442-9071.2003.00664.x; Chung BH, 2005, BBA-MOL CELL BIOL L, V1733, P76, DOI 10.1016/j.bbalip.2004.12.002; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2005, EXP EYE RES, V81, P731, DOI 10.1016/j.exer.2005.04.012; Curcio CA, 2005, EXP EYE RES, V80, P761, DOI 10.1016/j.exer.2004.09.017; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Decanini A, 2008, DIABETOLOGIA, V51, P1051, DOI 10.1007/s00125-008-0991-2; Del Priore LV, 1998, ARCH OPHTHALMOL-CHIC, V116, P335, DOI 10.1001/archopht.116.3.335; Dentchev T, 2003, MOL VIS, V9, P184; DOWHAN W, 2002, BIOCH LIPIDS LIPOPRO, P1; Duncan KG, 2002, BIOCHEM BIOPH RES CO, V292, P1017, DOI 10.1006/bbrc.2002.6756; During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fujihara M, 2009, EXP EYE RES, V88, P1115, DOI 10.1016/j.exer.2009.01.017; GAMBLE W, 1978, J LIPID RES, V19, P1068; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gouras P, 2009, GRAEF ARCH CLIN EXP, V247, P1051, DOI 10.1007/s00417-009-1091-9; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Gullapalli VK, 2008, EXP EYE RES, V86, P189, DOI 10.1016/j.exer.2007.10.009; GUYTON JR, 1988, J HISTOCHEM CYTOCHEM, V36, P1319, DOI 10.1177/36.10.2458408; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haimovici R, 2001, INVEST OPHTH VIS SCI, V42, P1592; HAYES KC, 1989, INVEST OPHTH VIS SCI, V30, P225; Holm C, 1999, METH MOL B, V109, P109; ISHIBASHI T, 1986, AM J OPHTHALMOL, V101, P342, DOI 10.1016/0002-9394(86)90830-5; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kamei M, 2007, INVEST OPHTH VIS SCI, V48, P1801, DOI 10.1167/iovs.06-0699; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Kochounian H, 2009, EXP EYE RES, V88, P1129, DOI 10.1016/j.exer.2009.01.019; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lengyel I, 2004, INVEST OPHTH VIS SCI, V45, P2886, DOI 10.1167/iovs.03-1083; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Li CM, 2007, EXP EYE RES, V85, P192, DOI 10.1016/j.exer.2007.04.002; Li CM, 2006, INVEST OPHTH VIS SCI, V47, P3119, DOI 10.1167/iovs.05-1446; Li CM, 2005, INVEST OPHTH VIS SCI, V46, P2576, DOI 10.1167/iovs.05-0034; Li CM, 2005, J LIPID RES, V46, P628, DOI 10.1194/jlr.M400428-JLR200; Lin MY, 2007, MOL VIS, V13, P1203; Loane E, 2008, SURV OPHTHALMOL, V53, P68, DOI 10.1016/j.survophthal.2007.10.008; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Mullins RF, 1999, J HISTOCHEM CYTOCHEM, V47, P1533, DOI 10.1177/002215549904701205; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ng KP, 2008, MOL CELL PROTEOMICS, V7, P1397, DOI 10.1074/mcp.M700525-MCP200; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; Oksjoki R, 2007, FRONT BIOSCI-LANDMRK, V12, P4696, DOI 10.2741/2419; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; PAULEIKHOFF D, 1992, OPHTHALMOLOGY, V99, P1548; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Rudolf M, 2008, INVEST OPHTH VIS SCI, V49, P1200, DOI 10.1167/iovs.07-1466; Sallo FB, 2009, EXP EYE RES, V89, P178, DOI 10.1016/j.exer.2009.03.006; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; SARKS SH, 1980, AUST J OPHTHALMOL, V8, P117, DOI 10.1111/j.1442-9071.1980.tb01670.x; Schloendorn J, 2009, REJUV RES, V12, P411, DOI 10.1089/rej.2009.0917; Schmidt-Erfurth U, 2008, INVEST OPHTH VIS SCI, V49, P390, DOI 10.1167/iovs.07-0227; Schreck SF, 2000, BBA-PROTEIN STRUCT M, V1482, P199, DOI 10.1016/S0167-4838(00)00155-2; Seth A, 2008, INVEST OPHTH VIS SCI, V49, P743, DOI 10.1167/iovs.07-1072; Spaide RF, 1999, RETINA-J RET VIT DIS, V19, P141, DOI 10.1097/00006982-199902000-00010; Suzuki M, 2007, MOL VIS, V13, P772; Tezel TH, 2004, INVEST OPHTH VIS SCI, V45, P3337, DOI 10.1167/iovs.04-0193; Tserentsoodol N, 2006, MOL VIS, V12, P1319; VANDERSCHAFT TL, 1992, OPHTHALMOLOGY, V99, P278; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Warburton S, 2007, MOL VIS, V13, P318; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; West KA, 2003, MOL CELL PROTEOMICS, V2, P37, DOI 10.1074/mcp.D200001-MCP200; White C Roger, 2009, Vasc Dis Prev, V6, P122; WOLTER JR, 1962, ARCH OPHTHALMOL-CHIC, V68, P219; Yamada Y, 2008, J NEUROCHEM, V105, P1187, DOI 10.1111/j.1471-4159.2008.05211.x; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Zerbib J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007341; [No title captured]; [No title captured]; [No title captured]; [No title captured]	97	226	229	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10329	10.1371/journal.pone.0010329	http://dx.doi.org/10.1371/journal.pone.0010329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428236	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300016
J	Kumada, Y; Zhang, SG				Kumada, Yoshiyuki; Zhang, Shuguang			Significant Type I and Type III Collagen Production from Human Periodontal Ligament Fibroblasts in 3D Peptide Scaffolds without Extra Growth Factors	PLOS ONE			English	Article							SELF-COMPLEMENTARY OLIGOPEPTIDE; ENAMEL MATRIX PROTEINS; FURCATION DEFECTS; NANOFIBER SCAFFOLDS; TISSUE REGENERATION; BONE REGENERATION; BEAGLE DOGS; FACTOR-BETA; CELLS; ATTACHMENT	We here report the development of two peptide scaffolds designed for periodontal ligament fibroblasts. The scaffolds consist of one of the pure self-assembling peptide scaffolds RADA16 through direct coupling to short biologically active motifs. The motifs are 2-unit RGD binding sequence PRG (PRGDSGYRGDS) and laminin cell adhesion motif PDS (PDSGR). RGD and laminin have been previously shown to promote specific biological activities including periodontal ligament fibroblasts adhesion, proliferation and protein production. Compared to the pure RADA16 peptide scaffold, we here show that these designer peptide scaffolds significantly promote human periodontal ligament fibroblasts to proliferate and migrate into the scaffolds (for similar to 300 mu m/two weeks). Moreover these peptide scaffolds significantly stimulated periodontal ligament fibroblasts to produce extracellular matrix proteins without using extra additional growth factors. Immunofluorescent images clearly demonstrated that the peptide scaffolds were almost completely covered with type I and type III collagens which were main protein components of periodontal ligament. Our results suggest that these designer self-assembling peptide nanofiber scaffolds may be useful for promoting wound healing and especially periodontal ligament tissue regeneration.	[Kumada, Yoshiyuki; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Kumada, Yoshiyuki] Olympus Amer Inc, Center Valley, PA USA	Massachusetts Institute of Technology (MIT); Olympus Corporation	Kumada, Y (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752	Olympus America	Olympus America	Olympus America sent a researcher who is fully funded by Olympus America to Zhang's laboratory at MIT to carry out the research. Olympus America also provided reagents and material funding for the researcher. However the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOVITZ BKB, 1990, EUR J ORTHODONT, V12, P51, DOI 10.1093/ejo/12.1.51; Camelo M, 1998, INT J PERIODONT REST, V18, P321; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Chiquet M, 2007, APPL PHYSIOL NUTR ME, V32, P967, DOI 10.1139/H07-053; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6; GANTES B, 1988, J CLIN PERIODONTOL, V15, P232, DOI 10.1111/j.1600-051X.1988.tb01576.x; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Giannobile WV, 1996, BONE, V19, pS23, DOI 10.1016/S8756-3282(96)00127-5; Giannopoulou C, 1996, J DENT RES, V75, P895, DOI 10.1177/00220345960750030601; Grzesik WJ, 1998, J DENT RES, V77, P1606, DOI 10.1177/00220345980770080801; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Jovanovic SA, 2007, CLIN ORAL IMPLAN RES, V18, P224, DOI 10.1111/j.1600-0501.2006.01324.x; KARIMBUX NY, 1995, J DENT RES, V74, P313, DOI 10.1177/00220345950740010501; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106; LINDHE J, 1995, J CLIN PERIODONTOL, V22, P276, DOI 10.1111/j.1600-051X.1995.tb00148.x; MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4; MATSUDA N, 1992, J PERIODONTOL, V63, P515, DOI 10.1902/jop.1992.63.6.515; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x; Okubo K, 2003, J PERIODONTAL RES, V38, P1, DOI 10.1034/j.1600-0765.2003.01607.x; Palaiologou AA, 2001, J PERIODONTOL, V72, P798, DOI 10.1902/jop.2001.72.6.798; PARK JB, 1995, J PERIODONTOL, V66, P462, DOI 10.1902/jop.1995.66.6.462; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785; Taba M Jr, 2005, Orthod Craniofac Res, V8, P292; Takayama S, 1997, J PERIODONTAL RES, V32, P667, DOI 10.1111/j.1600-0765.1997.tb00577.x; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; Wang XM, 2008, SOFT MATTER, V4, P2388, DOI 10.1039/b807155a; Windisch P, 2002, J PERIODONTOL, V73, P409, DOI 10.1902/jop.2002.73.4.409; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915; Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; ZHANG S, 2005, SCAFFOLDING TISSUE E, P218; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	43	79	90	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10305	10.1371/journal.pone.0010305	http://dx.doi.org/10.1371/journal.pone.0010305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421985	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600022
J	Roperto, S; De Tullio, R; Raso, C; Stifanese, R; Russo, V; Gaspari, M; Borzacchiello, G; Averna, M; Paciello, O; Cuda, G; Roperto, F				Roperto, Sante; De Tullio, Roberta; Raso, Cinzia; Stifanese, Roberto; Russo, Valeria; Gaspari, Marco; Borzacchiello, Giuseppe; Averna, Monica; Paciello, Orlando; Cuda, Gianni; Roperto, Franco			Calpain3 Is Expressed in a Proteolitically Active Form in Papillomavirus-Associated Urothelial Tumors of the Urinary Bladder in Cattle	PLOS ONE			English	Article							MUSCLE-SPECIFIC CALPAIN; SKELETAL-MUSCLE; RETINOBLASTOMA PROTEIN; CELLULAR PROLIFERATION; CANCER-RESEARCH; ANIMAL-MODEL; BRACKEN-FERN; GROWTH; CELLS; OVEREXPRESSION	Background: Calpain 3 (Capn3), also named p94, is a skeletal muscle tissue-specific protein known to be responsible for limb-girdle muscular dystrophy type 2A (LGMD2A). Recent experimental studies have hypothesized a pro-apoptotic role of Capn3 in some melanoma cell lines. So far the link between calpain3 and tumors comes from in vitro studies. The objective of this study was to describe Capn3 activation in naturally occurring urothelial tumors of the urinary bladder in cattle. Methods and Findings: Here we describe, for the first time in veterinary and comparative oncology, the activation of Capn3 in twelve urothelial tumor cells of the urinary bladder of cattle. Capn3 protein was initially identified with nanoscale liquid chromatography coupled with tandem mass spectrometry (nano LC-MS/MS) in a co-immunoprecipitation experiment on E2F3, known to be a transcription factor playing a crucial role in bladder carcinogenesis in humans. Capn3 expression was then confirmed by reverse transcription polymerase chain reaction (RT-PCR). Finally, the Ca2+-dependent proteolytic activity of Capn3 was assayed following ion exchange chromatography. Morphologically, Capn3 expression was documented by immunohistochemical methods. In fact numerous tumor cells showed an intracytoplasmic immunoreactivity, which was more rarely evident also at nuclear level. In urothelial tumors, bovine papillomavirus type 2 (BPV-2) DNA was amplified by PCR and the expression of E5 protein, the major oncogenic protein of BVP-2, was detected by western blotting, immunohistochemistry, and immunofluorescence. E2F3 overexpression and pRb protein downregulation were shown by western blotting. Conclusion: The role of capn3 protein in urothelial cancer of the urinary bladder remains to be elucidated: further studies would be required to determine the precise function of this protease in tumor development and progression. However, we suggest that activated Capn3 may be involved in molecular pathways leading to the overexpression of E2F3, which in turn could be responsible for urothelial tumor cell proliferation also in cattle, though other mechanisms are likely to exist. If further studies corroborate the important role of Capn3 in urothelial tumors of the urinary bladder, cattle with urinary tumors may prove useful as animal model for bladder carcinogenesis.	[Roperto, Sante] Univ Naples Federico II, Div Infect Dis, Dept Pathol & Anim Hlth, Naples, Italy; [De Tullio, Roberta; Stifanese, Roberto; Averna, Monica] Univ Genoa, Dept Expt Med, DIMES, Biochem Sect, Genoa, Italy; [De Tullio, Roberta; Stifanese, Roberto; Averna, Monica] Univ Genoa, CEBR, Genoa, Italy; [Raso, Cinzia; Gaspari, Marco; Cuda, Gianni] Univ Catanzaro Magna Graecia, Dept Expt Med & Clin, Catanzaro, Italy; [Russo, Valeria; Borzacchiello, Giuseppe; Paciello, Orlando; Roperto, Franco] Univ Naples Federico II, Dept Pathol & Anim Hlth, Div Gen Pathol, Naples, Italy	University of Naples Federico II; University of Genoa; University of Genoa; Magna Graecia University of Catanzaro; University of Naples Federico II	Roperto, S (corresponding author), Univ Naples Federico II, Div Infect Dis, Dept Pathol & Anim Hlth, Naples, Italy.	sante.roperto@unina.it	Gaspari, Marco/ABE-1539-2020; Cuda, Giovanni/F-5359-2012; AVERNA, MONICA/R-5719-2019; Cuda, Giovanni/AAC-2821-2019; Gaspari, Marco/HGB-2399-2022; Gaspari, Marco/C-2756-2009	Gaspari, Marco/0000-0002-5411-8800; Cuda, Giovanni/0000-0001-6313-1866; AVERNA, MONICA/0000-0002-9463-7533; Cuda, Giovanni/0000-0001-6313-1866; Gaspari, Marco/0000-0002-5411-8800; Borzacchiello, Giuseppe/0000-0003-3943-2604; roperto, sante/0000-0001-6210-5519; DE TULLIO, ROBERTA/0000-0001-6925-3207	Ministero delle Politiche Agricole, Alimentari, Forestali; Assessorato alla Sanita della Regione Campania e della Regione Basilicata; Legge Regionale; PRIN 2007 and 2008	Ministero delle Politiche Agricole, Alimentari, Forestali; Assessorato alla Sanita della Regione Campania e della Regione Basilicata; Legge Regionale; PRIN 2007 and 2008(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by grants from the Ministero delle Politiche Agricole, Alimentari, Forestali, as well as from the Assessorato alla Sanita della Regione Campania e della Regione Basilicata, from the Legge Regionale n. 5 and PRIN 2007 and 2008. The funders had no role in study design, interpretation of data, writing of the paper, and decision to submit it for publication.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Azuma M, 2000, CURR EYE RES, V21, P710, DOI 10.1076/0271-3683(200009)21:3;1-R;FT710; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; BESSER TE, 1990, AM J MED GENET, V37, P159, DOI 10.1002/ajmg.1320370137; Blazquez L, 2008, NEUROGENETICS, V9, P173, DOI 10.1007/s10048-008-0129-1; Borzacchiello G, 2006, ONCOGENE, V25, P1251, DOI 10.1038/sj.onc.1209152; Borzacchiello G, 2008, VET RES, V39, DOI 10.1051/vetres:2008022; Burger MM, 2000, INT J CANCER, V85, P303, DOI 10.1002/(SICI)1097-0215(20000201)85:3<303::AID-IJC1>3.0.CO;2-2; CAMPO MS, 1992, CANCER RES, V52, P6898; Chan E, 2009, BJU INT, V104, P1286, DOI 10.1111/j.1464-410X.2009.08577.x; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Darnell GA, 2007, J BIOL CHEM, V282, P37492, DOI 10.1074/jbc.M706860200; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; Demarchi F, 2007, AUTOPHAGY, V3, P235, DOI 10.4161/auto.3661; Demarchi F, 2007, CELL CYCLE, V6, P136; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Huynh KM, 2009, GENE, V433, P32, DOI 10.1016/j.gene.2008.11.013; Kawabata Y, 2003, FEBS LETT, V555, P623, DOI 10.1016/S0014-5793(03)01324-3; Konig N, 2003, J CHEM NEUROANAT, V25, P129, DOI 10.1016/S0891-0618(02)00102-3; Kuznetsov S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003997; Lee SJ, 2007, INT J GYNECOL CANCER, V17, P248, DOI 10.1111/j.1525-1438.2006.00756.x; Ma H, 2000, CURR EYE RES, V20, P183, DOI 10.1076/0271-3683(200003)20:3;1-9;FT183; Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098; Murphy RM, 2009, J BIOL CHEM, V284, P7811, DOI 10.1074/jbc.M808655200; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Olsson AY, 2007, ONCOGENE, V26, P1028, DOI 10.1038/sj.onc.1209854; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; PAMUKCU AM, 1976, VET PATHOL, V13, P110, DOI 10.1177/030098587601300205; PONTREMOLI S, 1991, ARCH BIOCHEM BIOPHYS, V288, P646, DOI 10.1016/0003-9861(91)90247-G; Rey MA, 2002, FEBS LETT, V532, P401, DOI 10.1016/S0014-5793(02)03722-5; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Roperto S, 2010, J COMP PATHOL, V142, P95, DOI 10.1016/j.jcpa.2009.08.156; Roperto S, 2010, J COMP PATHOL, V142, P19, DOI 10.1016/j.jcpa.2009.06.001; Roperto S, 2008, J GEN VIROL, V89, P3027, DOI 10.1099/vir.0.2008/004457-0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Stifanese R, 2008, ARCH BIOCHEM BIOPHYS, V479, P145, DOI 10.1016/j.abb.2008.09.002; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zeng CB, 2007, CANCER RES, V67, P6708, DOI 10.1158/0008-5472.CAN-06-3803; Zhang WF, 2010, VIROLOGY, V397, P139, DOI 10.1016/j.virol.2009.10.051	50	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10299	10.1371/journal.pone.0010299	http://dx.doi.org/10.1371/journal.pone.0010299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421977	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600016
J	Teklenburg, G; Salker, M; Molokhia, M; Lavery, S; Trew, G; Aojanepong, T; Mardon, HJ; Lokugamage, AU; Rai, R; Landles, C; Roelen, BAJ; Quenby, S; Kuijk, EW; Kavelaars, A; Heijnen, CJ; Regan, L; Brosens, JJ; Macklon, NS				Teklenburg, Gijs; Salker, Madhuri; Molokhia, Mariam; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Mardon, Helen J.; Lokugamage, Amali U.; Rai, Raj; Landles, Christian; Roelen, Bernard A. J.; Quenby, Siobhan; Kuijk, Ewart W.; Kavelaars, Annemieke; Heijnen, Cobi J.; Regan, Lesley; Brosens, Jan J.; Macklon, Nick S.			Natural Selection of Human Embryos: Decidualizing Endometrial Stromal Cells Serve as Sensors of Embryo Quality upon Implantation	PLOS ONE			English	Article							ONGOING PREGNANCY; MATERNAL AGE; EXPRESSION; RECEPTIVITY; INHIBITION; ACTIVATION; MORPHOLOGY; RATES	Background: Pregnancy is widely viewed as dependent upon an intimate dialogue, mediated by locally secreted factors between a developmentally competent embryo and a receptive endometrium. Reproductive success in humans is however limited, largely because of the high prevalence of chromosomally abnormal preimplantation embryos. Moreover, the transient period of endometrial receptivity in humans uniquely coincides with differentiation of endometrial stromal cells (ESCs) into highly specialized decidual cells, which in the absence of pregnancy invariably triggers menstruation. The role of cyclic decidualization of the endometrium in the implantation process and the nature of the decidual cytokines and growth factors that mediate the crosstalk with the embryo are unknown. Methodology/Principal Findings: We employed a human co-culture model, consisting of decidualizing ESCs and single hatched blastocysts, to identify the soluble factors involved in implantation. Over the 3-day co-culture period, approximately 75% of embryos arrested whereas the remainder showed normal development. The levels of 14 implantation factors secreted by the stromal cells were determined by multiplex immunoassay. Surprisingly, the presence of a developing embryo had no significant effect on decidual secretions, apart from a modest reduction in IL-5 levels. In contrast, arresting embryos triggered a strong response, characterized by selective inhibition of IL-1 beta, -6, -10, -17, -18, eotaxin, and HB-EGF secretion. Co-cultures were repeated with undifferentiated ESCs but none of the secreted cytokines were affected by the presence of a developing or arresting embryo. Conclusions: Human ESCs become biosensors of embryo quality upon differentiation into decidual cells. In view of the high incidence of gross chromosomal errors in human preimplantation embryos, cyclic decidualization followed by menstrual shedding may represent a mechanism of natural embryo selection that limits maternal investment in developmentally impaired pregnancies.	[Teklenburg, Gijs; Kuijk, Ewart W.; Macklon, Nick S.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Salker, Madhuri; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Rai, Raj; Landles, Christian; Regan, Lesley; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London, England; [Molokhia, Mariam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Mardon, Helen J.] Univ Oxford, John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynecol, Oxford OX3 9DU, England; [Lokugamage, Amali U.] Whittington Hosp NHS Trust, Dept Obstet & Gynecol, London, England; [Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Quenby, Siobhan] Univ Liverpool, Liverpool Womens Hosp, Dept Reprod & Dev Hlth, Liverpool L69 3BX, Merseyside, England; [Teklenburg, Gijs; Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Psychoneuroimmunol, Utrecht, Netherlands; [Macklon, Nick S.] Univ Southampton, Princess Anne Hosp, Div Dev Origins Hlth & Dis, Southampton, Hants, England	Utrecht University; Utrecht University Medical Center; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Utrecht University; University of Liverpool; Utrecht University; Utrecht University Medical Center; University of Southampton	Teklenburg, G (corresponding author), Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands.	j.brosens@imperial.ac.uk	Kuijk, Ewart/I-2569-2019	Kuijk, Ewart/0000-0002-1385-6516; Quenby, Siobhan/0000-0003-3221-5471; Salker, Madhuri Sonal/0000-0002-7939-289X; Brosens, Jan/0000-0003-0116-9329; Landles, Christian/0000-0001-9715-6447; Lokugamage, Amali/0000-0002-7439-2700	Netherlands Organisation for Scientific Research; CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) [640510, CIG-08-122]; Wellcome Trust [084336]; Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR); Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by funds from the Netherlands Organisation for Scientific Research (NWO; http://www. nwo. nl), CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) Grant (640510) (CIG-08-122; http://www.conrad.org/), the Wellcome Trust (084336; http://www.wellcome.ac.uk/), the Institute of Obstetrics and Gynaecology (IOG) Trust (www. iogt. org. uk) and the NIHR Biomedical Research Centre funding scheme (http://www.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki R, 2000, SEMIN REPROD MED, V18, P265, DOI 10.1055/s-2000-12564; Benson GV, 1996, DEVELOPMENT, V122, P2687; Boomsma CM, 2009, HUM REPROD, V24, P1427, DOI 10.1093/humrep/dep011; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; de Jong D, 2002, J ASSIST REPROD GEN, V19, P561, DOI 10.1023/A:1021211115337; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Donaghay M, 2007, SEMIN REPROD MED, V25, P461, DOI 10.1055/s-2007-991044; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; GELLERSEN B, 2010, HUM REPROD; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Haig D, 1996, J EVOLUTION BIOL, V9, P357, DOI 10.1046/j.1420-9101.1996.9030357.x; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Ledbetter DH, 2009, NAT MED, V15, P490, DOI 10.1038/nm0509-490; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Munne S, 2007, REPROD BIOMED ONLINE, V14, P628, DOI 10.1016/S1472-6483(10)61057-7; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; Nakamura H, 2006, FEBS LETT, V580, P2717, DOI 10.1016/j.febslet.2006.04.029; Promislow JHE, 2007, HUM REPROD, V22, P853, DOI 10.1093/humrep/del417; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vitzthum VJ, 2001, CONTRACEPTION, V64, P319, DOI 10.1016/S0010-7824(01)00260-8; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; WYNN RM, 1974, AM J OBSTET GYNECOL, V118, P652, DOI 10.1016/S0002-9378(16)33740-1	39	193	199	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10258	10.1371/journal.pone.0010258	http://dx.doi.org/10.1371/journal.pone.0010258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422011	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000276952500016
J	Zhang, YJ; Xuan, JH; de los Reyes, BG; Clarke, R; Ressom, HW				Zhang, Yuji; Xuan, Jianhua; de los Reyes, Benildo G.; Clarke, Robert; Ressom, Habtom W.			Reconstruction of Gene Regulatory Modules in Cancer Cell Cycle by Multi-Source Data Integration	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTION; TRANSCRIPTIONAL REGULATION; INTERACTION NETWORK; DNA-REPLICATION; EXPRESSION DATA; MICROARRAY DATA; IDENTIFICATION; BIOLOGY; E2F; COREGULATION	Background: Precise regulation of the cell cycle is crucial to the growth and development of all organisms. Understanding the regulatory mechanism of the cell cycle is crucial to unraveling many complicated diseases, most notably cancer. Multiple sources of biological data are available to study the dynamic interactions among many genes that are related to the cancer cell cycle. Integrating these informative and complementary data sources can help to infer a mutually consistent gene transcriptional regulatory network with strong similarity to the underlying gene regulatory relationships in cancer cells. Results and Principal Findings: We propose an integrative framework that infers gene regulatory modules from the cell cycle of cancer cells by incorporating multiple sources of biological data, including gene expression profiles, gene ontology, and molecular interaction. Among 846 human genes with putative roles in cell cycle regulation, we identified 46 transcription factors and 39 gene ontology groups. We reconstructed regulatory modules to infer the underlying regulatory relationships. Four regulatory network motifs were identified from the interaction network. The relationship between each transcription factor and predicted target gene groups was examined by training a recurrent neural network whose topology mimics the network motif(s) to which the transcription factor was assigned. Inferred network motifs related to eight well-known cell cycle genes were confirmed by gene set enrichment analysis, binding site enrichment analysis, and comparison with previously published experimental results. Conclusions: We established a robust method that can accurately infer underlying relationships between a given transcription factor and its downstream target genes by integrating different layers of biological data. Our method could also be beneficial to biologists for predicting the components of regulatory modules in which any candidate gene is involved. Such predictions can then be used to design a more streamlined experimental approach for biological validation. Understanding the dynamics of these modules will shed light on the processes that occur in cancer cells resulting from errors in cell cycle regulation.	[Zhang, Yuji; Clarke, Robert; Ressom, Habtom W.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Zhang, Yuji; Xuan, Jianhua] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA USA; [de los Reyes, Benildo G.] Univ Maine, Sch Biol & Ecol, Orono, ME USA	Georgetown University; Virginia Polytechnic Institute & State University; University of Maine System; University of Maine Orono	Zhang, YJ (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	hwr@georgetown.edu	Zhang, Yuji/J-4599-2013; zhang, yuji/B-9446-2012; Clarke, Robert/A-6485-2008	Clarke, Robert/0000-0002-9278-0854; Zhang, Yuji/0000-0002-5429-6762	National Institutes of Health [CA109872, NS29525, EB00830, CA096483]; Department of Defense [BC030280]; NATIONAL CANCER INSTITUTE [R01CA096483, R21CA109872, R33CA109872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000830, R33EB000830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported in part by grants from the National Institutes of Health (CA109872, NS29525, EB00830, and CA096483) and the Department of Defense (BC030280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chen HC, 2004, BIOINFORMATICS, V20, P1914, DOI 10.1093/bioinformatics/bth178; Chen L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-416; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; de Hoon MJL, 2002, BIOINFORMATICS, V18, P1477, DOI 10.1093/bioinformatics/18.11.1477; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; JAMES CB, RECOGNITION FUZZY OB, P256; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Keedwell E, 2005, IEEE ACM T COMPUT BI, V2, P231, DOI 10.1109/TCBB.2005.40; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li CW, 2006, CANCER INFORM, V2, P223; Lin D., 1998, ICML, V98, P296; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Ressom H, 2003, PHYSIOL GENOMICS, V13, P107, DOI 10.1152/physiolgenomics.00097.2002; RESSOM HW, 2006, P 28 IEEE ENG MED BI, P4241; Romer KA, 2007, NUCLEIC ACIDS RES, V35, pW217, DOI 10.1093/nar/gkm376; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Takahashi Y, 2000, GENE DEV, V14, P804; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; XU R, 2005, GENE REGULATORY NETW, P286; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	56	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10268	10.1371/journal.pone.0010268	http://dx.doi.org/10.1371/journal.pone.0010268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422009	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500020
J	da Hora, RR; Delabie, JHC; dos Santos, CG; Serrao, JE				da Hora, Riviane Rodigues; Charles Delabie, Jacques Hubert; dos Santos, Carolina Goncalves; Serrao, Jose Eduardo			Glandular Epithelium as a Possible Source of a Fertility Signal in Ectatomma tuberculatum (Hymenoptera: Formicidae) Queens	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; NESTMATE RECOGNITION; REPRODUCTIVE STATUS; GERMAN-COCKROACH; WAX SECRETION; ANT; LARVAE; CUTICLE; BIOSYNTHESIS; CIRCULATION	The wax layer covering the insect's cuticle plays an important protective role, as for example, uncontrolled water loss. In social insects, wax production is well-known in some bees that use it for nest building. Curiously, mated-fertile queens of the ant Ectatomma tuberculatum produce an uncommon extra-wax coat and, consequently queens (mated-fertile females) are matte due to such extra cuticular hydrocarbon (CHC) coat that covers the cuticle and masks the brightness of the queens' cuticle while gynes (virgin-infertile queens) are shiny. In this study, histological analysis showed differences in the epidermis between fertile (i.e., queens or gynes with highly ovarian activity) and infertile females ( gynes or workers with non developed ovaries). In fertile females the epidermis is a single layer of cubic cells found in all body segments whereas in infertile females it is a thin layer of flattened cells. Ultrastructural features showed active secretory tissue from fertile females similar to the glandular epithelium of wax-producing bees ( type I gland). Different hypotheses related to the functions of the glandular epithelium exclusive to the E. tuberculatum fertile queens are discussed.	[da Hora, Riviane Rodigues; dos Santos, Carolina Goncalves; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [da Hora, Riviane Rodigues; Charles Delabie, Jacques Hubert] Convenio UESC CEPEC CEPLAC, UPA Lab Mirmecol, Itabuna, Brazil	Universidade Federal de Vicosa; Universidade Estadual de Santa Cruz	da Hora, RR (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.	jeserrao@ufv.br	Serrão, Jose Eduardo/H-2935-2012; Delabie, Jacques H C/F-3405-2010	Delabie, Jacques H C/0000-0002-2695-1061	National Council of Research (CNPq); Minas Gerais State Research Agency (FAPEMIG); PRONEX FAPESB/CNPq [PNX0011/2009]	National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Research Agency (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); PRONEX FAPESB/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian research agencies National Council of Research (CNPq), Minas Gerais State Research Agency (FAPEMIG) and PRONEX FAPESB/CNPq PNX0011/2009. The funders had no role in study design, data collection and and analysis, decision to publish, or preparation of the manuscript.	Agarwala BK, 2001, ENTOMOL EXP APPL, V100, P101, DOI 10.1023/A:1019234526303; Azevedo DD, 2007, ANIM BIOL, V57, P329, DOI 10.1163/157075607781753074; Billen J, 2002, BELG J ZOOL, V132, P175; Billen J, 2006, ACTA ZOOL-STOCKHOLM, V87, P291, DOI 10.1111/j.1463-6395.2006.00244.x; BLOMQUIST GJ, 1980, INSECT BIOCHEM, V10, P313, DOI 10.1016/0020-1790(80)90026-8; BRADLEY GA, 1973, CAN ENTOMOL, V105, P1113, DOI 10.4039/Ent1051113-8; BREED MD, 1988, P NATL ACAD SCI USA, V85, P8766, DOI 10.1073/pnas.85.22.8766; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cruz Landim C. da., 1963, Journal of the New York Entomological Society, V71, P2; CRUZLANDIM C, 1993, NATURALIA, V8, P173; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; Dapporto L, 2008, J INSECT PHYSIOL, V54, P89, DOI 10.1016/j.jinsphys.2007.08.005; de Biseau JC, 2004, J INSECT PHYSIOL, V50, P585, DOI 10.1016/j.jinsphys.2004.04.005; DIEHL PA, 1975, J INSECT PHYSIOL, V21, P1237, DOI 10.1016/0022-1910(75)90093-1; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; Eelen D, 2004, ARTHROPOD STRUCT DEV, V33, P471, DOI 10.1016/j.asd.2004.08.001; EISNER T, 1994, J CHEM ECOL, V20, P2743, DOI 10.1007/BF02036205; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Falleiros Angela M. F., 1995, Revista Brasileira de Zoologia, V12, P751, DOI 10.1590/S0101-81751995000400004; Fan YL, 2003, NATURWISSENSCHAFTEN, V90, P121, DOI 10.1007/s00114-003-0402-y; GAMBOA GJ, 1986, ANNU REV ENTOMOL, V31, P431, DOI 10.1146/annurev.en.31.010186.002243; Gibbs AG, 1998, AM ZOOL, V38, P268; Gobin B, 2003, ACTA ZOOL-STOCKHOLM, V84, P285, DOI 10.1046/j.1463-6395.2003.00149.x; GU X, 1995, J INSECT PHYSIOL, V41, P257, DOI 10.1016/0022-1910(94)00100-U; Guerino Adriane C., 2003, Neotrop. entomol., V32, P261, DOI 10.1590/S1519-566X2003000200010; Hadley N.F., 1984, BIOL INTEGUMENT INVE, P685; HADLEY NF, 1982, J EXP ZOOL, V222, P239, DOI 10.1002/jez.1402220306; HADLEY NF, 1979, SCIENCE, V203, P367, DOI 10.1126/science.203.4378.367; Hannonen M, 2002, ANIM BEHAV, V64, P477, DOI 10.1006/anbe.2002.4001; Hefetz Abraham, 2007, Myrmecological News, V10, P59; HOLLDOBLER B, 1994, INSECT SOC, V41, P63, DOI 10.1007/BF01240573; Hora RR, 2008, NATURWISSENSCHAFTEN, V95, P55, DOI 10.1007/s00114-007-0287-2; Hora RR, 2005, INSECT SOC, V52, P194, DOI 10.1007/s00040-004-0794-5; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Johnson RA, 2004, J INSECT PHYSIOL, V50, P943, DOI 10.1016/j.jinsphys.2004.07.006; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Lucas C, 2004, J INSECT PHYSIOL, V50, P595, DOI 10.1016/j.jinsphys.2004.04.006; Manfredini F, 2008, TISSUE CELL, V40, P103, DOI 10.1016/j.tice.2007.10.003; Marques-Silva S, 2006, MICROSC RES TECHNIQ, V69, P885, DOI 10.1002/jemt.20356; MICHENER C D, 1974, P404; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; Monnin T, 2006, ANN ZOOL FENN, V43, P515; MOTA M H V B, 1988, Revista Brasileira de Zoologia, V5, P119, DOI 10.1590/S0101-81751988000100010; NOIROT C, 1991, ANN SOC ENTOMOL FR, V27, P123; Oettler J, 2008, J INSECT PHYSIOL, V54, P672, DOI 10.1016/j.jinsphys.2008.01.004; Patel Sejal, 2001, Journal of Insect Science (Tucson), V1, P1; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Pope R.D., 1985, Antenna, V9, P4; POPE RD, 1979, SYST ENTOMOL, V4, P171, DOI 10.1111/j.1365-3113.1979.tb00632.x; Raccaud-Schoeller J., 1980, INSECTES PHYSL DEV, P296; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROMA CR, 2010, MICRON, DOI DOI 10.1016/J.MICRON.2009.12.007; Roma GC, 2009, ANIM BIOL, V59, P241, DOI 10.1163/157075609X437745; ROMER F, 1980, HISTOCHEMISTRY, V69, P69, DOI 10.1007/BF00508368; Schal C, 1998, AM ZOOL, V38, P382; Serrao JE, 2009, MICROSC RES TECHNIQ, V72, P28, DOI 10.1002/jemt.20641; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Soroker V, 2000, J INSECT PHYSIOL, V46, P1097, DOI 10.1016/S0022-1910(99)00219-X; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; TAKABAYASHI J, 1993, J INSECT BEHAV, V6, P107, DOI 10.1007/BF01049151; Turillazzi S, 2006, CURR BIOL, V16, pR530, DOI 10.1016/j.cub.2006.06.050; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Volkl W, 1996, OECOLOGIA, V107, P498, DOI 10.1007/BF00333941; Zinck L, 2007, BEHAV ECOL, V18, P701, DOI 10.1093/beheco/arm033	69	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10219	10.1371/journal.pone.0010219	http://dx.doi.org/10.1371/journal.pone.0010219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419093	Green Published, Green Submitted, gold			2022-12-27	WOS:000276853800011
J	Rapin, N; Lund, O; Bernaschi, M; Castiglione, F				Rapin, Nicolas; Lund, Ole; Bernaschi, Massimo; Castiglione, Filippo			Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System	PLOS ONE			English	Article							MHC CLASS-I; HIV TYPE-1 INFECTION; DIPLOID CELL STRAINS; T-CELLS; PEPTIDE-BINDING; VIRAL DYNAMICS; QUANTITATIVE PREDICTIONS; VACCINE RESEARCH; VIRUS-INFECTION; COMPUTER-MODEL	We present a new approach to the study of the immune system that combines techniques of systems biology with information provided by data-driven prediction methods. To this end, we have extended an agent-based simulator of the immune response, C-IMMSIM, such that it represents pathogens, as well as lymphocytes receptors, by means of their amino acid sequences and makes use of bioinformatics methods for T and B cell epitope prediction. This is a key step for the simulation of the immune response, because it determines immunogenicity. The binding of the epitope, which is the immunogenic part of an invading pathogen, together with activation and cooperation from T helper cells, is required to trigger an immune response in the affected host. To determine a pathogen's epitopes, we use existing prediction methods. In addition, we propose a novel method, which uses Miyazawa and Jernigan protein-protein potential measurements, for assessing molecular binding in the context of immune complexes. We benchmark the resulting model by simulating a classical immunization experiment that reproduces the development of immune memory. We also investigate the role of major histocompatibility complex (MHC) haplotype heterozygosity and homozygosity with respect to the influenza virus and show that there is an advantage to heterozygosity. Finally, we investigate the emergence of one or more dominating clones of lymphocytes in the situation of chronic exposure to the same immunogenic molecule and show that high affinity clones proliferate more than any other. These results show that the simulator produces dynamics that are stable and consistent with basic immunological knowledge. We believe that the combination of genomic information and simulation of the dynamics of the immune system, in one single tool, can offer new perspectives for a better understanding of the immune system.	[Rapin, Nicolas] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Rapin, Nicolas] Univ Copenhagen, Bioinformat Ctr, Copenhagen, Denmark; [Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Bernaschi, Massimo; Castiglione, Filippo] CNR, Inst Comp Applicat, Rome, Italy	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Consiglio Nazionale delle Ricerche (CNR)	Rapin, N (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.	f.castiglione@iac.rm.cnr.it	Lund, Ole/F-4437-2014; Castiglione, Filippo/B-1366-2010	Lund, Ole/0000-0003-1108-0491; Castiglione, Filippo/0000-0002-1442-3552; Rapin, Nicolas/0000-0001-5208-8874	European Community [FP6-2004-IST-4]	European Community(European Commission)	This work was supported by the European Community under the contract FP6-2004-IST-4, No. 028069 (ImmunoGrid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PM, 1987, IMMUNOL TODAY, V8, P270, DOI 10.1016/0167-5699(87)90187-3; ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; Bernaschi M, 2001, COMPUT BIOL MED, V31, P303, DOI 10.1016/S0010-4825(01)00011-7; Berzofsky J A, 1985, Year Immunol, P18; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; BRUSIC V, 1994, NUCLEIC ACIDS RES, V22, P3663, DOI 10.1093/nar/22.17.3663; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Castiglione F, 2004, AIDS RES HUM RETROV, V20, P1314, DOI 10.1089/aid.2004.20.1314; Castiglione F, 2007, BIOINFORMATICS, V23, P1371, DOI 10.1093/bioinformatics/btm044; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; CELADA F, 1971, PROG ALLERGY, V15, P223; Celada F, 1996, EUR J IMMUNOL, V26, P1350, DOI 10.1002/eji.1830260626; Cheng YM, 2009, VACCINE, V27, P833, DOI 10.1016/j.vaccine.2008.11.109; DEBOER RJ, 1994, J THEOR BIOL, V169, P375, DOI 10.1006/jtbi.1994.1160; deJong MD, 1997, AIDS, V11, pF79, DOI 10.1097/00002030-199711000-00002; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; ESSUNGER P, 1994, J THEOR BIOL, V170, P367, DOI 10.1006/jtbi.1994.1199; FARMER JD, 1986, PHYSICA D, V22, P187, DOI 10.1016/0167-2789(86)90240-X; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Herz AVM, 1996, P NATL ACAD SCI USA, V93, P7247, DOI 10.1073/pnas.93.14.7247; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; HOWARD JC, 1985, NATURE, V314, P494, DOI 10.1038/314494a0; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Kalita J K, 2006, Int J Bioinform Res Appl, V2, P63; Klenerman P, 1996, P NATL ACAD SCI USA, V93, P15323, DOI 10.1073/pnas.93.26.15323; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LARSEN JE, 2006, IMMUNOME RES, V2; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Lundegaard C, 2007, BIOINFORMATICS, V23, P3265, DOI 10.1093/bioinformatics/btm471; MANCA F, 1985, EUR J IMMUNOL, V15, P345, DOI 10.1002/eji.1830150408; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MCLEAN AR, 1992, AIDS, V6, P71, DOI 10.1097/00002030-199201000-00009; MEIERSCHELLERSH.M, 1999, SIMMUNE TOOL SIMULAT; Mittler JE, 1996, J ACQ IMMUN DEF SYND, V12, P233, DOI 10.1097/00042560-199607000-00003; Miyazawa S, 2000, PROTEIN ENG, V13, P459, DOI 10.1093/protein/13.7.459; Miyazawa S, 1999, PROTEINS, V36, P357, DOI 10.1002/(SICI)1097-0134(19990815)36:3<357::AID-PROT10>3.3.CO;2-L; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MORPURGO D, 1995, INT IMMUNOL, V7, P505, DOI 10.1093/intimm/7.4.505; Motta Santo, 2005, Immunome Res, V1, P5, DOI 10.1186/1745-7580-1-5; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Nowak MA, 1997, J THEOR BIOL, V184, P205, DOI 10.1006/jtbi.1996.0307; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PERELSON AS, 1989, IMMUNOL REV, V110, P5, DOI 10.1111/j.1600-065X.1989.tb00025.x; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; RAPIN N, 2008, IMMUNOGENETICS; Reche PA, 2005, BIOINFORMATICS, V21, P2140, DOI 10.1093/bioinformatics/bti269; Santoni D, 2008, BIOINFORMATICS, V24, P1374, DOI 10.1093/bioinformatics/btn135; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SEIDEN PE, 1992, J THEOR BIOL, V158, P329, DOI 10.1016/S0022-5193(05)80737-4; SEIDMAN JG, 1978, NATURE, V276, P790, DOI 10.1038/276790a0; Sette A, 2005, IMMUNOGENETICS, V57, P53, DOI 10.1007/s00251-004-0749-z; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; Stilianakis NI, 1997, J VIROL, V71, P161, DOI 10.1128/JVI.71.1.161-168.1997; Sulzer B, 1996, MATH BIOSCI, V135, P147, DOI 10.1016/0025-5564(96)00022-3; Tang ST, 2008, ARCH VIROL, V153, P1833, DOI 10.1007/s00705-008-0194-7; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wein LM, 1997, J THEOR BIOL, V185, P15, DOI 10.1006/jtbi.1996.0253; WHITACRE CC, 1991, J IMMUNOL, V147, P2155; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	85	280	287	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e9862	10.1371/journal.pone.0009862	http://dx.doi.org/10.1371/journal.pone.0009862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419125	Green Submitted, Green Published, gold			2022-12-27	WOS:000276743500004
J	Feunou, PF; Bertout, J; Locht, C				Feunou, Pascal Feunou; Bertout, Julie; Locht, Camille			T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; FILAMENTOUS HEMAGGLUTININ; TH17 CELLS; RESPIRATORY-INFECTION; HELPER TYPE-1; MURINE MODEL; WHOLE-CELL; IMMUNITY; TOXIN; EPIDEMIOLOGY	Background: Despite the extensive use of efficacious vaccines, pertussis still ranks among the major causes of childhood mortality worldwide. Two types of pertussis vaccines are currently available, whole-cell, and the more recent acellular vaccines. Because of reduced reactogenicity and comparable efficacy acellular vaccines progressively replace whole-cell vaccines. However, both types require repeated administrations for optimal efficacy. We have recently developed a live attenuated vaccine candidate, named BPZE1, able to protect infant mice after a single nasal administration. Methodology/Principal Findings: We determined the protective mechanism of BPZE1-mediated immunity by using passive transfer of T cells and antibodies from BPZE1-immunized mice to SCID mice. Clearance of Bordetella pertussis from the lungs was mediated by both BPZE1-induced antibodies and CD4(+), but not by CD8(+) T cells. The protective CD4(+) T cells comprised IFN-gamma-producing and IL-17-producing subsets, indicating that BPZE1 induces both Th1 and Th17 CD4(+) T cells. In addition, and in contrast to acellular pertussis vaccines, BPZE1 also cross-protected against Bordetella parapertussis infection, but in this case only the transfer of CD4(+) T cells conferred protection. Serum from BPZE1-immunized mice was not able to kill B. parapertussis and did not protect SCID mice against B. parapertussis infection. Conclusions/Significance: The novel live attenuated pertussis vaccine BPZE1 protects in a pre-clinical mouse model against B. pertussis challenge by both BPZE1-induced antibodies and CD4(+) T cell responses. It also protects against B. parapertussis infection. However, in this case protection is only T cell mediated.	[Feunou, Pascal Feunou; Locht, Camille] INSERM, U1019, F-59045 Lille, France; [Feunou, Pascal Feunou; Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, F-59019 Lille, France; [Feunou, Pascal Feunou; Bertout, Julie; Locht, Camille] Univ Lille Nord France, Lille, France; [Bertout, Julie] IFR142, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Feunou, PF (corresponding author), INSERM, U1019, F-59045 Lille, France.	camille.locht@pasteur-lille.fr	Locht, Camille/L-3516-2018	Locht, Camille/0000-0001-7295-7336	Agence Nationale de Recherche (ANR), France [BP-VAC MIME 2005]; European Commission [201502]	Agence Nationale de Recherche (ANR), France(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the Agence Nationale de Recherche (ANR), France, under grant number BP-VAC MIME 2005 and by a grant from the European Commission under the grant agreement number 201502 (Child-Innovac). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; ANTOINE R, 1990, INFECT IMMUN, V58, P1518, DOI 10.1128/IAI.58.6.1518-1526.1990; Bergfors E, 1999, Int J Infect Dis, V3, P140, DOI 10.1016/S1201-9712(99)90035-8; Byrne P, 2004, EUR J IMMUNOL, V34, P2579, DOI 10.1002/eji.200425092; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P131; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; Decker MD, 2000, PEDIATR CLIN N AM, V47, P309, DOI 10.1016/S0031-3955(05)70209-1; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Edwards KM, 2005, PEDIATR INFECT DIS J, V24, pS104, DOI 10.1097/01.inf.0000166154.47013.47; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Feunou PF, 2008, VACCINE, V26, P5722, DOI 10.1016/j.vaccine.2008.08.018; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Greenberg David P, 2005, Pediatr Infect Dis J, V24, pS39, DOI 10.1097/01.inf.0000160911.65632.e1; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He QS, 1998, JAMA-J AM MED ASSOC, V280, P635, DOI 10.1001/jama.280.7.635; HEININGER U, 1994, PEDIATR INFECT DIS J, V13, P306, DOI 10.1097/00006454-199404000-00011; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Jefferson T, 2003, VACCINE, V21, P2003, DOI 10.1016/S0264-410X(02)00770-3; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Letowska I, 2004, EUR J CLIN MICROBIOL, V23, P499, DOI 10.1007/s10096-004-1141-5; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mahon BP, 1997, J EXP MED, V186, P1843, DOI 10.1084/jem.186.11.1843; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Mastrantonio P, 1997, DEV BIOL STAND, V89, P255; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; MENOZZI FD, 1994, INFECT IMMUN, V62, P769, DOI 10.1128/IAI.62.3.769-778.1994; MENOZZI FD, 1991, FEMS MICROBIOL LETT, V78, P59; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Mills KHG, 1998, INFECT IMMUN, V66, P594, DOI 10.1128/IAI.66.2.594-602.1998; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Page G, 2004, AM J PATHOL, V164, P409, DOI 10.1016/S0002-9440(10)63131-8; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pichichero ME, 1997, PEDIATRICS, V100, P772, DOI 10.1542/peds.100.5.772; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; SATO Y, 1984, LANCET, V1, P122; SEKURA RD, 1983, J BIOL CHEM, V258, P4647; Storsaeter J, 2007, BORDETELLA MOL MICRO, P245; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Watanabe M, 2001, INFECT IMMUN, V69, P6981, DOI 10.1128/IAI.69.11.6981-6986.2001; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07	52	52	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10178	10.1371/journal.pone.0010178	http://dx.doi.org/10.1371/journal.pone.0010178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419113	gold, Green Submitted, Green Published			2022-12-27	WOS:000276707100006
J	Ruchala, P; Navab, M; Jung, CL; Hama-Levy, S; Micewicz, ED; Luong, H; Reyles, JE; Sharma, S; Waring, AJ; Fogelman, AM; Lehrer, RI				Ruchala, Piotr; Navab, Mohamad; Jung, Chun-Ling; Hama-Levy, Susan; Micewicz, Ewa D.; Luong, Hai; Reyles, Jonathan E.; Sharma, Shantanu; Waring, Alan J.; Fogelman, Alan M.; Lehrer, Robert I.			Oxpholipin 11D: An Anti-Inflammatory Peptide That Binds Cholesterol and Oxidized Phospholipids	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN-1; POLYUNSATURATED FATTY-ACIDS; MIMETIC PEPTIDES; INFLAMMATORY MEDIATORS; MEMBRANE INTERACTIONS; RHEUMATOID-ARTHRITIS; SECONDARY STRUCTURE; CIRCULAR-DICHROISM	Background: Many Gram-positive bacteria produce pore-forming exotoxins that contain a highly conserved, 12-residue (ECTGLAWEWWRT) that binds cholesterol. This domain is usually flanked N-terminally by arginine and C-terminally valine. We used this 14-residue sequence as a template to create a small library of peptides that bind cholesterol and lipids. Methodology/Results: Several of these peptides manifested anti-inflammatory properties in a predictive in vitro monocyte assay, and some also diminished the pro-inflammatory effects of low-density lipoprotein in apoE-deficient The most potent analog, Oxpholipin-11D (OxP-11D), contained D-amino acids exclusively and was identical to the 14-design template except that diphenylalanine replaced cysteine-3. In surface plasmon resonance binding studies, 11D bound oxidized (phospho) lipids and sterols in much the same manner as D-4F, a widely studied cardioprotective I-mimetic peptide with anti-inflammatory properties. In contrast to D-4F, which adopts a stable a-helical structure in the OxP-11D structure was flexible and contained multiple turn-like features. Conclusion: Given the substantial evidence that oxidized phospholipids are pro-inflammatory in vivo, OxP-11D and other may have therapeutic potential.	[Ruchala, Piotr; Navab, Mohamad; Jung, Chun-Ling; Hama-Levy, Susan; Luong, Hai; Waring, Alan J.; Fogelman, Alan M.; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Micewicz, Ewa D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Reyles, Jonathan E.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Dept Chem, Pomona, CA 91768 USA; [Reyles, Jonathan E.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Ctr Macromol Modeling & Mat Design, Pomona, CA 91768 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California State University System; California State Polytechnic University Pomona; California State University System; California State Polytechnic University Pomona	Ruchala, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	pruchala@mednet.ucla.edu		RUCHALA, PIOTR/0000-0002-5574-2779	U.S. Public Health Service [HL-30568]; Laubisch; Castera; UCLA; Dean's Office of the David Geffen School of Medicine at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Laubisch; Castera; UCLA; Dean's Office of the David Geffen School of Medicine at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported in part by U.S. Public Health Service Grant HL-30568, the Laubisch, Castera, and M.K. Grey Funds at UCLA and funds from the Adams and Burnham endowments provided by the Dean's Office of the David Geffen School of Medicine at UCLA (PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharamaiah GM, 2006, CURR OPIN LIPIDOL, V17, P233, DOI 10.1097/01.mol.0000226114.89812.75; Back M, 2009, CARDIOVASC DRUG THER, V23, P41, DOI 10.1007/s10557-008-6140-9; BECHINGER B, 1991, CHEM PHYS LIPIDS, V58, P1, DOI 10.1016/0009-3084(91)90105-K; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Boyce JA, 2008, CURR MOL MED, V8, P335, DOI 10.2174/156652408785160989; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Capra V, 2006, CURR MED CHEM, V13, P3213, DOI 10.2174/092986706778742963; Chiesa G, 2003, CURR OPIN LIPIDOL, V14, P159, DOI 10.1097/00041433-200304000-00007; Claria J, 2006, RECENT PAT ANTI-CANC, V1, P369, DOI 10.2174/157489206778776961; Datta G, 2004, J BIOL CHEM, V279, P26509, DOI 10.1074/jbc.M314276200; Datta G, 2001, J LIPID RES, V42, P1096; Epand RM, 2004, J BIOL CHEM, V279, P51404, DOI 10.1074/jbc.M408581200; Epand RM, 2004, BIOCHEMISTRY-US, V43, P5073, DOI 10.1021/bi049786u; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FOGELMAN AM, 1988, J LIPID RES, V29, P1243; Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirata I, 2001, DIGESTION, V63, P73, DOI 10.1159/000051915; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keane D, 2008, BIOCHEM SOC T, V36, P955, DOI 10.1042/BST0360955; KLINGENBERG R, 2009, EUR HEART J; Krishnamoorthy Sriram, 2008, V49, P145, DOI 10.1007/978-1-4020-8831-5_6; Ku IA, 2009, CIRC J, V73, P977, DOI 10.1253/circj.CJ-09-0274; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Montecucco F, 2009, RHEUMATOLOGY, V48, P11, DOI 10.1093/rheumatology/ken395; Montecucco F, 2009, BEST PRACT RES CL EN, V23, P389, DOI 10.1016/j.beem.2008.12.003; Montecucco F, 2009, SEMIN IMMUNOPATHOL, V31, P127, DOI 10.1007/s00281-009-0150-y; Montecucco F, 2009, SEMIN IMMUNOPATHOL, V31, P1, DOI 10.1007/s00281-009-0146-7; Moreno JJ, 2009, BIOCHEM PHARMACOL, V77, P1, DOI 10.1016/j.bcp.2008.07.033; Moubayed SP, 2007, CURR OPIN LIPIDOL, V18, P638, DOI 10.1097/MOL.0b013e3282f0ee11; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Navab M, 2000, J LIPID RES, V41, P1495; Navab M, 2005, CIRC RES, V97, P524, DOI 10.1161/01.RES.0000181229.69508.2f; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Navab M, 2008, CURR DRUG TARGETS, V9, P204, DOI 10.2174/138945008783755584; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel MI, 2008, J UROLOGY, V179, P1668, DOI 10.1016/j.juro.2007.12.037; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Riccioni G, 2002, INT J IMMUNOPATH PH, V15, P171, DOI 10.1177/039463200201500303; Riccioni G, 2008, J LEUKOCYTE BIOL, V84, P1374, DOI 10.1189/jlb.0808476; Roccatano D, 2005, PROTEIN SCI, V14, P2582, DOI 10.1110/ps.051426605; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sethi AA, 2007, CURR OPIN INVEST DR, V8, P201; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Torocsik D, 2009, MOL ASPECTS MED, V30, P134, DOI 10.1016/j.mam.2009.02.002; ULRICH AS, 1994, BIOPHYS J, V66, P1441, DOI 10.1016/S0006-3495(94)80934-8; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; Vejux A, 2009, MOL ASPECTS MED, V30, P153, DOI 10.1016/j.mam.2009.02.006; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; Yamaguchi H, 2003, BIOSCI BIOTECH BIOCH, V67, P2269, DOI 10.1271/bbb.67.2269; Yamaguchi S, 2001, BIOPHYS J, V81, P2203, DOI 10.1016/S0006-3495(01)75868-7; Zhu XW, 2005, J LIPID RES, V46, P1303, DOI 10.1194/jlr.M400401-JLR200	75	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10181	10.1371/journal.pone.0010181	http://dx.doi.org/10.1371/journal.pone.0010181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418958	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706800018
J	Strunk, T; Coombs, MRP; Currie, AJ; Richmond, P; Golenbock, DT; Stoler-Barak, L; Gallington, LC; Otto, M; Burgner, D; Levy, O				Strunk, Tobias; Coombs, Melanie R. Power; Currie, Andrew J.; Richmond, Peter; Golenbock, Douglas T.; Stoler-Barak, Liat; Gallington, Leighanne C.; Otto, Michael; Burgner, David; Levy, Ofer			TLR2 Mediates Recognition of Live Staphylococcus epidermidis and Clearance of Bacteremia	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; PHENOL-SOLUBLE MODULIN; CUTTING EDGE; CYTOKINE PRODUCTION; SIGNAL-TRANSDUCTION; IFN-GAMMA; AUREUS; ACTIVATION; CELLS; PHAGOCYTOSIS	Background: Staphylococcus epidermidis (SE) is a nosocomial pathogen that causes catheter-associated bacteremia in the immunocompromised, including those at the extremes of age, motivating study of host clearance mechanisms. SE-derived soluble components engage TLR2; but additional signaling pathways have also been implicated, and TLR2 can play complex, at times detrimental, roles in host defense against other Staphylococcal spp. The role of TLR2 in responses of primary blood leukocytes to live SE and in clearance of SE bacteremia, the most common clinical manifestation of SE infection, is unknown. Methodology/Principal Findings: We studied TLR2-mediated recognition of live clinical SE strain 1457 employing TLR2-transfected cells, neutralizing anti-TLR antibodies and TLR2-deficient mice. TLR2 mediated SE-induced cytokine production in human embryonic kidney cells, human whole blood and murine primary macrophages, in part via recognition of a soluble TLR2 agonist. After i.v. challenge with SE, early (1 h) cytokine/chemokine production and subsequent clearance of bacteremia (24-48 h) were markedly impaired in TLR2-deficient mice. Conclusions/Significance: TLR2 mediates recognition of live SE and clearance of SE bacteremia in vivo.	[Strunk, Tobias; Currie, Andrew J.; Richmond, Peter; Burgner, David] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Coombs, Melanie R. Power; Stoler-Barak, Liat; Gallington, Leighanne C.; Levy, Ofer] Childrens Hosp Boston, Div Infect Dis, Boston, MA USA; [Coombs, Melanie R. Power; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Otto, Michael] NIAID, NIH, Bethesda, MD 20892 USA; [Burgner, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Western Australia; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Strunk, T (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	ofer.levy@childrens.harvard.edu	Coombs, Melanie/GQH-9000-2022; Currie, Andrew/C-2778-2015; Richmond, Peter C/G-3379-2012; Gallington, Leighanne C/G-9341-2011; Strunk, Tobias/AIE-3407-2022	Richmond, Peter C/0000-0001-7562-7228; Gallington, Leighanne C/0000-0002-0383-7522; Strunk, Tobias/0000-0001-7079-2339; Coombs, Melanie/0000-0002-2036-8414; Currie, Andrew/0000-0002-5193-3404; Otto, Michael/0000-0002-2222-4115; Burgner, David/0000-0002-8304-4302; Levy, Ofer/0000-0002-5859-1945	National Institute of Allergy and Infectious Diseases, National Institutes of Health [RO1 AI067353-01A1]; Princess Margaret Hospital; Women's and Infants' Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; U. Western Australia; Rebecca Cooper Medical Research Foundation; Channel7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council, Australia; Intramural Research Program of the National Institute of Allergy and Infectious Diseases; U.S. National Institutes of Health; Deutsche Forschungsgemeinschaft [STR1022/1-1]; University of Western Australia; Harvard Club of Australia; Canadian Institutes of Health Research; Children's Health Research Foundation of Western Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080, R01AI067353, R01AI052455] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Princess Margaret Hospital; Women's and Infants' Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; U. Western Australia; Rebecca Cooper Medical Research Foundation; Channel7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Western Australia; Harvard Club of Australia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Health Research Foundation of Western Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support: National Institute of Allergy and Infectious Diseases, National Institutes of Health RO1 AI067353-01A1 (O. L.); Princess Margaret Hospital, Women's and Infants' Research Foundation Western Australia, Clive and Vera Ramaciotti Medical Research Foundation, U. Western Australia, Rebecca Cooper Medical Research Foundation, Channel7 Telethon, European Society for Paediatric Infectious Diseases and the National Health and Medical Research Council, Australia (T. S., A. C., P. R., and D. B.); Intramural Research Program of the National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health (M. O.). T. S. was supported by a Research Fellowship of the Deutsche Forschungsgemeinschaft (STR1022/1-1) and an International Postgraduate Research Scholarship of the University of Western Australia. Support was also provided by fellowships from the Harvard Club of Australia (O. L.), Canadian Institutes of Health Research (M. C.) and the Children's Health Research Foundation of Western Australia (A. J. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Albanyan EA, 2000, INFECT IMMUN, V68, P5794, DOI 10.1128/IAI.68.10.5794-5802.2000; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cuzzola M, 2000, J IMMUNOL, V164, P5871, DOI 10.4049/jimmunol.164.11.5871; Equils O, 2003, J IMMUNOL, V170, P5159, DOI 10.4049/jimmunol.170.10.5159; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gekara NO, 2009, J INFECT DIS, V199, P124, DOI 10.1086/595562; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hartel C, 2008, ARCH DIS CHILD-FETAL, V93, pF140, DOI 10.1136/adc.2007.124685; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Karchmer AW, 2008, CLIN INFECT DIS, V46, pS342, DOI 10.1086/533589; Knuefermann P, 2004, CIRCULATION, V110, P3693, DOI 10.1161/01.CIR.0000143081.13042.04; Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Levy O, 2003, INFECT IMMUN, V71, P6344, DOI 10.1128/IAI.71.11.6344-6353.2003; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Megyeri K, 2002, CYTOKINE, V19, P206, DOI 10.1006/cyto.2002.0876; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Natsuka M, 2008, INNATE IMMUN-LONDON, V14, P298, DOI 10.1177/1753425908096518; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2004, J INFECT DIS, V190, P748, DOI 10.1086/422157; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; ROBINSON WA, 1977, NEW ENGL J MED, V297, P1129, DOI 10.1056/NEJM197711242972101; Rowe J, 2004, J ALLERGY CLIN IMMUN, V113, P710, DOI 10.1016/j.jaci.2003.12.585; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Schaffer AC, 2009, INFECT DIS CLIN N AM, V23, P153, DOI 10.1016/j.idc.2008.10.005; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; STEVENS NT, 2008, CELL MICROBIOL; Strunk T, 2007, CURR OPIN INFECT DIS, V20, P370, DOI 10.1097/QCO.0b013e3281a7ec98; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuyt RJL, 2003, CYTOKINE, V21, P65, DOI 10.1016/S1043-4666(02)00501-X; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Venkatesh Mohan P, 2006, Semin Pediatr Infect Dis, V17, P120, DOI 10.1053/j.spid.2006.06.005; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Wetzler LM, 2003, VACCINE, V21, pS55, DOI 10.1016/S0264-410X(03)00201-9	46	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10111	10.1371/journal.pone.0010111	http://dx.doi.org/10.1371/journal.pone.0010111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404927	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482100022
J	Moussaid, M; Perozo, N; Garnier, S; Helbing, D; Theraulaz, G				Moussaid, Mehdi; Perozo, Niriaska; Garnier, Simon; Helbing, Dirk; Theraulaz, Guy			The Walking Behaviour of Pedestrian Social Groups and Its Impact on Crowd Dynamics	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; SELF-ORGANIZATION; PARTICIPATION; DISTANCE; FLIGHT; MODEL; SIZE	Human crowd motion is mainly driven by self-organized processes based on local interactions among pedestrians. While most studies of crowd behaviour consider only interactions among isolated individuals, it turns out that up to 70% of people in a crowd are actually moving in groups, such as friends, couples, or families walking together. These groups constitute medium-scale aggregated structures and their impact on crowd dynamics is still largely unknown. In this work, we analyze the motion of approximately 1500 pedestrian groups under natural condition, and show that social interactions among group members generate typical group walking patterns that influence crowd dynamics. At low density, group members tend to walk side by side, forming a line perpendicular to the walking direction. As the density increases, however, the linear walking formation is bent forward, turning it into a V-like pattern. These spatial patterns can be well described by a model based on social communication between group members. We show that the V-like walking pattern facilitates social interactions within the group, but reduces the flow because of its "non-aerodynamic" shape. Therefore, when crowd density increases, the group organization results from a trade-off between walking faster and facilitating social exchange. These insights demonstrate that crowd dynamics is not only determined by physical constraints induced by other pedestrians and the environment, but also significantly by communicative, social interactions among individuals.	[Moussaid, Mehdi; Perozo, Niriaska; Garnier, Simon; Theraulaz, Guy] Univ Toulouse 3, Ctr Rech Cognit Anim, F-31062 Toulouse, France; [Moussaid, Mehdi; Helbing, Dirk] ETH, Swiss Fed Inst Technol, Chair Sociol, Zurich, Switzerland; [Moussaid, Mehdi; Theraulaz, Guy] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Perozo, Niriaska] Univ Centroccidental Lisandro Alvarado, Unidad Invest Inteligencia Artificial, Barquisimeto, Venezuela; [Helbing, Dirk] Santa Fe Inst, Santa Fe, NM 87501 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; The Santa Fe Institute	Moussaid, M (corresponding author), Univ Toulouse 3, Ctr Rech Cognit Anim, F-31062 Toulouse, France.	moussaid@cict.fr	Theraulaz, Guy/H-8464-2016; Garnier, Simon/A-3998-2010; Moussaïd, Mehdi/G-2366-2010; Garnier, Simon/N-3814-2019	Theraulaz, Guy/0000-0002-3062-4215; Garnier, Simon/0000-0002-3886-3974	ETH Zurich; CNRS;  [ANR-08-SYSC-015]	ETH Zurich(ETH Zurich); CNRS(Centre National de la Recherche Scientifique (CNRS)); 	This work was supported by the ANR-08-SYSC-015. Mehdi Moussaid is supported by a jointly financed doctoral-engineer fellowship from ETH Zurich and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini G, 2006, TRANSPORT RES B-METH, V40, P667, DOI 10.1016/j.trb.2005.09.006; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; AVENI AF, 1977, SOCIOMETRY, V40, P96, DOI 10.2307/3033551; Ball P., 2004, CRITICAL MASS ONE TH; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; COLEMAN JS, 1961, SOCIOMETRY, V24, P36, DOI 10.2307/2785927; COLLINS RD, 1995, J NEUROSCI METH, V60, P95, DOI 10.1016/0165-0270(94)00224-5; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; DAAMEN W, 2002, J TRANSPORT INFRASTR, V3, P39; Hare AP, 1962, HDB SMALL GROUP RES; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2001, ENVIRON PLANN B, V28, P361, DOI 10.1068/b2697; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; HEPPNER FH, 1974, BIRD BANDING, V45, P160, DOI 10.2307/4512025; Hoogendoorn SP, 2005, TRANSPORT SCI, V39, P147, DOI 10.1287/trsc.1040.0102; HORVATH WJ, 1965, BEHAV SCI, V10, P164, DOI 10.1002/bs.3830100206; James J, 1953, AM SOCIOL REV, V18, P569, DOI 10.2307/2087444; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10001; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10014; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; MORI M, 1987, TRANSPORT RES A-POL, V21, P223, DOI 10.1016/0191-2607(87)90016-1; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Seyfried A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10002; Singh H, 2009, APPL MATH MODEL, V33, P4408, DOI 10.1016/j.apm.2009.03.020; Stephan FF, 1952, AM SOCIOL REV, V17, P598, DOI 10.2307/2088227; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; WEIDMANN U, 1993, 90 SCHRIFTENREIHEIVT; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105	31	544	572	9	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10047	10.1371/journal.pone.0010047	http://dx.doi.org/10.1371/journal.pone.0010047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580MX	20383280	Green Published, Green Submitted, gold			2022-12-27	WOS:000276454000011
J	Dutta, K; Ghosh, D; Nazmi, A; Kumawat, KL; Basu, A				Dutta, Kallol; Ghosh, Debapriya; Nazmi, Arshed; Kumawat, Kanhaiya Lal; Basu, Anirban			A Common Carcinogen Benzo[a]pyrene Causes Neuronal Death in Mouse via Microglial Activation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BENZO(A)PYRENE; EXPOSURE; BENZO<A>PYRENE; NEUROTOXICITY; METABOLISM; EXPRESSION; CANCER; FOOD; RAT	Background: Benzo[a]pyrene (B[a]P) belongs to a class of polycyclic aromatic hydrocarbons that serve as micropollutants in the environment. B[a]P has been reported as a probable carcinogen in humans. Exposure to B[a]P can take place by ingestion of contaminated (especially grilled, roasted or smoked) food or water, or inhalation of polluted air. There are reports available that also suggests neurotoxicity as a result of B[a]P exposure, but the exact mechanism of action is unknown. Methodology/Principal Findings: Using neuroblastoma cell line and primary cortical neuron culture, we demonstrated that B[a]P has no direct neurotoxic effect. We utilized both in vivo and in vitro systems to demonstrate that B[a]P causes microglial activation. Using microglial cell line and primary microglial culture, we showed for the first time that B[a]P administration results in elevation of reactive oxygen species within the microglia thereby causing depression of antioxidant protein levels; enhanced expression of inducible nitric oxide synthase, that results in increased production of NO from the cells. Synthesis and secretion of proinflammatory cytokines were also elevated within the microglia, possibly via the p38MAP kinase pathway. All these factors contributed to bystander death of neurons, in vitro. When administered to animals, B[a]P was found to cause microglial activation and astrogliosis in the brain with subsequent increase in proinflammatory cytokine levels. Conclusions/Significance: Contrary to earlier published reports we found that B[a]P has no direct neurotoxic activity. However, it kills neurons in a bystander mechanism by activating the immune cells of the brain viz the microglia. For the first time, we have provided conclusive evidence regarding the mechanism by which the micropollutant B[a]P may actually cause damage to the central nervous system. In today's perspective, where rising pollution levels globally are a matter of grave concern, our study throws light on other health hazards that such pollutants may exert.	[Dutta, Kallol; Ghosh, Debapriya; Nazmi, Arshed; Kumawat, Kanhaiya Lal; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dutta, K (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in	Nazmi, Arshed/I-2645-2015; Dutta, Kallol/J-5827-2019	Dutta, Kallol/0000-0001-6402-1300; Ghosh, Debapriya/0000-0002-8251-6945; Basu, Anirban/0000-0002-5200-2054; Nazmi, Arshed/0000-0002-5073-2061	National Brain Research Centre; Department of Biotechnology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	National Brain Research Centre; Department of Biotechnology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by the core grants of National Brain Research Centre to A. B. and also supported by an extramural grant from Department of Biotechnology to A. B. K. D. is a recipient of Research Associateship in Biotechnology and Life Sciences from the Department of Biotechnology, Government of India; A. N. is a recipient of Junior Research Fellowship from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JD, 1987, CARCINOGENESIS, V8, P729, DOI 10.1093/carcin/8.5.729; Agarwal T, 2009, J HAZARD MATER, V171, P894, DOI 10.1016/j.jhazmat.2009.06.081; ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Aygun SF, 2005, INT J FOOD SCI NUTR, V56, P581, DOI 10.1080/09637480500465436; Basu A, 2002, GLIA, V40, P109, DOI 10.1002/glia.10118; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; CHAO CC, 1992, J IMMUNOL, V149, P2736; Conroy SM, 2004, J NEUROIMMUNOL, V155, P43, DOI 10.1016/j.jneuroim.2004.06.014; Courter LA, 2007, MUTAT RES-FUND MOL M, V625, P72, DOI 10.1016/j.mrfmmm.2007.05.005; Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X; DANHEISER SL, 1989, MUTAT RES, V210, P143, DOI 10.1016/0027-5107(89)90053-5; DARBY FW, 1986, ANN OCCUP HYG, V30, P445, DOI 10.1093/annhyg/30.4.445; DAS M, 1985, B ENVIRON CONTAM TOX, V35, P500, DOI 10.1007/BF01636545; DAVIES GM, 1986, ANN OCCUP HYG, V30, P51, DOI 10.1093/annhyg/30.1.51; DENNIS MJ, 1983, FOOD CHEM TOXICOL, V21, P569, DOI 10.1016/0278-6915(83)90142-4; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; FROEHNER S, 2009, ENV MONIT ASSESS; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Ghosh D, 2009, J NEUROCHEM, V110, P1070, DOI 10.1111/j.1471-4159.2009.06203.x; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; HAMMOND EC, 1976, ANN NY ACAD SCI, V271, P116, DOI 10.1111/j.1749-6632.1976.tb23100.x; HATTEMERFREY HA, 1991, TOXICOL IND HEALTH, V7, P141, DOI 10.1177/074823379100700303; HECHT SS, 1979, FOOD COSMET TOXICOL, V17, P223, DOI 10.1016/0015-6264(79)90284-0; HOPIA A, 1986, J AM OIL CHEM SOC, V63, P889, DOI 10.1007/BF02540921; KAISERMAN MJ, 1992, AM J PUBLIC HEALTH, V82, P1023, DOI 10.2105/AJPH.82.7.1023; Karle IL, 2004, P NATL ACAD SCI USA, V101, P1433, DOI 10.1073/pnas.0307305101; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; LARSSON BK, 1983, J AGR FOOD CHEM, V31, P867, DOI 10.1021/jf00118a049; Lee BM, 2007, J TOXICOL ENV HEAL A, V70, P1391, DOI 10.1080/15287390701434182; Leonoudakis D, 2004, NEURON GLIA BIOL, V1, P263, DOI 10.1017/S1740925X05000608; Lin HW, 2009, J NEUROCHEM, V111, P808, DOI 10.1111/j.1471-4159.2009.06366.x; LIOY PL, 1988, ARCH ENVIRON HEALTH, V43, P304, DOI 10.1080/00039896.1988.10545954; Lloyd J W, 1971, J Occup Med, V13, P53, DOI 10.1097/00043764-197102000-00001; McCarthy JF, 2003, ARCH ENVIRON CON TOX, V45, P364, DOI 10.1007/s00244-003-2148-0; Moret S, 2000, J CHROMATOGR A, V882, P245, DOI 10.1016/S0021-9673(00)00079-0; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Nwaneshiudu OC, 2007, J ENVIRON SCI HEAL B, V42, P201, DOI 10.1080/03601230601125321; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Redondo PC, 2005, BIOCHEM BIOPH RES CO, V333, P794, DOI 10.1016/j.bbrc.2005.05.178; Ross JS, 2001, ANN NY ACAD SCI, V947, P271; ROUET P, 1981, CARCINOGENESIS, V2, P919, DOI 10.1093/carcin/2.9.919; Saunders CR, 2006, J APPL TOXICOL, V26, P427, DOI 10.1002/jat.1157; Saunders CR, 2001, NEUROTOX RES, V3, DOI 10.1007/BF03033211; Schwab JM, 2004, CELL DEATH DIFFER, V11, P1245, DOI 10.1038/sj.cdd.4401487; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Tang Y, 2003, J TOXICOL ENV HEAL A, V66, P919, DOI 10.1080/15287390306455; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Tu Baijie, 2004, Wei Sheng Yan Jiu, V33, P15; Tu Baijie, 2004, Wei Sheng Yan Jiu, V33, P660; Waldman J M, 1991, J Expo Anal Environ Epidemiol, V1, P193; Wei TT, 2000, BBA-MOL CELL RES, V1498, P72, DOI 10.1016/S0167-4889(00)00078-1; Weng MW, 2004, TOXICOL LETT, V151, P345, DOI 10.1016/j.toxlet.2004.03.007; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; ZHONG Z, 1994, DRUG METAB DISPOS, V22, P680	56	66	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9984	10.1371/journal.pone.0009984	http://dx.doi.org/10.1371/journal.pone.0009984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376308	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200054
J	Hong, PY; Lee, BW; Aw, M; Shek, LPC; Yap, GC; Chua, KY; Liu, WT				Hong, Pei-Ying; Lee, Bee Wah; Aw, Marion; Shek, Lynette Pei Chi; Yap, Gaik Chin; Chua, Kaw Yan; Liu, Wen-Tso			Comparative Analysis of Fecal Microbiota in Infants with and without Eczema	PLOS ONE			English	Article							OLIGONUCLEOTIDE PRIMER EXTENSION; INTESTINAL MICROBIOTA; GUT MICROBIOTA; ASIAN INFANTS; HEALTHY; MICROFLORA; BIFIDOBACTERIUM; COMMUNITIES; PROBIOTICS; DIVERSITY	Eczema is a chronic form of childhood disorder that is gaining in prevalence in affluent societies. Previous studies hypothesized that the development of eczema is correlated with changes in microbial profile and composition of early life endemic microbiota, but contradictory conclusions were obtained, possibly due to the lack of minimization of apparent non-health related confounders (e.g., age, antibiotic consumption, diet and mode of delivery). In this study, we recruited seven caesarean-delivered and total formula-fed infants, and comparatively examined the early-life endemic microbiota in these infants with and without eczema. Using 16S pyrosequencing, infants' fecal microbiota were observed to comprise Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes as the four main phyla, and the presence and absence of specific populations within these four phyla are primarily mediated by ageing. Quantitative analysis of bacterial targets on a larger sample size (n = 36 at 1, 3, and 12 months of age) revealed that the abundances of Bifidobacterium and Enterobacteriaceae were different among caesarean-delivered infants with and without eczema, and the bacterial targets may be potential biomarkers that can correlate to the health status of these infants. Our overall findings suggest that the minimization of possible confounders is essential prior to comparative evaluation and correlation of fecal microbiota to health status, and that stool samples collected from caesarean-delivered infants at less than 1 year of age may represent a good cohort to study for potential biomarkers that can distinguish infants with eczema from those without. These findings would greatly facilitate future efforts in understanding the possible pathogenesis behind certain bacterial targets, and may lead to a timely intervention that reduces the occurrence of early life eczema and possibly allergic disorders in later life.	[Hong, Pei-Ying; Liu, Wen-Tso] Natl Univ Singapore, Div Environm Sci & Engn, Singapore 117548, Singapore; [Hong, Pei-Ying; Lee, Bee Wah; Aw, Marion; Shek, Lynette Pei Chi; Yap, Gaik Chin; Chua, Kaw Yan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA	National University of Singapore; National University of Singapore; University of Illinois System; University of Illinois Urbana-Champaign	Hong, PY (corresponding author), Natl Univ Singapore, Div Environm Sci & Engn, Singapore 117548, Singapore.	wtliu@illinois.edu	Liu, Wen-Tso/C-8788-2011; Aw, Marion/D-8882-2015; Shek, Lynette/D-8016-2015; Hong, Peiying/A-4813-2009	Liu, Wen-Tso/0000-0002-8700-9803; Hong, Peiying/0000-0002-4474-6600; Shek, Lynette/0000-0001-9064-8983	National University of Singapore Environmental Research Initiatives (NERI) [R-706-000-001-646]; National Medical Research Council (NMCR) [R178-000-085-213]	National University of Singapore Environmental Research Initiatives (NERI); National Medical Research Council (NMCR)	The research was supported in part by a National University of Singapore Environmental Research Initiatives (NERI grant number R-706-000-001-646) to WTL, and National Medical Research Council (NMCR grant number R178-000-085-213) to BWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga TMM, 2009, J PEDIAT-BRAZIL, V85, P415, DOI [10.2223/JPED.1924, 10.1590/S0021-75572009000500008]; Beasley R, 1998, LANCET, V351, P1406, DOI 10.1016/S0140-6736(05)79446-0; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Brown SJ, 2009, J INVEST DERMATOL, V129, P543, DOI 10.1038/jid.2008.413; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DUBOS R, 1966, PEDIATRICS, V38, P789; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; He F, 2001, FEMS IMMUNOL MED MIC, V30, P43, DOI 10.1111/j.1574-695X.2001.tb01548.x; Hong PY, 2009, ENVIRON MICROBIOL, V11, P1672, DOI 10.1111/j.1462-2920.2009.01892.x; Hong PY, 2009, APPL ENVIRON MICROB, V75, P2573, DOI 10.1128/AEM.02576-08; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Liu WT, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P139; Mah KW, 2006, INT ARCH ALLERGY IMM, V140, P157, DOI 10.1159/000092555; Mah KW, 2007, PEDIATR RES, V62, P674, DOI 10.1203/PDR.0b013e31815991d5; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MSHVILDADZE M, 2009, J PEDIAT; Murray CS, 2005, CLIN EXP ALLERGY, V35, P741, DOI 10.1111/j.1365-2222.2005.02259.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, CLIN EXP ALLERGY, V36, P1602, DOI 10.1111/j.1365-2222.2006.02599.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Sepp E, 2005, CLIN EXP ALLERGY, V35, P1141, DOI 10.1111/j.1365-2222.2005.02315.x; Soh SE, 2009, CLIN EXP ALLERGY, V39, P571, DOI 10.1111/j.1365-2222.2008.03133.x; Sudo N, 1997, J IMMUNOL, V159, P1739; Tannock GW, 2005, INT J EPIDEMIOL, V34, P13; Wang M, 2004, J MICROBIOL METH, V59, P53, DOI 10.1016/j.mimet.2004.06.002; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Watanabe S, 2003, J ALLERGY CLIN IMMUN, V111, P587, DOI 10.1067/mai.2003.105; Wu JH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm413; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	42	76	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9964	10.1371/journal.pone.0009964	http://dx.doi.org/10.1371/journal.pone.0009964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376357	gold, Green Submitted, Green Published			2022-12-27	WOS:000276418200038
J	Doherty, KE; Naugle, DE; Evans, JS				Doherty, Kevin E.; Naugle, David E.; Evans, Jeffrey S.			A Currency for Offsetting Energy Development Impacts: Horse-Trading Sage-Grouse on the Open Market	PLOS ONE			English	Article							WINTER HABITAT SELECTION; METHANE DEVELOPMENT; SAGEBRUSH HABITATS; CONSERVATION; VULNERABILITY; MOVEMENTS; PATTERNS; FIDELITY; BANKING; NESTS	Background: Biodiversity offsets provide a mechanism to compensate for unavoidable damages from new energy development as the U. S. increases its domestic production. Proponents argue that offsets provide a partial solution for funding conservation while opponents contend the practice is flawed because offsets are negotiated without the science necessary to backup resulting decisions. Missing in negotiations is a biologically-based currency for estimating sufficiency of offsets and a framework for applying proceeds to maximize conservation benefits. Methodology/Principal Findings: Here we quantify a common currency for offsets for greater sage-grouse (Centrocercus urophasianus) by estimating number of impacted birds at 4 levels of development commonly permitted. Impacts were indiscernible at 1-12 wells per 32.2 km(2). Above this threshold lek losses were 2-5 times greater inside than outside of development and bird abundance at remaining leks declined by -32 to -77%. Findings reiterated the importance of time-lags as evidenced by greater impacts 4 years after initial development. Clustering well locations enabled a few small leks to remain active inside of developments. Conclusions/Significance: Documented impacts relative to development intensity can be used to forecast biological tradeoffs of newly proposed or ongoing developments, and when drilling is approved, anticipated bird declines form the biological currency for negotiating offsets. Monetary costs for offsets will be determined by true conservation cost to mitigate risks such as sagebrush tillage to other populations of equal or greater number. If this information is blended with landscape level conservation planning, the mitigation hierarchy can be improved by steering planned developments away from conservation priorities, ensuring compensatory mitigation projects deliver a higher return for conservation that equate to an equal number of birds in the highest priority areas, provide on-site mitigation recommendations, and provide a biologically based cost for mitigating unavoidable impacts.	[Doherty, Kevin E.] Wyoming Audubon, Natl Audubon Soc Sci, Laramie, WY USA; [Naugle, David E.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Evans, Jeffrey S.] Nature Conservancy, N Amer Sci, Ft Collins, CO USA	University of Montana System; University of Montana; Nature Conservancy	Doherty, KE (corresponding author), Wyoming Audubon, Natl Audubon Soc Sci, Laramie, WY USA.	kdoherty@audubon.org		Evans, Jeffrey/0000-0002-5533-7044	United States Bureau of Land Management in Montana and Wyoming; Wolf Creek Charitable Foundation; Hewlett Foundation; Liz Claiborne and Art Ortenberg Foundation; University of Montana	United States Bureau of Land Management in Montana and Wyoming; Wolf Creek Charitable Foundation; Hewlett Foundation; Liz Claiborne and Art Ortenberg Foundation; University of Montana	Funding was provided by the state offices of the United States Bureau of Land Management in Montana and Wyoming, Wolf Creek Charitable Foundation, Hewlett Foundation, Liz Claiborne and Art Ortenberg Foundation and the University of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt RJF, 2000, BIOL CONSERV, V96, P169, DOI 10.1016/S0006-3207(00)00064-1; Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Baxter RJ, 2008, J WILDLIFE MANAGE, V72, P179, DOI 10.2193/2006-402; Bergquist E, 2007, ENVIRON MONIT ASSESS, V128, P381, DOI 10.1007/s10661-006-9321-7; BERRY JD, 1985, J WILDLIFE MANAGE, V49, P237, DOI 10.2307/3801877; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burgin S, 2008, BIODIVERS CONSERV, V17, P807, DOI 10.1007/s10531-008-9319-2; CARROLL N, 2009, EARTHSCAN; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; CONNELLY JW, 2010, STUDIES AVI IN PRESS; Doherty K. E., 2008, THESIS U MONTANA MIS; DOHERTY KE, 2010, STUDIES AVI IN PRESS; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; DUNN PO, 1985, AUK, V102, P621, DOI 10.1093/auk/102.3.621; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Holloran M., 2005, THESIS U WYOMING LAR; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Holloran MRJ, 2005, CONDOR, V107, P742, DOI 10.1650/7749.1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Energy Agency, 2008, WORLD EN OUTL 2008; JOHNSON G, 2009, GREATER SAGE GROUSE; KIESECKER JM, 2010, FRONT ECOL IN PRESS; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Mandel JT, 2010, FRONT ECOL ENVIRON, V8, P44, DOI 10.1890/070170; Naugle D. E., 2010, STUDIES AVI IN PRESS; NIEMUTH ND, 1995, CAN J ZOOL, V73, P819, DOI 10.1139/z95-096; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reese K. P., 2007, COLL NATURAL RESOURC, V88; Reese KP, 1997, WILDLIFE BIOL, V3, P235, DOI 10.2981/wlb.1997.029; Robertson MM, 2006, FRONT ECOL ENVIRON, V4, P297, DOI 10.1890/1540-9295(2006)4[297:EESMTI]2.0.CO;2; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Schroeder M.A., 2003, COLL NATURAL RESOURC, V80; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stewart GB, 2007, ENVIRON CONSERV, V34, P1, DOI 10.1017/S0376892907003554; Stiver S. J., 2006, GREATER SAGE G UNPUB; ten Kate K., 2004, BIODIVERSITY OFFSETS; U. S. Department of Energy, 2008, 20 WIND EN 2030 INCR; *US BUR LAND MAN, 2008, FIN SUPPL MONT STAT, V1; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; *WYOM GAM FISH DEP, 2003, WYOM GREAT SAG GROUS; *WYOM GAM FISH DEP, 2006, GREAT SAG GROUS JOB; Yates D, 1999, PRACTICE STAT, V1st; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2	50	35	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10339	10.1371/journal.pone.0010339	http://dx.doi.org/10.1371/journal.pone.0010339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442770	Green Published, Green Submitted, gold			2022-12-27	WOS:000277154200003
J	Chang, G; Miao, YL; Zhang, Y; Liu, S; Kou, ZH; Ding, JJ; Chen, DY; Sun, QY; Gao, SR				Chang, Gang; Miao, Yi-Liang; Zhang, Yu; Liu, Sheng; Kou, Zhaohui; Ding, Junjun; Chen, Da-Yuan; Sun, Qing-Yuan; Gao, Shaorong			Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells	PLOS ONE			English	Article							NUCLEAR TRANSFER; TUMOR-SUPPRESSOR; SELF-RENEWAL; P53; GENERATION; MICE; INDUCTION; CLONING; CANCER; GENE	Somatic cell nuclear transfer (SCNT) has been proved capable of reprogramming various differentiated somatic cells into pluripotent stem cells. Recently, induced pluripotent stem cells (iPS) have been successfully derived from mouse and human somatic cells by the over-expression of a combination of transcription factors. However, the molecular mechanisms underlying the reprogramming mediated by either the SCNT or iPS approach are poorly understood. Increasing evidence indicates that many tumor pathways play roles in the derivation of iPS cells. Embryonal carcinoma (EC) cells have the characteristics of both stem cells and cancer cells and thus they might be the better candidates for elucidating the details of the reprogramming process. Although previous studies indicate that EC cells cannot be reprogrammed into real pluripotent stem cells, the reasons for this remain unclear. Here, nuclei from mouse EC cells (P19) were transplanted into enucleated oocytes and pluripotent stem cells (P19 NTES cells) were subsequently established. Interestingly, P19 NTES cells prolonged the development of tetraploid aggregated embryos compared to EC cells alone. More importantly, we found that the expression recovery of the imprinted H19 gene was dependent on the methylation state in the differential methylation region (DMR). The induction of Nanog expression, however, was independent of the promoter region DNA methylation state in P19 NTES cells. A whole-genome transcriptome analysis further demonstrated that P19 NTES cells were indeed the intermediates between P19 cells and ES cells and many interesting genes were uncovered that may be responsible for the failed reprogramming of P19 cells. To our knowledge, for the first time, we linked incomplete reprogramming to the improved pluripotency of EC cell-derived pluripotent stem cells. The candidate genes we discovered may be useful not only for understanding the mechanisms of reprogramming, but also for deciphering the transition between tumorigenesis and pluripotency.	[Chang, Gang; Miao, Yi-Liang; Chen, Da-Yuan; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Chang, Gang; Miao, Yi-Liang; Zhang, Yu; Liu, Sheng; Kou, Zhaohui; Ding, Junjun; Gao, Shaorong] Natl Inst Biol Sci, Beijing, Peoples R China; [Chang, Gang] Capital Med Univ, Dept Histol & Embryol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; National Institute of Biological Sciences, Beijing; Capital Medical University	Chang, G (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn; gaoshaorong@nibs.ac.cn	Ding, Junjun/C-4098-2012; Ding, Junjun/F-8618-2015	Ding, Junjun/0000-0002-9936-882X	National High Technology [2005AA210930, 2008AA022311]; National Basic Research Program of China [2006CB504004, 2006CB944004]; Chinese Academy of Sciences [KSCX2-YW-N-017]; National Natural Science Foundation of China [30430530]	National High Technology(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Project 863 (2005AA210930 and 2008AA022311) to SG and the National Basic Research Program of China (2006CB504004 and 2006CB944004), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-N-017) and the National Natural Science Foundation of China (30430530) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Curtin JC, 2005, ONCOGENE, V24, P1481, DOI 10.1038/sj.onc.1208130; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Guillou L, 1996, AM J PATHOL, V149, P1221; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li L, 2003, CANCER RES, V63, P2733; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; Moore BE, 2001, APPL IMMUNOHISTO M M, V9, P203, DOI 10.1097/00022744-200109000-00002; NAGY A, 1990, DEVELOPMENT, V110, P815; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; OREN M, 1982, MOL CELL BIOL, V2, P443, DOI 10.1128/MCB.2.4.443; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; REIK W, 1994, HUM MOL GENET, V3, P1297, DOI 10.1093/hmg/3.8.1297; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	51	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10320	10.1371/journal.pone.0010320	http://dx.doi.org/10.1371/journal.pone.0010320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436676	Green Submitted, Green Published, gold			2022-12-27	WOS:000277079500009
J	Converse, PJ; Eisenach, KD; Theus, SA; Nuermberger, EL; Tyagi, S; Ly, LH; Geiman, DE; Guo, HD; Nolan, ST; Akar, NC; Klinkenberg, LG; Gupta, R; Lun, S; Karakousis, PC; Lamichhane, G; McMurray, DN; Grosset, JH; Bishai, WR				Converse, Paul J.; Eisenach, Kathleen D.; Theus, Sue A.; Nuermberger, Eric L.; Tyagi, Sandeep; Ly, Lan H.; Geiman, Deborah E.; Guo, Haidan; Nolan, Scott T.; Akar, Nicole C.; Klinkenberg, Lee G.; Gupta, Radhika; Lun, Shichun; Karakousis, Petros C.; Lamichhane, Gyanu; McMurray, David N.; Grosset, Jacques H.; Bishai, William R.			The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models	PLOS ONE			English	Article							SIGMA-FACTOR; RESISTANCE; EXPRESSION; RELEVANCE; LIPIDS; MICE	Background: It has been hypothesized that the virulence of lab-passaged Mycobacterium tuberculosis and recombinant M. tuberculosis mutants might be reduced due to multiple in vitro passages, and that virulence might be augmented by passage of these strains through mice before quantitative virulence testing in the mouse or guinea pig aerosol models. Methodology/Principal Findings: By testing three M. tuberculosis H37Rv samples, one deletion mutant, and one recent clinical isolate for survival by the quantitative organ CFU counting method in mouse or guinea pig aerosol or intravenous infection models, we could discern no increase in bacterial fitness as a result of passaging of M. tuberculosis strains in mice prior to quantitative virulence testing in two animal models. Surface lipid expression as assessed by neutral red staining and thin-layer chromatography for PDIM analysis also failed to identify virulence correlates. Conclusions/Significance: These results indicate that animal passaging of M. tuberculosis strains prior to quantitative virulence testing in mouse or guinea pig models does not enhance or restore potency to strains that may have lost virulence due to in vitro passaging. It is critical to verify virulence of parental strains before genetic manipulations are undertaken and comparisons are made.	[Converse, Paul J.; Nuermberger, Eric L.; Tyagi, Sandeep; Geiman, Deborah E.; Guo, Haidan; Nolan, Scott T.; Akar, Nicole C.; Klinkenberg, Lee G.; Gupta, Radhika; Lun, Shichun; Karakousis, Petros C.; Lamichhane, Gyanu; Grosset, Jacques H.; Bishai, William R.] Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD 21218 USA; [Eisenach, Kathleen D.; Theus, Sue A.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Ly, Lan H.; McMurray, David N.] Texas A&M Univ, Dept Microbial & Mol Pathogenesis, College Stn, TX USA	Johns Hopkins University; University of Arkansas System; University of Arkansas Medical Sciences; Texas A&M University System; Texas A&M University College Station	Converse, PJ (corresponding author), Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD 21218 USA.	pconvers@jhsph.edu	Karakousis, Petros Constantine/AAR-7899-2020	Gupta, Radhika/0000-0002-0445-0194; Lamichhane, Gyanu/0000-0002-2214-0114	National Institutes of Health [N01-AI30036]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The support of National Institutes of Health contract N01-AI30036 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Andreu N, 2008, TUBERCULOSIS, V88, P553, DOI 10.1016/j.tube.2008.03.005; [Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; BLOCH H, 1950, J EXP MED, V92, P507, DOI 10.1084/jem.92.6.507; Brock TD., 1988, R KOCH LIFE MED BACT; Calmette A, 1920, INFECT BACILLAIRE TU; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cardona PJ, 2006, MICROBES INFECT, V8, P183, DOI 10.1016/j.micinf.2005.06.011; Collins FM, 1998, TUBERCLE LUNG DIS, V78, P99, DOI 10.1016/S0962-8479(98)80002-6; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CUMMINGS DONALD E., 1932, AMER REV TUBERC, V26, P369; Daniel Thomas M., 2000, PIONEERS MED THEIR I; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; DUBOS RJ, 1948, AM REV TUBERC PULM, V58, P698; FALK IS, 1928, NEWER KNOWLEDGE BACT; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; GROSSET J, 1988, MYCOBACTERIA, V2; HADLEY P, 1928, NEWER KNOWLEDGE BACT; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Koch R, 1901, Br Med J, V2, P189; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; KRAMNIK I, 2007, COMMUNICATION; KUBICA G P, 1972, International Journal of Systematic Bacteriology, V22, P99; Linton Derek S., 2005, E VONBEHRING INFECT; MITCHISON DA, 1954, BRIT MED J, V1, P128, DOI 10.1136/bmj.1.4854.128; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Parrish NM, 1999, J ANTIMICROB CHEMOTH, V43, P219, DOI 10.1093/jac/43.2.219; PIERCE CH, 1953, J EXP MED, V97, P189, DOI 10.1084/jem.97.2.189; Rich A., 1951, PATHOGENESIS TUBERCU, V2nd; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; SMITH H, 1988, J COMP PATHOL, V98, P253, DOI 10.1016/0021-9975(88)90036-9; STEENKEN W, 1950, AM REV TUBERC PULM, V62, P22; STEENKEN W, 1946, AM REV TUBERC PULM, V54, P62; Sun RG, 2004, MOL MICROBIOL, V52, P25, DOI 10.1111/j.1365-2958.2003.03958.x; VONBEHRING E, 1967, NOBEL LECT PHYSL MED; VONBEHRING E, 1903, COMBATTING TUBERCULO; WIEGESHAUS EH, 1970, AM REV RESPIR DIS, V102, P422; WILLIS HENRY STUART, 1933, AMER REV TUBERC, V28, P884	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10289	10.1371/journal.pone.0010289	http://dx.doi.org/10.1371/journal.pone.0010289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422019	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500034
J	Bish, LT; Morine, KJ; Sleeper, MM; Sweeney, HL				Bish, Lawrence T.; Morine, Kevin J.; Sleeper, Meg M.; Sweeney, H. Lee			Myostatin Is Upregulated Following Stress in an Erk-Dependent Manner and Negatively Regulates Cardiomyocyte Growth in Culture and in a Mouse Model	PLOS ONE			English	Article							CARDIAC GENE-TRANSFER; SKELETAL-MUSCLE MASS; MUSCULAR-DYSTROPHY; TRANSFER SUPERIOR; EXPRESSION; MICE; HYPERTROPHY; VECTORS; MODULATION; TRANSDUCTION	Myostatin is well established as a negative regulator of skeletal muscle growth, but its role in the heart is controversial. Our goal in this study was to characterize myostatin regulation following cardiomyocyte stress and to examine the role of myostatin in the regulation of cardiomyocyte size. Neonatal cardiomyocytes were cultured and stressed with phenylephrine. Adenovirus was used to overexpress myostatin or dominant negative myostatin in culture. Adeno-associated virus was used to overexpress myostatin or dominant negative myostatin in mice. Myostatin is upregulated following cardiomyocyte stress in an Erk-dependent manner that is associated with increased nuclear translocation and DNA binding activity of MEF-2. Myostatin overexpression leads to decreased and myostatin inhibition to increased cardiac growth both in vitro and in vivo due to modulation of Akt and NFAT3 pathways. Myostatin is a negative regulator of cardiac growth, and further studies are warranted to investigate the role of myostatin in the healthy and failing heart.	[Bish, Lawrence T.; Morine, Kevin J.; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Sleeper, Meg M.] Univ Penn, Vet Hosp, Dept Clin Studies, Cardiol Sect, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Bish, LT (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	bish@mail.med.upenn.edu	Sweeney, H Lee/F-1862-2010		National Institutes of Health [P01-HL059407, U54-AR052646, T32-HL-007748]; Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407, T32HL007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (P01-HL059407 to H. L. S., U54-AR052646 to H. L. S., T32-HL-007748 to L. T. B.); and by the Parent Project Muscular Dystrophy (to H. L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Artaza JN, 2007, J ENDOCRINOL, V194, P63, DOI 10.1677/JOE-07-0072; Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123; BISH LT, 2010, VIRUS METHODS PROTOC; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Bunger L, 2004, GENET RES, V84, P161, DOI 10.1017/S0016672304007165; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Dunn SE, 2001, J BIOL CHEM, V276, P45243, DOI 10.1074/jbc.M105445200; Gao G, 2003, GENE THER, V10, P1926, DOI 10.1038/sj.gt.3302088; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gaussin V, 2005, CARDIOVASC RES, V68, P347, DOI 10.1016/j.cardiores.2005.09.007; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; Matsakas A, 2006, EXP PHYSIOL, V91, P983, DOI 10.1113/expphysiol.2006.033571; Mckoy G, 2007, CARDIOVASC RES, V74, P304, DOI 10.1016/j.cardiores.2007.02.023; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Michel RN, 2004, P NUTR SOC, V63, P341, DOI 10.1079/PNS2004362; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Qiao CP, 2008, HUM GENE THER, V19, P241, DOI 10.1089/hum.2007.159; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Silcocks PB, 1997, HEART, V78, P237, DOI 10.1136/hrt.78.3.237; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Wang RW, 2008, J ENDOCRINOL, V197, P85, DOI 10.1677/JOE-07-0596; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Zhang JCL, 1999, J MOL CELL CARDIOL, V31, P721, DOI 10.1006/jmcc.1998.0905; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	59	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10230	10.1371/journal.pone.0010230	http://dx.doi.org/10.1371/journal.pone.0010230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419100	Green Published, gold			2022-12-27	WOS:000276853800020
J	Hawtin, RE; Stockett, DE; Byl, JAW; McDowell, RS; Tan, N; Arkin, MR; Conroy, A; Yang, WJ; Osheroff, N; Fox, JA				Hawtin, Rachael E.; Stockett, David E.; Byl, Jo Ann W.; McDowell, Robert S.; Tan, Nguyen; Arkin, Michelle R.; Conroy, Andrew; Yang, Wenjin; Osheroff, Neil; Fox, Judith A.			Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II	PLOS ONE			English	Article							7-SUBSTITUTED 1,4-DIHYDRO-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDS; ANTHRACYCLINE ANTITUMOR DRUGS; CANCER-CHEMOTHERAPY; IN-VITRO; CELLS; DOXORUBICIN; AGENTS; CLEAVAGE; CARDIOTOXICITY; DAUNORUBICIN	Background: Topoisomerase II is critical for DNA replication, transcription and chromosome segregation and is a well validated target of anti-neoplastic drugs including the anthracyclines and epipodophyllotoxins. However, these drugs are limited by common tumor resistance mechanisms and side-effect profiles. Novel topoisomerase II-targeting agents may benefit patients who prove resistant to currently available topoisomerase II-targeting drugs or encounter unacceptable toxicities. Voreloxin is an anticancer quinolone derivative, a chemical scaffold not used previously for cancer treatment. Voreloxin is completing Phase 2 clinical trials in acute myeloid leukemia and platinum-resistant ovarian cancer. This study defined voreloxin's anticancer mechanism of action as a critical component of rational clinical development informed by translational research. Methods/Principal Findings: Biochemical and cell-based studies established that voreloxin intercalates DNA and poisons topoisomerase II, causing DNA double-strand breaks, G2 arrest, and apoptosis. Voreloxin is differentiated both structurally and mechanistically from other topoisomerase II poisons currently in use as chemotherapeutics. In cell-based studies, voreloxin poisoned topoisomerase II and caused dose-dependent, site-selective DNA fragmentation analogous to that of quinolone antibacterials in prokaryotes; in contrast etoposide, the nonintercalating epipodophyllotoxin topoisomerase II poison, caused extensive DNA fragmentation. Etoposide's activity was highly dependent on topoisomerase II while voreloxin and the intercalating anthracycline topoisomerase II poison, doxorubicin, had comparable dependence on this enzyme for inducing G2 arrest. Mechanistic interrogation with voreloxin analogs revealed that intercalation is required for voreloxin's activity; a nonintercalating analog did not inhibit proliferation or induce G2 arrest, while an analog with enhanced intercalation was 9.5-fold more potent. Conclusions/Significance: As a first-in-class anticancer quinolone derivative, voreloxin is a toposiomerase II-targeting agent with a unique mechanistic signature. A detailed understanding of voreloxin's molecular mechanism, in combination with its evolving clinical profile, may advance our understanding of structure-activity relationships to develop safer and more effective topoisomerase II-targeted therapies for the treatment of cancer.	[Hawtin, Rachael E.; Stockett, David E.; Conroy, Andrew; Fox, Judith A.] Sunesis Pharmaceut Inc, San Francisco, CA USA; [Byl, Jo Ann W.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Byl, Jo Ann W.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [McDowell, Robert S.] 3V Biosci, Palo Alto, CA USA; [Tan, Nguyen] Genentech Inc, San Francisco, CA 94080 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Yang, Wenjin] Eiger Biopharmaceut Inc, Palo Alto, CA USA	Vanderbilt University; Vanderbilt University; Roche Holding; Genentech; University of California System; University of California San Francisco	Hawtin, RE (corresponding author), Sunesis Pharmaceut Inc, San Francisco, CA USA.	rhawtin@sunesis.com	arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	arkin, michelle/0000-0002-9366-6770; 	Sunesis Pharmaceuticals; NIH [GM33944]; Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	Sunesis Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The experiments were conducted at Vanderbilt University and Sunesis Pharmaceuticals. The funders for the study are Sunesis Pharmaceuticals and the NIH (Grant number GM33944). The research objectives and plan were formulated collaboratively between the Osheroff laboratory (Vanderbilt University) and the Sunesis scientific research employees who are listed as co-authors. Data were generated, collected from experiments and analyzed by researchers at each site. For data generated at Vanderbilt University, Sunesis provided financial support and the decision to publish was mutual. Sunesis lead authors drafted the manuscript in collaboration with co-authors from the Osheroff laboratory.	Anderson VE, 2001, CURR PHARM DESIGN, V7, P337, DOI 10.2174/1381612013398013; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; BODLEY A, 1989, CANCER RES, V49, P5969; BUZDAR AU, 1985, CANCER, V55, P2761, DOI 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P6611, DOI 10.1093/nar/18.22.6611; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Doroshow JH, 2001, BLOOD, V97, P2839, DOI 10.1182/blood.V97.9.2839; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Guo A, 2002, DRUG METAB DISPOS, V30, P457, DOI 10.1124/dmd.30.4.457; Hanada M, 2007, CANCER SCI, V98, P447, DOI 10.1111/j.1349-7006.2007.00404.x; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; HIRTE H, 2009, AM SOC CLIN ONC ASCO; Hoch U, 2009, CANCER CHEMOTH PHARM, V64, P53, DOI 10.1007/s00280-008-0850-3; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Igawa S, 2008, ANTICANCER RES, V28, P3855; Jannazzo A, 2008, ANN PHARMACOTHER, V42, P99, DOI 10.1345/aph.1K359; Kato S, 2000, CHEM RES TOXICOL, V13, P509, DOI 10.1021/tx000008m; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; LANCET J, 2009, P AM SOC CLIN ONC AS; LANCET JE, 2009, ASH ANN M, V114, P635; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; McClendon AK, 2006, BIOCHEMISTRY-US, V45, P3040, DOI 10.1021/bi051987q; Mechetner E, 1998, CLIN CANCER RES, V4, P389; MILLER KG, 1981, J BIOL CHEM, V256, P9334; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Noble CG, 2003, ANTIMICROB AGENTS CH, V47, P854, DOI 10.1128/AAC.47.3.854-862.2003; O'Reilly EK, 2002, BIOCHEMISTRY-US, V41, P7989, DOI 10.1021/bi025897m; Osheroff N., 2001, METHODS MOL BIOL, V95; POMMIER Y, 1993, CANCER CHEMOTH PHARM, V32, P103, DOI 10.1007/BF00685611; Ravandi F, 2009, ASH ANN M, V114, P1037; Richter SN, 2007, NUCLEIC ACIDS RES, V35, P6075, DOI 10.1093/nar/gkm653; Scatena C, 2010, CANC CHEMOTHERA 0107; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; SHAW JL, 1975, ANAL BIOCHEM, V65, P125, DOI 10.1016/0003-2697(75)90498-4; Skeel RT, 2003, HDB CANC CHEMOTHERAP, V98-9, P425; Spencer DMS, 2008, MUTAT RES-FUND MOL M, V638, P110, DOI 10.1016/j.mrfmmm.2007.09.005; SUBRAMANIAN D, 1995, CANCER RES, V55, P2097; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Taatjes DJ, 2001, CURR MED CHEM, V8, P15, DOI 10.2174/0929867013374029; Tomita K, 2002, J MED CHEM, V45, P5564, DOI 10.1021/jm010057b; Tsuzuki Y, 2004, J MED CHEM, V47, P2097, DOI 10.1021/jm0304966; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; Yu TW, 1997, MUTAT RES-FUND MOL M, V379, P201, DOI 10.1016/S0027-5107(97)00141-3; Zeman SM, 1998, P NATL ACAD SCI USA, V95, P11561, DOI 10.1073/pnas.95.20.11561	53	103	109	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10186	10.1371/journal.pone.0010186	http://dx.doi.org/10.1371/journal.pone.0010186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419121	gold, Green Published, Green Submitted			2022-12-27	WOS:000276707100007
J	Dhanoa, PK; Richardson, LGL; Smith, MD; Gidda, SK; Henderson, MPA; Andrews, DW; Mullen, RT				Dhanoa, Preetinder K.; Richardson, Lynn G. L.; Smith, Matthew D.; Gidda, Satinder K.; Henderson, Matthew P. A.; Andrews, David W.; Mullen, Robert T.			Distinct Pathways Mediate the Sorting of Tail-Anchored Proteins to the Plastid Outer Envelope	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; IMPORT APPARATUS; PLANT BIOLOGY; CYTOCHROME B5; GTP-BINDING; ASCORBATE PEROXIDASE; TRANSMEMBRANE DOMAIN; CHLOROPLAST IMPORT; CYTOSOLIC PROTEINS	Background: Tail-anchored (TA) proteins are a distinct class of membrane proteins that are sorted post-translationally to various organelles and function in a number of important cellular processes, including redox reactions, vesicular trafficking and protein translocation. While the molecular targeting signals and pathways responsible for sorting TA proteins to their correct intracellular destinations in yeasts and mammals have begun to be characterized, relatively little is known about TA protein biogenesis in plant cells, especially for those sorted to the plastid outer envelope. Methodology/Principal Findings: Here we investigated the biogenesis of three plastid TA proteins, including the 33-kDa and 34-kDa GTPases of the translocon at the outer envelope of chloroplasts (Toc33 and Toc34) and a novel 9-kDa protein of unknown function that we define here as an outer envelope TA protein (OEP9). Using a combination of in vivo and in vitro assays we show that OEP9 utilizes a different sorting pathway than that used by Toc33 and Toc34. For instance, while all three TA proteins interact with the cytosolic OEP chaperone/receptor, AKR2A, the plastid targeting information within OEP9 is distinct from that within Toc33 and Toc34. Toc33 and Toc34 also appear to differ from OEP9 in that their insertion is dependent on themselves and the unique lipid composition of the plastid outer envelope. By contrast, the insertion of OEP9 into the plastid outer envelope occurs in a proteinaceous-dependent, but Toc33/34-independent manner and membrane lipids appear to serve primarily to facilitate normal thermodynamic integration of this TA protein. Conclusions/Significance: Collectively, the results provide evidence in support of at least two sorting pathways for plastid TA outer envelope proteins and shed light on not only the complex diversity of pathways involved in the targeting and insertion of proteins into plastids, but also the molecular mechanisms that underlie the delivery of TA proteins to their proper intracellular locations in general.	[Dhanoa, Preetinder K.; Richardson, Lynn G. L.; Gidda, Satinder K.; Mullen, Robert T.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Smith, Matthew D.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada; [Henderson, Matthew P. A.; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	University of Guelph; Wilfrid Laurier University; McMaster University	Dhanoa, PK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rtmullen@uoguelph.ca	Smith, Matthew/M-4726-2014	Smith, Matthew/0000-0002-2855-5126; Andrews, David/0000-0002-9266-7157	Canadian Institutes of Heath Research [FRN 10490]; Natural Sciences and Engineering Research Council (NSERC) [312143-05, 217291]; Ontario Graduate Scholarship Program; Ontario Early Researcher Award	Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was supported by grants from the Canadian Institutes of Heath Research (www.cihr-irsc.gc.ca/) (FRN 10490) to D. W. A. and the Natural Sciences and Engineering Research Council (NSERC) (www.nserc-crsng.gc.ca/) (312143-05) to M. D. S. and (217291) to R. T. M. M. P. A. H. and L. R. were supported by an NSERC Graduate Scholarship and P. K. D. was supported by a post-graduate award from the Ontario Graduate Scholarship Program (http://osap.gov.on.ca/). D. W. A. holds a Canada Research Chair in Membrane Biogenesis, R. T. M. holds a University of Guelph Research Chair, and M. D. S. is a recipient of an Ontario Early Researcher Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Bae W, 2008, NAT CELL BIOL, V10, P220, DOI 10.1038/ncb1683; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Baginsky S, 2004, J PROTEOME RES, V3, P1128, DOI 10.1021/pr0499186; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Chen DD, 1997, J BIOL CHEM, V272, P6614, DOI 10.1074/jbc.272.10.6614; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; CHUA NH, 1978, P NATL ACAD SCI USA, V75, P6110, DOI 10.1073/pnas.75.12.6110; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Delille HK, 2008, J BIOL CHEM, V283, P31107, DOI 10.1074/jbc.M803332200; Dhugga KS, 1997, P NATL ACAD SCI USA, V94, P7679, DOI 10.1073/pnas.94.14.7679; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fritze CE, 2000, METHOD ENZYMOL, V327, P3, DOI 10.1016/S0076-6879(00)27263-7; Gutensohn M, 2000, PLANT J, V23, P771, DOI 10.1046/j.1365-313x.2000.00849.x; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Hawes C., 2003, CURR PROTOC CELL BIO, V19, P1, DOI [DOI 10.1002/0471143030.CB0107S19, 10.1002/0471143030.cb0107s19]; Heins L, 2002, EMBO J, V21, P2616, DOI 10.1093/emboj/21.11.2616; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Henderson MPA, 2007, BIOCHEM J, V401, P701, DOI 10.1042/BJ20060990; Hofmann NR, 2005, TRENDS PLANT SCI, V10, P450, DOI 10.1016/j.tplants.2005.07.009; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; Inoue K, 2007, J INTEGR PLANT BIOL, V49, P1100, DOI 10.1111/j.1672-9072.2007.00543.x; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KRIECHBAUMER V, 2009, TRAFFIC IN PRESS; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; KUNCE CM, 1988, BIOCHEM J, V251, P147, DOI 10.1042/bj2510147; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; LEE J, 2009, J BIOL CHEM IN PRESS; Lee MS, 1997, PLANT CELL, V9, P185, DOI 10.1105/tpc.9.2.185; Lee YJ, 2004, MOL CELLS, V17, P281; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; Leister D, 2008, CELL RES, V18, P1081, DOI 10.1038/cr.2008.297; Li HM, 1997, J BIOL CHEM, V272, P10968; Lingard MJ, 2008, PLANT CELL, V20, P1567, DOI 10.1105/tpc.107.057679; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; LUETHY MH, 1995, J PLANT PHYSL, V145, P442; Maggio C, 2007, J EXP BOT, V58, P1365, DOI 10.1093/jxb/erl303; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; May T, 1998, J CELL BIOL, V141, P895, DOI 10.1083/jcb.141.4.895; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Meyers BC, 2004, PLANT PHYSIOL, V135, P801, DOI 10.1104/pp.104.039495; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; Nito K, 2001, PLANT CELL PHYSIOL, V42, P20, DOI 10.1093/pcp/pce003; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Qbadou S, 2003, J CELL SCI, V116, P837, DOI 10.1242/jcs.00291; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schleiff E, 2001, MOL BIOL CELL, V12, P4090, DOI 10.1091/mbc.12.12.4090; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SEEDORF M, 1995, PLANT J, V7, P401, DOI 10.1046/j.1365-313X.1995.7030401.x; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Simpson JP, 2008, J EXP BOT, V59, P2545, DOI 10.1093/jxb/ern123; Smith Matthew D, 2003, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1116s17; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; SULOWAY CJ, 2009, P NATL ACAD IN PRESS; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Tsai LY, 1999, J BIOL CHEM, V274, P18735, DOI 10.1074/jbc.274.26.18735; Tu SL, 2000, PLANT CELL, V12, P1951, DOI 10.1105/tpc.12.10.1951; Tu SL, 2004, PLANT CELL, V16, P2078, DOI 10.1105/tpc.104.023952; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	81	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10098	10.1371/journal.pone.0010098	http://dx.doi.org/10.1371/journal.pone.0010098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418952	gold, Green Published, Green Submitted			2022-12-27	WOS:000276706800008
J	Dong, QC; Meng, P; Wang, T; Qin, WW; Qin, WJ; Wang, FL; Yuan, JL; Chen, ZN; Yang, AG; Wang, H				Dong, Qingchuan; Meng, Ping; Wang, Tao; Qin, Weiwei; Qin, Weijun; Wang, Fuli; Yuan, Jianlin; Chen, Zhinan; Yang, Angang; Wang, He			MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2	PLOS ONE			English	Article							TRANSCRIPTIONAL NETWORK; COLON-CANCER; EXPRESSION; DIFFERENTIATION; SUPPRESSOR; REPRESSES; PROGNOSIS; FAMILY; GROWTH	Background: Previous work has shown reduced expression levels of let-7 in lung tumors. But little is known about the expression or mechanisms of let-7a in prostate cancer. In this study, we used in vitro and in vivo approaches to investigate whether E2F2 and CCND2 are direct targets of let-7a, and if let-7a acts as a tumor suppressor in prostate cancer by down-regulating E2F2 and CCND2. Methodology/Principal: Findings Real-time RT-PCR demonstrated that decreased levels of let-7a are present in resected prostate cancer samples and prostate cancer cell lines. Cellular proliferation was inhibited in PC3 cells and LNCaP cells after transfection with let-7a. Cell cycle analysis showed that let-7a induced cell cycle arrest at the G1/S phase. A dual-luciferase reporter assay demonstrated that the 3'UTR of E2F2 and CCND2 were directly bound to let-7a and western blotting analysis further indicated that let-7a down-regulated the expression of E2F2 and CCND2. Our xenograft models of prostate cancer confirmed the capability of let-7a to inhibit prostate tumor development in vivo. Conclusions/Significance: These findings help to unravel the anti-proliferative mechanisms of let-7a in prostate cancer. Let-7a may also be novel therapeutic candidate for prostate cancer given its ability to induce cell-cycle arrest and inhibit cell growth, especially in hormone-refractory prostate cancer.	[Dong, Qingchuan; Meng, Ping; Qin, Weijun; Wang, Fuli; Yuan, Jianlin; Wang, He] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Wang, Tao; Qin, Weiwei; Yang, Angang] Fourth Mil Med Univ, Dept Biochem, Xian 710032, Peoples R China; [Chen, Zhinan] Fourth Mil Med Univ, State Key Lab Canc Biol, Cell Engn Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Dong, QC (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China.	dongqc168@yahoo.com.cn	Jackson, Benjamin L/C-4297-2012; Wang, Tao/ABB-7764-2021; Wang, Tao/AEN-3843-2022		National Basic Research Program of China [2009CB521705]; Nature Science Foundation of China [30672097]	National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China, 2009CB521705; and the Nature Science Foundation of China, 30672097. The funders had no role in study design, data collection and analysis, decision to publish.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dhillon VS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-33; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lee YS, 2006, CURR OPIN INVEST DR, V7, P560; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Okamoto OK, 2007, BBA-GENE STRUCT EXPR, V1769, P437, DOI 10.1016/j.bbaexp.2007.05.002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takano Y, 2000, AM J PATHOL, V156, P585, DOI 10.1016/S0002-9440(10)64763-3; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	25	193	204	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10147	10.1371/journal.pone.0010147	http://dx.doi.org/10.1371/journal.pone.0010147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418948	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706800010
J	Inghammar, M; Ekbom, A; Engstrom, G; Ljungberg, B; Romanus, V; Lofdahl, CG; Egesten, A				Inghammar, Malin; Ekbom, Anders; Engstrom, Gunnar; Ljungberg, Bengt; Romanus, Victoria; Lofdahl, Claes-Goran; Egesten, Arne			COPD and the Risk of Tuberculosis - A Population-Based Cohort Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-DISEASE; RESPIRATORY SYMPTOMS; SOUTHERN SWEDEN; NORTHERN SWEDEN; PREVALENCE; SMOKING; TOBACCO; METAANALYSIS; ASSOCIATION	Background: Both chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) primarily affect the lungs and are major causes of morbidity and mortality worldwide. COPD and TB have common risk factors such as smoking, low socioeconomic status and dysregulation of host defence functions. COPD is a prevalent co-morbid condition, especially in elderly with TB but in contrast to other diseases known to increase the risk of TB, relatively little is known about the specific relationship and impact from COPD on TB-incidence and mortality. Methods and Findings: All individuals $40 years of age, discharged with a diagnosis of COPD from Swedish hospitals 1987-2003 were identified in the Swedish Inpatient Register (n = 115,867). Records were linked to the Swedish Tuberculosis Register 1989-2007 and the relative risk of active TB in patients with COPD compared to control subjects randomly selected from the general population (matched for sex, year of birth and county of residence) was estimated using Cox regression. The analyses were stratified by year of birth, sex and county of residence and adjusted for immigration status, socioeconomic status (SES) and inpatient co-morbidities previously known to increase the risk of TB. COPD patients had a three-fold increased hazard ratio (HR) of developing active TB (HR 3.0 (95% confidence interval 2.4 to 4.0)) that was mainly dependent on an increased risk of pulmonary TB. In addition, logistic regression estimates showed that COPD patients who developed active TB had a two-fold increased risk of death from all causes within first year after the TB diagnosis compared to the general population control subjects with TB (OR 2.2, 95% confidence interval 1.2 to 4.1). Conclusions: This population-based study comprised of a large number of COPD patients shows that these patients have an increased risk of developing active TB compared to the general population. The results raise concerns that the increasing global burden of COPD will increase the incidence of active TB. The underlying contributory factors need to be disentangled in further studies.	[Inghammar, Malin; Ljungberg, Bengt] Lund Univ, Univ Lund Hosp, Dept Clin Sci Lund, Sect Infect Med, Lund, Sweden; [Inghammar, Malin; Lofdahl, Claes-Goran; Egesten, Arne] Lund Univ, Univ Lund Hosp, Dept Clin Sci Lund, Sect Resp Med, Lund, Sweden; [Ekbom, Anders] Karolinska Hosp & Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Ekbom, Anders] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Engstrom, Gunnar] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden; [Romanus, Victoria] Swedish Inst Infect Dis Control, Stockholm, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Lund University; Skane University Hospital; Swedish Institute for Infectious Disease Control	Inghammar, M (corresponding author), Lund Univ, Univ Lund Hosp, Dept Clin Sci Lund, Sect Infect Med, Lund, Sweden.	malin.inghammar@med.lu.se		Engstrom, Gunnar/0000-0002-8618-9152; Inghammar, Malin/0000-0003-2995-1312	Swedish Heart and Lung Foundation [20080246]; GlaxoSmithKline; Swedish Research Council [K2008-57X-20674]; Avtal om Lakares Forskning (ALF); University Hospital in Lund; Foundation of Th C Bergh; Foundation of Crafood; Foundation of Hedberg; Foundation of Bengt Ihre; Foundation of Greta Johan Kock; Foundation of Alfred Osterlund; Foundation of Marianne & Marcus Wallenberg	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); GlaxoSmithKline(GlaxoSmithKline); Swedish Research Council(Swedish Research CouncilEuropean Commission); Avtal om Lakares Forskning (ALF); University Hospital in Lund; Foundation of Th C Bergh; Foundation of Crafood; Foundation of Hedberg; Foundation of Bengt Ihre; Foundation of Greta Johan Kock; Foundation of Alfred Osterlund; Foundation of Marianne & Marcus Wallenberg	This study was supported by grants from the Swedish Heart and Lung Foundation (project 20080246), an unrestricted grant from GlaxoSmithKline, the Swedish Research Council (project K2008-57X-20674), the Swedish Government Funds for Clinical Research, i.e. Avtal om Lakares Forskning (ALF), the University Hospital in Lund, and the Foundations of Th C Bergh, Crafoord, Hedberg, Bengt Ihre, Greta & Johan Kock, Alfred Osterlund, and Marianne & Marcus Wallenberg. M. I. is the recipient of a fellowship from ALF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Bahceciler NN, 2000, PEDIATR INFECT DIS J, V19, P215, DOI 10.1097/00006454-200003000-00008; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Benfield T, 2008, CHEST, V134, P46, DOI 10.1378/chest.07-2933; Calverley PMA, 2003, LANCET, V362, P1053, DOI 10.1016/S0140-6736(03)14416-9; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; *CTR EP, 2009, CAUS DEATH 2007; *CTR EP SWED NAT B, 2009, COD QUAL HOSP DISCH; *CTR EP SWED NAT B, 2008, QUAL CONT SWED HOSP; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Hasselgren M, 2001, SCAND J PRIM HEALTH, V19, P54, DOI 10.1080/028134301300034701; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Lindberg A, 2005, RESPIRATION, V72, P471, DOI 10.1159/000087670; Liu SF, 2005, INT J TUBERC LUNG D, V9, P111; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Montnemery P, 2006, INT J TUBERC LUNG D, V10, P490; Montnemery P, 1998, RESP MED, V92, P1337, DOI 10.1016/S0954-6111(98)90139-1; Ormerod LP, 2002, INT J TUBERC LUNG D, V6, P662; ROMANUS V, 2003, SMITTSKYDDSBOKEN STU, P377; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; SCHATZ M, 1976, ANN INTERN MED, V84, P261, DOI 10.7326/0003-4819-84-3-261; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; *STAT SWED, 1982, SOC CLASS; Stenfors N, 2006, CHEST, V130, P666, DOI 10.1378/chest.130.3.666; *SWED I INF DIS, 2008, EP ANN REP; Wang JY, 2005, INT J TUBERC LUNG D, V9, P777; 2007, CONSUPTION ALCOHOL T	41	86	91	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10138	10.1371/journal.pone.0010138	http://dx.doi.org/10.1371/journal.pone.0010138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405056	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706300003
J	Ross, B; Schneider, B; Snyder, JS; Alain, C				Ross, Bernhard; Schneider, Bruce; Snyder, Joel S.; Alain, Claude			Biological Markers of Auditory Gap Detection in Young, Middle-Aged, and Older Adults	PLOS ONE			English	Article							DETECTION THRESHOLDS; GAMMA-ACTIVITY; SELECTIVE ATTENTION; EVOKED-POTENTIALS; LATENCY RESPONSE; CEREBRAL-CORTEX; WITHIN-CHANNEL; BRAIN ACTIVITY; FREQUENCY; NOISE	The capability of processing rapid fluctuations in the temporal envelope of sound declines with age and this contributes to older adults' difficulties in understanding speech. Although, changes in central auditory processing during aging have been proposed as cause for communication deficits, an open question remains which stage of processing is mostly affected by age related changes. We investigated auditory temporal resolution in young, middle-aged, and older listeners with neuromagnetic evoked responses to gap stimuli with different leading marker and gap durations. Signal components specific for processing the physical details of sound stimuli as well as the auditory objects as a whole were derived from the evoked activity and served as biological markers for temporal processing at different cortical levels. Early oscillatory 40-Hz responses were elicited by the onsets of leading and lagging markers and indicated central registration of the gap with similar amplitude in all three age groups. High-gamma responses were predominantly related to the duration of no-gap stimuli or to the duration of gaps when present, and decreased in amplitude and phase locking with increasing age. Correspondingly, low-frequency activity around 200 ms and later was reduced in middle aged and older participants. High-gamma band, and long-latency low-frequency responses were interpreted as reflecting higher order processes related to the grouping of sound items into auditory objects and updating of memory for these objects. The observed effects indicate that age-related changes in auditory acuity have more to do with higher-order brain functions than previously thought.	[Ross, Bernhard; Alain, Claude] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Ross, Bernhard] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schneider, Bruce; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Snyder, Joel S.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Ross, B (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	bross@rotman-baycrest.on.ca	Snyder, Joel S/B-4675-2008; /AIE-5811-2022	Snyder, Joel S/0000-0002-5565-3063; Ross, Bernhard/0000-0001-7290-631X	Canadian Institutes of Health Research [81135, 74482]; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by funds from the Canadian Institutes of Health Research (Grant No. 81135 to BR and Grant No. 74482 to CA) and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL SM, 1990, SCAND AUDIOL, V19, P43, DOI 10.3109/01050399009070751; Alain C, 2002, J ACOUST SOC AM, V111, P990, DOI 10.1121/1.1434942; Alain C, 2007, J NEUROSCI, V27, P1308, DOI 10.1523/JNEUROSCI.5433-06.2007; Barsz K, 2002, NEUROBIOL AGING, V23, P565, DOI 10.1016/S0197-4580(02)00008-8; BASAR E, 1987, INT J NEUROSCI, V33, P103; BERTRAND O, 1994, IEEE T BIO-MED ENG, V41, P77, DOI 10.1109/10.277274; Buus S., 1985, TIME RESOLUTION AUDI, P159; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CHAMBERS RD, 1991, HEARING RES, V51, P1, DOI 10.1016/0378-5955(91)90002-Q; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Draganova R, 2002, EAR HEARING, V23, P254, DOI 10.1097/00003446-200206000-00009; Eddins AC, 1999, J SPEECH LANG HEAR R, V42, P516, DOI 10.1044/jslhr.4203.516; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Eggermont JJ, 2000, J NEUROPHYSIOL, V84, P1453, DOI 10.1152/jn.2000.84.3.1453; Gage N, 2006, BRAIN RES, V1069, P166, DOI 10.1016/j.brainres.2005.11.023; GORDONSALANT S, 1993, J SPEECH HEAR RES, V36, P1276, DOI 10.1044/jshr.3606.1276; GREEN DM, 1989, J ACOUST SOC AM, V86, P961, DOI 10.1121/1.398731; Guo YQ, 2002, HEARING RES, V171, P158, DOI 10.1016/S0378-5955(02)00496-3; Heinrich A, 2004, NEUROREPORT, V15, P2051, DOI 10.1097/00001756-200409150-00011; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kobayashi T, 1999, IEEE T BIO-MED ENG, V46, P951, DOI 10.1109/10.775405; Lagerlund TD, 1997, J CLIN NEUROPHYSIOL, V14, P73, DOI 10.1097/00004691-199701000-00007; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; Lister JJ, 2007, EAR HEARING, V28, P862, DOI 10.1097/AUD.0b013e3181576cba; Llinas R, 2001, ANN NY ACAD SCI, V929, P166; Llinas R, 2003, INT CONGR SER, V1250, P409, DOI 10.1016/S0531-5131(03)01067-7; MCCROSKEY RL, 1980, J LEARN DISABIL, V13, P69, DOI 10.1177/002221948001300205; Metherate R, 1999, EXP BRAIN RES, V126, P160, DOI 10.1007/s002210050726; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; NAATANEN R, 2007, CLIN NEUROPHYSIOL; Pantev C, 1998, AUDIOL NEURO-OTOL, V3, P183, DOI 10.1159/000013789; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Phillips D P, 1999, J Am Acad Audiol, V10, P343; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; Pratt H, 2005, CLIN NEUROPHYSIOL, V116, P2648, DOI 10.1016/j.clinph.2005.08.001; Pratt H, 2007, CLIN NEUROPHYSIOL, V118, P1078, DOI 10.1016/j.clinph.2007.01.005; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; ROBIN DA, 1989, PSYCHOL AGING, V4, P144; ROBIN DA, 1987, J ACOUST SOC AM, V82, P1207, DOI 10.1121/1.395257; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; Ross B, 2007, J NEUROSCI, V27, P11172, DOI 10.1523/JNEUROSCI.1813-07.2007; Ross B, 2009, NEUROIMAGE, V47, P678, DOI 10.1016/j.neuroimage.2009.04.051; Rupp A, 2000, NEUROREPORT, V11, P3731, DOI 10.1097/00001756-200011270-00028; Rupp A, 2004, J NEUROPHYSIOL, V92, P2239, DOI 10.1152/jn.00163.2004; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SCHNEIDER BA, 1994, J ACOUST SOC AM, V95, P980, DOI 10.1121/1.408403; Schneider BA, 1999, J ACOUST SOC AM, V106, P371, DOI 10.1121/1.427062; SHAILER MJ, 1983, J ACOUST SOC AM, V74, P467, DOI 10.1121/1.389812; Snell KB, 1999, J ACOUST SOC AM, V106, P3571, DOI 10.1121/1.428210; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; WOODS DL, 1986, ELECTROEN CLIN NEURO, V65, P297, DOI 10.1016/0168-5597(86)90008-0	55	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10101	10.1371/journal.pone.0010101	http://dx.doi.org/10.1371/journal.pone.0010101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404929	gold, Green Published, Green Submitted			2022-12-27	WOS:000276482100017
J	Oglesby-Sherrouse, AG; Vasil, ML				Oglesby-Sherrouse, Amanda G.; Vasil, Michael L.			Characterization of a Heme-Regulated Non-Coding RNA Encoded by the prrF Locus of Pseudomonas aeruginosa	PLOS ONE			English	Article							VIRULENCE FACTOR PRODUCTION; FERRIC UPTAKE REGULATOR; BINDING PROTEIN PHUS; SERRATIA-MARCESCENS; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; SIGNAL-TRANSDUCTION; IRON TRANSPORT; GENE; SIDEROPHORE	Pseudomonas aeruginosa, an opportunistic pathogen, requires iron for virulence and can obtain this nutrient via the acquisition of heme, an abundant source of iron in the human body. A surplus of either iron or heme can lead to oxidative stress; thus, the Fur (ferric uptake regulator) protein blocks expression of genes required for iron and heme uptake in iron-replete environments. Fur also represses expression of two nearly identical genes encoding the 116- and 114-nucleotide (nt) long PrrF1 and PrrF2 RNAs, respectively. While other Pseudomonads encode for the two PrrF RNAs at separate genomic loci, PrrF1 and PrrF2 are encoded in tandem in all sequenced strains of P. aeruginosa. In this report we characterize a third longer transcript encoded by the prrF locus, PrrH, which is repressed by heme as well as iron. We mapped the PrrH RNA in PA01 using 5' rapid amplification of cDNA ends (RACE) and northern analysis, demonstrating the PrrH RNA is 325 nt in length. Accordingly, transcription of PrrH initiates at the 5' end of prrF1, proceeds through the prrF1 terminator and prrF1-prrF2 intergenic sequence (95 nt), and terminates at the 3' end of the prrF2 gene. We also present evidence that repression of PrrH by heme causes increased expression of previously identified PrrF-regulated genes, as well as newly identified iron-and heme-activated genes. Thus, the PrrH RNA appears to impart a novel heme regulatory mechanism to P. aeruginosa.	[Oglesby-Sherrouse, Amanda G.; Vasil, Michael L.] Univ Colorado, Dept Microbiol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Oglesby-Sherrouse, AG (corresponding author), Univ Colorado, Dept Microbiol, Anschutz Med Campus, Aurora, CO USA.	Amanda.Oglesby@ucdenver.edu		Oglesby, Mandy/0000-0003-4440-3840	Cystic Fibrosis Foundation [OGLESB08F0]; National Institutes of Health [R37-NIH AI15940]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015940] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Cystic Fibrosis Foundation (http://cff.org/) Grant OGLESB08F0 (to A.G.O.) and National Institutes of Health (http://nih.gov/) Grant R37-NIH AI15940 (to M. L. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Alontaga AY, 2009, BIOCHEMISTRY-US, V48, P96, DOI 10.1021/bi801860g; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bibb LA, 2007, INFECT IMMUN, V75, P2421, DOI 10.1128/IAI.01821-06; Brickman TJ, 2006, INFECT IMMUN, V74, P1741, DOI 10.1128/IAI.74.3.1741-1744.2006; COX CD, 1982, INFECT IMMUN, V36, P17, DOI 10.1128/IAI.36.1.17-23.1982; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; GUDAT JC, 1973, BIOCHIM BIOPHYS ACTA, V292, P376, DOI 10.1016/0005-2728(73)90044-3; Hagan EC, 2009, MOL MICROBIOL, V71, P79, DOI 10.1111/j.1365-2958.2008.06509.x; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jung YS, 2008, CURR MICROBIOL, V57, P593, DOI 10.1007/s00284-008-9248-z; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 1996, MOL MICROBIOL, V21, P1019, DOI 10.1046/j.1365-2958.1996.481425.x; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; PRINCE RW, 1991, MOL MICROBIOL, V5, P2823, DOI 10.1111/j.1365-2958.1991.tb01991.x; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sapriel G, 2003, J BACTERIOL, V185, P80, DOI 10.1128/JB.185.1.80-88.2003; Stauff DL, 2007, J BIOL CHEM, V282, P26111, DOI 10.1074/jbc.M703797200; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Takase H, 2000, INFECT IMMUN, V68, P4498, DOI 10.1128/IAI.68.8.4498-4504.2000; TAYLOR RK, 1989, J BACTERIOL, V171, P1870, DOI 10.1128/jb.171.4.1870-1878.1989; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vanderpool CK, 2003, J BACTERIOL, V185, P909, DOI 10.1128/JB.185.3.909-917.2003; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001; Wilson MJ, 2000, BIOCHEM BIOPH RES CO, V273, P578, DOI 10.1006/bbrc.2000.2996; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	53	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9930	10.1371/journal.pone.0009930	http://dx.doi.org/10.1371/journal.pone.0009930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386693	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482000002
J	Schildkraut, JM; Iversen, ES; Wilson, MA; Clyde, MA; Moorman, PG; Palmieri, RT; Whitaker, R; Bentley, RC; Marks, JR; Berchuck, A				Schildkraut, Joellen M.; Iversen, Edwin S.; Wilson, Melanie A.; Clyde, Merlise A.; Moorman, Patricia G.; Palmieri, Rachel T.; Whitaker, Regina; Bentley, Rex C.; Marks, Jeffrey R.; Berchuck, Andrew			Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; OVEREXPRESSION; P53; SUSCEPTIBILITY; OVULATION; MUTATION; BENIGN	Background: We analyzed the association between 53 genes related to DNA repair and p53-mediated damage response and serous ovarian cancer risk using case-control data from the North Carolina Ovarian Cancer Study (NCOCS), a population-based, case-control study. Methods/Principal Findings: The analysis was restricted to 364 invasive serous ovarian cancer cases and 761 controls of white, non-Hispanic race. Statistical analysis was two staged: a screen using marginal Bayes factors (BFs) for 484 SNPs and a modeling stage in which we calculated multivariate adjusted posterior probabilities of association for 77 SNPs that passed the screen. These probabilities were conditional on subject age at diagnosis/interview, batch, a DNA quality metric and genotypes of other SNPs and allowed for uncertainty in the genetic parameterizations of the SNPs and number of associated SNPs. Six SNPs had Bayes factors greater than 10 in favor of an association with invasive serous ovarian cancer. These included rs5762746 (median OR(odds ratio)(per allele) = 0.66; 95% credible interval (CI) = 0.44-1.00) and rs6005835 (median ORper (allele) = 0.69; 95% CI = 0.53-0.91) in CHEK2, rs2078486 (median ORper allele = 1.65; 95% CI = 1.21-2.25) and rs12951053 (median ORper allele = 1.65; 95% CI = 1.20-2.26) in TP53, rs411697 (median ORrare homozygote = 0.53; 95% CI = 0.35-0.79) in BACH1 and rs10131 (median ORrare homozygote = not estimable) in LIG4. The six most highly associated SNPs are either predicted to be functionally significant or are in LD with such a variant. The variants in TP53 were confirmed to be associated in a large follow-up study. Conclusions/Significance: Based on our findings, further follow-up of the DNA repair and response pathways in a larger dataset is warranted to confirm these results.	[Schildkraut, Joellen M.; Moorman, Patricia G.] Duke Univ, Med Ctr, Dept Community, Durham, NC 27706 USA; [Schildkraut, Joellen M.; Moorman, Patricia G.] Duke Univ, Med Ctr, Dept Family Med, Durham, NC USA; [Schildkraut, Joellen M.; Iversen, Edwin S.; Moorman, Patricia G.; Marks, Jeffrey R.; Berchuck, Andrew] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Iversen, Edwin S.; Wilson, Melanie A.; Clyde, Merlise A.] Duke Univ, Med Ctr, Dept Stat Sci, Durham, NC USA; [Palmieri, Rachel T.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Whitaker, Regina; Berchuck, Andrew] Duke Univ, Med Ctr, Obstet & Gynecol Div Gynecol Oncol, Durham, NC USA; [Bentley, Rex C.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Marks, Jeffrey R.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Marks, Jeffrey R.; Berchuck, Andrew] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University	Schildkraut, JM (corresponding author), Duke Univ, Med Ctr, Dept Community, Durham, NC 27706 USA.	schil001@mc.duke.edu	Clyde, Merlise/ABG-3538-2020	Clyde, Merlise/0000-0002-3595-1872; Weber, Rachel/0000-0001-7119-7734	National Institutes of Health [1-R01-CA76016, 1-R01-HL090559]; NATIONAL CANCER INSTITUTE [R01CA076016, U01CA084955] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript was supported by grants from the National Institutes of Health 1-R01-CA76016 and 1-R01-HL090559. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscipt.	American Cancer Society, 2009, CANC FACTS FIG 2009; AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; Auranen A, 2005, INT J CANCER, V117, P611, DOI 10.1002/ijc.21047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beesley J, 2007, CANCER EPIDEM BIOMAR, V16, P2557, DOI 10.1158/1055-9965.EPI-07-0542; BERCHUCK A, 1994, GYNECOL ONCOL, V52, P232, DOI 10.1006/gyno.1994.1037; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Clyde M, 2004, STAT SCI, V19, P81, DOI 10.1214/088342304000000035; EMIGH TH, 1980, COMP TESTS HARDY WEI, P627; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Havrilesky L, 2003, J CLIN ONCOL, V21, P3814, DOI 10.1200/JCO.2003.11.052; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hoeting JA, 2000, STAT SCI, V15, P193, DOI 10.1214/ss/1009212814; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Modugno F, 2004, AM J OBSTET GYNECOL, V191, P733, DOI 10.1016/j.ajog.2004.03.035; Moorman PG, 2008, AM J EPIDEMIOL, V167, P1059, DOI 10.1093/aje/kwn006; Moorman PG, 2002, CANCER CAUSE CONTROL, V13, P807, DOI 10.1023/A:1020678100977; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Murdoch WJ, 2001, BIOL REPROD, V65, P1417, DOI 10.1095/biolreprod65.5.1417; Ness RB, 2002, AM J EPIDEMIOL, V155, P217, DOI 10.1093/aje/155.3.217; Pearce CL, 2009, BRIT J CANCER, V100, P412, DOI 10.1038/sj.bjc.6604820; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; Schildkraut JM, 2008, CANCER EPIDEM BIOMAR, V17, P585, DOI 10.1158/1055-9965.EPI-07-0596; Schildkraut JM, 2007, CANCER EPIDEM BIOMAR, V16, P473, DOI 10.1158/1055-9965.EPI-06-0868; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; Song HL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000268; Song HL, 2006, CARCINOGENESIS, V27, P2235, DOI 10.1093/carcin/bgl089; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; WILSON MA, 2009, ANN APPL ST IN PRESS; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	38	55	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10061	10.1371/journal.pone.0010061	http://dx.doi.org/10.1371/journal.pone.0010061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386703	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482000007
J	Chen, CC; Tyler, CW				Chen, Chien-Chung; Tyler, Christopher W.			Symmetry: Modeling the Effects of Masking Noise, Axial Cueing and Salience	PLOS ONE			English	Article							MIRROR SYMMETRY; BILATERAL SYMMETRY; OBJECT RECOGNITION; CONTRAST DETECTION; SPATIAL FILTERS; VISUAL SYMMETRY; EXTERNAL NOISE; DISCRIMINATION; PERCEPTION; MECHANISMS	Symmetry detection is an interesting probe of pattern processing because it requires the matching of novel patterns without the benefit of prior recognition. However, there is evidence that prior knowledge of the axis location plays an important role in symmetry detection. We investigated how the prior information about the symmetry axis affects symmetry detection under noise-masking conditions. The target stimuli were random-dot displays structured to be symmetric about vertical, horizontal, or diagonal axes and viewed through eight apertures (1.2 degrees diameter) evenly distributed around a 6 degrees diameter circle. The information about axis orientation was manipulated by (1) cueing of axis orientation before the trial and (2) varying axis salience by including or excluding the axis region within the noise apertures. The percentage of correct detection of the symmetry was measured at for a range of both target and masking noise densities. The threshold vs. noise density function was flat at low noise density and increased with a slope of 0.75-0.8 beyond a critical density. Axis cueing reduced the target threshold 2-4fold at all noise densities while axis salience had an effect only at high noise density. Our results are inconsistent with an ideal observer or signal-to-noise account of symmetry detection but can be explained by a multiple-channel model is which the response in each channel is the ratio between the nonlinear transform of the responses of sets of early symmetry detectors and the sum of external and intrinsic sources of noise.	[Chen, Chien-Chung] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Ctr Neurobiol & Cognit Sci, Taipei 10764, Taiwan; [Tyler, Christopher W.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	National Taiwan University; National Taiwan University; The Smith-Kettlewell Eye Research Institute	Chen, CC (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.	c3chen@ntu.edu.tw		Chen, Chien-Chung/0000-0002-3848-0180	NSC [96-2413-H-002-006-MY3]; AFOSR [09-NL-072]	NSC(Ministry of Science and Technology, Taiwan); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Supported by NSC (http://www.nsc.gov.tw) 96-2413-H-002-006-MY3 to CCC and AFOSR (http://www.afosr.af.mil/) grant # 09-NL-072 to CWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW HB, 1979, VISION RES, V19, P783, DOI 10.1016/0042-6989(79)90154-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CARMODY DP, 1977, PERCEPT MOTOR SKILL, V45, P1267, DOI 10.2466/pms.1977.45.3f.1267; Chen CC, 1999, COMMUN STAT-SIMUL C, V28, P177, DOI 10.1080/03610919908813542; Chen CC, 2001, P ROY SOC B-BIOL SCI, V268, P509, DOI 10.1098/rspb.2000.1387; CORBALLIS MC, 1975, J EXP PSYCHOL HUMAN, V1, P221, DOI 10.1037/0096-1523.1.3.221; Csatho A, 2004, ACTA PSYCHOL, V117, P233, DOI 10.1016/j.actpsy.2004.06.004; DAKIN SC, 1994, SPATIAL VISION, V8, P393, DOI 10.1163/156856894X00071; Dakin SC, 1997, VISION RES, V37, P2915, DOI 10.1016/S0042-6989(97)00031-X; Dakin SC, 1998, P ROY SOC B-BIOL SCI, V265, P659, DOI 10.1098/rspb.1998.0344; de Kuijer J, 2004, ACTA PSYCHOL, V116, P75, DOI 10.1016/j.actpsy.2003.12.013; Foley JM, 1999, VISION RES, V39, P3855, DOI 10.1016/S0042-6989(99)00104-2; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; GRAHAM N, 1978, VISION RES, V21, P409; Green DM, 1966, SIGNAL DETECTION THE; Gurnsey R, 1998, VISION RES, V38, P3795, DOI 10.1016/S0042-6989(98)00106-0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; JENKINS B, 1983, J EXP PSYCHOL HUMAN, V9, P258, DOI 10.1037/0096-1523.9.2.258; JOHNSTONE RA, 1994, NATURE, V372, P172, DOI 10.1038/372172a0; LABONTE F, 1995, SPATIAL VISION, V9, P33, DOI 10.1163/156856895X00106; Lu ZL, 2008, PSYCHOL REV, V115, P44, DOI 10.1037/0033-295X.115.1.44; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; OSORIO D, 1994, TRENDS ECOL EVOL, V9, P346, DOI 10.1016/0169-5347(94)90162-7; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P105, DOI 10.1098/rspb.1996.0017; PASHLER H, 1990, J EXP PSYCHOL HUMAN, V16, P150, DOI 10.1037/0096-1523.16.1.150; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Rainville SJM, 2002, VISION RES, V42, P351, DOI 10.1016/S0042-6989(01)00290-5; Rainville SJM, 1999, J OPT SOC AM A, V16, P2112, DOI 10.1364/JOSAA.16.002112; Rainville SJM, 2000, VISION RES, V40, P2621, DOI 10.1016/S0042-6989(00)00110-3; Saarinen J, 2000, NEUROREPORT, V11, P2133, DOI 10.1097/00001756-200007140-00015; Scognamillo R, 2003, P ROY SOC B-BIOL SCI, V270, P1727, DOI 10.1098/rspb.2003.2434; STILES WS, 1959, P NATL ACAD SCI USA, V45, P100, DOI 10.1073/pnas.45.1.100; Tjan BS, 2005, J VISION, V5, P888, DOI 10.1167/5.10.10; TOMONAGA M, 1991, PSYCHOL REP, V68, P51, DOI 10.2466/PR0.68.1.51-60; Tyler CW, 1997, SPATIAL VISION, V10, P479, DOI 10.1163/156856897X00410; Tyler CW, 2000, VISION RES, V40, P3121, DOI 10.1016/S0042-6989(00)00157-7; TYLER CW, 1995, SPATIAL VISION, V9, P79, DOI 10.1163/156856895X00124; Tyler CW, 1996, HUMAN SYMMETRY PERCE, P157; vanderHelm PA, 1996, PSYCHOL REV, V103, P429, DOI 10.1037/0033-295X.103.3.429; VETTER T, 1994, SPATIAL VISION, V8, P443, DOI 10.1163/156856894X00107; WAGEMANS J, 1993, J EXP PSYCHOL HUMAN, V19, P364, DOI 10.1037/0096-1523.19.2.364; WAGEMANS J, 1995, SPATIAL VISION, V9, P9, DOI 10.1163/156856895X00098; Wenderoth P, 2000, Q J EXP PSYCHOL-A, V53, P165, DOI 10.1080/027249800390727; WU CC, 2010, J VIS, P10	46	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e9840	10.1371/journal.pone.0009840	http://dx.doi.org/10.1371/journal.pone.0009840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580BA	20386600	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000276420400001
J	Lee, TY; Folkman, J; Javaherian, K				Lee, Tong-Young; Folkman, Judah; Javaherian, Kashi			HSPG-Binding Peptide Corresponding to the Exon 6a-Encoded Domain of VEGF Inhibits Tumor Growth by Blocking Angiogenesis in Murine Model	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; IDENTIFICATION; DROSOPHILA; RECEPTOR; MIGRATION; VARIANTS; HEDGEHOG; ISOFORM	Vascular endothelial growth factor VEGF165 is a critical element for development of the vascular system in physiological and pathological angiogenesis. VEGF isoforms have different affinities for heparan sulphate proteoglycan (HSPG) as well as for VEGF receptors; HSPGs are important regulators in vascular development. Therefore, inhibition of interactions between VEGF and HSPGs may prevent angiogenesis. Here, we demonstrate that an HSPG-binding synthetic peptide, corresponding to exon 6a-encoded domain of VEGF gene, has anti-angiogenic property. This 20 amino acids synthetic peptide prevents VEGF165 binding to several different cell types, mouse embryonic sections and inhibits endothelial cell migration, despite its absence in VEGF165 sequence. Our in vivo anti-tumor studies show that the peptide inhibits tumor growth in both mouse Lewis-Lung Carcinoma and human Liposarcoma tumor-bearing animal models. This is the first evidence that a synthetic VEGF fragment corresponding to exon 6a has functional antagonism both in vitro and in vivo. We conclude that the above HPSG binding peptide (6a-P) is a potent inhibitor of angiogenesis-dependent diseases.	[Lee, Tong-Young; Folkman, Judah; Javaherian, Kashi] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Lee, Tong-Young; Folkman, Judah; Javaherian, Kashi] Harvard Univ, Sch Med, Boston, MA USA; [Javaherian, Kashi] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Dept Med,Ctr Canc Syst Biol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; St. Elizabeth's Medical Center; Tufts University	Lee, TY (corresponding author), Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA.	tongyounglee@gmail.com; kashi.javaherian@caritaschristi.org			National Institutes of Health (NIH) [R01-CA064481, P01-CA45548]; The Breast Cancer Research Foundation [DOE (DE-SC0002606)]; NATIONAL CANCER INSTITUTE [R01CA064481, P01CA045548] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants R01-CA064481 (J.F.), NIH P01-CA45548 (J.F.), Department of Defense Grant W81XWH-05-1-0115 (J.F.), a grant from The Breast Cancer Research Foundation (J.F.), and a grant from DOE (DE-SC0002606) (K.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brekken RA, 1998, CANCER RES, V58, P1952; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Herve MA, 2005, EXP CELL RES, V309, P24, DOI 10.1016/j.yexcr.2005.05.022; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Neufeld G, 1996, CANCER METAST REV, V15, P153, DOI 10.1007/BF00437467; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; OLANDER JV, 1991, BIOCHEM BIOPH RES CO, V175, P68, DOI 10.1016/S0006-291X(05)81201-X; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Robinson CJ, 2001, J CELL SCI, V114, P853; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Stringer SE, 1997, INT J BIOCHEM CELL B, V29, P709, DOI 10.1016/S1357-2725(96)00170-7; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tournaire R, 2004, EMBO REP, V5, P262, DOI 10.1038/sj.embor.7400100; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988	33	36	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9945	10.1371/journal.pone.0009945	http://dx.doi.org/10.1371/journal.pone.0009945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376344	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200021
J	Pinter, R; Hindges, R				Pinter, Rita; Hindges, Robert			Perturbations of MicroRNA Function in Mouse Dicer Mutants Produce Retinal Defects and Lead to Aberrant Axon Pathfinding at the Optic Chiasm	PLOS ONE			English	Article							BRAIN MORPHOGENESIS; BINOCULAR VISION; DISTINCT ASPECTS; GENE-EXPRESSION; HOMEOBOX GENE; SMALL RNAS; GUIDANCE; MIDLINE; IDENTIFICATION; GROWTH	Background: During development axons encounter a variety of choice points where they have to make appropriate pathfinding decisions. The optic chiasm is a major decision point for retinal ganglion cell (RGC) axons en route to their target in order to ensure the correct wiring of the visual system. MicroRNAs (miRNAs) belong to the class of small non-coding RNA molecules and have been identified as important regulators of a variety of processes during embryonic development. However, their involvement in axon guidance decisions is less clear. Methodology/Principal Findings: We report here that the early loss of Dicer, an essential protein for the maturation of miRNAs, in all cells of the forming retina and optic chiasm leads to severe phenotypes of RGC axon pathfinding at the midline. Using a conditional deletion approach in mice, we find in homozygous Dicer mutants a marked increase of ipsilateral projections, RGC axons extending outside the optic chiasm, the formation of a secondary optic tract and a substantial number of RGC axons projecting aberrantly into the contralateral eye. In addition, the mutant mice display a microphthalmia phenotype. Conclusions: Our work demonstrates an important role of Dicer controlling the extension of RGC axons to the brain proper. It indicates that miRNAs are essential regulatory elements for mechanisms that ensure correct axon guidance decisions at the midline and thus have a central function in the establishment of circuitry during the development of the nervous system.	[Pinter, Rita; Hindges, Robert] Kings Coll London, MRC, Ctr Dev Neurobiol, London, England	University of London; King's College London	Pinter, R (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Guys Campus, London, England.	robert.hindges@kcl.ac.uk	Hindges, Robert/C-5344-2009	Hindges, Robert/0000-0003-0095-7913	MRC [G0601182]; Wellcome Trust [087883/Z/08/Z]; Medical Research Council [G0601182, G0901899] Funding Source: researchfish; MRC [G0901899] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC Grant G0601182 (www.mrc.ac.uk) and Wellcome Trust Grant 087883/Z/08/Z (www.wellcome.ac.uk) to RH. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Brown LY, 2003, GENE EXPR PATTERNS, V3, P361, DOI 10.1016/S1567-133X(03)00043-7; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Decembrini S, 2008, INT J DEV BIOL, V52, P1099, DOI 10.1387/ijdb.082646sd; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Erskine L, 2000, J NEUROSCI, V20, P4975; Fabre PJ, 2010, J NEUROSCI, V30, P266, DOI 10.1523/JNEUROSCI.3778-09.2010; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Garcia-Frigola C, 2008, DEVELOPMENT, V135, P1833, DOI 10.1242/dev.020693; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jin ZB, 2009, MOL VIS, V15, P523; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Makarev E, 2006, MOL VIS, V12, P1386; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marcus RC, 1999, J COMP NEUROL, V403, P346; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Mui SH, 2002, DEVELOPMENT, V129, P797; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Petros TJ, 2009, J NEUROSCI, V29, P3463, DOI 10.1523/JNEUROSCI.5655-08.2009; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Pratt T, 2004, DEVELOPMENT, V131, P3773, DOI 10.1242/dev.01246; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; Thompson H, 2009, DEV BIOL, V335, P418, DOI 10.1016/j.ydbio.2009.09.034; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Torres MA, 1996, DEVELOPMENT, V122, P3381; Trousse F, 2001, DEVELOPMENT, V128, P3927; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhang L, 2000, GENESIS, V28, P135, DOI 10.1002/1526-968X(200011/12)28:3/4<135::AID-GENE70>3.0.CO;2-P	76	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e10021	10.1371/journal.pone.0010021	http://dx.doi.org/10.1371/journal.pone.0010021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20386732	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200066
J	Zhang, NY; Gur, A; Gibon, Y; Sulpice, R; Flint-Garcia, S; McMullen, MD; Stitt, M; Buckler, ES				Zhang, Nengyi; Gur, Amit; Gibon, Yves; Sulpice, Ronan; Flint-Garcia, Sherry; McMullen, Michael D.; Stitt, Mark; Buckler, Edward S.			Genetic Analysis of Central Carbon Metabolism Unveils an Amino Acid Substitution That Alters Maize NAD-Dependent Isocitrate Dehydrogenase Activity	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; LINKAGE DISEQUILIBRIUM; ENZYME-ACTIVITIES; DROSOPHILA-MELANOGASTER; ALCOHOL-DEHYDROGENASE; CANDIDATE GENES; HIGHER-PLANTS; ASSOCIATION; ARABIDOPSIS; EXPRESSION	Background: Central carbon metabolism (CCM) is a fundamental component of life. The participating genes and enzymes are thought to be structurally and functionally conserved across and within species. Association mapping utilizes a rich history of mutation and recombination to achieve high resolution mapping. Therefore, applying association mapping in maize (Zea mays ssp. mays), the most diverse model crop species, to study the genetics of CCM is a particularly attractive system. Methodology/Principal Findings: We used a maize diversity panel to test the CCM functional conservation. We found heritable variation in enzyme activity for every enzyme tested. One of these enzymes was the NAD-dependent isocitrate dehydrogenase (IDH, E.C. 1.1.1.41), in which we identified a novel amino-acid substitution in a phylogenetically conserved site. Using candidate gene association mapping, we identified that this non-synonymous polymorphism was associated with IDH activity variation. The proposed mechanism for the IDH activity variation includes additional components regulating protein level. With the comparison of sequences from maize and teosinte (Zea mays ssp. Parviglumis), the maize wild ancestor, we found that some CCM genes had also been targeted for selection during maize domestication. Conclusions/Significance: Our results demonstrate the efficacy of association mapping for dissecting natural variation in primary metabolic pathways. The considerable genetic diversity observed in maize CCM genes underlies heritable phenotypic variation in enzyme activities and can be useful to identify putative functional sites.	[Zhang, Nengyi; Gur, Amit; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Gibon, Yves; Sulpice, Ronan; Stitt, Mark] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Flint-Garcia, Sherry; McMullen, Michael D.] Univ Missouri, USDA ARS, Columbia, MO 65211 USA; [Flint-Garcia, Sherry; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Buckler, Edward S.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA	Cornell University; Max Planck Society; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Zhang, NY (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY USA.	nz45@cornell.edu	Buckler, Edward/GPS-4932-2022; Gibon, Yves/B-9919-2011; Gur, Amit/AFT-6744-2022; Buckler, Edward/L-7651-2019; Sulpice, Ronan/I-2738-2013; Stitt, Mark/GVT-1242-2022	Buckler, Edward/0000-0002-3100-371X; Sulpice, Ronan/0000-0002-6113-9570; Stitt, Mark/0000-0002-4900-1763; Flint-Garcia, Sherry/0000-0003-4156-5318; Gibon, Yves/0000-0001-8161-1089	National Science Foundation [DBI-0501700, DBI-0321467, DBI-0820619]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS); Vaadia-BARD Postdoctoral Fellowship, BARD [FI-360-2004]; United States - Israel Binational Agricultural Research and Development Fund; Max Planck Society	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Vaadia-BARD Postdoctoral Fellowship, BARD; United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by National Science Foundation DBI-0501700, DBI-0321467 and DBI-0820619, United States Department of Agriculture-Agricultural Research Service (USDA-ARS), Vaadia-BARD Postdoctoral Fellowship Award (FI-360-2004) from BARD, the United States - Israel Binational Agricultural Research and Development Fund, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY A, 1993, GENETICS, V134, P869; Bradbury P.J., 2007, BIOINFORMATICS; Busch W, 2007, CURR OPIN PLANT BIOL, V10, P136, DOI 10.1016/j.pbi.2007.01.002; Carrari F, 2003, PLANT PHYSIOL, V133, P1322, DOI 10.1104/pp.103.026716; CAUSSE M, 1995, MOL BREEDING, V1, P259, DOI 10.1007/BF02277426; CLARK AG, 1993, GENES ECOLOGY, P193; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gallais A, 2004, J EXP BOT, V55, P295, DOI 10.1093/jxb/erh006; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; Huege J, 2007, PHYTOCHEMISTRY, V68, P2258, DOI 10.1016/j.phytochem.2007.03.026; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Keurentjes JJB, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r129; Limami AM, 2002, PLANT PHYSIOL, V130, P1860, DOI 10.1104/pp.009647; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Manjunath S, 1998, PLANT PHYSIOL, V117, P997, DOI 10.1104/pp.117.3.997; McIntosh CA, 1997, PLANT SCI, V129, P9, DOI 10.1016/S0168-9452(97)00162-3; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Mitchell-Olds T, 1998, GENETICS, V149, P739; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; POWERS DA, 1991, ANNU REV GENET, V25, P629; Prioul JL, 1999, J EXP BOT, V50, P1281, DOI 10.1093/jexbot/50.337.1281; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Szalma SJ, 2005, THEOR APPL GENET, V110, P1324, DOI 10.1007/s00122-005-1973-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Tracy WF, 2006, CROP SCI, V46, pS49, DOI 10.2135/cropsci2006-03-0149tpg; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Weber AL, 2008, GENETICS, V180, P1221, DOI 10.1534/genetics.108.090134; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Whitt Sr, 2003, METH MOL B, V236, P123; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	45	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9991	10.1371/journal.pone.0009991	http://dx.doi.org/10.1371/journal.pone.0009991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376324	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200060
J	Arav-Boger, R; He, R; Chiou, CJ; Liu, JY; Woodard, L; Rosenthal, A; Jones-Brando, L; Forman, M; Posner, G				Arav-Boger, Ravit; He, Ran; Chiou, Chuang-Jiun; Liu, Jianyong; Woodard, Lauren; Rosenthal, Andrew; Jones-Brando, Lorraine; Forman, Michael; Posner, Gary			Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers	PLOS ONE			English	Article							PROTEAN CLINICAL MANIFESTATIONS; STEM-CELL TRANSPLANTATION; CYTOMEGALOVIRUS-INFECTION; ANTIVIRAL ACTIVITY; TRIOXANE DIMERS; UBIQUITOUS AGENTS; IN-VITRO; ARTESUNATE; DISEASE; ANTIMALARIAL	Background: Artesunate, an artemisinin-derived monomer, was reported to inhibit Cytomegalovirus (CMV) replication. We aimed to compare the in-vitro anti-CMV activity of several artemisinin-derived monomers and newly synthesized artemisinin dimers. Methods: Four artemisinin monomers and two novel artemisinin-derived dimers were tested for anti-CMV activity in human fibroblasts infected with luciferase-tagged highly-passaged laboratory adapted strain (Towne), and a clinical CMV isolate. Compounds were evaluated for CMV inhibition and cytotoxicity. Results: Artemisinin dimers effectively inhibited CMV replication in human foreskin fibroblasts and human embryonic lung fibroblasts (EC(50) for dimer sulfone carbamate and dimer primary alcohol 0.06 +/- 0.00 mu M and 0.15 +/- 0.02 mu M respectively, in human foreskin fibroblasts) with no cytotxicity at concentrations required for complete CMV inhibition. All four artemisinin monomers (artemisinin, artesunate, artemether and artefanilide) shared a similar degree of CMV inhibition amongst themselves (in mM concentrations) which was significantly less than the inhibition achieved with artemisinin dimers (P<0.0001). Similar to monomers, inhibition of CMV with artemisinin dimers appeared early in the virus life cycle as reflected by decreased expression of the immediate early (IE1) protein. Conclusions: Artemisinin dimers are potent and non-cytotoxic inhibitors of CMV replication. These compounds should be studied as potential therapeutic agents for the treatment of CMV infection in humans.	[Arav-Boger, Ravit; He, Ran; Jones-Brando, Lorraine] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Chiou, Chuang-Jiun; Liu, Jianyong] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Woodard, Lauren; Rosenthal, Andrew; Posner, Gary] Johns Hopkins Univ, Dept Chem, Sch Arts & Sci, Baltimore, MD 21218 USA; [Forman, Michael] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Arav-Boger, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	boger@jhmi.edu			NIH [AI 34885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093701, K08AI074907, R01AI034885, R37AI034885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH AI 34885 (GHP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; Alagbala AA, 2006, J MED CHEM, V49, P7836, DOI 10.1021/jm060803i; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; Chou S, 1999, Transpl Infect Dis, V1, P105, DOI 10.1034/j.1399-3062.1999.010204.x; Chou SW, 2006, ANTIMICROB AGENTS CH, V50, P2557, DOI 10.1128/AAC.00207-06; CHRISP P, 1991, DRUGS, V41, P104, DOI 10.2165/00003495-199141010-00009; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2008, CLIN INFECT DIS, V47, P804, DOI 10.1086/591195; Firestone GL, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001239; Griffiths PD, 2000, J ANTIMICROB CHEMOTH, V45, P29, DOI 10.1093/jac/45.suppl_4.29; Jones-Brando L, 2006, ANTIMICROB AGENTS CH, V50, P4206, DOI 10.1128/AAC.00793-06; Kaptein SJF, 2006, ANTIVIR RES, V69, P60, DOI 10.1016/j.antiviral.2005.10.003; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Krosky PM, 2003, J VIROL, V77, P905, DOI 10.1128/JVI.77.2.905-914.2003; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; MATTHEWS T, 1988, REV INFECT DIS, V10, pS490; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; NEYTS J, 1990, VIROLOGY, V179, P41, DOI 10.1016/0042-6822(90)90271-R; Osawa R, 2009, CRIT CARE, V13, DOI 10.1186/cc7875; Posner GH, 2003, J MED CHEM, V46, P1060, DOI 10.1021/jm020461q; Posner GH, 1999, J MED CHEM, V42, P4275, DOI 10.1021/jm990363d; Rosenthal AS, 2009, J MED CHEM, V52, P1198, DOI 10.1021/jm801484v; Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293; Schreiber A, 2009, EXPERT OPIN PHARMACO, V10, P191, DOI [10.1517/14656560802678138, 10.1517/14656560802678138 ]; Shapira MY, 2008, CLIN INFECT DIS, V46, P1455, DOI 10.1086/587106; Sia IG, 2000, CLIN MICROBIOL REV, V13, P83, DOI 10.1128/CMR.13.1.83-121.2000; STINSKI MF, 1978, J VIROL, V26, P686, DOI 10.1128/JVI.26.3.686-701.1978; Tanaka Y, 2002, BONE MARROW TRANSPL, V30, P315, DOI 10.1038/sj.bmt.1703661; WELLER TH, 1971, NEW ENGL J MED, V285, P203, DOI 10.1056/NEJM197107222850406; WELLER TH, 1971, NEW ENGL J MED, V285, P267, DOI 10.1056/NEJM197107292850507; Williams SL, 2003, ANTIMICROB AGENTS CH, V47, P2186, DOI 10.1128/AAC.47.7.2186-2192.2003; Winston DJ, 2008, BLOOD, V111, P5403, DOI 10.1182/blood-2007-11-121558; Woodard LE, 2009, J MED CHEM, V52, P7458, DOI 10.1021/jm9005934; Yust I, 2004, EUR J CLIN MICROBIOL, V23, P550, DOI 10.1007/s10096-004-1160-2	39	47	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10370	10.1371/journal.pone.0010370	http://dx.doi.org/10.1371/journal.pone.0010370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442781	Green Submitted, gold, Green Published			2022-12-27	WOS:000277154200012
J	Sander, V; Eivers, E; Choi, RH; De Robertis, EM				Sander, Veronika; Eivers, Edward; Choi, Renee H.; De Robertis, Edward M.			Drosophila Smad2 Opposes Mad Signaling during Wing Vein Development	PLOS ONE			English	Article							BETA FAMILY-MEMBERS; RECEPTOR COMPLEXES; MORPHOGEN GRADIENT; PATTERN-FORMATION; I RECEPTORS; DPP; GENE; ACTIVATION; EXPRESSION; GROWTH	In the vertebrates, the BMP/Smad1 and TGF-b/Smad2 signaling pathways execute antagonistic functions in different contexts of development. The differentiation of specific structures results from the balance between these two pathways. For example, the gastrula organizer/node of the vertebrates requires a region of low Smad1 and high Smad2 signaling. In Drosophila, Mad regulates tissue determination and growth in the wing, but the function of dSmad2 in wing patterning is largely unknown. In this study, we used an RNAi loss-of-function approach to investigate dSmad2 signaling during wing development. RNAi-mediated knockdown of dSmad2 caused formation of extra vein tissue, with phenotypes similar to those seen in Dpp/Mad gain-of-function. Clonal analyses revealed that the normal function of dSmad2 is to inhibit the response of wing intervein cells to the extracellular Dpp morphogen gradient that specifies vein formation, as measured by expression of the activated phospho-Mad protein. The effect of dSmad2 depletion in promoting vein differentiation was dependent on Medea, the co-factor shared by Mad and dSmad2. Furthermore, double RNAi experiments showed that Mad is epistatic to dSmad2. In other words, depletion of Smad2 had no effect in Mad-deficient wings. Our results demonstrate a novel role for dSmad2 in opposing Mad-mediated vein formation in the wing. We propose that the main function of dActivin/dSmad2 in Drosophila wing development is to antagonize Dpp/Mad signaling. Possible molecular mechanisms for the opposition between dSmad2 and Mad signaling are discussed.	[Sander, Veronika; Eivers, Edward; Choi, Renee H.; De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90024 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Sander, V (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90024 USA.	ederobertis@mednet.ucla.edu	Sander, Veronika/R-5190-2019	Sander, Veronika/0000-0002-2918-833X; De Robertis, Edward/0000-0002-7843-1869	NIH [HD21502-23S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502, R01HD021502] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	NIH HD21502-23S1 http://www.nih.gov HHMIhttp://www.hhmi.org. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Bharathy S, 2008, CANCER RES, V68, P1656, DOI 10.1158/0008-5472.CAN-07-5089; Bickel D, 2008, MECH DEVELOP, V125, P117, DOI 10.1016/j.mod.2007.09.013; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BLAIR SS, 1992, DEV BIOL, V152, P263, DOI 10.1016/0012-1606(92)90134-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Candia AF, 1997, DEVELOPMENT, V124, P4467; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; COUSO JP, 1994, DEVELOPMENT, V120, P621; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Das P, 1998, DEVELOPMENT, V125, P1519; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eivers E, 2008, CURR OPIN GENET DEV, V18, P304, DOI 10.1016/j.gde.2008.06.001; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; Eivers E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006543; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Garcia-Bellido A, 2009, INT J DEV BIOL, V53, P1291, DOI 10.1387/ijdb.072459ag; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nicholls RE, 1998, GENETICS, V149, P203; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sotillos S, 2006, MECH DEVELOP, V123, P241, DOI 10.1016/j.mod.2005.12.002; Sotillos S, 2005, DEV DYNAM, V232, P738, DOI 10.1002/dvdy.20270; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Takaesu NT, 2005, DEVELOPMENT, V132, P4883, DOI 10.1242/dev.02048; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yan SJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.35; Yu K, 2000, DEVELOPMENT, V127, P2143; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	58	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10383	10.1371/journal.pone.0010383	http://dx.doi.org/10.1371/journal.pone.0010383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442782	gold, Green Published			2022-12-27	WOS:000277154200019
J	Casarotto, S; Lauro, LJR; Bellina, V; Casali, AG; Rosanova, M; Pigorini, A; Defendi, S; Mariotti, M; Massimini, M				Casarotto, Silvia; Lauro, Leonor J. Romero; Bellina, Valentina; Casali, Adenauer G.; Rosanova, Mario; Pigorini, Andrea; Defendi, Stefano; Mariotti, Maurizio; Massimini, Marcello			EEG Responses to TMS Are Sensitive to Changes in the Perturbation Parameters and Repeatable over Time	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; CORTICAL EXCITABILITY; EVOKED-POTENTIALS; COIL ORIENTATION; BRAIN RESPONSES; CONNECTIVITY; HUMANS; SLEEP; DEPRESSION	Background: High-density electroencephalography (hd-EEG) combined with transcranial magnetic stimulation (TMS) provides a direct and non-invasive measure of cortical excitability and connectivity in humans and may be employed to track over time pathological alterations, plastic changes and therapy-induced modifications in cortical circuits. However, the diagnostic/monitoring applications of this technique would be limited to the extent that TMS-evoked potentials are either stereotypical (non-sensitive) or random (non-repeatable) responses. Here, we used controlled changes in the stimulation parameters (site, intensity, and angle of stimulation) and repeated longitudinal measurements (same day and one week apart) to evaluate the sensitivity and repeatability of TMS/hd-EEG potentials. Methodology/Principal Findings: In 10 volunteers, we performed 92 single-subject comparisons to evaluate the similarities/differences between pairs of TMS-evoked potentials recorded in the same/different stimulation conditions. For each pairwise comparison, we used non-parametric statistics to calculate a Divergence Index (DI), i.e., the percentage of samples that differed significantly, considering all scalp locations and the entire post-stimulus period. A receiver operating characteristic analysis showed that it was possible to find an optimal DI threshold of 1.67%, yielding 96.7% overall accuracy of TMS/hd-EEG in detecting whether a change in the perturbation parameters occurred or not. Conclusions/Significance: These results demonstrate that the EEG responses to TMS essentially reflect deterministic properties of the stimulated neuronal circuits as opposed to stereotypical responses or uncontrolled variability. To the extent that TMS-evoked potentials are sensitive to changes and repeatable over time, they may be employed to detect longitudinal changes in the state of cortical circuits.	[Casarotto, Silvia; Lauro, Leonor J. Romero; Bellina, Valentina; Casali, Adenauer G.; Rosanova, Mario; Pigorini, Andrea; Defendi, Stefano; Mariotti, Maurizio; Massimini, Marcello] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy	University of Milan	Casarotto, S (corresponding author), Univ Milan, Dept Clin Sci L Sacco, Milan, Italy.	marcello.massimini@unimi.it	Pigorini, Andrea/ABC-8351-2021; Rosanova, Mario/S-8440-2017; Lauro, Leonor Josefina Romero/AAB-2491-2019; Casali, Adenauer G/G-9911-2012; Casarotto, Silvia/Q-9402-2019; Casarotto, Silvia/F-1251-2015; Massimini, Marcello/T-8115-2017	Pigorini, Andrea/0000-0002-1856-3413; Rosanova, Mario/0000-0001-7486-7617; Lauro, Leonor Josefina Romero/0000-0002-6478-2502; Casali, Adenauer G/0000-0001-7024-9029; Casarotto, Silvia/0000-0002-7548-7664; Casarotto, Silvia/0000-0002-7548-7664; MARIOTTI, MAURIZIO/0000-0001-8415-4880; Massimini, Marcello/0000-0003-2271-957X	European Grant Strep [LSHM-CT-2005-51818, ICT-2007-224328]; PRIN 2006; Italian Ministry of Research and University	European Grant Strep; PRIN 2006(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	This work was supported by European Grant Strep LSHM-CT-2005-51818, by PRIN 2006 (Progetti di Ricerca di Interesse Nazionale - National Interest Research Projects) supported by the Italian Ministry of Research and University, and by European Grant Strep ICT-2007-224328 "Predict AD" (to M. Massimini). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CJ, 2001, SCAND J PSYCHOL, V42, P297, DOI 10.1111/1467-9450.00239; Balslev D, 2007, J NEUROSCI METH, V162, P309, DOI 10.1016/j.jneumeth.2007.01.021; Bender S, 2005, ANN NEUROL, V58, P58, DOI 10.1002/ana.20521; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P58, DOI 10.1016/0013-4694(94)90113-9; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Boly M, 2009, PROG BRAIN RES, V177, P383, DOI 10.1016/S0079-6123(09)17727-0; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Butefisch CM, 2003, BRAIN, V126, P470, DOI 10.1093/brain/awg044; Casali AG, 2010, NEUROIMAGE, V49, P1459, DOI 10.1016/j.neuroimage.2009.09.026; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Chistyakov AV, 2005, CLIN NEUROPHYSIOL, V116, P386, DOI 10.1016/j.clinph.2004.09.008; Clarkson AN, 2009, BIOCHEM SOC T, V37, P1412, DOI 10.1042/BST0371412; Dubach P, 2004, CLIN NEUROPHYSIOL, V115, P862, DOI 10.1016/j.clinph.2003.11.033; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Friston KJ, 2006, HUM BRAIN MAPP, V27, P722, DOI 10.1002/hbm.20214; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Hill AC, 2000, NEUROREPORT, V11, P3257, DOI 10.1097/00001756-200009280-00041; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Ilmoniemi RJ, 2010, BRAIN TOPOGR, V22, P233, DOI 10.1007/s10548-009-0123-4; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kahkonen S, 2005, PSYCHOPHARMACOLOGY, V181, P16, DOI 10.1007/s00213-005-2197-3; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; Kahkonen S, 2004, CLIN NEUROPHYSIOL, V115, P583, DOI 10.1016/j.clinph.2003.10.032; Kahkonen S, 2003, NEUROPSYCHOPHARMACOL, V28, P747, DOI 10.1038/sj.npp.1300099; Kahkonen S, 2001, NEUROIMAGE, V14, P322, DOI 10.1006/nimg.2001.0849; Kahkonen S, 2005, ALCOHOL, V37, P129, DOI 10.1016/j.alcohol.2006.03.003; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2002, CLIN NEUROPHYSIOL, V113, P175, DOI 10.1016/S1388-2457(01)00721-0; Lioumis P, 2009, HUM BRAIN MAPP, V30, P1387, DOI 10.1002/hbm.20608; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; Massimini M, 2009, PROG BRAIN RES, V177, P201, DOI 10.1016/S0079-6123(09)17714-2; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Paus T, 1998, HUM BRAIN MAPP, V6, P399, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<399::AID-HBM13>3.0.CO;2-H; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Thut G, 2005, J NEUROSCI METH, V141, P207, DOI 10.1016/j.jneumeth.2004.06.016; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Tikhonov A., 1977, SOLUTIONS ILL POSED; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; van de Velde M, 1998, ELECTROEN CLIN NEURO, V107, P149, DOI 10.1016/S0013-4694(98)00052-2; Van der Werf YD, 2006, EXP BRAIN RES, V175, P231, DOI 10.1007/s00221-006-0551-2; Virtanen J, 1999, MED BIOL ENG COMPUT, V37, P322, DOI 10.1007/BF02513307; YOUNDEN WJ, 1950, CANCER, V3, P32	52	136	139	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10281	10.1371/journal.pone.0010281	http://dx.doi.org/10.1371/journal.pone.0010281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421968	Green Published, gold			2022-12-27	WOS:000276952600005
J	Kumar, P; Sen, MK; Chauhan, DS; Katoch, VM; Singh, S; Prasad, HK				Kumar, Parameet; Sen, Manas K.; Chauhan, Devendra S.; Katoch, Vishwa M.; Singh, Sarman; Prasad, Hanumanthappa K.			Assessment of the N-PCR Assay in Diagnosis of Pleural Tuberculosis: Detection of M. tuberculosis in Pleural Fluid and Sputum Collected in Tandem	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; EFFUSION; BOVIS; PATIENT; UTILITY; SAMPLES; BLOOD	Background: The nonspecific clinical presentation and paucibacillary nature of tuberculous pleuritis remains a challenge for diagnosis. Diagnosis of tuberculous pleural effusion depends on the demonstration of the presence of tubercle bacilli in the sputum, pleural fluid, or pleural biopsy specimen, or demonstration of granuloma in pleura by histological examination. We examined the clinical utility of the diagnosis of pleural tuberculosis using the in house N-PCR assay, AFB smear microscopy and culture. Besides pleural fluid the inclusion of sputum in the efficacy of diagnosis of pleural tuberculosis was scrutinized. Methodology/Principal Findings: Pleural fluid and sputum samples of 58 tuberculous and 42 non-tuberculous pleural effusion patients were processed for AFB smear microscopy, culture and the N-PCR assay. Mycobacteria were detected exclusively in tuberculous pleural effusion samples. None of the non-tuberculous pleural effusion samples were positive for mycobacteria. Comparative analysis showed that the N-PCR assay had the highest sensitivity. Inclusion of sputum along with pleural fluid increased N-PCR sensitivity from 51.7 to 70.6% (p<0.0001). This improved sensitivity was reflected in AFB smear microscopy and isolation by culture. The sensitivity enhanced on inclusion of sputum from 3.4 ( p = 0.50) to 10.3% ( p = 0.038) for AFB smear microscopy and for isolation of mycobacteria from 10.3(p = 0.03) to 22.4% ( p = 0.0005). Thirteen isolates were obtained from 58 pleural tuberculosis patients. Eleven mycobacterial isolates were identified as M. tuberculosis and two as M. fortuitum and M. chelonae. Complete concordance was seen between the biochemical identification of isolates and the N-PCR identification of mycobacterial species prior to isolation. Conclusions/Significance: To the best of our knowledge this is the first PCR based report on utility of sputum for diagnosis of pleural tuberculosis. The present study demonstrates that a combination of pleural fluid with sputum sample and N- PCR improved the diagnosis of pleural tuberculosis.	[Kumar, Parameet; Prasad, Hanumanthappa K.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Sen, Manas K.] VMMC, Dept Pulm Crit Care & Sleep Med, New Delhi, India; [Sen, Manas K.] Safdarjang Hosp, New Delhi, India; [Chauhan, Devendra S.] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Katoch, Vishwa M.] Indian Council Medial Res, New Delhi, India; [Katoch, Vishwa M.] Minist Hlth & Family Welfare, Dept Hlth Res, New Delhi, India; [Singh, Sarman] All India Inst Med Sci, Dept Lab Med, Div Clin Microbiol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; All India Institute of Medical Sciences (AIIMS) New Delhi	Kumar, P (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	hk_prasad@hotmail.com	Kumar, Parameet/E-2272-2013; Singh, Sarman/AAR-8914-2020	Singh, Sarman/0000-0002-0749-9647; Chauhan, Devendra Singh/0000-0001-6519-3200	Department of Biotechnology (DBT), Government of India; Indian Council of Medical Research (ICMR); National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI-75320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI075320] Funding Source: NIH RePORTER	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The financial support of the Department of Biotechnology (DBT), Government of India, is acknowledged. Fellowship to Parameet Kumar from Indian Council of Medical Research (ICMR) is acknowledged. TB Research Materials and Vaccine Testing, National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant AI-75320 is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoe K, 2003, CHEST, V123, P740, DOI 10.1378/chest.123.3.740; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; BERGER HW, 1973, CHEST, V63, P88, DOI 10.1378/chest.63.1.88; Chakrabarti B, 2006, Monaldi Arch Chest Dis, V65, P26; Conde MB, 2003, AM J RESP CRIT CARE, V167, P723, DOI 10.1164/rccm.2111019; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; EPSTEIN DM, 1987, CHEST, V91, P106, DOI 10.1378/chest.91.1.106; Ferrer J, 1997, EUR RESPIR J, V10, P942; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Hasaneen NA, 2003, CHEST, V124, P2105, DOI 10.1378/chest.124.6.2105; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Hsieh HC, 2008, J MED MICROBIOL, V57, P664, DOI 10.1099/jmm.0.47574-0; KENT TP, 1985, PUBLIC HLTH MYCOBACT; Kumar P, 2008, J CLIN MICROBIOL, V46, P4068, DOI 10.1128/JCM.01162-08; Kumar P, 2009, J MOL DIAGN, V11, P430, DOI 10.2353/jmoldx.2009.080135; LASSENCE A, 1992, THORAX, V47, P265; Liam C K, 2000, Respirology, V5, P33, DOI 10.1046/j.1440-1843.2000.00223.x; Light RW, 2001, PLEURAL DIS; Liu Kuan-Ting, 2007, J Chin Med Assoc, V70, P148; Mattei R, 2009, J CLIN MICROBIOL, V47, P711, DOI 10.1128/JCM.01712-08; Mirza S, 2003, AM J TROP MED HYG, V69, P461, DOI 10.4269/ajtmh.2003.69.461; Mishra A, 2005, J CLIN MICROBIOL, V43, P5670, DOI 10.1128/JCM.43.11.5670-5678.2005; Moon JW, 2005, CLIN INFECT DIS, V41, P660, DOI 10.1086/432474; Nagesh BS, 2001, CHEST, V119, P1737, DOI 10.1378/chest.119.6.1737; REPO UK, 1975, SCAND J RESPIR DIS, V56, P329; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Shah NP, 2006, J CLIN MICROBIOL, V44, P1352, DOI 10.1128/JCM.44.4.1352-1358.2006; Sharma S K, 2001, Indian J Chest Dis Allied Sci, V43, P149; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; *TUB COAL TECHN AS, INT STAND TUB CAR; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; VERMA A, 1995, INDIAN J BIOCHEM BIO, V32, P429; Vestal AL, 1977, US DHEW PUBLICATION; Villegas MV, 2000, CHEST, V118, P1355, DOI 10.1378/chest.118.5.1355	35	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10220	10.1371/journal.pone.0010220	http://dx.doi.org/10.1371/journal.pone.0010220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419090	Green Published, gold, Green Submitted			2022-12-27	WOS:000276853800012
J	Raman, D; Sai, JQ; Neel, NF; Chew, CS; Richmond, A				Raman, Dayanidhi; Sai, Jiqing; Neel, Nicole F.; Chew, Catherine S.; Richmond, Ann			LIM and SH3 Protein-1 Modulates CXCR2-Mediated Cell Migration	PLOS ONE			English	Article							INFLUENCES ZYXIN LOCALIZATION; II INTERLEUKIN-8 RECEPTOR; CAMP SIGNALING PATHWAY; BREAST-CANCER; TUMOR-GROWTH; LLKIL MOTIF; IN-VITRO; LASP-1; CXCR2; CHEMOTAXIS	Background: The chemokine receptor CXCR2 plays a pivotal role in migration of neutrophils, macrophages and endothelial cells, modulating several biological responses such as angiogenesis, wound healing and acute inflammation. CXCR2 is also involved in pathogenesis of chronic inflammation, sepsis and atherosclerosis. The ability of CXCR2 to associate with a variety of proteins dynamically is responsible for its effects on directed cell migration or chemotaxis. The dynamic network of such CXCR2 binding proteins is termed as "CXCR2 chemosynapse''. Proteomic analysis of proteins that co-immunoprecipitated with CXCR2 in neutrophil-like dHL-60 cells revealed a novel protein, LIM and SH3 protein 1 (LASP-1), binds CXCR2 under both basal and ligand activated conditions. LASP-1 is an actin binding cytoskeletal protein, involved in the cell migration. Methodology/Principal Findings: We demonstrate that CXCR2 and LASP-1 co-immunoprecipitate and co-localize at the leading edge of migrating cells. The LIM domain of LASP-1 directly binds to the carboxy-terminal domain (CTD) of CXCR2. Moreover, LASP-1 also directly binds the CTD of CXCR1, CXCR3 and CXCR4. Using a site-directed and deletion mutagenesis approach, Iso323-Leu324 of the conserved LKIL motif on CXCR2-CTD was identified as the binding site for LASP-1. Interruption of the interaction between CXCR2-CTD and LIM domain of LASP-1 by dominant negative and knock down approaches inhibited CXCR2-mediated chemotaxis. Analysis for the mechanism for inhibition of CXCR2-mediated chemotaxis indicated that LASP-1/CXCR2 interaction is essential for cell motility and focal adhesion turnover involving activation of Src, paxillin, PAK1, p130CAS and ERK1/2. Conclusions/Significance: We demonstrate here for the first time that LASP-1 is a key component of the "CXCR2 chemosynapse'' and LASP-1 interaction with CXCR2 is critical for CXCR2-mediated chemotaxis. Furthermore, LASP-1 also directly binds the CTD of CXCR1, CXCR3 and CXCR4, suggesting that LASP-1 is a general mediator of CXC chemokine mediated chemotaxis. Thus, LASP-1 may serve as a new link coordinating the flow of information between chemokine receptors and nascent focal adhesions, especially at the leading edge. Thus the association between the chemokine receptors and LASP-1 suggests to the presence of a CXC chemokine receptor-LASP-1 pro-migratory module in cells governing the cell migration.	[Raman, Dayanidhi; Sai, Jiqing; Neel, Nicole F.; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Richmond, Ann] Dept Vet Affairs, Nashville, TN USA; [Chew, Catherine S.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	Vanderbilt University; University System of Georgia; Augusta University	Raman, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health (NIH) [CA-34590, DK-20593, DK-58404, HD-15052, DK-59637, EY-08126]; Specialized Neuroscience Research Program [U54NS041071-6, CA-64845]; Department of Veterans Affairs and Ingram; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA119925, T32CA009592, R23CA034590, P30CA068485, R01CA034590] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, U2CDK059637, P60DK020593, U24DK059637, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Neuroscience Research Program; Department of Veterans Affairs and Ingram; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in whole or in part by National Institutes of Health (NIH) Grants - CA-34590 (A. R.), Specialized Neuroscience Research Program grant U54NS041071-6 under Project 2 (A. R.), and CA-64845 (A. R.) in support of the Vanderbilt-Ingram Cancer Center. This work was also supported by a Senior Research Career Scientist Award from the Department of Veterans Affairs and Ingram Professorship (A. R.). The authors acknowledge the VUMC cell imaging shared resource used in confocal studies (supported by NIH grants DK-20593, DK-58404, HD-15052, DK-59637 and EY-08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Baugher PJ, 2008, J BIOL CHEM, V283, P30868, DOI 10.1074/jbc.M804054200; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chew CS, 2000, J CELL SCI, V113, P2035; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Horton LW, 2007, CANCER RES, V67, P9791, DOI 10.1158/0008-5472.CAN-07-0246; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; NEEL NF, 2008, THESIS VANDERBILT U; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Raman D, 2009, METHOD ENZYMOL, V460, P315, DOI 10.1016/S0076-6879(09)05215-X; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Sai JQ, 2004, J CELL SCI, V117, P5489, DOI 10.1242/jcs.01398; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SCHRAW W, 1995, BIOCHEMISTRY-US, V34, P13760, DOI 10.1021/bi00042a006; Siesser PMF, 2008, CELL MOTIL CYTOSKEL, V65, P25, DOI 10.1002/cm.20241; Spence HJ, 2006, MOL CELL BIOL, V26, P1480, DOI 10.1128/MCB.26.4.1480-1495.2006; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Wang DZ, 2002, BIOCHEMISTRY-US, V41, P7100, DOI 10.1021/bi025902m; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zhang H, 2009, PHYSIOL GENOMICS, V38, P372, DOI 10.1152/physiolgenomics.00048.2009	60	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10050	10.1371/journal.pone.0010050	http://dx.doi.org/10.1371/journal.pone.0010050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419088	Green Published, gold, Green Submitted			2022-12-27	WOS:000276853800001
J	Doering, P; Stoltenberg, M; Penkowa, M; Rungby, J; Larsen, A; Danscher, G				Doering, Peter; Stoltenberg, Meredin; Penkowa, Milena; Rungby, Jorgen; Larsen, Agnete; Danscher, Gorm			Chemical Blocking of Zinc Ions in CNS Increases Neuronal Damage Following Traumatic Brain Injury (TBI) in Mice	PLOS ONE			English	Article							ENRICHED ZEN TERMINALS; HIPPOCAMPAL-NEURONS; CONTAINING PATHWAYS; MOUSE-BRAIN; CELL-DEATH; IN-VIVO; LOCALIZATION; BOUTONS; TRANSLOCATION; ACCUMULATION	Background: Traumatic brain injury (TBI) is one of the leading causes of disability and death among young people. Although much is already known about secondary brain damage the full range of brain tissue responses to TBI remains to be elucidated. A population of neurons located in cerebral areas associated with higher cognitive functions harbours a vesicular zinc pool co-localized with glutamate. This zinc enriched pool of synaptic vesicles has been hypothesized to take part in the injurious signalling cascade that follows pathological conditions such as seizures, ischemia and traumatic brain injury. Pathological release of excess zinc ions from pre-synaptic vesicles has been suggested to mediate cell damage/death to postsynaptic neurons. Methodology/Principal Findings: In order to substantiate the influence of vesicular zinc ions on TBI, we designed a study in which damage and zinc movements were analysed in several different ways. Twenty-four hours after TBI ZnT3-KO mice (mice without vesicular zinc) were compared to littermate Wild Type (WT) mice (mice with vesicular zinc) with regard to histopathology. Furthermore, in order to evaluate a possible neuro-protective dimension of chemical blocking of vesicular zinc, we treated lesioned mice with either DEDTC or selenite. Our study revealed that chemical blocking of vesicular zinc ions, either by chelation with DEDTC or accumulation in zinc-selenium nanocrystals, worsened the effects on the aftermath of TBI in the WT mice by increasing the number of necrotic and apoptotic cells within the first 24 hours after TBI, when compared to those of chemically untreated WT mice. Conclusion/Significance: ZnT3-KO mice revealed more damage after TBI compared to WT controls. Following treatment with DEDTC or selenium an increase in the number of both dead and apoptotic cells were seen in the controls within the first 24 hours after TBI while the degree of damage in the ZnT3-KO mice remained largely unchanged. Further analyses revealed that the damage development in the two mouse strains was almost identical after either zinc chelation or zinc complexion therapy.	[Doering, Peter; Stoltenberg, Meredin; Larsen, Agnete; Danscher, Gorm] Univ Aarhus, Inst Anat, Aarhus, Denmark; [Penkowa, Milena] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Sect Neuroprotect,Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Rungby, Jorgen] Univ Aarhus, Dept Pharmacol, Aarhus, Denmark	Aarhus University; University of Copenhagen; Aarhus University	Doering, P (corresponding author), Univ Aarhus, Inst Anat, Aarhus, Denmark.	pdj@neuro.au.dk	Doering, Peter/GYQ-8720-2022; Rungby, Jørgen/AAQ-4332-2021	Doering, Peter/0000-0002-5561-9076; Larsen, Agnete/0000-0001-8765-8443	Augustinus Foundation; Aase and Ejnar Danielsen Foundation; Aarhus University Research Foundation; Beckett Foundation; Danish Medical Association; Lundbeck Foundation; Direktor Jacob Madsen og Hustrus Fond	Augustinus Foundation; Aase and Ejnar Danielsen Foundation; Aarhus University Research Foundation; Beckett Foundation; Danish Medical Association; Lundbeck Foundation(Lundbeckfonden); Direktor Jacob Madsen og Hustrus Fond	This study was supported by The Augustinus Foundation, The Aase and Ejnar Danielsen Foundation, The Aarhus University Research Foundation, The Beckett Foundation, The Danish Medical Association Research Fund, The Lundbeck Foundation and Direktor Jacob Madsen og Hustrus Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; Brown CE, 2004, J COMP NEUROL, V479, P156, DOI 10.1002/cne.20308; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Cote A, 2005, J PHYSIOL-LONDON, V566, P821, DOI 10.1113/jphysiol.2005.089458; DANSCHER G, 1982, HISTOCHEMISTRY, V76, P281, DOI 10.1007/BF00543951; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; DANSCHER G, 1975, BRAIN RES, V85, P522, DOI 10.1016/0006-8993(75)90825-2; DANSCHER G, 1973, EXP BRAIN RES, V16, P521, DOI 10.1007/BF00234478; DANSCHER G, 1976, THESIS AARHUS U; DANSCHER G, 1984, NEUROBIOLOGY ZINC B, P177; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Dominguez MI, 2006, EPILEPSIA, V47, P887, DOI 10.1111/j.1528-1167.2006.00501.x; Frederickson CJ, 2005, J ALZHEIMERS DIS, V8, P155; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Hellmich HL, 2008, NEUROSCI LETT, V440, P155, DOI 10.1016/j.neulet.2008.05.068; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Ismail T, 2008, NEUROSCIENCE, V157, P697, DOI 10.1016/j.neuroscience.2008.09.011; Kitamura Y, 2006, J PHARMACOL SCI, V100, P142, DOI 10.1254/jphs.FP0050805; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Larsen A, 2008, HISTOCHEM CELL BIOL, V130, P681, DOI 10.1007/s00418-008-0448-1; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; Maret W, 2009, BIOMETALS, V22, P149, DOI 10.1007/s10534-008-9186-z; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SLOMIANKA L, 1990, NEUROSCIENCE, V38, P843, DOI 10.1016/0306-4522(90)90076-G; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Sorensen JC, 1998, BRAIN RES, V812, P265, DOI 10.1016/S0006-8993(98)00943-3; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2001, BRAIN RES, V895, P25, DOI 10.1016/S0006-8993(01)01996-5; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2000, BRAIN RES REV, V34, P137, DOI 10.1016/S0165-0173(00)00044-8; Takeda A, 2001, BIOMETALS, V14, P343, DOI 10.1023/A:1012982123386; Valente T, 2002, MOL CELL NEUROSCI, V21, P189, DOI 10.1006/mcne.2002.1159; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Wang ZY, 2001, BRAIN RES, V921, P165, DOI 10.1016/S0006-8993(01)03114-6; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Yeiser EC, 2002, NUTR NEUROSCI, V5, P345, DOI 10.1080/1028415021000033811; Yeiser EC, 1999, NEUROSCI LETT, V277, P75, DOI 10.1016/S0304-3940(99)00825-3	55	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10131	10.1371/journal.pone.0010131	http://dx.doi.org/10.1371/journal.pone.0010131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20396380	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482100027
J	Igosheva, N; Abramov, AY; Poston, L; Eckert, JJ; Fleming, TP; Duchen, MR; McConnell, J				Igosheva, Natalia; Abramov, Andrey Y.; Poston, Lucilla; Eckert, Judith J.; Fleming, Tom P.; Duchen, Michael R.; McConnell, Josie			Maternal Diet-Induced Obesity Alters Mitochondrial Activity and Redox Status in Mouse Oocytes and Zygotes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HIGH-FAT DIET; OXIDATIVE STRESS; PREIMPLANTATION DEVELOPMENT; LEPTIN; DNA; TRANSITION; LIVER; HYPERLEPTINEMIA; REPRODUCTION	The negative impact of obesity on reproductive success is well documented but the stages at which development of the conceptus is compromised and the mechanisms responsible for the developmental failure still remain unclear. Recent findings suggest that mitochondria may be a contributing factor. However to date no studies have directly addressed the consequences of maternal obesity on mitochondria in early embryogenesis. Using an established murine model of maternal diet induced obesity and a live cell dynamic fluorescence imaging techniques coupled with molecular biology we have investigated the underlying mechanisms of obesity-induced reduced fertility. Our study is the first to show that maternal obesity prior to conception is associated with altered mitochondria in mouse oocytes and zygotes. Specifically, maternal diet-induced obesity in mice led to an increase in mitochondrial potential, mitochondrial DNA content and biogenesis. Generation of reactive oxygen species (ROS) was raised while glutathione was depleted and the redox state became more oxidised, suggestive of oxidative stress. These altered mitochondrial properties were associated with significant developmental impairment as shown by the increased number of obese mothers who failed to support blastocyst formation compared to lean dams. We propose that compromised oocyte and early embryo mitochondrial metabolism, resulting from excessive nutrient exposure prior to and during conception, may underlie poor reproductive outcomes frequently reported in obese women.	[Igosheva, Natalia; Poston, Lucilla; McConnell, Josie] Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England; [Abramov, Andrey Y.] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Eckert, Judith J.] Univ Southampton, Sch Med, Southampton, Hants, England; [Fleming, Tom P.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London, England	University of London; King's College London; University of London; University College London; University of Southampton; University of Southampton; University of London; University College London	Igosheva, N (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England.	ni4@sanger.ac.uk	duchen, michael/A-2116-2009; Abramov, Andrey/AAC-6712-2019; Abramov, Andrey Y/H-9053-2012	duchen, michael/0000-0003-2548-4294; Abramov, Andrey/0000-0002-7646-7235; Abramov, Andrey Y/0000-0002-7646-7235; Poston, Lucilla/0000-0003-1100-2821	Biotechnology and Biological Sciences Research Council [BB/C518273/1, F007450]; Tommys Charity, UK; Biotechnology and Biological Sciences Research Council [G18784, BB/F007450/1] Funding Source: researchfish; Medical Research Council [G0601943, G0100558] Funding Source: researchfish; BBSRC [BB/F007450/1] Funding Source: UKRI; MRC [G0601943, G0100558] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tommys Charity, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (grants BB/C518273/1; F007450) and by Tommys Charity, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; Baker P., 2007, OBESITY REPROD HLTH; Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647; Brannian JD, 2005, REPROD NUTR DEV, V45, P143, DOI 10.1051/rnd:2005011; Brannian JD, 2001, HUM REPROD, V16, P1819, DOI 10.1093/humrep/16.9.1819; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Cummins JM, 2004, EUR J OBSTET GYN R B, V115, pS23, DOI 10.1016/j.ejogrb.2004.01.011; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Dumollard R, 2009, SEMIN CELL DEV BIOL, V20, P346, DOI 10.1016/j.semcdb.2008.12.013; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Fedorcsak P, 2003, BIOL REPROD, V69, P1531, DOI 10.1095/biolreprod.103.019034; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; GARDINER CS, 1995, ARCH BIOCHEM BIOPHYS, V318, P30, DOI 10.1006/abbi.1995.1200; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Jansen RPS, 2004, MITOCHONDRION, V4, P577, DOI 10.1016/j.mito.2004.07.038; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Malik NM, 2001, ENDOCRINOLOGY, V142, P5198, DOI 10.1210/en.142.12.5198; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; McConnell JML, 2004, REPROD BIOMED ONLINE, V9, P418, DOI 10.1016/S1472-6483(10)61277-1; Metwally M, 2007, OBES REV, V8, P515, DOI 10.1111/j.1467-789X.2007.00406.x; Minamikawa T, 1999, EXP CELL RES, V246, P26, DOI 10.1006/excr.1998.4290; Minge CE, 2008, ENDOCRINOLOGY, V149, P2646, DOI 10.1210/en.2007-1570; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Mollica MP, 1998, MOL CELL BIOCHEM, V178, P213, DOI 10.1023/A:1006899632413; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; MUGGLETONHARRIS AL, 1988, HUM REPROD, V3, P1020, DOI 10.1093/oxfordjournals.humrep.a136815; Ramsay JE, 2006, BMJ-BRIT MED J, V333, P1159, DOI 10.1136/bmj.39049.439444.DE1; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Robker Rebecca L, 2008, Pathophysiology, V15, P115, DOI 10.1016/j.pathophys.2008.04.004; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Shitara H, 2000, GENETICS, V156, P1277; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Thouas GA, 2006, BIOL REPROD, V74, P969, DOI 10.1095/biolreprod.105.048611; Van Blerkom J, 2008, REPROD BIOMED ONLINE, V16, P553, DOI 10.1016/S1472-6483(10)60463-4; Wakefield SL, 2008, AM J PHYSIOL-ENDOC M, V294, pE425, DOI 10.1152/ajpendo.00409.2007; Wilding M, 2002, Reprod Biomed Online, V5, P39	54	329	345	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10074	10.1371/journal.pone.0010074	http://dx.doi.org/10.1371/journal.pone.0010074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404917	gold, Green Published, Green Submitted			2022-12-27	WOS:000276482100005
J	Svensson, AKE; Bilsel, O; Kayatekin, C; Adefusika, JA; Zitzewitz, JA; Matthews, CR				Svensson, Anna-Karin E.; Bilsel, Osman; Kayatekin, Can; Adefusika, Jessica A.; Zitzewitz, Jill A.; Matthews, C. Robert			Metal-Free ALS Variants of Dimeric Human Cu,Zn-Superoxide Dismutase Have Enhanced Populations of Monomeric Species	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; FREE-ENERGY SURFACE; DISULFIDE REDUCTION; FREE CYSTEINES; FAMILIAL ALS; MUTANT; SOD1; COPPER; AGGREGATION	Amino acid replacements at dozens of positions in the dimeric protein human, Cu, Zn superoxide dismutase (SOD1) can cause amyotrophic lateral sclerosis (ALS). Although it has long been hypothesized that these mutations might enhance the populations of marginally-stable aggregation-prone species responsible for cellular toxicity, there has been little quantitative evidence to support this notion. Perturbations of the folding free energy landscapes of metal-free versions of five ALS-inducing variants, A4V, L38V, G93A, L106V and S134N SOD1, were determined with a global analysis of kinetic and thermodynamic folding data for dimeric and stable monomeric versions of these variants. Utilizing this global analysis approach, the perturbations on the global stability in response to mutation can be partitioned between the monomer folding and association steps, and the effects of mutation on the populations of the folded and unfolded monomeric states can be determined. The 2- to 10-fold increase in the population of the folded monomeric state for A4V, L38V and L106V and the 80- to 480-fold increase in the population of the unfolded monomeric states for all but S134N would dramatically increase their propensity for aggregation through high-order nucleation reactions. The wild-type-like populations of these states for the metal-binding region S134N variant suggest that even wild-type SOD1 may also be prone to aggregation in the absence of metals.	[Svensson, Anna-Karin E.; Bilsel, Osman; Kayatekin, Can; Adefusika, Jessica A.; Zitzewitz, Jill A.; Matthews, C. Robert] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Svensson, AKE (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	jill.zitzewitz@umassmed.edu; c.robert.matthews@umassmed.edu	Kayatekin, Can/B-6618-2009	Bilsel, Osman/0000-0003-0414-3060; Kayatekin, Can/0000-0002-4367-9645	National Institutes of Health [GM 54836, 5R25HL92610-2]; National Institutute of Child Health and Human Development Intellectual and Developmental Disabilities Research Center [HD04147]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutute of Child Health and Human Development Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant GM 54836 to C. R. M. Support for mass spectrometry analysis was provided by National Institutute of Child Health and Human Development Intellectual and Developmental Disabilities Research Center Core Grant HD04147 (http://www.iddrc.org/). Summer undergraduate research support for J.A.A. was provided by NIH grant 5R25HL92610-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crow JP, 1997, J NEUROCHEM, V69, P1936; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; KAYATEKIN C, 2010, J MOL BIOL IN PRESS; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mulligan VK, 2008, J MOL BIOL, V383, P424, DOI 10.1016/j.jmb.2008.08.024; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Noel AF, 2009, J MOL BIOL, V387, P1002, DOI 10.1016/j.jmb.2008.12.061; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; PRUDENCIO M, 2009, HUM MOL GENET; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Rumfeldt JAO, 2009, J MOL BIOL, V385, P278, DOI 10.1016/j.jmb.2008.10.003; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	53	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10064	10.1371/journal.pone.0010064	http://dx.doi.org/10.1371/journal.pone.0010064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404910	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100003
J	Das, BC; McCartin, K; Liu, TC; Peterson, RT; Evans, T				Das, Bhaskar C.; McCartin, Kellie; Liu, Ting-Chun; Peterson, Randall T.; Evans, Todd			A Forward Chemical Screen in Zebrafish Identifies a Retinoic Acid Derivative with Receptor Specificity	PLOS ONE			English	Article							GENETICS	Background: Retinoids regulate key developmental pathways throughout life, and have potential uses for differentiation therapy. It should be possible to identify novel retinoids by coupling new chemical reactions with screens using the zebrafish embryonic model. Principal Findings: We synthesized novel retinoid analogues and derivatives by amide coupling, obtaining 80-92% yields. A small library of these compounds was screened for bioactivity in living zebrafish embryos. We found that several structurally related compounds significantly affect development. Distinct phenotypes are generated depending on time of exposure, and we characterize one compound (BT10) that produces specific cardiovascular defects when added 1 day post fertilization. When compared to retinoic acid (ATRA), BT10 shows similar but not identical changes in the expression pattern of embryonic genes that are known targets of the retinoid pathway. Reporter assays determined that BT10 interacts with all three RAR receptor sub-types, but has no activity for RXR receptors, at all concentrations tested. Conclusions: Our screen has identified a novel retinoid with specificity for retinoid receptors. This lead compound may be useful for manipulating components of retinoid signaling networks, and may be further derivatized for enhanced activity.	[Das, Bhaskar C.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Das, Bhaskar C.] Albert Einstein Coll Med, Dept Nucl Med, New York, NY USA; [McCartin, Kellie; Liu, Ting-Chun; Evans, Todd] Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10021 USA; [Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA	Yeshiva University; Yeshiva University; Cornell University; Harvard University; Massachusetts General Hospital	Das, BC (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA.	bhaskar.das@einstein.yu.edu; tre2003@med.cornell.edu		Peterson, Randall/0000-0003-0727-3469	Albert Einstein College of Medicine; National Science Foundation (NSF) [DBI9601607, DBI0331934]; National Institutes of Health (NIH) [RR017998, HL056182, HL064282]; Howard Hughes Medical Institute (HHMI) Research Resources for Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017998] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064282, R37HL056182, R01HL056182] Funding Source: NIH RePORTER	Albert Einstein College of Medicine; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI) Research Resources for Biomedical Sciences(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	B. C. D. is thankful to the Albert Einstein College of Medicine for start up funding. The instrumentation in the Structural Nuclear Magnetic Resonance Resource is supported by the Albert Einstein College of Medicine and in part by Grants from the National Science Foundation (NSF) (DBI9601607 and DBI0331934), the National Institutes of Health (NIH) (RR017998) and the Howard Hughes Medical Institute (HHMI) Research Resources for Biomedical Sciences. T. E. is supported by the NIH (HL056182, HL064282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Das BC, 2009, CHEM COMMUN, P2133, DOI 10.1039/b823063c; Garattini E, 2007, CURR PHARM DESIGN, V13, P1375, DOI 10.2174/138161207780618786; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lokey RS, 2003, CURR OPIN CHEM BIOL, V7, P91, DOI 10.1016/S1367-5931(02)00002-9; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; Malvasi A, 2009, EUR REV MED PHARMACO, V13, P393; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Skromne I, 2008, DEV DYNAM, V237, P861, DOI 10.1002/dvdy.21484; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; STAINIER DYR, 1992, DEV BIOL, V153, P91, DOI 10.1016/0012-1606(92)90094-W; Tan DS, 2002, NAT BIOTECHNOL, V20, P561, DOI 10.1038/nbt0602-561; Waxman JS, 2009, DEV DYNAM, V238, P1207, DOI 10.1002/dvdy.21951; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705	24	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10004	10.1371/journal.pone.0010004	http://dx.doi.org/10.1371/journal.pone.0010004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368991	Green Published, gold, Green Submitted			2022-12-27	WOS:000276419900008
J	Cui, CY; Kunisada, M; Piao, Y; Childress, V; Ko, MSH; Schlessinger, D				Cui, Chang-Yi; Kunisada, Makoto; Piao, Yulan; Childress, Victoria; Ko, Minoru S. H.; Schlessinger, David			Dkk4 and Eda Regulate Distinctive Developmental Mechanisms for Subtypes of Mouse Hair	PLOS ONE			English	Article							SWEAT GLAND DEVELOPMENT; FOLLICLE MORPHOGENESIS; ECTODERMAL DYSPLASIA; SONIC-HEDGEHOG; BETA-CATENIN; GENE-EXPRESSION; WNT; SKIN; DIFFERENTIATION; ECTODYSPLASIN	The mouse hair coat comprises protective "primary'' and thermo-regulatory "secondary'' hairs. Primary hair formation is ectodysplasin (Eda) dependent, but it has been puzzling that Tabby (Eda(-/y)) mice still make secondary hair. We report that Dickkopf 4 (Dkk4), a Wnt antagonist, affects an auxiliary pathway for Eda-independent development of secondary hair. A Dkk4 transgene in wild-type mice had no effect on primary hair, but secondary hairs were severely malformed. Dkk4 action on secondary hair was further demonstrated when the transgene was introduced into Tabby mice: the usual secondary follicle induction was completely blocked. The Dkk4-regulated secondary hair pathway, like the Eda-dependent primary hair pathway, is further mediated by selective activation of Shh. The results thus reveal two complex molecular pathways that distinctly regulate subtype-based morphogenesis of hair follicles, and provide a resolution for the longstanding puzzle of hair formation in Tabby mice lacking Eda.	[Cui, Chang-Yi; Kunisada, Makoto; Piao, Yulan; Childress, Victoria; Ko, Minoru S. H.; Schlessinger, David] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cui, CY (corresponding author), NIA, Genet Lab, NIH, Baltimore, MD 21224 USA.	SchlessingerD@grc.nia.nih.gov	Cui, Chang-Yi/AAO-8984-2021; Ko, Minoru/B-7969-2009	KUNISADA, Makoto/0000-0003-2210-6108; Cui, Chang-Yi/0000-0002-9856-9427; Ko, Minoru/0000-0002-3530-3015	NIH/National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000643, ZIAAG000702, ZIAAG000662] Funding Source: NIH RePORTER	NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the IRP of the NIH/National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2009, J CLIN GASTROENTEROL, V43, P327, DOI 10.1097/MCG.0b013e31816256ff; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Cui CY, 2007, HUM MOL GENET, V16, P2583, DOI 10.1093/hmg/ddm210; Cui CY, 2006, P NATL ACAD SCI USA, V103, P9142, DOI 10.1073/pnas.0509678103; Cui CY, 2009, J INVEST DERMATOL, V129, P984, DOI 10.1038/jid.2008.318; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Durmowicz MC, 2002, GENE, V285, P203, DOI 10.1016/S0378-1119(02)00407-9; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Kunisada M, 2009, HUM MOL GENET, V18, P1769, DOI 10.1093/hmg/ddp089; Laurikkala J, 2002, DEVELOPMENT, V129, P2541; Millar SE, 2003, J INVEST DERMATOL, V120, P7, DOI 10.1046/j.1523-1747.2003.00001.x; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Schlake T, 2005, MECH DEVELOP, V122, P988, DOI 10.1016/j.mod.2005.04.012; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Sharov AA, 2006, P NATL ACAD SCI USA, V103, P18166, DOI 10.1073/pnas.0608899103; Shindo M, 2004, BIOCHEM BIOPH RES CO, V315, P73, DOI 10.1016/j.bbrc.2004.01.025; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vielkind U, 1996, ACTA ANAT, V157, P183; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Yamago G, 2001, ARCH DERMATOL RES, V293, P435, DOI 10.1007/s004030100252; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Zhang N, 2009, J GLOB INF MANAG, V17, P49, DOI 10.4018/jgim.2009010103	47	27	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e10009	10.1371/journal.pone.0010009	http://dx.doi.org/10.1371/journal.pone.0010009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20386733	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200064
J	Christopher, DJ; Daley, P; Armstrong, L; James, P; Gupta, R; Premkumar, B; Michael, JS; Radha, V; Zwerling, A; Schiller, I; Dendukuri, N; Pai, M				Christopher, Devasahayam J.; Daley, Peter; Armstrong, Lois; James, Prince; Gupta, Richa; Premkumar, Beulah; Michael, Joy Sarojini; Radha, Vedha; Zwerling, Alice; Schiller, Ian; Dendukuri, Nandini; Pai, Madhukar			Tuberculosis Infection among Young Nursing Trainees in South India	PLOS ONE			English	Article							HEALTH-CARE WORKERS; DRUG-RESISTANT TUBERCULOSIS; RISK; PREVALENCE; DIAGNOSIS; TESTS; ASSAY	Background: Among healthcare workers in developing countries, nurses spend a large amount of time in direct contact with tuberculosis (TB) patients, and are at high risk for acquisition of TB infection and disease. To better understand the epidemiology of nosocomial TB among nurses, we recruited a cohort of young nursing trainees at Christian Medical College, a large, tertiary medical school hospital in Southern India. Methodology/Principal Findings: Among 535 nursing students enrolled in 2007, 468 gave consent to participate, and 436 underwent two-step tuberculin skin testing (TST). A majority (95%) were females, and almost 80% were under 22 years of age. Detailed TB exposure information was obtained using interviews and clinical log books. Prevalence of latent TB infection (LTBI) was estimated using Bayesian latent class analyses (LCA). Logistic regression analyses were done to determine the association between LTBI prevalence and TB exposure and risk factors. 219 of 436 students (50.2%, 95% CI: 45.4-55.0) were TST positive using the 10 mm or greater cut-off. Based on the LCA, the prevalence of LTBI was 47.8% (95% credible interval 17.8% to 65.6%). In the multivariate analysis, TST positivity was strongly associated with time spent in health care, after adjusting for age at entry into healthcare. Conclusions: Our study showed a high prevalence of LTBI even in young nursing trainees. With the recent TB infection control (TBIC) policy guidance from the World Health Organization as the reference, Indian healthcare providers and the Indian Revised National TB Control Programme will need to implement TBIC interventions, and enhance capacity for TBIC at the country level. Young trainees and nurses, in particular, will need to be targeted for TBIC interventions.	[Christopher, Devasahayam J.; James, Prince; Gupta, Richa] Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India; [Daley, Peter; Armstrong, Lois] Christian Med Coll & Hosp, Dept Med, Unit 1, Vellore, Tamil Nadu, India; [Premkumar, Beulah; Radha, Vedha] Christian Med Coll & Hosp, Coll Nursing, Vellore, Tamil Nadu, India; [Michael, Joy Sarojini] Christian Med Coll & Hosp, Dept Microbiol, Vellore, Tamil Nadu, India; [Zwerling, Alice; Dendukuri, Nandini; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Schiller, Ian; Dendukuri, Nandini] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada; [Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; McGill University; McGill University; McGill University	Christopher, DJ (corresponding author), Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India.	madhukar.pai@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Daley, Peter/J-8908-2017	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Daley, Peter/0000-0001-7068-8056	Canadian Institutes of Health Research (CIHR) [MOP-81362, MOP-89857]; European Commission; Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This study was funded by the Canadian Institutes of Health Research (CIHR) operating grants [MOP-81362 & MOP-89857], and European Commission (EU-FP7; TBSusgent grant). MP is a recipient of a CIHR New Investigator award and a Fonds de la recherche en sante du Quebec (FRSQ) establishment grant, and ND is a recipient of a FRSQ salary award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Balaji V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009527; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; *CENTR TB DIV, 2009, TB IND 2009 RNTCP ST, P1; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Corbett EL, 2007, CLIN INFECT DIS, V44, P317, DOI 10.1086/509926; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; James P, 2009, INT J TUBERC LUNG D, V13, P795; Joshi R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000805; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, EMERG INFECT DIS, V12, P1311, DOI 10.3201/eid1209.051663; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; World Health Organization, 2009, WHO POL TB INF CONTR	24	45	49	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10408	10.1371/journal.pone.0010408	http://dx.doi.org/10.1371/journal.pone.0010408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454447	Green Published, gold, Green Submitted			2022-12-27	WOS:000277240100017
J	Nomellini, JF; Li, C; Lavallee, D; Shanina, I; Cavacini, LA; Horwitz, MS; Smit, J				Nomellini, John F.; Li, Carmen; Lavallee, Danielle; Shanina, Iryna; Cavacini, Lisa A.; Horwitz, Marc S.; Smit, John			Development of an HIV-1 Specific Microbicide Using Caulobacter crescentus S-Layer Mediated Display of CD4 and MIP1 alpha	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VAGINAL LACTOBACILLUS STRAIN; 2-DOMAIN CD4; FRESH-WATER; SURFACE; PROTEIN; MUTAGENESIS; INHIBITION; SECRETION; ENTRY	The development of alternative strategies to prevent HIV infection is a global public health priority. Initial efforts in anti-HIV microbicide development have met with poor success as the strategies have relied on a non-specific mechanism of action. Here, we report the development of a microbicide aimed at specifically blocking HIV entry by displaying molecular components of the HIV/host cell attachment complex on the surface of Caulobacter crescentus, a harmless aquatic bacterium. This bacterium can be readily manipulated to present heterologous proteins at high density on its surface by genetic insertion into its crystalline surface layer protein [1,2]. In separate constructions, we generated bacteria displaying domain 1 of CD4 and MIP1 alpha. Each moiety reacted with specific antibodies by Western immunoblot and immunofluorescence microscopy. Microbicide functionality was assessed using an HIV pseudotype virus assay system representing Clade B subtypes. Bacteria displaying MIP1 alpha reduced infectivity by 35-78% depending on the specific subtype while CD4 display reduced infection by as much as 56%. Combinations of both constructs reduced infectivity by nearly 98%. We demonstrated that HIV infection could be inhibited using a strategy aimed at HIV-specific molecular interactions with Caulobacter surface protein display, and that sufficient protein folding and conformation could be mimicked to bind and block entry. Further, this is the first demonstration that Caulobacter surface protein display may be a useful approach to preventing HIV infection or other viruses as a microbicide. We propose that this harmless bacterium, which is inexpensive to produce and formulate, might be suitable for topical applications as a viable alternative in the search for effective microbicides to counteract the world wide incidence of HIV infection.	[Nomellini, John F.; Li, Carmen; Lavallee, Danielle; Shanina, Iryna; Horwitz, Marc S.; Smit, John] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Cavacini, Lisa A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of British Columbia; Harvard University; Beth Israel Deaconess Medical Center	Nomellini, JF (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	jsmit@interchange.ubc.ca			Campbell Foundation and Harvard Center; University of British Columbia University-Industry Liaison Office Prototype Development Fund	Campbell Foundation and Harvard Center; University of British Columbia University-Industry Liaison Office Prototype Development Fund	This work was funded by grants from the Campbell Foundation and Harvard Center for AIDS Research to J. S., L. C. and M. S. H. and the University of British Columbia University-Industry Liaison Office Prototype Development Fund to J. S. and M. S. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASIMWEOKIROR G, 2007, HIV AIDS EPIDEMEOLOG; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Bhatnagar PK, 2006, CANCER BIOL THER, V5, P485, DOI 10.4161/cbt.5.5.2553; Bingle WH, 1997, MOL MICROBIOL, V26, P277, DOI 10.1046/j.1365-2958.1997.5711932.x; Bingle WH, 1997, J BACTERIOL, V179, P601, DOI 10.1128/jb.179.3.601-611.1997; Bradley J, 2004, J BIOMOL SCREEN, V9, P516, DOI 10.1177/1087057104264577; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; GILCHRIST A, 1991, J BACTERIOL, V173, P921, DOI 10.1128/jb.173.2.921-925.1991; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; Harrison PF, 2003, CLIN INFECT DIS, V36, P1290, DOI 10.1086/374834; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu JJ, 2007, CELL MICROBIOL, V9, P120, DOI 10.1111/j.1462-5822.2006.00772.x; Liu XM, 2008, APPL ENVIRON MICROB, V74, P4626, DOI 10.1128/AEM.00104-08; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Nomellini JF, 2007, APPL ENVIRON MICROB, V73, P3245, DOI 10.1128/AEM.02900-06; Samuelson P, 2002, J BIOTECHNOL, V96, P129, DOI 10.1016/S0168-1656(02)00043-3; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; *UNAIDS, 2008, 2008 REP GLOB AIDS E; WALKER SG, 1992, J BACTERIOL, V174, P1783, DOI 10.1128/jb.174.6.1783-1792.1992; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	22	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10366	10.1371/journal.pone.0010366	http://dx.doi.org/10.1371/journal.pone.0010366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442778	gold, Green Submitted, Green Published			2022-12-27	WOS:000277154200008
J	Patel, A; Mamtani, M; Dibley, MJ; Badhoniya, N; Kulkarni, H				Patel, Archana; Mamtani, Manju; Dibley, Michael J.; Badhoniya, Neetu; Kulkarni, Hemant			Therapeutic Value of Zinc Supplementation in Acute and Persistent Diarrhea: A Systematic Review	PLOS ONE			English	Article							VITAMIN-A SUPPLEMENTATION; ORAL REHYDRATION; DOUBLE-BLIND; MALNOURISHED CHILDREN; BANGLADESHI CHILDREN; CHILDHOOD DIARRHEA; CONTROLLED-TRIAL; YOUNG-CHILDREN; COPPER SUPPLEMENTATION; DEVELOPING-COUNTRIES	Background: For over a decade, the importance of zinc in the treatment of acute and persistent diarrhea has been recognized. In spite of recently published reviews, there remain several unanswered questions about the role of zinc supplementation in childhood diarrhea in the developing countries. Our study aimed to assess the therapeutic benefits of zinc supplementation in the treatment of acute or persistent diarrhea in children, and to examine the causes of any heterogeneity of response to zinc supplementation. Methods and Findings: EMBASE (R), MEDLINE (R) and CINAHL (R) databases were searched for published reviews and meta-analyses on the use of zinc supplementation for the prevention and treatment of childhood diarrhea. Additional RCTs published following the meta-analyses were also sought. The reviews and published RCTs were qualitatively mapped followed by updated random-effects meta-analyses, subgroup meta-analyses and meta-regression to quantify and characterize the role of zinc supplementation with diarrhea-related outcomes. We found that although there was evidence to support the use of zinc to treat diarrhea in children, there was significant unexplained heterogeneity across the studies for the effect of zinc supplementation in reducing important diarrhea outcomes. Zinc supplementation reduced the mean duration of diarrhea by 19.7% but had no effect on stool frequency or stool output, and increased the risk of vomiting. Our subgroup meta-analyses and meta-regression showed that age, stunting, breast-feeding and baseline zinc levels could not explain the heterogeneity associated with differential reduction in the mean diarrheal duration. However, the baseline zinc levels may not be representative of the existing zinc deficiency state. Conclusions: Understanding the predictors of zinc efficacy including the role of diarrheal disease etiology on the response to zinc would help to identify the populations most likely to benefit from supplementation. To improve the programmatic use of zinc, further evaluations of the zinc salts used, the dose, the frequency and duration of supplementation, and its acceptability are required. The significant heterogeneity of responses to zinc suggests the need to revisit the strategy of universal zinc supplementation in the treatment children with acute diarrhea in developing countries.	[Patel, Archana; Mamtani, Manju; Badhoniya, Neetu; Kulkarni, Hemant] Lata Med Res Fdn, Nagpur, Maharashtra, India; [Patel, Archana] Indira Gandhi Govt Med Coll, Nagpur, Maharashtra, India; [Mamtani, Manju; Kulkarni, Hemant] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Dibley, Michael J.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Texas System; University of Texas Health San Antonio; University of Sydney	Patel, A (corresponding author), Lata Med Res Fdn, Nagpur, Maharashtra, India.	hemant_kulkarnius@yahoo.com	Kulkarni, Hemant/AEM-5750-2022					Aggarwal R, 2007, PEDIATRICS, V119, P1120, DOI 10.1542/peds.2006-3481; Al-Sonboli N, 2003, ANN TROP PAEDIATR, V23, P3, DOI 10.1179/000349803125002797; Awasthi S, 2006, J PEDIATR GASTR NUTR, V42, P300; Bahl R, 2002, J PEDIATR-US, V141, P677, DOI 10.1067/mpd.2002.128543; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bhan MK, 2000, INT J ANTIMICROB AG, V14, P71, DOI 10.1016/S0924-8579(99)00150-8; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhatnagar S, 2004, J PEDIATR GASTR NUTR, V38, P34, DOI 10.1097/00005176-200401000-00010; Bhutta ZA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e42; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Black RE, 2003, J NUTR, V133, p1485S, DOI 10.1093/jn/133.5.1485S; Black RE, 2001, BRIT J NUTR, V85, pS125, DOI 10.1079/BJN2000304; Black RE, 1998, AM J CLIN NUTR, V68, p476S, DOI 10.1093/ajcn/68.2.476S; Boran P, 2006, ARCH DIS CHILD, V91, P296, DOI 10.1136/adc.2005.079939; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Brooks WA, 2005, AM J CLIN NUTR, V82, P605, DOI 10.1093/ajcn/82.3.605; Brown KH, 2009, FOOD NUTR BULL, V30, pS179, DOI 10.1177/15648265090301S110; Canani RB, 2005, J INFECT DIS, V191, P1072, DOI 10.1086/428504; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Dutta P, 2000, J TROP PEDIATRICS, V46, P259, DOI 10.1093/tropej/46.5.259; Fajolu I B, 2008, Nig Q J Hosp Med, V18, P101; Faruque ASG, 1999, ACTA PAEDIATR, V88, P154, DOI 10.1080/08035259950170312; Forsberg BC, 2007, B WORLD HEALTH ORGAN, V85, P42, DOI 10.2471/BLT.06.030866; Friedrich JO, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-32; Gregorio GV, 2007, J CLIN EPIDEMIOL, V60, P560, DOI 10.1016/j.jclinepi.2006.08.004; Haider BA, 2009, FOOD NUTR BULL, V30, pS41, DOI 10.1177/15648265090301S104; HIDAYAT A, 1998, MED J INDONESIA, V7, P237; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Khan AM, 2007, J HEALTH POPUL NUTR, V25, P127; Khatun UHF, 2001, ACTA PAEDIATR, V90, P376, DOI 10.1080/080352501750126159; KING JC, 1994, J NUTR, V124, P508, DOI 10.1093/jn/124.4.508; Larson CP, 2008, J HEALTH POPUL NUTR, V26, P356; Larson CP, 2005, J HEALTH POPUL NUTR, V23, P311; Lazzerini M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005436.pub2; Long KZ, 2007, PEDIATRICS, V120, pE846, DOI 10.1542/peds.2006-2187; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; McMillan E M, 1987, Prog Clin Biol Res, V227B, P295; Naheed A, 2009, J PEDIATR GASTR NUTR, V48, P89, DOI 10.1097/MPG.0b013e31817f0182; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Patel AB, 2005, INDIAN PEDIATR, V42, P433; Patel A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-22; Patro B, 2008, ALIMENT PHARM THER, V28, P713, DOI 10.1111/j.1365-2036.2008.03787.x; Penny ME, 1999, J PEDIATR-US, V135, P208, DOI 10.1016/S0022-3476(99)70024-7; Polat TB, 2003, PEDIATR INT, V45, P555, DOI 10.1046/j.1442-200X.2003.01772.x; Raqib R, 2004, AM J CLIN NUTR, V79, P444; Roy SK, 2008, EUR J CLIN NUTR, V62, P849, DOI 10.1038/sj.ejcn.1602795; Roy SK, 2008, BMJ-BRIT MED J, V336, P266, DOI 10.1136/bmj.39416.646250.AE; Roy SK, 2007, J HEALTH POPUL NUTR, V25, P67; Roy SK, 1998, ACTA PAEDIATR, V87, P1235, DOI 10.1080/080352598750030898; Roy SK, 1997, ARCH DIS CHILD, V77, P196, DOI 10.1136/adc.77.3.196; SACHDEV HPS, 1988, J PEDIATR GASTR NUTR, V7, P877, DOI 10.1097/00005176-198811000-00015; SACHDEV HPS, 1990, ANN TROP PAEDIATR, V10, P63, DOI 10.1080/02724936.1990.11747411; Salvatore S, 2007, NUTRITION, V23, P498, DOI 10.1016/j.nut.2007.03.008; SAZAWAL S, 1995, NEW ENGL J MED, V333, P839, DOI 10.1056/NEJM199509283331304; Strand TA, 2002, PEDIATRICS, V109, P898, DOI 10.1542/peds.109.5.898; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Turner SM, 2006, FEMS MICROBIOL LETT, V263, P10, DOI 10.1111/j.1574-6968.2006.00401.x; Valery PC, 2005, MED J AUSTRALIA, V182, P530, DOI 10.5694/j.1326-5377.2005.tb00021.x; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054; Walker CLF, 2007, FOOD NUTR BULL, V28, pS454, DOI 10.1177/15648265070283S305; Walker CLF, 2006, J PEDIATR GASTR NUTR, V43, P357, DOI 10.1097/01.mpg.0000232018.40907.00; Winch PJ, 2008, J HEALTH POPUL NUTR, V26, P1; World Health Organization, 2004, WORLD HEAL J, V1, P11, DOI DOI 10.1089/ACM.2009.0657	67	64	68	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10386	10.1371/journal.pone.0010386	http://dx.doi.org/10.1371/journal.pone.0010386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442848	Green Submitted, Green Published, gold			2022-12-27	WOS:000277154200022
J	Talamini, LM; de Haan, L; Nieman, DH; Linszen, DH; Meeter, M				Talamini, Lucia M.; de Haan, Lieuwe; Nieman, Dorien H.; Linszen, Don H.; Meeter, Martijn			Reduced Context Effects on Retrieval in First-Episode Schizophrenia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEMORY IMPAIRMENT; HIPPOCAMPAL-FORMATION; RECOGNITION MEMORY; ENTORHINAL CORTEX; FALSE RECOGNITION; EPISODIC MEMORY; SPATIAL CONTEXT; NAIVE PATIENTS; VERBAL MEMORY	Background: A recent modeling study by the authors predicted that contextual information is poorly integrated into episodic representations in schizophrenia, and that this is a main cause of the retrieval deficits seen in schizophrenia. Methodology/Principal Findings: We have tested this prediction in patients with first-episode schizophrenia and matched controls. The benefit from contextual cues in retrieval was strongly reduced in patients. On the other hand, retrieval based on item cues was spared. Conclusions/Significance: These results suggest that reduced integration of context information into episodic representations is a core deficit in schizophrenia and one of the main causes of episodic memory impairment.	[Talamini, Lucia M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [de Haan, Lieuwe; Nieman, Dorien H.; Linszen, Don H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Meeter, Martijn] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Talamini, LM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	L.M.Talamini@uva.nl	Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717; Nieman, Dorien/0000-0002-9846-4254	Dutch National Science Foundation (NWO) [051-04- 102, 402-01-635, 451-05-006]	Dutch National Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	Grant sponsor: Dutch National Science Foundation (NWO; http://www.nwo.nl). Grant numbers: 051-04- 102, 402-01-635 and 451-05-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2003, BRAIN COGNITION, V53, P121, DOI 10.1016/S0278-2626(03)00092-7; Achim AM, 2007, ARCH GEN PSYCHIAT, V64, P999, DOI 10.1001/archpsyc.64.9.999; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; [Anonymous], 1983, CANADIAN PSYCHOL; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; Bachevalier J, 2008, HIPPOCAMPUS, V18, P64, DOI 10.1002/hipo.20369; Bazin N, 2000, SCHIZOPHR RES, V45, P93, DOI 10.1016/S0920-9964(99)00167-X; Brebion G, 1997, J NERV MENT DIS, V185, P247, DOI 10.1097/00005053-199704000-00005; Brebion G, 1999, PSYCHIAT RES, V88, P15, DOI 10.1016/S0165-1781(99)00076-1; Brebion G, 2004, J CLIN EXP NEUROPSYC, V26, P1093, DOI 10.1080/13803390490515513; Brebion G, 1997, PSYCHOL MED, V27, P383, DOI 10.1017/S0033291796004448; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Danion JM, 1999, ARCH GEN PSYCHIAT, V56, P639, DOI 10.1001/archpsyc.56.7.639; DeLisi LE, 1997, PSYCHIAT RES-NEUROIM, V74, P129, DOI 10.1016/S0925-4927(97)00012-7; Diaz-Asper C, 2008, PSYCHIAT RES, V159, P259, DOI 10.1016/j.psychres.2007.02.018; Elvevag B, 2000, NEUROPSYCHOLOGIA, V38, P1565, DOI 10.1016/S0028-3932(00)00074-9; Elvevag B, 2000, PSYCHOL MED, V30, P885, DOI 10.1017/S003329179900255X; Elvevag B, 2004, NEUROPSYCHOLOGIA, V42, P546, DOI 10.1016/j.neuropsychologia.2003.08.013; Gold JM, 2000, J ABNORM PSYCHOL, V109, P534, DOI 10.1037//0021-843X.109.3.534; GOLD JM, 1992, J ABNORM PSYCHOL, V101, P487, DOI 10.1037/0021-843X.101.3.487; Goldberg TE, 1996, J CLIN PSYCHIAT, V57, P62; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Harvey PD, 2001, AM J PSYCHIAT, V158, P176, DOI 10.1176/appi.ajp.158.2.176; HARVEY PD, 1988, SCHIZOPHRENIA BULL, V14, P57, DOI 10.1093/schbul/14.1.57; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Hemby SE, 2002, ARCH GEN PSYCHIAT, V59, P631, DOI 10.1001/archpsyc.59.7.631; Hill SK, 2004, SCHIZOPHR RES, V68, P127, DOI 10.1016/S0920-9964(03)00125-7; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Keefe RSE, 1999, PSYCHOL MED, V29, P903, DOI 10.1017/S0033291799008673; Lee YS, 2007, PSYCHOL MED, V37, P559, DOI 10.1017/S0033291706009044; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Meeter M, 2002, NEUROCOMPUTING, V44, P929, DOI 10.1016/S0925-2312(02)00493-9; Moritz S, 2003, PSYCHOL MED, V33, P131, DOI 10.1017/S0033291702006852; Mortimer AM, 1997, PHARMACOL BIOCHEM BE, V56, P789, DOI 10.1016/S0091-3057(96)00425-X; Nuyen J, 2005, J INT NEUROPSYCH SOC, V11, P152, DOI 10.1017/S1355617705050162; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; Rizzo L, 1996, NEUROPSYCHOLOGY, V10, P376, DOI 10.1037/0894-4105.10.3.376; Rolls ET, 2005, J NEUROPHYSIOL, V94, P833, DOI 10.1152/jn.01063.2004; Rushe TM, 1999, SCHIZOPHR RES, V35, P85, DOI 10.1016/S0920-9964(98)00117-0; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Salisbury DF, 2000, PSYCHOPHYSIOLOGY, V37, P456, DOI 10.1017/S0048577200980028; Salisbury DF, 2002, CLIN NEUROPHYSIOL, V113, P383, DOI 10.1016/S1388-2457(02)00003-2; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Sitnikova T, 2002, PSYCHOPHYSIOLOGY, V39, P851, DOI 10.1111/1469-8986.3960851; SPITZER RL, 1985, COMPREHENSIVE TXB PS; SPOHN HE, 1989, J ABNORM PSYCHOL, V98, P367, DOI 10.1037/0021-843X.98.4.367; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Talamini LM, 2005, ARCH GEN PSYCHIAT, V62, P485, DOI 10.1001/archpsyc.62.5.485; Talamini LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006505; Tendolkar I, 2002, PSYCHOL MED, V32, P1261, DOI 10.1017/S0033291702006335; Van Berkum JJA, 2008, J COGNITIVE NEUROSCI, V20, P580, DOI 10.1162/jocn.2008.20054; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; Waters FAV, 2004, SCHIZOPHR RES, V68, P119, DOI 10.1016/S0920-9964(03)00221-4; Wechsler D., 1997, WECHSLER ADULT INTEL; Weickert Thomas W, 2005, Curr Psychiatry Rep, V7, P304, DOI 10.1007/s11920-005-0085-5; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Weiss AP, 2002, AM J PSYCHIAT, V159, P1506, DOI 10.1176/appi.ajp.159.9.1506; Wood SJ, 2002, PSYCHOL MED, V32, P429, DOI 10.1017/S0033291702005275; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	61	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10356	10.1371/journal.pone.0010356	http://dx.doi.org/10.1371/journal.pone.0010356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588NX	20436915	Green Submitted, gold, Green Published			2022-12-27	WOS:000277079700009
J	Inoue, N; Kasahara, T; Ikawa, M; Okabe, M				Inoue, Naokazu; Kasahara, Tatsuya; Ikawa, Masahito; Okabe, Masaru			Identification and Disruption of Sperm-Specific Angiotensin Converting Enzyme-3 (ACE3) in Mouse	PLOS ONE			English	Article							EGG PLASMA-MEMBRANE; CD9-DEFICIENT MICE; MALE-FERTILITY; PROTEIN IZUMO; FUSION; FERTILIZATION; MECHANISMS; HOMOLOG; BINDING; TESTIS	Background: IZUMO1 is the only sperm protein which is proven to be essential for sperm-egg fusion. However, the IZUMO1 is a structurally simple protein with single Ig domain and seems not to include either a "fusogenic peptide" or a fusion machinery domain. This led us to assume the existence of an ZUMO1-interacting protein(s) which makes a functional fusion machine interacting with IZUMO1. Methodology/Principal Findings: We produced a transgenic mouse line which expresses His-tagged IZUMO1 in the Izumo1(-/-) genetic background. After solubilization of sperm membranes, we purified His-tagged IZUMO1 using anti-His affinity chromatography and found a protein that interacts with IZUMO1. After being separated on SDS-PAGE gel, the IZUMO1-interacting protein was subjected to LC-MS/MS analysis and from the partial fragments, we identified the protein as ACE3. We raised the antibody against ACE3 and found that ACE3 is localized on the acrosomal cap area as in the case of IZUMO1. However, ACE3 disappeared from sperm after acrosome reaction while IZUMO1 remained on sperm. In order to investigate the role of ACE3 in vivo, we generated Ace3-deficient mice by homologous recombination and examined the fertilizing ability of the males. Unexpectedly, the male mice showed no defect in fertilizing ability in in vivo or in an in vitro fertilization system. Conclusions/Significance: We identified an IZUMO1-interacting protein in sperm, which we identified as testis specific ACE homologue ACE3. We produced an Ace3 disrupted mouse line, and found the localization of IZUMO1 spread in a little wider area on sperm, but the elimination of ACE3 did not result in a loss of sperm fertilizing ability, differing from the case of ACE disruption.	[Inoue, Naokazu; Kasahara, Tatsuya; Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Osaka University	Inoue, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Osaka, Japan.	Okabe@gen-info.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Inoue, Naokazu/0000-0002-6187-8293; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nakajima Foundation; Uehara Memorial Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Senri Life Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakajima Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Senri Life Science Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, The Nakajima Foundation, The Uehara Memorial Foundation, NOVARTIS Foundation (Japan) for the Promotion of Science, and The Senri Life Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Deguchi E, 2007, BIOL REPROD, V77, P794, DOI 10.1095/biolreprod.107.060004; Douglas GC, 2004, ENDOCRINOLOGY, V145, P4703, DOI 10.1210/en.2004-0443; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Fuchs S, 2005, NAT MED, V11, P1140, DOI 10.1038/nm1105-1140; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue Naokazu, 2007, Soc Reprod Fertil Suppl, V65, P363; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kessler SP, 2000, J BIOL CHEM, V275, P26259, DOI 10.1074/jbc.M004006200; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Ramalho-Santos J, 2001, EXP CELL RES, V267, P45, DOI 10.1006/excr.2000.5119; Rella M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-194; Sun XO, 2008, BIOL CHEM, V389, P1477, DOI 10.1515/BC.2008.168; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x	23	38	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10301	10.1371/journal.pone.0010301	http://dx.doi.org/10.1371/journal.pone.0010301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421979	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952600018
J	Cooper, PR; Mesaros, AC; Zhang, J; Christmas, P; Stark, CM; Douaidy, K; Mittelman, MA; Soberman, RJ; Blair, IA; Panettieri, RA				Cooper, Philip R.; Mesaros, A. Clementina; Zhang, Jie; Christmas, Peter; Stark, Christopher M.; Douaidy, Karim; Mittelman, Michael A.; Soberman, Roy J.; Blair, Ian A.; Panettieri, Reynold A., Jr.			20-HETE Mediates Ozone-Induced, Neutrophil-Independent Airway Hyper-Responsiveness in Mice	PLOS ONE			English	Article							ALLERGEN-SENSITIZED MICE; 20-HYDROXYEICOSATETRAENOIC ACID; CYTOCHROME-P450 4A; MESSENGER-RNA; GUINEA-PIGS; INFLAMMATION; EXPOSURE; LUNG; RAT; INHIBITION	Background: Ozone, a pollutant known to induce airway hyper-responsiveness (AHR), increases morbidity and mortality in patients with obstructive airway diseases and asthma. We postulate oxidized lipids mediate in vivo ozone-induced AHR in murine airways. Methodology/Principal Findings: Male BALB/c mice were exposed to ozone (3 or 6 ppm) or filtered air (controls) for 2 h. Precision cut lung slices (PCLS; 250 mu m thickness) containing an intrapulmonary airway (similar to 0.01 mm(2) lumen area) were prepared immediately after exposure or 16 h later. After 24 h, airways were contracted to carbachol (CCh). Log EC(50) and E(max) values were then calculated by measuring the airway lumen area with respect to baseline. In parallel studies, dexamethasone (2.5 mg/kg), or 1-aminobenzotriazol (ABT) (50 mg/kg) were given intraperitoneal injection to naive mice 18 h prior to ozone exposure. Indomethacin (10 mg/kg) was administered 2 h prior. Cell counts, cytokine levels and liquid chromatography-mass spectrometry (LC-MS) for lipid analysis were assessed in bronchoalveolar lavage (BAL) fluid from ozone exposed and control mice. Ozone acutely induced AHR to CCh. Dexamethasone or indomethacin had little effect on the ozone-induced AHR; while, ABT, a cytochrome P450 inhibitor, markedly attenuated airway sensitivity. BAL fluid from ozone exposed animals, which did not contain an increase in neutrophils or interleukin (IL)-6 levels, increased airway sensitivity following in vitro incubation with a naive PCLS. In parallel, significant increases in oxidized lipids were also identified using LC-MS with increases of 20-HETE that were decreased following ABT treatment. Conclusions/Significance: These data show that ozone acutely induces AHR to CCh independent of inflammation and is insensitive to steroid treatment or cyclooxygenase (COX) inhibition. BAL fluid from ozone exposed mice mimicked the effects of in vivo ozone exposure that were associated with marked increases in oxidized lipids. 20-HETE plays a pivotal role in mediating acute ozone-induced AHR.	[Cooper, Philip R.; Zhang, Jie; Mittelman, Michael A.; Panettieri, Reynold A., Jr.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Cooper, Philip R.; Zhang, Jie; Mittelman, Michael A.; Panettieri, Reynold A., Jr.] Univ Penn, Sch Med, Airways Biol Initiat, Philadelphia, PA 19104 USA; [Mesaros, A. Clementina; Blair, Ian A.; Panettieri, Reynold A., Jr.] Univ Penn, Ctr Canc Pharmacol, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Christmas, Peter] Radford Univ, Dept Biol, Radford, VA 24142 USA; [Christmas, Peter; Stark, Christopher M.; Douaidy, Karim; Soberman, Roy J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Charlestown, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Radford University; Harvard University	Cooper, PR (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	RAP@mail.med.upenn.edu; RAP@mail.med.upenn.edu	Blair, Ian A/B-3320-2010; panettieri, reynold/AAG-9485-2019	Stark, Christopher/0000-0003-1146-7063	NIH [RO1 AI-068871, RO1 RO1DK74821, P30ES013508, R01CA091016]; NATIONAL CANCER INSTITUTE [R01CA091016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH RO1 AI-068871, RO1 RO1DK74821, P30ES013508 and R01CA091016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MF, 2007, EXP LUNG RES, V33, P115, DOI 10.1080/01902140701364367; Arjomandi M, 2005, AM J RESP CRIT CARE, V172, P427, DOI 10.1164/rccm.200502-272OC; Balmes JR, 1996, AM J RESP CRIT CARE, V153, P904, DOI 10.1164/ajrccm.153.3.8630571; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Blomberg A, 1999, EUR RESPIR J, V13, P1418, DOI 10.1034/j.1399-3003.1999.13f31.x; Chen C, 2007, ENVIRON HEALTH PERSP, V115, P1732, DOI 10.1289/ehp.10294; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; Cloutier M, 2003, AM J PHYSIOL-LUNG C, V285, pL560, DOI 10.1152/ajplung.00381.2002; Depuydt P, 1999, EUR RESPIR J, V14, P125, DOI 10.1034/j.1399-3003.1999.14a21.x; EVANS TW, 1988, AM REV RESPIR DIS, V138, P140, DOI 10.1164/ajrccm/138.1.140; Galan I, 2003, EUR RESPIR J, V22, P802, DOI 10.1183/09031936.03.00013003; Hazucha MJ, 1996, EUR J APPL PHYSIOL O, V73, P17, DOI 10.1007/BF00262805; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Imig JD, 1996, AM J PHYSIOL-REG I, V270, pR217, DOI 10.1152/ajpregu.1996.270.1.R217; Ito K, 2008, AM J RESP CELL MOL, V39, P543, DOI 10.1165/rcmb.2008-0028OC; Jang AS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-24; Jorres RA, 2000, AM J RESP CRIT CARE, V161, P1855; Kafoury RM, 1998, TOXICOL APPL PHARM, V150, P338, DOI 10.1006/taap.1998.8418; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; Kroetz DL, 2005, ANNU REV PHARMACOL, V45, P413, DOI 10.1146/annurev.pharmtox.45.120403.100045; Le Bouquin R, 2004, FUND CLIN PHARMACOL, V18, P181, DOI 10.1111/j.1472-8206.2004.00228.x; LEE HK, 1985, AM REV RESPIR DIS, V132, P1005; Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; MESAROS C, 2009, J CHROMATOGR B; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Morin C, 2007, AM J PHYSIOL-LUNG C, V293, pL1037, DOI 10.1152/ajplung.00145.2007; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Nakano H, 2000, EUR J PHARMACOL, V403, P267, DOI 10.1016/S0014-2999(00)00524-0; PINO MV, 1992, TOXICOL APPL PHARM, V114, P268, DOI 10.1016/0041-008X(92)90077-6; PRAKASH C, 1992, BIOCHEM BIOPH RES CO, V185, P728, DOI 10.1016/0006-291X(92)91686-K; Ratto J, 2006, ENVIRON HEALTH PERSP, V114, P209, DOI 10.1289/ehp.8341; SCHELEGLE ES, 1991, AM REV RESPIR DIS, V143, P1353, DOI 10.1164/ajrccm/143.6.1353; SCHLESINGER RB, 1990, J TOXICOL ENV HEALTH, V31, P275, DOI 10.1080/15287399009531456; SELTZER J, 1986, J APPL PHYSIOL, V60, P1321, DOI 10.1152/jappl.1986.60.4.1321; Stokstad E, 2008, SCIENCE, V319, P1602, DOI 10.1126/science.319.5870.1602a; Su P, 1998, AM J PHYSIOL-REG I, V275, pR426, DOI 10.1152/ajpregu.1998.275.2.R426; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Williams AS, 2007, J PHARMACOL EXP THER, V322, P351, DOI 10.1124/jpet.107.121624; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Zhu DL, 2002, J APPL PHYSIOL, V93, P330, DOI 10.1152/japplphysiol.01159.2001; Zhu DL, 1998, AM J RESP CELL MOL, V19, P121, DOI 10.1165/ajrcmb.19.1.3145	44	35	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10235	10.1371/journal.pone.0010235	http://dx.doi.org/10.1371/journal.pone.0010235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422032	Green Published, gold, Green Submitted			2022-12-27	WOS:000276854300005
J	de Souza, JB; Okomo, U; Alexander, ND; Aziz, N; Owens, BMJ; Kaur, H; Jasseh, M; Muangnoicharoen, S; Sumariwalla, PF; Warhurst, DC; Ward, SA; Conway, DJ; Ulloa, L; Tracey, KJ; Foxwell, BMJ; Kaye, PM; Walther, M				de Souza, J. Brian; Okomo, Uduak; Alexander, Neal D.; Aziz, Naveed; Owens, Benjamin M. J.; Kaur, Harparkash; Jasseh, Momodou; Muangnoicharoen, Sant; Sumariwalla, Percy F.; Warhurst, David C.; Ward, Stephen A.; Conway, David J.; Ulloa, Luis; Tracey, Kevin J.; Foxwell, Brian M. J.; Kaye, Paul M.; Walther, Michael			Oral Activated Charcoal Prevents Experimental Cerebral Malaria in Mice and in a Randomized Controlled Clinical Trial in Man Did Not Interfere with the Pharmacokinetics of Parenteral Artesunate	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; TUMOR-NECROSIS-FACTOR; CELL DEFORMABILITY; IMMUNE-RESPONSE; KENYAN CHILDREN; EXPRESSION; QUININE; RECEPTOR; TANZANIA; HOST	Background: Safe, cheap and effective adjunct therapies preventing the development of, or reducing the mortality from, severe malaria could have considerable and rapid public health impact. Oral activated charcoal (oAC) is a safe and well tolerated treatment for acute poisoning, more recently shown to have significant immunomodulatory effects in man. In preparation for possible efficacy trials in human malaria, we sought to determine whether oAC would i) reduce mortality due to experimental cerebral malaria (ECM) in mice, ii) modulate immune and inflammatory responses associated with ECM, and iii) affect the pharmacokinetics of parenteral artesunate in human volunteers. Methods/Principal Findings: We found that oAC provided significant protection against P. berghei ANKA-induced ECM, increasing overall survival time compared to untreated mice (p<0.0001; hazard ratio 16.4; 95% CI 6.73 to 40.1). Protection from ECM by oAC was associated with reduced numbers of splenic TNF(+) CD4(+) T cells and multifunctional IFN gamma(+) TNF(+) CD4(+) and CD8(+) T cells. Furthermore, we identified a whole blood gene expression signature (68 genes) associated with protection from ECM. To evaluate whether oAC might affect current best available anti-malarial treatment, we conducted a randomized controlled open label trial in 52 human volunteers (ISRCTN NR. 64793756), administering artesunate ( AS) in the presence or absence of oAC. We demonstrated that co-administration of oAC was safe and well-tolerated. In the 26 subjects further analyzed, we found no interference with the pharmacokinetics of parenteral AS or its pharmacologically active metabolite dihydroartemisinin. Conclusions/Significance: oAC protects against ECM in mice, and does not interfere with the pharmacokinetics of parenteral artesunate. If future studies succeed in establishing the efficacy of oAC in human malaria, then the characteristics of being inexpensive, well-tolerated at high doses and requiring no sophisticated storage would make oAC a relevant candidate for adjunct therapy to reduce mortality from severe malaria, or for immediate treatment of suspected severe malaria in a rural setting.	[de Souza, J. Brian; Alexander, Neal D.; Kaur, Harparkash; Jasseh, Momodou; Warhurst, David C.; Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [de Souza, J. Brian] UCL, Dept Immunol, Div Infect & Immun, London, England; [Okomo, Uduak; Conway, David J.; Walther, Michael] MRC Labs, Banjul, Gambia; [Aziz, Naveed] Univ York, Dept Biol, Technol Facil, York YO10 5DD, N Yorkshire, England; [Owens, Benjamin M. J.; Kaye, Paul M.] Univ York, Hull York Med Sch, Ctr Immunol & Infect, York, N Yorkshire, England; [Muangnoicharoen, Sant; Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Sumariwalla, Percy F.; Foxwell, Brian M. J.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London, England; [Ulloa, Luis; Tracey, Kevin J.] N Shore LIJ Res Inst, Ctr Immunol & Inflammat, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; MRC Laboratory Molecular Biology; University of York - UK; University of Hull; University of York - UK; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London; University of Oxford; Northwell Health	de Souza, JB (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	pmk2@york.ac.uk; mwalther@mrc.gm	Jasseh, Momodou/AAB-6071-2022; Ward, Steve/G-6003-2015; de Souza, Joseph B/D-4979-2009; warhurst, david c/C-3428-2013; Ulloa, Luis/AAE-8751-2019; Okomo, Uduak/U-7156-2019	Ward, Steve/0000-0003-2331-3192; Ulloa, Luis/0000-0002-7702-7549; Okomo, Uduak/0000-0002-9923-1196; Owens, Benjamin/0000-0003-4710-6841; Conway, David/0000-0002-8711-3037; Tracey, Kevin J/0000-0003-1884-6314; Muangnoicharoen, Sant/0000-0002-8236-8954; Kaye, Paul/0000-0002-8796-4755	British Medical Research Council [G0400786]; Medical Research Council Laboratories (UK); North Shore-LIJ Faculty Award; NIGMS; North Shore-LIJ GCRC [1MO1RR018535]; MRC [MC_U190085853, G0700837, G0400786] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084125, R01GM057226] Funding Source: NIH RePORTER; Medical Research Council [G0400786, G0700837, MC_U190085853] Funding Source: researchfish	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Laboratories (UK); North Shore-LIJ Faculty Award; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); North Shore-LIJ GCRC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	British Medical Research Council (#G0400786 to PMK; http://www.mrc.ac.uk/index.htm), the Medical Research Council Laboratories (UK) core funding to the MRC Gambia Unit, a North Shore-LIJ Faculty Award to LU, the NIGMS, and the North Shore-LIJ GCRC (#1MO1RR018535; http://www.feinsteininstitute.org/Feinstein/GCRC). BO is supported by a MRC Postgraduate Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINTONWA A, 1990, VET HUM TOXICOL, V32, P567; Armitage P, 2001, STAT METHODS MED RES, V4th; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Boggild AK, 2009, CLIN INFECT DIS, V49, P841, DOI 10.1086/605431; BRADBERRY SM, 1995, J TOXICOL-CLIN TOXIC, V33, P407, DOI 10.3109/15563659509013749; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Chakravorty SJ, 2007, INT J PARASITOL, V37, P975, DOI 10.1016/j.ijpara.2007.02.006; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Clark IA, 2003, PHARMACOL THERAPEUT, V99, P221, DOI 10.1016/S0163-7258(03)00060-3; Clark IA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-208; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Delahaye NF, 2006, J INFECT DIS, V193, P312, DOI 10.1086/498579; Dondorp AM, 1997, AM J TROP MED HYG, V57, P507, DOI 10.4269/ajtmh.1997.57.507; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Faiz MA, 2005, LANCET, V366, P717; Griffith JW, 2007, J INFECT DIS, V196, P1553, DOI 10.1086/522865; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; HASAN MM, 1990, J PHARM PHARMACOL, V42, P85, DOI 10.1111/j.2042-7158.1990.tb05359.x; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Jackson GDF, 2000, INFECT IMMUN, V68, P4714, DOI 10.1128/IAI.68.8.4714-4719.2000; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kellum JA, 2002, CRIT CARE MED, V30, P1387, DOI 10.1097/00003246-200206000-00047; LOCKEY D, 1989, BRIT J CLIN PHARMACO, V27, P92, DOI 10.1111/j.1365-2125.1989.tb05340.x; Lovegrove FE, 2007, AM J PATHOL, V171, P1894, DOI 10.2353/ajpath.2007.070630; Lovegrove FE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-295; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; PRESCOTT LF, 1989, BRIT J CLIN PHARMACO, V27, P95, DOI 10.1111/j.1365-2125.1989.tb05341.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Schulman G, 2006, BLOOD PURIFICAT, V24, P143, DOI 10.1159/000089451; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; VANBELLE G, 1993, AM STAT, V47, P163; vanHensbroek MB, 1996, J INFECT DIS, V174, P1091, DOI 10.1093/infdis/174.5.1091; Wang E, 2008, IMMUNITY, V29, P9, DOI 10.1016/j.immuni.2008.07.002; WHO, 2008, WHO WORLD MAL REP	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e9867	10.1371/journal.pone.0009867	http://dx.doi.org/10.1371/journal.pone.0009867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419161	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000276707100001
J	Kuznetsov, IR; Herant, M; Dembo, M				Kuznetsov, Igor R.; Herant, Marc; Dembo, Micah			Analysis of Actin FLAP Dynamics in the Leading Lamella	PLOS ONE			English	Article							NEUTROPHIL PHAGOCYTOSIS; CRAWLING CELLS; MECHANICS; FIBROBLASTS; MORPHOLOGY; MOTION; LOCOMOTION; CYTOPLASM; TRANSPORT; SURFACE	Background: The transport of labeled G-actin from the mid-lamella region to the leading edge in a highly motile malignant rat fibroblast line has been studied using fluorescence localization after photobleaching or FLAP, and the transit times recorded in these experiments were so fast that simple diffusion was deemed an insufficient explanation (see Zicha et al., Science, v. 300, pp. 142-145 [ 1]). Methodology/Principal Findings: We re-examine the Zicha FLAP experiments using a two-phase reactive interpenetrating flow formalism to model the cytoplasm and the transport dynamics of bleached and unbleached actin. By allowing an improved treatment of effects related to the retrograde flow of the cytoskeleton and of the geometry and finite thickness of the lamella, this new analysis reveals a mechanism that can realistically explain the timing and the amplitude of all the FLAP signals observed in [ 1] without invoking special transport modalities. Conclusions/Significance: We conclude that simple diffusion is sufficent to explain the observed transport rates, and that variations in the transport of labeled actin through the lamella are minor and not likely to be the cause of the observed physiological variations among different segments of the leading edge. We find that such variations in labeling can easily arise from differences and changes in the microscopic actin dynamics inside the edge compartment, and that the key dynamical parameter in this regard is the so-called "dilatation rate'' ( the velocity of cytoskeletal retrograde flow divided by a characteristic dimension of the edge compartment where rapid polymerization occurs). If our dilatation hypothesis is correct, the transient kinetics of bleached actin relocalization constitute a novel and very sensitive method for probing the cytoskeletal dynamics in leading edge micro-environments which are otherwise very difficult to directly interrogate.	[Kuznetsov, Igor R.; Herant, Marc; Dembo, Micah] Boston Univ, Boston, MA 02215 USA	Boston University	Kuznetsov, IR (corresponding author), Boston Univ, Boston, MA 02215 USA.	kouznets@bu.edu	Dembo, Micah/C-2755-2013		Whitaker biomedical engineering research [RG-02-0714]; National Institutes of Health (NIH) [RO1 GM72002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072002] Funding Source: NIH RePORTER	Whitaker biomedical engineering research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Whitaker biomedical engineering research grant RG-02-0714 to MH and National Institutes of Health (NIH) grant RO1 GM72002 to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Atilgan E, 2005, BIOPHYS J, V89, P3589, DOI 10.1529/biophysj.105.065383; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; DEMBO M, 1989, BIOPHYS J, V55, P1053, DOI 10.1016/S0006-3495(89)82904-2; DEMBO M, 1981, J CELL BIOL, V91, P528, DOI 10.1083/jcb.91.2.528; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; Drury JL, 2001, BIOPHYS J, V81, P3166, DOI 10.1016/S0006-3495(01)75953-X; DUNN G, 2004, CURRENT PROTOCOLS CE, V21, P1; Dunn GA, 2002, J MICROSC-OXFORD, V205, P109, DOI 10.1046/j.0022-2720.2001.001007.x; Fischer H.B., 1979, MIXING INLAND COASTA, P80, DOI [10.1016/B978-0-08-051177-1.50008-8, DOI 10.1016/B978-0-08-051177-1.50008-8, 10.1016/13978-0-08-051177-1.50008-8]; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; He XY, 1997, EXP CELL RES, V233, P252, DOI 10.1006/excr.1997.3585; HEACOCK CS, 1984, EXP CELL RES, V153, P402, DOI 10.1016/0014-4827(84)90609-8; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; Herant M, 2003, BIOPHYS J, V84, P3389, DOI 10.1016/S0006-3495(03)70062-9; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; Keller H, 2002, CELL MOTIL CYTOSKEL, V53, P189, DOI 10.1002/cm.10063; Olbris DJ, 1999, BIOPHYS J, V77, P3407, DOI 10.1016/S0006-3495(99)77172-9; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Revell CM, 2006, MATRIX BIOL, V25, P523, DOI 10.1016/j.matbio.2006.07.007; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	27	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10082	10.1371/journal.pone.0010082	http://dx.doi.org/10.1371/journal.pone.0010082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419164	Green Submitted, Green Published, gold			2022-12-27	WOS:000276707100003
J	Liu, SP; Lee, SD; Lee, HT; Liu, DD; Wang, HJ; Liu, RS; Lin, SZ; Shyu, WC				Liu, Shih-Ping; Lee, Shin-Da; Lee, Hsu-Tung; Liu, Demeral David; Wang, Hsiao-Jung; Liu, Ren-Shyan; Lin, Shinn-Zong; Shyu, Woei-Cherng			Granulocyte Colony-Stimulating Factor Activating HIF-1 alpha Acts Synergistically with Erythropoietin to Promote Tissue Plasticity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SMOOTH-MUSCLE-CELLS; FACTOR-I; BONE-MARROW; STEM-CELLS; G-CSF; MYELODYSPLASTIC SYNDROMES; FUNCTIONAL RECOVERY; PROGENITOR CELLS	Stroke and peripheral limb ischemia are serious clinical problems with poor prognosis and limited treatment. The cytokines erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) have been used to induce endogenous cell repair and angiogenesis. Here, we demonstrated that the combination therapy of EPO and G-CSF exerted synergistic effects on cell survival and functional recovery from cerebral and peripheral limbs ischemia. We observed that even under normoxic conditions, G-CSF activates hypoxia-inducible factor-1 alpha (HIF-1 alpha), which then binds to the EPO promoter and enhances EPO expression. Serum EPO level was significantly increased by G-CSF injection, with the exception of Tg-HIF-1 alpha(+f/+f) mice. The neuroplastic mechanisms exerted by EPO combined with G-CSF included enhanced expression of the antiapoptotic protein of Bcl-2, augmented neurotrophic factors synthesis, and promoted neovascularization. Further, the combination therapy significantly increased homing and differentiation of bone marrow stem cells (BMSCs) and intrinsic neural progenitor cells (INPCs) into the ischemic area. In summary, EPO in combination with G-CSF synergistically enhanced angiogenesis and tissue plasticity in ischemic animal models, leading to greater functional recovery than either agent alone.	[Liu, Shih-Ping; Wang, Hsiao-Jung; Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Liu, Shih-Ping] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lee, Shin-Da] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Lee, Shin-Da] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Lee, Hsu-Tung] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Liu, Demeral David] China Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Liu, Ren-Shyan] Natl Yang Ming Univ, Dept Nucl Med, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan	Liu, SP (corresponding author), China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan.	shyu9423@yahoo.com.tw	Lee, Shin-Da/Q-2798-2015; Lin, Shinn-Zong/AAX-2379-2020	Lee, Shin-Da/0000-0002-8393-8349; Liu, Shih-Ping/0000-0002-5803-4460	Chen-Han Foundation for Education; China Medical University [CMU98-N1-07]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; Topnotch Stroke Center (CMUH); National Science Council [NSC97-2628-B-039-001-MY3]	Chen-Han Foundation for Education; China Medical University(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence; Topnotch Stroke Center (CMUH); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by research grants from the Chen-Han Foundation for Education, the China Medical University (CMU98-N1-07), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004), Topnotch Stroke Center (CMUH) and the National Science Council (NSC97-2628-B-039-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleari E, 2006, ANN HEMATOL, V85, P174, DOI 10.1007/s00277-005-0044-6; Bath PMW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub3; Casadevall N, 2004, BLOOD, V104, P321, DOI 10.1182/blood-2003-07-2252; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; DEHAAN G, 1994, BLOOD, V84, P4157, DOI 10.1182/blood.V84.12.4157.bloodjournal84124157; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Doronzo G, 2006, DIABETOLOGIA, V49, P1049, DOI 10.1007/s00125-006-0156-0; FRAMPTON JE, 1994, DRUGS, V48, P731, DOI 10.2165/00003495-199448050-00007; Franklin TB, 2006, PSYCHONEUROENDOCRINO, V31, P38, DOI 10.1016/j.psyneuen.2005.05.008; Fujii K, 2004, BRIT J HAEMATOL, V124, P190, DOI 10.1046/j.1365-2141.2003.04745.x; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 2002, J BIOL CHEM, V277, P41750, DOI 10.1074/jbc.M207280200; Ieda Y, 2007, J MOL CELL CARDIOL, V42, P540, DOI 10.1016/j.yjmcc.2006.11.015; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Park HK, 2005, BRAIN RES, V1041, P125, DOI 10.1016/j.brainres.2004.11.067; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Pi XC, 2005, CIRC RES, V96, P1145, DOI 10.1161/01.RES.0000168802.43528.e1; Pierelli L, 1999, J CLIN ONCOL, V17, P1288, DOI 10.1200/JCO.1999.17.4.1288; Richard DE, 2000, J BIOL CHEM, V275, P26765; Roeder I, 1998, BLOOD, V91, P3222, DOI 10.1182/blood.V91.9.3222.3222_3222_3229; Ryan HE, 2000, CANCER RES, V60, P4010; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sehara Y, 2007, NEUROSCI LETT, V418, P248, DOI 10.1016/j.neulet.2007.03.047; Shams Imad, 2005, FASEB J, V19, P307; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SHWEIKI D, 1992, NATURE, V359, P845; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Signore AP, 2006, J NEUROCHEM, V96, P428, DOI 10.1111/j.1471-4159.2005.03587.x; Spandou E, 2005, BRAIN RES, V1045, P22, DOI 10.1016/j.brainres.2005.03.013; Tan YH, 2007, CARDIOVASC RES, V73, P823, DOI 10.1016/j.cardiores.2006.12.015; ULICH TR, 1991, BLOOD, V78, P1954; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wei L, 2006, J PHARMACOL EXP THER, V317, P109, DOI 10.1124/jpet.105.094391; Wenger RH, 2000, J EXP BIOL, V203, P1253; Zhao LR, 2007, STROKE, V38, P2584, DOI 10.1161/STROKEAHA.106.476457	52	26	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10093	10.1371/journal.pone.0010093	http://dx.doi.org/10.1371/journal.pone.0010093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404921	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482100013
J	Maniscalco, JM; Springer, AM; Parker, P				Maniscalco, John M.; Springer, Alan M.; Parker, Pamela			High Natality Rates of Endangered Steller Sea Lions in Kenai Fjords, Alaska and Perceptions of Population Status in the Gulf of Alaska	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; SEQUENTIAL MEGAFAUNAL COLLAPSE; MATERNAL ATTENDANCE PATTERNS; PUPS EUMETOPIAS-JUBATUS; NORTH PACIFIC-OCEAN; REPRODUCTIVE-PERFORMANCE; DECLINING POPULATION; WEDDELL SEALS; FEMALE; COSTS	Steller sea lions experienced a dramatic population collapse of more than 80% in the late 1970s through the 1990s across their western range in Alaska. One of several competing hypotheses about the cause holds that reduced female reproductive rates (natality) substantively contributed to the decline and continue to limit recovery in the Gulf of Alaska despite the fact that there have been very few attempts to directly measure natality in this species. We conducted a longitudinal study of natality among individual Steller sea lions (n = 151) at a rookery and nearby haulouts in Kenai Fjords, Gulf of Alaska during 2003-2009. Multi-state models were built and tested in Program MARK to estimate survival, resighting, and state transition probabilities dependent on whether or not a female gave birth in the previous year. The models that most closely fit the data suggested that females which gave birth had a higher probability of surviving and giving birth in the following year compared to females that did not give birth, indicating some females are more fit than others. Natality, estimated at 69%, was similar to natality for Steller sea lions in the Gulf of Alaska prior to their decline (67%) and much greater than the published estimate for the 2000s (43%) which was hypothesized from an inferential population dynamic model. Reasons for the disparity are discussed, and could be resolved by additional longitudinal estimates of natality at this and other rookeries over changing ocean climate regimes. Such estimates would provide an appropriate assessment of a key parameter of population dynamics in this endangered species which has heretofore been lacking. Without support for depressed natality as the explanation for a lack of recovery of Steller sea lions in the Gulf of Alaska, alternative hypotheses must be more seriously considered.	[Maniscalco, John M.; Springer, Alan M.; Parker, Pamela] Alaska SeaLife Ctr, Dept Sci, Seward, AK USA; [Springer, Alan M.] Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks	Maniscalco, JM (corresponding author), Alaska SeaLife Ctr, Dept Sci, Seward, AK USA.	john_maniscalco@alaskasealife.org			National Marine Fisheries Service [NA16FX2846, NA07NMF4390312, NA09NMF4390169, NA05NMF4391148]	National Marine Fisheries Service	Funding for this study was provided by grants (Nos. NA16FX2846, NA07NMF4390312, NA09NMF4390169, NA05NMF4391148) to the Alaska SeaLife Center from the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Atkinson S, 2008, MAR MAMMAL SCI, V24, P276, DOI 10.1111/j.1748-7692.2008.00188.x; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Berman MD, 2008, MAR POLICY, V32, P580, DOI 10.1016/j.marpol.2007.10.007; Boyd IL, 1999, BEHAV ECOL, V10, P198, DOI 10.1093/beheco/10.2.198; BOYD IL, 1995, J ANIM ECOL, V64, P505, DOI 10.2307/5653; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burek KA, 2005, J WILDLIFE DIS, V41, P512, DOI 10.7589/0090-3558-41.3.512; Calkins DG, 1998, MAR MAMMAL SCI, V14, P232, DOI 10.1111/j.1748-7692.1998.tb00713.x; Choquet R., 2005, U CARE 2 2 USERS MAN; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Dabin W, 2004, CAN J ZOOL, V82, P1043, DOI 10.1139/Z04-079; Dalton R, 2005, NATURE, V436, P14, DOI 10.1038/436014a; DEMASTER D, 2002, AKSG0202 U AL SEA GR; Donnelly CP, 2003, BRIT J NUTR, V89, P71, DOI 10.1079/BJN2002750; Doroff AM, 2003, J MAMMAL, V84, P55, DOI 10.1644/1545-1542(2003)084<0055:SOPDIT>2.0.CO;2; Eberhardt LL, 2005, MAR MAMMAL SCI, V21, P728, DOI 10.1111/j.1748-7692.2005.tb01262.x; Fowler SL, 2007, FUNCT ECOL, V21, P922, DOI 10.1111/j.1365-2435.2007.01295.x; Fowler SL, 2006, J ANIM ECOL, V75, P358, DOI 10.1111/j.1365-2656.2006.01055.x; Fritz L, 2005, NMFSAFSC183 NOAA US; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; FRITZ LW, 2008, SURV AD JUV STELL SE; Hadley GL, 2007, J ANIM ECOL, V76, P448, DOI 10.1111/j.1365-2656.2007.01219.x; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Hood WR, 1997, CAN J ZOOL, V75, P1241, DOI 10.1139/z97-146; Horning Markus, 2010, Endangered Species Research, V10, P135, DOI 10.3354/esr00220; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kaplan CC, 2008, MAR MAMMAL SCI, V24, P443, DOI 10.1111/j.1748-7692.2008.00203.x; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco John M., 2008, Aquatic Mammals, V34, P277, DOI 10.1578/AM.34.3.2008.277; Mashburn KL, 2007, GEN COMP ENDOCR, V150, P246, DOI 10.1016/j.ygcen.2006.08.009; MATHISEN OA, 1963, US FISH WILDLIFE SER, V424, P20; McKenzie J, 2005, J MAMMAL, V86, P1237, DOI 10.1644/05-MAMM-A-085R.1; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; Myers MJ, 2008, SCI TOTAL ENVIRON, V396, P60, DOI 10.1016/j.scitotenv.2008.02.008; National Research Council, 2003, DECL STELL SEA LION; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; PITCHER KW, 1990, MAR MAMMAL SCI, V6, P121, DOI 10.1111/j.1748-7692.1990.tb00234.x; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Rea LD, 1998, COMP BIOCHEM PHYS A, V120, P617, DOI 10.1016/S1095-6433(98)10074-0; Rosen DAS, 2000, P 3 COMP NUTR SOC S, P182; SEASE JL, 2001, NMFSAFSC122 NOAA US; Springer AM, 2008, MAR MAMMAL SCI, V24, P414, DOI 10.1111/j.1748-7692.2008.00185.x; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; TESTA JW, 1987, CAN J ZOOL, V65, P1091, DOI 10.1139/z87-173; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	57	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10076	10.1371/journal.pone.0010076	http://dx.doi.org/10.1371/journal.pone.0010076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386691	gold, Green Published, Green Submitted			2022-12-27	WOS:000276482000012
J	Romanuk, TN; Levings, CD				Romanuk, Tamara N.; Levings, Colin D.			Reciprocal Subsidies and Food Web Pathways Leading to Chum Salmon Fry in a Temperate Marine-Terrestrial Ecotone	PLOS ONE			English	Article							SANDY BEACH; BRITISH-COLUMBIA; TROPHIC POSITION; STABLE ISOTOPES; CARBON ISOTOPES; HOWE-SOUND; MACROFAUNA; NITROGEN; WRACK; COMMUNITIES	Stable isotope analysis was used to determine the relative proportions of terrestrial and marine subsidies of carbon to invertebrates along a tidal gradient (low-intertidal, mid-intertidal, high-intertidal, supralittoral) and to determine the relative importance of terrestrial carbon in food web pathways leading to chum salmon fry Oncorhynchus keta (Walbaum) in Howe Sound, British Columbia. We found a clear gradient in the proportion of terrestrially derived carbon along the tidal gradient ranging from 68% across all invertebrate taxa in the supralittoral to 25% in the high-intertidal, 20% in the mid-intertidal, and 12% in the low-intertidal. Stable isotope values of chum salmon fry indicated carbon contributions from both terrestrial and marine sources, with terrestrially derived carbon ranging from 12.8 to 61.5% in the muscle tissue of chum salmon fry (mean 30%). Our results provide evidence for reciprocal subsidies of marine and terrestrially derived carbon on beaches in the estuary and suggest that the vegetated supralittoral is an important trophic link in supplying terrestrial carbon to nearshore food webs.	[Romanuk, Tamara N.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Levings, Colin D.] Ctr Aquaculture & Environm Res, Dept Fisheries & Oceans, W Vancouver, BC, Canada	Dalhousie University; Fisheries & Oceans Canada	Romanuk, TN (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tromanuk@gmail.com	Romanuk, t N/C-6493-2008		NSERC PDF; Department of Fisheries and Oceans (Canada)	NSERC PDF(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Fisheries and Oceans (Canada)	NSERC PDF and Discovery Grant to TNR. Department of Fisheries and Oceans (Canada) provided funding for the data collection, stable isotope analysis, and gut content analysis. The funders had no role in the analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 1998, OIKOS, V81, P75, DOI 10.2307/3546469; Barnes RSF, 1988, INTRO MARINE ECOLOGY; Colombini I, 2000, MAR BIOL, V136, P531, DOI 10.1007/s002270050713; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; FARQUHAR GD, 1989, PHILOS T ROY SOC B, V323, P357, DOI 10.1098/rstb.1989.0016; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Hasler A. D., 1975, COUPLING LAND WATER; Healey M., 1982, ESTUARINE COMP, P315; Healey MC, 1980, SALMONID ECOSYSTEMS, P203; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Hocking MD, 2009, OIKOS, V118, P1307, DOI 10.1111/j.1600-0706.2009.17302.x; Hunt R.L., 1975, COUPLING LAND WATER, P137; INGLIS G, 1989, J EXP MAR BIOL ECOL, V125, P203, DOI 10.1016/0022-0981(89)90097-X; Jedrzejczak MF, 2002, OCEANOLOGIA, V44, P367; Levings CD, 2004, HYDROBIOLOGIA, V525, P185, DOI 10.1023/B:HYDR.0000038866.20304.3d; Levings Colin, 2004, Canadian Manuscript Report of Fisheries and Aquatic Sciences, V2680, P3; Lewis TL, 2007, ESTUAR COAST, V30, P451, DOI 10.1007/BF02819391; Maier GO, 2009, ESTUAR COAST, V32, P984, DOI 10.1007/s12237-009-9197-1; Mann K.H., 1991, DYNAMICS MARINE ECOS, DOI 10.1002/9781118687901; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Olabarria C, 2007, MAR ENVIRON RES, V63, P19, DOI 10.1016/j.marenvres.2006.06.001; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; RAU GH, 1980, CAN J FISH AQUAT SCI, V37, P742, DOI 10.1139/f80-098; Romanuk TN, 2005, FISHERIES MANAG ECOL, V12, P113, DOI 10.1111/j.1365-2400.2004.00432.x; Romanuk TN, 2003, ENVIRON ENTOMOL, V32, P1343, DOI 10.1603/0046-225X-32.6.1343; ROUNICK JS, 1986, BIOSCIENCE, V36, P171, DOI 10.2307/1310304; Sobocinski K.L., 2003, THESIS U WASHINGTON; SYVITSKI JPM, 1982, CAN J EARTH SCI, V19, P1025, DOI 10.1139/e82-085; Toft JD, 2007, N AM J FISH MANAGE, V27, P465, DOI 10.1577/M05-158.1; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Wipfli MS, 1997, CAN J FISH AQUAT SCI, V54, P1259, DOI 10.1139/cjfas-54-6-1259	36	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10073	10.1371/journal.pone.0010073	http://dx.doi.org/10.1371/journal.pone.0010073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386705	Green Published, gold			2022-12-27	WOS:000276482000011
J	Poole, AC; Thomas, RE; Yu, S; Vincow, ES; Pallanck, L				Poole, Angela C.; Thomas, Ruth E.; Yu, Selina; Vincow, Evelyn S.; Pallanck, Leo			The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway	PLOS ONE			English	Article							DROSOPHILA-PARKIN MUTANTS; SUBSTANTIA-NIGRA NEURONS; OXIDATIVE STRESS; DNA DELETIONS; DISEASE; PINK1; EXPRESSION; DYSFUNCTION; PATHOLOGY; FISSION	Loss-of-function mutations in the PINK1 or parkin genes result in recessive heritable forms of parkinsonism. Genetic studies of Drosophila orthologs of PINK1 and parkin indicate that PINK1, a mitochondrially targeted serine/threonine kinase, acts upstream of Parkin, a cytosolic ubiquitin-protein ligase, to promote mitochondrial fragmentation, although the molecular mechanisms by which the PINK1/Parkin pathway promotes mitochondrial fragmentation are unknown. We tested the hypothesis that PINK1 and Parkin promote mitochondrial fragmentation by targeting core components of the mitochondrial morphogenesis machinery for ubiquitination. We report that the steady-state abundance of the mitochondrial fusion-promoting factor Mitofusin (dMfn) is inversely correlated with the activity of PINK1 and Parkin in Drosophila. We further report that dMfn is ubiquitinated in a PINK1- and Parkin-dependent fashion and that dMfn co-immunoprecipitates with Parkin. By contrast, perturbations of PINK1 or Parkin did not influence the steady-state abundance of the mitochondrial fission-promoting factor Drp1 or the mitochondrial fusion-promoting factor Opa1, or the subcellular distribution of Drp1. Our findings suggest that dMfn is a direct substrate of the PINK1/Parkin pathway and that the mitochondrial morphological alterations and tissue degeneration phenotypes that derive from mutations in PINK1 and parkin result at least in part from reduced ubiquitin-mediated turnover of dMfn.	[Poole, Angela C.; Thomas, Ruth E.; Yu, Selina; Vincow, Evelyn S.; Pallanck, Leo] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Vincow, Evelyn S.] Univ Washington, Neurobiol & Behav Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Poole, AC (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	pallanck@u.washington.edu		Poole, Angela/0000-0003-0278-7655	Genetic Approaches to Aging [5T32AG000057-32]; National Institutes of Health [1R01GM086394-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	Genetic Approaches to Aging; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Genetic Approaches to Aging Training Grant (5T32AG000057-32) to A. C. P. and a National Institutes of Health Grant (1R01GM086394-01) to L. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Hwa JJ, 2002, MECH DEVELOP, V116, P213, DOI 10.1016/S0925-4773(02)00141-7; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160; Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004; Thomas KJ, 2009, INT J BIOCHEM CELL B, V41, P2025, DOI 10.1016/j.biocel.2009.02.018; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VIVESBAUZA C, 2009, P NATL ACAD SCI US; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; YANG Y, 2008, P NATL ACAD SCI US; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; ZIVIANI E, 2010, P NATL ACAD SCI US	39	346	348	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10054	10.1371/journal.pone.0010054	http://dx.doi.org/10.1371/journal.pone.0010054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383334	Green Submitted, Green Published, gold			2022-12-27	WOS:000276454000014
J	Kovanen, L; Saarikoski, ST; Aromaa, A; Lonnqvist, J; Partonen, T				Kovanen, Leena; Saarikoski, Sirkku T.; Aromaa, Arpo; Lonnqvist, Jouko; Partonen, Timo			ARNTL (BMAL1) and NPAS2 Gene Variants Contribute to Fertility and Seasonality	PLOS ONE			English	Article							TO-HIP RATIO; CLOCK GENE; AFFECTIVE-DISORDER; CIRCADIAN-RHYTHMS; PROTEIN BMAL1; CDNA CLONING; POLYMORPHISM; ASSOCIATION; SLEEP; TESTOSTERONE	Background: Circadian clocks guide the metabolic, cell-division, sleep-wake, circadian and seasonal cycles. Abnormalities in these clocks may be a health hazard. Circadian clock gene polymorphisms have been linked to sleep, mood and metabolic disorders. Our study aimed to examine polymorphisms in four key circadian clock genes in relation to seasonal variation, reproduction and well-being in a sample that was representative of the general population, aged 30 and over, living in Finland. Methodology/Principal Findings: Single-nucleotide polymorphisms in the ARNTL, ARNTL2, CLOCK and NPAS2 genes were genotyped in 511 individuals. 19 variants were analyzed in relation to 31 phenotypes that were assessed in a health interview and examination study. With respect to reproduction, women with ARNTL rs2278749 TT genotype had more miscarriages and pregnancies, while NPAS2 rs11673746 T carriers had fewer miscarriages. NPAS2 rs2305160 A allele carriers had lower Global Seasonality Scores, a sum score of six items i.e. seasonal variation of sleep length, social activity, mood, weight, appetite and energy level. Furthermore, carriers of A allele at NPAS2 rs6725296 had greater loadings on the metabolic factor (weight and appetite) of the global seasonality score, whereas individuals with ARNTL rs6290035 TT genotype experienced less seasonal variation of energy level. Conclusions/Significance: ARNTL and NPAS2 gene variants were associated with reproduction and with seasonal variation. Earlier findings have linked ARNTL to infertility in mice, but this is the first time when any polymorphism of these genes is linked to fertility in humans.	[Kovanen, Leena; Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Kovanen, Leena; Saarikoski, Sirkku T.] Natl Inst Hlth & Welf, Dept Alcohol Drugs & Addict, Helsinki, Finland; [Aromaa, Arpo] Natl Inst Hlth & Welf, Div Welf & Hlth Policies, Helsinki, Finland; [Lonnqvist, Jouko] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki	Kovanen, L (corresponding author), Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland.	timo.partonen@thl.fi	Partonen, Timo/G-1105-2012	Partonen, Timo/0000-0003-1951-2455; Kovanen, Leena/0000-0002-3552-124X	Academy of Finland [210262]; Yrjo Jahnsson Foundation [6113]	Academy of Finland(Academy of Finland); Yrjo Jahnsson Foundation	Funding for this study was provided in part by the grant # 210262 from the Academy of Finland (http://www.aka.fi/en-gb/A/) to Dr Partonen, and the grant # 6113 from Yrjo Jahnsson Foundation (http://www.yjs.fi/) to Ms Kovanen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Bailer U, 2005, EUR NEUROPSYCHOPHARM, V15, P51, DOI 10.1016/j.euroneuro.2004.05.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benedetti F, 2008, GENES BRAIN BEHAV, V7, P20, DOI 10.1111/j.1601-183X.2007.00312.x; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Boden MJ., 2004, REPROD FERT DEVELOP, V16, P280; Boden MJ., 2005, REPROD FERT DEVELOP, V17, P126, DOI [10.1071/SRB05Abs297, DOI 10.1071/SRB05ABS297]; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Chu LW, 2008, CANCER EPIDEM BIOMAR, V17, P3268, DOI 10.1158/1055-9965.EPI-08-0073; Desan PH, 2000, AM J MED GENET, V96, P418, DOI 10.1002/1096-8628(20000612)96:3<418::AID-AJMG34>3.0.CO;2-S; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; Grimaldi S, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/165013; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Iwase T, 2002, PSYCHIAT RES, V109, P121, DOI 10.1016/S0165-1781(02)00006-9; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Kishi T, 2009, EUR ARCH PSY CLIN N, V259, P293, DOI 10.1007/s00406-009-0869-4; Kishi T, 2009, NEUROMOL MED, V11, P53, DOI 10.1007/s12017-009-8060-7; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lavebratt C, 2010, AM J MED GENET B, V153B, P570, DOI 10.1002/ajmg.b.31021; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Magnusson A, 2005, CNS SPECTRUMS, V10, P625, DOI 10.1017/S1092852900019593; Mishima K, 2005, AM J MED GENET B, V133B, P101, DOI 10.1002/ajmg.b.30110; Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Pedrazzoli M, 2007, CHRONOBIOL INT, V24, P1, DOI 10.1080/07420520601139789; Perry HM, 2000, METABOLISM, V49, P1085, DOI 10.1053/meta.2000.7710; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Robilliard DL, 2002, J SLEEP RES, V11, P305, DOI 10.1046/j.1365-2869.2002.00320.x; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Ruhayel Y, 2007, CLIN ENDOCRINOL, V67, P85, DOI 10.1111/j.1365-2265.2007.02843.x; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sasaki M, 2009, J BIOL CHEM, V284, P25149, DOI 10.1074/jbc.M109.040758; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Svartberg J, 2003, J CLIN ENDOCR METAB, V88, P3099, DOI 10.1210/jc.2002-021878; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; van Anders SM, 2006, PSYCHONEUROENDOCRINO, V31, P895, DOI 10.1016/j.psyneuen.2006.03.002; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wehr T., 1984, SEASONAL PATTERN ASS; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zitzmann M, 2006, AGING MALE, V9, P195, DOI 10.1080/13685530601040679	58	68	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10007	10.1371/journal.pone.0010007	http://dx.doi.org/10.1371/journal.pone.0010007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368993	Green Submitted, Green Published, gold			2022-12-27	WOS:000276419900010
J	Bouwman, V; Adriaanse, MC; van't Riet, E; Snoek, FJ; Dekker, JM; Nijpels, G				Bouwman, Vanessa; Adriaanse, Marcel C.; van't Riet, Esther; Snoek, Frank J.; Dekker, Jacqueline M.; Nijpels, Giel			Depression, Anxiety and Glucose Metabolism in the General Dutch Population: The New Hoorn Study	PLOS ONE			English	Article							HOSPITAL ANXIETY; DIABETES-MELLITUS; SYMPTOMS; SCALE; ASSOCIATION; VALIDITY; PEOPLE; IMPACT; MEN	Background: There is a well recognized association between depression and diabetes. However, there is little empirical data about the prevalence of depressive symptoms and anxiety among different groups of glucose metabolism in population based samples. The aim of this study was to determine whether the prevalence of increased levels of depression and anxiety is different between patients with type 2 diabetes and subjects with impaired glucose metabolism (IGM) and normal glucose metabolism (NGM). Methodology/Principal Findings: Cross-sectional data from a population- based cohort study of 2667 residents, 1261 men and 1406 women aged 40-65 years from the Hoorn region, the Netherlands. Depressive symptoms and anxiety were measured using the Centre for Epidemiologic Studies Depression Scale (CES-D, score >= 16) and the Hospital Anxiety and Depression Scale-Anxiety Subscale (HADS-A, score >= 8), respectively. Glucose metabolism status was determined by oral glucose tolerance test. In the total study population the prevalence of depressive symptoms and anxiety for the NGM, IGM and type 2 diabetes were 12.5, 12.2 and 21.0% (P=0.004) and 15.0, 15.3 and 19.9% (p=0.216), respectively. In men, the prevalence of depressive symptoms was 7.7, 9.5 and 19.6% (p<0.001), and in women 16.4, 15.8 and 22.6 (p=0.318), for participants with NGM, IGM and type 2 diabetes, respectively. Anxiety was not associated with glucose metabolism when stratified for sex. Intergroup differences (NGM vs. IGM and IGM vs. type 2 diabetes) revealed that higher prevalences of depressive symptoms are mainly manifested in participants with type 2 diabetes, and not in participants with IGM. Conclusions: Depressive symptoms, but not anxiety are associated with glucose metabolism. This association is mainly determined by a higher prevalence of depressive symptoms in participants with type 2 diabetes and not in participants with IGM.	[Bouwman, Vanessa; Adriaanse, Marcel C.] Vrije Univ Amsterdam, Dept Prevent & Publ Hlth, Fac Earth & Life Sci, Amsterdam, Netherlands; [Bouwman, Vanessa; Adriaanse, Marcel C.; van't Riet, Esther; Snoek, Frank J.; Dekker, Jacqueline M.; Nijpels, Giel] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van't Riet, Esther; Dekker, Jacqueline M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Nijpels, Giel] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bouwman, V (corresponding author), Vrije Univ Amsterdam, Dept Prevent & Publ Hlth, Fac Earth & Life Sci, Amsterdam, Netherlands.	marcel.adriaanse@falw.vu.nl		Snoek, Frank/0000-0001-9563-6762	VU University Medical Center of Amsterdam	VU University Medical Center of Amsterdam	Funding for this study was provided by the VU University Medical Center of Amsterdam. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x; Aujla N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007755; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Gale CR, 2010, BIOL PSYCHIAT, V67, P189, DOI 10.1016/j.biopsych.2009.09.019; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Holt RIG, 2009, DIABETIC MED, V26, P641, DOI 10.1111/j.1464-5491.2009.02742.x; Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9; Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Morsink LFJ, 2007, PSYCHONEUROENDOCRINO, V32, P874, DOI 10.1016/j.psyneuen.2007.06.009; Penninx BWJH, 2007, AM J GERIAT PSYCHIAT, V15, P522, DOI 10.1097/JGP.0b013e318033ed80; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Rhee MK, 2008, DIABETIC MED, V25, P1361, DOI 10.1111/j.1464-5491.2008.02543.x; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; World Health Organization, DEF DIAGN DIAB MELL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	71	72	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9971	10.1371/journal.pone.0009971	http://dx.doi.org/10.1371/journal.pone.0009971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580AG	20376307	Green Published, gold			2022-12-27	WOS:000276418200044
J	Singer, G; Besemer, K; Schmitt-Kopplin, P; Hodl, I; Battin, TJ				Singer, Gabriel; Besemer, Katharina; Schmitt-Kopplin, Philippe; Hoedl, Iris; Battin, Tom J.			Physical Heterogeneity Increases Biofilm Resource Use and Its Molecular Diversity in Stream Mesocosms	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; ENVIRONMENTAL HETEROGENEITY; BIOPHYSICAL CONTROLS; ECOSYSTEM PROCESSES; SPECIES RICHNESS; BIODIVERSITY; CARBON; COMPLEMENTARITY; ASSEMBLAGES; DYNAMICS	Background: Evidence increasingly shows that stream ecosystems greatly contribute to global carbon fluxes. This involves a tight coupling between biofilms, the dominant form of microbial life in streams, and dissolved organic carbon (DOC), a very significant pool of organic carbon on Earth. Yet, the interactions between microbial biodiversity and the molecular diversity of resource use are poorly understood. Methodology/Principal Findings: Using six 40-m-long streamside flumes, we created a gradient of streambed landscapes with increasing spatial flow heterogeneity to assess how physical heterogeneity, inherent to streams, affects biofilm diversity and DOC use. We determined bacterial biodiversity in all six landscapes using 16S-rRNA fingerprinting and measured carbon uptake from glucose and DOC experimentally injected to all six flumes. The diversity of DOC molecules removed from the water was determined from ultrahigh-resolution Fourier Transform Ion Cyclotron Resonance mass spectrometry (FTICR-MS). Bacterial beta diversity, glucose and DOC uptake, and the molecular diversity of DOC use all increased with increasing flow heterogeneity. Causal modeling and path analyses of the experimental data revealed that the uptake of glucose was largely driven by physical processes related to flow heterogeneity, whereas biodiversity effects, such as complementarity, most likely contributed to the enhanced uptake of putatively recalcitrant DOC compounds in the streambeds with higher flow heterogeneity. Conclusions/Significance: Our results suggest biophysical mechanisms, including hydrodynamics and microbial complementarity effects, through which physical heterogeneity induces changes of resource use and carbon fluxes in streams. These findings highlight the importance of fine-scale streambed heterogeneity for microbial biodiversity and ecosystem functioning in streams, where homogenization and loss of habitats increasingly reduce biodiversity.	[Singer, Gabriel; Besemer, Katharina; Hoedl, Iris; Battin, Tom J.] Univ Vienna, Dept Freshwater Ecol, Vienna, Austria; [Singer, Gabriel; Besemer, Katharina; Hoedl, Iris; Battin, Tom J.] WasserKluster Lunz GmbH, Lunz Am See, Austria; [Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Inst Ecol Chem, Helmholtz Zentrum Munchen, Neuherberg, Germany	University of Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Battin, TJ (corresponding author), Univ Vienna, Dept Freshwater Ecol, Vienna, Austria.	tom.battin@univie.ac.at	BAttin, Tom/H-7971-2012; Singer, Gabriel/C-6285-2012; Schmitt-Kopplin, Philippe/H-6271-2011	Singer, Gabriel/0000-0002-7389-9788; Schmitt-Kopplin, Philippe/0000-0003-0824-2664	Austrian Science Foundation (FWF); European Science Foundation (EuroDIVERSITY, COMIX); Land Niederoesterreich, Austria	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); European Science Foundation (EuroDIVERSITY, COMIX)(European Science Foundation (ESF)); Land Niederoesterreich, Austria	This research was supported by the Austrian Science Foundation (FWF), the European Science Foundation (EuroDIVERSITY, COMIX) and the Land Niederoesterreich, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Homoud A, 2008, APPL MICROBIOL BIOT, V79, P643, DOI 10.1007/s00253-008-1446-x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Battin TJ, 2003, FRESHWATER BIOL, V48, P995, DOI 10.1046/j.1365-2427.2003.01062.x; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Besemer K, 2009, APPL ENVIRON MICROB, V75, P7189, DOI 10.1128/AEM.01284-09; Besemer K, 2009, ISME J, V3, P1318, DOI 10.1038/ismej.2009.73; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Bottacin-Busolin A, 2009, ENVIRON SCI TECHNOL, V43, P7337, DOI 10.1021/es900852w; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Buzas Martin A., 1996, Biodiversity Letters, V3, P40, DOI 10.2307/2999767; Cardenas MB, 2007, ADV WATER RESOUR, V30, P301, DOI 10.1016/j.advwatres.2006.06.009; Cardinale BJ, 2002, ECOLOGY, V83, P412, DOI 10.1890/0012-9658(2002)083[0412:TIOSHO]2.0.CO;2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chesson P., 2001, FUNCTIONAL CONSEQUEN, P213; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Dittmar T, 2007, MAR CHEM, V107, P378, DOI 10.1016/j.marchem.2007.04.006; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Einsiedl F, 2007, GEOCHIM COSMOCHIM AC, V71, P5474, DOI 10.1016/j.gca.2007.09.024; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; GANTZER CJ, 1988, WATER RES, V22, P709, DOI 10.1016/0043-1354(88)90182-0; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Gordon ND, 2004, STREAM HYDROLOGY INT; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4; Hertkorn N, 2008, ANAL CHEM, V80, P8908, DOI 10.1021/ac800464g; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; HOOPER DU, 2005, ECOL MONOGR, V75, P12844; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kim S, 2006, LIMNOL OCEANOGR, V51, P1054, DOI 10.4319/lo.2006.51.2.1054; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Legendre P., 2012, NUMERICAL ECOLOGY; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Orr CH, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000825; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Qualls RG, 2005, ENVIRON SCI TECHNOL, V39, P1616, DOI 10.1021/es049090o; R Development Core Team, 2005, R LANG ENV STAT COMP; Raffaelli D, 2004, SCIENCE, V306, P1141, DOI 10.1126/science.1106365; Seitzinger SP, 2005, LIMNOL OCEANOGR, V50, P1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; THURMAN EM, 1981, ENVIRON SCI TECHNOL, V15, P463, DOI 10.1021/es00086a012; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Vallino JJ, 1996, LIMNOL OCEANOGR, V41, P1591, DOI 10.4319/lo.1996.41.8.1591; Wacker L, 2008, BASIC APPL ECOL, V9, P467, DOI 10.1016/j.baae.2007.08.003; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; Wickland KP, 2007, ECOSYSTEMS, V10, P1323, DOI 10.1007/s10021-007-9101-4; WOLFAARDT GM, 1994, CAN J MICROBIOL, V40, P331, DOI 10.1139/m94-055	68	75	76	9	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9988	10.1371/journal.pone.0009988	http://dx.doi.org/10.1371/journal.pone.0009988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376323	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200058
J	Goicoechea, SM; Bednarski, B; Stack, C; Cowan, DW; Volmar, K; Thorne, L; Cukierman, E; Rustgi, AK; Brentnall, T; Hwang, RF; McCulloch, CAG; Yeh, JJ; Bentrem, DJ; Hochwald, SN; Hingorani, SR; Kim, HJ; Otey, CA				Goicoechea, Silvia M.; Bednarski, Brian; Stack, Christianna; Cowan, David W.; Volmar, Keith; Thorne, Leigh; Cukierman, Edna; Rustgi, Anil K.; Brentnall, Teresa; Hwang, Rosa F.; McCulloch, Christopher A. G.; Yeh, Jen Jen; Bentrem, David J.; Hochwald, Steven N.; Hingorani, Sunil R.; Kim, Hong Jin; Otey, Carol A.			Isoform-Specific Upregulation of Palladin in Human and Murine Pancreas Tumors	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CARCINOMA-CELLS; CANCER; FIBROBLASTS; EXPRESSION; PROTEIN; STROMA; IDENTIFICATION; KRAS(G12D); COOPERATE	Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with a characteristic pattern of early metastasis, which is driving a search for biomarkers that can be used to detect the cancer at an early stage. Recently, the actin-associated protein palladin was identified as a candidate biomarker when it was shown that palladin is mutated in a rare inherited form of PDA, and overexpressed in many sporadic pancreas tumors and premalignant precursors. In this study, we analyzed the expression of palladin isoforms in murine and human PDA and explored palladin's potential use in diagnosing PDA. We performed immunohistochemistry and immunoblot analyses on patient samples and tumor-derived cells using an isoform-selective monoclonal antibody and a pan-palladin polyclonal antibody. Immunoblot and real-time quantitative reverse transcription-PCR were used to quantify palladin mRNA levels in human samples. We show that there are two major palladin isoforms expressed in pancreas: 65 and 85-90 kDa. The 65 kDa isoform is expressed in both normal and neoplastic ductal epithelial cells. The 85-90 kDa palladin isoform is highly overexpressed in tumor-associated fibroblasts (TAFs) in both primary and metastatic tumors compared to normal pancreas, in samples obtained from either human patients or genetically engineered mice. In tumor-derived cultured cells, expression of palladin isoforms follows cell-type specific patterns, with the 85-90 kDa isoform in TAFs, and the 65 kDa isoform predominating in normal and neoplastic epithelial cells. These results suggest that upregulation of 85-90 kDa palladin isoform may play a role in the establishment of the TAF phenotype, and thus in the formation of a desmoplastic tumor microenvironment. Thus, palladin may have a potential use in the early diagnosis of PDA and may have much broader significance in understanding metastatic behavior.	[Goicoechea, Silvia M.; Stack, Christianna; Otey, Carol A.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Bednarski, Brian; Yeh, Jen Jen; Kim, Hong Jin] Univ N Carolina, Dept Surg, Div Surg Oncol, Chapel Hill, NC USA; [Bednarski, Brian; Cowan, David W.; Thorne, Leigh; Yeh, Jen Jen; Kim, Hong Jin; Otey, Carol A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Volmar, Keith; Thorne, Leigh] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Cukierman, Edna] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Rustgi, Anil K.] Univ Penn, Dept Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Dept Genet, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Brentnall, Teresa] Univ Washington, Dept Med, Seattle, WA USA; [Hwang, Rosa F.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [McCulloch, Christopher A. G.] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON, Canada; [Bentrem, David J.] NW Med Fac Fdn, Chicago, IL USA; [Hochwald, Steven N.] Univ Florida, Div Surg Oncol, Gainesville, FL USA; [Hingorani, Sunil R.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center	Goicoechea, SM (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	sgoico@med.unc.edu	Core, UNC Microbiome/AAB-3304-2022; Cukierman, Edna/A-3951-2013; cukierman, edna/AAU-8932-2020	cukierman, edna/0000-0002-1452-9576; Hingorani, Sunil/0000-0002-3869-8729; Goicoechea, Silvia/0000-0003-1107-389X	Elsa U. Pardee Foundation; UNC Center for Gastrointestinal Biology and Disease; National Institutes of Health (NIH) [R01-GM081505, CA113451, K08-CA098240, T32-CA09688, CA15704, CA114028, CA129357, DK0606994]; Fox Chase Cancer Center's (FCCC) Kidney Keystone Program; Mead Foundation; Rosenzweig Foundation; PanCAN; CIHR [MOP-36332]; UNC SPORE in Gastrointestinal Cancers [P50-CA10699]; National Cancer Institute (NCI) [P50-CA106991]; NATIONAL CANCER INSTITUTE [K08CA138912, R21CA155650, K08CA098240, P30CA015704, T32CA009688, P50CA106991, R01CA113451, R01CA129357, K08CA114028] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081505] Funding Source: NIH RePORTER	Elsa U. Pardee Foundation; UNC Center for Gastrointestinal Biology and Disease; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center's (FCCC) Kidney Keystone Program; Mead Foundation; Rosenzweig Foundation; PanCAN; CIHR(Canadian Institutes of Health Research (CIHR)); UNC SPORE in Gastrointestinal Cancers; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Elsa U. Pardee Foundation, http://www.pardeefoundation.org/ (C. A. Otey and H.J. Kim), UNC Center for Gastrointestinal Biology and Disease, https://cgibd.med.unc.edu/index. php (C. A. Otey), National Institutes of Health (NIH) R01-GM081505 (C. A. Otey), National Cancer Institute (NCI)/NIH CA113451 and Fox Chase Cancer Center's (FCCC) Kidney Keystone Program Grant (E. Cukierman). Mead Foundation, http://gileswmeadfoundation.org/; Rosenzweig Foundation, http://jrpancan.org/; and PanCAN, http://www.pancan.org/ (S. Hingorani), NIH, http://www.nih.gov/ to H.J. Kim (K08-CA098240), B. Bednarski (T32-CA09688), S. Hingorani (CA15704, CA114028, CA129357) and A. Rustigi (DK0606994). CIHR, http://www.cihr-irsc.gc.ca/ operating grant MOP-36332 (C. A. G. McCulloch). UNC SPORE in Gastrointestinal Cancers, http://cancer.med.unc.edu/patient/programs/gi. asp P50-CA10699 (H.J. Kim). NCI SPORE in Gastrointestinal Cancers, http://spores.nci.nih.gov/current/gi/index. htm P50-CA106991 (Jen Jjen Yeh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1999, EXP CELL RES, V250, P155, DOI 10.1006/excr.1999.4521; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Cleary SP, 2004, J AM COLL SURGEONS, V198, P722, DOI 10.1016/j.jamcollsurg.2004.01.008; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; Corsino P, 2007, CANCER RES, V67, P3135, DOI 10.1158/0008-5472.CAN-06-3815; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JIN L, 2008, J BIOL CHEM; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; MCCULLOCH CAG, 1993, J CELL PHYSIOL, V155, P461, DOI 10.1002/jcp.1041550305; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Rozen P, 2009, ISR MED ASSOC J, V11, P710; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136	34	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10347	10.1371/journal.pone.0010347	http://dx.doi.org/10.1371/journal.pone.0010347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436683	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079500017
J	Martel, J; Wu, CY; Young, JD				Martel, Jan; Wu, Cheng-Yeu; Young, John D.			Critical Evaluation of Gamma-Irradiated Serum Used as Feeder in the Culture and Demonstration of Putative Nanobacteria and Calcifying Nanoparticles	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; FETUIN-MINERAL COMPLEX; FETAL BOVINE SERUM; HUMAN-DERIVED NANOPARTICLES; CALCIUM-PHOSPHATE; STONE FORMATION; BIOLOGIC NANOPARTICLES; VASCULAR CALCIFICATION; SECONDARY STRUCTURE; FTIR SPECTROSCOPY	The culture and demonstration of putative nanobacteria (NB) and calcifying nanoparticles (CNP) from human and animal tissues has relied primarily on the use of a culture supplement consisting of FBS that had been gamma-irradiated at a dose of 30 kGy (gamma-FBS). The use of gamma-FBS is based on the assumption that this sterilized fluid has been rid entirely of any residual NB/CNP, while it continues to promote the slow growth in culture of NB/CNP from human/animal tissues. We show here that gamma-irradiation (5-50 kGy) produces extensive dose-dependent serum protein breakdown as demonstrated through UV and visible light spectrophotometry, fluorometry, Fourier-transformed infrared spectroscopy, and gel electrophoresis. Yet, both gamma-FBS and gamma-irradiated human serum (gamma-HS) produce NB/CNP in cell culture conditions that are morphologically and chemically indistinguishable from their normal serum counterparts. Contrary to earlier claims, gamma-FBS does not enhance the formation of NB/CNP from several human body fluids (saliva, urine, ascites, and synovial fluid) tested. In the presence of additional precipitating ions, both c-irradiated serum (FBS and HS) and c-irradiated proteins (albumin and fetuin-A) retain the inherent dual NB inhibitory and seeding capabilities seen also with their untreated counterparts. By gel electrophoresis, the particles formed from both gamma-FBS and gamma-HS are seen to have assimilated into their scaffold the same smeared protein profiles found in the gamma-irradiated sera. However, their protein compositions as identified by proteomics are virtually identical to those seen with particles formed from untreated serum. Moreover, particles derived from human fluids and cultured in the presence of gamma-FBS contain proteins derived from both gamma-FBS and the human fluid under investigation-a confusing and unprecedented scenario indicating that these particles harbor proteins from both the host tissue and the FBS used as feeder. Thus, the NB/CNP described in the literature clearly bear hybrid protein compositions belonging to different species. We conclude that there is no basis to justify the use of gamma-FBS as a feeder for the growth and demonstration of NB/CNP or any NB-like particles in culture. Moreover, our results call into question the validity of the entire body of literature accumulated to date on NB and CNP.	[Martel, Jan; Wu, Cheng-Yeu; Young, John D.] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Martel, Jan] Chang Gung Univ, Dept Biochem & Mol Biol, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Young, John D.] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; [Young, John D.] Mingchi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Rockefeller University; Ming Chi University of Technology	Martel, J (corresponding author), Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan.	dingeyoung@hotmail.com		Wu, Cheng-Yeu/0000-0002-1545-0835; Martel, Jan/0000-0003-0879-109X	Primordia Institute of New Sciences and Medicine; Chang Gung University [FMRPD2T02]; Mingchi University of Technology [0XB0]	Primordia Institute of New Sciences and Medicine; Chang Gung University; Mingchi University of Technology	This study was supported by Primordia Institute of New Sciences and Medicine and by grants from Chang Gung University (FMRPD2T02) and Mingchi University of Technology (0XB0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Akerman KK, 1997, P SOC PHOTO-OPT INS, V3111, P436, DOI 10.1117/12.278798; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BESARAB A, 1981, J CLIN PATHOL, V34, P1361, DOI 10.1136/jcp.34.12.1361; Bjorklund M, 1998, P SOC PHOTO-OPT INS, V3441, P123, DOI 10.1117/12.319827; Bonucci E, 2002, J BONE MINER METAB, V20, P249, DOI 10.1007/s007740200037; BOSKEY AL, 1991, CRIT REV ORAL BIOL M, V2, P369, DOI 10.1177/10454411910020030501; BOSKEY AL, 2008, METAL IONS LIFE SCI, V4, P457; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Carson DA, 1998, P NATL ACAD SCI USA, V95, P7846, DOI 10.1073/pnas.95.14.7846; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1999, PROC SPIE, V3755, P113, DOI 10.1117/12.375069; Ciftcioglu N, 1997, VACCINES, P99; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; CIFTCIOGLU N, 2010, PEDIAT RES IN PRESS; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S; CUERPO EG, 2000, ARCH ESP UROL, V53, P291; Dogan A, 2007, FOOD CHEM, V100, P1106, DOI 10.1016/j.foodchem.2005.11.017; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Dorrell S, 1999, MOL MED TODAY, V5, P373, DOI 10.1016/S1357-4310(99)01553-1; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; Du J, 2004, INT J BIOCHEM CELL B, V36, P2334, DOI 10.1016/j.biocel.2004.05.012; Eftink M.R., 2000, TOPICS FLUORESCENCE, P1, DOI DOI 10.1007/0-306-47102-7_1; FOGHANDERSEN N, 1977, CLIN CHEM, V23, P2122; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Frankenberg UM, 2009, EXP DERMATOL, V18, P275; GARNETT J, 1990, BIOCHEM J, V266, P863; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; GILMAN H, 1994, J INORG BIOCHEM, V55, P21, DOI 10.1016/0162-0134(94)85129-8; Giroux M, 1998, FOOD RES INT, V31, P257, DOI 10.1016/S0963-9969(98)00092-1; GORNETSCHELNOKOW U, 1993, EUR J BIOCHEM, V213, P1235, DOI 10.1111/j.1432-1033.1993.tb17874.x; Grieb T, 2002, BIOLOGICALS, V30, P207, DOI 10.1006/biol.2002.0330; GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969; Grootveld M, 1986, Free Radic Res Commun, V1, P243, DOI 10.3109/10715768609051634; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; HICKS M, 1986, FEBS LETT, V199, P92, DOI 10.1016/0014-5793(86)81230-3; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; Hohling H J, 1997, Adv Dent Res, V11, P462; HU YR, 2009, CARDIOVASC IN PRESS; Iqbal MS, 2001, J RADIOANAL NUCL CH, V250, P397, DOI 10.1023/A:1017940906191; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Johansson JS, 1997, J BIOL CHEM, V272, P17961, DOI 10.1074/jbc.272.29.17961; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Jones JA, 2008, CURR CLIN UROL, P221, DOI 10.1007/978-1-59745-472-8_17; Jones JA, 2009, UROLOGY, V73, DOI 10.1016/j.urology.2008.01.033; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kajander EO, 1999, PROC SPIE, V3755, P106, DOI 10.1117/12.375068; KATO A, 1988, J AGR FOOD CHEM, V36, P1156, DOI 10.1021/jf00084a007; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Lacroix M, 2000, FOOD RES INT, V33, P719, DOI 10.1016/S0963-9969(00)00085-5; Lee Y, 2002, J BIOCHEM MOL BIOL, V35, P590; Li Y, 2006, BIOORGAN MED CHEM, V14, P1431, DOI 10.1016/j.bmc.2005.09.066; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; Loohuis KMO, 2010, KIDNEY INT, V77, P77, DOI 10.1038/ki.2009.407; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Maruyama T, 2001, BIOTECHNOL BIOENG, V75, P233, DOI 10.1002/bit.10001; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Miller VM, 2009, NANOMEDICINE-UK, V4, P725, DOI [10.2217/nnm.09.61, 10.2217/NNM.09.61]; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Naseem F, 2003, BBA-PROTEINS PROTEOM, V1649, P164, DOI 10.1016/S1570-9639(03)00169-9; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97; Pillay AE, 2003, ANAL BIOANAL CHEM, V375, P751, DOI 10.1007/s00216-003-1830-4; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Puskas LG, 2005, ACTA BIOL HUNG, V56, P233, DOI 10.1556/ABiol.56.2005.3-4.7; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Robinson C, 2007, J DENT RES, V86, P677, DOI 10.1177/154405910708600801; Sambrook J., 2001, MOL CLONING LAB MANU; SAROFF HA, 1963, J PHYS CHEM-US, V67, P1211, DOI 10.1021/j100800a011; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2009, NANOMEDICINE-UK, V4, P931, DOI 10.2217/NNM.09.72; Schwartz MK, 2009, AM J PHYSIOL-HEART C, V296, pH1434, DOI 10.1152/ajpheart.00993.2008; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Smirnov GV, 2008, CONTEMP PROBL ECOL+, V1, P111, DOI 10.1134/S1995425508010128; Sommer AP, 2006, CRYST GROWTH DES, V6, P492, DOI 10.1021/cg050418e; Sommer AP, 2005, J PROTEOME RES, V4, P180, DOI 10.1021/pr0498382; Speer MY, 2004, CARDIOVASC PATHOL, V13, P63, DOI 10.1016/S1054-8807(03)00130-3; SUSI H, 1986, METHOD ENZYMOL, V130, P290; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Toyran N, 2004, EUR BIOPHYS J BIOPHY, V33, P549, DOI 10.1007/s00249-004-0396-1; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Vuckovic M, 2005, J SERB CHEM SOC, V70, P1255, DOI 10.2298/JSC0511255V; Wainwright M, 2004, MICROBIOL-SGM, V150, P756, DOI 10.1099/mic.0.26907-0; Wainwright M, 2003, FEMS MICROBIOL LETT, V218, P161, DOI 10.1111/j.1574-6968.2003.tb11513.x; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Wickramasinghe JT, 2006, ASTROPHYS SPACE SCI, V305, P411, DOI 10.1007/s10509-006-9181-1; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005421; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; ZHANG QH, 2009, J ANDROL IN PRESS; Zhang QH, 2010, INT UROGYNECOL J, V21, P103, DOI 10.1007/s00192-009-0994-7; Zhang SM, 2008, BIOORGAN MED CHEM, V16, P7853, DOI 10.1016/j.bmc.2008.02.034; Zhang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007472; Zhang SM, 2009, J PERIODONTOL, V80, P1462, DOI 10.1902/jop.2009.080659; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	128	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10343	10.1371/journal.pone.0010343	http://dx.doi.org/10.1371/journal.pone.0010343			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436679	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079500014
J	Bergen, MJ; Pan, CH; Greer, CE; Legg, HS; Polo, JM; Griffin, DE				Bergen, M. Jeff; Pan, Chien-Hsiung; Greer, Catherine E.; Legg, Harold S.; Polo, John M.; Griffin, Diane E.			Comparison of the Immune Responses Induced by Chimeric Alphavirus-Vectored and Formalin-Inactivated Alum-Precipitated Measles Vaccines in Mice	PLOS ONE			English	Article							LIVED PLASMA-CELLS; VENEZUELAN EQUINE ENCEPHALITIS; RESPIRATORY SYNCYTIAL VIRUS; GENE-BASED VACCINE; ATYPICAL MEASLES; RHESUS MACAQUES; SINDBIS-VIRUS; REPLICON PARTICLES; ALTERED REACTIVITY; ANTIBODY-RESPONSE	A variety of vaccine platforms are under study for development of new vaccines for measles. Problems with past measles vaccines are incompletely understood and underscore the need to understand the types of immune responses induced by different types of vaccines. Detailed immune response evaluation is most easily performed in mice. Although mice are not susceptible to infection with wild type or vaccine strains of measles virus, they can be used for comparative evaluation of the immune responses to measles vaccines of other types. In this study we compared the immune responses in mice to a new protective alphavirus replicon particle vaccine expressing the measles virus hemagglutinin (VEE/SIN-H) with a non-protective formalin-inactivated, alum-precipitated measles vaccine (FI-MV). MV-specific IgG levels were similar, but VEE/SINH antibody was high avidity IgG2a with neutralizing activity while FI-MV antibody was low-avidity IgG1 without neutralizing activity. FI-MV antibody was primarily against the nucleoprotein with no priming to H. Germinal centers appeared, peaked and resolved later for FI-MV. Lymph node MV antibody-secreting cells were more numerous after FI-MV than VEE/SIN-H, but were similar in the bone marrow. VEE/SIN-H-induced T cells produced IFN-gamma and IL-4 both spontaneously ex vivo and after stimulation, while FI-MV-induced T cells produced IL-4 only after stimulation. In summary, VEE/SIN-H induced a balanced T cell response and high avidity neutralizing IgG2a while FI-MV induced a type 2 T cell response, abundant plasmablasts, late germinal centers and low avidity non-neutralizing IgG1 against the nucleoprotein.	[Bergen, M. Jeff; Griffin, Diane E.] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD USA; [Bergen, M. Jeff; Pan, Chien-Hsiung; Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Greer, Catherine E.; Legg, Harold S.; Polo, John M.] Novartis Vaccines & Diagnost, Cambridge, MA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Novartis	Bergen, MJ (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA.	dgriffin@jhsph.edu	Pan, Chien-Hsiung/K-6922-2013; Pan, Chien-Hsiung/E-3857-2010		Bill and Melinda Gates Foundation; Novartis Vaccines and Diagnostics	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis Vaccines and Diagnostics	This study was supported by funds from The Bill and Melinda Gates Foundation. Novartis Vaccines and Diagnostics provided salary support for Drs. Greer, Legg and Polo and produced the VEE/SIN-H vaccine. The funders had no role in study design, data collection and analysis or decision to publish.	ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; ANNUNZIATO D, 1982, PEDIATRICS, V70, P203; Auwaerter PG, 1999, J INFECT DIS, V180, P950, DOI 10.1086/314993; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; BEAUVERGER P, 1993, J VIROL METHODS, V44, P199, DOI 10.1016/0166-0934(93)90055-V; BENNER R, 1974, IMMUNOLOGY, V26, P247; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; BREDENBEEK PJ, 1993, J VIROL, V67, P6439, DOI 10.1128/JVI.67.11.6439-6446.1993; BRODSKY AL, 1972, J AMER MED ASSOC, V222, P1415, DOI 10.1001/jama.222.11.1415; Capozzo AVE, 2006, J IMMUNOL, V176, P5671, DOI 10.4049/jimmunol.176.9.5671; CARTER CH, 1962, JAMA-J AM MED ASSOC, V179, P848, DOI 10.1001/jama.1962.03050110016003; Chabot S, 2005, VACCINE, V23, P1374, DOI 10.1016/j.vaccine.2004.09.010; Chen M, 2002, J IMMUNOL, V169, P3208, DOI 10.4049/jimmunol.169.6.3208; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; de Swart RL, 2005, J VIROL, V79, P11547, DOI 10.1128/JVI.79.17.11547-11551.2005; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; ENDERS JF, 1962, AM J DIS CHILD, V103, P335, DOI 10.1001/archpedi.1962.02080020347030; ENDERS JF, 1954, P SOC EXP BIOL MED, V86, P277, DOI 10.3181/00379727-86-21073; Ertl OT, 2003, ARCH VIROL, V148, P2195, DOI 10.1007/s00705-003-0159-9; Etchart N, 1997, J GEN VIROL, V78, P1577, DOI 10.1099/0022-1317-78-7-1577; FAHRER AM, 1995, J IMMUNOL, V155, P2849; FELDMAN HA, 1962, AM J DIS CHILD, V103, P423, DOI 10.1001/archpedi.1962.02080020435053; Fournier P, 1996, INT IMMUNOL, V8, P1441, DOI 10.1093/intimm/8.9.1441; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; FULGINITI VA, 1969, J PEDIATR-US, V75, P609, DOI 10.1016/S0022-3476(69)80456-7; Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527; Gardner JP, 2000, J VIROL, V74, P11849, DOI 10.1128/JVI.74.24.11849-11857.2000; GOKIERT JG, 1970, CAN MED ASSOC J, V103, P724; GRAVES M, 1984, J VIROL, V49, P409, DOI 10.1128/JVI.49.2.409-412.1984; Greer CE, 2007, VACCINE, V25, P481, DOI 10.1016/j.vaccine.2006.07.048; Griffin DE, 2009, CURR TOP MICROBIOL, V330, P191; GRUN JL, 1989, CELL IMMUNOL, V121, P134, DOI 10.1016/0008-8749(89)90011-7; Halassy B, 2006, VACCINE, V24, P185, DOI 10.1016/j.vaccine.2005.07.057; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; HOLT EA, 1993, J INFECT DIS, V168, P1087, DOI 10.1093/infdis/168.5.1087; KATZ SL, 1962, AM J PUBLIC HEALTH N, V52, P5, DOI 10.2105/AJPH.52.Suppl_2.5; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; Knudsen KM, 1996, INT J EPIDEMIOL, V25, P665, DOI 10.1093/ije/25.3.665; Kolla RV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001044; Konopka JL, 2007, PLOS PATHOG, V3, P2038, DOI 10.1371/journal.ppat.0030199; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; Leitner WW, 2006, VACCINE, V24, P5110, DOI 10.1016/j.vaccine.2006.04.059; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; MALVOISIN E, 1990, J VIROL, V64, P5160, DOI 10.1128/JVI.64.10.5160-5162.1990; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; MARTIN DB, 1979, ANN INTERN MED, V90, P877, DOI 10.7326/0003-4819-90-6-877; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; MCLEAN DM, 1970, CAN MED ASSOC J, V103, P743; Meissner HC, 2004, PEDIATRICS, V114, P1065, DOI 10.1542/peds.2004-0440; MERZ DC, 1980, J EXP MED, V151, P275, DOI 10.1084/jem.151.2.275; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; Mok H, 2008, J VIROL, V82, P11410, DOI 10.1128/JVI.01688-08; Mok H, 2007, J VIROL, V81, P13710, DOI 10.1128/JVI.01351-07; Moss WJ, 2006, NAT REV MICROBIOL, V4, P900, DOI 10.1038/nrmicro1550; MULLER CP, 1995, MOL IMMUNOL, V32, P37, DOI 10.1016/0161-5890(94)00132-K; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nair N, 2007, J INFECT DIS, V196, P1339, DOI 10.1086/522519; NICHOLS EM, 1979, AM J PUBLIC HEALTH, V69, P160, DOI 10.2105/AJPH.69.2.160; NORRBY E, 1975, J INFECT DIS, V132, P262, DOI 10.1093/infdis/132.3.262; Orenstein WA, 2000, AM J PUBLIC HEALTH, V90, P1521, DOI 10.2105/AJPH.90.10.1521; Pan CH, 2005, P NATL ACAD SCI USA, V102, P11581, DOI 10.1073/pnas.0504592102; PAN CH, 2010, J VIROL IN PRESS; Pan CH, 2008, CLIN VACCINE IMMUNOL, V15, P1214, DOI 10.1128/CVI.00120-08; Pan CH, 2008, CLIN VACCINE IMMUNOL, V15, P697, DOI 10.1128/CVI.00045-08; Pasetti MF, 2003, J VIROL, V77, P5209, DOI 10.1128/JVI.77.9.5209-5217.2003; Perri S, 2003, J VIROL, V77, P10394, DOI 10.1128/JVI.77.19.10394-10403.2003; Polack FP, 2000, NAT MED, V6, P776, DOI 10.1038/77506; Polack FP, 1999, NAT MED, V5, P629, DOI 10.1038/9473; Polack FP, 2003, NAT MED, V9, P1209, DOI 10.1038/nm918; Polo JM, 1999, P NATL ACAD SCI USA, V96, P4598, DOI 10.1073/pnas.96.8.4598; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; RAUH LW, 1965, AM J DIS CHILD, V109, P232, DOI 10.1001/archpedi.1965.02090020234007; Rayner JO, 2002, REV MED VIROL, V12, P279, DOI 10.1002/rmv.360; Rivailler P, 1998, EUR J IMMUNOL, V28, P1301, DOI 10.1002/(SICI)1521-4141(199804)28:04<1301::AID-IMMU1301>3.0.CO;2-S; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Song MK, 2005, J VIROL, V79, P9854, DOI 10.1128/JVI.79.15.9854-9861.2005; Stittelaar KJ, 2000, VACCINE, V18, P2482, DOI 10.1016/S0264-410X(00)00026-8; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Thompson JM, 2006, P NATL ACAD SCI USA, V103, P3722, DOI 10.1073/pnas.0600287103; Thompson JM, 2008, VACCINE, V26, P4998, DOI 10.1016/j.vaccine.2008.07.011; Thompson JM, 2008, J IMMUNOL, V181, P574, DOI 10.4049/jimmunol.181.1.574; van Els CACM, 2002, VIRAL IMMUNOL, V15, P435, DOI 10.1089/088282402760312322; WARREN J, 1962, AM J DIS CHILD, V103, P452, DOI 10.1001/archpedi.1962.02080020464063; WARREN J, 1962, AM J DIS CHILD, V103, P248; Webster DE, 2002, J VIROL, V76, P7910, DOI 10.1128/JVI.76.15.7910-7912.2002; White LJ, 2007, J VIROL, V81, P10329, DOI 10.1128/JVI.00512-07	98	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10297	10.1371/journal.pone.0010297	http://dx.doi.org/10.1371/journal.pone.0010297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421972	gold, Green Submitted, Green Published			2022-12-27	WOS:000276952600014
J	Larriba, MJ; Casado-Vela, J; Pendas-Franco, N; Pena, R; de Herreros, AG; Berciano, MT; Lafarga, M; Casal, JI; Munoz, A				Jesus Larriba, Maria; Casado-Vela, Juan; Pendas-Franco, Natalia; Pena, Raul; Garcia de Herreros, Antonio; Teresa Berciano, Maria; Lafarga, Miguel; Ignacio Casal, J.; Munoz, Alberto			Novel Snail1 Target Proteins in Human Colon Cancer Identified by Proteomic Analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; ERBB-3 BINDING-PROTEIN; VITAMIN-D-RECEPTOR; CELL-CYCLE REGULATION; E-CADHERIN; GENE-EXPRESSION; BREAST-CANCER; BETA-CATENIN; MEDIATED TRANSCRIPTION	Background: The transcription factor Snail1 induces epithelial-to-mesenchymal transition (EMT), a process responsible for the acquisition of invasiveness during tumorigenesis. Several transcriptomic studies have reported Snail1-regulated genes in different cell types, many of them involved in cell adhesion. However, only a few studies have used proteomics as a tool for the characterization of proteins mediating EMT. Methodology/Principal Findings: We identified by proteomic analysis using 2D-DIGE electrophoresis combined with MALDI-TOF-TOF and ESI-linear ion trap mass spectrometry a number of proteins with variable functions whose expression is modulated by Snail1 in SW480-ADH human colon cancer cells. Validation was performed by Western blot and immunofluorescence analyses. Snail1 repressed several members of the 14-3-3 family of phosphoserine/phosphothreonine binding proteins and also the expression of the Proliferation-associated protein 2G4 (PA2G4) that was mainly localized at the nuclear Cajal bodies. In contrast, the expression of two proteins involved in RNA processing, the Cleavage and polyadenylation specificity factor subunit 6 (CPSF6) and the Splicing factor proline/glutamine-rich (SFPQ), was higher in Snail1-expressing cells than in controls. The regulation of 14-3-3 epsilon, 14-3-3 tau, 14-3-3 zeta and PA2G4 by Snail1 was reproduced in HT29 colon cancer cells. In addition, we found an inverse correlation between 14-3-3 sigma and Snail1 expression in human colorectal tumors. Conclusions/Significance: We have identified a set of novel Snail1 target proteins in colon cancer that expand the cellular processes affected by Snail1 and thus its relevance for cell function and phenotype.	[Jesus Larriba, Maria; Pendas-Franco, Natalia; Munoz, Alberto] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Casado-Vela, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Pena, Raul; Garcia de Herreros, Antonio] Hosp Mar, IMIM, Barcelona, Spain; [Teresa Berciano, Maria; Lafarga, Miguel] Univ Cantabria, Dept Anat & Biol Celular, Inst Formac & Invest Marques Valdecilla, E-39005 Santander, Spain; [Ignacio Casal, J.] CSIC, Ctr Invest Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Larriba, MJ (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain.	mjlarriba@iib.uam.es	Casado-Vela, Juan/C-5086-2013; Casal, Ignacio/M-2312-2014; Lafarga, Miguel/K-3733-2014; Munoz, Alberto/O-6393-2014; LARRIBA, MARIA JESUS/O-4652-2014; de Herreros, A Garcia/H-3104-2014	Casado-Vela, Juan/0000-0001-5924-6601; Casal, Ignacio/0000-0003-1085-2840; Munoz, Alberto/0000-0003-3890-4251; LARRIBA, MARIA JESUS/0000-0001-9035-7414; de Herreros, A Garcia/0000-0001-5270-0808; Berciano, Maria T./0000-0002-8225-6995; Pena Arranz, Raul/0000-0002-1650-9720; Lafarga, Miguel/0000-0003-3402-1152	Ministerio de Ciencia e Innovacion of Spain [SAF2007-60341, BIO2006-07689, RD06/0020/0009, RD06/0020/0040]; Comunidad de Madrid [S-GEN-0266/2006]; European Union [MRTN-CT-2005-019496]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain (SAF2007-60341, BIO2006-07689, ISCIII-RETIC RD06/0020/0009 and RD06/0020/0040), Comunidad de Madrid (S-GEN-0266/2006) and the European Union (MRTN-CT-2005-019496, NucSys). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casado-Vela J, 2007, PROTEOMICS, V7, P2522, DOI 10.1002/pmic.200700026; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; Gonzalez-Santiago L, 2007, J PROTEOME RES, V6, P1286, DOI 10.1021/pr060430+; Guweidhi A, 2004, CARCINOGENESIS, V25, P1575, DOI 10.1093/carcin/bgh159; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hidalgo-Curtis C, 2008, GENE CHROMOSOME CANC, V47, P379, DOI 10.1002/gcc.20541; Higashikawa K, 2008, CANCER LETT, V264, P256, DOI 10.1016/j.canlet.2008.01.045; Holm R, 2009, ONCOL REP, V22, P11, DOI 10.3892/or_00000399; Honore B, 2000, BBA-GENE STRUCT EXPR, V1492, P108, DOI 10.1016/S0167-4781(00)00092-0; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Joyce T, 2009, CLIN EXP METASTAS, V26, P569, DOI 10.1007/s10585-009-9256-9; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kowalinski E, 2007, FEBS LETT, V581, P4450, DOI 10.1016/j.febslet.2007.08.024; Lafarga M, 2009, CHROMOSOMA, V118, P437, DOI 10.1007/s00412-009-0212-x; Larriba MJ, 2007, ENDOCR-RELAT CANCER, V14, P141, DOI 10.1677/ERC-06-0028; Lessor TJ, 2000, J CELL PHYSIOL, V183, P321, DOI 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Liu SH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-162; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Madoz-Gurpide J, 2006, MOL CELL PROTEOMICS, V5, P1471, DOI 10.1074/mcp.M600048-MCP200; Mathias RA, 2009, BBA-PROTEINS PROTEOM, V1794, P1325, DOI 10.1016/j.bbapap.2009.05.001; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schultz J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-53; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Taki M, 2006, INT J ONCOL, V28, P487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Xia XM, 2001, J CELL PHYSIOL, V187, P209, DOI 10.1002/jcp.1075; Yoo JY, 2000, BRIT J CANCER, V82, P683; Yu YC, 2007, INT J CANCER, V120, P1909, DOI 10.1002/ijc.22541; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhang Y, 2008, CANCER LETT, V265, P298, DOI 10.1016/j.canlet.2008.02.024; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; Zhang YX, 2002, ONCOGENE, V21, P5609, DOI 10.1038/sj.onc.1205638	64	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10221	10.1371/journal.pone.0010221	http://dx.doi.org/10.1371/journal.pone.0010221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421926	Green Published, Green Submitted, gold			2022-12-27	WOS:000276854300004
J	Daemen, A; Signoretto, M; Gevaert, O; Suykens, JAK; De Moor, B				Daemen, Anneleen; Signoretto, Marco; Gevaert, Olivier; Suykens, Johan A. K.; De Moor, Bart			Improved Microarray-Based Decision Support with Graph Encoded Interactome Data	PLOS ONE			English	Article							BREAST-CANCER; GENE-EXPRESSION; HISTOLOGIC GRADE; CLASSIFICATION; PREDICTION; TARGETS; CHEMOTHERAPY; CLASSIFIERS; METASTASIS; COLLECTION	In the past, microarray studies have been criticized due to noise and the limited overlap between gene signatures. Prior biological knowledge should therefore be incorporated as side information in models based on gene expression data to improve the accuracy of diagnosis and prognosis in cancer. As prior knowledge, we investigated interaction and pathway information from the human interactome on different aspects of biological systems. By exploiting the properties of kernel methods, relations between genes with similar functions but active in alternative pathways could be incorporated in a support vector machine classifier based on spectral graph theory. Using 10 microarray data sets, we first reduced the number of data sources relevant for multiple cancer types and outcomes. Three sources on metabolic pathway information (KEGG), protein-protein interactions (OPHID) and miRNA-gene targeting (microRNA.org) outperformed the other sources with regard to the considered class of models. Both fixed and adaptive approaches were subsequently considered to combine the three corresponding classifiers. Averaging the predictions of these classifiers performed best and was significantly better than the model based on microarray data only. These results were confirmed on 6 validation microarray sets, with a significantly improved performance in 4 of them. Integrating interactome data thus improves classification of cancer outcome for the investigated microarray technologies and cancer types. Moreover, this strategy can be incorporated in any kernel method or non-linear version of a non-kernel method.	[Daemen, Anneleen; Signoretto, Marco; Gevaert, Olivier; Suykens, Johan A. K.; De Moor, Bart] Katholieke Univ Leuven, Dept Elect Engn, ESAT SCD, Leuven, Belgium	KU Leuven	Daemen, A (corresponding author), Katholieke Univ Leuven, Dept Elect Engn, ESAT SCD, Leuven, Belgium.	anneleen.daemen@esat.kuleuven.be	Suykens, Johan A.K./C-9781-2014; Gevaert, Olivier/H-3413-2019	Suykens, Johan A.K./0000-0002-8846-6352; Gevaert, Olivier/0000-0002-9965-5466	Scientific Research - Flanders (FWO-Vlaanderen); Research Council KUL [CoE EF/05/007]; SymBioSys; PTROMEA [0241.04, 0499.04, 0318.05, 0302.07]	Scientific Research - Flanders (FWO-Vlaanderen)(FWO); Research Council KUL(KU Leuven); SymBioSys; PTROMEA	AD is research assistant of the Fund for Scientific Research - Flanders (FWO-Vlaanderen). OG is supported by the Research Foundation - Flanders (FWO). JS is a professor and BDM a full professor at the Katholieke Universiteit Leuven, Belgium. This work is partially supported by: 1. Research Council KUL: GOA AMBioRICS, CoE EF/05/007 SymBioSys, PTROMEA, several PhD/postdoc & fellow grants. 2. Flemish Government: a. FWO: PhD/postdoc grants, projects G.0241.04 (Functional Genomics), G.0499.04 (Statistics), G.0318.05 (subfunctionalization), G.0302.07 (SVM/Kernel), research communities (ICCoS, ANMMM, MLDM); b. IWT: PhD Grants, GBOU-McKnow-E (Knowledge management algorithms), GBOU-ANA (biosensors), TAD-BioScope-IT, Silicos; SBO-BioFrame, SBO-MoKa, TBM-Endometriosis. 3. Belgian Federal Science Policy Office: IUAP P6/25 (BioMaGNet, Bioinformatics and Modeling: from Genomes to Networks, 2007 - 2011). 4. EU-RTD: ERNSI: European Research Network on System Identification; FP6-NoE Biopattern; FP6-IP e-Tumours, FP6-MC-EST Bioptrain, FP6-STREP Strokemap. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bjorkholm P, 2009, BIOINFORMATICS, V25, P3020, DOI 10.1093/bioinformatics/btp522; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cawley GC, 2006, IEEE IJCNN, P1661; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Daemen A, 2009, GENOME MED, V1, DOI 10.1186/gm39; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Demsar J, 2006, J MACH LEARN RES, V7, P1; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Duin RPW, 2002, INT C PATT RECOG, P765, DOI 10.1109/ICPR.2002.1048415; Duin RPW, 2000, LECT NOTES COMPUT SC, V1857, P16; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Futschik Matthias E, 2003, Appl Bioinformatics, V2, pS53; Galperin MY, 2009, NUCLEIC ACIDS RES, V37, pD1, DOI 10.1093/nar/gkn942; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hanisch D., 2002, BIOINFORMATICS, V18, pS145, DOI [10.1093/bioinformatics/18.suppl_1.S145, DOI 10.1093/BI0INF0RMATICS/18.SUPPL_]; HANSEN PC, 1992, INVERSE PROBL, V8, P849, DOI 10.1088/0266-5611/8/6/005; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kittler J, 1998, PATTERN ANAL APPL, V1, P18, DOI 10.1007/BF01238023; Kondor R. I., 2002, PROC 19 INT C MACH L, P315; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lewis DP, 2006, BIOINFORMATICS, V22, P2753, DOI 10.1093/bioinformatics/btl475; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Oakman C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2238; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Pochet N, 2004, BIOINFORMATICS, V20, P3185, DOI 10.1093/bioinformatics/bth383; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Raudys S, 1998, PATTERN RECOGN LETT, V19, P385, DOI 10.1016/S0167-8655(98)00016-6; Rish I., 2001, P IJCAI 01 WORKSH EM, P41; Romero P, 2005, GENOME BIOL, V6; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scholkopf B., 2004, KERNEL METHODS COMPU; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sima C, 2008, PATTERN RECOGN LETT, V29, P1667, DOI 10.1016/j.patrec.2008.04.010; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vapnik V., 1998, STAT LEARNING THEORY; Vert JP, 2003, BIOINFORMATICS, V19, pII238, DOI 10.1093/bioinformatics/btg1084; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182	77	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10225	10.1371/journal.pone.0010225	http://dx.doi.org/10.1371/journal.pone.0010225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419106	Green Submitted, Green Published, gold			2022-12-27	WOS:000276853800015
J	Volpe, S; Thelen, S; Pertel, T; Lohse, MJ; Thelen, M				Volpe, Silvia; Thelen, Sylvia; Pertel, Thomas; Lohse, Martin J.; Thelen, Marcus			Polarization of Migrating Monocytic Cells Is Independent of PI 3-Kinase Activity	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NEUTROPHIL CHEMOTAXIS; CHEMOKINE RECEPTORS; LEADING-EDGE; LIVING CELLS; ALPHA(2)-ADRENERGIC RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; INTRACELLULAR TRAFFICKING; CHEMOATTRACTANT PROTEIN-1; FLUORESCENT PROTEIN	Background: Migration of mammalian cells is a complex cell type and environment specific process. Migrating hematopoietic cells assume a rapid amoeboid like movement when exposed to gradients of chemoattractants. The underlying signaling mechanisms remain controversial with respect to localization and distribution of chemotactic receptors within the plasma membrane and the role of PI 3-kinase activity in cell polarization. Methodology/Principal Findings: We present a novel model for the investigation of human leukocyte migration. Monocytic THP-1 cells transfected with the alpha(2A)-adrenoceptor (alpha(2A)AR) display comparable signal transduction responses, such as calcium mobilization, MAP-kinase activation and chemotaxis, to the noradrenaline homlogue UK 14'304 as when stimulated with CCL2, which binds to the endogenous chemokine receptor CCR2. Time-lapse video microcopy reveals that chemotactic receptors remain evenly distributed over the plasma membrane and that their internalization is not required for migration. Measurements of intramolecular fluorescence resonance energy transfer ( FRET) of alpha(2A)AR-YFP/CFP suggest a uniform activation of the receptors over the entire plasma membrane. Nevertheless, PI 3-kinse activation is confined to the leading edge. When reverting the gradient of chemoattractant by moving the dispensing micropipette, polarized monocytes - in contrast to neutrophils - rapidly flip their polarization axis by developing a new leading edge at the previous posterior side. Flipping of the polarization axis is accompanied by re-localization of PI-3-kinase activity to the new leading edge. However, reversal of the polarization axis occurs in the absence of PI 3-kinase activation. Conclusions/Significance: Accumulation and internalization of chemotactic receptors at the leading edge is dispensable for cell migration. Furthermore, uniformly distributed receptors allow the cells to rapidly reorient and adapt to changes in the attractant cue. Polarized monocytes, which display typical amoeboid like motility, can rapidly develop a new leading edge facing the highest chemoattractant concentration at any site of the plasma membrane, including the uropod. The process appears to be independent of PI 3-kinase activity.	[Volpe, Silvia; Thelen, Sylvia; Thelen, Marcus] Biomed Res Inst, Bellinzona, Switzerland; [Pertel, Thomas] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany; [Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany	Universita della Svizzera Italiana; University of Geneva; University of Wurzburg; University of Wurzburg	Volpe, S (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	marcus.thelen@irb.unisi.ch	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510; Pertel, Thomas/0000-0002-2286-6011	European Community; 6th Framework Program, Network of Excellence Grant (MAIN) [LSHG-CT-2003-502935]; Swiss National Science Foundation [316000-117395]; Helmut Horten Foundation	European Community(European Commission); 6th Framework Program, Network of Excellence Grant (MAIN); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation	The study was co-financed by the European Community through a Marie Curie Action (INTEGRAMM) and the 6th Framework Program, Network of Excellence Grant (MAIN) LSHG-CT-2003-502935 and supported by the Swiss National Science Foundation program R'Equip 316000-117395. The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dalous J, 2008, BIOPHYS J, V94, P1063, DOI 10.1529/biophysj.107.114702; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Dormann D, 2006, EMBO J, V25, P3480, DOI 10.1038/sj.emboj.7601227; DOWNING JR, 1991, MOL CELL BIOL, V11, P2489, DOI 10.1128/MCB.11.5.2489; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Knaus AE, 2007, NEUROCHEM INT, V51, P277, DOI 10.1016/j.neuint.2007.06.036; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ogilvie P, 2004, J IMMUNOL, V172, P6715, DOI 10.4049/jimmunol.172.11.6715; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; ROMMELSPACHER H, 1987, J NEURAL TRANSM, V69, P85, DOI 10.1007/BF01244099; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Thelen M, 1995, BIOCHEM BIOPH RES CO, V217, P1255, DOI 10.1006/bbrc.1995.2903; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; YOSHIMURA T, 1990, J IMMUNOL, V145, P292; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	71	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10159	10.1371/journal.pone.0010159	http://dx.doi.org/10.1371/journal.pone.0010159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419163	Green Published, Green Submitted, gold			2022-12-27	WOS:000276707100005
J	Maffettone, C; Chen, GH; Drozdov, I; Ouzounis, C; Pantopoulos, K				Maffettone, Carmen; Chen, Guohua; Drozdov, Ignat; Ouzounis, Christos; Pantopoulos, Kostas			Tumorigenic Properties of Iron Regulatory Protein 2 (IRP2) Mediated by Its Specific 73-Amino Acids Insert	PLOS ONE			English	Article							RESPONSIVE ELEMENT; DEPENDENT DEGRADATION; TARGETED DELETION; HOMEOSTASIS; FERRITIN; OXYGEN; MICE; MYC; METABOLISM; EXPRESSION	Iron regulatory proteins, IRP1 and IRP2, bind to mRNAs harboring iron responsive elements and control their expression. IRPs may also perform additional functions. Thus, IRP1 exhibited apparent tumor suppressor properties in a tumor xenograft model. Here we examined the effects of IRP2 in a similar setting. Human H1299 lung cancer cells or clones engineered for tetracycline-inducible expression of wild type IRP2, or the deletion mutant IRP2D73 (lacking a specific insert of 73 amino acids), were injected subcutaneously into nude mice. The induction of IRP2 profoundly stimulated the growth of tumor xenografts, and this response was blunted by addition of tetracycline in the drinking water of the animals, to turnoff the IRP2 transgene. Interestingly, IRP2D73 failed to promote tumor growth above control levels. As expected, xenografts expressing the IRP2 transgene exhibited high levels of transferrin receptor 1 (TfR1); however, the expression of other known IRP targets was not affected. Moreover, these xenografts manifested increased c-MYC levels and ERK1/2 phosphorylation. A microarray analysis identified distinct gene expression patterns between control and tumors containing IRP2 or IRP1 transgenes. By contrast, gene expression profiles of control and IRP2D73-related tumors were more similar, consistently with their growth phenotype. Collectively, these data demonstrate an apparent pro-oncogenic activity of IRP2 that depends on its specific 73 amino acids insert, and provide further evidence for a link between IRPs and cancer biology.	[Maffettone, Carmen; Chen, Guohua; Pantopoulos, Kostas] McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada; [Maffettone, Carmen; Chen, Guohua; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada; [Drozdov, Ignat] Kings Coll London, Div Cardiovasc, Ctr Excellence, BHF, London WC2R 2LS, England; [Drozdov, Ignat; Ouzounis, Christos] Kings Coll London, Sch Phys Sci & Engn, Ctr Bioinformat, London WC2R 2LS, England	Lady Davis Institute; McGill University; McGill University; University of London; King's College London; University of London; King's College London	Maffettone, C (corresponding author), McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada.	kostas.pantopoulos@mcgill.ca	Ouzounis, Christos A/G-2302-2010; Pantopoulos, Kostas/A-9668-2008	Ouzounis, Christos A/0000-0002-0086-8657; Pantopoulos, Kostas/0000-0002-2305-0057; Drozdov, Ignat/0000-0001-6727-4688	Cancer Research Society Inc; Government of CanadaBritish Heart Foundation (BHF) Centre of Excellence, Cardiovascular Division, King's College London; Fonds de la Recherche en Sante du Quebec	Cancer Research Society Inc; Government of CanadaBritish Heart Foundation (BHF) Centre of Excellence, Cardiovascular Division, King's College London(British Heart Foundation); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Cancer Research Society Inc (http://src-crs.ca/main.php?lang=2). CM was a recipient of a Post-Doctoral Research Fellowship (PDFR) from the Government of Canada (http://www.scholarships.gc.ca/PDRFNonCdn-BRPDEtr-Eng.aspx). ID holds a pre-doctoral fellowship from the British Heart Foundation (BHF) Centre of Excellence, Cardiovascular Division, King's College London. KP holds a Chercheur National senior career award from the Fonds de la Recherche en Sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GH, 2007, CARCINOGENESIS, V28, P785, DOI 10.1093/carcin/bgl210; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Dycke C, 2007, BIOCHEM J, V408, P429, DOI 10.1042/BJ20070983; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Mueller S, 2002, METHOD ENZYMOL, V348, P324, DOI 10.1016/S0076-6879(02)48651-X; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Schumann K, 2010, J TRACE ELEM MED BIO, V24, P58, DOI 10.1016/j.jtemb.2009.10.002; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2002, MOL CELL BIOL, V22, P4638, DOI 10.1128/MCB.22.13.4638-4651.2002; Wang J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-15; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	34	51	54	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10163	10.1371/journal.pone.0010163	http://dx.doi.org/10.1371/journal.pone.0010163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405006	gold, Green Published, Green Submitted			2022-12-27	WOS:000276706300017
J	Nakatani, SM; Santos, CA; Riediger, IN; Krieger, MA; Duarte, CAB; Lacerda, MA; Biondo, AW; Carilho, FJ; Ono-Nita, SK				Nakatani, Sueli M.; Santos, Carlos A.; Riediger, Irina N.; Krieger, Marco A.; Duarte, Cesar A. B.; Lacerda, Marco A.; Biondo, Alexander W.; Carilho, Flair J.; Ono-Nita, Suzane K.			Development of Hepatitis C Virus Genotyping by Real-Time PCR Based on the NS5B Region	PLOS ONE			English	Article							MELTING CURVE ANALYSIS; ASSAY; INFECTION	Background: Hepatitis C virus (HCV) genotyping is the most significant predictor of the response to antiviral therapy. The aim of this study was to develop and evaluate a novel real-time PCR method for HCV genotyping based on the NS5B region. Methodology/Principal Findings: Two triplex reaction sets were designed, one to detect genotypes 1a, 1b and 3a; and another to detect genotypes 2a, 2b, and 2c. This approach had an overall sensitivity of 97.0%, detecting 295 of the 304 tested samples. All samples genotyped by real-time PCR had the same type that was assigned using LiPA version 1 (Line in Probe Assay). Although LiPA v. 1 was not able to subtype 68 of the 295 samples (23.0%) and rendered different subtype results from those assigned by real-time PCR for 12/295 samples (4.0%), NS5B sequencing and real-time PCR results agreed in all 146 tested cases. Analytical sensitivity of the real-time PCR assay was determined by end-point dilution of the 5000 IU/ml member of the OptiQuant HCV RNA panel. The lower limit of detection was estimated to be 125 IU/ml for genotype 3a, 250 IU/ml for genotypes 1b and 2b, and 500 IU/ml for genotype 1a. Conclusions/Significance: The total time required for performing this assay was two hours, compared to four hours required for LiPA v. 1 after PCR-amplification. Furthermore, the estimated reaction cost was nine times lower than that of available commercial methods in Brazil. Thus, we have developed an efficient, feasible, and affordable method for HCV genotype identification.	[Nakatani, Sueli M.; Riediger, Irina N.] LACEN PR, Lab Cent Estado, Sao Jose Dos Pinhais, Parana, Brazil; [Santos, Carlos A.] Ctr Genomas, Sao Paulo, Brazil; [Krieger, Marco A.; Duarte, Cesar A. B.] ICC FioCruz, Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Lacerda, Marco A.] Indiana Univ, Div Gastroenterol & Hepatol, Indianapolis, IN 46204 USA; [Biondo, Alexander W.] Univ Fed Parana, Dept Vet Med, BR-80060000 Curitiba, Parana, Brazil; [Biondo, Alexander W.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Nakatani, Sueli M.; Carilho, Flair J.; Ono-Nita, Suzane K.] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Riediger, Irina N.] Univ Fed Parana, Dept Biol Celular, BR-80060000 Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz; Indiana University System; Indiana University-Purdue University Indianapolis; Universidade Federal do Parana; University of Illinois System; University of Illinois Urbana-Champaign; Universidade de Sao Paulo; Universidade Federal do Parana	Nakatani, SM (corresponding author), LACEN PR, Lab Cent Estado, Sao Jose Dos Pinhais, Parana, Brazil.	skon@usp.br	BIONDO, ALEXANDER WELKER/AAU-8955-2021; Ono, Suzane K/I-3107-2012; BIONDO, ALEXANDER WELKER W/E-8823-2018; Krieger, Marco/AAE-8611-2020; Publica, Inct Saude/J-9544-2013; P, CM/B-1358-2013	BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; Krieger, Marco Aurelio/0000-0003-0030-3952	Secretaria de Estado da Saude do Parana; Araucaria Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Alves de Queiroz Family Fund for Research	Secretaria de Estado da Saude do Parana; Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Alves de Queiroz Family Fund for Research	These investigations were partially supported by grants from Secretaria de Estado da Saude do Parana, Araucaria Foundation, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Alves de Queiroz Family Fund for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bullock GC, 2002, CLIN CHEM, V48, P2147; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Cantaloube JF, 2006, J CLIN MICROBIOL, V44, P2051, DOI 10.1128/JCM.02463-05; Cook L, 2006, J CLIN MICROBIOL, V44, P4149, DOI 10.1128/JCM.01230-06; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Fujigaki H, 2004, ANN CLIN BIOCHEM, V41, P130, DOI 10.1258/000456304322880014; Holland PV, 1996, J CLIN MICROBIOL, V34, P2372, DOI 10.1128/JCM.34.10.2372-2378.1996; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; KUSSER W, PROTOCOL REAL TIME R; Levi JE, 2002, J CLIN MICROBIOL, V40, P2645, DOI 10.1128/JCM.40.7.2645-2647.2002; Lindh M, 2005, J CLIN VIROL, V34, P108, DOI 10.1016/j.jcv.2005.02.002; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Peters IR, 2004, J IMMUNOL METHODS, V286, P203, DOI 10.1016/j.jim.2004.01.003; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Rolfe KJ, 2005, J CLIN VIROL, V34, P115, DOI 10.1016/j.jcv.2005.02.011; Schroter M, 2002, J CLIN MICROBIOL, V40, P2046, DOI 10.1128/JCM.40.6.2046-2050.2002; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON WD, 1988, J CLIN EPIDEMIOL, V41, P969, DOI 10.1016/0895-4356(88)90033-9; Weck K, 2005, EXPERT REV MOL DIAGN, V5, P507, DOI 10.1586/14737159.5.4.507	24	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10150	10.1371/journal.pone.0010150	http://dx.doi.org/10.1371/journal.pone.0010150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405017	Green Published, Green Submitted, gold			2022-12-27	WOS:000276706300007
J	Novitsky, V; Wang, R; Bussmann, H; Lockman, S; Baum, M; Shapiro, R; Thior, I; Wester, C; Wester, CW; Ogwu, A; Asmelash, A; Musonda, R; Campa, A; Moyo, S; van Widenfelt, E; Mine, M; Moffat, C; Mmalane, M; Makhema, J; Marlink, R; Gilbert, P; Seage, GR; DeGruttola, V; Essex, M				Novitsky, Vladimir; Wang, Rui; Bussmann, Hermann; Lockman, Shahin; Baum, Marianna; Shapiro, Roger; Thior, Ibou; Wester, Carolyn; Wester, C. William; Ogwu, Anthony; Asmelash, Aida; Musonda, Rosemary; Campa, Adriana; Moyo, Sikhulile; van Widenfelt, Erik; Mine, Madisa; Moffat, Claire; Mmalane, Mompati; Makhema, Joseph; Marlink, Richard; Gilbert, Peter; Seage, George R., III; DeGruttola, Victor; Essex, M.			HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the "Test-and-Treat'' Approach to Reduce HIV Transmission	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CLINICAL-TRIAL; ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; TYPE-1 INFECTION; NATURAL-HISTORY; SOUTHERN AFRICA; RISK-FACTORS; RNA LEVELS; BOTSWANA	The first aim of the study is to assess the distribution of HIV-1 RNA levels in subtype C infection. Among 4,348 drug-naive HIV-positive individuals participating in clinical studies in Botswana, the median baseline plasma HIV-1 RNA levels differed between the general population cohorts (4.1-4.2 log(10)) and cART-initiating cohorts (5.1-5.3 log(10)) by about one log(10). The proportion of individuals with high (>= 50,000 (4.7 log(10)) copies/ml) HIV-1 RNA levels ranged from 24%-28% in the general HIV-positive population cohorts to 65%-83% in cART-initiating cohorts. The second aim is to estimate the proportion of individuals who maintain high HIV-1 RNA levels for an extended time and the duration of this period. For this analysis, we estimate the proportion of individuals who could be identified by repeated 6- vs. 12-month-interval HIV testing, as well as the potential reduction of HIV transmission time that can be achieved by testing and ARV treating. Longitudinal analysis of 42 seroconverters revealed that 33% (95% CI: 20%-50%) of individuals maintain high HIV-1 RNA levels for at least 180 days post seroconversion (p/s) and the median duration of high viral load period was 350 ( 269; 428) days p/s. We found that it would be possible to identify all HIV-infected individuals with viral load >= 50,000 ( 4.7 log(10)) copies/ml using repeated six-month-interval HIV testing. Assuming individuals with high viral load initiate cART after being identified, the period of high transmissibility due to high viral load can potentially be reduced by 77% ( 95% CI: 71%-82%). Therefore, if HIV-infected individuals maintaining high levels of plasma HIV-1 RNA for extended period of time contribute disproportionally to HIV transmission, a modified "test-and-treat'' strategy targeting such individuals by repeated HIV testing (followed by initiation of cART) might be a useful public health strategy for mitigating the HIV epidemic in some communities.	[Novitsky, Vladimir; Bussmann, Hermann; Lockman, Shahin; Shapiro, Roger; Thior, Ibou; Wester, Carolyn; Wester, C. William; Ogwu, Anthony; Asmelash, Aida; Musonda, Rosemary; Moffat, Claire; Makhema, Joseph; Marlink, Richard; Essex, M.] Harvard Univ, Sch Publ Hlth, AIDS Initiat, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Novitsky, Vladimir; Bussmann, Hermann; Lockman, Shahin; Shapiro, Roger; Thior, Ibou; Wester, Carolyn; Wester, C. William; Ogwu, Anthony; Asmelash, Aida; Musonda, Rosemary; Moyo, Sikhulile; van Widenfelt, Erik; Mine, Madisa; Moffat, Claire; Mmalane, Mompati; Makhema, Joseph; Marlink, Richard; Essex, M.] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Wang, Rui; DeGruttola, Victor] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Baum, Marianna; Campa, Adriana] Florida Int Univ, Dept Nutr & Dietet, Robert R Stempel Sch Publ Hlth, Miami, FL 33199 USA; [Gilbert, Peter] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Gilbert, Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wester, C. William] Vanderbilt Univ, Sch Med, Div Infect Dis, VIGH, Nashville, TN 37212 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; Florida International University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University	Novitsky, V (corresponding author), Harvard Univ, Sch Publ Hlth, AIDS Initiat, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	Wang, Rui/X-1699-2019; Moyo, Sikhulile/E-1464-2015	Wang, Rui/0000-0001-5007-193X; Moyo, Sikhulile/0000-0003-3821-4592	NIH [R01 HD37793, R01 HD44391, R01 AI057027, R01 AI052032, R01 DA016551, R37 AI24643, U01 AI066454]; Bristol-Myers Squibb Foundation; African Comprehensive HIV/AIDS Partnerships (ACHAP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044391, R01HD037793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051164, K23AI073141, R01AI052032, R01AI057027, U01AI066454, R37AI024643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016551] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); African Comprehensive HIV/AIDS Partnerships (ACHAP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The studies presented were supported and funded by NIH grants R01 HD37793 (Mashi), R01 HD44391 (Mashi+), R01 AI057027 (Tshedimoso), R01 AI052032 (Botsogo), R01 DA016551 (Dikotlana), R37 AI24643, and U01 AI066454 (Mma Bana), by a grant from the Bristol-Myers Squibb Foundation (Tshepo), and by a grant from the African Comprehensive HIV/AIDS Partnerships (ACHAP) (Bomolemo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner WA, 2004, J INFECT DIS, V189, P1793, DOI 10.1086/386306; Bussmann H, 2009, JAIDS-J ACQ IMM DEF, V51, P37, DOI 10.1097/QAI.0b013e31819ff102; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Dyer JR, 1998, J INFECT DIS, V177, P1742, DOI 10.1086/517436; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray CM, 2005, AIDS RES HUM RETROV, V21, P285, DOI 10.1089/aid.2005.21.285; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Kaufmann GR, 1998, J INFECT DIS, V178, P1812, DOI 10.1086/314480; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumwenda JJ, 2008, CLIN INFECT DIS, V46, P1913, DOI 10.1086/588478; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; *LOS AL HIV, LOS AL HIV DAT COMP; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mmiro FA, 2009, JAIDS-J ACQ IMM DEF, V52, P32, DOI 10.1097/QAI.0b013e3181afd352; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2007, CLIN INFECT DIS, V45, pE68, DOI 10.1086/520683; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rezza G, 2000, J ACQ IMMUN DEF SYND, V25, P56, DOI 10.1097/00126334-200009010-00008; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Shapiro RL, 2005, J INFECT DIS, V192, P720, DOI 10.1086/432483; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Shapiro RL, 2009, J INFECT DIS, V199, P414, DOI 10.1086/596034; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tovanabutra S, 2002, J ACQ IMMUN DEF SYND, V29, P275, DOI 10.1097/00126334-200203010-00008; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walensky Rochelle P, 2009, Top HIV Med, V17, P130; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f	49	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10148	10.1371/journal.pone.0010148	http://dx.doi.org/10.1371/journal.pone.0010148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405044	Green Published, Green Submitted, gold			2022-12-27	WOS:000276705900023
J	Salomaa, V; Havulinna, A; Saarela, O; Zeller, T; Jousilahti, P; Jula, A; Munzel, T; Aromaa, A; Evans, A; Kuulasmaa, K; Blankenberg, S				Salomaa, Veikko; Havulinna, Aki; Saarela, Olli; Zeller, Tanja; Jousilahti, Pekka; Jula, Antti; Muenzel, Thomas; Aromaa, Arpo; Evans, Alun; Kuulasmaa, Kari; Blankenberg, Stefan			Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; MIDDLE-AGED MEN; ATHEROSCLEROSIS RISK; ELEVATED LEVELS; LIFE-STYLE; TYPE-2; ANTAGONIST; MELLITUS; ADIPONECTIN	Background: The prevalence of diabetes is increasing in all industrialized countries and its prevention has become a public health priority. However, the predictors of diabetes risk are insufficiently understood. We evaluated, whether 31 novel biomarkers could help to predict the risk of incident diabetes. Methods and Findings: The biomarkers were evaluated primarily in the FINRISK97 cohort (n = 7,827; 417 cases of clinically incident diabetes during the follow-up). The findings were replicated in the Health 2000 cohort (n = 4,977; 179 cases of clinically incident diabetes during the follow-up). We used Cox proportional hazards models to calculate the relative risk of diabetes, after adjusting for the classic risk factors, separately for each biomarker. Next, we assessed the discriminatory ability of single biomarkers using receiver operating characteristic curves and C-statistics, integrated discrimination improvement (IDI) and net reclassification improvement (NRI). Finally, we derived a biomarker score in the FINRISK97 cohort and validated it in the Health 2000 cohort. A score consisting of adiponectin, apolipoprotein B, C-reactive protein and ferritin almost doubled the relative risk of diabetes in the validation cohort (HR per one standard deviation increase 1.88, p = 2.8 e-5). It also improved discrimination of the model (IDI = 0.0149, p < 0.0001) and reclassification of diabetes risk (NRI = 11.8%, p = 0.006). Gender-specific analyses suggested that the best score differed between men and women. Among men, the best results were obtained with the score of four biomarkers: adiponectin, apolipoprotein B, ferritin and interleukin-1 receptor antagonist, which gave an NRI of 25.4% (p < 0.0001). Among women, the best score included adiponectin, apolipoprotein B, C-reactive protein and insulin. It gave an NRI of 13.6% (p = 0.041). Conclusions: We identified novel biomarkers that were associated with the risk of clinically incident diabetes over and above the classic risk factors. This gives new insights into the pathogenesis of diabetes and may help with targeting prevention and treatment.	[Salomaa, Veikko; Havulinna, Aki; Saarela, Olli; Jousilahti, Pekka; Jula, Antti; Aromaa, Arpo; Kuulasmaa, Kari] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Evans, Alun] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Zeller, Tanja; Muenzel, Thomas; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany	Finland National Institute for Health & Welfare; Queens University Belfast; Johannes Gutenberg University of Mainz	Salomaa, V (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	veikko.salomaa@thl.fi; blankenberg@2-med.klinik.uni-mainz.de	Munzel, Thomas/A-2912-2014; Havulinna, Aki/AAM-4769-2021	Munzel, Thomas/0000-0001-5503-4150; Kuulasmaa, Kari/0000-0003-2165-1411; Zeller, Tanja/0000-0003-3379-2641; Blankenberg, Stefan/0000-0001-6488-2362	Medical Research Council London [Medical Research Council London (G0601463]; Finnish Foundation for Cardiovascular Research; Finnish Academy [129494]; MRC [G0601463] Funding Source: UKRI; Medical Research Council [G0601463] Funding Source: researchfish	Medical Research Council London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Finnish Foundation for Cardiovascular Research; Finnish Academy(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The biomarker determinations in FINRISK97 were funded in part by the Medical Research Council London (G0601463, ID no: 80983: Biomarkers in the MORGAM populations). Abbott Diagnostics, BRAHMS AG, Diadexus and Roche Diagnostics provided test reagents (for details see Supplementary Table S1). VS was supported by the Finnish Foundation for Cardiovascular Research and by the Finnish Academy, grant no 129494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Caramori ML, 2003, CURR OPIN NEPHROL HY, V12, P273, DOI 10.1097/00041552-200305000-00008; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Herder C, 2009, DIABETES CARE, V32, P421, DOI 10.2337/dc08-1161; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; STEYERBERG EW, ANN INTERN MED, V152, P196; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vartiainen E, 2009, INT J EPIDEMIOL; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Wannamethee SG, 2008, NUTR METAB CARDIOVAS, V18, P581, DOI 10.1016/j.numecd.2008.07.002; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	35	134	143	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10100	10.1371/journal.pone.0010100	http://dx.doi.org/10.1371/journal.pone.0010100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20396381	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100016
J	Kitko, RD; Wilks, JC; Garduque, GM; Slonczewski, JL				Kitko, Ryan D.; Wilks, Jessica C.; Garduque, Gian M.; Slonczewski, Joan L.			Osmolytes Contribute to pH Homeostasis of Escherichia coli	PLOS ONE			English	Article							POTASSIUM-TRANSPORT; INTRACELLULAR PH; ACID RESISTANCE; BACTERIA; K+; CATABOLISM; GRADIENT; CELLS; K-12; ACCUMULATION	Background: Cytoplasmic pH homeostasis in Escherichia coli includes numerous mechanisms involving pH-dependent catabolism and ion fluxes. An important contributor is transmembrane K(+) flux, but the actual basis of K(+) compensation for pH stress remains unclear. Osmoprotection could mediate the pH protection afforded by K(+) and other osmolytes. Methods and Principal Findings: The cytoplasmic pH of E. coli K-12 strains was measured by GFPmut3 fluorimetry. The wild-type strain Frag1 was exposed to rapid external acidification by HCl addition. Recovery of cytoplasmic pH was enhanced equally by supplementation with NaCl, KCl, proline, or sucrose. A triple mutant strain TK2420 defective for the Kdp, Trk and Kup K(+) uptake systems requires exogenous K(+) for steady-state pH homeostasis and for recovery from sudden acid shift. The K(+) requirement however was partly compensated by supplementation with NaCl, choline chloride, proline, or sucrose. Thus, the K(+) requirement was mediated in part by osmolarity, possibly by relieving osmotic stress which interacts with pH stress. The rapid addition of KCl to strain TK2420 suspended at external pH 5.6 caused a transient decrease in cytoplasmic pH, followed by slow recovery to an elevated steady-state pH. In the presence of 150 mM KCl, however, rapid addition of another 150 mM KCl caused a transient increase in cytoplasmic pH. These transient effects may arise from secondary K(+) fluxes occurring through other transport processes in the TK2420 strain. Conclusions: Diverse osmolytes including NaCl, KCl, proline, or sucrose contribute to cytoplasmic pH homeostasis in E. coli, and increase the recovery from rapid acid shift. Osmolytes other than K(+) restore partial pH homeostasis in a strain deleted for K(+) transport.	[Kitko, Ryan D.; Wilks, Jessica C.; Garduque, Gian M.; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA	Kenyon College	Kitko, RD (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu			National Science Foundation [MCB-0644167]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant MCB-0644167 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; Booth IR, 1999, NOVART FDN SYMP, V221, P19; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Buurman ET, 2004, J BACTERIOL, V186, P4238, DOI 10.1128/JB.186.13.4238-4245.2004; Casey PG, 2002, INT J FOOD MICROBIOL, V76, P199, DOI 10.1016/S0168-1605(02)00018-1; Chapman B, 2006, APPL ENVIRON MICROB, V72, P5165, DOI 10.1128/AEM.02522-05; Chapman B, 2009, APPL ENVIRON MICROB, V75, P3605, DOI 10.1128/AEM.02462-08; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Kitko RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008255; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; KROLL RG, 1981, BIOCHEM J, V198, P691, DOI 10.1042/bj1980691; Krulwich TA, 2009, MOL MICROBIOL, V74, P257, DOI 10.1111/j.1365-2958.2009.06842.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Miller J.H., 1972, EXPT MOL GENETICS; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1976, EUR J BIOCHEM, V63, P533, DOI 10.1111/j.1432-1033.1976.tb10257.x; Richard H, 2007, MICROBIOL-SGM, V153, P3154, DOI 10.1099/mic.0.2007/007575-0; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; STEWART LMD, 1985, J GEN MICROBIOL, V131, P77; Trchounian A, 1997, ANAEROBE, V3, P355, DOI 10.1006/anae.1997.0122; Trchounian A, 2000, BIOSCIENCE REP, V20, P277, DOI 10.1023/A:1026493024066; WHITE S, 1992, J BACTERIOL, V174, P1537, DOI 10.1128/jb.174.5.1537-1543.1992; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zakharyan E, 2001, FEMS MICROBIOL LETT, V204, P61, DOI 10.1111/j.1574-6968.2001.tb10863.x; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	36	35	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10078	10.1371/journal.pone.0010078	http://dx.doi.org/10.1371/journal.pone.0010078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386696	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482000013
J	Pelletier, J; Hughes, DT; Luetje, CW; Leal, WS				Pelletier, Julien; Hughes, David T.; Luetje, Charles W.; Leal, Walter S.			An Odorant Receptor from the Southern House Mosquito Culex pipiens quinquefasciatus Sensitive to Oviposition Attractants	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; PHEROMONE; PROTEINS; IDENTIFICATION; EXPRESSION; RESPONSES; DIPTERA; PALPS	Background: Insect odorant receptors (ORs) are heteromers comprised of highly variable odorant-binding subunits associated with one conserved co-receptor. They are potential molecular targets for the development of novel mosquito attractants and repellents. ORs have been identified in the malaria mosquito, Anopheles gambiae, and in the yellow fever mosquito, Aedes aegypti. However, they are still unknown in the Southern house mosquito, Culex quinquefasciatus, which transmits pathogens that cause human diseases throughout the world, including West Nile Virus in the United States. Methodology: We have employed a combination of bioinformatics, molecular cloning and electrophysiology approaches to identify and characterize the response profile of an OR in Cx. quinquefasciatus. First, we have unveiled a large multigenic family of one-hundred-fifty-eight putative ORs in this species, including a subgroup of conserved ORs in three mosquito species. Using the Xenopus oocytes expression system, we have determined the response profile of CquiOR2, an antennae-specific OR, which shares high identity with putative orthologs in Anopheles gambiae (AgamOR2) and Aedes aegypti (AaegOR2). Conclusion: We show that CquiOR2 is highly sensitive to indole, an oviposition attractant for Cx. quinquefasciatus. The response profile of CquiOR2 expressed in Xenopus oocytes resembles that of an olfactory receptor neuron housed in the antennal short blunt-tipped sensilla (A2) of Cx. quinquefasciatus, which are natural detectors for oviposition attractants. This first Culex OR de-orphanized is, therefore, a potential molecular target for screening oviposition attractants.	[Pelletier, Julien; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hughes, David T.; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of California System; University of California Davis; University of Miami	Pelletier, J (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	National Science Foundation [0918177]; National Institutes of Health [DC008119]; Cooperative Agreement with Bedoukian Research, Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008119, R01DC011091] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative Agreement with Bedoukian Research, Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Science Foundation (0918177 to W. S. L), National Institutes of Health (DC008119 to C. W. L.), and a Cooperative Agreement with Bedoukian Research, Inc., but the funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Carey AF, 2010, NATURE; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Du YJ, 1999, J MED ENTOMOL, V36, P158, DOI 10.1093/jmedent/36.2.158; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2010, NATURE, V464, P37, DOI 10.1038/464037a; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MCIVER S, 1970, CAN J ZOOLOG, V48, P293, DOI 10.1139/z70-048; MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11; MORDUE AJ, 1992, EXPERIENTIA, V48, P1109, DOI 10.1007/BF01947999; Olagbemiro TO, 2004, J CHEM ECOL, V30, P965, DOI 10.1023/B:JOEC.0000028461.86243.19; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WANG G, 2010, P NATL ACAD IN PRESS; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	35	87	91	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10090	10.1371/journal.pone.0010090	http://dx.doi.org/10.1371/journal.pone.0010090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386699	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482000018
J	Prahalad, P; Dakshanamurthy, S; Ressom, H; Byers, SW				Prahalad, Priya; Dakshanamurthy, Sivanesan; Ressom, Habtom; Byers, Stephen W.			Retinoic Acid Mediates Regulation of Network Formation by COUP-TFII and VE-Cadherin Expression by TGF beta Receptor Kinase in Breast Cancer Cells	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; VASCULOGENIC MIMICRY; TYROSINE KINASE; DOWN-REGULATION; TIE2 RECEPTOR; IN-VITRO; GROWTH; ANGIOGENESIS; ACTIVATION; PLASTICITY	Tumor development, growth, and metastasis depend on the provision of an adequate vascular supply. This can be due to regulated angiogenesis, recruitment of circulating endothelial progenitors, and/or vascular transdifferentiation. Our previous studies showed that retinoic acid (RA) treatment converts a subset of breast cancer cells into cells with significant endothelial genotypic and phenotypic elements including marked induction of VE-cadherin, which was responsible for some but not all morphological changes. The present study demonstrates that of the endothelial-related genes induced by RA treatment, only a few were affected by knockdown of VE-cadherin, ruling it out as a regulator of the RA-induced endothelial genotypic switch. In contrast, knockdown of the RA-induced gene COUP-TFII prevented the formation of networks in Matrigel but had no effect on VE-cadherin induction or cell fusion. Two pan-kinase inhibitors markedly blocked RA-induced VE-cadherin expression and cell fusion. However, RA treatment resulted in a marked and broad reduction in tyrosine kinase activity. Several genes in the TGF beta signaling pathway were induced by RA, and specific inhibition of the TGF beta type I receptor blocked both RA-induced VE-cadherin expression and cell fusion. Together these data indicate a role for the TGF beta pathway and COUP-TFII in mediating the endothelial transdifferentiating properties of RA.	[Prahalad, Priya; Dakshanamurthy, Sivanesan; Ressom, Habtom; Byers, Stephen W.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University	Prahalad, P (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA.	byerss@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121	NIH [1R01CA129813, R01 DK58196]; DOD [W81XWH-08-1-0103]; Lombardi Comprehensive Cancer Center [NIH P30 CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA129813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Lombardi Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: NIH 1R01CA129813, NIH R01 DK58196 (S. W. B.) and DOD W81XWH-08-1-0103 (P. P.). The authors acknowledge the support of the following Shared Resources supported by the Lombardi Comprehensive Cancer Center grant NIH P30 CA51008: Microscopy and Imaging, Genomics and Epigenomics, Tissue Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombeli T, 1997, THROMB HAEMOSTASIS, V77, P408; Camacho M, 2008, J LIPID RES, V49, P1707, DOI 10.1194/jlr.M700559-JLR200; Cong RH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-124; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Endo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002714; Esser S, 1998, J CELL SCI, V111, P1853; Faloon P, 2000, DEVELOPMENT, V127, P1931; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FLAMME I, 1992, DEVELOPMENT, V116, P435; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fujimoto A, 2006, ANTICANCER RES, V26, P59; Gifford SM, 2004, J ENDOCRINOL, V182, P485, DOI 10.1677/joe.0.1820485; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hansen LA, 2000, CARCINOGENESIS, V21, P1271, DOI 10.1093/carcin/21.7.1271; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hendrix MJC, 2000, BREAST CANCER RES, V2, P417, DOI 10.1186/bcr88; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Nagasaki S, 2009, CANCER SCI, V100, P639, DOI 10.1111/j.1349-7006.2008.01078.x; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Piao M, 2006, ENDOTHELIUM-J ENDOTH, V13, P249, DOI 10.1080/10623320600903940; Seftor EA, 2002, CRIT REV ONCOL HEMAT, V44, P17, DOI 10.1016/S1040-8428(01)00199-8; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sharma N, 2002, PROSTATE, V50, P189, DOI 10.1002/pros.10048; Shirakawa K, 2002, BRIT J CANCER, V87, P1454, DOI 10.1038/sj.bjc.6600610; Shirakawa K, 2002, CANCER RES, V62, P560; Sood AK, 2004, AM J OBSTET GYNECOL, V190, P899, DOI 10.1016/j.ajog.2004.02.011; Sun BC, 2006, ONCOL REP, V16, P693; Sun BC, 2004, INT J ONCOL, V25, P1609; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Yang QF, 2002, BREAST CANCER RES TR, V76, P167, DOI 10.1023/A:1020576606004; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zanetta L, 2005, THROMB HAEMOSTASIS, V93, P1041, DOI 10.1160/TH04-10-0680	47	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10023	10.1371/journal.pone.0010023	http://dx.doi.org/10.1371/journal.pone.0010023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386594	Green Submitted, Green Published, gold			2022-12-27	WOS:000276420400005
J	Jensen, CJ; Stankovich, J; Van der Walt, A; Bahlo, M; Taylor, BV; van der Mei, IAF; Foote, SJ; Kilpatrick, TJ; Johnson, LJ; Wilkins, E; Field, J; Danoy, P; Brown, MA; Rubio, JP; Butzkueven, H				Jensen, Cathy J.; Stankovich, Jim; Van der Walt, Anneke; Bahlo, Melanie; Taylor, Bruce V.; van der Mei, Ingrid A. F.; Foote, Simon J.; Kilpatrick, Trevor J.; Johnson, Laura J.; Wilkins, Ella; Field, Judith; Danoy, Patrick; Brown, Matthew A.; Rubio, Justin P.; Butzkueven, Helmut		Australian & New Zealand Multiple	Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENES; HLA; AGE; INTERLEUKIN-4; POLYMORPHISMS; DISABILITY; DIAGNOSIS; VARIANTS; HLA-DRB1	Recent association studies in multiple sclerosis (MS) have identified and replicated several single nucleotide polymorphism (SNP) susceptibility loci including CLEC16A, IL2RA, IL7R, RPL5, CD58, CD40 and chromosome 12q13-14 in addition to the well established allele HLA-DR15. There is potential that these genetic susceptibility factors could also modulate MS disease severity, as demonstrated previously for the MS risk allele HLA-DR15. We investigated this hypothesis in a cohort of 1006 well characterised MS patients from South-Eastern Australia. We tested the MS-associated SNPs for association with five measures of disease severity incorporating disability, age of onset, cognition and brain atrophy. We observed trends towards association between the RPL5 risk SNP and time between first demyelinating event and relapse, and between the CD40 risk SNP and symbol digit test score. No associations were significant after correction for multiple testing. We found no evidence for the hypothesis that these new MS disease risk-associated SNPs influence disease severity.	[Jensen, Cathy J.; Johnson, Laura J.; Wilkins, Ella; Field, Judith; Rubio, Justin P.; Butzkueven, Helmut] Howard Florey Inst Expt Physiol & Med, Melbourne, Vic, Australia; [Jensen, Cathy J.] Monash Univ, Dept Physiol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3168, Australia; [Stankovich, Jim; Taylor, Bruce V.; van der Mei, Ingrid A. F.; Foote, Simon J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Van der Walt, Anneke; Butzkueven, Helmut] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Van der Walt, Anneke; Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Van der Walt, Anneke; Butzkueven, Helmut] Box Hill Hosp, Box Hill, Vic, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Brown, Matthew A.] Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Oxford, England	Florey Institute of Neuroscience & Mental Health; Monash University; University of Tasmania; Menzies Institute for Medical Research; Royal Melbourne Hospital; University of Melbourne; Box Hill Hospital; Walter & Eliza Hall Institute; University of Queensland; University of Oxford	Jensen, CJ (corresponding author), Howard Florey Inst Expt Physiol & Med, Melbourne, Vic, Australia.	helmut.butzkueven@florey.edu.au	Foote, Simon J/F-2802-2013; van der Mei, Ingrid/AAI-2566-2020; MOSCATO, PABLO ALBERTO/G-7668-2013; Kermode, Allan/G-3568-2019; Brown, Matthew A/E-5749-2010; Browning, Brian L/A-1178-2010; van der Mei, Ingrid/J-7457-2014; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	van der Mei, Ingrid/0000-0001-9009-7472; Kermode, Allan/0000-0002-4476-4016; Brown, Matthew A/0000-0003-0538-8211; Browning, Brian L/0000-0001-6454-6633; van der Mei, Ingrid/0000-0001-9009-7472; Scott, Rodney/0000-0001-7724-3404; Moscato, Pablo/0000-0003-2570-5966; Foote, Simon/0000-0002-9142-2107; Butzkueven, Helmut/0000-0003-3940-8727; Slee, Mark/0000-0003-4323-2453; Griffiths, Lyn/0000-0002-6774-5475; Stankovich, Jim/0000-0001-9344-7749; RUBIO, JUSTIN/0000-0003-3750-917X; Field, Judith/0000-0002-7089-0999; Lechner-Scott, Jeannette/0000-0002-3850-447X; Bahlo, Melanie/0000-0001-5132-0774; Kilpatrick, Trevor/0000-0003-3999-085X	Peter Doherty Post-doctoral Fellowship (NHMRC); NHMRC Biomedical Career Development Awards; NHMRC Australian Research Training Fellowship; NHMRC Principal Research Fellowship; Multiple Sclerosis Research Australia Fellowship; Monash Departmental Scholarship; Multiple Sclerosis Research Australia; Australia Research Council [LP0776744]	Peter Doherty Post-doctoral Fellowship (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Biomedical Career Development Awards(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australian Research Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia Fellowship; Monash Departmental Scholarship; Multiple Sclerosis Research Australia; Australia Research Council(Australian Research Council)	HB is supported by a Peter Doherty Post-doctoral Fellowship (NHMRC). JPR and MB are supported by NHMRC Biomedical Career Development Awards, IvdM by a NHMRC Australian Research Training Fellowship (Part-Time) and MAB by an NHMRC Principal Research Fellowship. JF is supported by a Multiple Sclerosis Research Australia Fellowship and CJJ is supported by a Monash Departmental Scholarship. This study was supported by Multiple Sclerosis Research Australia (http://www.msaustralia.org.au/msra) and an Australia Research Council (http://www.arc.gov.au/) Linkage Grant (LP0776744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barcellos LF, 2002, BRAIN, V125, P150; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; Butzkueven H, 2008, J CLIN NEUROSCI, V15, P130, DOI 10.1016/j.jocn.2007.02.089; Celius EG, 2000, J NEUROL SCI, V178, P132, DOI 10.1016/S0022-510X(00)00389-0; Fiotti N, 2004, J NEUROIMMUNOL, V152, P147, DOI 10.1016/j.jneuroim.2004.03.009; Hackstein H, 2001, J NEUROIMMUNOL, V113, P240, DOI 10.1016/S0165-5728(00)00455-0; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; HAUSER SL, 2000, NEUROLOGY, V54; Hensiek AE, 2002, J NEUROL NEUROSUR PS, V72, P184, DOI 10.1136/jnnp.72.2.184; Kantarci OH, 2000, J NEUROIMMUNOL, V106, P220, DOI 10.1016/S0165-5728(00)00202-2; Kantarci OH, 2003, J NEUROIMMUNOL, V137, P134, DOI 10.1016/S0165-5728(03)00046-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Mirel DB, 2004, GENES IMMUN, V5, P138, DOI 10.1038/sj.gene.6364048; MIROWSKAGUZEL D, J NEUROIMMU IN PRESS; Nelissen I, 2000, J NEUROIMMUNOL, V105, P58, DOI 10.1016/S0165-5728(00)00189-2; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; PERERA D, 2009, J NEUROIMMUNOL; Ramagopalan SV, 2008, J NEUROL, V255, P1215, DOI 10.1007/s00415-008-0878-7; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; RUBIO JP, 2008, GENES IMMUN; RUNMARKER B, 1994, J NEUROL, V241, P385, DOI 10.1007/BF02033356; Smestad C, 2007, EUR J NEUROL, V14, P835, DOI 10.1111/j.1468-1331.2007.01825.x; STANKOVICH J, 2009, TISSUE ANTIGENS; Suppiah V, 2005, INT J IMMUNOGENET, V32, P383, DOI 10.1111/j.1744-313X.2005.00542.x; THORPE JW, 1994, J NEUROL NEUROSUR PS, V57, P491, DOI 10.1136/jnnp.57.4.491; van der Walt A, 2009, NEUROLOGY, V73, P1018, DOI 10.1212/WNL.0b013e3181b9c85e; VANDERWALT A, 2009, MULT SCLER, V15, pS151; Weatherby SJM, 2001, J NEUROL, V248, P304, DOI 10.1007/s004150170205; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171; Zivadinov R, 2003, J NEUROL, V250, P1099, DOI 10.1007/s00415-003-0164-7	36	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10003	10.1371/journal.pone.0010003	http://dx.doi.org/10.1371/journal.pone.0010003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368992	Green Published, gold, Green Submitted			2022-12-27	WOS:000276419900007
J	Ozaki, Y; Uda, S; Saito, TH; Chung, J; Kubota, H; Kuroda, S				Ozaki, Yu-ichi; Uda, Shinsuke; Saito, Takeshi H.; Chung, Jaehoon; Kubota, Hiroyuki; Kuroda, Shinya			A Quantitative Image Cytometry Technique for Time Series or Population Analyses of Signaling Networks	PLOS ONE			English	Article							NUCLEAR TRANSLOCATION; GROWTH-FACTOR; ERK; DIFFERENTIATION; ACTIVATION; DYNAMICS; KINASES; CASCADE	Background: Modeling of cellular functions on the basis of experimental observation is increasingly common in the field of cellular signaling. However, such modeling requires a large amount of quantitative data of signaling events with high spatio-temporal resolution. A novel technique which allows us to obtain such data is needed for systems biology of cellular signaling. Methodology/Principal Findings: We developed a fully automatable assay technique, termed quantitative image cytometry (QIC), which integrates a quantitative immunostaining technique and a high precision image-processing algorithm for cell identification. With the aid of an automated sample preparation system, this device can quantify protein expression, phosphorylation and localization with subcellular resolution at one-minute intervals. The signaling activities quantified by the assay system showed good correlation with, as well as comparable reproducibility to, western blot analysis. Taking advantage of the high spatio-temporal resolution, we investigated the signaling dynamics of the ERK pathway in PC12 cells. Conclusions/Significance: The QIC technique appears as a highly quantitative and versatile technique, which can be a convenient replacement for the most conventional techniques including western blot, flow cytometry and live cell imaging. Thus, the QIC technique can be a powerful tool for investigating the systems biology of cellular signaling.	[Ozaki, Yu-ichi; Uda, Shinsuke; Saito, Takeshi H.; Chung, Jaehoon; Kubota, Hiroyuki; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Kuroda, Shinya] Univ Tokyo, CREST, Japan Sci & Technol Agcy, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Ozaki, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	oza@bi.s.u-tokyo.ac.jp; skuroda@bi.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [17017005]; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by a grant in-aid for scientific research on priority areas "Systems Genomics" (17017005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and by a grant in-aid from Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SANO M, 1995, BRAIN RES, V688, P213, DOI 10.1016/0006-8993(95)00558-8; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Volmat V, 2001, J CELL SCI, V114, P3433; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	26	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9955	10.1371/journal.pone.0009955	http://dx.doi.org/10.1371/journal.pone.0009955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376360	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200031
J	Fernando, GJP; Chen, XF; Prow, TW; Crichton, ML; Fairmaid, EJ; Roberts, MS; Frazer, IH; Brown, LE; Kendall, MAF				Fernando, Germain J. P.; Chen, Xianfeng; Prow, Tarl W.; Crichton, Michael L.; Fairmaid, Emily J.; Roberts, Michael S.; Frazer, Ian H.; Brown, Lorena E.; Kendall, Mark A. F.			Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model	PLOS ONE			English	Article							EPIDERMAL LANGERHANS CELLS; COATED MICRONEEDLE ARRAYS; PANDEMIC INFLUENZA; DENDRITIC CELLS; GENE DELIVERY; IMMUNIZATION; PATCH; CHALLENGE; INJECTION; PATHOGENS	Background: Over 14 million people die each year from infectious diseases despite extensive vaccine use [1]. The needle and syringe-first invented in 1853-is still the primary delivery device, injecting liquid vaccine into muscle. Vaccines could be far more effective if they were precisely delivered into the narrow layer just beneath the skin surface that contains a much higher density of potent antigen-presenting cells (APCs) essential to generate a protective immune response. We hypothesized that successful vaccination could be achieved this way with far lower antigen doses than required by the needle and syringe. Methodology/Principal Findings: To meet this objective, using a probability-based theoretical analysis for targeting skin APCs, we designed the Nanopatch (TM), which contains an array of densely packed projections (21025/cm(2)) invisible to the human eye (110 mu m in length, tapering to tips with a sharpness of <1000 nm), that are dry-coated with vaccine and applied to the skin for two minutes. Here we show that the Nanopatches deliver a seasonal influenza vaccine (Fluvax (R) 2008) to directly contact thousands of APCs, in excellent agreement with theoretical prediction. By physically targeting vaccine directly to these cells we induced protective levels of functional antibody responses in mice and also protection against an influenza virus challenge that are comparable to the vaccine delivered intramuscularly with the needle and syringe-but with less than 1/100(th) of the delivered antigen. Conclusions/Significance: Our results represent a marked improvement-an order of magnitude greater than reported by others-for injected doses administered by other delivery methods, without reliance on an added adjuvant, and with only a single vaccination. This study provides a proven mathematical/engineering delivery device template for extension into human studies-and we speculate that successful translation of these findings into humans could uniquely assist with problems of vaccine shortages and distribution-together with alleviating fear of the needle and the need for trained practitioners to administer vaccine, e.g., during an influenza pandemic.	[Fernando, Germain J. P.; Chen, Xianfeng; Prow, Tarl W.; Crichton, Michael L.; Kendall, Mark A. F.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Delivery Drugs & Genes Grp D2G2, Brisbane, Qld, Australia; [Roberts, Michael S.] Univ Queensland, Sch Med, Therapeut Res Unit, Brisbane, Qld, Australia; [Frazer, Ian H.; Kendall, Mark A. F.] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Fairmaid, Emily J.; Brown, Lorena E.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Queensland; University of Queensland; University of Queensland; University of Melbourne	Fernando, GJP (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Delivery Drugs & Genes Grp D2G2, Brisbane, Qld, Australia.	m.kendall@uq.edu.au	Kendall, Mark/M-4122-2017; Roberts, Michael S/C-5247-2014; Crichton, Michael/B-5970-2014; Roberts, Michael/F-4289-2010; Fernando, Germain JP/C-3733-2009; Prow, Tarl/AAB-8359-2019; Chen, Xianfeng/O-3359-2019; Roberts, Michael/F-7502-2010; Chen, Xianfeng/D-1709-2010; Prow, Tarl W/A-4764-2010; Frazer, Ian/A-1137-2007	Roberts, Michael S/0000-0003-3894-5301; Crichton, Michael/0000-0002-3683-802X; Roberts, Michael/0000-0002-5837-246X; Fernando, Germain JP/0000-0003-3260-0548; Prow, Tarl/0000-0003-2892-6238; Chen, Xianfeng/0000-0002-3189-2756; Chen, Xianfeng/0000-0002-3189-2756; Prow, Tarl W/0000-0003-2892-6238; Frazer, Ian/0000-0002-8002-4680; Brown, Lorena/0000-0001-9342-909X	National Health and Medical Research Council (Australia) [569726, 456150]; Australian Research Council [DP077464]; Queensland Smart State Scheme	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Queensland Smart State Scheme	National Health and Medical Research Council (Australia) Grants ID# 569726 (MAFK, GJPF, LEB), ID# 456150 (MAFK), Australian Research Council Grant ID# DP077464 (MAFK, MSR) and the Queensland Smart State Scheme funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XF, 2009, J CONTROL RELEASE, V139, P212, DOI 10.1016/j.jconrel.2009.06.029; Coulter A, 1998, VACCINE, V16, P1243, DOI 10.1016/S0264-410X(98)80125-4; Crichton ML, 2010, BIOMATERIALS, V31, P4562, DOI 10.1016/j.biomaterials.2010.02.022; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Doukas AG, 1996, ULTRASOUND MED BIOL, V22, P151, DOI 10.1016/0301-5629(95)02026-8; FALSTIEJENSEN N, 1988, SCAND J CLIN LAB INV, V48, P519, DOI 10.3109/00365518809085767; FERNANDO GJP, 1995, VACCINE, V13, P1460, DOI 10.1016/0264-410X(95)00029-Z; Fernando GJP, 1998, J IMMUNOL, V161, P2421; Food and Drug Administration, 2007, GUID IND CLIN DAT NE; FRIEDMANN PS, 1981, BRIT J DERMATOL, V105, P219, DOI 10.1111/j.1365-2133.1981.tb01209.x; Frolov VG, 2008, INFLUENZA OTHER RESP, V2, P53, DOI 10.1111/j.1750-2659.2008.00040.x; FURTH PA, 1995, HYBRIDOMA, V14, P149, DOI 10.1089/hyb.1995.14.149; Glenn Gregory M, 2003, Expert Rev Vaccines, V2, P253, DOI 10.1586/14760584.2.2.253; Han SW, 2005, BIOCHEM BIOPH RES CO, V332, P633, DOI 10.1016/j.bbrc.2005.04.059; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Kendall M, 2004, J BIOMECH, V37, P1733, DOI 10.1016/j.jbiomech.2004.01.032; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; KOLS A, HPV VACCINES PROMISE; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; KOYAMA Y, 1987, J INVEST DERMATOL, V88, P541, DOI 10.1111/1523-1747.ep12470104; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Laurent PE, 2007, VACCINE, V25, P8833, DOI 10.1016/j.vaccine.2007.10.020; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Mulholland WJ, 2006, J INVEST DERMATOL, V126, P1541, DOI 10.1038/sj.jid.5700290; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; Palache B, 2008, VACCINE, V26, P6232, DOI 10.1016/j.vaccine.2008.07.022; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Reed ML, 2004, P IEEE, V92, P56, DOI 10.1109/JPROC.2003.820542; Seielstad M, 2000, NAT GENET, V26, P131, DOI 10.1038/79829; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Tacket CO, 1999, VACCINE, V17, P2826, DOI 10.1016/S0264-410X(99)00094-8; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049; YU RC, 1994, BRIT J DERMATOL, V131, P843, DOI 10.1111/j.1365-2133.1994.tb08587.x; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	42	127	134	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10266	10.1371/journal.pone.0010266	http://dx.doi.org/10.1371/journal.pone.0010266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422002	Green Accepted, Green Published, gold			2022-12-27	WOS:000276952500018
J	Ballentine, B; Greenberg, R				Ballentine, Barbara; Greenberg, Russell			Common Garden Experiment Reveals Genetic Control of Phenotypic Divergence between Swamp Sparrow Subspecies That Lack Divergence in Neutral Genotypes	PLOS ONE			English	Article							EVOLUTIONARY PROCESSES; BIOLOGICAL DIVERSITY; CONSERVATION; POPULATIONS; DIFFERENTIATION; DIMORPHISM; ADAPTATION; MARKERS; ECOLOGY; PATTERN	Background: Adaptive divergence between populations in the face of strong selection on key traits can lead to morphological divergence between populations without concomitant divergence in neutral DNA. Thus, the practice of identifying genetically distinct populations based on divergence in neutral DNA may lead to a taxonomy that ignores evolutionarily important, rapidly evolving, locally-adapted populations. Providing evidence for a genetic basis of morphological divergence between rapidly evolving populations that lack divergence in selectively neutral DNA will not only inform conservation efforts but also provide insight into the mechanisms of the early processes of speciation. The coastal plain swamp sparrow, a recent colonist of tidal marsh habitat, differs from conspecific populations in a variety of phenotypic traits yet remains undifferentiated in neutral DNA. Methods and Principal Findings: Here we use an experimental approach to demonstrate that phenotypic divergence between ecologically separated populations of swamp sparrows is the result of local adaptation despite the lack of divergence in neutral DNA. We find that morphological ( bill size and plumage coloration) and life history ( reproductive effort) differences observed between wild populations were maintained in laboratory raised individuals suggesting genetic divergence of fitness related traits. Conclusions and Significance: Our results support the hypothesis that phenotypic divergence in swamps sparrows is the result of genetic differentiation, and demonstrate that adaptive traits have evolved more rapidly than neutral DNA in these ecologically divergent populations that may be in the early stages of speciation. Thus, identifying evolutionarily important populations based on divergence in selectively neutral DNA could miss an important level of biodiversity and mislead conservation efforts.	[Ballentine, Barbara] Univ W Georgia, Smithsonian Migratory Bird Ctr, Natl Zool Pk, Carrollton, GA USA; [Greenberg, Russell] Smithsonian Inst, Natl Zool Pk, Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA	Smithsonian Institution; University System of Georgia; University of West Georgia; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Ballentine, B (corresponding author), Univ W Georgia, Smithsonian Migratory Bird Ctr, Natl Zool Pk, Carrollton, GA USA.	bballent@westga.edu			Smithsonian Institution Endowment; Smithsonian Institution; National Zoo; Maryland Ornithological Society	Smithsonian Institution Endowment; Smithsonian Institution(Smithsonian Institution); National Zoo(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Maryland Ornithological Society	Funding for this project was provided to Russell Greenberg through a Smithsonian Institution Endowment Grant. Funding for this project to Barbara Ballentine was provided by the Smithsonian Institution, Friends of the National Zoo and The Maryland Ornithological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1990, SALTMARSH ECOLOGY; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Avise J.C., 2000, PHYLOGEOGRAPHY; BALABAN E, 1988, BEHAVIOUR, V105, P250, DOI 10.1163/156853988X00043; Buerkle CA, 1999, EVOLUTION, V53, P1915, DOI 10.1111/j.1558-5646.1999.tb04572.x; Bulgin NL, 2003, MOL ECOL, V12, P831, DOI 10.1046/j.1365-294X.2003.01774.x; BURTT JEH, 2004, GLOGERS RULE FEATHER, P681; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Endler J.A., 1986, Monographs in Population Biology, pviii; Fallon SM, 2007, CONSERV BIOL, V21, P1186, DOI 10.1111/j.1523-1739.2007.00775.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Grant PR, 2006, BIOL J LINN SOC, V88, P17, DOI 10.1111/j.1095-8312.2006.00595.x; Grapputo A, 1998, MOL ECOL, V7, P1173, DOI 10.1046/j.1365-294x.1998.00441.x; GREENBERG R, 1990, CONDOR, V92, P393, DOI 10.2307/1368236; Greenberg R, 1998, AUK, V115, P706, DOI 10.2307/4089418; GREENBERG R, 1988, J FIELD ORNITHOL, V59, P149; Greenberg Russell, 2006, Studies in Avian Biology, P96; Grenier JL, 2005, EVOLUTION, V59, P1588; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; JAMES FC, 1983, SCIENCE, V221, P184, DOI 10.1126/science.221.4606.184; Leck M. A., 1989, ECOLOGY SOIL SEED BA, P283; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; Malamud-Roam Karl P., 2006, Studies in Avian Biology, P11; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mundy N.I., 2006, BIRD COLORATION; Neigel J. E., 1986, PHYLOGENETIC RELATIO; Olsen B, 2008, OECOLOGIA, V158, P421, DOI 10.1007/s00442-008-1148-1; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; PATTEN MA, 2010, ORNITHOLOGI IN PRESS; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; StatSoft Inc, 2003, STATISTICA DAT AN SO; Winker Kevin, 2007, Ornithological Monographs, V63, P30, DOI 10.1642/0078-6594(2007)63[30:VBTASD]2.0.CO;2; Zink RM, 2007, ANIM CONSERV, V10, P369, DOI 10.1111/j.1469-1795.2007.00125.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	35	35	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10229	10.1371/journal.pone.0010229	http://dx.doi.org/10.1371/journal.pone.0010229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419104	Green Submitted, gold, Green Published			2022-12-27	WOS:000276853800019
J	McCabe, CJ; Goldie, SJ; Fisman, DN				McCabe, Caitlin J.; Goldie, Sue J.; Fisman, David N.			The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERSISTENT MITOCHONDRIAL DYSFUNCTION; ELECTIVE CESAREAN DELIVERY; MONTE-CARLO-SIMULATION; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; GESTATIONAL-AGE; PRETERM INFANTS; VIRAL LOAD; ADHERENCE	Background: In HIV-infected pregnant women, viral suppression prevents mother-to-child HIV transmission. Directly observed highly-active antiretroviral therapy (HAART) enhances virological suppression, and could prevent transmission. Our objective was to project the effectiveness and cost-effectiveness of directly observed administration of antiretroviral drugs in pregnancy. Methods and Findings: A mathematical model was created to simulate cohorts of one million asymptomatic HIV-infected pregnant women on HAART, with women randomly assigned self-administered or directly observed antiretroviral therapy (DOT), or no HAART, in a series of Monte Carlo simulations. Our primary outcome was the quality-adjusted life expectancy in years (QALY) of infants born to HIV-infected women, with the rates of Caesarean section and HIV-transmission after DOT use as intermediate outcomes. Both self-administered HAART and DOT were associated with decreased costs and increased life-expectancy relative to no HAART. The use of DOT was associated with a relative risk of HIV transmission of 0.39 relative to conventional HAART; was highly cost-effective in the cohort as a whole (cost-utility ratio $14,233 per QALY); and was cost-saving in women whose viral loads on self-administered HAART would have exceeded 1000 copies/ml. Results were stable in wide-ranging sensitivity analyses, with directly observed therapy cost-saving or highly cost-effective in almost all cases. Conclusions: Based on the best available data, programs that optimize adherence to HAART through direct observation in pregnancy have the potential to diminish mother-to-child HIV transmission in a highly cost-effective manner. Targeted use of DOT in pregnant women with high viral loads, who could otherwise receive self-administered HAART would be a cost-saving intervention. These projections should be tested with randomized clinical trials.	[McCabe, Caitlin J.; Fisman, David N.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Goldie, Sue J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Fisman, David N.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University of Toronto	McCabe, CJ (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	david.fisman@gmail.com			Ontario Ministry of Research and Innovation	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	Dr. Fisman is supported by an Early Researcher Award of the Ontario Ministry of Research and Innovation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Ades AE, 2000, PHARMACOECONOMICS, V18, P9, DOI 10.2165/00019053-200018010-00002; Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; [Anonymous], 2009, CHOOS INT AR COST EF; Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Bulterys M, 2000, J ACQ IMMUN DEF SYND, V25, P261, DOI 10.1097/00126334-200011010-00009; *BUR LAB STAT, 2009, PRIC LIV COND; Burdge DR, 2003, CAN MED ASSOC J, V168, P1683; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; *CDCP, 2009, VITALSTATS; *CDCP, 2009, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P285; Chen KT, 2001, OBSTET GYNECOL, V97, P161, DOI 10.1016/S0029-7844(00)01107-8; Chesney MA, 1999, AIDS, V13, pS271; Clumeck N, 2003, AIDS, V17, pS3, DOI 10.1097/01.aids.0000060397.18106.12; COHEN H, 2003, 2003 DRUG TOPICS RED; Dabis F, 2004, JAIDS-J ACQ IMM DEF, V35, P167, DOI 10.1097/00126334-200402010-00011; De Jose MI, 2001, ARCH INTERN MED, V161, P2738, DOI 10.1001/archinte.161.22.2738; de Kleine MJK, 2003, ARCH DIS CHILD, V88, P870, DOI 10.1136/adc.88.10.870; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DeHovitz JA, 2000, J INFECT DIS, V182, P1527, DOI 10.1086/315875; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Gilbert WM, 2003, OBSTET GYNECOL, V102, P488, DOI 10.1016/S0029-7844(03)00617-3; Granados JMS, 2003, PEDIATR INFECT DIS J, V22, P863, DOI 10.1097/01.inf.0000091282.70253.5f; Halpern EF, 2000, MED DECIS MAKING, V20, P314, DOI 10.1177/0272989X0002000308; Halpern MT, 2000, AIDS, V14, P691, DOI 10.1097/00002030-200004140-00008; Havens PL, 1997, PEDIATR INFECT DIS J, V16, P607, DOI 10.1097/00006454-199706000-00012; Holmgren PA, 2001, ACTA OBSTET GYN SCAN, V80, P525, DOI 10.1034/j.1600-0412.2001.080006525.x; Immergluck LC, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e54; Ioannidis JPA, 1999, NEW ENGL J MED, V341, P1698; Ioannidis JPA, 2001, J INFECT DIS, V183, P539, DOI 10.1086/318530; John-Stewart G, 2004, JAIDS-J ACQ IMM DEF, V35, P196, DOI 10.1097/00126334-200402010-00015; Khanlou H, 2003, JAIDS-J ACQ IMM DEF, V33, P651, DOI 10.1097/00126334-200308150-00017; Kirkland LR, 2002, CLIN INFECT DIS, V34, P511, DOI 10.1086/338400; Laine C, 2000, OBSTET GYNECOL, V95, P167, DOI 10.1016/S0029-7844(99)00523-2; Lanzafame M, 2000, J ACQ IMMUN DEF SYND, V25, P200, DOI 10.1097/00126334-200010010-00018; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Lipshultz SE, 2002, LANCET, V360, P368, DOI 10.1016/S0140-6736(02)09607-1; Lucas GM, 2002, AIDS PATIENT CARE ST, V16, P527, DOI 10.1089/108729102761041083; Macalino GE, 2007, AIDS, V21, P1473, DOI 10.1097/QAD.0b013e32811ebf68; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mitty JA, 2002, CLIN INFECT DIS, V34, P984, DOI 10.1086/339447; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mrus JM, 2000, AIDS, V14, P2543, DOI 10.1097/00002030-200011100-00017; Mrus JM, 2002, MED DECIS MAKING, V22, pS38, DOI 10.1177/027298902237710; NEWELL ML, 1994, LANCET, V343, P1464; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; *PER HIV GUID WORK, 2009, REC US ANT DRUGS PRE, P1; Pinkerton SD, 2000, PREV MED, V30, P64, DOI 10.1006/pmed.1999.0601; SANDE M, 2003, ANTIRETROVIRAL THERA, P18; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Selik RM, 2003, PEDIATR INFECT DIS J, V22, P635, DOI 10.1097/00006454-200307000-00013; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Snyder DC, 1999, AM J RESP CRIT CARE, V160, P582, DOI 10.1164/ajrccm.160.2.9901049; Stone VE, 2001, J ACQ IMMUN DEF SYND, V28, P124, DOI 10.1097/00042560-200110010-00003; Tarnow-Mordi W, 2000, ARCH DIS CHILD-FETAL, V82, pF118; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; Turner BJ, 2000, MED CARE, V38, P911, DOI 10.1097/00005650-200009000-00005; Turner BJ, 2000, AM J PUBLIC HEALTH, V90, P85, DOI 10.2105/AJPH.90.1.85; Vollmer B, 2003, PEDIATRICS, V112, P1108, DOI 10.1542/peds.112.5.1108; WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; White BL, 2006, AIDS PATIENT CARE ST, V20, P408, DOI 10.1089/apc.2006.20.408; Wohl AR, 2006, CLIN INFECT DIS, V42, P1619, DOI 10.1086/503906; World Bank, 2009, DAT STAT COUNTR GROU; Zaric GS, 2000, J ACQ IMMUN DEF SYND, V25, P403, DOI 10.1097/00126334-200012150-00004; Zupancic JAF, 2003, PEDIATRICS, V111, P146, DOI 10.1542/peds.111.1.146	80	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10154	10.1371/journal.pone.0010154	http://dx.doi.org/10.1371/journal.pone.0010154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583UV	20405011	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706300010
J	Crum-Cianflone, N; Roediger, MP; Eberly, L; Headd, M; Marconi, V; Ganesan, A; Weintrob, A; Barthel, RV; Fraser, S; Agan, BK				Crum-Cianflone, Nancy; Roediger, Mollie Poehlman; Eberly, Lynn; Headd, Maryam; Marconi, Vincent; Ganesan, Anuradha; Weintrob, Amy; Barthel, R. Vincent; Fraser, Susan; Agan, Brian K.		Infect Dis Clinical Res Program HI	Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; WEIGHT-LOSS; BODY-COMPOSITION; RISK; ERA; OVERWEIGHT; PREDICTORS; HIV/AIDS; SURVIVAL	Background: The prevalence and factors associated with overweight/obesity among human immunodeficiency virus (HIV)-infected persons are unknown. Methods: We evaluated prospective data from a U. S. Military HIV Natural History Study (1985-2004) consisting of early diagnosed patients. Statistics included multivariate linear regression and longitudinal linear mixed effects models. Results: Of 1682 patients, 2% were underweight, 37% were overweight, and 9% were obese at HIV diagnosis. Multivariate predictors of a higher body mass index (BMI) at diagnosis included more recent year of HIV diagnosis, older age, African American race, and earlier HIV stage (all p < 0.05). The majority of patients (62%) gained weight during HIV infection. Multivariate factors associated with a greater increase in BMI during HIV infection included more recent year of diagnosis, lower BMI at diagnosis, higher CD4 count, lower HIV RNA level, lack of AIDS diagnosis, and longer HIV duration (all p < 0.05). Nucleoside agents were associated with less weight gain; other drug classes had no significant impact on weight change in the HAART era. Conclusions: HIV-infected patients are increasingly overweight/obese at diagnosis and during HIV infection. Weight gain appears to reflect improved health status and mirror trends in the general population. Weight management programs may be important components of HIV care.	[Crum-Cianflone, Nancy; Roediger, Mollie Poehlman; Eberly, Lynn; Marconi, Vincent; Ganesan, Anuradha; Weintrob, Amy; Barthel, R. Vincent; Fraser, Susan; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Crum-Cianflone, Nancy] USN, Infect Dis Clin, San Diego Med Ctr, San Diego, CA 92152 USA; [Crum-Cianflone, Nancy; Headd, Maryam] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Roediger, Mollie Poehlman; Eberly, Lynn] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Marconi, Vincent] San Antonio Mil Med Ctr, Infect Dis Clin, San Antonio, TX USA; [Ganesan, Anuradha] Natl Naval Med Ctr, Infect Dis Clin, Bethesda, MD USA; [Weintrob, Amy] Walter Reed Army Med Ctr, Infect Dis Clin, Washington, DC 20307 USA; [Barthel, R. Vincent] USN, Med Ctr Portsmouth, Infect Dis Clin, Portsmouth, VA USA; [Fraser, Susan] Tripler Med Ctr, Infect Dis Clin, Honolulu, HI USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Navy; California State University System; San Diego State University; University of Minnesota System; University of Minnesota Twin Cities; San Antonio Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy	Crum-Cianflone, N (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	nancy.crum@med.navy.mil	Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/N-3210-2014	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Agan, Brian/0000-0002-5114-1669; Eberly, Lynn/0000-0003-4763-330X	Infectious Disease Clinical Research Program (IDCRP); Department of Defense (DoD); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP); Department of Defense (DoD)(United States Department of Defense); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; [Anonymous], 1995, PHYS STAT US INT ANT; Blanck H. M., 2006, Morbidity and Mortality Weekly Report, V55, P985; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bray RM, 2005, DEP DEFENSE SURVEY H; Campa A, 2005, CLIN INFECT DIS, V41, P1179, DOI 10.1086/444499; Crum-Cianflone N, 2008, AIDS PATIENT CARE ST, V22, P925, DOI 10.1089/apc.2008.0082; Dube MP, 2000, CLIN INFECT DIS, V31, P1467, DOI 10.1086/317491; Duran ACFL, 2008, J HUM NUTR DIET, V21, P346, DOI 10.1111/j.1365-277X.2008.00886.x; Ferrando SJ, 2005, AIDS PATIENT CARE ST, V19, P216, DOI 10.1089/apc.2005.19.216; Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Forrester JE, 2001, PUBLIC HEALTH NUTR, V4, P743, DOI 10.1079/PHN200099; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Hendricks KM, 2006, J AM COLL NUTR, V25, P321, DOI 10.1080/07315724.2006.10719542; Hodgson LM, 2001, AIDS, V15, P2341, DOI 10.1097/00002030-200111230-00024; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jaime PC, 2006, REV SAUDE PUBL, V40, P634, DOI 10.1590/S0034-89102006000500012; Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005; McDermott AY, 2005, CLIN INFECT DIS, V41, P1662, DOI 10.1086/498022; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V21, P401; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PALENICEK JP, 1995, J ACQ IMMUN DEF SYND, V10, P366; Parikh NI, 2007, AM J MED, V120, P242, DOI 10.1016/j.amjmed.2006.06.004; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; REDFIELD RR, 1986, NEW ENGL J MED, V314, P131, DOI 10.1056/NEJM198601093140232; Shevitz AH, 2001, CLIN INFECT DIS, V32, P1769, DOI 10.1086/320761; Shikuma CM, 2004, CLIN INFECT DIS, V39, P1223, DOI 10.1086/424665; Shor-Posner G, 2000, J ACQ IMMUN DEF SYND, V23, P81; Smit E, 2002, AM J EPIDEMIOL, V156, P211, DOI 10.1093/aje/kwf039; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Tang AM, 2005, JAIDS-J ACQ IMM DEF, V40, P70, DOI 10.1097/01.qai.0000159627.54149.2e; Wanke CA, 2000, CLIN INFECT DIS, V31, P803, DOI 10.1086/314027; Wheeler DA, 1998, J ACQ IMMUN DEF SYND, V18, P80, DOI 10.1097/00042560-199805010-00012; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	40	160	163	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10106	10.1371/journal.pone.0010106	http://dx.doi.org/10.1371/journal.pone.0010106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20419086	Green Published, gold, Green Submitted			2022-12-27	WOS:000276482100019
J	Oh, CD; Maity, SN; Lu, JF; Zhang, JX; Liang, SD; Coustry, F; de Crombrugghe, B; Yasuda, H				Oh, Chun-do; Maity, Sankar N.; Lu, Jing-Fang; Zhang, Jiexin; Liang, Shoudan; Coustry, Francoise; de Crombrugghe, Benoit; Yasuda, Hideyo			Identification of SOX9 Interaction Sites in the Genome of Chondrocytes	PLOS ONE			English	Article							PRO-ALPHA-1(II) COLLAGEN GENE; SEX DETERMINATION; TRANSGENIC MICE; BONE-FORMATION; ENDOCHONDRAL OSSIFICATION; CAMPOMELIC DYSPLASIA; SKELETAL DEVELOPMENT; PARATHYROID-HORMONE; SONIC-HEDGEHOG; RETINOIC ACID	Background: Our previous work has provided strong evidence that the transcription factor SOX9 is completely needed for chondrogenic differentiation and cartilage formation acting as a "master switch" in this differentiation. Heterozygous mutations in SOX9 cause campomelic dysplasia, a severe skeletal dysmorphology syndrome in humans characterized by a generalized hypoplasia of endochondral bones. To obtain insights into the logic used by SOX9 to control a network of target genes in chondrocytes, we performed a ChIP-on-chip experiment using SOX9 antibodies. Methodology/Principal Findings: The ChIP DNA was hybridized to a microarray, which covered 80 genes, many of which are involved in chondrocyte differentiation. Hybridization peaks were detected in a series of cartilage extracellular matrix (ECM) genes including Col2a1, Col11a2, Aggrecan and Cdrap as well as in genes for specific transcription factors and signaling molecules. Our results also showed SOX9 interaction sites in genes that code for proteins that enhance the transcriptional activity of SOX9. Interestingly, a strong SOX9 signal was also observed in genes such as Col1a1 and Osx, whose expression is strongly down regulated in chondrocytes but is high in osteoblasts. In the Col2a1 gene, in addition to an interaction site on a previously identified enhancer in intron 1, another strong interaction site was seen in intron 6. This site is free of nucleosomes specifically in chondrocytes suggesting an important role of this site on Col2a1 transcription regulation by SOX9. Conclusions/Significance: Our results provide a broad understanding of the strategies used by a "master" transcription factor of differentiation in control of the genetic program of chondrocytes.	[Oh, Chun-do; Maity, Sankar N.; Lu, Jing-Fang; Coustry, Francoise; de Crombrugghe, Benoit; Yasuda, Hideyo] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Zhang, Jiexin; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Oh, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	bdecromb@mdanderson.org; hyasuda@mdanderson.org		Maity, Sankar/0000-0002-2387-6545; Oh, Chundo/0000-0002-5419-8011	NIH [RO1 AR053568]; Arthritis Foundation; NATIONAL CANCER INSTITUTE [K25CA123344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant, RO1 AR053568, (to B. de Crombrugghe) and postdoctoral fellowships from the Arthritis Foundation (to C. Oh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; BAICI A, 1988, ANN RHEUM DIS, V47, P684, DOI 10.1136/ard.47.8.684; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101; Flannery CR, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1925; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Kirsch T, 2002, J BIOL CHEM, V277, P42171, DOI 10.1074/jbc.M207209200; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; Kitagaki J, 2003, OSTEOARTHR CARTILAGE, V11, P36, DOI 10.1053/joca.2002.0863; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; LEE K, 1993, BONE, V14, P341, DOI 10.1016/8756-3282(93)90162-4; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Martel-Pelletier J, 1999, FRONT BIOSCI, V4, pD694; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Naski MC, 1998, DEVELOPMENT, V125, P4977; OLLIVIERRE F, 1986, BIOCHEM BIOPH RES CO, V141, P904, DOI 10.1016/S0006-291X(86)80128-0; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Savage SA, 2007, CANCER EPIDEM BIOMAR, V16, P1667, DOI 10.1158/1055-9965.EPI-07-0214; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103; Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200; ZHOU G, 1995, J CELL SCI, V108, P3677	74	70	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10113	10.1371/journal.pone.0010113	http://dx.doi.org/10.1371/journal.pone.0010113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404928	Green Submitted, gold, Green Published			2022-12-27	WOS:000276482100023
J	Athanasiadou, R; de Sousa, D; Myant, K; Merusi, C; Stancheva, I; Bird, A				Athanasiadou, Rodoniki; de Sousa, Dina; Myant, Kevin; Merusi, Cara; Stancheva, Irina; Bird, Adrian			Targeting of De Novo DNA Methylation Throughout the Oct-4 Gene Regulatory Region in Differentiating Embryonic Stem Cells	PLOS ONE			English	Article							METHYLTRANSFERASES DNMT3A; CPG ISLAND; MAINTENANCE; EXPRESSION; PROMOTER; BINDING; TRANSCRIPTION; LYSINE-9; SITES; LSH	Differentiation of embryonic stem (ES) cells is accompanied by silencing of the Oct-4 gene and de novo DNA methylation of its regulatory region. Previous studies have focused on the requirements for promoter region methylation. We therefore undertook to analyse the progression of DNA methylation of the similar to 2000 base pair regulatory region of Oct-4 in ES cells that are wildtype or deficient for key proteins. We find that de novo methylation is initially seeded at two discrete sites, the proximal enhancer and distal promoter, spreading later to neighboring regions, including the remainder of the promoter. De novo methyltransferases Dnmt3a and Dnmt3b cooperate in the initial targeted stage of de novo methylation. Efficient completion of the pattern requires Dnmt3a and Dnmt1, but not Dnmt3b. Methylation of the Oct-4 promoter depends on the histone H3 lysine 9 methyltransferase G9a, as shown previously, but CpG methylation throughout most of the regulatory region accumulates even in the absence of G9a. Analysis of the Oct-4 regulatory domain as a whole has allowed us to detect targeted de novo methylation and to refine our understanding the roles of key protein components in this process.	[Athanasiadou, Rodoniki; de Sousa, Dina; Myant, Kevin; Merusi, Cara; Stancheva, Irina; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Athanasiadou, R (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Mol Genet, New York, NY 10033 USA.	A.Bird@ed.ac.uk	Stancheva, Irina/B-4461-2014	Stancheva, Irina/0000-0002-5127-5245; myant, kevin/0000-0001-8017-1093; Bird, Adrian/0000-0002-8600-0372	The Wellcome Trust [077224]; Darwin Trust Scholarship [C7215/A8983, C7215/A4399]; Cancer Research UK [8983] Funding Source: researchfish	The Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust Scholarship; Cancer Research UK(Cancer Research UK)	This work was supported by The Wellcome Trust (http://www.wellcome.ac.uk,grant number: 077224) and Cancer Research-UK (http://www.cancerresearchuk.org, grant numbers: C7215/A8983 and C7215/A4399). R. A. was supported by a Darwin Trust Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; GALLAIS R, 2007, MOL ENDOCRINOLOGY ME, P2006; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Sakamoto H, 2007, GENES CELLS, V12, P1123, DOI 10.1111/j.1365-2443.2007.01120.x; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Xi SC, 2009, STEM CELLS, V27, P2691, DOI 10.1002/stem.183; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	51	48	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9937	10.1371/journal.pone.0009937	http://dx.doi.org/10.1371/journal.pone.0009937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376339	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200014
J	O'Connell, J; Lynch, L; Cawood, TJ; Kwasnik, A; Nolan, N; Geoghegan, J; McCormick, A; O'Farrelly, C; O'Shea, D				O'Connell, Jean; Lynch, Lydia; Cawood, Tom J.; Kwasnik, Anna; Nolan, Niamh; Geoghegan, Justin; McCormick, Aiden; O'Farrelly, Cliona; O'Shea, Donal			The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; ENDOCRINE ORGAN; CELL SIZE; EXPRESSION; WOMEN; RISK; INFLAMMATION	Objective: Several studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity. Subjects: Thirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71). Results: There was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9 +/- 10.9 mu m) when compared with metabolically unhealthy patients (100.0 +/- 7.6 mu m, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1 +/- 8.5 mu m versus 107.9 +/- 7.1 mu m). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis. Conclusion: Metabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.	[O'Connell, Jean; Lynch, Lydia; Kwasnik, Anna; O'Shea, Donal] St Vincents Univ Hosp, Obes Res Grp, Educ & Res Ctr, Dublin 4, Ireland; [Cawood, Tom J.] Christchurch Hosp, Dept Endocrinol, Christchurch, New Zealand; [Nolan, Niamh] St Vincents Univ Hosp, Dept Pathol, Dublin 4, Ireland; [Nolan, Niamh; Geoghegan, Justin; O'Shea, Donal] St Columcilles Hosp, Dublin, Ireland; [Geoghegan, Justin] St Vincents Univ Hosp, Dept Surg, Dublin 4, Ireland; [McCormick, Aiden] St Vincents Univ Hosp, Liver Transplant Unit, Dublin 4, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [O'Shea, Donal] St Vincents Univ Hosp, Dept Endocrinol, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital; Christchurch Hospital New Zealand; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin; University College Dublin; Saint Vincent's University Hospital	O'Connell, J (corresponding author), St Vincents Univ Hosp, Obes Res Grp, Educ & Res Ctr, Dublin 4, Ireland.	jeanoco@gmail.com	Lynch, Lydia/ABD-5598-2021	Lynch, Lydia/0000-0002-4273-4681; O'Shea, Donal/0000-0002-1408-5274; O'Farrelly, Cliona/0000-0002-0616-2874; O'Connell, Jean/0000-0001-7241-8025	Irish Health Research Board; Medical Research Charities Group and Diabetes Federation of Ireland	Irish Health Research Board; Medical Research Charities Group and Diabetes Federation of Ireland	This work was supported by a clinical fellowship from the Irish Health Research Board and an award from the Medical Research Charities Group and Diabetes Federation of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES R, 1980, INT J OBESITY, V4, P381; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; ARNER E, DIABETES, V59, P105; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Drolet R, 2009, OBESITY, V17, P424, DOI 10.1038/oby.2008.555; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Imbeault P, 1999, METABOLISM, V48, P355, DOI 10.1016/S0026-0495(99)90085-9; JACOBSSON B, 1972, J LIPID RES, V13, P651; Jensen MD, 1996, METABOLISM, V45, P662, DOI 10.1016/S0026-0495(96)90040-2; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; LONN M, 2009, FASEB J; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Palekar NA, 2006, LIVER INT, V26, P151, DOI 10.1111/j.1478-3231.2005.01209.x; Rasmussen MS, 2006, OBESITY, V14, P28, DOI 10.1038/oby.2006.5; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shen W, 2003, OBES RES, V11, P5, DOI 10.1038/oby.2003.3; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Tchoukalova YD, 2008, AM J CLIN NUTR, V87, P56, DOI 10.1093/ajcn/87.1.56; Tordjman J, 2009, J HEPATOL, V51, P354, DOI 10.1016/j.jhep.2009.02.031; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Votruba SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1823, DOI 10.1152/ajpendo.00601.2006; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Yang X, 2007, DIABETOLOGIA, V50, P1127, DOI 10.1007/s00125-007-0640-1; Yang YK, 2008, CELL PHYSIOL BIOCHEM, V22, P531, DOI 10.1159/000185527; Youssef WI, 2002, BEST PRACT RES CL GA, V16, P733, DOI 10.1053/bega.2002.0334	46	145	146	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9997	10.1371/journal.pone.0009997	http://dx.doi.org/10.1371/journal.pone.0009997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376319	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200062
J	Weiller, D; Martin, R; Dahne, S; Engel, AK; Konig, P				Weiller, Daniel; Maertin, Robert; Daehne, Sven; Engel, Andreas K.; Koenig, Peter			Involving Motor Capabilities in the Formation of Sensory Space Representations	PLOS ONE			English	Article							STATISTICS	A goal of sensory coding is to capture features of sensory input that are behaviorally relevant. Therefore, a generic principle of sensory coding should take into account the motor capabilities of an agent. Up to now, unsupervised learning of sensory representations with respect to generic coding principles has been limited to passively received sensory input. Here we propose an algorithm that reorganizes an agent's representation of sensory space by maximizing the predictability of sensory state transitions given a motor action. We applied the algorithm to the sensory spaces of a number of simple, simulated agents with different motor parameters, moving in two-dimensional mazes. We find that the optimization algorithm generates compact, isotropic representations of space, comparable to hippocampal place fields. As expected, the size and spatial distribution of these place fields-like representations adapt to the motor parameters of the agent as well as to its environment. The representations prove to be well suited as a basis for path planning and navigation. They not only possess a high degree of state-transition predictability, but also are temporally stable. We conclude that the coding principle of predictability is a promising candidate for understanding place field formation as the result of sensorimotor reorganization.	[Weiller, Daniel; Maertin, Robert; Daehne, Sven; Koenig, Peter] Univ Osnabruck, Dept Neurobiopsychol, Inst Cognit Sci, Osnabruck, Germany; [Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Weiller, D (corresponding author), Univ Osnabruck, Dept Neurobiopsychol, Inst Cognit Sci, Osnabruck, Germany.	dweiller@uos.de	Engel, Andreas K/C-7781-2012; König, Peter/ABB-2380-2020; Engel, Andreas K./AAH-6384-2019	Engel, Andreas K/0000-0003-4899-8466; König, Peter/0000-0003-3654-5267; Engel, Andreas K./0000-0003-4899-8466	European Commission [FP7-ICT-2007-1, 217148]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission FP7-ICT-2007-1 (Grant Agreement Number 217148 (PK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Bellman R., 1957, DYNAMIC PROGRAMMING; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; CHRISMAN L, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P183; Creutzig F, 2008, NEURAL COMPUT, V20, P1026, DOI 10.1162/neco.2008.01-07-455; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Franzius M, 2007, PLOS COMPUT BIOL, V3, P1605, DOI 10.1371/journal.pcbi.0030166; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; JAHNE B, 2002, DIGITALE BILDVERARBE; KARVANEN J, 2003, P 4 INT S IND COMP A, P125; Konig P, 2006, BIOL CYBERN, V94, P325, DOI [10.1007/s00422-006-0050-3, 10.1007/S00422-006-0050-3]; Kording KP, 2004, J NEUROPHYSIOL, V91, P206, DOI 10.1152/jn.00149.2003; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; MCCALLUM AK, 1996, P SAB96; McCallum R. A., 1993, P 10 INT C MACH LEAR, P190, DOI DOI 10.1016/B978-1-55860-307-3.50031-9; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MOORE AW, 1991, P IWML 1991; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Reynolds S. I., 2000, P 17 INT C MACH LEAR, P783; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SINGH SP, 1995, 7 NIPS; Sprekeler H, 2007, PLOS COMPUT BIOL, V3, P1136, DOI 10.1371/journal.pcbi.0030112; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; WEILLER D, 2007, UNSUPERVISED LEARNIN; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wyss R, 2006, PLOS BIOL, V4, P836, DOI 10.1371/journal.pbio.0040120	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10377	10.1371/journal.pone.0010377	http://dx.doi.org/10.1371/journal.pone.0010377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442849	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200017
J	Laval, G; Patin, E; Barreiro, LB; Quintana-Murci, L				Laval, Guillaume; Patin, Etienne; Barreiro, Luis B.; Quintana-Murci, Lluis			Formulating a Historical and Demographic Model of Recent Human Evolution Based on Resequencing Data from Noncoding Regions	PLOS ONE			English	Article							ALLELE FREQUENCY-SPECTRUM; MODERN HUMAN COLONIZATION; DNA-SEQUENCE DATA; Y-CHROMOSOME; HUMAN GENOME; MITOCHONDRIAL-DNA; MULTIREGIONAL EVOLUTION; NATURAL-SELECTION; GENETIC-EVIDENCE; LINKAGE DISEQUILIBRIUM	Background: Estimating the historical and demographic parameters that characterize modern human populations is a fundamental part of reconstructing the recent history of our species. In addition, the development of a model of human evolution that can best explain neutral genetic diversity is required to identify confidently regions of the human genome that have been targeted by natural selection. Methodology/Principal Findings: We have resequenced 20 independent noncoding autosomal regions dispersed throughout the genome in 213 individuals from different continental populations, corresponding to a total of similar to 6 Mb of diploid resequencing data. We used these data to explore and co-estimate an extensive range of historical and demographic parameters with a statistical framework that combines the evaluation of multiple models of human evolution via a best-fit approach, followed by an Approximate Bayesian Computation (ABC) analysis. From a methodological standpoint, evaluating the accuracy of the parameter co-estimation allowed us to identify the most accurate set of statistics to be used for the estimation of each of the different historical and demographic parameters characterizing recent human evolution. Conclusions/Significance: Our results support a model in which modern humans left Africa through a single major dispersal event occurring similar to 60,000 years ago, corresponding to a drastic reduction of similar to 5 times the effective population size of the ancestral African population of similar to 13,800 individuals. Subsequently, the ancestors of modern Europeans and East Asians diverged much later, similar to 22,500 years ago, from the population of ancestral migrants. This late diversification of Eurasians after the African exodus points to the occurrence of a long maturation phase in which the ancestral Eurasian population was not yet diversified.	[Laval, Guillaume; Patin, Etienne; Barreiro, Luis B.; Quintana-Murci, Lluis] Inst Pasteur, Paris, France; [Laval, Guillaume; Quintana-Murci, Lluis] Ctr Natl Rech Sci, URA3012, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Laval, G (corresponding author), Inst Pasteur, Paris, France.	quintana@pasteur.fr	Patin, Etienne/G-6768-2012; Quintana-Murci, Lluis/AAB-7468-2022; Barreiro, Luis/I-7772-2015	Patin, Etienne/0000-0002-9911-4459; Barreiro, Luis/0000-0001-9456-367X; Quintana-Murci, Lluis/0000-0003-2429-6320	Institut Pasteur; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) [ANR-05-JCJC-0124-01]; 'Fundacao para a Ciencia e a Tecnologia' [SFRH/BD/18580/2004]; "Fondation pour la Recherche Medicale" (FRM)	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); 'Fundacao para a Ciencia e a Tecnologia'(Portuguese Foundation for Science and TechnologyEuropean Commission); "Fondation pour la Recherche Medicale" (FRM)(Fondation pour la Recherche Medicale)	Financial support was provided by Institut Pasteur, by the Centre National de la Recherche Scientifique (CNRS), and by the Agence Nationale de la Recherche (ANR) research grant (ANR-05-JCJC-0124-01) to L. Q.-M. L. B. B. was supported by a 'Fundacao para a Ciencia e a Tecnologia' fellowship (SFRH/BD/18580/2004), and E.P. by the "Fondation pour la Recherche Medicale" (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken Martin Jim, 1993, ORIGIN MODERN HUMANS; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Beaumont MA, 2004, HEREDITY, V92, P365, DOI 10.1038/sj.hdy.6800447; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2002, GENETICS, V162, P2025; Blum MGB, 2007, GENETICS, V176, P1741, DOI 10.1534/genetics.106.066233; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chaix R, 2004, AM J HUM GENET, V75, P1113, DOI 10.1086/425938; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; ECKHARDT RB, 1993, SCIENCE, V262, P973, DOI 10.1126/science.262.5136.973-b; Eswaran V, 2005, J HUM EVOL, V49, P1, DOI 10.1016/j.jhevol.2005.02.006; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; EXCOFFIER L, 1992, GENETICS, V131, P491; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fay JC, 2000, GENETICS, V155, P1405; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, MOL BIOL EVOL, V14, P195, DOI 10.1093/oxfordjournals.molbev.a025753; Fu YX, 1997, GENETICS, V147, P915; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; GRIFFITHS RC, 1994, THEOR POPUL BIOL, V46, P131, DOI 10.1006/tpbi.1994.1023; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HAWKS J, 2006, PALEOANTHROPOLOGY, P101; Jin L, 2000, ANN HUM GENET, V64, P117, DOI 10.1017/S0003480000008034; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Marth G, 2003, P NATL ACAD SCI USA, V100, P376, DOI 10.1073/pnas.222673099; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mellars P, 2007, P NATL ACAD SCI USA, V104, P3657, DOI 10.1073/pnas.0608053104; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Pluzhnikov A, 2002, GENETICS, V161, P1209; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; STRINGER CB, 1990, SCI AM, V263, P98, DOI 10.1038/scientificamerican1290-98; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; Tavare S, 1997, GENETICS, V145, P505; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; THORNE AG, 1992, SCI AM, V266, P76, DOI 10.1038/scientificamerican0492-76; THORNE AG, 1993, SCIENCE, V261, P1507, DOI 10.1126/science.8372344; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2008, GENOME RES, V18, P1354, DOI 10.1101/gr.075630.107; Wall JD, 2006, CURR OPIN GENET DEV, V16, P606, DOI 10.1016/j.gde.2006.09.006; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; WILSON AC, 1992, SCI AM, V266, P68; Wolpoff MH, 1996, SCIENCE, V274, P704; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354	85	68	69	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10284	10.1371/journal.pone.0010284	http://dx.doi.org/10.1371/journal.pone.0010284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YT	20421973	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600008
J	Dietrich, N; Lienenklaus, S; Weiss, S; Gekara, NO				Dietrich, Nicole; Lienenklaus, Stefan; Weiss, Siegfried; Gekara, Nelson O.			Murine Toll-Like Receptor 2 Activation Induces Type I Interferon Responses from Endolysosomal Compartments	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; IFN-BETA; GENE INDUCTION; TARGETED DISRUPTION; VIRAL-INFECTION; INNATE IMMUNITY; TLR2; RECOGNITION; EXPRESSION; MACROPHAGES	Background: Toll-like receptors (TLRs) are among the first-line sentinels for immune detection and responsiveness to pathogens. The TLR2 subfamily of TLRs (TLR1, TLR2, TLR6) form heterodimers with each other and are thus able to recognize a broad range of components from several microbes such as yeast, Gram-positive bacteria and protozoa. Until now, TLR2 activation by bacterial ligands has long been associated with pro-inflammatory cytokines but not type I interferon responses. Methodology/Principal Findings: Using a variety of transgenic mice, here we provide in vivo and in vitro data showing that TLR2 activation does in fact induce interferon-beta and that this occurs via MyD88-IRF1 and -IRF7 pathways. Interestingly, by microscopy we demonstrate that although a cell surface receptor, TLR2 dependent induction of type I interferons occurs in endolysosomal compartments where it is translocated to upon ligand engagement. Furthermore, we could show that blocking receptor internalization or endolysosomal acidification inhibits the ability of TLR2 to trigger the induction type I interferon but not pro-inflammatory responses. Conclusion/Significance: The results indicate that TLR2 activation induces pro-inflammatory and type I interferon responses from distinct subcellular sites: the plasma membrane and endolysosomal compartments respectively. Apart from identifying and characterizing a novel pathway for induction of type I interferons, the present study offers new insights into how TLR signaling discriminates and regulates the nature of responses to be elicited against extracellular and endocytosed microbes. These findings may also have clinical implication. Excessive production of pro-inflammatory cytokines and type I IFNs following activation of TLRs is a central pathologic event in several hyper-inflammatory conditions. The discovery that the induction of pro-inflammatory and type I IFN responses can be uncoupled through pharmacological manipulation of endolysosomal acidification suggests new avenues for potential therapeutic intervention against inflammations and sepsis.	[Dietrich, Nicole; Lienenklaus, Stefan; Weiss, Siegfried; Gekara, Nelson O.] Helmholtz Ctr Infect Res, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Dietrich, N (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	nelson.gekara@gmail.com	Gekara, Nelson/P-9208-2019; Gekara, Nelson/AAG-7944-2020; Lienenklaus, Stefan/HIK-0899-2022	Lienenklaus, Stefan/0000-0003-4790-3445; Gekara, Nelson O./0000-0002-1269-8288	German Research Council (DFG) [SFB 566]; Kultusministerium of Niedersachsen via the Lichtenberg PhD program; centre for infection biology (ZIB) [VH-KO-106]; Helmholtz International Research School for Infection Biology (HIRSIB); German Federal Ministry of Education and Research (BMBF)	German Research Council (DFG)(German Research Foundation (DFG)); Kultusministerium of Niedersachsen via the Lichtenberg PhD program; centre for infection biology (ZIB); Helmholtz International Research School for Infection Biology (HIRSIB); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported in part by the German Research Council (DFG) via SFB 566, the Kultusministerium of Niedersachsen via the Lichtenberg PhD program, the centre for infection biology (ZIB) via contract number VH-KO-106, the Helmholtz International Research School for Infection Biology (HIRSIB) and the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Cole BC, 2005, INFECT IMMUN, V73, P6039, DOI 10.1128/IAI.73.9.6039-6047.2005; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	47	117	119	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10250	10.1371/journal.pone.0010250	http://dx.doi.org/10.1371/journal.pone.0010250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422028	Green Published, Green Submitted, gold			2022-12-27	WOS:000276854300013
J	Mohapatra, SK; Guri, AJ; Climent, M; Vives, C; Carbo, A; Horne, WT; Hontecillas, R; Bassaganya-Riera, J				Mohapatra, Saroj K.; Guri, Amir J.; Climent, Montse; Vives, Cristina; Carbo, Adria; Horne, William T.; Hontecillas, Raquel; Bassaganya-Riera, Josep			Immunoregulatory Actions of Epithelial Cell PPAR gamma at the Colonic Mucosa of Mice with Experimental Inflammatory Bowel Disease	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; COLITIS; ROSIGLITAZONE; PROTECTION; MODELS	Background: Peroxisome proliferator-activated receptors are nuclear receptors highly expressed in intestinal epithelial cells (IEC) and immune cells within the gut mucosa and are implicated in modulating inflammation and immune responses. The objective of this study was to investigate the effect of targeted deletion of PPAR gamma in IEC on progression of experimental inflammatory bowel disease (IBD). Methodology/Principal Findings: In the first phase, PPAR gamma flfl; Villin Cre- (VC-) and PPAR gamma flfl; Villin Cre+ (VC+) mice in a mixed FVB/C57BL/6 background were challenged with 2.5% dextran sodium sulfate (DSS) in drinking water for 0, 2, or 7 days. VC+ mice express a transgenic recombinase under the control of the Villin-Cre promoter that causes an IEC-specific deletion of PPAR gamma. In the second phase, we generated VC- and VC+ mice in a C57BL/6 background that were challenged with 2.5% DSS. Mice were scored on disease severity both clinically and histopathologically. Flow cytometry was used to phenotypically characterize lymphocyte and macrophage populations in blood, spleen and mesenteric lymph nodes. Global gene expression analysis was profiled using Affymetrix microarrays. The IEC-specific deficiency of PPAR gamma in mice with a mixed background worsened colonic inflammatory lesions, but had no effect on disease activity (DAI) or weight loss. In contrast, the IEC-specific PPAR gamma null mice in C57BL/6 background exhibited more severe inflammatory lesions, DAI and weight loss in comparison to their littermates expressing PPAR gamma in IEC. Global gene expression profiling revealed significantly down-regulated expression of lysosomal pathway genes and flow cytometry results demonstrated suppressed production of IL-10 by CD4+ T cells in mesenteric lymph nodes (MLN) of IEC-specific PPAR gamma null mice. Conclusions/Significance: Our results demonstrate that adequate expression of PPAR gamma in IEC is required for the regulation of mucosal immune responses and prevention of experimental IBD, possibly by modulation of lysosomal and antigen presentation pathways.	[Mohapatra, Saroj K.; Guri, Amir J.; Climent, Montse; Vives, Cristina; Carbo, Adria; Horne, William T.; Hontecillas, Raquel; Bassaganya-Riera, Josep] Virginia Polytech Inst & State Univ, Nutr Immunol & Mol Nutr Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Mohapatra, SK (corresponding author), Virginia Polytech Inst & State Univ, Nutr Immunol & Mol Nutr Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu; jbassaga@vt.edu	Climent, Montserrat/K-6490-2019; Vives, Cristina/Y-2136-2019	Climent, Montserrat/0000-0002-9029-7914; Vives, Cristina/0000-0001-7190-4320; Mohapatra, Saroj Kant/0000-0003-4723-5109	Virginia Bioinformatics Institute exploratory	Virginia Bioinformatics Institute exploratory	This research was funded by a Virginia Bioinformatics Institute exploratory grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen L, 2006, MOL CELL ENDOCRINOL, V251, P17, DOI 10.1016/j.mce.2006.02.006; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GURI AJ, 2010, CLIN NUTR IN PRESS; GURI AJ, 2010, BMC GASTROE IN PRESS; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jiang M, 2010, CELL DEATH DIFFER, V17, P469, DOI 10.1038/cdd.2009.148; Jiang M, 2010, AUTOPHAGY, V6, P175, DOI 10.4161/auto.6.1.10700; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Lonnstedt I, 2002, STAT SINICA, V12, P31; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Matsutani T, 2005, CYTOKINE, V30, P168, DOI 10.1016/j.cyto.2004.12.019; OMORAIN C, 1984, GUT, V25, P455, DOI 10.1136/gut.25.5.455; R Core Team, 2020, R LANG ENV STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto-Furusho JK, 2007, WORLD J GASTROENTERO, V13, P5594, DOI 10.3748/wjg.v13.i42.5594; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200	30	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10215	10.1371/journal.pone.0010215	http://dx.doi.org/10.1371/journal.pone.0010215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422041	Green Published, gold, Green Submitted			2022-12-27	WOS:000276854300003
J	Driskell, JD; Zhu, Y; Kirkwood, CD; Zhao, YP; Dluhy, RA; Tripp, RA				Driskell, Jeremy D.; Zhu, Yu; Kirkwood, Carl D.; Zhao, Yiping; Dluhy, Richard A.; Tripp, Ralph A.			Rapid and Sensitive Detection of Rotavirus Molecular Signatures Using Surface Enhanced Raman Spectroscopy	PLOS ONE			English	Article							MULTIVARIATE STATISTICAL TECHNIQUES; TRANSFORM INFRARED-SPECTROSCOPY; OBLIQUE ANGLE DEPOSITION; SCATTERING SERS; IDENTIFICATION; BACTERIA; DISCRIMINATION; CLASSIFICATION; PATHOGENS; VIRUS	Human enteric virus infections range from gastroenteritis to life threatening diseases such as myocarditis and aseptic meningitis. Rotavirus is one of the most common enteric agents and mortality associated with infection can be very significant in developing countries. Most enteric viruses produce diseases that are not distinct from other pathogens, and current diagnostics is limited in breadth and sensitivity required to advance virus detection schemes for disease intervention strategies. A spectroscopic assay based on surface enhanced Raman scattering (SERS) has been developed for rapid and sensitive detection of rotavirus. The SERS method relies on the fabrication of silver nanorod array substrates that are extremely SERS-active allowing for direct structural characterization of viruses. SERS spectra for eight rotavirus strains were analyzed to qualitatively identify rotaviruses and to classify each according to G and P genotype and strain with >96% accuracy, and a quantitative model based on partial least squares regression analysis was evaluated. This novel SERS-based virus detection method shows that SERS can be used to identify spectral fingerprints of human rotaviruses, and suggests that this detection method can be used for pathogen detection central to human health care.	[Driskell, Jeremy D.; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Zhu, Yu; Zhao, Yiping] Univ Georgia, Dept Phys, Athens, GA 30602 USA; [Dluhy, Richard A.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Kirkwood, Carl D.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Enter Virus Grp, Parkville, Vic 3052, Australia	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Driskell, JD (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Zhao, Yiping/A-4968-2008; Tripp, Ralph/F-5218-2011	Zhao, Yiping/0000-0002-3710-4159; Tripp, Ralph/0000-0002-2924-9956; Driskell, Jeremy/0000-0001-5082-898X	U.S. Army Research Laboratory [W911NF-07-0065]; Georgia Research Alliance	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Georgia Research Alliance	This work was supported by the U.S. Army Research Laboratory (http://www.arl.army.mil/www/default.htm) contract number W911NF-07-0065 and the Georgia Research Alliance (http://www.gra.org/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M. J., 2004, CHEMOMETRICS ANAL SP; Alexander TA, 2008, SPECTROSCOPY, V23, P36; Alexander TA, 2008, ANAL CHEM, V80, P2817, DOI 10.1021/ac702464w; Amiali NM, 2007, J MICROBIOL METH, V68, P236, DOI 10.1016/j.mimet.2006.08.010; Bao PD, 2001, J RAMAN SPECTROSC, V32, P227, DOI 10.1002/jrs.665; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beebe K.R., 1998, CHEMOMETRICS PRACTIC, V1st; Bishop R.F., 1994, VIRAL INFECT GASTROI, P131; Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z; COULSON BS, 1987, J CLIN MICROBIOL, V25, P509, DOI 10.1128/JCM.25.3.509-515.1987; DESSELBERGER U, 2000, METHODS MOL MED ROTA, P1; Driskell JD, 2008, IEEE SENS J, V8, P863, DOI 10.1109/JSEN.2008.922682; Driskell JD, 2008, J PHYS CHEM C, V112, P895, DOI 10.1021/jp075288u; Estes M.K., 1996, FIELDS VIROLOGY, P1625; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Golightly RS, 2009, ACS NANO, V3, P2859, DOI 10.1021/nn9013593; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Guicheteau J., 2006, P SPIE, V6218; Harz A, 2009, CYTOM PART A, V75A, P104, DOI 10.1002/cyto.a.20682; Huang WE, 2004, ANAL CHEM, V76, P4452, DOI 10.1021/ac049753k; Hutsebaut D, 2004, ANAL CHEM, V76, P6274, DOI 10.1021/ac049228l; Jarvis RM, 2006, FARADAY DISCUSS, V132, P281, DOI 10.1039/b506413a; Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c; Jarvis RM, 2008, CHEM SOC REV, V37, P931, DOI 10.1039/b705973f; Kalasinsky KS, 2007, ANAL CHEM, V79, P2658, DOI 10.1021/ac0700575; Kirschner C, 2001, J CLIN MICROBIOL, V39, P1763, DOI 10.1128/JCM.39.5.1763-1770.2001; Laucks ML, 2005, APPL SPECTROSC, V59, P1222, DOI 10.1366/000370205774430891; Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003; Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h; Musumarra G, 2004, J CHEMOMETR, V18, P125, DOI 10.1002/cem.846; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patel IS, 2008, J RAMAN SPECTROSC, V39, P1660, DOI 10.1002/jrs.2064; Pearman WF, 2006, APPL SPECTROSC, V60, P356, DOI 10.1366/000370206776593744; Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n; Premasiri WR, 2005, PROC SPIE, V5795, P19, DOI 10.1117/12.605742; Rebuffo CA, 2006, APPL ENVIRON MICROB, V72, P994, DOI 10.1128/AEM.72.2.994-1000.2006; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sengupta A, 2005, APPL SPECTROSC, V59, P1016, DOI 10.1366/0003702054615124; Shah K, 2006, J MED VIROL, V78, P1124, DOI 10.1002/jmv.20672; Shanmukh S, 2008, ANAL BIOANAL CHEM, V390, P1551, DOI 10.1007/s00216-008-1851-0; Shanmukh S, 2006, NANO LETT, V6, P2630, DOI 10.1021/nl061666f	42	67	70	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10222	10.1371/journal.pone.0010222	http://dx.doi.org/10.1371/journal.pone.0010222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419101	Green Published, Green Submitted, gold			2022-12-27	WOS:000276853800013
J	Piekema, C; Rijpkema, M; Fernandez, G; Kessels, RPC				Piekema, Carinne; Rijpkema, Mark; Fernandez, Guillen; Kessels, Roy P. C.			Dissociating the Neural Correlates of Intra-Item and Inter-Item Working-Memory Binding	PLOS ONE			English	Article							SHORT-TERM-MEMORY; MEDIAL TEMPORAL-LOBE; COGNITIVE NEUROSCIENCE; ASSOCIATIVE MEMORY; RECOGNITION MEMORY; HIPPOCAMPUS; SYSTEMS; FMRI; ORGANIZATION; INFORMATION	Background: Integration of information streams into a unitary representation is an important task of our cognitive system. Within working memory, the medial temporal lobe (MTL) has been conceptually linked to the maintenance of bound representations. In a previous fMRI study, we have shown that the MTL is indeed more active during working-memory maintenance of spatial associations as compared to non-spatial associations or single items. There are two explanations for this result, the mere presence of the spatial component activates the MTL, or the MTL is recruited to bind associations between neurally non-overlapping representations. Methodology/Principal Findings: The current fMRI study investigates this issue further by directly comparing intrinsic intra-item binding (object/colour), extrinsic intra-item binding (object/location), and inter-item binding (object/object). The three binding conditions resulted in differential activation of brain regions. Specifically, we show that the MTL is important for establishing extrinsic intra-item associations and inter-item associations, in line with the notion that binding of information processed in different brain regions depends on the MTL. Conclusions/Significance: Our findings indicate that different forms of working-memory binding rely on specific neural structures. In addition, these results extend previous reports indicating that the MTL is implicated in working-memory maintenance, challenging the classic distinction between short-term and long-term memory systems.	[Piekema, Carinne; Rijpkema, Mark; Fernandez, Guillen; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Piekema, Carinne] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Fernandez, Guillen] Radboud Univ Nijmegen, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Geriatr Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Oxford; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Piekema, C (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	r.kessels@donders.ru.nl	Rijpkema, Mark/D-1974-2010; Fernandez, Guillen/B-3771-2009; Kessels, Roy P.C./D-1902-2010	Rijpkema, Mark/0000-0002-8495-4703; Fernandez, Guillen/0000-0002-5522-0604; Kessels, Roy P.C./0000-0001-9500-9793; Kessels, Roy/0000-0002-7107-8900	Brain Foundation of the Netherlands [13F05.03]; Netherlands Organisation for Scientific Research [452-08-005]	Brain Foundation of the Netherlands; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was funded by a grant from the Brain Foundation of the Netherlands (no. 13F05.03) and a VIDI innovational grant from the Netherlands Organisation for Scientific Research (NWO, no. 452-08-005), both awarded to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, NEUROPSYCHOLOGIA, V48, P1089, DOI 10.1016/j.neuropsychologia.2009.12.009; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Ecker UKH, 2007, MEM COGNITION, V35, P1483, DOI 10.3758/BF03193618; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; EICHENBAUM H, 1995, CURR DIR PSYCHOL SCI, V4, P19, DOI 10.1111/1467-8721.ep10770954; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GAZZANIGA MS, 1989, SCIENCE, V245, P947, DOI 10.1126/science.2672334; Gold JJ, 2006, LEARN MEMORY, V13, P644, DOI 10.1101/lm.258406; Heil M, 2003, BEHAV BRAIN SCI, V26, P739, DOI 10.1017/S0140525X0333016X; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Mayes AR, 2004, HIPPOCAMPUS, V14, P763, DOI 10.1002/hipo.10211; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Murphy K, 2004, NEUROIMAGE, V21, P219, DOI 10.1016/j.neuroimage.2003.09.016; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olson IR, 2006, J COGNITIVE NEUROSCI, V18, P1087, DOI 10.1162/jocn.2006.18.7.1087; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; OWEN AM, 1995, NEUROPSYCHOLOGIA, V33, P1, DOI 10.1016/0028-3932(94)00098-A; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Parra MA, 2009, BRAIN, V132, P1057, DOI 10.1093/brain/awp036; Piekema C, 2007, BRAIN RES, V1172, P103, DOI 10.1016/j.brainres.2007.07.066; Piekema C, 2006, NEUROIMAGE, V33, P374, DOI 10.1016/j.neuroimage.2006.06.035; Piekema C, 2009, LEARN MEMORY, V16, P231, DOI 10.1101/lm.1283109; Ranganath C, 2005, TRENDS COGN SCI, V9, P374, DOI 10.1016/j.tics.2005.06.009; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Toni I, 1999, CEREB CORTEX, V9, P35, DOI 10.1093/cercor/9.1.35; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Troyer AK, 2000, CAN J EXP PSYCHOL, V54, P161, DOI 10.1037/h0087338; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yonelinas AP, 1999, J EXP PSYCHOL LEARN, V25, P1415, DOI 10.1037/0278-7393.25.6.1415; Zimmer H.D., 2012, HDB BINDING MEMORY P, P3, DOI [DOI 10.1093/ACPROF:OSO/9780198529675.003.0001, 10.1093/acprof:oso/9780198529675.003.0001]	49	59	59	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10214	10.1371/journal.pone.0010214	http://dx.doi.org/10.1371/journal.pone.0010214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	585UC	20419095	gold, Green Published, Green Submitted			2022-12-27	WOS:000276853800010
J	Morgan, JL; Darling, AE; Eisen, JA				Morgan, Jenna L.; Darling, Aaron E.; Eisen, Jonathan A.			Metagenomic Sequencing of an In Vitro-Simulated Microbial Community	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PHYLOGENETIC CLASSIFICATION; DNA; GENOME; EXTRACTION; SOILS; DIVERSITY; LIBRARIES; INFERENCE; ALIGNMENT	Background: Microbial life dominates the earth, but many species are difficult or even impossible to study under laboratory conditions. Sequencing DNA directly from the environment, a technique commonly referred to as metagenomics, is an important tool for cataloging microbial life. This culture-independent approach involves collecting samples that include microbes in them, extracting DNA from the samples, and sequencing the DNA. A sample may contain many different microorganisms, macroorganisms, and even free-floating environmental DNA. A fundamental challenge in metagenomics has been estimating the abundance of organisms in a sample based on the frequency with which the organism's DNA was observed in reads generated via DNA sequencing. Methodology/Principal Findings: We created mixtures of ten microbial species for which genome sequences are known. Each mixture contained an equal number of cells of each species. We then extracted DNA from the mixtures, sequenced the DNA, and measured the frequency with which genomic regions from each organism was observed in the sequenced DNA. We found that the observed frequency of reads mapping to each organism did not reflect the equal numbers of cells that were known to be included in each mixture. The relative organism abundances varied significantly depending on the DNA extraction and sequencing protocol utilized. Conclusions/Significance: We describe a new data resource for measuring the accuracy of metagenomic binning methods, created by in vitro-simulation of a metagenomic community. Our in vitro simulation can be used to complement previous in silico benchmark studies. In constructing a synthetic community and sequencing its metagenome, we encountered several sources of observation bias that likely affect most metagenomic experiments to date and present challenges for comparative metagenomic studies. DNA preparation methods have a particularly profound effect in our study, implying that samples prepared with different protocols are not suitable for comparative metagenomics.	[Morgan, Jenna L.; Darling, Aaron E.; Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Morgan, Jenna L.; Darling, Aaron E.; Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Morgan, Jenna L.; Eisen, Jonathan A.] Joint Genome Inst, US DOE, Walnut Creek, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Morgan, JL (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Eisen, Jonathan A./H-2706-2019; Darling, Aaron/G-8119-2017	Eisen, Jonathan A./0000-0002-0159-2197; Darling, Aaron/0000-0003-2397-7925; Lang, Jenna/0000-0002-4871-4497	Lawrence Berkeley National Laboratory; Office of Science of the U.S. Department of Energy [DE-AC02-5CH11231]; NSF [DBI-0630765]	Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This project was funded primarily by Laboratory Directed Research and Development Program funds from the Lawrence Berkeley National Laboratory. The work was conducted in part at the U.S. Department of Energy Joint Genome Institute which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-5CH11231. A. Darling was supported by NSF fellowship DBI-0630765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Bertrand H, 2005, J MICROBIOL METH, V62, P1, DOI 10.1016/j.mimet.2005.01.003; Blow N, 2008, NATURE, V453, P687, DOI 10.1038/453687a; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Carrigg C, 2007, APPL MICROBIOL BIOT, V77, P955, DOI 10.1007/s00253-007-1219-y; Chan CKK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-215; Chan CKK, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/513701; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Darling A, 2003, 4 INT C LIN CLUST CL; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Donachie WD, 2001, MOL MICROBIOL, V40, P779, DOI 10.1046/j.1365-2958.2001.02439.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Goffeau A, 1996, YEAST, V12, P1603; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jakobsen JS, 2004, J BACTERIOL, V186, P4361, DOI 10.1128/JB.186.13.4361-4368.2004; Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206; Krsek M, 1999, J MICROBIOL METH, V39, P1, DOI 10.1016/S0167-7012(99)00093-7; Kugelberg E, 2006, P NATL ACAD SCI USA, V103, P17319, DOI 10.1073/pnas.0608309103; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; LANGILLE M, 2010, PLOS ONE IN PRESS; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Palenik B, 2009, ENVIRON MICROBIOL, V11, P349, DOI 10.1111/j.1462-2920.2008.01772.x; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Singh Jagtar, 2009, Biotechnology Journal, V4, P480, DOI 10.1002/biot.200800201; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Temperton B, 2009, ISME J, V3, P792, DOI 10.1038/ismej.2009.32; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Van Burik JAH, 1998, MED MYCOL, V36, P299, DOI 10.1080/02681219880000471; Venkateswaran K, 1998, INT J SYST BACTERIOL, V48, P965, DOI 10.1099/00207713-48-3-965; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	47	152	157	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10209	10.1371/journal.pone.0010209	http://dx.doi.org/10.1371/journal.pone.0010209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419134	Green Published, Green Submitted, gold			2022-12-27	WOS:000276743500016
J	Suarez-Alvarez, B; Rodriguez, RM; Calvanese, V; Blanco-Gelaz, MA; Suhr, ST; Ortega, F; Otero, J; Cibelli, JB; Moore, H; Fraga, MF; Lopez-Larrea, C				Suarez-Alvarez, Beatriz; Rodriguez, Ramon M.; Calvanese, Vincenzo; Blanco-Gelaz, Miguel A.; Suhr, Steve T.; Ortega, Francisco; Otero, Jesus; Cibelli, Jose B.; Moore, Harry; Fraga, Mario F.; Lopez-Larrea, Carlos			Epigenetic Mechanisms Regulate MHC and Antigen Processing Molecules in Human Embryonic and Induced Pluripotent Stem Cells	PLOS ONE			English	Article							CHAIN-RELATED MOLECULES; I-RELATED CHAIN; DIFFERENTIATED DERIVATIVES; DOWN-REGULATION; NKG2D RECEPTOR; APM COMPONENTS; HLA-F; EXPRESSION; LIGANDS; IMMUNOGENICITY	Background: Human embryonic stem cells (hESCs) are an attractive resource for new therapeutic approaches that involve tissue regeneration. hESCs have exhibited low immunogenicity due to low levels of Mayor Histocompatibility Complex (MHC) class-I and absence of MHC class-II expression. Nevertheless, the mechanisms regulating MHC expression in hESCs had not been explored. Methodology/Principal Findings: We analyzed the expression levels of classical and non-classical MHC class-I, MHC class-II molecules, antigen-processing machinery (APM) components and NKG2D ligands (NKG2D-L) in hESCs, induced pluripotent stem cells (iPSCs) and NTera2 (NT2) teratocarcinoma cell line. Epigenetic mechanisms involved in the regulation of these genes were investigated by bisulfite sequencing and chromatin immunoprecipitation (ChIP) assays. We showed that low levels of MHC class-I molecules were associated with absent or reduced expression of the transporter associated with antigen processing 1 (TAP-1) and tapasin (TPN) components in hESCs and iPSCs, which are involved in the transport and load of peptides. Furthermore, lack of beta 2-microglobulin (beta 2m) light chain in these cells limited the expression of MHC class I trimeric molecule on the cell surface. NKG2D ligands (MICA, MICB) were observed in all pluripotent stem cells lines. Epigenetic analysis showed that H3K9me3 repressed the TPN gene in undifferentiated cells whilst HLA-B and beta 2m acquired the H3K4me3 modification during the differentiation to embryoid bodies (EBs). Absence of HLA-DR and HLA-G expression was regulated by DNA methylation. Conclusions/Significance: Our data provide fundamental evidence for the epigenetic control of MHC in hESCs and iPSCs. Reduced MHC class I and class II expression in hESCs and iPSCs can limit their recognition by the immune response against these cells. The knowledge of these mechanisms will further allow the development of strategies to induce tolerance and improve stem cell allograft acceptance.	[Suarez-Alvarez, Beatriz; Blanco-Gelaz, Miguel A.; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain; [Rodriguez, Ramon M.; Suhr, Steve T.; Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci & Physiol, E Lansing, MI 48824 USA; [Ortega, Francisco] Hosp Univ Cent Asturias, Dept Nephrol, Oviedo, Spain; [Rodriguez, Ramon M.; Otero, Jesus] Hosp Univ Cent Asturias, Unidad Coordinac Trasplantes & Terapia Celular, Oviedo, Spain; [Calvanese, Vincenzo; Fraga, Mario F.] Hosp Univ Cent Asturias, IUOPA, Canc Epigenet Lab, Oviedo, Spain; [Calvanese, Vincenzo; Fraga, Mario F.] CSIC, CNB, Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain; [Cibelli, Jose B.] Programa Andaluz Terapia Celular & Med Regenerat, Andalucia, Spain; [Moore, Harry] Univ Sheffield, Western Bank, Ctr Stem Cell Biol, Sheffield, S Yorkshire, England; [Ortega, Francisco; Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez Toledo, Madrid, Spain	Central University Hospital Asturias; Michigan State University; Central University Hospital Asturias; Central University Hospital Asturias; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Sheffield	Suarez-Alvarez, B (corresponding author), Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain.	inmuno@hca.es	Calvanese, Vincenzo/E-1145-2016; Fraga, Mario F/H-7824-2017; Calvanese, Vincenzo/AAO-4311-2020; Otero, Jesus/J-1858-2017; Rodriguez, Ramon Maria/AAF-9376-2019	Calvanese, Vincenzo/0000-0002-7937-1511; Fraga, Mario F/0000-0001-8450-2603; Calvanese, Vincenzo/0000-0002-7937-1511; Otero, Jesus/0000-0003-4097-3846; Rodriguez, Ramon Maria/0000-0002-6770-5123; Lopez-Larrea, Carlos/0000-0001-9988-1730; Cibelli, Jose/0000-0002-2176-3854	Red de Investigacion Renal (REDinREN); Institute Carlos III [PI051707, PI080566]; Fundacion Mutua Madrilena [2007-2009]; MRC [G0801059] Funding Source: UKRI; Medical Research Council [G0801059] Funding Source: researchfish	Red de Investigacion Renal (REDinREN); Institute Carlos III(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Red de Investigacion Renal (REDinREN) grant, FIS PI051707 and PI080566 from Institute Carlos III grants, and Fundacion Mutua Madrilena 2007-2009 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera-Gonzalez S, 2009, J IMMUNOL, V182, P4800, DOI 10.4049/jimmunol.0800713; Apps R, 2008, HUM REPROD, V23, P2535, DOI 10.1093/humrep/den223; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Bubenik J, 2004, INT J ONCOL, V25, P487; Cabrera CM, 2007, CELL BIOL INT, V31, P1072, DOI 10.1016/j.cellbi.2007.03.015; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Chou SD, 2005, INT IMMUNOL, V17, P1483, DOI 10.1093/intimm/dxh326; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frenzel LP, 2009, STEM CELLS, V27, P307, DOI 10.1634/stemcells.2008-0528; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Grinnemo KH, 2008, CELL TISSUE RES, V331, P67, DOI 10.1007/s00441-007-0486-3; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; HUNT JS, 2009, CURR OPIN PHARM 0629; Ishitani A, 2006, J REPROD IMMUNOL, V69, P101, DOI 10.1016/j.jri.2005.10.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koch CA, 2008, STEM CELLS, V26, P89, DOI 10.1634/stemcells.2007-0151; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Lopez-Larrea C, 2008, TRENDS MOL MED, V14, P179, DOI 10.1016/j.molmed.2008.02.004; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Megiorni F, 2005, NEUROSCI LETT, V373, P105, DOI 10.1016/j.neulet.2004.09.070; Menendez L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-43; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Morandi F, 2008, STEM CELLS, V26, P1275, DOI 10.1634/stemcells.2007-0878; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Seliger B, 2008, J IMMUNOTOXICOL, V5, P361, DOI 10.1080/15476910802482870; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Suarez-Alvarez B, 2009, AM J TRANSPLANT, V9, P251, DOI 10.1111/j.1600-6143.2008.02526.x; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van den Elsen PJ, 2001, J REPROD IMMUNOL, V52, P129, DOI 10.1016/S0165-0378(01)00115-2; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yachimovich-Cohen N, 2010, J IMMUNOL, V184, P1300, DOI 10.4049/jimmunol.0804261; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zika E, 2005, CURR OPIN IMMUNOL, V17, P58, DOI 10.1016/j.coi.2004.11.008	51	83	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10192	10.1371/journal.pone.0010192	http://dx.doi.org/10.1371/journal.pone.0010192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419139	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000276743500012
J	Fu, J; Jin, F; Zhang, JR; Fong, K; Bassi, DE; De Cicco, RL; Ramaraju, D; Braunewell, KH; Conti, C; Benavides, F; Klein-Szanto, AJP				Fu, Jian; Jin, Fang; Zhang, Jirong; Fong, Kathryn; Bassi, Daniel E.; De Cicco, Ricardo Lopez; Ramaraju, Divya; Braunewell, Karl-Heinz; Conti, Claudio; Benavides, Fernando; Klein-Szanto, Andres J. P.			VILIP-1 Expression In Vivo Results in Decreased Mouse Skin Keratinocyte Proliferation and Tumor Development	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; VISININ-LIKE PROTEIN-1; TISSUE INHIBITOR; HACAT KERATINOCYTES; DIFFERENTIATION; FAMILY; METALLOPROTEINASE-1; CARCINOGENESIS; PROGRESSION; SUPPRESSES	VILIP-1, a member of the neuronal Ca(2+) sensor protein family, is able to act as a tumor suppressor in carcinoma cells by inhibiting cell proliferation and migration. In order to study the role of VILIP-1 in skin carcinogenesis we generated transgenic mice overexpressing VILIP-1 in epidermis under the control of the bovine keratin K5 promoter (K5-VILIP-1). We studied the susceptibility of FVB wild type and VILIP-1 transgenic mice to chemically mediated carcinogenesis. After 30 weeks of treatment with a two-stage carcinogenesis protocol, all animals showed numerous skin tumors. Nevertheless, K5-VILIP-1 mice showed decreased squamous cell carcinoma (SCC) multiplicity of similar to 49% (p<0.02) with respect to the corresponding SCC multiplicity observed in wild type (WT) mice. In addition, the relative percentage of low-grade cutaneous SCCs grade I (defined by the differentiation pattern according to the Broders grading scale) increased approximately 50% in the K5-VILIP1 mice when compared with SCCs in WT mice. Similar tendency was observed using a complete carcinogenesis protocol for skin carcinogenesis using benzo(a) pyrene (B(a)P). Further studies of tumors and primary epidermal keratinocyte cultures showed that matrix metalloproteinase 9 (MMP-9) levels and cell proliferation decreased in K5-VILIP-1 mice when compared with their wild counterparts. In addition tissue inhibitor of metalloproteinase 1 (TIMP-1) expression was higher in K5-VILIP-1 keratinocytes. These results show that VILIP-1 overexpression decreases the susceptibility to skin carcinogenesis in experimental mouse cancer models, thus supporting its role as a tumor suppressor gene.	[Fu, Jian; Jin, Fang; Zhang, Jirong; Fong, Kathryn; Bassi, Daniel E.; De Cicco, Ricardo Lopez; Ramaraju, Divya; Klein-Szanto, Andres J. P.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Fu, Jian; Bassi, Daniel E.; De Cicco, Ricardo Lopez; Klein-Szanto, Andres J. P.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Braunewell, Karl-Heinz] So Res Inst, Birmingham, AL 35255 USA; [Conti, Claudio; Benavides, Fernando] MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fu, J (corresponding author), Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA.	aj_klein-szanto@fccc.edu		Benavides, Fernando/0000-0003-1275-4320	National Institutes of Health [CA107257, CA06927]; Commonwealth of Pennsylvania; Deutsche Krebshilfe; NATIONAL CANCER INSTITUTE [R01CA107257, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health CA107257, CA06927 and by an appropriation from the Commonwealth of Pennsylvania. K.-H. B. was supported by a grant from Deutsche Krebshilfe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi DE, 2005, CANCER RES, V65, P7310, DOI 10.1158/0008-5472.CAN-05-1213; Boekhoff I, 1997, EUR J CELL BIOL, V72, P151; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Braunewell KH, 1997, NEUROSCI LETT, V234, P139, DOI 10.1016/S0304-3940(97)00696-4; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; CHIBA M, 1991, INVAS METAST, V11, P288; Fu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001698; Gierke P, 2004, BIOCHEM BIOPH RES CO, V323, P38, DOI 10.1016/j.bbrc.2004.08.055; Glick AB, 2005, SEMIN CANCER BIOL, V15, P75, DOI 10.1016/j.semcancer.2004.08.008; Gronning LM, 2000, BIOL REPROD, V62, P1040, DOI 10.1095/biolreprod62.4.1040; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; Junghanel A, 1998, Mund Kiefer Gesichtschir, V2, P250, DOI 10.1007/s100060050069; KLEINSZANTO AJP, 1980, CARCINOGENESIS, V1, P1007, DOI 10.1093/carcin/1.12.1007; Kralisch S, 2006, J ENDOCRINOL, V189, P665, DOI 10.1677/joe.1.06645; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Mahloogi H, 2003, CANCER RES, V63, P4997; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; Mammone T, 1998, SKIN PHARMACOL APPL, V11, P152, DOI 10.1159/000029821; Mitsunaga S, 1997, J CELL BIOCHEM, P81; Papp H, 2003, EXP DERMATOL, V12, P811, DOI 10.1111/j.0906-6705.2003.00097.x; PATSKAN GJ, 1987, CANCER LETT, V34, P121, DOI 10.1016/0304-3835(87)90002-4; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Ree AH, 1996, CLIN EXP METASTAS, V14, P381, DOI 10.1007/BF00123397; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; RUGGERI B, 1992, AM J PATHOL, V140, P1179; Slaga T J, 1980, Curr Probl Dermatol, V10, P193; Slaga T J, 1995, Prog Clin Biol Res, V391, P1; TANAKA K, 1995, CANCER RES, V55, P2927; Tumuluri V, 2002, J ORAL PATHOL MED, V31, P598, DOI 10.1034/j.1600-0714.2002.00042.x; Wickborn C, 2006, MOL CARCINOGEN, V45, P572, DOI 10.1002/mc.20201	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10196	10.1371/journal.pone.0010196	http://dx.doi.org/10.1371/journal.pone.0010196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419170	gold, Green Submitted, Green Published			2022-12-27	WOS:000276707100012
J	Wines-Samuelson, M; Schulte, EC; Smith, MJ; Aoki, C; Liu, XR; Kelleher, RJ; Shen, J				Wines-Samuelson, Mary; Schulte, Eva C.; Smith, Miriam J.; Aoki, Chiye; Liu, Xinran; Kelleher, Raymond J., III; Shen, Jie			Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant Mice	PLOS ONE			English	Article							INDUCED APOPTOTIC NEURODEGENERATION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; ACTIVATION; MEMORY; RESPONSES; KNOCKOUT; CELLS	Presenilins are the major causative genes of familial Alzheimer's disease ( AD). Our previous study has demonstrated essential roles of presenilins in memory and neuronal survival. Here, we explore further how loss of presenilins results in age-related, progressive neurodegeneration in the adult cerebral cortex, where the pathogenesis of AD occurs. To circumvent the requirement of presenilins for embryonic development, we used presenilin conditional double knockout (Psen cDKO) mice, in which presenilin inactivation is restricted temporally and spatially to excitatory neurons of the postnatal forebrain beginning at 4 weeks of age. Increases in the number of degenerating (Fluoro-Jade B+, 7.6-fold) and apoptotic (TUNEL+, 7.4-fold) neurons, which represent similar to 0.1% of all cortical neurons, were first detected at 2 months of age when there is still no significant loss of cortical neurons and volume in Psen cDKO mice. By 4 months of age, significant loss of cortical neurons (similar to 9%) and gliosis was found in Psen cDKO mice. The apoptotic cell death is associated with caspase activation, as shown by increased numbers of cells immunoreactive for active caspases 9 and 3 in the Psen cDKO cortex. The vulnerability of cortical neurons to loss of presenilins is region-specific with cortical neurons in the lateral cortex most susceptible. Compared to the neocortex, the increase in apoptotic cell death and the extent of neurodegeneration are less dramatic in the Psen cDKO hippocampus, possibly in part due to increased neurogenesis in the aging dentate gyrus. Neurodegeneration is also accompanied with mitochondrial defects, as indicated by reduced mitochondrial density and altered mitochondrial size distribution in aging Psen cortical neurons. Together, our findings show that loss of presenilins in cortical neurons causes apoptotic cell death occurring in a very small percentage of neurons, which accumulates over time and leads to substantial loss of cortical neurons in the aging brain. The low occurrence and significant delay of apoptosis among cortical neurons lacking presenilins suggest that loss of presenilins may induce apoptotic neuronal death through disruption of cellular homeostasis rather than direct activation of apoptosis pathways.	[Wines-Samuelson, Mary; Schulte, Eva C.; Smith, Miriam J.; Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA; [Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Liu, Xinran] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kelleher, Raymond J., III] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; New York University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wines-Samuelson, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Shen, Jie/GXH-9449-2022; Schulte, Eva C./AAT-2410-2021; Smith, Miriam/J-4001-2015; Aoki, Chiye/T-9405-2019	Smith, Miriam/0000-0002-3184-0817; Aoki, Chiye/0000-0003-4010-9425; Schulte, Eva Christina/0000-0003-3105-5672	National Institutes of Health [5R01NS41783]; Alzheimer's Association (IIRG); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783, R01NS075346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association (IIRG)(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (5R01NS41783) and the Alzheimer's Association (IIRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Auer RN, 2002, GREENFIELDS NEUROPAT, P233; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Cole-Edwards KK, 2006, J NEUROSCI, V26, P8295, DOI 10.1523/JNEUROSCI.1986-05.2006; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; GRAEBER MB, 2002, GREENFIELDS NEUROPAT, P123; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Handler M, 2000, DEVELOPMENT, V127, P2593; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Olney JW, 2000, APOPTOSIS, V5, P515, DOI 10.1023/A:1009685428847; Olney JW, 2001, MENT RETARD DEV D R, V7, P267, DOI 10.1002/mrdd.1037; Perry G, 1998, NAT MED, V4, P897, DOI 10.1038/nm0898-897; Perry G, 1998, SCIENCE, V282, P1268; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Summers B, 1995, VET NEUROPATHOLOGY; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu G, 2007, NEUROLOGY, V69, P1650, DOI 10.1212/01.wnl.0000296941.06685.22; Yu HK, 2000, GENESIS, V26, P5, DOI 10.1002/(SICI)1526-968X(200001)26:1<5::AID-GENE3>3.0.CO;2-8; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	37	63	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10195	10.1371/journal.pone.0010195	http://dx.doi.org/10.1371/journal.pone.0010195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419112	Green Published, gold, Green Submitted			2022-12-27	WOS:000276707100011
J	Baltgalvis, KA; Greising, SM; Warren, GL; Lowe, DA				Baltgalvis, Kristen A.; Greising, Sarah M.; Warren, Gordon L.; Lowe, Dawn A.			Estrogen Regulates Estrogen Receptors and Antioxidant Gene Expression in Mouse Skeletal Muscle	PLOS ONE			English	Article							MESSENGER-RNA; CONTRACTILE FUNCTION; FEMALE MICE; ER-ALPHA; ESTRADIOL; BETA; OVARIECTOMY; CELLS; RAT; TISSUE	Background: Estrogens are associated with the loss of skeletal muscle strength in women with age. Ovarian hormone removal by ovariectomy in mice leads to a loss of muscle strength, which is reversed with 17 beta-estradiol replacement. Aging is also associated with an increase in antioxidant stress, and estrogens can improve antioxidant status via their interaction with estrogen receptors (ER) to regulate antioxidant gene expression. The purpose of this study was to determine if ER and antioxidant gene expression in skeletal muscle are responsive to changes in circulating estradiol, and if ERs regulate antioxidant gene expression in this tissue. Methodology/Principal Findings: Adult C57BL/6 mice underwent ovariectomies or sham surgeries to remove circulating estrogens. These mice were implanted with placebo or 17 beta-estradiol pellets acutely or chronically. A separate experiment examined mice that received weekly injections of Faslodex to chronically block ERs. Skeletal muscles were analyzed for expression of ER genes and proteins and antioxidant genes. ER alpha was the most abundant, followed by Gper and ER beta in both soleus and EDL muscles. The loss of estrogens through ovariectomy induced ER alpha gene and protein expression in the soleus, EDL, and TA muscles at both the acute and chronic time points. Gpx3 mRNA was also induced both acutely and chronically in all 3 muscles in mice receiving 17 beta-estradiol. When ERs were blocked using Faslodex, Gpx3 mRNA was downregulated in the soleus muscle, but not the EDL and TA muscles. Conclusions/Significance: These data suggest that Gpx3 and ER alpha gene expression are sensitive to circulating estrogens in skeletal muscle. ERs may regulate Gpx3 gene expression in the soleus muscle, but skeletal muscle regulation of Gpx3 via ERs is dependent upon muscle type. Further work is needed to determine the indirect effects of estrogen and ER alpha on Gpx3 expression in skeletal muscle, and their importance in the aging process.	[Baltgalvis, Kristen A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Greising, Sarah M.; Lowe, Dawn A.] Univ Minnesota, Sch Med, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA; [Warren, Gordon L.] Georgia State Univ, Div Phys Therapy, Atlanta, GA 30303 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; Georgia State University	Baltgalvis, KA (corresponding author), Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	baltg001@umn.edu	Warren, Gordon/A-9794-2008	Warren, Gordon/0000-0002-7073-8524; Lowe, Dawn/0000-0002-5784-9289	NIH [R01AG031743]; NATIONAL INSTITUTE ON AGING [R01AG031743, K02AG036827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a grant awarded to Dawn A. Lowe from the NIH (R01AG031743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland R, 2008, STEROIDS, V73, P859, DOI 10.1016/j.steroids.2007.12.027; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Brown M, 2009, AM J PHYSIOL-ENDOC M, V296, pE854, DOI 10.1152/ajpendo.90696.2008; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Deroo BJ, 2004, ENDOCRINOLOGY, V145, P5485, DOI 10.1210/en.2004-0471; Dieli-Conwright CM, 2009, ACTA PHYSIOL, V197, P187, DOI 10.1111/j.1748-1716.2009.01997.x; Enns DL, 2008, ACTA PHYSIOL, V194, P81, DOI 10.1111/j.1748-1716.2008.01861.x; Galluzzo P, 2009, AM J PHYSIOL-CELL PH, V297, pC1249, DOI 10.1152/ajpcell.00188.2009; Gorzek JF, 2007, MED SCI SPORT EXER, V39, P248, DOI 10.1249/01.mss.0000241649.15006.b8; Greising SM, 2009, J GERONTOL A-BIOL, V64, P1071, DOI 10.1093/gerona/glp082; Gustafsson J A, 1984, Prog Clin Biol Res, V142, P261; Hansen PA, 1996, J APPL PHYSIOL, V80, P1605, DOI 10.1152/jappl.1996.80.5.1605; Hertrampf T, 2008, BRIT J PHARMACOL, V153, P1432, DOI 10.1038/sj.bjp.0707664; Isensee J, 2009, ENDOCRINOLOGY, V150, P1722, DOI 10.1210/en.2008-1488; Kamanga-Sollo E, 2008, DOMEST ANIM ENDOCRIN, V35, P254, DOI 10.1016/j.domaniend.2008.06.001; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Lemoine S, 2003, MED SCI SPORT EXER, V35, P439, DOI 10.1249/01.MSS.0000053654.14410.78; Lemoine S, 2002, ACTA PHYSIOL SCAND, V175, P211, DOI 10.1046/j.1365-201X.2002.00992.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundholm L, 2008, J ENDOCRINOL, V196, P547, DOI 10.1677/JOE-07-0277; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; Milanesi L, 2008, J CELL BIOCHEM, V104, P1254, DOI 10.1002/jcb.21706; Milanesi L, 2009, STEROIDS, V74, P489, DOI 10.1016/j.steroids.2009.01.005; Mohamed MK, 2000, EUR J ENDOCRINOL, V142, P307, DOI 10.1530/eje.0.1420307; Moran AL, 2006, J APPL PHYSIOL, V100, P548, DOI 10.1152/japplphysiol.01029.2005; Moran AL, 2007, J APPL PHYSIOL, V102, P1387, DOI 10.1152/japplphysiol.01305.2006; Munoz-Castaneda JR, 2005, EUR J PHARMACOL, V523, P86, DOI 10.1016/j.ejphar.2005.08.056; Ogawa S, 2003, ENDOCRINOLOGY, V144, P230, DOI 10.1210/en.2002-220519; Owman C, 1996, BIOCHEM BIOPH RES CO, V228, P285, DOI 10.1006/bbrc.1996.1654; Papaconstantinou AD, 2000, TOXICOL SCI, V56, P332, DOI 10.1093/toxsci/56.2.332; Pedraza-Alva G, 2009, BIOCHEM BIOPH RES CO, V389, P360, DOI 10.1016/j.bbrc.2009.08.153; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; ROGERS NH, BIOCH BIOPHYS RES CO, V392, P1; Rogers NH, 2009, BIOCHEM BIOPH RES CO, V382, P646, DOI 10.1016/j.bbrc.2009.02.154; Ronkainen PHA, 2009, J APPL PHYSIOL, V107, P25, DOI 10.1152/japplphysiol.91518.2008; Rush JWE, 2003, CLIN BIOCHEM, V36, P345, DOI 10.1016/S0009-9120(03)00039-0; SAARTOK T, 1984, INT J SPORTS MED, V5, P130, DOI 10.1055/s-2008-1025894; Sen CK, 1999, MOL CELL BIOCHEM, V196, P31, DOI 10.1023/A:1006910011048; Sitnick M, 2006, J APPL PHYSIOL, V100, P286, DOI 10.1152/japplphysiol.00869.2005; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; THOMAS A, ACTA PHYSL OXF, V198, P81; Thompson LV, 2009, EXP GERONTOL, V44, P106, DOI 10.1016/j.exger.2008.05.003; Vasconsuelo A, 2008, J ENDOCRINOL, V196, P385, DOI 10.1677/JOE-07-0250; VINA J, 2005, SCI AGING KNOWLEDGE; WADE GN, 1993, AM J PHYSIOL, V265, pR1392, DOI 10.1152/ajpregu.1993.265.6.R1392; Warren GL, 1996, J APPL PHYSIOL, V80, P1660, DOI 10.1152/jappl.1996.80.5.1660; Wiik A, 2003, ACTA PHYSIOL SCAND, V179, P381, DOI 10.1046/j.0001-6772.2003.01186.x; Wiik A, 2005, HISTOCHEM CELL BIOL, V124, P161, DOI 10.1007/s00418-005-0030-z; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x	52	108	112	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10164	10.1371/journal.pone.0010164	http://dx.doi.org/10.1371/journal.pone.0010164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405008	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706300018
J	Jimenez-Guri, E; Udina, F; Colas, JF; Sharpe, J; Padron-Barthe, L; Torres, M; Pujades, C				Jimenez-Guri, Eva; Udina, Frederic; Colas, Jean-Francois; Sharpe, James; Padron-Barthe, Laura; Torres, Miguel; Pujades, Cristina			Clonal Analysis in Mice Underlines the Importance of Rhombomeric Boundaries in Cell Movement Restriction during Hindbrain Segmentation	PLOS ONE			English	Article							CHICK-EMBRYO HINDBRAIN; LINEAGE RESTRICTIONS; ZEBRAFISH; SPECIFICATION; DROSOPHILA	Background: Boundaries that prevent cell movement allow groups of cells to maintain their identity and follow independent developmental trajectories without the need for ongoing instructive signals from surrounding tissues. This is the case of vertebrate rhombomeric boundaries. Analysis in the developing chick hindbrain provided the first evidence that rhombomeres are units of cell lineage. The appearance of morphologically visible rhombomeres requires the segment restricted expression of a series of transcription factors, which position the boundaries and prefigure where morphological boundaries will be established. When the boundaries are established, when the cells are committed to a particular rhombomere and how they are organized within the hindbrain are important questions to our understanding of developmental regionalization. Methodology/Principal Findings: Sophisticated experimental tools with high-resolution analysis have allowed us to explore cell lineage restriction within the hindbrain in mouse embryos. This novel strategy is based on knock-in alleles of ubiquitous expression and allows unrestricted clonal analysis of cell lineage from the two-cell stage to the adult mouse. Combining this analysis with statistical and mathematical tools we show that there is lineage compartmentalization along the anteroposterior axis from very early stages of mouse embryonic development. Conclusions: Our results show that the compartment border coincides with the morphological boundary in the mouse hindbrain. The restriction of the cells to cross rhombomeric boundaries seen in chick is also observed in mouse. We show that the rhombomeric boundaries themselves are involved in cell movement restriction, although an underlying pre-pattern during early embryonic development might influence the way that cell populations organize.	[Jimenez-Guri, Eva; Pujades, Cristina] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Jimenez-Guri, Eva; Pujades, Cristina] PRBB, Barcelona, Spain; [Udina, Frederic] Univ Pompeu Fabra, Dept Econ & Business, Barcelona, Spain; [Sharpe, James] CRG, EMBL, Syst Biol Res Unit, ICREA, Barcelona, Spain; [Padron-Barthe, Laura; Torres, Miguel] CNIC, Madrid, Spain	Pompeu Fabra University; Pompeu Fabra University; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); ICREA; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Jimenez-Guri, E (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.	cristina.pujades@upf.edu	Sharpe, James/L-1150-2014; Padron-Barthe, Laura/G-8897-2015; Sharpe, James/AAB-7948-2019; Torres, Miguel/A-7388-2013; Udina, Frederic/D-6772-2013; Torres, Miguel/CAG-0003-2022; Pujades, Cristina/F-7908-2014; udina, frederic/O-7572-2019	Sharpe, James/0000-0002-1434-9743; Padron-Barthe, Laura/0000-0002-7726-7761; Torres, Miguel/0000-0003-0906-4767; Udina, Frederic/0000-0002-7155-4153; Torres, Miguel/0000-0003-0906-4767; Pujades, Cristina/0000-0001-6423-7451; jimenez-guri, eva/0000-0002-9592-1077	MICINN, Spain [MTM2009-09063, BFU2007-62744/BMC, BFU2009-07010]; MADRICEL [S-SAL-0190-2006]; ICREA Funding Source: Custom; Medical Research Council [MC_U127574434] Funding Source: researchfish; MRC [MC_U127574434] Funding Source: UKRI	MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MADRICEL; ICREA(ICREA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EJG was a recipient of a postdoctoral fellowship Beatriu de Pinos (Generalitat de Catalunya, Spain). The work was funded by MTM2009-09063 to FU, BFU2007-62744/BMC (MICINN, Spain) to JS, MADRICEL S-SAL-0190-2006 (Madrid Regional Government) to MT and BFU2009-07010 (MICINN, Spain) to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Aragon F, 2005, DEV DYNAM, V234, P567, DOI 10.1002/dvdy.20528; Arques CG, 2007, DEVELOPMENT, V134, P3713, DOI 10.1242/dev.02873; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; GUTHRIE S, 1991, J NEUROBIOL, V22, P742, DOI 10.1002/neu.480220709; Hastie T, 2011, GAM GEN ADDITIVE MOD; HASTIE TJ, 1990, GEN ADDITIVE; Kemp HA, 2009, DEV BIOL, V327, P313, DOI 10.1016/j.ydbio.2008.12.010; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; LAWRENCE PA, 1973, NATURE-NEW BIOL, V242, P31, DOI 10.1038/newbio242031a0; LUMSDEN A, 1991, PHILOS T R SOC B, V331, P281, DOI 10.1098/rstb.1991.0017; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; R Core Team, 2020, R LANG ENV STAT COMP; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; WILKINSON DG, 1995, PERSPECT DEV NEUROBI, V3, P29; Wizenmann A, 1997, MOL CELL NEUROSCI, V9, P448, DOI 10.1006/mcne.1997.0642; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	22	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10112	10.1371/journal.pone.0010112	http://dx.doi.org/10.1371/journal.pone.0010112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404937	gold, Green Published, Green Submitted			2022-12-27	WOS:000276705900001
J	Yamamoto, Y; Moore, R; Flavell, RA; Lu, BF; Negishi, M				Yamamoto, Yukio; Moore, Rick; Flavell, Richard A.; Lu, Binfeng; Negishi, Masahiko			Nuclear Receptor CAR Represses TNF alpha-Induced Cell Death by Interacting with the Anti-Apoptotic GADD45B	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CROSS-TALK; LIVER; GENE; ACTIVATION; MICE; METABOLISM; MKK7/JNKK2; INDUCTION	Background: Phenobarbital (PB) is the most well-known among numerous non-genotoxic carcinogens that cause the development of hepatocellular carcinoma (HCC). PB activates nuclear xenobiotic receptor Constitutive Active/Androstane Receptor ( CAR; NR1I3) and this activation is shown to determine PB promotion of HCC in mice. The molecular mechanism of CAR-mediated tumor promotion, however, remains elusive at the present time. Here we have identified Growth Arrest and DNA Damage-inducible 45 beta (GADD45B) as a novel CAR target, through which CAR represses cell death. Methodology/Principal Findings: PB activation of nuclear xenobiotic receptor CAR is found to induce the Gadd45b gene in mouse liver throughout the development of HCC as well as in liver tumors. Given the known function of GADD45B as a factor that represses Mitogen-activated protein Kinase Kinase 7 - c-Jun N-terminal Kinase (MKK7-JNK) pathway-mediated apoptosis, we have now demonstrated that CAR interacts with GADD45B to repress Tumor Necrosis Factor alpha (TNF alpha)-induced JNK1 phosphorylation as well as cell death. Primary hepatocytes, prepared from Car(+/+), Car(-/-), Gadd45b(+/+) and Gadd45b(-/-) mice, were treated with TNF alpha and Actinomycin D to induce phosphorylation of JNK1 and cell death. Co-treatment with the CAR activating ligand TCPOBOP (1,4 bis[2-(3,5-dichloropyridyloxy)]benzene) has resulted in repression of both phosphorylation and cell death in the primary hepatocytes from Car(+/+) but not Car(-/-) mice. Repression by TCPOBOP was not observed in those prepared from Gadd45b(-/-) mice. In vitro protein-protein interaction and phosphorylation assays have revealed that CAR interacts with MKK7 and represses the MKK7-mediated phosphorylation of JNK1. Conclusions/Significance: CAR can form a protein complex with GADD45B, through which CAR represses MKK7-mediated phosphorylation of JNK1. In addition to activating the Gadd45b gene, CAR may repress death of mouse primary hepatocytes by forming a GADD45B complex and repressing MKK7-mediated phosphorylation of JNK1. The present finding that CAR can repress cell death via its interaction with GADD45B provides an insight for further investigations into the CAR-regulated molecular mechanism by which PB promotes development of HCC.	[Yamamoto, Yukio; Moore, Rick; Negishi, Masahiko] Natl Inst Environm Hlth Sci, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC USA; [Flavell, Richard A.] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT USA; [Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yamamoto, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928; Yamamoto, Yukio/0000-0002-8530-0701	National Institutes of Health (NIH); National Institute of Environmental Health [Z01ES71005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, Z01ES071005] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health: Z01ES71005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOLLAHI A, 1991, ONCOGENE, V6, P165; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403; LEIST M, 1994, J IMMUNOL, V153, P1778; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; PITOT HC, 1978, NATURE, V271, P456, DOI 10.1038/271456a0; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; SELVAKUMARAN M, 1994, BLOOD, V84, P1036; Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361	30	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10121	10.1371/journal.pone.0010121	http://dx.doi.org/10.1371/journal.pone.0010121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404936	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000276705900006
J	Jesse, S; Steinacker, P; Lehnert, S; Sdzuj, M; Cepek, L; Tumani, H; Jahn, O; Schmidt, H; Otto, M				Jesse, Sarah; Steinacker, Petra; Lehnert, Stefan; Sdzuj, Martin; Cepek, Lukas; Tumani, Hayrettin; Jahn, Olaf; Schmidt, Holger; Otto, Markus			A Proteomic Approach for the Diagnosis of Bacterial Meningitis	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NORMAL CEREBROSPINAL-FLUID; CREUTZFELDT-JAKOB-DISEASE; FIBRILLARY ACIDIC PROTEIN; BETA-TRACE PROTEIN; ALZHEIMERS-DISEASE; DIFFERENTIAL-DIAGNOSIS; MULTIPLE-SCLEROSIS; MENINGOCOCCAL MENINGITIS; CLINICAL-FEATURES	Background: The discrimination of bacterial meningitis (BM) versus viral meningitis (VM) shapes up as a problem, when laboratory data are not equivocal, in particular, when Gram stain is negative. Methodology/Principal Findings: With the aim to determine reliable marker for bacterial or viral meningitis, we subjected cerebrospinal fluid (CSF) to a quantitative proteomic screening. By using a recently established 2D-DIGE protocol which was adapted to the individual CSF flow, we compared a small set of patients with proven BM and VM. Thereby, we identified six potential biomarkers out of which Prostaglandin-H2 D-isomerase was already described in BM, showing proof of concept. In the subsequent validation phase on a more comprehensive collective of 80 patients, we could validate that in BM high levels of glial fibrillary acidic protein (GFAP) and low levels of soluble amyloid precursor protein alpha/beta (sAPP alpha/beta) are present as possible binding partner of Fibulin-1. Conclusions/Significance: We conclude that our CSF flow-adapted 2D-DIGE protocol is valid especially in comparing samples with high differences in total protein and suppose that GFAP and sAPP alpha/beta have a high potential as additional diagnostic markers for differentiation of BM from VM. In the clinical setting, this might lead to an improved early diagnosis and to an individual therapy.	[Jesse, Sarah; Steinacker, Petra; Lehnert, Stefan; Sdzuj, Martin; Cepek, Lukas; Tumani, Hayrettin; Otto, Markus] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Schmidt, Holger] Univ Goettingen, Dept Neurol, Gottingen, Germany; [Jahn, Olaf] DFG Res Ctr Mol Physiol Brain, Gottingen, Germany; [Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, Gottingen, Germany	Ulm University; University of Gottingen; German Research Foundation (DFG); Max Planck Society	Jesse, S (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	markus.otto@uni-ulm.de	Otto, Markus/F-4304-2015; Jahn, Olaf/AAD-8212-2020	Otto, Markus/0000-0003-4273-4267; Jahn, Olaf/0000-0002-3397-8924	Landesstiftung Baden-Wuerttemberg [P-LS-Prot/42]; European Commission; German Ministry of Science and Technology; German Ministry of Health	Landesstiftung Baden-Wuerttemberg; European Commission(European CommissionEuropean Commission Joint Research Centre); German Ministry of Science and Technology; German Ministry of Health	This project was in part supported by the Landesstiftung Baden-Wuerttemberg (P-LS-Prot/42), the European Commission (cNeupro, NeuroTAS, Anteprion), the German Ministry of Science and Technology and the German Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; BERG B, 1982, SCAND J INFECT DIS, V14, P111, DOI 10.3109/inf.1982.14.issue-2.07; Boving MK, 2009, J CLIN MICROBIOL, V47, P908, DOI 10.1128/JCM.01966-08; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Chakrabarti P, 2009, INDIAN J MED RES, V129, P182; COLL MT, 1994, J INFECTION, V29, P289, DOI 10.1016/S0163-4453(94)91197-5; Cunha BA, 2006, INTENS CARE MED, V32, P1272, DOI 10.1007/s00134-006-0210-x; Deisenhammer F, 2006, EUR J NEUROL, V13, P913, DOI 10.1111/j.1468-1331.2006.01493.x; Del Prete R, 2009, NEW MICROBIOL, V32, P143; FELGENHAUER K, 1985, J NEUROL, V232, P157, DOI 10.1007/BF00313892; HANSSON LO, 1993, SCAND J INFECT DIS, V25, P625, DOI 10.3109/00365549309008552; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; Jesse S, 2009, J ALZHEIMERS DIS, V17, P541, DOI 10.3233/JAD-2009-1075; KARANDANIS D, 1976, SOUTHERN MED J, V69, P449, DOI 10.1097/00007611-197604000-00021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewczuk P, 2008, EUR ARCH PSY CLIN N, V258, P44, DOI 10.1007/s00406-008-5005-3; Linker RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007624; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mattsson N, 2009, MULT SCLER J, V15, P448, DOI 10.1177/1352458508100031; MIQ K, 2001, QUALITATSSTANDARDS M; Naylor R, 2008, CURR ALZHEIMER RES, V5, P533, DOI 10.2174/156720508786898433; Noris-Garcia E, 2008, REV NEUROLOGIA, V47, P394, DOI 10.33588/rn.4708.2008267; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; ONORATO IM, 1980, JAMA-J AM MED ASSOC, V244, P1469; Otto M, 2008, METHODS, V44, P289, DOI 10.1016/j.ymeth.2007.06.012; PARADOWSKI M, 1995, CLIN BIOCHEM, V28, P459, DOI 10.1016/0009-9120(95)00028-8; Pena JA, 1999, REV NEUROLOGIA, V29, P311, DOI 10.33588/rn.2904.99094; POLK DB, 1987, PEDIATR INFECT DIS J, V6, P1040, DOI 10.1097/00006454-198706110-00008; POWERS WJ, 1985, AM J MED, V79, P216, DOI 10.1016/0002-9343(85)90012-9; Rao KSJ, 2006, PROG NEUROBIOL, V78, P364, DOI 10.1016/j.pneurobio.2006.03.004; RASMUSSEN HH, 1992, AGE AGEING, V21, P216, DOI 10.1093/ageing/21.3.216; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Sjogren M, 2001, NEUROSCI LETT, V314, P33, DOI 10.1016/S0304-3940(01)02285-6; Steinacker P, 2009, J NEURAL TRANSM, V116, P1169, DOI 10.1007/s00702-009-0271-4; Storey E, 1999, NEUROPATH APPL NEURO, V25, P81; Tankhiwale S S, 2001, Indian J Med Microbiol, V19, P159; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; Tumani H, 1998, ANN NEUROL, V44, P882, DOI 10.1002/ana.410440606; Tumani H, 1998, NEUROSCI LETT, V242, P5, DOI 10.1016/S0304-3940(98)00021-4; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Weber JR, 2007, J NEUROIMMUNOL, V184, P45, DOI 10.1016/j.jneuroim.2006.11.016; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Zhu H, 2007, J NEUROSCI RES, V85, P2783, DOI 10.1002/jnr.21257	49	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10079	10.1371/journal.pone.0010079	http://dx.doi.org/10.1371/journal.pone.0010079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386697	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482000014
J	Smith-McCune, KK; Shiboski, S; Chirenje, MZ; Magure, T; Tuveson, J; Ma, YF; Da Costa, M; Moscicki, AB; Palefsky, JM; Makunike-Mutasa, R; Chipato, T; van der Straten, A; Sawaya, GF				Smith-McCune, Karen K.; Shiboski, Stephen; Chirenje, Mike Z.; Magure, Tsitsi; Tuveson, Jennifer; Ma, Yifei; Da Costa, Maria; Moscicki, Anna-Barbara; Palefsky, Joel M.; Makunike-Mutasa, Rudo; Chipato, Tsungai; van der Straten, Ariane; Sawaya, George F.			Type-Specific Cervico-Vaginal Human Papillomavirus Infection Increases Risk of HIV Acquisition Independent of Other Sexually Transmitted Infections	PLOS ONE			English	Article							LUBRICANT GEL; WOMEN; CLASSIFICATION; DIAPHRAGM; VACCINE; SYSTEM; HERPES; CELLS	Background: Sexually transmitted infections (STIs) such as herpes simplex virus (HSV)-2 are associated with an increased risk of HIV infection. Human papillomavirus (HPV) is a common STI, but little is know about its role in HIV transmission. The objective of this study was to determine whether cervico-vaginal HPV infection increases the risk of HIV acquisition in women independent of other common STIs. Methods and Findings: This prospective cohort study followed 2040 HIV-negative Zimbabwean women (average age 27 years, range 18-49 years) for a median of 21 months. Participants were tested quarterly for 29 HPV types (with L1 PCR primers) and HIV (antibody testing on blood samples with DNA or RNA PCR confirmation). HIV incidence was 2.7 per 100 woman-years. Baseline HPV prevalence was 24.5%, and the most prevalent HPV types were 58 (5.0%), 16 (4.7%), 70 (2.4%), and 18 (2.3%). In separate regression models adjusting for baseline variables (including age, high risk partner, positive test for STIs, positive HSV-2 serology and condom use), HIV acquisition was associated with having baseline prevalent infection with HPV 58 (aHR 2.13; 95% CI 1.09-4.15) or HPV 70 (aHR 2.68; 95% CI 1.08-6.66). In separate regression models adjusting for both baseline variables and time-dependent variables (including HSV-2 status, incident STIs, new sexual partner and condom use), HIV acquisition was associated with concurrent infection with any non-oncogenic HPV type (aHR 1.70; 95% CI 1.02-2.85), any oncogenic HPV type (aHR 1.96; 95% CI 1.16-3.30), HPV 31 (aHR 4.25; 95% CI 1.81-9.97) or HPV 70 (aHR 3.30; 95% CI 1.50-7.20). Detection of any oncogenic HPV type within the previous 6 months was an independent predictor of HIV acquisition, regardless of whether HPV status at the HIV acquisition visit was included (aHR 1.95; 95% CI 1.19-3.21) or excluded (aHR 1.96; 95% CI 1.02-2.85) from the analysis. Conclusions/Significance: Cervico-vaginal HPV infection was associated with an increased risk of HIV acquisition in women, and specific HPV types were implicated in this association. The observational nature of our study precludes establishment of causation between HPV infection and HIV acquisition. However, given the high prevalence of HPV infection in women, further investigation of the role of HPV in HIV transmission is warranted.	[Smith-McCune, Karen K.; Tuveson, Jennifer; Sawaya, George F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Smith-McCune, Karen K.; Moscicki, Anna-Barbara; Palefsky, Joel M.; Sawaya, George F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Shiboski, Stephen; Sawaya, George F.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Ma, Yifei; Moscicki, Anna-Barbara] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Da Costa, Maria; Palefsky, Joel M.; van der Straten, Ariane] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Chirenje, Mike Z.; Magure, Tsitsi; Makunike-Mutasa, Rudo; Chipato, Tsungai] Univ Zimbabwe, Dept Obstet & Gynecol, Harare, Zimbabwe; [van der Straten, Ariane] RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Zimbabwe; Research Triangle Institute	Smith-McCune, KK (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	kmccune@cc.ucsf.edu	Moscicki, Anna-Barbara/AAP-3806-2021	van der Straten, Ariane/0000-0001-8536-648X	Bill and Melinda Gates Foundation [21082]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding was obtained from the Bill and Melinda Gates Foundation (number 21082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Bjorge T, 2002, BRIT J CANCER, V87, P61, DOI 10.1038/sj.bjc.6600350; Cao YC, 2008, J IMMUNOL, V180, P7681, DOI 10.4049/jimmunol.180.11.7681; Castellsague X, 2007, HPV CERVICAL CANC WO; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; EDWARDS RP, 1995, CANCER-AM CANCER SOC, V76, P1411, DOI 10.1002/1097-0142(19951015)76:8<1411::AID-CNCR2820760817>3.0.CO;2-V; Frazer IH, 2009, VIROLOGY, V384, P410, DOI 10.1016/j.virol.2008.10.004; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Fukuchi E, 2009, SEX TRANSM DIS, V36, P305, DOI 10.1097/OLQ.0b013e318194eb76; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; RAMJEE G, 2008, PLOS ONE, P3; Sawaya GF, 2008, OBSTET GYNECOL, V112, P990, DOI 10.1097/AOG.0b013e318189a8a4; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231	23	77	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10094	10.1371/journal.pone.0010094	http://dx.doi.org/10.1371/journal.pone.0010094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386706	Green Submitted, gold, Green Published			2022-12-27	WOS:000276482000020
J	Csibi, A; Communi, D; Muller, N; Bottari, SP				Csibi, Alfredo; Communi, David; Mueller, Nathalie; Bottari, Serge P.			Angiotensin II Inhibits Insulin-Stimulated GLUT4 Translocation and Akt Activation through Tyrosine Nitration-Dependent Mechanisms	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS; SKELETAL-MUSCLE; METABOLIC SYNDROME; PROTEIN-KINASES; HIGH-RISK; SENSITIVITY; RECEPTOR; PEROXYNITRITE	Angiotensin II (Ang II) plays a major role in the pathogenesis of insulin resistance and diabetes by inhibiting insulin's metabolic and potentiating its trophic effects. Whereas the precise mechanisms involved remain ill-defined, they appear to be associated with and dependent upon increased oxidative stress. We found Ang II to block insulin-dependent GLUT4 translocation in L6 myotubes in an NO- and O-2(center dot-)-dependent fashion suggesting the involvement of peroxynitrite. This hypothesis was confirmed by the ability of Ang II to induce tyrosine nitration of the MAP kinases ERK1/2 and of protein kinase B/Akt (Akt). Tyrosine nitration of ERK1/2 was required for their phosphorylation on Thr and Tyr and their subsequent activation, whereas it completely inhibited Akt phosphorylation on Ser(473) and Thr(308) as well as its activity. The inhibitory effect of nitration on Akt activity was confirmed by the ability of SIN-1 to completely block GSK3 alpha phosphorylation in vitro. Inhibition of nitric oxide synthase and NAD(P)Hoxidase and scavenging of free radicals with myricetin restored insulin-stimulated Akt phosphorylation and GLUT4 translocation in the presence of Ang II. Similar restoration was obtained by inhibiting the ERK activating kinase MEK, indicating that these kinases regulate Akt activation. We found a conserved nitration site of ERK1/2 to be located in their kinase domain on Tyr(156/139), close to their active site Asp(166/149), in agreement with a permissive function of nitration for their activation. Taken together, our data show that Ang II inhibits insulin-mediated GLUT4 translocation in this skeletal muscle model through at least two pathways: first through the transient activation of ERK1/2 which inhibit IRS-1/2 and second through a direct inhibitory nitration of Akt. These observations indicate that not only oxidative but also nitrative stress play a key role in the pathogenesis of insulin resistance. They underline the role of protein nitration as a major mechanism in the regulation of Ang II and insulin signaling pathways and more particularly as a key regulator of protein kinase activity.	[Csibi, Alfredo; Mueller, Nathalie; Bottari, Serge P.] Grenoble Univ, INSERM, Lab Bioenerget Fondamentale & Appliquee, U884, Grenoble, France; [Communi, David] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Bottari, Serge P.] CHU Grenoble, F-38043 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Libre de Bruxelles; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Csibi, A (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Serge.Bottari@ujf-grenoble.fr	Bottari, Serge/ABF-3990-2021	Bottari, Serge P./0000-0002-4172-2400	AGIR	AGIR	This work was partly supported by AGIR a dom, grant: "Nitration and insulin resistance" (www.agiradom.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Barnett AH, 2005, ACTA DIABETOL, V42, pS42, DOI 10.1007/s00592-005-0180-4; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Blendea MC, 2005, AM J PHYSIOL-ENDOC M, V288, pE353, DOI 10.1152/ajpendo.00402.2004; BROVKOVYCH V, 2009, J CELL MOL MED; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Ceriello A, 2004, DIABETOLOGIA, V47, P1535, DOI 10.1007/s00125-004-1487-3; Ceriello A, 2002, DIABETES CARE, V25, P1439, DOI 10.2337/diacare.25.8.1439; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453; Coyle JD, 2004, ANN PHARMACOTHER, V38, P1731, DOI 10.1345/aph.1E182; Daiber A, 2009, FREE RADICAL BIO MED, V47, P458, DOI 10.1016/j.freeradbiomed.2009.05.019; Dorenkamp M, 2005, EUR J PHARMACOL, V520, P179, DOI 10.1016/j.ejphar.2005.07.020; Duplain H, 2008, J PHYSIOL-LONDON, V586, P4011, DOI 10.1113/jphysiol.2008.154302; El Bekay R, 2007, J MOL ENDOCRINOL, V39, P351, DOI 10.1677/JME-07-0074; Fan QL, 2004, NEPHROL DIAL TRANSPL, V19, P3012, DOI 10.1093/ndt/gfh499; Frank GD, 2000, ENDOCRINOLOGY, V141, P3120, DOI 10.1210/en.141.9.3120; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Guo W, 2003, AM J PHYSIOL-HEART C, V285, pH1396, DOI 10.1152/ajpheart.00096.2003; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Ischiropoulos H, 2005, TOXICOLOGY, V208, P299, DOI 10.1016/j.tox.2004.11.018; Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kintscher U, 2008, EXPERT OPIN THER TAR, V12, P1257, DOI [10.1517/14728222.12.10.1257, 10.1517/14728222.12.10.1257 ]; Kintscher U, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-12; Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b; Klotz LO, 2000, BIOCHEM J, V352, P219, DOI 10.1042/0264-6021:3520219; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Leiter LA, 2005, AM J HYPERTENS, V18, P121, DOI 10.1016/j.amjhyper.2004.07.001; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; NAVARROCID J, 1995, HYPERTENSION, V26, P1074, DOI 10.1161/01.HYP.26.6.1074; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pacher P, 2006, CURR OPIN PHARMACOL, V6, P136, DOI 10.1016/j.coph.2006.01.001; Perkins JM, 2008, CURR OPIN ENDOCRINOL, V15, P147, DOI 10.1097/MED.0b013e3282f7026f; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pinzar E, 2005, FEBS LETT, V579, P5100, DOI 10.1016/j.febslet.2005.08.019; Pueyo ME, 1998, AM J PHYSIOL-CELL PH, V274, pC214, DOI 10.1152/ajpcell.1998.274.1.C214; Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38; Redon J, 2008, J HYPERTENS, V26, P1891, DOI 10.1097/HJH.0b013e328302ca38; Richey JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE920, DOI 10.1152/ajpendo.1999.277.5.E920; Scheen AJ, 2004, DIABETES METAB, V30, P498, DOI 10.1016/S1262-3636(07)70147-7; Shiuchi T, 2004, HYPERTENSION, V43, P1003, DOI 10.1161/01.HYP.0000125142.41703.64; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Sloniger JA, 2005, METABOLISM, V54, P1659, DOI 10.1016/j.metabol.2005.06.016; Sowers JR, 2004, AM J PHYSIOL-HEART C, V286, pH1597, DOI 10.1152/ajpheart.00026.2004; Sowers JR, 2002, NEW ENGL J MED, V346, P1999, DOI 10.1056/NEJMe020054; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Ullrich V, 2006, J INORG BIOCHEM, V100, P2079, DOI 10.1016/j.jinorgbio.2006.09.019; Wattanapitayakul SK, 2000, FASEB J, V14, P271, DOI 10.1096/fasebj.14.2.271; Wayenberg JL, 2009, FREE RADICAL BIO MED, V47, P975, DOI 10.1016/j.freeradbiomed.2009.07.003; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Whaley-Connell A, 2005, ENDOCRIN METAB CLIN, V34, P63, DOI 10.1016/j.ecl.2004.11.007; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yonemitsu S, 2001, DIABETES, V50, P1093, DOI 10.2337/diabetes.50.5.1093; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	69	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10070	10.1371/journal.pone.0010070	http://dx.doi.org/10.1371/journal.pone.0010070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383279	gold, Green Submitted, Green Published			2022-12-27	WOS:000276454000020
J	Groves, CP; Fernando, P; Robovsky, J				Groves, Colin P.; Fernando, Prithiviraj; Robovsky, Jan			The Sixth Rhino: A Taxonomic Re-Assessment of the Critically Endangered Northern White Rhinoceros	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM-COTTONI; PHYLOGEOGRAPHY; AFRICAN	Background: The two forms of white rhinoceros; northern and southern, have had contrasting conservation histories. The Northern form, once fairly numerous is now critically endangered, while the southern form has recovered from a few individuals to a population of a few thousand. Since their last taxonomic assessment over three decades ago, new material and analytical techniques have become available, necessitating a review of available information and re-assessment of the taxonomy. Results: Dental morphology and cranial anatomy clearly diagnosed the southern and northern forms. The differentiation was well supported by dental metrics, cranial growth and craniometry, and corresponded with differences in post-cranial skeleton, external measurements and external features. No distinctive differences were found in the limited descriptions of their behavior and ecology. Fossil history indicated the antiquity of the genus, dating back at least to early Pliocene and evolution into a number of diagnosable forms. The fossil skulls examined fell outside the two extant forms in the craniometric analysis. Genetic divergence between the two forms was consistent across both nuclear and mitochondrial genomes, and indicated a separation of over a million years. Conclusions: On re-assessing the taxonomy of the two forms we find them to be morphologically and genetically distinct, warranting the recognition of the taxa formerly designated as subspecies; Ceratotherium simum simum the southern form and Ceratotherium simum cottoni the northern form, as two distinct species Ceratotherium simum and Ceratotherium cottoni respectively. The recognition of the northern form as a distinct species has profound implications for its conservation.	[Groves, Colin P.] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Fernando, Prithiviraj] Ctr Conservat & Res, Rajagiriya, Sri Lanka; [Robovsky, Jan] Univ S Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic	Australian National University; University of South Bohemia Ceske Budejovice	Groves, CP (corresponding author), Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia.	Colin.Groves@anu.edu.au	Robovsky, Jan/AAL-3362-2020; Fernando, Prithiviraj/I-8238-2012	Robovsky, Jan/0000-0001-8720-9314; Fernando, Prithiviraj/0000-0001-6968-4189	Czech MSMT 6007665801	Czech MSMT 6007665801	JR was partly supported by Czech grant No. MSMT 6007665801; neither of the other authors were financially supported for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A., 1965, Lammergeyer, V3, P1; Arambourg C., 1970, Annls Mus. natn. Hist, nat. Paris (Ser. 7), V10, P1; Backhaus D., 1964, Zoologische Garten Leipzig, V29, P93; CAVE A. J. E., 1959, PROC ZOOL SOC LONDON, V132, P99; CINKOVA I, 2006, THESIS PALACKY U OLO; Fernando P, 2000, HEREDITY, V84, P362, DOI 10.1046/j.1365-2540.2000.00674.x; Fernando P, 2006, CONSERV GENET, V7, P439, DOI 10.1007/s10592-006-9139-4; Garcia-Rodriguez AI, 1998, MOL ECOL, V7, P1137, DOI 10.1046/j.1365-294x.1998.00430.x; GEORGE M, 1993, RHINOCEROS BIOLOGY AND CONSERVATION, P105; GEORGE M, 1983, INT STUDBOOK AFRICAN, V2, P60; Geraads D, 2005, J VERTEBR PALEONTOL, V25, P451, DOI 10.1671/0272-4634(2005)025[0451:PRMFHA]2.0.CO;2; GROVES C P, 1975, Saeugetierkundliche Mitteilungen, V23, P200; GROVES C P, 1972, Mammalian Species, V8, P1; Guerin C., 1987, P320; Guerin C., 1979, Bulletin de la Societe Geologique de France, V21, P283; GUERIN C, 1985, FAUNES PLIO PLEISTOC, P69; GUERIN C, 1980, DOCUM LAB GEOL LYON, V79; HARRIS JM, 1983, FOSSIL UNGULATES PRO, P130; Hayssen V., 1993, ASDELLS PATTERNS MAM; Heller E., 1913, SMITHSONIAN MISCELLA, V61, P1; HILLMANSMITH AKK, 1986, J ZOOL, V210, P355; HILLMANSMITH K, 1997, NASHORNER BEGEGNUNG, P173; HOLECKOVA D, 2000, DRUR KRALOVE ZOO, P1; Hooijer D.A., 1978, P371; HOOIJER DA, 1969, FOSSIL VERTEBRATES A, V1, P71; HOUCK ML, 1994, J HERED, V85, P30; Jentink F. A., 1892, MUSEUM HIST NATURELL, VXI; Kingston JD, 2007, PALAEOGEOGR PALAEOCL, V243, P272, DOI 10.1016/j.palaeo.2006.08.002; Kirby F. V., 1920, ANN DURBAN MUS, V2, P223; Kunes Martin, 2002, Acta Universitatis Palackianae Olomucensis Facultas Rerum Naturalium Biologica, V39-40, P81; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN EB, 1982, RUN RHINO RUN; MERENLENDER AM, 1989, J HERED, V80, P377, DOI 10.1093/oxfordjournals.jhered.a110878; Mikulica V., 1991, Zoologische Garten, V61, P365; MOLLOY PG, 1954, GRAND LIVRE FAUNE AF, P50; MORALES JC, 1994, MOL PHYLOGENET EVOL, V3, P128, DOI 10.1006/mpev.1994.1015; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Penny M, 1987, RHINOS ENDANGERED SP; PITMAN CRS, 1954, GRAND LIVRE FAUNE AF, P35; Player I. C., 1960, Lammergeyer, V1, P3; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Rachlow JL, 1998, J MAMMAL, V79, P1317, DOI 10.2307/1383023; ROOKMAAKER K, 1982, ZOONOOZ, V55, P4; Schomber H. W., 1966, Saugetierkundliche Mitteilungen, V14, P214; SILINSKI S, 2003, THESIS LUDWIG MAXIMI; SPASSOV N, 1991, ONGULES UNGULATES, V91, P467; STRATIL A, 1990, COMP BIOCHEM PHYS B, V95, P803, DOI 10.1016/0305-0491(90)90320-S; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Vahala Jiri, 1993, International Zoo Yearbook, V32, P16; VANGYSEGHEM R, 1984, Z SAUGETIERKD, V49, P348; 1987, PACHYDERM, V9, P6	52	55	57	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e9703	10.1371/journal.pone.0009703	http://dx.doi.org/10.1371/journal.pone.0009703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383328	Green Published, gold			2022-12-27	WOS:000276454000001
J	Thompson, EJ; DePaul, AJ; Patel, SS; Sorin, EJ				Thompson, Erik J.; DePaul, Allison J.; Patel, Sarav S.; Sorin, Eric J.			Evaluating Molecular Mechanical Potentials for Helical Peptides and Proteins	PLOS ONE			English	Article							DYNAMICS SIMULATIONS; COIL TRANSITION; FORCE-FIELDS; APOLIPOPHORIN-III; APOLIPOPROTEIN; BINDING; CHARGE	Multiple variants of the AMBER all-atom force field were quantitatively evaluated with respect to their ability to accurately characterize helix-coil equilibria in explicit solvent simulations. Using a global distributed computing network, absolute conformational convergence was achieved for large ensembles of the capped A(21) and F-s helical peptides. Further assessment of these AMBER variants was conducted via simulations of a flexible 164-residue five-helix-bundle protein, apolipophorin-III, on the 100 ns timescale. Of the contemporary potentials that had not been assessed previously, the AMBER-99SB force field showed significant helix-destabilizing tendencies, with beta bridge formation occurring in helical peptides, and unfolding of apolipophorin-III occurring on the tens of nanoseconds timescale. The AMBER-03 force field, while showing adequate helical propensities for both peptides and stabilizing apolipophorin-III, (i) predicts an unexpected decrease in helicity with ALA -> ARG(+) substitution, (ii) lacks experimentally observed 3(10) helical content, and (iii) deviates strongly from average apolipophorin-III NMR structural properties. As is observed for AMBER-99SB, AMBER-03 significantly overweighs the contribution of extended and polyproline backbone configurations to the conformational equilibrium. In contrast, the AMBER-99 phi force field, which was previously shown to best reproduce experimental measurements of the helix-coil transition in model helical peptides, adequately stabilizes apolipophorin-III and yields both an average gyration radius and polar solvent exposed surface area that are in excellent agreement with the NMR ensemble.	[Thompson, Erik J.] Calif State Univ Long Beach, Dept Chem Engn, Long Beach, CA 90840 USA; [DePaul, Allison J.; Patel, Sarav S.; Sorin, Eric J.] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA	California State University System; California State University Long Beach; California State University System; California State University Long Beach	Thompson, EJ (corresponding author), Calif State Univ Long Beach, Dept Chem Engn, Long Beach, CA 90840 USA.	esorin@csulb.edu	Astorga, Carla/AAG-3468-2021		Provost's Undergraduate Student Summer Research Stipend; Women & Philanthropy Undergraduate Research and Creative Activity; Research Corporation Cottrell College; CSULB Academic Technologies Division	Provost's Undergraduate Student Summer Research Stipend; Women & Philanthropy Undergraduate Research and Creative Activity; Research Corporation Cottrell College(Research Corporation for Science Advancement); CSULB Academic Technologies Division	E.J.T. was supported by a Provost's Undergraduate Student Summer Research Stipend and A.J.D. was supported by a Women & Philanthropy Undergraduate Research and Creative Activity Scholarship. The computation was supported by a Research Corporation Cottrell College Science Award (www.rescorp.org/) and support from the CSULB Academic Technologies Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fan DP, 2003, J BIOL CHEM, V278, P21212, DOI 10.1074/jbc.M208486200; Garcia AE, 2004, POLYMER, V45, P669, DOI 10.1016/j.polymer.2003.10.070; Garcia AE, 2002, P NATL ACAD SCI USA, V99, P2782, DOI 10.1073/pnas.042496899; Gross E, 2006, BIOPHYS J, V90, P1362, DOI 10.1529/biophysj.105.075069; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ianoul A, 2002, J PHYS CHEM A, V106, P3621, DOI 10.1021/jp013537n; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kollman PA, 1996, ACCOUNTS CHEM RES, V29, P461, DOI 10.1021/ar9500675; Leon LJ, 2006, BIOCHEM BIOPH RES CO, V348, P1328, DOI 10.1016/j.bbrc.2006.07.199; LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LOCKHART DJ, 1993, SCIENCE, V260, P198, DOI 10.1126/science.8469972; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Shepherd CM, 2004, J BIOMOL STRUCT DYN, V21, P555, DOI 10.1080/07391102.2004.10506948; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Sorin EJ, 2006, J MOL BIOL, V356, P248, DOI 10.1016/j.jmb.2005.11.058; Sorin EJ, 2005, J COMPUT CHEM, V26, P682, DOI 10.1002/jcc.02028; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Sorin EJ, 2006, J AM CHEM SOC, V128, P6316, DOI 10.1021/ja060917j; Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; Weers PMM, 2005, BIOCHEMISTRY-US, V44, P8810, DOI 10.1021/bi050502v; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p; Zagrovic B, 2005, P NATL ACAD SCI USA, V102, P11698, DOI 10.1073/pnas.0409693102; Zagrovic B, 2001, J MOL BIOL, V313, P151, DOI 10.1006/jmbi.2001.5033	37	26	26	0	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10056	10.1371/journal.pone.0010056	http://dx.doi.org/10.1371/journal.pone.0010056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20418937	Green Published, gold, Green Submitted			2022-12-27	WOS:000276454000016
J	Burian, M; Wolz, C; Goerke, C				Burian, Marc; Wolz, Christiane; Goerke, Christiane			Regulatory Adaptation of Staphylococcus aureus during Nasal Colonization of Humans	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; DEVICE-RELATED INFECTION; CLUMPING FACTOR-B; IN-VITRO; SIGNAL-TRANSDUCTION; BIOFILM FORMATION; IMMUNE EVASION; TEICHOIC-ACIDS; PROTEIN; TRANSCRIPTION	The nasopharynx is the main ecological niche of the human pathogen Staphylococcus aureus. Although colonization of the nares is asymptomatic, nasal carriage is a known risk factor for endogenous staphylococcal infection. We quantified S. aureus mRNA levels in nose swabs of persistent carriers to gain insight into the regulatory adaptation of the bacterium to the nasal environment. We could elucidate a general response of the pathogen to the surrounding milieu independent of the strain background or the human host. Colonizing bacteria preferentially express molecules necessary for tissue adherence or immune-evasion whereas toxins are down regulated. From the analysis of regulatory loci we found evidence for a predominate role of the essential two-component system WalKR of S. aureus. The results suggest that during persistent colonization the bacteria are metabolically active with a high cell surface turnover. The increased understanding of bacterial factors that maintain the colonization state can open new therapeutic options to control nasal carriage and subsequent infections.	[Burian, Marc; Wolz, Christiane; Goerke, Christiane] Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Tubingen, Germany	Eberhard Karls University of Tubingen	Burian, M (corresponding author), Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Tubingen, Germany.	christiane.goerke@med.uni-tuebingen.de		Wolz, Christiane/0000-0003-3909-5281	Deutsche Forschungsgemeinschaft [TR34, SFB766]; IZKF, Universitat Tubingen [1596-0-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF, Universitat Tubingen	This work was supported by grants from the Deutsche Forschungsgemeinschaft (TR34 and SFB766) and from the IZKF, Universitat Tubingen (1596-0-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito Y, 2000, RNA, V6, P668, DOI 10.1017/S1355838200992550; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; BURIAN M, 2010, J INFECT DI IN PRESS, V201; Casado B, 2005, PROTEOMICS, V5, P2949, DOI 10.1002/pmic.200401172; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Cole AM, 2002, J IMMUNOL, V169, P6985, DOI 10.4049/jimmunol.169.12.6985; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dubrac S, 2008, ADV EXP MED BIOL, V631, P214, DOI 10.1007/978-0-387-78885-2_15; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Goerke C, 2000, J INFECT DIS, V181, P984, DOI 10.1086/315331; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Qian ZL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-74; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wolz C, 2002, INFECT IMMUN, V70, P2758, DOI 10.1128/IAI.70.6.2758-2762.2002	51	83	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10040	10.1371/journal.pone.0010040	http://dx.doi.org/10.1371/journal.pone.0010040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386721	Green Submitted, Green Published, gold			2022-12-27	WOS:000276420400011
J	Liou, LY; Walsh, KB; Vartanian, AR; de Bernabe, DBV; Welch, M; Campbell, KP; Oldstone, MBA; Kunz, S				Liou, Li-Ying; Walsh, Kevin B.; Vartanian, Arineh R.; de Bernabe, Daniel Beltran-Valero; Welch, Megan; Campbell, Kevin P.; Oldstone, Michael B. A.; Kunz, Stefan			Functional Glycosylation of Dystroglycan Is Crucial for Thymocyte Development in the Mouse	PLOS ONE			English	Article							T-CELL DEVELOPMENT; IMMUNOLOGICAL SYNAPSE; ALPHA-DYSTROGLYCAN; SURVIVAL; CD8(+); VIRUS; LYMPHOCYTES; ACTIVATION; DELETION; RECEPTOR	Background: Alpha-dystroglycan (alpha-DG) is a cell surface receptor providing a molecular link between the extracellular matrix (ECM) and the actin-based cytoskeleton. During its biosynthesis, alpha-DG undergoes specific and unusual O-glycosylation crucial for its function as a high-affinity cellular receptor for ECM proteins. Methodology/Principal Findings: We report that expression of functionally glycosylated alpha-DG during thymic development is tightly regulated in developing T cells and largely confined to CD4(-) CD8(-) double negative (DN) thymocytes. Ablation of DG in T cells had no effect on proliferation, migration or effector function but did reduce the size of the thymus due to a significant loss in absolute numbers of thymocytes. While numbers of DN thymocytes appeared normal, a marked reduction in CD4(+) CD8(+) double positive (DP) thymocytes occurred. In the periphery mature naive T cells deficient in DG showed both normal proliferation in response to allogeneic cells and normal migration, effector and memory T cell function when tested in acute infection of mice with either lymphocytic choriomeningitis virus (LCMV) or influenza virus. Conclusions/Significance: Our study demonstrates that DG function is modulated by glycosylation during T cell development in vivo and that DG is essential for normal development and differentiation of T cells.	[Liou, Li-Ying; Walsh, Kevin B.; Vartanian, Arineh R.; Welch, Megan; Oldstone, Michael B. A.; Kunz, Stefan] Scripps Res Inst, Dept Immunol & Microbial Sci, Viral Immunobiol Lab, La Jolla, CA 92037 USA; [de Bernabe, Daniel Beltran-Valero; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys,Dept Neurol, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys,Dept Internal Med, Iowa City, IA 52242 USA; [Oldstone, Michael B. A.] Scripps Florida, Dept Infectol, Jupiter, FL USA; [Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Kunz, Stefan] Univ Lausanne, Lausanne, Switzerland	Scripps Research Institute; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; State University System of Florida; University of Florida; University of Lausanne	Liou, LY (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, Viral Immunobiol Lab, La Jolla, CA 92037 USA.	mbaobo@scripps.edu; stefan.kunz@chuv.ch	; Kunz, Stefan/K-5840-2017	Campbell, Kevin/0000-0003-2066-5889; Kunz, Stefan/0000-0001-6030-9550	US Public Health Service [AI009484, AI045927, AI055540, AI074564, NS041219]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [NS053672]; National Science Foundation [3100A0-120250/1]; Marie Curie International Reintegration [224780]; European Community; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055540, R01AI045927, R01AI009484, R01AI055540, U01AI074564, R37AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672, T32NS041219] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center(Ohio State University); National Science Foundation(National Science Foundation (NSF)); Marie Curie International Reintegration(European Commission); European Community(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US Public Health Service grants AI009484, AI045927, AI055540, AI074564 and training grant NS041219 to L-Y.L. and K. B. W. This work was also supported in part by the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant NS053672. K. P. C. is an Investigator of the Howard Hughes Medical Institute. S. K. was supported by a Medical Research Position Award of the Foundation Prof. Dr. Max Cloetta (Switzerland), by Swiss National Science Foundation grant Nr. 3100A0-120250/1, and the Marie Curie International Reintegration Grant Nr. 224780 of the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Berger DP, 2000, VIROLOGY, V266, P257, DOI 10.1006/viro.1999.0074; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; BORROW P, 1991, J EXP MED, V174, P203, DOI 10.1084/jem.174.1.203; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Cohn RD, 2005, NEUROMUSCULAR DISORD, V15, P207, DOI 10.1016/j.nmd.2004.11.005; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Gong YP, 2008, FASEB J, V22, P1426, DOI 10.1096/fj.07-9264com; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 2001, J CELL SCI, V114, P1137; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Iwao M, 2000, IMMUNOLOGY, V99, P481, DOI 10.1046/j.1365-2567.2000.00990.x; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Kutlesa S, 2002, IMMUNOLOGY, V105, P407, DOI 10.1046/j.1365-2567.2002.01384.x; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miller NE, 2005, J VIROL, V79, P9419, DOI 10.1128/JVI.79.15.9419-9429.2005; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Zhang JP, 2006, FASEB J, V20, P50, DOI 10.1096/fj.04-3303com	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9915	10.1371/journal.pone.0009915	http://dx.doi.org/10.1371/journal.pone.0009915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369005	Green Published, Green Submitted, gold			2022-12-27	WOS:000276163100009
J	Antunes, DA; Vieira, GF; Rigo, MM; Cibulski, SP; Sinigaglia, M; Chies, JAB				Antunes, Dinler A.; Vieira, Gustavo F.; Rigo, Mauricio M.; Cibulski, Samuel P.; Sinigaglia, Marialva; Chies, Jose A. B.			Structural Allele-Specific Patterns Adopted by Epitopes in the MHC-I Cleft and Reconstruction of MHC:peptide Complexes to Cross-Reactivity Assessment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INFLUENZA-A VIRUS; PEPTIDE LIGANDS; DNA PRIME; BINDING; PROTEIN; PREDICTION; VACCINE; CTL; VISUALIZATION	The immune system is engaged in a constant antigenic surveillance through the Major Histocompatibility Complex (MHC) class I antigen presentation pathway. This is an efficient mechanism for detection of intracellular infections, especially viral ones. In this work we describe conformational patterns shared by epitopes presented by a given MHC allele and use these features to develop a docking approach that simulates the peptide loading into the MHC cleft. Our strategy, to construct in silico MHC: peptide complexes, was successfully tested by reproducing four different crystal structures of MHC-I molecules available at the Protein Data Bank (PDB). An in silico study of cross-reactivity potential was also performed between the wildtype complex HLA-A2-NS31073 and nine MHC: peptide complexes presenting alanine exchange peptides. This indicates that structural similarities among the complexes can give us important clues about cross reactivity. The approach used in this work allows the selection of epitopes with potential to induce cross-reactive immune responses, providing useful tools for studies in autoimmunity and to the development of more comprehensive vaccines.	[Antunes, Dinler A.; Vieira, Gustavo F.; Rigo, Mauricio M.; Cibulski, Samuel P.; Sinigaglia, Marialva; Chies, Jose A. B.] Univ Fed Rio Grande do Sul, Nucleo Bioinformat, Lab Imunogenet, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Antunes, DA (corresponding author), Univ Fed Rio Grande do Sul, Nucleo Bioinformat, Lab Imunogenet, Dept Genet, Porto Alegre, RS, Brazil.	jabchies@terra.com.br	vieira, gustavo F/G-4846-2012; Rigo, Mauricio Menegatti/N-8532-2018; Sinigaglia, Marialva/AAG-3172-2020; Antunes, Dinler Amaral/Z-4437-2019; Cibulski, Samuel P/G-5190-2017; Chies, Jose/K-9664-2015	vieira, gustavo F/0000-0002-2380-8059; Rigo, Mauricio Menegatti/0000-0002-1584-6194; Antunes, Dinler Amaral/0000-0001-7947-6455; Chies, Jose/0000-0001-7025-0660; Cibulski, Samuel/0000-0003-0503-8692	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Bill & Melinda Gates Foundation	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	DAA and JABC received a CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) grant and GFV received a CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) grant. Funded by a grant from Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Apostolopoulos V, 1998, NAT BIOTECHNOL, V16, P276, DOI 10.1038/nbt0398-276; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Buslepp J, 2001, J BIOL CHEM, V276, P47320, DOI 10.1074/jbc.M109231200; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cucchiarini M, 2000, CELL IMMUNOL, V203, P111, DOI 10.1006/cimm.2000.1683; *DEL SCI LLC, PYMOL; DIBROV A, 2009, ACTA BIOTHEOR; Frankild S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001831; Fytili P, 2008, VACCINE, V26, P3818, DOI 10.1016/j.vaccine.2008.05.045; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Kmiecik S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-43; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Madurga S, 2005, PROTEIN SCI, V14, P2069, DOI 10.1110/ps.051351605; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; MORRIS GM, 1998, J COMPUTATIONAL CHEM, V19; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reali E, 1999, J IMMUNOL, V162, P106; Rigo MM, 2009, LECT N BIOINFORMAT, V5676, P160, DOI 10.1007/978-3-642-03223-3_17; Sandalova T, 2005, J BIOL CHEM, V280, P27069, DOI 10.1074/jbc.M500927200; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Sieker F, 2009, CURR PROTEIN PEPT SC, V10, P286, DOI 10.2174/138920309788452191; Tian FF, 2008, PROTEIN PEPTIDE LETT, V15, P1033, DOI 10.2174/092986608786071120; Todman SJ, 2008, J MOL GRAPH MODEL, V26, P957, DOI 10.1016/j.jmgm.2007.07.005; Tong JC, 2004, PROTEIN SCI, V13, P2523, DOI 10.1110/ps.04631204; Trott O., 2009, J COMPUT CHEM; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Velloso LM, 2004, J IMMUNOL, V172, P5504, DOI 10.4049/jimmunol.172.9.5504; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2007, NAT REV MICROBIOL, V5, P555, DOI 10.1038/nrmicro1709; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wulf M, 2009, METHODS MOL BIOL, V524, P361, DOI 10.1007/978-1-59745-450-6_26; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zeng J, 2001, J COMPUT AID MOL DES, V15, P573, DOI 10.1023/A:1011145123635; Zhang C, 1998, J MOL BIOL, V281, P929, DOI 10.1006/jmbi.1998.1982; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10353	10.1371/journal.pone.0010353	http://dx.doi.org/10.1371/journal.pone.0010353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20442757	gold, Green Submitted, Green Published			2022-12-27	WOS:000277079500021
J	Goltermann, L; Larsen, MSY; Banerjee, R; Joerger, AC; Ibba, M; Bentin, T				Goltermann, Lise; Larsen, Marie Sofie Yoo; Banerjee, Rajat; Joerger, Andreas C.; Ibba, Michael; Bentin, Thomas			Protein Evolution via Amino Acid and Codon Elimination	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; DIRECTED EVOLUTION; GENE-EXPRESSION; MUTATIONS; STABILITY; DESIGN; INTERMEDIATE	Background: Global residue-specific amino acid mutagenesis can provide important biological insight and generate proteins with altered properties, but at the risk of protein misfolding. Further, targeted libraries are usually restricted to a handful of amino acids because there is an exponential correlation between the number of residues randomized and the size of the resulting ensemble. Using GFP as the model protein, we present a strategy, termed protein evolution via amino acid and codon elimination, through which simplified, native-like polypeptides encoded by a reduced genetic code were obtained via screening of reduced-size ensembles. Methodology/Principal Findings: The strategy involves combining a sequential mutagenesis scheme to reduce library size with structurally stabilizing mutations, chaperone complementation, and reduced temperature of gene expression. In six steps, we eliminated a common buried residue, Phe, from the green fluorescent protein (GFP), while retaining activity. A GFP variant containing 11 Phe residues was used as starting scaffold to generate 10 separate variants in which each Phe was replaced individually (in one construct two adjacent Phe residues were changed simultaneously), while retaining varying levels of activity. Combination of these substitutions to generate a Phe-free variant of GFP abolished fluorescence. Combinatorial re-introduction of five Phe residues, based on the activities of the respective single amino acid replacements, was sufficient to restore GFP activity. Successive rounds of mutagenesis generated active GFP variants containing, three, two, and zero Phe residues. These GFPs all displayed progenitor-like fluorescence spectra, temperature-sensitive folding, a reduced structural stability and, for the least stable variants, a reduced steady state abundance. Conclusions/Significance: The results provide strategies for the design of novel GFP reporters. The described approach offers a means to enable engineering of active proteins that lack certain amino acids, a key step towards expanding the functional repertoire of uniquely labeled proteins in synthetic biology.	[Goltermann, Lise; Larsen, Marie Sofie Yoo; Bentin, Thomas] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Banerjee, Rajat; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Joerger, Andreas C.] Ctr Prot Engn, MRC, Cambridge, England	University of Copenhagen; University System of Ohio; Ohio State University; University of Cambridge	Goltermann, L (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.	bentin@sund.ku.dk		Larsen, Marie Sofie Yoo/0000-0003-1046-5277; Joerger, Andreas/0000-0002-1232-0138; Goltermann, Lise/0000-0002-6679-9762	Danish Agency for Science, Technology, and Innovation [272-06-0553]; Lundbeck Foundation; National Science Foundation [MCB-0344002]	Danish Agency for Science, Technology, and Innovation; Lundbeck Foundation(Lundbeckfonden); National Science Foundation(National Science Foundation (NSF))	TB was supported by grant 272-06-0553 from the Danish Agency for Science, Technology, and Innovation and by the Lundbeck Foundation. MI was supported by grant MCB-0344002 from the National Science Foundation. LG received travel support from The Faculty of Health Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Branden C., 1999, INTRO PROTEIN STRUCT; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hayes RJ, 2002, P NATL ACAD SCI USA, V99, P15926, DOI 10.1073/pnas.212627499; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Link AJ, 2005, METHODS, V36, P291, DOI 10.1016/j.ymeth.2005.04.005; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sasidharan R, 2007, P NATL ACAD SCI USA, V104, P10080, DOI 10.1073/pnas.0703737104; Steiner T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001680; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Treynor TP, 2007, P NATL ACAD SCI USA, V104, P48, DOI 10.1073/pnas.0609647103; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walter KU, 2005, J BIOL CHEM, V280, P37742, DOI 10.1074/jbc.M507210200; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Yoo TH, 2007, P NATL ACAD SCI USA, V104, P13887, DOI 10.1073/pnas.0701904104	39	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10104	10.1371/journal.pone.0010104	http://dx.doi.org/10.1371/journal.pone.0010104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436666	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079500002
J	Wang, Y; Barakat, A; Zhou, HW				Wang, Yun; Barakat, Amey; Zhou, Hongwei			Electrotonic Coupling between Pyramidal Neurons in the Neocortex	PLOS ONE			English	Article							CONNEXIN 36-DEFICIENT MICE; CORTEX IN-VITRO; GAP-JUNCTIONS; ELECTRICAL SYNAPSES; NETWORK OSCILLATIONS; FREQUENCY OSCILLATIONS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL SLICES; PREFRONTAL CORTEX; MAMMALIAN BRAIN	Electrotonic couplings (i.e., electrical synapses or gap junctions) are fundamental to neuronal synchronization, and thus essential for many physiological functions and pathological disorders. Interneuron electrical synapses have been studied intensively. Although studies on electrotonic couplings between pyramidal cells (PCs) are emerging, particularly in the hippocampus, evidence is still rare in the neocortex. The electrotonic coupling of PCs in the neocortex is therefore largely unknown in terms of electrophysiological, anatomical and synaptological properties. Using multiple patch-clamp recording with differential interference contrast infrared videomicroscopy (IR-DIC) visualization, histochemical staining, and 3D-computer reconstruction, electrotonic coupling was recorded between close PCs, mainly in the medial prefrontal cortex as well as in the visual cortical regions of ferrets and rats. Compared with interneuron gap junctions, these electrotonic couplings were characterized by several special features. The recording probability of an electrotonic coupling between PCs is extremely low; but the junctional conductance is notably high, permitting the direct transmission of action potentials (APs) and even tonic firing between coupled neurons. AP firing is therefore perfectly synchronized between coupled PCs; Postjunctional APs and spikelets alternate following slight changes of membrane potentials; Postjunctional spikelets, especially at high frequencies, are summated and ultimately reach AP-threshold to fire. These properties of pyramidal electrotonic couplings largely fill the needs, as predicted by simulation studies, for the synchronization of a neuronal assembly. It is therefore suggested that the electrotonic coupling of PCs plays a unique role in the generation of neuronal synchronization in the neocortex.	[Wang, Yun; Barakat, Amey; Zhou, Hongwei] Tufts Univ, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA; [Wang, Yun] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China	St. Elizabeth's Medical Center; Tufts University; Wenzhou Medical University	Wang, Y (corresponding author), Tufts Univ, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA.	yun.wang@tufts.edu			NIMH-RO1; NIH/NEI-RO1; Natalie V Zucker Award; Charlton Research Grants at Tufts University School of Medicine	NIMH-RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NEI-RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natalie V Zucker Award; Charlton Research Grants at Tufts University School of Medicine	This work was supported by a NIMH-RO1 and a NIH/NEI-RO1, by Natalie V Zucker Award and by Charlton Research Grants at Tufts University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bennett M., 1977, HDB PHYSL          1, P357; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Buhl DL, 2003, J NEUROSCI, V23, P1013; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Devor A, 2002, ANN NY ACAD SCI, V978, P508, DOI 10.1111/j.1749-6632.2002.tb07594.x; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Hormuzdi SG, 2004, BBA-BIOMEMBRANES, V1662, P113, DOI 10.1016/j.bbamem.2003.10.023; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jedlicka P, 2006, PHYSIOL RES, V55, P139, DOI 10.33549/physiolres.930764; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Long MA, 2002, J NEUROSCI, V22, P10898; MACVICAR BA, 1982, J NEUROPHYSIOL, V47, P579, DOI 10.1152/jn.1982.47.4.579; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Maier N, 2002, J PHYSIOL-LONDON, V541, P521, DOI 10.1113/jphysiol.2002.017624; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; Mercer A, 2006, BRAIN CELL BIOL, V35, P13, DOI 10.1007/s11068-006-9005-9; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; SLOPER JJ, 1972, BRAIN RES, V44, P640, DOI 10.1016/0006-8993(72)90327-7; SLOPER JJ, 1978, PROC R SOC SER B-BIO, V203, P39, DOI 10.1098/rspb.1978.0089; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; TRAUB RD, 1985, NEUROSCIENCE, V14, P1033, DOI 10.1016/0306-4522(85)90274-X; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008366	43	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10253	10.1371/journal.pone.0010253	http://dx.doi.org/10.1371/journal.pone.0010253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436674	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079500003
J	Woyke, T; Tighe, D; Mavromatis, K; Clum, A; Copeland, A; Schackwitz, W; Lapidus, A; Wu, DY; McCutcheon, JP; McDonald, BR; Moran, NA; Bristow, J; Cheng, JF				Woyke, Tanja; Tighe, Damon; Mavromatis, Konstantinos; Clum, Alicia; Copeland, Alex; Schackwitz, Wendy; Lapidus, Alla; Wu, Dongying; McCutcheon, John P.; McDonald, Bradon R.; Moran, Nancy A.; Bristow, James; Cheng, Jan-Fang			One Bacterial Cell, One Complete Genome	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; MICROBIAL COMMUNITIES; XYLELLA-FASTIDIOSA; SYMBIONTS; EVOLUTION; HEMIPTERA; METAGENOMICS; CICADELLIDAE; DYNAMICS; INSIGHTS	While the bulk of the finished microbial genomes sequenced to date are derived from cultured bacterial and archaeal representatives, the vast majority of microorganisms elude current culturing attempts, severely limiting the ability to recover complete or even partial genomes from these environmental species. Single cell genomics is a novel culture-independent approach, which enables access to the genetic material of an individual cell. No single cell genome has to our knowledge been closed and finished to date. Here we report the completed genome from an uncultured single cell of Candidatus Sulcia muelleri DMIN. Digital PCR on single symbiont cells isolated from the bacteriome of the green sharpshooter Draeculacephala minerva bacteriome allowed us to assess that this bacteria is polyploid with genome copies ranging from approximately 200-900 per cell, making it a most suitable target for single cell finishing efforts. For single cell shotgun sequencing, an individual Sulcia cell was isolated and whole genome amplified by multiple displacement amplification (MDA). Sanger-based finishing methods allowed us to close the genome. To verify the correctness of our single cell genome and exclude MDA-derived artifacts, we independently shotgun sequenced and assembled the Sulcia genome from pooled bacteriomes using a metagenomic approach, yielding a nearly identical genome. Four variations we detected appear to be genuine biological differences between the two samples. Comparison of the single cell genome with bacteriome metagenomic sequence data detected two single nucleotide polymorphisms (SNPs), indicating extremely low genetic diversity within a Sulcia population. This study demonstrates the power of single cell genomics to generate a complete, high quality, non-composite reference genome within an environmental sample, which can be used for population genetic analyzes.	[Woyke, Tanja; Tighe, Damon; Mavromatis, Konstantinos; Clum, Alicia; Copeland, Alex; Schackwitz, Wendy; Lapidus, Alla; Wu, Dongying; Bristow, James; Cheng, Jan-Fang] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [McCutcheon, John P.; McDonald, Bradon R.; Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Arizona	Woyke, T (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA USA.	JFCheng@lbl.gov	Lapidus, Alla L/I-4348-2013; Moran, Nancy A/G-1591-2010; Schackwitz, Wendy/GXH-9536-2022; McDonald, Bradon/F-8386-2013	Lapidus, Alla L/0000-0003-0427-8731; McDonald, Bradon/0000-0002-6150-8735; Schackwitz, Wendy/0000-0002-3013-9180; Mavrommatis, Konstantinos/0000-0003-4549-385X; Cheng, Jan-Fang/0000-0001-7315-7613; McCutcheon, John/0000-0002-5489-6039	US Department of Energy; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; University of California, Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; University of California, Los Alamos National Laboratory [DE-AC02-06NA25396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); University of California, Lawrence Livermore National Laboratory(University of California System); University of California, Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National LaboratoryUniversity of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Cabrera-La Rosa JC, 2008, J ECON ENTOMOL, V101, P1105, DOI 10.1603/0022-0493(2008)101[1105:SPDODM]2.0.CO;2; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Komaki K, 2000, INSECT BIOCHEM MOLEC, V30, P253, DOI 10.1016/S0965-1748(99)00125-3; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; LaButti K, 2008, POLISHER TOOL USING; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Selosse MA, 2001, TRENDS ECOL EVOL, V16, P135, DOI 10.1016/S0169-5347(00)02084-X; Shcherbakov D. V., 2000, Molekulyarnaya Biologiya (Moscow), V34, P572; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	39	171	173	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10314	10.1371/journal.pone.0010314	http://dx.doi.org/10.1371/journal.pone.0010314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428247	Green Submitted, Green Published, gold			2022-12-27	WOS:000277079300008
J	Gregoretti, F; Belcastro, V; di Bernardo, D; Oliva, G				Gregoretti, Francesco; Belcastro, Vincenzo; di Bernardo, Diego; Oliva, Gennaro			A Parallel Implementation of the Network Identification by Multiple Regression (NIR) Algorithm to Reverse-Engineer Regulatory Gene Networks	PLOS ONE			English	Article								The reverse engineering of gene regulatory networks using gene expression profile data has become crucial to gain novel biological knowledge. Large amounts of data that need to be analyzed are currently being produced due to advances in microarray technologies. Using current reverse engineering algorithms to analyze large data sets can be very computational-intensive. These emerging computational requirements can be met using parallel computing techniques. It has been shown that the Network Identification by multiple Regression (NIR) algorithm performs better than the other ready-to-use reverse engineering software. However it cannot be used with large networks with thousands of nodes - as is the case in biological networks - due to the high time and space complexity. In this work we overcome this limitation by designing and developing a parallel version of the NIR algorithm. The new implementation of the algorithm reaches a very good accuracy even for large gene networks, improving our understanding of the gene regulatory networks that is crucial for a wide range of biomedical applications.	[Gregoretti, Francesco; Oliva, Gennaro] Inst High Performance Comp & Networking, Naples, Italy; [Belcastro, Vincenzo; di Bernardo, Diego] Telethon Inst Genet & Med, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Calcolo e Reti ad Alte Prestazioni (ICAR-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Gregoretti, F (corresponding author), Inst High Performance Comp & Networking, Naples, Italy.	francesco.gregoretti@na.icar.cnr.it; gennaro.oliva@na.icar.cnr.it	di Bernardo, Diego/I-9440-2012; di Bernardo, Diego/AAF-5881-2021; Gregoretti, Francesco/B-7600-2015	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Gregoretti, Francesco/0000-0003-3822-1215; Oliva, Gennaro/0000-0001-5676-2133; Belcastro, Vincenzo/0000-0003-3749-0018	Telethon [TGM06E01] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON E, 1992, LAPACKS USERS GUIDE; [Anonymous], 1995, TUTORIAL LEARNING BA; BANSAL M, 2007, MOL SYST BIOL, V3; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Butte A J, 2000, Pac Symp Biocomput, P418; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	10	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10179	10.1371/journal.pone.0010179	http://dx.doi.org/10.1371/journal.pone.0010179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422008	gold, Green Published, Green Submitted			2022-12-27	WOS:000276952500005
J	Rafalska-Metcalf, IU; Powers, SL; Joo, LM; LeRoy, G; Janicki, SM				Rafalska-Metcalf, Ilona U.; Powers, Sara Lawrence; Joo, Lucy M.; LeRoy, Gary; Janicki, Susan M.			Single Cell Analysis of Transcriptional Activation Dynamics	PLOS ONE			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; LIVING CELLS; GENE-EXPRESSION; IN-VIVO; P-TEFB; HISTONE ACETYLATION; ORDERED RECRUITMENT; MITOTIC CHROMOSOMES; CHROMATIN-STRUCTURE	Background: Gene activation is thought to occur through a series of temporally defined regulatory steps. However, this process has not been completely evaluated in single living mammalian cells. Methodology/Principal Findings: To investigate the timing and coordination of gene activation events, we tracked the recruitment of GCN5 (histone acetyltransferase), RNA polymerase II, Brd2 and Brd4 (acetyl-lysine binding proteins), in relation to a VP16-transcriptional activator, to a transcription site that can be visualized in single living cells. All accumulated rapidly with the VP16 activator as did the transcribed RNA. RNA was also detected at significantly more transcription sites in cells expressing the VP16-activator compared to a p53-activator. After a-amanitin pre-treatment, the VP16-activator, GCN5, and Brd2 are still recruited to the transcription site but the chromatin does not decondense. Conclusions/Significance: This study demonstrates that a strong activator can rapidly overcome the condensed chromatin structure of an inactive transcription site and supercede the expected requirement for regulatory events to proceed in a temporally defined order. Additionally, activator strength determines the number of cells in which transcription is induced as well as the extent of chromatin decondensation. As chromatin decondensation is significantly reduced after alpha-amanitin pre-treatment, despite the recruitment of transcriptional activation factors, this provides further evidence that transcription drives large-scale chromatin decondensation.	[Rafalska-Metcalf, Ilona U.; Powers, Sara Lawrence; Joo, Lucy M.; Janicki, Susan M.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [LeRoy, Gary] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	The Wistar Institute; Princeton University	Rafalska-Metcalf, IU (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA.	sjanicki@wistar.org			Emerald Foundation; Mallinckrodt Foundation; Beckman Young Investigators Program; V Foundation; Wistar Institute Cancer Center [P30CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	Emerald Foundation; Mallinckrodt Foundation; Beckman Young Investigators Program; V Foundation; Wistar Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following foundations: The Emerald Foundation, The Mallinckrodt Foundation, the Beckman Young Investigators Program, the V Foundation, and the Wistar Institute Cancer Center Support Grant (P30CA10815) for use of the Genomics/Sequencing Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dey A, 2009, MOL BIOL CELL; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hu Y, 2009, J CELL BIOL, V185, P87, DOI 10.1083/jcb.200809196; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Muller WG, 2007, J CELL BIOL, V177, P957, DOI 10.1083/jcb.200703157; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rafalska-Metcalf IU, 2007, J CELL SCI, V120, P2301, DOI 10.1242/jcs.008664; Rickards B, 2007, MOL CELL BIOL, V27, P937, DOI 10.1128/MCB.01584-06; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Toyama R, 2008, DEV DYNAM, V237, P1636, DOI 10.1002/dvdy.21576; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; YAN J, J VIROL, V84, P76; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yao J, 2008, METHODS, V45, P233, DOI 10.1016/j.ymeth.2008.06.004; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06	62	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10272	10.1371/journal.pone.0010272	http://dx.doi.org/10.1371/journal.pone.0010272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422051	Green Published, gold			2022-12-27	WOS:000276952500027
J	Salker, M; Teklenburg, G; Molokhia, M; Lavery, S; Trew, G; Aojanepong, T; Mardon, HJ; Lokugamage, AU; Rai, R; Landles, C; Roelen, BAJ; Quenby, S; Kuijk, EW; Kavelaars, A; Heijnen, CJ; Regan, L; Macklon, NS; Brosens, JJ				Salker, Madhuri; Teklenburg, Gijs; Molokhia, Mariam; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Mardon, Helen J.; Lokugamage, Amali U.; Rai, Raj; Landles, Christian; Roelen, Bernard A. J.; Quenby, Siobhan; Kuijk, Ewart W.; Kavelaars, Annemieke; Heijnen, Cobi J.; Regan, Lesley; Macklon, Nick S.; Brosens, Jan J.			Natural Selection of Human Embryos: Impaired Decidualization of Endometrium Disables Embryo-Maternal Interactions and Causes Recurrent Pregnancy Loss	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; RECEPTORS; CELLS; IMPLANTATION; MISCARRIAGE; EXPRESSION; EPITHELIUM; PROLACTIN; TIME	Background: Recurrent pregnancy loss (RPL), defined as 3 or more consecutive miscarriages, is widely attributed either to repeated chromosomal instability in the conceptus or to uterine factors that are poorly defined. We tested the hypothesis that abnormal cyclic differentiation of endometrial stromal cells (ESCs) into specialized decidual cells predisposes to RPL, based on the observation that this process may not only be indispensable for placenta formation in pregnancy but also for embryo recognition and selection at time of implantation. Methodology/Principal Findings: Analysis of mid-secretory endometrial biopsies demonstrated that RPL is associated with decreased expression of the decidual marker prolactin (PRL) but increased levels of prokineticin-1 (PROK1), a cytokine that promotes implantation. These in vivo findings were entirely recapitulated when ESCs were purified from patients with and without a history of RPL and decidualized in culture. In addition to attenuated PRL production and prolonged and enhanced PROK1 expression, RPL was further associated with a complete dysregulation of both markers upon treatment of ESC cultures with human chorionic gonadotropin, a glycoprotein hormone abundantly expressed by the implanting embryo. We postulated that impaired embryo recognition and selection would clinically be associated with increased fecundity, defined by short time-to-pregnancy (TTP) intervals. Woman-based analysis of the mean and mode TTP in a cohort of 560 RPL patients showed that 40% can be considered "superfertile'', defined by a mean TTP of 3 months or less. Conclusions: Impaired cyclic decidualization of the endometrium facilitates implantation yet predisposes to subsequent pregnancy failure by disabling natural embryo selection and by disrupting the maternal responses to embryonic signals. These findings suggest a novel pathological pathway that unifies maternal and embryonic causes of RPL.	[Salker, Madhuri; Lavery, Stuart; Trew, Geoffrey; Aojanepong, Tepchongchit; Rai, Raj; Landles, Christian; Regan, Lesley; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London, England; [Teklenburg, Gijs; Kuijk, Ewart W.; Macklon, Nick S.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Molokhia, Mariam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Mardon, Helen J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynecol, Womens Ctr, Oxford OX3 9DU, England; [Lokugamage, Amali U.] Whittington Hosp NHS Trust, Dept Obstet & Gynecol, London, England; [Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Quenby, Siobhan] Univ Liverpool, Dept Reprod & Dev Hlth, Liverpool Womens Hosp, Liverpool L69 3BX, Merseyside, England; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Psychoneuroimmunol, Utrecht, Netherlands; [Macklon, Nick S.] Univ Southampton, Div Dev Origins Hlth & Dis, Princess Anne Hosp, Southampton, Hants, England	Imperial College London; Utrecht University; Utrecht University Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Utrecht University; University of Liverpool; Utrecht University; Utrecht University Medical Center; University of Southampton	Salker, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London, England.	j.brosens@imperial.ac.uk	Kuijk, Ewart/I-2569-2019	Kuijk, Ewart/0000-0002-1385-6516; Landles, Christian/0000-0001-9715-6447; Salker, Madhuri Sonal/0000-0002-7939-289X; Quenby, Siobhan/0000-0003-3221-5471; Brosens, Jan/0000-0003-0116-9329; Lokugamage, Amali/0000-0002-7439-2700	Netherlands Organisation for Scientific Research (NWO); CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) [640510, CIG-08-122]; Wellcome Trust [084336]; Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR); Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Obstetrics and Gynaecology (IOG) Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by funds from the Netherlands Organisation for Scientific Research (NWO; http://www.nwo.nl), CONRAD/Consortium for Industrial Collaboration in Contraceptive Research (CICCR) Grant (640510) (CIG-08-122; http://www.conrad.org/), the Wellcome Trust (084336; http://www.wellcome.ac.uk/), the Institute of Obstetrics and Gynaecology (IOG) Trust (www.iogt.org.uk) and the NIHR Biomedical Research Centre funding scheme (http://www. nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin JD, 1996, AM J REPROD IMMUNOL, V35, P261; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; Berndt S, 2006, FASEB J, V20, P2630, DOI 10.1096/fj.06-5885fje; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 2010, MOL HUM REPROD, V16, P273, DOI 10.1093/molehr/gap108; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Christiansen OB, 2008, GYNECOL OBSTET INVES, V66, P257, DOI 10.1159/000149575; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Fluhr H, 2006, FERTIL STERIL, V86, P236, DOI 10.1016/j.fertnstert.2005.12.031; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hiby SE, 2008, HUM REPROD, V23, P972, DOI 10.1093/humrep/den011; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jasinska A, 2006, ENDOCRINOLOGY, V147, P4112, DOI 10.1210/en.2005-1577; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux E, 2006, HUM REPROD, V21, P2216, DOI 10.1093/humrep/del150; Joffe M, 2005, AM J EPIDEMIOL, V162, P115, DOI 10.1093/aje/kwi172; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kane N, 2009, ENDOCRINOLOGY, V150, P2882, DOI 10.1210/en.2008-1309; KORN EL, 1990, AM STAT, V44, P270, DOI 10.2307/2684345; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Quenby S, 2002, HUM REPROD, V17, P1959, DOI 10.1093/humrep/17.8.1959; Quinn CE, 2009, HUM REPROD UPDATE, V15, P229, DOI 10.1093/humupd/dmn052; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Simon L, 2009, ENDOCRINOLOGY, V150, P3871, DOI 10.1210/en.2008-1691; TIETZE C, 1950, FERTIL STERIL, V1, P338; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304	31	245	265	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10287	10.1371/journal.pone.0010287	http://dx.doi.org/10.1371/journal.pone.0010287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422017	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000276952500032
J	Williams, CT; Azad, AF				Williams, Calvin T.; Azad, Abdu F.			Transcriptional Analysis of the Pre-Erythrocytic Stages of the Rodent Malaria Parasite, Plasmodium yoelii	PLOS ONE			English	Article							INDUCED FALCIPARUM MALARIA; GENE-EXPRESSION; MICROARRAY PLATFORMS; CLUSTER-ANALYSIS; LIVER STAGES; SPOROZOITES; VACCINE; PROTEIN; IMMUNIZATION; RADIATION	The molecular biology of the clinically silent pre-erythrocytic stages of mammalian Plasmodium spp, composed of both the sporozoite and liver stages, has remained largely uncharacterized. Improved understanding of the biological processes required for progression through the pre-erythrocytic stages could lead to the identification of novel drug and vaccine targets. To gain insights into the molecular events that occur during the pre-erythrocytic stages of Plasmodium, comparative transcriptional analysis was performed on radiation attenuated sporozoites (RAS), wild type sporozoites (wtSPZ) and liver stage parasites collected either 24 hours (24hrLS) or 48 hours (48hrLS) after mice were infected with Plasmodium yoelii. Our results revealed 1100 Plasmodium genes that were differentially expressed in one or more constituents of the pre-erythrocytic stages relative to the mixed blood stages. Overall, the transcriptional profile of P. yoelii gradually became more similar to the mixed blood stages as pre-erythrocytic stage development progressed into the mature liver stage schizont. The transcriptional profiles of RAS and wtSPZ were found to be nearly identical. Likewise, the transcriptional profile of 24hrLS was very similar to that of the 48hrLS parasites. The largest differences in gene expression were observed when comparing wtSPZ or RAS to either of the liver stage samples. Further characterization of the differentially expressed genes identified in this study could help elucidate the biological mechanisms employed by Plasmodium during the pre-erythrocytic stages.	[Williams, Calvin T.; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Williams, CT (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	aazad@umaryland.edu			NIH [A107828-26]; NIAID [AI07540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant A107828-26 to A. A and NIAID T32 Training Grant: AI07540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Bodescot M, 2004, PARASITOL RES, V92, P449, DOI 10.1007/s00436-003-1061-9; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; CLYDE DF, 1973, AM J MED SCI, V266, P398, DOI 10.1097/00000441-197312000-00001; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Doolan DL, 1996, J BIOL CHEM, V271, P17861, DOI 10.1074/jbc.271.30.17861; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; GREENWOOD BM, 1990, B WORLD HEALTH ORGAN, V68, P184; Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487; Hoffman BU, 2008, EXP PARASITOL, V118, P247, DOI 10.1016/j.exppara.2007.08.014; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Pei Y, 2010, MOL MICROBIOL, V75, P957, DOI 10.1111/j.1365-2958.2009.07034.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; RICHARDS W. H. G., 1966, NATURE, V212, P1492, DOI 10.1038/2121492a0; Roxas BAP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-187; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; Sharma SK, 2003, J BIOL CHEM, V278, P45661, DOI 10.1074/jbc.M304283200; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Silvie O, 2002, PARASITE IMMUNOL, V24, P221, DOI 10.1046/j.1365-3024.2002.00450.x; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	43	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10267	10.1371/journal.pone.0010267	http://dx.doi.org/10.1371/journal.pone.0010267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422005	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952500019
J	Neueder, A; Jakob, S; Poll, G; Linnemann, J; Deutzmann, R; Tschochner, H; Milkereit, P				Neueder, Andreas; Jakob, Steffen; Poell, Gisela; Linnemann, Jan; Deutzmann, Rainer; Tschochner, Herbert; Milkereit, Philipp			A Local Role for the Small Ribosomal Subunit Primary Binder rpS5 in Final 18S rRNA Processing in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; RIBONUCLEOPROTEIN PARTICLE; CYTOPLASMIC MATURATION; THERMUS-THERMOPHILUS; 40S RIBOSOME; 80S RIBOSOME; PROTEINS; DOMAIN; BIOGENESIS	In vivo depletion of the yeast small ribosomal subunit (SSU) protein S5 (rpS5) leads to nuclear degradation of nascent SSUs and to a perturbed global assembly state of the SSU head domain. Here, we report that rpS5 plays an additional local role at the head/platform interface in efficient SSU maturation. We find that yeast small ribosomal subunits which incorporated an rpS5 variant lacking the seven C-terminal amino acids have a largely assembled head domain and are exported to the cytoplasm. On the other hand, 39 processing of 18S rRNA precursors is inhibited in these ribosomal particles, although they associate with the putative endonuclease Nob1p and other late acting 40S biogenesis factors. We suggest that the SSU head component rpS5 and platform components as rpS14 are crucial constituents of a highly defined spatial arrangement in the head - platform interface of nascent SSUs, which is required for efficient processing of the therein predicted SSU rRNA 39 end. Positioning of rpS5 in nascent SSUs, including its relative orientation towards platform components in the head-platform cleft, will depend on the general assembly and folding state of the head domain. Therefore, the suggested model can explain 18S precursor rRNA 39 processing phenotypes observed in many eukaryotic SSU head assembly mutants.	[Neueder, Andreas; Jakob, Steffen; Poell, Gisela; Linnemann, Jan; Deutzmann, Rainer; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Inst Biochem Genetik & Mikrobiol, Regensburg, Germany	University of Regensburg	Neueder, A (corresponding author), Univ Regensburg, Inst Biochem Genetik & Mikrobiol, Regensburg, Germany.	herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de	Neueder, Andreas/K-4319-2015	Neueder, Andreas/0000-0002-2389-5236	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was in part financed by the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/) research unit FOR 1068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalarov SC, 1998, P NATL ACAD SCI USA, V95, P999, DOI 10.1073/pnas.95.3.999; Agalarov SC, 1999, EUR J BIOCHEM, V266, P533, DOI 10.1046/j.1432-1327.1999.00890.x; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Burke D., 2000, METHODS YEAST GENETI; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Fang F, 2004, MOL CELL BIOL, V24, P10766, DOI 10.1128/MCB.24.24.10766-10776.2004; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ford CL, 1999, CANCER RES, V59, P704; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; LAFONTAINE D, 1994, J MOL BIOL, V241, P492, DOI 10.1006/jmbi.1994.1525; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lumsden T, 2010, NUCLEIC ACIDS RES, V38, P1261, DOI 10.1093/nar/gkp1113; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; PERTSCHY B, 2009, J BIOL CHEM; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Robert F, 2003, J BIOL CHEM, V278, P44913, DOI 10.1074/jbc.M306534200; Robert F, 2001, NUCLEIC ACIDS RES, V29, P677, DOI 10.1093/nar/29.3.677; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Sambrook J., 2002, MOL CLONING LAB MANU; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; SOUDET J, EMBO J; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Sykes MT, 2009, ANNU REV BIOPHYS, V38, P197, DOI 10.1146/annurev.biophys.050708.133615; Tabb-Massey A, 2003, NUCLEIC ACIDS RES, V31, P6798, DOI 10.1093/nar/gkg899; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; TRAPMAN J, 1976, BIOCHIM BIOPHYS ACTA, V442, P265, DOI 10.1016/0005-2787(76)90301-4; UDEM SA, 1973, J BIOL CHEM, V248, P1412; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; WEITZMANN CJ, 1993, FASEB J, V7, P177, DOI 10.1096/fasebj.7.1.7916699; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	52	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10194	10.1371/journal.pone.0010194	http://dx.doi.org/10.1371/journal.pone.0010194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419091	Green Submitted, gold, Green Published			2022-12-27	WOS:000276853800007
J	Macey, PM; Woo, MA; Kumar, R; Cross, RL; Harper, RM				Macey, Paul M.; Woo, Mary A.; Kumar, Rajesh; Cross, Rebecca L.; Harper, Ronald M.			Relationship between Obstructive Sleep Apnea Severity and Sleep, Depression and Anxiety Symptoms in Newly-Diagnosed Patients	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; QUALITY-OF-LIFE; INTERMITTENT HYPOXIA; PSYCHOMETRIC EVALUATION; NEURAL ALTERATIONS; INVENTORY-II; RISK-FACTOR; INDEX; HYPERTENSION; RELIABILITY	Obstructive sleep apnea (OSA) occurs in at least 10% of the population, and leads to higher morbidity and mortality; however, relationships between OSA severity and sleep or psychological symptoms are unclear. Existing studies include samples with wide-ranging comorbidities, so we assessed relationships between severity of OSA and common sleep and psychological disturbances in recently diagnosed OSA patients with minimal co-morbidities. We studied 49 newly diagnosed, untreated OSA patients without major co-morbidities such as mental illness, cardiovascular disease, or stroke; subjects were not using psychoactive medications or tobacco (mean +/- std age: 46.8 +/- 9.1 years; apnea/hyponea index [AHI]: 32.1 +/- 20.5 events/hour; female/male: 12/37; weight <125 kg). We evaluated relationships between the AHI and daytime sleepiness (Epworth Sleepiness Scale; ESS), sleep quality (Pittsburg Sleep Quality Index; PSQI), depressive symptoms (Beck Depression Inventory-II; BDI), and anxiety symptoms (Beck Anxiety Inventory; BAI), as well as sex and body mass index (BMI). AHI was similar in females and males. Mean levels of all symptoms were above normal thresholds, but AHI was not correlated with age, ESS, PSQI, BDI, or BAI; only BMI was correlated with OSA severity. No differences in mean AHI appeared when subjects were grouped by normal versus elevated values of ESS, PSQI, BDI, or BAI. Consistent with other studies, a strong link between OSA severity and psychological symptoms did not appear in these newly diagnosed patients, suggesting that mechanisms additional to the number and frequency of hypoxic events and arousals occurring with apneas contribute to adverse health effects in OSA. OSA patients presenting with mild or moderate severity, and no major comorbidities will not necessarily have low levels of sleep or psychological disturbances.	[Macey, Paul M.; Woo, Mary A.; Cross, Rebecca L.] Univ Calif Los Angeles, Sch Nursing, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Macey, Paul M.; Harper, Ronald M.] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Kumar, Rajesh; Harper, Ronald M.] Univ Calif Los Angeles, Dept Neurobiol, David Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Macey, PM (corresponding author), Univ Calif Los Angeles, Sch Nursing, David Geffen Sch Med, Los Angeles, CA 90024 USA.	pmacey@ucla.edu	Macey, Paul M./B-5037-2008	Macey, Paul M./0000-0003-4093-7458	National Institutes of Health [HL60296, NR009116, NR011230]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR011230, R01NR009116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funded by the National Institutes of Health HL60296, NR009116, and NR011230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashiba T, 2002, CHEST, V122, P861, DOI 10.1378/chest.122.3.861; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; ASANO K, 2009, RESPIRATION; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Baguet JP, 2005, CHEST, V128, P3407, DOI 10.1378/chest.128.5.3407; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Borak J, 1996, J SLEEP RES, V5, P123, DOI 10.1046/j.1365-2869.1996.d01-60.x; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Cross RL, 2008, SLEEP, V31, P1103; Dominici M, 2009, ARQ NEURO-PSIQUIAT, V67, P35, DOI 10.1590/S0004-282X2009000100009; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; Gozal E, 2005, AM J PHYSIOL-CELL PH, V288, pC535, DOI 10.1152/ajpcell.00270.2004; Harper RM, 2009, SLEEP, V32, pA341; Hossain JL, 2005, J SLEEP RES, V14, P245, DOI 10.1111/j.1365-2869.2005.00466.x; Iber C., 2007, AASM MANUAL SCORING; Johansson P, 2009, SLEEP MED, V10, P1005, DOI 10.1016/j.sleep.2009.01.011; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kezirian EJ, 2009, SLEEP, V32, P253, DOI 10.1093/sleep/32.2.253; Kumar R, 2009, DEPRESS ANXIETY, V26, P480, DOI 10.1002/da.20531; Lamm J, 2008, J AM ACAD NURSE PRAC, V20, P225, DOI 10.1111/j.1745-7599.2008.00308.x; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Lopez-Jimenez F, 2006, SLEEP, V29, P743, DOI 10.1093/sleep/29.6.743; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; MACEY PM, 2008, 7 ANN RES EV BAS PRA; Marshall NS, 2008, SLEEP, V31, P1079; McCall WV, 2006, J CLIN SLEEP MED, V2, P424; Mediano O, 2007, EUR RESPIR J, V30, P110, DOI 10.1183/09031936.00009506; MILLMAN RP, 1989, J CLIN PSYCHIAT, V50, P348; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Naismith S, 2004, J CLIN EXP NEUROPSYC, V26, P43, DOI 10.1076/jcen.26.1.43.23929; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; REYNOLDS CF, 1984, J CLIN PSYCHIAT, V45, P287; Richardson HL, 2008, J SLEEP RES, V17, P450, DOI [10.1111/j.1365-2869.2008.00663.x, 10.1111/j.1365-2869.2008.00667.x, 10.1111/j.1365-2869.2008.00682.x, 10.1111/j.1365-2869.2008.00672.x, 10.1111/j.1365-2869.2008.00683.x]; Ronksley PE, 2009, THORAX, V64, P834, DOI 10.1136/thx.2009.115105; Roure N, 2008, SLEEP MED, V9, P727, DOI 10.1016/j.sleep.2008.02.006; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Sauter C, 2000, J SLEEP RES, V9, P293; Seneviratne U, 2004, SLEEP MED, V5, P339, DOI 10.1016/j.sleep.2004.01.021; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Thong JF, 2008, J OTOLARYNGOL-HEAD N, V37, P894, DOI 10.2310/7070.2008.OA0200; VALLADARES EM, 2007, SOC NEUR ABS; Vandeputte M, 2003, SLEEP MED, V4, P343, DOI 10.1016/S1389-9457(03)00059-5; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Veasey SC, 2006, SLEEP MED, V7, P5, DOI 10.1016/j.sleep.2005.08.012; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Young T, 2008, SLEEP, V31, P1071; YUE HJ, 2009, SLEEP BREATH	58	115	120	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10211	10.1371/journal.pone.0010211	http://dx.doi.org/10.1371/journal.pone.0010211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	584HZ	20419135	Green Published, gold, Green Submitted			2022-12-27	WOS:000276743500017
J	Zhan, SH; Lukens, L				Zhan, Shuhua; Lukens, Lewis			Identification of Novel miRNAs and miRNA Dependent Developmental Shifts of Gene Expression in Arabidopsis thaliana	PLOS ONE			English	Article							MICRORNA METABOLISM; PHASE-CHANGE; RNA; BIOGENESIS; TARGETS; PROTEIN; EVOLUTION; CLEAVAGE; EXPORT; DICER	microRNAs (miRNAs) are small, endogenous RNAs of 20,25 nucleotides, processed from stem-loop regions of longer RNA precursors. Plant miRNAs act as negative regulators of target mRNAs predominately by slicing target transcripts, and a number of miRNAs play important roles in development. We analyzed a number of published datasets from Arabidopsis thaliana to characterize novel miRNAs, novel miRNA targets, and miRNA-regulated developmental changes in gene expression. These data include microarray profiling data and small RNA (sRNA) deep sequencing data derived from miRNA biogenesis/transport mutants, microarray profiling data of mRNAs in a developmental series, and computational predictions of conserved genomic stem-loop structures. Our conservative analyses identified five novel mature miRNAs and seven miRNA targets, including one novel target gene. Two complementary miRNAs that target distinct mRNAs were encoded by one gene. We found that genes targeted by known miRNAs, and genes up-regulated or down-regulated in miRNA mutant inflorescences, are highly expressed in the wild type inflorescence. In addition, transcripts upregulated within the mutant inflorescences were abundant in wild type leaves and shoot meristems and low in pollen and seed. Downregulated transcripts were abundant in wild type pollen and seed and low in shoot meristems, roots and leaves. Thus, disrupting miRNA function causes the inflorescence transcriptome to resemble the leaf and meristem and to differ from pollen and seed. Applications of our computational approach to other species and the use of more liberal criteria than reported here will further expand the number of identified miRNAs and miRNA targets. Our findings suggest that miRNAs have a global role in promoting vegetative to reproductive transitions in A. thaliana.	[Zhan, Shuhua; Lukens, Lewis] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph	Zhan, SH (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	llukens@uoguelph.ca		Lukens, Lewis/0000-0003-3963-2008	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada, www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Backman TWH, 2008, NUCLEIC ACIDS RES, V36, pD982, DOI 10.1093/nar/gkm997; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2008, CURR TOP MICROBIOL, V320, P117; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pouch-Pelissier MN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000096; Ray A, 1996, DEVELOPMENT, V122, P2631; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Willmann MR, 2007, CURR OPIN PLANT BIOL, V10, P503, DOI 10.1016/j.pbi.2007.07.004; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716	52	17	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10157	10.1371/journal.pone.0010157	http://dx.doi.org/10.1371/journal.pone.0010157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405016	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706300013
J	Lim, RH; Kobzik, L; Dahl, M				Lim, Robert H.; Kobzik, Lester; Dahl, Morten			Risk for Asthma in Offspring of Asthmatic Mothers versus Fathers: A Meta-Analysis	PLOS ONE			English	Article							CHILDHOOD ASTHMA; ALLERGIC RHINITIS; BRONCHIAL HYPERRESPONSIVENESS; MATERNAL TRANSMISSION; SCHOOL-CHILDREN; FAMILY-HISTORY; BIRTH COHORT; RESPIRATORY-INFECTIONS; AIRWAY RESPONSIVENESS; ENVIRONMENTAL-FACTORS	Background: Many human epidemiologic studies demonstrate that maternal asthma confers greater risk of asthma to offspring than does paternal disease. However, a handful have shown the opposite. Given this disparity, a meta-analysis is necessary to determine the veracity and magnitude of the "maternal effect.'' Methodology/Principal Findings: We screened the medical literature from 1966 to 2009 and performed a meta-analysis to compare the effect of maternal asthma vs. paternal asthma on offspring asthma susceptibility. Aggregating data from 33 studies, the odds ratio for asthma in children of asthmatic mothers compared with non-asthmatic mothers was significantly increased at 3.04 (95% confidence interval: 2.59-3.56). The corresponding odds ratio for asthma in children of asthmatic fathers was increased at 2.44 (2.14-2.79). When comparing the odds ratios, maternal asthma conferred greater risk of disease than did paternal asthma ( 3.04 vs. 2.44, p = 0.037). When analyzing the studies in which asthma was diagnosed by a physician the odds ratios were attenuated and no significant differences were observed (2.85 vs. 2.48, N = 18, p = 0.37). Similarly, no significant differences were observed between maternal and paternal odds ratios when analyzing the studies in which the patient population was 5 years or older (3.15 vs. 2.60, p = 0.14). However, in all cases the trend remained the same, that maternal asthma was a greater risk factor for asthma than paternal. Conclusions/Significance: The results show that maternal asthma increases offspring disease risk to a greater extent than paternal disease.	[Lim, Robert H.; Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Dahl, Morten] Copenhagen Univ Hosp Herlev, Dept Clin Biochem, Copenhagen, Denmark; [Lim, Robert H.] Childrens Hosp, Dept Pulm Med, Boston, MA 02115 USA; [Kobzik, Lester] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Copenhagen; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Lim, RH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	mordah02@heh.regionh.dk	Dahl, Morten/F-4219-2014	Dahl, Morten/0000-0002-6686-312X	Danish Lung Association;  [R01 ES017588]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017588] Funding Source: NIH RePORTER	Danish Lung Association; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by R01 ES017588 and the Danish Lung Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 1996, Respirology, V1, P291, DOI 10.1111/j.1440-1843.1996.tb00045.x; Akinbami LJ, 2005, PEDIATRICS, V115, P1254, DOI 10.1542/peds.2004-0897; Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; ANANDAN C, 2009, ALLERGY; Arnedo A, 2007, MED CLIN-BARCELONA, V129, P165, DOI 10.1157/13107792; Arshad SH, 2005, CHEST, V127, P502, DOI 10.1378/chest.127.2.502; ARSHAD SH, 1993, CLIN EXP ALLERGY, V23, P504, DOI 10.1111/j.1365-2222.1993.tb03238.x; BACAB MAB, 1997, REV PANAM SALUD PUBL, V2, P299; Backer C, 2009, REV PANAM SALUD PUBL, V25, P431, DOI 10.1590/S1020-49892009000500008; Balemans WAF, 2006, J CLIN EPIDEMIOL, V59, P1207, DOI 10.1016/j.jclinepi.2006.02.011; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barrett EG, 2008, PULM PHARMACOL THER, V21, P474, DOI 10.1016/j.pupt.2007.06.005; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; Belanger K, 2003, AM J EPIDEMIOL, V158, P195, DOI 10.1093/aje/kwg148; Belousova EG, 1999, AUST NZ J MED, V29, P794, DOI 10.1111/j.1445-5994.1999.tb00782.x; Berz JB, 2007, J PEDIATR PSYCHOL, V32, P154, DOI 10.1093/jpepsy/jsj123; Bjerg A, 2007, PEDIATRICS, V120, P741, DOI 10.1542/peds.2006-3742; Bracken MB, 2002, EPIDEMIOL REV, V24, P176, DOI 10.1093/epirev/mxf012; Celedon JC, 2001, CHEST, V120, P785, DOI 10.1378/chest.120.3.785; Chowgule RV, 1998, AM J RESP CRIT CARE, V158, P547, DOI 10.1164/ajrccm.158.2.9708064; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; de Marco R, 2004, J ALLERGY CLIN IMMUN, V113, P845, DOI 10.1016/j.jaci.2004.01.780; De Sario M, 2006, J ASTHMA, V43, P633, DOI 10.1080/02770900600878974; DOLD S, 1992, ARCH DIS CHILD, V67, P1018, DOI 10.1136/adc.67.8.1018; Dong GH, 2008, J INVEST ALLERG CLIN, V18, P207; Duncan JM, 2008, CURR OPIN ALLERGY CL, V8, P398, DOI 10.1097/ACI.0b013e32830d82ed; Duse M, 2007, PEDIAT ALLERG IMM-UK, V18, P201, DOI 10.1111/j.1399-3038.2006.00523.x; Ehrlich RI, 1996, AM J RESP CRIT CARE, V154, P681, DOI 10.1164/ajrccm.154.3.8810605; El-Sharif N, 2003, CLIN EXP ALLERGY, V33, P176, DOI 10.1046/j.1365-2222.2003.01598.x; Elizur A, 2007, ANN ALLERG ASTHMA IM, V98, P540, DOI 10.1016/S1081-1206(10)60732-6; FEDULOV AV, 2007, AM J RESP CELL MOL B; FERGUSSON DM, 1983, J CHRON DIS, V36, P517, DOI 10.1016/0021-9681(83)90129-7; Fernandez-Benitez M, 2007, ALLERGOL IMMUNOPATH, V35, P193, DOI 10.1157/13110314; Forno E, 2009, CURR OPIN ALLERGY CL, V9, P154, DOI 10.1097/ACI.0b013e3283292207; FRISCHER T, 1993, EUR J PEDIATR, V152, P771, DOI 10.1007/BF01954000; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; GUILBERT TW, 2007, AM J RESP CRIT CARE; Halonen M, 1999, AM J RESP CRIT CARE, V160, P564, DOI 10.1164/ajrccm.160.2.9809038; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Illi S, 2001, J ALLERGY CLIN IMMUN, V108, P709, DOI 10.1067/mai.2001.118786; Jaakkola JJK, 2001, ENVIRON HEALTH PERSP, V109, P579, DOI 10.2307/3455031; Jacobson JS, 2008, J ASTHMA, V45, P301, DOI 10.1080/02770900801911186; Jan IS, 2004, J FORMOS MED ASSOC, V103, P259; Jenkins MA, 1997, GENET EPIDEMIOL, V14, P317, DOI 10.1002/(SICI)1098-2272(1997)14:3<317::AID-GEPI9>3.0.CO;2-1; Johnson CC, 2004, J ALLERGY CLIN IMMUN, V114, P105, DOI 10.1016/j.jaci.2004.04.007; Karino S, 2008, ANN ALLERG ASTHMA IM, V101, P153, DOI 10.1016/S1081-1206(10)60203-7; Karunasekera KAW, 2001, J TROP PEDIATRICS, V47, P142, DOI 10.1093/tropej/47.3.142; Keil T, 2009, ALLERGY, V64, P445, DOI 10.1111/j.1398-9995.2008.01867.x; KELLY YJ, 1995, THORAX, V50, P525, DOI 10.1136/thx.50.5.525; Koh YY, 1998, J ALLERGY CLIN IMMUN, V102, P921, DOI 10.1016/S0091-6749(98)70329-X; KOZYRSKYJ AL, 2009, AM J PUBLIC HLTH; Kurt E, 2007, PEDIAT ALLERG IMM-UK, V18, P566, DOI 10.1111/j.1399-3038.2007.00551.x; Kurukulaaratchy RJ, 2005, ACTA PAEDIATR, V94, P553, DOI 10.1080/08035250510027282; Lannero E, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-3; Larsson M, 2008, ACTA PAEDIATR, V97, P1210, DOI 10.1111/j.1651-2227.2008.00910.x; Lee SL, 2004, PEDIAT ALLERG IMM-UK, V15, P72, DOI 10.1046/j.0905-6157.2003.00109.x; Leme AS, 2006, J IMMUNOL, V176, P762, DOI 10.4049/jimmunol.176.2.762; Leung TF, 2008, CURR OPIN ALLERGY CL, V8, P384, DOI 10.1097/ACI.0b013e3283103a8e; Lim RH, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-56; Lim RH, 2009, AM J REPROD IMMUNOL, V61, P1, DOI 10.1111/j.1600-0897.2008.00671.x; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P1075, DOI 10.1016/j.jaci.2008.03.005; London SJ, 2001, EPIDEMIOLOGY, V12, P577, DOI 10.1097/00001648-200109000-00019; Loyo-Berrios NI, 2006, J ASTHMA, V43, P619, DOI 10.1080/02770900600878693; Ly NP, 2008, CHEST, V133, P107, DOI 10.1378/chest.07-2130; Mai XM, 2007, J ALLERGY CLIN IMMUN, V120, P551, DOI 10.1016/j.jaci.2007.05.004; Maier WC, 1997, ENVIRON HEALTH PERSP, V105, P208, DOI 10.1289/ehp.97105208; Majeed R, 2008, JCPSP-J COLL PHYSICI, V18, P299, DOI 05.2008/JCPSP.299302; Martel MJ, 2009, AM J EPIDEMIOL, V169, P195, DOI 10.1093/aje/kwn309; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 1997, CIBA F SYMP, V206, P233; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McDaniel M, 2006, PEDIATRICS, V117, pE868, DOI 10.1542/peds.2005-1721; Metsala J, 2008, AM J EPIDEMIOL, V168, P170, DOI 10.1093/aje/kwn105; Millar W J, 1998, Health Rep, V10, P9; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; Morais-Almeida M, 2007, ALLERGY ASTHMA PROC, V28, P183, DOI 10.2500/aap.2007.28.2953; Oddy WH, 2004, J ASTHMA, V41, P605, DOI 10.1081/JAS-200026402; Pattenden S, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015065; Peat JK, 2002, CURR OPIN ALLERGY CL, V2, P167, DOI 10.1097/00130832-200206000-00003; PEAT JK, 1992, EUR RESPIR J, V5, P921; Raby BA, 2005, AM J RESP CRIT CARE, V172, P552, DOI 10.1164/rccm.200501-010OC; Rona RJ, 1997, J ALLERGY CLIN IMMUN, V99, P454, DOI 10.1016/S0091-6749(97)70070-8; Sandin A, 2004, PEDIATR ALLERGY IMMU, V15, P316, DOI 10.1111/j.1399-3038.2004.00166.x; Saxena S, 2002, BMJ-BRIT MED J, V325, P520, DOI 10.1136/bmj.325.7363.520; SCHUHL JF, 1989, ALLERGOL IMMUNOPATH, V17, P15; SHAW R, 1994, NEW ZEAL MED J, V107, P387; SHERMAN CB, 1990, AM J EPIDEMIOL, V132, P83, DOI 10.1093/oxfordjournals.aje.a115646; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Simoes EAF, 2007, PEDIATRICS, V119, P1210, DOI 10.1542/peds.2007-0869; Soto-Quiros ME, 2002, PEDIATR PULM, V33, P237, DOI 10.1002/ppul.10070; Sunyer J, 2001, THORAX, V56, P290, DOI [10.1136/thorax.56.4.290, 10.1136/thorax.56.11.897a]; Sunyer Y, 1997, EUR RESPIR J, V10, P2490, DOI 10.1183/09031936.97.10112490; Taveras EM, 2006, PEDIATR PULM, V41, P643, DOI 10.1002/ppul.20427; von Maffei J, 2001, J ASTHMA, V38, P555, DOI 10.1081/JAS-100107120; Wang TN, 2001, J ASTHMA, V38, P485, DOI 10.1081/JAS-100105869; Wickens K, 2001, AUST NZ J PUBL HEAL, V25, P44, DOI 10.1111/j.1467-842X.2001.tb00549.x; Wong G W K, 2004, Paediatr Respir Rev, V5 Suppl A, pS163, DOI 10.1016/S1526-0542(04)90032-2; Wright AL, 2001, THORAX, V56, P192, DOI 10.1136/thorax.56.3.192; Yuan W, 2003, EUR J EPIDEMIOL, V18, P763, DOI 10.1023/A:1025390420122	101	144	146	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10134	10.1371/journal.pone.0010134	http://dx.doi.org/10.1371/journal.pone.0010134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583UR	20405032	Green Submitted, gold, Green Published			2022-12-27	WOS:000276705900016
J	Zanetti, M; Teardo, E; La Rocca, N; Zulkifli, L; Checchetto, V; Shijuku, T; Sato, Y; Giacometti, GM; Uozumi, N; Bergantino, E; Szabo, I				Zanetti, Manuela; Teardo, Enrico; La Rocca, Nicoletta; Zulkifli, Lalu; Checchetto, Vanessa; Shijuku, Toshiaki; Sato, Yuki; Giacometti, Giorgio Mario; Uozumi, Noboyuki; Bergantino, Elisabetta; Szabo, Ildiko			A Novel Potassium Channel in Photosynthetic Cyanobacteria	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; GATED K+ CHANNEL; THYLAKOID MEMBRANES; ESCHERICHIA-COLI; ION-CHANNEL; FUNCTIONAL-CHARACTERIZATION; STREPTOMYCES-LIVIDANS; PATCH-CLAMP; ARABIDOPSIS; SYSTEM	Elucidation of the structure-function relationship of a small number of prokaryotic ion channels characterized so far greatly contributed to our knowledge on basic mechanisms of ion conduction. We identified a new potassium channel (SynK) in the genome of the cyanobacterium Synechocystis sp. PCC6803, a photosynthetic model organism. SynK, when expressed in a K+-uptake-system deficient E. coli strain, was able to recover growth of these organisms. The protein functions as a potassium selective ion channel when expressed in Chinese Hamster Ovary cells. The location of SynK in cyanobacteria in both thylakoid and plasmamembranes was revealed by immunogold electron microscopy and Western blotting of isolated membrane fractions. SynK seems to be conserved during evolution, giving rise to a TPK (two-pore K+ channel) family member which is shown here to be located in the thylakoid membrane of Arabidopsis. Our work characterizes a novel cyanobacterial potassium channel and indicates the molecular nature of the first higher plant thylakoid cation channel, opening the way to functional studies.	[Zanetti, Manuela; Teardo, Enrico; La Rocca, Nicoletta; Checchetto, Vanessa; Giacometti, Giorgio Mario; Bergantino, Elisabetta; Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy; [Zulkifli, Lalu; Shijuku, Toshiaki; Sato, Yuki; Uozumi, Noboyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 980, Japan	University of Padua; Tohoku University	Zanetti, M (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	elisabetta.bergantino@unipd.it; ildi@civ.bio.unipd.it	Szabo, Ildiko/AAW-5972-2021; Padova, Ildiko/K-5344-2016; Zanetti, Manuela/C-3535-2015; La Rocca, Nicoletta/AAA-2241-2021; Uozumi, Nobuyuki/AAG-3252-2019; Zulkifli, Lalu/AAD-8401-2021	Szabo, Ildiko/0000-0002-3637-3947; Zanetti, Manuela/0000-0002-9176-6313; La Rocca, Nicoletta/0000-0003-4866-5952; Zulkifli, Lalu/0000-0001-9213-1670; Uozumi, Nobuyuki/0000-0003-4268-1126; checchetto, vanessa/0000-0001-8911-6146	Italian Ministry for University and Research (MIUR); University of Padova; MEXT [17078005, 19380058, 20-08103]; JSPS	Italian Ministry for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Padova; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The European Molecular Biology Organization (Young Investigator Program grant to I. S.), the Italian Ministry for University and Research (MIUR) (to I. S.) and the University of Padova (to E. B. and I. S.) are acknowledged for financial support. This work was also supported by grant FISR from MIUR to G. M. G. This work was also supported by grants-in-aid for scientific research (17078005, 19380058 and 20-08103 to N.U.) from MEXT and JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2008, MOL MICROBIOL, V70, P140, DOI 10.1111/j.1365-2958.2008.06401.x; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Derst C, 1998, J EXP BIOL, V201, P2791; Downey P, 2000, J BIOL CHEM, V275, P39420, DOI 10.1074/jbc.M002962200; ENZ C, 1993, BIOCHIM BIOPHYS ACTA, V1143, P67, DOI 10.1016/0005-2728(93)90217-4; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; FANG ZW, 1995, PLANT PHYSIOL, V108, P1725, DOI 10.1104/pp.108.4.1725; Gazzarrini S, 2003, FEBS LETT, V552, P12, DOI 10.1016/S0014-5793(03)00777-4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Herrero A., 2008, CYANOBACTERIA MOL BI; HILLE B, 2003, ION CHANNELS EXCITAB, pCH5; Hinnah SC, 1998, EUR J BIOCHEM, V253, P606, DOI 10.1046/j.1432-1327.1998.2530606.x; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Ishikawa M, 2009, PLANT CELL PHYSIOL, V50, P773, DOI 10.1093/pcp/pcp027; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kaneko T, 1996, DNA Res, V3, P109; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Ma S, 2004, PLANT J, V40, P845, DOI 10.1111/j.1365-313X.2004.02265.x; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Matsuda N, 2006, BIOSCI BIOTECH BIOCH, V70, P273, DOI 10.1271/bbb.70.273; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Pottosin II, 1996, J MEMBRANE BIOL, V152, P223, DOI 10.1007/s002329900100; Pulina MV, 2006, J BIOL CHEM, V281, P19645, DOI 10.1074/jbc.M602033200; Rascio N, 1999, PLANT CELL ENVIRON, V22, P205, DOI 10.1046/j.1365-3040.1999.00394.x; REMIS D, 1986, BIOCHIM BIOPHYS ACTA, V852, P68, DOI 10.1016/0005-2728(86)90057-5; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Sato Naoki, 2006, V23, P75; SCHONKNECHT G, 1988, NATURE, V336, P589, DOI 10.1038/336589a0; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; TESTER M, 1989, PLANT PHYSIOL, V91, P249, DOI 10.1104/pp.91.1.249; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; Uozumi N, 2001, AM J PHYSIOL-CELL PH, V281, pC733, DOI 10.1152/ajpcell.2001.281.3.C733; Voelker C, 2006, PLANT J, V48, P296, DOI 10.1111/j.1365-313X.2006.02868.x; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	50	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10118	10.1371/journal.pone.0010118	http://dx.doi.org/10.1371/journal.pone.0010118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20404935	gold, Green Published			2022-12-27	WOS:000276705900005
J	Gluck, JM; Hoffmann, S; Koenig, BW; Willbold, D				Glueck, Julian M.; Hoffmann, Silke; Koenig, Bernd W.; Willbold, Dieter			Single Vector System for Efficient N-myristoylation of Recombinant Proteins in E. coli	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; CD4 CYTOPLASMIC DOMAIN; LENGTH HIV-1 NEF; ESCHERICHIA-COLI; CATALYTIC SUBUNIT; MEMBRANE-BINDING; BACTERIAL EXPRESSION; NMR-SPECTROSCOPY; CALCIUM; KINASE	Background: N-myristoylation is a crucial covalent modification of numerous eukaryotic and viral proteins that is catalyzed by N-myristoyltransferase (NMT). Prokaryotes are lacking endogeneous NMT activity. Recombinant production of N-myristoylated proteins in E. coli cells can be achieved by coexpression of heterologous NMT with the target protein. In the past, dual plasmid systems were used for this purpose. Methodology/Principal Findings: Here we describe a single vector system for efficient coexpression of substrate and enzyme suitable for production of co- or posttranslationally modified proteins. The approach was validated using the HIV-1 Nef protein as an example. A simple and efficient protocol for production of highly pure and completely N-myristoylated Nef is presented. The yield is about 20 mg myristoylated Nef per liter growth medium. Conclusions/Significance: The single vector strategy allows diverse modifications of target proteins recombinantly coexpressed in E. coli with heterologous enzymes. The method is generally applicable and provides large amounts of quantitatively processed target protein that are sufficient for comprehensive biophysical and structural studies.	[Glueck, Julian M.; Hoffmann, Silke; Koenig, Bernd W.; Willbold, Dieter] Res Ctr Julich, Inst Struct Biol & Biophys, Julich, Germany; [Glueck, Julian M.; Koenig, Bernd W.; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Gluck, JM (corresponding author), Res Ctr Julich, Inst Struct Biol & Biophys, Julich, Germany.	d.willbold@fz-juelich.de	Willbold, Dieter/A-6280-2013; Hoffmann, Silke/H-5059-2013; Gluck, Julian/G-5668-2013; Koenig, Bernd W/B-4315-2008	Willbold, Dieter/0000-0002-0065-7366; Hoffmann, Silke/0000-0003-1414-8957; Gluck, Julian/0000-0002-2833-3988; Koenig, Bernd W/0000-0002-5300-6276	Helmholtz Society	Helmholtz Society(Helmholtz Association)	This work was supported by a grant of the Helmholtz Society (www.helmholtz.de, "Virtual Institute for Structural Biology") to D. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2004, ARCH PHARM RES, V27, P319, DOI 10.1007/BF02980067; AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Arien KK, 2008, CURR HIV RES, V6, P200, DOI 10.2174/157016208784325001; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Briese L, 2005, J BIOMED SCI, V12, P451, DOI 10.1007/s11373-005-6797-z; BURNETTE B, 1992, PROTEIN EXPRES PURIF, V3, P395, DOI 10.1016/S1046-5928(05)80041-5; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; DURONIO RJ, 1992, P NATL ACAD SCI USA, V89, P4129, DOI 10.1073/pnas.89.9.4129; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Gillam EMJ, 1997, ARCH BIOCHEM BIOPHYS, V346, P81, DOI 10.1006/abbi.1997.0286; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; Harrer E, 2005, ANTIVIR THER, V10, P285; Hermida-Matsumoto L, 1999, J VIROL, V73, P1902, DOI 10.1128/JVI.73.3.1902-1908.1999; Hoffmann S, 2007, BIOL CHEM, V388, P181, DOI 10.1515/BC.2007.020; Kim KJ, 2004, PROTEIN SCI, V13, P1698, DOI 10.1110/ps.04644504; Kirchhoff F, 2009, NAT REV MICROBIOL, V7, P467, DOI 10.1038/nrmicro2111; LADANT D, 1995, J BIOL CHEM, V270, P3179; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Ma HH, 2003, PROTEIN EXPRES PURIF, V27, P49, DOI 10.1016/S1046-5928(02)00541-7; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Preusser A, 2002, BIOCHEM BIOPH RES CO, V292, P734, DOI 10.1006/bbrc.2002.6700; Preusser A, 2001, J VIROL, V75, P3960, DOI 10.1128/JVI.75.8.3960-3964.2001; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHUMAN S, 1990, J BIOL CHEM, V265, P11960; Stangler T, 2007, BIOL CHEM, V388, P611, DOI 10.1515/BC.2007.075; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; WEAVER TA, 1990, J VIROL, V64, P3995, DOI 10.1128/JVI.64.8.3995-4001.1990; Willbold D, 2005, PROTEIN REV, V1, P269; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Wittlich M, 2007, BBA-BIOMEMBRANES, V1768, P2949, DOI 10.1016/j.bbamem.2007.10.023; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	52	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10081	10.1371/journal.pone.0010081	http://dx.doi.org/10.1371/journal.pone.0010081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404920	gold, Green Published			2022-12-27	WOS:000276482100008
J	Godet, AN; Guergnon, J; Maire, V; Croset, A; Garcia, A				Godet, Angelique N.; Guergnon, Julien; Maire, Virginie; Croset, Amelie; Garcia, Alphonse			The Combinatorial PP1-Binding Consensus Motif (R/K)x V-(0,V-1)/IxFxx(R/K)x(R/K) Is a New Apoptotic Signature	PLOS ONE			English	Article							PROTEIN PHOSPHATASE-1; PEPTIDES; INSIGHTS; PP1	Background: Previous studies established that PP1 is a target for Bcl-2 proteins and an important regulator of apoptosis. The two distinct functional PP1 consensus docking motifs, R/Kx((0,1))V/IxF and FxxR/KxR/K, involved in PP1 binding and cell death were previously characterized in the BH1 and BH3 domains of some Bcl-2 proteins. Principal Findings: In this study, we demonstrate that DPT-AIF(1), a peptide containing the AIF(562-571) sequence located in a c-terminal domain of AIF, is a new PP1 interacting and cell penetrating molecule. We also showed that DPT-AIF(1) provoked apoptosis in several human cell lines. Furthermore, DPT-APAF(1) a bi-partite cell penetrating peptide containing APAF-1(122-131), a non penetrating sequence from APAF-1 protein, linked to our previously described DPT-sh1 peptide shuttle, is also a PP1-interacting death molecule. Both AIF(562-571) and APAF-1(122-131) sequences contain a common R/Kx(0,1) V/IxFxxR/KxR/K motif, shared by several proteins involved in control of cell survival pathways. This motif combines the two distinct PP1c consensus docking motifs initially identified in some Bcl-2 proteins. Interestingly DPT-AIF(2) and DPT-APAF(2) that carry a F to A mutation within this combinatorial motif, no longer exhibited any PP1c binding or apoptotic effects. Moreover the F to A mutation in DPT-AIF(2) also suppressed cell penetration. Conclusion: These results indicate that the combinatorial PP1c docking motif R/Kx((0,1))V/IxFxxR/KxR/K, deduced from AIF(562-571) and APAF-1(122-131) sequences, is a new PP1c-dependent Apoptotic Signature. This motif is also a new tool for drug design that could be used to characterize potential anti-tumour molecules.	[Godet, Angelique N.; Guergnon, Julien; Maire, Virginie; Croset, Amelie; Garcia, Alphonse] Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Godet, AN (corresponding author), Inst Pasteur, Lab Phosphatases E3, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	agarcia@pasteur.fr			Institut Pasteur; MRT (Ministere Recherche et Technologie), French Government; CANAM (Caisse Nationale de Maladie)	Institut Pasteur(European Commission); MRT (Ministere Recherche et Technologie), French Government; CANAM (Caisse Nationale de Maladie)	This work was supported by the Institut Pasteur. A.N.G. is a recipient of an MRT (Ministere Recherche et Technologie) fellowship from the French Government. A. C. was supported by Institut Pasteur. V. M. was supported by a fellowship grant from Institut Pasteur, Direction de Valorisation et Partenariats Industriels (DVPI). J.G. was supported by CANAM (Caisse Nationale de Maladie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya C, 2007, CELL BIOL INT, V31, P263, DOI 10.1016/j.cellbi.2006.11.007; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Cohen PTW, 2002, J CELL SCI, V115, P241; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Frank R, 1996, Methods Mol Biol, V66, P149; Garcia A, 2004, CR BIOL, V327, P93, DOI 10.1016/j.crvi.2004.01.001; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Gebrim LC, 2009, BIOLOGICALS, V37, P222, DOI 10.1016/j.biologicals.2009.01.010; Guergnon J, 2006, MOL PHARMACOL, V69, P1115, DOI 10.1124/mol.105.019364; Helps NR, 1998, FEBS LETT, V438, P131, DOI 10.1016/S0014-5793(98)01286-1; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Lin WJ, 2009, PEPTIDES, V30, P283, DOI 10.1016/j.peptides.2008.10.007; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Onishi J, 2008, J PEPT SCI, V14, P1032, DOI 10.1002/psc.1039; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Valle M, 1999, PROTEIN SCI, V8, P883	17	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9981	10.1371/journal.pone.0009981	http://dx.doi.org/10.1371/journal.pone.0009981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376316	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200052
J	Lohmus, M; Sundstrom, LF; Bjorklund, M; Devlin, RH				Lohmus, Mare; Sundstrom, L. Fredrik; Bjorklund, Mats; Devlin, Robert H.			Genotype-Temperature Interaction in the Regulation of Development, Growth, and Morphometrics in Wild-Type, and Growth-Hormone Transgenic Coho Salmon	PLOS ONE			English	Article							RAINBOW-TROUT; GENE-EXPRESSION; ENVIRONMENTAL-TEMPERATURE; ONCORHYNCHUS-KISUTCH; INDIVIDUAL VARIATION; BODY-COMPOSITION; GH/IGF SYSTEM; BEHAVIOR; MORPHOLOGY; PHYSIOLOGY	Background: The neuroendocrine system is an important modulator of phenotype, directing cellular genetic responses to external cues such as temperature. Behavioural and physiological processes in poikilothermic organisms (e. g. most fishes), are particularly influenced by surrounding temperatures. Methodology/Principal Findings: By comparing the development and growth of two genotypes of coho salmon (wild-type and transgenic with greatly enhanced growth hormone production) at six different temperatures, ranging between 8 degrees and 18 degrees C, we observed a genotype-temperature interaction and possible trend in directed neuroendocrine selection. Differences in growth patterns of the two genotypes were compared by using mathematical models, and morphometric analyses of juvenile salmon were performed to detect differences in body shape. The maximum hatching and alevin survival rates of both genotypes occurred at 12 degrees C. At lower temperatures, eggs containing embryos with enhanced GH production hatched after a shorter incubation period than wild-type eggs, but this difference was not apparent at and above 16 degrees C. GH transgenesis led to lower body weights at the time when the yolk sack was completely absorbed compared to the wild genotype. The growth of juvenile GH-enhanced salmon was to a greater extent stimulated by higher temperatures than the growth of the wild-type. Increased GH production significantly influenced the shape of the salmon growth curves. Conclusions: Growth hormone overexpression by transgenesis is able to stimulate the growth of coho salmon over a wide range of temperatures. Temperature was found to affect growth rate, survival, and body morphology between GH transgenic and wild genotype coho salmon, and differential responses to temperature observed between the genotypes suggests they would experience different selective forces should they ever enter natural ecosystems. Thus, GH transgenic fish would be expected to differentially respond and adapt to shifts in environmental conditions compared with wild type, influencing their ability to survive and interact in ecosystems. Understanding these relationships would assist environmental risk assessments evaluating potential ecological effects.	[Lohmus, Mare; Sundstrom, L. Fredrik; Devlin, Robert H.] Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada; [Lohmus, Mare] Natl Vet Inst, Dept Chem Environm & Feed Hyg, Sect Environm & Biosecur, S-75007 Uppsala, Sweden; [Bjorklund, Mats] Uppsala Univ, Evolutionary Biol Ctr, Anim Ecol Dept Ecol & Evolut, Uppsala, Sweden	Fisheries & Oceans Canada; National Veterinary Institute SVA; Uppsala University	Lohmus, M (corresponding author), Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada.	mare.lohmus@sva.se	Sundstrom, Fred/E-6736-2011; Lõhmus, Mare/E-2442-2012; Bjørklund, Geir/B-7319-2014	Sundstrom, Fred/0000-0002-3157-7289; Bjørklund, Geir/0000-0003-2632-3935; Lohmus, Mare/0000-0002-6619-9679; Bjorklund, Mats/0000-0001-5436-6989	Canadian Regulatory System for Biotechnology; Marie Curie Outgoing International Fellowship, European Community [MOIF-CT-2005-8141]	Canadian Regulatory System for Biotechnology; Marie Curie Outgoing International Fellowship, European Community(European Commission)	The work was carried out with financial support from the Canadian Regulatory System for Biotechnology (RHD). LFS was funded as a Marie Curie Outgoing International Fellowship under contract MOIF-CT-2005-8141 from the European Community's Sixth Framework Program. The present work does not necessarily reflect the Community's views and in no way anticipates its future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MV, 1999, ANIM BEHAV, V58, P933, DOI 10.1006/anbe.1999.1229; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adkins-Regan E, 2008, PHILOS T R SOC B, V363, P1599, DOI 10.1098/rstb.2007.0005; Ball GF, 2008, PHILOS T R SOC B, V363, P1699, DOI 10.1098/rstb.2007.0010; Bjornsson BT, 2002, FISH PHYSIOL BIOCHEM, V27, P227, DOI 10.1023/B:FISH.0000032728.91152.10; Bjornsson BT, 1997, FISH PHYSIOL BIOCHEM, V17, P9, DOI 10.1023/A:1007712413908; BRANNAS E, 1995, EVOL ECOL, V9, P411, DOI 10.1007/BF01237763; Brannon EL, 2004, REV FISH SCI, V12, P99, DOI 10.1080/10641260490280313; Brett J.R., 1979, FISH PHYSIO, V8, P599; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; DANZMANN RG, 1990, CAN J FISH AQUAT SCI, V47, P1292, DOI 10.1139/f90-148; Devlin RH, 1995, AQUACULTURE, V137, P161, DOI 10.1016/0044-8486(95)01090-4; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Dunham RA, 2002, MAR BIOTECHNOL, V4, P604, DOI 10.1007/s10126-002-0034-9; Farrell AP, 1997, CAN J ZOOL, V75, P335, DOI 10.1139/z97-043; Gabillard JC, 2005, CYBIUM, V29, P107; Gabillard JC, 2003, GEN COMP ENDOCR, V133, P233, DOI 10.1016/S0016-6480(03)00167-9; Gabillard JC, 2003, J EXP ZOOL PART A, V298A, P134, DOI 10.1002/jez.a.10280; Gabillard JC, 2003, GEN COMP ENDOCR, V133, P17, DOI 10.1016/S0016-6480(03)00156-4; Gabillard JC, 2006, J ENDOCRINOL, V190, P29, DOI 10.1677/joe.1.06695; HAZEL JR, 1974, MOL MECH TEMPERATURE, P620; IWAMA GK, 1981, CAN J FISH AQUAT SCI, V38, P649, DOI 10.1139/f81-087; IWAMA GK, 1996, PRINCIPLES SALMONID, P467, DOI DOI 10.1016/S0167-9309(96)80010-X; Johansson V, 2005, GEN COMP ENDOCR, V141, P58, DOI 10.1016/j.ygcen.2004.11.014; Jonsson E, 2003, HORM BEHAV, V43, P367, DOI 10.1016/S0018-506X(03)00010-2; Li M, 2006, COMP BIOCHEM PHYS A, V143, P514, DOI 10.1016/j.cbpa.2006.01.024; Li M, 2007, GEN COMP ENDOCR, V153, P302, DOI 10.1016/j.ygcen.2007.02.012; Lohmus M, 2008, HORM BEHAV, V54, P506, DOI 10.1016/j.yhbeh.2008.02.010; MALCOLM J, 2003, AQUAC RES, V34, P581; McCormick SD, 2000, AM J PHYSIOL-REG I, V278, pR1352, DOI 10.1152/ajpregu.2000.278.5.R1352; Mingarro M, 2002, GEN COMP ENDOCR, V128, P102, DOI 10.1016/S0016-6480(02)00042-4; Mori T, 1999, MOL CELL ENDOCRINOL, V149, P129, DOI 10.1016/S0303-7207(98)00248-2; Oakes JD, 2007, AQUACULTURE, V265, P309, DOI 10.1016/j.aquaculture.2007.01.015; Ostenfeld TH, 1998, J FISH BIOL, V52, P850, DOI 10.1111/j.1095-8649.1998.tb00825.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299; Raven PA, 2006, AQUACULTURE, V254, P730, DOI 10.1016/j.aquaculture.2005.11.009; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Rohlf FJ, 2008, TPSDIG DIGITIZE LAND; Rohlf FJ, 2007, TPSRELW RELATIVE WAR; ROHLF FJ, 2005, TPSSMALL VERSION 1 1; ROMBOUGH P, 2005, COMP DEV PHYSL CONTR, P99; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Sullivan K., 2000, ANAL EFFECTS TEMPERA; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Sundstrom LF, 2004, ETHOLOGY, V110, P381, DOI 10.1111/j.1439-0310.2004.00985.x; Sundstrom LF, 2003, ETHOLOGY, V109, P701, DOI 10.1046/j.1439-0310.2003.00908.x; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Tabachnik B. G., 2001, USING MULTIVARIATE S; Tatar M, 2000, TRENDS ECOL EVOL, V15, P207, DOI 10.1016/S0169-5347(00)01834-6; Taylor JF, 2003, FISH PHYSIOL BIOCHEM, V28, P449, DOI 10.1023/B:FISH.0000030626.46003.b1; Welsh HH, 2001, N AM J FISH MANAGE, V21, P464, DOI 10.1577/1548-8675(2001)021&lt;0464:DOJCSI&gt;2.0.CO;2; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149	61	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9980	10.1371/journal.pone.0009980	http://dx.doi.org/10.1371/journal.pone.0009980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376315	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200051
J	Yoo, JS; Ayati, MH; Kim, HB; Zhang, WB; Soh, KS				Yoo, Jung Sun; Ayati, M. Hossein; Kim, Hong Bae; Zhang, Wei-bo; Soh, Kwang-Sup			Characterization of the Primo-Vascular System in the Abdominal Cavity of Lung Cancer Mouse Model and Its Differences from the Lymphatic System	PLOS ONE			English	Article							THREAD-LIKE STRUCTURES; BONGHAN DUCTS; VISUALIZE; PATHWAYS; SURFACES; VESSELS	Cancer growth and dissemination have been extensively studied for a long time. Nevertheless, many new observations on anatomy and histopathology of cancer events are still reported such as formation of a vasculogenic-like network inside aggressive tumors. In this research, new kinds of micro-conduits, named primo-vessels, were found inside the abdominal cavity of NCI-H460 lung cancer murine xenograft models. These vascular threads were largely distributed on the surfaces of various organs and were often connected to peritoneal tumor nodules. Histological and immunofluorescent investigations showed that the primo-vessels had characteristic features that were distinctively different from those of similar-looking lymphatic vessels. They had multiple channels surrounded with loose collageneous matrices, which is in contrast to the single-channel structure of other vascular systems. The rod-shaped nuclei aligned longitudinally along the channels were assumed to be the endothelial cells of the primo-vessels, but LYVE-1, a specific marker of lymphatics, was not expressed, which indicates a clear difference from lymphatic endothelial cells. Taken together these findings on and characterization of the novel threadlike vascular structures in cancer models may have important implications for cancer prognosis and for therapy.	[Yoo, Jung Sun; Kim, Hong Bae; Soh, Kwang-Sup] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea; [Ayati, M. Hossein] Beijing Univ Chinese Med, Sch Acupuncture, Beijing, Peoples R China; [Zhang, Wei-bo] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China	Seoul National University (SNU); Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS	Yoo, JS (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	kssoh1@gmail.com	Yoo, Jung Sun/I-8760-2017; Ayati, Mohammad Hossein/I-1221-2019	Yoo, Jung Sun/0000-0002-8865-0424; Ayati, Mohammad Hossein/0000-0002-1290-1135; Soh, Kwang-Sup/0000-0001-8776-7877	Gwangju Institute of Science and Technology. Jung Sun Yoo; Seoul Science Fellowship	Gwangju Institute of Science and Technology. Jung Sun Yoo; Seoul Science Fellowship	This research was supported by a Systems Biology Infrastructure Establishment Grant from the Gwangju Institute of Science and Technology. Jung Sun Yoo was supported by the Seoul Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; FUJIWARA S, 1967, IGAKU NO AYUMI, V60, P567; Johng HM, 2007, EVID-BASED COMPL ALT, V4, P77, DOI 10.1093/ecam/nel057; Kato S, 2006, ANAT SCI INT, V81, P71, DOI 10.1111/j.1447-073X.2006.00142.x; Kim BH, 1963, J ACAD MED SCI DPR K, V90, P1; Lee BC, 2008, LYMPHOLOGY, V41, P178; Lee BC, 2007, MICROSC RES TECHNIQ, V70, P34, DOI 10.1002/jemt.20383; Lee BC, 2009, J ACUPUNCT MERIDIAN, V2, P79, DOI 10.1016/S2005-2901(09)60020-0; Lee BC, 2009, J ACUPUNCT MERIDIAN, V2, P66, DOI 10.1016/S2005-2901(09)60017-0; Lee Changhoon, 2006, Lymphatic Research and Biology, V4, P181, DOI 10.1089/lrb.2006.4402; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Melles GRJ, 1999, J CATARACT REFR SURG, V25, P7, DOI 10.1016/S0886-3350(99)80004-2; NORN MS, 1980, ACTA OPHTHALMOL, V58, P550; Ogay V, 2009, J ACUPUNCT MERIDIAN, V2, P107, DOI 10.1016/S2005-2901(09)60042-X; Shin Hak-Soo, 2005, Anatomical Record Part B:The New Anatomist, V284, P35, DOI 10.1002/ar.b.20061; SU CC, 2010, PHYTOTHER RES; Sung B, 2008, NATURWISSENSCHAFTEN, V95, P117, DOI 10.1007/s00114-007-0300-9; Sung B, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.022901; Veckeneer M, 2001, GRAEF ARCH CLIN EXP, V239, P698, DOI 10.1007/s004170100341; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Yoo JS, 2009, J ACUPUNCT MERIDIAN, V2, P118, DOI 10.1016/S2005-2901(09)60043-1	22	63	64	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9940	10.1371/journal.pone.0009940	http://dx.doi.org/10.1371/journal.pone.0009940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376343	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200017
J	Cohen, TS; Lawrence, GG; Khasgiwala, A; Margulies, SS				Cohen, Taylor S.; Lawrence, Gladys Gray; Khasgiwala, Amit; Margulies, Susan S.			MAPk Activation Modulates Permeability of Isolated Rat Alveolar Epithelial Cell Monolayers Following Cyclic Stretch	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; PROTEIN-KINASE; VENTILATION; PATHWAYS; STRESS; INHIBITION; EXPRESSION; PREVENTION; MECHANISM	We cultured (5 days) rat alveolar epithelial cells to investigate the role of mitogen-activated protein kinase (MAPk) signaling in ventilator induced epithelial barrier dysfunction. Cells were stretched to a magnitude of 12% or 37% change in surface area at a rate of 0.25 Hz with and without pretreatment with either the JNK inhibitor SP600125 or the ERK inhibitor U0126. Following stretch (0, 10, 30, or 60 min), MAPk phosphorylation was examined, monolayer permeability to the uncharged tracer carboxyfluorescein measured (0, 10, 60 min of stretch), and occludin expression determined (0 and 60 min of stretch). Stretch to 12%, previously shown not to increase monolayer permeability, did not alter phosphorylation of any MAPk or occludin expression at any time point. Following stretch to 37%, phosphorylation of JNK, ERK, and p38 was significantly higher by 10 minutes than in unstretched monolayers. Phosphorylation of JNK and p38 subsided as stretch continued, and by 30 minutes returned to unstretched levels. Phosphorylation of ERK remained significantly elevated compared to unstretched levels at all stretch durations. Epithelial permeability increased significantly by 10 minutes of stretch compared to unstretched controls, with further significant increases by 60 minutes. Inhibition with U0126 and SP600125 prevented stretch-induced phosphorylation increases of ERK and JNK, respectively, however neither prevented increases in permeability following 10 minutes. Separately, inhibition of JNK or ERK prevented subsequent additional permeability increases as stretch continued to 60 minute time points. Inhibition of JNK, not ERK, prevented loss of occludin, and minimized loss of cell-cell contact following 60 minutes of stretch. These data suggest that stretch-induced JNK signaling modulates epithelial permeability through regulation tight junction protein expression, and is a potential target for clinical treatments during mechanical ventilation.	[Cohen, Taylor S.; Lawrence, Gladys Gray; Khasgiwala, Amit; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Cohen, TS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	NIH [RO1-HL57204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by the NIH: RO1-HL57204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Boncoeur E, 2008, INT J BIOCHEM CELL B, V40, P432, DOI 10.1016/j.biocel.2007.08.013; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Cavanaugh KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1179, DOI 10.1152/ajpcell.00355.2004; Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; EGAN EA, 1976, J PHYSIOL-LONDON, V260, P409, DOI 10.1113/jphysiol.1976.sp011522; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; HAAKE R, 1987, CHEST, V91, P608, DOI 10.1378/chest.91.4.608; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; KIM KJ, 1985, J APPL PHYSIOL, V59, P1290, DOI 10.1152/jappl.1985.59.4.1290; KIM KJ, 1982, J APPL PHYSIOL, V52, P1498, DOI 10.1152/jappl.1982.52.6.1498; KIM KJ, 1983, J APPL PHYSIOL, V54, P140, DOI 10.1152/jappl.1983.54.1.140; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Li LF, 2004, AM J RESP CRIT CARE, V169, P518, DOI 10.1164/rccm.200305-660OC; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Ning QM, 2007, MED HYPOTHESES, V68, P356, DOI 10.1016/j.mehy.2006.06.053; Oswari J, 2001, AM J PHYSIOL-LUNG C, V281, pL1068, DOI 10.1152/ajplung.2001.281.5.L1068; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; ROQUE T, 2008, J PHARM EXP THER; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; Zar JH, 1999, BIOSTATISTICAL ANAL	37	48	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10385	10.1371/journal.pone.0010385	http://dx.doi.org/10.1371/journal.pone.0010385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442784	Green Submitted, gold, Green Published			2022-12-27	WOS:000277154200021
J	Govorunova, EG; Moussaif, M; Kullyev, A; Nguyen, KCQ; McDonald, TV; Hall, DH; Sze, JY				Govorunova, Elena G.; Moussaif, Mustapha; Kullyev, Andrey; Nguyen, Ken C. Q.; McDonald, Thomas V.; Hall, David H.; Sze, Ji Y.			A Homolog of FHM2 Is Involved in Modulation of Excitatory Neurotransmission by Serotonin in C. elegans	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; NERVOUS-SYSTEM; MISSENSE MUTATION; PLC-BETA; CAENORHABDITIS; GENE; MIGRAINE; NA,K-ATPASE; BEHAVIOR; RECEPTORS	The C. elegans eat-6 gene encodes a Na+, K+-ATPase a subunit and is a homolog of the familial hemiplegic migraine candidate gene FHM2. Migraine is the most common neurological disorder linked to serotonergic dysfunction. We sought to study the pathophysiological mechanisms of migraine and their relation to serotonin (5-HT) signaling using C. elegans as a genetic model. In C. elegans, exogenous 5-HT inhibits paralysis induced by the acetylcholinesterase inhibitor aldicarb. We found that the eat-6(ad467) mutation or RNAi of eat-6 increases aldicarb sensitivity and causes complete resistance to 5-HT treatment, indicating that EAT-6 is a component of the pathway that couples 5-HT signaling and ACh neurotransmission. While a postsynaptic role of EAT-6 at the bodywall NMJs has been well established, we found that EAT-6 may in addition regulate presynaptic ACh neurotransmission. We show that eat-6 is expressed in ventral cord ACh motor neurons, and that cell-specific RNAi of eat-6 in the ACh neurons leads to hypersensitivity to aldicarb. Electron microscopy showed an increased number of synaptic vesicles in the ACh neurons in the eat-6(ad467) mutant. Genetic analyses suggest that EAT-6 interacts with EGL-30 G alpha q, EGL-8 phospholipase C and SLO-1 BK channel signaling to modulate ACh neurotransmission and that either reduced or excessive EAT-6 function may lead to increased ACh neurotransmission. Study of the interaction between eat-6 and 5-HT receptors revealed both stimulatory and inhibitory 5-HT inputs to the NMJs. We show that the inhibitory and stimulatory 5-HT signals arise from distinct 5-HT neurons. The role of eat-6 in modulation of excitatory neurotransmission by 5-HT may provide a genetic explanation for the therapeutic effects of the drugs targeting 5-HT receptors in the treatment of migraine patients.	[Govorunova, Elena G.; Moussaif, Mustapha; Kullyev, Andrey; McDonald, Thomas V.; Sze, Ji Y.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Nguyen, Ken C. Q.; Hall, David H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Govorunova, EG (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	jiying.sze@einstein.yu.edu	Kullyev, Andrey/A-1673-2017	Kullyev, Andrey/0000-0002-3547-4041; Govorunova, Elena/0000-0003-0522-9683	National Institutes of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064747, R01MH083982] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an award from the Department of Defense Autism Spectrum Disorder Research Program and grants from the National Institutes of Mental Health (to J.Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AVERY L, 1993, GENETICS, V133, P897; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bastiani CA, 2003, GENETICS, V165, P1805; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Carre-Pierrat Maite, 2006, Invertebrate Neuroscience, V6, P189, DOI 10.1007/s10158-006-0033-z; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis MW, 1995, J NEUROSCI, V15, P8408; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Doi M, 2008, MOL CELL NEUROSCI, V38, P548, DOI 10.1016/j.mcn.2008.05.003; EDGLEY M, 2006, WORMBOOK C ELEGANS R; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Estevez M, 2006, HEADACHE, V46, pS25, DOI 10.1111/j.1526-4610.2006.00487.x; FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307; Gargus JJ, 2009, ANN NY ACAD SCI, V1151, P133, DOI 10.1111/j.1749-6632.2008.03572.x; Goadsby PJ, 2007, TRENDS MOL MED, V13, P39, DOI 10.1016/j.molmed.2006.11.005; Goldstein I, 2009, BIOL PSYCHIAT, V65, P985, DOI 10.1016/j.biopsych.2008.10.033; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; HALL D, 1995, ELECT MICROSCOPY 3D, P395; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hamel E, 2007, Cephalalgia, V27, P1293, DOI 10.1111/j.1468-2982.2007.01476.x; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Montagna P, 2004, NEUROL SCI, V25, pS93, DOI 10.1007/s10072-004-0261-0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Okamura H, 2003, J MEMBRANE BIOL, V191, P13, DOI 10.1007/s00232-002-1041-5; OKKEMA PG, 1993, GENETICS, V135, P385; Perez-Mansilla B, 2009, ADV GENET, V65, P145, DOI 10.1016/S0065-2660(09)65004-5; Peters MA, 2007, CURR BIOL, V17, P1601, DOI 10.1016/j.cub.2007.08.031; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Sandoval GM, 2006, NAT NEUROSCI, V9, P599, DOI 10.1038/nn1685; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Shima Y, 1998, BIOCHEM BIOPH RES CO, V248, P778, DOI 10.1006/bbrc.1998.8981; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; TRENT C, 1983, GENETICS, V104, P619; van de Ven RCG, 2007, ARCH NEUROL-CHICAGO, V64, P643, DOI 10.1001/archneur.64.5.643; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Weimer Robby M., 2006, V351, P203; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	65	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10368	10.1371/journal.pone.0010368	http://dx.doi.org/10.1371/journal.pone.0010368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442779	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200010
J	Kumasaka, N; Nakamura, Y; Kamatani, N				Kumasaka, Natsuhiko; Nakamura, Yusuke; Kamatani, Naoyuki			The Textile Plot: A New Linkage Disequilibrium Display of Multiple-Single Nucleotide Polymorphism Genotype Data	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; HUMAN GENOME; HAPLOTYPE MAP; ASSOCIATION; POPULATION; VISUALIZATION	Linkage disequilibrium (LD) is a major concern in many genetic studies because of the markedly increased density of SNP (Single Nucleotide Polymorphism) genotype markers. This dramatic increase in the number of SNPs may cause problems in statistical analyses, such as by introducing multiple comparisons in hypothesis testing and colinearity in logistic regression models, because of the presence of complex LD structures. Inferences must be made about the underlying genetic variation through the LD structure before applying statistical models to the data. Therefore, we introduced the textile plot to provide a visualization of LD to improve the analysis of the genetic variation present in multiple-SNP genotype data. The plot can accentuate LD by displaying specific geometrical shapes, and allowing for the underlying haplotype structure to be inferred without any haplotype-phasing algorithms. Application of this technique to simulated and real data sets illustrated the potential usefulness of the textile plot as an aid to the interpretation of LD in multiple-SNP genotype data. The initial results of LD mapping and haplotype analyses of disease genes are encouraging, indicating that the textile plot may be useful in disease association studies.	[Kumasaka, Natsuhiko; Nakamura, Yusuke; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Tokyo, Japan	RIKEN; University of Tokyo	Kumasaka, N (corresponding author), RIKEN, Ctr Genom Med, Tokyo, Japan.	kumasaka@stat.math.keio.ac.jp			Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CALSON CS, 2004, AM J HUM GENET, V74, P106; Chambers JM., 1992, STAT MODELS S; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry B.J, 2004, COMPUTATIONAL INFORM; Gifi A., 1990, NONLINEAR MULTIVARIA; Greenacre Michael, 1984, THEORY APPL CORRES A; Hurley CB, 2004, J COMPUT GRAPH STAT, V13, P788, DOI 10.1198/106186004X12425; Inselberg A, 1985, VISUAL COMPUT, V1, P69, DOI 10.1007/BF01898350; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kumasaka N, 2008, COMPUT STAT DATA AN, V52, P3616, DOI 10.1016/j.csda.2007.11.016; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Smith LP, 2009, GENET EPIDEMIOL, V33, P344, DOI 10.1002/gepi.20387; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wadman M, 2006, NATURE, V444, P256, DOI 10.1038/444256a; WEGMAN EJ, 1990, J AM STAT ASSOC, V85, P664, DOI 10.2307/2290001	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10207	10.1371/journal.pone.0010207	http://dx.doi.org/10.1371/journal.pone.0010207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436909	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079700002
J	Obeso, D; Dawson, DS				Obeso, David; Dawson, Dean S.			Temporal Characterization of Homology-Independent Centromere Coupling in Meiotic Prophase	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX PROTEIN; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; BUDDING YEAST; MEIOSIS; PROMOTES; RECOMBINATION; BEHAVIOR; MUTANTS	Background: Over the past thirty years several reports of the pairing or association of non-homologous centromeres during meiotic prophase have appeared in the literature. Recently, the homology-independent pairwise association of centromeres, termed centromere coupling, was also reported in budding yeast. It seems paradoxical that centromeres would pair with non-homologous partners during a process intended to align homologous chromosomes, yet the conservation of this phenomenon across a wide range of species suggests it may play an important role in meiosis. Principal Findings: To better define the role of this phenomenon in budding yeast, experiments were preformed to place centromere coupling within the context of landmark meiotic events. Soon after the initiation of the meiotic program, centromeres were found to re-organize from a single cluster into non-homologous couples. Centromere coupling is detected as soon as chromosome replication is finished and persists while the recombination protein Dmc1 is loaded onto the chromosomes, suggesting that centromere coupling persists through the time of double strand break formation. In the absence of the synaptonemal complex component, Zip1, centromere coupling was undetectable, at all times examined, confirming the essential role of this protein on this process. Finally, the timely release of centromere coupling depends on the recombination-initiating enzyme, Spo11, suggesting a connection between events in homologous pairing/recombination and the regulation of centromere coupling. Conclusions: Based on our results we propose a role for centromere coupling in blocking interactions between homologous centromeres as recombination initiation is taking place.	[Obeso, David; Dawson, Dean S.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Obeso, David; Dawson, Dean S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Obeso, D (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	dawsond@omrf.org			Barrett Scholarship; National Institutes of Health (NIH) [GM75363]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075363] Funding Source: NIH RePORTER	Barrett Scholarship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Barrett Scholarship to DO and National Institutes of Health (NIH) grant GM75363 to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDHAN A, 2010, MOL BIOL CE IN PRESS; Bhuiyan H, 2004, GENETICS, V168, P775, DOI 10.1534/genetics.104.029660; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Burke D., 2000, METHODS YEAST GENETI; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; CHURCH K, 1976, CHROMOSOMA, V56, P249, DOI 10.1007/BF00293189; CLARKE L, 1983, NATURE, V305, P23, DOI 10.1038/305023a0; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; Gladstone MN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000771; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Haase Steven B, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0723s26; Hayashi A, 1998, GENES CELLS, V3, P587, DOI 10.1046/j.1365-2443.1998.00215.x; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; LAMBIE EJ, 1986, GENETICS, V114, P769; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; NAG DK, 1995, GENETICS, V141, P75; Newnham L, 2010, P NATL ACAD SCI USA, V107, P781, DOI 10.1073/pnas.0913435107; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Stewart MN, 2008, TRENDS GENET, V24, P564, DOI 10.1016/j.tig.2008.08.006; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; Tsubouchi T, 2008, GENE DEV, V22, P3217, DOI 10.1101/gad.1709408; Tung KS, 1998, GENETICS, V149, P817; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3	31	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10336	10.1371/journal.pone.0010336	http://dx.doi.org/10.1371/journal.pone.0010336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428251	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079300020
J	Etchegaray, JP; Yu, EA; Indic, P; Dallmann, R; Weaver, DR				Etchegaray, Jean-Pierre; Yu, Elizabeth A.; Indic, Premananda; Dallmann, Robert; Weaver, David R.			Casein Kinase 1 Delta (CK1 delta) Regulates Period Length of the Mouse Suprachiasmatic Circadian Clock In Vitro	PLOS ONE			English	Article							GENE-EXPRESSION; CKI-EPSILON; WAVELET ANALYSIS; RHYTHMS; MAMMALS; PHOSPHORYLATION; DEGRADATION; PROTEINS; REVEALS; ROLES	Background: Casein kinase 1 delta (CK1 delta) plays a more prominent role in the regulation of circadian cycle length than its homologue casein kinase 1 epsilon (CK1 epsilon) in peripheral tissues such as liver and embryonic fibroblasts. Mice lacking CK1 delta die shortly after birth, so it has not been possible to assess the impact of loss of CK1 delta on behavioral rhythms controlled by the master circadian oscillator in the suprachiasmatic nuclei (SCN). Methodology/Principal Findings: In the present study, mPER2::LUCIFERASE bioluminescence rhythms were monitored from SCN explants collected from neonatal mice. The data demonstrate that SCN explants from neonatal CK1 delta-deficient mice oscillate, but with a longer circadian period than littermate controls. The cycle length of rhythms recorded from neonatal SCN explants of CK1 epsilon-deficient mice did not differ from control explants. Conclusions/Significance: The results indicate that CK1 delta plays a more prominent role than CK1 epsilon in the maintenance of 24-hour rhythms in the master circadian oscillator.	[Etchegaray, Jean-Pierre; Yu, Elizabeth A.; Dallmann, Robert; Weaver, David R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Indic, Premananda] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Etchegaray, JP (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	David.weaver@umassmed.edu	Dallmann, Bob/AAA-4929-2022	Dallmann, Robert/0000-0002-7490-0218; Weaver, David/0000-0001-7941-6719	National Institutes of Neurological Diseases and Stroke, National Institutes of Health [R01 NS056125]; Deutsche Forschungsgemeinschaft (DFG) [DA525/2-1]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056125] Funding Source: NIH RePORTER	National Institutes of Neurological Diseases and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Award R01 NS056125 from the National Institutes of Neurological Diseases and Stroke (to DRW). RD was supported in part by grant DA525/2-1 from the Deutsche Forschungsgemeinschaft (DFG). Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. DRW is a member of the University of Massachusetts Medical School Diabetes and Endocrinology Research Center (DK 32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Carmona RA, 1999, IEEE T SIGNAL PROCES, V47, P480, DOI 10.1109/78.740131; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Price TS, 2008, BIOINFORMATICS, V24, P2794, DOI 10.1093/bioinformatics/btn521; Priestley M. B., 1981, SPECTRAL ANAL TIME S; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Sprouse J, 2009, PSYCHOPHARMACOLOGY, V204, P735, DOI 10.1007/s00213-009-1503-x; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7	25	33	35	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10303	10.1371/journal.pone.0010303	http://dx.doi.org/10.1371/journal.pone.0010303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421981	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600020
J	Gao, MC; Bellugi, U; Dai, L; Mills, DL; Sobel, EM; Lange, K; Korenberg, JR				Gao, Michael C.; Bellugi, Ursula; Dai, Li; Mills, Debra L.; Sobel, Eric M.; Lange, Kenneth; Korenberg, Julie R.			Intelligence in Williams Syndrome Is Related to STX1A, Which Encodes a Component of the Presynaptic SNARE Complex	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; GENE-EXPRESSION; MOLECULAR-GENETICS; SYNTAXIN; IMMUNE; BRAIN; 1A; COGNITION; DOPAMINE; GTF2IRD1	Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.	[Gao, Michael C.; Korenberg, Julie R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Gao, Michael C.; Sobel, Eric M.; Lange, Kenneth; Korenberg, Julie R.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Gao, Michael C.; Korenberg, Julie R.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Bellugi, Ursula] Salk Inst Biol Studies, Cognit Neurosci Lab, La Jolla, CA USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Dept Pediat, Inst Brain, Ctr Integrated Neurosci & Human Behav, Salt Lake City, UT USA; [Mills, Debra L.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Lange, Kenneth] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Lange, Kenneth] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Salk Institute; Utah System of Higher Education; University of Utah; Bangor University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gao, MC (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA.	julie.korenberg@hsc.utah.edu		Sobel, Eric/0000-0002-1718-0031	National Institute of Child Health and Human Development [P01 HD33113]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD033113] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development Grant: P01 HD33113 (U.B., J.R.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, WAIS R MANUAL; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Botta A, 1999, J MED GENET, V36, P478; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Collette JC, 2009, J HUM GENET, V54, P193, DOI 10.1038/jhg.2009.5; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Dick DM, 2007, BEHAV GENET, V37, P265, DOI 10.1007/s10519-006-9131-2; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Enns RA, 1998, J CLIN PSYCHOL, V54, P447, DOI 10.1002/(SICI)1097-4679(199806)54:4<447::AID-JCLP7>3.0.CO;2-K; FARAJ BA, 1991, PHARMACOLOGY, V42, P135, DOI 10.1159/000138790; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Howlin P, 1998, J CHILD PSYCHOL PSYC, V39, P183, DOI 10.1017/S0021963097001789; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Joy S, 2003, ASSESSMENT, V10, P56, DOI 10.1177/0095399702250335; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Minger SL, 2001, J NEUROPATH EXP NEUR, V60, P929, DOI 10.1093/jnen/60.10.929; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Quick MW, 1997, J NEUROSCI, V17, P2967; RuizMontasell B, 1996, EUR J NEUROSCI, V8, P2544, DOI 10.1111/j.1460-9568.1996.tb01548.x; Ryten Mina, 2009, Briefings in Functional Genomics & Proteomics, V8, P194, DOI 10.1093/bfgp/elp028; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Wang Y, 2008, J IMMUNOL, V181, P8226, DOI 10.4049/jimmunol.181.12.8226; Yamaguchi Y, 2004, AM J PHYSIOL-ENDOC M, V287, pE970, DOI 10.1152/ajpendo.00027.2003	43	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10292	10.1371/journal.pone.0010292	http://dx.doi.org/10.1371/journal.pone.0010292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422020	Green Published, gold			2022-12-27	WOS:000276952500035
J	Halsey, LG; White, CR				Halsey, Lewis G.; White, Craig R.			Measuring Energetics and Behaviour Using Accelerometry in Cane Toads Bufo marinus	PLOS ONE			English	Article							ESTIMATING ENERGY-EXPENDITURE; DOUBLY LABELED WATER; HEART-RATE; METABOLIC-RATE; LOCOMOTORY ENERGETICS; BODY-TEMPERATURE; THERMAL-DEPENDENCE; OXYGEN-CONSUMPTION; DYNAMIC ACTION; MEAL SIZE	Cane toads Bufo marinus were introduced to Australia as a control agent but now have a rapidly progressing invasion front and damage new habitats they enter. Predictive models that can give expansion rates as functions of energy supply and feeding ground distribution could help to maximise control efficiency but to date no study has measured rates of field energy expenditure in an amphibian. In the present study we used the accelerometry technique to generate behavioural time budgets and, through the derivation of ODBA (overall dynamic body acceleration), to obtain estimates of energetics in free ranging cane toads. This represents the first time that accelerometers have been used to not only quantify the behaviour of animals but also assign to those behaviours rates of energy expenditure. Firstly, laboratory calibrations between ODBA and metabolic rate were obtained and used to generate a common prediction equation for the subject toads (R-2 = 0.74). Furthermore, acceleration data recorded during different behaviours was studied to ascertain threshold values for objectively defining behaviour categories. Importantly, while subsequent accelerometer field deployments were relatively short they agreed with previous studies on the proportion of time that cane toads locomote yet suggest that the metabolic rate of cane toads in the wild may sometimes be considerably higher than might be assumed based on data for other species.	[Halsey, Lewis G.] Roehampton Univ, Sch Life Sci, London, England; [White, Craig R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	Roehampton University; University of Queensland	Halsey, LG (corresponding author), Roehampton Univ, Sch Life Sci, London, England.	l.halsey@roehampton.ac.uk	Halsey, Lewis/B-8498-2011; White, Craig R/F-9062-2010	Halsey, Lewis/0000-0002-0786-7585; White, Craig R/0000-0002-0200-2187	University of Queensland; Royal Society; Australian Research Council [DP0987626]	University of Queensland(University of Queensland); Royal Society(Royal Society of London); Australian Research Council(Australian Research Council)	LGH was supported by a University of Queensland Travel Award for International Collaborative Research and a Royal Society International Travel Grant. CRW is an Australian Research Council QEII Fellow (project number DP0987626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Barton DP, 1997, AUST J ECOL, V22, P316, DOI 10.1111/j.1442-9993.1997.tb00677.x; Beebee TJC, 2002, CONSERV BIOL, V16, P1454, DOI 10.1046/j.1523-1739.2002.02102.x; BENNETT AF, 1984, J COMP PHYSIOL B, V155, P21, DOI 10.1007/BF00688787; Boland CRJ, 2004, BIOL CONSERV, V120, P53, DOI 10.1016/j.biocon.2004.01.025; BOYD IL, 1995, FUNCT ECOL, V9, P151, DOI 10.2307/2390559; Bryce JM, 2001, P ROY SOC B-BIOL SCI, V268, P1731, DOI 10.1098/rspb.2001.1700; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Clark TD, 2005, PHYSIOL BIOCHEM ZOOL, V78, P347, DOI 10.1086/430034; EVANS DL, 1988, J COMP PHYSIOL B, V157, P791, DOI 10.1007/BF00691010; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; HALSEY L, COMP BIOC A IN PRESS; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; HALSEY LG, PHYSL BIOCH IN PRESS; HERREID CF, 1981, J EXP BIOL, V94, P189; HUTCHISON VH, 1971, Z VERGL PHYSIOL, V75, P367, DOI 10.1007/BF00630557; JOHNALDER HB, 1983, J COMP PHYSIOL, V151, P119, DOI 10.1007/BF00689909; JOHNALDER HB, 1981, AM J PHYSIOL, V241, pR342, DOI 10.1152/ajpregu.1981.241.5.R342; JOHNSON C R, 1972, Journal of Herpetology, V6, P35, DOI 10.2307/1563091; KARASOV WH, 1992, AM ZOOL, V32, P238, DOI 10.1093/icb/32.2.238; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kram R, 1996, J EXP BIOL, V199, P609; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; LIGHTON JRB, 1993, J EXP BIOL, V181, P49; LIGHTON JRB, 1989, NATURE, V342, P174, DOI 10.1038/342174a0; MOBERLY WR, 1968, COMP BIOCHEM PHYSIOL, V27, P21, DOI 10.1016/0010-406X(68)90750-0; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Natori Y, 2007, ECOL APPL, V17, P1441, DOI 10.1890/06-1785.1; Phillips BL, 2008, WILDLIFE RES, V35, P222, DOI 10.1071/WR07101; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Schmidt-Nielsen, 1984, SCALING WHY IS ANIMA; Secor SM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P557, DOI 10.1086/344493; Secor SM, 2007, J COMP PHYSIOL B, V177, P165, DOI 10.1007/s00360-006-0119-2; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; SHEPARD E, 2008, IDENTIFICATION ANIMA; SHEPARD E, 2009, P ROYAL SOC LONDON B; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Todd M. Jason, 2003, Journal of the North Carolina Academy of Science, V119, P103; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; WALTON M, 1988, J EXP BIOL, V136, P273; Walton P, 1998, ANIM BEHAV, V56, P165, DOI 10.1006/anbe.1998.0759; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2001, AUST J ZOOL, V49, P663, DOI 10.1071/ZO00076; White CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P977, DOI 10.1086/505994; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2	55	53	53	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10170	10.1371/journal.pone.0010170	http://dx.doi.org/10.1371/journal.pone.0010170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422048	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500003
J	Malyarchuk, B; Derenko, M; Grzybowski, T; Perkova, M; Rogalla, U; Vanecek, T; Tsybovsky, I				Malyarchuk, Boris; Derenko, Miroslava; Grzybowski, Tomasz; Perkova, Maria; Rogalla, Urszula; Vanecek, Tomas; Tsybovsky, Iosif			The Peopling of Europe from the Mitochondrial Haplogroup U5 Perspective	PLOS ONE			English	Article							DNA VARIABILITY; MODERN HUMANS; EASTERN; WESTERN; POPULATION; PHYLOGENY; DISPERSAL; LINEAGES; HISTORY; SAAMI	It is generally accepted that the most ancient European mitochondrial haplogroup, U5, has evolved essentially in Europe. To resolve the phylogeny of this haplogroup, we completely sequenced 113 mitochondrial genomes (79 U5a and 34 U5b) of central and eastern Europeans (Czechs, Slovaks, Poles, Russians and Belorussians), and reconstructed a detailed phylogenetic tree, that incorporates previously published data. Molecular dating suggests that the coalescence time estimate for the U5 is similar to 25-30 thousand years (ky), and similar to 16-20 and similar to 20-24 ky for its subhaplogroups U5a and U5b, respectively. Phylogeographic analysis reveals that expansions of U5 subclusters started earlier in central and southern Europe, than in eastern Europe. In addition, during the Last Glacial Maximum central Europe (probably, the Carpathian Basin) apparently represented the area of intermingling between human flows from refugial zones in the Balkans, the Mediterranean coastline and the Pyrenees. Age estimations amounting for many U5 subclusters in eastern Europeans to similar to 15 ky ago and less are consistent with the view that during the Ice Age eastern Europe was an inhospitable place for modern humans.	[Malyarchuk, Boris; Derenko, Miroslava; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Far E Branch, Magadan, Russia; [Grzybowski, Tomasz; Rogalla, Urszula] Nicolaus Copernicus Univ, Inst Forens Med, Ludwik Rydygier Coll Medicum, Dept Mol & Forens Genet, Bydgoszcz, Poland; [Vanecek, Tomas] Charles Univ Prague, Med Fac Hosp, Dept Pathol, Plzen, Czech Republic; [Tsybovsky, Iosif] Ctr Forens Expertise & Criminalist, Minsk, BELARUS	Institute of Biological Problems of the North; Russian Academy of Sciences; Nicolaus Copernicus University; Charles University Prague	Malyarchuk, B (corresponding author), Russian Acad Sci, Inst Biol Problems N, Far E Branch, Magadan, Russia.	malyarchuk@ibpn.ru	Derenko, Miroslava/J-1495-2018; Grzybowski, Tomasz/A-1676-2015; Malyarchuk, Boris/D-5783-2018; Rogalla, Urszula/E-3342-2014	Derenko, Miroslava/0000-0002-1849-784X; Grzybowski, Tomasz/0000-0001-6228-6460; Malyarchuk, Boris/0000-0002-0304-0652; Rogalla, Urszula/0000-0002-2778-9844	Program of Presidium of Russian Academy of Sciences; Russian Foundation for Basic Research [07-04-00445]; Nicolaus Copernicus University, Poland [UMK03/2007]	Program of Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Nicolaus Copernicus University, Poland	The study was supported by the Program of Presidium of Russian Academy of Sciences "Biodiversity (Gene Pools and Genetic Diversity)'', the Russian Foundation for Basic Research (07-04-00445) and the grant from the Nicolaus Copernicus University, Poland (UMK03/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; ALEKSEEVA TI, 1997, NEOLITHIC WOODLAND E, P18; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; [Anonymous], 2002, DESOLATE LANDSCAPES; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Costa MD, 2009, MECH AGEING DEV, V130, P222, DOI 10.1016/j.mad.2008.12.001; Dolukhanov P. M., 2000, ROOTS PEOPLES LANGUA, P71; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Gamble Clive., 1986, PALAEOLITHIC SETTLEM; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; KRAUSE J, 2010, CURR BIOL IN PRESS; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Malyarchuk BA, 2006, HUM BIOL, V78, P681, DOI 10.1353/hub.2007.0014; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Pichler I, 2010, EUR J HUM GENET, V18, P463, DOI 10.1038/ejhg.2009.172; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Svoboda J., 1996, HUNTERS E W PALEOLIT; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; TAMBETS K, 2003, EXAMINING FARMING LA, P449; Terberger T, 2002, ANTIQUITY, V76, P691, DOI 10.1017/S0003598X00091134; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Velichko A.A., 2003, PRIRODA, V3, P52; Vishnyatsky LB, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P80	39	60	62	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10285	10.1371/journal.pone.0010285	http://dx.doi.org/10.1371/journal.pone.0010285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422015	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952500024
J	Popelut, A; Valet, F; Fromentin, O; Thomas, A; Bouchard, P				Popelut, Antoine; Valet, Fabien; Fromentin, Olivier; Thomas, Aurelie; Bouchard, Philippe			Relationship between Sponsorship and Failure Rate of Dental Implants: A Systematic Approach	PLOS ONE			English	Article							FIXED PARTIAL DENTURES; LEAST 5 YEARS; COMPLICATION RATES; OBSERVATION PERIOD; COST-EFFECTIVENESS; TOOTH LOSS; SURVIVAL; OUTCOMES; REPLACEMENT; FPDS	Background: The number of dental implant treatments increases annually. Dental implants are manufactured by competing companies. Systematic reviews and meta-analysis have shown a clear association between pharmaceutical industry funding of clinical trials and pro-industry results. So far, the impact of industry sponsorship on the outcomes and conclusions of dental implant clinical trials has never been explored. The aim of the present study was to examine financial sponsorship of dental implant trials, and to evaluate whether research funding sources may affect the annual failure rate. Methods and Findings: A systematic approach was used to identify systematic reviews published between January 1993 and December 2008 that specifically deal with the length of survival of dental implants. Primary articles were extracted from these reviews. The failure rate of the dental implants included in the trials was calculated. Data on publication year, Impact Factor, prosthetic design, periodontal status reporting, number of dental implants included in the trials, methodological quality of the studies, presence of a statistical advisor, and financial sponsorship were extracted by two independent reviewers (kappa = 0.90; CI95% [0.77-1.00]). Univariate quasi-Poisson regression models and multivariate analysis were used to identify variables that were significantly associated with failure rates. Five systematic reviews were identified from which 41 analyzable trials were extracted. The mean annual failure rate estimate was 1.09%.(CI95% [0.84-1.42]). The funding source was not reported in 63% of the trials (26/41). Sixty-six percent of the trials were considered as having a risk of bias (27/41). Given study age, both industry associated (OR = 0.21; CI95% [0.12-0.38]) and unknown funding source trials (OR = 0.33; (CI95% [0.21-0.51]) had a lower annual failure rates compared with non-industry associated trials. A conflict of interest statement was disclosed in 2 trials. Conclusions: When controlling for other factors, the probability of annual failure for industry associated trials is significantly lower compared with non-industry associated trials. This bias may have significant implications on tooth extraction decision making, research on tooth preservation, and governmental health care policies.	[Popelut, Antoine; Bouchard, Philippe] Paris 7 Denis Diderot Univ, Dept Periodontol, Serv Odontol, AP HP,UFR Odontol,Hotel Dieu Hosp, Paris, France; [Valet, Fabien] Inst Curie, Dept Biostat, Paris, France; [Fromentin, Olivier] Paris 7 Denis Diderot Univ, Dept Prosthet Dent, Serv Odontol, AP HP,UFR Odontol,Hotel Dieu Hosp, Paris, France; [Thomas, Aurelie] Paris 7 Denis Diderot Univ, Lib Odontol, UFR Odontol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Popelut, A (corresponding author), Paris 7 Denis Diderot Univ, Dept Periodontol, Serv Odontol, AP HP,UFR Odontol,Hotel Dieu Hosp, Paris, France.	phbouch@noos.fr		Bouchard, Philippe/0000-0003-2500-3219	University Paris Diderot, U.F.R. of Odontologie (Paris, France)	University Paris Diderot, U.F.R. of Odontologie (Paris, France)	This study was supported by a grant from the University Paris Diderot, U.F.R. of Odontologie (Paris, France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 2002, CATEGORICAL DATA ANA, P385; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bouchard P, 2009, CLIN ORAL IMPLAN RES, V20, P583, DOI 10.1111/j.1600-0501.2008.01702.x; Bragger U, 2005, CLIN ORAL IMPLAN RES, V16, P335, DOI 10.1111/j.1600-0501.2005.01112.x; Branemark PI., 1977, SCAND J PLAST RECO S, V16, P1; BRESLOW NE, 1996, STAT APPL, V8, P23; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Doucet M, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.022467; Esposito M, 1999, INT J ORAL MAX IMPL, V14, P473; Esposito M, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003878.PUB4; ESPOSITO M, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003815.PUB3; ESPOSITO MA, 2006, COCHRANE DB SYST REV, V4; Goodacre CJ, 2003, J PROSTHET DENT, V90, P121, DOI 10.1016/S0022-3913(03)00212-9; HUNTER JM, 1995, SOC SCI MED, V40, P1331, DOI 10.1016/0277-9536(94)00255-R; Jones JA, 2003, INT DENT J, V53, P327, DOI 10.1111/j.1875-595X.2003.tb00906.x; Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x; Karoussis IK, 2007, CLIN ORAL IMPLAN RES, V18, P669, DOI 10.1111/j.1600-0501.2007.01406.x; KIRKWOOD BR, 2004, ESSENTIAL MED STAT, P272; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lang NP, 2004, CLIN ORAL IMPLAN RES, V15, P643, DOI 10.1111/j.1600-0501.2004.01118.x; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lindh T, 1998, CLIN ORAL IMPLAN RES, V9, P80, DOI 10.1034/j.1600-0501.1998.090203.x; *MILL RES GROUP, 2009, EUR MARK DENT IMPL 2; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Neely AL, 2005, J CLIN PERIODONTOL, V32, P984, DOI 10.1111/j.1600-051X.2005.00797.x; Ong CTT, 2008, J CLIN PERIODONTOL, V35, P438, DOI 10.1111/j.1600-051X.2008.01207.x; Pjetursson BE, 2004, CLIN ORAL IMPLAN RES, V15, P625, DOI 10.1111/j.1600-0501.2004.01117.x; Salinas TJ, 2007, INT J ORAL MAX IMPL, V22, P71; Tonetti MS, 2008, J CLIN PERIODONTOL, V35, P168, DOI 10.1111/j.1600-051X.2008.01268.x; Torabinejad M, 2007, J PROSTHET DENT, V98, P285, DOI 10.1016/S0022-3913(07)60102-4; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; VENABLES WN, 2002, MODERN APPL STAT S, P172; *WINTERGREEN, 2009, WORLDWIDE NAN DENT I; World Health Organization, 2009, HLTH STAT HLTH INF S; Zuur Alain F., 2009, P1; 2007, PLOS MED, V4, P399	38	57	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10274	10.1371/journal.pone.0010274	http://dx.doi.org/10.1371/journal.pone.0010274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422000	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500029
J	Tillmann, B; Jolicoeur, P; Ishihara, M; Gosselin, N; Bertrand, O; Rossetti, Y; Peretz, I				Tillmann, Barbara; Jolicoeur, Pierre; Ishihara, Masami; Gosselin, Nathalie; Bertrand, Olivier; Rossetti, Yves; Peretz, Isabelle			The Amusic Brain: Lost in Music, but Not in Space	PLOS ONE			English	Article							LINE BISECTION; CONGENITAL AMUSIA; TONE-DEAFNESS; INDIVIDUAL VARIATION; SPATIAL NEGLECT; PERCEPTION; DEFICITS; PITCH; REPRESENTATION; DISCRIMINATION	Congenital amusia is a neurogenetic disorder of music processing that is currently ascribed to a deficit in pitch processing. A recent study challenges this view and claims the disorder might arise as a consequence of a general spatial-processing deficit. Here, we assessed spatial processing abilities in two independent samples of individuals with congenital amusia by using line bisection tasks (Experiment 1) and a mental rotation task (Experiment 2). Both amusics and controls showed the classical spatial effects on bisection performance and on mental rotation performance, and amusics and controls did not differ from each other. These results indicate that the neurocognitive impairment of congenital amusia does not affect the processing of space.	[Tillmann, Barbara; Bertrand, Olivier; Rossetti, Yves] Univ Lyon 1, F-69365 Lyon, France; [Tillmann, Barbara] CNRS, UMR 5020, Lyon, France; [Jolicoeur, Pierre; Gosselin, Nathalie; Peretz, Isabelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Jolicoeur, Pierre; Gosselin, Nathalie; Peretz, Isabelle] Univ Montreal, BRAMS Lab, Montreal, PQ H3C 3J7, Canada; [Ishihara, Masami] Max Planck Inst CBS, Leipzig, Germany; [Bertrand, Olivier] INSERM, U821, F-69008 Lyon, France; [Rossetti, Yves] Hosp Civils Lyon, INSERM, U864, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Montreal; Universite de Montreal; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tillmann, B (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	barbara.tillmann@olfac.univ-lyon1.fr	Rossetti, Yves/H-3693-2017; Bertrand, Olivier/B-6165-2008	Rossetti, Yves/0000-0001-8867-4496; Bertrand, Olivier/0000-0003-0733-7979	Cluster 11 of the Region Rhone-Alpes; Fonds de Recherche en Sante du Quebec; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft	Cluster 11 of the Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by grants from the Cluster 11 of the Region Rhone-Alpes to BT and OB, by an infrastructure grant from the Fonds de Recherche en Sante du Quebec to IP and PJ, research grants from the Natural Sciences and Engineering Research Council of Canada to PJ and to IP, grants from the Canadian Foundation for Innovation to IP and PJ, a grant from the Canadian Institutes of Health Research to IP, and a grant from the Deutsche Forschungsgemeinschaft to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Beecham R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005543; Brochard R, 2004, BRAIN COGNITION, V54, P103, DOI 10.1016/S0278-2626(03)00264-1; Brozzoli C, 2008, P NATL ACAD SCI USA, V105, P5644, DOI 10.1073/pnas.0708414105; Calabria M, 2005, NEUROPSYCHOLOGIA, V43, P779, DOI 10.1016/j.neuropsychologia.2004.06.027; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; Foxton JM, 2006, BRAIN COGNITION, V62, P24, DOI 10.1016/j.bandc.2006.03.005; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Golay L, 2005, NEUROPSYCHOLOGIA, V43, P1258, DOI 10.1016/j.neuropsychologia.2004.12.006; HALLIGAN PW, 1990, NEUROPSYCHOLOGIA, V28, P1043, DOI 10.1016/0028-3932(90)90139-F; HARVEY M, 1994, CORTEX, V30, P343, DOI 10.1016/S0010-9452(13)80204-3; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; ISHIAI S, 1989, BRAIN, V112, P1485, DOI 10.1093/brain/112.6.1485; ISHIHARA M, LOWER HIGHE IN PRESS; Ishihara M, 2006, NEUROPSYCHOLOGIA, V44, P1009, DOI 10.1016/j.neuropsychologia.2005.11.008; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; Keller P. E., 2006, ADV COGN PSYCHOL, V2, P269, DOI [10.2478/v10053-008-0061-9, DOI 10.2478/V10053-008-0061-9]; Leonards U, 2007, PERCEPTION, V36, P171; Lidji P, 2007, J EXP PSYCHOL HUMAN, V33, P1189, DOI 10.1037/0096-1523.33.5.1189; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; MANNING L, 1990, NEUROPSYCHOLOGIA, V28, P647, DOI 10.1016/0028-3932(90)90119-9; McIntosh RD, 2005, COGNITIVE BRAIN RES, V25, P833, DOI 10.1016/j.cogbrainres.2005.09.008; Michel F, 2004, BEHAV NEUROL, V15, P3, DOI 10.1155/2004/836830; MILNER AD, 1992, NEUROPSYCHOLOGIA, V30, P515, DOI 10.1016/0028-3932(92)90055-Q; MUDD SA, 1963, J EXP PSYCHOL, V66, P347, DOI 10.1037/h0040045; OLSHO LW, 1982, DEV PSYCHOL, V18, P721; Oriet C, 2005, MEM COGNITION, V33, P913, DOI 10.3758/BF03193085; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Patston LLM, 2006, PSYCHOL SCI, V17, P1029, DOI 10.1111/j.1467-9280.2006.01823.x; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2008, CURR DIR PSYCHOL SCI, V17, P329, DOI 10.1111/j.1467-8721.2008.00600.x; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Stewart L, 2007, CURR BIOL, V17, pR892, DOI 10.1016/j.cub.2007.08.012; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885	45	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10173	10.1371/journal.pone.0010173	http://dx.doi.org/10.1371/journal.pone.0010173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YS	20422050	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500004
J	Lin, BY; Madan, A; Yoon, JG; Fang, XF; Yan, XW; Kim, TK; Hwang, D; Hood, L; Foltz, G				Lin, Biaoyang; Madan, Anup; Yoon, Jae-Geun; Fang, Xuefeng; Yan, Xiaowei; Kim, Taek-Kyun; Hwang, Daehee; Hood, Leroy; Foltz, Gregory			Massively Parallel Signature Sequencing and Bioinformatics Analysis Identifies Up-Regulation of TGFBI and SOX4 in Human Glioblastoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; MICROARRAY ANALYSIS; CELL; CANCER; PROGRESSION; TUMORIGENICITY; PROLIFERATION; TRANSCRIPTION; NEUROGRANIN	Background: A comprehensive network-based understanding of molecular pathways abnormally altered in glioblastoma multiforme (GBM) is essential for developing effective therapeutic approaches for this deadly disease. Methodology/Principal Findings: Applying a next generation sequencing technology, massively parallel signature sequencing (MPSS), we identified a total of 4535 genes that are differentially expressed between normal brain and GBM tissue. The expression changes of three up-regulated genes, CHI3L1, CHI3L2, and FOXM1, and two down-regulated genes, neurogranin and L1CAM, were confirmed by quantitative PCR. Pathway analysis revealed that TGF- beta pathway related genes were significantly up-regulated in GBM tumor samples. An integrative pathway analysis of the TGF beta signaling network identified two alternative TGF-beta signaling pathways mediated by SOX4 ( sex determining region Y-box 4) and TGFBI ( Transforming growth factor beta induced). Quantitative RT-PCR and immunohistochemistry staining demonstrated that SOX4 and TGFBI expression is elevated in GBM tissues compared with normal brain tissues at both the RNA and protein levels. In vitro functional studies confirmed that TGFBI and SOX4 expression is increased by TGF- beta stimulation and decreased by a specific inhibitor of TGF- beta receptor 1 kinase. Conclusions/Significance: Our MPSS database for GBM and normal brain tissues provides a useful resource for the scientific community. The identification of non-SMAD mediated TGF-beta signaling pathways acting through SOX4 and TGFBI ( GENE ID: 7045) in GBM indicates that these alternative pathways should be considered, in addition to the canonical SMAD mediated pathway, in the development of new therapeutic strategies targeting TGF-beta signaling in GBM. Finally, the construction of an extended TGF- beta signaling network with overlaid gene expression changes between GBM and normal brain extends our understanding of the biology of GBM.	[Lin, Biaoyang; Yoon, Jae-Geun; Foltz, Gregory] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Lin, Biaoyang; Fang, Xuefeng] Zhejiang Univ, Zhejiang Calif Int NanoSyst Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Yan, Xiaowei; Hood, Leroy; Foltz, Gregory] Inst Syst Biol, Seattle, WA USA; [Madan, Anup] Seattle Mol Diagnost Res Inst, Bellevue, WA USA; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, Kyungbuk, South Korea; [Kim, Taek-Kyun; Hwang, Daehee] Pohang Univ Sci & Technol, I Bio Program, Pohang, South Korea	Swedish Medical Center; University of Washington; University of Washington Seattle; Zhejiang University; Institute for Systems Biology (ISB); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lin, BY (corresponding author), Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA.	Biaoyang.Lin@swedish.org; Greg.Foltz@swedish.org	Lin, Biaoyang/AAA-1258-2020; Kim, Taekkyun/A-9810-2017	Lin, Biaoyang/0000-0002-2189-0407; Kim, Taekkyun/0000-0002-3703-6790	Swedish Medical Foundation	Swedish Medical Foundation	We thank the Swedish Medical Foundation for providing financial support for the studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; FOLTZ G, 2009, ONCOGENE; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Gui JG, 2007, INT J BIOL SCI, V3, P212; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Izumoto S, 1996, CANCER RES, V56, P1440; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kawataki T, 2000, NEUROPATHOLOGY, V20, P161, DOI 10.1046/j.1440-1789.2000.00327.x; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; Lesne S, 2002, J CEREBR BLOOD F MET, V22, P1114, DOI 10.1097/00004647-200209000-00009; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Munaut C, 2003, INT J CANCER, V106, P848, DOI 10.1002/ijc.11313; Oudes AJ, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-86; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piek E, 1999, INT J CANCER, V80, P756, DOI 10.1002/(SICI)1097-0215(19990301)80:5<756::AID-IJC21>3.0.CO;2-N; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Ruebel KH, 2008, ENDOCRINE, V33, P62, DOI 10.1007/s12020-008-9060-3; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tanwar MK, 2002, CANCER RES, V62, P4364; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang Y, 2005, J NANOSCI NANOTECHNO, V5, P1249, DOI 10.1166/jnn.2005.218; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; WOLFF JM, 1988, J BIOL CHEM, V263, P11943	56	69	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10210	10.1371/journal.pone.0010210	http://dx.doi.org/10.1371/journal.pone.0010210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419098	Green Submitted, Green Published, gold			2022-12-27	WOS:000276853800008
J	Neri, M; Maderna, C; Ferrari, D; Cavazzin, C; Vescovi, AL; Gritti, A				Neri, Margherita; Maderna, Claudio; Ferrari, Daniela; Cavazzin, Chiara; Vescovi, Angelo L.; Gritti, Angela			Robust Generation of Oligodendrocyte Progenitors from Human Neural Stem Cells and Engraftment in Experimental Demyelination Models in Mice	PLOS ONE			English	Article							SUBCORTICAL WHITE-MATTER; CENTRAL-NERVOUS-SYSTEM; RAT CEREBRAL-CORTEX; EMBRYONIC HUMAN CNS; ADULT HUMAN BRAIN; GROWTH-FACTORS; SPINAL-CORD; IN-VITRO; NEUROTROPHIC FACTOR; PRECURSOR CELLS	Background: Cell-based therapy holds great promises for demyelinating diseases. Human-derived fetal and adult oligodendrocyte progenitors (OPC) gave encouraging results in experimental models of dysmyelination but their limited proliferation in vitro and their potential immunogenicity might restrict their use in clinical applications. Virtually unlimited numbers of oligodendroglial cells could be generated from long-term self-renewing human (h)-derived neural stem cells (hNSC). However, robust oligodendrocyte production from hNSC has not been reported so far, indicating the need for improved understanding of the molecular and environmental signals controlling hNSC progression through the oligodendroglial lineage. The aim of this work was to obtain enriched and renewable cultures of hNSC-derived oligodendroglial cells by means of epigenetic manipulation. Methodology/Principal Findings: We report here the generation of large numbers of hNSC-derived oligodendroglial cells by concurrent/sequential in vitro exposure to combinations of growth factors (FGF2, PDGF-AA), neurotrophins (NT3) and hormones (T3). In particular, the combination FGF2+NT3+PDGF-AA resulted in the maintenance and enrichment of an oligodendroglial cell population displaying immature phenotype (i.e., proliferation capacity and expression of PDGFR alpha, Olig1 and Sox10), limited self-renewal and increased migratory activity in vitro. These cells generate large numbers of oligodendroglial progeny at the early stages of maturation, both in vitro and after transplantation in models of CNS demyelination. Conclusions/Significance: We describe a reliable method to generate large numbers of oligodendrocytes from a renewable source of somatic, non-immortalized NSC from the human foetal brain. We also provide insights on the mechanisms underlying the pro-oligodendrogenic effect of the treatments in vitro and discuss potential issues responsible for the limited myelinating capacity shown by hNSC-derived oligodendrocytes in vivo.	[Neri, Margherita; Maderna, Claudio; Cavazzin, Chiara; Gritti, Angela] San Raffaele Telethon Inst Gene Therapy HSR TIGET, San Raffaele Sci Inst, Milan, Italy; [Neri, Margherita] Univ Vita Salute San Raffaele, Milan, Italy; [Ferrari, Daniela; Vescovi, Angelo L.] Univ Milano Bicocca, Biosci & Biotechnol Dept, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milano-Bicocca	Neri, M (corresponding author), San Raffaele Telethon Inst Gene Therapy HSR TIGET, San Raffaele Sci Inst, Milan, Italy.	vescovi@tin.it; gritti.angela@hsr.it	Vescovi, Angelo Luigi/A-4919-2015; Ferrari, Daniela/AHE-7647-2022; Gritti, Angela/K-2729-2016	Vescovi, Angelo Luigi/0000-0002-1742-4112; Ferrari, Daniela/0000-0001-7251-9854; Gritti, Angela/0000-0002-9845-0370; maderna, claudio/0000-0002-1404-5408	Italian Ministry of Health [RF03.168]; Italian Multiple Sclerosis Foundation [2002/R/33]; Fondazione Telethon Funding Source: Custom	Italian Ministry of Health(Ministry of Health, Italy); Italian Multiple Sclerosis Foundation; Fondazione Telethon(Fondazione Telethon)	This work was supported by the Italian Ministry of Health (RF03.168; www.ministerosalute.it) and the Italian Multiple Sclerosis Foundation (FISM; grant 2002/R/33; www.aism.it) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Barres BA, 1996, MOL CELL NEUROSCI, V8, P146, DOI 10.1006/mcne.1996.0053; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Billon N, 2002, EMBO J, V21, P6452, DOI 10.1093/emboj/cdf662; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Buchet D, 2009, NEUROSCI LETT, V456, P112, DOI 10.1016/j.neulet.2008.09.086; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; CAVAZZIN C, 2005, GLIA; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; De Filippis L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003310; Decker L, 2000, MOL CELL NEUROSCI, V16, P422, DOI 10.1006/mcne.2000.0885; Decker L, 2004, J NEUROSCI, V24, P3816, DOI 10.1523/JNEUROSCI.5725-03.2004; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Ebert AD, 2005, REJUV RES, V8, P131, DOI 10.1089/rej.2005.8.131; FERNANDEZ M, 2009, INT J DEV NEUROSCI; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gallo V, 2008, CURR OPIN NEUROL, V21, P278, DOI 10.1097/WCO.0b013e3282fd1875; Goldman SA, 2007, CLIN PHARMACOL THER, V82, P453, DOI 10.1038/sj.clpt.6100337; Grever WE, 1999, J NEUROSCI RES, V57, P304, DOI 10.1002/(SICI)1097-4547(19990801)57:3<304::AID-JNR2>3.0.CO;2-6; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Gritti A, 2009, J COMP NEUROL, V517, P333, DOI 10.1002/cne.22153; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kumar S, 2007, NEUROCHEM RES, V32, P783, DOI 10.1007/s11064-006-9208-6; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; MACIACZYK J, 2009, STEM CELLS DEV; MAIRE CL, 2009, J NEUROSCI RES; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Murray K, 1997, J NEUROSCI RES, V50, P146; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; RAO RC, 2008, STEM CELLS; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rodriguez-Pena A, 1999, J NEUROBIOL, V40, P497, DOI 10.1002/(SICI)1097-4695(19990915)40:4<497::AID-NEU7>3.0.CO;2-#; Rosser AE, 2007, CURR OPIN NEUROL, V20, P688, DOI 10.1097/WCO.0b013e3282f132fc; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; Targett MP, 1996, NEUROPATH APPL NEURO, V22, P199; Terada N, 2005, GLIA, V50, P212, DOI 10.1002/glia.20175; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Wilson HC, 2003, GLIA, V44, P153, DOI 10.1002/glia.10280; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wu CS, 2009, J NEUROSCI, V29, P7649, DOI 10.1523/JNEUROSCI.1027-09.2009; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Zhang SC, 2000, J NEUROSCI RES, V59, P421, DOI 10.1002/(SICI)1097-4547(20000201)59:3<421::AID-JNR17>3.3.CO;2-3	73	31	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10145	10.1371/journal.pone.0010145	http://dx.doi.org/10.1371/journal.pone.0010145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405042	gold, Green Submitted, Green Published			2022-12-27	WOS:000276705900022
J	Zhao, FQ; Bai, J; Wu, JY; Liu, J; Zhou, MM; Xia, SL; Wang, SJ; Yao, XD; Yi, HG; Lin, ML; Gao, SJ; Zhou, TL; Xu, ZY; Niu, YX; Bao, QY				Zhao, Fangqing; Bai, Jie; Wu, Jinyu; Liu, Jing; Zhou, Mingming; Xia, Shilin; Wang, Shanjin; Yao, Xiaoding; Yi, Huiguang; Lin, Meili; Gao, Shengjie; Zhou, Tieli; Xu, Zuyuan; Niu, Yuxin; Bao, Qiyu			Sequencing and Genetic Variation of Multidrug Resistance Plasmids in Klebsiella pneumoniae	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; BETA-LACTAMASES	Background: The development of multidrug resistance is a major problem in the treatment of pathogenic microorganisms by distinct antimicrobial agents. Characterizing the genetic variation among plasmids from different bacterial species or strains is a key step towards understanding the mechanism of virulence and their evolution. Results: We applied a deep sequencing approach to 206 clinical strains of Klebsiella pneumoniae collected from 2002 to 2008 to understand the genetic variation of multidrug resistance plasmids, and to reveal the dynamic change of drug resistance over time. First, we sequenced three plasmids ( 70 Kb, 94 Kb, and 147 Kb) from a clonal strain of K. pneumoniae using Sanger sequencing. Using the Illumina sequencing technology, we obtained more than 17 million of short reads from two pooled plasmid samples. We mapped these short reads to the three reference plasmid sequences, and identified a large number of single nucleotide polymorphisms ( SNPs) in these pooled plasmids. Many of these SNPs are present in drug-resistance genes. We also found that a significant fraction of short reads could not be mapped to the reference sequences, indicating a high degree of genetic variation among the collection of K. pneumoniae isolates. Moreover, we identified that plasmid conjugative transfer genes and antibiotic resistance genes are more likely to suffer from positive selection, as indicated by the elevated rates of nonsynonymous substitution. Conclusion: These data represent the first large-scale study of genetic variation in multidrug resistance plasmids and provide insight into the mechanisms of plasmid diversification and the genetic basis of antibiotic resistance.	[Zhao, Fangqing; Bai, Jie; Wu, Jinyu; Liu, Jing; Zhou, Mingming; Xia, Shilin; Wang, Shanjin; Yao, Xiaoding; Yi, Huiguang; Lin, Meili; Gao, Shengjie; Zhou, Tieli; Xu, Zuyuan; Niu, Yuxin; Bao, Qiyu] Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Zhao, Fangqing] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Bai, Jie] Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China	Wenzhou Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Fudan University	Zhao, FQ (corresponding author), Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	niuyuxin@gmail.com; baoqy@genomics.org.cn	Zhao, Fangqing/P-6309-2019; Bao, Qiyu/AAH-6113-2020; Gao, Shengjie/S-4016-2017	Bao, Qiyu/0000-0001-6523-8763; Xia, Shilin/0000-0003-1187-3192; Gao, Shengjie/0000-0002-5221-8381; Zhao, Fangqing/0000-0002-6216-1235; Yi, Huiguang/0000-0002-9676-7438	Science and Technology Foundation of Zhejiang Province [2008C23074]; Natural Science Foundation of Zhejiang Province [Y2090694]; Zhejiang Provincial Medical Foundation [2009QN021]; Foundation of Zhejiang Provincial Top Key Discipline of Laboratory Medicine, China	Science and Technology Foundation of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Medical Foundation; Foundation of Zhejiang Provincial Top Key Discipline of Laboratory Medicine, China	This work was supported by the Science and Technology Foundation of Zhejiang Province (2008C23074), Natural Science Foundation of Zhejiang Province (Y2090694), Zhejiang Provincial Medical Foundation (No. 2009QN021) and Foundation of Zhejiang Provincial Top Key Discipline of Laboratory Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BERES SB, P NATL ACAD SCI US; Bistue AJCS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001800; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chen YT, 2007, ANTIMICROB AGENTS CH, V51, P3004, DOI 10.1128/AAC.00167-07; Chen YT, 2006, ANTIMICROB AGENTS CH, V50, P3861, DOI 10.1128/AAC.00456-06; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Deguchi T, 1997, ANTIMICROB AGENTS CH, V41, P699, DOI 10.1128/AAC.41.3.699; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Fu YM, 2008, ANTIMICROB AGENTS CH, V52, P2980, DOI 10.1128/AAC.00151-08; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HEASLET H, 2009, PROTEINS; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; McKeegan KS, 2002, TRENDS MICROBIOL, V10, pS8, DOI 10.1016/S0966-842X(02)02429-0; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Ogawa W, 2005, BIOL PHARM BULL, V28, P1505, DOI 10.1248/bpb.28.1505; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Sarno R, 2002, ANTIMICROB AGENTS CH, V46, P3422, DOI 10.1128/AAC.46.11.3422-3427.2002; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; SOUGAKOFF W, 1988, REV INFECT DIS, V10, P879	26	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10141	10.1371/journal.pone.0010141	http://dx.doi.org/10.1371/journal.pone.0010141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405037	Green Submitted, Green Published, gold			2022-12-27	WOS:000276705900019
J	Gundlfinger, A; Breustedt, J; Sullivan, D; Schmitz, D				Gundlfinger, Anja; Breustedt, Joerg; Sullivan, David; Schmitz, Dietmar			Natural Spike Trains Trigger Short- and Long-Lasting Dynamics at Hippocampal Mossy Fiber Synapses in Rodents	PLOS ONE			English	Article							TERM POTENTIATION; SYNAPTIC PLASTICITY; UNIT-ACTIVITY; CA3; RECEPTORS; LTP; FACILITATION; INFORMATION; SEPARATION; PATTERNS	Background: Synapses exhibit strikingly different forms of plasticity over a wide range of time scales, from milliseconds to hours. Studies on synaptic plasticity typically use constant-frequency stimulation to activate synapses, whereas in vivo activity of neurons is irregular. Methodology/Principal Findings: Using extracellular and whole-cell electrophysiological recordings, we have here studied the synaptic responses at hippocampal mossy fiber synapses in vitro to stimulus patterns obtained from in vivo recordings of place cell firing of dentate gyrus granule cells in behaving rodents. We find that synaptic strength is strongly modulated on short-and long-lasting time scales during the presentation of the natural stimulus trains. Conclusions/Significance: We conclude that dynamic short- and long-term synaptic plasticity at the hippocampal mossy fiber synapse plays a prominent role in normal synaptic function.	[Gundlfinger, Anja; Breustedt, Joerg; Schmitz, Dietmar] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany; [Gundlfinger, Anja; Schmitz, Dietmar] Humboldt Univ, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Sullivan, David] Rutgers State Univ, Ctr Mol & Behav Neurobiol, Newark, NJ 07102 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Rutgers State University Newark; Rutgers State University New Brunswick	Gundlfinger, A (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	dietmar.schmitz@charite.de		Schmitz, Dietmar/0000-0003-2741-5241	Deutsche Forschungsgemeinschaft [SFB665, SFB618, GRK1123, EXC257]; Bundesministerium fur Bildung und Forschung [01GQ0410]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by the Deutsche Forschungsgemeinschaft (Grants SFB665, SFB618, GRK1123, EXC257 to D.S.) and the Bundesministerium fur Bildung und Forschung (Bernstein Center for Computational Neuroscience Berlin, Grant 01GQ0410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUZSAKI G, 1992, EPILEPSY RES, P281; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; deKay JGT, 2006, HIPPOCAMPUS, V16, P66, DOI 10.1002/hipo.20132; Dobrunz LE, 1999, NEURON, V22, P157, DOI 10.1016/S0896-6273(00)80687-X; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Frerking M, 2006, J NEUROPHYSIOL, V96, P2139, DOI 10.1152/jn.00243.2006; Gundlfinger A, 2007, J PHYSIOL-LONDON, V585, P853, DOI 10.1113/jphysiol.2007.143925; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Isaac JTR, 2009, J NEUROSCI, V29, P6840, DOI 10.1523/JNEUROSCI.0731-09.2009; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MIZUMORI SJY, 1989, J NEUROPHYSIOL, V61, P15, DOI 10.1152/jn.1989.61.1.15; Mori-Kawakami F, 2003, J PHYSIOL-LONDON, V553, P37, DOI 10.1113/jphysiol.2003.045948; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	38	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9961	10.1371/journal.pone.0009961	http://dx.doi.org/10.1371/journal.pone.0009961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376354	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000276418200035
J	Ray, HJ; Chu, P; Wu, TH; Lyons, CR; Murthy, AK; Guentzel, MN; Klose, KE; Arulanandam, BP				Ray, Heather J.; Chu, Ping; Wu, Terry H.; Lyons, C. Rick; Murthy, Ashlesh K.; Guentzel, M. Neal; Klose, Karl E.; Arulanandam, Bernard P.			The Fischer 344 Rat Reflects Human Susceptibility to Francisella Pulmonary Challenge and Provides a New Platform for Virulence and Protection Studies	PLOS ONE			English	Article							LIVE VACCINE STRAIN; NITRIC-OXIDE PRODUCTION; CD4(+) T-CELLS; INTRANASAL VACCINATION; MURINE MACROPHAGES; TULARENSIS-LVS; IFN-GAMMA; TULAREMIA; IMMUNITY; INFECTION	Background: The pathogenesis of Francisella tularensis, the causative agent of tularemia, has been primarily characterized in mice. However, the high degree of sensitivity of mice to bacterial challenge, especially with the human virulent strains of F. tularensis, limits this animal model for screening of defined attenuated vaccine candidates for protection studies. Methods and Findings: We analyzed the susceptibility of the Fischer 344 rat to pulmonary (intratracheal) challenge with three different subspecies (subsp) of F. tularensis that reflect different levels of virulence in humans, and characterized the bacterial replication profile in rat bone marrow-derived macrophages (BMDM). In contrast to the mouse, Fischer 344 rats exhibit a broader range of sensitivity to pulmonary challenge with the human virulent subsp. tularensis and holarctica. Unlike mice, Fischer rats exhibited a high degree of resistance to pulmonary challenge with LVS (an attenuated derivative of subsp. holarctica) and subsp. novicida. Within BMDM, subsp. tularensis and LVS showed minimal replication, subsp. novicida showed marginal replication, and subsp. holartica replicated robustly. The limited intramacrophage replication of subsp. tularensis and novicida strains was correlated with the induction of nitric oxide production. Importantly, Fischer 344 rats that survived pulmonary infection with subsp. novicida were markedly protected against subsequent pulmonary challenge with subsp. tularensis, suggesting that subsp. novicida may be a useful platform for the development of vaccines against subsp. tularensis. Conclusions: The Fischer 344 rat exhibits similar sensitivity to F. tularensis strains as that reported for humans, and thus the Fischer 344 ray may serve as a better animal model for tularemia vaccine development.	[Ray, Heather J.; Chu, Ping; Murthy, Ashlesh K.; Guentzel, M. Neal; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Ray, Heather J.; Chu, Ping; Murthy, Ashlesh K.; Guentzel, M. Neal; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Wu, Terry H.; Lyons, C. Rick] Univ New Mexico, Ctr Infect Dis & Immun, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of New Mexico; University of New Mexico's Health Sciences Center	Ray, HJ (corresponding author), Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.	Bernard.arulanandam@utsa.edu	Arulanandam, Bernard P/O-9501-2014	Ray, Heather/0000-0003-0292-8403	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200500040C, PO1 AI057986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986, T32AI007538] Funding Source: NIH RePORTER	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with Federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200500040C and Grant PO1 AI057986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY LSD, 1987, MICROB PATHOGENESIS, V2, P3, DOI 10.1016/0882-4010(87)90110-0; Barker JR, 2007, ANN NY ACAD SCI, V1105, P138, DOI 10.1196/annals.1409.010; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; CANONICO PG, 1975, INFECT IMMUN, V12, P42, DOI 10.1128/IAI.12.1.42-47.1975; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; COSTA DL, 1986, LAB ANIM SCI, V36, P256; DOWNS CM, 1949, J IMMUNOL, V63, P117; DOWNS CM, 1947, J IMMUNOL, V56, P217; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ELKINS KL, 1992, MICROB PATHOGENESIS, V13, P417, DOI 10.1016/0882-4010(92)90085-3; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Frank DW, 2007, ANN NY ACAD SCI, V1105, P67, DOI 10.1196/annals.1409.008; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; JEMSKI JV, 1981, INFECT IMMUN, V34, P766, DOI 10.1128/IAI.34.3.766-772.1981; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; KELLER R, 1992, INFECT IMMUN, V60, P3664, DOI 10.1128/IAI.60.9.3664-3672.1992; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Kmonickova E, 2007, NITRIC OXIDE-BIOL CH, V17, P160, DOI 10.1016/j.niox.2007.06.006; KOSTIALA AAI, 1975, IMMUNOLOGY, V28, P855; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Mahawar M, 2009, J BACTERIOL, V191, P4798, DOI 10.1128/JB.00212-09; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; Pierini LM, 2006, CELL MICROBIOL, V8, P1361, DOI 10.1111/j.1462-5822.2006.00719.x; Powell HJ, 2008, IMMUNOL CELL BIOL, V86, P515, DOI 10.1038/icb.2008.31; Rao KMK, 2000, J TOXICOL ENV HEAL B, V3, P27, DOI 10.1080/109374000281131; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Raymond CR, 2009, MICROB PATHOGENESIS, V46, P231, DOI 10.1016/j.micpath.2009.01.002; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; TARNVIK A, 1989, REV INFECT DIS, V11, P440; WEINBERG JB, 1995, BLOOD, V86, P1184; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	45	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9952	10.1371/journal.pone.0009952	http://dx.doi.org/10.1371/journal.pone.0009952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376351	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200028
J	Smith, SL; Trachtenberg, JT				Smith, Spencer L.; Trachtenberg, Joshua T.			The Refinement of Ipsilateral Eye Retinotopic Maps Is Increased by Removing the Dominant Contralateral Eye in Adult Mice	PLOS ONE			English	Article							VISUAL-CORTEX; MONOCULAR DEPRIVATION; RECEPTIVE-FIELDS; CORTICAL MAPS; EPHRIN-AS; PLASTICITY; ACUITY; CONTRAST	Background: Shortly after eye opening, initially disorganized visual cortex circuitry is rapidly refined to form smooth retinotopic maps. This process asymptotes long before adulthood, but it is unknown whether further refinement is possible. Prior work from our lab has shown that the retinotopic map of the non-dominant ipsilateral eye develops faster when the dominant contralateral eye is removed. We examined whether input from the contralateral eye might also limit the ultimate refinement of the ipsilateral eye retinotopic map in adults. In addition, we examined whether the increased refinement involved the recruitment of adjacent cortical area. Methodology/Principal Findings: By surgically implanting a chronic optical window over visual cortex in mice, we repeatedly measured the degree of retinotopic map refinement using quantitative intrinsic signal optical imaging over four weeks. We removed the contralateral eye and observed that the retinotopic map for the ipsilateral eye was further refined and the maximum magnitude of response increased. However, these changes were not accompanied by an increase in the area of responsive cortex. Conclusions/Significance: Since the retinotopic map was functionally refined to a greater degree without taking over adjacent cortical area, we conclude that input from the contralateral eye limits the normal refinement of visual cortical circuitry in mice. These findings suggest that the refinement capacity of cortical circuitry is normally saturated.	[Smith, Spencer L.; Trachtenberg, Joshua T.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Smith, SL (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	spencer.smith@wibr.ucl.ac.uk; jtrachtenberg@mednet.ucla.edu			NIH R01 [5R01EY016052]; Klingenstein Foundation; NIH NRSA [1F32EY016633]; A. P. Giannini Foundation; NATIONAL EYE INSTITUTE [R01EY016052, F32EY016633] Funding Source: NIH RePORTER	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. P. Giannini Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an NIH R01 (5R01EY016052, JTT), the Klingenstein Foundation (JTT), an NIH NRSA (1F32EY016633, SLS), and the A. P. Giannini Foundation (SLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Faguet J, 2009, J NEUROPHYSIOL, V101, P855, DOI 10.1152/jn.90893.2008; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; FREEMAN RD, 1980, J NEUROPHYSIOL, V43, P1645, DOI 10.1152/jn.1980.43.6.1645; Hirsch JA, 2006, TRENDS NEUROSCI, V29, P30, DOI 10.1016/j.tins.2005.11.001; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nicholas JJ, 1996, VISION RES, V36, P175, DOI 10.1016/0042-6989(95)00119-K; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Steeves JKE, 2004, VISION RES, V44, P943, DOI 10.1016/j.visres.2003.11.015; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273	20	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9925	10.1371/journal.pone.0009925	http://dx.doi.org/10.1371/journal.pone.0009925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369001	Green Submitted, Green Published, gold			2022-12-27	WOS:000276163100017
J	Zhang, BY; Cressman, R; Tao, Y				Zhang, Bo-Yu; Cressman, Ross; Tao, Yi			Cooperation and Stability through Periodic Impulses	PLOS ONE			English	Article							EVOLUTIONARILY STABLE STRATEGIES; GAMES	Basic games, where each individual chooses between two strategies, illustrate several issues that immediately emerge from the standard approach that applies strategic reasoning, based on rational decisions, to predict population behavior where no rationality is assumed. These include how mutual cooperation (which corresponds to the best outcome from the population perspective) can evolve when the only individually rational choice is to defect, illustrated by the Prisoner's Dilemma (PD) game, and how individuals can randomize between two strategies when neither is individually rational, illustrated by the Battle of the Sexes (BS) game that models male-female conflict over parental investment in offspring. We examine these questions from an evolutionary perspective where the evolutionary dynamics includes an impulsive effect that models sudden changes in collective population behavior. For the PD game, we show analytically that cooperation can either coexist with defection or completely take over the population, depending on the strength of the impulse. By extending these results for the PD game, we also show that males and females each evolve to a single strategy in the BS game when the impulsive effect is strong and that weak impulses stabilize the randomized strategies of this game.	[Zhang, Bo-Yu; Tao, Yi] Chinese Acad Sci, Inst Zool, Ctr Computat Biol & Evolut, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhang, Bo-Yu] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Cressman, Ross] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Normal University; Wilfrid Laurier University	Zhang, BY (corresponding author), Chinese Acad Sci, Inst Zool, Ctr Computat Biol & Evolut, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	rcressman@wlu.ca; yitao@ioz.ac.cn		Tao, Yi/0000-0002-0749-6614	National Basic Research Program (973) [2007CB109107]; Natural Sciences and Engineering Research Council of Canada	National Basic Research Program (973)(National Basic Research Program of China); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by The National Basic Research Program (973) (No. 2007CB109107) of the People's Republic of China and by an Individual Discovery Grant from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Dawkins Richard, 1976, SELFISH GENE; DEALESSI L, 1975, AM ECON REV, V65, P127; DOUTY CM, 1972, AM ECON REV, V62, P580; Echenique F, 2004, J ECON THEORY, V118, P61, DOI 10.1016/j.jet.2003.10.004; Frey Bruno S, 2009, CESIFO WORKING PAPER, V2551; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Korn R, 1999, MATH METHOD OPER RES, V50, P493, DOI 10.1007/s001860050083; Maynard Smith J., 1982, pi; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; SCHUSTER P, 1981, ANIM BEHAV, V29, P186, DOI 10.1016/S0003-3472(81)80165-0; SELTEN R, 1980, J THEOR BIOL, V84, P93, DOI 10.1016/S0022-5193(80)81038-1; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; SMITH JM, 1988, J THEOR BIOL, V130, P247, DOI 10.1016/S0022-5193(88)80100-0; Taylor PD, 2007, J EVOLUTION BIOL, V20, P301, DOI 10.1111/j.1420-9101.2006.01196.x; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Wang SC, 2008, J THEOR BIOL, V254, P384, DOI 10.1016/j.jtbi.2008.05.016	26	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9882	10.1371/journal.pone.0009882	http://dx.doi.org/10.1371/journal.pone.0009882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369003	Green Published, gold, Green Submitted			2022-12-27	WOS:000276163100004
J	Wang, B; Ling, SY; Lin, WC				Wang, Bing; Ling, Shiyun; Lin, Weei-Chin			14-3-3 tau Regulates Beclin 1 and Is Required for Autophagy	PLOS ONE			English	Article							BREAST-CANCER; CELL INVASION; EXPRESSION; INDUCTION; APOPTOSIS; PROTEIN; TOPBP1; E2F1; TUMORIGENESIS; INHIBITION	Background: Beclin 1 plays an essential role in autophagy; however, the regulation of Beclin 1 expression remains largely unexplored. An earlier ChIP-on-chip study suggested Beclin 1 could be an E2F target. Previously, we also reported that 14-3-3 tau regulates E2F1 stability, and is required for the expression of several E2F1 target genes. 14-3-3 proteins mediate many cellular signaling processes, but its role in autophagy has not been investigated. We hypothesize that 14-3-3 tau could regulate Beclin 1 expression through E2F1 and thus regulate autophagy. Methods and Findings: Using the RNAi technique we demonstrate a novel role for one of 14-3-3 isoforms, 14-3-3 tau, in the regulation of Beclin 1 expression and autophagy. Depletion of 14-3-3 tau inhibits the expression of Beclin 1 in many different cell lines; whereas, upregulation of 14-3-3 tau induces Beclin 1. The regulation is physiologically relevant as an extracellular matrix protein tenascin-C, a known 14-3-3 tau inducer, can induce Beclin 1 through 14-3-3 tau. Moreover, rapamycin-induced, serum free-induced and amino acid starvation-induced autophagy depends on 14-3-3 tau. We also show the expression of Beclin 1 depends on E2F, and E2F can transactivate the Beclin 1 promoter in a promoter reporter assay. Upregulation of Beclin 1 by 14-3-3 tau requires E2F1. Depletion of E2F1, like 14-3-3 tau, also inhibits autophagy. Conclusion: Taken together, this study uncovers a role for 14-3-3 tau in Beclin 1 and autophagy regulation probably through regulation of E2F1.	[Wang, Bing; Ling, Shiyun; Lin, Weei-Chin] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Ling, Shiyun; Lin, Weei-Chin] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, B (corresponding author), Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA.	weeichil@bcm.edu	Ling, Shiyun/P-2242-2014		National Institutes of Health [CA 100857, CA138641]; Department of Defense [W81XWH-09-1-0338]; NATIONAL CANCER INSTITUTE [R01CA100857, R01CA138641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grants from National Institutes of Health (CA 100857, CA138641) and Department of Defense Breast Cancer Research Program (W81XWH-09-1-0338). W-C. L. is a Leukemia and Lymphoma Society Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN Y, 2009, PATHOL ONCOL RES; Chiquet-Ehrismann R, 1991, CURR OPIN CELL BIOL, V3, P800, DOI 10.1016/0955-0674(91)90053-2; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Jahkola T, 1998, BRIT J CANCER, V78, P1507, DOI 10.1038/bjc.1998.714; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KUSAMA Y, 2009, APOPTOSIS; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Martin D, 2003, J CELL BIOL, V160, P171, DOI 10.1083/jcb.200206109; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Miracco C, 2007, INT J ONCOL, V30, P429; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sarkar S, 2006, CANCER RES, V66, P11771, DOI 10.1158/0008-5472.CAN-05-0470; Shi YH, 2009, AUTOPHAGY, V5, P380, DOI 10.4161/auto.5.3.7658; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001	37	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10409	10.1371/journal.pone.0010409	http://dx.doi.org/10.1371/journal.pone.0010409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454448	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240100018
J	Waterston, ML; Pack, CC				Waterston, Michael L.; Pack, Christopher C.			Improved Discrimination of Visual Stimuli Following Repetitive Transcranial Magnetic Stimulation	PLOS ONE			English	Article							THETA-BURST STIMULATION; NEURONAL RESPONSES; CONTROLLED-TRIAL; WORKING-MEMORY; CORTEX; PERCEPTION; MECHANISMS; FREQUENCY; MOTION; RTMS	Background: Repetitive transcranial magnetic stimulation (rTMS) at certain frequencies increases thresholds for motor-evoked potentials and phosphenes following stimulation of cortex. Consequently rTMS is often assumed to introduce a "virtual lesion'' in stimulated brain regions, with correspondingly diminished behavioral performance. Methodology/Principal Findings: Here we investigated the effects of rTMS to visual cortex on subjects' ability to perform visual psychophysical tasks. Contrary to expectations of a visual deficit, we find that rTMS often improves the discrimination of visual features. For coarse orientation tasks, discrimination of a static stimulus improved consistently following theta-burst stimulation of the occipital lobe. Using a reaction-time task, we found that these improvements occurred throughout the visual field and lasted beyond one hour post-rTMS. Low-frequency (1 Hz) stimulation yielded similar improvements. In contrast, we did not find consistent effects of rTMS on performance in a fine orientation discrimination task. Conclusions/Significance: Overall our results suggest that rTMS generally improves or has no effect on visual acuity, with the nature of the effect depending on the type of stimulation and the task. We interpret our results in the context of an ideal-observer model of visual perception.	[Waterston, Michael L.; Pack, Christopher C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Waterston, ML (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	christopher.pack@mcgill.ca			Canadian National Institute	Canadian National Institute	This work was supported by grants from the Canadian National Institute for the Blind, the Alfred P. Sloan Foundation, and Mrs. Anna Engel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Antal A, 2002, NEUROREPORT, V13, P2229, DOI 10.1097/00001756-200212030-00013; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Aydin-Abidin S, 2006, J PHYSIOL-LONDON, V574, P443, DOI 10.1113/jphysiol.2006.108464; Azouz R, 1999, J NEUROSCI, V19, P2209; Battelli L, 2002, NEUROLOGY, V58, P1066, DOI 10.1212/WNL.58.7.1066; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Boroojerdi B, 2001, P NATL ACAD SCI USA, V98, P14698, DOI 10.1073/pnas.251357198; Cattaneo Z, 2009, EUR J NEUROSCI, V30, P1393, DOI 10.1111/j.1460-9568.2009.06911.x; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Clarke Beverley M, 2006, J Headache Pain, V7, P341, DOI 10.1007/s10194-006-0329-8; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; Cowey A, 2006, EXP BRAIN RES, V171, P558, DOI 10.1007/s00221-006-0479-6; DAFOTAKIS M, 2008, J NEURAL TRANSMISSIO; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fierro B, 2005, J PHYSIOL-LONDON, V565, P659, DOI 10.1113/jphysiol.2004.080184; Fitzgerald PB, 2006, AM J PSYCHIAT, V163, P88, DOI 10.1176/appi.ajp.163.1.88; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; George MS, 1996, J NEUROPSYCH CLIN N, V8, P172; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Hamidi M, 2008, BRAIN RES, V1230, P202, DOI 10.1016/j.brainres.2008.07.008; Hamidi M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.014.2009; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kirton A, 2008, LANCET NEUROL, V7, P507, DOI 10.1016/S1474-4422(08)70096-6; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Koski L, 2004, NEUROREHAB NEURAL RE, V18, P230, DOI 10.1177/1545968304269210; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lappin JS, 2009, J VISION, V9, DOI 10.1167/9.1.30; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; McKeefry DJ, 2008, J NEUROSCI, V28, P6848, DOI 10.1523/JNEUROSCI.1287-08.2008; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; PascualLeone A, 1996, NEUROLOGY, V46, P499, DOI 10.1212/WNL.46.2.499; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pasley BN, 2009, NEURON, V62, P291, DOI 10.1016/j.neuron.2009.03.012; POGGIO GF, 1988, J NEUROSCI, V8, P4531; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Silvanto J, 2008, J NEUROPHYSIOL, V99, P2725, DOI 10.1152/jn.01392.2007; Silvanto J, 2007, EUR J NEUROSCI, V26, P523, DOI 10.1111/j.1460-9568.2007.05682.x; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P333, DOI 10.1016/j.clinph.2006.10.014; Thompson B, 2008, CURR BIOL, V18, P1067, DOI 10.1016/j.cub.2008.06.052; Thompson B, 2009, HUM BRAIN MAPP, V30, P3115, DOI 10.1002/hbm.20736; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	56	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10354	10.1371/journal.pone.0010354	http://dx.doi.org/10.1371/journal.pone.0010354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442776	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200005
J	Miyazaki, JI; Martins, LD; Fujita, Y; Matsumoto, H; Fujiwara, Y				Miyazaki, Jun-Ichi; de Oliveira Martins, Leonardo; Fujita, Yuko; Matsumoto, Hiroto; Fujiwara, Yoshihiro			Evolutionary Process of Deep-Sea Bathymodiolus Mussels	PLOS ONE			English	Article							HYDROTHERMAL VENT MUSSELS; NORTH FIJI BASIN; COLD-SEEP; PHYLOGENETIC-RELATIONSHIPS; BIVALVIA MYTILIDAE; WOODEN STEPS; NEW-ZEALAND; RATES; ENDOSYMBIONTS; POPULATIONS	Background: Since the discovery of deep-sea chemosynthesis-based communities, much work has been done to clarify their organismal and environmental aspects. However, major topics remain to be resolved, including when and how organisms invade and adapt to deep-sea environments; whether strategies for invasion and adaptation are shared by different taxa or unique to each taxon; how organisms extend their distribution and diversity; and how they become isolated to speciate in continuous waters. Deep-sea mussels are one of the dominant organisms in chemosynthesis-based communities, thus investigations of their origin and evolution contribute to resolving questions about life in those communities. Methodology/Principal Finding: We investigated worldwide phylogenetic relationships of deep-sea Bathymodiolus mussels and their mytilid relatives by analyzing nucleotide sequences of the mitochondrial cytochrome c oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4) genes. Phylogenetic analysis of the concatenated sequence data showed that mussels of the subfamily Bathymodiolinae from vents and seeps were divided into four groups, and that mussels of the subfamily Modiolinae from sunken wood and whale carcasses assumed the outgroup position and shallow-water modioline mussels were positioned more distantly to the bathymodioline mussels. We provisionally hypothesized the evolutionary history of Bathymodilolus mussels by estimating evolutionary time under a relaxed molecular clock model. Diversification of bathymodioline mussels was initiated in the early Miocene, and subsequently diversification of the groups occurred in the early to middle Miocene. Conclusions/Significance: The phylogenetic relationships support the "Evolutionary stepping stone hypothesis,'' in which mytilid ancestors exploited sunken wood and whale carcasses in their progressive adaptation to deep-sea environments. This hypothesis is also supported by the evolutionary transition of symbiosis in that nutritional adaptation to the deep sea proceeded from extracellular to intracellular symbiotic states in whale carcasses. The estimated evolutionary time suggests that the mytilid ancestors were able to exploit whales during adaptation to the deep sea.	[Miyazaki, Jun-Ichi] Univ Yamanashi, Fac Educ & Human Sci, Yamanashi, Japan; [de Oliveira Martins, Leonardo] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Fujita, Yuko; Matsumoto, Hiroto] Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan; [Fujiwara, Yoshihiro] Japan Agcy Marine Earth Sci & Technol, Res Program Marine Biol & Ecol, Kanagawa, Japan	University of Yamanashi; Universidade de Vigo; University of Tsukuba; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Miyazaki, JI (corresponding author), Univ Yamanashi, Fac Educ & Human Sci, Yamanashi, Japan.	miyazaki@yamanashi.ac.jp	de Oliveira Martins, Leonardo/I-4606-2013	de Oliveira Martins, Leonardo/0000-0001-5247-1320	Ministry of Education, Culture, Sports, Science and Technology of Japan [21570093]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 21570093, http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burton KW, 1997, NATURE, V386, P382, DOI 10.1038/386382a0; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Collins LS, 1996, P NATL ACAD SCI USA, V93, P6069, DOI 10.1073/pnas.93.12.6069; COLLINS TM, 1989, THESIS YALE U NEW HA; CRADDOCK C, 1995, MAR BIOL, V121, P477, DOI 10.1007/BF00349456; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; DISTEL DL, 1988, J BACTERIOL, V170, P2506, DOI 10.1128/jb.170.6.2506-2510.1988; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Dubilier N, 1998, MAR ECOL PROG SER, V165, P187, DOI 10.3354/meps165187; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; FISHER CR, 1993, PSZNI MAR ECOL, V14, P277; Fujita Yuko, 2009, Venus (Tokyo), V67, P123; Fujiwara Y, 2000, MAR ECOL PROG SER, V208, P147, DOI 10.3354/meps208147; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Gros O, 2007, CAH BIOL MAR, V48, P103; Gustafson RG, 1998, MALACOLOGIA, V40, P63; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Hashimoto Jun, 2005, Venus (Tokyo), V64, P1; Hashimoto Jun, 2001, Venus (Tokyo), V60, P141; Hashimoto Jun, 2007, Venus (Tokyo), V66, P57; Hashimoto Jun, 1994, Venus the Japanese Journal of Malacology, V53, P61; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Iwasaki H, 2006, MAR BIOL, V149, P1111, DOI 10.1007/s00227-006-0268-6; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; KENK VC, 1985, MALACOLOGIA, V26, P253; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kyuno Akiko, 2009, Journal of Marine Biology, V2009, P1; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Miyazaki JI, 2004, MAR BIOL, V144, P527, DOI 10.1007/s00227-003-1208-3; OKUTANI T, 2004, VENUS, V63, P97; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Samadi S, 2007, CR BIOL, V330, P446, DOI 10.1016/j.crvi.2007.04.001; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Smith PJ, 2004, MAR BIOL, V144, P537, DOI 10.1007/s00227-003-1207-4; SQUIRES RL, 1991, NATURE, V349, P574, DOI 10.1038/349574a0; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; von Cosel R, 2003, NAUTILUS, V117, P31; Von Cosel R, 1999, VELIGER, V42, P218; von Cosel R, 1998, CR ACAD SCI III-VIE, V321, P655, DOI 10.1016/S0764-4469(98)80005-X; von Cosel Rudo, 2002, Zoosystema, V24, P259; von Cosel R, 2008, RAFFLES B ZOOL, P105; von Cosel R, 2008, ARCH MOLLUSKENKD, V137, P195, DOI 10.1127/arch.moll/0003-9284/137/195-224; VONCOSEL R, 1994, VELIGER, V37, P374; Yamanaka T, 2003, J MAR BIOL ASSOC UK, V83, P841, DOI 10.1017/S0025315403007872h; Yamanaka Toshiro, 2000, Benthos Research, V55, P63; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	59	60	65	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10363	10.1371/journal.pone.0010363	http://dx.doi.org/10.1371/journal.pone.0010363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436906	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079700011
J	Michels, L; Bucher, K; Luchinger, R; Klaver, P; Martin, E; Jeanmonod, D; Brandeis, D				Michels, Lars; Bucher, Kerstin; Luechinger, Rafael; Klaver, Peter; Martin, Ernst; Jeanmonod, Daniel; Brandeis, Daniel			Simultaneous EEG-fMRI during a Working Memory Task: Modulations in Low and High Frequency Bands	PLOS ONE			English	Article							SHORT-TERM-MEMORY; ANTERIOR CINGULATE CORTEX; DEFAULT MODE NETWORK; ALPHA-RHYTHM; GAMMA-OSCILLATIONS; PREFRONTAL CORTEX; CAUDATE-NUCLEUS; BRAIN ACTIVITY; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL	Background: EEG studies of working memory (WM) have demonstrated load dependent frequency band modulations. FMRI studies have localized load modulated activity to the dorsolateral prefrontal cortex (DLPFC), medial prefrontal cortex (MPFC), and posterior parietal cortex (PPC). Recently, an EEG-fMRI study found that low frequency band (theta and alpha) activity negatively correlated with the BOLD signal during the retention phase of a WM task. However, the coupling of higher (beta and gamma) frequencies with the BOLD signal during WM is unknown. Methodology: In 16 healthy adult subjects, we first investigated EEG-BOLD signal correlations for theta (5-7 Hz), alpha1 (8-10), alpha2 (10-12 Hz), beta1 (13-20), beta2 (20-30 Hz), and gamma (30-40 Hz) during the retention period of a WM task with set size 2 and 5. Secondly, we investigated whether load sensitive brain regions are characterised by effects that relate frequency bands to BOLD signals effects. Principal Findings: We found negative theta-BOLD signal correlations in the MPFC, PPC, and cingulate cortex (ACC and PCC). For alpha1 positive correlations with the BOLD signal were found in ACC, MPFC, and PCC; negative correlations were observed in DLPFC, PPC, and inferior frontal gyrus (IFG). Negative alpha2-BOLD signal correlations were observed in parieto-occipital regions. Beta1-BOLD signal correlations were positive in ACC and negative in precentral and superior temporal gyrus. Beta2 and gamma showed only positive correlations with BOLD, e. g., in DLPFC, MPFC (gamma) and IFG (beta2/gamma). The load analysis revealed that theta and-with one exception-beta and gamma demonstrated exclusively positive load effects, while alpha1 showed only negative effects. Conclusions: We conclude that the directions of EEG-BOLD signal correlations vary across brain regions and EEG frequency bands. In addition, some brain regions show both load sensitive BOLD and frequency band effects. Our data indicate that lower as well as higher frequency brain oscillations are linked to neurovascular processes during WM.	[Michels, Lars; Jeanmonod, Daniel] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Bucher, Kerstin; Klaver, Peter; Martin, Ernst] Univ Childrens Hosp, MR Ctr, Zurich, Switzerland; [Luechinger, Rafael; Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Klaver, Peter; Martin, Ernst; Jeanmonod, Daniel; Brandeis, Daniel] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Brandeis, Daniel] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, D-6800 Mannheim, Germany	University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Central Institute of Mental Health	Michels, L (corresponding author), Univ Zurich Hosp, CH-8091 Zurich, Switzerland.	lars.michels@kispi.uzh.ch	Klaver, Peter/G-7988-2011; Michels, Lars/X-6939-2018; Klaver, Peter/M-9506-2019	Klaver, Peter/0000-0002-6541-9975; Klaver, Peter/0000-0002-6541-9975; Michels, Lars/0000-0003-3750-1100	Zurich Center for Integrative Human Physiology (ZIHP)	Zurich Center for Integrative Human Physiology (ZIHP)	This work has been supported by the Zurich Center for Integrative Human Physiology (ZIHP; http://www.zihp.uzh.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetelashvili OK, 2007, B EXP BIOL MED+, V143, P302, DOI 10.1007/s10517-007-0095-x; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Axmacher N, 2008, J NEUROSCI, V28, P7304, DOI 10.1523/JNEUROSCI.1778-08.2008; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Bastiaansen MCM, 2002, CLIN NEUROPHYSIOL, V113, P1882, DOI 10.1016/S1388-2457(02)00303-6; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brem S, 2005, NEUROREPORT, V16, P45, DOI 10.1097/00001756-200501190-00011; BRESSLER SL, 1984, ELECTROEN CLIN NEURO, V57, P270, DOI 10.1016/0013-4694(84)90128-7; Brett M., 2002, 8 INT C FUNCT MAPP H; Brookes MJ, 2005, NEUROIMAGE, V26, P302, DOI 10.1016/j.neuroimage.2005.01.050; BURIANOVA H, NEUROIMAGE, V49, P865; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Fisher R.A., 1937, DESIGN EXPT; Frei E, 2001, HUM BRAIN MAPP, V14, P152, DOI 10.1002/hbm.1049; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HENSON R, 1999, HUM BRAIN MAPP C DUS; Hochberg Y., 1987, MULTIPLE COMP PROCED; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kaiser J, 2003, NEUROIMAGE, V20, P816, DOI 10.1016/S1053-8119(03)00350-1; Kilner JM, 2005, NEUROIMAGE, V28, P280, DOI 10.1016/j.neuroimage.2005.06.008; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Krause CM, 2000, CLIN NEUROPHYSIOL, V111, P2071, DOI 10.1016/S1388-2457(00)00429-6; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Leiberg S, 2006, BRAIN RES, V1120, P131, DOI 10.1016/j.brainres.2006.08.066; Levy R, 1997, J NEUROSCI, V17, P3870; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lutzenberger W, 2002, J NEUROSCI, V22, P5630; LUTZENBERGER W, 1995, NEUROSCI LETT, V183, P39, DOI 10.1016/0304-3940(94)11109-V; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2007, NEUROIMAGE, V34, P598, DOI 10.1016/j.neuroimage.2006.09.037; McEvoy LK, 2001, COGNITIVE BRAIN RES, V11, P363, DOI 10.1016/S0926-6410(01)00009-X; MEDENDORP WP, 2006, CEREB CORTEX; Meltzer JA, 2008, CEREB CORTEX, V18, P1843, DOI 10.1093/cercor/bhm213; Meltzer JA, 2007, CLIN NEUROPHYSIOL, V118, P2419, DOI 10.1016/j.clinph.2007.07.023; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; Missonnier P, 2007, NEUROSCIENCE, V150, P346, DOI 10.1016/j.neuroscience.2007.09.009; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Mulert C, 2008, NEUROIMAGE, V42, P158, DOI 10.1016/j.neuroimage.2008.04.236; Muller MM, 1996, EXP BRAIN RES, V112, P96; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pipa G, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.025.2009; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sammer G, 2007, HUM BRAIN MAPP, V28, P793, DOI 10.1002/hbm.20309; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; SENKOWSKI D, 2009, EXP BRAIN RES; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tallon-Baudry C, 1999, VISUAL NEUROSCI, V16, P449, DOI 10.1017/S0952523899163065; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TULADHAR AM, 2007, HUM BRAIN MAPP; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Tyvaert L, 2008, CLIN NEUROPHYSIOL, V119, P2762, DOI 10.1016/j.clinph.2008.07.284; Vanni S, 1997, J NEUROSCI, V17, P7141; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; White NM, 2009, BEHAV BRAIN RES, V199, P3, DOI 10.1016/j.bbr.2008.12.003; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	99	146	146	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10298	10.1371/journal.pone.0010298	http://dx.doi.org/10.1371/journal.pone.0010298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421978	Green Published, gold			2022-12-27	WOS:000276952600015
J	Espina, V; Mariani, BD; Gallagher, RI; Tran, K; Banks, S; Wiedemann, J; Huryk, H; Mueller, C; Adamo, L; Deng, JH; Petricoin, EF; Pastore, L; Zaman, S; Menezes, G; Mize, J; Johal, J; Edmiston, K; Liotta, LA				Espina, Virginia; Mariani, Brian D.; Gallagher, Rosa I.; Tran, Khoa; Banks, Stacey; Wiedemann, Joy; Huryk, Heather; Mueller, Claudius; Adamo, Luana; Deng, Jianghong; Petricoin, Emanuel F., III; Pastore, Lucia; Zaman, Syed; Menezes, Geetha; Mize, James; Johal, Jasbir; Edmiston, Kirsten; Liotta, Lance A.			Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival	PLOS ONE			English	Article							CARCINOMA IN-SITU; DUCTAL CARCINOMA; STEM-CELL; CANCER PROGRESSION; STAGA COMPLEX; HUMAN GENOME; COPY NUMBER; RESISTANCE; THERAPY; MICROENVIRONMENT	Background: While it is accepted that a majority of invasive breast cancer progresses from a ductal carcinoma in situ ( DCIS) precursor stage, very little is known about the factors that promote survival of DCIS neoplastic cells within the hypoxic, nutrient deprived intraductal microenvironment. Methodology and Principal Findings: We examined the hypothesis that fresh human DCIS lesions contain pre-existing carcinoma precursor cells. We characterized these cells by full genome molecular cytogenetics (Illumina HumanCytoSNP profile), and signal pathway profiling ( Reverse Phase Protein Microarray, 59 endpoints), and demonstrated that autophagy is required for survival and anchorage independent growth of the cytogenetically abnormal tumorigenic DCIS cells. Ex vivo organoid culture of fresh human DCIS lesions, without enzymatic treatment or sorting, induced the emergence of neoplastic epithelial cells exhibiting the following characteristics: a) spontaneous generation of hundreds of spheroids and duct-like 3D structures in culture within 2-4 weeks; b) tumorigenicity in NOD/SCID mice; c) cytogenetically abnormal ( copy number loss or gain in chromosomes including 1, 5, 6, 8, 13, 17) compared to the normal karyotype of the non-neoplastic cells in the source patient's breast tissue; d) in vitro migration and invasion of autologous breast stroma; and e) up-regulation of signal pathways linked to, and components of, cellular autophagy. Multiple autophagy markers were present in the patient's original DCIS lesion and the mouse xenograft. We tested whether autophagy was necessary for survival of cytogenetically abnormal DCIS cells. The lysosomotropic inhibitor ( chloroquine phosphate) of autophagy completely suppressed the generation of DCIS spheroids/3-D structures, suppressed ex vivo invasion of autologous stroma, induced apoptosis, suppressed autophagy associated proteins including Atg5, AKT/PI3 Kinase and mTOR, eliminated cytogenetically abnormal spheroid forming cells from the organ culture, and abrogated xenograft tumor formation. Conclusions: Cytogenetically abnormal spheroid forming, tumorigenic, and invasive neoplastic epithelial cells pre-exist in human DCIS and require cellular autophagy for survival.	[Espina, Virginia; Gallagher, Rosa I.; Mueller, Claudius; Adamo, Luana; Deng, Jianghong; Petricoin, Emanuel F., III; Liotta, Lance A.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Mariani, Brian D.; Tran, Khoa] AGTCtr Genet, Fairfax, VA USA; [Mariani, Brian D.; Tran, Khoa] IVF Inst, Fairfax, VA USA; [Banks, Stacey; Wiedemann, Joy; Huryk, Heather; Edmiston, Kirsten] Inova Fairfax Hosp, Canc Translat Res Ctr, Inova Hlth Syst, Falls Church, VA USA; [Adamo, Luana] Ist Oncol Mediterraneo, Dept Pathol, Catania, Italy; [Pastore, Lucia; Zaman, Syed; Menezes, Geetha; Mize, James; Johal, Jasbir] Inova Fairfax Hosp, Inova Hlth Syst, Dept Pathol, Falls Church, VA USA	George Mason University; Inova Fairfax Hospital; Inova Health System; Mediterranean Institute of Oncology; Inova Fairfax Hospital; Inova Health System	Espina, V (corresponding author), George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA.	vespina@gmu.edu	Mueller, Claudius/A-4459-2012	Mueller, Claudius/0000-0003-4499-4724; Gallagher, Rosa Isela/0000-0003-3887-8399; Espina, Virginia/0000-0001-5080-5972				Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Beckhove P, 2003, INT J CANCER, V105, P444, DOI 10.1002/ijc.11125; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Damonte P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2104; de Roos MA, 2007, ANN SURG ONCOL, V14, P2097, DOI 10.1245/s10434-007-9395-7; Espina V, 2008, MOL CELL PROTEOMICS, V7, P1998, DOI 10.1074/mcp.M700596-MCP200; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; GAO W, 2009, J BIOL CHEM; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Kalirai H, 2006, J PATHOL, V208, P7, DOI 10.1002/path.1881; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LAGIOS MD, 1995, CANCER LETT, V90, P97, DOI 10.1016/0304-3835(94)03683-A; Li CI, 2006, CANCER-AM CANCER SOC, V106, P2104, DOI 10.1002/cncr.21864; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Loehberg CR, 2007, CANCER RES, V67, P12026, DOI 10.1158/0008-5472.CAN-07-3058; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; RAO SK, 2009, J NEUROONCOL; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Tlsty T, 2008, NATURE, V453, P604, DOI 10.1038/453604a; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855	52	93	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10240	10.1371/journal.pone.0010240	http://dx.doi.org/10.1371/journal.pone.0010240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421921	Green Submitted, Green Published, gold			2022-12-27	WOS:000276854300007
J	Green, S; Studholme, DJ; Laue, BE; Dorati, F; Lovell, H; Arnold, D; Cottrell, JE; Bridgett, S; Blaxter, M; Huitema, E; Thwaites, R; Sharp, PM; Jackson, RW; Kamoun, S				Green, Sarah; Studholme, David J.; Laue, Bridget E.; Dorati, Federico; Lovell, Helen; Arnold, Dawn; Cottrell, Joan E.; Bridgett, Stephen; Blaxter, Mark; Huitema, Edgar; Thwaites, Richard; Sharp, Paul M.; Jackson, Robert W.; Kamoun, Sophien			Comparative Genome Analysis Provides Insights into the Evolution and Adaptation of Pseudomonas syringae pv. aesculi on Aesculus hippocastanum	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; ESCHERICHIA-COLI; PLANT-DISEASE; SEQUENCE; VIRULENCE; REVEALS; GENES; IDENTIFICATION; RECOMBINATION; COLONIZATION	A recently emerging bleeding canker disease, caused by Pseudomonas syringae pathovar aesculi (Pae), is threatening European horse chestnut in northwest Europe. Very little is known about the origin and biology of this new disease. We used the nucleotide sequences of seven commonly used marker genes to investigate the phylogeny of three strains isolated recently from bleeding stem cankers on European horse chestnut in Britain (E-Pae). On the basis of these sequences alone, the E-Pae strains were identical to the Pae type-strain (I-Pae), isolated from leaf spots on Indian horse chestnut in India in 1969. The phylogenetic analyses also showed that Pae belongs to a distinct clade of P. syringae pathovars adapted to woody hosts. We generated genome-wide Illumina sequence data from the three E-Pae strains and one strain of I-Pae. Comparative genomic analyses revealed pathovar-specific genomic regions in Pae potentially implicated in virulence on a tree host, including genes for the catabolism of plant-derived aromatic compounds and enterobactin synthesis. Several gene clusters displayed intra-pathovar variation, including those encoding type IV secretion, a novel fatty acid biosynthesis pathway and a sucrose uptake pathway. Rates of single nucleotide polymorphisms in the four Pae genomes indicate that the three E-Pae strains diverged from each other much more recently than they diverged from I-Pae. The very low genetic diversity among the three geographically distinct E-Pae strains suggests that they originate from a single, recent introduction into Britain, thus highlighting the serious environmental risks posed by the spread of an exotic plant pathogenic bacterium to a new geographic location. The genomic regions in Pae that are absent from other P. syringae pathovars that infect herbaceous hosts may represent candidate genetic adaptations to infection of the woody parts of the tree.	[Green, Sarah; Laue, Bridget E.] Ctr Forestry & Climate Change, Roslin, Midlothian, Scotland; [Studholme, David J.; Huitema, Edgar; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Dorati, Federico; Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Lovell, Helen; Arnold, Dawn] Univ W England, Ctr Res Plant Sci, Bristol BS16 1QY, Avon, England; [Lovell, Helen; Arnold, Dawn] Univ W England, Ctr Res Plant Sci, Bristol, Somerset, England; [Cottrell, Joan E.] Ctr Human & Ecol Sci, Roslin, Midlothian, Scotland; [Bridgett, Stephen; Blaxter, Mark] Univ Edinburgh, GenePool Genom Facil, Edinburgh, Lothian Borders, Scotland; [Blaxter, Mark; Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Lothian Borders, Scotland; [Thwaites, Richard] Food & Environm Res Agcy, Sand Hutton, Yorks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Reading; University of West England; University of West England; University of Edinburgh; University of Edinburgh; Food & Environment Research Agency	Green, S (corresponding author), Ctr Forestry & Climate Change, Roslin, Midlothian, Scotland.	sarah.green@forestry.gsi.gov.uk	Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022; Kamoun, Sophien/B-3529-2009; Studholme, David/H-6790-2019; Arnold, Dawn/AAF-3484-2021; Huitema, Edgar/G-3760-2011; Blaxter, Mark/O-2535-2019; Sharp, Paul/Y-3787-2019; Jackson, Robert W/C-2973-2009; Blaxter, Mark/B-4113-2010	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Kamoun, Sophien/0000-0002-0290-0315; Studholme, David/0000-0002-3010-6637; Huitema, Edgar/0000-0002-5766-0830; Jackson, Robert W/0000-0002-2042-4105; Arnold, Donald/0000-0003-0943-8853; Blaxter, Mark/0000-0003-2861-949X; Bridgett, Stephen/0000-0001-9330-5820	'Forest Research CEO Innovation fund'; Gatsby Charitable Foundation; MRC [G0900740] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish	'Forest Research CEO Innovation fund'; Gatsby Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The 'Forest Research CEO Innovation fund' supported the sequencing and analysis of E-Pae strain 2250. The sequencing and analysis of the three other Pae strains were funded by the Gatsby Charitable Foundation (http://www.gatsby.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bultreys A., 2008, PSEUDOMONAS SYRINGAE, P283; D'Autreaux B, 2008, METHOD ENZYMOL, V437, P235, DOI 10.1016/S0076-6879(07)37013-4; Das A, 2009, MOL PLANT MICROBE IN, V22, P73, DOI 10.1094/MPMI-22-1-0073; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; DURGAPAL J C, 1971, Indian Phytopathology, V24, P392; Durgapal J. C., 1980, Indian Phytopathology, V33, P533; ESAU K, 1965, PLANT ANATOMY, P270; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Forestry Commission, 2008, REP NAT SURV ASS PRE; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Green S, 2009, PLANT PATHOL, V58, P731, DOI 10.1111/j.1365-3059.2009.02065.x; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; GUNASEKARAN P, 1990, J BACTERIOL, V172, P6727, DOI 10.1128/jb.172.12.6727-6735.1990; HARDESTY C, 1991, J BACTERIOL, V173, P449, DOI 10.1128/jb.173.2.449-456.1991; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Helmick RA, 2005, ANTIMICROB AGENTS CH, V49, P1837, DOI 10.1128/AAC.49.5.1837-1843.2005; Inatsuka CS, 2005, P NATL ACAD SCI USA, V102, P18578, DOI 10.1073/pnas.0507910102; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kasai D, 2007, FEMS MICROBIOL LETT, V274, P323, DOI 10.1111/j.1574-6968.2007.00855.x; KAZEMPOUR MN, 2006, IRAN J AGR SCI, V37, P849; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; KING EO, 1954, J LAB CLIN MED, V44, P301; KOZLOWSKI TT, 1997, PHYSL WOODY PLANTS, P160; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; McGuirk P, 2000, J INFECT DIS, V182, P1286, DOI 10.1086/315838; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; NICHOLS NN, 1995, J BACTERIOL, V177, P7033, DOI 10.1128/jb.177.24.7033-7040.1995; OGIMI C, 1981, Annals of the Phytopathological Society of Japan, V47, P443, DOI 10.3186/jjphytopath.47.443; Perez-Losada M, 2007, INFECT GENET EVOL, V7, P271, DOI 10.1016/j.meegid.2006.11.003; Perez-Martinez I, 2008, J BACTERIOL, V190, P625, DOI 10.1128/JB.01067-07; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schmidt O, 2008, FOREST PATHOL, V38, P124, DOI 10.1111/j.1439-0329.2007.00539.x; Schwarzenbacher R, 2004, J BIOL CHEM, V279, P29320, DOI 10.1074/jbc.M401268200; Snyder LAS, 2009, MICROB ECOL, V57, P1, DOI 10.1007/s00248-008-9465-9; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; WEBBER JF, 2008, PLANT PATHOL NEW DIS, V15, P1; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson LA, 2006, MOL BIOL EVOL, V23, P1156, DOI 10.1093/molbev/msj125; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	62	83	85	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10224	10.1371/journal.pone.0010224	http://dx.doi.org/10.1371/journal.pone.0010224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419105	Green Published, gold, Green Submitted			2022-12-27	WOS:000276853800014
J	Vigh-Conrad, KA; Conrad, DF; Preuss, D				Vigh-Conrad, Katinka A.; Conrad, Donald F.; Preuss, Daphne			A Protein Allergen Microarray Detects Specific IgE to Pollen Surface, Cytoplasmic, and Commercial Allergen Extracts	PLOS ONE			English	Article							RECOMBINANT ALLERGENS; MOLECULAR-CLONING; CROSS-REACTIVITY; MAJOR ALLERGEN; DIAGNOSIS; ASTHMA; GENE; LOCALIZATION; DISEASES; COAT	Background: Current diagnostics for allergies, such as skin prick and radioallergosorbent tests, do not allow for inexpensive, high-throughput screening of patients. Additionally, extracts used in these methods are made from washed pollen that lacks pollen surface materials that may contain allergens. Methodology/Principal Findings: We sought to develop a high-throughput assay to rapidly measure allergen-specific IgE in sera and to explore the relative allergenicity of different pollen fractions (i.e. surface, cytoplasmic, commercial extracts). To do this, we generated a protein microarray containing surface, cytoplasmic, and commercial extracts from 22 pollen species, commercial extracts from nine non-pollen allergens, and five recombinant allergenic proteins. Pollen surface and cytoplasmic fractions were prepared by extraction into organic solvents and aqueous buffers, respectively. Arrays were incubated with <25 uL of serum from 176 individuals and bound IgE was detected by indirect immunofluorescence, providing a high-throughput measurement of IgE. We demonstrated that the allergen microarray is a reproducible method to measure allergen-specific IgE in small amounts of sera. Using this tool, we demonstrated that specific IgE clusters according to the phylogeny of the allergen source. We also showed that the pollen surface, which has been largely overlooked in the past, contained potent allergens. Although, as a class, cytoplasmic fractions obtained by our pulverization/precipitation method were comparable to commercial extracts, many individual allergens showed significant differences. Conclusions/Significance: These results support the hypothesis that protein microarray technology is a useful tool for both research and in the clinic. It could provide a more efficient and less painful alternative to traditionally used skin prick tests, making it economically feasible to compare allergen sensitivity of different populations, monitor individual responses over time, and facilitate genetic studies on pollen allergy.	[Vigh-Conrad, Katinka A.; Conrad, Donald F.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Preuss, Daphne] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Vigh-Conrad, KA (corresponding author), Abcam Plc, Cambridge, England.	kvigh@uchicago.edu			Strategic Program for Asthma Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	Strategic Program for Asthma Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by the Strategic Program for Asthma Research (www.spar-aaf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Asturias JA, 2002, ALLERGY, V57, P221, DOI 10.1034/j.1398-9995.2002.03406.x; Bacarese-Hamilton T, 2002, CLIN CHEM, V48, P1367; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Cookson WOCM, 1998, CLIN EXP ALLERGY, V28, P88; Crameri R, 2006, IMMUNOL ALLERGY CLIN, V26, P179, DOI 10.1016/j.iac.2006.02.003; Deinhofer K, 2004, METHODS, V32, P249, DOI 10.1016/j.ymeth.2003.08.018; Dickinson H G, 1998, Symp Soc Exp Biol, V51, P51; Fall BI, 2003, ANAL CHEM, V75, P556, DOI 10.1021/ac026016k; Fernandes J, 2003, CLIN EXP ALLERGY, V33, P956, DOI 10.1046/j.1365-2222.2003.01722.x; Ferreira F, 2004, ALLERGY, V59, P243, DOI 10.1046/j.1398-9995.2003.00407.x; Grier TJ, 2001, CLIN REV ALLERG IMMU, V21, P111, DOI 10.1385/CRIAI:21:2-3:111; GROTE M, 1984, J HISTOCHEM CYTOCHEM, V32, P869, DOI 10.1177/32.8.6430993; Hamilton RG, 2004, J ALLERGY CLIN IMMUN, V114, P213, DOI 10.1016/j.jaci.2004.06.046; Harwanegg C, 2005, CLIN CHEM LAB MED, V43, P1321, DOI 10.1515/CCLM.2005.226; Harwanegg C, 2003, CLIN EXP ALLERGY, V33, P7, DOI 10.1046/j.1365-2222.2003.01550.x; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; Hoffjan S, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-14; Ibarrola I, 2004, J ALLERGY CLIN IMMUN, V113, P1185, DOI 10.1016/j.jaci.2004.02.031; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Kattah MG, 2006, NAT METHODS, V3, P745, DOI 10.1038/nmeth910; Kawamoto S, 2002, CLIN EXP ALLERGY, V32, P1064, DOI 10.1046/j.1365-2222.2002.01405.x; Kim TE, 2002, EXP MOL MED, V34, P152, DOI 10.1038/emm.2002.22; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; KING TP, 1994, INT ARCH ALLERGY IMM, V105, P224, DOI 10.1159/000236761; Kingsmore SF, 2003, CURR OPIN BIOTECH, V14, P74, DOI 10.1016/S0958-1669(02)00019-8; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lebrun SJ, 2005, J IMMUNOL METHODS, V300, P24, DOI 10.1016/j.jim.2005.01.019; Liccardi G, 2006, J INVEST ALLERG CLIN, V16, P75; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; Murphy DJ, 2006, PROTOPLASMA, V228, P31, DOI 10.1007/s00709-006-0163-5; Nathan RA, 1996, ANN ALLERG ASTHMA IM, V77, P255, DOI 10.1016/S1081-1206(10)63315-7; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Ober C, 2005, J ALLERGY CLIN IMMUN, V116, P274, DOI 10.1016/j.jaci.2005.04.039; Puc M, 2003, ANN AGR ENV MED, V10, P143; Rodriguez R, 2007, BIOMED PHARMACOTHER, V61, P1, DOI 10.1016/j.biopha.2006.09.014; Spinozzi F, 2007, IMMUNOL ALLERGY CLIN, V27, P79, DOI 10.1016/j.iac.2006.11.004; Suck R, 2002, ALLERGY, V57, P821, DOI 10.1034/j.1398-9995.2002.23705.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Toriyama K, 1998, FEBS LETT, V424, P234, DOI 10.1016/S0014-5793(98)00174-4; TWELL D, 1990, DEVELOPMENT, V109, P705; Verdino P, 2006, CLIN REV ALLERG IMMU, V30, P73, DOI 10.1385/CRIAI:30:2:73; VITHANAGE HIMV, 1982, HISTOCHEM J, V14, P949, DOI 10.1007/BF01005236; Wiltshire S, 2000, CLIN CHEM, V46, P1990	47	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10174	10.1371/journal.pone.0010174	http://dx.doi.org/10.1371/journal.pone.0010174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419087	Green Published, gold, Green Submitted			2022-12-27	WOS:000276743500009
J	Zheng, LQ; Cheng, ZQ; Ai, CX; Jiang, XH; Bei, XS; Zheng, Y; Glahn, RP; Welch, RM; Miller, DD; Lei, XG; Shou, HX				Zheng, Luqing; Cheng, Zhiqiang; Ai, Chunxiang; Jiang, Xinhang; Bei, Xiaoshu; Zheng, Ye; Glahn, Raymond P.; Welch, Ross M.; Miller, Dennis D.; Lei, Xin Gen; Shou, Huixia			Nicotianamine, a Novel Enhancer of Rice Iron Bioavailability to Humans	PLOS ONE			English	Article							FORTIFICATION; EXPRESSION; AVAILABILITY; ACCUMULATION; FERRITIN; IDENTIFICATION; ABSORPTION; GENOTYPES; CITRATE; GENES	Background: Polished rice is a staple food for over 50% of the world's population, but contains little bioavailable iron (Fe) to meet human needs. Thus, biofortifying the rice grain with novel promoters or enhancers of Fe utilization would be one of the most effective strategies to prevent the high prevalence of Fe deficiency and iron deficiency anemia in the developing world. Methodology/Principal Findings: We transformed an elite rice line cultivated in Southern China with the rice nicotianamine synthase gene (OsNAS1) fused to a rice glutelin promoter. Endosperm overexpression of OsNAS1 resulted in a significant increase in nicotianamine (NA) concentrations in both unpolished and polished grain. Bioavailability of Fe from the high NA grain, as measured by ferritin synthesis in an in vitro Caco-2 cell model that simulates the human digestive system, was twice as much as that of the control line. When added at 1: 1 molar ratio to ferrous Fe in the cell system, NA was twice as effective when compared to ascorbic acid (one of the most potent known enhancers of Fe bioavailability) in promoting more ferritin synthesis. Conclusions: Our data demonstrated that NA is a novel and effective promoter of iron utilization. Biofortifying polished rice with this compound has great potential in combating global human iron deficiency in people dependent on rice for their sustenance.	[Zheng, Luqing; Jiang, Xinhang; Bei, Xiaoshu; Zheng, Ye; Shou, Huixia] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Zhiqiang; Ai, Chunxiang; Bei, Xiaoshu; Miller, Dennis D.; Lei, Xin Gen] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Cheng, Zhiqiang; Ai, Chunxiang; Bei, Xiaoshu; Miller, Dennis D.; Lei, Xin Gen] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Glahn, Raymond P.; Welch, Ross M.] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Zhejiang University; Cornell University; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Zheng, LQ (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	xl20@cornell.edu; huixia@zju.edu.cn	Shou, Huixia/I-3052-2015	Bei, Xiaoshu/0000-0003-1772-7161; Zheng, Luqing/0000-0003-2711-780X	HarvestPlus-China [8019]; National Natural Science Foundation of China [30770191, 30871585]; Ministry of Agriculture [2009ZX08010-013B, 2009ZX08009-123B]	HarvestPlus-China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by HarvestPlus-China (Project No. 8019), the National Natural Science Foundation of China (30770191 and 30871585), and the Ministry of Agriculture (2009ZX08010-013B and 2009ZX08009-123B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANDELA E, 1984, J NUTR, V114, P2204, DOI 10.1093/jn/114.12.2204; Chen SY, 2003, PLANT J, V36, P105, DOI 10.1046/j.1365-313X.2003.01860.x; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; COOK JD, 1983, AM J CLIN NUTR, V38, P648, DOI 10.1093/ajcn/38.4.648; Douchkov D, 2005, PLANT CELL ENVIRON, V28, P365, DOI 10.1111/j.1365-3040.2005.01273.x; Glahn RP, 1998, J NUTR, V128, P1555, DOI 10.1093/jn/128.9.1555; Glahn RP, 1998, J NUTR, V128, P257, DOI 10.1093/jn/128.2.257; Glahn RP, 2002, J AGR FOOD CHEM, V50, P3586, DOI 10.1021/jf0116496; Hayashi A, 2007, J NUTR SCI VITAMINOL, V53, P331, DOI 10.3177/jnsv.53.331; HAZELL T, 1987, BRIT J NUTR, V57, P223, DOI 10.1079/BJN19870028; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; Higuchi K, 1996, J PLANT NUTR, V19, P1235, DOI 10.1080/01904169609365194; Hurrell RF, 2004, INT J VITAM NUTR RES, V74, P387, DOI 10.1024/0300-9831.74.6.387; KINOSHITA E, 1993, BIOSCI BIOTECH BIOCH, V57, P1107, DOI 10.1271/bbb.57.1107; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Lynch SR, 2003, J NUTR, V133, p2978S; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; PICH A, 1994, PLANT SOIL, V165, P189, DOI 10.1007/BF00008061; Poletti S, 2004, CURR OPIN BIOTECH, V15, P162, DOI 10.1016/j.copbio.2004.03.002; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1111/j.1467-7652.2004.00055.x; Qu LQ, 2005, PLANTA, V222, P225, DOI 10.1007/s00425-005-1530-8; Shojima S, 1989, BIOL METALS, V2, P142; TANAKA K, 1974, SOIL SCI PLANT NUTR, V20, P87; Usuda K, 2009, PLANT BIOTECHNOL J, V7, P87, DOI 10.1111/j.1467-7652.2008.00374.x; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Wada Y, 2007, BIOSCI BIOTECH BIOCH, V71, P435, DOI 10.1271/bbb.60496; Welch RM, 2002, J NUTR, V132, p495S, DOI 10.1093/jn/132.3.495S; Xuan Y, 2006, J CHROMATOGR A, V1136, P73, DOI 10.1016/j.chroma.2006.09.060; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	34	105	108	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10190	10.1371/journal.pone.0010190	http://dx.doi.org/10.1371/journal.pone.0010190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419136	Green Published, gold, Green Submitted			2022-12-27	WOS:000276743500003
J	Valley, JK; Swinton, P; Boscardin, WJ; Lue, TF; Rinaudo, PF; Wu, MC; Garcia, MM				Valley, Justin K.; Swinton, Paul; Boscardin, W. John; Lue, Tom F.; Rinaudo, Paolo F.; Wu, Ming C.; Garcia, Maurice M.			Preimplantation Mouse Embryo Selection Guided by Light-Induced Dielectrophoresis	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; FIELD-FLOW FRACTIONATION; UNITED-STATES; SINGLE CELLS; MANIPULATION; SEPARATION; CULTURE; PARAMETERS; TWEEZERS	Selection of optimal quality embryos for in vitro fertilization (IVF) transfer is critical to successful live birth outcomes. Currently, embryos are chosen based on subjective assessment of morphologic developmental maturity. A non-invasive means to quantitatively measure an embryo's developmental maturity would reduce the variability introduced by the current standard. We present a method that exploits the scaling electrical properties of pre-transfer embryos to quantitatively discern embryo developmental maturity using light-induced dielectrophoresis (DEP). We show that an embryo's DEP response is highly correlated with its developmental stage. Uniquely, this technique allows one to select, in sequence and under blinded conditions, the most developmentally mature embryos among a mixed cohort of morphologically indistinguishable embryos cultured in optimized and sub-optimal culture media. Following assay, embryos continue to develop normally in vitro. Light-induced dielectrophoresis provides a non-invasive, quantitative, and reproducible means to select embryos for applications including IVF transfer and embryonic stem cell harvest.	[Valley, Justin K.; Wu, Ming C.] Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA; [Swinton, Paul] Univ Calif San Francisco, Gladstone Transgen Gene Targeting Core Lab, San Francisco, CA 94143 USA; [Boscardin, W. John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lue, Tom F.; Garcia, Maurice M.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Rinaudo, Paolo F.] Univ Calif San Francisco, Dept Obstet & Gynaecol, Div Reprod Endocrinol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Valley, JK (corresponding author), Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA.	mgarcia@urology.ucsf.edu	Wu, Ming C/J-9906-2012	Wu, Ming C/0000-0003-4808-6686	NIH/NCRR UCSF-CTSI [UL1 RR024131]; NIH [K-12, PN2 EY018228]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER	NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	M. G. acknowledges funding and publication support from NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131, and NIH K-12 Men's Reproductive Health Research (MRHR) Grant. J.V. and M. W. acknowledge funding and publication support from NIH Grant Number PN2 EY018228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; *ASRM, 2009, FREQ ASK QUEST INF; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BENOS DJ, 1981, J PHYSIOL-LONDON, V316, P191, DOI 10.1113/jphysiol.1981.sp013782; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Biggers JD, 1998, INT J DEV BIOL, V42, P879; *CDC, 2009, ASS REPR TECHN; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Choi W, 2008, BIOMED MICRODEVICES, V10, P337, DOI 10.1007/s10544-007-9141-8; Creasy RK., 2009, CREASY RESNIKS MATER; Dessie SW, 2007, REPRODUCTION, V133, P931, DOI 10.1530/REP-06-0277; Fiedler S, 1998, ANAL CHEM, V70, P1909, DOI 10.1021/ac971063b; GASCOYNE PRC, 1992, MEAS SCI TECHNOL, V3, P439, DOI 10.1088/0957-0233/3/5/001; Grigorenko AN, 2008, NAT PHOTONICS, V2, P365, DOI 10.1038/nphoton.2008.78; Gurgan T, 2004, REPROD BIOMED ONLINE, V9, P237, DOI 10.1016/S1472-6483(10)62136-0; Hsu HY, 2010, LAB CHIP, V10, P165, DOI 10.1039/b906593h; Huang Y, 1997, BIOPHYS J, V73, P1118, DOI 10.1016/S0006-3495(97)78144-X; Jamshidi A, 2008, NAT PHOTONICS, V2, P85, DOI 10.1038/nphoton.2007.277; Jones T. B., 1995, ELECTROMECHANICS PAR; Kjellberg AT, 2006, HUM REPROD, V21, P210, DOI 10.1093/humrep/dei298; Kovalevsky G, 2005, FERTIL STERIL, V84, P325, DOI 10.1016/j.fertnstert.2005.04.020; Lei U, 2009, LAB CHIP, V9, P1349, DOI 10.1039/b822809d; Ludwig AK, 2005, SEMIN REPROD MED, V23, P348, DOI 10.1055/s-2005-923392; Manaresi N, 2003, IEEE J SOLID-ST CIRC, V38, P2297, DOI 10.1109/JSSC.2003.819171; Nagy ZP, 2008, REPROD BIOMED ONLINE, V17, P502, DOI 10.1016/S1472-6483(10)60236-2; Ohta AT, 2007, J MICROELECTROMECH S, V16, P491, DOI 10.1109/JMEMS.2007.896717; PALMER JF, 1970, J EMBRYOL EXP MORPH, V24, P535; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; *SART, 2007, ASS REPR SUCC RAT NA; Schoolcraft WB, 1999, FERTIL STERIL, V72, P604, DOI 10.1016/S0015-0282(99)00311-8; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; STEPTOE PC, 1978, LANCET, V2, P366; WANG XB, 1993, J PHYS D APPL PHYS, V26, P1278, DOI 10.1088/0022-3727/26/8/019; Warner CM, 2008, REPROD BIOMED ONLINE, V17, P470, DOI 10.1016/S1472-6483(10)60233-7; Yang J, 1999, ANAL CHEM, V71, P911, DOI 10.1021/ac981250p; YING H, 1992, PHYS MED BIOL, V37, P1499, DOI 10.1088/0031-9155/37/7/003	36	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10160	10.1371/journal.pone.0010160	http://dx.doi.org/10.1371/journal.pone.0010160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405021	gold, Green Published			2022-12-27	WOS:000276706300015
J	Norgaard, O; Lazarus, JV				Norgaard, Ole; Lazarus, Jeffrey V.			Searching PubMed during a Pandemic	PLOS ONE			English	Article							HEALTH-PROFESSIONALS; DECISION-MAKERS; INFLUENZA; KNOWLEDGE; DISSEMINATION; INFORMATION; VIRUS	Background: The 2009 influenza A(H1N1) pandemic has generated thousands of articles and news items. However, finding relevant scientific articles in such rapidly developing health crises is a major challenge which, in turn, can affect decision-makers' ability to utilise up-to-date findings and ultimately shape public health interventions. This study set out to show the impact that the inconsistent naming of the pandemic can have on retrieving relevant scientific articles in PubMed/MEDLINE. Methodology: We first formulated a PubMed search algorithm covering different names of the influenza pandemic and simulated the results that it would have retrieved from weekly searches for relevant new records during the first 10 weeks of the pandemic. To assess the impact of failing to include every term in this search, we then conducted the same searches but omitted in turn "h1n1," "swine," "influenza" and "flu" from the search string, and compared the results to those for the full string. Principal Findings: On average, our core search string identified 44.3 potentially relevant new records at the end of each week. Of these, we determined that an average of 27.8 records were relevant. When we excluded one term from the string, the percentage of records missed out of the total number of relevant records averaged 18.7% for omitting "h1n1," 13.6% for "swine," 17.5% for "influenza," and 20.6% for "flu." Conclusions: Due to inconsistent naming, while searching for scientific material about rapidly evolving situations such as the influenza A(H1N1) pandemic, there is a risk that one will miss relevant articles. To address this problem, the international scientific community should agree on nomenclature and the specific name to be used earlier, and the National Library of Medicine in the US could index potentially relevant materials faster and allow publishers to add alert tags to such materials.	[Norgaard, Ole] Natl Board Hlth, Natl Ctr Hlth Promot & Dis Prevent, Copenhagen, Denmark; [Norgaard, Ole; Lazarus, Jeffrey V.] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Lazarus, Jeffrey V.] Univ Copenhagen, Copenhagen Sch Global Hlth, Copenhagen, Denmark	World Health Organization; University of Copenhagen	Norgaard, O (corresponding author), Natl Board Hlth, Natl Ctr Hlth Promot & Dis Prevent, Copenhagen, Denmark.	JeffLaz@pubhealth.ku.dk	Norgaard, Ole/B-2607-2013; Lazarus, Jeffrey V./R-6248-2018	Norgaard, Ole/0000-0002-1681-4338; Lazarus, Jeffrey V./0000-0001-9618-2299				Baden LR, 2009, NEW ENGL J MED, V360, P2666, DOI 10.1056/NEJMe0903992; Camitz M., 2009, Eurosurveillance, V14, P19256; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Duncan B, 2009, EUROSURVEILLANCE, V14, P15; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Hatchette TF, 2009, CAN J PUBLIC HEALTH, V100, P204, DOI 10.1007/BF03405541; Jankowski T. A., 2008, MED LIB ASS ESSENTIA; Kerner J, 2005, HEALTH PSYCHOL, V24, P443, DOI 10.1037/0278-6133.24.5.443; Lavis JN, 2003, MILBANK Q, V81, P221, DOI 10.1111/1468-0009.t01-1-00052; LOMAS J, 1993, ANN NY ACAD SCI, V703, P226, DOI 10.1111/j.1749-6632.1993.tb26351.x; Mermel LA, 2009, LANCET, V373, P2108, DOI 10.1016/S0140-6736(09)61145-4; *NAT LIB MED, 2010, LAT H1N1 CIT PUBMED; *NAT LIB MED, 2009, XML HELP PUBMED DAT; *NAT LIB MED, 2010, PUBMED HELP; *NAT LIB MED, 2009, FACT SHEET WHATS DIF; *NAT LIB MED, 2007, MED SUBJ HEAD MESH D; Revere D, 2007, J BIOMED INFORM, V40, P410, DOI 10.1016/j.jbi.2006.12.008; Robinson SM, 2009, EMERG MED J, V26, P497, DOI 10.1136/emj.2008.061499; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Timpka T, 2009, B WORLD HEALTH ORGAN, V87, P305, DOI 10.2471/BLT.07.050203; U. S. N ational L ibrary of M edicine, 2008, FACT SHEET MED SUBJ; van't Hoff G, 2009, PUBLIC HEALTH, V123, P422, DOI 10.1016/j.puhe.2009.04.003; While Alison, 2009, Br J Community Nurs, V14, P270; *WHO, 2010, PAND H1N1 2010 UPD 8; WIWANITKIT V, 2009, ARCH GYNECO IN PRESS; Yuan J, 2009, EPIDEMIOL INFECT, V137, P988, DOI 10.1017/S0950268809002726; 2009, WKLY EPIDEMIOL REC, V84, P197	27	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10039	10.1371/journal.pone.0010039	http://dx.doi.org/10.1371/journal.pone.0010039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383330	gold, Green Submitted, Green Published			2022-12-27	WOS:000276454000009
J	Twine, SM; Petit, MD; Fulton, KM; House, RV; Conlan, JW				Twine, Susan M.; Petit, Mireille D.; Fulton, Kelly M.; House, Robert V.; Conlan, J. Wayne			Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)	PLOS ONE			English	Article							TULAREMIA	Background: Francisella tularensis subspecies tularensis is the causative agent of a spectrum of diseases collectively known as tularemia. An attenuated live vaccine strain (LVS) has been shown to be efficacious in humans, but safety concerns have prevented its licensure by the FDA. Recently, F. tularensis LVS has been produced under Current Good Manufacturing Practice (CGMP guidelines). Little is known about the immunogenicity of this new vaccine preparation in comparison with extensive studies conducted with laboratory passaged strains of LVS. Thus, the aim of the current work was to evaluate the repertoire of antibodies produced in mouse strains vaccinated with the new LVS vaccine preparation. Methodology/Principal Findings: In the current study, we used an immunoproteomics approach to examine the repertoire of antibodies induced following successful immunization of BALB/c versus unsuccessful vaccination of C57BL/6 mice with the new preparation of F. tularensis LVS. Successful vaccination of BALB/c mice elicited antibodies to nine identified proteins that were not recognized by antisera from vaccinated but unprotected C57BL/6 mice. In addition, the CGMP formulation of LVS stimulated a greater repertoire of antibodies following vaccination compared to vaccination with laboratory passaged ATCC LVS strain. A total of 15 immunoreactive proteins were identified in both studies, however, 16 immunoreactive proteins were uniquely reactive with sera from the new formulation of LVS. Conclusions/Significance: This is the first report characterising the antibody based immune response of the new formulation of LVS in the widely used murine model of tularemia. Using two mouse strains, we show that successfully vaccinated mice can be distinguished from unsuccessfully vaccinated mice based upon the repertoire of antibodies generated. This opens the door towards downselection of antigens for incorporation into tularemia subunit vaccines. In addition, this work also highlights differences in the humoral immune response to vaccination with the commonly used laboratory LVS strain and the new vaccine formulation of LVS.	[Twine, Susan M.; Petit, Mireille D.; Fulton, Kelly M.; Conlan, J. Wayne] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [House, Robert V.] DynPort Vaccine Co LLC, Frederick, MD USA	National Research Council Canada	Twine, SM (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	susan.twine@nrc-cnrc.gc.ca		Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN26620050041C]; National Research Council	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Research Council	This work has been funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN26620050041C. This contract was awarded to the Dynport Vaccine Company, who administered funds. National Research Council was a subcontractor of this award. All research described was funded by NIH; no funding was received directly from Dynport Vaccine Company outside the NIH award. The Dynport Vaccine Company were in no way sponsors of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government.	Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Chen CS, 2005, J CREATIVE BEHAV, V39, P89, DOI 10.1002/j.2162-6057.2005.tb01252.x; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2008, MOL IMMUNOL, V45, P2962, DOI 10.1016/j.molimm.2008.01.022; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; CONLAN JW, 2004, EXPERT REV VACCINES, V3; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Cowley SC, 2003, J EXP MED, V198, P379, DOI 10.1084/jem.20030687; DIENST FT, 1963, J LA STATE MED SOC, V115, P14; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Gosselin EJ, 2005, HUM IMMUNOL, V66, P1039, DOI 10.1016/j.humimm.2005.08.240; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; Havlasova J, 2002, PROTEOMICS, V2, P857, DOI 10.1002/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; JANOVSKA S, 2007, IMMUNOL LETT, V13, P35; Kirimanjeswara GS, 2008, IMMUNOL REV, V225, P244, DOI 10.1111/j.1600-065X.2008.00689.x; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Macela A, 1996, FEMS IMMUNOL MED MIC, V13, P235, DOI 10.1111/j.1574-695X.1996.tb00243.x; MANSFIELD MA, 1995, ANAL BIOCHEM, V229, P140, DOI 10.1006/abio.1995.1391; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; OYSTON PC, 2005, ANTON LEEUW INT J G, V87, P77; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; SASLAW S, 1961, ARCH INTERN MED, V107; Shen H, 2004, VACCINE, V22, P2116, DOI 10.1016/j.vaccine.2003.12.003; SJOSTEDT A, 1992, IMMUNOLOGY, V76, P584; SJOSTEDT A, 2001, BERGERYS MANUAL SYST; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Titball RW, 2003, EXPERT OPIN BIOL TH, V3, P645, DOI 10.1517/14712598.3.4.645; Twine SM, 2005, J PROTEOME RES, V4, P1848, DOI 10.1021/pr050102u; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070; WAYNE CJ, 2007, ANN NY ACAD SCI, V1105, P25; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	38	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10000	10.1371/journal.pone.0010000	http://dx.doi.org/10.1371/journal.pone.0010000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368994	Green Published, Green Submitted, gold			2022-12-27	WOS:000276419900004
J	Becq, J; Churlaud, C; Deschavanne, P				Becq, Jennifer; Churlaud, Cecile; Deschavanne, Patrick			A Benchmark of Parametric Methods for Horizontal Transfers Detection	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; GENOMIC ISLANDS; ESCHERICHIA-COLI; SURROGATE METHODS; BACTERIAL; SIGNATURE; IDENTIFICATION; ACQUISITION; RESISTANCE; EVOLUTION	Horizontal gene transfer (HGT) has appeared to be of importance for prokaryotic species evolution. As a consequence numerous parametric methods, using only the information embedded in the genomes, have been designed to detect HGTs. Numerous reports of incongruencies in results of the different methods applied to the same genomes were published. The use of artificial genomes in which all HGT parameters are controlled allows testing different methods in the same conditions. The results of this benchmark concerning 16 representative parametric methods showed a great variety of efficiencies. Some methods work very poorly whatever the type of HGTs and some depend on the conditions or on the metrics used. The best methods in terms of total errors were those using tetranucleotides as criterion for the window methods or those using codon usage for gene based methods and the Kullback-Leibler divergence metric. Window methods are very sensitive but less specific and detect badly lone isolated gene. On the other hand gene based methods are often very specific but lack of sensitivity. We propose using two methods in combination to get the best of each category, a gene based one for specificity and a window based one for sensitivity.	[Becq, Jennifer] Univ Paris Diderot, Inst Natl Transfus Sanguine, UMR S 665, INSERM, Paris, France; [Churlaud, Cecile; Deschavanne, Patrick] Univ Paris Diderot, INSERM, UMR S 973, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Becq, J (corresponding author), Univ Paris Diderot, Inst Natl Transfus Sanguine, UMR S 665, INSERM, Paris, France.	patrick.deschavanne@univ-paris-diderot.fr			French Education and Research Ministry	French Education and Research Ministry	JB was supported by grants from the French Education and Research Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PATHOGENICITY ISLAND; Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Azad RK, 2005, PLOS COMPUT BIOL, V1, P461, DOI 10.1371/journal.pcbi.0010056; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Cortez Diego Q., 2005, In Silico Biology, V5, P581; Daubin V, 2001, Genome Inform, V12, P155; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Deschavanne P, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P161, DOI 10.1109/BIBE.2000.889603; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Doolittle WF, 1999, TRENDS CELL BIOL, V15, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Guindon S, 2001, MOL BIOL EVOL, V18, P1838, DOI 10.1093/oxfordjournals.molbev.a003972; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hamady M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-476; Hayes WS, 1998, GENOME RES, V8, P1154, DOI 10.1101/gr.8.11.1154; HOOPER SD, 2002, J MOL EVOL, P365; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Ip M, 2007, ANTIMICROB AGENTS CH, V51, P2690, DOI 10.1128/AAC.00258-07; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Koski LB, 2001, MOL BIOL EVOL, V18, P404, DOI 10.1093/oxfordjournals.molbev.a003816; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; LERAT E, 2005, PLOS BIOL; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Lio P, 2000, BIOINFORMATICS, V16, P932, DOI 10.1093/bioinformatics/16.10.932; Lio P, 1996, J THEOR BIOL, V183, P455, DOI 10.1006/jtbi.1996.0235; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Merkl R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-22; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Perriere G, 2002, NUCLEIC ACIDS RES, V30, P4548, DOI 10.1093/nar/gkf565; POPTSOVA M, 2007, BMC EVOLUTIONARY BIO; Ragan MA, 2006, TRENDS MICROBIOL, V14, P4, DOI 10.1016/j.tim.2005.11.004; Ragan MA, 2001, CURR OPIN GENET DEV, V11, P620, DOI 10.1016/S0959-437X(00)00244-6; Ragan MA, 2001, FEMS MICROBIOL LETT, V201, P187, DOI 10.1111/j.1574-6968.2001.tb10755.x; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; ROLFE R, 1959, P NATL ACAD SCI USA, V45, P1039, DOI 10.1073/pnas.45.7.1039; RUITING L, 1996, MOL BIOL EVOL, V13, P47; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; SUEOKA N, 1993, J MOL EVOL, P137; SUEOKA N, 1992, J MOL EVOL, P95; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P922, DOI 10.1093/nar/gki187; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; van Passel MWJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-163; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang B, 2001, J MOL EVOL, V53, P244, DOI 10.1007/s002390010214; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184	59	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9989	10.1371/journal.pone.0009989	http://dx.doi.org/10.1371/journal.pone.0009989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376325	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200059
J	Garbian, Y; Ovadia, O; Dadon, S; Mishmar, D				Garbian, Yael; Ovadia, Ofer; Dadon, Sarah; Mishmar, Dan			Gene Expression Patterns of Oxidative Phosphorylation Complex I Subunits Are Organized in Clusters	PLOS ONE			English	Article							STEADY-STATE LEVELS; MITOCHONDRIAL-DNA; TRANSCRIPTION; COEXPRESSION; EVOLUTION; GENOME	After the radiation of eukaryotes, the NUO operon, controlling the transcription of the NADH dehydrogenase complex of the oxidative phosphorylation system (OXPHOS complex I), was broken down and genes encoding this protein complex were dispersed across the nuclear genome. Seven genes, however, were retained in the genome of the mitochondrion, the ancient symbiote of eukaryotes. This division, in combination with the three-fold increase in subunit number from bacteria (N = similar to 14) to man (N = 45), renders the transcription regulation of OXPHOS complex I a challenge. Recently bioinformatics analysis of the promoter regions of all OXPHOS genes in mammals supported patterns of co-regulation, suggesting that natural selection favored a mechanism facilitating the transcriptional regulatory control of genes encoding subunits of these large protein complexes. Here, using real time PCR of mitochondrial (mtDNA)- and nuclear DNA (nDNA)-encoded transcripts in a panel of 13 different human tissues, we show that the expression pattern of OXPHOS complex I genes is regulated in several clusters. Firstly, all mtDNA-encoded complex I subunits (N = 7) share a similar expression pattern, distinct from all tested nDNA-encoded subunits (N = 10). Secondly, two sub-clusters of nDNA-encoded transcripts with significantly different expression patterns were observed. Thirdly, the expression patterns of two nDNA-encoded genes, NDUFA4 and NDUFA5, notably diverged from the rest of the nDNA-encoded subunits, suggesting a certain degree of tissue specificity. Finally, the expression pattern of the mtDNA-encoded ND4L gene diverged from the rest of the tested mtDNA-encoded transcripts that are regulated by the same promoter, consistent with post-transcriptional regulation. These findings suggest, for the first time, that the regulation of complex I subunits expression in humans is complex rather than reflecting global co-regulation.	[Garbian, Yael; Ovadia, Ofer; Dadon, Sarah; Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Garbian, Yael; Dadon, Sarah; Mishmar, Dan] Ben Gurion Univ Negev, Natl Inst Biotechnol NIBN, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Garbian, Y (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	dmishmar@bgu.ac.il	Ovadia, Ofer OO/C-8292-2012; Mishmar, Dan/AAJ-6109-2020	Mishmar, Dan/0000-0003-3488-8792; Ovadia, Ofer/0000-0002-4941-4947	Israel Science Foundation (ISF); Bikurah F.I.R.S.T. Foundation; Israeli Cancer Association	Israel Science Foundation (ISF)(Israel Science Foundation); Bikurah F.I.R.S.T. Foundation; Israeli Cancer Association	This work was supported by grants from the Israel Science Foundation (ISF), Bikurah F.I.R.S.T. Foundation and the Israeli Cancer Association awarded to D. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Duborjal H, 2002, GENOME RES, V12, P1901, DOI 10.1101/gr.194102; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; KING MP, 1993, J BIOL CHEM, V268, P10228; LABBE D, 1991, J BIOL CHEM, V266, P10844; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Legendre L, NUMERICAL ECOLOGY; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; TORRESBACETE J, 2009, J BIOL CHEM; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707	20	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9985	10.1371/journal.pone.0009985	http://dx.doi.org/10.1371/journal.pone.0009985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376309	gold, Green Submitted, Green Published			2022-12-27	WOS:000276418200055
J	Jennings, RM; Bucklin, A; Pierrot-Bults, A				Jennings, Robert M.; Bucklin, Ann; Pierrot-Bults, Annelies			Barcoding of Arrow Worms (Phylum Chaetognatha) from Three Oceans: Genetic Diversity and Evolution within an Enigmatic Phylum	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DNA; PHYLOGENIES; INFERENCE; ACCURATE; BRANCHES	Arrow worms (Phylum Chaetognatha) are abundant planktonic organisms and important predators in many food webs; yet, the classification and evolutionary relationships among chaetognath species remain poorly understood. A seemingly simple body plan is underlain by subtle variation in morphological details, obscuring the affinities of species within the phylum. Many species achieve near global distributions, spanning the same latitudinal bands in all ocean basins, while others present disjunct ranges, in some cases with the same species apparently found at both poles. To better understand how these complex evolutionary and geographic variables are reflected in the species makeup of chaetognaths, we analyze DNA barcodes of the mitochondrial cytochrome oxidase c subunit I (COI) gene, from 52 specimens of 14 species of chaetognaths collected mainly from the Atlantic Ocean. Barcoding analysis was highly successful at discriminating described species of chaetognaths across the phylum, and revealed little geographical structure. This barcode analysis reveals hitherto unseen genetic variation among species of arrow worms, and provides insight into some species relationships of this enigmatic group.	[Jennings, Robert M.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Bucklin, Ann] Univ Connecticut, Dept Marine Sci, Groton, CT USA; [Pierrot-Bults, Annelies] Zool Museum, Amsterdam, Netherlands	University of Massachusetts System; University of Massachusetts Boston; University of Connecticut	Jennings, RM (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	rob.jennings@umb.edu	Jennings, Robert/D-4393-2009	Jennings, Robert/0000-0003-4714-5824; Bucklin, Ann/0000-0003-3750-9348	NOAA's Office of Ocean Exploration [NA050AR4601079]; Russian Foundation for Basic Research [06-05-65187]; Alfred P. Sloan Foundation	NOAA's Office of Ocean Exploration(National Oceanic Atmospheric Admin (NOAA) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was partially funded by NOAA's Office of Ocean Exploration (Award No. NA050AR4601079). Funding to APB was provided by MAR-ECO (www.mar-eco.no).Samples collected by Ksenia Kosobokova and kindly contributed by her were supported by the Russian Foundation for Basic Research (Award No. 06-05-65187). The authors gratefully acknowledge the support of the Alfred P. Sloan Foundation. This study is a contribution from the Census of Marine Zooplankton (CMarZ, www.CMarZ.org), an ocean realm field project of the Census of Marine Life (www.coml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; BIERI R, 1991, P122; Bone Q, 1991, BIOL CHAETOGNATHS; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GHIRARDELLI E, 1968, ADV MAR BIOL, V6, P271; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Halanych KM, 1996, SYST BIOL, V45, P223, DOI 10.2307/2413616; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Matus DQ, 2006, CURR BIOL, V16, pR575, DOI 10.1016/j.cub.2006.07.017; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Papillon D, 2006, MOL PHYLOGENET EVOL, V38, P621, DOI 10.1016/j.ympev.2005.12.004; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Peijnenburg KTCA, 2005, MAR BIOL, V147, P1279, DOI 10.1007/s00227-005-0041-2; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Pierrot-Bults AC, 2008, DEEP-SEA RES PT II, V55, P137, DOI 10.1016/j.dsr2.2007.09.016; PIERROT-BULTS A C, 1976, Bulletin Zoologisch Museum Universiteit van Amsterdam, V5, P59; Pleijel F, 2008, MOL PHYLOGENET EVOL, V48, P369, DOI 10.1016/j.ympev.2008.03.024; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telford MJ, 1997, J MOL EVOL, V44, P135, DOI 10.1007/PL00006130; Telford MJ, 2004, NATURE, V431, P254, DOI 10.1038/431254b; TELFORD MJ, 1993, MOL BIOL EVOL, V10, P660; Tokioka T., 1965, Publications of the Seto Marine Biological Laboratory, V12, P335; VANDERSPOEL S, 1973, ZOOGEOGRAPHY DIVERSI; Vannier J, 2007, P ROY SOC B-BIOL SCI, V274, P627, DOI 10.1098/rspb.2006.3761; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529	38	28	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9949	10.1371/journal.pone.0009949	http://dx.doi.org/10.1371/journal.pone.0009949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376348	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200025
J	Krylova, EM; Sahling, H				Krylova, Elena M.; Sahling, Heiko			Vesicomyidae (Bivalvia): Current Taxonomy and Distribution	PLOS ONE			English	Article							COLD-SEEP COMMUNITIES; DEEP-SEA; HYDROTHERMAL VENT; EVOLUTIONARY RELATIONSHIPS; CLAMS; GULF	Vesicomyid bivalves are a consistent component of communities of sulphide-rich reducing environments distributed worldwide from 77 degrees N to 70 degrees S at depths from 100 to 9050 m. Up-to-now the taxonomy of the family has been uncertain. In this paper, the current state of vesicomyid taxonomy and distribution at the generic rank are considered. This survey is founded on a database including information both from literature sources and also unpublished data of the authors on all recent species of vesicomyids. We suggest that the Vesicomyidae is not a synonym of Kelliellidae, and is therefore a valid family name. We propose to divide the family Vesicomyidae into two subfamilies: Vesicomyinae and Pliocardiinae. The Vesicomyinae includes one genus, Vesicomya, which comprises small-sized bivalves characterized by non-reduced gut and the absence of subfilamental tissue in gills. Symbiosis with chemoautotrophic bacteria has, so far, not been proved for Vesicomya and the genus is not restricted to sulphide-rich reducing habitats. The subfamily Pliocardiinae currently contains about 15 genera with mostly medium or large body size, characterized by the presence of subfilamental tissue in the gills. The Pliocardiinae are highly specialized for sulphide-rich reducing environments, harbouring chemoautrophic bacteria in their gills. This is the first summary of the generic structure of the family Vesicomyidae that allow us to analyze the distribution of vesicomyids at the generic level. We recognize here five different distribution patterns that are related to the specific environmental demands. The general trends in the distribution patterns of the vesicomyids are an occurrence of the majority of genera in broad geographical ranges and the prevalence of near continental type of distribution.	[Krylova, Elena M.] PP Shirshov Oceanol Inst, Lab Ocean Benth Fauna, Moscow, Russia; [Sahling, Heiko] Univ Bremen, Dept Geosci, MARUM Ctr Marine Environm Sci, Bremen, Germany	Russian Academy of Sciences; Shirshov Institute of Oceanology; University of Bremen	Krylova, EM (corresponding author), PP Shirshov Oceanol Inst, Lab Ocean Benth Fauna, Moscow, Russia.	elenamkr@mail.ru	Krylova, Elena M./A-4418-2017; Sahling, Heiko/B-7701-2017	Krylova, Elena M./0000-0003-1341-1709; Sahling, Heiko/0000-0002-1022-9816	DFG [SA 13483-1]	DFG(German Research Foundation (DFG))	This study was partly funded through DFG-Research Center/Excellence Cluster "The Ocean in the Earth System". In addition, funding was provided by the "Deutsche Forschungsgemeinschaft" DFG project number SA 13483-1. Publishing costs will be published by CheSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2001, ZOOL J LINN SOC-LOND, V131, P199, DOI 10.1006/zjils.2000.0233; [Anonymous], 2000, SANTA BARBARA MUSEUM, P764; Barry JP, 1997, LIMNOL OCEANOGR, V42, P318, DOI 10.4319/lo.1997.42.2.0318; BELIAEV GM, 1959, DOKL AKAD NAUK SSSR+, V129, P658; BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; BERNARD F R, 1974, Allan Hancock Monographs in Marine Biology, V8, P1; BOSS K. J., 1967, BREVOIRA MUS COMP ZOOL [HARVARD], V266, P1; Boss K. J., 1970, Mitt. zool. Mus. Berl., V46, P67; BOSS KJ, 1980, MALACOLOGIA, V20, P161; BOSS KJ, 1968, B MAR SCI, V18, P731; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; CARNEY RS, 1994, GEO-MAR LETT, V14, P149, DOI 10.1007/BF01203726; Clarke A. H. Jr., 1962, Bulletin National Museum of Canada, VNo. 181, P1; COSEL VR, RECORDS MUS IN PRESS; COSEL VR, 2008, ZOOSYSTEMA, V30, P929; Dall W.H., 1908, B MUS COMP ZOOL HARV, V43, P415; Dall W.H., 1891, US NATL MUSEUM P, V14, P173, DOI [DOI 10.5479/SI.00963801.14-849.173, 10.5479/si.00963801.14-849.173]; Egorova E.N., 1998, Zoosystematica Rossica, V7, P245; Filatova Z. A., 1971, Trudy Inst Okeanol, V92, P46; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Gay A, 2007, MAR GEOL, V244, P68, DOI 10.1016/j.margeo.2007.06.003; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; HASHIMOTO J, 1993, ZOOL SCI, V10, P1063; Kanno S., 1998, RES REPORT SHINSHUSH, V1, P17; KEEN AM, 1969, TREATISE INVERTEBRAT, P663; Knudsen J, 1970, GALATHEA REP, V11, P7; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Krylova E.M., 2000, Ruthenica, V10, P76; Krylova Elena M., 2006, Archiv fuer Molluskenkunde, V135, P231; Krylova EM, 2006, J MOLLUS STUD, V72, P359, DOI 10.1093/mollus/eyl022; KRYLOVA EM, J MOLLUS ST IN PRESS; Mironov A.N., 1985, Trudy Instituta Okeanologii Akademii Nauk SSSR, V120, P70; Mironov A.N., 2002, BIOLOGIYA GIDROTERMA, P410; Mironov A.N., 2006, BIOGEOGRAPHY N ATLAN, P22; Okutani Takashi, 2000, Venus the Japanese Journal of Malacology, V59, P83; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Prashad B., 1932, Siboga Expeditie Leiden, V53c, P1; Sahling H, 2005, LIMNOL OCEANOGR, V50, P598, DOI 10.4319/lo.2005.50.2.0598; Sahling H, 2003, DEEP-SEA RES PT I, V50, P1391, DOI 10.1016/j.dsr.2003.08.004; Sahling H, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001978; SCARLATO O.A., 1981, BIVALVE MOLLUSCS LOW; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sibuet M, 2009, DEEP-SEA RES PT II, V56, P2156, DOI 10.1016/j.dsr2.2009.04.015; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thiele J, 1929, HDB SYSTEMATISCHEN W; Thiele J., 1931, VALDIVIA, V21, P159; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; von Cosel R, 2001, SARSIA, V86, P333, DOI 10.1080/00364827.2001.10425523; von Cosel R, 2009, DEEP-SEA RES PT II, V56, P2350, DOI 10.1016/j.dsr2.2009.04.016; WOODRING WP, 1938, US GEOLOGICAL SURVEY, V190, P1	51	98	107	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9957	10.1371/journal.pone.0009957	http://dx.doi.org/10.1371/journal.pone.0009957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376362	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200032
J	Spilman, P; Podlutskaya, N; Hart, MJ; Debnath, J; Gorostiza, O; Bredesen, D; Richardson, A; Strong, R; Galvan, V				Spilman, Patricia; Podlutskaya, Natalia; Hart, Matthew J.; Debnath, Jayanta; Gorostiza, Olivia; Bredesen, Dale; Richardson, Arlan; Strong, Randy; Galvan, Veronica			Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							APP TRANSGENIC MICE; LIFE-SPAN; MAMMALIAN PROTEIN; ALPHA-SYNUCLEIN; AUTOPHAGY; YEAST; TOR; INDUCTION; PATHWAY; EXPRESSION	Background: Reduced TOR signaling has been shown to significantly increase lifespan in a variety of organisms [1,2,3,4]. It was recently demonstrated that long-term treatment with rapamycin, an inhibitor of the mTOR pathway[5], or ablation of the mTOR target p70S6K[6] extends lifespan in mice, possibly by delaying aging. Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined. Methodology/Principal Findings: We used rapamycin administration and behavioral tools in a mouse model of AD as well as standard biochemical and immunohistochemical measures in brain tissue to provide answers for this question. Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of A beta(42), a major toxic species in AD[7], in the PDAPP transgenic mouse model. These data indicate that inhibition of the mTOR pathway can reduce A beta(42) levels in vivo and block or delay AD in mice. As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in A beta and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of A beta. Conclusions/Significance: Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease. Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.	[Spilman, Patricia; Gorostiza, Olivia; Bredesen, Dale] Buck Inst Age Res, Novato, CA USA; [Podlutskaya, Natalia; Galvan, Veronica] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Podlutskaya, Natalia; Richardson, Arlan; Strong, Randy; Galvan, Veronica] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Richardson, Arlan; Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Hart, Matthew J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA; [Richardson, Arlan; Strong, Randy] S Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX USA; [Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Buck Institute for Research on Aging; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of California System; University of California San Francisco	Spilman, P (corresponding author), Buck Inst Age Res, Novato, CA USA.	galvanv@uthscsa.edu		Debnath, Jayanta/0000-0002-8745-4069; Hart, Matthew/0000-0002-2683-480X	Alzheimer's Association [NIRG-DDC-120433]; NIA Interventions Testing Center [U01AG022307]; San Antonio Nathan Shock Aging Center [P30AG-13319]; Research and Development Service of the Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA126792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG022307, P30AG013319] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIA Interventions Testing Center; San Antonio Nathan Shock Aging Center; Research and Development Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIRG-DDC-120433 from the Alzheimer's Association to V. G. and by the NIA Interventions Testing Center (U01AG022307) to R. S. The authors also recognize the support of the San Antonio Nathan Shock Aging Center (P30AG-13319, A.R.) and the VA Neurodegeneration Research Center (REAP) from the Research and Development Service of the Department of Veterans Affairs (A.R., R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Galvan V, 2008, BEHAV BRAIN RES, V191, P246, DOI 10.1016/j.bbr.2008.03.035; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KOO EH, 1994, J BIOL CHEM, V269, P17386; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Menzies FM, 2006, AUTOPHAGY, V2, P224, DOI 10.4161/auto.2696; MIZUSHIMA N, 2009, CURR OPIN CELL BIOL, V22, P1; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myskiw JC, 2008, NEUROBIOL LEARN MEM, V89, P338, DOI 10.1016/j.nlm.2007.10.002; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roskam S, 2010, NEUROSCI BIOBEHAV R, V34, P487, DOI 10.1016/j.neubiorev.2009.10.006; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Saganich MJ, 2006, J NEUROSCI, V26, P13428, DOI 10.1523/JNEUROSCI.4180-06.2006; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhang JL, 2010, BEHAV BRAIN RES, V206, P202, DOI 10.1016/j.bbr.2009.09.013	50	731	773	0	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9979	10.1371/journal.pone.0009979	http://dx.doi.org/10.1371/journal.pone.0009979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376313	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200050
J	Cashmore, TJ; Peter, JG; van Zyl-Smit, RN; Semple, PL; Maredza, A; Meldau, R; Zumla, A; Nurse, B; Dheda, K				Cashmore, Tamaryn J.; Peter, Jonathan G.; van Zyl-Smit, Richard N.; Semple, Patricia L.; Maredza, Alice; Meldau, Richard; Zumla, Alimuddin; Nurse, Barbara; Dheda, Keertan			Feasibility and Diagnostic Utility of Antigen-Specific Interferon-gamma Responses for Rapid Immunodiagnosis of Tuberculosis Using Induced Sputum	PLOS ONE			English	Article							SMEAR-NEGATIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; BRONCHOSCOPY; INDUCTION	Background: The diagnosis of smear-negative or sputum-scarce tuberculosis (TB) is problematic as culture takes several weeks and representative biological samples are difficult to obtain. RD-1 antigen-specific interferon-c release assays (IGRAs) are sensitive and specific blood-based tests for the diagnosis of M. tuberculosis infection. The feasibility and diagnostic utility of this rapid immunodiagnostic assay, using cells from induced sputum, is unknown. Methodology/Principal Findings: Cells isolated from induced sputum were co-cultured with ESAT-6 and CFP-10 antigens using a standardized enzyme-linked immunospot (ELISPOT) assay (T-SPOT (R).TB) in 101 consecutively recruited TB suspects or non-TB controls. An optimization phase using 28 samples was followed by a validation phase using samples from 73 participants (20 with definite or probable TB, and 48 with non-TB). Despite optimization of sputum processing 65/73 (89%) of the IGRAs in the validation phase were inconclusive. 44/73 (60%) tests failed due to sputum induction-related factors [sputum induction-related adverse events (n = 5), inadequate sputum volume (n = 8), non-homogenisable sputum (n = 7), and insufficient numbers of cells to perform the assay (n = 24)], whilst 20/73 (27%) tests failed due T-SPOT (R).TB assay-related factors [excessive debris precluding reading of spots in the ELISPOT well (n = 6), failure of the positive control (n = 11), or high spot count in the negative control (n = 3)]. Only 8/73 (11%) of the available samples could therefore be correctly categorized (7 definite or probable TB, and 1 non-TB patient). Thus, 13/20 (65%) of the definite or probable TB cases remained undiagnosed. Conclusions/Significance: Rapid immunodiagnosis of pulmonary TB by antigen-specific IFN-gamma ELISPOT responses, using cells from induced sputum, is possible. However, the test, in its current ELISPOT format, is not clinically useful because the majority of the assays are inconclusive.	[Cashmore, Tamaryn J.; Peter, Jonathan G.; van Zyl-Smit, Richard N.; Semple, Patricia L.; Maredza, Alice; Meldau, Richard; Dheda, Keertan] Univ Cape Town, Dept Med, Div Pulmonol,Lung Infect & Immun Unit, Lung Inst & Clin Immunol, ZA-7925 Cape Town, South Africa; [Nurse, Barbara] Univ Cape Town, Dept Clin Lab Sci, Natl Hlth Lab Servi, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Zumla, Alimuddin; Dheda, Keertan] UCL Med Sch, Ctr Infect Dis & Int Hlth, Dept Infect, Sch Med, London, England	University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School	Cashmore, TJ (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol,Lung Infect & Immun Unit, Lung Inst & Clin Immunol, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; Peter, Jonathan/0000-0002-2658-0723	National Research Foundation (NRF); European Commission; SATBAT; Discovery Foundation; Centre National Institutes of Health [R24TW007988]; EDCTP; SA MRC Career Development Award; Canadian CIHR; NRF/SARChI; EU (TrDNA); EuropeAID (ADAT); MRC (UK); NIHR UCLH-CBRC; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	National Research Foundation (NRF); European Commission(European CommissionEuropean Commission Joint Research Centre); SATBAT; Discovery Foundation; Centre National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EDCTP; SA MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian CIHR(Canadian Institutes of Health Research (CIHR)); NRF/SARChI; EU (TrDNA)(European Commission); EuropeAID (ADAT); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR UCLH-CBRC; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the National Research Foundation (NRF) and a TBSusgent grant from the European Commission (EU-FP7). JP is supported by a SATBAT award, a Discovery Foundation Fellowship and by the Fogarty International Clinical Research Scholars/Fellows Support Centre National Institutes of Health grant R24TW007988. RVZS is supported by a Discovery Foundation Fellowship and by the Fogarty International Clinical Research Scholars/Fellows Support Centre NIH grant R24TW007988. KD is supported by a TBsusgent grant from the European Commission (EU-FP7), the EDCTP, a SA MRC Career Development Award, a Canadian CIHR award, and a NRF/SARChI award. Prof. A. Zumla receives support from EU (TrDNA), EuropeAID (ADAT), EDCTP, MRC (UK) and the NIHR UCLH-CBRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breen RAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001335; Brown M, 2007, CLIN INFECT DIS, V44, P1415, DOI 10.1086/516782; Conde MB, 2000, AM J RESP CRIT CARE, V162, P2238, DOI 10.1164/ajrccm.162.6.2003125; Dheda K, 2005, CURR OPIN PULM MED, V11, P195, DOI 10.1097/01.mcp.0000158726.13159.5e; Dheda K, 2009, THORAX, V64, P847, DOI 10.1136/thx.2009.116376; Gonzalez Anne V, 2008, Evid Based Med, V13, P14, DOI 10.1136/ebm.13.1.14; JAFARI C, 2009, AM J RESP CRIT CARE; MARTINEZMAZA O, 1984, J IMMUNOL, V132, P251; McWilliams T, 2002, THORAX, V57, P1010, DOI 10.1136/thorax.57.12.1010; Moore DAJ, 2007, LANCET, V370, P1033, DOI 10.1016/S0140-6736(07)61474-3; Morse M, 2008, INT J TUBERC LUNG D, V12, P1279; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; PATEL V, 2010, AJRCCM IN PRESS; QUIDING M, 1993, CLIN EXP IMMUNOL, V91, P157; ROBINSON BWS, 1985, J CLIN INVEST, V75, P1488, DOI 10.1172/JCI111852; Schoch OD, 2007, AM J RESP CRIT CARE, V175, P80, DOI 10.1164/rccm.200608-1092OC; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; VANZYLSMIT R, AM J RESP CRIT CARE, V181, P289; *WHO, 2009, WHO GLOB TUB REP 200	19	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10389	10.1371/journal.pone.0010389	http://dx.doi.org/10.1371/journal.pone.0010389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442850	Green Submitted, gold, Green Published			2022-12-27	WOS:000277154200024
J	Guezou, A; Trueman, M; Buddenhagen, CE; Chamorro, S; Guerrero, AM; Pozo, P; Atkinson, R				Guezou, Anne; Trueman, Mandy; Buddenhagen, Christopher Evan; Chamorro, Susana; Mireya Guerrero, Ana; Pozo, Paola; Atkinson, Rachel			An Extensive Alien Plant Inventory from the Inhabited Areas of Galapagos	PLOS ONE			English	Article							SANTA-CRUZ; INVASIONS; PACIFIC; HOMOGENIZATION; ERADICATION; PATTERNS; IMPACTS; ISLAND; FLORA	Background: Plant invasions are causing habitat degradation in Galapagos. Problems are concentrated on the four inhabited islands. Plants introduced to rural areas in the humid highlands and urban areas on the arid coast act as foci for invasion of the surrounding Galapagos National Park. Methodology/Principal Findings: Here we present results of the most comprehensive inventory to date of alien vascular plants in the inhabited areas of Galapagos. The survey was conducted between 2002 and 2007, in 6031 properties (97% of the total) on Floreana, Isabela, San Cristobal and Santa Cruz Islands. In total 754 alien vascular plant taxa were recorded, representing 468 genera in 123 families. Dicotyledons represented 554 taxa, monocotyledons 183, there were 7 gymnosperms and 10 pteridophytes. Almost half (363) of the taxa were herbaceous. The most represented families were Fabaceae (sensu lato), Asteraceae and Poaceae. The three most recorded species in the humid rural areas were Psidium guajava, Passiflora edulis and Bryophyllum pinnatum, and in the dry urban areas, Aloe vera, Portulaca oleracea and Carica papaya. In total, 264 (35%) taxa were recorded as naturalized. The most common use for taxa was ornamental (52%). Conclusions/Significance: This extensive survey has increased the known alien vascular flora of Galapagos by 257 species, giving a ratio of alien to native taxa of 1.57:1. It provides a crucial baseline for plant invasion management in the archipelago and contributes data for meta analyses of invasion processes worldwide. A repeat of the survey in the future would act as an effective early detection tool to help avoid further invasion of the Galapagos National Park.	[Guezou, Anne; Trueman, Mandy; Mireya Guerrero, Ana; Pozo, Paola; Atkinson, Rachel] Charles Darwin Fdn, Puerto Ayora, Galapagos, Ecuador; [Trueman, Mandy] Univ Western Australia, Crawley, WA, Australia; [Buddenhagen, Christopher Evan] SWCA Environm Consultants, Honolulu, HI USA; [Chamorro, Susana] Inst Mediterraneo Estudios Avanzados, Islas Baleares, Spain	University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC)	Guezou, A (corresponding author), Charles Darwin Fdn, Puerto Ayora, Galapagos, Ecuador.	anne.guezou@fcdarwin.org.ec	Buddenhagen, Christopher/J-3942-2019; Trueman, Mandy/E-7093-2013	Buddenhagen, Christopher/0000-0002-3016-1054; Chamorro, Susana/0000-0002-2574-8424	Global Environment Facility (GEF) [ECU/00/G31]; Ministry of Environment; TAME Airlines; Galapagos Conservation Trust; Galapagos Conservancy	Global Environment Facility (GEF); Ministry of Environment(Ministry of Environment (ME), Republic of Korea); TAME Airlines; Galapagos Conservation Trust; Galapagos Conservancy	This work was accomplished with the support of Project ECU/00/G31 "Control of Invasive Species in the Galapagos Archipelago'', a donation from the Global Environment Facility (GEF) to the Ecuadorian Government, represented by the Ministry of Environment. The Project was implemented by the United Nations Development Programme (UNDP) and was executed by the Galapagos National Park Service (GNPS), Charles Darwin Foundation (CDF), National Institute for Galapagos (INGALA) and Ecuadorian Service for Agriculture and Livestock Sanitation-Galapagos (SESA-Galapagos). Additional financial support was provided by TAME Airlines, Galapagos Conservation Trust and Galapagos Conservancy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SWCA is included in the article because it relates to Christopher Buddenhagen's current place of employment, but SWCA did not fund any of the work and does not have any relation with the submitted article. C. Buddenhagen was employed by the Charles Darwin Foundation at the time of the inventory, and any subsequent work in relation with the submitted article was done on his own personal time.	Bensted-Smith, 2002, BIODIVERSITY VISION; Burt JW, 2007, BIOL INVASIONS, V9, P909, DOI 10.1007/s10530-007-9090-4; BUSTAMENTE R, ENV ENCOUNTERS SERIE; Castro SA, 2008, BIOL INVASIONS, V10, P1299, DOI 10.1007/s10530-007-9204-z; Castro SA, 2007, J BIOGEOGR, V34, P213, DOI 10.1111/j.1365-2699.2006.01605.x; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; *CDB, 2002, 6 C PART HAG NETH 7; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Denslow JS, 2009, BIOTROPICA, V41, P162, DOI 10.1111/j.1744-7429.2008.00469.x; DIAZPJAZ P, 2010, LIST ALL KNOWN SPECI; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; ELREDGE LG, 2003, BISHOP MUSEUM OCCASI, V76, P1; Gardener MR, 2010, RESTOR ECOL, V18, P20, DOI 10.1111/j.1526-100X.2009.00614.x; Guerrero A. M., 2008, Pacific Conservation Biology, V14, P93; Guezou A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001042; Hickman J, 1985, ENCHANTED ISLANDS GA; HOSKINS JR, 14 AUSTR WEEDS C, P68; INEC, 2007, DIF RES DEF CENS POB; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jager H, 2009, J ECOL, V97, P1252, DOI 10.1111/j.1365-2745.2009.01578.x; JORGENSEN PM, 1999, MONOGRAPHS MISSOURI, V75; Lambdon PW, 2008, PRESLIA, V80, P101; LAWESSON JE, 1987, ANNOTATED CHECKLIST; Lundh J. P., 2006, Galapagos Research, V64, P12; MACK RN, 2000, ISSUES ECOL, V5, P1; MACK RN, 2000, TURNING TIDE ERADICA, P164; Meyer JY, 2004, DIVERS DISTRIB, V10, P333, DOI 10.1111/j.1366-9516.2004.00094.x; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Panetta F. D., 2004, Plant Protection Quarterly, V19, P5; Porter D. M., 1983, PATTERNS EVOLUTION G, P33; PROANO ME, 2007, INFORM GALAPAGOS 200, P31; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; R Development Core Team, 2007, R LANG ENV STAT COMP; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Snell H. L., 2002, BIODIVERSITY VISION, P30; SOUBEYRAN Y, 2008, ESPECES EXOTIQUES EN; SOUBEYRAN Y, 2007, CONSERVATOIRE BOT NA; Timmins SM, 2004, WEED TECHNOL, V18, P1292, DOI 10.1614/0890-037X(2004)018[1292:HWLHPN]2.0.CO;2; TRUEMAN M, RESIDENCE T IN PRESS; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; Tye A., 2001, Weed risk assessment, P153; TYE A., 2002, BIODIVERSITY VISION; Tye Alan, 2007, Plant Protection Quarterly, V22, P33; Villasenor JL, 2004, DIVERS DISTRIB, V10, P113, DOI 10.1111/j.1366-9516.2004.00059.x; WATKINS G, 2009, 2 SIDES COIN; WATKINS G, 2007, INFORM GALAPAGOS 200, P7; Watson J, 2010, ORYX, V44, P79, DOI 10.1017/S0030605309990226; Wu SH, 2004, DIVERS DISTRIB, V10, P349, DOI 10.1111/j.1366-9516.2004.00121.x	50	65	68	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10276	10.1371/journal.pone.0010276	http://dx.doi.org/10.1371/journal.pone.0010276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421999	gold, Green Published, Green Submitted			2022-12-27	WOS:000276952500021
J	Miranda, LS; Collins, AG; Marques, AC				Miranda, Lucilia S.; Collins, Allen G.; Marques, Antonio C.			Molecules Clarify a Cnidarian Life Cycle - The "Hydrozoan'' Microhydrula limopsicola Is an Early Life Stage of the Staurozoan Haliclystus antarcticus	PLOS ONE			English	Article							STAUROMEDUSA; SCYPHOZOA; EVOLUTION; AURICULA; AURELIA; PHYLOGENETICS; NEMATOCYSTS; MEDUSOZOA; PACIFIC; UTILITY	Background: Life cycles of medusozoan cnidarians vary widely, and have been difficult to document, especially in the most recently proposed class Staurozoa. However, molecular data can be a useful tool to elucidate medusozoan life cycles by tying together different life history stages. Methodology/Principal Findings: Genetic data from fast-evolving molecular markers (mitochondrial 16S, nuclear ITS1, and nuclear ITS2) show that animals that were presumed to be a hydrozoan, Microhydrula limopsicola (Limnomedusae, Microhydrulidae), are actually an early stage of the life cycle of the staurozoan Haliclystus antarcticus (Stauromedusae, Lucernariidae). Conclusions/Significance: Similarity between the haplotypes of three markers of Microhydrula limopsicola and Haliclystus antarcticus settles the identity of these taxa, expanding our understanding of the staurozoan life cycle, which was thought to be more straightforward and simple. A synthetic discussion of prior observations makes sense of the morphological, histological and behavioral similarities/congruence between Microhydrula and Haliclystus. The consequences are likely to be replicated in other medusozoan groups. For instance we hypothesize that other species of Microhydrulidae are likely to represent life stages of other species of Staurozoa.45	[Miranda, Lucilia S.; Marques, Antonio C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Collins, Allen G.] Smithsonian Inst, Natl Museum Nat Hist, Natl Marine Fisheries Serv, Natl Systemat Lab, Washington, DC 20560 USA	Universidade de Sao Paulo; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Miranda, LS (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	mirandals@ib.usp.br	Miranda, Lucília Souza/L-4930-2015; Collins, Allen G/A-7944-2008; Marques, Antonio Carlos/E-8049-2011	Miranda, Lucília Souza/0000-0003-4121-8340; Collins, Allen G/0000-0002-3664-9691; Marques, Antonio Carlos/0000-0002-2884-0541	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/09961-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [55.7333/2005-9, 490348/2006-8, 305735/2006-3, 474672/2007-7]; National Science Foundation [0531779]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) ( research grant 2004/09961-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (55.7333/2005-9, 490348/2006-8, 305735/2006-3, 474672/2007-7), and the National Science Foundation through Assembling the Tree of Life Grant (0531779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boero F, 2002, REPRO BIOL, V11, P141; BOUILLON J, 1967, CAH BIOL MAR, V8, P253; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; CALDER DR, 1971, T AM MICROSC SOC, V90, P269, DOI 10.2307/3225186; CALDER DR, 1983, CAN J ZOOL, V61, P1185, DOI 10.1139/z83-161; CARLGREN OSKAR, 1930, FURTHER ZOOL RESULTS SWEDISH ANTARCTIC EXPED 1901 1908, V2, P1; Chen SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008116; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2005, BIOL BULL-US, V208, P221, DOI 10.2307/3593154; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins AG, 2008, J MAR BIOL ASSOC UK, V88, P1673, DOI 10.1017/S0025315408001732; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Davenport J, 1998, J MAR BIOL ASSOC UK, V78, P663, DOI 10.1017/S0025315400041709; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2004, HYDROBIOLOGIA, V530, P249, DOI 10.1007/s10750-004-2659-3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galea HR, 2007, ZOOTAXA, P39; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARTOG JC, 1976, TRAV STAT BIOL ROSCO, V23, P3; Hirano Y.M., 1986, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V24, P182; Jarms G, 1996, SCI MAR, V60, P109; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; KIKINGER R, 1995, J MAR BIOL ASSOC UK, V75, P899, DOI 10.1017/S0025315400038236; Kramp PL, 1961, J MAR BIOL ASSOC UK, V40, P292, DOI [10.1017/S0025315400007438, DOI 10.1017/S0025315400007438]; LARSON RJ, 1989, CAN J ZOOL, V67, P1543, DOI 10.1139/z89-219; LARSON RJ, 1988, CAN J ZOOL, V66, P2301, DOI 10.1139/z88-341; LARSON RJ, 1980, B MAR SCI, V30, P102; LESHLAURIE GE, 1991, MICROSCOPIC ANATOMY, V2, P195; Marques AC, 2004, INVERTEBR BIOL, V123, P23; MIANZAN H W, 1989, Investigaciones Marinas CICIMAR, V4, P15; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miglietta MP, 2009, BIOL INVASIONS, V11, P825, DOI 10.1007/s10530-008-9296-0; Mills Claudia E., 2007, P168; Miranda LS, 2009, POLAR BIOL, V32, P1507, DOI 10.1007/s00300-009-0648-8; Morandini AC, 2009, J MAR BIOL ASSOC UK, V89, P67, DOI 10.1017/S0025315408002968; Muhlenhardt-Siegel U., 1989, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V86, P153; Otto J.J., 1978, P13; Otto JJ, 1976, COELENTERATE ECOLOGY, P319; Pfeffer G., 1889, JAHRB HAMBURG WISS A, V6, P37; Puce S, 2005, MAR ECOL-EVOL PERSP, V26, P73, DOI 10.1111/j.1439-0485.2005.00050.x; SALVINI-PLAWEN L V, 1987, Journal of the Marine Biological Association of the United Kingdom, V67, P623; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; UCHIDA TOHRU, 1929, JAPANESE JOUR ZOOL, V2, P103; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; WEILL ROBERT, 1934, TRAV STAT ZOOL WIMEREUX, V10, P1; Wietrzykowski W., 1912, Archives de Zoologie Paris (Ser 5), V10; Wietrzykowski W, 1910, ARCH ZOOL EXP, V2, P10; Zagal CJ, 2008, J MAR BIOL ASSOC UK, V88, P259, DOI 10.1017/S0025315408000179; Zagal CJ, 2004, J MAR BIOL ASSOC UK, V84, P331, DOI 10.1017/S0025315404009233h; Zagal CJ, 2004, J MAR BIOL ASSOC UK, V84, P337, DOI 10.1017/S0025315404009245h	51	43	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10182	10.1371/journal.pone.0010182	http://dx.doi.org/10.1371/journal.pone.0010182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418959	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706800019
J	Hale, JS; Frock, RL; Mamman, SA; Fink, PJ; Kennedy, BK				Hale, J. Scott; Frock, Richard L.; Mamman, Sara A.; Fink, Pamela J.; Kennedy, Brian K.			Cell-Extrinsic Defective Lymphocyte Development in Lmna(-/-) Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LAMIN-A; NUCLEAR-ENVELOPE; T-CELLS; A/C; EXPRESSION; DISEASE; DIFFERENTIATION; EMERIN; MEMORY	Background: Mutations in the LMNA gene, which encodes all A-type lamins, result in a variety of human diseases termed laminopathies. Lmna(-/-) mice appear normal at birth but become runted as early as 2 weeks of age and develop multiple tissue defects that mimic some aspects of human laminopathies. Lmna(-/-) mice also display smaller spleens and thymuses. In this study, we investigated whether altered lymphoid organ sizes are correlated with specific defects in lymphocyte development. Principal Findings: Lmna(-/-) mice displayed severe age-dependent defects in T and B cell development which coincided with runting. Lmna(-/-) bone marrow reconstituted normal T and B cell development in irradiated wild-type recipients, driving generation of functional and self-MHC restricted CD4(+) and CD8(+) T cells. Transplantation of Lmna(-/-) neonatal thymus lobes into syngeneic wild-type recipients resulted in good engraftment of thymic tissue and normal thymocyte development. Conclusions: Collectively, these data demonstrate that the severe defects in lymphocyte development that characterize Lmna(-/-) mice do not result directly from the loss of A-type lamin function in lymphocytes or thymic stroma. Instead, the immune defects in Lmna(-/-) mice likely reflect indirect damage, perhaps resulting from prolonged stress due to the striated muscle dystrophies that occur in these mice.	[Hale, J. Scott; Fink, Pamela J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Frock, Richard L.; Mamman, Sara A.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hale, JS (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	bkenn@u.washington.edu	Frock, Richard/I-6934-2019	Frock, Richard/0000-0001-6963-4931; Kennedy, Brian/0000-0002-5754-1874	National Institute on Aging (NIA) [R01 AG024287]; National Institutes of Health (NIH) [R01 AG13078]; Cardiovascular and Pathology Training [5T32HL007312-32]; National Cancer Institute Basic and Cancer Immunology [T32CA09537]; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013078, R01AG024287] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular and Pathology Training; National Cancer Institute Basic and Cancer Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging (NIA) grant R01 AG024287 to B. K. K. and National Institutes of Health (NIH) grant R01 AG13078 to P.J.F. R. L. F. is supported by the Cardiovascular and Pathology Training Grant (5T32HL007312-32). J.S.H. is supported by the National Cancer Institute Basic and Cancer Immunology Grant (T32CA09537). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheimer M, 2004, J CELL SCI, V117, P1173, DOI 10.1242/jcs.00975; BLADON T, 1988, BIOCHEM CELL BIOL, V66, P40, DOI 10.1139/o88-006; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; GUILLY MN, 1990, EXP CELL RES, V189, P145, DOI 10.1016/0014-4827(90)90267-E; GUILLY MN, 1987, EMBO J, V6, P3795, DOI 10.1002/j.1460-2075.1987.tb02715.x; Hendricks DW, 2009, J IMMUNOL, V182, P4267, DOI 10.4049/jimmunol.0804180; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jansen MPHM, 1997, HISTOPATHOLOGY, V31, P304, DOI 10.1046/j.1365-2559.1997.2820881.x; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lee DC, 2009, EXP CELL RES, V315, P996, DOI 10.1016/j.yexcr.2009.01.003; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; OZAKI T, 1994, ONCOGENE, V9, P2649; ROBER RA, 1990, J CELL SCI, V95, P587; ROBER RA, 1989, DEVELOPMENT, V105, P365; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; STADELMANN B, 1990, LEUKEMIA RES, V14, P815, DOI 10.1016/0145-2126(90)90076-L; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742	26	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10127	10.1371/journal.pone.0010127	http://dx.doi.org/10.1371/journal.pone.0010127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405040	Green Published, gold, Green Submitted			2022-12-27	WOS:000276705900011
J	Arendrup, MC; Mavridou, E; Mortensen, KL; Snelders, E; Frimodt-Moller, N; Khan, H; Melchers, WJG; Verweij, PE				Arendrup, Maiken Cavling; Mavridou, Eleftheria; Mortensen, Klaus Leth; Snelders, Eveline; Frimodt-Moller, Niels; Khan, Humara; Melchers, Willem J. G.; Verweij, Paul E.			Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence	PLOS ONE			English	Article							14-ALPHA-STEROL DEMETHYLASE CYP51A; IN-VITRO; ITRACONAZOLE RESISTANCE; 14-ALPHA-DEMETHYLASE GENE; FUNGICIDE RESISTANCE; CROSS-RESISTANCE; SUSCEPTIBILITY; MECHANISMS; MUTATIONS; EVOLUTION	Four sequential Aspergillus fumigatus isolates from a patient with chronic granulomatous disease (CGD) eventually failing azole-echinocandin combination therapy were investigated. The first two isolates (1 and 2) were susceptible to antifungal azoles, but increased itraconazole, voriconazole and posaconazole MICs were found for the last two isolates (3 and 4). Microsatellite typing showed that the 4 isolates were isogenic, suggesting that resistance had been acquired during azole treatment of the patient. An immunocompromised mouse model confirmed that the in vitro resistance corresponded with treatment failure. Mice challenged with the resistant isolate 4 failed to respond to posaconazole therapy, while those infected by susceptible isolate 2 responded. Posaconazole-anidulafungin combination therapy was effective in mice challenged with isolate 4. No mutations were found in the Cyp51A gene of the four isolates. However, expression experiments of the Cyp51A showed that the expression was increased in the resistant isolates, compared to the azole-susceptible isolates. The microscopic morphology of the four isolates was similar, but a clear alteration in radial growth and a significantly reduced growth rate of the resistant isolates on solid and in broth medium was observed compared to isolates 1 and 2 and to unrelated wild-type controls. In the mouse model the virulence of isolates 3 and 4 was reduced compared to the susceptible ones and to wild-type controls. For the first time, the acquisition of azole resistance despite azole-echinocandin combination therapy is described in a CGD patient and the resistance demonstrated to be directly associated with significant change of virulence.	[Arendrup, Maiken Cavling; Mortensen, Klaus Leth] Statens Serum Inst, Unit Mycol & Parasitol, DK-2300 Copenhagen, Denmark; [Mavridou, Eleftheria; Snelders, Eveline; Melchers, Willem J. G.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Frimodt-Moller, Niels] Statens Serum Inst, Natl Ctr Antimicrobials & Infect Control, DK-2300 Copenhagen, Denmark; [Khan, Humara; Verweij, Paul E.] Sydvestjysk Sygehus, Dept Internal Med, Esbjerg, Denmark	Statens Serum Institut; Radboud University Nijmegen; Statens Serum Institut	Arendrup, MC (corresponding author), Statens Serum Inst, Unit Mycol & Parasitol, DK-2300 Copenhagen, Denmark.	mad@ssi.dk	Melchers, Willem/C-8819-2015; Frimodt-Moller, Niels/G-1187-2018; Snelders, Eveline/HHS-5284-2022; Mortensen, Klaus Leth/AAS-3059-2021; Verweij, P.E./H-8108-2014	Melchers, Willem/0000-0002-5446-2230; Frimodt-Moller, Niels/0000-0003-1966-8302; Verweij, P.E./0000-0002-8600-9860; Mortensen, Klaus Leth/0000-0003-2719-5154; Snelders, Eveline/0000-0002-7868-7928; Arendrup, Maiken Cavling/0000-0002-4747-0144	Netherlands Organization for Health Research and Development [50-50800-98-030]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was funded in part by The Netherlands Organization for Health Research and Development (ZonMW; grant 50-50800-98-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2008, ANTIMICROB AGENTS CH, V52, P3504, DOI 10.1128/AAC.00190-08; Arendrup MC, 2009, ANTIMICROB AGENTS CH, V53, P1185, DOI 10.1128/AAC.01292-08; Chen J, 2005, J ANTIMICROB CHEMOTH, V55, P31, DOI 10.1093/jac/dkh507; CLSI Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI NCCLS; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; Denning DW, 1997, ANTIMICROB AGENTS CH, V41, P1364, DOI 10.1128/AAC.41.6.1364; Denning DW, 1997, J ANTIMICROB CHEMOTH, V40, P401, DOI 10.1093/jac/40.3.401; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Ferreira MED, 2004, ANTIMICROB AGENTS CH, V48, P4405, DOI [10.1128/AAC-.48.11.4405-4413.2004, 10.1128/AAC.48.11.4405-4413.2004]; Hamamoto H, 2000, APPL ENVIRON MICROB, V66, P3421, DOI 10.1128/AEM.66.8.3421-3426.2000; HARRISON E, 2009, P 49 INT C ANT AG CH; Hope WW, 2005, MED MYCOL, V43, pS207, DOI 10.1080/13693780400025179; Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Rodriguez-Tudela JL, 2008, ANTIMICROB AGENTS CH, V52, P2468, DOI 10.1128/AAC.00156-08; Luo CX, 2008, APPL ENVIRON MICROB, V74, P359, DOI 10.1128/AEM.02159-07; Ma ZH, 2006, APPL ENVIRON MICROB, V72, P2581, DOI 10.1128/AEM.72.4.2581-2585.2006; MANAVATHU EK, 2003, P 43 INT C ANT AG CH; Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003; Marichal P, 1997, ANTIMICROB AGENTS CH, V41, P2229, DOI 10.1128/AAC.41.10.2229; MAVRIDOU E, 2009, ANTIMICROB AGENTS CH; Meletiadis J, 2003, J CLIN MICROBIOL, V41, P4718, DOI 10.1128/JCM.41.10.4718-4725.2003; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mellado E, 2005, ANTIMICROB AGENTS CH, V49, P2536, DOI 10.1128/AAC.49.6.2536-2538.2005; Mellado E, 2004, ANTIMICROB AGENTS CH, V48, P2747, DOI 10.1128/AAC.48.7.2747-2750.2004; Nascimento AM, 2003, ANTIMICROB AGENTS CH, V47, P1719, DOI 10.1128/AAC.47.5.1719-1726.2003; REESLEV M, 1995, APPL ENVIRON MICROB, V61, P4236, DOI 10.1128/AEM.61.12.4236-4239.1995; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Tudela JLR, 2008, CLIN MICROBIOL INFEC, V14, P982, DOI 10.1111/j.1469-0691.2008.02086.x; van der Linden JWM, 2009, CLIN INFECT DIS, V48, P1111, DOI 10.1086/597465; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258	37	127	129	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10080	10.1371/journal.pone.0010080	http://dx.doi.org/10.1371/journal.pone.0010080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404915	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100007
J	Diancourt, L; Passet, V; Nemec, A; Dijkshoorn, L; Brisse, S				Diancourt, Laure; Passet, Virginie; Nemec, Alexandr; Dijkshoorn, Lenie; Brisse, Sylvain			The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool	PLOS ONE			English	Article							UNITED-STATES HOSPITALS; MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANCE; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; CLINICAL STRAINS; SP-NOV; IDENTIFICATION; WIDESPREAD; DIVERSITY	Outbreaks of hospital infections caused by multidrug resistant Acinetobacter baumannii strains are of increasing concern worldwide. Although it has been reported that particular outbreak strains are geographically widespread, little is known about the diversity and phylogenetic relatedness of A. baumannii clonal groups. Sequencing of internal portions of seven housekeeping genes (total 2,976 nt) was performed in 154 A. baumannii strains covering the breadth of known diversity and including representatives of previously recognized international clones, and in 19 representatives of other Acinetobacter species. Restricted amounts of diversity and a star-like phylogeny reveal that A. baumannii is a genetically compact species that suffered a severe bottleneck in the recent past, possibly linked to a restricted ecological niche. A. baumannii is neatly demarcated from its closest relative (genomic species 13TU) and other Acinetobacter species. Multilocus sequence typing analysis demonstrated that the previously recognized international clones I to III correspond to three clonal complexes, each made of a central, predominant genotype and few single locus variants, a hallmark of recent clonal expansion. Whereas antimicrobial resistance was almost universal among isolates of these and a novel international clone (ST15), isolates of the other genotypes were mostly susceptible. This dichotomy indicates that antimicrobial resistance is a major selective advantage that drives the ongoing rapid clonal expansion of these highly problematic agents of nosocomial infections.	[Diancourt, Laure; Passet, Virginie; Brisse, Sylvain] Inst Pasteur Genotyping Pathogens & Publ Hlth, Paris, France; [Nemec, Alexandr] Natl Inst Publ Hlth, Lab Bacterial Genet, Prague, Czech Republic; [Dijkshoorn, Lenie] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institute of Public Health (SZU) - Czech Republic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Diancourt, L (corresponding author), Inst Pasteur Genotyping Pathogens & Publ Hlth, Paris, France.	sylvain.brisse@pasteur.fr	Nemec, Alexandr/C-4447-2008; Brisse, Sylvain/M-8723-2013	Nemec, Alexandr/0000-0003-0608-9598; Brisse, Sylvain/0000-0002-2516-2108	Institut Pasteur; Institut de Veille Sanitaire; Conny-Maeva Charitable Foundation; Grant Agency of the Czech Republic [310/08/1747]	Institut Pasteur(European Commission); Institut de Veille Sanitaire; Conny-Maeva Charitable Foundation; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	Platform Genotyping of Pathogens and Public Health is supported by Institut Pasteur and the Institut de Veille Sanitaire; this work received, in addition, financial support from a generous gift by the Conny-Maeva Charitable Foundation. AN was supported by grant 310/08/1747 of the Grant Agency of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Berlau J, 1999, J HOSP INFECT, V42, P201, DOI 10.1053/jhin.1999.0602; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; BOUVET PJM, 1987, ANN INST PASTEUR MIC, V138, P569, DOI 10.1016/0769-2609(87)90042-1; Brisse S, 2000, J CLIN MICROBIOL, V38, P3636, DOI 10.1128/JCM.38.10.3636-3645.2000; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Da Silva G, 2007, CLIN MICROBIOL INFEC, V13, P190, DOI 10.1111/j.1469-0691.2006.01628.x; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; DIJKSHOORN L, 1993, J CLIN MICROBIOL, V31, P702, DOI 10.1128/JCM.31.3.702-705.1993; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dijkshoorn Lenie, 2008, P1; Ecker JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hoffmann MS, 2010, INFECT CONT HOSP EP, V31, P196, DOI 10.1086/650379; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Janssen P, 1997, INT J SYST BACTERIOL, V47, P1179, DOI 10.1099/00207713-47-4-1179; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Nemec A, 1999, J MED MICROBIOL, V48, P287, DOI 10.1099/00222615-48-3-287; Nemec A, 2004, J MED MICROBIOL, V53, P1233, DOI 10.1099/jmm.0.45716-0; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Nemec A, 2007, J ANTIMICROB CHEMOTH, V60, P483, DOI 10.1093/jac/dkm231; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; ORSKOV F, 1983, J INFECT DIS, V148, P346, DOI 10.1093/infdis/148.2.346; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Post V, 2009, ANTIMICROB AGENTS CH, V53, P2667, DOI 10.1128/AAC.01407-08; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salerno A, 2007, J BACTERIOL, V189, P7808, DOI 10.1128/JB.00796-07; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; SEIFERT H, 1994, J CLIN MICROBIOL, V32, P82, DOI 10.1128/JCM.32.1.82-86.1994; SELTMANN G, 1995, ZBL BAKT-INT J MED M, V282, P372; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Spence RP, 2004, J CLIN MICROBIOL, V42, P832, DOI 10.1128/JCM.42.2.832-834.2004; Spratt Brian G, 2004, Methods Mol Biol, V266, P323; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TJERNBERG I, 1989, APMIS, V97, P595, DOI 10.1111/j.1699-0463.1989.tb00449.x; Turton JF, 2009, EUR J CLIN MICROBIOL, V28, P499, DOI 10.1007/s10096-008-0659-3; Turton JF, 2006, J CLIN MICROBIOL, V44, P2630, DOI 10.1128/JCM.00547-06; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; Van Dessel H, 2002, J HOSP INFECT, V51, P89, DOI 10.1053/jhin.2002.1212; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; VANEECHOUTTE M, 1995, J CLIN MICROBIOL, V33, P11; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wisplinghoff H, 2008, CLIN MICROBIOL INFEC, V14, P708, DOI 10.1111/j.1469-0691.2008.02010.x; Wisplinghoff H, 2007, J HOSP INFECT, V66, P174, DOI 10.1016/j.jhin.2007.02.016; Wisplinghoff H, 2000, CLIN INFECT DIS, V31, P690, DOI 10.1086/314040; Wroblewska MM, 2008, FEMS IMMUNOL MED MIC, V53, P140, DOI 10.1111/j.1574-695X.2008.00403.x	73	469	478	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10034	10.1371/journal.pone.0010034	http://dx.doi.org/10.1371/journal.pone.0010034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383326	Green Submitted, Green Published, gold			2022-12-27	WOS:000276454000008
J	Melzi, R; Antonioli, B; Mercalli, A; Battaglia, M; Valle, A; Pluchino, S; Galli, R; Sordi, V; Bosi, E; Martino, G; Bonifacio, E; Doglioni, C; Piemonti, L				Melzi, Raffaella; Antonioli, Barbara; Mercalli, Alessia; Battaglia, Manuela; Valle, Andrea; Pluchino, Stefano; Galli, Rossella; Sordi, Valeria; Bosi, Emanuele; Martino, Gianvito; Bonifacio, Ezio; Doglioni, Claudio; Piemonti, Lorenzo			Co-Graft of Allogeneic Immune Regulatory Neural Stem Cells (NPC) and Pancreatic Islets Mediates Tolerance, while Inducing NPC-Derived Tumors in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-I; T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSPLANTATION; INSULIN; TRANSFORMATION; NEUROSPHERES; INSTABILITY; EXPRESSION	Background: Data available on the immunomodulatory properties of neural stem/precursor cells (NPC) support their possible use as modulators for immune-mediated process. The aim of this study was to define whether NPC administered in combination with pancreatic islets prevents rejection in a fully mismatched allograft model. Methodology/Principal Finding: Diabetic Balb/c mice were co-transplanted under the kidney capsule with pancreatic islets and GFP(+) NPC from fully mismatched C57BL/6 mice. The following 4 groups of recipients were used: mice receiving islets alone; mice receiving islets alone and treated with standard immunosuppression (IL-2R alpha chain mAbs + FK506 + Rapamycin); mice receiving a mixed islet/NPC graft under the same kidney capsule (Co-NPC-Tx); mice receiving the islet graft under the left kidney capsule and the NPC graft under the right kidney capsule (NPC-Tx). Our results demonstrate that only the co-transplantation and co-localization of NPC and islets (Co-NPC-Tx) induce stable long-term graft function in the absence of immunosuppression. This condition is associated with an expansion of CD4(+)CD25(+)FoxP3(+) T regulatory cells in the spleen. Unfortunately, stable graft function was accompanied by constant and reproducible development of NPC-derived cancer mainly sustained by insulin secretion. Conclusion: These data demonstrate that the use of NPC in combination with islets prevents graft rejection in a fully mismatched model. However, the development of NPC-derived cancer raises serious doubts about the safety of using adult stem cells in combination with insulin-producing cells outside the original microenvironment.	[Melzi, Raffaella; Antonioli, Barbara; Mercalli, Alessia; Battaglia, Manuela; Valle, Andrea; Sordi, Valeria; Piemonti, Lorenzo] Ist Sci San Raffaele, San Raffaele Diabet Res Inst HSR, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Pluchino, Stefano] Ist Sci San Raffaele, CNS Repair Unit, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Galli, Rossella] Ist Sci San Raffaele, Neural Stem Cell Biol Unit, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Bosi, Emanuele] Ist Sci San Raffaele, Dept Internal Med, Diabet & Endocrinol Unit, I-20132 Milan, Italy; [Martino, Gianvito] Ist Sci San Raffaele, Neuroimmunol Unit, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-8027 Dresden, Germany; [Doglioni, Claudio] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Doglioni, Claudio] Univ Vita Salute, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Technische Universitat Dresden; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Melzi, R (corresponding author), Ist Sci San Raffaele, San Raffaele Diabet Res Inst HSR, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.	piemonti.lorenzo@hsr.it	Sordi, Valeria/AAN-3913-2020; Galli, Rossella/AAI-8028-2020; Mercalli, Alessia/AAN-3811-2020; martino, gianvito/AAL-2682-2020; Piemonti, Lorenzo/P-7605-2017; Melzi, Raffaella/AAN-3825-2020; Pluchino, Stefano/AAE-9037-2019; Bonifacio, Ezio/E-7700-2010	Galli, Rossella/0000-0001-9023-7033; martino, gianvito/0000-0003-1295-9131; Piemonti, Lorenzo/0000-0002-2172-2198; Pluchino, Stefano/0000-0002-6267-9472; Bonifacio, Ezio/0000-0002-8704-4713; Sordi, Valeria/0000-0003-0179-1679; DOGLIONI, Claudio/0000-0002-4969-5216; Battaglia, Manuela/0000-0003-4535-3152	EU [HEALTH-F2-2008-202013]; Fondazione Cariplo [2007-5165]; Fondazione Siemens Italia (Milan, Italy); MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish	EU(European Commission); Fondazione Cariplo(Fondazione Cariplo); Fondazione Siemens Italia (Milan, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by EU (DIAPREPP Project, HEALTH-F2-2008-202013), by an award from Fondazione Cariplo (2007-5165) and by an award from Fondazione Siemens Italia (Milan, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIADES HN, 1992, INT J CANCER, V50, P215, DOI 10.1002/ijc.2910500210; Arcaro A, 2007, BIOCHEM J, V406, P57, DOI 10.1042/BJ20070309; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Beyer M, 2009, CURR PHARM DESIGN, V15, P1879, DOI 10.2174/138161209788453211; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Fainstein N, 2008, MOL CELL NEUROSCI, V39, P335, DOI 10.1016/j.mcn.2008.07.007; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Gritti A, 1996, J NEUROSCI, V16, P1091; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lu ZQ, 2009, J NEUROIMMUNOL, V206, P58, DOI 10.1016/j.jneuroim.2008.10.014; MARTIN DM, 1992, MOL BRAIN RES, V15, P241, DOI 10.1016/0169-328X(92)90114-Q; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Marzorati S, 2007, EXPERT OPIN BIOL TH, V7, P1627, DOI 10.1517/14712598.7.11.1627; Melzi R, 2007, TRANSPLANTATION, V83, P167, DOI 10.1097/01.tp.0000250659.24286.43; Miller RH, 2006, BRAIN RES, V1091, P258, DOI 10.1016/j.brainres.2006.01.073; Mineo D, 2008, AM J TRANSPLANT, V8, P1262, DOI 10.1111/j.1600-6143.2008.02230.x; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; TROJAN J, 1993, SCIENCE, V259, P94, DOI 10.1126/science.8418502; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wang L, 2009, EXP NEUROL, V216, P177, DOI 10.1016/j.expneurol.2008.11.017; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	39	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10357	10.1371/journal.pone.0010357	http://dx.doi.org/10.1371/journal.pone.0010357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436918	Green Submitted, gold, Green Published			2022-12-27	WOS:000277079700010
J	Khan, M; De Sevilla, L; Mahesh, VB; Brann, DW				Khan, Mohammad; De Sevilla, Liesl; Mahesh, Virendra B.; Brann, Darrell W.			Enhanced Glutamatergic and Decreased Gabaergic Synaptic Appositions to GnRH Neurons on Proestrus in the Rat: Modulatory Effect of Aging	PLOS ONE			English	Article							HORMONE-RELEASING HORMONE; MIDDLE-AGED RATS; MEDIAL PREOPTIC AREA; FEMALE RATS; GENE-EXPRESSION; LHRH NEURONS; FOS PROTEIN; SECRETION; SURGE; GABA	Background: Previous work by our lab and others has implicated glutamate as a major excitatory signal to gonadotropin hormone releasing hormone (GnRH) neurons, with gamma amino butyric acid (GABA) serving as a potential major inhibitory signal. However, it is unknown whether GABAergic and/or glutamatergic synaptic appositions to GnRH neurons changes on the day of the proestrous LH surge or is affected by aging. Methodology/Principal Findings: To examine this question, synaptic terminal appositions on GnRH neurons for VGAT (vesicular GABA transporter) and VGLUT2 (vesicular glutamate transporter-2), markers of GABAergic and glutamatergic synaptic terminals, respectively, was examined by immunohistochemistry and confocal microscopic analysis in young and middle-aged diestrous and proestrous rats. The results show that in young proestrous rats at the time of LH surge, we observed reciprocal changes in the VGAT and VGLUT2 positive terminals apposing GnRH neurons, where VGAT terminal appositions were decreased and VGLUT2 terminal appositions were significantly increased, as compared to young diestrus control animals. Interestingly, in middle-aged cycling animals this divergent modulation of VGAT and VGLUT2 terminal apposition was greatly impaired, as no significant differences were observed between VGAT and VGLUT2 terminals apposing GnRH neurons at proestrous. However, the density of VGAT and VGLUT2 terminals apposing GnRH neurons were both significantly increased in the middle-aged animals. Conclusions/Significance: In conclusion, there is an increase in glutamatergic and decrease in GABAergic synaptic terminal appositions on GnRH neurons on proestrus in young animals, which may serve to facilitate activation of GnRH neurons. In contrast, middle-aged diestrous and proestrous animals show a significant increase in both VGAT and VGLUT synaptic terminal appositions on GnRH neurons as compared to young animals, and the cycle-related change in these appositions between diestrus and proestrus that is observed in young animals is lost.	[Khan, Mohammad; De Sevilla, Liesl; Mahesh, Virendra B.; Brann, Darrell W.] Med Coll Georgia, Dev Neurobiol Program, Inst Mol Med & Genet, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Khan, M (corresponding author), Med Coll Georgia, Dev Neurobiol Program, Inst Mol Med & Genet, Augusta, GA 30912 USA.	dbrann@mcg.edu		Khan, Mohammad Badruzzaman/0000-0001-8231-1256	National Institutes of Aging (NIA), National Institutes of Health [17186, 29864]; National Institute of Child Health and Human Development (NICHD), National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028964] Funding Source: NIH RePORTER	National Institutes of Aging (NIA), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development (NICHD), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by Research Grants (#17186 and 29864) from the National Institutes of Aging (NIA), and National Institute of Child Health and Human Development (NICHD), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjan V, 2008, J NEUROENDOCRINOL, V20, P1147, DOI 10.1111/j.1365-2826.2008.01775.x; Beltran-Parrazal L, 2001, ENDOCRINE, V14, P189, DOI 10.1385/ENDO:14:2:189; Bilger M, 2001, ENDOCRINOLOGY, V142, P2102, DOI 10.1210/en.142.5.2102; BRANN DW, 1993, MOL CELL NEUROSCI, V4, P292, DOI 10.1006/mcne.1993.1037; Brann DW, 2005, STEROIDS, V70, P273, DOI 10.1016/j.steroids.2004.12.008; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Cashion AB, 2004, J NEUROENDOCRINOL, V16, P711, DOI 10.1111/j.1365-2826.2004.01225.x; Cashion AB, 2003, ENDOCRINOLOGY, V144, P274, DOI 10.1210/en.2002-220711; COOPER RL, 1980, BIOL REPROD, V23, P611, DOI 10.1095/biolreprod23.3.611; DeFazio RA, 2002, MOL ENDOCRINOL, V16, P2872, DOI 10.1210/me.2002-0163; DELAESCALERA GM, 1994, NEUROENDOCRINOLOGY, V59, P420, DOI 10.1159/000126687; Funabashi T, 1997, NEUROREPORT, V8, P771, DOI 10.1097/00001756-199702100-00038; HALES TG, 1994, NEUROENDOCRINOLOGY, V59, P297, DOI 10.1159/000126671; Han SK, 2004, ENDOCRINOLOGY, V145, P495, DOI 10.1210/en.2003-1333; HERBISON AE, 1991, NEUROENDOCRINOLOGY, V53, P317, DOI 10.1159/000125735; Khan MM, 2005, ENDOCRINOLOGY, V146, P5215, DOI 10.1210/en.2005-0276; Le WW, 2001, ENDOCRINOLOGY, V142, P4976, DOI 10.1210/en.142.11.4976; LLOYD JM, 1994, ENDOCRINOLOGY, V134, P1800, DOI 10.1210/en.134.4.1800; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Neal-Perry GS, 2008, BIOL REPROD, V79, P878, DOI 10.1095/biolreprod.108.069831; Neal-Perry GS, 2005, ENDOCRINOLOGY, V146, P4331, DOI 10.1210/en.2005-0575; Ottem EN, 2004, J NEUROSCI, V24, P8097, DOI 10.1523/JNEUROSCI.2267-04.2004; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Ramos SD, 2001, J APPL PHYSIOL, V91, P667, DOI 10.1152/jappl.2001.91.2.667; RUBIN BS, 1994, BIOL REPROD, V51, P1264, DOI 10.1095/biolreprod51.6.1264; RUBIN BS, 1995, ENDOCRINOLOGY, V136, P3823, DOI 10.1210/en.136.9.3823; Rubin BS, 2000, BIOL REPROD, V63, P968, DOI 10.1095/biolreprod63.4.968; RUBIN BS, 1992, BIOL REPROD, V47, P254, DOI 10.1095/biolreprod47.2.254; RUBIN BS, 1989, NEUROENDOCRINOLOGY, V49, P225, DOI 10.1159/000125121; RUBIN BS, 1995, NEUROENDOCRINOLOGY, V62, P259, DOI 10.1159/000127012; RUBIN BS, 1993, BRAIN RES, V601, P246, DOI 10.1016/0006-8993(93)91717-7; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tersawa E, 2001, VITAM HORM, V63, P91; URBANSKI HF, 1990, ENDOCRINOLOGY, V126, P1774, DOI 10.1210/endo-126-3-1774; Watanabe M, 2009, BIOL REPROD, V81, P327, DOI 10.1095/biolreprod.108.074583; WIEGAND SJ, 1980, NEUROENDOCRINOLOGY, V31, P147, DOI 10.1159/000123066; WISE PM, 1982, P SOC EXP BIOL MED, V169, P348, DOI 10.3181/00379727-169-41356; WITKIN JW, 1987, NEUROSCIENCE, V22, P1003, DOI 10.1016/0306-4522(87)92976-9; Zhang C, 2009, ENDOCRINOLOGY, V150, P2388, DOI 10.1210/en.2008-1313; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zuo Z, 1996, ENDOCRINOLOGY, V137, P2334, DOI 10.1210/en.137.6.2334	41	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10172	10.1371/journal.pone.0010172	http://dx.doi.org/10.1371/journal.pone.0010172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418960	Green Published, Green Submitted, gold			2022-12-27	WOS:000276706800014
J	Phillips, AJ; Arauco-Brown, R; Oceguera-Figueroa, A; Gomez, GP; Beltran, M; Lai, YT; Siddall, ME				Phillips, Anna J.; Arauco-Brown, Renzo; Oceguera-Figueroa, Alejandro; Gomez, Gloria P.; Beltran, Maria; Lai, Yi-Te; Siddall, Mark E.			Tyrannobdella rex N. Gen. N. Sp and the Evolutionary Origins of Mucosal Leech Infestations	PLOS ONE			English	Article							MEDICINAL LEECH; SEQUENCES; PRIMERS; MODEL	Background: Leeches have gained a fearsome reputation by feeding externally on blood, often from human hosts. Orificial hirudiniasis is a condition in which a leech enters a body orifice, most often the nasopharyngeal region, but there are many cases of leeches infesting the eyes, urethra, vagina, or rectum. Several leech species particularly in Africa and Asia are well-known for their propensity to afflict humans. Because there has not previously been any data suggesting a close relationship for such geographically disparate species, this unnerving tendency to be invasive has been regarded only as a loathsome oddity and not a unifying character for a group of related organisms. Principal Findings: A new genus and species of leech from Peru was found feeding from the nasopharynx of humans. Unlike any other leech previously described, this new taxon has but a single jaw with very large teeth. Phylogenetic analyses of nuclear and mitochondrial genes using parsimony and Bayesian inference demonstrate that the new species belongs among a larger, global clade of leeches, all of which feed from the mucosal surfaces of mammals. Conclusions: This new species, found feeding from the upper respiratory tract of humans in Peru, clarifies an expansion of the family Praobdellidae to include the new species Tyrannobdella rex n. gen. n.sp., along with others in the genera Dinobdella, Myxobdella, Praobdella and Pintobdella. Moreover, the results clarify a single evolutionary origin of a group of leeches that specializes on mucous membranes, thus, posing a distinct threat to human health.	[Phillips, Anna J.; Oceguera-Figueroa, Alejandro] CUNY, Grad Ctr, Dept Biol, New York, NY 10021 USA; [Phillips, Anna J.; Oceguera-Figueroa, Alejandro; Siddall, Mark E.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Arauco-Brown, Renzo] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Gomez, Gloria P.] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; [Beltran, Maria] Peruvian Hlth Inst, Peruvian Publ Hlth Ctr, Enteroparasitol Lab, Lima, Peru; [Lai, Yi-Te] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	City University of New York (CUNY) System; American Museum of Natural History (AMNH); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Instituto Nacional de Salud - Peru; Academia Sinica - Taiwan; National Taiwan University	Phillips, AJ (corresponding author), CUNY, Grad Ctr, Dept Biol, New York, NY 10021 USA.	siddall@amnh.org	Phillips, Anna J/H-6141-2019; Gómez-Pérez, Gloria Patricia/AAS-8208-2021	Phillips, Anna J/0000-0003-4883-0022; Gómez-Pérez, Gloria Patricia/0000-0001-8555-8596; Gomez-Perez, Gloria Patricia/0000-0002-8927-7297	National Science Foundation [DEB-0640463]; Stavros Niarchos fund for Expeditionary Research; Theodore Roosevelt Memorial Grant; CUNY	National Science Foundation(National Science Foundation (NSF)); Stavros Niarchos fund for Expeditionary Research; Theodore Roosevelt Memorial Grant; CUNY	This work was financially supported by the National Science Foundation (DEB-0640463), the Stavros Niarchos fund for Expeditionary Research, a Theodore Roosevelt Memorial Grant, and a CUNY Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam Shadrul, 2008, J Pediatr Urol, V4, P70, DOI 10.1016/j.jpurol.2007.02.004; ALMALLAH Z, 1968, J PARASITOL, V54, P637, DOI 10.2307/3277105; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Beltran M, 1997, REV MED EXP INS, V14, P42; BLANCHARD R, 1896, ARCH NATURGESCH, V63, P49; Borda E, 2008, MOL PHYLOGENET EVOL, V46, P142, DOI 10.1016/j.ympev.2007.09.006; Caballero CE, 1957, ANA I BIOL U NAC AUT, V28, P241; CABELLERO CE, 1932, AN I BIOL U MEX, V3, P43; CUNDALL DB, 1986, T ROY SOC TROP MED H, V80, P940, DOI 10.1016/0035-9203(86)90265-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Hamid MSA, 1996, BRIT J UROL, V77, P164, DOI 10.1046/j.1464-410X.1996.87237.x; Harding WA, 1927, FAUNA BRIT INDIA HIR; KOSE A, 2008, AM J EMERG MED, V26, pE6; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; Lukin EI, 1976, FAUNA USSR, V1; Masterman E. W. G., 1908, Parasitology Cambridge, V1; Montazeri F, 2009, EUR J PEDIATR, V168, P39, DOI 10.1007/s00431-008-0706-1; MOORE JP, 1958, ANN NAT MUS, V14, P327; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Phillips AJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-246; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PREDINI L, 2005, CAN J ZOOL, V83, P498; Raza Syed Nusrat, 2006, J Coll Physicians Surg Pak, V16, P175; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAWYER R.T., 1986, LEECH BIOL BEHAV, VII; Siddall ME, 2007, APPL ENVIRON MICROB, V73, P655, DOI 10.1128/AEM.01282-06; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SINGH M, 1979, LANCET, V2, P1374; TURNER FM, 1969, LANCET, V2, P1400; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x	33	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10057	10.1371/journal.pone.0010057	http://dx.doi.org/10.1371/journal.pone.0010057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418947	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706800005
J	Bain, MB; Cornwell, ER; Hope, KM; Eckerlin, GE; Casey, RN; Groocock, GH; Getchell, RG; Bowser, PR; Winton, JR; Batts, WN; Cangelosi, A; Casey, JW				Bain, Mark B.; Cornwell, Emily R.; Hope, Kristine M.; Eckerlin, Geofrey E.; Casey, Rufina N.; Groocock, Geoffrey H.; Getchell, Rodman G.; Bowser, Paul R.; Winton, James R.; Batts, William N.; Cangelosi, Allegra; Casey, James W.			Distribution of an Invasive Aquatic Pathogen (Viral Hemorrhagic Septicemia Virus) in the Great Lakes and Its Relationship to Shipping	PLOS ONE			English	Article							BALLAST-WATER; BIOLOGICAL INVASIONS; NORTH-SEA; CANADA; INTRODUCTIONS; ONTARIO; TROUT; OCEAN	Viral hemorrhagic septicemia virus (VHSV) is a rhabdovirus found in fish from oceans of the northern hemisphere and freshwaters of Europe. It has caused extensive losses of cultured and wild fish and has become established in the North American Great Lakes. Large die-offs of wild fish in the Great Lakes due to VHSV have alarmed the public and provoked government attention on the introduction and spread of aquatic animal pathogens in freshwaters. We investigated the relations between VHSV dispersion and shipping and boating activity in the Great Lakes by sampling fish and water at sites that were commercial shipping harbors, recreational boating centers, and open shorelines. Fish and water samples were individually analyzed for VHSV using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and cell culture assays. Of 1,221 fish of 17 species, 55 were VHSV positive with highly varied qRT-PCR titers (1 to 5,950,000 N gene copies). The detections of VHSV in fish and water samples were closely associated and the virus was detected in 21 of 30 sites sampled. The occurrence of VHSV was not related to type of site or shipping related invasion hotspots. Our results indicate that VHSV is widely dispersed in the Great Lakes and is both an enzootic and epizootic pathogen. We demonstrate that pathogen distribution information could be developed quickly and is clearly needed for aquatic ecosystem conservation, management of affected populations, and informed regulation of the worldwide trade of aquatic organisms.	[Bain, Mark B.; Eckerlin, Geofrey E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; [Cornwell, Emily R.; Hope, Kristine M.; Casey, Rufina N.; Groocock, Geoffrey H.; Getchell, Rodman G.; Bowser, Paul R.; Casey, James W.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Winton, James R.; Batts, William N.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Cangelosi, Allegra] NE Midwest Inst, Washington, DC USA	Cornell University; Cornell University; United States Department of the Interior; United States Geological Survey	Bain, MB (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	Mark.Bain@Cornell.edu		Getchell, Rodman/0000-0003-4063-4668	Great Lakes Protection Fund through the The Northeast-Midwest Institute; U.S. Department of Agriculture [NYC-147446]	Great Lakes Protection Fund through the The Northeast-Midwest Institute; U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Primary funding for this study was provided by The Great Lakes Protection Fund through the The Northeast-Midwest Institute. Additional funding came from the Great Lakes Research Consortium and the Cornell University Agricultural Experiment Station project No. NYC-147446 (U.S. Department of Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM FISH SOC, 2007, SUGG PROC DET ID CER; BASURCO B, 1995, VET RES, V26, P460; BATTS WN, 1993, DIS AQUAT ORGAN, V17, P61; *CAN COOP WILDL HL, 2005, WILDL HLTH CTR NEWSL, V11, P10; CANGELOSI A, 2006, GREAT SHIPS GREAT LA; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Chico V, 2006, J VIROL METHODS, V132, P154, DOI 10.1016/j.jviromet.2005.10.005; *CORN U COOP EXT, 2009, VIR HEM SEPT VHS NEW; *CTR FOOD SEC PUBL, 2009, VHS VIR HEMM SEPT AM; Doblin MA, 2007, HARMFUL ALGAE, V6, P519, DOI 10.1016/j.hal.2006.05.007; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Drake LA, 2007, MAR POLLUT BULL, V55, P333, DOI 10.1016/j.marpolbul.2006.11.007; Drake Lisa A., 2001, Biological Invasions, V3, P193, DOI 10.1023/A:1014561102724; Einer-Jensen K, 2005, VET MICROBIOL, V106, P167, DOI 10.1016/j.vetmic.2004.12.008; Elsayed E, 2006, J FISH DIS, V29, P611, DOI 10.1111/j.1365-2761.2006.00755.x; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Gagne N, 2007, J FISH DIS, V30, P213, DOI 10.1111/j.1365-2761.2007.00802.x; Grigorovich IA, 2003, CAN J FISH AQUAT SCI, V60, P740, DOI 10.1139/F03-053; Groocockl GH, 2007, DIS AQUAT ORGAN, V76, P187, DOI 10.3354/dao076187; Holeck KT, 2004, BIOSCIENCE, V54, P919, DOI 10.1641/0006-3568(2004)054[0919:BTWBIT]2.0.CO;2; HOPE KM, 2010, J AQUAT ANI IN PRESS; Kent ML, 1998, J AQUAT ANIM HEALTH, V10, P211, DOI 10.1577/1548-8667(1998)010&lt;0211:SOSPIO&gt;2.0.CO;2; King JA, 2001, DIS AQUAT ORGAN, V47, P81, DOI 10.3354/dao047081; *LAK SUP BAS NAT P, 2008, EM PREV RESP PLAN VI; Lumsden JS, 2007, DIS AQUAT ORGAN, V76, P99, DOI 10.3354/dao076099; Ma Y, 2009, PROG NAT SCI-MATER, V19, P947, DOI 10.1016/j.pnsc.2008.09.007; Meyers Theodore R., 1995, Annual Review of Fish Diseases, V5, P3, DOI 10.1016/0959-8030(95)00002-X; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; MIURA L, 2009, INVASIVE SPECIES PRE; MURPHY E, 2007, GREAT LAKES FISH MON; National Research Council, 1996, STEMM TID CONTR INTR, DOI 10.17226/5294; O'Gorman R., 2007, GREAT LAKES PREY FIS, V1001, P48105; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Said T, 1998, J GEN VIROL, V79, P47, DOI 10.1099/0022-1317-79-1-47; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Stewart C.J, 2002, REVISED GEOMORPHIC S; Stewart C.J, 2001, OPEN COAST REACH DEL; Stone DM, 1997, J GEN VIROL, V78, P1319, DOI 10.1099/0022-1317-78-6-1319; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Whelan GE, 2009, VIRAL HEMORRHAGIC SE; WINTON JR, 1989, AM FISH SOC FISH HLT, V17, P2; Wolf K., 1988, FISH VIRUSES FISH VI, P217, DOI [10.7591/9781501746383, DOI 10.7591/9781501746383]	43	73	73	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10156	10.1371/journal.pone.0010156	http://dx.doi.org/10.1371/journal.pone.0010156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405014	Green Submitted, gold, Green Published			2022-12-27	WOS:000276706300012
J	Frachon, I; Etienne, Y; Jobic, Y; Le Gal, G; Humbert, M; Leroyer, C				Frachon, Irene; Etienne, Yves; Jobic, Yannick; Le Gal, Gregoire; Humbert, Marc; Leroyer, Christophe			Benfluorex and Unexplained Valvular Heart Disease: A Case-Control Study	PLOS ONE			English	Article							APPETITE-SUPPRESSANT DRUGS; CARDIAC-VALVE REGURGITATION; DOPAMINE AGONISTS; OBESE-PATIENTS; FENFLURAMINE; RISK; PREVALENCE	Background: Recent case reports suggest that benfluorex, a fenfluramine derivative used in the management of overweight diabetic patients and dyslipidemia, is associated with cardiac valve regurgitation. Methods: We conducted a case-control study. Eligible patients were those admitted in the cardiology or the cardiac surgery units of our hospital between January, 1(st) 2003 and June 30(th) 2009, with mitral insufficiency diagnostic codes (ICD-10 I340 and I051). Patients with either a primary cause ( degenerative, known rheumatic heart disease, infectious endocarditis, congenital, radiation-induced valvular disease, associated connective and/or vasculitis disease, trauma, tumor) or a secondary ( functional) cause were considered as having an "explained'' mitral regurgitation. Other patients were considered as having an "unexplained'' mitral regurgitation and were included as cases. For each case, two controls were matched for gender and for the closest date of birth, among a list of patients with an "explained'' mitral regurgitation. Drug exposures were assessed blindly regarding the case or control status, through contacts with patients, their family and/or their physicians. Results: Out of the 682 eligible patients, 27 cases and 54 matched controls were identified. The use of benfluorex was reported in 22 patients: 19 of the 27 cases, versus 3 of the 54 controls, odds-ratio 17.1 (3.5 to 83), adjusted for body mass index, diabetes and dexfenfluramine use. Conclusion: The use of benfluorex is associated with unexplained mitral regurgitation.	[Frachon, Irene; Le Gal, Gregoire; Leroyer, Christophe] Univ Europeenne Bretagne, Brest, France; [Frachon, Irene; Leroyer, Christophe] Univ Brest, EA3878, IFR 148, GETBO, Brest, France; [Frachon, Irene; Leroyer, Christophe] CHU Cavale Blanche, Grp HTAP Bretagne Occidentale, Dept Med Interne & Pneumol, Brest, France; [Etienne, Yves; Jobic, Yannick] CHU Cavale Blanche, Dept Cardiol, Grp HTAP Bretagne Occidentale, Brest, France; [Le Gal, Gregoire] Univ Brest, INSERM, CIC 05 02, IFR148, Brest, France; [Humbert, Marc] Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France; [Humbert, Marc] Hop Antoine Beclere, AP HP, Ctr Natl Reference Hypertens Pulm Severe, Serv Pneumol & Reanimat Resp, Clamart, France; [Humbert, Marc] INSERM, U999, Le Plessis Robinson, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Frachon, I (corresponding author), Univ Europeenne Bretagne, Brest, France.	irene.frachon@chu-brest.fr	LE GAL, Gregoire/K-1077-2012; Humbert, Marc/AAC-8459-2019; Humbert, Marc/ABD-5112-2021	Humbert, Marc/0000-0003-0703-2892; Frachon, Irene/0000-0001-6666-9709; LE GAL, Gregoire/0000-0002-9253-248X; leroyer, christophe/0000-0002-7601-1692	 [GETBO EA3878 Brest]		This study was funded by the authors' institution (GETBO EA3878 Brest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; *AFSSAPS, 2009, SUSP AUT MIS MARCH M; Bhattacharyya S, 2009, LANCET, V374, P577, DOI 10.1016/S0140-6736(09)60252-X; Boutet K, 2009, EUR RESPIR J, V33, P684, DOI 10.1183/09031936.00086308; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Dahl CF, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-34; DUHAULT J, 1970, AMPHETAMINES RELATED, P619; Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; Noize P, 2006, FUND CLIN PHARMACOL, V20, P577, DOI 10.1111/j.1472-8206.2006.00441.x; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Ribera JR, 2003, REV ESP CARDIOL, V56, P215; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, CIRCULATION, V102, P2836; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830	19	61	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10128	10.1371/journal.pone.0010128	http://dx.doi.org/10.1371/journal.pone.0010128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405030	Green Published, gold, Green Submitted			2022-12-27	WOS:000276705900012
J	March, C; Regueiro, V; Llobet, E; Moranta, D; Morey, P; Garmendia, J; Bengoechea, JA				March, Catalina; Regueiro, Veronica; Llobet, Enrique; Moranta, David; Morey, Pau; Garmendia, Junkal; Bengoechea, Jose A.			Dissection of Host Cell Signal Transduction during Acinetobacter baumannii - Triggered Inflammatory Response	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; NF-KAPPA-B; LIPOPOLYSACCHARIDE-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; HUMAN AIRWAY EPITHELIA; CIGARETTE-SMOKE; BETA-DEFENSINS; PATHOGEN RECOGNITION; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2	Infected airway epithelial cells up-regulate the expression of chemokines, chiefly IL-8, and antimicrobial molecules including beta-defensins (BD). Acinetobacter baumannii is a cause of hospital-acquired pneumonia. We examined whether A. baumannii induced the expressions of IL-8 and BD2 by airway epithelial cells and the receptors implicated in bacterial detection. A549 and human primary airway cells released IL-8 upon infection. A. baumannii-infected cells also increased the expression of BD2 which killed A. baummannii strains. IL-8 induction was via NF-kappa B and mitogen-activated kinases p38 and p44/42-dependent pathways. A. baumannii engaged Toll-like receptor (TLR) 2 and TLR4 pathways and A549 cells could use soluble CD14 as TLRs co-receptor. A. baumannii lipopolysaccharide stimulated IL-8 release by A549 cells and sCD14 facilitated the recognition of the lipopolysaccharide. Mass spectrometry analysis revealed that A. baumannii lipid A structure matches those with endotoxic potential. These results demonstrate that airway epithelial cells produce mediators important for A. baumannii clearance.	[March, Catalina; Regueiro, Veronica; Llobet, Enrique; Moranta, David; Morey, Pau; Garmendia, Junkal; Bengoechea, Jose A.] Fundacio Caubet CIMERA Illes Balears, Program Infect & Immun, Bunyola, Spain; [March, Catalina; Regueiro, Veronica; Llobet, Enrique; Moranta, David; Morey, Pau; Garmendia, Junkal; Bengoechea, Jose A.] Ctr Invest Biomed Red Enfermedades Resp, Area Mol Basis Microbial Pathogenesis, Bunyola, Spain; [Garmendia, Junkal] Inst Agrobiotecnol, Pamplona, Spain; [Bengoechea, Jose A.] Univ Illes Balears, Fac Biol, Area Microbiol, Palma de Mallorca, Spain; [Bengoechea, Jose A.] CSIC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC)	March, C (corresponding author), Fundacio Caubet CIMERA Illes Balears, Program Infect & Immun, Bunyola, Spain.	bengoechea@caubet-cimera.es	Mesquida, David Moranta/H-4958-2012; Garmendia, Juncal/G-4360-2011; Morey, Pau/I-2521-2018	Mesquida, David Moranta/0000-0001-9528-4920; Garmendia, Juncal/0000-0002-7440-2737; Morey, Pau/0000-0003-3597-5054; Bengoechea, Jose/0000-0002-9677-8751	Fondo de Investigacian Sanitaria [PI04/1854]	Fondo de Investigacian Sanitaria	This work has been funded by a grant from Fondo de Investigacian Sanitaria (PI04/1854) to J.A.B. CIBERES is an initiative from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayram H, 1998, AM J RESP CELL MOL, V18, P441, DOI 10.1165/ajrcmb.18.3.2882; Bengoechea JA, 1996, INFECT IMMUN, V64, P4891, DOI 10.1128/IAI.64.12.4891-4899.1996; Chen MZ, 2001, CHEST, V120, P1072, DOI 10.1378/chest.120.4.1072; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; EL HA, 2005, J LIPID RES, V46, P1773; Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jia HP, 2001, GENE, V263, P211; Karim M, 1991, J Pak Med Assoc, V41, P35; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Leone S, 2006, CARBOHYD RES, V341, P582, DOI 10.1016/j.carres.2006.01.016; Leone S, 2007, J LIPID RES, V48, P1045, DOI 10.1194/jlr.M600323-JLR200; Leung AS, 2006, CHEST, V129, P102, DOI 10.1378/chest.129.1.102; LOPPNOW H, 1995, INFECT IMMUN, V63, P1020, DOI 10.1128/IAI.63.3.1020-1026.1995; Martin TR, 1997, AM J RESP CRIT CARE, V155, P937, DOI 10.1164/ajrccm.155.3.9117029; McCray PB, 1997, AM J RESP CELL MOL, V16, P343, DOI 10.1165/ajrcmb.16.3.9070620; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Pathmanathan S, 2003, OCCUP ENVIRON MED, V60, P892, DOI 10.1136/oem.60.11.892; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Qiu HY, 2009, MICROBES INFECT, V11, P946, DOI 10.1016/j.micinf.2009.06.003; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Schulz C, 2002, SCAND J IMMUNOL, V56, P294, DOI 10.1046/j.1365-3083.2002.01137.x; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tirsoaga A, 2007, APPL ENVIRON MICROB, V73, P1803, DOI 10.1128/AEM.02452-06; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; VAN FH, 2007, INFECT IMMUN, V75, P5597; Vinogradov EV, 1997, EUR J BIOCHEM, V243, P122, DOI 10.1111/j.1432-1033.1997.0122a.x; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i	57	51	53	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10033	10.1371/journal.pone.0010033	http://dx.doi.org/10.1371/journal.pone.0010033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383325	Green Published, Green Submitted, gold			2022-12-27	WOS:000276454000007
J	Li, CH; Ohn, T; Ivanov, P; Tisdale, S; Anderson, P				Li, Chi Ho; Ohn, Takbum; Ivanov, Pavel; Tisdale, Sarah; Anderson, Paul			eIF5A Promotes Translation Elongation, Polysome Disassembly and Stress Granule Assembly	PLOS ONE			English	Article							INITIATION-FACTOR 5A; O-GLCNAC MODIFICATION; PROTEIN-SYNTHESIS; DEOXYHYPUSINE SYNTHASE; HYPUSINE MODIFICATION; GROWTH; EIF-5A; INVOLVEMENT; INHIBITOR; DEPLETION	Stress granules (SGs) are cytoplasmic foci at which untranslated mRNAs accumulate in cells exposed to environmental stress. We have identified ornithine decarboxylase (ODC), an enzyme required for polyamine synthesis, and eIF5A, a polyamine (hypusine)-modified translation factor, as proteins required for arsenite-induced SG assembly. Knockdown of deoxyhypusine synthase (DHS) or treatment with a deoxyhypusine synthase inhibitor (GC7) prevents hypusine modification of eIF5A as well as arsenite-induced polysome disassembly and stress granule assembly. Time-course analysis reveals that this is due to a slowing of stress-induced ribosome run-off in cells lacking hypusine-eIF5A. Whereas eIF5A only marginally affects protein synthesis under normal conditions, it is required for the rapid onset of stress-induced translational repression. Our results reveal that hypusine-eIF5A-facilitated translation elongation promotes arsenite-induced polysome disassembly and stress granule assembly in cells subjected to adverse environmental conditions.	[Li, Chi Ho; Ohn, Takbum; Ivanov, Pavel; Tisdale, Sarah; Anderson, Paul] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Li, CH (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu	Ivanov, Pavel/F-3339-2016; Ivanov, Pavel/AAZ-9197-2021	Ivanov, Pavel/0000-0002-7986-7760; Ivanov, Pavel/0000-0002-7986-7760	NIAID NIH HHS [R56 AI033600, AI065858, P01 AI065858, R01 AI033600, AI033600] Funding Source: Medline; NIAMS NIH HHS [AR0514732] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033600, R56AI033600, P01AI065858] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON P, 2008, TRENDS BIOCH SCI; BENNE R, 1978, J BIOL CHEM, V253, P3078; Cano VSP, 2008, FEBS J, V275, P44, DOI 10.1111/j.1742-4658.2007.06172.x; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Dias CAO, 2008, FEBS J, V275, P1874, DOI 10.1111/j.1742-4658.2008.06345.x; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hopkins MT, 2008, PLANT PHYSIOL, V148, P479, DOI 10.1104/pp.108.118869; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; KANG HA, 1994, J BIOL CHEM, V269, P3934; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Luchessi AD, 2009, J CELL PHYSIOL, V218, P480, DOI 10.1002/jcp.21619; Moore CC, 2008, J INFECT DIS, V198, P1407, DOI 10.1086/592222; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shi XP, 1996, BBA-MOL CELL RES, V1310, P119, DOI 10.1016/0167-4889(95)00165-4; STEINKASSERER A, 1995, GENOMICS, V25, P749, DOI 10.1016/0888-7543(95)80025-H; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Svensson KJ, 2008, CANCER RES, V68, P9291, DOI 10.1158/0008-5472.CAN-08-2340; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zhao YJ, 2007, EUR J PHARMACOL, V562, P236, DOI 10.1016/j.ejphar.2007.01.096; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	34	81	85	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9942	10.1371/journal.pone.0009942	http://dx.doi.org/10.1371/journal.pone.0009942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376341	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200018
J	Chuykin, I; Lapidus, I; Popova, E; Vilianovich, L; Mosienko, V; Alenina, N; Binas, B; Chai, GX; Bader, M; Krivokharchenko, A				Chuykin, Ilya; Lapidus, Irina; Popova, Elena; Vilianovich, Larisa; Mosienko, Valentina; Alenina, Natalia; Binas, Bert; Chai, Guixuan; Bader, Michael; Krivokharchenko, Alexander			Characterization of Trophoblast and Extraembryonic Endoderm Cell Lineages Derived from Rat Preimplantation Embryos	PLOS ONE			English	Article							STEM-CELLS; GATA FACTORS; ES CELLS; MOUSE; DIFFERENTIATION; BLASTOCYSTS; LINES; GENERATION; TISSUES	Background: Previous attempts to isolate pluripotent cell lines from rat preimplantation embryo in mouse embryonic stem (ES) cell culture conditions (serum and LIF) were unsuccessful, however the resulting cells exhibited the expression of such traditional pluripotency markers as SSEA-1 and alkaline phosphatase. We addressed the question, which kind of cell lineages are produced from rat preimplantation embryo under "classical" mouse ES conditions. Results: We characterized two cell lines (C5 and B10) which were obtained from rat blastocysts in medium with serum and LIF. In the B10 cell line we found the expression of genes known to be expressed in trophoblast, Cdx-2, cytokeratin-7, and Hand-1. Also, B10 cells invaded the trophectodermal layer upon injection into rat blastocysts. In contrast to mouse Trophoblast Stem (TS) cells proliferation of B10 cells occurred independently of FGF4. Cells of the C5 line expressed traditional markers of extraembryonic-endoderm (XEN) cells, in particular, GATA-4, but also the pluripotency markers SSEA-1 and Oct-4. C5 cell proliferation exhibited dependence on LIF, which is not known to be required by mouse XEN cells. Conclusions: Our results confirm and extend previous findings about differences between blastocyst-derived cell lines of rat and mice. Our data show, that the B10 cell line represents a population of FGF4-independent rat TS-like cells. C5 cells show features that have recently become known as characteristic of rat XEN cells. Early passages of C5 and B10 cells contained both, TS and XEN cells. We speculate, that mechanisms maintaining self-renewal of cell lineages in rat preimplantation embryo and their in vitro counterparts, including ES, TS and XEN cells are different than in respective mouse lineages.	[Chuykin, Ilya; Lapidus, Irina; Popova, Elena; Vilianovich, Larisa; Mosienko, Valentina; Alenina, Natalia; Bader, Michael; Krivokharchenko, Alexander] Max Delbruck Ctr Mol Med, Berlin, Germany; [Binas, Bert] Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea; [Chai, Guixuan] HD Biosci Co Ltd, Shanghai, Peoples R China	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hanyang University	Chuykin, I (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	mbader@mdc-berlin.de	Mosienko, Valentina/AAN-5983-2020; Bader, Michael/K-2124-2013	Popova, Elena/0000-0002-3043-9650; Mosienko, Valentina/0000-0002-8562-532X; Bader, Michael/0000-0003-4780-4164	DAAD [A0890020, A0799669]; ESF [2007000003]; Russian fund for fundamental research and Helmholtz society [HRJRG 24]; European Union	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ESF(European Commission); Russian fund for fundamental research and Helmholtz society; European Union(European Commission)	I.C. and V. M. were supported by the grant of DAAD (A0890020 and A0799669). I. L. was supported by ESF (2007000003). This work was supported by a joint grant between the Russian fund for fundamental research and Helmholtz society (HRJRG 24) and by the EURATOOLS integrated project funded by the Sixth Framework Programme of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Galat V, 2009, STEM CELLS DEV, V18, P1309, DOI 10.1089/scd.2009.0115; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Krivokharchenko A, 2002, MOL REPROD DEV, V61, P460, DOI 10.1002/mrd.90001; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Li CL, 2009, CELL RES, V19, P173, DOI 10.1038/cr.2008.301; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Popova E, 2008, TRANSGENIC RES, V17, P955, DOI 10.1007/s11248-008-9189-0; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Shimosato D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-80; Sutherland A, 2003, DEV BIOL, V258, P241, DOI 10.1016/S0012-1606(03)00130-1; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844	31	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9794	10.1371/journal.pone.0009794	http://dx.doi.org/10.1371/journal.pone.0009794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369002	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000276163100002
J	Safavi-Hemami, H; Young, ND; Doyle, J; Llewellyn, L; Klueter, A				Safavi-Hemami, Helena; Young, Neil D.; Doyle, Jason; Llewellyn, Lyndon; Klueter, Anke			Characterisation of Nitric Oxide Synthase in Three Cnidarian-Dinoflagellate Symbioses	PLOS ONE			English	Article								Background: Nitric oxide synthase (NOS) is an enzyme catalysing the conversion of L-arginine to L-citrulline and nitric oxide (NO), the latter being an essential messenger molecule for a range of biological processes. Whilst its role in higher vertebrates is well understood little is known about the role of this enzyme in early metazoan groups. For instance, NOS-mediated signalling has been associated with Cnidaria-algal symbioses, however controversy remains about the contribution of enzyme activities by the individual partners of these mutualistic relationships. Methodology/Principal Findings: Using a modified citrulline assay we successfully measured NOS activity in three cnidarian-algal symbioses: the sea anemone Aiptasia pallida, the hard coral Acropora millepora, and the soft coral Lobophytum pauciflorum, so demonstrating a wide distribution of this enzyme in the phylum Cnidaria. Further biochemical (citrulline assay) and histochemical (NADPH-diaphorase) investigations of NOS in the host tissue of L. pauciflorum revealed the cytosolic and calcium dependent nature of this enzyme and its in situ localisation within the coral's gastrodermal tissue, the innermost layer of the body wall bearing the symbiotic algae. Interestingly, enzyme activity could not be detected in symbionts freshly isolated from the cnidarians, or in cultured algal symbionts. Conclusions/Significance: These results suggest that NOS-mediated NO release may be host-derived, a finding that has the potential to further refine our understanding of signalling events in cnidarian-algal symbioses.	[Safavi-Hemami, Helena] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Young, Neil D.] Univ Melbourne, Fac Vet Sci, Melbourne, Vic, Australia; [Doyle, Jason; Llewellyn, Lyndon; Klueter, Anke] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Klueter, Anke] Univ Maine, Sch Marine Sci, Orono, ME USA	University of Melbourne; University of Melbourne; Australian Institute of Marine Science; University of Maine System; University of Maine Orono	Safavi-Hemami, H (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.	a.klueter@aims.gov.au	Young, Neil David/AAU-4572-2020; Safavi-Hemami, Helena/E-7624-2015; Llewellyn, Lyndon E/F-6030-2011	Young, Neil David/0000-0001-8756-229X; Safavi-Hemami, Helena/0000-0002-1984-2721; Llewellyn, Lyndon E/0000-0003-1680-1796	Cooperative Research Centre for the Great Barrier Reef World Heritage Area	Cooperative Research Centre for the Great Barrier Reef World Heritage Area(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was funded by the Cooperative Research Centre for the Great Barrier Reef World Heritage Area (CRC Reef Research). URL: http//www.rrrc.org.au/crcreef/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; COLASANTI M, 1995, NATURE, V374, P505, DOI 10.1038/374505a0; Fabricius K., 2001, SOFT CORALS SEA FANS; Giovine M, 2001, NITRIC OXIDE-BIOL CH, V5, P427, DOI 10.1006/niox.2001.0366; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Kuzin B. A., 2005, Ontogenez, V36, P343; Moroz LL, 2004, J COMP NEUROL, V471, P26, DOI 10.1002/cne.20023; Morrall CE, 2000, COMP BIOCHEM PHYS B, V125, P483, DOI 10.1016/S0305-0491(00)00157-7; Owen R, 2002, MAR POLLUT BULL, V44, P623, DOI 10.1016/S0025-326X(01)00303-4; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Trapido-Rosenthal H, 2005, BIOL BULL-US, V208, P3, DOI 10.2307/3593094; Trapido-Rosenthal HG, 2001, AM ZOOL, V41, P247, DOI 10.1668/0003-1569(2001)041[0247:NOACDS]2.0.CO;2; von der Leyen HE, 2001, CIRCULATION, V103, P2760; Weinberg JB, 1998, ENVIRON HEALTH PERSP, V106, P1131, DOI 10.2307/3433975; Yamasaki H, 1999, TRENDS PLANT SCI, V4, P128, DOI 10.1016/S1360-1385(99)01393-X; [No title captured]	21	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10379	10.1371/journal.pone.0010379	http://dx.doi.org/10.1371/journal.pone.0010379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442851	Green Published, gold			2022-12-27	WOS:000277154200018
J	Sarmah, S; Barrallo-Gimeno, A; Melville, DB; Topczewski, J; Solnica-Krezel, L; Knapik, EW				Sarmah, Swapnalee; Barrallo-Gimeno, Alejandro; Melville, David B.; Topczewski, Jacek; Solnica-Krezel, Lilianna; Knapik, Ela W.			Sec24D-Dependent Transport of Extracellular Matrix Proteins Is Required for Zebrafish Skeletal Morphogenesis	PLOS ONE			English	Article							CONTROLS CELL POLARITY; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; TRANSGENIC MICE; COPII; CARTILAGE; BINDING; MUTATIONS; PERLECAN; GENE	Protein transport from endoplasmic reticulum ( ER) to Golgi is primarily conducted by coated vesicular carriers such as COPII. Here, we describe zebrafish bulldog mutations that disrupt the function of the cargo adaptor Sec24D, an integral component of the COPII complex. We show that Sec24D is essential for secretion of cartilage matrix proteins, whereas the preceding development of craniofacial primordia and pre-chondrogenic condensations does not depend on this isoform. Bulldog chondrocytes fail to secrete type II collagen and matrilin to extracellular matrix (ECM), but membrane bound receptor beta 1-Integrin and Cadherins appear to leave ER in Sec24D-independent fashion. Consequently, Sec24D-deficient cells accumulate proteins in the distended ER, although a subset of ER compartments and Golgi complexes as visualized by electron microscopy and NBD C6-ceramide staining appear functional. Consistent with the backlog of proteins in the ER, chondrocytes activate the ER stress response machinery and significantly upregulate BiP transcription. Failure of ECM secretion hinders chondroblast intercalations thus resulting in small and malformed cartilages and severe craniofacial dysmorphology. This defect is specific to Sec24D mutants since knockdown of Sec24C, a close paralog of Sec24D, does not result in craniofacial cartilage dysmorphology. However, craniofacial development in double Sec24C/Sec24D-deficient animals is arrested earlier than in bulldog/sec24d, suggesting that Sec24C can compensate for loss of Sec24D at initial stages of chondrogenesis, but Sec24D is indispensable for chondrocyte maturation. Our study presents the first developmental perspective on Sec24D function and establishes Sec24D as a strong candidate for cartilage maintenance diseases and craniofacial birth defects.	[Sarmah, Swapnalee; Barrallo-Gimeno, Alejandro; Melville, David B.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37235 USA; [Sarmah, Swapnalee; Barrallo-Gimeno, Alejandro; Melville, David B.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Barrallo-Gimeno, Alejandro; Knapik, Ela W.] Univ Freiburg, Inst Biol 1, D-7800 Freiburg, Germany; [Topczewski, Jacek; Solnica-Krezel, Lilianna] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; University of Freiburg; Vanderbilt University	Sarmah, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37235 USA.	ela.knapik@vanderbilt.edu	Topczewski, Jacek/D-5895-2016; Barrallo-Gimeno, Alejandro/L-1952-2013; Knapik, Ela W./J-6172-2014	Topczewski, Jacek/0000-0001-6023-9556; Barrallo-Gimeno, Alejandro/0000-0003-2086-8926; Knapik, Ela W./0000-0002-2977-3619	National Institute of Dental and Craniofacial Research [R01 DE018477]; Vanderbilt University Academic Venture Capital Fund (EWK); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018477] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Vanderbilt University Academic Venture Capital Fund (EWK); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work has been supported in part by the National Institute of Dental and Craniofacial Research grant R01 DE018477 and the Zebrafish Initiative of the Vanderbilt University Academic Venture Capital Fund (EWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Bosserhoff AK, 2004, GENE EXPR PATTERNS, V4, P473, DOI 10.1016/j.modgep.2003.12.002; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hall BK, 1995, INT J DEV BIOL, V39, P881; HALL BK, 1992, ANAT EMBRYOL, V186, P107; Henrotin Y, 2007, CURR OPIN RHEUMATOL, V19, P444, DOI 10.1097/BOR.0b013e32829fb3b5; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Ko YP, 2005, BIOCHEM J, V386, P367, DOI 10.1042/BJ20041486; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Li SW, 2001, DEV DYNAM, V222, P141, DOI 10.1002/dvdy.1178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; Pace JM, 1997, DEV DYNAM, V208, P25; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110	52	90	93	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10367	10.1371/journal.pone.0010367	http://dx.doi.org/10.1371/journal.pone.0010367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442775	Green Published, gold, Green Submitted			2022-12-27	WOS:000277154200009
J	Coppo, P; Schwarzinger, M; Buffet, M; Wynckel, A; Clabault, K; Presne, C; Poullin, P; Malot, S; Vanhille, P; Azoulay, E; Galicier, L; Lemiale, V; Mira, JP; Ridel, C; Rondeau, E; Pourrat, J; Girault, S; Bordessoule, D; Saheb, S; Ramakers, M; Hamidou, M; Vernant, JP; Guidet, B; Wolf, M; Veyradier, A				Coppo, Paul; Schwarzinger, Michael; Buffet, Marc; Wynckel, Alain; Clabault, Karine; Presne, Claire; Poullin, Pascale; Malot, Sandrine; Vanhille, Philippe; Azoulay, Elie; Galicier, Lionel; Lemiale, Virginie; Mira, Jean-Paul; Ridel, Christophe; Rondeau, Eric; Pourrat, Jacques; Girault, Stephane; Bordessoule, Dominique; Saheb, Samir; Ramakers, Michel; Hamidou, Mohamed; Vernant, Jean-Paul; Guidet, Bertrand; Wolf, Martine; Veyradier, Agnes		French Reference Ctr Thrombotic Mi	Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; HEMOLYTIC-UREMIC-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LOGISTIC-REGRESSION ANALYSIS; THROMBOCYTOPENIC-PURPURA; PLASMA-EXCHANGE; PROGNOSTIC VALUE; ANTIBODIES; RITUXIMAB	Severe ADAMTS13 deficiency occurs in 13% to 75% of thrombotic microangiopathies (TMA). In this context, the early identification of a severe, antibody-mediated, ADAMTS13 deficiency may allow to start targeted therapies such as B-lymphocytes-depleting monoclonal antibodies. To date, assays exploring ADAMTS13 activity require skill and are limited to only some specialized reference laboratories, given the very low incidence of the disease. To identify clinical features which may allow to predict rapidly an acquired ADAMTS13 deficiency, we performed a cross-sectional analysis of our national registry from 2000 to 2007. The clinical presentation of 160 patients with TMA and acquired ADAMTS13 deficiency was compared with that of 54 patients with detectable ADAMTS13 activity. ADAMTS13 deficiency was associated with more relapses during treatment and with a good renal prognosis. Patients with acquired ADAMTS13 deficiency had platelet count <30x10(-9)/L (adjusted odds ratio [OR] 9.1, 95% confidence interval [CI] 3.4-24.2, P<.001), serum creatinine level <= 200 mu mol/L (OR 23.4, 95% CI 8.8-62.5, P<.001), and detectable antinuclear antibodies (OR 2.8, 95% CI 1.0-8.0, P<.05). When at least 1 criteria was met, patients with a severe acquired ADAMTS13 deficiency were identified with positive predictive value of 85%, negative predictive value of 93.3%, sensitivity of 98.8%, and specificity of 48.1%. Our criteria should be useful to identify rapidly newly diagnosed patients with an acquired ADAMTS13 deficiency to better tailor treatment for different pathophysiological groups.	[Coppo, Paul; Buffet, Marc; Malot, Sandrine] Hop St Antoine, AP HP, Serv Hematol & Therapie Cellulaire, F-75571 Paris, France; [Coppo, Paul; Schwarzinger, Michael; Buffet, Marc; Malot, Sandrine; Guidet, Bertrand] Univ Paris 06, Paris, France; [Schwarzinger, Michael] INSERM, UMR S 707, Paris, France; [Wynckel, Alain] Hop Maison Blanche, Serv Nephrol, Reims, France; [Clabault, Karine] Hop Charles Nicolle, Serv Reanimat Med, Rouen, France; [Presne, Claire] Hop Sud, Serv Nephrol Med Interne, Amiens, France; [Poullin, Pascale] Hop Conception, Serv Hemapherese, Marseille, France; [Vanhille, Philippe] Ctr Hosp Valenciennes, Serv Nephrol, Valenciennes, France; [Azoulay, Elie] Univ Paris 07, Hop St Louis, AP HP, Serv Reanimat Polyvalente, Paris, France; [Galicier, Lionel] Univ Paris 07, Hop St Louis, AP HP, Serv Immunopathol, Paris, France; [Lemiale, Virginie; Mira, Jean-Paul] Univ Paris 05, Hop Cochin, AP HP, Serv Reanimat Polyvalente, Paris, France; [Ridel, Christophe; Rondeau, Eric] Univ Paris 06, Hop Tenon, AP HP, Serv Nephrol, Paris, France; [Pourrat, Jacques] CHU Rangueil, Serv Nephrol, F-31054 Toulouse, France; [Pourrat, Jacques] CHU Rangueil, Immunol Clin, F-31054 Toulouse, France; [Girault, Stephane; Bordessoule, Dominique] CHU Dupuytren, Serv Hematol Clin & Therapie Cellulaire, Limoges, France; [Saheb, Samir; Vernant, Jean-Paul] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Serv Hematol Clin & Therapie Cellulaire, Paris, France; [Ramakers, Michel] CHU Caen, Serv Reanimat Med, F-14000 Caen, France; [Hamidou, Mohamed] Hop Hotel Dieu, Serv Med Interne A, Nantes, France; [Guidet, Bertrand] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France; [Wolf, Martine; Veyradier, Agnes] Univ Paris 11, INSERM, U770, Le Kremlin Bicetre, France; [Wolf, Martine; Veyradier, Agnes] Hop Antoine Beclere, AP HP, Serv Hematol Biol, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Rouen; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU de Toulouse; CHU Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Coppo, P (corresponding author), Hop St Antoine, AP HP, Serv Hematol & Therapie Cellulaire, F-75571 Paris, France.	paul.coppo@sat.aphp.fr	Schwarzinger, Michael/F-7367-2011; vigneau, cecile/I-3178-2015	Schwarzinger, Michael/0000-0002-0573-6856; gruson, didier/0000-0002-1199-5125; Ojeda-Uribe, Mario/0000-0001-6881-6055; IFRAH, Norbert/0000-0003-3063-850X; Saheb, Samir/0000-0002-7764-6016; deschenes, georges/0000-0002-5158-2915	Etablissement Francais du Sang [CS/2002/009]; GIS Maladies Rares [GIS MR0428]	Etablissement Francais du Sang; GIS Maladies Rares	This work was funded by grants from the Etablissement Francais du Sang (CS/2002/009) and the GIS Maladies Rares (GIS MR0428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherson RA, 2008, AUTOIMMUN REV, V7, P164, DOI 10.1016/j.autrev.2007.11.009; Bianchi V, 2002, BLOOD, V100, P710, DOI 10.1182/blood-2002-02-0344; Coppo P, 2006, BRIT J HAEMATOL, V132, P66, DOI 10.1111/j.1365-2141.2005.05837.x; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Coppo P, 2003, MEDICINE, V82, P27, DOI 10.1097/00005792-200301000-00003; Elliott MA, 2009, EUR J HAEMATOL, V83, P365, DOI 10.1111/j.1600-0609.2009.01292.x; Fakhouri F, 2005, BLOOD, V106, P1932, DOI 10.1182/blood-2005-03-0848; Ferrari S, 2007, BLOOD, V109, P2815, DOI 10.1182/blood-2006-02-006064; Francavilla R, 2008, HELICOBACTER, V13, P127, DOI 10.1111/j.1523-5378.2008.00593.x; Froissart A, 2009, BLOOD, V114, P366; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Howard MA, 2006, TRANSFUSION, V46, P154, DOI 10.1111/j.1537-2995.2006.00687.x; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Letchumanan P, 2009, RHEUMATOLOGY, V48, P399, DOI 10.1093/rheumatology/ken510; Mannucci PM, 2003, HAEMATOLOGICA, V88, P914; Mannucci PM, 2001, BLOOD, V98, P2730, DOI 10.1182/blood.V98.9.2730; Matsumoto M, 2004, SEMIN HEMATOL, V41, P68, DOI 10.1053/j.seminhematol.2003.10.009; Mori Y, 2002, TRANSFUSION, V42, P572, DOI 10.1046/j.1537-2995.2002.00100.x; Raife T, 2004, TRANSFUSION, V44, P146, DOI 10.1111/j.1537-2995.2004.00626.x; Rieger M, 2005, BLOOD, V106, P1262, DOI 10.1182/blood-2004-11-4490; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Scully M, 2007, BRIT J HAEMATOL, V136, P451, DOI 10.1111/j.1365-2141.2006.06448.x; Shelat SG, 2006, J THROMB HAEMOST, V4, P1707, DOI 10.1111/j.1538-7836.2006.02025.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; Veyradier A, 2001, BLOOD, V98, P1765, DOI 10.1182/blood.V98.6.1765; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035	30	209	215	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10208	10.1371/journal.pone.0010208	http://dx.doi.org/10.1371/journal.pone.0010208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20436664	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079300001
J	Coslett, HB; Wiener, M; Chatterjee, A				Coslett, H. Branch; Wiener, Martin; Chatterjee, Anjan			Dissociable Neural Systems for Timing: Evidence from Subjects with Basal Ganglia Lesions	PLOS ONE			English	Article							PARKINSONS-DISEASE; TEMPORAL INFORMATION; CEREBELLAR LESIONS; PSYCHOMETRIC FUNCTION; REPETITIVE MOVEMENTS; STRIATAL NEURONS; TIME PERCEPTION; REPRESENTATION; MOTOR; HUMANS	Background: The neural basis of timing remains poorly understood. Although controversy persists, many lines of evidence, including studies in animals, functional imaging studies in humans and lesion studies in humans and animals suggest that the basal ganglia are important for temporal processing [1]. Methodology/Principal Findings: We report data from a wide range of timing tasks from two subjects with disabling neurologic deficits caused by bilateral lesions of the basal ganglia. Both subjects perform well on tasks assessing time estimation, reproduction and production tasks. Additionally, one subject performed normally on psychophysical tasks requiring the comparison of time intervals ranging from milliseconds to seconds; the second subject performed abnormally on the psychophysical task with a 300ms standard but did well with 600ms, 2000ms and 8000ms standards. Both subjects performed poorly on an isochronous rhythm production task on which they are required to maintain rhythmic tapping. Conclusions/Significance: As studies of subjects with brain lesions permit strong inferences regarding the necessity of brain structures, these data demonstrate that the basal ganglia are not crucial for many sub-or supra-second timing operations in humans but are needed for the timing procedures that underlie the production of movements. This dissociation suggests that distinct and dissociable processes may be employed to measure time intervals. Inconsistencies in findings regarding the neural basis of timing may reflect the availability of multiple temporal processing routines that are flexibly implemented in response to task demands.	[Coslett, H. Branch; Wiener, Martin; Chatterjee, Anjan] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania	Coslett, HB (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	hbc@mail.med.upenn.edu; wimartin@psych.upenn.edu; anjan@mail.med.upenn.edu			National Institutes of Health [RO1MH76227]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grant RO1MH76227 from the National Institutes of Health to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio P, 2005, BRAIN COGNITION, V58, P62, DOI 10.1016/j.bandc.2004.09.009; Beste C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001263; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P204, DOI 10.1162/jocn.2008.20017; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carroll CA, 2009, BRAIN COGNITION, V71, P345, DOI 10.1016/j.bandc.2009.06.009; Chiba A, 2008, EXP BRAIN RES, V186, P671, DOI 10.1007/s00221-008-1347-3; Craig AD, 2009, PHILOS T R SOC B, V364, P1933, DOI 10.1098/rstb.2009.0008; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DUCKEK JM, 1994, NEUROPSYCHOLOGY, V8, P218; Durstewitz D, 2004, NEUROREPORT, V15, P745, DOI 10.1097/00001756-200404090-00001; Freeman J S, 1996, Parkinsonism Relat Disord, V2, P81, DOI 10.1016/1353-8020(96)00009-0; Galvan A, 2008, CLIN NEUROPHYSIOL, V119, P1459, DOI 10.1016/j.clinph.2008.03.017; Gooch CM, 2010, NEUROPSYCHOLOGIA, V48, P1022, DOI 10.1016/j.neuropsychologia.2009.11.028; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 2004, BRAIN, V127, P561, DOI 10.1093/brain/awh065; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; M?nsterberg H.., 1889, BEITRAGE EXPT PSYCHO; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; Rammsayer TH, 1997, NEUROPSYCHOBIOLOGY, V35, P36, DOI 10.1159/000119328; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rao SM, 1997, J NEUROSCI, V17, P5528; Shin JC, 2005, BRAIN COGNITION, V58, P75, DOI 10.1016/j.bandc.2004.09.015; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; Toplak ME, 2003, J CHILD PSYCHOL PSYC, V44, P888, DOI 10.1111/1469-7610.00173; VICARIO CM, 2010, BRAIN COGNI IN PRESS; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Wearden JH, 2008, BRAIN COGNITION, V67, P264, DOI 10.1016/j.bandc.2008.01.010; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wiener M, 2010, J COGNITIVE NEUROSCI, V22, P23, DOI 10.1162/jocn.2009.21191; Wing A.M., 1980, ADV PSYCHOL, V1, P469, DOI [10.1016/S0166-4115(08)61963-9, DOI 10.1016/S0166-4115(08)61963-9, DOI 10.1016/S0166-4115(08)61963.9]; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; WING AM, 1984, ANN NY ACAD SCI, V423, P183, DOI 10.1111/j.1749-6632.1984.tb23428.x	50	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10324	10.1371/journal.pone.0010324	http://dx.doi.org/10.1371/journal.pone.0010324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428244	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079300014
J	Tanegashima, K; Okamoto, S; Nakayama, Y; Taya, C; Shitara, H; Ishii, R; Yonekawa, H; Minokoshi, Y; Hara, T				Tanegashima, Kosuke; Okamoto, Shiki; Nakayama, Yuki; Taya, Choji; Shitara, Hiroshi; Ishii, Rie; Yonekawa, Hiromichi; Minokoshi, Yasuhiko; Hara, Takahiko			CXCL14 Deficiency in Mice Attenuates Obesity and Inhibits Feeding Behavior in a Novel Environment	PLOS ONE			English	Article							FOOD-INTAKE; RECEPTOR; HORMONE; CELLS	Background: CXCL14 is a chemoattractant for macrophages and immature dendritic cells. We recently reported that CXCL14-deficient (CXCL14(-/-)) female mice in the mixed background are protected from obesity-induced hyperglycemia and insulin resistance. The decreased macrophage infiltration into visceral adipose tissues and the increased insulin sensitivity of skeletal muscle contributed to these phenotypes. Methodology/Principal Findings: In this study, we performed a comprehensive study for the body weight control of CXCL14(-/-) mice in the C57BL/6 background. We show that both male and female CXCL14(-/-) mice have a 7-11% lower body weight compared to CXCL14(+/-) and CXCL14(+/+) mice in adulthood. This is mainly caused by decreased food intake, and not by increased energy expenditure or locomotor activity. Reduced body weight resulting from the CXCL14 deficiency was more pronounced in double mutant CXCL14(-/-) ob/ob and CXCL14(-/-) A(y) mice. In the case of CXCL14(-/-) A(y) mice, oxygen consumption was increased compared to CXCL14(+/-) A(y) mice, in addition to the reduced food intake. In CXCL14(-/-) mice, fasting-induced up-regulation of Npy and Agrp mRNAs in the hypothalamus was blunted. As intracerebroventricular injection of recombinant CXCL14 did not change the food intake of CXCL14(-/-) mice, CXCL14 could indirectly regulate appetite. Intriguingly, the food intake of CXCL14(-/-) mice was significantly repressed when mice were transferred to a novel environment. Conclusions/Significance: We demonstrated that CXCL14 is involved in the body weight control leading to the fully obese phenotype in leptin-deficient or A(y) mutant mice. In addition, we obtained evidence indicating that CXCL14 may play an important role in central nervous system regulation of feeding behavior.	[Tanegashima, Kosuke; Nakayama, Yuki; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Stem Cell Project Grp, Setagaya Ku, Tokyo, Japan; [Okamoto, Shiki; Minokoshi, Yasuhiko] Natl Inst Physiol Sci, Div Endocrinol & Metab, Aichi, Japan; [Nakayama, Yuki] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan; [Taya, Choji; Shitara, Hiroshi; Ishii, Rie; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Lab Mouse Model Human Heritable Dis, Setagaya Ku, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kumamoto University; Tokyo Metropolitan Institute of Medical Science	Tanegashima, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Tokyo Metropolitan Org Med Res, Stem Cell Project Grp, Setagaya Ku, Tokyo, Japan.	hara-tk@igakuken.or.jp	Okamoto, Shiki/X-7274-2018	Okamoto, Shiki/0000-0002-2802-0527; Minokoshi, Yasuhiko/0000-0002-7119-4805	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Pharmaceutical Company Limited	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a research grant from Takeda Pharmaceutical Company Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagri A, 2002, DEVELOPMENT, V129, P4249; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hara T, 2009, VITAM HORM, V80, P107, DOI 10.1016/S0083-6729(08)00605-5; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Huising MO, 2004, EUR J BIOCHEM, V271, P4094, DOI 10.1111/j.1432-1033.2004.04347.x; LARSON BA, 1976, ENDOCRINOLOGY, V98, P139, DOI 10.1210/endo-98-1-139; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	14	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10321	10.1371/journal.pone.0010321	http://dx.doi.org/10.1371/journal.pone.0010321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428232	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300011
J	Weisenhaus, M; Allen, ML; Yang, LH; Lu, Y; Nichols, CB; Su, T; Hell, JW; McKnight, GS				Weisenhaus, Michael; Allen, Margaret L.; Yang, Linghai; Lu, Yuan; Nichols, C. Blake; Su, Thomas; Hell, Johannes W.; McKnight, G. Stanley			Mutations in AKAP5 Disrupt Dendritic Signaling Complexes and Lead to Electrophysiological and Behavioral Phenotypes in Mice	PLOS ONE			English	Article							PROTEIN-KINASE-A; LONG-TERM POTENTIATION; MICROTUBULE-ASSOCIATED PROTEIN-2; AMPA RECEPTOR TRAFFICKING; ANCHORING PROTEIN; REGULATORY SUBUNIT; DEFICIENT MICE; GENE-EXPRESSION; SPATIAL MEMORY; GLUR1 SUBUNIT	AKAP5 (also referred to as AKAP150 in rodents and AKAP79 in humans) is a scaffolding protein that is highly expressed in neurons and targets a variety of signaling molecules to dendritic membranes. AKAP5 interacts with PKA holoenzymes containing RII alpha or RII beta as well as calcineurin (PP2B), PKC, calmodulin, adenylyl cyclase type V/VI, L-type calcium channels, and beta-adrenergic receptors. AKAP5 has also been shown to interact with members of the MAGUK family of PSD-scaffolding proteins including PSD95 and SAP97 and target signaling molecules to receptors and ion channels in the postsynaptic density (PSD). We created two lines of AKAP5 mutant mice: a knockout of AKAP5 (KO) and a mutant that lacks the PKA binding domain of AKAP5 (D36). We find that PKA is delocalized in both the hippocampus and striatum of KO and D36 mice indicating that other neural AKAPs cannot compensate for the loss of PKA binding to AKAP5. In AKAP5 mutant mice, a significant fraction of PKA becomes localized to dendritic shafts and this correlates with increased binding to microtubule associated protein-2 (MAP2). Electrophysiological and behavioral analysis demonstrated more severe deficits in both synaptic plasticity and operant learning in the D36 mice compared with the complete KO animals. Our results indicate that the targeting of calcineurin or other binding partners of AKAP5 in the absence of the balancing kinase, PKA, leads to a disruption of synaptic plasticity and results in learning and memory defects.	[Weisenhaus, Michael; Allen, Margaret L.; Yang, Linghai; Nichols, C. Blake; Su, Thomas; McKnight, G. Stanley] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Lu, Yuan; Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis	Weisenhaus, M (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	mcknight@u.washington.edu	Yang, Linghai/C-2773-2012; Hell, Johannes W./P-5085-2019		National Institutes of Health [GM 032875, NS035563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant GM 032875 (G.S.M.) and NS035563 (J.W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MR, 1997, P NATL ACAD SCI USA, V94, P12157, DOI 10.1073/pnas.94.22.12157; Bannerman DM, 2003, BEHAV NEUROSCI, V117, P866, DOI 10.1037/0735-7044.117.4.866; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Brandon EP, 1998, J NEUROSCI, V18, P3639; Burton KA, 1999, J BIOL CHEM, V274, P24131, DOI 10.1074/jbc.274.34.24131; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Clark RE, 2000, J NEUROSCI, V20, P8853; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Few WP, 2007, P NATL ACAD SCI USA, V104, P5187, DOI 10.1073/pnas.0611619104; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Huang T, 2006, EUR J CELL BIOL, V85, P635, DOI 10.1016/j.ejcb.2006.02.005; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; Khuchua Z, 2003, NEUROSCIENCE, V119, P101, DOI 10.1016/S0306-4522(03)00094-0; Kim KS, 2008, J NEUROCHEM, V107, P105, DOI 10.1111/j.1471-4159.2008.05592.x; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; LUDVIG N, 1990, BRAIN RES, V520, P90, DOI 10.1016/0006-8993(90)91694-C; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Mok H, 2002, J NEUROSCI, V22, P5253; MORALES M, 1989, CELL TISSUE RES, V256, P447; Namekata K, 2006, MOL VIS, V12, P1586; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Nie T, 2007, J NEUROSCI, V27, P10278, DOI 10.1523/JNEUROSCI.1602-07.2007; Nolan MA, 2004, MOL ENDOCRINOL, V18, P2302, DOI 10.1210/me.2004-0194; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Ostroveanu A, 2007, BRAIN RES, V1145, P97, DOI 10.1016/j.brainres.2007.01.117; Phillips KG, 2008, J NEUROSCI, V28, P14031, DOI 10.1523/JNEUROSCI.3984-08.2008; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; SARKAR D, 1984, J BIOL CHEM, V259, P9840; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sharifzadeh M, 2005, J NEUROSCI RES, V79, P392, DOI 10.1002/jnr.20358; Suen P, 1998, MOL BRAIN RES, V59, P215, DOI 10.1016/S0169-328X(98)00157-0; Tao YM, 2005, J NEUROCHEM, V94, P1512, DOI 10.1111/j.1471-4159.2005.03297.x; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vinade L, 2003, J NEUROCHEM, V87, P1255, DOI 10.1046/j.1471-4159.2003.02091.x; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	72	65	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10325	10.1371/journal.pone.0010325	http://dx.doi.org/10.1371/journal.pone.0010325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428246	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300015
J	Matricon, J; Bellon, A; Frieling, H; Kebir, O; Le Pen, G; Beuvon, F; Daumas-Duport, C; Jay, TM; Krebs, MO				Matricon, Julien; Bellon, Alfredo; Frieling, Helge; Kebir, Oussama; Le Pen, Gwenaelle; Beuvon, Frederic; Daumas-Duport, Catherine; Jay, Therese M.; Krebs, Marie-Odile			Neuropathological and Reelin Deficiencies in the Hippocampal Formation of Rats Exposed to MAM; Differences and Similarities with Schizophrenia	PLOS ONE			English	Article							MEDIODORSAL THALAMIC NUCLEUS; PYRAMIDAL CELL DISARRAY; TOTAL NEURON NUMBER; ENTORHINAL CORTEX; METHYLAZOXYMETHANOL-ACETATE; BIPOLAR DISORDER; WORKING-MEMORY; ADULT RATS; SENSORIMOTOR CORTEX; MACAQUE MONKEY	Background: Adult rats exposed to methylazoxymethanol (MAM) at embryonic day 17 (E17) consistently display behavioral characteristics similar to that observed in patients with schizophrenia and replicate neuropathological findings from the prefrontal cortex of psychotic individuals. However, a systematic neuropathological analysis of the hippocampal formation and the thalamus in these rats is lacking. It is also unclear if reelin, a protein consistently associated with schizophrenia and potentially involved in the mechanism of action of MAM, participates in the neuropathological effects of this compound. Therefore, a thorough assessment including cytoarchitectural and neuromorphometric measurements of eleven brain regions was conducted. Numbers of reelin positive cells and reelin expression and methylation levels were also studied. Principal Findings: Compared to untreated rats, MAM-exposed animals showed a reduction in the volume of entorhinal cortex, hippocampus and mediodorsal thalamus associated with decreased neuronal soma. The entorhinal cortex also showed laminar disorganization and neuronal clusters. Reelin methylation in the hippocampus was decreased whereas reelin positive neurons and reelin expression were unchanged. Conclusions: Our results indicate that E17-MAM exposure reproduces findings from the hippocampal formation and the mediodorsal thalamus of patients with schizophrenia while providing little support for reelin's involvement. Moreover, these results strongly suggest MAM-treated animals have a diminished neuropil, which likely arises from abnormal neurite formation; this supports a recently proposed pathophysiological hypothesis for schizophrenia.	[Matricon, Julien; Bellon, Alfredo; Frieling, Helge; Kebir, Oussama; Le Pen, Gwenaelle; Jay, Therese M.; Krebs, Marie-Odile] Ctr Psychiat & Neurosci, INSERM, U894, Lab Physiopathol Malad Psychiat, Paris, France; [Beuvon, Frederic; Daumas-Duport, Catherine] Univ Paris 05, Fac Med Paris Descartes, Hop St Anne, Neuropathol Unit, Paris, France; [Frieling, Helge] Hannover Med Sch, Dept Psychiat Socialpsychiat & Psychotherapy, D-3000 Hannover, Germany; [Beuvon, Frederic; Daumas-Duport, Catherine] Ctr Psychiat & Neurosci, INSERM, U894, Lab Plast Gliale & Tumeurs Cerebrales, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Matricon, J (corresponding author), Univ Auvergne, Lab Pharmacol Fondamentale & Clin, Fac Med, INSERM,UMR766, Clermont Ferrand, France.	alfredo.bellon@inserm.fr; marie-odile.krebs@inserm.fr	Frieling, Helge/C-5299-2015; Krebs, Marie-Odile/O-2104-2017; Jay, Therese M/G-2297-2015; LE PEN, Gwenaëlle/M-9974-2017	Frieling, Helge/0000-0001-5146-9720; Krebs, Marie-Odile/0000-0002-4715-9890; Jay, Therese M/0000-0002-2468-1141; LE PEN, Gwenaëlle/0000-0002-5405-8094; Jay, Therese/0000-0003-3553-9236	Action Thematique Concertee [ASE2128CSA]; Agence Nationale pour la Recherche [ANR-05-NEUR-031-03]; Institut National de la Sante et de la Recherche Medicale; Fondation pour la Recherche Medicale [SPF20080511940]; Consejo Nacional de Ciencia y Tecnologia [74641]; American Psychiatric Association	Action Thematique Concertee; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); American Psychiatric Association	This work was supported by Action Thematique Concertee (ASE2128CSA to J.M.); Agence Nationale pour la Recherche (ANR-05-NEUR-031-03 PAIN to J.M.); Institut National de la Sante et de la Recherche Medicale; Fondation pour la Recherche Medicale (SPF20080511940 to A. B.); and Consejo Nacional de Ciencia y Tecnologia (74641 to A. B.). A. B. also receives support from The Young Minds in Psychiatry Award 2008 given by the American Psychiatric Association. None of the funding sources had any role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Akil M, 1997, AM J PSYCHIAT, V154, P1010; Altshuler LL, 2000, BIOL PSYCHIAT, V48, P147, DOI 10.1016/S0006-3223(00)00836-2; ALTSHULER LL, 1987, ARCH GEN PSYCHIAT, V44, P1094; Arnold SE, 1997, BIOL PSYCHIAT, V42, P639, DOI 10.1016/S0006-3223(97)00142-X; ARNOLD SE, 1995, AM J PSYCHIAT, V152, P738; ARNOLD SE, 1991, ARCH GEN PSYCHIAT, V48, P625; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; Baiano M, 2008, SCHIZOPHR RES, V102, P171, DOI 10.1016/j.schres.2007.11.035; BALDUINI W, 1991, NEUROTOXICOLOGY, V12, P179; Bayer S., 2004, RAT NERVOUS SYSTEM, P27; Bellon A, 2007, MOL PSYCHIATR, V12, P620, DOI 10.1038/sj.mp.4001985; BENES FM, 1991, SCHIZOPHRENIA BULL, V17, P597, DOI 10.1093/schbul/17.4.597; Benes FM, 2001, TRENDS NEUROSCI, V24, P11, DOI 10.1016/S0166-2236(00)01660-X; Bernstein HG, 1998, SCHIZOPHR RES, V33, P125, DOI 10.1016/S0920-9964(98)00071-1; BOGERTS B, 1990, PSYCHIAT RES-NEUROIM, V35, P1; Byne W, 2002, AM J PSYCHIAT, V159, P59, DOI 10.1176/appi.ajp.159.1.59; CANNON TD, 1994, SCHIZOPHRENIA BULL, V20, P89, DOI 10.1093/schbul/20.1.89; Cattabeni F, 1997, PHYSIOL REV, V77, P199, DOI 10.1152/physrev.1997.77.1.199; Ceranik K, 1999, EUR J NEUROSCI, V11, P4278, DOI 10.1046/j.1460-9568.1999.00860.x; Chance SA, 2002, BRIT J PSYCHIAT, V180, P331, DOI 10.1192/bjp.180.4.331; CHRISTISON GW, 1989, ARCH GEN PSYCHIAT, V46, P1027; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; CONRAD AJ, 1991, ARCH GEN PSYCHIAT, V48, P413; Cullen TJ, 2003, SCHIZOPHR RES, V60, P157, DOI 10.1016/S0920-9964(02)00297-9; Danos P, 2005, PSYCHIAT RES-NEUROIM, V140, P281, DOI 10.1016/j.pscychresns.2005.09.005; Danos P, 2003, SCHIZOPHR RES, V60, P141, DOI 10.1016/S0920-9964(02)00307-9; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dorph-Petersen KA, 2004, J COMP NEUROL, V472, P449, DOI 10.1002/cne.20055; Elston GN, 1998, NEUROREPORT, V9, P127, DOI 10.1097/00001756-199801050-00025; FALKAI P, 1986, EUR ARCH PSY CLIN N, V236, P154, DOI 10.1007/BF00380943; FALKAI P, 1988, BIOL PSYCHIAT, V24, P515, DOI 10.1016/0006-3223(88)90162-X; Falkai P, 2000, BIOL PSYCHIAT, V47, P937, DOI 10.1016/S0006-3223(99)00250-4; Falkai PG, 2003, SCHIZOPHR RES, V60, P71, DOI 10.1016/S0920-9964(03)80596-0; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Featherstone RE, 2007, NEUROPSYCHOPHARMACOL, V32, P483, DOI 10.1038/sj.npp.1301223; Fiore M, 1999, NEUROPHARMACOLOGY, V38, P857, DOI 10.1016/S0028-3908(99)00007-6; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Fleming K, 1997, BIOL PSYCHIAT, V41, P43, DOI 10.1016/S0006-3223(96)00263-6; FONNUM F, 1970, J NEUROCHEM, V17, P1029, DOI 10.1111/j.1471-4159.1970.tb02256.x; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; Gourevitch R, 2004, BEHAV PHARMACOL, V15, P287, DOI 10.1097/01.fbp.0000135703.48799.71; Grace AA, 1998, ORIGINS AND DEVELOPMENT OF SCHIZOPHRENIA, P123, DOI 10.1037/10305-005; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; HECKERS S, 1991, ARCH GEN PSYCHIAT, V48, P1002; Highley JR, 2003, BRIT J PSYCHIAT, V183, P414, DOI 10.1192/bjp.183.5.414; Hoffman JR, 1996, J NEUROSCI RES, V46, P349, DOI 10.1002/(SICI)1097-4547(19961101)46:3<349::AID-JNR8>3.0.CO;2-K; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; JAKOB H, 1994, J NEURAL TRANSM-GEN, V98, P83, DOI 10.1007/BF01277013; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; JESTE DV, 1989, ARCH GEN PSYCHIAT, V46, P1019; Jonsson SAT, 1997, EUR ARCH PSY CLIN N, V247, P120; Jonsson SAT, 1999, EUR ARCH PSY CLIN N, V249, P169, DOI 10.1007/s004060050083; Joyal CC, 2002, BIOL PSYCHIAT, V51, P1005, DOI 10.1016/S0006-3223(01)01368-3; KOVELMAN JA, 1984, BIOL PSYCHIAT, V19, P1601; Kreczmanski P, 2007, BRAIN, V130, P678, DOI 10.1093/brain/awl386; Krimer LS, 1997, CEREB CORTEX, V7, P732, DOI 10.1093/cercor/7.8.732; Lauer M, 2003, PSYCHIAT RES-NEUROIM, V122, P89, DOI 10.1016/S0925-4927(02)00122-1; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Le Pen G, 2006, NEUROSCIENCE, V143, P395, DOI 10.1016/j.neuroscience.2006.08.004; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; McDonald AJ, 1997, NEUROSCIENCE, V77, P445, DOI 10.1016/S0306-4522(96)00478-2; Moore H, 2001, SCHIZOPHR RES, V49, P48; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; NAGATA Y, 1969, P SOC EXP BIOL MED, V132, P383; Nelson MD, 1998, ARCH GEN PSYCHIAT, V55, P433, DOI 10.1001/archpsyc.55.5.433; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; PAKKENBERG B, 1992, SCHIZOPHR RES, V7, P95, DOI 10.1016/0920-9964(92)90038-7; PAKKENBERG B, 1990, ARCH GEN PSYCHIAT, V47, P1023; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penschuck S, 2006, EUR J NEUROSCI, V23, P279, DOI 10.1111/j.1460-9568.2005.04536.x; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Popken GJ, 2000, P NATL ACAD SCI USA, V97, P9276, DOI 10.1073/pnas.150243397; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Ruzicka WB, 2007, MOL PSYCHIATR, V12, P385, DOI 10.1038/sj.mp.4001954; Schmitt A, 2009, ACTA NEUROPATHOL, V117, P395, DOI 10.1007/s00401-008-0430-y; Schmitz C, 1999, TRENDS NEUROSCI, V22, P345, DOI 10.1016/S0166-2236(99)01418-6; SCHRODER J, 1995, BRIT J PSYCHIAT, V167, P197, DOI 10.1192/bjp.167.2.197; Schroder J, 1999, NEUROIMAGE, V9, P81, DOI 10.1006/nimg.1998.0387; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Selemon LD, 2002, BIOL PSYCHIAT, V51, P838, DOI 10.1016/S0006-3223(02)01323-9; SELEMON LD, 2002, BIOL PSYCHIAT, V51, P842; Senitz D, 2003, J NEURAL TRANSM, V110, P317, DOI 10.1007/s00702-002-0776-6; Sim K, 2006, SCHIZOPHRENIA BULL, V32, P332, DOI 10.1093/schbul/sbj030; SINGH SC, 1980, ACTA NEUROPATHOL, V49, P193, DOI 10.1007/BF00707106; Strakowski SM, 1999, ARCH GEN PSYCHIAT, V56, P254, DOI 10.1001/archpsyc.56.3.254; Talamini LM, 1998, BRAIN RES, V789, P293, DOI 10.1016/S0006-8993(98)00020-1; Talamini LM, 1999, BRAIN RES, V847, P105, DOI 10.1016/S0006-8993(99)02067-3; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; Thune JJ, 2000, BRAIN RES REV, V31, P200, DOI 10.1016/S0165-0173(99)00038-7; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tochigi M, 2008, BIOL PSYCHIAT, V63, P530, DOI 10.1016/j.biopsych.2007.07.003; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; VANHORN JD, 1992, BRIT J PSYCHIAT, V160, P687, DOI 10.1192/bjp.160.5.687; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Walker MA, 2002, AM J PSYCHIAT, V159, P821, DOI 10.1176/appi.ajp.159.5.821; Wallace CS, 2003, ENVIRON HEALTH PERSP, V111, P1294, DOI 10.1289/ehp.6088; WATANABE M, 1995, BRAIN RES, V670, P173, DOI 10.1016/0006-8993(94)01307-4; WEINBERGER DR, 1983, SCHIZOPHRENIA BULL, V9, P193, DOI 10.1093/schbul/9.2.193; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Wood SJ, 2002, PSYCHOL MED, V32, P429, DOI 10.1017/S0033291702005275; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; WYSS JM, 1981, J COMP NEUROL, V199, P495; Young KA, 2000, BIOL PSYCHIAT, V47, P944, DOI 10.1016/S0006-3223(00)00826-X; Zaidel DW, 1997, AM J PSYCHIAT, V154, P812; Zaidel DW, 1997, PSYCHOL MED, V27, P703, DOI 10.1017/S0033291796004618	118	26	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10291	10.1371/journal.pone.0010291	http://dx.doi.org/10.1371/journal.pone.0010291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421980	Green Submitted, gold, Green Published			2022-12-27	WOS:000276952600010
J	Fanelli, D				Fanelli, Daniele			Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data	PLOS ONE			English	Article							STATISTICAL POWER; PUBLICATION BIAS; METAANALYSIS; MISCONDUCT; ARTICLES; DECISION; QUALITY; ECOLOGY; TRIALS	The growing competition and "publish or perish'' culture in academia might conflict with the objectivity and integrity of research, because it forces scientists to produce "publishable'' results at all costs. Papers are less likely to be published and to be cited if they report "negative'' results (results that fail to support the tested hypothesis). Therefore, if publication pressures increase scientific bias, the frequency of "positive'' results in the literature should be higher in the more competitive and "productive'' academic environments. This study verified this hypothesis by measuring the frequency of positive results in a large random sample of papers with a corresponding author based in the US. Across all disciplines, papers were more likely to support a tested hypothesis if their corresponding authors were working in states that, according to NSF data, produced more academic papers per capita. The size of this effect increased when controlling for state's per capita R&D expenditure and for study characteristics that previous research showed to correlate with the frequency of positive results, including discipline and methodology. Although the confounding effect of institutions' prestige could not be excluded (researchers in the more productive universities could be the most clever and successful in their experiments), these results support the hypothesis that competitive academic environments increase not only scientists' productivity but also their bias. The same phenomenon might be observed in other countries where academic competition and pressures to publish are high.	[Fanelli, Daniele] Univ Edinburgh, INNOGEN, Edinburgh, Midlothian, Scotland; [Fanelli, Daniele] Univ Edinburgh, ISSTI, Edinburgh, Midlothian, Scotland	Innogenetics NV; University of Edinburgh; University of Edinburgh	Fanelli, D (corresponding author), Univ Edinburgh, INNOGEN, Edinburgh, Midlothian, Scotland.	dfanelli@staffmail.ed.ac.uk		Fanelli, Daniele/0000-0003-1780-1958	Marie Curie Intra-European Fellowship [PIEF-GA-2008-221441]; ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	Marie Curie Intra-European Fellowship(European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was entirely supported by a Marie Curie Intra-European Fellowship (Grant Agreement Number PIEF-GA-2008-221441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; Anderson MS, 2007, J EMPIR RES HUM RES, V2, P3, DOI 10.1525/jer.2007.2.4.3; ANDERSON MS, 1994, J HIGH EDUC, V65, P330, DOI 10.2307/2943971; [Anonymous], 2005, HIGHER ED EUROPE; BABBAGE C, 1830, WORKS C BABBAGE LOND; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Breau RH, 2006, J UROLOGY, V176, P263, DOI 10.1016/S0022-5347(06)00505-2; Brock JKU, 2003, J INT BUS STUD, V34, P90, DOI 10.1057/palgrave.jibs.8400006; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Csada RD, 1996, OIKOS, V76, P591, DOI 10.2307/3546355; Davis MS, 2007, SCI ENG ETHICS, V13, P395, DOI 10.1007/s11948-007-9045-2; De Vries R, 2006, J EMPIR RES HUM RES, V1, P43, DOI 10.1525/jer.2006.1.1.43; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Dyba T, 2006, INFORM SOFTWARE TECH, V48, P745, DOI 10.1016/j.infsof.2005.08.009; Etter JF, 2009, J CLIN EPIDEMIOL, V62, P831, DOI 10.1016/j.jclinepi.2008.09.015; FANELLI D, 2010, PLOS ONE IN PRESS; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Feller I, 1996, COMPETITIVENESS ACAD, P35; Florian RV, 2007, SCIENTOMETRICS, V72, P25, DOI 10.1007/s11192-007-1712-1; Gerber AS, 2008, SOCIOL METHOD RES, V37, P3, DOI 10.1177/0049124108318973; Gigerenzer G., 1990, EMPIRE CHANCE PROBAB; Giles J, 2007, NATURE, V445, P242; Hopewell S., 2007, COCHRANE DATABASE SY; Ioannidis JP, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-30; Jennions MD, 2003, BEHAV ECOL, V14, P438, DOI 10.1093/beheco/14.3.438; Jennions MD, 2002, BIOL REV, V77, P211, DOI 10.1017/S1464793101005875; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kjaergard LL, 2002, J CLIN EPIDEMIOL, V55, P407, DOI 10.1016/S0895-4356(01)00513-3; Kline R., 2004, SIGNIFICANCE TESTING; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; LOUIS KS, 1995, REV HIGH EDUC, V18, P393, DOI 10.1353/rhe.1995.0007; Maddock JE, 2001, HEALTH PSYCHOL, V20, P76, DOI 10.1037/027-6133.20.1.76; MAHONEY MJ, 1979, SOC STUD SCI, P3; Marsh DM, 2007, ETHOLOGY, V113, P1089, DOI 10.1111/j.1439-0310.2007.01406.x; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Mookerjee R, 2006, ECON LETT, V91, P395, DOI 10.1016/j.econlet.2005.12.020; Murtaugh PA, 2002, ECOLOGY, V83, P1162, DOI 10.2307/3071921; National Science Board, 2006, 0601 NSB; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Rosenthal, 1976, EXPT EFFECTS BEHAV R; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Shakiba B, 2008, ARCH IRAN MED, V11, P257, DOI 08113/AIM.005; Shapin S., 2008, SCI LIFE MORAL HIST; Song F., 2000, HLTH TECHNOLOGY ASSE, V4; STERLING TD, 1995, AM STAT, V49, P108, DOI 10.2307/2684823; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yousefi-Nooraie Reza, 2006, BMC Med Res Methodol, V6, P37, DOI 10.1186/1471-2288-6-37	49	349	353	2	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10271	10.1371/journal.pone.0010271	http://dx.doi.org/10.1371/journal.pone.0010271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YS	20422014	Green Published, gold			2022-12-27	WOS:000276952500026
J	Heath, L; Conway, S; Jones, L; Semrau, K; Nakamura, K; Walter, J; Decker, WD; Hong, J; Chen, T; Heil, M; Sinkala, M; Kankasa, C; Thea, DM; Kuhn, L; Mullins, JI; Aldrovandi, GM				Heath, Laura; Conway, Susan; Jones, Laura; Semrau, Katherine; Nakamura, Kyle; Walter, Jan; Decker, W. Don; Hong, Jason; Chen, Thomas; Heil, Marintha; Sinkala, Moses; Kankasa, Chipepo; Thea, Donald M.; Kuhn, Louise; Mullins, James I.; Aldrovandi, Grace M.			Restriction of HIV-1 Genotypes in Breast Milk Does Not Account for the Population Transmission Genetic Bottleneck That Occurs following Transmission	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; CD8(+) T-CELLS; SUBTYPE-C; ANTIRETROVIRAL THERAPY; SELECTIVE TRANSMISSION; SEQUENCE ALIGNMENT; PERIPHERAL-BLOOD; ENVELOPE PROTEIN; GENITAL-TRACT	Background: Breast milk transmission of HIV-1 remains a major route of pediatric infection. Defining the characteristics of viral variants to which breastfeeding infants are exposed is important for understanding the genetic bottleneck that occurs in the majority of mother-to-child transmissions. The blood-milk epithelial barrier markedly restricts the quantity of HIV-1 in breast milk, even in the absence of antiretroviral drugs. The basis of this restriction and the genetic relationship between breast milk and blood variants are not well established. Methodology/Principal Findings: We compared 356 HIV-1 subtype C gp160 envelope (env) gene sequences from the plasma and breast milk of 13 breastfeeding women. A trend towards lower viral population diversity and divergence in breast milk was observed, potentially indicative of clonal expansion within the breast. No differences in potential N-linked glycosylation site numbers or in gp160 variable loop amino acid lengths were identified. Genetic compartmentalization was evident in only one out of six subjects in whom contemporaneously obtained samples were studied. However, in samples that were collected 10 or more days apart, six of seven subjects were classified as having compartmentalized viral populations, highlighting the necessity of contemporaneous sampling for genetic compartmentalization studies. We found evidence of CXCR4 co-receptor using viruses in breast milk and blood in nine out of the thirteen subjects, but no evidence of preferential localization of these variants in either tissue. Conclusions/Significance: Despite marked restriction of HIV-1 quantities in milk, our data indicate intermixing of virus between blood and breast milk. Thus, we found no evidence that a restriction in viral genotype diversity in breast milk accounts for the genetic bottleneck observed following transmission. In addition, our results highlight the rapidity of HIV-1 env evolution and the importance of sample timing in analyses of gene flow.	[Heath, Laura; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Conway, Susan; Jones, Laura; Nakamura, Kyle; Walter, Jan; Decker, W. Don; Hong, Jason; Chen, Thomas; Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Semrau, Katherine; Thea, Donald M.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Nakamura, Kyle] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Heil, Marintha] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Sinkala, Moses] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Kankasa, Chipepo] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia; [Kuhn, Louise] Columbia Univ, New York, NY USA; [Mullins, James I.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Children's Hospital Los Angeles; Boston University; University of Southern California; University of Alabama System; University of Alabama Birmingham; University of Zambia; Columbia University; University of Washington; University of Washington Seattle	Heath, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	galdrovandi@chla.usc.edu		Thea, Donald/0000-0002-6933-1030; Walter, Jan/0000-0003-2247-5560; Hong, Jason/0000-0002-5062-8926; Semrau, Katherine/0000-0002-8360-1391	National Institute of Child Health and Human Development (NICHD); National Institutes of Health (NIH) [R01 HD 39611, R01 HD 40777]; International Maternal Pediatric Adolescent AIDS Clinical Trials Group [U01 AI068632-01]; National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program [T 32 067587]; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039611, R01HD040777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757, U01AI068632] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grants from the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) (R01 HD 39611 and R01 HD 40777) and the International Maternal Pediatric Adolescent AIDS Clinical Trials Group U01 AI068632-01. KJN was supported by the National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program Grant T 32 067587. GMA is a recipient of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Andreotti M, 2009, AIDS RES HUM RETROV, V25, P707, DOI 10.1089/aid.2008.0276; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Becquart P, 2002, VIROLOGY, V300, P109, DOI 10.1006/viro.2002.1537; Becquart P, 1999, AIDS, V13, P1323, DOI 10.1097/00002030-199907300-00008; Becquart P, 2007, VIROLOGY, V363, P256, DOI 10.1016/j.virol.2007.02.003; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Bull ME, 2009, J VIROL, V83, P6020, DOI 10.1128/JVI.02664-08; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Connell BJ, 2008, AIDS, V22, P896, DOI 10.1097/QAD.0b013e3282f57f7a; Critchlow DE, 2000, MATH COMPUT MODEL, V32, P69, DOI 10.1016/S0895-7177(00)00120-5; Delobel P, 2005, AIDS, V19, P1739, DOI 10.1097/01.aids.0000183125.93958.26; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Diem K, 2008, AIDS RES HUM RETROV, V24, P561, DOI 10.1089/aid.2007.0115; Dyer JR, 1996, J VIROL METHODS, V60, P161, DOI 10.1016/0166-0934(96)02063-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28; Esparza J, 2005, INT MICROBIOL, V8, P93; Fowler MG, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.06.048; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Fulcher JA, 2004, J VIROL, V78, P7883, DOI 10.1128/JVI.78.15.7883-7893.2004; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Ghosh MK, 2003, J CLIN MICROBIOL, V41, P2465, DOI 10.1128/JCM.41.6.2465-2470.2003; Gilbert PB, 2005, BIOMETRICS, V61, P106, DOI 10.1111/j.0006-341X.2005.020719.x; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habte HH, 2008, NEONATOLOGY, V93, P162, DOI 10.1159/000108414; Haddad DN, 2000, AIDS, V14, P2273, DOI 10.1097/00002030-200010200-00008; Heath L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006949; Henderson GJ, 2004, VIROLOGY, V330, P295, DOI 10.1016/j.virol.2004.09.004; Hudson RR, 2000, GENETICS, V155, P2011; ITESCU S, 1994, P NATL ACAD SCI USA, V91, P11378, DOI 10.1073/pnas.91.24.11378; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kourtis AP, 2003, LANCET INFECT DIS, V3, P786, DOI 10.1016/S1473-3099(03)00832-6; KUHN L, 2008, N ENGL J MED; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Nakamura KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009786; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; NEVILLE MC, 1991, AM J CLIN NUTR, V54, P81, DOI 10.1093/ajcn/54.1.81; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Permar SR, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-7; Philpott S, 2005, J VIROL, V79, P353, DOI 10.1128/JVI.79.1.353-363.2005; Pillai SK, 2006, BRAIN, V129, P1872, DOI 10.1093/brain/awl136; Pisoni G, 2007, VIROLOGY, V369, P119, DOI 10.1016/j.virol.2007.06.021; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Sabbaj S, 2005, J IMMUNOL, V174, P2951, DOI 10.4049/jimmunol.174.5.2951; Sabbaj S, 2002, J VIROL, V76, P7365, DOI 10.1128/JVI.76.15.7365-7373.2002; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Semba RD, 1999, CLIN DIAGN LAB IMMUN, V6, P671, DOI 10.1128/CDLI.6.5.671-674.1999; Semrau K, 2008, JAIDS-J ACQ IMM DEF, V47, P320, DOI 10.1097/QAI.0b013e31815e7436; Thea DM, 2004, CONTROL CLIN TRIALS, V25, P353, DOI 10.1016/j.cct.2004.06.005; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	74	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10213	10.1371/journal.pone.0010213	http://dx.doi.org/10.1371/journal.pone.0010213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422033	Green Published, gold, Green Submitted			2022-12-27	WOS:000276854300002
J	Puri, S; Faulkes, Z				Puri, Sakshi; Faulkes, Zen			Do Decapod Crustaceans Have Nociceptors for Extreme pH?	PLOS ONE			English	Article							PAIN EXPERIENCE; CRAYFISH; DROSOPHILA; NEURONS; EVOLUTIONARY; INNERVATION; MORPHOLOGY; PHYLOGENY; RECEPTORS; BEHAVIOR	Background: Nociception is the physiological detection of noxious stimuli. Because of its obvious importance, nociception is expected to be widespread across animal taxa and to trigger robust behaviours reliably. Nociception in invertebrates, such as crustaceans, is poorly studied. Methodology/Principal Findings: Three decapod crustacean species were tested for nociceptive behaviour: Louisiana red swamp crayfish (Procambarus clarkii), white shrimp (Litopenaeus setiferus), and grass shrimp (Palaemonetes sp.). Applying sodium hydroxide, hydrochloric acid, or benzocaine to the antennae caused no change in behaviour in the three species compared to controls. Animals did not groom the stimulated antenna, and there was no difference in movement of treated individuals and controls. Extracellular recordings of antennal nerves in P. clarkii revealed continual spontaneous activity, but no neurons that were reliably excited by the application of concentrated sodium hydroxide or hydrochloric acid. Conclusions/Significance: Previously reported responses to extreme pH are either not consistently evoked across species or were mischaracterized as nociception. There was no behavioural or physiological evidence that the antennae contained specialized nociceptors that responded to pH.	[Puri, Sakshi; Faulkes, Zen] Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78541 USA	University of Texas System; University of Texas Rio Grande Valley	Puri, S (corresponding author), Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78541 USA.	zfaulkes@utpa.edu	Faulkes, Zen/A-5777-2009	Faulkes, Zen/0000-0003-4049-7034	Howard Hughes Medical Undergraduate Science Education Program [52006321]; University of Texas-Pan American	Howard Hughes Medical Undergraduate Science Education Program; University of Texas-Pan American	S. P. was supported by Howard Hughes Medical Undergraduate Science Education Program grant (#52006321) and an Undergraduate Research Initiative grant from The University of Texas-Pan American. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2004, RAFFLES B ZOOL, V52, P673; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Appel M, 2009, ANIM BEHAV, V78, P1373, DOI 10.1016/j.anbehav.2009.09.008; Appel M, 2009, APPL ANIM BEHAV SCI, V119, P120, DOI 10.1016/j.applanim.2009.03.013; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Atwood HL, 1982, BIOL CRUSTACEA, V3; Barr S, 2008, ANIM BEHAV, V75, P745, DOI 10.1016/j.anbehav.2007.07.004; Basil J, 2000, ETHOLOGY, V106, P247, DOI 10.1046/j.1439-0310.2000.00524.x; BAUER R T, 1981, Journal of Crustacean Biology, V1, P153, DOI 10.2307/1548154; BAUER RT, 1978, MAR BIOL, V49, P69, DOI 10.1007/BF00390731; Bauer RT, 2002, AQUACULTURE, V208, P39, DOI 10.1016/S0044-8486(01)00794-3; BAUER RT, 1975, ZOOL J LINN SOC-LOND, V56, P45, DOI 10.1111/j.1096-3642.1975.tb00810.x; Elwood RW, 2009, APPL ANIM BEHAV SCI, V118, P128, DOI 10.1016/j.applanim.2009.02.018; Elwood RW, 2009, ANIM BEHAV, V77, P1243, DOI 10.1016/j.anbehav.2009.01.028; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Illich PA, 1997, J NEUROSCI, V17, P459, DOI 10.1523/JNEUROSCI.17-01-00459.1997; Immke DC, 2006, SEMIN CELL DEV BIOL, V17, P582, DOI 10.1016/j.semcdb.2006.09.004; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; KAVALIERS M, 1988, BRAIN RES BULL, V21, P923, DOI 10.1016/0361-9230(88)90030-5; Kawai N, 2004, BEHAV BRAIN RES, V150, P229, DOI 10.1016/S0166-4328(03)00261-4; KOCH LM, 2006, J EXPT BIOL, V209; LAMOTTE RH, 1992, J PHYSIOL-LONDON, V448, P749, DOI 10.1113/jphysiol.1992.sp019068; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lewin GR, 2004, CURR OPIN NEUROBIOL, V14, P443, DOI 10.1016/j.conb.2004.07.009; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; Pastor J, 1996, J NEUROPHYSIOL, V75, P2268, DOI 10.1152/jn.1996.75.6.2268; PAUL DH, 1986, J COMP PHYSIOL A, V158, P215, DOI 10.1007/BF01338564; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Puri S, 2009, INTEGR COMP BIOL, V49, pE139; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; SANDEMAN DC, 1989, J EXP BIOL, V141, P197; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; SCHOLTZ G, 1995, ZOOL J LINN SOC-LOND, V113, P289, DOI 10.1006/zjls.1995.0011; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2004, BRAIN RES REV, V46, P123, DOI 10.1016/j.brainresrev.2004.07.007; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; WESTON KM, 1984, J PHARMACOL METHOD, V12, P285, DOI 10.1016/0160-5402(84)90014-7; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477	45	21	21	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10244	10.1371/journal.pone.0010244	http://dx.doi.org/10.1371/journal.pone.0010244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422026	gold, Green Published, Green Submitted			2022-12-27	WOS:000276854300010
J	Arciero, JC; Ermentrout, GB; Upperman, JS; Vodovotz, Y; Rubin, JE				Arciero, Julia C.; Ermentrout, G. Bard; Upperman, Jeffrey S.; Vodovotz, Yoram; Rubin, Jonathan E.			Using a Mathematical Model to Analyze the Role of Probiotics and Inflammation in Necrotizing Enterocolitis	PLOS ONE			English	Article							BARRIER FUNCTION; PRETERM INFANTS; PATHOPHYSIOLOGY; DANGER; SEPSIS; MILK	Background: Necrotizing enterocolitis (NEC) is a severe disease of the gastrointestinal tract of pre-term babies and is thought to be related to the physiological immaturity of the intestine and altered levels of normal flora in the gut. Understanding the factors that contribute to the pathology of NEC may lead to the development of treatment strategies aimed at re-establishing the integrity of the epithelial wall and preventing the propagation of inflammation in NEC. Several studies have shown a reduced incidence and severity of NEC in neonates treated with probiotics ( beneficial bacteria species). Methodology/Principal Findings: The objective of this study is to use a mathematical model to predict the conditions under which probiotics may be successful in promoting the health of infants suffering from NEC. An ordinary differential equation model is developed that tracks the populations of pathogenic and probiotic bacteria in the intestinal lumen and in the blood/tissue region. The permeability of the intestinal epithelial layer is treated as a variable, and the role of the inflammatory response is included. The model predicts that in the presence of probiotics health is restored in many cases that would have been otherwise pathogenic. The timing of probiotic administration is also shown to determine whether or not health is restored. Finally, the model predicts that probiotics may be harmful to the NEC patient under very specific conditions, perhaps explaining the detrimental effects of probiotics observed in some clinical studies. Conclusions/Significance: The reduced, experimentally motivated mathematical model that we have developed suggests how a certain general set of characteristics of probiotics can lead to beneficial or detrimental outcomes for infants suffering from NEC, depending on the influences of probiotics on defined features of the inflammatory response.	[Arciero, Julia C.; Ermentrout, G. Bard; Rubin, Jonathan E.] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Upperman, Jeffrey S.] Univ So Calif, Dept Surg, Los Angeles, CA USA; [Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Arciero, JC (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	jarciero@pitt.edu	RUBIN, JONATHAN/AAD-9071-2019	Rubin, Jonathan/0000-0002-1513-1551	National Science Foundation [EMSW21-RTG 0739261]; National Institutes of Health [P50-GM-53789]; Division Of Mathematical Sciences [0739261] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant EMSW21-RTG 0739261 (http://www.nsf.gov/) and National Institutes of Health Grant P50-GM-53789 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlFaleh K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005496.pub2, 10.1097/AOG.0b013e3181726f2f]; AN G, 2009, WIRES IN PRESS; An G, 2008, J BURN CARE RES, V29, P277, DOI 10.1097/BCR.0b013e31816677c8; Barclay AR, 2007, J PEDIATR GASTR NUTR, V45, P569, DOI 10.1097/MPG.0b013e3181344694; Bewick S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008112; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Garcia-Lafuente A, 2001, GUT, V48, P503, DOI 10.1136/gut.48.4.503; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Guner YS, 2009, J SURG RES, V157, P21, DOI 10.1016/j.jss.2008.11.008; Hammerman C, 2006, CURR OPIN INFECT DIS, V19, P277, DOI 10.1097/01.qco.0000224823.73223.29; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3; Hunter CJ, 2008, PEDIATR RES, V63, P117, DOI 10.1203/PDR.0b013e31815ed64c; Hunter CJ, 2009, INFECT IMMUN, V77, P1031, DOI 10.1128/IAI.01192-08; Kennedy RJ, 2002, GUT, V50, P441, DOI 10.1136/gut.50.3.441; Koffeman GI, 2003, BEST PRACT RES CL GA, V17, P879, DOI 10.1016/S1521-6918(03)00099-4; KOSLOSKE AM, 1980, ANN SURG, V192, P202, DOI 10.1097/00000658-198008000-00013; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Kumar R, 2008, SHOCK, V29, P104, DOI 10.1097/SHK.0b013e318067da56; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; Mattar AF, 2001, PEDIATR SURG INT, V17, P265, DOI 10.1007/s003830100591; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Millar M, 2003, ARCH DIS CHILD-FETAL, V88, pF354, DOI 10.1136/fn.88.5.F354; Petty John K, 2005, Semin Pediatr Surg, V14, P191, DOI 10.1053/j.sempedsurg.2005.05.009; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; RICKETTS RR, 1990, WORLD J SURG, V14, P600, DOI 10.1007/BF01658800; Schanler RJ, 2001, PEDIATR CLIN N AM, V48, P207, DOI 10.1016/S0031-3955(05)70295-9; Szajewska H, 2006, J PEDIATR GASTR NUTR, V42, P454, DOI 10.1097/01.mpg.0000221913.88511.72; VODOVOTZ Y, 2009, IMMUNOTOXIC IN PRESS; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014	42	38	39	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10066	10.1371/journal.pone.0010066	http://dx.doi.org/10.1371/journal.pone.0010066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419099	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000276853800004
J	Elnaccash, TW; Tonsor, SJ				Elnaccash, Tarek W.; Tonsor, Stephen J.			Something Old and Something New: Wedding Recombinant Inbred Lines with Traditional Line Cross Analysis Increases Power to Describe Gene Interactions	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; POPULATION DIFFERENTIATION; EPISTASIS; EVOLUTION; SELECTION; SUSCEPTIBILITY; SPECIATION; ADAPTATION; COMPONENTS; PATTERNS	In this paper we present a novel approach to quantifying genetic architecture that combines recombinant inbred lines (RIL) with line cross analysis (LCA). LCA is a method of quantifying directional genetic effects (i.e. summed effects of all loci) that differentiate two parental lines. Directional genetic effects are thought to be critical components of genetic architecture for the long term response to selection and as a cause of inbreeding depression. LCA typically begins with two inbred parental lines that are crossed to produce several generations such as F1, F2, and backcrosses to each parent. When a RIL population (founded from the same P1 and P2 as was used to found the line cross population) is added to the LCA, the sampling variance of several nonadditive genetic effect estimates is greatly reduced. Specifically, estimates of directional dominance, additive x additive, and dominance x dominance epistatic effects are reduced by 92%, 94%, and 56% respectively. The RIL population can be simultaneously used for QTL identification, thus uncovering the effects of specific loci or genomic regions as elements of genetic architecture. LCA and QTL mapping with RIL provide two qualitatively different measures of genetic architecture with the potential to overcome weaknesses of each approach alone. This approach provides cross-validation of the estimates of additive and additive x additive effects, much smaller confidence intervals on dominance, additive x additive and dominance x dominance estimates, qualitatively different measures of genetic architecture, and the potential when used together to balance the weaknesses of LCA or RIL QTL analyses when used alone.	[Elnaccash, Tarek W.; Tonsor, Stephen J.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Elnaccash, TW (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	Tarek.Elnaccash@gmail.com		Elnaccash, Tarek/0000-0002-2129-9529	National Science Foundation [DEB-0130347, IOS-0809171, K-12 038135]; Leroy K. Irvis Fund of the University of Pittsburgh	National Science Foundation(National Science Foundation (NSF)); Leroy K. Irvis Fund of the University of Pittsburgh	The work was supported by National Science Foundation grants DEB-0130347 and IOS-0809171 to SJT, the Leroy K. Irvis Fund of the University of Pittsburgh and an National Science Foundation Grade K-12 038135 Fellowship to TWE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankra-Badu GA, 2009, INT J OBESITY, V33, P89, DOI 10.1038/ijo.2008.215; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Beavis William D., 1998, P145; BRADSHAW WE, 2000, EPISTASIS EVOLUTIONA; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; COCKERHAM CC, 1954, GENETICS, V39, P859; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Demuth JP, 2007, EVOLUTION, V61, P494, DOI 10.1111/j.1558-5646.2007.00048.x; Demuth JP, 2006, ANNU REV ECOL EVOL S, V37, P289, DOI 10.1146/annurev.ecolsys.37.091305.110124; Demuth JP, 2007, EVOLUTION, V61, P694, DOI 10.1111/j.1558-5646.2007.00049.x; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; Dobzhansky T., 1937; Dudley JW, 2007, CROP SCI, V47, pS20, DOI 10.2135/cropsci2007.04.0003IPBS; Dudley JW, 2008, CROP SCI, V48, P59, DOI 10.2135/cropsci2007.04.0242; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Erickson DL, 2006, EVOLUTION, V60, P225, DOI 10.1111/j.0014-3820.2006.tb01101.x; Fenster CB, 2000, EVOLUTION, V54, P1157, DOI 10.1111/j.0014-3820.2000.tb00551.x; FITSPATRICK BAM, 2008, AM NAT, V171, P491; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; Hallander J, 2007, HEREDITY, V98, P349, DOI 10.1038/sj.hdy.6800946; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; HAYMAN BI, 1955, BIOMETRICS, V11, P69, DOI 10.2307/3001481; Keightley P. D., 2004, Plant Breeding Reviews, V24, P227; Kelly JK, 2005, GENETICS, V171, P1917, DOI 10.1534/genetics.105.041525; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; Lopez-Fernandez H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001294; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Lynch M., 1998, GENETICS ANAL QUANTI; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Porter AH, 2002, EVOLUTION, V56, P2103; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roff DA, 2006, EVOLUTION, V60, P1981, DOI 10.1111/j.0014-3820.2006.tb01836.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Sun Z, 2006, PLANT BREEDING, V125, P277, DOI 10.1111/j.1439-0523.2006.01224.x; Tonsor SJ, 2005, PLANT CELL ENVIRON, V28, P2, DOI 10.1111/j.1365-3040.2004.01264.x; Wade MJ, 2000, EPISTASIS EVOLUTIONA, P213; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wegner KM, 2008, EVOLUTION, V62, P2381, DOI 10.1111/j.1558-5646.2008.00444.x; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wiltshire S, 2006, ANN HUM GENET, V70, P726, DOI 10.1111/j.1469-1809.2006.00289.x; *WOLFR RES INC, MATH VERS 6 0; Xu SZ, 2003, GENETICS, V165, P2259; Zeng ZB, 1999, GENET RES, V74, P279, DOI 10.1017/S0016672399004255	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10200	10.1371/journal.pone.0010200	http://dx.doi.org/10.1371/journal.pone.0010200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419131	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000276743500013
J	Molins, CR; Delorey, MJ; Yockey, BM; Young, JW; Sheldon, SW; Reese, SM; Schriefer, ME; Petersen, JM				Molins, Claudia R.; Delorey, Mark J.; Yockey, Brook M.; Young, John W.; Sheldon, Sarah W.; Reese, Sara M.; Schriefer, Martin E.; Petersen, Jeannine M.			Virulence Differences Among Francisella tularensis Subsp tularensis Clades in Mice	PLOS ONE			English	Article							TULAREMIA; STRAINS	Francisella tularensis subspecies tularensis (type A) and holarctica (type B) are of clinical importance in causing tularemia. Molecular typing methods have further separated type A strains into three genetically distinct clades, A1a, A1b and A2. Epidemiological analyses of human infections in the United States suggest that A1b infections are associated with a significantly higher mortality rate as compared to infections caused by A1a, A2 and type B. To determine if genetic differences as defined by molecular typing directly correlate with differences in virulence, A1a, A1b, A2 and type B strains were compared in C57BL/6 mice. Here we demonstrate significant differences between survival curves for infections caused by A1b versus A1a, A2 and type B, with A1b infected mice dying earlier than mice infected with A1a, A2 or type B; these results were conserved among multiple strains. Differences were also detected among type A clades as well as between type A clades and type B with respect to bacterial burdens, and gross anatomy in infected mice. Our results indicate that clades defined within F. tularensis subsp. tularensis by molecular typing methods correlate with virulence differences, with A1b strains more virulent than A1a, A2 and type B strains. These findings indicate type A strains are not equivalent with respect to virulence and have important implications for public health as well as basic research programs.	[Molins, Claudia R.; Delorey, Mark J.; Yockey, Brook M.; Young, John W.; Sheldon, Sarah W.; Reese, Sara M.; Schriefer, Martin E.; Petersen, Jeannine M.] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA	Molins, CR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA.	JPetersen@cdc.gov			American Society for Microbiology and Coordinating Center; Association of Public Health Laboratories	American Society for Microbiology and Coordinating Center; Association of Public Health Laboratories	Claudia R. Molins was funded by the American Society for Microbiology and Coordinating Center for Infectious Diseases as a postdoctoral fellow. Sara M. Reese is an Emerging Infectious Disease Research Fellow funded by the Association of Public Health Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Del Blanco NG, 2002, J CLIN MICROBIOL, V40, P2964, DOI 10.1128/JCM.40.8.2964-2972.2002; DOWNS CM, 1949, J IMMUNOL, V63, P147; DOWNS CM, 1947, J IMMUNOL, V56, P217; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Jellison WL, 1961, WILDLIFE DISEASE, V17, P1; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lee E, 2013, STAT METHODS SURVIVA; Molins-Schneekloth CR, 2008, APPL ENVIRON MICROB, V74, P336, DOI 10.1128/AEM.01522-07; National Research Council, 1996, GUIDE CARE USE LAB A, P1; OLSUFIEV N. G., 1959, JOUR HYG EPIDEMIOL MICROBIOL AND IMMUNOL, V3, P138; OLSUFJEV NG, 1982, J HYG EPID MICROB IM, V26, P291; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; SJOSTEDT AB, 2005, PROTEOBACTERIA B, V2, P200; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004	24	43	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10205	10.1371/journal.pone.0010205	http://dx.doi.org/10.1371/journal.pone.0010205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419133	Green Submitted, gold, Green Published			2022-12-27	WOS:000276743500015
J	Rodriguez-Rojas, A; Macia, MD; Couce, A; Gomez, C; Castaneda-Garcia, A; Oliver, A; Blazquez, J				Rodriguez-Rojas, Alexandro; Macia, Maria D.; Couce, Alejandro; Gomez, Cristina; Castaneda-Garcia, Alfredo; Oliver, Antonio; Blazquez, Jesus			Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PLANKTONIC CULTURES; URINARY-TRACT; MULTIPLE; STRAINS; IMMUNIZATION; CEFTAZIDIME; EXPRESSION	Background: Fosfomycin is a cell wall inhibitor used efficiently to treat uncomplicated urinary tract and gastrointestinal infections. A very convenient feature of fosfomycin, among others, is that although the expected frequency of resistant mutants is high, the biological cost associated with mutation impedes an effective growth rate, and bacteria cannot offset the obstacles posed by host defenses or compete with sensitive bacteria. Due to the current scarcity of new antibiotics, fosfomycin has been proposed as an alternative treatment for other infections caused by a wide variety of bacteria, particularly Pseudomonas aeruginosa. However, whether fosfomycin resistance in P. aeruginosa provides a fitness cost still remains unknown. Principal Findings: We herein present experimental evidence to show that fosfomycin resistance cannot only emerge easily during treatment, but that it is also cost-free for P. aeruginosa. We also tested if, as has been reported for other species such as Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis, fosfomycin resistant strains are somewhat compromised in their virulence. As concerns colonization, persistence, lung damage, and lethality, we found no differences between the fosfomycin resistant mutant and its sensitive parental strain. The probability of acquisition in vitro of resistance to the combination of fosfomycin with other antibiotics ( tobramycin and imipenem) has also been studied. While the combination of fosfomycin with tobramycin makes improbable the emergence of resistance to both antibiotics when administered together, the combination of fosfomycin plus imipenem does not avoid the appearance of mutants resistant to both antibiotics. Conclusions: We have reached the conclusion that the use of fosfomycin for P. aeruginosa infections, even in combined therapy, might not be as promising as expected. This study should encourage the scientific community to assess the in vivo cost of resistance for specific antibiotic-bacterial species combinations, and therefore avoid reaching universal conclusions from single model organisms.	[Rodriguez-Rojas, Alexandro; Couce, Alejandro; Castaneda-Garcia, Alfredo; Blazquez, Jesus] CSIC, CNB, Madrid, Spain; [Macia, Maria D.; Oliver, Antonio] IUNICS, Hosp Son Dureta, Microbiol Serv, Palma de Mallorca, Spain; [Macia, Maria D.; Oliver, Antonio] IUNICS, Hosp Son Dureta, Unidad Invest, Palma de Mallorca, Spain; [Gomez, Cristina] Hosp Son Dureta, Serv Anat Patol, Palma de Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Dureta	Rodriguez-Rojas, A (corresponding author), CSIC, CNB, Madrid, Spain.	arrojas@cnb.csic.es; blazquez@cnb.csic.es	Oliver, Antonio/V-5541-2019; IBIS, EVOLUCION/O-1921-2015; Rodríguez-Rojas, Alexandro/AAO-6084-2021; CastaÃeda, Alfredo/AAQ-5815-2020; Blazquez, Jesus/T-4680-2017; Castaneda, Alfredo/ABF-5497-2020; Oliver, Antonio/E-4048-2012	Oliver, Antonio/0000-0001-9327-1894; Rodríguez-Rojas, Alexandro/0000-0002-4119-8127; CastaÃeda, Alfredo/0000-0002-1441-6125; Blazquez, Jesus/0000-0003-0495-3848; Oliver, Antonio/0000-0001-9327-1894; Couce, Alejandro/0000-0002-4153-6018; Macia, Maria Dolores/0000-0001-5038-1356	Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III;  [PI070215]	Spanish Network for Research in Infectious Diseases; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); 	Grants PI070215 and the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), both from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos JI, 2007, REV ESP QUIM, V20, P211; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Blanc Dominique S., 1998, Clin Microbiol Infect, V4, P242; Castaneda-Garcia A, 2009, J BACTERIOL, V191, P6968, DOI 10.1128/JB.00748-09; CHIN NX, 1986, DRUG EXP CLIN RES, V12, P943; *CLSI, 2006, CLSI METH DIL ANT SU; CORDARO JC, 1976, J BACTERIOL, V128, P785, DOI 10.1128/JB.128.3.785-793.1976; DiGiandomenico A, 2007, P NATL ACAD SCI USA, V104, P4624, DOI 10.1073/pnas.0608657104; Falagas ME, 2008, EXPERT REV ANTI-INFE, V6, P593, DOI 10.1586/14787210.6.5.593; Falagas ME, 2008, CLIN INFECT DIS, V46, P1069, DOI 10.1086/527442; Falagas ME, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.10.021; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; GISMONDO MR, 1994, J CHEMOTHERAPY, V6, P167; HAAG R, 1981, IMMUN INFEKT, V9, P177; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; JOHANSEN HK, 1994, INFECT IMMUN, V62, P3146, DOI 10.1128/IAI.62.8.3146-3155.1994; JONES ME, 1994, GENETICS, V136, P1209; KADNER RJ, 1973, J BACTERIOL, V113, P895, DOI 10.1128/JB.113.2.895-900.1973; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kawaguchi K, 2002, BIOL PHARM BULL, V25, P1658, DOI 10.1248/bpb.25.1658; KLEIN U, 1985, CHEMOTHERAPY, V31, P138, DOI 10.1159/000238326; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lemieux MJ, 2004, RES MICROBIOL, V155, P623, DOI 10.1016/j.resmic.2004.05.016; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Marchese A, 2003, INT J ANTIMICROB AG, V22, pS53, DOI 10.1016/S0924-8579(03)00230-9; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Moya B, 2008, ANTIMICROB AGENTS CH, V52, P3694, DOI 10.1128/AAC.00172-08; Mueller-Ortiz SL, 2004, INFECT IMMUN, V72, P2899, DOI 10.1128/IAI.72.5.2899-2906.2004; Nilsson AI, 2003, ANTIMICROB AGENTS CH, V47, P2850, DOI 10.1128/AAC.47.9.2850-2858.2003; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OLAY T, 1978, J ANTIMICROB CHEMOTH, V4, P569, DOI 10.1093/jac/4.6.569; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P712, DOI 10.1093/jac/dkp288; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Rodriguez-Rojas A, 2009, J BACTERIOL, V191, P844, DOI 10.1128/JB.01081-08; SCHINDLER J, 1979, ZBL BAKT-INT J MED M, V243, P136; Schweizer HP, 1996, J BACTERIOL, V178, P5215, DOI 10.1128/jb.178.17.5215-5221.1996; Shorr AF, 2009, CRIT CARE MED, V37, P1463, DOI 10.1097/CCM.0b013e31819ced02; STRATEVA T, 2009, J MED MICROBIOL; SUAREZ JE, 1991, ANTIMICROB AGENTS CH, V35, P791, DOI 10.1128/AAC.35.5.791; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Tessier F, 1997, EUR J CLIN MICROBIOL, V16, P159, DOI 10.1007/BF01709477; TSURUOKA T, 1978, J ANTIBIOT, V31, P192, DOI 10.7164/antibiotics.31.192; Visalli MA, 1998, ANTIMICROB AGENTS CH, V42, P953, DOI 10.1128/AAC.42.4.953; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Ward H, 2009, J EVOLUTION BIOL, V22, P997, DOI 10.1111/j.1420-9101.2009.01712.x; Yonezawa M, 2000, J Infect Chemother, V6, P155, DOI 10.1007/s101560070015; ZENGEL JM, 1977, J BACTERIOL, V129, P1320, DOI 10.1128/JB.129.3.1320-1329.1977	52	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10193	10.1371/journal.pone.0010193	http://dx.doi.org/10.1371/journal.pone.0010193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419114	Green Submitted, gold, Green Published			2022-12-27	WOS:000276707100010
J	Sauguet, L; Klinge, S; Perera, RL; Maman, JD; Pellegrini, L				Sauguet, Ludovic; Klinge, Sebastian; Perera, Rajika L.; Maman, Joseph D.; Pellegrini, Luca			Shared Active Site Architecture between the Large Subunit of Eukaryotic Primase and DNA Photolyase	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; P58 SUBUNIT; INITIATION; REFINEMENT; MECHANISM; BINDING; REPAIR; DOMAIN	Background: DNA synthesis during replication relies on RNA primers synthesised by the primase, a specialised DNA-dependent RNA polymerase that can initiate nucleic acid synthesis de novo. In archaeal and eukaryotic organisms, the primase is a heterodimeric enzyme resulting from the constitutive association of a small (PriS) and large (PriL) subunit. The ability of the primase to initiate synthesis of an RNA primer depends on a conserved Fe-S domain at the C-terminus of PriL (PriL-CTD). However, the critical role of the PriL-CTD in the catalytic mechanism of initiation is not understood. Methodology/Principal Findings: Here we report the crystal structure of the yeast PriL-CTD at 1.55 angstrom resolution. The structure reveals that the PriL-CTD folds in two largely independent alpha-helical domains joined at their interface by a [4F-e4S] cluster. The larger N-terminal domain represents the most conserved portion of the PriL-CTD, whereas the smaller C-terminal domain is largely absent in archaeal PriL. Unexpectedly, the N-terminal domain reveals a striking structural similarity with the active site region of the DNA photolyase/cryptochrome family of flavoproteins. The region of similarity includes PriL-CTD residues that are known to be essential for initiation of RNA primer synthesis by the primase. Conclusion/Significance: Our study reports the first crystallographic model of the conserved Fe-S domain of the archaeal/eukaryotic primase. The structural comparison with a cryptochrome protein bound to flavin adenine dinucleotide and single-stranded DNA provides important insight into the mechanism of RNA primer synthesis by the primase.	[Sauguet, Ludovic; Klinge, Sebastian; Perera, Rajika L.; Maman, Joseph D.; Pellegrini, Luca] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Sauguet, L (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	lp212@cam.ac.uk	Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X; Perera, Rajika/0000-0002-4932-8168	Wellcome Trust; Gates Cambridge Trust scholarship; Medical Research Council	Wellcome Trust(Wellcome Trust); Gates Cambridge Trust scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust senior research fellowship award in basic biomedical science to LP. SK was funded by a Gates Cambridge Trust scholarship and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; BADARACCO G, 1986, EUR J BIOCHEM, V161, P435, DOI 10.1111/j.1432-1033.1986.tb10463.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; FOIANI M, 1989, MOL CELL BIOL, V9, P3081, DOI 10.1128/MCB.9.7.3081; FOIANI M, 1989, J BIOL CHEM, V264, P2189; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	29	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10083	10.1371/journal.pone.0010083	http://dx.doi.org/10.1371/journal.pone.0010083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404922	gold, Green Published, Green Submitted			2022-12-27	WOS:000276482100009
J	Rosenberg, MS				Rosenberg, Michael S.			A Generalized Formula for Converting Chi-Square Tests to Effect Sizes for Meta-Analysis	PLOS ONE			English	Article							FITNESS	The common formula used for converting a chi-square test into a correlation coefficient for use as an effect size in meta-analysis has a hidden assumption which may be violated in specific instances, leading to an overestimation of the effect size. A corrected formula is provided.	[Rosenberg, Michael S.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA; [Rosenberg, Michael S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Rosenberg, MS (corresponding author), Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA.	msr@asu.edu	Rohlf, F J/A-8710-2008; Rosenberg, Michael S/A-4621-2008	Rosenberg, Michael S/0000-0001-7882-2467	National Evolutionary Synthesis Center (NESCent; NSF) [EF-0905606]; National Science Foundation (NSF) [DBI-0542599]	National Evolutionary Synthesis Center (NESCent; NSF)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation (NSF)(National Science Foundation (NSF))	Supported by the National Evolutionary Synthesis Center (NESCent; http://www.nescent.org; NSF #EF-0905606), and the National Science Foundation (NSF; #DBI-0542599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Britten HB, 1996, EVOLUTION, V50, P2158, DOI 10.1111/j.1558-5646.1996.tb03606.x; Cohen J., 1965, HDB CLIN PSYCHOL, P95; Cooper H. M., 1998, SYNTHESIZING RES GUI, V3rd; Hedges LV, 2014, STAT METHODS META AN; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Koricheva J, HDB METAANA IN PRESS; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; ROSENBERG MS, HDB METAANALYSIS ECO; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rosenthal R., 2008, ESSENTIALS BEHAV RES; ROSENTHAL R, 2000, CONTRAST EFFECT SIZE; Rosenthal R, 1978, BEHAVIORAL BRAIN SCI, V3, P377; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231	16	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10059	10.1371/journal.pone.0010059	http://dx.doi.org/10.1371/journal.pone.0010059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383281	Green Published, gold, Green Submitted			2022-12-27	WOS:000276454000018
J	Sittig, LJ; Redei, EE				Sittig, Laura J.; Redei, Eva E.			Paternal Genetic Contribution Influences Fetal Vulnerability to Maternal Alcohol Consumption in a Rat Model of Fetal Alcohol Spectrum Disorder	PLOS ONE			English	Article							ETHANOL TERATOGENESIS; BIRTH-WEIGHT; PREGNANCY; HORMONE; GROWTH; MICE; ADRENALECTOMY; DEFICIENCY; DOMINANCE; DIAGNOSIS	Background: Fetal alcohol exposure causes in the offspring a collection of permanent physiological and neuropsychological deficits collectively termed Fetal Alcohol Spectrum Disorder (FASD). The timing and amount of exposure cannot fully explain the substantial variability among affected individuals, pointing to genetic influences that mediate fetal vulnerability. However, the aspects of vulnerability that depend on the mother, the father, or both, are not known. Methodology/Principal Findings: Using the outbred Sprague-Dawley (SD) and inbred Brown Norway (BN) rat strains as well as their reciprocal crosses, we administered ethanol (E), pair-fed (PF), or control (C) diets to the pregnant dams. The dams' plasma levels of free thyroxine (fT4), triiodothyronine (T3), free T3 (fT3), and thyroid stimulating hormone (TSH) were measured to elucidate potential differences in maternal thyroid hormonal environment, which affects specific aspects of FASD. We then compared alcohol-exposed, pair fed, and control offspring of each fetal strain on gestational day 21 (G21) to identify maternal and paternal genetic effects on bodyweight and placental weight of male and female fetuses. Conclusions: SD and BN dams exhibited different baseline hypothalamic-pituitary-thyroid function. Moreover, the thyroid function of SD dams was more severely affected by alcohol consumption while that of BN dams was relatively resistant. This novel finding suggests that genetic differences in maternal thyroid function are one source of maternal genetic effects on fetal vulnerability to FASD. The fetal vulnerability to decreased bodyweight after alcohol exposure depended on the genetic contribution of both parents, not only maternal contribution as previously thought. In contrast, the effect of maternal alcohol consumption on placental weight was consistent and not strain-dependent. Interestingly, placental weight in fetuses with different paternal genetic contributions exhibited opposite responses to caloric restriction (pair feeding). In summary, these novel findings demonstrate both maternal and paternal genetic contributions to in utero vulnerability to alcohol, refining our understanding of the genetically-based heterogeneity seen in human FASD.	[Sittig, Laura J.; Redei, Eva E.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Asher Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Sittig, LJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Asher Ctr, Chicago, IL 60611 USA.	e-redei@northwestern.edu		Sittig, Laura/0000-0001-5912-9528	NIH [AA013452]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017978, R01AA013452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was funded by grant NIH AA013452 to EER (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum AE, 2005, ENDOCRINOLOGY, V146, P870, DOI 10.1210/en.2004-0948; Bradford G E, 1979, J Anim Sci, V49 Suppl 2, P66; Burd L, 2007, J MATERN-FETAL NEO M, V20, P361, DOI 10.1080/14767050701298365; Chan SY, 2009, NAT CLIN PRACT ENDOC, V5, P45, DOI 10.1038/ncpendmet1026; CHASNOFF IJ, 1985, ACTA GENET MED GEMEL, V34, P229, DOI 10.1017/S0001566000004797; Das SC, 2006, INDIAN J MED RES, V124, P535; Das UG, 2004, ALCOHOL CLIN EXP RES, V28, P1598, DOI 10.1097/01.ALC.0000141816.14776.97; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; GILLIAM DM, 1990, ALCOHOL CLIN EXP RES, V14, P539, DOI 10.1111/j.1530-0277.1990.tb01196.x; Gilliam DM, 1997, ALCOHOL CLIN EXP RES, V21, P28; Guerri C, 2009, ALCOHOL ALCOHOLISM, V44, P108, DOI 10.1093/alcalc/agn105; GUNDOGAN F, 2009, ALCOHOL CLIN EXP RES; Hager R, 2009, EVOLUTION, V63, P1118, DOI 10.1111/j.1558-5646.2009.00638.x; HAYCOCK PC, 2009, BIOL REPROD; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Jacobson SW, 2006, J PEDIATR-US, V148, P30, DOI 10.1016/j.jpeds.2005.08.023; Kelly SJ, 2009, DEV DISABIL RES REV, V15, P200, DOI 10.1002/ddrr.69; Le Clair C, 2009, CAN J PHYSIOL PHARM, V87, P161, DOI [10.1139/Y09-006, 10.1139/y09-006]; Leamy LJ, 2008, HEREDITY, V101, P518, DOI 10.1038/hdy.2008.79; Lindsay RS, 2002, HUM GENET, V110, P503, DOI 10.1007/s00439-002-0718-2; Manning MA, 2007, NEUROSCI BIOBEHAV R, V31, P230, DOI 10.1016/j.neubiorev.2006.06.016; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Mantey C, 2005, J HERED, V96, P329, DOI 10.1093/jhered/esi044; Moeller LC, 2007, ENDOCRINOLOGY, V148, P4727, DOI 10.1210/en.2007-0236; Rasmussen SA, 2009, BIRTH DEFECTS RES A, V85, P82, DOI 10.1002/bdra.20506; RIIKONEN RS, 1994, PEDIATR NEUROL, V11, P332, DOI 10.1016/0887-8994(94)90012-4; Risnes KR, 2009, AM J EPIDEMIOL, V170, P622, DOI 10.1093/aje/kwp182; ROSENBERG MJ, ALCOHOL; Sinha P, 1997, ENDOCRINOLOGY, V138, P4792, DOI 10.1210/en.138.11.4792; Spencer HG, 2009, GENETICA, V136, P285, DOI 10.1007/s10709-008-9300-8; STREISSGUTH AP, 1993, AM J MED GENET, V47, P857, DOI 10.1002/ajmg.1320470612; Swerdlow NR, 2008, PHARMACOL BIOCHEM BE, V88, P280, DOI 10.1016/j.pbb.2007.08.013; WEINBERG J, 1984, NEUROBEH TOXICOL TER, V6, P261; Wilcoxon JS, 2005, MOL PSYCHIATR, V10, P961, DOI 10.1038/sj.mp.4001694; Wilcoxon JS, 2004, AM J PHYSIOL-ENDOC M, V287, pE318, DOI 10.1152/ajpendo.00022.2004; Wilcoxon JS, 2003, AM J PHYSIOL-ENDOC M, V285, pE31, DOI 10.1152/ajpendo.00552.2002	37	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10058	10.1371/journal.pone.0010058	http://dx.doi.org/10.1371/journal.pone.0010058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383339	gold, Green Published, Green Submitted			2022-12-27	WOS:000276454000017
J	Chigurupati, S; Mughal, MR; Chan, SL; Arumugam, TV; Baharani, A; Tang, SC; Yu, QS; Holloway, HW; Wheeler, R; Poosala, S; Greig, NH; Mattson, MP				Chigurupati, Srinivasulu; Mughal, Mohamed R.; Chan, Sic L.; Arumugam, Thiruma V.; Baharani, Akanksha; Tang, Sung-Chun; Yu, Qian-Sheng; Holloway, Harold W.; Wheeler, Ross; Poosala, Suresh; Greig, Nigel H.; Mattson, Mark P.			A Synthetic Uric Acid Analog Accelerates Cutaneous Wound Healing in Mice	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; GROWTH-FACTOR; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; NITRIC-OXIDE; GLUTATHIONE; PROTECTS; DAMAGE; ALPHA; EGF	Wound healing is a complex process involving intrinsic dermal and epidermal cells, and infiltrating macrophages and leukocytes. Excessive oxidative stress and associated inflammatory processes can impair wound healing, and antioxidants have been reported to improve wound healing in animal models and human subjects. Uric acid (UA) is an efficient free radical scavenger, but has a very low solubility and poor tissue penetrability. We recently developed novel UA analogs with increased solubility and excellent free radical-scavenging properties and demonstrated their ability to protect neural cells against oxidative damage. Here we show that the uric acid analog (6, 8 dithio-UA, but not equimolar concentrations of UA or 1, 7 dimethyl-UA) modified the behaviors of cultured vascular endothelial cells, keratinocytes and fibroblasts in ways consistent with enhancement of the wound healing functions of all three cell types. We further show that 6, 8 dithio-UA significantly accelerates the wound healing process when applied topically (once daily) to full-thickness wounds in mice. Levels of Cu/Zn superoxide dismutase were increased in wound tissue from mice treated with 6, 8 dithio-UA compared to vehicle-treated mice, suggesting that the UA analog enhances endogenous cellular antioxidant defenses. These results support an adverse role for oxidative stress in wound healing and tissue repair, and provide a rationale for the development of UA analogs in the treatment of wounds and for modulation of angiogenesis in other pathological conditions.	[Chigurupati, Srinivasulu; Mughal, Mohamed R.; Arumugam, Thiruma V.; Tang, Sung-Chun; Yu, Qian-Sheng; Holloway, Harold W.; Greig, Nigel H.; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Chigurupati, Srinivasulu; Poosala, Suresh] NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Wheeler, Ross] Univ Cent Florida, Dept Pathol & Med Educ, Orlando, FL 32816 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; University of Central Florida; Johns Hopkins University	Chigurupati, S (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Arumugam, Thiruma Valavan/B-4898-2011; Mattson, Mark P/F-6038-2012; Arumugam, Thiruma/AAG-6958-2019	Tang, Sung-Chun/0000-0003-3731-5973; Arumugam, Thiruma/0000-0002-3377-0939	National Institute on Aging, National Institutes of Helath (NIH); NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Helath (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging Intramural Research Program of the National Institutes of Helath (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva R, 2005, BIOCHEM BIOPH RES CO, V333, P404, DOI 10.1016/j.bbrc.2005.05.119; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; CUTLER RG, 1984, ARCH GERONTOL GERIAT, V3, P321, DOI 10.1016/0167-4943(84)90033-5; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Gilman Thomas, 2004, Int J Low Extrem Wounds, V3, P125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Ha XQ, 2003, CHINESE MED J-PEKING, V116, P1029; Haberman F, 2007, NEUROMOL MED, V9, P315, DOI 10.1007/s12017-007-8010-1; HEBDA PA, 1990, J INVEST DERMATOL, V95, P626, DOI 10.1111/1523-1747.ep12513528; HOCKEL M, 1987, J CELL PHYSIOL, V133, P1, DOI 10.1002/jcp.1041330102; Hong JP, 2006, ANN PLAS SURG, V56, P394, DOI 10.1097/01.sap.0000198731.12407.0c; Hooper DC, 1997, P NATL ACAD SCI USA, V94, P2528, DOI 10.1073/pnas.94.6.2528; Keller JN, 1998, J NEUROSCI, V18, P687; Khanolkar MP, 2008, QJM-INT J MED, V101, P685, DOI 10.1093/qjmed/hcn027; Kumin A, 2007, J CELL BIOL, V179, P747, DOI 10.1083/jcb.200706090; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004; MERRELL JG, 2009, CLIN EXP PH IN PRESS; Milne Catherine T, 2008, Adv Nurse Pract, V16, P53; Mudge BP, 2002, WOUND REPAIR REGEN, V10, P52, DOI 10.1046/j.1524-475X.2002.10803.x; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; SEN CK, 2008, BIOCH BIOPH IN PRESS; Senel O, 1997, ANN PLAS SURG, V39, P516; Serarslan G, 2007, CLIN EXP DERMATOL, V32, P709, DOI 10.1111/j.1365-2230.2007.02470.x; Shukla A, 1997, FREE RADICAL RES, V26, P93, DOI 10.3109/10715769709097788; Soneja A, 2005, PHARMACOL REP, V57, P108; STEED DL, 1992, DIABETES CARE, V15, P1598, DOI 10.2337/diacare.15.11.1598; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Ucuzian AA, 2007, WORLD J SURG, V31, P654, DOI 10.1007/s00268-006-0763-4; Weinberger Abraham, 1995, Current Opinion in Rheumatology, V7, P359, DOI 10.1097/00002281-199507000-00017; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Williams DT, 2003, CRIT CARE MED, V31, pS547, DOI 10.1097/01.CCM.0000081430.34066.1D; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1	40	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10044	10.1371/journal.pone.0010044	http://dx.doi.org/10.1371/journal.pone.0010044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386608	Green Published, gold, Green Submitted			2022-12-27	WOS:000276420400015
J	Swisher, KD; Parker, R				Swisher, Kylie D.; Parker, Roy			Localization to, and Effects of Pbp1, Pbp4, Lsm12, Dhh1, and Pab1 on Stress Granules in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA; P-BODIES; POLY(A)-BINDING PROTEIN; PROCESSING BODIES; IN-VIVO; YEAST; TRANSLATION; HELICASE; IDENTIFICATION; RAP55	The regulation of translation and mRNA degradation in eukaryotic cells involves the formation of cytoplasmic mRNP granules referred to as P-bodies and stress granules. The yeast Pbp1 protein and its mammalian ortholog, Ataxin-2, localize to stress granules and promote their formation. In Saccharomyces cerevisiae, Pbp1 also interacts with the Pab1, Lsm12, Pbp4, and Dhh1 proteins. In this work, we determined whether these Pbp1 interacting proteins also accumulated in stress granules and/or could affect their formation. These experiments revealed the following observations. First, the Lsm12, Pbp4, and Dhh1 proteins all accumulate in stress granules, whereas only the Dhh1 protein is a constitutive P-body component. Second, deletion or over-expression of the Pbp4 and Lsm12 proteins did not dramatically affect the formation of stress granules or P-bodies. In contrast, Pbp1 and Dhh1 over-expression inhibits cell growth, and for Dhh1, leads to the accumulation of stress granules. Finally, a strain lacking the Pab1 protein was reduced at forming stress granules, although they could still be detected. This indicates that Pab1 affects, but is not absolutely required for, stress granule formation. These observations offer new insight into the function of stress granule components with roles in stress granule assembly and mRNP regulation.	[Swisher, Kylie D.; Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ USA	University of Arizona	Parker, R (corresponding author), Univ Arizona, Howard Hughes Med Inst, Tucson, AZ USA.	rrparker@email.arizona.edu			Howard Hughes Medical Institute; National Institutes of Health [5R37GM45443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (www.hhmi.org) and the National Institutes of Health (5R37GM45443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Balagopal V, 2009, GENETICS, V181, P93, DOI 10.1534/genetics.108.092601; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 2004, MOL CELL BIOL, V24, P4196, DOI 10.1128/MCB.24.10.4196-4206.2004; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rajyaguru P, 2009, TRENDS CELL BIOL, V19, P24, DOI 10.1016/j.tcb.2008.11.001; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tritschler F, 2009, MOL CELL, V33, P661, DOI 10.1016/j.molcel.2009.02.014; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706	38	89	90	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e10006	10.1371/journal.pone.0010006	http://dx.doi.org/10.1371/journal.pone.0010006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368989	Green Published, gold, Green Submitted			2022-12-27	WOS:000276419900009
J	Chiriac, A; Nelson, TJ; Faustino, RS; Behfar, A; Terzic, A				Chiriac, Anca; Nelson, Timothy J.; Faustino, Randolph S.; Behfar, Atta; Terzic, Andre			Cardiogenic Induction of Pluripotent Stem Cells Streamlined Through a Conserved SDF-1/VEGF/BMP2 Integrated Network	PLOS ONE			English	Article							REGULATORY NETWORKS; PROGENITOR CELLS; SMOOTH-MUSCLE; DIFFERENTIATION; CARDIOMYOCYTE; MULTIPOTENT; LINEAGE; GROWTH; NOISE; STOCHASTICITY	Background: Pluripotent stem cells produce tissue-specific lineages through programmed acquisition of sequential gene expression patterns that function as a blueprint for organ formation. As embryonic stem cells respond concomitantly to diverse signaling pathways during differentiation, extraction of a pro-cardiogenic network would offer a roadmap to streamline cardiac progenitor output. Methods and Results: To resolve gene ontology priorities within precursor transcriptomes, cardiogenic subpopulations were here generated according to either growth factor guidance or stage-specific biomarker sorting. Innate expression profiles were independently delineated through unbiased systems biology mapping, and cross-referenced to filter transcriptional noise unmasking a conserved progenitor motif (55 up- and 233 down-regulated genes). The streamlined pool of 288 genes organized into a core biological network that prioritized the "Cardiovascular Development'' function. Recursive in silico deconvolution of the cardiogenic neighborhood and associated canonical signaling pathways identified a combination of integrated axes, CXCR4/SDF-1, Flk-1/VEGF and BMP2r/BMP2, predicted to synchronize cardiac specification. In vitro targeting of the resolved triad in embryoid bodies accelerated expression of Nkx2.5, Mef2C and cardiac-MHC, enhanced beating activity, and augmented cardiogenic yield. Conclusions: Transcriptome-wide dissection of a conserved progenitor profile thus revealed functional highways that coordinate cardiogenic maturation from a pluripotent ground state. Validating the bioinformatics algorithm established a strategy to rationally modulate cell fate, and optimize stem cell-derived cardiogenesis.	[Chiriac, Anca] Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Med, Rochester, MN 55905 USA; Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Med Genet, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Chiriac, A (corresponding author), Mayo Clin, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Dept Med, Rochester, MN 55905 USA.	terzic.andre@mayo.edu		Behfar, Atta/0000-0003-3775-5784; Nelson, Timothy/0000-0002-3862-7023	National Institutes of Health [R01HL083439, T32HL007111]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007111, R01HL083439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (R01HL083439, T32HL007111), Marriott Individualized Medicine Program, Asper Foundation, Marriott Heart Disease Research Program, Mayo Graduate School, and Mayo Clinic Clinician-Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Arrell DK, 2007, CLIN PHARMACOL THER, V82, P316, DOI 10.1038/sj.clpt.6100310; Arrell DK, 2008, STEM CELLS, V26, P387, DOI 10.1634/stemcells.2007-0599; Arrell DK, 2009, J PROTEOME RES, V8, P4823, DOI 10.1021/pr900561g; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Behfar A, 2008, J MOL CELL CARDIOL, V45, P523, DOI 10.1016/j.yjmcc.2008.09.122; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Braam SR, 2009, TRENDS PHARMACOL SCI, V30, P536, DOI 10.1016/j.tips.2009.07.001; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen Y, 2006, AM J PHYSIOL-HEART C, V291, pH1653, DOI 10.1152/ajpheart.00363.2005; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; CHUNG S, 2008, ANN NY ACAD SCI, V1147, P255; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Faustino RS, 2008, J CARDIOVASC TRANSL, V1, P120, DOI 10.1007/s12265-008-9019-z; Faustino RS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r6; Faustino RS, 2008, CTS-CLIN TRANSL SCI, V1, P174, DOI 10.1111/j.1752-8062.2008.00038.x; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Horton RE, 2009, REGEN MED, V4, P721, DOI 10.2217/RME.09.48; Huang FQ, 2008, NAT PROTOC, V3, P1848, DOI 10.1038/nprot.2008.185; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Leschik J, 2008, NAT PROTOC, V3, P1381, DOI 10.1038/nprot.2008.116; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Misra R P, 2001, BMC Biotechnol, V1, P12, DOI 10.1186/1472-6750-1-12; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nelson TJ, 2008, CLIN PHARMACOL THER, V84, P620, DOI 10.1038/clpt.2008.146; Nelson TJ, 2008, STEM CELLS, V26, P1464, DOI 10.1634/stemcells.2007-0808; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Nelson TJ, 2009, CTS-CLIN TRANSL SCI, V2, P222, DOI 10.1111/j.1752-8062.2009.00096.x; Nelson TJ, 2009, DIFFERENTIATION, V77, P248, DOI 10.1016/j.diff.2008.10.012; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Penn MS, 2009, CIRC RES, V104, P1133, DOI 10.1161/CIRCRESAHA.109.198929; Perez-Terzic C, 2003, CIRC RES, V92, P444, DOI 10.1161/01.RES.0000059415.25070.54; PEREZTERZIC C, 2007, NAT CLIN PRACT CARD, V4, pE68; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Zlatkovic J, 2009, PROTEOMICS, V9, P1314, DOI 10.1002/pmic.200800718	65	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9943	10.1371/journal.pone.0009943	http://dx.doi.org/10.1371/journal.pone.0009943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376342	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200019
J	Venturi, V; Bertani, I; Kerenyi, A; Netotea, S; Pongor, S				Venturi, Vittorio; Bertani, Iris; Kerenyi, Adam; Netotea, Sergiu; Pongor, Sandor			Co-Swarming and Local Collapse: Quorum Sensing Conveys Resilience to Bacterial Communities by Localizing Cheater Mutants in Pseudomonas aeruginosa	PLOS ONE			English	Article							SOCIAL EVOLUTION; COOPERATION	Background: Members of swarming bacterial consortia compete for nutrients but also use a co-operation mechanism called quorum sensing (QS) that relies on chemical signals as well as other secreted products ("public goods'') necessary for swarming. Deleting various genes of this machinery leads to cheater mutants impaired in various aspects of swarming cooperation. Methodology/Principal Findings: Pairwise consortia made of Pseudomonas aeruginosa, its QS mutants as well as B. cepacia cells show that a interspecies consortium can "combine the skills'' of its participants so that the strains can cross together barriers that they could not cross alone. In contrast, deleterious mutants are excluded from consortia either by competition or by local population collapse. According to modeling, both scenarios are the consequence of the QS signalling mechanism itself. Conclusion/Significance: The results indirectly explain why it is an advantage for bacteria to maintain QS systems that can cross-talk among different species, and conversely, why certain QS mutants which can be abundant in isolated niches, cannot spread and hence remain localized.	[Venturi, Vittorio; Bertani, Iris; Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Kerenyi, Adam; Netotea, Sergiu] Hungarian Acad Sci, Biol Res Ctr, H-6701 Szeged, Hungary	International Center for Genetic Engineering & Biotechnology (ICGEB); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Venturi, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	venturi@icgeb.org; pongor@icgeb.org	Venturi, Vittorio/AAO-3069-2021	Bertani, Iris/0000-0003-0378-7796; Venturi, Vittorio/0000-0003-4307-5697	Italian Cystic Fibrosis Research Foundation [9/2007]; Hungarian National Office for Research and Technology (NKTH) [TAMOP-4.2.2-08/1/2008-008]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Hungarian National Office for Research and Technology (NKTH)(National Office for Research and Technology)	I. B. was supported by a fellowship from the Italian Cystic Fibrosis Research Foundation (Project FFC#9/2007) with the contribution of the Delegazione FFC di Belluno. The work at BRC Szeged was partly supported by a grant no TAMOP-4.2.2-08/1/2008-008 from the Hungarian National Office for Research and Technology (NKTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Netotea S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-6; Paulsson J, 2002, GENETICS, V161, P1373; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Steindler L, 2009, APPL ENVIRON MICROB, V75, P5131, DOI 10.1128/AEM.02914-08; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Szathmary E, 1995, MAJOR TRANSITIONS EV; Venturi V, 2009, HFSP J, V3, P105, DOI 10.2976/1.3065673; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	25	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9998	10.1371/journal.pone.0009998	http://dx.doi.org/10.1371/journal.pone.0009998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376321	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200063
J	Zhao, RM; Leung, E; Gruner, S; Schapira, M; Houry, WA				Zhao, Rongmin; Leung, Elisa; Gruner, Stefan; Schapira, Matthieu; Houry, Walid A.			Tamoxifen Enhances the Hsp90 Molecular Chaperone ATPase Activity	PLOS ONE			English	Article							PROTEIN; CANCER; INHIBITOR; THERAPY; GROWTH; CELLS	Background: Hsp90 is an essential molecular chaperone that is also a novel anti-cancer drug target. There is growing interest in developing new drugs that modulate Hsp90 activity. Methodology/Principal Findings: Using a virtual screening approach, 4-hydroxytamoxifen, the active metabolite of the anti-estrogen drug tamoxifen, was identified as a putative Hsp90 ligand. Surprisingly, while all drugs targeting Hsp90 inhibit the chaperone ATPase activity, it was found experimentally that 4-hydroxytamoxifen and tamoxifen enhance rather than inhibit Hsp90 ATPase. Conclusions/Significance: Hence, tamoxifen and its metabolite are the first members of a new pharmacological class of Hsp90 activators.	[Zhao, Rongmin; Leung, Elisa; Gruner, Stefan; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto	Zhao, RM (corresponding author), Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada.	matthieu.schapira@utoronto.ca; walid.houry@utoronto.ca		Zhao, Rongmin/0000-0003-1300-5882	Canadian Institutes of Health Research [MOP-93778]; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported, in part, by a grant from the Canadian Institutes of Health Research (MOP-93778) to WAH and public and private funding to the Structural Genomics Consortium. The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck, the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Agatsuma T, 2002, BIOORGAN MED CHEM, V10, P3445, DOI 10.1016/S0968-0896(02)00260-2; An Jianghong, 2004, Genome Inform, V15, P31; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Dunn FB, 2002, J NATL CANCER I, V94, P1194; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Mosser DD, 2004, BIOCHEMISTRY-US, V43, P8107, DOI 10.1021/bi0493766; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Totrov M, 1997, PROTEINS, P215; Vilenchik M, 2004, CHEM BIOL, V11, P787, DOI 10.1016/j.chembiol.2004.04.008; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Workman P, 2002, CANCER DETECT PREV, V26, P405, DOI 10.1016/S0361-090X(02)00126-5; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9934	10.1371/journal.pone.0009934	http://dx.doi.org/10.1371/journal.pone.0009934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376192	Green Published, gold			2022-12-27	WOS:000276418200011
J	Hesselmann, G; Sadaghiani, S; Friston, KJ; Kleinschmidt, A				Hesselmann, Guido; Sadaghiani, Sepideh; Friston, Karl J.; Kleinschmidt, Andreas			Predictive Coding or Evidence Accumulation? False Inference and Neuronal Fluctuations	PLOS ONE			English	Article							ONGOING ACTIVITY FLUCTUATIONS; VISUAL-CORTEX; DECISION-MAKING; PERCEPTION; VARIABILITY; RESPONSES; SYSTEMS; NOISE; BIAS	Perceptual decisions can be made when sensory input affords an inference about what generated that input. Here, we report findings from two independent perceptual experiments conducted during functional magnetic resonance imaging (fMRI) with a sparse event-related design. The first experiment, in the visual modality, involved forced-choice discrimination of coherence in random dot kinematograms that contained either subliminal or periliminal motion coherence. The second experiment, in the auditory domain, involved free response detection of (non-semantic) near-threshold acoustic stimuli. We analysed fluctuations in ongoing neural activity, as indexed by fMRI, and found that neuronal activity in sensory areas (extrastriate visual and early auditory cortex) biases perceptual decisions towards correct inference and not towards a specific percept. Hits (detection of near-threshold stimuli) were preceded by significantly higher activity than both misses of identical stimuli or false alarms, in which percepts arise in the absence of appropriate sensory input. In accord with predictive coding models and the free-energy principle, this observation suggests that cortical activity in sensory brain areas reflects the precision of prediction errors and not just the sensory evidence or prediction errors per se.	[Hesselmann, Guido; Sadaghiani, Sepideh; Kleinschmidt, Andreas] INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Hesselmann, Guido; Sadaghiani, Sepideh; Kleinschmidt, Andreas] CEA, Direct Sci Vivant, Inst Imagerie Biomed NeuroSpin, Gif Sur Yvette, France; [Hesselmann, Guido] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sadaghiani, Sepideh] Univ Tubingen, Int Max Planck Res Sch Neural & Behav Sci, Tubingen, Germany; [Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Weizmann Institute of Science; Eberhard Karls University of Tubingen; Max Planck Society; University of London; University College London	Hesselmann, G (corresponding author), INSERM, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	andreas.kleinschmidt@cea.fr	Hesselmann, Guido/I-2880-2016; Friston, Karl/D-9230-2011	Hesselmann, Guido/0000-0002-8873-7212; Friston, Karl/0000-0001-7984-8909; Lauwereyns, Jan/0000-0003-0551-2550; Sadaghiani, Sepideh/0000-0001-8800-3959	Agence Nationale de la Recherche (SPONTACT; France); Friedrich-Ebert Foundation (Germany); Minerva fellowship (Max Planck Society)	Agence Nationale de la Recherche (SPONTACT; France)(French National Research Agency (ANR)); Friedrich-Ebert Foundation (Germany); Minerva fellowship (Max Planck Society)(Max Planck Society)	This fMRI experiment was part of a general research program on functional neuroimaging of the human brain which was sponsored by the Atomic Energy Commission (principal investigator Denis Le Bihan). This work was funded by the Agence Nationale de la Recherche (SPONTACT; France). S. S. is supported by the Friedrich-Ebert Foundation (Germany). G. H. is supported by a Minerva fellowship (Max Planck Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Deco G, 2008, TRENDS NEUROSCI, V31, P591, DOI 10.1016/j.tins.2008.08.007; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000211; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; Kroener S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006507; Laufs H, 2008, HUM BRAIN MAPP, V29, P762, DOI 10.1002/hbm.20600; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028	25	79	79	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2010	5	3							e9926	10.1371/journal.pone.0009926	http://dx.doi.org/10.1371/journal.pone.0009926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576QZ	20369004	gold, Green Published, Green Submitted			2022-12-27	WOS:000276163100018
J	Bithell, A; Hsu, T; Kandanearatchi, A; Landau, S; Everall, IP; Tsuang, MT; Chana, G; Williams, BP				Bithell, Angela; Hsu, Tony; Kandanearatchi, Apsara; Landau, Sabine; Everall, Ian P.; Tsuang, Ming T.; Chana, Gursharan; Williams, Brenda P.			Expression of the Rap1 Guanine Nucleotide Exchange Factor, MR-GEF, Is Altered in Individuals with Bipolar Disorder	PLOS ONE			English	Article							LOCAL CIRCUIT NEURONS; PREFRONTAL CORTEX; GENE-EXPRESSION; GABAERGIC NEURONS; MESSENGER-RNA; B-RECEPTOR; SCHIZOPHRENIA; BRAIN; INTERNEURONS; PLASTICITY	In the rodent forebrain GABAergic neurons are generated from progenitor cells that express the transcription factors Dlx1 and Dlx2. The Rap-1 guanine nucleotide exchange factor, MR-GEF, is turned on by many of these developing GABAergic neurons. Expression of both Dlx1/2 and MR-GEF is retained in both adult mouse and human forebrain where, in human, decreased Dlx1 expression has been associated with psychosis. Using in situ hybridization studies we show that MR-GEF expression is significantly down-regulated in the forebrain of Dlx1/2 double mutant mice suggesting that MR-GEF and Dlx1/2 form part of a common signalling pathway during GABAergic neuronal development. We therefore compared MR-GEF expression by in situ hybridization in individuals with major psychiatric disorders (schizophrenia, bipolar disorder, major depression) and control individuals. We observed a significant positive correlation between layers II and IV of the dorsolateral prefrontal cortex (DLPFC) in the percentage of MR-GEF expressing neurons in individuals with bipolar disorder, but not in individuals with schizophrenia, major depressive disorder or in controls. Since MR-GEF encodes a Rap1 GEF able to activate G-protein signalling, we suggest that changes in MR-GEF expression could potentially influence neurotransmission.	[Bithell, Angela] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav,Dept Psychol Med, London WC2R 2LS, England; [Hsu, Tony; Everall, Ian P.; Tsuang, Ming T.; Chana, Gursharan] Univ Calif San Diego, Dept Psychiat, Ctr Behav Genom, San Diego, CA 92103 USA; [Landau, Sabine] Kings Coll London, Inst Psychiat, Dept Biostat & Comp, London WC2R 2LS, England	University of London; King's College London; University of California System; University of California San Diego; University of London; King's College London	Bithell, A (corresponding author), Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav,Dept Psychol Med, London WC2R 2LS, England.	brenda.p.williams@kcl.ac.uk	Landau, Sabine/B-9354-2011	Bithell, Angela/0000-0002-0294-078X; Williams, Brenda Patricia/0000-0003-4690-5932; Landau, Sabine/0000-0002-3615-8075	Stanley Foundation; Wellcome Trust; Medical Research Council	Stanley Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Stanley Foundation (http://www.stanleyfoundation.org/), the Wellcome Trust ( http://www.wellcome.ac.uk/) and the Medical Research Council (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Beasley CL, 1997, SCHIZOPHR RES, V24, P349, DOI 10.1016/S0920-9964(96)00122-3; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Benes FM, 1996, NEUROSCIENCE, V75, P1021, DOI 10.1016/0306-4522(96)00328-4; Bithell A, 2003, DEV BRAIN RES, V146, P107, DOI 10.1016/j.devbrainres.2003.09.017; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Byne W, 2002, AM J PSYCHIAT, V159, P59, DOI 10.1176/appi.ajp.159.1.59; Chana G, 2003, BIOL PSYCHIAT, V53, P1086, DOI 10.1016/S0006-3223(03)00114-8; Chance SA, 2005, BRAIN RES, V1046, P32, DOI 10.1016/j.brainres.2005.03.045; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Costa E., 2004, Critical Reviews in Neurobiology, V16, P1, DOI 10.1615/CritRevNeurobiol.v16.i12.10; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Dean B, 1999, J NEUROCHEM, V72, P1593, DOI 10.1046/j.1471-4159.1999.721593.x; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Ishikawa M, 2005, NEUROSCI LETT, V383, P272, DOI 10.1016/j.neulet.2005.04.025; Kromkamp M, 2003, ARCH GEN PSYCHIAT, V60, P869, DOI 10.1001/archpsyc.60.9.869; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Letinic K, 2001, NAT NEUROSCI, V4, P931, DOI 10.1038/nn0901-931; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Mizukami K, 2002, PROG NEURO-PSYCHOPH, V26, P393, DOI 10.1016/S0278-5846(01)00247-0; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Murray RM, 2004, SCHIZOPHR RES, V71, P405, DOI 10.1016/j.schres.2004.03.002; Popken GJ, 2000, P NATL ACAD SCI USA, V97, P9276, DOI 10.1073/pnas.150243397; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rotaru DC, 2005, J COMP NEUROL, V490, P220, DOI 10.1002/cne.20661; Saino-Saito S, 2003, J COMP NEUROL, V461, P18, DOI 10.1002/cne.10611; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Talkowski ME, 2006, SCHIZOPHRENIA BULL, V32, P203, DOI 10.1093/schbul/sbj058; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10392	10.1371/journal.pone.0010392	http://dx.doi.org/10.1371/journal.pone.0010392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436929	Green Published, Green Accepted, gold			2022-12-27	WOS:000277154200027
J	Dasari, VR; Kaur, K; Velpula, KK; Gujrati, M; Fassett, D; Klopfenstein, JD; Dinh, DH; Rao, JS				Dasari, Venkata Ramesh; Kaur, Kiranpreet; Velpula, Kiran Kumar; Gujrati, Meena; Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Rao, Jasti S.			Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; X-LINKED INHIBITOR; BONE-MARROW; MALIGNANT GLIOMA; GLIOBLASTOMA FORMATION; INDUCED APOPTOSIS; CANCER-CELLS; TUMOR-GROWTH; IN-VIVO; AKT	Background: PTEN (phosphatase and tensin homologue deleted on chromosome ten) is a tumor suppressor gene implicated in a wide variety of human cancers, including glioblastoma. PTEN is a major negative regulator of the PI3K/Akt signaling pathway. Most human gliomas show high levels of activated Akt, whereas less than half of these tumors carry PTEN mutations or homozygous deletions. The unique ability of mesenchymal stem cells to track down tumor cells makes them as potential therapeutic agents. Based on this capability, new therapeutic approaches have been developed using mesenchymal stem cells to cure glioblastoma. However, molecular mechanisms of interactions between glioma cells and stem cells are still unknown. Methodology/Principal Findings: In order to study the mechanisms by which migration of glioma cells can be inhibited by the upregulation of the PTEN gene, we studied two glioma cell lines (SNB19 and U251) and two glioma xenograft cell lines (4910 and 5310) alone and in co-culture with human umbilical cord blood-derived mesenchymal stem cells (hUCBSC). Cocultures of glioma cells showed increased expression of PTEN as evaluated by immunofluorescence and immunoblotting assays. Upregulation of PTEN gene is correlated with the downregulation of many genes including Akt, JUN, MAPK14, PDK2, PI3K, PTK2, RAS and RAF1 as revealed by cDNA microarray analysis. These results have been confirmed by reverse-transcription based PCR analysis of PTEN and Akt genes. Upregulation of PTEN resulted in the inhibition of migration capability of glioma cells under in vitro conditions. Also, wound healing capability of glioma cells was significantly inhibited in co-culture with hUCBSC. Under in vivo conditions, intracranial tumor growth was inhibited by hUCBSC in nude mice. Further, hUCBSC upregulated PTEN and decreased the levels of XIAP and Akt, which are responsible for the inhibition of tumor growth in the mouse brain. Conclusions/Significance: Our studies indicated that upregulation of PTEN by hUCBSC in glioma cells and in the nude mice tumors downregulated Akt and PI3K signaling pathway molecules. This resulted in the inhibition of migration as well as wound healing property of the glioma cells. Taken together, our results suggest hUCBSC as a therapeutic agent in treating malignant gliomas.	[Dasari, Venkata Ramesh; Kaur, Kiranpreet; Velpula, Kiran Kumar; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Gujrati, Meena] Univ Illinois, Coll Med Peoria, Dept Pathol, Peoria, IL USA; [Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Dasari, VR (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu	Kaur, Kiran/R-3535-2018; Dasari, Venkata Ramesh/B-3098-2009	Kaur, Kiran/0000-0002-7285-5513; Dasari, Venkata Ramesh/0000-0003-0819-2935	National Institute of Neurological Disorders and Stroke (NINDS) [NS057529]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project was supported by Award Number NS057529 (J.S.R.) from the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin E, 2001, ENDOCRINOLOGY, V142, P2451, DOI 10.1210/en.142.6.2451; Asselin E, 2001, CANCER RES, V61, P1862; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Cheng CK, 2009, BRAIN PATHOL, V19, P112, DOI 10.1111/j.1750-3639.2008.00233.x; Dai Y, 2008, INT J CANCER, V122, P2858, DOI 10.1002/ijc.23443; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Fehlauer F, 2007, ONCOL REP, V17, P941; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gondi CS, 2010, INT J ONCOL, V36, P1165, DOI 10.3892/ijo_00000599; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; HAN L, 2009, MED ONCOL; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; James C. David, 1996, Current Opinion in Oncology, V8, P188; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; LOUIS DN, 1995, TRENDS GENET, V11, P412, DOI 10.1016/S0168-9525(00)89125-8; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Markov V, 2007, STEM CELLS DEV, V16, P53, DOI 10.1089/scd.2006.0660; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Miletic H, 2007, MOL THER, V15, P1373, DOI 10.1038/sj.mt.6300155; Mohan PM, 1999, CANCER RES, V59, P3369; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Nieder Carsten, 2004, Expert Rev Neurother, V4, P691, DOI 10.1586/14737175.4.4.691; Nieder C, 2006, CRIT REV ONCOL HEMAT, V60, P181, DOI 10.1016/j.critrevonc.2006.06.007; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Schwab M, 2008, CARCINOGENESIS, V29, P1407, DOI 10.1093/carcin/bgn118; Solves P, 2003, BONE MARROW TRANSPL, V31, P269, DOI 10.1038/sj.bmt.1703809; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Su FQ, 2009, J CANCER RES CLIN, V135, P1655, DOI 10.1007/s00432-009-0612-6; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Westermark Bengt, 1995, Current Opinion in Oncology, V7, P220, DOI 10.1097/00001622-199505000-00005; Williams B, 1996, CANCER GENET CYTOGEN, V91, P77, DOI 10.1016/S0165-4608(96)00155-0; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	58	108	118	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10350	10.1371/journal.pone.0010350	http://dx.doi.org/10.1371/journal.pone.0010350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436671	Green Submitted, Green Published, gold			2022-12-27	WOS:000277079500018
J	Pain, DJ; Cromie, RL; Newth, J; Brown, MJ; Crutcher, E; Hardman, P; Hurst, L; Mateo, R; Meharg, AA; Moran, AC; Raab, A; Taggart, MA; Green, RE				Pain, Deborah J.; Cromie, Ruth L.; Newth, Julia; Brown, Martin J.; Crutcher, Eric; Hardman, Pippa; Hurst, Louise; Mateo, Rafael; Meharg, Andrew A.; Moran, Annette C.; Raab, Andrea; Taggart, Mark A.; Green, Rhys E.			Potential Hazard to Human Health from Exposure to Fragments of Lead Bullets and Shot in the Tissues of Game Animals	PLOS ONE			English	Article							INTELLECTUAL IMPAIRMENT; CHILDREN; BIRDS; RISK	Background: Lead is highly toxic to animals. Humans eating game killed using lead ammunition generally avoid swallowing shot or bullets and dietary lead exposure from this source has been considered low. Recent evidence illustrates that lead bullets fragment on impact, leaving small lead particles widely distributed in game tissues. Our paper asks whether lead gunshot pellets also fragment upon impact, and whether lead derived from spent gunshot and bullets in the tissues of game animals could pose a threat to human health. Methodology/Principal Findings: Wild-shot gamebirds (6 species) obtained in the UK were X-rayed to determine the number of shot and shot fragments present, and cooked using typical methods. Shot were then removed to simulate realistic practice before consumption, and lead concentrations determined. Data from the Veterinary Medicines Directorate Statutory Surveillance Programme documenting lead levels in raw tissues of wild gamebirds and deer, without shot being removed, are also presented. Gamebirds containing >= 5 shot had high tissue lead concentrations, but some with fewer or no shot also had high lead concentrations, confirming X-ray results indicating that small lead fragments remain in the flesh of birds even when the shot exits the body. A high proportion of samples from both surveys had lead concentrations exceeding the European Union Maximum Level of 100 ppb w.w. (0.1 mg kg(-1) w.w.) for meat from bovine animals, sheep, pigs and poultry (no level is set for game meat), some by several orders of magnitude. High, but feasible, levels of consumption of some species could result in the current FAO/WHO Provisional Weekly Tolerable Intake of lead being exceeded. Conclusions/Significance: The potential health hazard from lead ingested in the meat of game animals may be larger than previous risk assessments indicated, especially for vulnerable groups, such as children, and those consuming large amounts of game.	[Pain, Deborah J.; Cromie, Ruth L.; Newth, Julia; Brown, Martin J.; Hardman, Pippa; Hurst, Louise] Wildfowl & Wetlands Trust, Slimbridge GL2 7BT, Glos, England; [Crutcher, Eric] Vet Med Directorate, Residues Surveillance Unit, Surrey, England; [Mateo, Rafael; Taggart, Mark A.] JCCM, UCLM, CSIC, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain; [Meharg, Andrew A.; Moran, Annette C.; Raab, Andrea] Univ Aberdeen, Inst Biol Environm Sci, Aberdeen, Scotland; [Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Aberdeen; Royal Society for Protection of Birds; University of Cambridge	Pain, DJ (corresponding author), Wildfowl & Wetlands Trust, Slimbridge GL2 7BT, Glos, England.	debbie.pain@wwt.org.uk	Mateo, Rafael/A-3117-2011; Mateo, Rafael/AAU-1480-2020; Meharg, Andrew Alexander/F-8182-2014	Mateo, Rafael/0000-0003-1307-9152; Mateo, Rafael/0000-0003-1307-9152; Meharg, Andrew Alexander/0000-0003-2019-0449; Raab, Andrea/0000-0003-2058-0105; Taggart, Mark/0000-0002-0649-8490	Ministerio de Ciencia e Innovacion (MICINN) [CGL2007-62797]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The analysis done at Instituto de Investigacion en Recursos Cinegeticos (IREC) for this study was funded by Ministerio de Ciencia e Innovacion (MICINN) (http://www.micinn.es/portal/site/MICINN) under CGL2007-62797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALTROP D, 1975, POSTGRAD MED J, V51, P805; BALTROP D, 1979, ARCH ENVIRON HEALTH, V34, P280; Bjerregaard P, 2004, ENVIRON HEALTH PERSP, V112, P1496, DOI 10.1289/ehp.7083; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; CASTELLINO N, 1995, INORGANIC LEAD EXPOS; CDC, 1975, INCR LEAD ABS LEAD P; *CDC, 1985, PREV LEAD POIS YOUNG; CDC, 2005, PREV LEAD POIS YOUNG; Centers for Disease Control, 1991, PREV LEAD POIS YOUNG; Chandramouli K, 2009, ARCH DIS CHILD, V94, P844, DOI 10.1136/adc.2008.149955; CHISOLM JJ, 1956, PEDIATRICS, V18, P943; COBURN H, 2003, TOT ENV, V54, P275; Coburn HL, 2005, VET REC, V157, P321, DOI 10.1136/vr.157.11.321; Dewailly E, 2001, ARCH ENVIRON HEALTH, V56, P350, DOI 10.1080/00039890109604467; Dobrowolska A, 2008, EUR J WILDLIFE RES, V54, P231, DOI 10.1007/s10344-007-0134-y; EISLER R, 1988, US FISH WILDL SERV B, V85; FRANK A, 1986, SCI TOTAL ENVIRON, V54, P275, DOI 10.1016/0048-9697(86)90272-X; *FSA, 2007, SURV MET VAR FOODS; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Johansen P, 2004, ENVIRON POLLUT, V127, P125, DOI 10.1016/S0269-7491(03)00255-0; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Kosnett MJ, 2009, INGESTION LEAD SPENT, P24, DOI DOI 10.4080/ILSA.2009.0103; Landrigan Philip, 2006, Med Lav, V97, P811; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Mateo R, 2007, SCI TOTAL ENVIRON, V372, P480, DOI 10.1016/j.scitotenv.2006.10.022; *MINT INT GROUP LT, 2007, GAM EX MEAT UK FEB 2; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PATTEE OH, 1981, J WILDLIFE MANAGE, V45, P806, DOI 10.2307/3808728; *RHM TECHN, 2006, AN ROOT VEG NUTS DRI; Scheuhammer AM, 1998, ENVIRON POLLUT, V102, P251, DOI 10.1016/S0269-7491(98)00083-9; *SCOOP, 2004, 3211 SCOOP; Snow DW, 1998, BIRDS W PALEARCTIC, V1; Tellez-Rojo MM, 2006, PEDIATRICS, V118, pE323, DOI 10.1542/peds.2005-3123; Thomas VG, 2009, SCI TOTAL ENVIRON, V407, P3494, DOI 10.1016/j.scitotenv.2009.02.003; *VENTR TECHN LTD, 2006, SURV LEAD CADM VAR F; *WHO, 2007, 44 WHO; ZIEGLER EE, 1978, PEDIATR RES, V12, P29, DOI 10.1203/00006450-197801000-00008; 2006, OFFICIAL J EURO 1220	41	79	83	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10315	10.1371/journal.pone.0010315	http://dx.doi.org/10.1371/journal.pone.0010315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436670	gold, Green Published			2022-12-27	WOS:000277079500006
J	Hovatta, O; Jaconi, M; Tohonen, V; Bena, F; Gimelli, S; Bosman, A; Holm, F; Wyder, S; Zdobnov, EM; Irion, O; Andrews, PW; Antonarakis, SE; Zucchelli, M; Kere, J; Feki, A				Hovatta, Outi; Jaconi, Marisa; Tohonen, Virpi; Bena, Frederique; Gimelli, Stefania; Bosman, Alexis; Holm, Frida; Wyder, Stefan; Zdobnov, Evgeny M.; Irion, Olivier; Andrews, Peter W.; Antonarakis, Stylianos E.; Zucchelli, Marco; Kere, Juha; Feki, Anis			A Teratocarcinoma-Like Human Embryonic Stem Cell (hESC) Line and Four hESC Lines Reveal Potentially Oncogenic Genomic Changes	PLOS ONE			English	Article							RAW COPY NUMBERS; GENOTYPING ARRAYS; FEEDER CELLS; CULTURE; DERIVATION; DIFFERENTIATION; FIBROBLASTS; BLASTOCYSTS; ADAPTATION; HISTORY	The first Swiss human embryonic stem cell (hESC) line, CH-ES1, has shown features of a malignant cell line. It originated from the only single blastomere that survived cryopreservation of an embryo, and it more closely resembles teratocarcinoma lines than other hESC lines with respect to its abnormal karyotype and its formation of invasive tumors when injected into SCID mice. The aim of this study was to characterize the molecular basis of the oncogenicity of CH-ES1 cells, we looked for abnormal chromosomal copy number (by array Comparative Genomic Hybridization, aCGH) and single nucleotide polymorphisms (SNPs). To see how unique these changes were, we compared these results to data collected from the 2102Ep teratocarcinoma line and four hESC lines (H1, HS293, HS401 and SIVF-02) which displayed normal G-banding result. We identified genomic gains and losses in CH-ES1, including gains in areas containing several oncogenes. These features are similar to those observed in teratocarcinomas, and this explains the high malignancy. The CH-ES1 line was trisomic for chromosomes 1, 9, 12, 17, 19, 20 and X. Also the karyotypically (based on G-banding) normal hESC lines were also found to have several genomic changes that involved genes with known roles in cancer. The largest changes were found in the H1 line at passage number 56, when large 5 Mb duplications in chromosomes 1q32.2 and 22q12.2 were detected, but the losses and gains were seen already at passage 22. These changes found in the other lines highlight the importance of assessing the acquisition of genetic changes by hESCs before their use in regenerative medicine applications. They also point to the possibility that the acquisition of genetic changes by ESCs in culture may be used to explore certain aspects of the mechanisms regulating oncogenesis.	[Hovatta, Outi; Holm, Frida] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden; [Jaconi, Marisa; Bosman, Alexis] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Tohonen, Virpi; Zucchelli, Marco; Kere, Juha] Karolinska Inst, Dept Biosci, Stockholm, Sweden; [Bena, Frederique; Gimelli, Stefania; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Irion, Olivier; Feki, Anis] Univ Hosp Geneva, Dept Obstet & Gynecol, Geneva, Switzerland; [Wyder, Stefan; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, Geneva, Switzerland; [Andrews, Peter W.] Univ Sheffield, Ctr Stem Cell Biol, Sheffield, S Yorkshire, England; [Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Karolinska Institutet; University of Geneva; Karolinska Institutet; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Sheffield; University of Sheffield	Hovatta, O (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden.	Outi.hovatta@ki.se	Antonarakis, Stylianos E/N-8866-2014; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Zdobnov, Evgeny M/K-1133-2012; Zdobnov, Evgeny/AAB-2745-2022; Jaconi, Marisa EE/J-4392-2013	Antonarakis, Stylianos E/0000-0001-8907-5823; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Zdobnov, Evgeny/0000-0002-5178-1498; Feki, Anis/0000-0002-9817-9445; Andrews, Peter/0000-0001-7215-4410; Wyder, Stefan/0000-0002-3412-0292; Jaconi, Marisa/0000-0002-2004-8226	Swiss National Foundation; Medical Research Council UK; Roche Research Foundation; Ernst & Lucie Schmidheiny Foundation; Geneva University Hospitals; Geneva Faculty of Medicine, Genico; EU; Swedish Research Council; Stockholm County; Karolinska Institutet; Medical Research Council [G0700785] Funding Source: researchfish; MRC [G0700785] Funding Source: UKRI	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Roche Research Foundation; Ernst & Lucie Schmidheiny Foundation; Geneva University Hospitals; Geneva Faculty of Medicine, Genico; EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swiss National Foundation, Medical Research Council UK, Roche Research Foundation, the Ernst & Lucie Schmidheiny Foundation, the Geneva University Hospitals, the Geneva Faculty of Medicine, Genico, the EU for ESTOOLS, the Swedish Research Council and RD grants from Stockholm County and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ambartsumyan G, 2008, HUM MOL GENET, V17, pR10, DOI 10.1093/hmg/ddn170; ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Bruce S, 2005, J MED GENET, V42, P847, DOI 10.1136/jmg.2005.032367; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Damjanov I, 2005, STEM CELL REV, V1, P273, DOI 10.1385/SCR:1:3:273; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Feki A, 2008, SWISS MED WKLY, V138, P540, DOI 2008/37/smw-12385; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hardarson T, 2003, HUM REPROD, V18, P399, DOI 10.1093/humrep/deg092; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; *NIH, 2009, HUM DIS DAT DAV BIOI; *NIH, 2009, OMIM DAT; OLIVER RTD, 1990, CANCER SURV, V9, P333; Oosterhuis JW, 2003, APMIS, V111, P32, DOI 10.1034/j.1600-0463.2003.11101061.x; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; 2010, DATABASE GENOMIC VAR	34	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10263	10.1371/journal.pone.0010263	http://dx.doi.org/10.1371/journal.pone.0010263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428235	Green Published, gold, Green Accepted			2022-12-27	WOS:000277079300003
J	Tremblay, KL; Inoue, K; McClannahan, K; Ross, B				Tremblay, Kelly L.; Inoue, Kayo; McClannahan, Katrina; Ross, Bernhard			Repeated Stimulus Exposure Alters the Way Sound Is Encoded in the Human Brain	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; PARTIAL LEAST-SQUARES; EVENT-RELATED POTENTIALS; SPEECH SOUNDS; TIME-COURSE; PLASTICITY; IDENTIFICATION; RESPONSES; CHILDREN; CORTEX	Auditory training programs are being developed to remediate various types of communication disorders. Biological changes have been shown to coincide with improved perception following auditory training so there is interest in determining if these changes represent biologic markers of auditory learning. Here we examine the role of stimulus exposure and listening tasks, in the absence of training, on the modulation of evoked brain activity. Twenty adults were divided into two groups and exposed to two similar sounding speech syllables during four electrophysiological recording sessions (24 hours, one week, and up to one year later). In between each session, members of one group were asked to identify each stimulus. Both groups showed enhanced neural activity from session-to-session, in the same P2 latency range previously identified as being responsive to auditory training. The enhancement effect was most pronounced over temporal-occipital scalp regions and largest for the group who participated in the identification task. The effects were rapid and long-lasting with enhanced synchronous activity persisting months after the last auditory experience. Physiological changes did not coincide with perceptual changes so results are interpreted to mean stimulus exposure, with and without being paired with an identification task, alters the way sound is processed in the brain. The cumulative effect likely involves auditory memory; however, in the absence of training, the observed physiological changes are insufficient to result in changes in learned behavior.	[Tremblay, Kelly L.; Inoue, Kayo; McClannahan, Katrina] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Ross, Bernhard] Rotman Res Inst, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Baycrest	Tremblay, KL (corresponding author), Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA.	tremblay@uw.edu	/AIE-5811-2022; McClannahan, Katrina S/AAO-5617-2021	McClannahan, Katrina S/0000-0002-7840-4262; Ross, Bernhard/0000-0001-7290-631X	National Institutes of Health [R01-DC007705, P30-DC04661]; National Institute on Deafness and Communication Disorders; Virginia Merrill Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661, R01DC007705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Virginia Merrill Bloedel Hearing Research Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health Grants (R01-DC007705 and P30-DC04661) from the National Institute on Deafness and Communication Disorders. Support from the Virginia Merrill Bloedel Hearing Research Center is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2010, J COGNITIVE NEUROSCI, V22, P392, DOI 10.1162/jocn.2009.21279; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Baumann S, 2008, J COGNITIVE NEUROSCI, V20, P2238, DOI 10.1162/jocn.2008.20157; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; Brattico E, 2003, NEUROREPORT, V14, P2489, DOI 10.1097/00001756-200312190-00039; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; ESCERA C, 1997, ELECTROENCEPHALOGRAP, V100, P549; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Gourevitch B, 2008, EUR J NEUROSCI, V27, P3310, DOI 10.1111/j.1460-9568.2008.06265.x; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hayes EA, 2003, CLIN NEUROPHYSIOL, V114, P673, DOI 10.1016/S1388-2457(02)00414-5; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; Kinoshita S, 1996, PHYSIOL BEHAV, V60, P1087, DOI 10.1016/0031-9384(96)00130-8; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Kuriki S, 2007, CEREB CORTEX, V17, P2725, DOI 10.1093/cercor/bhl182; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; MCCLASKEY CL, 1983, PERCEPT PSYCHOPHYS, V34, P323, DOI 10.3758/BF03203044; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Moucha R, 2006, PROG BRAIN RES, V157, P111, DOI 10.1016/S0079-6123(06)57007-4; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nikjeh DA, 2009, EAR HEARING, V30, P432, DOI 10.1097/AUD.0b013e3181a61bf2; Norena AJ, 2006, NAT NEUROSCI, V9, P932, DOI 10.1038/nn1720; Pienkowski M, 2009, HEARING RES, V257, P24, DOI 10.1016/j.heares.2009.07.011; ROGERS RL, 1990, ELECTROEN CLIN NEURO, V77, P237, DOI 10.1016/0168-5597(90)90043-D; Ross B, 2009, HEARING RES, V248, P48, DOI 10.1016/j.heares.2008.11.012; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin A, 2005, NEUROREPORT, V16, P1781, DOI 10.1097/01.wnr.0000185017.29316.63; Sheehan KA, 2005, COGNITIVE BRAIN RES, V25, P547, DOI 10.1016/j.cogbrainres.2005.08.007; Szpunar KK, 2004, J EXP PSYCHOL LEARN, V30, P370, DOI 10.1037/0278-7393.30.2.370; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Tremblay K, 1997, J ACOUST SOC AM, V102, P3762, DOI 10.1121/1.420139; Tremblay Kelly L., 2007, Seminars in Hearing, V28, P120, DOI 10.1055/s-2007-973438; Tremblay KL, 2009, CLIN NEUROPHYSIOL, V120, P128, DOI 10.1016/j.clinph.2008.10.005; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Uwer R, 2000, CLIN NEUROPHYSIOL, V111, P45, DOI 10.1016/S1388-2457(99)00204-7; van Wassenhove V, 2007, J NEUROSCI, V27, P2663, DOI 10.1523/JNEUROSCI.4844-06.2007; WOODS DL, 1986, ELECTROEN CLIN NEURO, V65, P447, DOI 10.1016/0168-5597(86)90024-9; Yonan CA, 2000, PSYCHOL AGING, V15, P88, DOI 10.1037/0882-7974.15.1.88; Zouridakis G, 1998, BRAIN TOPOGR, V10, P183, DOI 10.1023/A:1022246825461	48	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10283	10.1371/journal.pone.0010283	http://dx.doi.org/10.1371/journal.pone.0010283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YT	20421969	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952600007
J	Xu, JY; Chen, RQ; Zhang, J; Chen, C				Xu, Jian-Yi; Chen, Rongqing; Zhang, Jian; Chen, Chu			Endocannabinoids Differentially Modulate Synaptic Plasticity in Rat Hippocampal CA1 Pyramidal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPOLARIZATION-INDUCED SUPPRESSION; METABOTROPIC GLUTAMATE; ENDOGENOUS CANNABINOIDS; EXCITATORY SYNAPSES; DISTAL DENDRITES; CORTICAL INPUT; TRANSMISSION; INHIBITION; RECEPTOR	Background: Hippocampal CA1 pyramidal neurons receive two excitatory glutamatergic synaptic inputs: their most distal dendritic regions in the stratum lacunosum-moleculare (SLM) are innervated by the perforant path (PP), originating from layer III of the entorhinal cortex, while their more proximal regions of the apical dendrites in the stratum adiatum (SR) are innervated by the Schaffer-collaterals (SC), originating from hippocampal CA3 neurons. Endocannabinoids (eCBs) are naturally occurring mediators capable of modulating both GABAergic and glutamatergic synaptic transmission and plasticity via the CB1 receptor. Previous work on eCB modulation of excitatory synapses in the CA1 region largely focuses on the SC pathway. However, little information is available on whether and how eCBs modulate glutamatergic synaptic transmission and plasticity at PP synapses. Methodology/Principal Findings: By employing somatic and dendritic patch-clamp recordings, Ca2+ uncaging, and immunostaining, we demonstrate that there are significant differences in low-frequency stimulation (LFS)- or DHPG-, an agonist of group I metabotropic glutamate receptors (mGluRs), induced long-term depression (LTD) of excitatory synaptic transmission between SC and PP synapses in the same pyramidal neurons. These differences are eliminated by pharmacological inhibition with selective CB1 receptor antagonists or genetic deletion of the CB1 receptor, indicating that these differences likely result from differential modulation via a CB1 receptor-dependent mechanism. We also revealed that depolarization-induced suppression of excitation (DSE), a form of short-term synaptic plasticity, and photolysis of caged Ca2+-induced suppression of Excitatory postsynaptic currents (EPSCs) were less at the PP than that at the SC. In addition, application of WIN55212 (WIN) induced a more pronounced inhibition of EPSCs at the SC when compared to that at the PP. Conclusions/Significance: Our results suggest that CB1 dependent LTD and DSE are differentially expressed at the PP versus SC synapses in the same neurons, which may have an impact on synaptic scaling, integration and plasticity of hippocampal CA1 pyramidal neurons.	[Xu, Jian-Yi; Chen, Rongqing; Zhang, Jian; Chen, Chu] Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Xu, JY (corresponding author), Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA.	cchen@lsuhsc.edu		Chen, Rongqing/0000-0002-1668-8554	National Institutes of Health [NS054886, DA025971]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA025971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grant NS054886 and DA025971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Alger BE, 2002, PROG NEUROBIOL, V68, P247; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Arrigoni E, 2004, BRIT J PHARMACOL, V142, P317, DOI 10.1038/sj.bjp.0705744; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chen C, 2005, BIOCHEM BIOPH RES CO, V338, P1913, DOI 10.1016/j.bbrc.2005.10.169; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chiu CYQ, 2008, NEUROPHARMACOLOGY, V54, P68, DOI 10.1016/j.neuropharm.2007.06.026; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gloveli T, 1997, J NEUROPHYSIOL, V78, P3444, DOI 10.1152/jn.1997.78.6.3444; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hill MN, 2009, TRENDS PHARMACOL SCI, V30, P484, DOI 10.1016/j.tips.2009.06.006; HILL MN, 2009, JAMA-J AM MED ASSOC, V310, P1165; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kellogg R, 2009, J NEUROPHYSIOL, V102, P1160, DOI 10.1152/jn.00266.2009; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lovinger David M., 2008, V184, P435; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Otmakhova NA, 2005, J NEUROPHYSIOL, V94, P1413, DOI 10.1152/jn.00217.2005; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Otmakhova NA, 2000, ANN NY ACAD SCI, V911, P462; PITLER TA, 1994, NEURON, V13, P1447; Rammes G, 2003, J PHYSIOL-LONDON, V546, P455, DOI 10.1113/jphysiol.2002.033514; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Rouach N, 2003, EUR J NEUROSCI, V18, P1017, DOI 10.1046/j.1460-9568.2003.02823.x; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sergeeva OA, 2007, EUR J NEUROSCI, V26, P1889, DOI 10.1111/j.1460-9568.2007.05815.x; Slanina KA, 2005, NEUROPHARMACOLOGY, V49, P660, DOI 10.1016/j.neuropharm.2005.04.021; Spruston N, 2008, NAT NEUROSCI, V11, P733, DOI 10.1038/nn0708-733; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang J, 2001, J PHYSIOL-LONDON, V533, P757, DOI 10.1111/j.1469-7793.2001.t01-1-00757.x; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zhu PJ, 2007, J NEUROPHYSIOL, V97, P4386, DOI 10.1152/jn.01228.2006	71	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10306	10.1371/journal.pone.0010306	http://dx.doi.org/10.1371/journal.pone.0010306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421986	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600023
J	Deng, JY; Wang, W; Lu, LJ; Ma, J				Deng, Jingyuan; Wang, Wei; Lu, Long Jason; Ma, Jun			A Two-Dimensional Simulation Model of the Bicoid Gradient in Drosophila	PLOS ONE			English	Article							MORPHOGEN GRADIENT; POSITIONAL INFORMATION; MESSENGER-RNA; DEVELOPMENTAL BIOLOGY; DEPENDENT MANNER; NUCLEAR; PATTERN; EMBRYO; PROTEIN; SEGMENTATION	Background: Bicoid (Bcd) is a Drosophila morphogenetic protein responsible for patterning the anterior structures in embryos. Recent experimental studies have revealed important insights into the behavior of this morphogen gradient, making it necessary to develop a model that can recapitulate the biological features of the system, including its dynamic and scaling properties. Methodology/Principal Findings: We present a biologically realistic 2-D model of the dynamics of the Bcd gradient in Drosophila embryos. This model is based on equilibrium binding of Bcd molecules to non-specific, low affinity DNA sites throughout the Drosophila genome. It considers both the diffusion media within which the Bcd gradient is formed and the dynamic and other relevant properties of bcd mRNA from which Bcd protein is produced. Our model recapitulates key features of the Bcd protein gradient observed experimentally, including its scaling properties and the stability of its nuclear concentrations during development. Our simulation model also allows us to evaluate the effects of other biological activities on Bcd gradient formation, including the dynamic redistribution of bcd mRNA in early embryos. Our simulation results suggest that, in our model, Bcd protein diffusion is important for the formation of an exponential gradient in embryos. Conclusions/Significance: The 2-D model described in this report is a simple and versatile simulation procedure, providing a quantitative evaluation of the Bcd gradient system. Our results suggest an important role of Bcd binding to non-specific, low-affinity DNA sites in proper formation of the Bcd gradient in our model. They demonstrate that highly complex biological systems can be effectively modeled with relatively few parameters.	[Deng, Jingyuan; Wang, Wei; Lu, Long Jason; Ma, Jun] Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH USA; [Ma, Jun] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Deng, Jingyuan; Lu, Long Jason] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH USA; [Wang, Wei] Univ Cincinnati, Dept Chem Engn, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Deng, JY (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH USA.	jun.ma@cchmc.org	lu, lu/HGA-0894-2022; Ma, Jun/GLT-4809-2022; lu, lu/HII-7530-2022	Ma, Jun/0000-0002-1609-3294; 	National Science Foundation [IOS-0843424]; National Institutes of Health [GM072812, GM78381]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072812, R01GM078381] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by grants from the National Science Foundation (IOS-0843424) and the National Institutes of Health (GM072812, GM78381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aegerter-Wilmsen T, 2005, J THEOR BIOL, V234, P13, DOI 10.1016/j.jtbi.2004.11.002; AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BREUER HP, 1992, CHEM PHYS LETT, V190, P199, DOI 10.1016/0009-2614(92)85326-6; Coppey M, 2007, DEV BIOL, V312, P623, DOI 10.1016/j.ydbio.2007.09.058; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; DAMANTE G, 1993, BIOCHEM BIOPH RES CO, V197, P632, DOI 10.1006/bbrc.1993.2526; Day SJ, 2000, DEVELOPMENT, V127, P2977; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FOE VE, 1983, J CELL SCI, V61, P31; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Ghaffari M, 1997, BIOCHEM J, V328, P757, DOI 10.1042/bj3280757; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2008, DEV BIOL, V316, P350, DOI 10.1016/j.ydbio.2008.01.039; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; Hecht I, 2009, P NATL ACAD SCI USA, V106, P1710, DOI 10.1073/pnas.0807655106; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Ishihara S, 2006, J THEOR BIOL, V238, P683, DOI 10.1016/j.jtbi.2005.06.016; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lattin J., 2003, ANAL MULTIVARIATE DA; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Lipshitz HD, 2009, NAT REV MOL CELL BIO, V10, P509, DOI 10.1038/nrm2730; Lott SE, 2007, P NATL ACAD SCI USA, V104, P10926, DOI 10.1073/pnas.0701359104; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Mavrakis Manos, 2009, Commun Integr Biol, V2, P313; Miura S, 2008, BIOSYSTEMS, V93, P133, DOI 10.1016/j.biosystems.2008.05.002; Morishita Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061905; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; Patel NH, 2002, NATURE, V415, P748, DOI 10.1038/415748a; Quimby BB, 2001, CELL MOL LIFE SCI, V58, P1766, DOI 10.1007/PL00000816; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; STJOHNSTON D, 1989, DEVELOPMENT S, P13; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Tostevin F, 2007, PLOS COMPUT BIOL, V3, P763, DOI 10.1371/journal.pcbi.0030078; Wilkie J, 2008, CHEM PHYS, V353, P132, DOI 10.1016/j.chemphys.2008.08.001; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu YF, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-52	55	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10275	10.1371/journal.pone.0010275	http://dx.doi.org/10.1371/journal.pone.0010275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422054	Green Published, gold			2022-12-27	WOS:000276952500030
J	Nguyen, HH; Tumpey, TM; Park, HJ; Byun, YH; Tran, LD; Nguyen, VD; Kilgore, PE; Czerkinsky, C; Katz, JM; Seong, BL; Song, JM; Kim, YB; Do, HT; Nguyen, T; Nguyen, CV				Nguyen, Huan H.; Tumpey, Terrence M.; Park, Hae-Jung; Byun, Young-Ho; Tran, Linh D.; Nguyen, Van D.; Kilgore, Paul E.; Czerkinsky, Cecil; Katz, Jacqueline M.; Seong, Baik Lin; Song, Jae Min; Kim, Young Bong; Do, Hoa T.; Nguyen, Tung; Nguyen, Cam V.			Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice	PLOS ONE			English	Article							YOLK ANTIBODIES; CHICKEN ANTIBODIES; EGG-YOLK; MONOCLONAL-ANTIBODY; HELICOBACTER-PYLORI; ISOLATED WORLDWIDE; IMMUNOGLOBULIN-Y; INFECTIONS; RESISTANCE; HUMANS	Background: Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Attempts to develop monoclonal antibodies (mAbs) have been made. However, passive immunization based on mAbs may require a cocktail of mAbs with broader specificity in order to provide full protection since mAbs are generally specific for single epitopes. Chicken immunoglobulins (IgY) found in egg yolk have been used mainly for treatment of infectious diseases of the gastrointestinal tract. Because the recent epidemic of highly pathogenic avian influenza virus (HPAIV) strain H5N1 has resulted in serious economic losses to the poultry industry, many countries including Vietnam have introduced mass vaccination of poultry with H5N1 virus vaccines. We reasoned that IgY from consumable eggs available in supermarkets in Vietnam could provide protection against infections with HPAIV H5N1. Methods and Findings: We found that H5N1-specific IgY that are prepared from eggs available in supermarkets in Vietnam by a rapid and simple water dilution method cross-protect against infections with HPAIV H5N1 and related H5N2 strains in mice. When administered intranasally before or after lethal infection, the IgY prevent the infection or significantly reduce viral replication resulting in complete recovery from the disease, respectively. We further generated H1N1 virus-specific IgY by immunization of hens with inactivated H1N1 A/PR/8/34 as a model virus for the current pandemic H1N1/09 and found that such H1N1-specific IgY protect mice from lethal influenza virus infection. Conclusions: The findings suggest that readily available H5N1-specific IgY offer an enormous source of valuable biological material to combat a potential H5N1 pandemic. In addition, our study provides a proof-of-concept for the approach using virus-specific IgY as affordable, safe, and effective alternative for the control of influenza outbreaks, including the current H1N1 pandemic.	[Nguyen, Huan H.; Park, Hae-Jung; Kilgore, Paul E.; Czerkinsky, Cecil] Int Vaccine Inst, Seoul, South Korea; [Tumpey, Terrence M.; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Byun, Young-Ho; Seong, Baik Lin; Song, Jae Min] Yonsei Univ, Coll Engn, Dept Biotechnol, Seoul 120749, South Korea; [Tran, Linh D.; Nguyen, Van D.; Kim, Young Bong] Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea; [Do, Hoa T.; Nguyen, Tung; Nguyen, Cam V.] Natl Ctr Vet Diagnost, Dept Anim Hlth, Hanoi, Vietnam; [Nguyen, Huan H.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	International Vaccine Institute; Centers for Disease Control & Prevention - USA; Yonsei University; Konkuk University; University of Alabama System; University of Alabama Birmingham	Nguyen, HH (corresponding author), Int Vaccine Inst, Seoul, South Korea.	hhnguyen@ivi.int	CZERKINSKY, CECIL/G-6520-2015; Kilgore, Paul/AAD-2869-2019; Kilgore, Paul E/L-1462-2013	Kilgore, Paul/0000-0003-3214-4482; Kilgore, Paul E/0000-0003-3214-4482	government of the Republic of Korea; government of Sweden; government of the Netherlands; government of Kuwait; Bill & Melinda Gates Foundation; Korean Healthcare Technology [A085105]; Ministry of Health and Welfare Family Affairs, Republic of Korea; Korea Research Council of Fundamental Science Technology [KGM3110912]	government of the Republic of Korea(Korean Government); government of Sweden; government of the Netherlands(Netherlands Government); government of Kuwait; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Korean Healthcare Technology; Ministry of Health and Welfare Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Research Council of Fundamental Science Technology	The International Vaccine Institute is supported by the governments of the Republic of Korea, Sweden, the Netherlands, and Kuwait. This work was supported in part by the Bill & Melinda Gates Foundation (to HHN), the Korean Healthcare Technology R&D Project (A085105), the Ministry of Health and Welfare Family Affairs, Republic of Korea (to BLS), and the Top Brand Project grant, Korea Research Council of Fundamental Science & Technology and KRIBB Initiative program (KGM3110912 to YBK). The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA EM, 1992, J FOOD SCI, V57, P629, DOI 10.1111/j.1365-2621.1992.tb08058.x; AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Carlander D, 2000, IMMUNOL RES, V21, P1, DOI 10.1385/IR:21:1:1; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Gubareva LV, 1998, J INFECT DIS, V178, P1592, DOI 10.1086/314515; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hatta H, 1997, CARIES RES, V31, P268, DOI 10.1159/000262410; Horie K, 2004, J DAIRY SCI, V87, P4073, DOI 10.3168/jds.S0022-0302(04)73549-3; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Kollberg H, 2003, PEDIATR PULM, V35, P433, DOI 10.1002/ppul.10290; Kong L K, 2006, Hong Kong Med J, V12, P489; Kovacs-Nolan J, 2005, J AGR FOOD CHEM, V53, P8421, DOI 10.1021/jf050964f; Larsson A, 2003, UPSALA J MED SCI, V108, P129; LARSSON A, 1993, POULTRY SCI, V72, P1807, DOI 10.3382/ps.0721807; LARSSON A, 1991, CLIN CHEM, V37, P411; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Nilsson E, 2008, J AGR FOOD CHEM, V56, P11638, DOI 10.1021/jf802626t; Nilsson E, 2008, PEDIATR PULM, V43, P892, DOI 10.1002/ppul.20875; Peyre M, 2009, EPIDEMIOL INFECT, V137, P1, DOI 10.1017/S0950268808001039; REED LJ, 1938, AM J HYG, V27; RICHMOND JY, 2007, LAB BIOSAFETY LEVEL; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; RUSSELL MW, 1986, J CLIN IMMUNOL, V6, P74, DOI 10.1007/BF00915367; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Suzuki H, 2004, ALIMENT PHARM THER, V20, P185, DOI 10.1111/j.1365-2036.2004.02027.x; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; The World Health Organization Global Influenza Program Surveillance Network, 2005, EMERG INFECT DIS, V11, P1515; Tominack R L, 1987, Infect Dis Clin North Am, V1, P459; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Walsh WE, 2000, IMMUNOLOGY, V101, P467, DOI 10.1046/j.1365-2567.2000.00136.x; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5	43	51	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10152	10.1371/journal.pone.0010152	http://dx.doi.org/10.1371/journal.pone.0010152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405007	gold, Green Published			2022-12-27	WOS:000276706300008
J	Bottova, I; Sauder, U; Olivieri, V; Hehl, AB; Sonda, S				Bottova, Iveta; Sauder, Ursula; Olivieri, Vesna; Hehl, Adrian B.; Sonda, Sabrina			The P-glycoprotein Inhibitor GF120918 Modulates Ca2+-Dependent Processes and Lipid Metabolism in Toxoplasma Gondii	PLOS ONE			English	Article							REGULATORY VOLUME DECREASE; MULTIDRUG-RESISTANCE; HOST-CELLS; APICOMPLEXAN PARASITES; NEOSPORA-CANINUM; IN-VITRO; INTRACELLULAR CALCIUM; SUBCELLULAR-LOCALIZATION; EXPRESSION ANALYSIS; GLIDING MOTILITY	Up-regulation of the membrane-bound efflux pump P-glycoprotein (P-gp) is associated with the phenomenon of multidrug-resistance in pathogenic organisms, including protozoan parasites. In addition, P-gp plays a role in normal physiological processes, however our understanding of these P-gp functions remains limited. In this study we investigated the effects of the P-gp inhibitor GF120918 in Toxoplasma gondii, a model apicomplexan parasite and an important human pathogen. We found that GF120918 treatment severely inhibited parasite invasion and replication. Further analyses of the molecular mechanisms involved revealed that the P-gp inhibitor modulated parasite motility, microneme secretion and egress from the host cell, all cellular processes known to depend on Ca2+ signaling in the parasite. In support of a potential role of P-gp in Ca2+-mediated processes, immunoelectron and fluorescence microscopy showed that T. gondii Pgp was localized in acidocalcisomes, the major Ca2+ storage in the parasite, at the plasma membrane, and in the intravacuolar tubular network. In addition, metabolic labeling of extracellular parasites revealed that inhibition or down-regulation of T. gondii P-gp resulted in aberrant lipid synthesis. These results suggest a crucial role of T. gondii P-gp in essential processes of the parasite biology and further validate the potential of P-gp activity as a target for drug development.	[Bottova, Iveta; Hehl, Adrian B.; Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Sauder, Ursula; Olivieri, Vesna] Univ Basel, Biozentrum, Basel, Switzerland	University of Zurich; University of Basel	Bottova, I (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	sabrina.sonda@vetparas.uzh.ch		Hehl, Adrian/0000-0002-2110-4445	Marie Heim-Voegtlin Foundation; Fondation Pierre Mercier pour la Science; Swiss National Science Foundation [3100A0-112327]; SBF (Staatssekretariat fur Bildung und Forschung) [C03.0007]	Marie Heim-Voegtlin Foundation; Fondation Pierre Mercier pour la Science; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SBF (Staatssekretariat fur Bildung und Forschung)	This work was supported by grants of the Marie Heim-Voegtlin Foundation and Fondation Pierre Mercier pour la Science to SS and of the Swiss National Science Foundation (Grant nr. 3100A0-112327) and grant C03.0007 (COST Action 857) from the SBF (Staatssekretariat fur Bildung und Forschung) to ABH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; Austin C, 2000, CIRC RES, V86, P355, DOI 10.1161/01.RES.86.3.355; Bardelmeijer HA, 2004, INVEST NEW DRUG, V22, P219, DOI 10.1023/B:DRUG.0000026248.45084.21; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottova I, 2009, J BIOL CHEM, V284, P17438, DOI 10.1074/jbc.M809420200; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Charron AJ, 2002, J CELL SCI, V115, P3049; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Drozdowicz YM, 2003, J BIOL CHEM, V278, P1075, DOI 10.1074/jbc.M209436200; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Ernest S, 1999, J AM SOC NEPHROL, V10, P2306; Evers R, 2000, BRIT J CANCER, V83, P366, DOI 10.1054/bjoc.2000.1260; Ford JM, 1996, EUR J CANCER, V32A, P991, DOI 10.1016/0959-8049(96)00047-0; Fritz F, 1999, BIOCHEMISTRY-US, V38, P4214, DOI 10.1021/bi981929n; Fuchs N, 1998, J PARASITOL, V84, P753, DOI 10.2307/3284583; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hemphill A, 1996, INFECT IMMUN, V64, P4279, DOI 10.1128/IAI.64.10.4279-4287.1996; Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGH KP, 1994, TRANSPLANTATION, V57, P1689, DOI 10.1097/00007890-199457120-00001; Hoff EF, 2002, TRENDS PARASITOL, V18, P251, DOI 10.1016/S1471-4922(02)02240-7; Hoffman MM, 1997, BIOCHEMISTRY-US, V36, P11153, DOI 10.1021/bi970530g; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; HYAFIL F, 1993, CANCER RES, V53, P4595; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Lavine MD, 2008, EUKARYOT CELL, V7, P131, DOI 10.1128/EC.00301-07; Lefurgey A, 2005, J EUKARYOT MICROBIOL, V52, P277, DOI 10.1111/j.1550-7408.2005.00030.x; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Luo SH, 2005, MOL MICROBIOL, V55, P1034, DOI 10.1111/j.1365-2958.2004.04464.x; Maier P, 2006, RADIAT RES, V166, P463, DOI 10.1667/RR0550.1; McAllister MM, 1996, J PARASITOL, V82, P354, DOI 10.2307/3284181; MESTDAGH N, 1994, BIOCHEM PHARMACOL, V48, P709, DOI 10.1016/0006-2952(94)90048-5; Miranda K, 2008, EXP PARASITOL, V118, P2, DOI 10.1016/j.exppara.2007.07.009; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nagamune Kisaburo, 2008, V47, P70; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Persson EK, 2007, J IMMUNOL, V179, P8357, DOI 10.4049/jimmunol.179.12.8357; Robert J, 1998, Expert Opin Investig Drugs, V7, P929, DOI 10.1517/13543784.7.6.929; Rodrigues AC, 2009, EUR J PHARM SCI, V37, P486, DOI 10.1016/j.ejps.2009.04.006; Sauvage V, 2004, MOL BIOCHEM PARASIT, V134, P89, DOI 10.1016/j.molbiopara.2003.08.015; Sauvage V, 2006, MOL BIOCHEM PARASIT, V147, P177, DOI 10.1016/j.molbiopara.2006.02.008; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schmid A, 2009, MOL BIOCHEM PARASIT, V163, P54, DOI 10.1016/j.molbiopara.2008.09.010; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; Silverman JA, 1997, ANTIMICROB AGENTS CH, V41, P1859, DOI 10.1128/AAC.41.9.1859; SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Sulova Z, 2005, BIOCHEM BIOPH RES CO, V335, P777, DOI 10.1016/j.bbrc.2005.07.144; Tamai I, 2000, J PHARM SCI-US, V89, P1371, DOI 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D; TSURUO T, 1984, CANCER RES, V44, P5095; UEDA K, 1992, J BIOL CHEM, V267, P24248; Valverde MA, 1996, EMBO J, V15, P4460, DOI 10.1002/j.1460-2075.1996.tb00823.x; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Wallstab A, 1999, BRIT J CANCER, V79, P1053, DOI 10.1038/sj.bjc.6690169; Ward KW, 2004, J PHARMACOL EXP THER, V310, P703, DOI 10.1124/jpet.104.068288; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Witherspoon SM, 1996, CLIN CANCER RES, V2, P7; Zhang Y, 2003, ADV DRUG DELIVER REV, V55, P31, DOI 10.1016/S0169-409X(02)00170-9	69	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10062	10.1371/journal.pone.0010062	http://dx.doi.org/10.1371/journal.pone.0010062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386707	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000276482000008
J	Fanelli, D				Fanelli, Daniele			"Positive" Results Increase Down the Hierarchy of the Sciences	PLOS ONE			English	Article							STATISTICAL POWER; PUBLICATION BIAS; PARTICLE PHYSICS; ANIMAL BEHAVIOR; PSYCHOLOGY; ECOLOGY; SOFT; DISCIPLINE; JOURNALS; ARTICLES	The hypothesis of a Hierarchy of the Sciences with physical sciences at the top, social sciences at the bottom, and biological sciences in-between is nearly 200 years old. This order is intuitive and reflected in many features of academic life, but whether it reflects the "hardness" of scientific research-i.e., the extent to which research questions and results are determined by data and theories as opposed to non-cognitive factors-is controversial. This study analysed 2434 papers published in all disciplines and that declared to have tested a hypothesis. It was determined how many papers reported a "positive" (full or partial) or "negative" support for the tested hypothesis. If the hierarchy hypothesis is correct, then researchers in "softer" sciences should have fewer constraints to their conscious and unconscious biases, and therefore report more positive outcomes. Results confirmed the predictions at all levels considered: discipline, domain and methodology broadly defined. Controlling for observed differences between pure and applied disciplines, and between papers testing one or several hypotheses, the odds of reporting a positive result were around 5 times higher among papers in the disciplines of Psychology and Psychiatry and Economics and Business compared to Space Science, 2.3 times higher in the domain of social sciences compared to the physical sciences, and 3.4 times higher in studies applying behavioural and social methodologies on people compared to physical and chemical studies on non-biological material. In all comparisons, biological studies had intermediate values. These results suggest that the nature of hypotheses tested and the logical and methodological rigour employed to test them vary systematically across disciplines and fields, depending on the complexity of the subject matter and possibly other factors (e. g., a field's level of historical and/or intellectual development). On the other hand, these results support the scientific status of the social sciences against claims that they are completely subjective, by showing that, when they adopt a scientific approach to discovery, they differ from the natural sciences only by a matter of degree.	[Fanelli, Daniele] Univ Edinburgh, INNOGEN, Edinburgh, Midlothian, Scotland; [Fanelli, Daniele] Univ Edinburgh, ISSTI, Edinburgh, Midlothian, Scotland	Innogenetics NV; University of Edinburgh; University of Edinburgh	Fanelli, D (corresponding author), Univ Edinburgh, INNOGEN, Edinburgh, Midlothian, Scotland.	dfanelli@staffmail.ed.ac.uk		Fanelli, Daniele/0000-0003-1780-1958	Marie Curie Intra-European Fellowship [PIEF-GA-2008-221441]; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish; ESRC [ES/F028180/1] Funding Source: UKRI	Marie Curie Intra-European Fellowship(European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was entirely supported by a Marie Curie Intra-European Fellowship (Grant Agreement Number PIEF-GA-2008-221441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Douglas, 2005, Account Res, V12, P225, DOI 10.1080/08989620500217495; Alatalo RV, 1997, NATURE, V385, P402, DOI 10.1038/385402a0; BARBER TX, 1976, PITFALLS HUMAN RES E; Becher T., 2001, ACAD TRIBES TERRITOR; Best LA, 2001, BEHAV PROCESS, V54, P155, DOI 10.1016/S0376-6357(01)00156-5; BIGLAN A, 1973, J APPL PSYCHOL, V57, P195, DOI 10.1037/h0034701; Bishop R., 2007, PHILOS SOCIAL SCI IN; Breau RH, 2006, J UROLOGY, V176, P263, DOI 10.1016/S0022-5347(06)00505-2; BUNGE M, 1967, PROBLEMS PHILOS SCI; Cole, 2001, WHATS WRONG SOCIOLOG; COLE S, 1994, SOCIOL FORUM, V9, P133, DOI 10.1007/BF01476359; COLE S, 1983, AM J SOCIOL, V89, P111, DOI 10.1086/227835; COLLINS, 2003, COLLINS ENGLISH DICT; Collins H, 2009, NATURE, V458, P30, DOI 10.1038/458030a; Collins Harry, 1993, GOLEM WHAT EVERYONE; Collins HarryM., 1998, GOLEM WHAT YOU SHOUL; Comte Auguste, 1830, COURS PHILOS POSITIV; Conant J. B., 1950, HARVARD CASE STUDIES; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FEIGENBAUM S, 1996, INT J KNOWLEDGE TRAN, V9, P135; GLAESER EL, 2006, NBER TECHNICAL WORKI; HEDGES LV, 1987, AM PSYCHOL, V42, P443, DOI 10.1037/0003-066X.42.5.443; Hendry DavidF., 2000, ECONOMETRICS ALCHEMY, DOI DOI 10.1093/0198293542.003.0021; HUMPHREYS P, 1990, TOPOI-INT REV PHILOS, V9, P157, DOI 10.1007/BF00135895; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JARY D, 1991, DICT SOCIOLOGY; Jeng M, 2007, NUCL INSTRUM METH A, V571, P704, DOI 10.1016/j.nima.2006.11.024; Jennions MD, 2003, BEHAV ECOL, V14, P438, DOI 10.1093/beheco/14.3.438; Jennions MD, 2002, BIOL REV, V77, P211, DOI 10.1017/S1464793101005875; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Klein JR, 2005, ANNU REV NUCL PART S, V55, P141, DOI 10.1146/annurev.nucl.55.090704.151521; Kubina RM, 2008, BEHAV ANALYST, V31, P61, DOI 10.1007/BF03392161; Kuhn T., 1970, STRUCTURE SCI REVOLU; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Laird TFN, 2008, RES HIGH EDUC, V49, P469, DOI 10.1007/s11162-008-9088-5; LANGMUIR I, 1989, PHYS TODAY, V42, P36, DOI 10.1063/1.881205; Latour B, 2000, BRIT J SOCIOL, V51, P107, DOI 10.1111/j.1468-4446.2000.00107.x; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; Lewes G. H., 1853, COMTES PHILOS SCI; LOEHLE C, 1987, Q REV BIOL, V62, P397, DOI 10.1086/415619; Maddock JE, 2001, HEALTH PSYCHOL, V20, P76, DOI 10.1037/027-6133.20.1.76; MALANEY GD, 1986, RES HIGH EDUC, V25, P82, DOI 10.1007/BF00991880; Marsh DM, 2007, ETHOLOGY, V113, P1089, DOI 10.1111/j.1439-0310.2007.01406.x; MEEHL PE, 1978, J CONSULT CLIN PSYCH, V46, P806, DOI 10.1037/0022-006X.46.4.806; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Merton R.K., 1973, SOCIOLOGY SCI THEORE, P497; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Montgomerie B., 2005, ISBE NEWSLETTER, V17, P16; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Palmer AR, 1999, AM NAT, V154, P220, DOI 10.1086/303223; Popper K.R., 1959, LOGIC SCI DISCOVERY; Press J S, 2001, SUBJECTIVITY SCI BAY; Rosenthal, 1976, EXPT EFFECTS BEHAV R; Russell B., 1929, OUR KNOWLEDGE EXTERN; Rzhetsky A, 2006, P NATL ACAD SCI USA, V103, P4940, DOI 10.1073/pnas.0600591103; Shipman M., 1988, LIMITATIONS SOCIAL R; Simonton DK, 2006, REV GEN PSYCHOL, V10, P98, DOI 10.1037/1089-2680.10.2.98; Simonton DK, 2004, REV GEN PSYCHOL, V8, P59, DOI 10.1037/1089-2680.8.1.59; SMART JC, 1982, RES HIGH EDUC, V17, P213, DOI 10.1007/BF00976699; Smith LD, 2000, SOC STUD SCI, V30, P73, DOI 10.1177/030631200030001003; Song F., 2000, HLTH TECHNOLOGY ASSE, V4; STERLING TD, 1995, AM STAT, V49, P108, DOI 10.2307/2684823; STOECKER JL, 1993, RES HIGH EDUC, V34, P451, DOI 10.1007/BF00991854; STORER NW, 1967, B MED LIBR ASSOC, V55, P75; Szasz T, 2006, CURR PSYCHOL, V25, P42, DOI 10.1007/s12144-006-1015-3; Whewell William, 1840, PHILOS INDUCTIVE SCI; WIBLE JR, 1992, PHILOS SOC SCI, V22, P5, DOI 10.1177/004839319202200101; Woods SP, 2006, CLIN NEUROPSYCHOL, V20, P27, DOI 10.1080/13854040500203290; Zammito John H., 2004, NICE DERANGEMENT EPI; Zelder M, 2008, EAST ECON J, V34, P115, DOI 10.1057/palgrave.eej.9050006	72	392	398	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e10068	10.1371/journal.pone.0010068	http://dx.doi.org/10.1371/journal.pone.0010068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580MX	20383332	Green Submitted, Green Published, gold			2022-12-27	WOS:000276454000019
J	Fendel, R; Brandts, C; Rudat, A; Kreidenweiss, A; Steur, C; Appelmann, I; Ruehe, B; Schroder, P; Berdel, WE; Kremsner, PG; Mordmuller, B				Fendel, Rolf; Brandts, Christian; Rudat, Annika; Kreidenweiss, Andrea; Steur, Claudia; Appelmann, Iris; Ruehe, Bettina; Schroeder, Paul; Berdel, Wolfgang E.; Kremsner, Peter G.; Mordmueller, Benjamin			Hemolysis Is Associated with Low Reticulocyte Production Index and Predicts Blood Transfusion in Severe Malarial Anemia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; AFRICAN CHILDREN; INFECTED ERYTHROCYTES; CELL DEFORMABILITY; OXIDATIVE STRESS; RED-CELLS; PHAGOCYTOSIS; ERYTHROPOIESIS; CLEARANCE; ERYTHROPHAGOCYTOSIS	Background: Falciparum Malaria, an infectious disease caused by the apicomplexan parasite Plasmodium falciparum, is among the leading causes of death and morbidity attributable to infectious diseases worldwide. In Gabon, Central Africa, one out of four inpatients have severe malarial anemia (SMA), a life-threatening complication if left untreated. Emerging drug resistant parasites might aggravate the situation. This case control study investigates biomarkers of enhanced hemolysis in hospitalized children with either SMA or mild malaria (MM). Methods and Findings: Ninety-one children were included, thereof 39 SMA patients. Strict inclusion criteria were chosen to exclude other causes of anemia. At diagnosis, erythrophagocytosis (a direct marker for extravascular hemolysis, EVH) was enhanced in SMA compared to MM patients (5.0 arbitrary units (AU) (interquartile range (IR): 2.2-9.6) vs. 2.1 AU (IR: 1.3-3.9), p<0.01). Furthermore, indirect markers for EVH, (i.e. serum neopterin levels, spleen size enlargement and monocyte pigment) were significantly increased in SMA patients. Markers for erythrocyte ageing, such as CD35 (complement receptor 1), CD55 (decay acceleration factor) and phosphatidylserine exposure (annexin-V-binding) were investigated by flow cytometry. In SMA patients, levels of CD35 and CD55 on the red blood cell surface were decreased and erythrocyte removal markers were increased when compared to MM or reconvalescent patients. Additionally, intravascular hemolysis (IVH) was quantified using several indirect markers (LDH, alpha-HBDH, haptoglobin and hemopexin), which all showed elevated IVH in SMA. The presence of both IVH and EVH predicted the need for blood transfusion during antimalarial treatment (odds ratio 61.5, 95% confidence interval (CI): 8.9-427). Interestingly, this subpopulation is characterized by a significantly lowered reticulocyte production index (RPI, p<0.05). Conclusions: Our results show the multifactorial pathophysiology of SMA, whereby EVH and IVH play a particularly important role. We propose a model where removal of infected and non-infected erythrocytes of all ages (including reticulocytes) by EVH and IVH is a main mechanism of SMA. Further studies are underway to investigate the mechanism and extent of reticulocyte removal to identify possible interventions to reduce the risk of SMA development.	[Fendel, Rolf; Brandts, Christian; Rudat, Annika; Kreidenweiss, Andrea; Steur, Claudia; Appelmann, Iris; Ruehe, Bettina; Schroeder, Paul; Kremsner, Peter G.; Mordmueller, Benjamin] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Fendel, Rolf; Kreidenweiss, Andrea; Kremsner, Peter G.; Mordmueller, Benjamin] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Fendel, Rolf] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Brandts, Christian; Rudat, Annika; Appelmann, Iris; Berdel, Wolfgang E.] Univ Munster, Dept Med, Munster, Germany; [Brandts, Christian] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany	Eberhard Karls University of Tubingen; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Munster; Goethe University Frankfurt	Fendel, R (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	benjamin.mordmueller@uni-tuebingen.de	Mordmüller, Benjamin/A-5749-2010; Fendel, Rolf/K-3985-2013	Mordmüller, Benjamin/0000-0001-9101-2768; Fendel, Rolf/0000-0003-4716-0311; Kreidenweiss, Andrea/0000-0002-5025-7221; Brandts, Christian H./0000-0003-1732-2535	Deutsche Forschungsgemeinschaft [DFG MO 1071/4-1, BR 1945/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a grant (DFG MO 1071/4-1 and BR 1945/6-1) from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akech SO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-256; [Anonymous], 2008, WORLD MAL REP 2008; Ayi K, 2005, INFECT IMMUN, V73, P2559, DOI 10.1128/IAI.73.4.2559-2563.2005; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Casals-Pascual C, 2006, CURR MOL MED, V6, P155, DOI 10.2174/156652406776055159; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; COLEBUNDERS R, 1991, J INFECT DIS, V164, P450, DOI 10.1093/infdis/164.3.450; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Craig ML, 2005, J IMMUNOL, V174, P3059, DOI 10.4049/jimmunol.174.5.3059; DAVIS TME, 1990, J CLIN INVEST, V86, P793, DOI 10.1172/JCI114776; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; Dondorp AM, 2003, REDOX REP, V8, P292, DOI 10.1179/135100003225002934; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Fendel R, 2007, CYTOM PART A, V71A, P258, DOI 10.1002/cyto.a.20360; Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Helbok R, 2006, AM J TROP MED HYG, V75, P443, DOI 10.4269/ajtmh.2006.75.443; Helegbe GK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-165; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; Kremsner PG, 2009, J INFECT DIS, V199, P142, DOI 10.1086/595295; KREMSNER PG, 1995, ANTIMICROB AGENTS CH, V39, P1603, DOI 10.1128/AAC.39.7.1603; Kremsner PG, 2000, LANCET, V355, P40, DOI 10.1016/S0140-6736(99)04761-3; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Mahaffy JM, 1998, J THEOR BIOL, V190, P135, DOI 10.1006/jtbi.1997.0537; Mandal D, 2002, FEBS LETT, V513, P184, DOI 10.1016/S0014-5793(02)02294-9; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; McQueen PG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000149; Metzger WG, 1995, T ROY SOC TROP MED H, V89, P637, DOI 10.1016/0035-9203(95)90423-9; Moore A, 2001, LANCET, V358, P657, DOI 10.1016/S0140-6736(01)05783-X; Mordmuller B, 1998, CLIN INFECT DIS, V26, P850, DOI 10.1086/513926; Mordmuller BG, 1997, EUR CYTOKINE NETW, V8, P29; NEWTON CRJC, 1992, LANCET, V340, P917, DOI 10.1016/0140-6736(92)93334-J; Nuchsongsin F, 2007, AM J TROP MED HYG, V77, P617, DOI 10.4269/ajtmh.2007.77.617; Nyakoe NK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-7; Owuor B, 2008, MOL MED, V14, P89, DOI 10.2119/2007-00093.Owuor; OYAKHIROME S, 2010, AM J TROP M IN PRESS; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Riley RS, 2001, J CLIN LAB ANAL, V15, P267, DOI 10.1002/jcla.1039; Safeukui I, 2008, BLOOD, V112, P2520, DOI 10.1182/blood-2008-03-146779; Team RDC, 2019, R LANG ENV STAT COMP; Waitumbi JN, 2004, J INFECT DIS, V190, P1183, DOI 10.1086/423140; Waitumbi JN, 2000, BLOOD, V95, P1481, DOI 10.1182/blood.V95.4.1481.004k15_1481_1486; Wiesner J, 1997, EUR J IMMUNOL, V27, P2708, DOI 10.1002/eji.1830271034	47	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10038	10.1371/journal.pone.0010038	http://dx.doi.org/10.1371/journal.pone.0010038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386613	Green Published, gold, Green Submitted			2022-12-27	WOS:000276420400010
J	Krill, AM; Kirst, M; Kochian, LV; Buckler, ES; Hoekenga, OA				Krill, Allison M.; Kirst, Matias; Kochian, Leon V.; Buckler, Edward S.; Hoekenga, Owen A.			Association and Linkage Analysis of Aluminum Tolerance Genes in Maize	PLOS ONE			English	Article							ACID-SOIL TOLERANCE; GENOTYPIC DIFFERENCES; MALATE TRANSPORTERS; ROOT ELONGATION; COMPLEX TRAITS; RESISTANCE; TOXICITY; INHIBITION; EXUDATION; SELECTION	Background: Aluminum (Al) toxicity is a major worldwide constraint to crop productivity on acidic soils. Al becomes soluble at low pH, inhibiting root growth and severely reducing yields. Maize is an important staple food and commodity crop in acidic soil regions, especially in South America and Africa where these soils are very common. Al exclusion and intracellular tolerance have been suggested as two important mechanisms for Al tolerance in maize, but little is known about the underlying genetics. Methodology: An association panel of 282 diverse maize inbred lines and three F-2 linkage populations with approximately 200 individuals each were used to study genetic variation in this complex trait. Al tolerance was measured as net root growth in nutrient solution under Al stress, which exhibited a wide range of variation between lines. Comparative and physiological genomics-based approaches were used to select 21 candidate genes for evaluation by association analysis. Conclusions: Six candidate genes had significant results from association analysis, but only four were confirmed by linkage analysis as putatively contributing to Al tolerance: Zea mays AltSB like (ZmASL), Zea mays aluminum-activated malate transporter2 (ALMT2), S-adenosyl-L-homocysteinase (SAHH), and Malic Enzyme (ME). These four candidate genes are high priority subjects for follow-up biochemical and physiological studies on the mechanisms of Al tolerance in maize. Immediately, elite haplotype-specific molecular markers can be developed for these four genes and used for efficient marker-assisted selection of superior alleles in Al tolerance maize breeding programs.	[Krill, Allison M.; Kochian, Leon V.; Buckler, Edward S.; Hoekenga, Owen A.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Krill, Allison M.; Buckler, Edward S.; Hoekenga, Owen A.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Kirst, Matias; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Kirst, Matias] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Kochian, Leon V.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA	United States Department of Agriculture (USDA); Cornell University; Cornell University; State University System of Florida; University of Florida; Cornell University	Krill, AM (corresponding author), USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	Owen.Hoekenga@ars.usda.gov	Kochian, Leon/ABH-6148-2020; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Kochian, Leon/0000-0003-3416-089X; Buckler, Edward/0000-0002-3100-371X; Hoekenga, Owen/0000-0003-4427-2000	National Science Foundation (NSF) [0419435, 0453331]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Base Funds	National Science Foundation (NSF)(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Base Funds(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research described here was supported in part by an award from the National Science Foundation (NSF) Plant Genome Research Program (http://www.nsf.gov/dir/index.jsp?org=BIO; DBI # 0419435) to LVK, OAH, and ESB. Ms. Pleiman (Ball State University) and Mr. Thornblade (Hamilton College) were interns supported by an award from NSF Plant Genome Research Research Experience for Undergraduates (DBI # 0453331) to the Boyce Thompson Institute for Plant Research (G. Jander) and Cornell University (T. Owens). The research was also supported in part by United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Base Funds to LVK and ESB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Delhaize E, 2007, FEBS LETT, V581, P2255, DOI 10.1016/j.febslet.2007.03.057; Detarsio E, 2008, PLANT MOL BIOL, V68, P355, DOI 10.1007/s11103-008-9375-8; EDMEADES G, 1995, PHYSL STRESS RESISTA; Eticha D, 2005, PLANT CELL ENVIRON, V28, P1410, DOI 10.1111/j.1365-3040.2005.01375.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fontecha G, 2007, THEOR APPL GENET, V114, P249, DOI 10.1007/s00122-006-0427-7; Fu Y, 2005, P NATL ACAD SCI USA, V102, P12282, DOI 10.1073/pnas.0503394102; Garvin D. F., 2003, Handbook of soil acidity, P387; GRANADOS G, 1993, CROP SCI, V33, P936, DOI 10.2135/cropsci1993.0011183X003300050012x; HALL T, BIOLIGN 4 0 7 COMPUT; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Jones DL, 2006, PLANT CELL ENVIRON, V29, P1309, DOI 10.1111/j.1365-3040.2006.01509.x; JONES DL, 1995, PLANTA, V197, P672; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kollmeier M, 2000, PLANT PHYSIOL, V122, P945, DOI 10.1104/pp.122.3.945; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; Li CH, 2008, PLANTA, V228, P125, DOI 10.1007/s00425-008-0724-2; Ligaba A, 2006, PLANT PHYSIOL, V142, P1294, DOI 10.1104/pp.106.085233; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Magalhaes JV, 2004, GENETICS, V167, P1905, DOI 10.1534/genetics.103.023580; Magnavaca R., 1987, Genetic aspects of plant mineral nutrition, 16-20 June, 1985, Madison, USA, P255; Maron LG, 2008, NEW PHYTOL, V179, P116, DOI 10.1111/j.1469-8137.2008.02440.x; MASON PA, 2005, THESIS CORNELL U ITH; Ninamango-Cardenas FE, 2003, EUPHYTICA, V130, P223, DOI 10.1023/A:1022867416513; Pandey S., 2007, Plant Breeding Reviews, V28, P59; PANDEY S, 1994, CROP SCI, V34, P1511, DOI 10.2135/cropsci1994.0011183X003400060018x; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; Pineros MA, 2005, PLANT PHYSIOL, V137, P231, DOI 10.1104/pp.104.047357; Pineros MA, 2008, PLANT PHYSIOL, V147, P2131, DOI 10.1104/pp.108.119636; Pineros MA, 2008, PLANT J, V53, P352, DOI 10.1111/j.1365-313X.2007.03344.x; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; RAO IM, 1993, BIOSCIENCE, V43, P454, DOI 10.2307/1311905; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; RYAN PR, 1992, PLANT PHYSIOL, V99, P1193, DOI 10.1104/pp.99.3.1193; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sibov ST, 1999, GENOME, V42, P475, DOI 10.1139/gen-42-3-475; *SOFTB INC, PRED PROT SEC STRUCT; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; UEXKULL HR, 1995, PLANT SOIL INTERACTI, P5; UrreaGomez R, 1996, AGRON J, V88, P806, DOI 10.2134/agronj1996.00021962008800050020x; Vargas-Duque J, 1994, CROP SCI, V34, P50; Wang JK, 2007, THEOR APPL GENET, V115, P87, DOI 10.1007/s00122-007-0545-x; Welcker C, 2005, CROP SCI, V45, P2405, DOI 10.2135/cropsci2004.0606; Weretilnyk EA, 2001, PLANT PHYSIOL, V125, P856, DOI 10.1104/pp.125.2.856; Whitt Sr, 2003, METH MOL B, V236, P123; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yang JL, 2008, PLANT PHYSIOL, V146, P602, DOI 10.1104/pp.107.111989; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	59	68	74	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9958	10.1371/journal.pone.0009958	http://dx.doi.org/10.1371/journal.pone.0009958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376361	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200033
J	Saito, K; Hatsugai, N; Horikawa, K; Kobayashi, K; Matsu-ura, T; Mikoshiba, K; Nagai, T				Saito, Kenta; Hatsugai, Noriyuki; Horikawa, Kazuki; Kobayashi, Kentaro; Matsu-ura, Toru; Mikoshiba, Katsuhiko; Nagai, Takeharu			Auto-Luminescent Genetically-Encoded Ratiometric Indicator for Real-Time Ca2+ Imaging at the Single Cell Level	PLOS ONE			English	Article							FLUORESCENT INDICATORS; PROTEIN; AEQUORIN; RESISTANCE; CALCIUM	Background: Efficient bioluminescence resonance energy transfer (BRET) from a bioluminescent protein to a fluorescent protein with high fluorescent quantum yield has been utilized to enhance luminescence intensity, allowing single-cell imaging in near real time without external light illumination. Methodology/Principal Findings: We applied BRET to develop an autoluminescent Ca2+ indicator, BRAC, which is composed of Ca2+-binding protein, calmodulin, and its target peptide, M13, sandwiched between a yellow fluorescent protein variant, Venus, and an enhanced Renilla luciferase, RLuc8. Adjusting the relative dipole orientation of the luminescent protein's chromophores improved the dynamic range of BRET signal change in BRAC up to 60%, which is the largest dynamic range among BRET-based indicators reported so far. Using BRAC, we demonstrated successful visualization of Ca2+ dynamics at the single-cell level with temporal resolution at 1 Hz. Moreover, BRAC signals were acquired by ratiometric imaging capable of canceling out Ca2+-independent signal drifts due to change in cell shape, focus shift, etc. Conclusions/Significance: The brightness and large dynamic range of BRAC should facilitate high-sensitive Ca2+ imaging not only in single live cells but also in small living subjects.	[Saito, Kenta; Hatsugai, Noriyuki; Horikawa, Kazuki; Kobayashi, Kentaro; Nagai, Takeharu] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Hatsugai, Noriyuki] Hokkaido Univ, Res Ctr Cooperat Projects, Kita Ku, Sapporo, Hokkaido, Japan; [Matsu-ura, Toru; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Nagai, Takeharu] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	Hokkaido University; Hokkaido University; RIKEN; Japan Science & Technology Agency (JST)	Saito, K (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Kita 20,Nishi 10, Sapporo, Hokkaido, Japan.	tnagai@es.hokudai.ac.jp	Saito, Kenta/G-2443-2010; Matsu-ura, Toru/P-3461-2017; Mikoshiba, Katsuhiko/N-7943-2015; Hatsugai, Noriyuki/O-9156-2015	Saito, Kenta/0000-0003-4147-255X; Matsu-ura, Toru/0000-0002-9876-3086; Hatsugai, Noriyuki/0000-0002-5708-4263; Nagai, Takeharu/0000-0003-2650-9895; Horikawa, Kazuki/0000-0002-9285-4171	Ministry of Labor, Health and Welfare of Japan; Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency	Ministry of Labor, Health and Welfare of Japan; Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency	This work was partly supported by grants from Scientific Research on Advanced Medical Technology of the Ministry of Labor, Health and Welfare of Japan, and Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Dacres H, 2009, ANAL BIOCHEM, V385, P194, DOI 10.1016/j.ab.2008.10.040; De A, 2009, FASEB J, V23, P2702, DOI 10.1096/fj.08-118919; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hoshino H, 2007, NAT METHODS, V4, P637, DOI 10.1038/NMETH1069; Kaihara A, 2008, ANAL SCI, V24, P1405, DOI 10.2116/analsci.24.1405; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim SB, 2009, ANAL CHEM, V81, P67, DOI 10.1021/ac801658y; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; SHIMOMURA O, 1993, BIOCHEM J, V296, P549, DOI 10.1042/bj2960549; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P159, DOI 10.1142/9789812773647_0005; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	21	47	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9935	10.1371/journal.pone.0009935	http://dx.doi.org/10.1371/journal.pone.0009935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376337	Green Published, gold			2022-12-27	WOS:000276418200012
J	Abbatecola, AM; Lattanzio, F; Spazzafumo, L; Molinari, AM; Cioffi, M; Canonico, R; DiCioccio, L; Paolisso, G				Abbatecola, Angela Marie; Lattanzio, Fabrizia; Spazzafumo, Liana; Molinari, Anna Maria; Cioffi, Michele; Canonico, Raffaele; DiCioccio, Luigi; Paolisso, Giuseppe			Adiposity Predicts Cognitive Decline in Older Persons with Diabetes: A 2-Year Follow-Up	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE; PLASMA-GLUCOSE; DEMENTIA; OBESITY; RISK; HYPERTENSION; INFLAMMATION; ADIPONECTIN	Background: The mechanisms related to cognitive impairment in older persons with Type 2 diabetes (DM) remains unclear. We tested if adiposity parameters and body fat distribution could predict cognitive decline in older persons with DM vs. normal glucose tolerance (NGT). Methodology: 693 older persons with no dementia were enrolled: 253 with DM in good metabolic control; 440 with NGT (age range: 65-85 years). Longitudinal study comparing DM and NGT individuals according to the association of baseline adiposity parameters (body mass index (BMI), waist-hip-ratio (WHR), waist circumference (WC) and total body fat mass) to cognitive change (Mini Mental State Examination (MMSE), a composite score of executive and attention functioning (CCS) over time. Findings: At baseline, in DM participants, MMSE correlated with WHR (beta = -0.240; p = 0.043), WC (beta = -0.264; p = 0.041) while CCS correlated with WHR (beta = -0.238; p = 0.041), WC (beta = -0.326; p = 0.013) after adjusting for confounders. In NGT subjects, no significant correlations were found among any adiposity parameters and MMSE, while CCS was associated with WHR (beta = -0.194; p = 0.036) and WC (beta = -0.210; p = 0.024). Participants with DM in the 3(rd) tertile of total fat mass showed the greatest decline in cognitive performance compared to those in 1(st) tertile (tests for trend: MMSE(p = 0.007), CCS(p = 0.003)). Logistic regression models showed that 3(rd) vs. 1(st) tertile of total fat mass, WHR, and WC predicted an almost two-fold decline in cognitive function in DM subjects at 2(nd) yr (OR 1.68, 95% IC 1.08-3.52). Conclusions: Total fat mass and central adiposity predict an increased risk for cognitive decline in older person with DM.	[Abbatecola, Angela Marie; Lattanzio, Fabrizia] Italian Natl Res Ctr Aging, Sci Direct, Ancona, Italy; [Spazzafumo, Liana] Italian Natl Inst Aging, Dept Gerontol Res, Stat & Biometry Ctr, Ancona, Italy; [Molinari, Anna Maria; Cioffi, Michele] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Canonico, Raffaele; Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr Med & Metab Dis, Naples, Italy; [DiCioccio, Luigi] Santa Scolast Hosp, Dept Geriatr Med, Cassino, Italy	IRCCS INRCA; IRCCS INRCA; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Abbatecola, AM (corresponding author), Italian Natl Res Ctr Aging, Sci Direct, Ancona, Italy.	giuseppe.paolisso@unina2.it	paolisso, giuseppe/AAP-8516-2020; Spazzafumo, Liana/E-5488-2015; Lattanzio, Fabrizia/D-2896-2018	paolisso, giuseppe/0000-0002-2137-455X; Lattanzio, Fabrizia/0000-0003-4051-1289; Spazzafumo, Liana/0000-0002-9718-1658; CIOFFI, Michele/0000-0003-3883-111X; MOLINARI, Anna Maria/0000-0002-6503-432X				Abbatecola AM, 2006, NEUROLOGY, V67, P235, DOI 10.1212/01.wnl.0000224760.22802.e8; Beydoun MA, 2008, AM J EPIDEMIOL, V168, P1179, DOI 10.1093/aje/kwn229; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Geroldi C, 2005, ARCH NEUROL-CHICAGO, V62, P1067, DOI 10.1001/archneur.62.7.1067; Han Changsu, 2009, Arch Gerontol Geriatr, V49, pe133, DOI 10.1016/j.archger.2008.11.005; Holden KF, 2009, NEUROBIOL AGING, V30, P1483, DOI 10.1016/j.neurobiolaging.2007.11.024; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Muggeo M, 1997, CIRCULATION, V96, P1750, DOI 10.1161/01.CIR.96.6.1750; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ritchie JD, 2005, J AM DIET ASSOC, V105, P1617, DOI 10.1016/j.jada.2005.07.011; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Sam S, 2009, DIABETES CARE, V32, P932, DOI 10.2337/dc08-1856; Thomson R, 2007, CLIN NUTR, V26, P771, DOI 10.1016/j.clnu.2007.08.003; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	29	22	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10333	10.1371/journal.pone.0010333	http://dx.doi.org/10.1371/journal.pone.0010333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428239	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300017
J	Wheldon, LM; Haines, BP; Rajappa, R; Mason, I; Rigby, PW; Heath, JK				Wheldon, Lee M.; Haines, Bryan P.; Rajappa, Rajit; Mason, Ivor; Rigby, Peter W.; Heath, John K.			Critical Role of FLRT1 Phosphorylation in the Interdependent Regulation of FLRT1 Function and FGF Receptor Signalling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTORS; PROMOTES NEURITE OUTGROWTH; SENSORY NEURONS; CELL-ADHESION; FUTILE CYCLES; EXPRESSION; PROTEINS; FAMILY; DOMAIN; SRC	Background: Fibronectin leucine rich transmembrane (FLRT) proteins have dual properties as regulators of cell adhesion and potentiators of fibroblast growth factor (FGF) mediated signalling. The mechanism by which the latter is achieved is still unknown and is the subject of this investigation. Principal Findings: Here we show that FLRT1 is a target for tyrosine phosphorylation mediated by FGFR1 and implicate a non-receptor Src family kinase (SFK). We identify the target tyrosine residues in the cytoplasmic domain of FLRT1 and show that these are not direct substrates for Src kinase suggesting that the SFK may exert effects via potentiation of FGFR1 kinase activity. We show that whilst FLRT1 expression results in a ligand-dependent elevation of MAP kinase activity, a mutant version of FLRT1, defective as an FGFR1 kinase substrate (Y3F-FLRT1), has the property of eliciting ligand-independent chronic activation of the MAP kinase pathway which is suppressed by pharmacological inhibition of either FGFR1 or Src kinase. Functional investigation of FGFR1 and FLRT1 signalling in SH-SY5Y neuroblastoma cells reveals that FLRT1 alone acts to induce a multi-polar phenotype whereas the combination of FLRT1 and FGFR activation, or expression of Y3F-FLRT1, acts to induce neurite outgrowth via MAPK activation. Similar results were obtained in a dendrite outgrowth assay in primary hippocampal neurons. We also show that FGFR1, FLRT1 and activated Src are co-localized and this complex is trafficked toward the soma of the cell. The presence of Y3F-FLRT1 rather than FLRT1 resulted in prolonged localization of this complex within the neuritic arbour. Conclusions: This study shows that the phosphorylation state of FLRT1, which is itself FGFR1 dependent, may play a critical role in the potentiation of FGFR1 signalling and may also depend on a SFK-dependent phosphorylation mechanism acting via the FGFR. This is consistent with an 'in vivo' role for FLRT1 regulation of FGF signalling via SFKs. Furthermore, the phosphorylation-dependent futile cycle mechanism controlling FGFR1 signalling is concurrently crucial for regulation of FLRT1-mediated neurite outgrowth.	[Wheldon, Lee M.] Univ Nottingham, MBIG, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Haines, Bryan P.; Rigby, Peter W.] Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, London SW3 6JB, England; [Rajappa, Rajit; Mason, Ivor] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Heath, John K.] Univ Birmingham, Canc Res UK Growth Factor Grp, Sch Biosci, Birmingham, W Midlands, England	University of Nottingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; University of Birmingham	Wheldon, LM (corresponding author), Univ Nottingham, MBIG, Ctr Biomol Sci, Nottingham NG7 2RD, England.	j.k.heath@bham.ac.uk	Mason, Ivor/B-1859-2008	Mason, Ivor/0000-0001-8390-3050; Heath, John/0000-0003-4886-4070	Cancer Research UK; Medical Research Council; Wellcome Trust; Fp6 Endotrack; MRC [G0401199] Funding Source: UKRI; Cancer Research UK [10171] Funding Source: researchfish; Medical Research Council [G0401199] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fp6 Endotrack; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Cancer Research UK (www.cancer.org.uk), the Medical Research Council (www.mrc.ac.uk), the Wellcome Trust (www.wellcome.ac.uk), and Fp6 Endotrack (www.endotrack.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Haines BP, 2006, DEV BIOL, V297, P14, DOI 10.1016/j.ydbio.2006.04.004; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hausott B, 2008, NEUROSCIENCE, V153, P461, DOI 10.1016/j.neuroscience.2008.01.083; Huang P, 2005, CYTOKINE GROWTH F R, V16, P151, DOI 10.1016/j.cytogfr.2005.03.002; JANET T, 1995, J NEUROSCI RES, V40, P707, DOI 10.1002/jnr.490400602; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Krause C, 2006, DEV BIOL, V296, P253, DOI 10.1016/j.ydbio.2006.04.462; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Maretto S, 2008, DEV BIOL, V318, P184, DOI 10.1016/j.ydbio.2008.03.021; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Pruss T, 2006, MOL CELL NEUROSCI, V31, P354, DOI 10.1016/j.mcn.2005.10.009; Qian H, 2006, IEE P SYST BIOL, V153, P192, DOI 10.1049/ip-syb:20050086; Raguenez G, 1999, BIOCHEM BIOPH RES CO, V258, P745, DOI 10.1006/bbrc.1999.0613; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; SHOLL DA, 1953, J ANAT, V87, P387; Smith TG, 2006, INT J DEV BIOL, V50, P701, DOI 10.1387/ijdb.062192ts; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tsuji L, 2004, BIOCHEM BIOPH RES CO, V313, P1086, DOI 10.1016/j.bbrc.2003.12.047; Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615	30	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10264	10.1371/journal.pone.0010264	http://dx.doi.org/10.1371/journal.pone.0010264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421966	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952600004
J	Hioe, CE; Wrin, T; Seaman, MS; Yu, XS; Wood, B; Self, S; Williams, C; Gorny, MK; Zolla-Pazner, S				Hioe, Catarina E.; Wrin, Terri; Seaman, Michael S.; Yu, Xuesong; Wood, Blake; Self, Steve; Williams, Constance; Gorny, Miroslaw K.; Zolla-Pazner, Susan			Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; V3 DOMAIN; TYPE-1 INFECTION; CLADE-B; CORECEPTOR SELECTIVITY; ENVELOPE GLYCOPROTEIN; CROSS-REACTIVITY; STRUCTURAL BASIS; BINDING MODE; ENV CLONES	Background: The V3 loop of the HIV-1 envelope (Env) glycoprotein gp120 was identified as the "principal neutralizing domain'' of HIV-1, but has been considered too variable to serve as a neutralizing antibody (Ab) target. Structural and immunochemical data suggest, however, that V3 contains conserved elements which explain its role in binding to virus co-receptors despite its sequence variability. Despite this evidence of V3 conservation, the ability of anti-V3 Abs to neutralize a significant proportion of HIV-1 isolates from different subtypes (clades) has remained controversial. Methods: HIV-1 neutralization experiments were conducted in two independent laboratories to test human anti-V3 monoclonal Abs (mAbs) against pseudoviruses (psVs) expressing Envs of diverse HIV-1 subtypes from subjects with acute and chronic infections. Neutralization was defined by 50% inhibitory concentrations (IC(50)), and was statistically assessed based on the area under the neutralization titration curves (AUC). Results: Using AUC analyses, statistically significant neutralization was observed by >= 1 anti-V3 mAbs against 56/98 (57%) psVs expressing Envs of diverse subtypes, including subtypes A, AG, B, C and D. Even when the 10 Tier 1 psVs tested were excluded from the analysis, significant neutralization was detected by >= 1 anti-V3 mAbs against 46/88 (52%) psVs from diverse HIV-1 subtypes. Furthermore, 9/24 (37.5%) Tier 2 viruses from the clade B and C standard reference panels were neutralized by >= 1 anti-V3 mAbs. Each anti-V3 mAb tested was able to neutralize 28-42% of the psVs tested. By IC(50) criteria, 40/98 (41%) psVs were neutralized by >= 1 anti-V3 mAbs. Conclusions: Using standard and new statistical methods of data analysis, 6/7 anti-V3 human mAbs displayed cross-clade neutralizing activity and revealed that a significant proportion of viruses can be neutralized by anti-V3 Abs. The new statistical method for analysis of neutralization data provides many advantages to previously used analyses.	[Hioe, Catarina E.; Williams, Constance; Gorny, Miroslaw K.; Zolla-Pazner, Susan] NYU, Dept Pathol, Langone Sch Med, New York, NY 10016 USA; [Hioe, Catarina E.; Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA; [Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Viral Pathogenesis, Boston, MA 02215 USA; [Yu, Xuesong; Wood, Blake; Self, Steve] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA	New York University; NYU Langone Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fred Hutchinson Cancer Center	Hioe, CE (corresponding author), NYU, Dept Pathol, Langone Sch Med, 550 1St Ave, New York, NY 10016 USA.	catarina.hioe@nyumc.org	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666; Gorny, Miroslaw/0000-0002-2714-8780	Bill and Melinda Gates Foundation; National Institutes of Health [HL59725, AI36085]; New York University Center for AIDS Research [AI27742]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036085, P30AI027742] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Center for AIDS Research; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grants from the Bill and Melinda Gates Foundation, National Institutes of Health grants (HL59725 and AI36085), the Immunology Core of the New York University Center for AIDS Research (AI27742), and by research funds from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND D, AIDS RES HU IN PRESS; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cardozo T, 2009, AIDS RES HUM RETROV, V25, P441, DOI 10.1089/aid.2008.0188; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; CORTI D, PLOS ONE, V5, pE8805; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hill CM, 1997, J VIROL, V71, P6296, DOI 10.1128/JVI.71.9.6296-6304.1997; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; KAYMAN SC, 1994, J VIROL, V68, P400, DOI 10.1128/JVI.68.1.400-410.1994; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Krachmarov CP, 2001, AIDS RES HUM RETROV, V17, P1737, DOI 10.1089/08892220152741432; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Losman B, 2001, AIDS RES HUM RETROV, V17, P1067, DOI 10.1089/088922201300343753; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MOORE JP, 1995, J VIROL, V69, P122, DOI 10.1128/JVI.69.1.122-130.1995; NANDI A, VIROLOGY, V396, P339; Nolan KM, 2009, J VIROL, V83, P3798, DOI 10.1128/JVI.01751-08; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Seaman MS, J VIROL, V84, P1439; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039; ZWART G, 1991, VIROLOGY, V181, P481, DOI 10.1016/0042-6822(91)90880-K	63	95	102	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10254	10.1371/journal.pone.0010254	http://dx.doi.org/10.1371/journal.pone.0010254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20421997	Green Submitted, Green Published, gold			2022-12-27	WOS:000276952500015
J	Bianchi, L; Diez-Sampedro, A				Bianchi, Laura; Diez-Sampedro, Ana			A Single Amino Acid Change Converts the Sugar Sensor SGLT3 into a Sugar Transporter	PLOS ONE			English	Article							GLUCOSE-GALACTOSE MALABSORPTION; RABBIT SMALL-INTESTINE; NA+/GLUCOSE COTRANSPORTER; CAENORHABDITIS-ELEGANS; C-ELEGANS; CHEMOSENSORY NEURONS; VOLTAGE-CLAMP; CLC PROTEINS; CHANNELS; GENETICS	Background: Sodium-glucose cotransporter proteins ( SGLT) belong to the SLC5A family, characterized by the cotransport of Na(+) with solute. SGLT1 is responsible for intestinal glucose absorption. Until recently the only role described for SGLT proteins was to transport sugar with Na+. However, human SGLT3 (hSGLT3) does not transport sugar but causes depolarization of the plasma membrane when expressed in Xenopus oocytes. For this reason SGLT3 was suggested to be a sugar sensor rather than a transporter. Despite 70% amino acid identity between hSGLT3 and hSGLT1, their sugar transport, apparent sugar affinities, and sugar specificity differ greatly. Residue 457 is important for the function of SGLT1 and mutation at this position in hSGLT1 causes glucose-galactose malabsorption. Moreover, the crystal structure of vibrio SGLT reveals that the residue corresponding to 457 interacts directly with the sugar molecule. We thus wondered if this residue could account for some of the functional differences between SGLT1 and SGLT3. Methodology/Principal Findings: We mutated the glutamate at position 457 in hSGLT3 to glutamine, the amino acid present in all SGLT1 proteins, and characterized the mutant. Surprisingly, we found that E457Q-hSGLT3 transported sugar, had the same stoichiometry as SGLT1, and that the sugar specificity and apparent affinities for most sugars were similar to hSGLT1. We also show that SGLT3 functions as a sugar sensor in a living organism. We expressed hSGLT3 and E457Q-hSGLT3 in C. elegans sensory neurons and found that animals sensed glucose in an hSGLT3-dependent manner. Conclusions/Significance: In summary, we demonstrate that hSGLT3 functions as a sugar sensor in vivo and that mutating a single amino acid converts this sugar sensor into a sugar transporter similar to SGLT1.	[Bianchi, Laura; Diez-Sampedro, Ana] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of Miami	Bianchi, L (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	adiezsampedro@med.miami.edu	Alshali, Rasha A/K-8051-2012		Florida Biomedical Research Program [08KN-02-17217]; American Cancer Society [RGS-09-043-01-DDC]	Florida Biomedical Research Program; American Cancer Society(American Cancer Society)	This work was supported by a Florida Biomedical Research Program grant to ADS (08KN-02-17217, www.floridabiomed.com) and an American Cancer Society grant to LB (RGS-09-043-01-DDC, www.cancer.org/docroot/home/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Ashcroft F, 2009, PHILOS T R SOC B, V364, P145, DOI 10.1098/rstb.2008.0245; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BIRNIR B, 1991, PFLUG ARCH EUR J PHY, V418, P79, DOI 10.1007/BF00370455; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; DEAN PM, 1968, NATURE, V219, P389, DOI 10.1038/219389a0; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Diez-Sampedro A, 2001, AM J PHYSIOL-RENAL, V280, pF278, DOI 10.1152/ajprenal.2001.280.2.F278; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Freeman SL, 2006, AM J PHYSIOL-GASTR L, V291, pG439, DOI 10.1152/ajpgi.00079.2006; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hevener AL, 1997, DIABETES, V46, P1521, DOI 10.2337/diabetes.46.9.1521; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; IKEDA TS, 1989, J MEMBRANE BIOL, V110, P87, DOI 10.1007/BF01870995; Lam JT, 1999, BBA-MOL BASIS DIS, V1453, P297, DOI 10.1016/S0925-4439(98)00109-4; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lisal J, 2009, PHILOS T R SOC B, V364, P181, DOI 10.1098/rstb.2008.0123; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; O'Malley D, 2006, DIABETES, V55, P3381, DOI 10.2337/db06-0531; OOMURA Y, 1964, SCIENCE, V143, P484, DOI 10.1126/science.143.3605.484; Pardal R, 2002, NAT NEUROSCI, V5, P197, DOI 10.1038/nn812; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wang Y, 2008, EMBO J, V27, P2388, DOI 10.1038/emboj.2008.161; Wright EM, 2002, CELL BIOCHEM BIOPHYS, V36, P115, DOI 10.1385/CBB:36:2-3:115	32	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10241	10.1371/journal.pone.0010241	http://dx.doi.org/10.1371/journal.pone.0010241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421923	Green Published, gold, Green Submitted			2022-12-27	WOS:000276854300008
J	von Groll, A; Martin, A; Stehr, M; Singh, M; Portaels, F; da Silva, PEA; Palomino, JC				von Groll, Andrea; Martin, Anandi; Stehr, Matthias; Singh, Mahavir; Portaels, Francoise; Almeida da Silva, Pedro Eduardo; Palomino, Juan Carlos			Fitness of Mycobacterium tuberculosis Strains of the W-Beijing and Non-W-Beijing Genotype	PLOS ONE			English	Article							ISONIAZID RESISTANCE MUTATIONS; RIFAMPIN RESISTANCE; DRUG-RESISTANCE; RPOB GENE; KATG; COST; TRANSMISSION; VIRULENCE; FAMILY; INHA	Background: Multidrug resistant tuberculosis (MDR-TB) is a major threat for global tuberculosis control. The W-Beijing Mycobacterium tuberculosis genotype has been associated with drug resistance. Elucidation of the mechanisms underlying this epidemiological finding may have an important role in the control of MDR-TB. The aim of this study was to evaluate the fitness of drug-susceptible and MDR M. tuberculosis strains of the W-Beijing genotype compared with that of Non-W-Beijing strains. Methodology/Principal Findings: Fitness of M. tuberculosis strains was determined by evaluating the difference in the growth curves obtained in the MGIT960 automated system and assessing the competitive growth capacity between W-Beijing and non-W-Beijing strains. The W-Beijing MDR strains had a significant longer lag phase duration compared to the other strains but did not present a significant fitness cost. When grown in competition they had an advantage only in medium containing 0.1% Tween 80. Conclusions/Significance: It was not possible to confirm a selective advantage of W-Beijing strains to grow, except for differences in their resistance to Tween 80. Further studies are needed to elucidate the putative advantage of W-Beijing strains compared to other genotypes.	[von Groll, Andrea; Martin, Anandi; Portaels, Francoise; Palomino, Juan Carlos] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Stehr, Matthias; Singh, Mahavir] Helmholtz Ctr Infect Res, Dept Genome Anal, Braunswcheig, Germany; [Almeida da Silva, Pedro Eduardo] Univ Fed Rio Grande, Lab Mycobacteriol, Rio Grande, Brazil	Institute of Tropical Medicine (ITM); Helmholtz Association; Helmholtz-Center for Infection Research; Universidade Federal do Rio Grande	von Groll, A (corresponding author), Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.	avongrol@hotmail.com	da Silva, Pedro Almeida/B-6926-2012	da Silva, Pedro Almeida/0000-0003-1666-1295	UNESCO; Belgium Federal Government [BL/09/BR2]; EC [HEALTH-F3-2007-201690]; Brazilian Health Ministry; CNPq [410468/2006-1]	UNESCO; Belgium Federal Government; EC(European CommissionEuropean Commission Joint Research Centre); Brazilian Health Ministry; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	A. von Groll was partially supported by UNESCO-L'Oreal Co-Sponsored Fellowship for Young Women in Life Science and Belgium Federal Government Grant Programmatorische Federale Overheidsdienst Wetenschapsbeleid contract No. BL/09/BR2. This study was partially funded by EC project HEALTH-F3-2007-201690 (FAST-XDR-DETECT) and the Brazilian Health Ministry and CNPq grant MCT-CNPq/MS-SCTIE-DECIT (project 410468/2006-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Hillemann D, 2006, J CLIN MICROBIOL, V44, P302, DOI 10.1128/JCM.44.2.302-306.2006; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kiepiela P, 2000, TUBERCLE LUNG DIS, V80, P47, DOI 10.1054/tuld.1999.0231; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Mani C, 2001, J CLIN MICROBIOL, V39, P2987, DOI 10.1128/JCM.39.8.2987-2990.2001; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; MASAKI S, 1991, J CLIN MICROBIOL, V29, P1453, DOI 10.1128/JCM.29.7.1453-1456.1991; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Rigouts L, 2007, J CLIN MICROBIOL, V45, P252, DOI 10.1128/JCM.01489-06; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Von Groll A, 2010, FEMS IMMUNOL MED MIC, V58, P119, DOI 10.1111/j.1574-695X.2009.00611.x; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; WHO, 2020, WHO REPORT; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	33	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10191	10.1371/journal.pone.0010191	http://dx.doi.org/10.1371/journal.pone.0010191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419138	gold, Green Published, Green Submitted			2022-12-27	WOS:000276743500011
J	Carnevali, O; Tosti, L; Speciale, C; Peng, C; Zhu, Y; Maradonna, F				Carnevali, Oliana; Tosti, Luca; Speciale, Claudia; Peng, Chun; Zhu, Yong; Maradonna, Francesca			DEHP Impairs Zebrafish Reproduction by Affecting Critical Factors in Oogenesis	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-15; MEMBRANE PROGESTIN RECEPTOR; IN-UTERO EXPOSURE; OOCYTE MATURATION; GENE-EXPRESSION; PHTHALATE; BETA; GROWTH; CYCLOOXYGENASE-2; CLONING	Public concerns on phthalates distributions in the environment have been increasing since they can cause liver cancer, structural abnormalities and reduce sperm counts in male reproductive system. However, few data are actually available on the effects of Di-(2-ethylhexyl)-phthalate ( DEHP) in female reproductive system. The aim of this study was to assess the impacts of DEHP on zebrafish oogenesis and embryo production. Female Danio rerio were exposed to environmentally relevant doses of DEHP and a significant decrease in ovulation and embryo production was observed. The effects of DEHP on several key regulators of oocyte maturation and ovulation including bone morphogenetic protein-15 (BMP15), luteinizing hormone receptor (LHR), membrane progesterone receptors (mPRs) and cyclooxygenase (COX)-2 (ptgs2) were determined by real time PCR. The expressions of BMP15 and mPR proteins were further determined by Western analyses to strengthen molecular findings. Moreover, plasma vitellogenin (vtg) titers were assayed by an ELISA procedure to determine the estrogenic effects of DEHP and its effects on oocyte growth. A significant reduction of fecundity in fish exposed to DEHP was observed. The reduced reproductive capacity was associated with an increase in ovarian BMP15 levels. This rise, in turn, was concomitant with a significant reduction in LHR and mPRb levels. Finally, ptgs2 expression, the final trigger of ovulation, was also decreased by DEHP. By an in vitro maturation assay, the inhibitory effect of DEHP on germinal vesicle breakdown was further confirmed. In conclusion, DEHP affecting signals involved in oocyte growth ( vtg), maturation ( BMP15, LHR, mPRs,) and ovulation ( ptgs2), deeply impairs ovarian functions with serious consequences on embryo production. Since there is a significant genetic similarity between D. rerio and humans, the harmful effects observed at oocyte level may be relevant for further molecular studies on humans.	[Carnevali, Oliana; Tosti, Luca; Speciale, Claudia; Maradonna, Francesca] Polytech Univ Marche, Dept Marine Sci, Ancona, Italy; [Carnevali, Oliana; Maradonna, Francesca] Natl Inst Biostruct & Biosyst, Rome, Italy; [Peng, Chun] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Zhu, Yong] E Carolina Univ, Dept Biol, Greenville, NC USA	Marche Polytechnic University; York University - Canada; University of North Carolina; East Carolina University	Carnevali, O (corresponding author), Polytech Univ Marche, Dept Marine Sci, Ancona, Italy.	o.carnevali@univpm.it	Maradonna, Francesca/AAU-3017-2021; Maradonna, Francesca/AAU-5167-2021; Carnevali, Oliana/P-2751-2015	Maradonna, Francesca/0000-0001-6677-1017; Carnevali, Oliana/0000-0001-5994-0572; Zhu, Yong/0000-0003-0374-485X	Fondi di Ateneo Universita Politecnica delle Marche; INBB	Fondi di Ateneo Universita Politecnica delle Marche; INBB	This study was supported by Fondi di Ateneo 2004, 2007 Universita Politecnica delle Marche grant awarded to O.C. and by INBB for the fellowship grant to Dr. Maradonna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann GE, 2003, FRONT BIOSCI-LANDMRK, V8, pD1227, DOI 10.2741/1092; ARMSTRONG DT, 1981, J REPROD FERTIL, V62, P283; Arukwe A, 2001, ENVIRON TOXICOL PHAR, V10, P5, DOI 10.1016/S1382-6689(01)00063-1; Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6; Ben-Yehoshua LJ, 2007, MOL ENDOCRINOL, V21, P664, DOI 10.1210/me.2006-0256; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; Clark K, 2003, HANDB ENVIRON CHEM, V3, P227; Clelland E, 2006, ENDOCRINOLOGY, V147, P201, DOI 10.1210/en.2005-1017; Clelland ES, 2007, ENDOCRINOLOGY, V148, P5451, DOI 10.1210/en.2007-0674; Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; Hanna R, 2006, J ENDOCRINOL, V190, P247, DOI 10.1677/joe.1.06694; Hokanson R, 2006, HUM EXP TOXICOL, V25, P687, DOI 10.1177/0960327106071977; Kazeto Y, 2005, GEN COMP ENDOCR, V142, P204, DOI 10.1016/j.ygcen.2005.01.017; Khan I. A, 1999, ENCY REPROD, V3, P552; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Kortner TM, 2007, GEN COMP ENDOCR, V150, P419, DOI 10.1016/j.ygcen.2006.10.008; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278; Lister AL, 2009, MOL REPROD DEV, V76, P1064, DOI 10.1002/mrd.21072; Maia H, 2006, GYNECOL ENDOCRINOL, V22, P547, DOI 10.1080/09513590601005375; Migliarini B, 2008, MOL CELL ENDOCRINOL, V286, pS12, DOI 10.1016/j.mce.2008.01.021; Mosconi G, 1998, GEN COMP ENDOCR, V110, P252, DOI 10.1006/gcen.1998.7075; NAGAHAMA Y, 1995, CURR TOP DEV BIOL, V30, P103, DOI 10.1016/S0070-2153(08)60565-7; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Patino R, 2001, COMP BIOCHEM PHYS B, V129, P427, DOI 10.1016/S1096-4959(01)00344-X; Peng C, 2009, COMP BIOCHEM PHYS A, V153, P83, DOI 10.1016/j.cbpa.2008.09.034; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; Qiu HB, 2008, STEROIDS, V73, P1416, DOI 10.1016/j.steroids.2008.07.007; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Sirois J, 2004, HUM REPROD UPDATE, V10, P373, DOI 10.1093/humupd/dmh032; Tan Q, 2009, MOL CELL ENDOCRINOL, V312, P72, DOI 10.1016/j.mce.2009.03.011; Tan Q, 2009, COMP BIOCHEM PHYS A, V153, P18, DOI 10.1016/j.cbpa.2008.09.016; Thomas P, 2004, STEROIDS, V69, P567, DOI 10.1016/j.steroids.2004.05.004; Thomas P, 2002, STEROIDS, V67, P511, DOI 10.1016/S0039-128X(01)00180-5; Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002	36	101	109	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10201	10.1371/journal.pone.0010201	http://dx.doi.org/10.1371/journal.pone.0010201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419165	gold, Green Published, Green Submitted			2022-12-27	WOS:000276707100015
J	Grabowski, JH; Clesceri, EJ; Baukus, AJ; Gaudette, J; Weber, M; Yund, PO				Grabowski, Jonathan H.; Clesceri, Erika J.; Baukus, Adam J.; Gaudette, Julien; Weber, Matthew; Yund, Philip O.			Use of Herring Bait to Farm Lobsters in the Gulf of Maine	PLOS ONE			English	Article							HOMARUS-AMERICANUS; NEW-BRUNSWICK; LONG-TERM; COD; PSEUDOREPLICATION; POPULATION; BEHAVIOR; GROWTH	Background: Ecologists, fisheries scientists, and coastal managers have all called for an ecosystem approach to fisheries management, yet many species such as the American lobster ( Homarus americanus) are still largely managed individually. One hypothesis that has yet to be tested suggests that human augmentation of lobster diets via the use of Atlantic herring (Clupea harengus) as bait may contribute to recent increases in lobster landings. Currently 70% of Atlantic herring landings in the Gulf of Maine are used as bait to catch lobsters in traps throughout coastal New England. Methodology/Principal Findings: We examined the effects of this herring bait on the diet composition and growth rate of lobsters at heavily baited vs. seasonally closed (i.e., bait free) sites in coastal Maine. Our results suggest that human use of herring bait may be subsidizing juvenile lobster diets, thereby enhancing lobster growth and the overall economic value and yield of one of the most valuable fisheries in the U. S. Conclusions/Significance: Our study illustrates that shifting to an ecosystem approach to fisheries management should require consideration of cross-fishery interactions.	[Grabowski, Jonathan H.; Gaudette, Julien] Gulf Maine Res Inst, Portland, ME USA; [Clesceri, Erika J.] US Agcy Int Dev, Washington, DC 20523 USA; [Baukus, Adam J.] Univ So Maine, Portland, ME 04103 USA; [Yund, Philip O.] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	Gulf of Maine Research Institute; United States Agency for International Development (USAID); University of Maine System; University of Southern Maine; University of Maine System; University of Maine Orono	Grabowski, JH (corresponding author), Gulf Maine Res Inst, Portland, ME USA.	jgrabowski@gmri.org		Yund, Philip/0000-0003-0474-5205; Grabowski, Jonathan/0000-0003-4711-5481	The Northeast Consortium; The Davis Foundation; The Lobster Advisory Council, Maine Sea; NSF [OCE-01-22031, OCE-07-09527]	The Northeast Consortium; The Davis Foundation; The Lobster Advisory Council, Maine Sea; NSF(National Science Foundation (NSF))	The Northeast Consortium, The Davis Foundation, The Lobster Advisory Council, Maine Sea Grant Program, and NSF (OCE-01-22031; OCE-07-09527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames EP, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:ACSSIT]2.0.CO;2; *ATL STAT MAR FISH, 2000, AM LOBST STOCK ASS R; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Brandt S, 2006, MAR POLICY, V30, P659, DOI 10.1016/j.marpol.2005.09.007; CAMPBELL A, 1983, CAN J FISH AQUAT SCI, V40, P1667, DOI 10.1139/f83-193; Castro KM, 2001, MAR FRESHWATER RES, V52, P1253, DOI 10.1071/MF01095; CHRISTIANSEN R, 2006, 2005 REV FISHERY MAN; COBB JS, 1970, ECOLOGY, V52, P108; Cottenie K, 2003, OIKOS, V100, P394, DOI 10.1034/j.1600-0706.2003.11953.x; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Drinkwater KF, 1996, FISH OCEANOGR, V5, P176, DOI 10.1111/j.1365-2419.1996.tb00116.x; Dutil JD, 2003, FISH OCEANOGR, V12, P502, DOI 10.1046/j.1365-2419.2003.00243.x; ELNER RW, 1987, MAR ECOL PROG SER, V37, P131, DOI 10.3354/meps037131; ENNIS GP, 1973, J FISH RES BOARD CAN, V34, P2203; FAO, 2003, FISH MAN; Grabowski JH, 2009, NEW ZEAL J MAR FRESH, V43, P185, DOI 10.1080/00288330909509992; HUDON C, 1989, MAR ECOL PROG SER, V52, P155, DOI 10.3354/meps052155; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Incze LS, 2003, FISH RES, V65, P33, DOI 10.1016/j.fishres.2003.09.005; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JAMIESON GS, 1981, CANADIAN J FISHERIES, V39, P499; Janowicz M, 2001, ICES J MAR SCI, V58, P453, DOI 10.1006/jmsc.2000.1024; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jury SH, 2001, MAR FRESHWATER RES, V52, P1125, DOI 10.1071/MF01096; LAWTON P, 1987, CAN J FISH AQUAT SCI, V44, P1195, DOI 10.1139/f87-142; Lawton Peter, 1995, P47, DOI 10.1016/B978-012247570-2/50026-8; *MAR DEP MAR RES, 2010, DAT MAIN LOBST LAND; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Myers RA, 2007, CURR BIOL, V17, pR10, DOI 10.1016/j.cub.2006.11.045; *NAT MAR FISH SERV, 2010, COMM FISH LAND; NOAA (National Oceanic and Atmospheric Administration), 1999, EC BAS FISH MAN REP; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Rose GA, 2002, ICES J MAR SCI, V59, P1018, DOI 10.1006/jmsc.2002.1252; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Saila SB, 2002, N AM J FISH MANAGE, V22, P602, DOI 10.1577/1548-8675(2002)022<0602:DLTBIT>2.0.CO;2; SHERWOOD GD, 2007, DEEP SEA 2 IN PRESS, V2; Sinclair M., 2003, RESPONSIBLE FISHERIE; SLOBODKIN LAWRENCE B., 1961; Steneck RS, 2001, MAR FRESHWATER RES, V52, P1303, DOI 10.1071/MF01173; Steneck RS, 1997, P GULF MAIN EC DYN S, P91; Suring E, 2009, J EXP MAR BIOL ECOL, V370, P56, DOI 10.1016/j.jembe.2008.11.014; Swain DP, 2000, CAN J FISH AQUAT SCI, V57, P1321, DOI 10.1139/cjfas-57-7-1321; *TRANSB RES ASS CO, 2006, 200601 TRANSB RES AS; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Waddington KI, 2009, FISH RES, V99, P1, DOI 10.1016/j.fishres.2009.04.002; Waddy S.L., 1995, P217, DOI 10.1016/B978-012247570-2/50032-3; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; WITMAN JD, 1992, OECOLOGIA, V90, P305, DOI 10.1007/BF00317686; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	50	49	51	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10188	10.1371/journal.pone.0010188	http://dx.doi.org/10.1371/journal.pone.0010188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419167	Green Published, gold, Green Submitted			2022-12-27	WOS:000276707100009
J	Bonnet, E; Tatari, M; Joshi, A; Michoel, T; Marchal, K; Berx, G; Van de Peer, Y				Bonnet, Eric; Tatari, Marianthi; Joshi, Anagha; Michoel, Tom; Marchal, Kathleen; Berx, Geert; Van de Peer, Yves			Module Network Inference from a Cancer Gene Expression Data Set Identifies MicroRNA Regulated Modules	PLOS ONE			English	Article							C-FOS TRANSCRIPTION; MESENCHYMAL TRANSITION; MIR-200 FAMILY; MASTER REGULATOR; PROSTATE-CANCER; CHEMOKINE BRAK; CELLS; REPRESSION; RECEPTOR; BREAST	Background: MicroRNAs (miRNAs) are small RNAs that recognize and regulate mRNA target genes. Multiple lines of evidence indicate that they are key regulators of numerous critical functions in development and disease, including cancer. However, defining the place and function of miRNAs in complex regulatory networks is not straightforward. Systems approaches, like the inference of a module network from expression data, can help to achieve this goal. Methodology/Principal Findings: During the last decade, much progress has been made in the development of robust and powerful module network inference algorithms. In this study, we analyze and assess experimentally a module network inferred from both miRNA and mRNA expression data, using our recently developed module network inference algorithm based on probabilistic optimization techniques. We show that several miRNAs are predicted as statistically significant regulators for various modules of tightly co-expressed genes. A detailed analysis of three of those modules demonstrates that the specific assignment of miRNAs is functionally coherent and supported by literature. We further designed a set of experiments to test the assignment of miR-200a as the top regulator of a small module of nine genes. The results strongly suggest that miR-200a is regulating the module genes via the transcription factor ZEB1. Interestingly, this module is most likely involved in epithelial homeostasis and its dysregulation might contribute to the malignant process in cancer cells. Conclusions/Significance: Our results show that a robust module network analysis of expression data can provide novel insights of miRNA function in important cellular processes. Such a computational approach, starting from expression data alone, can be helpful in the process of identifying the function of miRNAs by suggesting modules of co-expressed genes in which they play a regulatory role. As shown in this study, those modules can then be tested experimentally to further investigate and refine the function of the miRNA in the regulatory network.	[Bonnet, Eric; Joshi, Anagha; Michoel, Tom; Van de Peer, Yves] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Bonnet, Eric; Joshi, Anagha; Michoel, Tom; Van de Peer, Yves] Univ Ghent, Dept Mol Genet, B-9000 Ghent, Belgium; [Tatari, Marianthi; Berx, Geert] VIB, Dept Mol Biomed Res, Unit Mol & Cellular Oncol, Ghent, Belgium; [Tatari, Marianthi; Berx, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Marchal, Kathleen] KULeuven, Dept Microbial & Mol Syst, CMPG, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven	Bonnet, E (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	yves.vandepeer@psb.vib-ugent.be	Van de Peer, Yves/AAE-7666-2019; Marchal, Kathleen/O-7936-2017; Marchal, Kathleen/B-5001-2013; Van de Peer, Yves/D-4388-2009	Van de Peer, Yves/0000-0003-4327-3730; Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Van de Peer, Yves/0000-0003-4327-3730; Berx, Geert/0000-0001-5770-2458; Bonnet, Eric/0000-0002-8468-2867; Tatari, Marianthi/0000-0002-6309-5057; Michoel, Tom/0000-0003-4749-4725; Joshi, Anagha/0000-0003-1184-3305	Innovatie door Wetenschap en Technologie (IWT); Interuniversity Attraction Pole (IUAP) [p6/25]	Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversity Attraction Pole (IUAP)(Belgian Federal Science Policy Office)	This work is supported by an Innovatie door Wetenschap en Technologie (IWT) grant for the Strategisch BasisOnderzoek (SBO) Bioframe project and by an Interuniversity Attraction Pole (IUAP) grant for the BioMaGNet project (Bioinformatics and Modelling: from Genomes to Networks, ref. p6/25). The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crambert G, 2005, MOL BIOL CELL, V16, P2363, DOI 10.1091/mbc.E04-10-0878; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; FRIEDMAN RC, 2008, GENOME RES; Gires O, 2003, ANTICANCER RES, V23, P3255; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grzmil M, 2004, INT J ONCOL, V24, P97; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Joshi A, 2008, BIOINFORMATICS, V24, P176, DOI 10.1093/bioinformatics/btm562; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; McCarthy KM, 2003, J BIOL CHEM, V278, P42106, DOI 10.1074/jbc.M308586200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SHAW PE, 1989, EMBO J, V8, P2567, DOI 10.1002/j.1460-2075.1989.tb08395.x; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Turesson C, 2006, MAYO CLIN PROC, V81, P94, DOI 10.4065/81.1.94; VANDEWALLE C, 2008, CELL MOL LIFE SCI; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898	56	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10162	10.1371/journal.pone.0010162	http://dx.doi.org/10.1371/journal.pone.0010162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418949	Green Published, Green Submitted, gold			2022-12-27	WOS:000276706800011
J	Kelly, SE; Di Benedetto, A; Greco, A; Howard, CM; Sollars, VE; Primerano, DA; Valluri, JV; Claudio, PP				Kelly, Sarah E.; Di Benedetto, Altomare; Greco, Adelaide; Howard, Candace M.; Sollars, Vincent E.; Primerano, Donald A.; Valluri, Jagan V.; Claudio, Pier Paolo			Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications	PLOS ONE			English	Article							MAMMARY STEM-CELLS; PROSTATE-CANCER; BREAST-CANCER; IN-VITRO; PROSPECTIVE IDENTIFICATION; SIDE POPULATION; OSTEOSARCOMA; CARCINOGENESIS; MECHANISM; CAPACITY	Cancer stem cells (CSCs) are considered a subset of the bulk tumor responsible for initiating and maintaining the disease. Several surface cellular markers have been recently used to identify CSCs. Among those is CD133, which is expressed by hematopoietic progenitor cells as well as embryonic stem cells and various cancers. We have recently isolated and cultured CD133 positive [CD133(+)] cells from various cancer cell lines using a NASA developed Hydrodynamic Focusing Bioreactor (HFB) (Celdyne, Houston, TX). For comparison, another bioreactor, the rotary cell culture system (RCCS) manufactured by Synthecon (Houston, TX) was used. Both the HFB and the RCCS bioreactors simulate aspects of hypogravity. In our study, the HFB increased CD133(+) cell growth from various cell lines compared to the RCCS vessel and to normal gravity control. We observed a (+) 15-fold proliferation of the CD133(+) cellular fraction with cancer cells that were cultured for 7-days at optimized conditions. The RCCS vessel instead yielded a (2) 4.8-fold decrease in the CD133(+) cellular fraction respect to the HFB after 7-days of culture. Interestingly, we also found that the hypogravity environment of the HFB greatly sensitized the CD133(+) cancer cells, which are normally resistant to chemo treatment, to become susceptible to various chemotherapeutic agents, paving the way to less toxic and more effective chemotherapeutic treatment in patients. To be able to test the efficacy of cytotoxic agents in vitro prior to their use in clinical setting on cancer cells as well as on cancer stem cells may pave the way to more effective chemotherapeutic strategies in patients. This could be an important advancement in the therapeutic options of oncologic patients, allowing for more targeted and personalized chemotherapy regimens as well as for higher response rates.	[Kelly, Sarah E.; Di Benedetto, Altomare; Greco, Adelaide; Howard, Candace M.; Sollars, Vincent E.; Primerano, Donald A.; Claudio, Pier Paolo] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Di Benedetto, Altomare] Univ Aquila, Fac Sci, Dept Basic & Appl Biol, I-67100 Laquila, Italy; [Greco, Adelaide] Adv Biotechnol Scarl, CEINGE, Naples, Italy; [Greco, Adelaide] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy; [Greco, Adelaide] CNR, IBB, I-80125 Naples, Italy; [Valluri, Jagan V.] Marshall Univ, Dept Biol, Huntington, WV USA; [Claudio, Pier Paolo] Marshall Univ, Dept Surg, Joan C Edwards Sch Med, Huntington, WV USA	Marshall University; University of L'Aquila; CEINGE Biotecnologie Avanzate; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Marshall University; Marshall University	Kelly, SE (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	claudiop@marshall.edu	Sollars, Vincent/R-3769-2019; Claudio, Pier Paolo/AAW-7282-2021; Greco, Adelaide/C-7679-2018	Claudio, Pier Paolo/0000-0001-7790-1622; Greco, Adelaide/0000-0001-6841-1963; Sollars, Vincent/0000-0002-5602-3610; Howard, Candace/0000-0001-6537-3551	Cell Differentiation and Development Center (CDDC) at Marshall University [NIH-CA138510, NIH-CA140024, NIH-COBRE 5P20RR020180]; West Virginia NASA Space Grant Consortium [WV-INBRE 5P20RR016477]; NATIONAL CANCER INSTITUTE [R03CA140024] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477, P20RR020180] Funding Source: NIH RePORTER	Cell Differentiation and Development Center (CDDC) at Marshall University; West Virginia NASA Space Grant Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was performed with funds received in part by the Cell Differentiation and Development Center (CDDC) at Marshall University, NIH-CA138510, NIH-CA140024, NIH-COBRE 5P20RR020180 (to P. P. C.); West Virginia NASA Space Grant Consortium (to S. K. and J.V.V.); WV-INBRE 5P20RR016477 (to D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Romaih K, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-14; BADHWAR GD, 1992, ADV SPACE RES-SERIES, V12, P195, DOI 10.1016/0273-1177(92)90108-A; Baisden DL, 2008, AVIAT SPACE ENVIR MD, V79, P629, DOI 10.3357/ASEM.2314.2008; Barr YR, 2007, AVIAT SPACE ENVIR MD, V78, pA26; Berend KR, 2001, J SURG ONCOL, V78, P162, DOI 10.1002/jso.1142; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2006, MOL INTERV, V6, P140, DOI 10.1124/mi.6.3.5; Dicello JF, 2003, HEALTH PHYS, V85, P94, DOI 10.1097/00004032-200307000-00017; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Fan XL, 2007, SEMIN CANCER BIOL, V17, P214, DOI 10.1016/j.semcancer.2006.04.002; Farnie G, 2006, Ernst Schering Found Symp Proc, P141; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Grun B, 2009, CELL PROLIFERAT, V42, P219, DOI 10.1111/j.1365-2184.2008.00579.x; Guo W, 2006, PEDIATR RES, V59, p59R, DOI 10.1203/01.pdr.0000203592.04530.06; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Kelly K, 2008, CELL RES, V18, P528, DOI 10.1038/cr.2008.50; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Lawrenson K, 2009, CELL PROLIFERAT, V42, P385, DOI 10.1111/j.1365-2184.2009.00604.x; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lin TL, 2007, PEDIATR RES, V62, P239, DOI 10.1203/PDR.0b013e3181515124; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Mihailova M, 2006, ANN NY ACAD SCI, V1091, P470, DOI 10.1196/annals.1378.089; Mitteregger R, 1999, INT J ARTIF ORGANS, V22, P816, DOI 10.1177/039139889902201207; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Okamoto OK, 2008, EXPERT REV MOL DIAGN, V8, P387, DOI 10.1586/14737159.8.4.387; Panagiotakos G, 2007, CURR NEUROL NEUROSCI, V7, P215, DOI 10.1007/s11910-007-0033-3; Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702; RAJAN P, 2008, STEM CELL REV; REEDIJK J, 1985, PHARM WEEKBLAD, V7, P173, DOI 10.1007/BF02307573; REN C, 2008, GENE THER; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakai S, 2009, J ORTHOP RES, V27, P517, DOI 10.1002/jor.20566; SARTIANO GP, 1979, J ANTIBIOT, V32, P1038, DOI 10.7164/antibiotics.32.1038; Schuetze Scott M, 2007, J Natl Compr Canc Netw, V5, P449; Shipitsin M, 2008, LAB INVEST, V88, P459, DOI 10.1038/labinvest.2008.14; Singh SK, 2003, CANCER RES, V63, P5821; Soltysova A, 2005, NEOPLASMA, V52, P435; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Tysnes BB, 2007, BBA-REV CANCER, V1775, P283, DOI 10.1016/j.bbcan.2007.01.001; Villanueva I, 2009, BIOTECHNOL BIOENG, V102, P1242, DOI 10.1002/bit.22134; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; WHITMORE PJ, 1981, J AEROSOL SCI, V12, P1, DOI 10.1016/0021-8502(81)90003-3; Williams JR, 1999, MUTAT RES-FUND MOL M, V430, P255, DOI 10.1016/S0027-5107(99)00137-2; WODINSKY I, 1968, CANCER CHEMOTH REP, V52, P251; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465; Zalupski MM, 2004, CANCER-AM CANCER SOC, V100, P818, DOI 10.1002/cncr.20021	60	45	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10035	10.1371/journal.pone.0010035	http://dx.doi.org/10.1371/journal.pone.0010035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386701	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482000006
J	Poulain, P; Gelly, JC; Flatters, D				Poulain, Pierre; Gelly, Jean-Christophe; Flatters, Delphine			Detection and Architecture of Small Heat Shock Protein Monomers	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; C-TERMINAL EXTENSION; FUNCTIONAL ELEMENT; A-CRYSTALLIN; IXI/V MOTIF; CHAPERONE; DOMAIN; IDENTIFICATION; SUPERFAMILY; FLEXIBILITY	Background: Small Heat Shock Proteins (sHSPs) are chaperone-like proteins involved in the prevention of the irreversible aggregation of misfolded proteins. Although many studies have already been conducted on sHSPs, the molecular mechanisms and structural properties of these proteins remain unclear. Here, we propose a better understanding of the architecture, organization and properties of the sHSP family through structural and functional annotations. We focused on the Alpha Crystallin Domain (ACD), a beta sandwich fold that is the hallmark of the sHSP family. Methodology/Principal Findings: We developed a new approach for detecting sHSPs and delineating ACDs based on an iterative Hidden Markov Model algorithm using a multiple alignment profile generated from structural data on ACD. Using this procedure on the UniProt databank, we found 4478 sequences identified as sHSPs, showing a very good coverage with the corresponding PROSITE and Pfam profiles. ACD was then delimited and structurally annotated. We showed that taxonomic-based groups of sHSPs (animals, plants, bacteria) have unique features regarding the length of their ACD and, more specifically, the length of a large loop within ACD. We detailed highly conserved residues and patterns specific to the whole family or to some groups of sHSPs. For 96% of studied sHSPs, we identified in the C-terminal region a conserved I/V/L-X-I/V/L motif that acts as an anchor in the oligomerization process. The fragment defined from the end of ACD to the end of this motif has a mean length of 14 residues and was named the C-terminal Anchoring Module (CAM). Conclusions/Significance: This work annotates structural components of ACD and quantifies properties of several thousand sHSPs. It gives a more accurate overview of the architecture of sHSP monomers.	[Poulain, Pierre] INSERM, UMR S 665, DSIMB, Paris, France; Univ Paris 07, INTS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Poulain, P (corresponding author), INSERM, UMR S 665, DSIMB, Paris, France.	pierre.poulain@univ-paris-diderot.fr; delphine.flatters@univ-paris-diderot.fr	Gelly, Jean-Christophe/A-9321-2010; Poulain, Pierre/A-8287-2009	Gelly, Jean-Christophe/0000-0001-5138-361X; Poulain, Pierre/0000-0003-4177-3619	French Ministry of Research; Paris Diderot - Paris 7 University; National Institute for Blood Transfusion (INTS); Institute for Health and Medical Care (INSERM)	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Paris Diderot - Paris 7 University; National Institute for Blood Transfusion (INTS); Institute for Health and Medical Care (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Financial support was provided by grants from the French Ministry of Research, the Paris Diderot - Paris 7 University, the National Institute for Blood Transfusion (INTS) and the Institute for Health and Medical Care (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bernardes JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-435; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DEJONG WW, 1988, J BIOL CHEM, V263, P5141; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; DELANO WL, 2010, POYMOL MOL GRAPHICS; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; Fu XM, 2006, BIOCHEMISTRY-MOSCOW+, V71, pS83, DOI 10.1134/S0006297906130141; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Goldstein P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-335; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hilario E, 2006, ACTA CRYSTALLOGR F, V62, P446, DOI 10.1107/S174430910601219X; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lindner RA, 2000, EUR J BIOCHEM, V267, P1923, DOI 10.1046/j.1432-1327.2000.01188.x; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Munchbach M, 1999, J BACTERIOL, V181, P83; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Pasta SY, 2004, MOL VIS, V10, P655; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; *R DEV COR TEAM, 2010, LANG ENV STATISTICAL; Saji H, 2008, PROTEINS, V71, P771, DOI 10.1002/prot.21762; Scheeff ED, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-410; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters ER, 1999, P NATL ACAD SCI USA, V96, P14394, DOI 10.1073/pnas.96.25.14394; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021	58	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2010	5	3							e9990	10.1371/journal.pone.0009990	http://dx.doi.org/10.1371/journal.pone.0009990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580MX	20383329	Green Published, Green Submitted, gold			2022-12-27	WOS:000276454000003
J	Colson, P; Richet, H; Desnues, C; Balique, F; Moal, V; Grob, JJ; Berbis, P; Lecoq, H; Harle, JR; Berland, Y; Raoult, D				Colson, Philippe; Richet, Herve; Desnues, Christelle; Balique, Fanny; Moal, Valerie; Grob, Jean-Jacques; Berbis, Philippe; Lecoq, Herve; Harle, Jean-Robert; Berland, Yvon; Raoult, Didier			Pepper Mild Mottle Virus, a Plant Virus Associated with Specific Immune Responses, Fever, Abdominal Pains, and Pruritus in Humans	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; FRANKLINIELLA-OCCIDENTALIS; ELECTRON-MICROSCOPY; VIRAL COMMUNITY; INFECTING VIRUS; INSECT VECTOR; COAT PROTEIN; LUNG CANCER; HUMAN FECES; VACCINE	Background: Recently, metagenomic studies have identified viable Pepper mild mottle virus (PMMoV), a plant virus, in the stool of healthy subjects. However, its source and role as pathogen have not been determined. Methods and Findings: 21 commercialized food products containing peppers, 357 stool samples from 304 adults and 208 stool samples from 137 children were tested for PMMoV using real-time PCR, sequencing, and electron microscopy. Anti-PMMoV IgM antibody testing was concurrently performed. A case-control study tested the association of biological and clinical symptoms with the presence of PMMoV in the stool. Twelve (57%) food products were positive for PMMoV RNA sequencing. Stool samples from twenty-two (7.2%) adults and one child (0.7%) were positive for PMMoV by real-time PCR. Positive cases were significantly more likely to have been sampled in Dermatology Units (p<10(-6)), to be seropositive for anti-PMMoV IgM antibodies (p = 0.026) and to be patients who exhibited fever, abdominal pains, and pruritus (p = 0.045, 0.038 and 0.046, respectively). Conclusions: Our study identified a local source of PMMoV and linked the presence of PMMoV RNA in stool with a specific immune response and clinical symptoms. Although clinical symptoms may be imputable to another cofactor, including spicy food, our data suggest the possibility of a direct or indirect pathogenic role of plant viruses in humans.	[Colson, Philippe; Richet, Herve; Desnues, Christelle; Balique, Fanny; Raoult, Didier] Univ Aix Marseille 2, URMITE, CNRS, UMR 6236,IRD 3R198,Fac Med & Pharm, Marseille, France; [Colson, Philippe; Raoult, Didier] CHU Timone, Marseille, France; [Moal, Valerie; Berland, Yvon] Ctr Hosp Univ Concept, Ctr Nephrol & Transplantat Renale, Marseille, France; [Grob, Jean-Jacques] Ctr Hosp Univ St Marguerite, Serv Dermatol, Marseille, France; [Berbis, Philippe] Ctr Hosp Univ Nord, Serv Dermatol, Marseille, France; [Balique, Fanny; Lecoq, Herve] INRA, UR 407, Unite Pathol Vegetale, F-84143 Montfavet, France; [Harle, Jean-Robert] Ctr Hosp Univ Concept, Serv Med Interne, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Colson, P (corresponding author), Univ Aix Marseille 2, URMITE, CNRS, UMR 6236,IRD 3R198,Fac Med & Pharm, Marseille, France.	didier.raoult@gmail.com	Desnues, Christelle/ABG-2910-2021; RAOULT, Didier/A-8434-2008; Desnues, Christelle/B-1383-2010; Colson, Philippe/P-6355-2014	Desnues, Christelle/0000-0002-2178-0355; RAOULT, Didier/0000-0002-0633-5974; Desnues, Christelle/0000-0002-2178-0355; Colson, Philippe/0000-0001-6285-0308; Grob, Jean-Jacques/0000-0002-0667-153X	French Centre National de la Recherche Scientifique (CNRS)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	Recurrent funding by the French Centre National de la Recherche Scientifique (CNRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTHWELL PW, 1960, LANCET, V1, P657; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brennan FR, 1999, J VIROL, V73, P930, DOI 10.1128/JVI.73.2.930-938.1999; Chikhi-Brachet R, 2002, J CLIN MICROBIOL, V40, P4266, DOI 10.1128/JCM.40.11.4266-4272.2002; Colson P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-21; Curry A, 2006, MICRON, V37, P91, DOI 10.1016/j.micron.2005.10.001; de Medeiros RB, 2005, P NATL ACAD SCI USA, V102, P1175, DOI 10.1073/pnas.0406668102; Denno Donna M., 2007, Animal Health Research Reviews, V8, P69, DOI 10.1017/S1466252307001302; FAUQUET CM, VIRUS TAXONOMY; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Florindo MI, 2002, BRAZ J MED BIOL RES, V35, P827, DOI 10.1590/S0100-879X2002000700011; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Hamada H, 2007, VIRUS GENES, V34, P205, DOI 10.1007/s11262-006-0049-9; Harrison BD, 1999, PHILOS T ROY SOC B, V354, P521, DOI 10.1098/rstb.1999.0403; HWANG DJ, 1994, P NATL ACAD SCI USA, V91, P9067, DOI 10.1073/pnas.91.19.9067; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; KATSILAMBROS L, 1960, LANCET, V2, P934; KITAJIMA EW, 1983, INTERVIROLOGY, V19, P129, DOI 10.1159/000149347; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; LECLAIR RA, 1967, AM REV RESPIR DIS, V95, P510; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Modelska A, 1998, P NATL ACAD SCI USA, V95, P2481, DOI 10.1073/pnas.95.5.2481; Musher DM, 2004, NEW ENGL J MED, V351, P2417, DOI 10.1056/NEJMra041837; Near KA, 2002, INFECT IMMUN, V70, P692, DOI 10.1128/IAI.70.2.692-701.2002; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Pascual DW, 2007, P NATL ACAD SCI USA, V104, P10757, DOI 10.1073/pnas.0704516104; Raoult D, 2010, FUTURE MICROBIOL, V5, P135, DOI 10.2217/FMB.09.119; Rogers SO, 2004, MED HYPOTHESES, V63, P773, DOI 10.1016/j.mehy.2004.04.004; ROSARIO K, 2009, APPL ENV MICROBIOL; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; WETTER C, 1984, PHYTOPATHOLOGY, V74, P405, DOI 10.1094/Phyto-74-405; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Yusibov Vidadi, 2006, Drugs R D, V7, P203, DOI 10.2165/00126839-200607040-00001; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; 2006, ICTVDB UNIVERSAL VIR	36	105	118	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e10041	10.1371/journal.pone.0010041	http://dx.doi.org/10.1371/journal.pone.0010041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386604	Green Published, gold, Green Submitted			2022-12-27	WOS:000276420400012
J	Beermann, ML; Ardelt, M; Girgenrath, M; Miller, JB				Beermann, Mary Lou; Ardelt, Magdalena; Girgenrath, Mahasweta; Miller, Jeffrey Boone			Prdm1 (Blimp-1) and the Expression of Fast and Slow Myosin Heavy Chain Isoforms during Avian Myogenesis In Vitro	PLOS ONE			English	Article							CHICK LIMB BUD; MUSCLE-FIBERS; CLONAL ANALYSIS; CELL LINEAGES; HEDGEHOG; ZEBRAFISH; SPECIFICATION; DIFFERENTIATION; REQUIREMENTS; DIVERSITY	Background: Multiple types of fast and slow skeletal muscle fibers form during early embryogenesis in vertebrates. In zebrafish, formation of the earliest slow myofibers in fin muscles requires expression of the zinc-finger transcriptional repressor Prdm1 (also known as Blimp1). To further understand how the role of Prdm1 in early myogenesis may vary through evolution and during development, we have now analyzed Prdm1 expression in the diverse types of myotubes that form in culture from somitic, embryonic, and fetal chicken myoblasts. Principal Findings: In cultures of somitic, embryonic limb, and fetal limb chicken cells, we found that Prdm1 was expressed in all of the differentiated muscle cells that formed, including those that expressed only fast myosin heavy chain isoforms, as well as those that co-expressed both fast and slow myosin heavy chain isoforms. Prdm1 was also expressed in Pax7-positive myoblasts, as well as in non-myogenic cells in the cultures. Furthermore, though all differentiated cells in control somite cultures co-expressed fast and slow myosin heavy chains, antisense knockdown of Prdm1 expression inhibited the formation of these co-expressing cells in somite cultures. Conclusions: In chicken myogenic cell cultures, Prdm1 was expressed in most Pax7-positive myoblasts and in all differentiated muscle cells, irrespective of the developmental stage of cell donor or the pattern of fast and slow myosin heavy chains expressed in the differentiated cells that were formed. Thus, Prdm1 was expressed in myogenic cells prior to terminal differentiation; and, after differentiation, Prdm1 expression was not limited to cells that expressed slow myosin heavy chain isoforms. In addition, Prdm1 appeared to be required for differentiation of the somitic myocytes, which are the earliest myocytes to form in the avian embryo.	[Beermann, Mary Lou; Ardelt, Magdalena; Miller, Jeffrey Boone] Boston Biomed Res Inst, Neuromuscular Biol & Dis Grp, Watertown, MA USA; [Beermann, Mary Lou; Miller, Jeffrey Boone] Boston Biomed Res Inst, Senator Paul D Wellstone Muscular Dystrophy Coope, Watertown, MA USA; [Girgenrath, Mahasweta] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Miller, Jeffrey Boone] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Boston Biomedical Research Institute; Boston Biomedical Research Institute; Boston University; Harvard University; Harvard Medical School	Beermann, ML (corresponding author), Boston Biomed Res Inst, Neuromuscular Biol & Dis Grp, Watertown, MA USA.	miller@bbri.org		Miller, Jeffrey/0000-0001-5273-2201	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2006-35206-16622]; National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health [2R01HL064641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064641] Funding Source: NIH RePORTER	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by Competitive Grant #2006-35206-16622 to J.B.M. from the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov) and by grant 2R01HL064641 to J.B.M. from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health (www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; BONNER PH, 1974, DEV BIOL, V37, P317, DOI 10.1016/0012-1606(74)90152-3; Bren-Mattison Y, 2002, DEV BIOL, V242, P130, DOI 10.1006/dbio.2001.0528; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Christ B, 2002, INT J DEV BIOL, V46, P905; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; DIMARIO JX, 1993, NATURE, V362, P165, DOI 10.1038/362165a0; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Ha AS, 2003, GENE EXPR PATTERNS, V3, P297, DOI 10.1016/S1567-133X(03)00042-5; Hammond KL, 2009, EVOL DEV, V11, P27, DOI 10.1111/j.1525-142X.2008.00300.x; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Ingham PW, 2005, EXP CELL RES, V306, P336, DOI 10.1016/j.yexcr.2005.03.019; John SA, 2009, EXP CELL RES, V315, P1077, DOI 10.1016/j.yexcr.2008.11.015; KELLY AM, 1986, MED SCI SPORT EXER, V18, P292, DOI 10.1249/00005768-198606000-00007; Li Xiaopeng, 2004, BMC Developmental Biology, V4, P1; Liew HP, 2008, DEV BIOL, V324, P226, DOI 10.1016/j.ydbio.2008.09.020; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Meves Friedr., 1909, Anatomischer Anzeiger, V34; MILLER JB, 1989, DEV BIOL, V136, P393, DOI 10.1016/0012-1606(89)90265-0; MILLER JB, 1986, J CELL BIOL, V103, P2197, DOI 10.1083/jcb.103.6.2197; MILLER JB, 1989, J BIOL CHEM, V264, P13122; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; MILLER JB, 1985, J CELL BIOL, V101, P1643, DOI 10.1083/jcb.101.5.1643; MILLER JB, 1986, P NATL ACAD SCI USA, V83, P3860, DOI 10.1073/pnas.83.11.3860; PAGE S, 1992, DEV BIOL, V154, P118, DOI 10.1016/0012-1606(92)90053-J; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Sacks LD, 2003, DEVELOPMENT, V130, P3391, DOI 10.1242/dev.00541; SEED J, 1984, DEV BIOL, V106, P389, DOI 10.1016/0012-1606(84)90237-9; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Stockdale FE, 2002, RES PRO CEL, V38, P199; STOCKDALE FE, 1987, DEV BIOL, V123, P1, DOI 10.1016/0012-1606(87)90420-9; VANSWEARINGEN J, 1995, DEV BIOL, V170, P321, DOI 10.1006/dbio.1995.1218; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Vishnudas VK, 2009, HUM MOL GENET, V18, P4467, DOI 10.1093/hmg/ddp399; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wilm TP, 2005, DEVELOPMENT, V132, P393, DOI 10.1242/dev.01572	42	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9951	10.1371/journal.pone.0009951	http://dx.doi.org/10.1371/journal.pone.0009951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376350	gold, Green Published			2022-12-27	WOS:000276418200027
J	Golding, J; Steer, C; Pembrey, M				Golding, Jean; Steer, Colin; Pembrey, Marcus			Parental and Grandparental Ages in the Autistic Spectrum Disorders: A Birth Cohort Study	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; PATERNAL AGE; MOUSE; CHECKLIST; CHILDREN; OOCYTES	Background: A number of studies have assessed ages of parents of children with autistic spectrum disorders (ASD), and reported both maternal and paternal age effects. Here we assess relationships with grandparental ages. Methods and Findings: We compared the parental and grandparental ages of children in the population-based Avon Longitudinal Study of Parents and Children (ALSPAC), according to their scores in regard to 4 autistic trait measures and whether they had been given a diagnosis of ASD. Mean maternal and paternal ages of ASD cases were raised, but this appears to be secondary to a maternal grandmother age effect (P = 0.006): OR = 1.66[95% CI 1.16, 2.37] for each 10-year increase in the grandmother's age at the birth of the mother. Trait measures also revealed an association between the maternal grandmother's age and the major autistic trait-the Coherence Scale (regression coefficient b = 0.142, [95% CI = 0.057, 0.228] P = 0.001). After allowing for confounders the effect size increased to b = 0.217[95% CI 0.125, 0.308](P<0.001) for each 10 year increase in age. Conclusions: Although the relationship between maternal grandmother's age and ASD and a major autistic trait was unexpected, there is some biological plausibility, for the maternal side at least, given that the timing of female meiosis I permits direct effects on the grandchild's genome during the grandmother's pregnancy. An alternative explanation is the meiotic mismatch methylation (3 M) hypothesis, presented here for the first time. Nevertheless the findings should be treated as hypothesis generating pending corroborative results from other studies.	[Golding, Jean; Steer, Colin; Pembrey, Marcus] Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Bristol	Golding, J (corresponding author), Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England.	jean.golding@bristol.ac.uk		Golding, Jean/0000-0003-2826-3307	The UK Medical Research Council (MRC); Wellcome Trust; MRC; Medical Research Council [G0400085, G9815508] Funding Source: researchfish; MRC [G0400085] Funding Source: UKRI	The UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. The statistical analyses for this paper were specifically funded by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Buss A., 1984, TEMPERAMENT EARLY DE; Chawarska K, 2007, J AUTISM DEV DISORD, V37, P62, DOI 10.1007/s10803-006-0330-8; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Fujino Y, 1996, HUM REPROD, V11, P1480; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hulten MA, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-21; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; JAGIELLO G, 1976, CHROMOSOMA, V58, P377, DOI 10.1007/BF00292845; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Levy Y, 2009, J CHILD PSYCHOL PSYC, V50, P657, DOI 10.1111/j.1469-7610.2008.01986.x; Lopes FL, 2009, HUM MOL GENET, V18, P2032, DOI 10.1093/hmg/ddp127; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; STEER C, TRAITS CONTRIB UNPUB; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095	33	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9939	10.1371/journal.pone.0009939	http://dx.doi.org/10.1371/journal.pone.0009939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580AG	20376340	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200016
J	Morrill, JC; Ikegami, T; Yoshikawa-Iwata, N; Lokugamage, N; Won, S; Terasaki, K; Zamoto-Niikura, A; Peters, CJ; Makino, S				Morrill, John C.; Ikegami, Tetsuro; Yoshikawa-Iwata, Naoko; Lokugamage, Nandadeva; Won, Sungyong; Terasaki, Kaori; Zamoto-Niikura, Aya; Peters, C. J.; Makino, Shinji			Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA	PLOS ONE			English	Article							GLYCOSAMINOGLYCAN-BINDING VARIANTS; ENCEPHALITIS-VIRUS; JAPANESE ENCEPHALITIS; VIRAL-RNA; EXPRESSION; DETERMINANTS; VACCINE; PROTEIN; NSS; LACKING	Background: Rift Valley fever virus (RVFV), a member of the genus Phlebovirus within the family Bunyaviridae, is a negative-stranded RNA virus with a tripartite genome. RVFV is transmitted by mosquitoes and causes fever and severe hemorrhagic illness among humans, while in livestock it causes fever and high abortion rates. Methodology/Principal Findings: Sequence analysis showed that a wild-type RVFV ZH501 preparation consisted of two major viral subpopulations, with a single nucleotide heterogeneity at nucleotide 847 of M segment (M847); one had a G residue at M847 encoding glycine in a major viral envelope Gn protein, while the other carried A residue encoding glutamic acid at the corresponding site. Two ZH501-derived viruses, rZH501-M847-G and rZH501-M847-A, carried identical genomic sequences, except that the former and the latter had G and A, respectively, at M847 were recovered by using a reverse genetics system. Intraperitoneal inoculation of rZH501-M847-A into mice caused a rapid and efficient viral accumulation in the sera, livers, spleens, kidneys and brains, and killed most of the mice within 8 days, whereas rZH501-M847-G caused low viremia titers, did not replicate as efficiently as did rZH501-M847-A in these organs, and had attenuated virulence to mice. Remarkably, as early as 2 days postinfection with rZH501-M847-G, the viruses carrying A at M847 emerged and became the major virus population thereafter, while replicating viruses retained the input A residue at M847 in rZH501-M847-A-infected mice. Conclusions/Significance: These data demonstrated that the single nucleotide substitution in the Gn protein substantially affected the RVFV mouse virulence and that a virus population carrying the virulent viral genotype quickly emerged and became the major viral population within a few days in mice that were inoculated with the attenuated virus.	[Morrill, John C.; Ikegami, Tetsuro; Yoshikawa-Iwata, Naoko; Lokugamage, Nandadeva; Won, Sungyong; Terasaki, Kaori; Zamoto-Niikura, Aya; Peters, C. J.; Makino, Shinji] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ikegami, Tetsuro; Peters, C. J.] Univ Texas Med Branch Galveston, Dept Pathol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Morrill, JC (corresponding author), Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	cjpeters@utmb.edu; shmakino@utmb.edu	Ikegami, Tetsuro/H-1329-2013; Ibrahim, Essam Hassan/G-1960-2018; Makino, Shinji/E-8014-2015	Ikegami, Tetsuro/0000-0001-8318-2783; Ibrahim, Essam Hassan/0000-0003-0130-2257; Makino, Shinji/0000-0002-7831-1576	Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, National Institutes of Health (NIH) [U54 AI057156]; NIH-NIAID [NIH-NIAID-DMID-02-24]; James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062636, U54AI057156] Funding Source: NIH RePORTER	Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants through the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, National Institutes of Health (NIH) grant number U54 AI057156, and by NIH-NIAID-DMID-02-24 Collaborative Grant on Emerging Viral Diseases. TI, SW, and KT were supported by the James W. McLaughlin Fellowship Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GW, 1987, MICROB PATHOGENESIS, V2, P283, DOI 10.1016/0882-4010(87)90126-4; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; BESSELAAR TG, 1991, ARCH VIROL, V121, P111, DOI 10.1007/BF01316748; Billecocq A, 2008, VIROLOGY, V378, P377, DOI 10.1016/j.virol.2008.05.033; Bird BH, 2008, J VIROL, V82, P2681, DOI 10.1128/JVI.02501-07; Bird BH, 2007, VIROLOGY, V362, P10, DOI 10.1016/j.virol.2007.01.046; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Briones C, 2006, GENE, V384, P129, DOI 10.1016/j.gene.2006.07.037; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; HARRINGTON DG, 1980, AM J VET RES, V41, P1559; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; KEEGAN K, 1986, J VIROL, V58, P263, DOI 10.1128/JVI.58.2.263-270.1986; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P8098, DOI 10.1073/pnas.85.21.8098; Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; Morrill JC, 1997, AM J VET RES, V58, P1104; MORVAN J, 1992, RES VIROLOGY, V143, P407, DOI 10.1016/S0923-2516(06)80134-2; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Nguku P., 2007, Morbidity and Mortality Weekly Report, V56, P73; NIKLASSON BS, 1984, ACTA PATH MICRO IM C, V92, P197; Peters C. J., 1981, Rift Valley fever. Proceedings of a Workshop on Rift Valley fever, Herzlia, Israel, March 18-21, 1980., P21; PETERS CJ, 1986, ANTIVIR RES, V6, P285, DOI 10.1016/0166-3542(86)90024-0; PETERS CJ, 1988, ARCH VIROL, V99, P31, DOI 10.1007/BF01311021; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; SALUZZO JF, 1990, VACCINE, V8, P369, DOI 10.1016/0264-410X(90)90096-5; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; SCHMALJOHN CS, 1989, VIROLOGY, V170, P184, DOI 10.1016/0042-6822(89)90365-6; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Sironen T, 2008, J GEN VIROL, V89, P1309, DOI 10.1099/vir.0.83662-0; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Vialat P, 2000, J VIROL, V74, P1538, DOI 10.1128/JVI.74.3.1538-1543.2000; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wang EY, 2003, J VIROL, V77, P1204, DOI 10.1128/JVI.77.2.1204-1210.2003; WON A, 2007, J VIROL IN PRESS, V81; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06	47	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9986	10.1371/journal.pone.0009986	http://dx.doi.org/10.1371/journal.pone.0009986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376320	Green Published, gold, Green Submitted			2022-12-27	WOS:000276418200056
J	Ye, JJ; Huang, CT; Shie, SS; Huang, PY; Su, LH; Chiu, CH; Leu, HS; Chiang, PC				Ye, Jung-Jr; Huang, Ching-Tai; Shie, Shian-Sen; Huang, Po-Yen; Su, Lin-Hui; Chiu, Cheng-Hsun; Leu, Hsieh-Shong; Chiang, Ping-Cherng			Multidrug Resistant Acinetobacter baumannii: Risk Factors for Appearance of Imipenem Resistant Strains on Patients Formerly with Susceptible Strains	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; CARBAPENEM RESISTANCE; ANTIBIOTIC-RESISTANCE; HOSPITAL OUTBREAK; IN-VITRO; ACQUISITION; INFECTIONS; EPIDEMIOLOGY; SULBACTAM	Background: Multidrug resistant Acinetobacter baumannii (MDRAB) is an important nosocomial pathogen usually susceptible to carbapenems; however, growing number of imipenem resistant MDRAB (IR-MDRAB) poses further clinical challenge. The study was designed to identify the risk factors for appearance of IR-MDRAB on patients formerly with imipenem susceptible MDRAB (IS-MDRAB) and the impact on clinical outcomes. Methodology/Principal Findings: A retrospective case control study was carried out for 209 consecutive episodes of IS-MDRAB infection or colonization from August 2001 to March 2005. Forty-nine (23.4%) episodes with succeeding clinical isolates of IR-MDRAB were defined as the cases and 160 (76.6%) with all subsequent clinical isolates of IS-MDRAB were defined as the controls. Quantified antimicrobial selective pressure, "time at risk'', severity of illness, comorbidity, and demographic data were incorporated for multivariate analysis, which revealed imipenem or meropenem as the only significant independent risk factor for the appearance of IR-MDRAB (adjusted OR, 1.18; 95% CI, 1.09 to 1.27). With selected cases and controls matched to exclude exogenous source of IR-MDRAB, multivariate analysis still identified carbapenem as the only independent risk factor (adjusted OR, 1.48; 95% CI, 1.14 to 1.92). Case patients had a higher crude mortality rate compared to control patients (57.1% vs. 31.3%, p = 0.001), and the mortality of case patients was associated with shorter duration of "time at risk'', i.e., faster appearance of IR-MDRAB (adjusted OR, 0.9; 95% CI, 0.83 to 0.98). Conclusions/Significance: Judicious use of carbapenem with deployment of antibiotics stewardship measures is critical for reducing IR-MDRAB and the associated unfavorable outcome.	[Ye, Jung-Jr; Huang, Ching-Tai; Shie, Shian-Sen; Huang, Po-Yen; Leu, Hsieh-Shong; Chiang, Ping-Cherng] Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan; [Su, Lin-Hui] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Pathol, Div Clin Pathol, Tao Yuan, Taiwan; [Chiu, Cheng-Hsun] Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Ye, JJ (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan.	chingtaihuang@gmail.com	Chuang, shengHao/C-8217-2012					Abbo A, 2005, EMERG INFECT DIS, V11, P22, DOI 10.3201/eid1101.040001; Afzal-Shah M, 1998, J ANTIMICROB CHEMOTH, V41, P576, DOI 10.1093/jac/41.5.576; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Cisneros JM, 2005, CLIN MICROBIOL INFEC, V11, P874, DOI 10.1111/j.1469-0691.2005.01256.x; *CLSI, 2001, PERF STAND ANT DISK; Corbella X, 2000, J CLIN MICROBIOL, V38, P4086, DOI 10.1128/JCM.38.11.4086-4095.2000; COURCOL RJ, 1989, J ANTIMICROB CHEMOTH, V23, P441, DOI 10.1093/jac/23.3.441; El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; GO ES, 1994, LANCET, V344, P1329, DOI 10.1016/S0140-6736(94)90694-7; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Hsueh PR, 2001, MICROB DRUG RESIST, V7, P373, DOI 10.1089/10766290152773383; Hsueh PR, 2002, EMERG INFECT DIS, V8, P827; Kiffer CRV, 2005, DIAGN MICR INFEC DIS, V52, P317, DOI 10.1016/j.diagmicrobio.2005.03.003; Kim YA, 2008, SCAND J INFECT DIS, V40, P234, DOI 10.1080/00365540701633004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Ko WC, 2004, J ANTIMICROB CHEMOTH, V53, P393, DOI 10.1093/jac/dkh080; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Paterson DL, 2002, CLIN INFECT DIS, V34, P1564, DOI 10.1086/340532; Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; SCHRECKENBERGER PC, 2003, MANNUAL CLIN MICROBI; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x	26	46	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9947	10.1371/journal.pone.0009947	http://dx.doi.org/10.1371/journal.pone.0009947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20369056	Green Submitted, gold, Green Published			2022-12-27	WOS:000276418200023
J	Leischner, U; Schierloh, A; Zieglgansberger, W; Dodt, HU				Leischner, Ulrich; Schierloh, Anja; Zieglgaensberger, Walter; Dodt, Hans-Ulrich			Formalin-Induced Fluorescence Reveals Cell Shape and Morphology in Biological Tissue Samples	PLOS ONE			English	Article							DIMENSIONS	Ultramicroscopy is a powerful tool to reveal detailed three-dimensional structures of large microscopical objects. Using high magnification, we observed that formalin induces fluorescence more in extra-cellular space and stains cellular structures negatively, rendering cells as dark objects in front of a bright background. Here, we show this effect on a three-dimensional image stack of a hippocampus sample, focusing on the CA1 region. This method, called FIF-Ultramicroscopy, allows for the three-dimensional observation of cellular structures in various tissue types without complicated staining techniques.	[Leischner, Ulrich; Schierloh, Anja; Zieglgaensberger, Walter; Dodt, Hans-Ulrich] Max Planck Inst Psychiat, Munich, Germany	Max Planck Society	Leischner, U (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	Ulrich.leischner@lrz.tum.de		Leischner, Ulrich/0000-0001-7771-2135	Hertie foundation;  [FSB 391]	Hertie foundation; 	This work was supported by grants from the Hertie foundation and FSB 391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYAD S, 1998, EXTRACELLULAR MATRIX, P1; Buytaert JAN, 2009, APPL OPTICS, V48, P941, DOI 10.1364/AO.48.000941; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; CORRODI H, 1967, J HISTOCHEM CYTOCHEM, V15, P65, DOI 10.1177/15.2.65; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; FALCK B, 1962, J HISTOCHEM CYTOCHEM, V10, P348, DOI 10.1177/10.3.348; FRAENKELCONRAT H, 1948, J BIOL CHEM, V174, P827; GONZALEZ RC, 2009, DIGITAL IMAGE PROCES, P486; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Leischner U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005785; Reynaud EG, 2008, HFSP J, V2, P266, DOI 10.2976/1.2974980; ROST FWD, 1995, FLUORESCENCE MICROSC, V2, P54; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; SPALTEHOLZ W, 2011, DURCHSICHTIGMACHEN M; STERNBERG SR, 1986, COMPUT VISION GRAPH, V35, P333, DOI 10.1016/0734-189X(86)90004-6; STERNBERG SR, 1983, BIOMEDICAL IMAGE PRO, P22; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wein W, 2007, LECT NOTES COMPUT SC, V4792, P718	19	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10391	10.1371/journal.pone.0010391	http://dx.doi.org/10.1371/journal.pone.0010391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436930	gold, Green Published, Green Submitted			2022-12-27	WOS:000277154200026
J	Marreddy, RKR; Geertsma, ER; Permentier, HP; Pinto, JPC; Kok, J; Poolman, B				Marreddy, Ravi K. R.; Geertsma, Eric R.; Permentier, Hjalmar P.; Pinto, Joao P. C.; Kok, Jan; Poolman, Bert			Amino Acid Accumulation Limits the Overexpression of Proteins in Lactococcus lactis	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; GREEN FLUORESCENT PROTEIN; STREPTOCOCCUS-CREMORIS; MEMBRANE-PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSPORT-SYSTEM; RECEPTOR OPPA; BINDING; IDENTIFICATION; CONSTRUCTION	Background: Understanding the biogenesis pathways for the functional expression of recombinant proteins, in particular membrane proteins and complex multidomain assemblies, is a fundamental issue in cell biology and of high importance for future progress in structural genomics. In this study, we employed a proteomic approach to understand the difference in expression levels for various multidomain membrane proteins in L. lactis cells grown in complex and synthetic media. Methodology/Principal Findings: The proteomic profiles of cells growing in media in which the proteins were expressed to high or low levels suggested a limitation in the availability of branched-chain amino acids, more specifically a too limited capacity to accumulate these nutrients. By supplying the cells with an alternative path for accumulation of Ile, Leu and/or Val, i.e., a medium supplement of the appropriate dipeptides, or by engineering the transport capacity for branched-chain amino acids, the expression levels could be increased several fold. Conclusions: We show that the availability of branched chain amino acids is a critical factor for the (over) expression of proteins in L. lactis. The forward engineering of cells for functional protein production required fine-tuning of co-expression of the branched chain amino acid transporter.	[Marreddy, Ravi K. R.; Geertsma, Eric R.; Permentier, Hjalmar P.; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr,Zernike Inst Adv Mat, Groningen, Netherlands; [Pinto, Joao P. C.; Kok, Jan] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands	University of Groningen; University of Groningen	Marreddy, RKR (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr,Zernike Inst Adv Mat, Groningen, Netherlands.	b.poolman@rug.nl	Marreddy, RaviKanthReddy/Q-5680-2018; Kok, Jan/C-9972-2012; Permentier, Hjalmar P/H-4190-2016; Institute, Zernike/W-7033-2019; Poolman, Bert/D-1882-2012	Marreddy, RaviKanthReddy/0000-0003-0425-406X; Permentier, Hjalmar P/0000-0001-7317-8887; Geertsma, Eric R./0000-0002-2789-5444	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); Human Frontier Science Program; Netherlands Proteomics Centre (NPC); European Membrane Protein Consortium EDICT (European Drug Initiative on Channels and Transporters); Netherlands Science Foundation (NWO) [700-56-302]	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); Human Frontier Science Program(Human Frontier Science Program); Netherlands Proteomics Centre (NPC); European Membrane Protein Consortium EDICT (European Drug Initiative on Channels and Transporters); Netherlands Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	ERG acknowledges a long-term fellowship from Federation of the Societies of Biochemistry and Molecular Biology (FEBS) and the Human Frontier Science Program. This research work was additionally supported by the Netherlands Proteomics Centre (NPC), the European Membrane Protein Consortium EDICT (European Drug Initiative on Channels and Transporters), and the Netherlands Science Foundation (NWO; Chemical Sciences Top Subsidy to BP; grant number 700-56-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berntsson RPA, 2009, PROTEIN SCI, V18, P1121, DOI 10.1002/pro.97; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Brooijmans RJW, 2007, J BACTERIOL, V189, P5203, DOI 10.1128/JB.00361-07; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Detmers FJM, 2000, P NATL ACAD SCI USA, V97, P12487, DOI 10.1073/pnas.220308797; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; DRIESSEN AJM, 1987, J BACTERIOL, V169, P5193, DOI 10.1128/jb.169.11.5193-5200.1987; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gorgens JF, 2005, APPL MICROBIOL BIOT, V67, P684, DOI 10.1007/s00253-004-1803-3; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Hagting A, 1997, EUR J BIOCHEM, V247, P581, DOI 10.1111/j.1432-1033.1997.00581.x; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; KUNJI ERS, 1995, J BIOL CHEM, V270, P1569, DOI 10.1074/jbc.270.4.1569; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; KUNJI ERS, 1993, J BACTERIOL, V175, P2052, DOI 10.1128/JB.175.7.2052-2059.1993; LINARES DM, 2010, EVOLVED LAC IN PRESS; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; Ngo JT, 2009, NAT CHEM BIOL, V5, P715, DOI 10.1038/nchembio.200; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; POOLMAN B, 1987, J BACTERIOL, V169, P1460, DOI 10.1128/jb.169.4.1460-1468.1987; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; 2008, BIOCH J, V409, P193	39	22	22	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10317	10.1371/journal.pone.0010317	http://dx.doi.org/10.1371/journal.pone.0010317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436673	Green Published, gold, Green Submitted			2022-12-27	WOS:000277079500007
J	Sliedrecht, T; Zhang, C; Shokat, KM; Kops, GJPL				Sliedrecht, Tale; Zhang, Chao; Shokat, Kevan M.; Kops, Geert J. P. L.			Chemical Genetic Inhibition of Mps1 in Stable Human Cell Lines Reveals Novel Aspects of Mps1 Function in Mitosis	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CHROMOSOME BI-ORIENTATION; SMALL-MOLECULE INHIBITOR; POLE BODY DUPLICATION; MITOTIC CHECKPOINT; AURORA-B; CENTROSOME DUPLICATION; PROTEIN-KINASES; KINETOCHORE; ANAPHASE	Background: Proper execution of chromosome segregation relies on tight control of attachment of chromosomes to spindle microtubules. This is monitored by the mitotic checkpoint that allows chromosome segregation only when all chromosomes are stably attached. Proper functioning of the attachment and checkpoint processes is thus important to prevent chromosomal instability. Both processes rely on the mitotic kinase Mps1. Principal Finding: We present here two cell lines in which endogenous Mps1 has been stably replaced with a mutant kinase (Mps1-as) that is specifically inhibited by bulky PP1 analogs. Mps1 inhibition in these cell lines is highly penetrant and reversible. Timed inhibition during bipolar spindle assembly shows that Mps1 is critical for attachment error-correction and confirms its role in Aurora B regulation. We furthermore show that Mps1 has multiple controls over mitotic checkpoint activity. Mps1 inhibition precludes Mad1 localization to unattached kinetochores but also accelerates mitosis. This acceleration correlates with absence of detectable mitotic checkpoint complex after Mps1 inhibition. Finally, we show that short-term inhibition of Mps1 catalytic activity is sufficient to kill cells. Conclusions/Significance: Mps1 is involved in the regulation of multiple key processes that ensure correct chromosome segregation and is a promising target for inhibition in anti-cancer strategies. We report here two cell lines that allow specific and highly penetrant inhibition of Mps1 in a reproducible manner through the use of chemical genetics. Using these cell lines we confirm previously suggested roles for Mps1 activity in mitosis, present evidence for novel functions and examine cell viability after short and prolonged Mps1 inhibition. These cell lines present the best cellular model system to date for investigations into Mps1 biology and the effects of penetrance and duration of Mps1 inhibition on cell viability.	[Sliedrecht, Tale; Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Dept Physiol Chem, Canc Genom Ctr, Utrecht, Netherlands; [Sliedrecht, Tale; Kops, Geert J. P. L.] Netherlands Prote Ctr, Utrecht, Netherlands; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco	Sliedrecht, T (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Canc Genom Ctr, Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl		Kops, Geert/0000-0003-3555-5295	Netherlands Organization for Scientific Research;  [ERC-StG-242617]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); 	This work was supported by the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research and ERC-StG-242617 to GJPLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Bourhis E, 2009, BIOCHEMISTRY-US, V48, P6783, DOI 10.1021/bi900530v; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; He XW, 1998, J CELL SCI, V111, P1635; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; KANG J, 2007, P NATL ACAD SCI; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 2004, CURR BIOL, V14, P1330, DOI 10.1016/j.cub.2004.07.028; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745	41	74	75	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10251	10.1371/journal.pone.0010251	http://dx.doi.org/10.1371/journal.pone.0010251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20422024	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600003
J	Fisher, A; van Jaarsveld, CHM; Llewellyn, CH; Wardle, J				Fisher, Abigail; van Jaarsveld, Cornelia H. M.; Llewellyn, Clare H.; Wardle, Jane			Environmental Influences on Children's Physical Activity: Quantitative Estimates Using a Twin Design	PLOS ONE			English	Article							ACTIVITY LEVEL; ACTIVITY THERMOGENESIS; INFANT TEMPERAMENT; ENERGY-EXPENDITURE; GENETIC INFLUENCES; EARLY-CHILDHOOD; MOTOR-ACTIVITY; BEHAVIOR; WEIGHT; EXERCISE	Background: Twin studies offer a 'natural experiment' that can estimate the magnitude of environmental and genetic effects on a target phenotype. We hypothesised that fidgetiness and enjoyment of activity would be heritable but that objectively-measured daily activity would show a strong shared environmental effect. Methodology/Principal Findings: In a sample of 9-12 year-old same-sex twin pairs ( 234 individuals; 57 MZ, 60 DZ pairs) we assessed three dimensions of physical activity: i) objectively-measured physical activity using accelerometry, ii) 'fidgetiness' using a standard psychometric scale, and iii) enjoyment of physical activity from both parent ratings and children's self-reports. Shared environment effects explained the majority (73%) of the variance in objectively-measured total physical activity (95% confidence intervals (CI): 0.63-0.81) with a smaller unshared environmental effect (27%; CI: 0.19-0.37) and no significant genetic effect. In contrast, fidgetiness was primarily under genetic control, with additive genetic effects explaining 75% (CI: 62-84%) of the variance, as was parent's report of children's enjoyment of low 74% (CI: 61-82%), medium 80% (CI: 71-86%), and high impact activity (85%; CI: 78-90%), and children's expressed activity preferences (60%, CI: 42-72%). Conclusions: Consistent with our hypothesis, the shared environment was the dominant influence on children's day-to-day activity levels. This finding gives a strong impetus to research into the specific environmental characteristics influencing children's activity, and supports the value of interventions focused on home or school environments.	[Fisher, Abigail; van Jaarsveld, Cornelia H. M.; Llewellyn, Clare H.; Wardle, Jane] UCL, Canc Res UK Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England	Cancer Research UK; University of London; University College London	Fisher, A (corresponding author), UCL, Canc Res UK Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England.	j.wardle@ucl.ac.uk	Van Jaarsveld, Ellen CHM/A-4632-2016	Van Jaarsveld, Ellen CHM/0000-0002-4269-0041; Llewellyn, Clare/0000-0002-0066-2827	Biotechnology and Biological Sciences Research Council [31/D19086]; Cancer Research UK [C1418/A7974]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	FThis research was supported by the Biotechnology and Biological Sciences Research Council (31/D19086, www.bbsrc.ac.uk) and Cancer Research UK (C1418/A7974, www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Anderson SE, 2004, INT J OBESITY, V28, P300, DOI 10.1038/sj.ijo.0802543; Auerbach JG, 2001, J CHILD PSYCHOL PSYC, V42, P777, DOI 10.1111/1469-7610.00774; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Duncan GE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002019; EISENMANN JC, 2008, PEDIAT EXERC SCI, V20, P229; Ekelund U, 2004, AM J CLIN NUTR, V79, P851; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; EPSTEIN LH, 1991, HEALTH PSYCHOL, V10, P311, DOI 10.1037/0278-6133.10.5.311; EPSTEIN LH, 1989, APPETITE, V12, P105, DOI 10.1016/0195-6663(89)90100-1; Esliger DW, 2010, MED SCI SPORT EXER, V42, P296, DOI 10.1249/MSS.0b013e3181b3afd2; Fox PW, 1996, NATURE, V384, P356, DOI 10.1038/384356a0; Franks PW, 2005, AM J CLIN NUTR, V82, P901, DOI 10.1093/ajcn/82.4.901; Gorely T, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-5; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Hwang J, 2003, INFANT BEHAV DEV, V26, P112, DOI 10.1016/S0163-6383(02)00173-X; Johannsen DL, 2008, CURR OPIN ENDOCRINOL, V15, P409, DOI 10.1097/MED.0b013e32830b10bb; Kiang M, 2003, J PSYCHIATR NEUROSCI, V28, P293; Levine JA, 2004, NUTR REV, V62, pS82, DOI 10.1111/j.1753-4887.2004.tb00094.x; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Llewellyn CH, 2008, AM J CLIN NUTR, V88, P1560, DOI 10.3945/ajcn.2008.26175; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; McMurray RG, 2002, J ADOLESCENT HEALTH, V31, P125, DOI 10.1016/S1054-139X(02)00348-8; NEALE MC, 1989, J PERS SOC PSYCHOL, V56, P446, DOI 10.1037/0022-3514.56.3.446; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; PLOMIN R, 1980, J PERS SOC PSYCHOL, V39, P680, DOI 10.1037/0022-3514.39.4.680; Plomin R., 2008, BEHAV GENET; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Purslow LR, 2009, PREV MED, V49, P28, DOI 10.1016/j.ypmed.2009.04.010; Purslow LR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-67; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Roemmich JN, 2008, PHYSIOL BEHAV, V93, P1011, DOI 10.1016/j.physbeh.2008.01.010; Sallis JF, 2009, AM J PREV MED, V36, pS72, DOI 10.1016/j.amepre.2008.10.006; Sallis RE, 2009, BRIT J SPORT MED, V43, P3, DOI 10.1136/bjsm.2008.054825; Saudino K J, 2000, Twin Res, V3, P224; Saudino KJ, 2008, CHILD DEV, V79, P930, DOI 10.1111/j.1467-8624.2008.01168.x; SAUDINO KJ, 1991, CHILD DEV, V62, P1167, DOI 10.1111/j.1467-8624.1991.tb01597.x; SAUDINO KJ, 1995, BRIT J DEV PSYCHOL, V13, P81, DOI 10.1111/j.2044-835X.1995.tb00666.x; Simonen RL, 2003, PHYSIOL BEHAV, V78, P751, DOI 10.1016/S0031-9384(03)00084-2; Stubbe JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000022; Stubbe JH, 2005, MED SCI SPORT EXER, V37, P563, DOI 10.1249/01.MSS.0000158181.75442.8B; TAYLOR E, 1984, J ABNORM CHILD PSYCH, V12, P143, DOI 10.1007/BF00913466; Thorburn A W, 2000, Obes Rev, V1, P87, DOI 10.1046/j.1467-789x.2000.00018.x; van Jaarsveld CHM, 2010, TWIN RES HUM GENET, V13, P72, DOI 10.1375/twin.13.1.72; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661; Webber LS, 2008, AM J PREV MED, V34, P173, DOI 10.1016/j.amepre.2007.11.018; Wood AC, 2008, BEHAV GENET, V38, P266, DOI 10.1007/s10519-008-9196-1; Wood AC, 2007, J CHILD PSYCHOL PSYC, V48, P695, DOI 10.1111/j.1469-7610.2007.01739.x	50	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10110	10.1371/journal.pone.0010110	http://dx.doi.org/10.1371/journal.pone.0010110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YS	20422046	gold, Green Published, Green Submitted			2022-12-27	WOS:000276952500001
J	Anas, AA; Hovius, JWR; van't Veer, C; van der Poll, T; de Vos, AF				Anas, Adam A.; Hovius, Joppe W. R.; van't Veer, Cornelis; van der Poll, Tom; de Vos, Alex F.			Role of CD14 in a Mouse Model of Acute Lung Inflammation Induced by Different Lipopolysaccharide Chemotypes	PLOS ONE			English	Article							ESCHERICHIA-COLI PNEUMONIA; TOLL-LIKE RECEPTORS; SOLUBLE CD14; INHALED ENDOTOXIN; EPITHELIAL-CELLS; GENE-EXPRESSION; LPS; COMPLEX; BINDING; INJURY	Background: Recognition of lipopolysaccharide (LPS) is required for effective defense against invading gram-negative bacteria. Recently, in vitro studies revealed that CD14 is required for activation of the myeloid differentiation factor (MyD)88-dependent Toll-like receptor (TLR)4 signaling pathway by smooth (S)-LPS, but not by rough (R)-LPS. The present study investigated the role of CD14 in induction of lung inflammation in mice by these different LPS chemotypes. Methodology/Results: Neutrophil accumulation and tumor necrosis factor (TNF) release in bronchoalveolar lavage fluid were determined 6 hours after intranasal treatment of wild type (WT) and CD14 knock-out (KO) mice with different doses S-LPS or R-LPS. The contribution of CD14 to lung inflammation induced by S-LPS or R-LPS depended on the LPS dose. At low doses, S-LPS and R-LPS induced neutrophil influx in a CD14-dependent manner. Low dose S-LPS-induced cytokine release also depended on CD14. Strikingly, neutrophil influx and TNF release induced by high dose S-LPS or R-LPS was diminished in the presence of CD14. Intranasal administration of sCD14 to CD14 KO mice treated with S-LPS partially reversed the inflammatory response to the response observed in WT mice. Conclusions: In conclusion, CD14 modulates effects of both S-LPS and R-LPS within the lung in a similar way. Except for R-LPS-induced TNF release, S-LPS and R-LPS at low dose induced acute lung inflammation in a CD14-dependent manner, while the inflammatory response triggered by high dose S-LPS or R-LPS was diminished by CD14.	[Anas, Adam A.] Univ Amsterdam, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Anas, AA (corresponding author), Univ Amsterdam, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands.	a.f.devos@amc.uva.nl	Hovius, Joppe/GZL-6894-2022	Hovius, Joppe/0000-0003-0066-2437	Academic Medical Center, Amsterdam, The Netherlands	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government)	This work was funded by the Academic Medical Center, Amsterdam, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Brass DM, 2007, AM J PHYSIOL-LUNG C, V293, pL77, DOI 10.1152/ajplung.00282.2006; Cai S, 2009, AM J RESP CELL MOL, V40, P701, DOI 10.1165/rcmb.2008-0152OC; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; HAZIOT A, 1994, J IMMUNOL, V152, P5868; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Knapp S, 2006, J IMMUNOL, V176, P3189, DOI 10.4049/jimmunol.176.5.3189; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Noulin N, 2005, J IMMUNOL, V175, P6861, DOI 10.4049/jimmunol.175.10.6861; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V305, P649, DOI 10.1016/S0006-291X(03)00837-4; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Saito T, 2005, CELL TISSUE RES, V321, P75, DOI 10.1007/s00441-005-1113-9; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Stelter F, 1998, EUR J CLIN INVEST, V28, P205; Tasaka S, 2003, AM J RESP CELL MOL, V29, P252, DOI 10.1165/rcmb.2002-0132OC; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777	31	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10183	10.1371/journal.pone.0010183	http://dx.doi.org/10.1371/journal.pone.0010183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419140	Green Published, Green Submitted, gold			2022-12-27	WOS:000276743500010
J	Tossidou, I; Teng, BN; Menne, J; Shushakova, N; Park, JK; Becker, JU; Modde, F; Leitges, M; Haller, H; Schiffer, M				Tossidou, Irini; Teng, Beina; Menne, Jan; Shushakova, Nelli; Park, Joon-Keun; Becker, Jan U.; Modde, Friedrich; Leitges, Michael; Haller, Hermann; Schiffer, Mario			Podocytic PKC-Alpha Is Regulated in Murine and Human Diabetes and Mediates Nephrin Endocytosis	PLOS ONE			English	Article							PROTEIN-KINASE-C; SLIT DIAPHRAGM; GENE; NEPHROPATHY; ALBUMIN	Background: Microalbuminuria is an early lesion during the development of diabetic nephropathy. The loss of high molecular weight proteins in the urine is usually associated with decreased expression of slit diaphragm proteins. Nephrin, is the major component of the glomerular slit diaphragm and loss of nephrin has been well described in rodent models of experimental diabetes as well as in human diabetic nephropathy. Methodology/Principal Findings: In this manuscript we analyzed the role of PKC-alpha (PKC alpha) on endocytosis of nephrin in podocytes. We found that treatment of diabetic mice with a PKC alpha-inhibitor (GO6976) leads to preserved nephrin expression and reduced proteinuria. In vitro, we found that high glucose stimulation would induce PKC alpha protein expression in murine and human podocytes. We can demonstrate that PKC alpha mediates nephrin endocytosis in podocytes and that overexpression of PKC alpha leads to an augmented endocytosis response. After PKC-activation, we demonstrate an inducible association of PKC alpha, PICK1 and nephrin in podocytes. Moreover, we can demonstrate a strong induction of PKC alpha in podocytes of patients with diabetic nephropathy. Conclusions/Significance: We therefore conclude that activation of PKC alpha is a pathomechanistic key event during the development of diabetic nephropathy. PKC alpha is involved in reduction of nephrin surface expression and therefore PKC alpha inhibition might be a novel target molecule for anti-proteinuric therapy.	[Tossidou, Irini; Teng, Beina; Menne, Jan; Shushakova, Nelli; Park, Joon-Keun; Leitges, Michael; Haller, Hermann; Schiffer, Mario] Hannover Med Sch, Dept Med, Div Nephrol, D-3000 Hannover, Germany; [Becker, Jan U.; Modde, Friedrich] Hannover Med Sch, Dept Pathol, D-3000 Hannover, Germany; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Hannover Medical School; Hannover Medical School; University of Oslo	Tossidou, I (corresponding author), Hannover Med Sch, Dept Med, Div Nephrol, D-3000 Hannover, Germany.	schiffer.mario@mh-hannover.de	Schiffer, Mario/U-7050-2019; Leitges, Michael/AAN-1953-2021	Schiffer, Mario/0000-0002-8414-1470; Leitges, Michael/0000-0003-4203-6995; Becker, Jan Ulrich/0000-0003-2929-8085	DFG [SCHI 587/2-2, ME3143/1-1]; SFB [566-B16]	DFG(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF))	This work was supported by a DFG-Emmy Noether Fellowship (SCHI 587/2-2) and SFB 566-B16 to M. S., and DFG-grant ME3143/1-1 to J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Dev KK, 2004, J BIOL CHEM, V279, P41393, DOI 10.1074/jbc.M404499200; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Hanley JG, 2006, BIOCHEM SOC T, V34, P931, DOI 10.1042/BST0340931; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Leitges M, 2007, BIOCHEM SOC T, V35, P1018, DOI 10.1042/BST0351018; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mundel P, 1996, EXP NEPHROL, V4, P263; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Rastaldi MP, 2006, KIDNEY INT, V70, P477, DOI 10.1038/sj.ki.5001563; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Tossidou I, 2009, CELL PHYSIOL BIOCHEM, V24, P627, DOI 10.1159/000257518; Tryggvason K, 1999, INT J DEV BIOL, V43, P445	28	57	59	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10185	10.1371/journal.pone.0010185	http://dx.doi.org/10.1371/journal.pone.0010185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584HZ	20419132	Green Published, gold, Green Submitted			2022-12-27	WOS:000276743500002
J	Potter, CJ; Luo, LQ				Potter, Christopher J.; Luo, Liqun			Splinkerette PCR for Mapping Transposable Elements in Drosophila	PLOS ONE			English	Article							GERM-LINE; P-ELEMENTS; HYBRID DYSGENESIS; MELANOGASTER; TRANSFORMATION; PIGGYBAC; VECTOR; GENOME; MUTAGENESIS; EXPRESSION	Transposable elements (such as the P-element and piggyBac) have been used to introduce thousands of transgenic constructs into the Drosophila genome. These transgenic constructs serve many roles, from assaying gene/cell function, to controlling chromosome arm rearrangement. Knowing the precise genomic insertion site for the transposable element is often desired. This enables identification of genomic enhancer regions trapped by an enhancer trap, identification of the gene mutated by a transposon insertion, or simplifying recombination experiments. The most commonly used transgene mapping method is inverse PCR (iPCR). Although usually effective, limitations with iPCR hinder its ability to isolate flanking genomic DNA in complex genomic loci, such as those that contain natural transposons. Here we report the adaptation of the splinkerette PCR (spPCR) method for the isolation of flanking genomic DNA of any P-element or piggyBac. We report a simple and detailed protocol for spPCR. We use spPCR to 1) map a GAL4 enhancer trap located inside a natural transposon, pinpointing a master regulatory region for olfactory neuron expression in the brain; and 2) map all commonly used centromeric FRT insertion sites. The ease, efficiency, and efficacy of spPCR could make it a favored choice for the mapping of transposable element in Drosophila.	[Potter, Christopher J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21218 USA; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Johns Hopkins University; Howard Hughes Medical Institute; Stanford University	Potter, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21218 USA.	cpotter@jhmi.edu	Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112	National Institutes of Health [R01-DC005982]; Human Frontiers Science Program; Damon Runyon Cancer Research Foundation [DRG-1766-03]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health [R01-DC005982]; the Human Frontiers Science Program; and the Damon Runyon Cancer Research Foundation [DRG-1766-03 to C.J.P.]. L. L. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdnik D, 2008, CURR BIOL, V18, P1754, DOI 10.1016/j.cub.2008.09.045; Bharathi V, 2004, J CELL SCI, V117, P1911, DOI 10.1242/jcs.01034; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BLACK DM, 1987, EMBO J, V6, P4125, DOI 10.1002/j.1460-2075.1987.tb02758.x; BLACKMAN RK, 1989, EMBO J, V8, P211, DOI 10.1002/j.1460-2075.1989.tb03366.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chou TB, 1996, GENETICS, V144, P1673; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; DING D, 1994, GENET RES, V64, P167, DOI 10.1017/S0016672300032833; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Laissue PP, 1999, J COMP NEUROL, V405, P543; LIDHOLM DA, 1993, GENETICS, V134, P859; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; LOUKERIS TG, 1995, P NATL ACAD SCI USA, V92, P9485, DOI 10.1073/pnas.92.21.9485; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; OBrochta DA, 1996, GENETICS, V142, P907; OCHMAN H, 1988, GENETICS, V120, P621; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; RASMUSSON KE, 1993, GENETICS, V133, P605; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; SENTRY JW, 1994, NUCLEIC ACIDS RES, V22, P3429, DOI 10.1093/nar/22.16.3429; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; XU T, 1993, DEVELOPMENT, V117, P1223	38	82	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10168	10.1371/journal.pone.0010168	http://dx.doi.org/10.1371/journal.pone.0010168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405015	gold, Green Submitted, Green Published			2022-12-27	WOS:000276706300021
J	Desgranges, B; Ramirez-Amaya, V; Ricano-Cornejo, I; Levy, F; Ferreira, G				Desgranges, Bertrand; Ramirez-Amaya, Victor; Ricano-Cornejo, Itzel; Levy, Frederic; Ferreira, Guillaume			Flavor Preference Learning Increases Olfactory and Gustatory Convergence onto Single Neurons in the Basolateral Amygdala but Not in the Insular Cortex in Rats	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; LONG-TERM POTENTIATION; STIMULUS CONVERGENCE; SYNAPTIC PLASTICITY; PROTEIN EXPRESSION; LATERAL AMYGDALA; ARC; TASTE; CONSOLIDATION; HIPPOCAMPAL	The basolateral amygdala (BLA) and the insular cortex (IC) represent two major areas for odor-taste associations, i.e. flavor integration. This learning may require the development of convergent odor and taste neuronal activation allowing the memory representation of such association. Yet identification of neurons that respond to such coincident input and the effect of flavor experience on odor-taste convergence remain unclear. In the present study we used the compartmental analysis of temporal activity using fluorescence in situ hybridization for Arc (catFISH) to visualize odor-taste convergence onto single neurons in the BLA and in the IC to assess the number of cells that were co-activated by both stimuli after odor-taste association. We used a sucrose conditioned odor preference as a flavor experience in rats, in which 9 odor-sucrose pairings induce a reliable odor-taste association. The results show that flavor experience induced a four-fold increase in the percentage of cells activated by both taste and odor stimulations in the BLA, but not in the IC. Because conditioned odor preference did not modify the number of cells responding selectively to one stimulus, this greater odor-taste convergence into individual BLA neurons suggests the recruitment of a neuronal population that can be activated by both odor and taste only after the association. We conclude that the development of convergent activation in amygdala neurons after odor-taste associative learning may provide a cellular basis of flavor memory.	[Desgranges, Bertrand; Levy, Frederic; Ferreira, Guillaume] Univ Tours, Lab Comportement Neurobiol & Adaptat, CNRS, INRA,UMR 6175,UMR 85, Nouzilly, France; [Ramirez-Amaya, Victor; Ricano-Cornejo, Itzel] Univ Nacl Autonoma Mexico, Inst Neurol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Universidad Nacional Autonoma de Mexico	Desgranges, B (corresponding author), Univ Tours, Lab Comportement Neurobiol & Adaptat, CNRS, INRA,UMR 6175,UMR 85, Nouzilly, France.	vramirez@unam.mx; guillaume.ferreira@bordeaux.inra.fr	Desgranges, Béatrice/L-7739-2015	Ferreira, Guillaume/0000-0001-5984-8143; Desgranges, Beatrice/0000-0002-3657-9996	AROMALIM Grant Agence National de la Recherche [ANR-05-PNRA-002]; CONACyT Mexico [51028]; PAPIIT UNAM [IN213907]; INRegion Centre	AROMALIM Grant Agence National de la Recherche(French National Research Agency (ANR)); CONACyT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); INRegion Centre	This work was supported by AROMALIM Grant Agence National de la Recherche ANR-05-PNRA-002 (GF), CONACyT Mexico 51028 and PAPIIT UNAM IN213907 (VRA). BD was supported by a PhD grant from INRegion Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton J. P., 2000, AMYGDALA FUNCTIONAL, P1; Barot SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006156; Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Desgranges B, 2008, BRAIN RES, V1236, P166, DOI 10.1016/j.brainres.2008.07.123; Gilbert PE, 2003, NEUROBIOL LEARN MEM, V79, P118, DOI 10.1016/S1074-7427(02)00013-8; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; LAMPRECHT R, 2000, AMYGDALA, P310; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Reilly S, 2005, NEUROSCI BIOBEHAV R, V29, P1067, DOI 10.1016/j.neubiorev.2005.03.025; Sakai N, 2001, NEUROBIOL LEARN MEM, V75, P128, DOI 10.1006/nlme.2000.3969; Sevelinges Y, 2009, LEARN MEMORY, V16, P235, DOI 10.1101/lm.1247609; Sewards TV, 2001, NEUROSCI BIOBEHAV R, V25, P395, DOI 10.1016/S0149-7634(01)00021-5; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Shionoya K, 2009, NEUROBIOL LEARN MEM, V92, P590, DOI 10.1016/j.nlm.2009.07.008; Shipley MT, 1996, J NEUROBIOL, V30, P123; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Touzani K, 2005, EUR J NEUROSCI, V22, P1767, DOI 10.1111/j.1460-9568.2005.04360.x; Touzani K, 2007, EUR J NEUROSCI, V26, P1692, DOI 10.1111/j.1460-9568.2007.05798.x; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Voronin LL, 1996, NEUROSCIENCE, V74, P323, DOI 10.1016/0306-4522(96)00207-2	34	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10097	10.1371/journal.pone.0010097	http://dx.doi.org/10.1371/journal.pone.0010097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580WU	20404918	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482100014
J	Podhraski, V; Campo-Fernandez, B; Worle, H; Piatti, P; Niederegger, H; Bock, G; Fyodorov, DV; Lusser, A				Podhraski, Valerie; Campo-Fernandez, Beatriz; Woerle, Hildegard; Piatti, Paolo; Niederegger, Harald; Boeck, Guenther; Fyodorov, Dmitry V.; Lusser, Alexandra			CenH3/CID Incorporation Is Not Dependent on the Chromatin Assembly Factor CHD1 in Drosophila	PLOS ONE			English	Article							CENTROMERE-SPECIFIC HISTONE; CENP-A; PROTEIN; HJURP; LOCALIZATION; MELANOGASTER; ASSOCIATION; PROPAGATION; DEPOSITION; ARREST	CHD1 is a SNF2-related ATPase that is required for the genome-wide incorporation of variant histone H3.3 in the paternal pronucleus as well as in transcriptionally active nuclei in Drosophila embryos. The S. pombe and vertebrate orthologs of CHD1 have been implicated in the assembly of the centromeric histone H3 variant CenH3(CENP-A), which occurs in a DNA replication-independent manner. Here, we examined whether CHD1 participates in the assembly of CenH3(CID) in Drosophila. In contrast to the findings in fission yeast and vertebrate cells, our evidence clearly argues against such a role for CHD1 in Drosophila. CHD1 does not localize to centromeres in either S2 cells or developing fly embryos. Down-regulation of CHD1 in S2 cells by RNAi reveals unchanged levels of CenH3 CID at the centromeres. Most notably, ablation of functional CHD1 in Chd1 mutant fly embryos does not interfere with centromere and kinetochore assembly, as the levels and localization of CenH3(CID), CENP-C and BubR1 in the mutant embryos remain similar to those seen in wild-type embryos. These results indicate that Drosophila CHD1 has no direct function in the incorporation of the centromeric H3 variant CenH3(CID) into chromatin. Therefore, centromeric chromatin assembly may involve different mechanisms in different organisms.	[Podhraski, Valerie; Campo-Fernandez, Beatriz; Woerle, Hildegard; Piatti, Paolo; Lusser, Alexandra] Innsbruck Med Univ, Div Mol Biol, Innsbruck, Austria; [Niederegger, Harald] Tyrolean Canc Res Inst, Innsbruck, Austria; [Boeck, Guenther] Innsbruck Med Univ, Div Expt Pathophysiol & Immunol, Bioctr, Innsbruck, Austria; [Fyodorov, Dmitry V.] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA	Medical University of Innsbruck; Medical University of Innsbruck; Yeshiva University	Podhraski, V (corresponding author), Innsbruck Med Univ, Div Mol Biol, Innsbruck, Austria.	alexandra.lusser@i-med.ac.at		Lusser, Alexandra/0000-0002-2226-9081; Piatti, Paolo/0000-0002-4863-5887	Austrian Science Foundation [START Y275-B12]; National Institutes of Health [GM74233]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233] Funding Source: NIH RePORTER	Austrian Science Foundation(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the Austrian Science Foundation (START Y275-B12) to A. L. and the National Institutes of Health (GM74233) to D. V. F. D. V. F. was a Scholar of the Sidney Kimmel Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Blower MD, 2006, PLOS GENET, V2, P1025, DOI 10.1371/journal.pgen.0020110; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foe Victoria E., 1993, P149; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Hanai K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000011; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kelley DE, 1999, CHROMOSOMA, V108, P10, DOI 10.1007/s004120050347; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Loppin B, 2001, CHROMOSOMA, V110, P430, DOI 10.1007/s004120100161; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Malik HS, 2001, GENETICS, V157, P1293; OKADA M, 2009, MOL BIOL CELL; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Talbert Paul B, 2004, J Biol, V3, P18, DOI 10.1186/jbiol11; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10120	10.1371/journal.pone.0010120	http://dx.doi.org/10.1371/journal.pone.0010120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20396651	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482100026
J	Dutta, NK; Mehra, S; Kaushal, D				Dutta, Noton K.; Mehra, Smriti; Kaushal, Deepak			A Mycobacterium tuberculosis Sigma Factor Network Responds to Cell-Envelope Damage by the Promising Anti-Mycobacterial Thioridazine	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; ANTITUBERCULAR ACTIVITY; DRUG-RESISTANCE; MUTANT LACKING; MACROPHAGES; PERSISTENCE; REVERSAL; STRESS; VIVO	Background: Novel therapeutics are urgently needed to control tuberculosis (TB). Thioridazine (THZ) is a candidate for the therapy of multidrug and extensively drug-resistant TB. Methodology/Principal Findings: We studied the impact of THZ on Mycobacterium tuberculosis (Mtb) by analyzing gene expression profiles after treatment at the minimal inhibitory (1x MIC) or highly inhibitory (4x MIC) concentrations between 1-6 hours. THZ modulated the expression of genes encoding membrane proteins, efflux pumps, oxido-reductases and enzymes involved in fatty acid metabolism and aerobic respiration. The Rv3160c-Rv3161c operon, a multi-drug transporter and the Rv3614c/3615c/3616c regulon, were highly induced in response to THZ. A significantly high number of Mtb genes co-expressed with sigma(B) (the sigma(B) regulon) was turned on by THZ treatment. sigma(B) has recently been shown to protect Mtb from envelope-damage. We hypothesized that THZ damages the Mtb cell-envelope, turning on the expression of the sigma(B) regulon. Consistent with this hypothesis, we present electron-microscopy data which shows that THZ modulates cell-envelope integrity. Moreover, the Mtb mutants in sigma(H) and sigma(E), two alternate stress response sigma factors that induce the expression of sB, exhibited higher sensitivity to THZ, indicating that the presence and expression of sigma(B) allows Mtb to resist the impact of THZ. Conditional induction of sigma(B) levels increased the survival of Mtb in the presence of THZ. Conclusions/Significance: THZ targets different pathways and can thus be used as a multi-target inhibitor itself as well as provide strategies for multi-target drug development for combination chemotherapy. Our results show that the Mtb sigma factor network comprising of sigma(H), sigma(E) and sigma(B) plays a crucial role in protecting the pathogen against cell-envelope damage.	[Dutta, Noton K.; Mehra, Smriti; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA USA; [Mehra, Smriti; Kaushal, Deepak] Tulane Natl Primate Res Ctr, DNA Microarray & Express Core, Covington, LA USA; [Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Dutta, NK (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA USA.	dkaushal@tulane.edu	Dutta, Noton K./K-5202-2012	Dutta, Noton K./0000-0002-5066-3342	NIH [R21RR026006, P20RR020159, P51RR164]; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Vaccine Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159, R21RR026006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Vaccine Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH (http://www.ncrr.nih.gov/) grants R21RR026006, P20RR020159 and P51RR164, with support from the Tulane Research Enhancement Fund (http://tulane.edu/news/newwave/20-million-fund-supports-research.cfm), Tulane Center for Infectious Diseases (http://tulane.edu/cid/) and the Louisiana Vaccine Center (http://www.louisianavc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L, 2008, CURR DRUG TARGETS, V9, P816, DOI 10.2174/138945008785747798; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Ando M, 2003, INFECT IMMUN, V71, P7170, DOI 10.1128/IAI.71.12.7170-7172.2003; ANDREW MB, 2008, ANTIMICROB AGENTS CH, V52, P3604; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bate AB, 2007, BIOORG MED CHEM LETT, V17, P1346, DOI 10.1016/j.bmcl.2006.11.091; Bishai WR, 1999, INFECT IMMUN, V67, P4931, DOI 10.1128/IAI.67.9.4931-4934.1999; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Dutta NK, 2009, J MED MICROBIOL, V58, P1667, DOI 10.1099/jmm.0.014027-0; Dutta NK, 2007, INT J ANTIMICROB AG, V30, P336, DOI 10.1016/j.ijantimicag.2007.04.016; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Gomez JE, 1997, TUBERCLE LUNG DIS, V78, P175, DOI 10.1016/S0962-8479(97)90024-1; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Haydel SE, 2006, J BACTERIOL, V188, P150, DOI 10.1128/JB.188.1.150-159.2006; Jensen-Cain DM, 2001, MICROB PATHOGENESIS, V30, P271, DOI 10.1006/mpat.2001.0431; JOANNA CB, 2003, ANTIMICROB AGENTS CH, V47, P2903; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; Kristiansen J. E., 1991, ASM News (Washington), V57, P135; Kristiansen JE, 2007, J ANTIMICROB CHEMOTH, V59, P1271, DOI 10.1093/jac/dkm071; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI [10.1128/jb.174.12.3843-3849.1992, :10.1128/jb.174.12.3843-3849.1992, DOI 10.1128/JB.174.12.3843-3849.1992]; Manca C, 1999, J IMMUNOL, V162, P6740; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Manganelli R, 2010, MOL MICROBIOL, V75, P538, DOI 10.1111/j.1365-2958.2009.07009.x; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Martins M, 2007, IN VIVO, V21, P771; Martins M, 2007, INT J ANTIMICROB AG, V29, P338, DOI 10.1016/j.ijantimicag.2006.10.013; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Molnar J, 2006, CURR DRUG TARGETS, V7, P789, DOI 10.2174/138945006777709584; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; PREDICH M, 1995, MOL MICROBIOL, V15, P355, DOI 10.1111/j.1365-2958.1995.tb02249.x; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; RATNAKAR P, 1992, FEMS MICROBIOL LETT, V97, P73; Raviglione MC, 2007, B WORLD HEALTH ORGAN, V85, P327, DOI 10.2471/BLT.06.038513; Reddy MV, 1996, J ANTIMICROB CHEMOTH, V37, P196, DOI 10.1093/jac/37.1.196; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Viveiros M, 2001, INT J ANTIMICROB AG, V17, P225, DOI 10.1016/S0924-8579(00)00343-5; Waddell SJ, 2004, TUBERCULOSIS, V84, P263, DOI 10.1016/j.tube.2003.12.005; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Xie ZF, 2005, ANTIMICROB AGENTS CH, V49, P4778, DOI 10.1128/AAC.49.11.4778-4780.2005; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200; 2008, TUBERCUL EDINB, V88, P164	58	62	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10069	10.1371/journal.pone.0010069	http://dx.doi.org/10.1371/journal.pone.0010069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386700	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482000009
J	Koraka, P; Lim, YP; Shin, MD; Setiati, TE; Mairuhu, ATA; van Gorp, ECM; Soemantri, A; Osterhaus, ADME; Martina, BEE				Koraka, Penelope; Lim, Yow-Pin; Shin, Michael D.; Setiati, Tatty E.; Mairuhu, Albert T. A.; van Gorp, Eric C. M.; Soemantri, Augustinus; Osterhaus, Albert D. M. E.; Martina, Byron E. E.			Plasma Levels of Inter-alpha Inhibitor Proteins in Children with Acute Dengue Virus Infection	PLOS ONE			English	Article							SEVERITY; SEPSIS; MORTALITY	Background: Inter-alpha inhibitor proteins (IaIp) belong to a family of protease inhibitors that are involved in the haemostatic and the vascular system. Dengue viruses (DENV) infections are characterized by coagulopathy and increased vascular permeability. In this study we measured the concentration of IaIp during DENV infections and evaluated its potential as a biomarker. Methods and Findings: Concentrations of IaIp were measured in patients with acute DENV infections using a quantitative, competitive enzyme linked immunoassay. Concentrations of IaIp measured in pediatric patients suffering from severe DENV infections were significantly lower than in healthy controls. Conclusions: This is the first report to demonstrate changes in concentration of IaIp during viral infections. The data also highlight the potential of IaIp as a biological marker for severity of DENV infections.	[Koraka, Penelope; van Gorp, Eric C. M.; Osterhaus, Albert D. M. E.; Martina, Byron E. E.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Lim, Yow-Pin; Shin, Michael D.] ProThera Biol Inc, E Providence, RI USA; [Setiati, Tatty E.; Soemantri, Augustinus] Dr Kariadi Hosp, Dept Pediat, Semarang, Indonesia; [Mairuhu, Albert T. A.; van Gorp, Eric C. M.] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands; [Mairuhu, Albert T. A.] Beth Israel Deaconess Med Ctr, Div Thrombosis & Haemostasis, Boston, MA 02215 USA	Erasmus University Rotterdam; Erasmus MC; Slotervaart Hospital; Harvard University; Beth Israel Deaconess Medical Center	Koraka, P (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	b.martina@erasmusmc.nl		Osterhaus, Albert/0000-0002-6074-1172; Martina, Byron/0000-0003-4980-4619	Royal Dutch Academy of Arts and Sciences (KNAW) [99-MED-04]; ProThera Biologics; Viroclinics BV	Royal Dutch Academy of Arts and Sciences (KNAW); ProThera Biologics; Viroclinics BV	The project was partly funded by the Royal Dutch Academy of Arts and Sciences (KNAW) grant number 99-MED-04, ProThera Biologics and Viroclinics BV. The funders played a role in study design, decision to publish and in data collection and analysis, but no role in preparation of the manuscript.	Brandenburg AH, 2000, J MED VIROL, V62, P267, DOI 10.1002/1096-9071(200010)62:2&lt;267::AID-JMV20&gt;3.0.CO;2-8; Chaaban H, 2009, J PEDIATR-US, V154, P620, DOI 10.1016/j.jpeds.2008.10.008; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Josic D, 2006, PROTEOMICS, V6, P2874, DOI 10.1002/pmic.200500563; Koraka P, 2004, J MED VIROL, V72, P445, DOI 10.1002/jmv.20007; Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Opal SM, 2005, INFECT IMMUN, V73, P5101, DOI 10.1128/IAI.73.8.5101-5105.2005; Setiati TE, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-22; van Gorp ECM, 2002, J MED VIROL, V67, P549, DOI 10.1002/jmv.10137; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Wu RQ, 2004, CRIT CARE MED, V32, P1747, DOI 10.1097/01.CCM.0000132903.14121.0E; 1997, DENGUE HAEMORRHAGIC	14	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2010	5	3							e9967	10.1371/journal.pone.0009967	http://dx.doi.org/10.1371/journal.pone.0009967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580BA	20386596	Green Submitted, gold, Green Published			2022-12-27	WOS:000276420400002
J	Aumakhan, B; Gaydos, CA; Quinn, TC; Beyrer, C; Benning, L; Minkoff, H; Merenstein, DJ; Cohen, M; Greenblatt, R; Nowicki, M; Anastos, K; Gange, SJ				Aumakhan, Bulbulgul; Gaydos, Charlotte A.; Quinn, Thomas C.; Beyrer, Chris; Benning, Lorie; Minkoff, Howard; Merenstein, Daniel J.; Cohen, Mardge; Greenblatt, Ruth; Nowicki, Marek; Anastos, Kathryn; Gange, Stephen J.			Clinical Reactivations of Herpes Simplex Virus Type 2 Infection and Human Immunodeficiency Virus Disease Progression Markers	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; WOMENS INTERAGENCY HIV; GENITAL HERPES; T-LYMPHOCYTES; VIRAL SYNERGY; RNA LEVELS; THERAPY; HSV-2; ACYCLOVIR; RISK	Background: The natural history of HSV-2 infection and role of HSV-2 reactivations in HIV disease progression are unclear. Methods: Clinical symptoms of active HSV-2 infection were used to classify 1,938 HIV/HSV-2 co-infected participants of the Women's Interagency HIV Study (WIHS) into groups of varying degree of HSV-2 clinical activity. Differences in plasma HIV RNA and CD4+ T cell counts between groups were explored longitudinally across three study visits and cross-sectionally at the last study visit. Results: A dose dependent association between markers of HIV disease progression and degree of HSV-2 clinical activity was observed. In multivariate analyses after adjusting for baseline CD4+ T cell levels, active HSV-2 infection with frequent symptomatic reactivations was associated with 21% to 32% increase in the probability of detectable plasma HIV RNA (trend p=0.004), an average of 0.27 to 0.29 log10 copies/ml higher plasma HIV RNA on a continuous scale (trend p<0.001) and 51 to 101 reduced CD4+ T cells/mm(3) over time compared to asymptomatic HSV-2 infection (trend p<0.001). Conclusions: HIV induced CD4+ T cell loss was associated with frequent symptomatic HSV-2 reactivations. However, effect of HSV-2 reactivations on HIV disease progression markers in this population was modest and appears to be dependent on the frequency and severity of reactivations. Further studies will be necessary to determine whether HSV-2 reactivations contribute to acceleration of HIV disease progression.	[Aumakhan, Bulbulgul; Beyrer, Chris; Benning, Lorie; Gange, Stephen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Gaydos, Charlotte A.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Quinn, Thomas C.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Minkoff, Howard] Maimonides Hosp, Brooklyn, NY 11219 USA; [Minkoff, Howard] SUNY Downstate, Brooklyn, NY USA; [Merenstein, Daniel J.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Cohen, Mardge] Cook Cty Med Ctr, Chicago, IL USA; [Greenblatt, Ruth] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA; [Greenblatt, Ruth] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Nowicki, Marek] Univ So Calif, Los Angeles, CA USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Maimonides Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Georgetown University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; Yeshiva University; Albert Einstein College of Medicine	Aumakhan, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	baumakhan@hivresearch.org	Gaydos, Charlotte A./E-9937-2010; Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X	National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources [UL1 RR024131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000358, ZIAAI000361, U01AI034993, U01AI035004, U01AI031834, U01AI034989, U01AI042590, U01AI034994] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript was collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/ Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington, DC Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli N, 2006, AIDS, V20, P1051, DOI 10.1097/01.aids.0000222078.75867.77; ASHLEY R, 1991, ANN INTERN MED, V115, P520, DOI 10.7326/0003-4819-115-7-520; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Ashley RL, 1999, CLIN MICROBIOL REV, V12, P1; Ashley RL, 1998, J CLIN MICROBIOL, V36, P294, DOI 10.1128/JCM.36.1.294-295.1998; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Barbour JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001080; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cheng RG, 2009, LANCET INFECT DIS, V9, P74, DOI 10.1016/S1473-3099(09)70002-7; Chretien F., 1997, Archives d'Anatomie et de Cytologie Pathologiques, V45, P153; Cowan FM, 2008, SEX TRANSM INFECT, V84, P548, DOI 10.1136/sti.2008.031153; Delany-Moretlwe Sinead, 2009, Curr Infect Dis Rep, V11, P135, DOI 10.1007/s11908-009-0020-8; DUNNE EF, 2008, J ACQUIR IMMUNE DEFI; Greenblatt RM, 1999, SEX TRANSM DIS, V26, P143, DOI 10.1097/00007435-199903000-00004; Haanpaa M, 2004, ACTA OBSTET GYN SCAN, V83, P946, DOI 10.1111/j.0001-6349.2004.00500.x; Harandi AM, 2001, J GEN VIROL, V82, P845, DOI 10.1099/0022-1317-82-4-845; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Koelle DM, 2000, J ANTIMICROB CHEMOTH, V45, P1, DOI 10.1093/jac/45.suppl_4.1; LINGAPPA JR, 2010, LANCET; Lisco A, 2009, LANCET INFECT DIS, V9, P522, DOI 10.1016/S1473-3099(09)70209-9; Milligan GN, 1998, J IMMUNOL, V160, P6093; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Posavad CM, 1997, P NATL ACAD SCI USA, V94, P10289, DOI 10.1073/pnas.94.19.10289; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tran THC, 2004, AM J OPHTHALMOL, V137, P872, DOI 10.1016/j.ajo.2003.12.036; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	33	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9973	10.1371/journal.pone.0009973	http://dx.doi.org/10.1371/journal.pone.0009973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376310	Green Submitted, Green Published, gold			2022-12-27	WOS:000276418200046
J	Ju, DH; Wang, XG; Ha, SW; Fu, JJ; Xie, YM				Ju, Donghong; Wang, Xiaogang; Ha, Seung-Wook; Fu, Jiejun; Xie, Youming			Inhibition of Proteasomal Degradation of Rpn4 Impairs Nonhomologous End-Joining Repair of DNA Double-Strand Breaks	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; S-PHASE; ATAXIA-TELANGIECTASIA; TRANSCRIPTION FACTOR; FEEDBACK-CIRCUIT; RNA INTERFERENCE; STRESS-RESPONSE; YEAST; EXPRESSION	Background: The proteasome homeostasis in Saccharomyces cerevisiae is regulated by a negative feedback circuit in which the transcription factor Rpn4 induces the proteasome genes and is rapidly degraded by the assembled proteasome. The integrity of the Rpn4-proteasome feedback loop is critical for cell viability under stressed conditions. We have demonstrated that inhibition of Rpn4 degradation sensitizes cells to DNA damage, particularly in response to high doses of DNA damaging agents. The underlying mechanism, however, remains unclear. Methodology/Principal Findings: Using yeast genetics and biochemical approach we show that inhibition of Rpn4 degradation displays a synthetic growth defect with deletion of the MEC1 checkpoint gene and sensitizes several checkpoint mutants to DNA damage. In addition, inhibition of Rpn4 degradation leads to a defect in repair of double-strand breaks (DSBs) by nonhomologous end-joining (NHEJ). The expression levels of several key NHEJ genes are downregulated and the recruitment of Yku70 to a DSB is reduced by inhibition of Rpn4 degradation. We find that Rpn4 and the proteasome are recruited to a DSB, suggesting their direct participation in NHEJ. Inhibition of Rpn4 degradation may result in a concomitant delay of release of Rpn4 and the proteasome from a DSB. Conclusion/Significance: This study provides the first evidence for the role of proteasomal degradation of Rpn4 in NHEJ.	[Ju, Donghong; Wang, Xiaogang; Ha, Seung-Wook; Fu, Jiejun; Xie, Youming] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA; [Xie, Youming] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Ju, DH (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA.	xiey@karmanos.org			National Science Foundation [MCB-0816974]; Div Of Molecular and Cellular Bioscience [0816974] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grant MCB-0816974 to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CY, 2008, DNA REPAIR, V7, P1531, DOI 10.1016/j.dnarep.2008.05.008; Clikeman JA, 2001, GENETICS, V157, P579; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Foss EJ, 2001, GENETICS, V157, P567; Fujimuro M, 1998, FEBS LETT, V423, P149, DOI 10.1016/S0014-5793(98)00084-2; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Guo N, 2008, YEAST, V25, P631, DOI 10.1002/yea.1614; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hausmann S, 2008, J BIOL CHEM, V283, P31706, DOI 10.1074/jbc.M806127200; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jessulat M, 2008, ARCH BIOCHEM BIOPHYS, V469, P157, DOI 10.1016/j.abb.2007.11.001; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2006, J BIOL CHEM, V281, P10657, DOI 10.1074/jbc.M513790200; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; Ju DD, 2007, BBA-MOL CELL RES, V1773, P1672, DOI 10.1016/j.bbamcr.2007.04.012; Ju DH, 2010, INT J BIOCHEM CELL B, V42, P282, DOI 10.1016/j.biocel.2009.11.003; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Lundgren J, 2003, MOL CELL BIOL, V23, P5320, DOI 10.1128/MCB.23.15.5320-5330.2003; Majka J, 2007, CELL CYCLE, V6, P1157, DOI 10.4161/cc.6.10.4221; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; NELSON MK, 1993, GENETICS, V134, P159; Owsianik G, 2002, MOL MICROBIOL, V43, P1295, DOI 10.1046/j.1365-2958.2002.02823.x; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; SIKORSKI RS, 1989, GENETICS, V122, P19; Teixeira MC, 2008, BIOCHEM BIOPH RES CO, V367, P249, DOI 10.1016/j.bbrc.2007.12.056; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Wilson TE, 2002, GENETICS, V162, P677; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xu HM, 2008, BREAST CANCER RES TR, V107, P267, DOI 10.1007/s10549-007-9553-4; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9877	10.1371/journal.pone.0009877	http://dx.doi.org/10.1371/journal.pone.0009877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376190	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200007
J	Holmes, MV; Jiang, BY; McNeill, K; Wong, M; Oakley, SP; Kirkham, B; Chowienczyk, PJ				Holmes, Michael V.; Jiang, Benyu; McNeill, Karen; Wong, Melinda; Oakley, Stephen P.; Kirkham, Bruce; Chowienczyk, Phil J.			Paradoxical Association of C-Reactive Protein with Endothelial Function in Rheumatoid Arthritis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; CARDIOVASCULAR EVENTS; NITRIC-OXIDE; CAROTID-ARTERY; OLDER-ADULTS; MYOCARDIAL-INFARCTION; VASCULAR FUNCTION; AORTIC STIFFNESS	Background: Within the general population, levels of C-reactive protein (CRP) are positively associated with atherosclerotic cardiovascular disease (CVD). Whether CRP is causally implicated in atherogenesis or is the results of atherosclerosis is disputed. A role of CRP to protect endothelium-derived nitric oxide (EDNO) has been suggested. We examined the association of CRP with EDNO-dependent vasomotor function and subclinical measures of atherosclerosis and arteriosclerosis in patients with raised CRP resulting from rheumatoid arthritis (RA). Methodology/Principal Findings: Patients with RA (n = 59) and healthy control subjects (n = 123), underwent measures of high sensitivity CRP, flow-mediated dilation (FMD, dependent on EDNO), intima-media thickness (IMT, a measure of subclinical atherosclerosis) and aortic pulse wave velocity (PWV, a measure of arteriosclerosis). IMT and PWV were elevated in patients with RA compared to controls but FMD was similar in the two groups. In patients with RA, IMT and PWV were not correlated with CRP but FMD was positively independently correlated with CRP (P<0.01). Conclusions/Significance: These findings argue against a causal role of CRP in atherogenesis and are consistent with a protective effect of CRP on EDNO bioavailability.	[Holmes, Michael V.; Jiang, Benyu; McNeill, Karen; Wong, Melinda; Chowienczyk, Phil J.] Kings Coll London, St Thomas Hosp, British Heart Fdn Ctr, Dept Clin Pharmacol, London WC2R 2LS, England; [Oakley, Stephen P.; Kirkham, Bruce] Guys & St Thomas Natl Hlth Serv Fdn Trust, Dept Rheumatol, London, England; [Kirkham, Bruce] Kings Coll London, Biomed Res Ctr, Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Holmes, MV (corresponding author), Kings Coll London, St Thomas Hosp, British Heart Fdn Ctr, Dept Clin Pharmacol, London WC2R 2LS, England.	phil.chowienczyk@kcl.ac.uk	Holmes, Michael/AAA-2208-2021	Chowienczyk, Phil/0000-0003-4507-038X	National Institute for Health Research (NIHR); National Health Service (NHS) Foundation Trust; King's College Hospital NHS Foundation Trust; Medical Research Council [G0802432] Funding Source: researchfish; MRC [G0802432] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Health Service (NHS) Foundation Trust; King's College Hospital NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Michael V. Holmes is funded by an Academic Clinical Fellowship from the National Institute for Health Research (NIHR). The authors acknowledge financial support from the Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Clapp BR, 2005, CIRCULATION, V111, P1530, DOI 10.1161/01.CIR.0000159336.31613.31; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goodson NJ, 2005, ARTHRITIS RHEUM-US, V52, P2293, DOI 10.1002/art.21204; Graf J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006242; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Jarvisalo MJ, 2002, ARTERIOSCL THROM VAS, V22, P1323, DOI 10.1161/01.ATV.0000024222.06463.21; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Matsushima Y, 2007, INT J CARDIOL, V117, P165, DOI 10.1016/j.ijcard.2006.04.063; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; MONCADA S, 1991, PHARMACOL REV, V43, P109; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pasceri V, 2000, CIRCULATION, V102, P2165; Pereira IA, 2009, ACTA REUMATOL PORT, V34, P58; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, ARTHRITIS RHEUM, V60, P1205, DOI 10.1002/art.24521; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rossi R, 2008, J AM COLL CARDIOL, V51, P997, DOI 10.1016/j.jacc.2007.11.044; Schunkert H, 2008, NEW ENGL J MED, V359, P1953, DOI 10.1056/NEJMe0807235; Shimbo D, 2007, ATHEROSCLEROSIS, V192, P197, DOI 10.1016/j.atherosclerosis.2006.05.005; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Takase B, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-61; Van Doornum S, 2003, ARTHRITIS RHEUM, V48, P72, DOI 10.1002/art.10735; Vitale Cristiana, 2003, Ital Heart J, V4, P627; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	44	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10242	10.1371/journal.pone.0010242	http://dx.doi.org/10.1371/journal.pone.0010242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436910	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079700004
J	Spiesser, TW; Diener, C; Barberis, M; Klipp, E				Spiesser, Thomas W.; Diener, Christian; Barberis, Matteo; Klipp, Edda			What Influences DNA Replication Rate in Budding Yeast?	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EPIGENETIC REGULATION; EUKARYOTIC CELLS; S-PHASE; ORIGINS; TRANSCRIPTION; COMPLEX; FORK; PROGRESSION; MODEL	Background: DNA replication begins at specific locations called replication origins, where helicase and polymerase act in concert to unwind and process the single DNA filaments. The sites of active DNA synthesis are called replication forks. The density of initiation events is low when replication forks travel fast, and is high when forks travel slowly. Despite the potential involvement of epigenetic factors, transcriptional regulation and nucleotide availability, the causes of differences in replication times during DNA synthesis have not been established satisfactorily, yet. Methodology/Principal Findings: Here, we aimed at quantifying to which extent sequence properties contribute to the DNA replication time in budding yeast. We interpreted the movement of the replication machinery along the DNA template as a directed random walk, decomposing influences on DNA replication time into sequence-specific and sequence-independent components. We found that for a large part of the genome the elongation time can be well described by a global average replication rate, thus by a single parameter. However, we also showed that there are regions within the genomic landscape of budding yeast with highly specific replication rates, which cannot be explained by global properties of the replication machinery. Conclusion/Significance: Computational models of DNA replication in budding yeast that can predict replication dynamics have rarely been developed yet. We show here that even beyond the level of initiation there are effects governing the replication time that can not be explained by the movement of the polymerase along the DNA template alone. This allows us to characterize genomic regions with significantly altered elongation characteristics, independent of initiation times or sequence composition.	[Spiesser, Thomas W.; Diener, Christian; Barberis, Matteo; Klipp, Edda] Humboldt Univ, Inst Biol, Berlin, Germany; [Barberis, Matteo] Max Planck Inst Mol Genet, Berlin, Germany	Humboldt University of Berlin; Max Planck Society	Spiesser, TW (corresponding author), Humboldt Univ, Inst Biol, Berlin, Germany.	matteo.barberis@biologie.hu-berlin.de; edda.klipp@rz.hu-berlin.de	Diener, Christian/X-9574-2019	Diener, Christian/0000-0002-7476-0868; Barberis, Matteo/0000-0001-5640-7422	European Commission [LSHG-CT-2005-518254]; German Research Foundation (DFG) [IRTG 1360]; Max Planck Society through IMPRS-CBSC (International Max Planck Research School for Computational Biology and Scientific Computing)	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society through IMPRS-CBSC (International Max Planck Research School for Computational Biology and Scientific Computing)	MB was supported by the Network of Excellence of the European Commission, Project ENFIN, contract number LSHG-CT-2005-518254. TWS was supported by the German Research Foundation (DFG) through IRTG 1360 (International Research Training Group). CD was supported by the Max Planck Society through IMPRS-CBSC (International Max Planck Research School for Computational Biology and Scientific Computing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Antequera F, 2004, EMBO J, V23, P4365, DOI 10.1038/sj.emboj.7600450; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Francon P, 1999, FEBS LETT, V452, P87, DOI 10.1016/S0014-5793(99)00585-2; Hamlin JL, 2008, J CELL BIOCHEM, V105, P321, DOI 10.1002/jcb.21828; Hiraga SI, 2005, GENES CELLS, V10, P297, DOI 10.1111/j.1365-2443.2005.00843.x; HOLM S, 1979, SCAND J STAT, V6, P65; JI N, 2001, EMBO J, V20, P2857; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kohzaki H, 1999, MOL CELL BIOL, V19, P7428; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LUCCHINI R, 1994, MOL CELL BIOL, V14, P318, DOI 10.1128/MCB.14.1.318; McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Mori S, 2007, J BIOL CHEM, V282, P4447, DOI 10.1074/jbc.M609671200; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; OKAZAKI R, 1967, JPN J MED SCI BIOL, V20, P255; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R Core Team, 2018, R LANG ENV STAT COMP; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Spiesser TW, 2009, MOL GENET GENOMICS, V282, P25, DOI 10.1007/s00438-009-0443-9; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Tabancay AP, 2006, CURR TOP DEV BIOL, V76, P129, DOI 10.1016/S0070-2153(06)76005-7; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Weigel C, 1997, EMBO J, V16, P6574, DOI 10.1093/emboj/16.21.6574; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wintersberger E, 2000, CHROMOSOMA, V109, P300, DOI 10.1007/s004120000080; Zannis-Hadjopoulos M, 1998, CRIT REV EUKAR GENE, V8, P81, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.40; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou J, 2005, CELL CYCLE, V4, P889, DOI 10.4161/cc.4.7.1823; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10203	10.1371/journal.pone.0010203	http://dx.doi.org/10.1371/journal.pone.0010203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436919	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079700001
J	Majava, V; Polverini, E; Mazzini, A; Nanekar, R; Knoll, W; Peters, J; Natali, F; Baumgartel, P; Kursula, I; Kursula, P				Majava, Viivi; Polverini, Eugenia; Mazzini, Alberto; Nanekar, Rahul; Knoll, Wiebke; Peters, Judith; Natali, Francesca; Baumgaertel, Peter; Kursula, Inari; Kursula, Petri			Structural and Functional Characterization of Human Peripheral Nervous System Myelin Protein P2	PLOS ONE			English	Article							LIPID-BINDING PROTEINS; T-CELL EPITOPE; FATTY-ACID; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; P-2 PROTEIN; FAMILY; P2-PROTEIN; TRANSPORT; MODEL	The myelin sheath is a tightly packed multilayered membrane structure insulating selected axons in the central and the peripheral nervous systems. Myelin is a biochemically unique membrane, containing a specific set of proteins. In this study, we expressed and purified recombinant human myelin P2 protein and determined its crystal structure to a resolution of 1.85 angstrom. A fatty acid molecule, modeled as palmitate based on the electron density, was bound inside the barrel-shaped protein. Solution studies using synchrotron radiation indicate that the crystal structure is similar to the structure of the protein in solution. Docking experiments using the high-resolution crystal structure identified cholesterol, one of the most abundant lipids in myelin, as a possible ligand for P2, a hypothesis that was proven by fluorescence spectroscopy. In addition, electrostatic potential surface calculations supported a structural role for P2 inside the myelin membrane. The potential membrane-binding properties of P2 and a peptide derived from its N terminus were studied. Our results provide an enhanced view into the structure and function of the P2 protein from human myelin, which is able to bind both monomeric lipids inside its cavity and membrane surfaces.	[Majava, Viivi; Nanekar, Rahul; Kursula, Petri] Univ Oulu, Dept Biochem, Oulu, Finland; [Polverini, Eugenia; Mazzini, Alberto] Univ Parma, Dept Phys, I-43100 Parma, Italy; [Knoll, Wiebke; Peters, Judith; Natali, Francesca] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [Knoll, Wiebke; Peters, Judith] Univ Grenoble 1, Grenoble, France; [Peters, Judith] Inst Biol Struct, Grenoble, France; [Natali, Francesca] Operat Grp Grenoble, Consiglio Nazl Ric, Grenoble, France; [Baumgaertel, Peter] Helmholtz Zentrum Berlin, BESSY 2, Berlin, Germany; [Kursula, Inari; Kursula, Petri] Helmholtz Ctr Infect Res, Ctr Struct Syst Biol, Braunschweig, Germany; [Kursula, Inari; Kursula, Petri] Univ Hamburg, Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; University of Parma; Institut Laue-Langevin (ILL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Helmholtz Association; Helmholtz-Center for Infection Research; University of Hamburg	Majava, V (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@oulu.fi	Peters, Judith/M-3817-2019; Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012; Kursula, Inari/AHB-9980-2022; Kursula, Inari/F-7140-2013	Peters, Judith/0000-0001-5151-7710; Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Kursula, Inari/0000-0001-5236-7056; Kursula, Inari/0000-0001-5236-7056	Academy of Finland; Multiple Sclerosis Foundation of Finland; Sigrid Juselius Foundation (Finland); Department of Biochemistry, University of Oulu (Finland); European Community [RII3-CT-2004-506008]	Academy of Finland(Academy of Finland); Multiple Sclerosis Foundation of Finland; Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); Department of Biochemistry, University of Oulu (Finland); European Community(European Commission)	This study has been financially supported by the Academy of Finland, the Multiple Sclerosis Foundation of Finland, the Sigrid Juselius Foundation (Finland), the Department of Biochemistry, University of Oulu (Finland), and the European Community (Research Infrastructure Action under the FP6 "Structuring the European Research Area" Programme, contract RII3-CT-2004-506008 (IA-SFS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; BROSTOFF SW, 1980, NATURE, V285, P103, DOI 10.1038/285103a0; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DEARMOND SJ, 1980, J HISTOCHEM CYTOCHEM, V28, P1275, DOI 10.1177/28.12.6785343; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hohoff C, 1999, BIOCHEMISTRY-US, V38, P12229, DOI 10.1021/bi990305u; HORROCKS LA, 1967, J LIPID RES, V8, P569; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter DJB, 2005, ACTA CRYSTALLOGR D, V61, P1067, DOI 10.1107/S0907444905014162; Inglis HR, 2007, J NEUROL NEUROSUR PS, V78, P419, DOI 10.1136/jnnp.2006.106617; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KHALILISHIRAZI A, 1993, J NEUROIMMUNOL, V46, P245, DOI 10.1016/0165-5728(93)90255-W; KNOLL W, 2010, SPECTROSCOPY; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Kursula P., 2004, J APPL CRYSTALLOGR, V37, P347; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Likic VA, 2000, PROTEIN SCI, V9, P497; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MAJAVA V, 2010, AMINO ACIDS; Makowska A, 2008, J NEUROL NEUROSUR PS, V79, P664, DOI 10.1136/jnnp.2007.123943; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesgaard LW, 2008, BIOPOLYMERS, V89, P779, DOI 10.1002/bip.21011; OLEE T, 1990, J NEUROIMMUNOL, V27, P187, DOI 10.1016/0165-5728(90)90068-X; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Polverini E, 2006, J STRUCT BIOL, V153, P253, DOI 10.1016/j.jsb.2005.11.010; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rich MR, 1996, BIOCHEMISTRY-US, V35, P1506, DOI 10.1021/bi951574x; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; ROSTAMI A, 1991, CELL IMMUNOL, V132, P433, DOI 10.1016/0008-8749(91)90040-I; Sanvito L, 2009, J NEUROL NEUROSUR PS, V80, P333, DOI 10.1136/jnnp.2008.159798; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sedzik J, 2003, J STRUCT BIOL, V142, P292, DOI 10.1016/S1047-8477(03)00031-5; SHAW MK, 1965, J BACTERIOL, V90, P141, DOI 10.1128/JB.90.1.141-146.1965; Stienekemeier M, 2001, P NATL ACAD SCI USA, V98, P13872, DOI 10.1073/pnas.241504598; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; TRAPP BD, 1983, J NEUROCHEM, V40, P47, DOI 10.1111/j.1471-4159.1983.tb12651.x; TRAPP BD, 1979, P NATL ACAD SCI USA, V76, P3552, DOI 10.1073/pnas.76.7.3552; TRAPP BD, 1984, J NEUROCHEM, V43, P944, DOI 10.1111/j.1471-4159.1984.tb12828.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UYEMURA K, 1982, J NEUROCHEM, V39, P895, DOI 10.1111/j.1471-4159.1982.tb07979.x; Uyemura K, 1978, Adv Exp Med Biol, V100, P95; UYEMURA K, 1984, NEUROCHEM RES, V9, P1509, DOI 10.1007/BF00964676; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213; WINTER J, 1982, J NEUROCYTOL, V11, P351, DOI 10.1007/BF01257982; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u	67	45	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10300	10.1371/journal.pone.0010300	http://dx.doi.org/10.1371/journal.pone.0010300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421974	Green Published, Green Submitted, gold			2022-12-27	WOS:000276952600017
J	Reynolds, SJ; Kityo, C; Hallahan, CW; Kabuye, G; Atwiine, D; Mbamanya, F; Ssali, F; Dewar, R; Daucher, M; Davey, RT; Mugyenyi, P; Fauci, AS; Quinn, TC; Dybul, MR				Reynolds, Steven J.; Kityo, Cissy; Hallahan, Claire W.; Kabuye, Geoffrey; Atwiine, Diana; Mbamanya, Frank; Ssali, Francis; Dewar, Robin; Daucher, Marybeth; Davey, Richard T., Jr.; Mugyenyi, Peter; Fauci, Anthony S.; Quinn, Thomas C.; Dybul, Mark R.			A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda	PLOS ONE			English	Article							TREATMENT INTERRUPTION STRATEGY; HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE; ADHERENCE; REGIMEN; PARAMETERS; LAMIVUDINE; STAVUDINE; TOXICITY; FAILURE	Background: Short cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs. Methods: A 72 week, non-inferiority trial enrolled one hundred forty six HIV positive persons receiving ART (CD4+ cell count >= 125 cells/mm(3) and HIV RNA plasma levels,50 copies/ml) in one of three arms: continuous, 7 days on/7 days off and 5 days on/2 days off treatment. Primary endpoint was ART treatment failure determined by plasma HIV RNA level, CD4+ cell count decrease, death attributed to study participation, or opportunistic infection. Results: Following enrollment of 32 participants, the 7 days on/7 days off arm was closed because of a failure rate of 31%. Six of 52 (11.5%) participants in the 5 days on/2 days off arm failed. Five had virologic failure and one participant had immunologic failure. Eleven of 51 (21.6%) participants in the continuous treatment arm failed. Nine had virologic failure with 1 death (lactic acidosis) and 1 clinical failure (extra-pulmonary TB). The upper 97.5% confidence boundary for the difference between the percent of non-failures in the 5 days on/2 days off arm (88.5% non-failure) compared to continuous treatment (78.4% non failure) was 4.8% which is well within the preset non-inferiority margin of 15%. No significant difference was found in time to failure in the 2 study arms (p = 0.39). Conclusions: Short cycle 5 days on/2 days off intermittent ART was at least as effective as continuous therapy.	[Reynolds, Steven J.; Hallahan, Claire W.; Daucher, Marybeth; Davey, Richard T., Jr.; Fauci, Anthony S.; Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Kityo, Cissy; Kabuye, Geoffrey; Atwiine, Diana; Mbamanya, Frank; Ssali, Francis; Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda; [Dewar, Robin] NCI, SAIC Frederick Inc, NIH, Bethesda, MD 20892 USA; [Dybul, Mark R.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Dybul, Mark R.] George W Bush Inst, Dallas, TX USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Joint Clinic Research Center - United Arab Emirates; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Georgetown University	Reynolds, SJ (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sjr@jhmi.edu		Reynolds, Steven/0000-0002-5403-2759	Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000865, ZIAAI000862, ZIAAI000984, ZIAAI000361] Funding Source: NIH RePORTER	Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded through the Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. SJR, CWH, MD, RTD, ASF, TCQ & MAD were employees of the NIH during the study design and implementation period and were involved in study design, conduct and publication.	Agresti A, 2001, BIOMETRICS, V57, P963, DOI 10.1111/j.0006-341X.2001.00963.x; Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; Cohen MC, 2008, PEDIATR DEVEL PATHOL, V11, P1, DOI 10.2350/07-01-0213.1; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2003, J INFECT DIS, V188, P388, DOI 10.1086/376535; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; FAY MP, 2007, R LANGUAGE ENV STAT; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Frost SDW, 2002, J VIROL, V76, P968, DOI 10.1128/JVI.76.3.968-979.2002; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Levine AJ, 2006, HEALTH PSYCHOL, V25, P329, DOI 10.1037/0278-6133.25.3.329; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; McComsey GA, 2008, CLIN INFECT DIS, V46, P1290, DOI 10.1086/529384; McComsey GA, 2008, ANTIVIR THER, V13, P715; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Nelson M, 2008, AIDS, V22, P1374, DOI 10.1097/QAD.0b013e328303be50; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Papasavvas E, 2004, PLOS MED, V1, P218, DOI 10.1371/journal.pmed.0010064; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Parruti G, 2006, AIDS PATIENT CARE ST, V20, P48, DOI 10.1089/apc.2006.20.48; REYNOLDS SJ, 2009, AIDS; Reynolds SJ, 2009, ANTIVIR THER, V14, P293; World Health Organization, 2006, ANT THER HIV INF AD; 2007, STATXACT 8 STAT SOFT, P433	32	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10307	10.1371/journal.pone.0010307	http://dx.doi.org/10.1371/journal.pone.0010307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20442758	gold, Green Submitted, Green Published			2022-12-27	WOS:000276952600024
J	Gutierrez-Reyes, G; de Leon, MDG; Varela-Fascinetto, G; Valencia, P; Tamayo, RP; Rosado, CG; Labonne, BF; Rochilin, NM; Garcia, RM; Valadez, JA; Latour, GT; Corona, DL; Diaz, GR; Zlotnik, A; Kershenobich, D				Gutierrez-Reyes, Gabriela; del Carmen Garcia de Leon, Maria; Varela-Fascinetto, Gustavo; Valencia, Pedro; Perez Tamayo, Ruy; Gonzalez Rosado, Claudia; Farfan Labonne, Blanca; Morales Rochilin, Norma; Martinez Garcia, Rosalinda; Aguirre Valadez, Jonathan; Togno Latour, Gabriela; Lau Corona, Dana; Robles Diaz, Guillermo; Zlotnik, Albert; Kershenobich, David			Cellular Senescence in Livers from Children with End Stage Liver Disease	PLOS ONE			English	Article							REPLICATIVE SENESCENCE; DNA-DAMAGE; HEPATITIS-C; CELLS; EXPRESSION; HEPATOCYTES; P16(INK4A); BIOMARKER; MARKERS; REPAIR	Background: Senescent cells occur in adults with cirrhotic livers independent of the etiology. Aim: Investigate the presence rate of cellular senescence and expression of cell cycle check points in livers from children with end stage disease. Methodology/Principal Findings: Livers of five children aged three years or less undergoing liver transplantation due to tyrosinemia (n = 1), biliary atresia (n = 2), or fulminant hepatitis (n = 2) were analyzed for senescence associated beta-galactosidase (SA-beta gal) activity and p16INK4a, p21cip1 and p53. All livers displayed positive cellular staining for SA-beta gal in the canals of Hering and interlobular biliary ducts. In the presence of cirrhosis (3/5 cases) SA-beta gal was found at the cholangioles and hepatocytes surrounding the regenerative nodules. Children with fulminant hepatic failure without cirrhosis had significant ductular transformation with intense SA-beta gal activity. No SA-beta gal activity was evident in the fibrous septa. Staining for p53 had a similar distribution to that observed for SA-beta gal. Staining for p16(INK4a) and p21(cip1) was positive in the explanted liver of the patient with tyrosinemia, in the hepatocytes, the canals of Hering, cholangioles and interlobular bile ducts. In the livers with fulminant hepatitis, p21(cip1) staining occurred in the areas of ductular transformation and in the interlobular bile ducts. Conclusions/Significance: Cellular senescence in livers of children with end stage disease is associated with damage rather than corresponding to an age dependent phenomenon. Further studies are needed to support the hypothesis that these senescence markers correlate with disease progression.	[Gutierrez-Reyes, Gabriela; del Carmen Garcia de Leon, Maria; Perez Tamayo, Ruy; Gonzalez Rosado, Claudia; Farfan Labonne, Blanca; Morales Rochilin, Norma; Martinez Garcia, Rosalinda; Aguirre Valadez, Jonathan; Togno Latour, Gabriela; Lau Corona, Dana; Robles Diaz, Guillermo; Kershenobich, David] Univ Nacl Autonoma Mexico, Sch Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Varela-Fascinetto, Gustavo; Valencia, Pedro] Hosp Infantil Mexico Dr Federico Gomez, Dept Surg & Pathol, Mexico City, DF, Mexico; [Zlotnik, Albert] Univ Calif Irvine, Irvine, CA USA	Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico Gomez; University of California System; University of California Irvine	Gutierrez-Reyes, G (corresponding author), Univ Nacl Autonoma Mexico, Sch Med, Dept Expt Med, Mexico City 04510, DF, Mexico.	kesdhipa@yahoo.com	Zlotnik, Albert/C-3791-2011	Varela-Fascinetto, Gustavo/0000-0001-8836-8448; Lau Corona, Dana/0000-0002-8743-6346	CONACYT-SALUD (Mexico) [2004-C01-175]; Universidad Nacional Autonoma de Mexico (UNAM) [SDI.PTID.05.6.]	CONACYT-SALUD (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	This study was supported by CONACYT-SALUD (Mexico), grant (2004-C01-175) and Universidad Nacional Autonoma de Mexico (UNAM) grant (NEEGPSP SDI.PTID.05.6.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Campisi J, 2000, IN VIVO, V14, P183; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Chen Jian-Hua, 2007, Methods Mol Biol, V371, P179; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919; Ju YJ, 2006, EXP MOL MED, V38, P686, DOI 10.1038/emm.2006.81; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Kiss A, 2001, LIVER, V21, P237, DOI 10.1034/j.1600-0676.2001.021004237.x; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Maier AB, 2007, ANN NY ACAD SCI, V1100, P323, DOI 10.1196/annals.1395.035; Martien S, 2007, ANN NY ACAD SCI, V1119, P51, DOI 10.1196/annals.1404.010; Obata M, 2001, MOL CARCINOGEN, V32, P9, DOI 10.1002/mc.1059; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Seki S, 2003, HEPATOL RES, V25, P149, DOI 10.1016/S1386-6346(02)00205-X; Shawi M, 2008, MECH AGEING DEV, V129, P3, DOI 10.1016/j.mad.2007.11.007; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9; Watanabe H, 2008, PATHOLOGY, V40, P272, DOI 10.1080/00313020801911546; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	26	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10231	10.1371/journal.pone.0010231	http://dx.doi.org/10.1371/journal.pone.0010231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422055	gold, Green Published			2022-12-27	WOS:000276952500009
J	Ong, JBS; Chen, MIC; Cook, AR; Lee, HC; Lee, VJ; Lin, RTP; Tambyah, PA; Goh, LG				Ong, Jimmy Boon Som; Chen, Mark I-Cheng; Cook, Alex R.; Lee, Huey Chyi; Lee, Vernon J.; Lin, Raymond Tzer Pin; Tambyah, Paul Ananth; Goh, Lee Gan			Real-Time Epidemic Monitoring and Forecasting of H1N1-2009 Using Influenza-Like Illness from General Practice and Family Doctor Clinics in Singapore	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; SURVEILLANCE; IMPACT; TRANSMISSION; VACCINATION; MODELS	Background: Reporting of influenza-like illness (ILI) from general practice/family doctor (GPFD) clinics is an accurate indicator of real-time epidemic activity and requires little effort to set up, making it suitable for developing countries currently experiencing the influenza A (H1N1-2009) pandemic or preparing for subsequent epidemic waves. Methodology/Principal Findings: We established a network of GPFDs in Singapore. Participating GPFDs submitted returns via facsimile or e-mail on their work days using a simple, standard data collection format, capturing: gender; year of birth; "ethnicity''; residential status; body temperature (degrees C); and treatment (antiviral or not); for all cases with a clinical diagnosis of an acute respiratory illness (ARI). The operational definition of ILI in this study was an ARI with fever of 37.8 degrees C or more. The data were processed daily by the study co-ordinator and fed into a stochastic model of disease dynamics, which was refitted daily using particle filtering, with data and forecasts uploaded to a website which could be publicly accessed. Twenty-three GPFD clinics agreed to participate. Data collection started on 2009-06-26 and lasted for the duration of the epidemic. The epidemic appeared to have peaked around 2009-08-03 and the ILI rates had returned to baseline levels by the time of writing. Conclusions/Significance: This real-time surveillance system is able to show the progress of an epidemic and indicates when the peak is reached. The resulting information can be used to form forecasts, including how soon the epidemic wave will end and when a second wave will appear if at all.	[Ong, Jimmy Boon Som; Chen, Mark I-Cheng] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Chen, Mark I-Cheng] Duke NUS Grad Med Sch, Singapore, Singapore; [Chen, Mark I-Cheng; Lee, Vernon J.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Cook, Alex R.; Lee, Huey Chyi] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Lee, Vernon J.] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Lin, Raymond Tzer Pin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Tambyah, Paul Ananth; Goh, Lee Gan] Natl Univ Singapore Hosp, Dept Med, Singapore 117548, Singapore; [Goh, Lee Gan] Coll Family Phys, Singapore, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; National University of Singapore; Australian National University; Ministry of Health-Singapore; National University of Singapore	Ong, JBS (corresponding author), Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore.	stacar@nus.edu.sg	Cook, Alex/S-3576-2019; Chen, Mark/CAG-2949-2022; Cook, Alex/B-5941-2011; Chen, Mark/AGC-5338-2022	Chen, Mark/0000-0001-9369-5830; Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830	National University of Singapore; National Medical Research Council, Singapore	National University of Singapore(National University of Singapore); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The National University of Singapore provided research funding to ARC and a scholarship to HCL. Staff time for JBSO and MI-CC was partially funded by the National Medical Research Council, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL:http://www.nus.edu.sg/ and https://www.nmrc.gov.sg/	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], INFECT DIS HUMANS; Bailey NTJ, 1975, MATH THEORY INFECT D; Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Berger J. O., 1988, LIKELIHOOD PRINCIPLE; Carrat F, 1998, J EPIDEMIOL COMMUN H, V52, p32S; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Clothier HJ, 2005, COMMUN DIS INTELL, V29, P231; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; DEFINETTI B, 1974, THEORY PROBABILITY; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Doucet A., 2001, SEQUENTIAL MONTE CAR; Emmanuel S. C., 2004, SMJ Singapore Medical Journal, V45, P199; Falcao IM, 1998, J EPIDEMIOL COMMUN H, V52, p39S; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gates P, 2009, VACCINE, V27, P6669, DOI 10.1016/j.vaccine.2009.08.094; Gordon A, 2009, EMERG INFECT DIS, V15, P408, DOI 10.3201/eid1503.080238; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Huang Q. S., 2009, Morbidity and Mortality Weekly Report, V58, P918; Jegat C, 2008, QUANT GEO G, V15, P23; KANAGARATNAM K, 1958, Public Health, V72, P143, DOI 10.1016/S0033-3506(58)80032-3; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kelly Heath, 2004, Aust Fam Physician, V33, P305; KEYFITZ N, 1972, J AM STAT ASSOC, V67, P347, DOI 10.2307/2284381; Lee PM, 2009, BAYESIAN STAT INTRO; Lee VJ, 2008, ANN ACAD MED SINGAP, V37, P470; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Lindley D.V., 2006, UNDERSTANDING UNCERT; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Magnus D, 2009, ARCH DIS CHILD, V94, P997, DOI 10.1136/adc.2009.171603; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Nishiura Hiroshi, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1075; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Taleb N., 2008, BLACK SWAN; Thomas L, 2005, AUST NZ J STAT, V47, P19, DOI 10.1111/j.1467-842X.2005.00369.x; Trenkel VM, 2000, J AM STAT ASSOC, V95, P363, DOI 10.2307/2669373; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Vynnycky E, 2008, VACCINE, V26, P5321, DOI 10.1016/j.vaccine.2008.06.101; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	66	112	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10036	10.1371/journal.pone.0010036	http://dx.doi.org/10.1371/journal.pone.0010036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418945	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706800004
J	Verdu, JR; Casas, JL; Lobo, JM; Numa, C				Verdu, Jose R.; Casas, Jose L.; Lobo, Jorge M.; Numa, Catherine			Dung Beetles Eat Acorns to Increase Their Ovarian Development and Thermal Tolerance	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SELF-SELECTION; THORECTES-LUSITANICUS; COLD-HARDINESS; ANTIFREEZE; COLEOPTERA; INSECTS; BODY; GEOTRUPIDAE; ENDOTHERMY	Animals eat different foods in proportions that yield a more favorable balance of nutrients. Despite known examples of these behaviors across different taxa, their ecological and physiological benefits remain unclear. We identified a surprising dietary shift that confers ecophysiological advantages in a dung beetle species. Thorectes lusitanicus, a Mediterranean ecosystem species adapted to eat semi-dry and dry dung (dung-fiber consumers) is also actively attracted to oak acorns, consuming and burying them. Acorn consumption appears to confer potential advantages over beetles that do not eat acorns: acorn-fed beetles showed important improvements in the fat body mass, hemolymph composition, and ovary development. During the reproductive period (October-December) beetles incorporating acorns into their diets should have greatly improved resistance to low-temperature conditions and improved ovarian development. In addition to enhancing the understanding of the relevance of dietary plasticity to the evolutionary biology of dung beetles, these results open the way to a more general understanding of the ecophysiological implications of differential dietary selection on the ecology and biogeography of these insects.	[Verdu, Jose R.; Casas, Jose L.; Numa, Catherine] Univ Alicante, IU CIBIO, E-03080 Alicante, Spain; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Universitat d'Alacant; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Verdu, JR (corresponding author), Univ Alicante, IU CIBIO, E-03080 Alicante, Spain.	jr.verdu@ua.es	Numa, Catherine/H-7486-2015; Casas, Jose Luis/L-9869-2014; Verdú, José/F-8269-2010; Lobo, Jorge M/E-2309-2013	Numa, Catherine/0000-0003-3213-1980; Casas, Jose Luis/0000-0001-8929-1331; Verdú, José/0000-0002-0805-8341; Lobo, Jorge M/0000-0002-3152-4769	Ministerio de Ciencia e Innovacion-Spain [CGL2008-03878]	Ministerio de Ciencia e Innovacion-Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Ministerio de Ciencia e Innovacion-Spain (CGL2008-03878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; ATAPUR M, 2009, CHANGES COLD HARDINE; AVILA J M, 1988, Elytron (Barcelona), V2, P41; AVILA JM, 1988, ACT 3 C IB ENT, P707; BALE JS, 1993, FUNCT ECOL, V7, P751; BARTHOLOMEW GA, 1978, J EXP BIOL, V73, P65; BAUST JG, 1982, COMP BIOCHEM PHYS A, V73, P563, DOI 10.1016/0300-9629(82)90263-8; BEENAKKERS AMT, 1985, PROG LIPID RES, V24, P19; Beucke K, 2009, COLEOPTS BULL, V63, P228, DOI 10.1649/1168.1; Bouderoua K, 2003, ANIM RES, V52, P377, DOI 10.1051/animres:2003027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambefort Y., 1991, P22; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; CANGUSSU JA, 1995, J INSECT PHYSIOL, V41, P223, DOI 10.1016/0022-1910(94)00099-3; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 1998, CAN J ZOOL, V76, P1123, DOI 10.1139/cjz-76-6-1123; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Dadd R.H., 1985, COMPREHENSIVE INSECT; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DENLINGER DL, INSECTS APPL INTEGRA, P55; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Fielding DJ, 2008, PHYSIOL ENTOMOL, V33, P264, DOI 10.1111/j.1365-3032.2008.00619.x; *FLIR SYST LTD, 2007, THERMACAM RES V 2 9; FRIEDMAN S, 1991, J INSECT PHYSIOL, V37, P919, DOI 10.1016/0022-1910(91)90007-M; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; HALFFTER G, 1982, ANALES ESCUELA NACL, V25, P117; HALFFTER G, 1966, FOLIA ENTOMOL MEX, V12, P14; HANSEN TN, 1988, BIOCHIM BIOPHYS ACTA, V957, P217, DOI 10.1016/0167-4838(88)90275-0; Hidalgo J.M., 1998, Boletin de la Asociacion Espanola de Entomologia, V22, P203; Hidalgo Juan M., 1994, Nouvelle Revue d'Entomologie, V11, P217; Lavy D, 1997, COMP BIOCHEM PHYS A, V118, P699, DOI 10.1016/S0300-9629(97)00019-4; Lee R.E. Jr, 1991, P17; LOBL I., CATALOGUE PALAEARCTI, V3; Lobo JM, 2006, DIVERS DISTRIB, V12, P179, DOI 10.1111/j.1366-9516.2005.00214.x; Lopes IMG, 2005, EUR J LIPID SCI TECH, V107, P12, DOI 10.1002/ejlt.200401039; Lu M, 2002, J THERM ANAL CALORIM, V67, P689, DOI 10.1023/A:1014369208229; Martin-Piera F., 2000, Fauna Iberica, V14; Meyer-Fernandes JR, 2000, INSECT BIOCHEM MOLEC, V30, P473, DOI 10.1016/S0965-1748(00)00016-3; Michaud MR, 2006, J INSECT PHYSIOL, V52, P1073, DOI 10.1016/j.jinsphys.2006.07.005; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Perez-Ramos IM, 2007, ECOL ENTOMOL, V32, P349, DOI 10.1111/j.1365-2311.2007.00874.x; Romero-Alcaraz E., 1998, Zoologica Baetica, V9, P47; SANCHEZ-PINERO F, 1991, EOS-Revista Espanola de Entomologia, V67, P23; Sayah F, 2008, ENTOMOL SCI, V11, P55, DOI 10.1111/j.1479-8298.2007.00254.x; Shimada T, 2003, POPUL ECOL, V45, P7, DOI 10.1007/s10144-002-0134-4; Sinclair BJ, 2002, POLAR BIOL, V25, P928, DOI 10.1007/s00300-002-0433-4; SOMME L, 1982, OIKOS, V38, P168, DOI 10.2307/3544016; StatsDirect Ltd, 2005, STATSDIRECT STAT SOF; Storey KB, 1996, ANNU REV ECOL SYST, V27, P365, DOI 10.1146/annurev.ecolsys.27.1.365; Storey Kenneth B., 1992, V1, P101; TYNDALEBISCOE M, 1984, B ENTOMOL RES, V74, P341, DOI 10.1017/S0007485300015637; Van der Horst D.J., 2005, P225; Verdu JR, 2007, ANIM BEHAV, V74, P1697, DOI 10.1016/j.anbehav.2007.03.016; Verdu JR, 2004, SYST ENTOMOL, V29, P509, DOI 10.1111/j.0307-6970.2004.00256.x; Verdu JR, 2004, J NAT HIST, V38, P705, DOI 10.1080/0022293021000041707; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Wolfe GR, 1998, J INSECT PHYSIOL, V44, P597, DOI 10.1016/S0022-1910(98)00035-3; XU L, 1991, J EXP ZOOL, V258, P288, DOI 10.1002/jez.1402580303	60	31	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10114	10.1371/journal.pone.0010114	http://dx.doi.org/10.1371/journal.pone.0010114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404931	Green Published, gold			2022-12-27	WOS:000276482100024
J	Verma, S; Kumar, R; Katara, GK; Singh, LC; Negi, NS; Ramesh, V; Salotra, P				Verma, Sandeep; Kumar, Rajesh; Katara, Gajendra Kumar; Singh, Laishram Chandreshwor; Negi, Narender Singh; Ramesh, V.; Salotra, Poonam			Quantification of Parasite Load in Clinical Samples of Leishmaniasis Patients: IL-10 Level Correlates with Parasite Load in Visceral Leishmaniasis	PLOS ONE			English	Article							REAL-TIME PCR; AZAR DERMAL LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; KALA-AZAR; INTERFERON-GAMMA; IFN-GAMMA; CUTANEOUS-LEISHMANIASIS; CYTOKINE PROFILES; OXIDE PRODUCTION; MOUSE-TISSUES	A rapid and accurate method to detect and quantify Leishmania parasite is urgently needed to facilitate early diagnosis of Leishmaniasis and monitoring of antileishmania therapy. In this study, real-time assay was applied to estimate parasite load in clinical samples of visceral leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL) patients. The mean parasite load in blood of VL patients (n = 31) was 8,372 parasites/ml, while the mean parasite load in bone marrow aspirate (BMA) was 194,962 parasites/million nucleated cells (n = 12). Parasite load was undetectable after treatment with amphotericin B (n = 9) in VL, while a residual parasite burden was detected in 2 of 6 patients following treatment with sodium antimony gluconate. Further, circulating levels of IFN-gamma, TNF-alpha, IL-10, IL-6, IL-4 and IL-2 were analysed in VL patients (n = 29) by Cytometric Bead Array to evaluate correlation with parasitic load. Interestingly, IL-10 levels correlated significantly with parasite load (r = 0.82, P < 0.0001). The mean parasite load in dermal lesions of PKDL patients was 9,502 parasites/mu g tissue DNA at pre-treatment stage (n = 25), with no detectable parasites after therapy (n = 5). Parasite burden was distinctly higher (P < 0.0001) in nodular lesions (n = 12) (19,586 parasites/mu g tissue DNA) compared to papular/macular lesions (n = 13, 193 parasites/mu g tissue DNA). Further, chronic PKDL lesions showed significantly (P = 0.0166) higher parasite load in comparison with acute lesions. Results indicate that chronic, nodular cases constitute the major parasite reservoir for anthroponotic transmission. Our results establish that the high parasite load in VL is strongly correlated with a high level of IL-10, implicating IL-10 as a marker of disease severity. The assay is applicable for diagnosis as well as prognosis of both VL and PKDL, providing a simple molecular tool to monitor the efficacy of antileishmanial drugs or vaccines.	[Verma, Sandeep; Kumar, Rajesh; Katara, Gajendra Kumar; Singh, Laishram Chandreshwor; Salotra, Poonam] ICMR, Inst Pathol, New Delhi, India; [Ramesh, V.] Safdarjang Hosp, Dept Dermatol, New Delhi, India; [Negi, Narender Singh] Safdarjang Hosp, Dept Med, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital	Verma, S (corresponding author), ICMR, Inst Pathol, Safdarjung Hosp Campus, New Delhi, India.	salotra@vsnl.com		Salotra, Poonam/0000-0002-4057-4872	Indian Council of Medical Research; Council of Scientific and Industrial Research (CSIR), India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance provided by the Indian Council of Medical Research is gratefully acknowledged. SV and GKK thank Council of Scientific and Industrial Research (CSIR), India, for providing research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 2002, T R SOC TROP MED S1, V96, P179; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Ansari NA, 2006, J INFECT DIS, V194, P958, DOI 10.1086/506624; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bossolasco S, 2003, J CLIN MICROBIOL, V41, P5080, DOI 10.1128/JCM.41.11.5080-5084.2003; Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; CENINI P, 1993, J INFECT DIS, V168, P986, DOI 10.1093/infdis/168.4.986; CILLARI E, 1995, CYTOKINE, V7, P740, DOI 10.1006/cyto.1995.0088; DEMADEIROS IM, 1998, REV INST MED TROP SP, V40, P31; DENIS M, 1993, J IMMUNOL, V151, P5425; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; GRADONI L, 1993, T ROY SOC TROP MED H, V87, P94, DOI 10.1016/0035-9203(93)90441-R; GREENBERGER MJ, 1995, J IMMUNOL, V155, P722; Hailu A, 2004, AM J TROP MED HYG, V71, P561, DOI 10.4269/ajtmh.2004.71.561; Harris E, 1998, J CLIN MICROBIOL, V36, P1989, DOI 10.1128/JCM.36.7.1989-1995.1998; Jauregui LH, 2001, J CLIN MICROBIOL, V39, P2065, DOI 10.1128/JCM.39.6.2065-2071.2001; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Kumar R, 2007, AM J TROP MED HYG, V76, P896, DOI 10.4269/ajtmh.2007.76.896; Kumar R, 2009, FEMS IMMUNOL MED MIC, V57, P239, DOI 10.1111/j.1574-695X.2009.00607.x; Manna L, 2008, CYTOKINE, V44, P288, DOI 10.1016/j.cyto.2008.08.017; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; MITRA RS, 1995, J IMMUNOL, V154, P2668; Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Ramesh V, 2007, TROP MED INT HEALTH, V12, P848, DOI 10.1111/j.1365-3156.2007.01854.x; REED SG, 1994, J IMMUNOL, V153, P3135; Rolao N, 2004, J PARASITOL, V90, P1150, DOI 10.1645/GE-264R1; ROMANI L, 1994, J IMMUNOL, V152, P3514; Salotra P, 2003, J CLIN PATHOL, V56, P840, DOI 10.1136/jcp.56.11.840; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; SCOTT P, 1991, J IMMUNOL, V147, P3149; Selvapandiyan A, 2005, J MOL DIAGN, V7, P268, DOI 10.1016/S1525-1578(10)60554-5; Selvapandiyan A, 2008, TRANSFUSION, V48, P1787, DOI 10.1111/j.1537-2995.2008.01798.x; Sundar S, 2000, T ROY SOC TROP MED H, V94, P200, DOI 10.1016/S0035-9203(00)90277-3; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; TAGA K, 1992, J IMMUNOL, V148, P1143; THAKUR CP, 1992, ANN TROP MED PARASIT, V86, P355, DOI 10.1080/00034983.1992.11812678; VANDERPOLL T, 1995, CLIN IMMUNOL IMMUNOP, V77, P111, DOI 10.1016/0090-1229(95)90144-2; Wortman G, 2007, AM J TROP MED HYG, V73, P999; Zijlstra EE, 2000, BRIT J DERMATOL, V143, P136, DOI 10.1046/j.1365-2133.2000.03603.x	49	105	107	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10107	10.1371/journal.pone.0010107	http://dx.doi.org/10.1371/journal.pone.0010107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404924	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100020
J	Kravitz, RL; Franks, P; Feldman, MD; Gerrity, M; Byrne, C; Tierney, WM				Kravitz, Richard L.; Franks, Peter; Feldman, Mitchell D.; Gerrity, Martha; Byrne, Cindy; Tierney, William M.			Editorial Peer Reviewers' Recommendations at a General Medical Journal: Are They Reliable and Do Editors Care?	PLOS ONE			English	Article							INTERRATER AGREEMENT; INTERNAL-MEDICINE; DECISION-MAKING; ABSTRACTS; MANUSCRIPTS; REJECTION; QUALITY	Background: Editorial peer review is universally used but little studied. We examined the relationship between external reviewers' recommendations and the editorial outcome of manuscripts undergoing external peer-review at the Journal of General Internal Medicine (JGIM). Methodology/Principal Findings: We examined reviewer recommendations and editors' decisions at JGIM between 2004 and 2008. For manuscripts undergoing peer review, we calculated chance-corrected agreement among reviewers on recommendations to reject versus accept or revise. Using mixed effects logistic regression models, we estimated intra-class correlation coefficients (ICC) at the reviewer and manuscript level. Finally, we examined the probability of rejection in relation to reviewer agreement and disagreement. The 2264 manuscripts sent for external review during the study period received 5881 reviews provided by 2916 reviewers; 28% of reviews recommended rejection. Chance corrected agreement (kappa statistic) on rejection among reviewers was 0.11 (p<.01). In mixed effects models adjusting for study year and manuscript type, the reviewer-level ICC was 0.23 (95% confidence interval [CI], 0.19-0.29) and the manuscript-level ICC was 0.17 (95% CI, 0.12-0.22). The editors' overall rejection rate was 48%: 88% when all reviewers for a manuscript agreed on rejection (7% of manuscripts) and 20% when all reviewers agreed that the manuscript should not be rejected (48% of manuscripts) (p<0.01). Conclusions/Significance: Reviewers at JGIM agreed on recommendations to reject vs. accept/revise at levels barely beyond chance, yet editors placed considerable weight on reviewers' recommendations. Efforts are needed to improve the reliability of the peer-review process while helping editors understand the limitations of reviewers' recommendations.	[Kravitz, Richard L.] Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA; [Franks, Peter] Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA; [Feldman, Mitchell D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Gerrity, Martha] Oregon Hlth & Sci Univ Portland, Dept Med, Portland, OR USA; [Byrne, Cindy; Tierney, William M.] Regenstrief Inst Hlth Care, Indianapolis, IN USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; Oregon Health & Science University; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Kravitz, RL (corresponding author), Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA.	rlkravitz@ucdavis.edu	Kravitz, Richard/AAF-7425-2021	Gerrity, Martha/0000-0002-8772-4591; Kravitz, Richard/0000-0001-5575-529X	University of California; Davis; Regenstrief Institute	University of California(University of California System); Davis; Regenstrief Institute	This work was funded, in part, from internal sources made available by the University of California, Davis and Regenstrief Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CULLEN DJ, 1992, ACAD MED, V67, P856, DOI 10.1097/00001888-199212000-00013; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Grzybowski A, 2009, MED SCI MONITOR, V15, pSR1; Gupta P, 2006, INDIAN PEDIATR, V43, P479; Hall SA, 2007, EPIDEMIOLOGY, V18, P262, DOI 10.1097/01.ede.0000254668.63378.32; HARGENS LL, 1988, AM SOCIOL REV, V53, P139, DOI 10.2307/2095739; Haynes RB, 2006, JAMA-J AM MED ASSOC, V295, P1801, DOI 10.1001/jama.295.15.1801; HAYNES RB, 1986, ANN INTERN MED, V105, P309, DOI 10.7326/0003-4819-105-2-309; Hojat M, 2003, ADV HEALTH SCI EDUC, V8, P75, DOI 10.1023/A:1022670432373; Howard L, 1998, BRIT J PSYCHIAT, V173, P110, DOI 10.1192/bjp.173.2.110; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3; Kemper KJ, 1996, ARCH PEDIAT ADOL MED, V150, P380, DOI 10.1001/archpedi.1996.02170290046007; Laine C, 1999, ANNU REV MED, V50, P99; Liesegang TJ, 2007, AM J OPHTHALMOL, V143, P551, DOI 10.1016/j.ajo.2006.12.004; Marusic A, 1998, Croat Med J, V39, P3; Montgomery AA, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-8; RELMAN AS, 1990, WESTERN J MED, V153, P520; Rothwell PM, 2000, BRAIN, V123, P1964, DOI 10.1093/brain/123.9.1964; RUBIN HR, 1993, J GEN INTERN MED, V8, P255, DOI 10.1007/BF02600092; Schroter S, 2006, JAMA-J AM MED ASSOC, V295, P314, DOI 10.1001/jama.295.3.314; SIEGELMAN SS, 1991, RADIOLOGY, V178, P637, DOI 10.1148/radiology.178.3.1994394; STRAYHORN J, 1993, AM J PSYCHIAT, V150, P947; TIERNEY W, 2008, J GEN INTERN MED, V23, P2145; TIERNEY W, 2009, J GEN INTER IN PRESS; Viera AJ, 2005, FAM MED, V37, P360; Wade Derick, 2004, Clin Rehabil, V18, P117, DOI 10.1191/0269215504cr726ed	26	91	92	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10072	10.1371/journal.pone.0010072	http://dx.doi.org/10.1371/journal.pone.0010072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386704	Green Published, gold			2022-12-27	WOS:000276482000010
J	Liu, CF; Parker, K; Yao, HHC				Liu, Chia-Feng; Parker, Keith; Yao, Humphrey H. -C.			WNT4/beta-Catenin Pathway Maintains Female Germ Cell Survival by Inhibiting Activin beta B in the Mouse Fetal Ovary	PLOS ONE			English	Article							SEX-REVERSAL; MAMMALIAN OVARY; GENE-EXPRESSION; CATENIN; MICE; WNT-4; DIFFERENTIATION; FOLLISTATIN; DEATH; STABILIZATION	Female germ cells are essential for organogenesis of the ovary; without them, ovarian follicles do not form and functional and structural characteristics of the ovary are lost. We and others showed previously that when either Wnt4 or beta-catenin was inactivated in the fetal ovary, female germ cells underwent degeneration. In this study, we set out to understand whether these two factors belong to the same pathway and how they maintain female germ cell survival. We found that activation of beta-catenin in somatic cells in the Wnt4 knockout ovary restored germ cell numbers, placing beta-catenin downstream of WNT4. In the absence of Wnt4 or beta-catenin, female germ cells entered meiosis properly; however, they underwent apoptosis afterwards. Activin beta B (Inhbb), a subunit of activins, was upregulated in the Wnt4 and beta-catenin knockout ovaries, suggesting that Inhbb could be the cause for the loss of female germ cells, which are positive for activin receptors. Indeed, removal of Inhbb in the Wnt4 knockout ovaries prevented female germ cells from undergoing degeneration. We conclude that WNT4 maintains female germ cell survival by inhibiting Inhbb expression via beta-catenin in the somatic cells. Maintenance of female germ cells hinge upon a delicate balance between positive (WNT4 and beta-catenin) and negative (activin beta B) regulators derived from the somatic cells in the fetal ovary.	[Liu, Chia-Feng; Yao, Humphrey H. -C.] Univ Illinois, Dept Vet Biosci, Urbana, IL 61801 USA; [Parker, Keith] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, CF (corresponding author), Univ Illinois, Dept Vet Biosci, 2001 S Lincoln Ave, Urbana, IL 61801 USA.	hhyao@illinois.edu	Yao, Hung-Chang Humphrey/B-4795-2010	Yao, Hung-Chang Humphrey/0000-0003-2944-8469	NIH [HD046861]; Basal O'Connor Starter Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basal O'Connor Starter Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research is supported by NIH HD046861 and Basal O'Connor Starter Award to H. H. Yao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JS, 2005, SEMIN CELL DEV BIOL, V16, P245, DOI 10.1016/j.semcdb.2004.12.008; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; Bingham NC, 2006, GENESIS, V44, P419, DOI 10.1002/dvg.20231; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; Chang H, 2009, BIOL REPROD, V81, P842, DOI 10.1095/biolreprod.109.077446; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Cohen PE, 2006, ENDOCR REV, V27, P398, DOI 10.1210/er.2005-0017; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; de Groot E, 2000, MOL BIOL REP, V27, P129, DOI 10.1023/A:1007159031000; Drews U, 2001, HISTOCHEM CELL BIOL, V116, P427, DOI 10.1007/s00418-001-0335-5; Farini D, 2005, DEV BIOL, V285, P49, DOI 10.1016/j.ydbio.2005.06.036; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HASHIMOTO N, 1990, J EXP ZOOL, V253, P61, DOI 10.1002/jez.1402530109; Heikkila M, 2005, ENDOCRINOLOGY, V146, P4016, DOI 10.1210/en.2005-0463; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Kimura T, 2006, DEV BIOL, V300, P545, DOI 10.1016/j.ydbio.2006.06.038; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Manuylov NL, 2008, DEVELOPMENT, V135, P3731, DOI 10.1242/dev.024653; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Miyoshi K, 2003, BREAST CANCER RES, V5, P63, DOI 10.1186/bcr566; Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Olaso R, 1998, ENDOCRINOLOGY, V139, P733, DOI 10.1210/en.139.2.733; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Paul S, 2008, NEOPLASMA, V55, P165; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Reinholdt Laura, 2004, Methods Mol Biol, V262, P87; Richards AJ, 1999, DEV BIOL, V207, P470, DOI 10.1006/dbio.1998.9174; Ross AJ, 2003, MOL CELL ENDOCRINOL, V211, P1, DOI 10.1016/j.mce.2003.09.021; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sato T, 2008, MECH DEVELOP, V125, P498, DOI 10.1016/j.mod.2008.01.004; Schulz R, 2008, CELL TISSUE RES, V334, P327, DOI 10.1007/s00441-008-0714-5; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Surendran K, 2003, AM J PHYSIOL-RENAL, V284, pF653, DOI 10.1152/ajprenal.00343.2002; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; VIGIER B, 1988, REPROD NUTR DEV, V28, P1113, DOI 10.1051/rnd:19880709; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2006, BIOL REPROD, V74, P978, DOI 10.1095/biolreprod.105.050286	55	57	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10382	10.1371/journal.pone.0010382	http://dx.doi.org/10.1371/journal.pone.0010382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454446	Green Submitted, Green Published, gold			2022-12-27	WOS:000277240100009
J	Forst, B; Hansen, MT; Klingelhofer, J; Moller, HD; Nielsen, GH; Grum-Schwensen, B; Ambartsumian, N; Lukanidin, E; Grigorian, M				Forst, Birgitte; Hansen, Matilde Thye; Klingelhofer, Jorg; Moller, Henrik Devitt; Nielsen, Gitte Helle; Grum-Schwensen, Birgitte; Ambartsumian, Noona; Lukanidin, Eugene; Grigorian, Mariam			Metastasis-Inducing S100A4 and RANTES Cooperate in Promoting Tumor Progression in Mice	PLOS ONE			English	Article							BREAST-CANCER; PROTEIN S100A4; RHEUMATOID-ARTHRITIS; MTS1/S100A4 PROTEIN; UP-REGULATION; CELLS; EXPRESSION; GROWTH; INVOLVEMENT; TARGET	Background: The tumor microenvironment has been described as a critical milieu determining tumor growth and metastases. A pivotal role of metastasis-inducing S100A4 in the development of tumor stroma has been proven in animal models and verified in human breast cancer biopsies. Expression and release of S100A4 has been shown in various types of stroma composing cells, including fibroblasts and immune cells. However, the events implicated in upstream and downstream pathways regulating the activity of the extracellular S100A4 protein in the tumor milieu remain unsolved. Methodology/Principal Findings: We studied the interplay between the tumor cell-derived cytokine regulated-upon-activation, normal T-cell expressed and secreted (RANTES; CCL5) and S100A4 which were shown to be critical factors in tumor progression. We found that RANTES stimulates the externalization of S100A4 via microparticle shedding from the plasma membrane of tumor and stroma cells. Conversely, the released S100A4 protein induces the upregulation of fibronectin (FN) in fibroblasts and a number of cytokines, including RANTES in tumor cells as well as stimulates cell motility in a wound healing assay. Importantly, using wild type and S100A4-deficient mouse models, we demonstrated a substantial influence of tumor cell-derived RANTES on S100A4 release into blood circulation which ultimately increases the metastatic burden in mice. Conclusions/Significance: Altogether, the data presented strongly validate the pro-metastatic function of S100A4 in the tumor microenvironment and define how the tumor cell-derived cytokine RANTES acts as a critical regulator of S100A4-dependent tumor cell dissemination. Additionally, for the first time we demonstrated the mechanism of S100A4 release associated with plasma membrane microparticle shedding from various cells types.	[Forst, Birgitte; Hansen, Matilde Thye; Klingelhofer, Jorg; Moller, Henrik Devitt; Nielsen, Gitte Helle; Grum-Schwensen, Birgitte; Ambartsumian, Noona; Lukanidin, Eugene; Grigorian, Mariam] Danish Canc Soc, Dept Mol Canc Biol, Copenhagen, Denmark	Danish Cancer Society	Forst, B (corresponding author), Danish Canc Soc, Dept Mol Canc Biol, Copenhagen, Denmark.	mg@cancer.dk	Klingelhöfer, Jörg/C-1676-2013; Møller, Henrik/K-5415-2014	Møller, Henrik/0000-0002-1886-3053; Grum-Schwensen, Birgitte/0000-0001-6677-1869	European Union [EU7 Tumic-Health-F2-2008-201662]; Danish Cancer Society; Cancer Research Foundation; Novo Nordisk Foundation; Familien Spogaards Fond	European Union(European Commission); Danish Cancer Society(Danish Cancer Society); Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Familien Spogaards Fond	Research was supported by European Union grant EU7 Tumic-Health-F2-2008-201662 (EL), the Danish Cancer Society (EL, MG, NA), Danish Cancer Research Foundation (BF, BGS), Novo Nordisk Foundation (MG, BF, MTH) and Familien Spogaards Fond (BGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Belot N, 2002, BBA-PROTEINS PROTEOM, V1600, P74, DOI 10.1016/S1570-9639(02)00447-8; Bjornland K, 1999, CANCER RES, V59, P4702; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Duarte WR, 1999, BIOCHEM BIOPH RES CO, V255, P416, DOI 10.1006/bbrc.1999.0214; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Grum-Schwensen B, 2010, CANCER RES, V70, P936, DOI 10.1158/0008-5472.CAN-09-3220; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kikuchi N, 2006, CANCER SCI, V97, P1061, DOI 10.1111/j.1349-7006.2006.00295.x; Klingelhofer J, 2007, ARTHRITIS RHEUM-US, V56, P779, DOI 10.1002/art.22398; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Leeb SN, 2004, AM J GASTROENTEROL, V99, P335, DOI 10.1111/j.1572-0241.2004.04044.x; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MACK RN, 2000, ISSUES ECOL, V5, P1; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pedersen MV, 2004, J NEUROSCI RES, V77, P777, DOI 10.1002/jnr.20221; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Schmidt-Hansen B, 2004, ONCOGENE, V23, P5487, DOI 10.1038/sj.onc.1207720; Schmidt-Hansen B, 2004, J BIOL CHEM, V279, P24498, DOI 10.1074/jbc.M400441200; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Senolt L, 2006, ANN RHEUM DIS, V65, P1645, DOI 10.1136/ard.2005.047704; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; Stormes KA, 2005, BREAST CANCER RES TR, V89, P209, DOI 10.1007/s10549-004-5328-3; Tang CH, 2010, BIOCHEM PHARMACOL, V79, P209, DOI 10.1016/j.bcp.2009.08.006; Tarabykina S, 2007, CURR CANCER DRUG TAR, V7, P217, DOI 10.2174/156800907780618329; Wente MN, 2008, INT J ONCOL, V33, P297, DOI 10.3892/ijo_00000009; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yammani RR, 2009, ARTHRITIS RHEUM, V60, P792, DOI 10.1002/art.24295; Zibert JR, 2010, J INVEST DERMATOL, V130, P150, DOI 10.1038/jid.2009.206	53	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10374	10.1371/journal.pone.0010374	http://dx.doi.org/10.1371/journal.pone.0010374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442771	Green Published, Green Submitted, gold			2022-12-27	WOS:000277154200014
J	Shinoda, Y; Tanaka, T; Tominaga-Yoshino, K; Ogura, A				Shinoda, Yo; Tanaka, Tsunehiro; Tominaga-Yoshino, Keiko; Ogura, Akihiko			Persistent Synapse Loss Induced by Repetitive LTD in Developing Rat Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; REPEATED PKA ACTIVATION; DENDRITIC SPINES; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; VISUAL-CORTEX	Synaptic pruning is a physiological event that eliminates excessive or inappropriate synapses to form proper synaptic connections during development of neurons. Appropriate synaptic pruning is required for normal neural development. However, the mechanism of synaptic pruning is not fully understood. Strength of synaptic activity under competitive circumstances is thought to act as a selective force for synaptic pruning. Long-term depression (LTD) is a synaptic plasticity showing persistent decreased synaptic efficacy, which is accompanied by morphological changes of dendritic spines including transient retraction. Repetitive induction of LTD has been shown to cause persistent loss of synapses in mature neurons. Here, we show that multiple, but not single, induction of LTD caused a persistent reduction in the number of dendritic synapses in cultured rat developing hippocampal neurons. When LTD was induced in 14 days in vitro cultures by application of (RS)-3,5-dihydroxyphenylglycine (DHPG), a group I metabotropic glutamate receptor (mGluR) agonist, and repeated three times with a one day interval, there was a significant decrease in the number of dendritic synapses. This effect continued up to at least two weeks after the triple LTD induction. The persistent reduction in synapse number occurred in the proximal dendrites, but not the distal dendrites, and was prevented by simultaneous application of the group I/II mGluR antagonist (S)-a-methyl-4-carboxyphenylglycine (MCPG). In conclusion, we found that repetitive LTD induction in developing neurons elicits synaptic pruning and contributes to activity-dependent regulation of synapse number in rat hippocampal neurons.	[Shinoda, Yo] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan; [Shinoda, Yo; Tanaka, Tsunehiro; Tominaga-Yoshino, Keiko; Ogura, Akihiko] Osaka Univ, Dept Neurosci, Grad Sch Frontier Biosci, Osaka, Japan; [Shinoda, Yo] JST CREST, Kawaguchi, Saitama, Japan	RIKEN; Osaka University; Japan Science & Technology Agency (JST)	Shinoda, Y (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan.	yshinoda-ns@umin.ac.jp	Shinoda, Yo/H-3091-2019	Shinoda, Yo/0000-0003-3253-2194	Japanese Ministry of Education, Culture, Sports, Science, and Technology [21790219]; CREST	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#21790219, http://www.mext.go.jp/english/) and CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; BROSE N, 1993, J BIOL CHEM, V268, P22663; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Defagot MC, 2002, DEV NEUROSCI-BASEL, V24, P272, DOI 10.1159/000066741; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Gonzalez-Burgos G, 2008, CEREB CORTEX, V18, P626, DOI 10.1093/cercor/bhm095; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Johnston MV, 2003, J CHILD NEUROL, V18, P688, DOI 10.1177/08830738030180100501; Kamikubo Y, 2006, EUR J NEUROSCI, V24, P1606, DOI 10.1111/j.1460-9568.2006.05032.x; KESHAVAN MS, 1994, J PSYCHIATR RES, V28, P239, DOI 10.1016/0022-3956(94)90009-4; Knafo S, 2005, EUR J NEUROSCI, V21, P927, DOI 10.1111/j.1460-9568.2005.03936.x; KNOBLAUCH A, 2010, NEURAL COMPUT, V289, P341; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Moody WJ, 1998, J NEUROBIOL, V37, P97, DOI 10.1002/(SICI)1097-4695(199810)37:1<97::AID-NEU8>3.0.CO;2-3; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; RAUSCHECKER JP, 1987, WHAT SIGNALS ARE RES, P193; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shinoda Y, 2005, BRAIN RES, V1042, P99, DOI 10.1016/j.brainres.2005.02.028; Shinoda Y, 2003, NEUROSCI RES, V47, P191, DOI 10.1016/S0168-0102(03)00199-8; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Tominaga-Yoshino K, 2002, NEUROSCI RES, V44, P357, DOI 10.1016/S0168-0102(02)00155-4; Tominaga-Yoshino K, 2008, HIPPOCAMPUS, V18, P281, DOI 10.1002/hipo.20391; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Urakubo T, 2006, NEUROSCI LETT, V407, P1, DOI 10.1016/j.neulet.2006.07.057; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Woo TUW, 2005, SCHIZOPHR RES, V73, P193, DOI 10.1016/j.schres.2004.07.022; Yamamoto M, 2005, BRAIN RES, V1042, P6, DOI 10.1016/j.brainres.2005.01.102; Young A, 2007, CHEM SENSES, V32, P783, DOI 10.1093/chemse/bjm046; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	54	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10390	10.1371/journal.pone.0010390	http://dx.doi.org/10.1371/journal.pone.0010390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436928	Green Published, Green Submitted, gold			2022-12-27	WOS:000277154200025
J	Schulze, J; Seitz, S; Saito, H; Schneebauer, M; Marshall, RP; Baranowsky, A; Busse, B; Schilling, AF; Friedrich, FW; Albers, J; Spiro, AS; Zustin, J; Streichert, T; Ellwanger, K; Niehrs, C; Amling, M; Baron, R; Schinke, T				Schulze, Jochen; Seitz, Sebastian; Saito, Hiroaki; Schneebauer, Michael; Marshall, Robert P.; Baranowsky, Anke; Busse, Bjoern; Schilling, Arndt F.; Friedrich, Felix W.; Albers, Joachim; Spiro, Alexander S.; Zustin, Jozef; Streichert, Thomas; Ellwanger, Kristina; Niehrs, Christof; Amling, Michael; Baron, Roland; Schinke, Thorsten			Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; SOST GENE; LRP5; MICE; SCLEROSTIN; EXPRESSION; DELETION; MUTATION; DKK1; MASS	Wnt signalling is a key pathway controlling bone formation in mice and humans. One of the regulators of this pathway is Dkk1, which antagonizes Wnt signalling through the formation of a ternary complex with the transmembrane receptors Krm1/2 and Lrp5/6, thereby blocking the induction of Wnt signalling by the latter ones. Here we show that Kremen-2 (Krm2) is predominantly expressed in bone, and that its osteoblast-specific over-expression in transgenic mice (Col1a1-Krm2) results in severe osteoporosis. Histomorphometric analysis revealed that osteoblast maturation and bone formation are disturbed in Col1a1-Krm2 mice, whereas bone resorption is increased. In line with these findings, primary osteoblasts derived from Col1a1-Krm2 mice display a cell-autonomous differentiation defect, impaired canonical Wnt signalling and decreased production of the osteoclast inhibitory factor Opg. To determine whether the observed effects of Krm2 on bone remodeling are physiologically relevant, we analyzed the skeletal phenotype of 24 weeks old Krm2-deficient mice and observed high bone mass caused by a more than three-fold increase in bone formation. Taken together, these data identify Krm2 as a regulator of bone remodeling and raise the possibility that antagonizing KRM2 might prove beneficial in patients with bone loss disorders.	[Schulze, Jochen; Seitz, Sebastian; Schneebauer, Michael; Marshall, Robert P.; Baranowsky, Anke; Busse, Bjoern; Schilling, Arndt F.; Friedrich, Felix W.; Albers, Joachim; Spiro, Alexander S.; Amling, Michael; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany; [Saito, Hiroaki; Baron, Roland] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Saito, Hiroaki; Baron, Roland] Harvard Univ, Sch Med, Boston, MA USA; [Zustin, Jozef] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Ellwanger, Kristina; Niehrs, Christof] Univ Heidelberg DKFZ ZMBH Alliance, German Canc Res Ctr, Res Program Cell & Tumor Biol, Div Mol Embryol, Heidelberg, Germany; [Ellwanger, Kristina; Niehrs, Christof] Univ Heidelberg DKFZ ZMBH Alliance, German Canc Res Ctr, Ctr Mol Biol, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Schulze, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany.	schinke@uke.uni-hamburg.de	Friedrich, Felix W./C-7366-2009; Busse, Björn/O-8462-2016; Busse, Björn/AAC-4033-2020; Marshall, Robert Percy/AAD-5269-2022	Busse, Björn/0000-0002-3099-8073; Busse, Björn/0000-0002-3099-8073; Marshall, Robert Percy/0000-0003-4247-1006; Friedrich, Felix/0000-0002-8400-9445; Albers, Joachim/0000-0003-0582-1863	Deutsche Forschungsgemeinschaft [SCHI 504/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to T. Schinke (SCHI 504/5-1) within the transregional research group 793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goldberg M, 2008, J DENT RES, V87, P9, DOI 10.1177/154405910808700103; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grundberg E, 2008, OSTEOPOROSIS INT, V19, P829, DOI 10.1007/s00198-007-0512-z; GUENET JL, 1981, J HERED, V72, P440, DOI 10.1093/oxfordjournals.jhered.a109554; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; Heinzel K, 2007, EUR J IMMUNOL, V37, P2562, DOI 10.1002/eji.200637474; Huebner AK, 2006, J BONE MINER RES, V21, P1924, DOI 10.1359/JBMR.060820; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Laroche M, 2008, AM J MED, V121, P744, DOI 10.1016/j.amjmed.2008.03.048; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Seitz S, 2009, J BONE MINER RES, V24, P62, DOI 10.1359/JBMR.080907; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wang CJ, 2008, J BONE MINER RES, V23, P837, DOI 10.1359/JBMR.080214; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	63	43	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10309	10.1371/journal.pone.0010309	http://dx.doi.org/10.1371/journal.pone.0010309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436912	Green Submitted, gold, Green Published			2022-12-27	WOS:000277079700005
J	Baron, T; Bencsik, A; Morignat, E				Baron, Thierry; Bencsik, Anna; Morignat, Eric			Prions of Ruminants Show Distinct Splenotropisms in an Ovine Transgenic Mouse Model	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRANSMISSIBLE MINK ENCEPHALOPATHY; MOLECULAR ANALYSIS; SCRAPIE; PROTEIN; SHEEP; INFECTION; ISOLATE; SIMILARITIES; DISEASE	Background: Transmissible agents involved in prion diseases differ in their capacities to target different regions of the central nervous system and lymphoid tissues, which are also host-dependent. Methodology/Principal Findings: Protease-resistant prion protein (PrPres) was analysed by Western blot in the spleen of transgenic mice (TgOvPrP4) that express the ovine prion protein under the control of the neuron-specific enolase promoter, after infection by intra-cerebral route with a variety of transmissible spongiform encephalopathies (TSEs) from cattle and small ruminants. Splenic PrPres was consistently detected in classical BSE and in most natural scrapie sources, the electrophoretic pattern showing similar features to that of cerebral PrPres. However splenic PrPres was not detected in L-type BSE and TME-in-cattle, or in the CH1641 experimental scrapie isolate, indicating that some TSE strains showed reduced splenotropism in the ovine transgenic mice. In contrast with CH1641, PrPres was also consistently detected in the spleen of mice infected with six natural "CH1641-like" scrapie isolates, but then showed clearly different molecular features from those identified in the brains (unglycosylated PrPres at similar to 18 kDa with removal of the 12B2 epitope) of ovine transgenic mice or of sheep. These features included different cleavage of the main PrPres cleavage product (unglycosylated PrPres at similar to 19 kDa with preservation of the 12B2 epitope) and absence of the additional C-terminally cleaved PrPres product (unglycosylated form at similar to 14 kDa) that was detected in the brain. Conclusion/Significance: Studies in a transgenic mouse model expressing the sheep prion protein revealed different capacities of ruminant prions to propagate in the spleen. They showed unexpected features in "CH1641-like" ovine scrapie suggesting that such isolates contain mixed conformers with distinct capacities to propagate in the brain or lymphoid tissues of these mice.	[Baron, Thierry; Bencsik, Anna; Morignat, Eric] Agence Francaise Secur Sanit Aliments Lyon, Unite ATNC, Lyon, France		Baron, T (corresponding author), Agence Francaise Secur Sanit Aliments Lyon, Unite ATNC, Lyon, France.	t.baron@afssa.fr	BENCSIK, Anna A/HGC-4260-2022	BENCSIK, Anna A/0000-0002-8671-6290	Neuroprion network of excellence [FOOD-CT-2004-506579]	Neuroprion network of excellence(European Commission)	This work was supported by grants from the Neuroprion network of excellence (FOOD-CT-2004-506579, EUROSTRAINS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Baron T, 2004, J VIROL, V78, P6243, DOI 10.1128/JVI.78.12.6243-6251.2004; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Baron T, 2007, J VIROL, V81, P7230, DOI 10.1128/JVI.02475-06; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Baron TGM, 2006, EMERG INFECT DIS, V12, P1125; Bartz JC, 2004, J GEN VIROL, V85, P265, DOI 10.1099/vir.0.19394-0; Bencsik AA, 2006, J HISTOCHEM CYTOCHEM, V54, P849, DOI 10.1369/jhc.5C6895.2006; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; COLLIS SC, 1985, FEMS MICROBIOL LETT, V29, P111; Cordier C, 2006, J GEN VIROL, V87, P3763, DOI 10.1099/vir.0.82062-0; Crozet C, 2001, EMBO REP, V2, P952, DOI 10.1093/embo-reports/kve204; Crozet C, 2001, J VIROL, V75, P5328, DOI 10.1128/JVI.75.11.5328-5334.2001; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; FARQUHAR CF, 1994, J GEN VIROL, V75, P495, DOI 10.1099/0022-1317-75-3-495; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; HADLOW WJ, 1987, CAN J VET RES, V51, P135; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Konold Timm, 2006, BMC Vet Res, V2, P31, DOI 10.1186/1746-6148-2-31; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Madec JY, 2000, MICROB PATHOGENESIS, V28, P353, DOI 10.1006/mpat.2000.0357; Nicot S, 2010, J GEN VIROL, V91, P570, DOI 10.1099/vir.0.014464-0; NONNO R, 2008, PRION 2008 C MADR SP; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Somerville RA, 1997, J GEN VIROL, V78, P2389, DOI 10.1099/0022-1317-78-9-2389; Sorby R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006885; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	42	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10310	10.1371/journal.pone.0010310	http://dx.doi.org/10.1371/journal.pone.0010310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436680	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079500004
J	Brown, RH; Kaczka, DW; Mitzner, W				Brown, Robert H.; Kaczka, David W.; Mitzner, Wayne			Effect of Parenchymal Stiffness on Canine Airway Size with Lung Inflation	PLOS ONE			English	Article							DEEP INSPIRATION; SMOOTH-MUSCLE; COMPUTED-TOMOGRAPHY; IN-VIVO; MECHANICAL RESPONSE; LENGTH OSCILLATION; TISSUE MECHANICS; TREE-STRUCTURES; SHEAR MODULUS; BRONCHOCONSTRICTION	Although airway patency is partially maintained by parenchymal tethering, this structural support is often ignored in many discussions of asthma. However, agonists that induce smooth muscle contraction also stiffen the parenchyma, so such parenchymal stiffening may serve as a defense mechanism to prevent airway narrowing or closure. To quantify this effect, specifically how changes in parenchymal stiffness alter airway size at different levels of lung inflation, in the present study, we devised a method to separate the effect of parenchymal stiffening from that of direct airway narrowing. Six anesthetized dogs were studied under four conditions: baseline, after whole lung aerosol histamine challenge, after local airway histamine challenge, and after complete relaxation of the airways. In each of these conditions, we used High resolution Computed Tomography to measure airway size and lung volume at five different airway pressures ( 0, 12, 25, 32, and 45 cm H(2)O). Parenchymal stiffening had a protective effect on airway narrowing, a fact that may be important in the airway response to deep inspiration in asthma. When the parenchyma was stiffened by whole lung aerosol histamine challenge, at every lung volume above FRC, the airways were larger than when they were directly challenged with histamine to the same initial constriction. These results show for the first time that a stiff parenchyma per se minimizes the airway narrowing that occurs with histamine challenge at any lung volume. Thus in clinical asthma, it is not simply increased airway smooth muscle contraction, but perhaps a lack of homogeneous parenchymal stiffening that contributes to the symptomatic airway hyperresponsiveness.	[Brown, Robert H.; Mitzner, Wayne] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA; [Brown, Robert H.; Mitzner, Wayne] Johns Hopkins Univ, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Brown, Robert H.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21205 USA; [Kaczka, David W.; Mitzner, Wayne] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Brown, RH (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA.	wmitzner@jhsph.edu	Kaczka, David Walter/A-2984-2008; Kaczka, David W./U-2580-2018	Kaczka, David Walter/0000-0003-4378-5242; Kaczka, David W./0000-0003-4378-5242	National Institutes of Health (NIH) [HL-10342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) research grant HL-10342. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRAV I, 1993, J APPL PHYSIOL, V75, P2239, DOI 10.1152/jappl.1993.75.5.2239; [Anonymous], 1977, HDB PHYSL SECTION RE; Bates JHT, 2005, RESP PHYSIOL NEUROBI, V148, P153, DOI 10.1016/j.resp.2005.04.021; BEAUPRE A, 1983, EUR J RESPIR DIS, V64, P108; BEAUPRE A, 1982, THORAX, V37, P124, DOI 10.1136/thx.37.2.124; Brown RH, 2000, J APPL PHYSIOL, V89, P956, DOI 10.1152/jappl.2000.89.3.956; Brown RH, 1998, J APPL PHYSIOL, V85, P2012, DOI 10.1152/jappl.1998.85.6.2012; Brown RH, 1996, J APPL PHYSIOL, V80, P1581, DOI 10.1152/jappl.1996.80.5.1581; Brusasco V, 1999, J APPL PHYSIOL, V87, P567, DOI 10.1152/jappl.1999.87.2.567; FISH JE, 1977, J ALLERGY CLIN IMMUN, V60, P41, DOI 10.1016/0091-6749(77)90081-1; Gunst SJ, 2001, J APPL PHYSIOL, V91, P2511, DOI 10.1152/jappl.2001.91.6.2511; HEROLD CJ, 1991, RADIOLOGY, V181, P369, DOI 10.1148/radiology.181.2.1924774; Kaczka DW, 2009, J APPL PHYSIOL, V106, P520, DOI 10.1152/japplphysiol.90576.2008; Kaczka DW, 1997, J APPL PHYSIOL, V82, P1531, DOI 10.1152/jappl.1997.82.5.1531; Kaczka DW, 1999, AM J RESP CRIT CARE, V159, P169, DOI 10.1164/ajrccm.159.1.9709109; KAPANCI Y, 1974, J CELL BIOL, V60, P375, DOI 10.1083/jcb.60.2.375; LAIFOOK SJ, 1978, J APPL PHYSIOL, V44, P859, DOI 10.1152/jappl.1978.44.6.859; Lambert RK, 1997, J APPL PHYSIOL, V83, P140, DOI 10.1152/jappl.1997.83.1.140; Lutchen KR, 1996, J APPL PHYSIOL, V80, P1696, DOI 10.1152/jappl.1996.80.5.1696; LUTCHEN KR, 1994, J APPL PHYSIOL, V77, P373, DOI 10.1152/jappl.1994.77.1.373; Macklin CC, 1929, PHYSIOL REV, V9, P1, DOI 10.1152/physrev.1929.9.1.1; MALMBERG P, 1993, EUR RESPIR J, V6, P680; MILICEMILI J, 1964, J APPL PHYSIOL, V19, P207, DOI 10.1152/jappl.1964.19.2.207; MITZNER W, 1992, J APPL PHYSIOL, V72, P158, DOI 10.1152/jappl.1992.72.1.158; NADEL JA, 1964, J APPL PHYSIOL, V19, P387, DOI 10.1152/jappl.1964.19.3.387; Noble PB, 2005, EUR RESPIR J, V26, P804, DOI 10.1183/09031936.05.00065405; Noble PB, 2002, J APPL PHYSIOL, V92, P1119, DOI 10.1152/japplphysiol.00662.2001; Okazawa M, 1999, J APPL PHYSIOL, V86, P496, DOI 10.1152/jappl.1999.86.2.496; OREHEK J, 1980, AM REV RESPIR DIS, V121, P297; Pyrgos G, 2003, AM J RESP CRIT CARE, V167, P1660, DOI 10.1164/rccm.2201048; Scichilone N, 2004, CURR ALLERGY ASTHM R, V4, P166, DOI 10.1007/s11882-004-0063-8; Scichilone N, 2001, INT ARCH ALLERGY IMM, V124, P262, DOI 10.1159/000053728; Scichilone N, 2008, J APPL PHYSIOL, V105, P832, DOI 10.1152/japplphysiol.01307.2007; Scichilone N, 2007, RESP MED, V101, P951, DOI 10.1016/j.rmed.2006.09.009; Shen X, 1997, J APPL PHYSIOL, V83, P739, DOI 10.1152/jappl.1997.83.3.739; Shen X, 1997, J APPL PHYSIOL, V83, P731, DOI 10.1152/jappl.1997.83.3.731; Silva PL, 2008, RESP PHYSIOL NEUROBI, V160, P239, DOI 10.1016/j.resp.2007.10.009; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; SMITH JC, 1980, J APPL PHYSIOL, V48, P450, DOI 10.1152/jappl.1980.48.3.450; SMITH JC, 1984, J APPL PHYSIOL, V57, P1422, DOI 10.1152/jappl.1984.57.5.1422; TEPPER RS, 1995, J APPL PHYSIOL, V79, P1190, DOI 10.1152/jappl.1995.79.4.1190; WOOD SA, 1995, J APPL PHYSIOL, V79, P1687, DOI 10.1152/jappl.1995.79.5.1687	42	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10332	10.1371/journal.pone.0010332	http://dx.doi.org/10.1371/journal.pone.0010332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436667	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079500012
J	Kim, YS; Ke, F; Lei, XY; Zhu, R; Zhang, QY				Kim, Yu-Sin; Ke, Fei; Lei, Xiao-Ying; Zhu, Rong; Zhang, Qi-Ya			Viral Envelope Protein 53R Gene Highly Specific Silencing and Iridovirus Resistance in Fish Cells by AmiRNA	PLOS ONE			English	Article							RANA-GRYLIO-VIRUS; RNA INTERFERENCE; PARALICHTHYS-OLIVACEUS; FUNCTIONAL-CHARACTERIZATION; EXPRESSION; LINE; INHIBITION; SYSTEM; SIRNA; REPLICATION	Background: Envelope protein 53R was identified from frog Rana grylio virus (RGV), a member of the family Iridoviridae, and it plays an important role in the virus assembly. Although inhibition of iridovirus major capsid protein (MCP) by small hairpin RNAs (shRNAs) has been shown to cause resistance to viral infection in vitro, RNA interference (RNAi) to inhibit aquatic animal virus envelope protein gene product has not been reported. Methodology: We devised artificial microRNAs (amiRNAs) that target a viral envelope protein gene RGV 53R. By incorporating sequences encoding amiRNAs specific to 53R of RGV into pre-miRNA155 (pSM155) vectors, which use the backbone of natural miR-155 sequence and could intracellularly express 53R-targeted pre-amiRNAs. The pre-amiRNAs could be processed by the RNase III-like enzyme Dicer into 21-25 nt amiRNAs (amiR-53Rs) in fish cell lines. The levels of 53R expression were analyzed through real-time PCR and RGV virions assembly were observed by electronic microscopy in fish cells transfected with or without amiR-53Rs at 72 h of RGV infection. Conclusion/Significance: The results argue that viral envelope protein RGV 53R can be silenced and the virions assembly was deficient by amiR-53R-1, and further identified the first amiRNA of envelope protein gene from iridovirus that was able to cause resistance to virus infection in fish cells. The data demonstrate that the viral infection is efficiently suppressed (58%) by amiR-53R-1 targeting positon 36-57 of RGV 53R. Moreover, electron microscopic observations revealed virion assembly defect or reduced virions assembly capacity was closely correlated to expression of amiR-53R-1. Based on real time PCR of the Mx gene, we found no evidence of activation of IFN by amiR-53R-1.	[Kim, Yu-Sin; Ke, Fei; Lei, Xiao-Ying; Zhu, Rong; Zhang, Qi-Ya] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Kim, Yu-Sin] Kim II Sung Univ, Coll Life Sci, Pyongyang, North Korea	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Kim, YS (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	zhangqy@ihb.ac.cn			National Major Basic Research Program [2009CB118704, 2010CB126303]; National Natural Science Foundation of China [30871938, 30800854]; Agriculture Commonweal Scientific Research Plan [200803013]; China Postdoctoral Science Foundation [20080440975]	National Major Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Commonweal Scientific Research Plan; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Major Basic Research Program (2009CB118704, 2010CB126303), the National Natural Science Foundation of China (30871938, 30800854), Agriculture Commonweal Scientific Research Plan (200803013) and China Postdoctoral Science Foundation (20080440975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Dang LT, 2008, ANTIVIR RES, V77, P142, DOI 10.1016/j.antiviral.2007.10.007; Dang LT, 2008, ANTIVIR RES, V80, P316, DOI 10.1016/j.antiviral.2008.07.005; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Huang XH, 2006, J VIROL METHODS, V133, P117, DOI 10.1016/j.jviromet.2005.10.029; Jiang J, 2009, MOL IMMUNOL, V46, P3131, DOI 10.1016/j.molimm.2009.05.183; Ke F, 2009, MOL BIOL REP, V36, P1651, DOI 10.1007/s11033-008-9365-6; MAGEE WE, 1972, LIFE SCI 2-BIOCH GEN, V11, P1081, DOI 10.1016/0024-3205(72)90216-0; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; Ooi EL, 2006, FISH SHELLFISH IMMUN, V21, P293, DOI 10.1016/j.fsi.2005.12.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; *SINONSAM, 2009, THESIS WUNAN U; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; Sun W, 2006, BIOCHEM BIOPH RES CO, V351, P44, DOI 10.1016/j.bbrc.2006.09.169; Williams T, 1996, ADV VIRUS RES, V46, P345, DOI 10.1016/S0065-3527(08)60076-7; Xie JF, 2005, VIROLOGY, V338, P43, DOI 10.1016/j.virol.2005.04.040; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhang QY, 1999, AQUACULTURE, V175, P185, DOI 10.1016/S0044-8486(99)00041-1; Zhang QY, 2006, AQUACULTURE, V251, P1, DOI 10.1016/j.aquaculture.2005.05.012; Zhang QY, 2003, DIS AQUAT ORGAN, V57, P27, DOI 10.3354/dao057027; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027; Zhao Z, 2008, J GEN VIROL, V89, P1866, DOI 10.1099/vir.0.2008/000810-0; Zhao Z, 2007, VIRUS RES, V123, P128, DOI 10.1016/j.virusres.2006.08.007; Zhao Z, 2009, VIRUS GENES, V38, P345, DOI 10.1007/s11262-008-0318-x	33	31	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10308	10.1371/journal.pone.0010308	http://dx.doi.org/10.1371/journal.pone.0010308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20428238	gold, Green Published, Green Submitted			2022-12-27	WOS:000277079300007
J	Pause, BM; Lubke, K; Laudien, JH; Ferstl, R				Pause, Bettina M.; Luebke, Katrin; Laudien, Joachim H.; Ferstl, Roman			Intensified Neuronal Investment in the Processing of Chemosensory Anxiety Signals in Non-Socially Anxious and Socially Anxious Individuals	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STRESS-INDUCED HYPERTHERMIA; ALARM PHEROMONE; EMOTIONAL EXPRESSIONS; GENDER-DIFFERENCES; MALE RATS; PHOBIA; FACES; PERCEPTION; DISORDER	Background: The ability to communicate anxiety through chemosensory signals has been documented in humans by behavioral, perceptual and brain imaging studies. Here, we investigate in a time-sensitive manner how chemosensory anxiety signals, donated by humans awaiting an academic examination, are processed by the human brain, by analyzing chemosensory event-related potentials (CSERPs, 64-channel recording with current source density analysis). Methodology/Principal Findings: In the first study cerebral stimulus processing was recorded from 28 non-socially anxious participants and in the second study from 16 socially anxious individuals. Each individual participated in two sessions, smelling sweat samples donated from either female or male donors (88 sessions; balanced session order). Most of the participants of both studies were unable to detect the stimuli olfactorily. In non-socially anxious females, CSERPs demonstrate an increased magnitude of the P3 component in response to chemosensory anxiety signals. The source of this P3 activity was allocated to medial frontal brain areas. In socially anxious females chemosensory anxiety signals require more neuronal resources during early pre-attentive stimulus processing (N1). The neocortical sources of this activity were located within medial and lateral frontal brain areas. In general, the event-related neuronal brain activity in males was much weaker than in females. However, socially anxious males processed chemosensory anxiety signals earlier (N1 latency) than the control stimuli collected during an ergometer training. Conclusions/Significance: It is concluded that the processing of chemosensory anxiety signals requires enhanced neuronal energy. Socially anxious individuals show an early processing bias towards social fear signals, resulting in a repression of late attentional stimulus processing.	[Pause, Bettina M.; Luebke, Katrin] Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany; [Laudien, Joachim H.; Ferstl, Roman] Univ Kiel, Dept Psychol, Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Pause, BM (corresponding author), Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany.	bettina.pause@uni-duesseldorf.de			German Research Foundation (DFG) [PA 937/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation to BMP (DFG, PA 937/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; [Anonymous], 2014, PHEROMONES ANIMAL BE; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Damasio A.R., 2005, DESCARTES ERROR EMOT; FANSELOW MS, 1985, BEHAV NEUROSCI, V99, P589, DOI 10.1037/0735-7044.99.3.589; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hirsch CR, 2004, CLIN PSYCHOL REV, V24, P799, DOI 10.1016/j.cpr.2004.07.005; Hideaki IA, 2008, PHYSIOL BEHAV, V93, P606, DOI 10.1016/j.physbeh.2007.10.021; Inagaki H, 2009, PHYSIOL BEHAV, V96, P749, DOI 10.1016/j.physbeh.2008.12.006; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kikusui T, 2001, PHYSIOL BEHAV, V72, P45, DOI 10.1016/S0031-9384(00)00370-X; Kiyokawa Y, 2005, BRAIN RES, V1043, P145, DOI 10.1016/j.brainres.2005.02.061; Kiyokawa Y, 2007, CHEM SENSES, V32, P57, DOI 10.1093/chemse/bjl036; Kobal G., 2003, HDB OLFACTION GUSTAT, P229; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kolassa IT, 2006, BRAIN RES, V1118, P130, DOI 10.1016/j.brainres.2006.08.019; Kolassa IT, 2009, COGNITION EMOTION, V23, P69, DOI 10.1080/02699930801940461; Laudien JH, 2008, NEUROIMAGE, V41, P1426, DOI 10.1016/j.neuroimage.2008.03.046; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; McClintock Martha K., 2002, P797; Morgan CD, 1997, EVOKED POTENTIAL, V104, P351, DOI 10.1016/S0168-5597(97)00020-8; Moser JS, 2008, BIOL PSYCHOL, V78, P93, DOI 10.1016/j.biopsycho.2008.01.005; Moynihan JA, 2000, J NEUROIMMUNOL, V102, P145, DOI 10.1016/S0165-5728(99)00173-3; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Olofsson JK, 2004, CHEM SENSES, V29, P629, DOI 10.1093/chemse/bjh066; Orozco S, 1998, BIOL PSYCHIAT, V44, P281, DOI 10.1016/S0006-3223(97)00487-3; Page MC, 2003, LEVINES GUIDE SPSS A; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2000, INT J PSYCHOPHYSIOL, V36, P105, DOI 10.1016/S0167-8760(99)00105-1; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Pause BM, 1999, INT J PSYCHOPHYSIOL, V32, P251, DOI 10.1016/S0167-8760(99)00020-3; Pause BM, 1998, GENETICA, V104, P285, DOI 10.1023/A:1026462701154; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; ROLLS ET, 1999, BRAIN EMOTION; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Stangier U, 1999, Z KLIN PSYCHOL-FORSC, V28, P28, DOI 10.1026//0084-5345.28.1.28; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Wittchen H.U., 1997, SKID STRUKTURIERTES; ZALAQUETT C, 1991, PHYSIOL BEHAV, V50, P221, DOI 10.1016/0031-9384(91)90524-R; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	56	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10342	10.1371/journal.pone.0010342	http://dx.doi.org/10.1371/journal.pone.0010342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588NU	20428249	gold, Green Submitted, Green Published			2022-12-27	WOS:000277079300022
J	Viadas, C; Rodriguez, MC; Sangari, FJ; Gorvel, JP; Garcia-Lobo, JM; Lopez-Goni, I				Viadas, Cristina; Rodriguez, Maria C.; Sangari, Felix J.; Gorvel, Jean-Pierre; Garcia-Lobo, Juan M.; Lopez-Goni, Ignacio			Transcriptome Analysis of the Brucella abortus BvrR/BvrS Two-Component Regulatory System	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI EXOR; OUTER-MEMBRANE PROTEINS; IV SECRETION SYSTEM; AGROBACTERIUM-TUMEFACIENS; VIRULENCE; MELITENSIS; GENES; PHOSPHORYLATION; SUCCINOGLYCAN; EXPRESSION	Background: The two-component BvrR/BvrS system is essential for Brucella abortus virulence. It was shown previously that its dysfunction alters the expression of some major outer membrane proteins and the pattern of lipid A acylation. To determine the genes regulated by BvrR/BvrS, we performed a whole-genome microarray analysis using B. abortus RNA obtained from wild type and bvrR mutant cells grown in the same conditions. Methodology/Principal Findings: A total of 127 differentially expressed genes were found: 83 were over expressed and 44 were less expressed in the bvrR mutant. Two operons, the phosphotransferase system and the maltose transport system, were down-regulated. Several genes involved in cell envelope or outer membrane biogenesis were differentially expressed: genes for outer membrane proteins (omp25a, omp25d), lipoproteins, LPS and fatty acid biosynthesis, stress response proteins, chaperones, flagellar genes, and twelve genes encoding ABC transport systems. Ten genes related with carbon metabolism (pckA and fumB among others) were up-regulated in the bvrR mutant, and denitrification genes (nirK, norC and nosZ) were also regulated. Notably, seven transcriptional regulators were affected, including VjbR, ExoR and OmpR that were less expressed in the bvrR mutant. Finally, the expression of eleven genes which have been previously related with Brucella virulence was also altered. Conclusions/Significance: All these data corroborate the impact of BvrR/BvrS on cell envelope modulation, confirm that this system controls the carbon and nitrogen metabolism, and suggest a cross-talk among some regulators to adjust the Brucella physiology to the shift expected to occur during the transit from the extracellular to the intracellular niche.	[Viadas, Cristina; Lopez-Goni, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Rodriguez, Maria C.; Sangari, Felix J.; Garcia-Lobo, Juan M.] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Rodriguez, Maria C.; Sangari, Felix J.; Garcia-Lobo, Juan M.] UC CSIC IDICAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain; [Gorvel, Jean-Pierre] Aix Marseille Univ, CIML, UMR6546, Fac Sci Luminy, Marseille, France; [Gorvel, Jean-Pierre] INSERM, U631, F-13258 Marseille, France; [Gorvel, Jean-Pierre] INSERM, UMR6102, F-13258 Marseille, France	University of Navarra; Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Viadas, C (corresponding author), Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.	ilgoni@unav.es	Sangari, Félix J/K-9104-2014; López-Goñi, Ignacio/K-2572-2017; Gorvel, Jean-Pierre/O-1332-2018; Rodriguez, Maria-Cruz/K-6533-2014; Lobo, Juan M Garcia/K-2727-2014	Sangari, Félix J/0000-0002-3298-6076; López-Goñi, Ignacio/0000-0002-3873-8743; Gorvel, Jean-Pierre/0000-0002-2829-9804; Rodriguez, Maria-Cruz/0000-0001-6778-1663; Lobo, Juan M Garcia/0000-0002-9187-0671	Ministerio de Ciencia y Tecnolog-ia of Spain [AGL2008-04514, BIO2007-63656]; Instituto de Salud Carlos III [PI050894]; Fundacion Marques de Valdecilla-IFIMAV	Ministerio de Ciencia y Tecnolog-ia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Marques de Valdecilla-IFIMAV	This work was supported by the Ministerio de Ciencia y Tecnolog-ia of Spain (AGL2008-04514 to ILG, and BIO2007-63656 to FJS) and Instituto de Salud Carlos III (PI050894 to JMG-L). Fellowship support to CV for the Gobierno Vasco and to MCR for Fundacion Marques de Valdecilla-IFIMAV are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger L, 2009, MOL MICROBIOL, V74, P1223, DOI 10.1111/j.1365-2958.2009.06931.x; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; CHAVESOLARTE E, 2003, BRUC 2003 INT RES C; Chen EJ, 2008, MOL MICROBIOL, V69, P1290, DOI 10.1111/j.1365-2958.2008.06362.x; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; DEUTSCHER J, 2005, BIOCHIM BIOPHYS ACTA, V754, P118; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Eskra L, 2001, INFECT IMMUN, V69, P7736, DOI 10.1128/IAI.69.12.7736-7742.2001; FUGIER E, PLOS PATHOG, V5; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Haine V, 2006, J BACTERIOL, V188, P1615, DOI 10.1128/JB.188.4.1615-1619.2006; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Keating DH, 2007, FEMS MICROBIOL LETT, V267, P23, DOI 10.1111/j.1574-6968.2006.00498.x; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Leonard S, 2007, J BACTERIOL, V189, P131, DOI 10.1128/JB.00712-06; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; Letesson J. J., 2004, Brucella: molecular and cellular biology, P117; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Liu P, 2005, J BACTERIOL, V187, P6039, DOI 10.1128/JB.187.17.6039-6045.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loisel-Meyer S, 2006, INFECT IMMUN, V74, P1973, DOI 10.1128/IAI.74.3.1973-1976.2006; Lopez-Goni I, 2002, VET MICROBIOL, V90, P329, DOI 10.1016/S0378-1135(02)00218-3; Manterola L, 2007, INFECT IMMUN, V75, P4867, DOI 10.1128/IAI.00439-07; MIZUNO T, 1990, MOL MICROBIOL, V4, P1077, DOI 10.1111/j.1365-2958.1990.tb00681.x; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Viadas C, 2009, MICROB PATHOGENESIS, V47, P189, DOI 10.1016/j.micpath.2009.06.002; Wells DH, 2007, MOL MICROBIOL, V64, P647, DOI 10.1111/j.1365-2958.2007.05680.x; Yao SY, 2004, J BACTERIOL, V186, P6042, DOI [10.1128/JB.186.18.6042-6049.2004, 10.1128/jb.186.18.6042-6049.2004]; YUZBASIOGLU A, 2010, EXP MOL PATHOL	40	65	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2010	5	4							e10216	10.1371/journal.pone.0010216	http://dx.doi.org/10.1371/journal.pone.0010216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YS	20422049	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952500008
J	Brown, KC; Witte, TR; Hardman, WE; Luo, HT; Chen, YC; Carpenter, AB; Lau, JK; Dasgupta, P				Brown, Kathleen C.; Witte, Ted R.; Hardman, W. Elaine; Luo, Haitao; Chen, Yi C.; Carpenter, A. Betts; Lau, Jamie K.; Dasgupta, Piyali			Capsaicin Displays Anti-Proliferative Activity against Human Small Cell Lung Cancer in Cell Culture and Nude Mice Models via the E2F Pathway	PLOS ONE			English	Article							INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; VANILLOID RECEPTOR; TUMOR-GROWTH; PROLIFERATION; ANGIOGENESIS; ACTIVATION; CARCINOMA; RB; CARCINOGENESIS	Background: Small cell lung cancer (SCLC) is characterized by rapid progression and low survival rates. Therefore, novel therapeutic agents are urgently needed for this disease. Capsaicin, the active ingredient of chilli peppers, displays anti-proliferative activity in prostate and epidermoid cancer in vitro. However, the anti-proliferative activity of capsaicin has not been studied in human SCLCs. The present manuscript fills this void of knowledge and explores the anti-proliferative effect of capsaicin in SCLC in vitro and in vivo. Methodology/Principal Findings: BrdU assays and PCNA ELISAs showed that capsaicin displays robust anti-proliferative activity in four human SCLC cell lines. Furthermore, capsaicin potently suppressed the growth of H69 human SCLC tumors in vivo as ascertained by CAM assays and nude mice models. The second part of our study attempted to provide insight into molecular mechanisms underlying the anti-proliferative activity of capsaicin. We found that the anti-proliferative activity of capsaicin is correlated with a decrease in the expression of E2F-responsive proliferative genes like cyclin E, thymidylate synthase, cdc25A and cdc6, both at mRNA and protein levels. The transcription factor E2F4 mediated the anti-proliferative activity of capsaicin. Ablation of E2F4 levels by siRNA methodology suppressed capsaicin-induced G1 arrest. ChIP assays demonstrated that capsaicin caused the recruitment of E2F4 and p130 on E2F-responsive proliferative promoters, thereby inhibiting cell proliferation. Conclusions/Significance: Our findings suggest that the anti-proliferative effects of capsaicin could be useful in the therapy of human SCLCs.	[Brown, Kathleen C.; Lau, Jamie K.; Dasgupta, Piyali] Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Witte, Ted R.; Hardman, W. Elaine] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV USA; [Luo, Haitao; Chen, Yi C.] Alderson Broaddus Coll, Dept Biol, Phillipi, WV USA; [Carpenter, A. Betts] Marshall Univ, Dept Anat & Pathol, Joan C Edwards Sch Med, Huntington, WV USA	Marshall University; Marshall University; Marshall University	Brown, KC (corresponding author), Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	dasgupta@marshall.edu	Wang, Weili/D-1546-2011		National Institutes of Health [5P20RR020180]; Pharmaceutical Manufacturers Association Foundation Research Starter; Marshall University ADVANCE fellowship; National Aeronautics and Space Administration; Young Clinical Scientist Award from the Flight Attendant Medical Research Institute [82115]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Manufacturers Association Foundation Research Starter; Marshall University ADVANCE fellowship; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Young Clinical Scientist Award from the Flight Attendant Medical Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Center of Biochemical Research Excellence Pilot Research Grant from the National Institutes of Health (grant number 5P20RR020180); the Pharmaceutical Manufacturers Association Foundation Research Starter Grant; the Marshall University ADVANCE fellowship; a Grant-in-Aid undergraduate research grant from National Aeronautics and Space Administration; and a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (grant number 82115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Anandakumar P., 2007, BIOMED PHARMACOTHER; Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V354, P50, DOI 10.1016/j.bbrc.2006.12.179; BANKOVIC J, 2009, LUNG CANC; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; Biro T, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P56, DOI 10.1038/jidsymp.1997.12; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chow J, 2007, BBA-MOL CELL RES, V1773, P565, DOI 10.1016/j.bbamcr.2007.01.001; Claudio PP, 2000, CLIN CANCER RES, V6, P754; Danielian PS, 2007, DEV BIOL, V305, P564, DOI 10.1016/j.ydbio.2007.02.037; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2004, MOL CELL BIOL, V24, P9527, DOI 10.1128/MCB.24.21.9527-9541.2004; Dasgupta P, 2004, J BIOL CHEM, V279, P38762, DOI 10.1074/jbc.M312273200; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; DeGregori J, 2006, CURR MOL MED, V6, P739; Gabellini C, 2006, ONCOGENE, V25, P5326, DOI 10.1038/sj.onc.1209631; GAZDAR AF, 1980, CANCER RES, V40, P3502; GAZDAR AF, 1985, CANCER RES, V45, P2924; Gil YG, 2008, LIFE SCI, V82, P997, DOI 10.1016/j.lfs.2008.02.020; Gu JW, 2005, CANCER-AM CANCER SOC, V103, P422, DOI 10.1002/cncr.20781; HEO DS, 1990, CANCER RES, V50, P3681; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Jang J J, 1989, In Vivo, V3, P49; Johnson DG, 2006, CURR MOL MED, V6, P731; Kinkade R, 2008, CANCER RES, V68, P3810, DOI 10.1158/0008-5472.CAN-07-6672; Knudsen Erik S, 2003, Methods Mol Biol, V218, P3; KRUG LM, 2008, SMALL CELL OTHER NEU; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Metro G, 2009, EXPERT OPIN EMERG DR, V14, P591, DOI 10.1517/14728210903206983; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Minna JD, 2003, CANCER CELL, V4, P163, DOI 10.1016/S1535-6108(03)00221-6; MINNA JD, 1993, CHEST, V103, pS449, DOI 10.1378/chest.103.4_Supplement.449S; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; NEVINS JR, 1991, COLD SPRING HARB SYM, V56, P157; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Parisi T, 2009, ONCOGENE, V28, P500, DOI 10.1038/onc.2008.406; Park KK, 1997, CANCER LETT, V114, P183, DOI 10.1016/S0304-3835(97)04657-0; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; Potemski P, 2006, JPN J CLIN ONCOL, V36, P142, DOI 10.1093/jjco/hyi246; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Rastogi S, 2006, MOL CELL BIOL, V26, P4161, DOI 10.1128/MCB.02142-05; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Shabbir M, 2003, EUR UROL SUPPL, V2, P24; Simpson DS, 2009, CANCER RES, V69, P8733, DOI 10.1158/0008-5472.CAN-09-1359; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; SWISS VA, 2009, GLIA; Tanaka T, 2002, CARCINOGENESIS, V23, P1361, DOI 10.1093/carcin/23.8.1361; THOENNISSEN NH, 2009, ONCOGENE; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsou MF, 2006, ANTICANCER RES, V26, P1965; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wu CC, 2006, MUTAT RES-FUND MOL M, V601, P71, DOI 10.1016/j.mrfmmm.2006.06.015	58	65	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10243	10.1371/journal.pone.0010243	http://dx.doi.org/10.1371/journal.pone.0010243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20421925	gold, Green Published, Green Submitted			2022-12-27	WOS:000276854300009
J	Suarez-Farinas, M; Lowes, MA; Zaba, LC; Krueger, JG				Suarez-Farinas, Mayte; Lowes, Michelle A.; Zaba, Lisa C.; Krueger, James G.			Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA)	PLOS ONE			English	Article							CELL CARCINOMA; T-CELL; EXPRESSION; MICROARRAY; REPRODUCIBILITY; ACTIVATION; SKIN	Background: Our objective was to develop a consistent molecular definition of psoriasis. There have been several published microarray studies of psoriasis, and we compared disease-related genes identified across these different studies of psoriasis with our own in order to establish a consensus. Methodology/Principal Findings: We present a psoriasis transcriptome from a group of 15 patients enrolled in a clinical study, and assessed its biological validity using a set of important pathways known to be involved in psoriasis. We also identified a key set of cytokines that are now strongly implicated in driving disease-related pathology, but which are not detected well on gene array platforms and require more sensitive methods to measure mRNA levels in skin tissues. Comparison of our transcriptome with three other published lists of psoriasis genes showed apparent inconsistencies based on the number of overlapping genes. We extended the well-established approach of Gene Set Enrichment Analysis (GSEA) to compare a new study with these other published list of differentially expressed genes (DEG) in a more comprehensive manner. We applied our method to these three published psoriasis transcriptomes and found them to be in good agreement with our study. Conclusions/Significance: Due to wide variability in clinical protocols, platform and sample handling, and subtle disease-related signals, intersection of published DEG lists was unable to establish consensus between studies. In order to leverage the power of multiple transcriptomes reported by several laboratories using different patients and protocols, more sophisticated methods like the extension of GSEA presented here, should be used in order to overcome the shortcomings of overlapping individual DEG approach.	[Suarez-Farinas, Mayte; Lowes, Michelle A.; Zaba, Lisa C.; Krueger, James G.] Rockefeller Univ, Lab Investigat Dermatol, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Suarez-Farinas, M (corresponding author), Rockefeller Univ, Lab Investigat Dermatol, 1230 York Ave, New York, NY 10021 USA.	jgk@rockefeller.edu	Zaba, Lisa/Q-9681-2019; Suarez-Farinas, Mayte/I-3558-2012; Lowes, Michelle A/G-9585-2016	Suarez-Farinas, Mayte/0000-0001-8712-3553; Zaba, Lisa/0000-0001-9036-5465; Lowes, Michelle A/0000-0003-4256-478X	Clinical and Translational Science Award [UL1RR024143]; Milstein Program in Medical Research; National Institutes of Health (NIH) Medical Scientist Training Program [GM07739]; Doris Duke Foundation;  [K23 AR052404-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR052404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Clinical and Translational Science Award; Milstein Program in Medical Research; National Institutes of Health (NIH) Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a Clinical and Translational Science Award grant UL1RR024143; MSF is supported by the Milstein Program in Medical Research; LZ is supported by National Institutes of Health (NIH) Medical Scientist Training Program grant GM07739; and ML by K23 AR052404-01A1 and the Doris Duke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Boury-Jamot M, 2006, BBA-BIOMEMBRANES, V1758, P1034, DOI 10.1016/j.bbamem.2006.06.013; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P635, DOI 10.1038/jid.2008.266; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kaporis HG, 2007, J INVEST DERMATOL, V127, P2391, DOI 10.1038/sj.jid.5700884; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Oestreicher J. L., 2001, Pharmacogenomics Journal, V1, P272; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Shi LM, 2008, CURR OPIN BIOTECH, V19, P10, DOI 10.1016/j.copbio.2007.11.003; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Suarez-Farinas M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-99; Suarez-Farinas Mayte, 2007, Methods Mol Biol, V377, P139; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; ZABA LC, 2010, J ALLERGY C IN PRESS; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	37	132	135	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2010	5	4							e10247	10.1371/journal.pone.0010247	http://dx.doi.org/10.1371/journal.pone.0010247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UH	20422035	Green Submitted, Green Published, gold			2022-12-27	WOS:000276854300011
J	Garcia-Nieto, S; Johal, RK; Shakesheff, KM; Emara, M; Royer, PJ; Chau, DYS; Shakib, F; Ghaemmaghami, AM				Garcia-Nieto, Samuel; Johal, Ramneek K.; Shakesheff, Kevin M.; Emara, Mohamed; Royer, Pierre-Joseph; Chau, David Y. S.; Shakib, Farouk; Ghaemmaghami, Amir M.			Laminin and Fibronectin Treatment Leads to Generation of Dendritic Cells with Superior Endocytic Capacity	PLOS ONE			English	Article							LYMPH-NODE; T-CELLS; ANTIGEN PRESENTATION; EXTRACELLULAR-MATRIX; PROTEOLYTIC ACTIVITY; MANNOSE RECEPTOR; INFORMATION; INTEGRINS; PROTEINS; ADHESION	Background: Sampling the microenvironment at sites of microbial exposure by dendritic cells ( DC) and their subsequent interaction with T cells in the paracortical area of lymph nodes are key events for initiating immune responses. Most of our knowledge of such events in human is based on in vitro studies performed in the absence of extracellular matrix (ECM) proteins. ECM in basement membranes and interstitial spaces of different tissues, including lymphoid organs, plays an important role in controlling specific cellular functions such as migration, intracellular signalling and differentiation. The aim of this study was, therefore, to investigate the impact of two abundant ECM components, fibronectin and laminin, on the phenotypical and functional properties of DC and how that might influence DC induced T-cell differentiation. Methodology/Principal Findings: Human monocyte derived DC were treated with laminin and fibronectin for up to 48 hours and their morphology and phenotype was analyzed using scanning electron microscopy, flow cytometry and real time PCR. The endocytic ability of DC was determined using flow cytometry. Furthermore, co-culture of DC and T cells were established and T cell proliferation and cytokine profile was measured using H-3-thymidine incorporation and ELISA respectively. Finally, we assessed formation of DC-T cell conjugates using different cell trackers and flow cytometry. Our data show that in the presence of ECM, DC maintain a 'more immature' phenotype and express higher levels of key endocytic receptors, and as a result become significantly better endocytic cells, but still fully able to mature in response to stimulation as evidenced by their superior ability to induce antigen-specific T cell differentiation. Conclusion: These studies underline the importance of including ECM components in in vitro studies investigating DC biology and DC-T cell interaction. Within the context of antigen specific DC induced T cell proliferation, inclusion of ECM proteins could lead to development of more sensitive assays.	[Garcia-Nieto, Samuel; Johal, Ramneek K.; Emara, Mohamed; Royer, Pierre-Joseph; Chau, David Y. S.; Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Allergy Res Grp, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Garcia-Nieto, Samuel; Johal, Ramneek K.; Emara, Mohamed; Royer, Pierre-Joseph; Chau, David Y. S.; Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Tissue Engn Grp, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Nottingham	Garcia-Nieto, S (corresponding author), Univ Nottingham, Allergy Res Grp, Sch Mol Med Sci, Nottingham NG7 2RD, England.	Amir.Ghaemmaghami@nottingham.ac.uk	Chau, David YS/U-2911-2019; Emara, Mohamed M./C-8220-2013; Shakesheff, Kevin M/O-6371-2018; Ghaemmaghami, Amir/AAP-2968-2020; Ghaemmaghami, Amir/S-2627-2019; Shakesheff, Kevin/AAR-6603-2021; Royer, Pierre-Joseph/D-4768-2015	Emara, Mohamed M./0000-0001-7708-9435; Shakesheff, Kevin M/0000-0003-3236-2439; Ghaemmaghami, Amir/0000-0003-3160-8759; Royer, Pierre-Joseph/0000-0001-5534-7982; Chau, David/0000-0001-9200-6749	UK Biotechnology and Biological Sciences Research Council [BB/F001142/1]; CONACYT-Mexico; BBSRC [BB/F001142/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F001142/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by a research grant from the UK Biotechnology and Biological Sciences Research Council (bbsrc.ac.uk) Grant Number BB/F001142/1. S.G.N. is a recipient of a CONACYT-Mexico PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CAS, 2006, INT IMMUNOL, V18, P1295, DOI 10.1093/intimm/dxl062; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Birdsall HH, 2005, J IMMUNOL, V175, P3347, DOI 10.4049/jimmunol.175.5.3347; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Ghaemmaghami AM, 2001, EUR J IMMUNOL, V31, P1211, DOI 10.1002/1521-4141(200104)31:4&lt;1211::AID-IMMU1211&gt;3.0.CO;2-R; Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048; Grashoff C, 2004, CURR OPIN CELL BIOL, V16, P565, DOI 10.1016/j.ceb.2004.07.004; Gretz JE, 1996, J IMMUNOL, V157, P495; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; HARA M, 1994, J CELL SCI, V107, P2739; HAYAKAWA M, 1988, ARCH HISTOL CYTOL, V51, P233, DOI 10.1679/aohc.51.233; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lauvau G, 2004, EUR J IMMUNOL, V34, P913, DOI 10.1002/eji.200424944; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sallusto F, 2002, ARTHRITIS RES THER, V4, pS127, DOI 10.1186/ar567; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Staquet MJ, 1997, J INVEST DERMATOL, V109, P738, DOI 10.1111/1523-1747.ep12340748; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Unsworth JM, 2003, J BIOMED MATER RES A, V66A, P425, DOI 10.1002/jbm.a.10592; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727	41	35	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10123	10.1371/journal.pone.0010123	http://dx.doi.org/10.1371/journal.pone.0010123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419094	Green Published, gold, Green Submitted			2022-12-27	WOS:000276853800006
J	Filippi, M; Ceccarelli, A; Pagani, E; Gatti, R; Rossi, A; Stefanelli, L; Falini, A; Comi, G; Rocca, MA				Filippi, Massimo; Ceccarelli, Antonia; Pagani, Elisabetta; Gatti, Roberto; Rossi, Alice; Stefanelli, Laura; Falini, Andrea; Comi, Giancarlo; Rocca, Maria Assunta			Motor Learning in Healthy Humans Is Associated to Gray Matter Changes: A Tensor-Based Morphometry Study	PLOS ONE			English	Article							BRAIN ABNORMALITIES; 3D PATTERN; PLASTICITY; NEUROGENESIS; CONTRACTION; PROGRESSION; MOVEMENT; STROKE; CORTEX; SKILLS	We used tensor-based morphometry (TBM) to: 1) map gray matter ( GM) volume changes associated with motor learning in young healthy individuals; 2) evaluate if GM changes persist three months after cessation of motor training; and 3) assess whether the use of different schemes of motor training during the learning phase could lead to volume modifications of specific GM structures. From 31 healthy subjects, motor functional assessment and brain 3D T1-weighted sequence were obtained: before motor training ( time 0), at the end of training ( two weeks) ( time 2), and three months later ( time 3). Fifteen subjects ( group A) were trained with goal-directed motor sequences, and 16 ( group B) with non purposeful motor actions of the right hand. At time 1 vs. time 0, the whole sample of subjects had GM volume increase in regions of the temporooccipital lobes, inferior parietal lobule (IPL) and middle frontal gyrus, while at time 2 vs. time 1, an increased GM volume in the middle temporal gyrus was seen. At time 1 vs. time 0, compared to group B, group A had a GM volume increase of the hippocampi, while the opposite comparison showed greater GM volume increase in the IPL and insula in group B vs. group A. Motor learning results in structural GM changes of different brain areas which are part of specific neuronal networks and tend to persist after training is stopped. The scheme applied during the learning phase influences the pattern of such structural changes.	[Filippi, Massimo; Ceccarelli, Antonia; Pagani, Elisabetta; Rocca, Maria Assunta] Ist Sci San Raffaele, Div Neurosci, Inst Expt Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy; [Filippi, Massimo; Ceccarelli, Antonia; Pagani, Elisabetta; Gatti, Roberto; Rossi, Alice; Stefanelli, Laura; Falini, Andrea; Comi, Giancarlo; Rocca, Maria Assunta] Univ Hosp San Raffaele, Milan, Italy; [Filippi, Massimo; Comi, Giancarlo; Rocca, Maria Assunta] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Gatti, Roberto; Rossi, Alice; Stefanelli, Laura] Ist Sci San Raffaele, Sch Physiotherapy, Lab Movement Anal, I-20132 Milan, Italy; [Falini, Andrea] Ist Sci San Raffaele, Dept Neuroradiol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Filippi, M (corresponding author), Ist Sci San Raffaele, Div Neurosci, Inst Expt Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy.	m.filippi@hsr.it	Filippi, Massimo/K-1755-2018; Rocca, Maria Assunta/K-1619-2018; ceccarelli, antonia/N-9563-2019; stefanelli, laura/AAA-8203-2020; Gatti, Roberto/J-6452-2018	Filippi, Massimo/0000-0002-5485-0479; Rocca, Maria Assunta/0000-0003-2358-4320; ceccarelli, antonia/0000-0002-1628-5667; Gatti, Roberto/0000-0002-4669-1287; falini, andrea/0000-0002-1461-8755; stefanelli, laura/0000-0002-3263-4791; Pagani, Elisabetta/0000-0002-1850-1175				Agosta F, 2009, AMYOTROPH LATERAL SC, V10, P168, DOI 10.1080/17482960802603841; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Ashburner J, 2000, HUM BRAIN MAPP, V9, P212, DOI 10.1002/(SICI)1097-0193(200004)9:4<212::AID-HBM3>3.0.CO;2-#; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brambati SM, 2009, NEUROBIOL AGING, V30, P103, DOI 10.1016/j.neurobiolaging.2007.05.014; Brambati SM, 2007, NEUROIMAGE, V35, P998, DOI 10.1016/j.neuroimage.2007.01.028; Ceccarelli A, 2009, NEUROIMAGE, V48, P585, DOI 10.1016/j.neuroimage.2009.07.009; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2008, CURR OPIN NEUROL, V21, P478, DOI 10.1097/WCO.0b013e328304b6a3; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Halsband U, 2006, J PHYSIOL-PARIS, V99, P414, DOI 10.1016/j.jphysparis.2006.03.007; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Lee AD, 2007, NEUROIMAGE, V34, P924, DOI 10.1016/j.neuroimage.2006.09.043; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Lepore N, 2006, LECT NOTES COMPUT SC, V4190, P191; Lepper M, 2008, ACTA PSYCHOL, V128, P139, DOI 10.1016/j.actpsy.2007.12.001; MANDELL RJ, 1984, AM J OCCUP THER, V38, P114, DOI 10.5014/ajot.38.2.114; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trombly CA, 1999, AM J OCCUP THER, V53, P333, DOI 10.5014/ajot.53.4.333; Tunik E, 2008, J NEUROSCI, V28, P13615, DOI 10.1523/JNEUROSCI.3303-08.2008; Wu CY, 2000, ARCH PHYS MED REHAB, V81, P95, DOI 10.1053/apmr.2000.0810095	36	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10198	10.1371/journal.pone.0010198	http://dx.doi.org/10.1371/journal.pone.0010198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419166	Green Published, gold, Green Submitted			2022-12-27	WOS:000276707100014
J	Ohnuki, S; Oka, S; Nogami, S; Ohya, Y				Ohnuki, Shinsuke; Oka, Satomi; Nogami, Satoru; Ohya, Yoshikazu			High-Content, Image-Based Screening for Drug Targets in Yeast	PLOS ONE			English	Article							MODE-OF-ACTION; RIBONUCLEOTIDE REDUCTASE; SACCHAROMYCES-CEREVISIAE; 1,3-BETA-D-GLUCAN SYNTHASE; GENE ONTOLOGY; V-ATPASES; H+-ATPASE; SUBUNIT; ENCODES; INHIBITION	Background: Drug discovery and development are predicated on elucidation of the potential mechanisms of action and cellular targets of candidate chemical compounds. Recent advances in high-content imaging techniques allow simultaneous analysis of a range of cellular events. In this study, we propose a novel strategy to identify drug targets by combining genetic screening and high-content imaging in yeast. Methodology: In this approach, we infer the cellular functions affected by candidate drugs by comparing morphologic changes induced by the compounds with the phenotypes of yeast mutants. Conclusions: Using this method and four well-characterized reagents, we successfully identified previously known target genes of the compounds as well as other genes involved with functionally related cellular pathways. This is the first demonstration of a genetic high-content assay that can be used to identify drug targets based on morphologic phenotypes of a reference mutant panel.	[Ohnuki, Shinsuke; Oka, Satomi; Nogami, Satoru; Ohya, Yoshikazu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan	University of Tokyo	Ohnuki, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan.	ohya@k.u-tokyo.ac.jp	Ohya, Yoshikazu/AAW-2200-2021; Nogami, Satoru/G-6061-2014	Ohya, Yoshikazu/0000-0003-0837-1239; Nogami, Satoru/0000-0002-4517-0180; Ohnuki, Shinsuke/0000-0001-6254-081X	Ministry of Education, Culture, Sports, Science and Technology of Japan [21310127]; New Energy and Industrial Technology Development Organization [P06008]; Japan Society for the Promotion of Science [209689]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 21310127, http://www.mext.go. jp/), and from the New Energy and Industrial Technology Development Organization (No. P06008, http://www.nedo.go.jp/), and from the Japan Society for the Promotion of Science (No. 209689, http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BASSON ME, 1986, P NATL ACAD SCI USA, V83, P5563, DOI 10.1073/pnas.83.15.5563; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CHANG CH, 1978, BIOCHEM PHARMACOL, V27, P2297, DOI 10.1016/0006-2952(78)90134-X; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; HANADA H, 1990, BIOCHEM BIOPH RES CO, V170, P873, DOI 10.1016/0006-291X(90)92172-V; HECTOR RF, 1993, CLIN MICROBIOL REV, V6, P1; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; INOUE SB, 1995, EUR J BIOCHEM, V231, P845, DOI 10.1111/j.1432-1033.1995.tb20770.x; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KINASHI H, 1981, TETRAHEDRON LETT, V22, P3857, DOI 10.1016/S0040-4039(01)91328-0; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; KRAKOFF IH, 1968, CANCER RES, V28, P1559; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Negishi T, 2009, J BIOTECHNOL, V141, P109, DOI 10.1016/j.jbiotec.2009.03.014; Ohnuki S, 2007, EUKARYOT CELL, V6, P817, DOI 10.1128/EC.00012-07; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; OKADA H, 2010, GENETICS IN PRESS; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; SAWISTOWSKASCHRODER ET, 1984, FEBS LETT, V173, P134, DOI 10.1016/0014-5793(84)81032-7; Stolz J, 1999, J BIOL CHEM, V274, P18747, DOI 10.1074/jbc.274.26.18747; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Vizeacoumar FJ, 2009, FEBS LETT, V583, P1656, DOI 10.1016/j.febslet.2009.03.068; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Wuster A, 2008, TRENDS BIOTECHNOL, V26, P252, DOI 10.1016/j.tibtech.2008.01.004	46	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10177	10.1371/journal.pone.0010177	http://dx.doi.org/10.1371/journal.pone.0010177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VA	20418956	Green Published, Green Submitted, gold			2022-12-27	WOS:000276706800017
J	Paulus, MP; Simmons, AN; Fitzpatrick, SN; Potterat, EG; Van Orden, KF; Bauman, J; Swain, JL				Paulus, Martin P.; Simmons, Alan N.; Fitzpatrick, Summer N.; Potterat, Eric G.; Van Orden, Karl F.; Bauman, James; Swain, Judith L.			Differential Brain Activation to Angry Faces by Elite Warfighters: Neural Processing Evidence for Enhanced Threat Detection	PLOS ONE			English	Article							AVERSIVE VISUAL-STIMULI; ANTERIOR CINGULATE; INSULA ACTIVATION; FUNCTIONAL NEUROANATOMY; ORBITOFRONTAL CORTEX; PREDICTION ERRORS; DECISION-MAKING; EMOTION; PERFORMANCE; STRESS	Background: Little is known about the neural basis of elite performers and their optimal performance in extreme environments. The purpose of this study was to examine brain processing differences between elite warfighters and comparison subjects in brain structures that are important for emotion processing and interoception. Methodology/Principal Findings: Navy Sea, Air, and Land Forces (SEALs) while off duty (n = 11) were compared with n = 23 healthy male volunteers while performing a simple emotion face-processing task during functional magnetic resonance imaging. Irrespective of the target emotion, elite warfighters relative to comparison subjects showed relatively greater right-sided insula, but attenuated left-sided insula, activation. Navy SEALs showed selectively greater activation to angry target faces relative to fearful or happy target faces bilaterally in the insula. This was not accounted for by contrasting positive versus negative emotions. Finally, these individuals also showed slower response latencies to fearful and happy target faces than did comparison subjects. Conclusions/Significance: These findings support the hypothesis that elite warfighters deploy greater processing resources toward potential threat-related facial expressions and reduced processing resources to non-threat-related facial expressions. Moreover, rather than expending more effort in general, elite warfighters show more focused neural and performance tuning. In other words, greater neural processing resources are directed toward threat stimuli and processing resources are conserved when facing a nonthreat stimulus situation.	[Paulus, Martin P.; Simmons, Alan N.; Fitzpatrick, Summer N.; Swain, Judith L.] Univ Calif San Diego, San Diego, CA 92103 USA; [Van Orden, Karl F.] Naval Hlth Res Ctr, San Diego, CA USA; [Bauman, James] US Olymp Training Ctr, Chula Vista, CA USA; [Potterat, Eric G.] Naval Special Warfare Ctr, San Diego, CA USA; [Paulus, Martin P.; Potterat, Eric G.; Van Orden, Karl F.; Bauman, James; Swain, Judith L.] OptiBrain Consortium, San Diego, CA USA; [Swain, Judith L.] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Swain, Judith L.] Natl Univ Singapore, Singapore 117548, Singapore	University of California System; University of California San Diego; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Paulus, MP (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.	mpaulus@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112	VA Center of Excellence for Stress and Mental Health (CESAMH); Department of Veterans Affairs	VA Center of Excellence for Stress and Mental Health (CESAMH); Department of Veterans Affairs(US Department of Veterans Affairs)	Some of this work was supported by the VA Center of Excellence for Stress and Mental Health (CESAMH), which is supported by Department of Veterans Affairs. CESAMH is affiliated with VISN 22, the Veterans Affairs San Diego Healthcare System, and the University of California, San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Augustine J R, 1985, Neurol Res, V7, P2; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Banzett RB, 2000, NEUROREPORT, V11, P2117, DOI 10.1097/00001756-200007140-00012; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chikama M, 1997, J NEUROSCI, V17, P9686; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Committee on Opportunities in Neuroscience for Future Army Applications N. R., 2009, OPP NEUR FUT ARM APP; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig A. D., 2007, HDB EMOTIONS, P272; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; DAVENPORT PW, 2008, RESP PHYSL NEUROBIOL; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Eddy WF, 1996, MAGNET RESON MED, V36, P923, DOI 10.1002/mrm.1910360615; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Feinle C, 1998, DEUT TIERARZTL WOCH, V105, P441; First M.B., 2016, STRUCTURED CLIN INTE; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Fudge JL, 2005, J COMP NEUROL, V490, P101, DOI 10.1002/cne.20660; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; HAXBY JV, 2000, TRENDS COGN IN PRESS; Huettel SA, 2004, BRAIN RES, V1000, P78, DOI 10.1016/j.brainres.2003.11.041; Jasmin L, 2004, J COMP NEUROL, V468, P425, DOI 10.1002/cne.10978; Johnstone T, 2005, NEUROIMAGE, V25, P1112, DOI 10.1016/j.neuroimage.2004.12.016; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LAHUERTA J, 1990, PAIN, V42, P23, DOI 10.1016/0304-3959(90)91087-Y; LAMOTTE RH, 1982, J NEUROSCI, V2, P765; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9; Light AR, 2003, J COMP NEUROL, V461, P137, DOI 10.1002/cne.10691; Morgan CA, 2007, PSYCHOPHYSIOLOGY, V44, P120, DOI 10.1111/j.1469-8986.2006.00475.x; Norusis M.J., 1990, SPSS BASE SYSTEM USE; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2009, NEUROSCI BIOBEHAV R, V33, P1080, DOI 10.1016/j.neubiorev.2009.05.003; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; Robinson SK, 2005, PSYCHOSOM MED, V67, P981, DOI 10.1097/01.psy.0000188479.04891.74; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schmelz M, 1997, J NEUROSCI, V17, P8003; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shipp S, 2005, PHILOS T R SOC B, V360, P797, DOI 10.1098/rstb.2005.1630; Simmons A, 2004, NEUROREPORT, V15, P2261, DOI 10.1097/00001756-200410050-00024; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; TAYLOR M, 2007, 0710 HLTH RES CTR; Taylor M.K., 2006, 0637 NAV HLTH RES CT; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Vaitl D, 1996, BIOL PSYCHOL, V42, P1, DOI 10.1016/0301-0511(95)05144-9; VALLBO AB, 1995, J PHYSIOL-LONDON, V483, P783, DOI 10.1113/jphysiol.1995.sp020622; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Yaguez L, 2005, GASTROENTEROLOGY, V128, P1819, DOI 10.1053/j.gastro.2005.02.068	73	32	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2010	5	4							e10096	10.1371/journal.pone.0010096	http://dx.doi.org/10.1371/journal.pone.0010096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583VA	20418943	Green Submitted, gold, Green Published			2022-12-27	WOS:000276706800007
J	Dirks, RP; van Geel, R; Hensen, SMM; van Genesen, ST; Lubsen, NH				Dirks, Ron P.; van Geel, Remon; Hensen, Sanne M. M.; van Genesen, Siebe T.; Lubsen, Nicolette H.			Manipulating Heat Shock Factor-1 in Xenopus Tadpoles: Neuronal Tissues Are Refractory to Exogenous Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-1; HSF1; PROTEIN; CELLS; EMBRYOS; MICE; STRESS; VECTOR; LAEVIS; GENE	Background: The aging related decline of heat shock factor-1 (HSF1) signaling may be causally related to protein aggregation diseases. To model such disease, we tried to cripple HSF1 signaling in the Xenopus tadpole. Results: Over-expression of heat shock factor binding protein-1 did not inhibit the heat shock response in Xenopus. RNAi against HSF1 mRNA inhibited the heat shock response by 70% in Xenopus A6 cells, but failed in transgenic tadpoles. Expression of XHSF380, a dominant-negative HSF1 mutant, was embryonic lethal, which could be circumvented by delaying expression via a tetracycline inducible promoter. HSF1 signaling is thus essential for embryonic Xenopus development. Surprisingly, transgenic expression of the XHSF380 or of full length HSF1, whether driven by a ubiquitous or a neural specific promoter, was not detectable in the larval brain. Conclusions: Our finding that the majority of neurons, which have little endogenous HSF1, refused to accept transgene-driven expression of HSF1 or its mutant suggests that HSF1 levels are strictly controlled in neuronal tissue.	[Dirks, Ron P.; van Geel, Remon; Hensen, Sanne M. M.; van Genesen, Siebe T.; Lubsen, Nicolette H.] Radboud Univ Nijmegen, Dept Biomol Chem, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Dirks, RP (corresponding author), ZF Screens BV, Leiden, Netherlands.	n.lubsen@science.ru.nl	Lubsen, Nicolette H./B-8426-2011		Senter IOP Genomics programme [IGE03018]	Senter IOP Genomics programme	Senter IOP Genomics programme, grant nr. IGE03018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Das B, 2004, P NATL ACAD SCI USA, V101, P4839, DOI 10.1073/pnas.0401011101; Dirks Ron P. H., 2003, Current Genomics, V4, P699, DOI 10.2174/1389202033490132; Doerwald L, 2003, J BIOL CHEM, V278, P49743, DOI 10.1074/jbc.M302914200; Evans TG, 2007, COMP BIOCHEM PHYS A, V146, P131, DOI 10.1016/j.cbpa.2006.09.023; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Izu H, 2004, BIOL REPROD, V70, P18, DOI 10.1095/biolreprod.103.020065; JOHNSON AD, 1994, GENE, V147, P223, DOI 10.1016/0378-1119(94)90070-1; Jurivich DA, 2005, EXP GERONTOL, V40, P948, DOI 10.1016/j.exger.2005.08.003; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Li M, 2006, CELL RES, V16, P99, DOI 10.1038/sj.cr.7310013; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Santos SD, 2004, NEUROSCIENCE, V126, P657, DOI 10.1016/j.neuroscience.2004.03.023; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tai LJ, 2002, J BIOL CHEM, V277, P735, DOI 10.1074/jbc.M108604200; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Tuttle AM, 2007, COMP BIOCHEM PHYS A, V147, P112, DOI 10.1016/j.cbpa.2006.12.003; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voellmy R, 2005, METHODS, V35, P199, DOI 10.1016/j.ymeth.2004.08.010; Wang GH, 2001, GENESIS, V30, P195, DOI 10.1002/gene.1064; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232	34	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10158	10.1371/journal.pone.0010158	http://dx.doi.org/10.1371/journal.pone.0010158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405018	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706300014
J	Hadwiger, G; Dour, S; Arur, S; Fox, P; Nonet, ML				Hadwiger, Gayla; Dour, Scott; Arur, Swathi; Fox, Paul; Nonet, Michael L.			A Monoclonal Antibody Toolkit for C. elegans	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; CAENORHABDITIS-ELEGANS; NUCLEAR-LOCALIZATION; FUNCTIONAL-ANALYSIS; GENETIC-ANALYSIS; L1CAM HOMOLOG; IN-VIVO; PROTEIN; IDENTIFICATION; DYNAMIN	Background: Antibodies are critical tools in many avenues of biological research. Though antibodies can be produced in the research laboratory setting, most research labs working with vertebrates avail themselves of the wide array of commercially available reagents. By contrast, few such reagents are available for work with model organisms. Methodology/Principal Findings: We report the production of monoclonal antibodies directed against a wide range of proteins that label specific subcellular and cellular components, and macromolecular complexes. Antibodies were made to synaptobrevin (SNB-1), a component of synaptic vesicles; to Rim (UNC-10), a protein localized to synaptic active zones; to transforming acidic coiled-coil protein (TAC-1), a component of centrosomes; to CENP-C (HCP-4), which in worms labels the entire length of their holocentric chromosomes; to ORC2 (ORC-2), a subunit of the DNA origin replication complex; to the nucleolar phosphoprotein NOPP140 (DAO-5); to the nuclear envelope protein lamin (LMN-1); to EHD1 (RME-1) a marker for recycling endosomes; to caveolin (CAV-1), a marker for caveolae; to the cytochrome P450 (CYP-33E1), a resident of the endoplasmic reticulum; to beta-1,3-glucuronyltransferase (SQV-8) that labels the Golgi; to a chaperonin (HSP-60) targeted to mitochondria; to LAMP (LMP-1), a resident protein of lysosomes; to the alpha subunit of the 20S subcomplex (PAS-7) of the 26S proteasome; to dynamin (DYN-1) and to the alpha-subunit of the adaptor complex 2 (APA-2) as markers for sites of clathrin-mediated endocytosis; to the MAGUK, protein disks large (DLG-1) and cadherin (HMR-1), both of which label adherens junctions; to a cytoskeletal linker of the ezrin-radixin-moesin family (ERM-1), which localized to apical membranes; to an ERBIN family protein (LET-413) which localizes to the basolateral membrane of epithelial cells and to an adhesion molecule (SAX-7) which localizes to the plasma membrane at cell-cell contacts. In addition to working in whole mount immunocytochemistry, most of these antibodies work on western blots and thus should be of use for biochemical fractionation studies. Conclusions/Significance: We have produced a set of monoclonal antibodies to subcellular components of the nematode C. elegans for the research community. These reagents are being made available through the Developmental Studies Hybridoma Bank (DSHB).	[Hadwiger, Gayla; Dour, Scott; Nonet, Michael L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Arur, Swathi; Fox, Paul] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hadwiger, G (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	nonetm@pcg.wustl.edu		Fox, Paul/0000-0002-5626-9637	National Center for Research Resources [R24 RR022234]; NIH [R01 GM63310, GM085150]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR022234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063310, R01GM085150] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was funded primarily by award number R24 RR022234 from the National Center for Research Resources. Work by S. A. and P. F. was conducted in Tim Schedl's laboratory under NIH R01 GM63310 and GM085150. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; Aono S, 2004, DEVELOPMENT, V131, P2865, DOI 10.1242/dev.01146; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Broadbent ID, 2002, CURR BIOL, V12, P59, DOI 10.1016/S0960-9822(01)00624-8; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; CAIRNS C, 1995, J CELL SCI, V108, P3339; Chakrapani BPS, 2008, J BIOSCIENCES, V33, P269, DOI 10.1007/s12038-008-0044-5; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Han SM, 2006, DEVELOPMENT, V133, P3597, DOI 10.1242/dev.02534; Hao W, 2008, CLIN VACCINE IMMUNOL, V15, P194, DOI 10.1128/CVI.00362-07; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; Inoue T, 2007, VET PARASITOL, V146, P281, DOI 10.1016/j.vetpar.2007.02.028; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Kelly S, 2006, EUKARYOT CELL, V5, P876, DOI 10.1128/EC.5.5.876-879.2006; Kostich M, 2000, J CELL SCI, V113, P2595; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Labrousse AM, 1998, MOL BIOL CELL, V9, P3227, DOI 10.1091/mbc.9.11.3227; Ladurner P, 2005, HISTOCHEM CELL BIOL, V123, P89, DOI 10.1007/s00418-004-0722-9; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; McCain J, 2006, CELL TISSUE RES, V323, P105, DOI 10.1007/s00441-005-0044-9; McMahon L, 2001, J CELL SCI, V114, P2265; Meier UT, 1996, J BIOL CHEM, V271, P19376; MEIER UT, 1990, J CELL BIOL, V111, P2235, DOI 10.1083/jcb.111.6.2235; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Moore LL, 1999, J CELL BIOL, V147, P471, DOI 10.1083/jcb.147.3.471; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; NEVESCARVALHO A, 2009, BIOCH BIOPHYS RES CO; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; Nunes F, 2005, BIOCHEM BIOPH RES CO, V338, P862, DOI 10.1016/j.bbrc.2005.10.023; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ono K, 2006, MOL BIOL CELL, V17, P2722, DOI 10.1091/mbc.E06-02-0114; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Parker Scott, 2007, Invertebrate Neuroscience, V7, P157, DOI 10.1007/s10158-007-0051-5; Parker S, 2009, MOL BIOL CELL, V20, P1763, DOI 10.1091/mbc.E08-08-0837; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Sasakura H, 2005, EMBO J, V24, P1477, DOI 10.1038/sj.emboj.7600621; Schaffer U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1178; Scheel J, 1999, NAT CELL BIOL, V1, P127, DOI 10.1038/10100; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schuske K, 2007, NAT NEUROSCI, V10, P846, DOI 10.1038/nn1920; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Shim J, 2000, MOL CELLS, V10, P309; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Takeda K, 2008, GENES CELLS, V13, P653, DOI 10.1111/j.1365-2443.2008.01195.x; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; van Furden D, 2004, DEV BIOL, V272, P262, DOI 10.1016/j.ydbio.2004.05.012; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Waggener JM, 2002, MOL BIOL CELL, V13, P362, DOI 10.1091/mbc.01-04-0162; Wang XL, 2005, DEV BIOL, V284, P273, DOI 10.1016/j.ydbio.2005.05.020; WARD S, 1986, J CELL BIOL, V102, P1778, DOI 10.1083/jcb.102.5.1778; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Zhou S, 2008, GENETICS, V180, P1429, DOI 10.1534/genetics.108.091272	86	63	84	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10161	10.1371/journal.pone.0010161	http://dx.doi.org/10.1371/journal.pone.0010161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405020	Green Published, gold, Green Submitted			2022-12-27	WOS:000276706300016
J	Sampaio, P; Santos, M; Correia, A; Amaral, FE; Chavez-Galarza, J; Costa-de-Oliveira, S; Castro, AG; Pedrosa, J; Pais, C				Sampaio, Paula; Santos, Marlene; Correia, Alexandra; Amaral, Fabio E.; Chavez-Galarza, Julio; Costa-de-Oliveira, Sofia; Castro, Antonio G.; Pedrosa, Jorge; Pais, Celia			Virulence Attenuation of Candida albicans Genetic Variants Isolated from a Patient with a Recurrent Bloodstream Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IN-VITRO MODEL; TRANSCRIPTIONAL RESPONSE; INCREASED SUSCEPTIBILITY; INTERFERON-GAMMA; DEFICIENT MICE; HOST-DEFENSE; G-CSF; STRAIN; IMMUNITY	The incidence of Candida albicans infections and the relapse episodes after antifungal treatment have increased in recent decades. Recurrences are mainly due to the persistence of the original infecting strain that may present genetic and genomic rearrangements during interaction with the host, reflecting strain adaptation. In this study, four isolates recovered from a patient during recurrent candidemia episodes were genotyped by microsatellite length polymorphism (MLP) and by multilocus sequence typing (MLST) and found to be genetic variants of the same strain. Using experimental mouse infections, a progressive reduction in the virulence of the four isolates was observed, with the first two isolates more virulent than the third and fourth. Additionally, in the mouse model, the first isolate resisted host control more efficiently, resulting in higher kidney fungal burdens and necrosis as compared to the third isolate. The resolution of inflammation was delayed in mice challenged with the first isolate and the message for IFN-gamma and TNF-alpha in the spleen was lower within the first few hours post-infection. Original and recurrent isolates also displayed different phenotypes regarding activity of secreted enzymes and response to stress agents. Overall, the comparative analysis indicated that the virulence decrease of these isolates was related to a lower ability to resist to the host anticandida effector mechanisms. We showed for the first time that C. albicans genetic variants of the same strain, sequentially isolated from an immunocompromised patient, underwent adaptations in the human host that resulted in virulence attenuation when tested in mice.	[Sampaio, Paula; Santos, Marlene; Correia, Alexandra; Chavez-Galarza, Julio; Pais, Celia] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Amaral, Fabio E.; Castro, Antonio G.; Pedrosa, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Chavez-Galarza, Julio] Univ Nacl Trujillo, Fac Ciencias Biol, Trujillo, Peru; [Costa-de-Oliveira, Sofia] Univ Porto, Fac Med Porto, Dept Microbiol, P-4100 Oporto, Portugal	Universidade do Minho; Universidade do Minho; Universidad Nacional de Trujillo; Universidade do Porto	Sampaio, P (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	cpais@bio.uminho.pt	Sampaio, Paula/I-7566-2015; Castro, António/F-5863-2011; Correia, Alexandra/AID-6313-2022; Santos, Marlene/GZN-2124-2022; Correia, Alexandra/J-7926-2013; Oliveira, Sofia/K-2156-2013; Pais, Célia/A-9186-2010; Castro, Gil/T-7584-2018; Pedrosa, Jorge/H-4877-2011	Sampaio, Paula/0000-0002-1415-4428; Castro, António/0000-0002-4684-4183; Correia, Alexandra/0000-0003-0408-6262; Santos, Marlene/0000-0001-5020-5942; Correia, Alexandra/0000-0003-0408-6262; Oliveira, Sofia/0000-0003-2899-6615; Pais, Célia/0000-0001-5959-290X; Castro, Gil/0000-0002-4684-4183; Pedrosa, Jorge/0000-0002-8204-4888; Amaral, Fabio/0000-0002-1547-8213; Chavez Galarza, Julio Cesar/0000-0002-8899-2862	Fundacao para a Ciencia e Tecnologia (FCT) [POCI/SAU-IMI/58014/2004]; Health Services of Fundacao Calouste Gulbenkian; ALbAN scholarship [E06M103915PE];  [SFRH/BD/31354/2006]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Health Services of Fundacao Calouste Gulbenkian; ALbAN scholarship; 	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT) through the project POCI/SAU-IMI/58014/2004 and by a Grant from the Health Services of Fundacao Calouste Gulbenkian. Julio Chavez-Galarza was supported by an ALbAN scholarship (N<SUP>o</SUP> E06M103915PE), and Alexandra Correia by SFRH/BD/31354/2006 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bartie KL, 2004, ORAL MICROBIOL IMMUN, V19, P293, DOI 10.1111/j.1399-302X.2004.00155.x; Basu S, 2000, BLOOD, V95, P3725; BISTONI F, 1985, ANTIMICROB AGENTS CH, V27, P625, DOI 10.1128/AAC.27.4.625; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Botelho AS, 2007, EXP PARASITOL, V115, P68, DOI 10.1016/j.exppara.2006.06.004; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bretagne S, 1997, J CLIN MICROBIOL, V35, P1777, DOI 10.1128/JCM.35.7.1777-1780.1997; Calera JA, 1999, INFECT IMMUN, V67, P4280, DOI 10.1128/IAI.67.8.4280-4284.1999; Campos PRA, 2009, EVOLUTION, V63, P950, DOI 10.1111/j.1558-5646.2008.00595.x; CENCI E, 1995, J INFECT DIS, V171, P1279, DOI 10.1093/infdis/171.5.1279; Cheng SJ, 2007, CELL MICROBIOL, V9, P492, DOI 10.1111/j.1462-5822.2006.00805.x; Diogo D, 2009, FUNGAL GENET BIOL, V46, P159, DOI 10.1016/j.fgb.2008.11.005; DJEU JY, 1986, J IMMUNOL, V137, P2980; DJEU JY, 1990, DIAGN MICR INFEC DIS, V13, P383, DOI 10.1016/0732-8893(90)90007-I; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Hu Y, 2006, MICROBES INFECT, V8, P612, DOI 10.1016/j.micinf.2005.08.011; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Jacobsen MD, 2008, FEMS YEAST RES, V8, P1334, DOI 10.1111/j.1567-1364.2008.00438.x; Kaposzta R, 1998, INFECT IMMUN, V66, P1708; Kretschmar M, 1999, INFECT IMMUN, V67, P6637; KULLBERG BJ, 1993, J INFECT DIS, V168, P436, DOI 10.1093/infdis/168.2.436; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lavigne LM, 1998, J IMMUNOL, V160, P284; Leigh JE, 1998, J ACQ IMMUN DEF SYND, V19, P373, DOI 10.1097/00042560-199812010-00008; Leigh JE, 2002, ORAL MICROBIOL IMMUN, V17, P311, DOI 10.1034/j.1399-302X.2002.170508.x; LOCKHART SR, 1995, J CLIN MICROBIOL, V33, P1501, DOI 10.1128/JCM.33.6.1501-1509.1995; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Mansour MK, 2002, CURR OPIN MICROBIOL, V5, P359, DOI 10.1016/S1369-5274(02)00342-9; Mencacci A, 1998, INT IMMUNOL, V10, P37, DOI 10.1093/intimm/10.1.37; Monod M, 1998, MICROBIOL-UK, V144, P2731, DOI 10.1099/00221287-144-10-2731; Mullaly SC, 2007, EUR J IMMUNOL, V37, P224, DOI 10.1002/eji.200636405; Murciano C, 2006, MED MYCOL, V44, P149, DOI 10.1080/13693780500294733; Netea MG, 1999, J IMMUNOL, V163, P1498; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; Oliveira MS, 2005, INFECT IMMUN, V73, P6299, DOI 10.1128/IAI.73.10.6299-6310.2005; Ortega E, 2005, EUR J APPL PHYSIOL, V93, P714, DOI 10.1007/s00421-004-1245-8; Pappas PG, 2006, INFECT DIS CLIN N AM, V20, P485, DOI 10.1016/j.idc.2006.07.004; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pirofski LA, 2009, J EXP MED, V206, P269, DOI 10.1084/jem.20090093; Richardson M, 2009, FRONT BIOSCI-LANDMRK, V14, P4363, DOI 10.2741/3533; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Romani L, 2003, CURR OPIN MICROBIOL, V6, P338, DOI 10.1016/S1369-5274(03)00081-X; Romani L, 2000, J LEUKOCYTE BIOL, V68, P175; Romani Luigina, 2004, Nat Rev Immunol, V4, P1, DOI 10.1038/nri2939; Rozell B, 2006, CURR DRUG TARGETS, V7, P483, DOI 10.2174/138945006776359449; SAMARANAYAKE LP, 1984, SABOURAUDIA, V22, P201; Sampaio P, 2005, J CLIN MICROBIOL, V43, P3869, DOI 10.1128/JCM.43.8.3869-3876.2005; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Shin JH, 2004, J CLIN MICROBIOL, V42, P4025, DOI 10.1128/JCM.42.9.4025-4031.2004; Shin YK, 2005, MOL CELLS, V20, P271; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavanti A, 2004, J CLIN MICROBIOL, V42, P4726, DOI 10.1128/JCM.42.10.4726-4734.2004; Tavares D, 2003, MICROBIOL-SGM, V149, P333, DOI 10.1099/mic.0.25915-0; Terron MP, 2004, J COMP PHYSIOL B, V174, P421, DOI 10.1007/s00360-004-0429-1; Thewes S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-187; Zhang HH, 2007, J LEUKOCYTE BIOL, V82, P915, DOI 10.1189/jlb.0107023	64	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2010	5	4							e10155	10.1371/journal.pone.0010155	http://dx.doi.org/10.1371/journal.pone.0010155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UV	20405013	Green Submitted, Green Published, gold			2022-12-27	WOS:000276706300011
J	Li, N; Thompson, S; Schultz, DC; Zhu, WL; Jiang, HL; Luo, C; Lieberman, PM				Li, Ning; Thompson, Scott; Schultz, David C.; Zhu, Weiliang; Jiang, Hualiang; Luo, Cheng; Lieberman, Paul M.			Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; ORIGIN-BINDING PROTEIN; SMALL-MOLECULE INHIBITORS; EBV NUCLEAR ANTIGEN-1; DNA-BINDING; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; REPLICATION; DOCKING; DATABASE	Background: Epstein-Barr Virus (EBV) latent infection is associated with several human malignancies and is a causal agent of lymphoproliferative diseases during immunosuppression. While inhibitors of herpesvirus DNA polymerases, like gancyclovir, reduce EBV lytic cycle infection, these treatments have limited efficacy for treating latent infection. EBNA1 is an EBV-encoded DNA-binding protein required for viral genome maintenance during latent infection. Methodology: Here, we report the identification of a new class of small molecules that inhibit EBNA1 DNA binding activity. These compounds were identified by virtual screening of 90,000 low molecular mass compounds using computational docking programs with the solved crystal structure of EBNA1. Four structurally related compounds were found to inhibit EBNA1-DNA binding in biochemical assays with purified EBNA1 protein. Compounds had a range of 20-100 mM inhibition of EBNA1 in fluorescence polarization assays and were further validated for inhibition using electrophoresis mobility shift assays. These compounds exhibited no significant inhibition of an unrelated DNA binding protein. Three of these compounds inhibited EBNA1 transcription activation function in cell-based assays and reduced EBV genome copy number when incubated with a Burkitt lymphoma cell line. Conclusions: These experiments provide a proof-of-principle that virtual screening can be used to identify specific inhibitors of EBNA1 that may have potential for treatment of EBV latent infection.	[Li, Ning; Zhu, Weiliang; Jiang, Hualiang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Thompson, Scott; Schultz, David C.; Lieberman, Paul M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; The Wistar Institute	Li, N (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	cluo@mail.shcnc.ac.cn; lieberman@wistar.org		Thompson, Scott/0000-0001-8270-1983	NIH [R01CA093606, R21NS063906]; National Natural Science Foundation of China [20972174]; Shanghai Committee of Science and Technologyy [10410703900, 08431900800]; State Key Program of Basic Research of China [2009CB918502]; NATIONAL CANCER INSTITUTE [R01CA093606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063906] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technologyy; State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by grants from NIH (R01CA093606 and R21NS063906) to PML and the National Natural Science Foundation of China (20972174), Shanghai Committee of Science and Technologyy grant (10410703900 and 08431900800) and the State Key Program of Basic Research of China grant (2009CB918502) to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; AMBINDER RF, 1990, J VIROL, V64, P2369, DOI 10.1128/JVI.64.5.2369-2379.1990; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; Bochkarev A, 1998, J MOL BIOL, V284, P1273, DOI 10.1006/jmbi.1998.2247; Bowser TE, 2007, BIOORG MED CHEM LETT, V17, P5652, DOI 10.1016/j.bmcl.2007.07.072; Ewing TJA, 1997, J COMPUT CHEM, V18, P1175, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO;2-O; Garber AC, 2002, J BIOL CHEM, V277, P27401, DOI 10.1074/jbc.M203489200; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; KENNEDY G, 2003, P NATL ACAD SCI US; Kieff E., 2007, FIELDS VIROLOGY; Kiessling A, 2006, CHEM BIOL, V13, P745, DOI 10.1016/j.chembiol.2006.05.011; KUNTZ ID, 1994, ACCOUNTS CHEM RES, V27, P117, DOI 10.1021/ar00041a001; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORRIS GM, 1999, AUTODOCK VERSION 3 0; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; Rickinson A., 2007, EPSTEIN BARR VIRUS; Rishi V, 2005, ANAL BIOCHEM, V340, P259, DOI 10.1016/j.ab.2005.02.012; Schnecke V, 1998, PROTEINS, V33, P74, DOI 10.1002/(SICI)1097-0134(19981001)33:1<74::AID-PROT7>3.0.CO;2-L; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Vangrevelinghe E, 2003, J MED CHEM, V46, P2656, DOI 10.1021/jm030827e; Wang JD, 2006, MOL CELL BIOL, V26, P1124, DOI 10.1128/MCB.26.3.1124-1134.2006; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yin QY, 2006, VIROLOGY, V346, P385, DOI 10.1016/j.virol.2005.11.021; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zavodszky MI, 2002, J COMPUT AID MOL DES, V16, P883, DOI 10.1023/A:1023866311551; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609	33	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2010	5	4							e10126	10.1371/journal.pone.0010126	http://dx.doi.org/10.1371/journal.pone.0010126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UR	20405039	Green Published, gold			2022-12-27	WOS:000276705900010
J	Tan, JL; Peng, X; Luo, GX; Ma, B; Cao, C; He, WF; Yuan, SZ; Li, SR; Wilkins, JA; Wu, J				Tan, Jianglin; Peng, Xu; Luo, Gaoxing; Ma, Bing; Cao, Chuan; He, Weifeng; Yuan, Shunzong; Li, Shirong; Wilkins, John A.; Wu, Jun			Investigating the Role of P311 in the Hypertrophic Scar	PLOS ONE			English	Article							MYOFIBROBLAST PHENOTYPE; GRANULATION-TISSUE; WOUND CONTRACTION; FIBROBLASTS; EXPRESSION; PROLIFERATION; REGENERATION; MECHANISMS; GROWTH; HIC-5	The mechanisms of hypertrophic scar formation are not fully understood. We previously screened the differentially expressed genes of human hypertrophic scar tissue and identified P311 gene as upregulated. As the activities of P311 in human fibroblast function are unknown, we examined the distribution of it and the effects of forced expression or silencing of expression of P311. P311 expression was detected in fibroblast-like cells from the hypertrophic scar of burn injury patients but not in peripheral blood mononuclear cells, bone marrow mesenchymal stem cells, epidermal cells or normal skin dermal cells. Transfection of fibroblasts with P311 gene stimulated the expression of alpha-smooth muscle actin (alpha-SMA), TGF-beta 1 and alpha 1(I) collagen (COL1A1), and enhanced the contraction of fibroblast populated collagen lattices (FPCL). In contrast, interference of fibroblast P311 gene expression decreased the TGF-beta 1 mRNA expression and reduced the contraction of fibroblasts in FPCL. These results suggest that P311 may be involved in the pathogenesis of hypertrophic scar via induction of a myofibroblastic phenotype and of functions such as TGF-beta 1 expression. P311 could be a novel target for the control of hypertrophic scar development.	[Tan, Jianglin; Peng, Xu; Luo, Gaoxing; He, Weifeng; Yuan, Shunzong; Wu, Jun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Luo, Gaoxing; He, Weifeng; Wu, Jun] Chongqing Key Lab Dis Prote, Chongqing, Peoples R China; [Ma, Bing] Chengdu Med Coll, Affiliated Hosp 1, Dept Plast Surg, Chengdu, Sichuan Prov, Peoples R China; [Cao, Chuan; Li, Shirong] Third Mil Med Univ, Dept Plast Surg, Southwest Hosp, Chongqing, Peoples R China; [Wilkins, John A.] Univ Manitoba, Dept Internal Med, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada	Army Medical University; Chengdu Medical College; Army Medical University; University of Manitoba	Tan, JL (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	dmabing@hotmail.com; junwupro1@yahoo.com.cn	Yuan, Shunzong/AAO-3551-2020; Gaoxing, LUO/AAE-4505-2020	LUO, Gaoxing/0000-0003-4764-3209	NSFC [30872695, 30672174]; 863 project in China [2006AA02A121]; State Key Lab Funding in China [SKLZZ200808, SKLZZ200820]	NSFC(National Natural Science Foundation of China (NSFC)); 863 project in China(National High Technology Research and Development Program of China); State Key Lab Funding in China	This work was supported by NSFC (No: 30872695 and 30672174), and partly by "863" project in China (2006AA02A121), by State Key Lab Funding in China (SKLZZ200808 to J. W., SKLZZ200820 to G. L.). The relevant grant number is 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baryza Mary Jo, 1995, Journal of Burn Care and Rehabilitation, V16, P535, DOI 10.1097/00004630-199509000-00013; Brown JJ, 2009, BRIT J DERMATOL, V161, P8, DOI 10.1111/j.1365-2133.2009.09258.x; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; Ramos MLC, 2008, J BURN CARE RES, V29, P363, DOI 10.1097/BCR.0b013e3181667557; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; English RS, 1999, DERMATOL SURG, V25, P631, DOI 10.1046/j.1524-4725.1999.98257.x; Fujitani M, 2004, J NEUROCHEM, V91, P737, DOI 10.1111/j.1471-4159.2004.02738.x; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Li FF, 2009, BIOCHEM BIOPH RES CO, V382, P259, DOI 10.1016/j.bbrc.2009.02.165; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mutalik Sharad, 2005, Indian J Dermatol Venereol Leprol, V71, P3; Pan DS, 2002, J CLIN INVEST, V110, P1349, DOI 10.1172/JCI200215614; Phan TT, 2003, J TRAUMA, V54, P1212, DOI 10.1097/01.TA.0000030630.72836.32; Shin DM, 2004, PLAST RECONSTR SURG, V113, P633, DOI 10.1097/01.PRS.0000101530.33096.5B; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Taylor GA, 2000, J BIOL CHEM, V275, P4215, DOI 10.1074/jbc.275.6.4215; Taylor GA, 2008, GENES BRAIN BEHAV, V7, P786, DOI 10.1111/j.1601-183X.2008.00420.x; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Wu J, 2004, J TRAUMA, V57, P1276, DOI 10.1097/01.TA.0000108997.49513.DC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	25	48	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e9995	10.1371/journal.pone.0009995	http://dx.doi.org/10.1371/journal.pone.0009995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404911	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482100002
J	Odgren, PR; Pratt, CH; MacKay, CA; Mason-Savas, A; Curtain, M; Shopland, L; Ichicki, T; Sundberg, JP; Donahue, LR				Odgren, Paul R.; Pratt, Craig H.; MacKay, Carole A.; Mason-Savas, April; Curtain, Michelle; Shopland, Lindsay; Ichicki, Tsutomu; Sundberg, John P.; Donahue, Leah Rae			Disheveled Hair and Ear (Dhe), a Spontaneous Mouse Lmna Mutation Modeling Human Laminopathies	PLOS ONE			English	Article							LINKAGE TESTING STOCK; A-TYPE LAMINS; NUCLEAR-ENVELOPE; RESTRICTIVE DERMOPATHY; MUSCULAR-DYSTROPHY; IN-VITRO; EXPRESSION; PROTEINS; MICE; RAT	Background: Investigations of naturally-occurring mutations in animal models provide important insights and valuable disease models. Lamins A and C, along with lamin B, are type V intermediate filament proteins which constitute the proteinaceous boundary of the nucleus. LMNA mutations in humans cause a wide range of phenotypes, collectively termed laminopathies. To identify the mutation and investigate the phenotype of a spontaneous, semi-dominant mutation that we have named Disheveled hair and ear (Dhe), which causes a sparse coat and small external ears in heterozygotes and lethality in homozygotes by postnatal day 10. Findings: Genetic mapping identified a point mutation in the Lmna gene, causing a single amino acid change, L52R, in the coiled coil rod domain of lamin A and C proteins. Cranial sutures in Dhe/+ mice failed to close. Gene expression for collagen types I and III in sutures was deficient. Skulls were small and disproportionate. Skeletons of Dhe/+ mice were hypomineralized and total body fat was deficient in males. In homozygotes, skin and oral mucosae were dysplastic and ulcerated. Nuclear morphometry of cultured cells revealed gene dose-dependent blebbing and wrinkling. Conclusion: Dhe mice should provide a useful new model for investigations of the pathogenesis of laminopathies.	[Odgren, Paul R.; MacKay, Carole A.; Mason-Savas, April] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Pratt, Craig H.; Shopland, Lindsay] Inst Mol Biophys, Bar Harbor, ME USA; [Curtain, Michelle; Donahue, Leah Rae] Genet Resource Sci, Bar Harbor, ME USA; [Pratt, Craig H.; Curtain, Michelle; Shopland, Lindsay; Ichicki, Tsutomu; Sundberg, John P.; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Odgren, PR (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	LeahRae.Donahue@jax.org		Pratt, Herb/0000-0002-4964-8292	National Institute of Dental and Craniofacial Research [DE 007444]; National Center for Research Resources [RR01183]; National Eye Institute [EY015073]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR49288]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE007444] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was made possible by grants DE 007444 to PRO from the National Institute of Dental and Craniofacial Research; RR01183 from the National Center for Research Resources and EY015073 from the National Eye Institute to LRD; AR49288 from National Institute of Arthritis and Musculoskeletal and Skin Diseases to JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; BAUSCHATZ JDG, 2001, PRELIMINARY SKULL CH; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; DECAUDAIN A, 2007, J CLIN ENDOCRINOL ME; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Jacob KN, 2006, MOL GENET METAB, V87, P289, DOI 10.1016/j.ymgme.2005.10.018; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kosho T, 2007, AM J MED GENET A, V143A, P2598, DOI 10.1002/ajmg.a.31983; Lenton KA, 2005, CURR TOP DEV BIOL, V66, P287, DOI 10.1016/S0070-2153(05)66009-7; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; Marks SC, 1999, DEV DYNAM, V215, P117; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nagano A, 2000, CURR OPIN NEUROL, V13, P533, DOI 10.1097/00019052-200010000-00005; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Odgren PR, 2006, CONNECT TISSUE RES, V47, P229, DOI 10.1080/03008200600860086; Odgren PR, 1996, PROTEINS, V24, P467, DOI 10.1002/(SICI)1097-0134(199604)24:4<467::AID-PROT6>3.0.CO;2-B; ODGREN PR, 2003, EPICENTRE FORUM, V10, P6; OPPERMAN LA, 1995, J BONE MINER RES, V10, P1978; Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; SEYMOUR R, 2004, HDB EXPT ANIMALS LAB, P495; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TAYLOR BA, 1993, GENOMICS, V16, P380, DOI 10.1006/geno.1993.1201; TAYLOR BA, 1989, GENOMICS, V5, P221, DOI 10.1016/0888-7543(89)90050-5; Vantyghem MC, 2007, CLIN ENDOCRINOL, V67, P247, DOI 10.1111/j.1365-2265.2007.02870.x; VERLOES A, 1992, AM J MED GENET, V43, P539, DOI 10.1002/ajmg.1320430308; Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105; Xu J, 2000, J CELL BIOCHEM, V77, P103, DOI 10.1002/(SICI)1097-4644(20000401)77:1<103::AID-JCB11>3.0.CO;2-G; Yang MH, 2006, BLOOD, V107, P2262, DOI 10.1182/blood-2005-08-3365; YOUNG L W, 1971, Birth Defects Original Article Series, V7, P291; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	39	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9959	10.1371/journal.pone.0009959	http://dx.doi.org/10.1371/journal.pone.0009959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376364	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200034
J	Southgate, TD; McGinn, OJ; Castro, FV; Rutkowski, AJ; Al-Muftah, M; Marinov, G; Smethurst, GJ; Shaw, D; Ward, CM; Miller, CJ; Stern, PL				Southgate, Thomas D.; McGinn, Owen J.; Castro, Fernanda V.; Rutkowski, Andrzej J.; Al-Muftah, Mariam; Marinov, Georgi; Smethurst, Graeme J.; Shaw, David; Ward, Christopher M.; Miller, Crispin J.; Stern, Peter L.			CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; TROPHOBLAST GLYCOPROTEIN; ANTIGEN-EXPRESSION; TUMOR-GROWTH; PROTEIN; CARCINOMA; ADHESION; CANCER; CXCL12; DIFFERENTIATION	5T4 oncofetal molecules are highly expressed during development and upregulated in cancer while showing only low levels in some adult tissues. Upregulation of 5T4 expression is a marker of loss of pluripotency in the early differentiation of embryonic stem (ES) cells and forms an integrated component of an epithelial-mesenchymal transition, a process important during embryonic development and metastatic spread of epithelial tumors. Investigation of the transcriptional changes in early ES differentiation showed upregulation of CXCL12 and down-regulation of a cell surface protease, CD26, which cleaves this chemokine. CXCL12 binds to the widely expressed CXCR4 and regulates key aspects of development, stem cell motility and tumour metastasis to tissues with high levels of CXCL12. We show that the 5T4 glycoprotein is required for optimal functional cell surface expression of the chemokine receptor CXCR4 and CXCL12 mediated chemotaxis in differentiating murine embryonic stem cells and embryo fibroblasts (MEF). Cell surface expression of 5T4 and CXCR4 molecules is colocalized in differentiating ES cells and MEF. By contrast, differentiating ES and MEF derived from 5T4 knockout (KO) mice show only intracellular CXCR4 expression but infection with adenovirus encoding mouse 5T4 restores CXCL12 chemotaxis and surface co-localization with 5T4 molecules. A series of chimeric constructs with interchanged domains of 5T4 and the glycoprotein CD44 were used to map the 5T4 sequences relevant for CXCR4 membrane expression and function in 5T4KO MEF. These data identified the 5T4 transmembrane domain as sufficient and necessary to enable CXCR4 cell surface expression and chemotaxis. Furthermore, some monoclonal antibodies against m5T4 can inhibit CXCL12 chemotaxis of differentiating ES cells and MEF which is not mediated by simple antigenic modulation. Collectively, these data support a molecular interaction of 5T4 and CXCR4 occurring at the cell surface which directly facilitates the biological response to CXCL12. The regulation of CXCR4 surface expression by 5T4 molecules is a novel means to control responses to the chemokine CXCL12 for example during embryogenesis but can also be selected to advantage the spread of a 5T4 positive tumor from its primary site.	[Southgate, Thomas D.; McGinn, Owen J.; Castro, Fernanda V.; Rutkowski, Andrzej J.; Al-Muftah, Mariam; Marinov, Georgi; Smethurst, Graeme J.; Shaw, David; Ward, Christopher M.; Stern, Peter L.] Univ Manchester, Paterson Inst Canc Res, Immunol Grp, Manchester, Lancs, England; [Rutkowski, Andrzej J.; Smethurst, Graeme J.; Miller, Crispin J.] Univ Manchester, Paterson Inst Canc Res, Appl Computat Biol & Bioinformat Grp, Manchester, Lancs, England	Paterson Institute for Cancer Research; University of Manchester; Paterson Institute for Cancer Research; University of Manchester	Southgate, TD (corresponding author), Univ Manchester, Paterson Inst Canc Res, Immunol Grp, Manchester, Lancs, England.	pstern@picr.man.ac.uk		Miller, Crispin/0000-0003-4341-1283; Ward, Christopher/0000-0001-7389-4488	Cancer Research UK [R108032Q]	Cancer Research UK(Cancer Research UK)	Work was funded by Cancer Research UK (www.cancerresearchuk.org) Grant No. R108032Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awan A, 2002, BIOCHEM BIOPH RES CO, V290, P1030, DOI 10.1006/bbrc.2001.6288; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barrow KM, 2005, DEV DYNAM, V233, P1535, DOI 10.1002/dvdy.20482; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CARSBERG CJ, 1995, J CELL SCI, V108, P2905; Carsberg CJ, 1996, INT J CANCER, V68, P84, DOI 10.1002/(SICI)1097-0215(19960927)68:1<84::AID-IJC15>3.0.CO;2-6; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths RW, 2005, BRIT J CANCER, V93, P670, DOI 10.1038/sj.bjc.6602776; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hildinger M, 1998, GENE THER, V5, P1575, DOI 10.1038/sj.gt.3300759; HOLE N, 1988, BRIT J CANCER, V57, P239, DOI 10.1038/bjc.1988.53; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; King KW, 1999, BBA-GENE STRUCT EXPR, V1445, P257, DOI 10.1016/S0167-4781(99)00055-X; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOFUKU Y, 2009, J BIOL CHEM; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese Adriano, 2006, V327, P139; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Mulder WMC, 1997, CLIN CANCER RES, V3, P1923; Mulryan K, 2002, MOL CANCER THER, V1, P1129; MYERS KA, 1994, J BIOL CHEM, V269, P9319; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Shaw DM, 2002, BIOCHEM J, V363, P137, DOI 10.1042/0264-6021:3630137; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; SMETHURST G, 2006, MICROARRAY ANAL MOUS; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; SOUTHALL PJ, 1990, BRIT J CANCER, V61, P89, DOI 10.1038/bjc.1990.20; SOUTHGATE TD, 2001, CURR PROTOC NEUROSCI, pCH4; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Starzynska T, 1998, EUR J GASTROEN HEPAT, V10, P479, DOI 10.1097/00042737-199806000-00008; STARZYNSKA T, 1994, BRIT J CANCER, V69, P899, DOI 10.1038/bjc.1994.173; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Ward CM, 2006, EXP CELL RES, V312, P1713, DOI 10.1016/j.yexcr.2006.02.006; Ward CM, 2003, J CELL SCI, V116, P4533, DOI 10.1242/jcs.00767; Woods AM, 2002, BIOCHEM J, V366, P353, DOI 10.1042/BJ20020104; WRIGLEY E, 1995, INT J GYNECOL CANCER, V5, P269, DOI 10.1046/j.1525-1438.1995.05040269.x; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhang J, 2005, CARCINOGENESIS, V26, P2069, DOI 10.1093/carcin/bgi183; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	66	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9982	10.1371/journal.pone.0009982	http://dx.doi.org/10.1371/journal.pone.0009982			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376365	Green Published, Green Submitted, gold			2022-12-27	WOS:000276418200053
J	Jarlestedt, K; Rousset, CI; Faiz, M; Wilhelmsson, U; Stahlberg, A; Sourkova, H; Pekna, M; Mallard, C; Hagberg, H; Pekny, M				Jarlestedt, Katarina; Rousset, Catherine I.; Faiz, Maryam; Wilhelmsson, Ulrika; Stahlberg, Anders; Sourkova, Hana; Pekna, Marcela; Mallard, Carina; Hagberg, Henrik; Pekny, Milos			Attenuation of Reactive Gliosis Does Not Affect Infarct Volume in Neonatal Hypoxic-Ischemic Brain Injury in Mice	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENTS; HYPOTONIC STRESS; ASTROCYTES; VIMENTIN; GFAP; REGENERATION; DEFICIENT; PCR; NEUROGENESIS	Background: Astroglial cells are activated following injury and up-regulate the expression of the intermediate filament proteins glial fibrillary acidic protein (GFAP) and vimentin. Adult mice lacking the intermediate filament proteins GFAP and vimentin (GFAP(-/-) Vim(-/-)) show attenuated reactive gliosis, reduced glial scar formation and improved regeneration of neuronal synapses after neurotrauma. GFAP(-/-) Vim(-/-) mice exhibit larger brain infarcts after middle cerebral artery occlusion suggesting protective role of reactive gliosis after adult focal brain ischemia. However, the role of astrocyte activation and reactive gliosis in the injured developing brain is unknown. Methodology/Principal Findings: We subjected GFAP(-/-) Vim(-/-) and wild-type mice to unilateral hypoxia-ischemia (HI) at postnatal day 9 (P9). Bromodeoxyuridine (BrdU; 25 mg/kg) was injected intraperitoneally twice daily from P9 to P12. On P12 and P31, the animals were perfused intracardially. Immunohistochemistry with MAP-2, BrdU, NeuN, and S100 antibodies was performed on coronal sections. We found no difference in the hemisphere or infarct volume between GFAP(-/-) Vim(-/-) and wild-type mice at P12 and P31, i.e. 3 and 22 days after HI. At P31, the number of NeuN(+) neurons in the ischemic and contralateral hemisphere was comparable between GFAP(-/-) Vim(-/-) and wild-type mice. In wild-type mice, the number of S100(+) astrocytes was lower in the ipsilateral compared to contralateral hemisphere (65.0 +/- 50.1 vs. 85.6 +/- 34.0, p<0.05). In the GFAP(-/-) Vim(-/-) mice, the number of S100(+) astrocytes did not differ between the ischemic and contralateral hemisphere at P31. At P31, GFAP(-/-) Vim(-/-) mice showed an increase in NeuN(+)BrdU(+) (surviving newly born) neurons in the ischemic cortex compared to wild-type mice (6.7 +/- 7.7; n = 29 versus 2.9 +/- 3.6; n = 28, respectively, p<0.05), but a comparable number of S100(+)BrdU(+) (surviving newly born) astrocytes. Conclusions/Significance: Our results suggest that attenuation of reactive gliosis in the developing brain does not affect the hemisphere or infarct volume after HI, but increases the number of surviving newborn neurons.	[Jarlestedt, Katarina; Mallard, Carina; Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden; [Rousset, Catherine I.; Hagberg, Henrik] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Pekna, Marcela] Univ Gothenburg, Sahlgrenska Acad, Dept Med Chem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Faiz, Maryam; Wilhelmsson, Ulrika; Stahlberg, Anders; Sourkova, Hana; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Imperial College London; University of Gothenburg; University of Gothenburg; University of Gothenburg	Jarlestedt, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden.	Milos.Pekny@neuro.gu.se	Pekna, Marcela/AAM-3261-2021; Pekna, Marcela/AAM-3249-2021	Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Mallard, Carina/0000-0001-8953-919X; Wilhelmsson, Ulrika/0000-0003-3227-2687; Stahlberg, Anders/0000-0003-4243-0191; Faiz, Maryam/0000-0003-0671-3557; Hagberg, Henrik/0000-0003-3962-1448	Swedish Research Council [11548, 20116, 09455, 14185]; Medical Research Council (United Kingdom) [P19381]; LUA/ALF Gothenburg; Region of Vastra Gotaland; Ragnar and Torsten Soderberg's Foundations; Hjarnfonden; Edith Jacobsson's Foundation; John and Brit Wennerstrom's Foundation; W. and M. Lundgren's Foundation; A. and U. Amlov's Foundation; Free Mason Foundation; Swedish Stroke Foundation;  [ALFGBG7592];  [ALFGBG11267];  [ALFGBG2863]; MRC [G0802853] Funding Source: UKRI; Medical Research Council [G0802853] Funding Source: researchfish; Action Medical Research [1764] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); LUA/ALF Gothenburg; Region of Vastra Gotaland; Ragnar and Torsten Soderberg's Foundations; Hjarnfonden; Edith Jacobsson's Foundation; John and Brit Wennerstrom's Foundation; W. and M. Lundgren's Foundation; A. and U. Amlov's Foundation; Free Mason Foundation; Swedish Stroke Foundation; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research	This study was supported by the Swedish Research Council, 11548 ( M. P.), 20116 ( M. P.), 09455 ( H. H.), 14185 ( C. M.), Medical Research Council (United Kingdom) contract: P19381 ( H. H.), LUA/ALF Gothenburg, ALFGBG7592 ( M. P.), ALFGBG11267 ( M. P.), ALFGBG2863 ( H. H.), The Region of Vastra Gotaland ( RUN), Ragnar and Torsten Soderberg's Foundations, Hjarnfonden, Edith Jacobsson's Foundation, John and Brit Wennerstrom's Foundation for Neurological Research, W. and M. Lundgren's Foundation, A. and U. Amlov's Foundation, The Free Mason Foundation and the Swedish Stroke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderova M, 2001, GLIA, V35, P189, DOI 10.1002/glia.1084; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; Iwata-Ichikawa E, 1999, J NEUROCHEM, V72, P2334, DOI 10.1046/j.1471-4159.1999.0722334.x; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; MCRAE A, 1995, DEV BRAIN RES, V84, P245, DOI 10.1016/0165-3806(94)00177-2; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sent E, 2006, MENT RETARD DEV D R, V12, P97, DOI 10.1002/mrdd.20106; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Sullivan SM, 2010, GLIA, V58, P181, DOI 10.1002/glia.20911; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	32	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10397	10.1371/journal.pone.0010397	http://dx.doi.org/10.1371/journal.pone.0010397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442854	gold, Green Published, Green Submitted			2022-12-27	WOS:000277154200029
J	Masuda, H; Matsuzaki, Y; Hiratsu, E; Ono, M; Nagashima, T; Kajitani, T; Arase, T; Oda, H; Uchida, H; Asada, H; Ito, M; Yoshimura, Y; Maruyama, T; Okano, H				Masuda, Hirotaka; Matsuzaki, Yumi; Hiratsu, Emi; Ono, Masanori; Nagashima, Takashi; Kajitani, Takashi; Arase, Toru; Oda, Hideyuki; Uchida, Hiroshi; Asada, Hironori; Ito, Mamoru; Yoshimura, Yasunori; Maruyama, Tetsuo; Okano, Hideyuki			Stem Cell-Like Properties of the Endometrial Side Population: Implication in Endometrial Regeneration	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; BCRP1/ABCG2; CONTRIBUTE; MODEL	Background: The human endometrium undergoes cyclical regeneration throughout a woman's reproductive life. Ectopic implantation of endometrial cells through retrograde menstruation gives rise to endometriotic lesions which affect approximately 10% of reproductive-aged women. The high regenerative capacity of the human endometrium at eutopic and ectopic sites suggests the existence of stem/progenitor cells and a unique angiogenic system. The objective of this study was to isolate and characterize putative endometrial stem/progenitor cells and to address how they might be involved in the physiology of endometrium. Methodology/Principal Findings: We found that approximately 2% of the total cells obtained from human endometrium displayed a side population (SP) phenotype, as determined by flow cytometric analysis of Hoechst-stained cells. The endometrial SP (ESP) cells exhibited preferential expression of several endothelial cell markers compared to endometrial main population (EMP) cells. A medium specific for endothelial cell culture enabled ESP cells to proliferate and differentiate into various types of endometrial cells, including glandular epithelial, stromal and endothelial cells in vitro, whereas in the same medium, EMP cells differentiated only into stromal cells. Furthermore, ESP cells, but not EMP cells, reconstituted organized endometrial tissue with well-delineated glandular structures when transplanted under the kidney capsule of severely immunodeficient mice. Notably, ESP cells generated endothelial cells that migrated into the mouse kidney parenchyma and formed mature blood vessels. This potential for in vivo angiogenesis and endometrial cell regeneration was more prominent in the ESP fraction than in the EMP fraction, as the latter mainly gave rise to stromal cells in vivo. Conclusions/Significance: These results indicate that putative endometrial stem cells are highly enriched in the ESP cells. These unique characteristics suggest that ESP cells might drive physiological endometrial regeneration and be involved in the pathogenesis of endometriosis.	[Masuda, Hirotaka; Matsuzaki, Yumi; Hiratsu, Emi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Masuda, Hirotaka; Ono, Masanori; Nagashima, Takashi; Kajitani, Takashi; Arase, Toru; Oda, Hideyuki; Uchida, Hiroshi; Asada, Hironori; Yoshimura, Yasunori; Maruyama, Tetsuo] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Ito, Mamoru] Cent Inst Expt Anim, Kanagawa, Japan	Keio University; Keio University	Masuda, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	penguin@sc.itc.keio.ac.jp; tetsuo@sc.itc.keio.ac.jp	UCHIDA, HIROSHI/AAB-2296-2019; Ono, Masanori/F-7443-2019	UCHIDA, HIROSHI/0000-0001-6148-7658; Ono, Masanori/0000-0001-9249-6813; Matsuzaki, Yumi/0000-0002-3729-2997	Ministry of Education, Science, and Culture of Japan; High-Tech Research Center in a Private University; Ministry of Education, Science, and Culture of Japan to Keio University	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High-Tech Research Center in a Private University; Ministry of Education, Science, and Culture of Japan to Keio University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by the Ministry of Education, Science, and Culture of Japan (to T. M., Y.Y., and H. M.), by a National Grant-in-Aid for the Establishment of a High-Tech Research Center in a Private University (to T. M.) and by a grant-in-aid from the Global Centers of Excellence program of the Ministry of Education, Science, and Culture of Japan to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Critchley HOD, 2001, J CLIN ENDOCR METAB, V86, P1370, DOI 10.1210/jc.86.3.1370; Dabrosin C, 2002, AM J PATHOL, V161, P909, DOI 10.1016/S0002-9440(10)64251-4; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; FERENCZY A, 1976, AM J OBSTET GYNECOL, V124, P582, DOI 10.1016/0002-9378(76)90059-4; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Garry R, 2009, HUM REPROD, V24, P1393, DOI 10.1093/humrep/dep036; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hishikawa K, 2005, J CELL BIOL, V169, P921, DOI 10.1083/jcb.200412167; Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Okulicz W.C, 2002, ENDOMETRIUM, P110; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; PADYKULA HA, 1989, BIOL REPROD, V40, P681, DOI 10.1095/biolreprod40.3.681; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; PRIANISHNIKOV VA, 1978, CONTRACEPTION, V18, P213, DOI 10.1016/S0010-7824(78)80015-8; Salamonsen LA, 2003, REPRODUCTION, V125, P301, DOI 10.1530/rep.0.1250301; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; TIMMERMANS F, 2008, J CELL MOL MED; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Zhou S, 2003, BIOTECHNIQUES, V35, P1248, DOI 10.2144/03356ss04; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	38	198	215	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10387	10.1371/journal.pone.0010387	http://dx.doi.org/10.1371/journal.pone.0010387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442847	Green Published, Green Submitted, gold			2022-12-27	WOS:000277154200023
J	Witten, IB; Knudsen, PF; Knudsen, EI				Witten, Ilana B.; Knudsen, Phyllis F.; Knudsen, Eric I.			A Dominance Hierarchy of Auditory Spatial Cues in Barn Owls	PLOS ONE			English	Article							FREQUENCY-SPECIFIC ADJUSTMENTS; OPTIC TECTUM; BINAURAL INTERFERENCE; INFERIOR COLLICULUS; SPACE MAP; TYTO-ALBA; LOCALIZATION; MIDBRAIN; REPRESENTATION; RESPONSES	Background: Barn owls integrate spatial information across frequency channels to localize sounds in space. Methodology/Principal Findings: We presented barn owls with synchronous sounds that contained different bands of frequencies (3-5 kHz and 7-9 kHz) from different locations in space. When the owls were confronted with the conflicting localization cues from two synchronous sounds of equal level, their orienting responses were dominated by one of the sounds: they oriented toward the location of the low frequency sound when the sources were separated in azimuth; in contrast, they oriented toward the location of the high frequency sound when the sources were separated in elevation. We identified neural correlates of this behavioral effect in the optic tectum (OT, superior colliculus in mammals), which contains a map of auditory space and is involved in generating orienting movements to sounds. We found that low frequency cues dominate the representation of sound azimuth in the OT space map, whereas high frequency cues dominate the representation of sound elevation. Conclusions/Significance: We argue that the dominance hierarchy of localization cues reflects several factors: 1) the relative amplitude of the sound providing the cue, 2) the resolution with which the auditory system measures the value of a cue, and 3) the spatial ambiguity in interpreting the cue. These same factors may contribute to the relative weighting of sound localization cues in other species, including humans.	[Witten, Ilana B.; Knudsen, Phyllis F.; Knudsen, Eric I.] Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Witten, IB (corresponding author), Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA.	eknudsen@stanford.edu			National Institutes of Health (NIH); National Science Foundation (NSF); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH) and National Science Foundation (NSF) graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best V, 2007, J ACOUST SOC AM, V121, P1070, DOI 10.1121/1.2407738; Blauert J., 1997, SPATIAL HEARING PSYC; Bregman AS, 1990, AUDITORY SCENE ANAL, pxiii; BUELL TN, 1991, J ACOUST SOC AM, V90, P1894, DOI 10.1121/1.401668; DeBello WM, 2004, J NEUROSCI, V24, P6853, DOI 10.1523/JNEUROSCI.0480-04.2004; Fischer BJ, 2007, J NEUROPHYSIOL, V98, P1181, DOI 10.1152/jn.00370.2007; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; Gold JI, 2000, J NEUROSCI, V20, P862, DOI 10.1523/JNEUROSCI.20-02-00862.2000; HELLER LM, 1995, J ACOUST SOC AM, V97, P1808, DOI 10.1121/1.413096; Heller LM, 1996, J ACOUST SOC AM, V99, P3632, DOI 10.1121/1.414961; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, J NEUROPHYSIOL, V41, P870, DOI 10.1152/jn.1978.41.4.870; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; Koppl C, 1997, J NEUROSCI, V17, P3312; LICKLIDER JCR, 1950, J ACOUST SOC AM, V22; Litovsky RY, 1998, J NEUROPHYSIOL, V80, P1285, DOI 10.1152/jn.1998.80.3.1285; MANLEY GA, 1988, J NEUROSCI, V8, P2665; MCFADDEN D, 1976, J ACOUST SOC AM, V59, P634, DOI 10.1121/1.380913; MIDDLEBROOKS JC, 1989, J ACOUST SOC AM, V86, P89, DOI 10.1121/1.398224; PAYNE RS, 1971, J EXP BIOL, V54, P535; Pena JL, 2001, J NEUROSCI, V21, P9455, DOI 10.1523/JNEUROSCI.21-23-09455.2001; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Spitzer MW, 2006, J NEUROPHYSIOL, V95, P3571, DOI 10.1152/jn.00982.2005; Spitzer MW, 2004, J NEUROPHYSIOL, V92, P2051, DOI 10.1152/jn.01235.2003; TAKAHASHI TT, 1994, J NEUROSCI, V14, P4780; WAGNER H, 1987, J NEUROSCI, V7, P3105; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	29	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10396	10.1371/journal.pone.0010396	http://dx.doi.org/10.1371/journal.pone.0010396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442852	Green Submitted, gold, Green Published			2022-12-27	WOS:000277154200028
J	Nilsen, IW; Overbo, K; Havdalen, LJ; Elde, M; Gjellesvik, DR; Lanes, O				Nilsen, Inge W.; Overbo, Kersti; Havdalen, Linda Jensen; Elde, Morten; Gjellesvik, Dag Rune; Lanes, Olav			The Enzyme and the cDNA Sequence of a Thermolabile and Double-Strand Specific DNase from Northern Shrimps (Pandalus borealis)	PLOS ONE			English	Article							DUPLEX-SPECIFIC NUCLEASE; ALKALINE-PHOSPHATASE; SERRATIA-MARCESCENS; PYLORIC CECA; ACTIVE-SITE; HEPATOPANCREAS; ENDONUCLEASE; PROTEIN; CRAB; DEOXYRIBONUCLEASE	Background: We have previously isolated a thermolabile nuclease specific for double-stranded DNA from industrial processing water of Northern shrimps (Pandalus borealis) and developed an application of the enzyme in removal of contaminating DNA in PCR-related technologies. Methodology/Principal Findings: A 43 kDa nuclease with a high specific activity of hydrolysing linear as well as circular forms of DNA was purified from hepatopancreas of Northern shrimp (Pandalus borealis). The enzyme displayed a substrate preference that was shifted from exclusively double-stranded DNA in the presence of magnesium to also encompass significant activity against single-stranded DNA when calcium was added. No activity against RNA was detected. Although originating from a cold-environment animal, the shrimp DNase has only minor low-temperature activity. Still, the enzyme was irreversibly inactivated by moderate heating with a half-life of 1 min at 65 degrees C. The purified protein was partly sequenced and derived oligonucleotides were used to prime amplification of the encoding cDNA. This cDNA sequence revealed an open reading frame encoding a 404 amino acid protein containing a signal peptide. By sequence similarity the enzyme is predicted to belong to a family of DNA/RNA non-specific nucleases even though this shrimp DNase lacks RNase activity and is highly double-strand specific in some respects. These features are in agreement with those previously established for endonucleases classified as similar to the Kamchatka crab duplex-specific nuclease (Par_DSN). Sequence comparisons and phylogenetic analyses confirmed that the Northern shrimp nuclease resembles the Par_DSN-like nucleases and displays a more distant relationship to the Serratia family of nucleases. Conclusions/Significance: The shrimp nuclease contains enzyme activity that may be controlled by temperature or buffer compositions. The double-stranded DNA specificity, as well as the thermolabile feature, strengthens its potential for in vitro applications.	[Nilsen, Inge W.; Overbo, Kersti] Nofima Marin, Tromso, Norway; [Havdalen, Linda Jensen; Elde, Morten; Gjellesvik, Dag Rune; Lanes, Olav] Marine Biochem, Tromso, Norway	Nofima	Nilsen, IW (corresponding author), Nofima Marin, Tromso, Norway.	ol@marinebiochem.com			Research council of Norway [138822/130]; Nofima Marin; Biotec Marine Biochemicals	Research council of Norway(Research Council of Norway); Nofima Marin(Nofima); Biotec Marine Biochemicals	This work was supported by the Research council of Norway, project number 138822/130, Nofima Marin and Biotec Marine Biochemicals. Since IWN and KO are employees at Nofima Marin and LJH, ME, DRG and OL are employees at Marine Biochemicals the funders played a role in the design, data analysis and the decision to publish.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova VE, 2008, GENE, V418, P41, DOI 10.1016/j.gene.2008.04.005; Anisimova VE, 2009, BIOTECHNOL LETT, V31, P251, DOI 10.1007/s10529-008-9850-y; Anisimova Veronika E., 2008, BMC Biochemistry, V9, P14, DOI 10.1186/1471-2091-9-14; BALL TK, 1987, GENE, V57, P183, DOI 10.1016/0378-1119(87)90121-1; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; EDMAN P, 1956, ACTA CHEM SCAND, V10, P761, DOI 10.3891/acta.chem.scand.10-0761; FRIEDHOFF P, 1994, NUCLEIC ACIDS RES, V22, P3280, DOI 10.1093/nar/22.16.3280; Friedhoff P, 1996, NUCLEIC ACIDS RES, V24, P2632, DOI 10.1093/nar/24.14.2632; FULLER CW, 1998, Patent No. 5756285; KUNITZ M, 1950, J GEN PHYSIOL, V33, P349, DOI 10.1085/jgp.33.4.349; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Menzorova N.I., 1993, Biokhimiya, V58, P681; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; MOORE S, 1981, ENZYMES A, V14, P281; Nilsen IW, 2001, COMP BIOCHEM PHYS B, V129, P853, DOI 10.1016/S1096-4959(01)00391-8; Nilsen IW, 2003, US patent, Patent No. [6,541,204, 6541204]; OLSEN RL, 1991, COMP BIOCHEM PHYS B, V99, P755, DOI 10.1016/0305-0491(91)90139-5; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 2001, MOL CLONING LAB MANU; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; STRAETKVERN KO, 1990, FISH PHYSIOL BIOCHEM, V8, P529, DOI 10.1007/BF00003411; STRAETKVERN KO, 1992, FISH PHYSIOL BIOCHEM, V9, P439, DOI 10.1007/BF02274225; Wang WY, 2000, BIOCHEM J, V346, P799, DOI 10.1042/0264-6021:3460799; YAMAMOTO M, 1971, BIOCHIM BIOPHYS ACTA, V228, P95, DOI 10.1016/0005-2787(71)90549-1	29	19	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2010	5	4							e10295	10.1371/journal.pone.0010295	http://dx.doi.org/10.1371/journal.pone.0010295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YT	20421970	Green Published, gold, Green Submitted			2022-12-27	WOS:000276952600012
J	Higgins, JA; Bailey, PC; Laurie, DA				Higgins, Janet A.; Bailey, Paul C.; Laurie, David A.			Comparative Genomics of Flowering Time Pathways Using Brachypodium distachyon as a Model for the Temperate Grasses	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; ARABIDOPSIS CIRCADIAN CLOCK; PSEUDO-RESPONSE-REGULATOR; FLORAL INDUCTIVE SIGNALS; HOMEOBOX GENES PENNYWISE; ZINC-FINGER PROTEIN; CONSTANS-LIKE GENE; TRANSCRIPTION FACTOR; PHOTOPERIOD SENSITIVITY; EVOLUTIONARY ANALYSIS	Brachypodium distachyon (Brachypodium) is a model for the temperate grasses which include important cereals such as barley, wheat and oats. Comparison of the Brachypodium genome accession (Bd21) with those of the model dicot Arabidopsis thaliana and the tropical cereal rice (Oryza sativa) provides an opportunity to compare and contrast genetic pathways controlling important traits. We analysed the homologies of genes controlling the induction of flowering using pathways curated in Arabidopsis Reactome as a starting point. Pathways include those detecting and responding to the environmental cues of day length (photoperiod) and extended periods of low temperature (vernalization). Variation in these responses has been selected during cereal domestication, providing an interesting comparison with the wild genome of Brachypodium. Brachypodium Bd21 has well conserved homologues of circadian clock, photoperiod pathway and autonomous pathway genes defined in Arabidopsis and homologues of vernalization pathway genes defined in cereals with the exception of VRN2 which was absent. Bd21 also lacked a member of the CO family (CO3). In both cases flanking genes were conserved showing that these genes are deleted in at least this accession. Segmental duplication explains the presence of two CO-like genes in temperate cereals, of which one (Hd1) is retained in rice, and explains many differences in gene family structure between grasses and Arabidopsis. The conserved fine structure of duplications shows that they largely evolved to their present structure before the divergence of the rice and Brachypodium. Of four flowering-time genes found in rice but absent in Arabidopsis, two were found in Bd21 (Id1, OsMADS51) and two were absent (Ghd7, Ehd1). Overall, results suggest that an ancient core photoperiod pathway promoting flowering via the induction of FT has been modified by the recruitment of additional lineage specific pathways that promote or repress FT expression.	[Higgins, Janet A.; Laurie, David A.] John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England; [Bailey, Paul C.] John Innes Ctr, Dept Computat & Syst Biol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Higgins, JA (corresponding author), John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England.	janet.higgins@bbsrc.ac.uk	Higgins, Janet/A-5002-2011		United Kingdom Biotechnology and Biological Research Council; 6th European Integrated Projects [LSHG-CT-2006-037704]; Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA286] Funding Source: researchfish; BBSRC [BBS/E/J/000CA286] Funding Source: UKRI	United Kingdom Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 6th European Integrated Projects; Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by a core grant from the United Kingdom Biotechnology and Biological Research Council, 6th European Integrated Projects AGRON-OMICS (LSHG-CT-2006-037704), and a Daphne Jackson Fellowship funded by The Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Bailey PC, 2008, PHYTOCHEMISTRY, V69, P2417, DOI 10.1016/j.phytochem.2008.08.003; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Bommert P, 2005, PLANT CELL PHYSIOL, V46, P69, DOI 10.1093/pcp/pci504; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Chardon F, 2005, J MOL EVOL, V61, P579, DOI 10.1007/s00239-004-0179-4; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Cockram J, 2010, GENOME, V53, P231, DOI [10.1139/G09-101, 10.1139/g09-101]; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Colasanti J, 2009, PLANT PHYSIOL, V149, P56, DOI 10.1104/pp.108.130500; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Dennis Elizabeth S., 2009, Journal of Biology (London), V8, P57, DOI 10.1186/jbiol156; DISTELFELD A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI DOI 10.1016/j.pbi.2008.12.010; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Dunford RP, 2002, GENETICS, V161, P825; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fu C, 2009, PLANT BIOLOGY, V11, P751, DOI 10.1111/j.1438-8677.2008.00156.x; Fu DL, 2007, MOL GENET GENOMICS, V277, P301, DOI 10.1007/s00438-006-0189-6; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hassidim M, 2009, PLANTA, V230, P481, DOI 10.1007/s00425-009-0958-7; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; Ikeda Y, 2007, PLANT CELL PHYSIOL, V48, P205, DOI 10.1093/pcp/pcl061; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Ishikawa M, 2006, PLANT J, V46, P736, DOI 10.1111/j.1365-313X.2006.02737.x; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Jang YH, 2009, PLANT CELL PHYSIOL, V50, P1479, DOI 10.1093/pcp/pcp093; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kane NA, 2005, PLANT PHYSIOL, V138, P2354, DOI 10.1104/pp.105.061762; Kane NA, 2007, PLANT J, V51, P670, DOI 10.1111/j.1365-313X.2007.03172.x; Kanrar S, 2008, PLANT J, V54, P924, DOI 10.1111/j.1365-313X.2008.03458.x; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim S, 2006, PLANT CELL, V18, P2985, DOI 10.1105/tpc.106.045179; Kim SL, 2007, PLANT PHYSIOL, V145, P1484, DOI 10.1104/pp.107.103291; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kumar Sachin, 2009, BMC Res Notes, V2, P93, DOI 10.1186/1756-0500-2-93; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Mayfield JD, 2007, PLANT PHYSIOL, V145, P1692, DOI 10.1104/pp.107.108654; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Murakami M, 2005, BIOSCI BIOTECH BIOCH, V69, P410, DOI 10.1271/bbb.69.410; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; NAGAMURA Y, 1995, BREEDING SCI, V45, P373; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Park SJ, 2008, PLANT J, V56, P1018, DOI 10.1111/j.1365-313X.2008.03667.x; Peng LT, 2008, J PLANT PHYSIOL, V165, P876, DOI 10.1016/j.jplph.2007.07.010; Peng LT, 2007, BIOCHEM BIOPH RES CO, V360, P251, DOI 10.1016/j.bbrc.2007.06.041; Preston JC, 2007, PLANT J, V52, P69, DOI 10.1111/j.1365-313X.2007.03209.x; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Purwestri YA, 2009, PLANT CELL PHYSIOL, V50, P429, DOI 10.1093/pcp/pcp012; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Romanel EAC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005791; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schwartz CJ, 2010, BIOENERG RES, V3, P38, DOI 10.1007/s12155-009-9069-3; Shaw LM, 2009, FUNCT INTEGR GENOMIC, V9, P485, DOI 10.1007/s10142-009-0130-2; Shitsukawa N, 2007, PHYSIOL PLANTARUM, V130, P627, DOI 10.1111/j.1399-3054.2007.00927.x; Shitsukawa N, 2007, GENES GENET SYST, V82, P167, DOI 10.1266/ggs.82.167; Smith HMS, 2004, CURR BIOL, V14, P812, DOI 10.1016/j.cub.2004.04.032; Song HR, 2009, PLANT CELL, V21, P1195, DOI 10.1105/tpc.108.064774; Szucs P, 2006, THEOR APPL GENET, V112, P1277, DOI 10.1007/s00122-006-0229-y; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Tsesmetzis N, 2008, PLANT CELL, V20, P1426, DOI 10.1105/tpc.108.057976; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Veley KM, 2008, PLANT PHYSIOL, V147, P682, DOI 10.1104/pp.108.118927; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Winichayakul S, 2005, FUNCT PLANT BIOL, V32, P345, DOI 10.1071/FP04245; Wollenberg AC, 2008, PLANT PHYSIOL, V148, P1681, DOI 10.1104/pp.108.125468; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Wu CY, 2008, P NATL ACAD SCI USA, V105, P12915, DOI 10.1073/pnas.0806019105; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; YOSHIDA R, 2009, NEW PHYTOL; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	139	208	216	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2010	5	4							e10065	10.1371/journal.pone.0010065	http://dx.doi.org/10.1371/journal.pone.0010065			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585UC	20419097	Green Published, Green Submitted, gold			2022-12-27	WOS:000276853800003
J	Arnold, DH; Tear, M; Schindel, R; Roseboom, W				Arnold, Derek H.; Tear, Morgan; Schindel, Ryan; Roseboom, Warrick			Audio-Visual Speech Cue Combination	PLOS ONE			English	Article							VISUAL-MOTION SIGNALS; INTEGRATION; INFORMATION	Background: Different sources of sensory information can interact, often shaping what we think we have seen or heard. This can enhance the precision of perceptual decisions relative to those made on the basis of a single source of information. From a computational perspective, there are multiple reasons why this might happen, and each predicts a different degree of enhanced precision. Relatively slight improvements can arise when perceptual decisions are made on the basis of multiple independent sensory estimates, as opposed to just one. These improvements can arise as a consequence of probability summation. Greater improvements can occur if two initially independent estimates are summated to form a single integrated code, especially if the summation is weighted in accordance with the variance associated with each independent estimate. This form of combination is often described as a Bayesian maximum likelihood estimate. Still greater improvements are possible if the two sources of information are encoded via a common physiological process. Principal Findings: Here we show that the provision of simultaneous audio and visual speech cues can result in substantial sensitivity improvements, relative to single sensory modality based decisions. The magnitude of the improvements is greater than can be predicted on the basis of either a Bayesian maximum likelihood estimate or a probability summation. Conclusion: Our data suggest that primary estimates of speech content are determined by a physiological process that takes input from both visual and auditory processing, resulting in greater sensitivity than would be possible if initially independent audio and visual estimates were formed and then subsequently combined.	[Arnold, Derek H.; Tear, Morgan; Schindel, Ryan; Roseboom, Warrick] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Arnold, DH (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	d.arnold@psy.uq.edu.au		Arnold, Derek/0000-0003-1027-6222	Australian Research Council [DP0878140]	Australian Research Council(Australian Research Council)	Australian Research Council Discovery Grant DP0878140 http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Arrighi R, 2009, J VISION, V9, DOI 10.1167/9.4.25; Bresciani JP, 2005, EXP BRAIN RES, V162, P172, DOI 10.1007/s00221-004-2128-2; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Green DM, 1966, SIGNAL DETECTION THE; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Koene A, 2007, J VISION, V7, DOI 10.1167/7.11.14; Lopez-Moliner J, 2007, J VISION, V7, DOI 10.1167/7.13.11; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; Macmillan NA, 2005, DETECTION THEORY USE; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meese TS, 2001, PERCEPTION, V30, P1189, DOI 10.1068/p3196; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Soto-Faraco S, 2004, COGNITION, V92, pB13, DOI 10.1016/j.cognition.2003.10.005; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Treisman M, 1998, PSYCHOL METHODS, V3, P252, DOI 10.1037/1082-989X.3.2.252; Wuerger SM, 2003, PERCEPT PSYCHOPHYS, V65, P1188, DOI 10.3758/BF03194844; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	25	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2010	5	4							e10217	10.1371/journal.pone.0010217	http://dx.doi.org/10.1371/journal.pone.0010217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	584HZ	20419130	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000276743500018
J	Bitan, M; Weiss, L; Zeira, M; Zcharia, E; Slavin, S; Nagler, A; Vlodavsky, I				Bitan, Menachem; Weiss, Lola; Zeira, Michael; Zcharia, Eyal; Slavin, Shimon; Nagler, Arnon; Vlodavsky, Israel			Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; SULFATE PROTEOGLYCANS; MAMMALIAN HEPARANASE; CYTOKINE PRODUCTION; CANCER METASTASIS; TUMOR-GROWTH; T-CELLS; ANGIOGENESIS; EXPRESSION	Background: Heparanase, endoglycosidase that cleaves heparan sulfate side chains of heparan sulfate proteoglycans, plays important roles in cancer metastasis, angiogenesis and inflammation. Design and Methods: Applying a mouse model of bone marrow transplantation and transgenic mice over-expressing heparanase, we evaluated the effect of heparanase on the engraftment process and the development of graft-versus-host disease. Results: Analysis of F1 mice undergoing allogeneic bone marrow transplantation from C57BL/6 mice demonstrated a better and faster engraftment in mice receiving cells from donors that were pretreated with heparanase. Moreover, heparanase treated recipient F1 mice showed only a mild appearance of graft-versus-host disease and died 27 days post transplantation while control mice rapidly developed signs of graft-versus-host disease (i.e., weight loss, hair loss, diarrhea) and died after 12 days, indicating a protective effect of heparanase against graft-versus-host disease. Similarly, we applied transgenic mice over-expressing heparanase in most tissues as the recipients of BMT from C57BL/6 mice. Monitoring clinical parameters of graft-versus-host disease, the transgenic mice showed 100% survival on day 40 post transplantation, compared to only 50% survival on day 14, in the control group. In vitro and in vivo studies revealed that heparanase inhibited T cell function and activation through modulation of their cytokine repertoire, indicated by a marked increase in the levels of Interleukin-4, Interleukin-6 and Interleukin-10, and a parallel decrease in Interleukin-12, tumor necrosis factor-alfa and interferon-gamma. Using point mutated inactive enzyme, we found that the shift in cytokine profile was independent of heparanase enzymatic activity. Conclusions: Our results indicate a significant role of heparanase in bone marrow transplantation biology, facilitating engraftment and suppressing graft-versus-host disease, apparently through an effect on T cell activation and cytokine production pattern.	[Bitan, Menachem; Weiss, Lola; Zeira, Michael; Slavin, Shimon] Hadassah Hebrew Univ, Med Ctr, Dept Bone Marrow Transplantat, Jerusalem, Israel; [Zcharia, Eyal] Hadassah Hebrew Univ, Med Ctr, Dept Oncol, Jerusalem, Israel; [Nagler, Arnon] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel; [Vlodavsky, Israel] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Bruce Rappaport Fac Med, Haifa, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Bitan, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Bone Marrow Transplantat, Jerusalem, Israel.	Vlodavsk@cc.huji.ac.il			Israel Science Foundation [549/06]; National Cancer Institute [RO1-CA106456]; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (grant 549/06); National Cancer Institute (RO1-CA106456). I. Vlodavsky is a Research Professor of the ICRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; ABBOUDJARROUS G, 2008, J BIOL CHEM; ANTIN JH, 1992, BLOOD, V80, P2964; Barrett AJ, 1997, STEM CELLS, V15, P248, DOI 10.1002/stem.150248; Ben-Zaken O, 2008, INT J BIOCHEM CELL B, V40, P530, DOI 10.1016/j.biocel.2007.09.003; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bitan M, 2008, DIABETES-METAB RES, V24, P413, DOI 10.1002/dmrr.868; BORTIN MM, 1973, SCIENCE, V179, P811, DOI 10.1126/science.179.4075.811; Casu B, 2002, BIOCHEMISTRY-US, V41, P10519, DOI 10.1021/bi020118n; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Ferro V, 2004, MINI-REV MED CHEM, V4, P693, DOI 10.2174/1389557043403729; FOWLER DH, 1994, BLOOD, V84, P3540; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Goker H, 2001, EXP HEMATOL, V29, P259, DOI 10.1016/S0301-472X(00)00677-9; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; HOLLER E, 1990, BLOOD, V75, P1011; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Ilan Y, 2000, BLOOD, V95, P3613, DOI 10.1182/blood.V95.11.3613.011k31_3613_3619; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kappel LW, 2009, BLOOD, V113, P945, DOI 10.1182/blood-2008-08-172155; Kim DH, 2008, BIOL BLOOD MARROW TR, V14, P1408, DOI 10.1016/j.bbmt.2008.09.022; Korngold R, 2003, BIOL BLOOD MARROW TR, V9, P292, DOI 10.1016/S1083-8791(03)00087-9; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Li RW, 2008, ARTHRITIS RHEUM, V58, P1590, DOI 10.1002/art.23489; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; McKenzie E, 2003, BIOCHEM J, V373, P423, DOI 10.1042/BJ20030318; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mielcarek M, 2003, BLOOD, V102, P756, DOI 10.1182/blood-2002-08-2628; Nagler A, 1998, CYTOKINES CELL MOL T, V4, P161; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Ostrovsky O, BLOOD, V115, P2319; PAN LY, 1995, BLOOD, V86, P4422, DOI 10.1182/blood.V86.12.4422.bloodjournal86124422; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Porgador A, 1997, P NATL ACAD SCI USA, V94, P13140, DOI 10.1073/pnas.94.24.13140; Pugatsch T, 1996, BONE MARROW TRANSPL, V17, P273; ROMAGNANI S, 1991, INT J CLIN LAB RES, V21, P152; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; ROY J, 1995, TRANSPLANTATION, V60, P343; RUS V, 1995, J IMMUNOL, V155, P2396; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; SLAVIN S, 1977, J EXP MED, V146, P34, DOI 10.1084/jem.146.1.34; Spiegel A, 2008, BLOOD, V111, P4934, DOI 10.1182/blood-2007-10-116145; Tanaka J, 1997, BONE MARROW TRANSPL, V19, P571, DOI 10.1038/sj.bmt.1700708; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1992, INVAS METAST, V12, P112; VLODAVSKY I, 1993, BASEMENT MEMBRANES C, P327; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weiss L, 2002, CYTOKINE, V19, P85, DOI 10.1006/cyto.2002.1956; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zecchina G, 2001, J HEMATOTH STEM CELL, V10, P769, DOI 10.1089/152581601317210863; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733	67	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2010	5	4							e10135	10.1371/journal.pone.0010135	http://dx.doi.org/10.1371/journal.pone.0010135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583VD	20419162	Green Published, Green Submitted, gold			2022-12-27	WOS:000276707100004
J	Azcutia, V; Abu-Taha, M; Romacho, T; Vazquez-Bella, M; Matesanz, N; Luscinskas, FW; Rodriguez-Manas, L; Sanz, MJ; Sanchez-Ferrer, CF; Peiro, C				Azcutia, Veronica; Abu-Taha, May; Romacho, Tania; Vazquez-Bella, Marta; Matesanz, Nuria; Luscinskas, Francis W.; Rodriguez-Manas, Leocadio; Jesus Sanz, Maria; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion			Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo	PLOS ONE			English	Article							FACTOR-KAPPA-B; LEUKOCYTE ADHESION; MOLECULE-1 VCAM-1; DIABETES-MELLITUS; HYPERGLYCEMIA; EXPRESSION; PROTEIN; ACTIVATION; ICAM-1; COMPLICATIONS	Background: Hyperglycemia is acknowledged as an independent risk factor for developing diabetes-associated atherosclerosis. At present, most therapeutic approaches are targeted at a tight glycemic control in diabetic patients, although this fails to prevent macrovascular complications of the disease. Indeed, it remains highly controversial whether or not the mere elevation of extracellular D-glucose can directly promote vascular inflammation, which favors early proatherosclerotic events. Methods and Findings: In the present work, increasing extracellular D-glucose from 5.5 to 22 mmol/L was neither sufficient to induce intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression, analyzed by flow cytometry, nor to promote leukocyte adhesion to human umbilical vein endothelial cells (HUVEC) in vitro, measured by flow chamber assays. Interestingly, the elevation of D-glucose levels potentiated ICAM-1 and VCAM-1 expression and leukocyte adhesion induced by a pro-inflammatory stimulus, such as interleukin (IL)-1 beta (5 ng/mL). In HUVEC, high D-glucose augmented the activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) and nuclear transcription factor-kappa B (NF-kappa B) elicited by IL-1 beta, measured by Western blot and electromobility shift assay (EMSA), respectively, but had no effect by itself. Both ERK 1/2 and NF-kappa B were necessary for VCAM-1 expression, but not for ICAM-1 expression. In vivo, leukocyte trafficking was evaluated in the rat mesenteric microcirculation by intravital microscopy. In accordance with the in vitro data, the acute intraperitoneal injection of D-glucose increased leukocyte rolling flux, adhesion and migration, but only when IL-1 beta was co-administered. Conclusions: These results indicate that the elevation of extracellular D-glucose levels is not sufficient to promote vascular inflammation, and they highlight the pivotal role of a pro-inflammatory environment in diabetes, as a critical factor conditioning the early pro-atherosclerotic actions of hyperglycemia.	[Azcutia, Veronica; Romacho, Tania; Vazquez-Bella, Marta; Matesanz, Nuria; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Madrid, Spain; [Abu-Taha, May; Jesus Sanz, Maria] Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain; [Luscinskas, Francis W.] Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Luscinskas, Francis W.] Harvard Univ, Sch Med, Boston, MA USA; [Rodriguez-Manas, Leocadio] Hosp Univ Getafe, Serv Geriatria, Madrid, Spain; [Rodriguez-Manas, Leocadio] Hosp Univ Getafe, Unidad Invest, Madrid, Spain	Autonomous University of Madrid; University of Valencia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Hospital Universitario de Getafe; Hospital Universitario de Getafe	Azcutia, V (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Madrid, Spain.	concha.peiro@uam.es	Azcutia, Veronica/A-7704-2017; Romacho, Tania/AAB-3306-2021; Romacho, Tania/B-2663-2016; Peiro, Concepcion/B-9545-2017; Azcutia, Veronica/AAW-2443-2020; Abu Taha, May/AAA-3460-2019	Azcutia, Veronica/0000-0003-2160-5175; Romacho, Tania/0000-0002-0962-7163; Romacho, Tania/0000-0002-0962-7163; Peiro, Concepcion/0000-0002-9690-7816; Azcutia, Veronica/0000-0003-2160-5175; Rodriguez-Manas, Leocadio/0000-0002-6551-1333; Sanz, Maria Jesus/0000-0002-8885-294X; Matesanz, Nuria/0000-0002-5756-3424; Luscinskas, Francis/0000-0001-7100-4103; Abu Taha, May/0000-0002-5862-4348	Ministerio de Educacion y Ciencia [SAF2008-00942, SAF2008-01291, SAF2008-03477]; Instituto de Salud Carlos III [RETICEF RD06/0013]; Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Farmacologia/Laboratorios Almirall; Universidad Autonoma de Madrid; Ministerio de Asuntos Exteriores; Ministerio de Ciencia e Innovacion	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Farmacologia/Laboratorios Almirall(Almirall); Universidad Autonoma de Madrid; Ministerio de Asuntos Exteriores; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from Ministerio de Educacion y Ciencia (SAF2008-00942, SAF2008-01291 and SAF2008-03477); Instituto de Salud Carlos III (RETICEF RD06/0013); Fundacion de Investigacion Medica Mutua Madrilena; and Sociedad Espanola de Farmacologia/Laboratorios Almirall. V.A., M.A.-T., and T.R. are recipients of grants from Universidad Autonoma de Madrid, Ministerio de Asuntos Exteriores, and Ministerio de Ciencia e Innovacion, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altannavch TS, 2004, PHYSIOL RES, V53, P77; Alvarez A, 2004, BLOOD, V104, P402, DOI 10.1182/blood-2003-08-2974; Booth G, 2001, AM J PHYSIOL-ENDOC M, V280, pE848, DOI 10.1152/ajpendo.2001.280.6.E848; Borch-Johnsen K, 1999, LANCET, V354, P617; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Dilley RJ, 2008, J HYPERTENS, V26, P396, DOI 10.1097/HJH.0b013e3282f4e35d; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fogelstrand L, 2004, DIABETOLOGIA, V47, P1948, DOI 10.1007/s00125-004-1553-x; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gao L, 2006, J PHARMACOL EXP THER, V318, P53, DOI 10.1124/jpet.106.101444; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Harari OA, 2006, CIRC RES, V98, P1134, DOI 10.1161/01.RES.0000220105.85182.28; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jager A, 2000, DIABETES, V49, P485, DOI 10.2337/diabetes.49.3.485; Kado S, 2001, LIFE SCI, V68, P727, DOI 10.1016/S0024-3205(00)00968-1; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kirpichnikov D, 2001, TRENDS ENDOCRIN MET, V12, P225, DOI 10.1016/S1043-2760(01)00391-5; Lafuente N, 2008, J HYPERTENS, V26, P478, DOI 10.1097/HJH.0b013e3282f331fb; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liu WL, 2000, AM J PHYSIOL-ENDOC M, V279, pE782, DOI 10.1152/ajpendo.2000.279.4.E782; Lu HF, 2004, ENDOCRINOLOGY, V145, P4934, DOI 10.1210/en.2004-0737; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marfella R, 2000, CIRCULATION, V101, P2247, DOI 10.1161/01.CIR.101.19.2247; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Munoz C, 1996, J IMMUNOL, V157, P3587; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Otsuki M, 1997, DIABETES, V46, P2096, DOI 10.2337/diabetes.46.12.2096; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Peiro C, 2003, BRIT J PHARMACOL, V140, P681, DOI 10.1038/sj.bjp.0705483; Peiro C, 2007, J HYPERTENS, V25, P2421, DOI 10.1097/HJH.0b013e3282f0143c; Piconi L, 2004, J THROMB HAEMOST, V2, P1453, DOI 10.1111/j.1538-7836.2004.00835.x; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Rasmussen LM, 2002, SCAND J CLIN LAB INV, V62, P485; Ray KK, 2007, EUR HEART J, V28, P806, DOI 10.1093/eurheartj/ehm010; Razani B, 2009, NAT MED, V15, P372, DOI 10.1038/nm0409-372; RIM JA, 1994, DIABETES, V43, P1103; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tschope C, 2005, FASEB J, V19, P2057, DOI 10.1096/fj.05-4095fje; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje; WEBER C, 1994, ARTERIOSCLER THROMB, V14, P1665, DOI 10.1161/01.ATV.14.10.1665; Xin XP, 2004, LAB INVEST, V84, P1451, DOI 10.1038/labinvest.3700178; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007	50	50	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10091	10.1371/journal.pone.0010091	http://dx.doi.org/10.1371/journal.pone.0010091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386708	Green Published, Green Submitted, gold			2022-12-27	WOS:000276482000019
J	Ramakrishna, M; Williams, LH; Boyle, SE; Bearfoot, JL; Sridhar, A; Speed, TP; Gorringe, KL; Campbell, IG				Ramakrishna, Manasa; Williams, Louise H.; Boyle, Samantha E.; Bearfoot, Jennifer L.; Sridhar, Anita; Speed, Terence P.; Gorringe, Kylie L.; Campbell, Ian G.			Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis	PLOS ONE			English	Article							PANCREATIC-CANCER; PROGNOSTIC MARKER; DNA; KINASE; AMPLIFICATION; ABNORMALITIES; ONCOGENE; PATTERNS; ECT2; PROTEINS	Ovarian cancer is a disease characterised by complex genomic rearrangements but the majority of the genes that are the target of these alterations remain unidentified. Cataloguing these target genes will provide useful insights into the disease etiology and may provide an opportunity to develop novel diagnostic and therapeutic interventions. High resolution genome wide copy number and matching expression data from 68 primary epithelial ovarian carcinomas of various histotypes was integrated to identify genes in regions of most frequent amplification with the strongest correlation with expression and copy number. Regions on chromosomes 3, 7, 8, and 20 were most frequently increased in copy number (>40% of samples). Within these regions, 703/1370 (51%) unique gene expression probesets were differentially expressed when samples with gain were compared to samples without gain. 30% of these differentially expressed probesets also showed a strong positive correlation (r >= 0.6) between expression and copy number. We also identified 21 regions of high amplitude copy number gain, in which 32 known protein coding genes showed a strong positive correlation between expression and copy number. Overall, our data validates previously known ovarian cancer genes, such as ERBB2, and also identified novel potential drivers such as MYNN, PUF60 and TPX2.	[Ramakrishna, Manasa; Boyle, Samantha E.; Bearfoot, Jennifer L.; Sridhar, Anita; Gorringe, Kylie L.; Campbell, Ian G.] Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia; [Ramakrishna, Manasa; Bearfoot, Jennifer L.; Gorringe, Kylie L.; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Williams, Louise H.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Ramakrishna, M (corresponding author), Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia.	kylie.gorringe@petermac.org	Gorringe, Kylie L/H-3264-2019; campbell, Ian G/F-6006-2011; Speed, Terence P/B-8085-2009	Gorringe, Kylie L/0000-0001-5681-2022; Speed, Terence P/0000-0002-5403-7998; Campbell, Ian/0000-0002-7773-4155	Cancer Council Victoria Postgraduate Scholarship; National Health and Medical Research Council (NHMRC) of Australia [566603]	Cancer Council Victoria Postgraduate Scholarship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	MR is supported by the Cancer Council Victoria Postgraduate Scholarship. This work is funded by a grant from the National Health and Medical Research Council (NHMRC) of Australia (ID: 566603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Alliel PM, 2000, BIOCHEM BIOPH RES CO, V273, P385, DOI 10.1006/bbrc.2000.2862; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bodmer W, 2003, GYNECOL ONCOL, V88, pS22, DOI 10.1006/gyno.2002.6678; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Fujimoto T, 2009, FEBS LETT, V583, P568, DOI 10.1016/j.febslet.2008.12.063; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; Gray JW, 2003, GYNECOL ONCOL, V88, pS16, DOI 10.1006/gyno.2002.6677; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Gyorffy B, 2008, INT J GYNECOL CANCER, V18, P1215, DOI 10.1111/j.1525-1438.2007.01169.x; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hyman E, 2002, CANCER RES, V62, P6240; Israeli O, 2005, CANCER GENET CYTOGEN, V160, P35, DOI 10.1016/j.cancergencyto.2004.11.011; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Katoh Y, 2009, J BIOL CHEM, V284, P27646, DOI 10.1074/jbc.M109.034884; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; Lukasiewicz KB, 2009, ENVIRON MOL MUTAGEN, V50, P602, DOI 10.1002/em.20533; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; R Core Team, 2018, R LANG ENV STAT COMP; Ran YL, 2008, CLIN CANCER RES, V14, P6538, DOI 10.1158/1078-0432.CCR-08-0476; Sakamoto K, 2008, J CELL SCI, V121, P1613, DOI 10.1242/jcs.023119; SANTARIUS T, NAT REV CANC, V10, P59; Storlazzi CT, 2003, GENE CHROMOSOME CANC, V37, P195, DOI 10.1002/gcc.10210; Taetle R, 1999, GENE CHROMOSOME CANC, V25, P290, DOI 10.1002/(SICI)1098-2264(199907)25:3<290::AID-GCC12>3.0.CO;2-G; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Watanabe T, 2002, JPN J CANCER RES, V93, P1114, DOI 10.1111/j.1349-7006.2002.tb01213.x; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang L, 2005, CANCER RES, V65, P925; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhao S, 2008, DNA CELL BIOL, V27, P159, DOI 10.1089/dna.2007.0634; Zorn KK, 2003, CLIN CANCER RES, V9, P4811; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	69	86	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e9983	10.1371/journal.pone.0009983	http://dx.doi.org/10.1371/journal.pone.0009983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386695	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482000004
J	Wang, Y; Coffey, RJ; Osheroff, N; Neufeld, KL				Wang, Yang; Coffey, Robert J.; Osheroff, Neil; Neufeld, Kristi L.			Topoisomerase II alpha Binding Domains of Adenomatous Polyposis Coli Influence Cell Cycle Progression and Aneuploidy	PLOS ONE			English	Article							HL-60 LEUKEMIA-CELLS; WNT SIGNALING PATHWAY; BETA-CATENIN; CHROMOSOMAL INSTABILITY; GENETIC INSTABILITY; REDUCED EXPRESSION; MESSENGER-RNA; APC; PROTEIN; RESISTANCE	Background: Truncating mutations in the tumor suppressor gene APC (Adenomatous Polyposis Coli) are thought to initiate the majority of colorectal cancers. The 15- and 20-amino acid repeat regions of APC bind beta-catenin and have been widely studied for their role in the negative regulation of canonical Wnt signaling. However, functions of APC in other important cellular processes, such as cell cycle control or aneuploidy, are only beginning to be studied. Our previous investigation implicated the 15- amino acid repeat region of APC (M2-APC) in the regulation of the G2/M cell cycle transition through interaction with topoisomerase II alpha (topo II alpha). Methodology/Principal Findings: We now demonstrate that the 20-amino acid repeat region of APC (M3-APC) also interacts with topo II alpha in colonic epithelial cells. Expression of M3-APC in cells with full-length endogenous APC causes cell accumulation in G2. However, cells with a mutated topo II alpha isoform and lacking topo II beta did not arrest, suggesting that the cellular consequence of M2- or M3-APC expression depends on functional topoisomerase II. Both purified recombinant M2- and M3-APC significantly enhanced the activity of topo II alpha. Of note, although M3-APC can bind beta-catenin, the G2 arrest did not correlate with beta-catenin expression or activity, similar to what was seen with M2- APC. More importantly, expression of either M2- or M3-APC also led to increased aneuploidy in cells with full-length endogenous APC but not in cells with truncated endogenous APC that includes the M2- APC region. Conclusions/Significance: Together, our data establish that the 20-amino acid repeat region of APC interacts with topo II alpha to enhance its activity in vitro, and leads to G2 cell cycle accumulation and aneuploidy when expressed in cells containing full-length APC. These findings provide an additional explanation for the aneuploidy associated with many colon cancers that possess truncated APC.	[Wang, Yang; Neufeld, Kristi L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	University of Kansas; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Wang, Y (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	klneuf@ku.edu	Wang, Yang/O-2300-2013	Wang, Yang/0000-0003-2801-8416; Neufeld, Kristi/0000-0003-3653-9385	NIH [RO1 CA10922]; GI Special Program of Research Excellence [CA95103]; NCI [RO1 CA46413, GM33944]; Higuchi Biosciences Center; J.R. Inez Jay Award; KUCC Pilot Project Award; NATIONAL CANCER INSTITUTE [R01CA046413, R01CA109220, P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GI Special Program of Research Excellence; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Higuchi Biosciences Center; J.R. Inez Jay Award; KUCC Pilot Project Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by NIH RO1 CA10922 (Y. W. and K. L. N.), GI Special Program of Research Excellence CA95103 (R. J. C), NCI RO1 CA46413 (R. J. C), GM33944 (N. O.), Higuchi Biosciences Center J.R. & Inez Jay Award (Y. W. and K. L. N.), and the KUCC Pilot Project Award (Y. W. and K. L. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bhattacharjee RN, 1996, BIOCHEM BIOPH RES CO, V220, P192, DOI 10.1006/bbrc.1996.0379; Cardoso J, 2006, CANCER RES, V66, P2514, DOI 10.1158/0008-5472.CAN-05-2407; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fortune JM, 2000, METH MOL B, V95, P275; GORBSKY GJ, 1994, CANCER RES, V54, P1042; Grue P, 1998, J BIOL CHEM, V273, P33660, DOI 10.1074/jbc.273.50.33660; HARKER WG, 1989, CANCER RES, V49, P4542; HARKER WG, 1991, BIOCHEMISTRY-US, V30, P9953, DOI 10.1021/bi00105a020; HARKER WG, 1995, CANCER RES, V55, P4962; HARKER WG, 1995, CANCER RES, V55, P1707; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Heinen CD, 2002, GASTROENTEROLOGY, V123, P751, DOI 10.1053/gast.2002.35382; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Jaiswal AS, 2004, J CELL BIOCHEM, V93, P345, DOI 10.1002/jcb.20156; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kingma PS, 1997, BIOCHEMISTRY-US, V36, P5934, DOI 10.1021/bi970507v; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kleivi K, 2004, CANCER GENET CYTOGEN, V155, P119, DOI 10.1016/j.cancergencyto.2004.03.014; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; *NCI, 2001, NCI NCBIS SKY M FISH; Neufeld KL, 2009, ADV EXP MED BIOL, V656, P13, DOI 10.1007/978-1-4419-1145-2_2; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; QUIRKE P, 1988, GUT, V29, P603, DOI 10.1136/gut.29.5.603; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; Sugimoto K, 2008, ONCOGENE, V27, P3091, DOI 10.1038/sj.onc.1210978; SVENDSEN LB, 1993, DAN MED BULL, V40, P546; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang Y, 2008, MOL BIOL CELL, V19, P4076, DOI 10.1091/mbc.E07-12-1296; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2010	5	3							e9994	10.1371/journal.pone.0009994	http://dx.doi.org/10.1371/journal.pone.0009994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AW	20368985	gold, Green Published, Green Submitted			2022-12-27	WOS:000276419900002
J	Schulze, M; Nitsche, A; Schweiger, B; Biere, B				Schulze, Martin; Nitsche, Andreas; Schweiger, Brunhilde; Biere, Barbara			Diagnostic Approach for the Differentiation of the Pandemic Influenza A(H1N1)v Virus from Recent Human Influenza Viruses by Real-Time PCR	PLOS ONE			English	Article							H1N1; 1ST	Background: The current spread of pandemic influenza A(H1N1)v virus necessitates an intensified surveillance of influenza virus infections worldwide. So far, in many laboratories routine diagnostics were limited to generic influenza virus detection only. To provide interested laboratories with real-time PCR assays for type and subtype identification, we present a bundle of PCR assays with which any human influenza A and B virus can be easily identified, including assays for the detection of the pandemic A(H1N1)v virus. Principal Findings: The assays show optimal performance characteristics in their validation on plasmids containing the respective assay target sequences. All assays have furthermore been applied to several thousand clinical samples since 2007 (assays for seasonal influenza) and April 2009 (pandemic influenza assays), respectively, and showed excellent results also on clinical material. Conclusions: We consider the presented assays to be well suited for the detection and subtyping of circulating influenza viruses.	[Schulze, Martin; Schweiger, Brunhilde; Biere, Barbara] Fachgebiet 17 Influenza Respirator Viren, Robert Koch Inst, Berlin, Germany; [Nitsche, Andreas] Zentrum Biol Sicherheit 1, Robert Koch Inst, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Schulze, M (corresponding author), Fachgebiet 17 Influenza Respirator Viren, Robert Koch Inst, Berlin, Germany.	biereb@rki.de		Nitsche, Andreas/0000-0001-8185-3176	German Federal Ministry of Health; Federal Ministry of Food, Agriculture and Consumer Protection; Federal Ministry of Education and Research	German Federal Ministry of Health; Federal Ministry of Food, Agriculture and Consumer Protection; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was in part supported by the German "Forschungssofortprogramm Influenza" of the German Federal Ministry of Health (http://www.bmg.bund.de); the Federal Ministry of Food, Agriculture and Consumer Protection (http://www.bmelv.de); and the Federal Ministry of Education and Research (http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MG, 2009, EUROSURVEILLANCE, V14, P6; BIERE B, 2010, J CLIN MICR IN PRESS; Biere B, 2009, LANCET INFECT DIS, V9, P721, DOI 10.1016/S1473-3099(09)70301-9; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Cretikos MA, 2009, EUROSURVEILLANCE, V14, P28; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Fielding JE, 2009, EUROSURVEILLANCE, V14, P37; Gilsdorf A, 2009, EUROSURVEILLANCE, V14, P2; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; JIANG T, 2009, J VIROL METHODS, V6, P6; Jonges M, 2009, ANTIVIR RES, V83, P290, DOI 10.1016/j.antiviral.2009.07.003; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Neumaier M, 1998, CLIN CHEM, V44, P12; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pabbaraju K, 2009, J CLIN MICROBIOL, V47, P3454, DOI 10.1128/JCM.01103-09; Poon LLM, 2009, CLIN CHEM, V55, P1555, DOI 10.1373/clinchem.2009.130229; Schout D, 2009, CLINICS, V64, P1025, DOI 10.1590/S1807-59322009001000014; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Thouillot F, 2009, EUROSURVEILLANCE, V14, P7; *WHO, 2010, INFL SEAS FACT SHEET; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	22	59	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2010	5	3							e9966	10.1371/journal.pone.0009966	http://dx.doi.org/10.1371/journal.pone.0009966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580AG	20376359	gold, Green Submitted, Green Published			2022-12-27	WOS:000276418200040
J	Gu, A; Zhang, ZF; Zhang, N; Tsark, W; Shively, JE				Gu, Angel; Zhang, Zhifang; Zhang, Nan; Tsark, Walter; Shively, John E.			Generation of Human CEACAM1 Transgenic Mice and Binding of Neisseria Opa Protein to Their Neutrophils	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; SHORT CYTOPLASMIC DOMAIN; CARCINOEMBRYONIC ANTIGEN; BILIARY GLYCOPROTEIN; EPITHELIAL-CELLS; MUTATIONAL ANALYSIS; LUMEN FORMATION; KEY RESIDUES; GROWTH-FACTOR; IN-VIVO	Background: Human CEACAM1 is a cell-cell adhesion molecule with multiple functions including insulin clearance in the liver, vasculogenesis in endothelial cells, lumen formation in the mammary gland, and binding of certain human pathogens. Principal Findings: Three genomic BAC clones containing the human CEACAM1 gene were microinjected into pronuclei of fertilized FVB mouse oocytes. The embryos were implanted in the oviducts of pseudopregnant females and allowed to develop to term. DNA from newborn mice was evaluated by PCR for the presence of the human CEACAM1 gene. Feces of the PCR positive offspring screened for expression of human CEACAM1. Using this assay, one out of five PCR positive lines was positive for human CEACAM1 expression and showed stable transmission to the F1 generation with the expected transmission frequency (0.5) for heterozygotes. Liver, lung, intestine, kidney, mammary gland, and prostate were strongly positive for the dual expression of both murine and human CEACAM1 and mimic that seen in human tissue. Peripheral blood and bone marrow granulocytes stained strongly for human CEACAM1 and bound Neisseria Opa proteins similar to that in human neutrophils. Conclusion: These transgenic animals may serve as a model for the binding of human pathogens to human CEACAM1.	[Gu, Angel; Zhang, Zhifang; Zhang, Nan; Shively, John E.] Beckman Res Inst City Hope, Dept Immunol, Duarte, CA USA; [Tsark, Walter] Beckman Res Inst City Hope, Dept Biol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Gu, A (corresponding author), Beckman Res Inst City Hope, Dept Immunol, Duarte, CA USA.	jshively@coh.org		Montoro, Daniel/0000-0002-6222-2149	National Institutes of Health (NIH) [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) CA84202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen ZG, 2008, J IMMUNOL, V180, P6085, DOI 10.4049/jimmunol.180.9.6085; Clarke P, 1998, CANCER RES, V58, P1469; COUTELIER JP, 1994, EUR J IMMUNOL, V24, P1383, DOI 10.1002/eji.1830240622; Daniels E, 1996, DEV DYNAM, V206, P272, DOI 10.1002/(SICI)1097-0177(199607)206:3<272::AID-AJA5>3.3.CO;2-U; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Godfraind C, 1998, ADV EXP MED BIOL, V440, P569; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; HINODA Y, 1990, INT J CANCER, V45, P875, DOI 10.1002/ijc.2910450516; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huang J, 1999, J CELL SCI, V112, P4193; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; Jin L, 2008, EXP BIOL MED, V233, P849, DOI 10.3181/0712-RM-352; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; Lobo EO, 2009, J LEUKOCYTE BIOL, V86, P205, DOI 10.1189/jlb.0109037; Nagaishi T, 2008, MUCOSAL IMMUNOL, V1, pS39, DOI 10.1038/mi.2008.50; Nagaishi T, 2006, ANN NY ACAD SCI, V1072, P155, DOI 10.1196/annals.1326.004; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Phan D, 2004, CANCER RES, V64, P3072, DOI 10.1158/0008-5472.CAN-03-3730; Phan D, 2001, MOL CELL ENDOCRINOL, V184, P115, DOI 10.1016/S0303-7207(01)00638-4; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; ROBBINS J, 1991, GENOMICS, V10, P583, DOI 10.1016/0888-7543(91)90439-L; Robitaille J, 1999, EUR J BIOCHEM, V264, P534, DOI 10.1046/j.1432-1327.1999.00660.x; Sadekova S, 2000, MOL BIOL CELL, V11, P65, DOI 10.1091/mbc.11.1.65; SCHEDL A, 1993, NUCLEIC ACIDS RES, V21, P4783, DOI 10.1093/nar/21.20.4783; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Singer BB, 2005, EUR J IMMUNOL, V35, P1949, DOI 10.1002/eji.200425691; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; SVENBERG T, 1979, CLIN EXP IMMUNOL, V36, P436; Villullas S, 2007, CELL MICROBIOL, V9, P329, DOI 10.1111/j.1462-5822.2006.00789.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; WAGENER C, 1983, J IMMUNOL, V130, P2308; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Zhang ZF, 2008, J LEUKOCYTE BIOL, V84, P780, DOI 10.1189/jlb.0208086	51	205	208	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2010	5	4							e10067	10.1371/journal.pone.0010067	http://dx.doi.org/10.1371/journal.pone.0010067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WU	20404914	gold, Green Published, Green Submitted			2022-12-27	WOS:000276482100004
J	Del Genio, CI; Kim, H; Toroczkai, Z; Bassler, KE				Del Genio, Charo I.; Kim, Hyunju; Toroczkai, Zoltan; Bassler, Kevin E.			Efficient and Exact Sampling of Simple Graphs with Given Arbitrary Degree Sequence	PLOS ONE			English	Article								Uniform sampling from graphical realizations of a given degree sequence is a fundamental component in simulation-based measurements of network observables, with applications ranging from epidemics, through social networks to Internet modeling. Existing graph sampling methods are either link-swap based (Markov-Chain Monte Carlo algorithms) or stub-matching based (the Configuration Model). Both types are ill-controlled, with typically unknown mixing times for link-swap methods and uncontrolled rejections for the Configuration Model. Here we propose an efficient, polynomial time algorithm that generates statistically independent graph samples with a given, arbitrary, degree sequence. The algorithm provides a weight associated with each sample, allowing the observable to be measured either uniformly over the graph ensemble, or, alternatively, with a desired distribution. Unlike other algorithms, this method always produces a sample, without backtracking or rejections. Using a central limit theorem-based reasoning, we argue, that for large N, and for degree sequences admitting many realizations, the sample weights are expected to have a lognormal distribution. As examples, we apply our algorithm to generate networks with degree sequences drawn from power-law distributions and from binomial distributions.	[Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Dept Phys, Houston, TX 77004 USA; [Del Genio, Charo I.; Bassler, Kevin E.] Univ Houston, Texas Ctr Superconduct TcSUH, Houston, TX USA; [Kim, Hyunju; Toroczkai, Zoltan] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat ICeN, Notre Dame, IN 46556 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Notre Dame	Del Genio, CI (corresponding author), Univ Houston, Dept Phys, Houston, TX 77004 USA.	Kevin.E.Bassler@mail.uh.edu	Toroczkai, Zoltan/AAC-8446-2019; del Genio, Charo I/F-7249-2010	Toroczkai, Zoltan/0000-0002-6602-2849; del Genio, Charo I/0000-0001-9958-017X	National Science Foundation (NSF) [DMR-0908286]; Norman Hackerman Advanced Research Program [95921]; NSF [BCS-0826958]; Defense Threat Reduction Agency (DTRA) [HDTRA 201473-35045]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Norman Hackerman Advanced Research Program; NSF(National Science Foundation (NSF)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	CIDG and KEB are supported by the National Science Foundation (NSF) through grant DMR-0908286 and by the Norman Hackerman Advanced Research Program through grant 95921. HK and ZT are supported in part by the NSF BCS-0826958 and by the Defense Threat Reduction Agency (DTRA) through HDTRA 201473-35045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Bianconi G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016114; Bianconi G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036114; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Burda Z, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046118; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; Cooper C, 2007, COMB PROBAB COMPUT, V16, P557, DOI 10.1017/S0963548306007978; ERDOS P, 1960, MAT LAPOK, V11, P477; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Havel V., 1955, CASOPIS PROPESTOV MA, V80, P477, DOI DOI 10.21136/CPM.1955.108220; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kim H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/39/392001; KOREN M, 1976, J COMB THEORY B, V21, P235, DOI 10.1016/S0095-8956(76)80007-X; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman M., 1999, MONTE CARLO METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; TAYLOR R, 1982, SIAM J ALGEBRA DISCR, V3, P114, DOI 10.1137/0603011; Tripathi A, 2003, DISCRETE MATH, V265, P417, DOI 10.1016/S0012-365X(02)00886-5; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45	28	113	113	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2010	5	4							e10012	10.1371/journal.pone.0010012	http://dx.doi.org/10.1371/journal.pone.0010012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580WT	20386694	Green Submitted, Green Published, gold			2022-12-27	WOS:000276482000005
J	Li, K; Wang, R; Lozada, E; Fan, W; Orren, DK; Luo, JY				Li, Kai; Wang, Rui; Lozada, Enerlyn; Fan, Wei; Orren, David K.; Luo, Jianyuan			Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; DNA-REPAIR; RECQ HELICASES; SYNDROME GENE; TRANSCRIPTION; DAMAGE; DEACETYLATION; LOCALIZATION; COACTIVATOR; MUTATIONS	Background: WRN is a multi-functional protein involving DNA replication, recombination and repair. WRN acetylation has been demonstrated playing an important role in response to DNA damage. We previously found that WRN acetylation can regulate its enzymatic activities and nuclear distribution. Methodology/Principal Finding: Here, we investigated the factors involved in WRN acetylation and found that CBP and p300 are the only major acetyltransferases for WRN acetylation. We further identified 6 lysine residues in WRN that are subject to acetylation. Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect. CBP dramatically increases the half-life of wild type WRN, while mutation of these 6 lysine residues (WRN-6KR) abrogates this increase. We further found that WRN stability is regulated by the ubiquitination pathway and WRN acetylation by CBP significantly reduces its ubiquitination. Importantly, we found that WRN is strongly acetylated and stabilized in response to mitomycin C (MMC) treatment. H1299 cells stably expressing WRN-6KR, which mimics unacetylated WRN, display significantly higher MMC sensitivity compared with the cells expressing wild-type WRN. Conclusion/Significance: Taken together, these data demonstrate that WRN acetylation regulates its stability and has significant implications regarding the role of acetylation on WRN function in response to DNA damage.	[Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA; [Lozada, Enerlyn; Orren, David K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Kentucky	Li, K (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	Jianyuan.luo@umassmed.edu	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Institutes of Health National Institute on Aging (NIH/NIA) [R01AG026534, R01AG027258]; NATIONAL CANCER INSTITUTE [R01CA113371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026534, R01AG027258] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health National Institute on Aging (NIH/NIA) grant R01AG026534 to J. Luo and R01AG027258 to D. Orren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Karmakar P, 2005, MECH AGEING DEV, V126, P1146, DOI 10.1016/j.mad.2005.06.004; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kusumoto R, 2007, MECH AGEING DEV, V128, P50, DOI 10.1016/j.mad.2006.11.010; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; MARTIN GM, 1970, LAB INVEST, V23, P86; Muftuoglu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001918; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; STEFANINI M, 1989, MUTAT RES, V219, P179, DOI 10.1016/0921-8734(89)90013-1; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	27	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10341	10.1371/journal.pone.0010341	http://dx.doi.org/10.1371/journal.pone.0010341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20808827	Green Published, Green Submitted, gold			2022-12-27	WOS:000277079300021
